PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Aydin, Z; Marcussen, T; Ertekin, AS; Oxelman, B				Aydin, Zeynep; Marcussen, Thomas; Ertekin, Alaattin Selcuk; Oxelman, Bengt			Marginal Likelihood Estimate Comparisons to Obtain Optimal Species Delimitations in Silene sect. Cryptoneurae (Caryophyllaceae)	PLOS ONE			English	Article							BAYESIAN-INFERENCE; MOLECULAR CLOCKS; CRYPTIC DIVERSITY; MULTILOCUS DATA; GENE TREES; COALESCENT; PHYLOGENY; EVOLUTION; ACCURACY; EXAMPLE	Coalescent-based inference of phylogenetic relationships among species takes into account gene tree incongruence due to incomplete lineage sorting, but for such methods to make sense species have to be correctly delimited. Because alternative assignments of individuals to species result in different parametric models, model selection methods can be applied to optimise model of species classification. In a Bayesian framework, Bayes factors (BF), based on marginal likelihood estimates, can be used to test a range of possible classifications for the group under study. Here, we explore BF and the Akaike Information Criterion (AIC) to discriminate between different species classifications in the flowering plant lineage Silene sect. Cryptoneurae (Caryophyllaceae). We estimated marginal likelihoods for different species classification models via the Path Sampling (PS), Stepping Stone sampling (SS), and Harmonic Mean Estimator (HME) methods implemented in BEAST. To select among alternative species classification models a posterior simulation-based analog of the AIC through Markov chain Monte Carlo analysis (AICM) was also performed. The results are compared to outcomes from the software BP&P. Our results agree with another recent study that marginal likelihood estimates from PS and SS methods are useful for comparing different species classifications, and strongly support the recognition of the newly described species S. ertekinii.	[Aydin, Zeynep; Marcussen, Thomas; Oxelman, Bengt] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Aydin, Zeynep; Ertekin, Alaattin Selcuk] Dicle Univ, Fac Sci, Dept Biol, Diyarbakir, Turkey	University of Gothenburg; Dicle University	Aydin, Z (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	ilgimd@gmail.com	Marcussen, Thomas/I-7768-2019; Toprak, Zeynep/AAI-9272-2021	Toprak, Zeynep/0000-0002-2103-4141; Marcussen, Thomas/0000-0002-1960-9508	Swedish Research Council [2012-3719]; Lundgrenska Stiftelserna; Dicle University Scientific Research Centre [10-FF-112]; Turkish Higher Education Board	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lundgrenska Stiftelserna; Dicle University Scientific Research Centre(Dicle University); Turkish Higher Education Board(Ministry of National Education - Turkey)	This work was supported by the Swedish Research Council (grant no: 2012-3719), Lundgrenska Stiftelserna (http://www.wmlundgren.se/), Dicle University Scientific Research Centre (project no: 10-FF-112), and Turkish Higher Education Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin Z, 2014, PHYTOTAXA IN PRESS; Baele G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-85; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bernasconi G, 2009, HEREDITY, V103, P5, DOI 10.1038/hdy.2009.34; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Carlstrom A., 1986, WILLDENOWIA, V16, P73; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; CHOWDHURI P. K., 1957, NOTES ROY BOT GARDEN EDINBURGH, V22, P221; Coode M. J. E., 1967, FLORA TURKEY E AEGEA, P179; Davalos LM, 2009, MOL PHYLOGENET EVOL, V53, P234, DOI 10.1016/j.ympev.2009.06.003; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Desfeux C, 1996, CR ACAD SCI III-VIE, V319, P351; Desfeux C, 1996, P ROY SOC B-BIOL SCI, V263, P409, DOI 10.1098/rspb.1996.0062; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Egge JJD, 2006, ZOOL SCR, V35, P581, DOI 10.1111/j.1463-6409.2006.00247.x; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Erixon P, 2008, MOL PHYLOGENET EVOL, V48, P313, DOI 10.1016/j.ympev.2008.04.015; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Gelman A, 1998, STAT SCI, V13, P163; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Harrington RC, 2012, SYST BIOL, V61, P63, DOI 10.1093/sysbio/syr077; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kubatko LS, 2011, SYST BIOL, V60, P393, DOI 10.1093/sysbio/syr011; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Mayr E., 1942, P1; Minin VN, 2005, BIOINFORMATICS, V21, P3034, DOI 10.1093/bioinformatics/bti459; Muller Kai, 2005, Appl Bioinformatics, V4, P65; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; OXELMAN B, 1995, TAXON, V44, P525, DOI 10.2307/1223498; Oxelman B, 1997, FLORA HELLENICA, V1, P248; Oxelman B., 2013, SILENEAE TAXONOMY SY; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067729; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Popp M, 2004, SYST BIOL, V53, P914, DOI 10.1080/10635150490888840; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Raftery AE, 2007, BAYESIAN STAT, V8, P1; Rambaut A, 2008, TRACER V1 4; Rannala B, 2003, GENETICS, V164, P1645; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Scheen AC, 2012, MOL ECOL RESOUR, V12, P128, DOI 10.1111/j.1755-0998.2011.03070.x; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sloan DB, 2010, GENETICS, V185, P1369, DOI 10.1534/genetics.110.118000; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	73	31	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106990	10.1371/journal.pone.0106990	http://dx.doi.org/10.1371/journal.pone.0106990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216034	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300034
J	Meng, XW; Hashiya, K				Meng, Xianwei; Hashiya, Kazuhide			Pointing Behavior in Infants Reflects the Communication Partner's Attentional and Knowledge States: A Possible Case of Spontaneous Informing	PLOS ONE			English	Article							SHARED EXPERIENCE; GAZE; COGNITION; MECHANISMS; EVOLUTION; CONSCIOUSNESS; CHILDREN; BELIEFS; OBJECTS; COMMON	Inferring the epistemic states of others is considered to be an essential requirement for humans to communicate; however, the developmental trajectory of this ability is unclear. The aim of the current study was to determine developmental trends in this ability by using pointing behavior as a dependent measure. Infants aged 13 to 18 months (n = 32, 16 females) participated in the study. The experiment consisted of two phases. In the Shared Experience Phase, both the participant and the experimenter experienced (played with) an object, and the participant experienced a second object while the experimenter was absent. In the Pointing Phase, the participant was seated on his/her mother's lap, facing the experimenter, and the same two objects from the Shared Experience Phase were presented side-by-side behind the experimenter. The participants' spontaneous pointing was analyzed from video footage. While the analysis of the Shared Experience Phase suggested that there was no significant difference in the duration of the participants' visual attention to the two objects, the participants pointed more frequently to the object that could be considered "new'' for the experimenter (in Experiment 1). This selective pointing was not observed when the experimenter could be considered unfamiliar with both of the objects (in Experiment 2). These findings suggest that infants in this age group spontaneously point, presumably to inform about an object, reflecting the partner's attentional and knowledge states.	[Meng, Xianwei] Kyushu Univ, Grad Sch Human Environm Studies, Fukuoka 812, Japan; [Hashiya, Kazuhide] Kyushu Univ, Fac Human Environm Studies, Fukuoka 812, Japan	Kyushu University; Kyushu University	Meng, XW (corresponding author), Kyushu Univ, Grad Sch Human Environm Studies, Fukuoka 812, Japan.	mokeni1211@gmail.com		Meng, Xianwei/0000-0002-7873-7518	Ministry of Education, Culture, Sports, Science, and Technology, Japan [4501]; JSPS grant of Program for Leading Graduate Schools [P02]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS grant of Program for Leading Graduate Schools	This work is supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Empathetic Systems'' (No. 4501) of The Ministry of Education, Culture, Sports, Science, and Technology, Japan. (http://empatheticsystems.jp/index-e.html), and is partly supported by the JSPS grant of Program for Leading Graduate Schools P02 (http://ketsudan.kyushu-u.ac.jp/?ing=e&ing=e). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Ando J, 2012, CARLS SERIES ADV STU, P147; BATES E, 1975, MERRILL PALMER QUART, V21, P205; Bates E, 1979, EMERGENCE SYMBOLS CO, P69; Begus K, 2012, DEVELOPMENTAL SCI, V15, P611, DOI 10.1111/j.1467-7687.2012.01160.x; Behne T, 2005, DEV PSYCHOL, V41, P328, DOI 10.1037/0012-1649.41.2.328; BENNETT J, 1978, BEHAV BRAIN SCI, V1, P557, DOI 10.1017/S0140525X00076573; Brooks R, 2002, DEV PSYCHOL, V38, P958, DOI 10.1037//0012-1649.38.6.958; Bruner J, 1983, CHILDS TALK LEARNING; BUTTERWORTH G, 1991, BRIT J DEV PSYCHOL, V9, P55, DOI 10.1111/j.2044-835X.1991.tb00862.x; CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; Caron AJ, 2002, BRIT J DEV PSYCHOL, V20, P225, DOI 10.1348/026151002166424; Clark HerbertH., 1981, ELEMENTS DISCOURSE U, P10; Csibra G, 2008, BRIT J DEV PSYCHOL, V26, P1, DOI 10.1348/026151007X185987; Csibra G, 2011, PHILOS T R SOC B, V366, P1149, DOI 10.1098/rstb.2010.0319; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; D'Entremont B, 2007, CHILD DEV, V78, P723, DOI 10.1111/j.1467-8624.2007.01026.x; DENNETT DC, 1978, BEHAV BRAIN SCI, V1, P568, DOI 10.1017/S0140525X00076664; Doherty MJ, 1999, COGNITIVE DEV, V14, P549, DOI 10.1016/S0885-2014(99)00019-2; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Fogarty L, 2011, EVOLUTION, V65, P2760, DOI 10.1111/j.1558-5646.2011.01370.x; Franco F, 1996, J CHILD LANG, V23, P307, DOI 10.1017/S0305000900008813; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; HARMAN G, 1978, BEHAV BRAIN SCI, V1, P576, DOI 10.1017/S0140525X00076743; Harris PL, 2006, CHILD DEV, V77, P505, DOI 10.1111/j.1467-8624.2006.00886.x; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kato-Shimizu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070915; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Kobayashi H, 2011, EVOL HUM BEHAV, V32, P157, DOI 10.1016/j.evolhumbehav.2010.08.003; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Kuroki M, 2007, INFANT BEHAV DEV, V30, P606, DOI 10.1016/j.infbeh.2007.03.008; Lee BPH, 2001, J PRAGMATICS, V33, P21, DOI 10.1016/S0378-2166(99)00128-9; Legerstee M, 2003, COGNITIVE DEV, V18, P91, DOI 10.1016/S0885-2014(02)00165-X; Liebal K, 2010, INFANCY, V15, P545, DOI 10.1111/j.1532-7078.2009.00028.x; Liebal K, 2009, DEVELOPMENTAL SCI, V12, P264, DOI 10.1111/j.1467-7687.2008.00758.x; Liszkowski U, 2004, DEVELOPMENTAL SCI, V7, P297, DOI 10.1111/j.1467-7687.2004.00349.x; Liszkowski U, 2008, COGNITION, V108, P732, DOI 10.1016/j.cognition.2008.06.013; Liszkowski U, 2006, J COGN DEV, V7, P173, DOI 10.1207/s15327647jcd0702_2; Liszkowski U, 2007, J CHILD LANG, V34, P1, DOI 10.1017/S0305000906007689; Liszkowski U, 2007, DEVELOPMENTAL SCI, V10, P1, DOI 10.1111/j.1467-7687.2006.00552.x; Lucas AJ, 2010, HUM DEV, V53, P167, DOI 10.1159/000320044; Meristo M, 2013, COGNITION, V129, P102, DOI 10.1016/j.cognition.2013.06.006; Mifune N, 2010, EVOL HUM BEHAV, V31, P109, DOI 10.1016/j.evolhumbehav.2009.09.004; Moll H, 2004, DEVELOPMENTAL SCI, V7, pF1, DOI 10.1111/j.1467-7687.2004.00315.x; Moll H, 2007, DEVELOPMENTAL SCI, V10, P826, DOI 10.1111/j.1467-7687.2007.00615.x; Molnar-Szakacs I, 2011, J ECON BEHAV ORGAN, V77, P76, DOI 10.1016/j.jebo.2010.02.019; Mundy P, 2003, DEVELOPMENTAL SCI, V6, P48, DOI 10.1111/1467-7687.00253; Mundy P, 1996, EMOTIONAL DEVELOPMENT IN ATYPICAL CHILDREN, P65; Murakami T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00523; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Saylor MM, 2007, DEV PSYCHOL, V43, P696, DOI 10.1037/0012-1649.43.3.696; Seibert J. M., 1982, INFANT MENT HEALTH J, V3, P244, DOI [10.1002/1097-0355(198224)3:43.0.CO;2-R, DOI 10.1002/1097-0355(198224)3:43.0.CO;2-R, DOI 10.1002/1097-0355(198224)3:4<244::AID-IMHJ2280030406>3.0.CO;2-R]; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Southgate V, 2007, CHILD DEV, V78, P735, DOI 10.1111/j.1467-8624.2007.01028.x; Southgate V, 2010, DEVELOPMENTAL SCI, V13, P907, DOI 10.1111/j.1467-7687.2009.00946.x; SPERBER D, 1987, BEHAV BRAIN SCI, V10, P697, DOI 10.1017/S0140525X00055345; Sperber D, 1986, RELEVANCE COMMUNICAT, P15; Thornton A, 2008, ANIM BEHAV, V75, P1823, DOI [10.1016/j.anbehav.2007.12.014, 10.1111/j.1558-5646.2011.01370.x]; Tomasello M, 2003, DEV PSYCHOL, V39, P906, DOI 10.1037/0012-1649.39.5.906; Tomasello M, 2007, CHILD DEV, V78, P705, DOI 10.1111/j.1467-8624.2007.01025.x; Tomasello M, 2008, JEAN NICOD LECT, P1; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Warneken F, 2009, BRIT J PSYCHOL, V100, P455, DOI 10.1348/000712608X379061	66	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107579	10.1371/journal.pone.0107579	http://dx.doi.org/10.1371/journal.pone.0107579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1UA	25211279	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900086
J	Parsanejad, M; Bourquard, N; Qu, DB; Zhang, Y; Huang, E; Rousseaux, MWC; Aleyasin, H; Irrcher, I; Callaghan, S; Vaillant, DC; Kim, RH; Slack, RS; Mak, TW; Reddy, ST; Figeys, D; Park, DS				Parsanejad, Mohammad; Bourquard, Noam; Qu, Dianbo; Zhang, Yi; Huang, En; Rousseaux, Maxime W. C.; Aleyasin, Hossein; Irrcher, Isabella; Callaghan, Steve; Vaillant, Dominique C.; Kim, Raymond H.; Slack, Ruth S.; Mak, Tak W.; Reddy, Srinivasa T.; Figeys, Daniel; Park, David S.			DJ-1 Interacts with and Regulates Paraoxonase-2, an Enzyme Critical for Neuronal Survival in Response to Oxidative Stress	PLOS ONE			English	Article							PROTEIN DJ-1; MITOCHONDRIAL LOCALIZATION; CLUSTER POLYMORPHISMS; DOPAMINERGIC-NEURONS; GENE POLYMORPHISMS; PON2 EXPRESSION; ALPHA-SYNUCLEIN; CELL-CYCLE; DISEASE; PATHWAY	Loss-of-function mutations in DJ-1 (PARK7) gene account for about 1% of all familial Parkinson's disease (PD). While its physiological function(s) are not completely clear, DJ-1 protects neurons against oxidative stress in both in vitro and in vivo models of PD. The molecular mechanism(s) through which DJ-1 alleviates oxidative stress-mediated damage remains elusive. In this study, we identified Paraoxonase-2 (PON2) as an interacting target of DJ-1. PON2 activity is elevated in response to oxidative stress and DJ-1 is crucial for this response. Importantly, we showed that PON2 deficiency hypersensitizes neurons to oxidative stress induced by MPP+ (1-methyl-4-phenylpyridinium). Conversely, over-expression of PON2 protects neurons in this death paradigm. Interestingly, PON2 effectively rescues DJ-1 deficiency-mediated hypersensitivity to oxidative stress. Taken together, our data suggest a model by which DJ-1 exerts its antioxidant activities, at least partly through regulation of PON2.	[Parsanejad, Mohammad; Qu, Dianbo; Zhang, Yi; Huang, En; Rousseaux, Maxime W. C.; Aleyasin, Hossein; Irrcher, Isabella; Callaghan, Steve; Vaillant, Dominique C.; Slack, Ruth S.; Park, David S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Bourquard, Noam; Reddy, Srinivasa T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Bourquard, Noam; Reddy, Srinivasa T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Rousseaux, Maxime W. C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Irrcher, Isabella] Queens Univ, Dept Ophthalmol, Kingston, ON, Canada; [Kim, Raymond H.; Mak, Tak W.] Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Figeys, Daniel] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Park, David S.] Pusan Natl Univ, Dept Cognomechatron Engn, Pusan, South Korea; [Aleyasin, Hossein] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Aleyasin, Hossein] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA	University of Ottawa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baylor College of Medicine; Queens University - Canada; University of Ottawa; Pusan National University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Park, DS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	dpark@uottawa.ca	, Dianbo/AAU-8480-2021	, Dianbo/0000-0002-0435-9585; Figeys, Daniel/0000-0002-5373-7546; Slack, Ruth/0000-0002-1552-2835; Kim, Raymond/0000-0002-2147-8674; Park, David/0000-0002-4490-3784; Aleyasin, Hossein/0000-0002-0021-2586; Rousseaux, Maxime/0000-0002-2737-6193	Parkinson's Society Canada (PSC); Ontario Graduate Scholarships in Science and Technology (OGSST); Canadian Institutes of Health Research (CIHR); National Heart, Lung, and Blood Institute (NHLBI) [1RO1HL71776]; Heart and Stroke Foundation of Ontario (HSFO); Neuroscience Canada (Brain Repair Grant); Parkinson's Disease Foundation (PDF); Michael J. Fox foundation for Parkinson's research (MJFOX); Centre for Stroke Recovery (CSR); World Class University program (WCU) through the National Research Foundation of Korea - Ministry of Education, Science and Technology, South Korea [R31-2008-000-20004-0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071776] Funding Source: NIH RePORTER	Parkinson's Society Canada (PSC); Ontario Graduate Scholarships in Science and Technology (OGSST); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Heart and Stroke Foundation of Ontario (HSFO)(Heart & Stroke Foundation of Ontario); Neuroscience Canada (Brain Repair Grant); Parkinson's Disease Foundation (PDF); Michael J. Fox foundation for Parkinson's research (MJFOX); Centre for Stroke Recovery (CSR); World Class University program (WCU) through the National Research Foundation of Korea - Ministry of Education, Science and Technology, South Korea; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from Parkinson's Society Canada (PSC); Ontario Graduate Scholarships in Science and Technology (OGSST); the Canadian Institutes of Health Research (CIHR); National Heart, Lung, and Blood Institute (NHLBI) [1RO1HL71776 to S. T. R]; Heart and Stroke Foundation of Ontario (HSFO); Neuroscience Canada (Brain Repair Grant); Parkinson's Disease Foundation (PDF); The Michael J. Fox foundation for Parkinson's research (MJFOX); the Centre for Stroke Recovery (CSR) and World Class University program (WCU) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, South Korea R31-2008-000-20004-0 to D. S. P]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedova SN, 2001, J NEUROL SCI, V184, P179, DOI 10.1016/S0022-510X(01)00439-7; Aleyasin H, 2004, J NEUROSCI, V24, P2963, DOI 10.1523/JNEUROSCI.0155-04.2004; Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Ben-Shaul Y, 2006, EUR J NEUROSCI, V23, P2915, DOI 10.1111/j.1460-9568.2006.04812.x; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Carmine A, 2002, MOVEMENT DISORD, V17, P764, DOI 10.1002/mds.10172; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cooley MA, 2010, MICROBES INFECT, V12, P231, DOI 10.1016/j.micinf.2009.12.009; Desai VG, 1996, BRAIN RES, V715, P1, DOI 10.1016/0006-8993(95)01255-9; Devarajan A, 2011, ANTIOXID REDOX SIGN, V14, P341, DOI 10.1089/ars.2010.3430; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Draganov DI, 2010, CHEM-BIOL INTERACT, V187, P370, DOI 10.1016/j.cbi.2010.01.039; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gan L, 2010, EUR J NEUROSCI, V31, P967, DOI 10.1111/j.1460-9568.2010.07138.x; Godeiro C, 2010, NEUROSCI LETT, V469, P155, DOI 10.1016/j.neulet.2009.11.064; GRAY KM, 1994, J BACTERIOL, V176, P3076, DOI 10.1128/JB.176.10.3076-3080.1994; Gu L, 2009, BIOCHEM BIOPH RES CO, V383, P469, DOI 10.1016/j.bbrc.2009.04.037; Hagmann H, 2014, FASEB J, V28, P1769, DOI 10.1096/fj.13-240309; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.3.CO;2-8; Horke S, 2008, BIOCHEM J, V416, P395, DOI 10.1042/BJ20080775; Huang E, 2010, NAT CELL BIOL, V12, P563, DOI 10.1038/ncb2058; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Janka Z, 2002, MOL PSYCHIATR, V7, P110, DOI 10.1038/sj/mp/4000916; Jasna JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101380; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kaneko Y, 2014, CNS NEUROSCI THER, V20, P275, DOI 10.1111/cns.12208; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klinefelter GR, 1997, J ANDROL, V18, P139; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lavara-Culebras E, 2007, GENE, V400, P158, DOI 10.1016/j.gene.2007.06.013; Lazaros L, 2010, EUR J NEUROL, V17, P757, DOI 10.1111/j.1468-1331.2009.02860.x; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Ng CJ, 2006, MOL GENET METAB, V89, P368, DOI 10.1016/j.ymgme.2006.07.004; Ng CJ, 2006, J BIOL CHEM, V281, P29491, DOI 10.1074/jbc.M605379200; Ng CJ, 2005, FREE RADICAL BIO MED, V38, P153, DOI 10.1016/j.freeradbiomed.2004.09.035; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Parsanejad M, 2014, J NEUROSCI, V34, P8043, DOI 10.1523/JNEUROSCI.1244-13.2014; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; POIRIER J, 1985, BIOCHEM BIOPH RES CO, V131, P1284, DOI 10.1016/0006-291X(85)90230-X; Polonikov AV, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/708903; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Precourt LP, 2011, ATHEROSCLEROSIS, V214, P20, DOI 10.1016/j.atherosclerosis.2010.08.076; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; RAMSAY RR, 1986, J BIOL CHEM, V261, P7585; RAMSAY RR, 1987, ARCH BIOCHEM BIOPHYS, V259, P645, DOI 10.1016/0003-9861(87)90531-5; Rosenblat M, 2003, ARTERIOSCL THROM VAS, V23, P468, DOI 10.1161/01.ATV.0000059385.95664.4D; Roshon M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-2; Saeed M, 2006, NEUROLOGY, V67, P771, DOI 10.1212/01.wnl.0000227187.52002.88; Saleh AM, 2003, TOXICOL APPL PHARM, V190, P47, DOI 10.1016/S0041-008X(03)00126-1; Sanyal J, 2010, CAN J NEUROL SCI, V37, P637, DOI 10.1017/S0317167100010829; Shi JJ, 2004, MOL BRAIN RES, V120, P201, DOI 10.1016/j.molbrainres.2003.10.018; Shiner M, 2004, FREE RADICAL BIO MED, V37, P2052, DOI 10.1016/j.freeradbiomed.2004.09.003; Shiner M, 2007, ATHEROSCLEROSIS, V195, P313, DOI 10.1016/j.atherosclerosis.2007.01.007; SINHA BK, 1986, BIOCHEM BIOPH RES CO, V135, P583, DOI 10.1016/0006-291X(86)90033-1; Slowik A, 2006, NEUROLOGY, V67, P766, DOI 10.1212/01.wnl.0000219565.32247.11; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Tanner CM, 2011, ENV HLTH PERSPECT; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Valdmanis PN, 2008, NEUROLOGY, V71, P514, DOI 10.1212/01.wnl.0000324997.21272.0c; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; van Duijn C. M., 2001, American Journal of Human Genetics, V69, P629, DOI 10.1086/322996; Yang F, 2005, FEBS LETT, V579, P3713, DOI 10.1016/j.febslet.2005.05.060; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006; Zhang Y, 2010, J NEUROCHEM, V112, P497, DOI 10.1111/j.1471-4159.2009.06476.x	80	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106601	10.1371/journal.pone.0106601	http://dx.doi.org/10.1371/journal.pone.0106601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210784	gold, Green Submitted, Green Published			2022-12-27	WOS:000341855900019
J	Raposo, C; Odorissi, PAM; Savioli, SF; Hell, RCR; Simoes, GF; Ruela-de-Sousa, RR; de Oliveira, ALR; da Cruz-Hofling, MA				Raposo, Catarina; Miranda Odorissi, Paulo Alexandre; Savioli, Stefania Fioravanti; Rodrigues Hell, Rafaela Chitarra; Simoes, Gustavo Ferreira; Ruela-de-Sousa, Roberta R.; Rodrigues de Oliveira, Alexandre Leite; da Cruz-Hoefling, Maria Alice			Triggering of Protection Mechanism against Phoneutria nigriventer Spider Venom in the Brain	PLOS ONE			English	Article							EXPRESSION; RESISTANCE; BARRIER; PROLIFERATION; TRANSPORT; COMMUNICATION; GLUTATHIONE; ACTIVATION; CONNEXIN43; INCREASES	Severe accidents caused by the "armed'' spider Phoneutria nigriventer cause neurotoxic manifestations in victims. In experiments with rats, P. nigriventer venom (PNV) temporarily disrupts the properties of the BBB by affecting both the transcellular and the paracellular route. However, it is unclear how cells and/or proteins participate in the transient opening of the BBB. The present study demonstrates that PNV is a substrate for the multidrug resistance protein-1 (MRP1) in cultured astrocyte and endothelial cells (HUVEC) and increases mrp1 and cx43 and down-regulates glut1 mRNA transcripts in cultured astrocytes. The inhibition of nNOS by 7-nitroindazole suggests that NO derived from nNOS mediates some of these effects by either accentuating or opposing the effects of PNV. In vivo, MRP1, GLUT1 and Cx43 protein expression is increased differentially in the hippocampus and cerebellum, indicating region-related modulation of effects. PNV contains a plethora of Ca2+, K+ and Na+ channel-acting neurotoxins that interfere with glutamate handling. It is suggested that the findings of the present study are the result of a complex interaction of signaling pathways, one of which is the NO, which regulates BBB-associated proteins in response to PNV interference on ions physiology. The present study provides additional insight into PNV-induced BBB dysfunction and shows that a protective mechanism is activated against the venom. The data shows that PNV has qualities for potential use in drug permeability studies across the BBB.	[Raposo, Catarina; Miranda Odorissi, Paulo Alexandre; Savioli, Stefania Fioravanti; Ruela-de-Sousa, Roberta R.; da Cruz-Hoefling, Maria Alice] Univ Estadual Campinas, UNICAMP, Dept Biochem & Tissue Biol, Sao Paulo, Brazil; [Rodrigues Hell, Rafaela Chitarra; Simoes, Gustavo Ferreira; Rodrigues de Oliveira, Alexandre Leite] Univ Estadual Campinas, UNICAMP, Dept Funct & Struct Biol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	da Cruz-Hofling, MA (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Biochem & Tissue Biol, Sao Paulo, Brazil.	hofling@unicamp.br	Ruela de Sousa, Roberta/C-6825-2012; Oliveira, Alexandre/AAI-6815-2020; Oliveira, Alexandre L. R./C-4436-2012	Ruela de Sousa, Roberta/0000-0002-3762-2247; Oliveira, Alexandre/0000-0003-4224-4575; Oliveira, Alexandre L. R./0000-0003-4224-4575; Raposo, Catarina/0000-0001-8804-497X; Simoes, Gustavo/0000-0001-5362-4085	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/50242-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [81316/2008-6]; Coordenacao de Pessoal de Nivel Superior (CAPES/Brazilian Ministry of Education); FAPESP [07/50272-6, 07/56715-7]; CNPq [504732/2007-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Pessoal de Nivel Superior (CAPES/Brazilian Ministry of Education); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work has been funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP #07/50242-6); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq #81316/2008-6) and Coordenacao de Pessoal de Nivel Superior (CAPES/Brazilian Ministry of Education). CR and PAMO were recipients of scholarship from FAPESP (grants #07/50272-6 and #07/56715-7, respectively); S.F.S. was recipient from scholarship from CNPq (grant #504732/2007-2). M.A.C.H. is 1A Research Fellow from CNPq (#305099/2011-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aronica E, 2004, EPILEPSIA, V45, P441, DOI 10.1111/j.0013-9580.2004.57703.x; Banks WA, 2008, ENDOCRINOLOGY, V149, P1514, DOI 10.1210/en.2007-1091; Borges M.H., 2009, ANIMAL TOXINS STATE, P291; BOSMANS F, 2009, ANIMAL TOXINS STATE, P269; Bucaretchi Fabio, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P17, DOI 10.1590/S0036-46652000000100003; Choeiri C, 2005, NEUROSCIENCE, V130, P591, DOI 10.1016/j.neuroscience.2004.09.011; Chuman Y, 1998, CANCER LETT, V129, P69, DOI 10.1016/S0304-3835(98)00083-4; da Cruz-Hofling MA, 2009, NEUROTOXICOLOGY, V30, P636, DOI 10.1016/j.neuro.2009.04.004; da Cruz-Hofling MA, 2007, BRAIN RES BULL, V73, P114, DOI 10.1016/j.brainresbull.2007.01.017; Dauchy S, 2009, BIOCHEM PHARMACOL, V77, P897, DOI 10.1016/j.bcp.2008.11.001; De Bock M, 2013, PROG NEUROBIOL, V108, P1, DOI 10.1016/j.pneurobio.2013.06.001; Decleves X, 2000, J NEUROSCI RES, V60, P594, DOI 10.1002/(SICI)1097-4547(20000601)60:5<594::AID-JNR4>3.0.CO;2-6; DEMONTELLANO PRO, 1986, MOL PHARMACOL, V30, P666; Gangoso E, 2012, GLIA, V60, P2040, DOI 10.1002/glia.22418; Giaume C, 1997, GLIA, V21, P114; Gomez MV, 2002, CELL MOL NEUROBIOL, V22, P579, DOI 10.1023/A:1021836403433; Hagemeyer CE, 2003, NEUROSCIENCE, V117, P521, DOI 10.1016/S0306-4522(02)00955-7; Han HY, 1998, BIOCHEM BIOPH RES CO, V243, P816, DOI 10.1006/bbrc.1997.8132; HANSSON T, 1990, NEUROSCIENCE, V34, P451, DOI 10.1016/0306-4522(90)90154-V; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Herrero-Gonzalez S, 2009, GLIA, V57, P222, DOI 10.1002/glia.20748; Karpuk N, 2011, J NEUROSCI, V31, P414, DOI 10.1523/JNEUROSCI.5247-10.2011; Kushmerick C, 1999, J NEUROCHEM, V72, P1472, DOI 10.1046/j.1471-4159.1999.721472.x; Le Sueur LD, 2003, ACTA NEUROPATHOL, V105, P125, DOI 10.1007/s00401-002-0623-8; Le Sueur LP, 2004, BRAIN RES, V1027, P38, DOI 10.1016/j.brainres.2004.08.055; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martell RL, 1997, BRIT J CANCER, V75, P161, DOI 10.1038/bjc.1997.27; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mendonca MCP, 2013, TOXINS, V5, P2572, DOI 10.3390/toxins5122572; MONTOLIU C, 1995, J NEUROCHEM, V65, P2561; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; Nunes KP, 2012, INT J IMPOT RES, V24, P69, DOI 10.1038/ijir.2011.47; Nunes KP, 2009, ANIMAL TOXINS STATE, P313; Mendonca MCP, 2012, TOXICON, V60, P656, DOI 10.1016/j.toxicon.2012.05.015; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raposo C, 2007, BRAIN RES, V1149, P18, DOI 10.1016/j.brainres.2007.02.086; Raposo C, 2012, NEUROCHEM RES, V37, P1967, DOI 10.1007/s11064-012-0817-y; Rouach N, 2004, NEUROCHEM INT, V45, P265, DOI 10.1016/j.neuint.2003.07.004; Scheiber IF, 2011, NEUROSCI LETT, V498, P42, DOI 10.1016/j.neulet.2011.04.058; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Stavale LM, 2013, TOXICON, V66, P37, DOI 10.1016/j.toxicon.2013.01.026; Tabernero A, 2006, J NEUROCHEM, V99, P1049, DOI 10.1111/j.1471-4159.2006.04088.x; Utepbergenov DI, 1998, FEBS LETT, V424, P197, DOI 10.1016/S0014-5793(98)00173-2; VERSANTVOORT CHM, 1995, BRIT J CANCER, V72, P82, DOI 10.1038/bjc.1995.281; Virgintino D, 1997, J SUBMICR CYTOL PATH, V29, P365; Yamane Y, 1998, J BIOL CHEM, V273, P31075, DOI 10.1074/jbc.273.47.31075	47	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107292	10.1371/journal.pone.0107292	http://dx.doi.org/10.1371/journal.pone.0107292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211468	gold, Green Submitted, Green Published			2022-12-27	WOS:000341855900057
J	Scales, M; Jager, R; Migliorini, G; Houlston, RS; Henrion, MYR				Scales, Matthew; Jaeger, Roland; Migliorini, Gabriele; Houlston, Richard S.; Henrion, Marc Y. R.			visPIG - A Web Tool for Producing Multi-Region, Multi-Track, Multi-Scale Plots of Genetic Data	PLOS ONE			English	Article							BROWSER	We present VISual Plotting Interface for Genetics (visPIG; http://vispig.icr.ac.uk), a web application to produce multi-track, multi-scale, multi-region plots of genetic data. visPIG has been designed to allow users not well versed with mathematical software packages and/or programming languages such as R [1], Matlab (R), Python, etc., to integrate data from multiple sources for interpretation and to easily create publication-ready figures. While web tools such as the UCSC Genome Browser [2] or the WashU Epigenome Browser [3] allow custom data uploads, such tools are primarily designed for data exploration. such as Circos [6] require significant computer skills of the user. The visPIG web application is a menu-based interface that allows users to upload custom data tracks and set track-specific parameters. Figures can be downloaded as PDF or PNG files. For sensitive data, the underlying R [1] code can also be downloaded and run locally. visPIG is multi-track: it can display many different data types (e.g association, functional annotation, intensity, interaction, heat map data,.). It also allows annotation of genes and other custom features in the plotted region(s). Data tracks can be plotted individually or on a single figure. visPIG is multi-region: it supports plotting multiple regions, be they kilo- or megabases apart or even on different chromosomes. Finally, visPIG is multi-scale: a sub-region of particular interest can be 'zoomed' in. We describe the various features of visPIG and illustrate its utility with examples.	[Scales, Matthew; Jaeger, Roland; Migliorini, Gabriele; Houlston, Richard S.; Henrion, Marc Y. R.] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Scales, Matthew] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England	University of London; Institute of Cancer Research - UK; Imperial College London	Henrion, MYR (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England.	marc.henrion@icr.ac.uk	Henrion, Marc/AAT-7088-2020	Henrion, Marc/0000-0003-1242-839X; Houlston, Richard/0000-0002-5268-0242; Jager, Roland/0000-0003-4530-1344	European Union (FP7) [258236]; FP7 collaborative project SYSCOL; COST Action [BM1206]; Cancer Research UK [C1298/A8362]; Leukaemia Lymphoma Research [LRF05001, LRF06002]; Austrian Science Fund (FWF); Institute of Cancer Research (ICR)/Engineering and Physical Sciences Research Council (EPSRC); Austrian Science Fund (FWF) [J 3269] Funding Source: researchfish; Cancer Research UK [15116] Funding Source: researchfish	European Union (FP7)(European Commission); FP7 collaborative project SYSCOL; COST Action(European Cooperation in Science and Technology (COST)); Cancer Research UK(Cancer Research UK); Leukaemia Lymphoma Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Institute of Cancer Research (ICR)/Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Cancer Research UK(Cancer Research UK)	This work is supported by grants from the European Union (FP7/207-2013) under grant 258236, FP7 collaborative project SYSCOL and COST Action BM1206, Cancer Research UK (C1298/A8362-Bobby Moore Fund) and Leukaemia Lymphoma Research (LRF05001 and LRF06002). R.J. was in receipt of an Erwin Schrodinger Fellowship from the Austrian Science Fund (FWF). M.S. was funded by an Institute of Cancer Research (ICR)/Engineering and Physical Sciences Research Council (EPSRC) summer student bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Jager R, 2014, CAPTURE HI C C UNPUB; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; RStudio Inc, 2013, SHIN WEB APPL FRAM R; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Su JH, 2020, CELL, V182, P1641, DOI 10.1016/j.cell.2020.07.032; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Whiffin N, 2013, HUM MOL GENET, V22, P5075, DOI 10.1093/hmg/ddt357; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772	15	35	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107497	10.1371/journal.pone.0107497	http://dx.doi.org/10.1371/journal.pone.0107497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208325	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300085
J	Gordon, RR; Wu, MC; Huang, CY; Harris, WP; Sim, HG; Lucas, JM; Coleman, I; Higano, CS; Gulati, R; True, LD; Vessella, R; Lange, PH; Garzotto, M; Beer, TM; Nelson, PS				Gordon, Ryan R.; Wu, Mengchu; Huang, Chung-Ying; Harris, William P.; Sim, Hong Gee; Lucas, Jared M.; Coleman, Ilsa; Higano, Celestia S.; Gulati, Roman; True, Lawrence D.; Vessella, Robert; Lange, Paul H.; Garzotto, Mark; Beer, Tomasz M.; Nelson, Peter S.			Chemotherapy-Induced Monoamine Oxidase Expression in Prostate Carcinoma Functions as a Cytoprotective Resistance Enzyme and Associates with Clinical Outcomes	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NEOADJUVANT DOCETAXEL; RADICAL PROSTATECTOMY; IN-VIVO; CANCER-CELLS; IONIZING-RADIATION; L-DEPRENYL; PHASE-II; MITOXANTRONE; CLORGYLINE	To identify molecular alterations in prostate cancers associating with relapse following neoadjuvant chemotherapy and radical prostatectomy patients with high-risk localized prostate cancer were enrolled into a phase I-II clinical trial of neoadjuvant chemotherapy with docetaxel and mitoxantrone followed by prostatectomy. Pre-treatment prostate tissue was acquired by needle biopsy and post-treatment tissue was acquired by prostatectomy. Prostate cancer gene expression measurements were determined in 31 patients who completed 4 cycles of neoadjuvant chemotherapy. We identified 141 genes with significant transcript level alterations following chemotherapy that associated with subsequent biochemical relapse. This group included the transcript encoding monoamine oxidase A (MAOA). In vitro, cytotoxic chemotherapy induced the expression of MAOA and elevated MAOA levels enhanced cell survival following docetaxel exposure. MAOA activity increased the levels of reactive oxygen species and increased the expression and nuclear translocation of HIF1 alpha. The suppression of MAOA activity using the irreversible inhibitor clorgyline augmented the apoptotic responses induced by docetaxel. In summary, we determined that the expression of MAOA is induced by exposure to cytotoxic chemotherapy, increases HIF1 alpha, and contributes to docetaxel resistance. As MAOA inhibitors have been approved for human use, regimens combining MAOA inhibitors with docetaxel may improve clinical outcomes.	[Gordon, Ryan R.; Wu, Mengchu; Huang, Chung-Ying; Harris, William P.; Sim, Hong Gee; Lucas, Jared M.; Coleman, Ilsa; Gulati, Roman; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Gordon, Ryan R.; Wu, Mengchu; Huang, Chung-Ying; Harris, William P.; Sim, Hong Gee; Lucas, Jared M.; Coleman, Ilsa; Gulati, Roman; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Beer, Tomasz M.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Higano, Celestia S.; Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA USA; [True, Lawrence D.; Nelson, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Higano, Celestia S.; True, Lawrence D.; Vessella, Robert; Lange, Paul H.; Nelson, Peter S.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Garzotto, Mark] Oregon Hlth & Sci Univ, Dept Urol, Portland, OR 97201 USA; [Garzotto, Mark] Oregon Hlth & Sci Univ, Inst Canc, Portland, OR 97201 USA; [Garzotto, Mark] Portland VA Med Ctr, Urol Sect, Portland, OR USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Nelson, PS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	pnelson@fhcrc.org	Gulati, Roman/AAE-4298-2019	Gulati, Roman/0000-0002-7592-6567	AUA Foundation; DOD CDMRP in Prostate Cancer [PC050489, PC110257]; PNW Prostate Cancer SPORE [CA097186];  [R01CA119125];  [PC093509];  [P01CA085859]; NATIONAL CANCER INSTITUTE [R01CA119125, P30CA069533, P50CA097186, P01CA085859] Funding Source: NIH RePORTER	AUA Foundation; DOD CDMRP in Prostate Cancer; PNW Prostate Cancer SPORE; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MW was supported by a fellowship from the AUA Foundation. CYH was supported by a fellowship from the DOD CDMRP in Prostate Cancer (PC050489). RG was supported by a fellowship from the DOD CDMRP in Prostate Cancer (PC110257). This work was supported by grants R01CA119125, PC093509, P01CA085859, and the PNW Prostate Cancer SPORE (CA097186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer TM, 2004, CLIN CANCER RES, V10, P1306, DOI 10.1158/1078-0432.CCR-1021-03; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Chi KN, 2008, J UROLOGY, V180, P565, DOI 10.1016/j.juro.2008.04.012; Chi KN, 2008, J UROLOGY, V180, P570; Cubas R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-253; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dizeyi N, 2004, PROSTATE, V59, P328, DOI 10.1002/pros.10374; Dreicer R, 2004, UROLOGY, V63, P1138, DOI 10.1016/j.urology.2004.01.040; Febbo PG, 2005, CLIN CANCER RES, V11, P5233, DOI 10.1158/1078-0432.CCR-05-0299; Fowler JS, 2002, METHODS, V27, P263, DOI 10.1016/S1046-2023(02)00083-X; FRY AM, 1991, CANCER RES, V51, P6592; Garzotto M, 2006, UROL ONCOL-SEMIN ORI, V24, P254, DOI 10.1016/j.urolonc.2005.11.034; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Haase VH, 2009, KIDNEY INT, V76, P492, DOI 10.1038/ki.2009.222; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Huang CY, 2007, CLIN CANCER RES, V13, P5825, DOI 10.1158/1078-0432.CCR-07-1037; Hussain M, 2003, UROLOGY, V61, P774, DOI 10.1016/S0090-4295(02)02519-0; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Magi-Galluzzi C, 2007, CANCER-AM CANCER SOC, V110, P1248, DOI 10.1002/cncr.22897; Maragos WF, 2004, NEUROCHEM RES, V29, P741, DOI 10.1023/B:NERE.0000018845.82808.45; Maragos WF, 1999, BRAIN RES, V834, P168, DOI 10.1016/S0006-8993(99)01487-0; O'Brien C, AM J CLIN PATHOL, V133, P654; O'Connell Michael J, 2004, Oncology (Williston Park), V18, P751; O'Connell MJ, 2004, ONCOLOGY WILLISTON P, V18, P755; Orlefors H, 2003, NUCL MED BIOL, V30, P669, DOI 10.1016/S0969-8051(03)00034-9; Patiar S, 2006, ENDOCR-RELAT CANCER, V13, pS61, DOI 10.1677/erc.1.01290; Perez-Pinera P, 2006, P NATL ACAD SCI USA, V103, P17795, DOI 10.1073/pnas.0607299103; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Seymour CB, 2003, BRIT J CANCER, V89, P1979, DOI 10.1038/sj.bjc.6601361; Shannon C, 2003, CRIT REV ONCOL HEMAT, V45, P77, DOI 10.1016/S1040-8428(02)00091-4; Siddiqui EJ, 2006, J UROLOGY, V176, P1648, DOI 10.1016/j.juro.2006.06.087; Singh RP, 2004, CLIN CANCER RES, V10, P244, DOI 10.1158/1078-0432.CCR-1080-3; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; ThyagaRajan S, 1998, CANCER LETT, V123, P177, DOI 10.1016/S0304-3835(97)00431-X; Toninello A, 2006, BBA-REV CANCER, V1765, P1, DOI 10.1016/j.bbcan.2005.09.001; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Xie Y, 2007, CARCINOGENESIS, V28, P2122, DOI 10.1093/carcin/bgm147; Yi H, 2006, J NEUROCHEM, V96, P541, DOI 10.1111/j.1471-4159.2005.03573.x; Zhao H, 2008, DIFFERENTIATION; Zhao HJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-55	46	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e104271	10.1371/journal.pone.0104271	http://dx.doi.org/10.1371/journal.pone.0104271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198178	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700008
J	Hampras, SS; Giuliano, AR; Lin, HY; Fisher, KJ; Abrahamsen, ME; Sirak, BA; Iannacone, MR; Gheit, T; Tommasino, M; Rollison, DE				Hampras, Shalaka S.; Giuliano, Anna R.; Lin, Hui-Yi; Fisher, Kate J.; Abrahamsen, Martha E.; Sirak, Bradley A.; Iannacone, Michelle R.; Gheit, Tarik; Tommasino, Massimo; Rollison, Dana E.			Natural History of Cutaneous Human Papillomavirus (HPV) Infection in Men: The HIM Study	PLOS ONE			English	Article							MICROARRAY PRIMER EXTENSION; SQUAMOUS-CELL CARCINOMA; EPIDERMODYSPLASIA-VERRUCIFORMIS; SUNLIGHT EXPOSURE; CERVICAL-CANCER; MULTIPLEX PCR; BASAL-CELL; SKIN; RISK; PREVALENCE	Accumulating evidence suggests that cutaneous human papillomavirus (HPV) infection is associated with non-melanoma skin cancer (NMSC). Little is known about the natural history of cutaneous HPV. A sub-cohort of 209 men with no NMSC history, initially enrolled in the HPV infection in men (HIM) study, were followed for a median of 12.6 months. Epidemiological data were collected through self-administered questionnaires. Cutaneous HPV DNA was measured in normal skin swabs (SS) and eyebrow hairs (EB) for 25 and 16 HPV types in genera beta and gamma, respectively. Any beta HPV infection was more prevalent in SS (67.3%) compared to EB (56.5%, p = 0.04). Incidence in SS was higher than 20 per 1,000 person-months for HPV types 4, 5, 23, 38 and 76. Median duration of persistence of beta and gamma HPV infection was 8.6 and 6.1 months in EB, respectively, and 11.3 months and 6.3 months, in SS, respectively. Older age (>44 years vs. 18-30 years) was significantly associated with prevalent (SS OR = 3.0, 95% CI = 1.2-7.0) and persistent beta HPV infection (EB OR = 6.1, 95% CI = 2.6-14.1). History of blistering sunburn was associated with prevalent (OR = 2.8, 95% CI = 1.3-5.8) and persistent (OR = 2.3, 95% CI = 1.2-4.6) beta HPV infection in SS. Cutaneous HPV is highly prevalent in men, with age and blistering sunburn being significant risk factors for cutaneous beta HPV infection.	[Hampras, Shalaka S.; Giuliano, Anna R.; Abrahamsen, Martha E.; Sirak, Bradley A.; Rollison, Dana E.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Lin, Hui-Yi; Fisher, Kate J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL USA; [Iannacone, Michelle R.] Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia; [Gheit, Tarik; Tommasino, Massimo] WHO, Int Agcy Res Cancer, Infect & Canc Biol Grp, Lyon, France	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; World Health Organization; International Agency for Research on Cancer (IARC)	Rollison, DE (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA.	dana.rollison@moffitt.org		Tommasino, Massimo/0000-0002-0890-8596; Lin, Hui-Yi/0000-0002-3307-5549	National Cancer Institute at the National Institutes of Health [RO1CA098803, R25 CA078447]; NATIONAL CANCER INSTITUTE [R25CA078447, R01CA098803] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute at the National Institutes of Health (RO1CA098803 and R25 CA078447 to C.M. Nielson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson K, 2012, AM J EPIDEMIOL, V175, P685, DOI 10.1093/aje/kwr373; Anic GM, 2011, J INFECT DIS, V204, P1886, DOI 10.1093/infdis/jir652; [Anonymous], EPA UV IND; Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2003, J CLIN MICROBIOL, V41, P2509, DOI 10.1128/JCM.41.6.2509-2514.2003; Antonsson A, 2010, VIROLOGY, V407, P26, DOI 10.1016/j.virol.2010.07.046; Boxman ILA, 1997, J INVEST DERMATOL, V108, P712, DOI 10.1111/1523-1747.ep12292090; Braaten Kari P, 2008, Rev Obstet Gynecol, V1, P2; Bzhalava D, 2013, VIROLOGY, V445, P224, DOI 10.1016/j.virol.2013.07.015; Castellsague X, 2013, INT J CANCER, V13, P28665; Chen ACH, 2008, J GEN VIROL, V89, P2891, DOI 10.1099/vir.0.2008/003665-0; Chiantore MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036909; de Koning MNC, 2007, J GEN VIROL, V88, P1489, DOI 10.1099/vir.0.82732-0; de Koning MNC, 2009, J GEN VIROL, V90, P1611, DOI 10.1099/vir.0.010017-0; Escutia B, 2011, J EUR ACAD DERMATOL, V25, P832, DOI 10.1111/j.1468-3083.2010.03875.x; Farzan SF, 2013, INT J CANCER, V28, P28176; Gheit T, 2006, J CLIN MICROBIOL, V44, P2025, DOI 10.1128/JCM.02305-05; Gheit T, 2007, J CLIN MICROBIOL, V45, P2537, DOI 10.1128/JCM.00747-07; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Heideman DAM, 2007, J CLIN ONCOL, V25, P4550, DOI 10.1200/JCO.2007.12.3182; Hsu JYC, 2009, J MED VIROL, V81, P1444, DOI 10.1002/jmv.21529; Iannacone MR, 2013, J INVEST DERMATOL, V133, P1512, DOI 10.1038/jid.2012.478; Iannacone MR, 2012, CANCER EPIDEM BIOMAR, V21, P1303, DOI 10.1158/1055-9965.EPI-12-0032; Iannacone MR, 2012, J INFECT DIS, V206, P399, DOI 10.1093/infdis/jis374; Iannacone MR, 2010, J INFECT DIS, V201, P760, DOI 10.1086/650466; Iannacone MR, 2013, INT J CANCER, V17, P28552; JABLONSKA S, 1972, CANCER RES, V32, P583; Jackson S, 2000, ONCOGENE, V19, P592, DOI 10.1038/sj.onc.1203339; Mansour M, 2007, VIROLOGY, V367, P1, DOI 10.1016/j.virol.2007.05.005; Michaud DS, 2014, INT J CANCER, V26, P28811; Muschik D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027655; Neale RE, 2013, CANCER EPIDEM BIOMAR, V22, P719, DOI 10.1158/1055-9965.EPI-12-0917-T; PECORARO G, 1989, P NATL ACAD SCI USA, V86, P563, DOI 10.1073/pnas.86.2.563; Proby CM, 2011, AM J TRANSPLANT, V11, P1498, DOI 10.1111/j.1600-6143.2011.03589.x; Rollison DE, 2008, INT J CANCER, V123, P2337, DOI 10.1002/ijc.23795; Sampogna F, 2012, J GEN VIROL, V93, P165, DOI 10.1099/vir.0.035493-0; Schmitt M, 2010, J CLIN MICROBIOL, V48, P143, DOI 10.1128/JCM.00991-09; Schneider I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-186; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Struijk L, 2003, J INVEST DERMATOL, V121, P1531, DOI 10.1046/j.1523-1747.2003.12632.x; Termorshuizen F, 2004, J INVEST DERMATOL, V122, P1456, DOI 10.1111/j.0022-202X.2004.22617.x; Viera AJ, 2005, FAM MED, V37, P360	42	51	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e104843	10.1371/journal.pone.0104843	http://dx.doi.org/10.1371/journal.pone.0104843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198694	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700013
J	Carter, AW; Chen, SC; Lovell, NH; Vickery, RM; Morley, JW				Carter, Andrew W.; Chen, Spencer C.; Lovell, Nigel H.; Vickery, Richard M.; Morley, John W.			Convergence across Tactile Afferent Types in Primary and Secondary Somatosensory Cortices	PLOS ONE			English	Article							VIBROTACTILE STIMULATION; AREA-II; NEURONS; ORGANIZATION; CORTEX; INFORMATION; MONKEYS; FLUTTER; FIBERS; CATS	Integration of information by convergence of inputs onto sensory cortical neurons is a requisite for processing higher-order stimulus features. Convergence across defined peripheral input classes has generally been thought to occur at levels beyond the primary sensory cortex, however recent work has shown that this does not hold for the convergence of slowly-adapting and rapidly-adapting inputs in primary somatosensory cortex. We have used a new analysis method for multi-unit recordings, to show convergence of inputs deriving from the rapidly-adapting and Pacinian channels in a proportion of neurons in both primary and secondary somatosensory cortex in the anaesthetised cat. We have validated this method using single-unit recordings. The secondary somatosensory cortex has a greater proportion of sites that show convergence of this type than primary somatosensory cortex. These findings support the hypothesis that the more complex features processed in higher cortical areas require a greater degree of convergence across input classes, but also shows that this convergence is apparent in the primary somatosensory cortex.	[Carter, Andrew W.; Chen, Spencer C.; Vickery, Richard M.; Morley, John W.] UNSW Australia, Sch Med Sci, Sydney, NSW, Australia; [Chen, Spencer C.; Lovell, Nigel H.] UNSW Australia, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Chen, Spencer C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Morley, John W.] Univ Western Sydney, Sch Med, Penrith, NSW 1797, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Western Sydney University	Morley, JW (corresponding author), UNSW Australia, Sch Med Sci, Sydney, NSW, Australia.	j.morley@uws.edu.au	Lovell, Nigel H/AGF-6679-2022	Lovell, Nigel H/0000-0003-1637-1079; Vickery, Richard/0000-0002-2968-7358	Australian Research Council (ARC) Thinking Systems Grant [TS0669860]	Australian Research Council (ARC) Thinking Systems Grant(Australian Research Council)	The work was supported by funding from the Australian Research Council (ARC) Thinking Systems Grant TS0669860. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT RE, 1980, J NEUROPHYSIOL, V43, P292, DOI 10.1152/jn.1980.43.2.292; BURTON H, 1991, BRAIN RES, V538, P127, DOI 10.1016/0006-8993(91)90386-A; Chen LM, 2001, J NEUROPHYSIOL, V86, P3011, DOI 10.1152/jn.2001.86.6.3011; DOUGLAS PR, 1978, J PHYSIOL-LONDON, V285, P493, DOI 10.1113/jphysiol.1978.sp012585; DYKES RW, 1986, J NEUROPHYSIOL, V56, P1521, DOI 10.1152/jn.1986.56.6.1521; FERRINGTON DG, 1980, J NEUROPHYSIOL, V43, P310, DOI 10.1152/jn.1980.43.2.310; FISHER GR, 1983, J NEUROPHYSIOL, V49, P75, DOI 10.1152/jn.1983.49.1.75; Harvey MA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001558; HERRON P, 1986, J NEUROPHYSIOL, V56, P1475, DOI 10.1152/jn.1986.56.6.1475; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Pei YC, 2009, J NEUROPHYSIOL, V102, P1843, DOI 10.1152/jn.00235.2009; PONS TP, 1987, SCIENCE, V237, P417, DOI 10.1126/science.3603028; Reed JL, 2010, J NEUROPHYSIOL, V103, P2139, DOI 10.1152/jn.00709.2009; Sakurai K, 2013, CELL REP, V5, P87, DOI 10.1016/j.celrep.2013.08.051; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; SRETAVAN D, 1983, J COMP NEUROL, V213, P381, DOI 10.1002/cne.902130403; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Tommerdahl M, 2005, SOMATOSENS MOT RES, V22, P151, DOI 10.1080/08990220500084461; Tommerdahl M, 1999, J NEUROPHYSIOL, V82, P16, DOI 10.1152/jn.1999.82.1.16; Tommerdahl M, 2010, NEUROSCI BIOBEHAV R, V34, P160, DOI 10.1016/j.neubiorev.2009.08.009; VICKERY RM, 1994, J PHYSIOL-LONDON, V474, P379, DOI 10.1113/jphysiol.1994.sp020030; Whitsel BL, 2001, SOMATOSENS MOT RES, V18, P263; Yau JM, 2013, J NEUROPHYSIOL, V109, P2999, DOI 10.1152/jn.00804.2012; Zhang HQ, 2001, J NEUROPHYSIOL, V85, P1823, DOI 10.1152/jn.2001.85.5.1823	26	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107617	10.1371/journal.pone.0107617	http://dx.doi.org/10.1371/journal.pone.0107617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215534	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300087
J	Ma, S; Kemmeren, P; Gresham, D; Statnikov, A				Ma, Sisi; Kemmeren, Patrick; Gresham, David; Statnikov, Alexander			De-Novo Learning of Genome-Scale Regulatory Networks in S-cerevisiae	PLOS ONE			English	Article							MARKOV BLANKET INDUCTION; FALSE DISCOVERY RATE; FEATURE-SELECTION; CAUSAL DISCOVERY; LOCAL CAUSAL; TRANSCRIPTION; ASSOCIATIONS; DATABASE; NORMALIZATION; VISUALIZATION	De-novo reverse-engineering of genome-scale regulatory networks is a fundamental problem of biological and translational research. One of the major obstacles in developing and evaluating approaches for de-novo gene network reconstruction is the absence of high-quality genome-scale gold-standard networks of direct regulatory interactions. To establish a foundation for assessing the accuracy of de-novo gene network reverse-engineering, we constructed high-quality genome-scale gold-standard networks of direct regulatory interactions in Saccharomyces cerevisiae that incorporate binding and gene knockout data. Then we used 7 performance metrics to assess accuracy of 18 statistical association-based approaches for de-novo network reverse-engineering in 13 different datasets spanning over 4 data types. We found that most reconstructed networks had statistically significant accuracies. We also determined which statistical approaches and datasets/data types lead to networks with better reconstruction accuracies. While we found that de-novo reverse-engineering of the entire network is a challenging problem, it is possible to reconstruct sub-networks around some transcription factors with good accuracy. The latter transcription factors can be identified by assessing their connectivity in the inferred networks. Overall, this study provides the gene network reverse-engineering community with a rigorous assessment of the accuracy of S. cerevisiae gene network reconstruction and variability in performance of various approaches for learning both the entire network and sub-networks around transcription factors.	[Ma, Sisi; Statnikov, Alexander] New York Univ Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Statnikov, Alexander] NYU, Sch Med, Dept Med, New York, NY USA; [Kemmeren, Patrick] Univ Med Ctr, Ctr Mol Med, Utrecht, Netherlands; [Gresham, David] NYU, Dept Biol, New York, NY USA	New York University; New York University; Utrecht University; Utrecht University Medical Center; New York University	Statnikov, A (corresponding author), New York Univ Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA.	Alexander.Statnikov@med.nyu.edu	Ma, Sisi/E-6367-2015	Kemmeren, Patrick/0000-0003-2237-7354	NIH from the National Center for Research Resources [1UL1 RR029893]; NIH from the National Library of Medicine [R01 LM011179-01A1]; National Institute of General Medical Sciences [R01 GM107466]; NSF [MCB-1244219]; Netherlands Organization of Scientific Research (NWO) [863.07.007, 864.11.010]; Dupont Young Professor award; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107466] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011179] Funding Source: NIH RePORTER	NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH from the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dupont Young Professor award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported in part by the NIH grants 1UL1 RR029893 from the National Center for Research Resources (A.S.), R01 LM011179-01A1 from the National Library of Medicine (A.S. and S.M.), R01 GM107466 from the National Institute of General Medical Sciences (D.G.); by the NSF grant MCB-1244219 (D.G.); by the grants from the Netherlands Organization of Scientific Research (NWO) 863.07.007 (P.K.) and 864.11.010 (P.K.); and by a Dupont Young Professor award (D.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens ME, 2008, DRUG DISCOV TODAY, V13, P856, DOI 10.1016/j.drudis.2008.06.013; Agresti A, 2002, CATEGORICAL DATA ANA, Vxv; Airoldi EM, 2014, DYNAMICS CELL UNPUB; Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Aliferis CF, 2010, J MACH LEARN RES, V11, P235; Anderson TW, 2003, INTRO MULTIVARIATE S, Vxx; Anderson TW., 2003, INTRO MULTIVARIATE S, V3; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chu TJ, 2003, BIOINFORMATICS, V19, P1147, DOI 10.1093/bioinformatics/btg011; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Cooper GF, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P116; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Glymour C., 1999, COMPUTATION CAUSATIO; Good P, 2000, PERMUTATION TESTS PR; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; He YB, 2008, J MACH LEARN RES, V9, P2523; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Huttenhower C, 2009, BIOINFORMATICS, V25, P2404, DOI 10.1093/bioinformatics/btp397; Hyttinen A, 2012, J MACH LEARN RES, V13, P3387; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kemmeren P, 2014, CELL IN PRESS; Kuffner R, 2012, BIOINFORMATICS, V28, P1376, DOI 10.1093/bioinformatics/bts143; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Meganck S, 2006, LECT NOTES ARTIF INT, V3885, P58; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Narendra V, 2011, GENOMICS, V97, P7, DOI 10.1016/j.ygeno.2010.10.003; Neapolitan R.E., 2004, LEARNING BAYESIAN NE; Nobelprize.org, 2012, PRIZ EC SCI 2011; Nobelprize.org, 2002, SVER RIKSB PRIZ EC S; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shmelkov E, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-15; SIMS CA, 1972, AM ECON REV, V62, P540; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spirtes P., 2000, CAUSATION PREDICTION; Statnikov RB, 1995, MULTICRITERIA OPTIMI, P1; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Wiese R, 2004, MATH VIS, P173; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yeung KY, 2011, P NATL ACAD SCI USA, V108, P19436, DOI 10.1073/pnas.1116442108; Yoo C, 2002, Pac Symp Biocomput, P498	62	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106479	10.1371/journal.pone.0106479	http://dx.doi.org/10.1371/journal.pone.0106479			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215507	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300014
J	Hsieh, C; Kong, J; Kirsch, I; Edwards, RR; Jensen, KB; Kaptchuk, TJ; Gollub, RL				Hsieh, Christine; Kong, Jian; Kirsch, Irving; Edwards, Robert R.; Jensen, Karin B.; Kaptchuk, Ted J.; Gollub, Randy L.			Well-Loved Music Robustly Relieves Pain: A Randomized, Controlled Trial	PLOS ONE			English	Article							PLACEBO-INDUCED EXPECTATIONS; DOPAMINE RELEASE; NUCLEUS-ACCUMBENS; OPIOID SYSTEMS; ANALGESIA; EXPECTANCY; EMOTION; REWARD; DEPRESSION; RESPONSES	Music has pain-relieving effects, but its mechanisms remain unclear. We sought to verify previously studied analgesic components and further elucidate the underpinnings of music analgesia. Using a well-characterized conditioning-enhanced placebo model, we examined whether boosting expectations would enhance or interfere with analgesia from strongly preferred music. A two-session experiment was performed with 48 healthy, pain experiment-naive participants. In a first cohort, 36 were randomized into 3 treatment groups, including music enhanced with positive expectancy, non-musical sound enhanced with positive expectancy, and no expectancy enhancement. A separate replication cohort of 12 participants received only expectancy-enhanced music following the main experiment to verify the results of expectancy-manipulation on music. Primary outcome measures included the change in subjective pain ratings to calibrated experimental noxious heat stimuli, as well as changes in treatment expectations. Without conditioning, expectations were strongly in favor of music compared to non-musical sound. While measured expectations were enhanced by conditioning, this failed to affect either music or sound analgesia significantly. Strongly preferred music on its own was as pain relieving as conditioning-enhanced strongly preferred music, and more analgesic than enhanced sound. Our results demonstrate the pain-relieving power of personal music even over enhanced expectations.	[Hsieh, Christine; Kong, Jian; Jensen, Karin B.; Gollub, Randy L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Hsieh, Christine; Kong, Jian; Jensen, Karin B.; Gollub, Randy L.] Harvard Univ, Sch Med, Boston, MA USA; [Kirsch, Irving; Kaptchuk, Ted J.] Harvard Univ, Sch Med, Program Placebo Studies & Therapeut Encounter PiP, Boston, MA USA; [Kirsch, Irving; Kaptchuk, Ted J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kirsch, Irving] Univ Plymouth, Dept Psychol, Plymouth PL4 8AA, Devon, England; [Edwards, Robert R.] Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Jensen, Karin B.; Gollub, Randy L.] Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA USA; [Jensen, Karin B.; Gollub, Randy L.] Massachusetts Gen Hosp, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Plymouth; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Hsieh, C (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	xtine.hsieh@gmail.com	Kirsch, Irving/P-9316-2019	Gollub, Randy L./0000-0002-9434-4044; Jensen, Karin/0000-0003-2521-3160	Harvard-MIT Health Sciences and Technology IDEA2 award; NIH [R01 AT 005280]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT005280] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006364, P01AT006663] Funding Source: NIH RePORTER	Harvard-MIT Health Sciences and Technology IDEA2 award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the Harvard-MIT Health Sciences and Technology IDEA2 award (Hsieh) and NIH grant R01 AT 005280 (Gollub/Kaptchuk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 1999, J NEUROSCI, V19, P3639; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Bernatzky G, 2011, NEUROSCI BIOBEHAV R, V35, P1989, DOI 10.1016/j.neubiorev.2011.06.005; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Corlett PR, 2010, PROG NEUROBIOL, V92, P345, DOI 10.1016/j.pneurobio.2010.06.007; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Gabrielsson A., 2001, MUSIC EMOTION THEORY; GARDNER WJ, 1960, SCIENCE, V132, P32, DOI 10.1126/science.132.3418.32; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; GOLDSTEIN A, 1980, PHYSIOL PSYCHOL, V8, P126; Hall KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048135; Janata P, 2009, CEREB CORTEX, V19, P2579, DOI 10.1093/cercor/bhp008; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2001, MUSIC EMOTION THEORY; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kirsch I, 2000, AM J CLIN HYPN, V42, P274, DOI 10.1080/00029157.2000.10734362; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2009, ANN NY ACAD SCI, V1169, P374, DOI 10.1111/j.1749-6632.2009.04592.x; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Kong J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067485; Kong J, 2009, NEUROIMAGE, V45, P940, DOI 10.1016/j.neuroimage.2008.12.025; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Laverdure-Dupont D, 2009, J NEUROSCI, V29, P11745, DOI 10.1523/JNEUROSCI.1224-09.2009; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Lidstone SC, 2010, ARCH GEN PSYCHIAT, V67, P857, DOI 10.1001/archgenpsychiatry.2010.88; Mitchell LA, 2006, EUR J PAIN, V10, P343, DOI 10.1016/j.ejpain.2005.03.005; Mitchell LA, 2006, J MUSIC THER, V43, P295, DOI 10.1093/jmt/43.4.295; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Perlini AH, 1996, CAN J BEHAV SCI, V28, P292, DOI 10.1037/0008-400X.28.4.292; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Roy M, 2012, EUR J PAIN, V16, P870, DOI 10.1002/j.1532-2149.2011.00030.x; Roy M, 2008, PAIN, V134, P140, DOI 10.1016/j.pain.2007.04.003; Salimpoor VN, 2013, SCIENCE, V340, P216, DOI 10.1126/science.1231059; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; TURNER JA, 1984, J CLIN PSYCHOL, V40, P909, DOI 10.1002/1097-4679(198407)40:4<909::AID-JCLP2270400407>3.0.CO;2-J; Villarreal EAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029397; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; VOUDOURIS NJ, 1989, PAIN, V38, P109, DOI 10.1016/0304-3959(89)90080-8; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Zatorre RJ, 2013, P NATL ACAD SCI USA, V110, P10430, DOI 10.1073/pnas.1301228110	49	21	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107390	10.1371/journal.pone.0107390	http://dx.doi.org/10.1371/journal.pone.0107390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1UA	25211164	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900070
J	Liu, J; Song, HS; Liu, DL; Zuo, T; Lu, FM; Zhuang, H; Gao, F				Liu, Jia; Song, Hongshuo; Liu, Donglai; Zuo, Tao; Lu, Fengmin; Zhuang, Hui; Gao, Feng			Extensive Recombination Due to Heteroduplexes Generates Large Amounts of Artificial Gene Fragments during PCR	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE MUTATIONS; POLYMERASE-CHAIN-REACTION; MEDIATED RECOMBINATION; DNA-POLYMERASE; VIRAL POPULATIONS; AMPLIFICATION; DIVERSITY; EVOLUTION; ANTIBODIES	Artificial recombinants can be generated during PCR when more than two genetically distinct templates coexist in a single PCR reaction. These recombinant amplicons can lead to the false interpretation of genetic diversity and incorrect identification of biological phenotypes that do not exist in vivo. We investigated how recombination between 2 or 35 genetically distinct HIV-1 genomes was affected by different PCR conditions using the parallel allele-specific sequencing (PASS) assay and the next generation sequencing method. In a standard PCR condition, about 40% of amplicons in a PCR reaction were recombinants. The high recombination frequency could be significantly reduced if the number of amplicons in a PCR reaction was below a threshold of 10(13)-10(14) using low thermal cycles, fewer input templates, and longer extension time. Heteroduplexes (each DNA strand from a distinct template) were present at a large proportion in the PCR products when more thermal cycles, more templates, and shorter extension time were used. Importantly, the majority of recombinants were identified in heteroduplexes, indicating that the recombinants were mainly generated through heteroduplexes. Since prematurely terminated extension fragments can form heteroduplexes by annealing to different templates during PCR amplification, recombination has a better chance to occur with samples containing different genomes when the number of amplicons accumulate over the threshold. New technologies are warranted to accurately characterize complex quasispecies gene populations.	[Liu, Jia; Lu, Fengmin; Zhuang, Hui] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China; [Song, Hongshuo; Liu, Donglai; Zuo, Tao; Gao, Feng] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Liu, Donglai; Zuo, Tao; Gao, Feng] Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China	Peking University; Duke University; Jilin University	Gao, F (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	fgao@duke.edu		Lu, fengmin/0000-0002-1832-3209	National Natural Science Foundation of China [81101238]; National Institutes of Health [GM065057]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065057] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant from the National Natural Science Foundation of China (81101238) and a grant from the National Institutes of Health (GM065057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; Fang GW, 1998, J VIROL METHODS, V76, P139, DOI 10.1016/S0166-0934(98)00133-5; Gorzer I, 2010, J VIROL METHODS, V169, P248, DOI 10.1016/j.jviromet.2010.07.040; GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kijak GH, 2013, AIDS RES HUM RETROV, V29, P1361, DOI [10.1089/aid.2013.0175, 10.1089/AID.2013.0175]; Kirchherr JL, 2007, J VIROL METHODS, V143, P104, DOI 10.1016/j.jviromet.2007.02.015; Krause JC, 2011, J IMMUNOL, V187, P3704, DOI 10.4049/jimmunol.1101823; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lawyer F C, 1993, PCR Methods Appl, V2, P275; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002880; Liao HX, 2013, J VIROL, V87, P4185, DOI 10.1128/JVI.02297-12; Liu J, 2011, ANTIMICROB AGENTS CH, V55, P1114, DOI 10.1128/AAC.01492-10; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067606; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; MATTILA P, 1991, NUCLEIC ACIDS RES, V19, P4967, DOI 10.1093/nar/19.18.4967; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Nishijima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035052; OLSEN DB, 1989, NUCLEIC ACIDS RES, V17, P9613, DOI 10.1093/nar/17.23.9613; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rodriguez-Frias F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037874; Rozak DA, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni081; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SALMINEN MO, 1995, VIROLOGY, V213, P80, DOI 10.1006/viro.1995.1548; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shafikhani S, 2002, ENVIRON MICROBIOL, V4, P482, DOI 10.1046/j.1462-2920.2002.00326.x; Shao W, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-18; Song HS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-89; Wang DN, 2011, J VIROL, V85, P6403, DOI 10.1128/JVI.02389-10; Wang GCY, 1996, MICROBIOL-SGM, V142, P1107, DOI 10.1099/13500872-142-5-1107; Warren EH, 2013, BLOOD, V122, P19, DOI 10.1182/blood-2013-03-453142; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Yu W, 2006, BIOTECHNIQUES, V40, P499, DOI 10.2144/000112124; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110	45	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106658	10.1371/journal.pone.0106658	http://dx.doi.org/10.1371/journal.pone.0106658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211143	Green Submitted, Green Published, gold			2022-12-27	WOS:000341855900022
J	Trudeau, MB; Sunderland, EM; Jindrich, DL; Dennerlein, JT				Trudeau, Matthieu B.; Sunderland, Elsie M.; Jindrich, Devin L.; Dennerlein, Jack T.			A Data-Driven Design Evaluation Tool for Handheld Device Soft Keyboards	PLOS ONE			English	Article							MOTOR-PERFORMANCE VARIES; THUMB; MOVEMENT; MODEL	Thumb interaction is a primary technique used to operate small handheld devices such as smartphones. Despite the different techniques involved in operating a handheld device compared to a personal computer, the keyboard layouts for both devices are similar. A handheld device keyboard that considers the physical capabilities of the thumb may improve user experience. We developed and applied a design evaluation tool for different geometries of the QWERTY keyboard using a performance evaluation model. The model utilizes previously collected data on thumb motor performance and posture for different tap locations and thumb movement directions. We calculated a performance index (PITOT, 0 is worst and 2 is best) for 663 designs consisting in different combinations of three variables: the keyboard's radius of curvature (R) (mm), orientation (O) (degrees), and vertical location on the screen (L). The current standard keyboard performed poorly (PITOT = 0.28) compared to other designs considered. Keyboard location (L) contributed to the greatest variability in performance out of the three design variables, suggesting that designers should modify this variable first. Performance was greatest for designs in the middle keyboard location. In addition, having a slightly upward curve (R = -20 mm) and orientated perpendicular to the thumb's long axis (O = -20 degrees) improved performance to PITOT = 1.97. Poorest performances were associated with placement of the keyboard's spacebar in the bottom right corner of the screen (e. g., the worst was for R = 20 mm, O = 40 degrees, L = Bottom (PITOT = 0.09)). While this evaluation tool can be used in the design process as an ergonomic reference to promote user motor performance, other design variables such as visual access and usability still remain unexplored.	[Trudeau, Matthieu B.] Univ Calgary, Calgary, AB, Canada; [Trudeau, Matthieu B.; Sunderland, Elsie M.; Dennerlein, Jack T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sunderland, Elsie M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Jindrich, Devin L.] Calif State Univ, San Marcos, CA USA; [Dennerlein, Jack T.] Northeastern Univ, Boston, MA 02115 USA	University of Calgary; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; California State University System; California State University San Marcos; Northeastern University	Trudeau, MB (corresponding author), Univ Calgary, Calgary, AB, Canada.	mtrudeau@ucalgary.ca	Sunderland, Elsie M/D-5511-2014	Sunderland, Elsie M/0000-0003-0386-9548; Dennerlein, Jack/0000-0001-7703-643X	National Science Foundation [0964220]	National Science Foundation(National Science Foundation (NSF))	Funding from a National Science Foundation grant 0964220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, 92419 ISO; Card S. K., 1983, PSYCHOL HUMAN COMPUT; CARD SK, 1980, COMMUN ACM, V23, P396, DOI 10.1145/358886.358895; Dell'Amico M, 2009, COMPUT OPER RES, V36, P3002, DOI 10.1016/j.cor.2009.01.018; Douglas SA, 1999, TESTING POINTING DEV, P215; El-Erian MA, 2013, HUFFINGTON POST; FITTS PM, 1992, J EXP PSYCHOL GEN, V121, P262, DOI 10.1037/0096-3445.121.3.262; Gold JE, 2012, APPL ERGON, V43, P408, DOI 10.1016/j.apergo.2011.06.015; Gray W. D., 1993, Human-Computer Interaction, V8, P237, DOI 10.1207/s15327051hci0803_3; Hogg NA, 2010, DESIGN THUMB KEYBOAR; John BE, 1996, ACM T COMPUT-HUM INT, V3, P287, DOI [DOI 10.1145/235833.236050, 10.1145/235833.236050]; Karlson AK, 2008, HDB RES USER INTERFA, P86; Li YZ, 2006, INT J IND ERGONOM, V36, P695, DOI 10.1016/j.ergon.2006.04.009; Merlin B, 2012, COGNITIVELY INFORM I, P21, DOI DOI 10.4018/978-1-4666-1628-8.CH002; Otten EW, 2013, HUM FACTORS, V55, P48, DOI 10.1177/0018720812470689; Park YS, 2010, INT J IND ERGONOM, V40, P746, DOI 10.1016/j.ergon.2010.08.001; Park YS, 2010, INT J IND ERGONOM, V40, P68, DOI 10.1016/j.ergon.2009.08.002; Rainie, 2012, CELL PHONE ACTIVITIE; Rainie L, 2012, 23 YOUNG ADULTS THOS; Rempel D, 2008, HUM FACTORS, V50, P385, DOI 10.1518/001872008X312215; Shieh KK, 1999, PERCEPT MOTOR SKILL, V88, P113, DOI 10.2466/PMS.88.1.113-125; Soukoreff RW, 2004, INT J HUM-COMPUT ST, V61, P751, DOI 10.1016/j.ijhcs.2004.09.001; Trudeau MB, 2012, J BIOMECH, V45, P2349, DOI 10.1016/j.jbiomech.2012.07.012; Trudeau MB, 2012, HUM FACTORS, V54, P52, DOI 10.1177/0018720811423660; Wagner MO, 2003, J ENG DESIGN, V14, P187, DOI 10.1080/0954482031000091509	25	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107070	10.1371/journal.pone.0107070	http://dx.doi.org/10.1371/journal.pone.0107070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1UA	25211465	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900041
J	Haapala, EA; Poikkeus, AM; Kukkonen-Harjula, K; Tompuri, T; Lintu, N; Vaisto, J; Leppanen, PHT; Laaksonen, DE; Lindi, V; Lakka, TA				Haapala, Eero A.; Poikkeus, Anna-Maija; Kukkonen-Harjula, Katriina; Tompuri, Tuomo; Lintu, Niina; Vaisto, Juuso; Leppanen, Paavo H. T.; Laaksonen, David E.; Lindi, Virpi; Lakka, Timo A.			Associations of Physical Activity and Sedentary Behavior with Academic Skills - A Follow-Up Study among Primary School Children	PLOS ONE			English	Article							COGNITIVE CONTROL; BRAIN HEALTH; ACHIEVEMENT; PERFORMANCE; EXERCISE; ADIPOSITY; FITNESS; MOTOR; RISK; ADOLESCENTS	Background: There are no prospective studies that would have compared the relationships of different types of physical activity (PA) and sedentary behavior (SB) with academic skills among children. We therefore investigated the associations of different types of PA and SB with reading and arithmetic skills in a follow-up study among children. Methods: The participants were 186 children (107 boys, 79 girls, 6-8 yr) who were followed-up in Grades 1-3. PA and SB were assessed using a questionnaire in Grade 1. Reading fluency, reading comprehension and arithmetic skills were assessed using standardized tests at the end of Grades 1-3. Results: Among all children more recess PA and more time spent in SB related to academic skills were associated with a better reading fluency across Grades 1-3. In boys, higher levels of total PA, physically active school transportation and more time spent in SB related to academic skills were associated with a better reading fluency across the Grades 1-3. Among girls, higher levels of total PA were related to worse arithmetic skills across Grades 1-3. Moreover, total PA was directly associated with reading fluency and arithmetic skills in Grades 1-3 among girls whose parents had a university degree, whereas these relationships were inverse in girls of less educated parents. Conclusions: Total PA, physically active school transportation and SB related to academic skills may be beneficial for the development of reading skills in boys, whereas factors that are independent of PA or SB may be more important for academic skills in girls.	[Haapala, Eero A.; Tompuri, Tuomo; Lintu, Niina; Vaisto, Juuso; Laaksonen, David E.; Lindi, Virpi; Lakka, Timo A.] Univ Eastern Finland, Inst Biomed, Dept Physiol, Kuopio, Finland; [Poikkeus, Anna-Maija] Univ Jyvaskyla, Dept Teacher Educ, Jyvaskyla, Finland; [Kukkonen-Harjula, Katriina] UKK Inst Hlth Promot Res, Tampere, Finland; [Tompuri, Tuomo; Lakka, Timo A.] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland; [Vaisto, Juuso] Univ Eastern Finland, Sch Med, Inst Dent, Kuopio, Finland; [Leppanen, Paavo H. T.] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland; [Laaksonen, David E.] Kuopio Univ Hosp, Inst Clin Med, SF-70210 Kuopio, Finland; [Lakka, Timo A.] Kuopio Res Inst Exercise Med, Kuopio, Finland	University of Eastern Finland; University of Jyvaskyla; UKK Institute; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Jyvaskyla; Kuopio University Hospital; University of Eastern Finland	Haapala, EA (corresponding author), Univ Eastern Finland, Inst Biomed, Dept Physiol, Kuopio, Finland.	e.a.haapala@outlook.com	Väistö, Juuso/F-4602-2014; Lindi, Virpi/K-9008-2018; Meijer, Anna/K-5118-2016	Väistö, Juuso/0000-0001-7026-5934; Lindi, Virpi/0000-0001-6257-7209; Tompuri, Tuomo/0000-0003-3748-7580; Haapala, Eero/0000-0001-5096-851X; Poikkeus, Anna-Maija/0000-0001-7913-8691; Lintu, Niina/0000-0002-5456-1490; Lakka, Timo/0000-0002-9199-2871; Leppanen, Paavo/0000-0002-8941-2225	Ministry of Social Affairs and Health of Finland; Ministry of Education and Culture of Finland; University of Eastern Finland; Finnish Innovation Fund Sitra; Social Insurance Institution of Finland; Finnish Cultural Foundation; Juho Vainio Foundation; Foundation for Pediatric Research; Paulo Foundation; Paavo Nurmi Foundation; Diabetes Research Foundation; Kuopio University Hospital (EVO) [5031343]; Research Committee of the Kuopio University Hospital Catchment Area	Ministry of Social Affairs and Health of Finland; Ministry of Education and Culture of Finland; University of Eastern Finland; Finnish Innovation Fund Sitra; Social Insurance Institution of Finland; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Juho Vainio Foundation; Foundation for Pediatric Research; Paulo Foundation; Paavo Nurmi Foundation; Diabetes Research Foundation; Kuopio University Hospital (EVO); Research Committee of the Kuopio University Hospital Catchment Area	This work has been financially supported by grants from the Ministry of Social Affairs and Health of Finland, the Ministry of Education and Culture of Finland, the University of Eastern Finland, the Finnish Innovation Fund Sitra, the Social Insurance Institution of Finland, the Finnish Cultural Foundation, the Juho Vainio Foundation, the Foundation for Pediatric Research, the Paulo Foundation, the Paavo Nurmi Foundation, The Diabetes Research Foundation, the Kuopio University Hospital (EVO funding number 5031343) and the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed Y, 2007, MED SCI SPORT EXER, V39, P371, DOI 10.1249/01.mss.0000241654.45500.8e; Best JR, 2010, DEV REV, V30, P331, DOI 10.1016/j.dr.2010.08.001; Booth JN, 2014, BRIT J SPORT MED, V48, P265, DOI 10.1136/bjsports-2013-092334; Borzekowski DLG, 2005, ARCH PEDIAT ADOL MED, V159, P607, DOI 10.1001/archpedi.159.7.607; Bradley RH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-33; CDC (Centers for Disease Control and Prevention), 2010, ASS SCH BAS PHYS ACT; Chaddock-Heyman L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00072; Clements DH, 2011, SCIENCE, V333, P968, DOI 10.1126/science.1204537; Colley Rachel C, 2011, Health Rep, V22, P15; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Davis CL, 2011, HEALTH PSYCHOL, V30, P91, DOI 10.1037/a0021766; Donnelly JE, 2009, PREV MED, V49, P336, DOI 10.1016/j.ypmed.2009.07.022; Ekelund U, 2011, BRIT J SPORT MED, V45, P859, DOI 10.1136/bjsports-2011-090190; Eloranta AM, 2012, INT J OBESITY, V36, P950, DOI 10.1038/ijo.2012.89; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fernandez-Alvira JM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-5; Fox CK, 2010, J SCHOOL HEALTH, V80, P31, DOI 10.1111/j.1746-1561.2009.00454.x; GORTMAKER SL, 1990, PUBLIC OPIN QUART, V54, P594, DOI 10.1086/269230; Haapala EA, 2014, MED SCI SPORT EXER, V46, P1016, DOI 10.1249/MSS.0000000000000186; Haapala EA, 2013, J HUM KINET, V36, P55, DOI 10.2478/hukin-2013-0006; Hillman CH, 2009, NEUROSCIENCE, V159, P1044, DOI 10.1016/j.neuroscience.2009.01.057; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069; Jonker L, 2010, J SPORT SCI, V28, P1605, DOI 10.1080/02640414.2010.516270; Kamijo K, 2012, OBESITY, V20, P2406, DOI 10.1038/oby.2012.112; Kamijo K, 2011, DEVELOPMENTAL SCI, V14, P1046, DOI 10.1111/j.1467-7687.2011.01054.x; Kantomaa MT, 2010, HEALTH EDUC RES, V25, P368, DOI 10.1093/her/cyp048; Kempermann G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00189; Kiuru N, 2012, J SCHOOL PSYCHOL, V50, P799, DOI 10.1016/j.jsp.2012.07.001; Kwak L, 2009, J PEDIATR-US, V155, P914, DOI 10.1016/j.jpeds.2009.06.019; Lambiase MJ, 2010, MED SCI SPORT EXER, V42, P1609, DOI 10.1249/MSS.0b013e3181d0c77b; LeBlanc MM, 2012, J DEV BEHAV PEDIATR, V33, P486, DOI 10.1097/DBP.0b013e31825b849e; Li XM, 2004, PEDIATRICS, V113, P1715, DOI 10.1542/peds.113.6.1715; Lindeman J., 1998, ALLU ALA ASTEEN LUKU; Lintu N, 2014, J SPORT SCI, V32, P652, DOI 10.1080/02640414.2013.845681; Magnussen CG, 2010, CIRCULATION, V122, P1604, DOI 10.1161/CIRCULATIONAHA.110.940809; Martinez-Gomez D, 2011, ARCH PEDIAT ADOL MED, V165, P300, DOI 10.1001/archpediatrics.2010.244; McDonald NC, 2007, AM J PREV MED, V32, P509, DOI 10.1016/j.amepre.2007.02.022; Murray R, 2013, PEDIATRICS, V131, P183, DOI 10.1542/peds.2012-2993; Nurmi JE, 2013, LEARN INDIVID DIFFER, V23, P72, DOI 10.1016/j.lindif.2012.07.012; Palve KS, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000594; Pontifex MB, 2013, J PEDIATR-US, V162, P543, DOI 10.1016/j.jpeds.2012.08.036; Rasanen P, 2007, TEST ARITHMETICS TES; Rasberry CN, 2011, PREV MED, V52, pS10, DOI 10.1016/j.ypmed.2011.01.027; Sallis J, 1997, RES Q EXERCISE SPORT, V70, P127; Schellenberg EG, 2006, J EDUC PSYCHOL, V98, P457, DOI 10.1037/0022-0663.98.2.457; Shephard RJ, 1996, NUTR REV, V54, pS32; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Sigfusdottir ID, 2007, HEALTH EDUC RES, V22, P70, DOI 10.1093/her/cyl044; Silinskas G, 2010, EUR J PSYCHOL EDUC, V25, P243, DOI 10.1007/s10212-010-0014-9; Singh A, 2012, ARCH PEDIAT ADOL MED, V166, P49, DOI 10.1001/archpediatrics.2011.716; Syvaoja HJ, 2013, MED SCI SPORT EXER, V45, P2098, DOI 10.1249/MSS.0b013e318296d7b8; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Tompuri TT, 2015, CLIN PHYSIOL FUNCT I, V35, P21, DOI 10.1111/cpf.12118; Torppa M, 2006, DEV PSYCHOL, V42, P1128, DOI 10.1037/0012-1649.42.6.1128; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Tremblay MS, 2000, PEDIATR EXERC SCI, V12, P312, DOI 10.1123/pes.12.3.312; Trudeau F, 2010, AM J LIFESTYLE MED, V4, P138, DOI 10.1177/1559827609351133; Vaisto J, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-55; van der Ploeg HP, 2008, PREV MED, V46, P60, DOI 10.1016/j.ypmed.2007.06.002; Veijalainen A, 2011, CLIN PHYSIOL FUNCT I, V31, P132, DOI 10.1111/j.1475-097X.2010.00989.x; Verloigne M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-34	65	45	45	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107031	10.1371/journal.pone.0107031	http://dx.doi.org/10.1371/journal.pone.0107031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25207813	Green Submitted, gold, Green Published			2022-12-27	WOS:000342030300056
J	Scurich, N; Shniderman, A				Scurich, Nicholas; Shniderman, Adam			The Selective Allure of Neuroscientific Explanations	PLOS ONE			English	Article							BRAIN IMAGES; JUDGMENTS; SCIENCE; IMPACT; NEUROIMAGES; SKEPTICISM	Some claim that recent advances in neuroscience will revolutionize the way we think about human nature and legal culpability. Empirical support for this proposition is mixed. Two highly-cited empirical studies found that irrelevant neuroscientific explanations and neuroimages were highly persuasive to laypersons. However, attempts to replicate these effects have largely been unsuccessful. Two separate experiments tested the hypothesis that neuroscience is susceptible to motivated reasoning, which refers to the tendency to selectively credit or discredit information in a manner that reinforces preexisting beliefs. Participants read a newspaper article about a cutting-edge neuroscience study. Consistent with the hypothesis, participants deemed the hypothetical study sound and the neuroscience persuasive when the outcome of the study was congruent with their prior beliefs, but gave the identical study and neuroscience negative evaluations when it frustrated their beliefs. Neuroscience, it appears, is subject to the same sort of cognitive dynamics as other types of scientific evidence. These findings qualify claims that neuroscience will play a qualitatively different role in the way in which it shapes people's beliefs and informs issues of social policy.	[Scurich, Nicholas] Univ Calif Irvine, Dept Criminol Law & Soc Sch Law, Dept Psychol & Social Behav, Irvine, CA 92697 USA; [Shniderman, Adam] Texas Christian Univ, Dept Criminal Justice, Ft Worth, TX 76129 USA	University of California System; University of California Irvine; Texas Christian University	Scurich, N (corresponding author), Univ Calif Irvine, Dept Criminol Law & Soc Sch Law, Dept Psychol & Social Behav, Irvine, CA 92697 USA.	nscurich@uci.edu						[Anonymous], 2007, J BEHAV FINANC; Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Aue T, 2009, INT J PSYCHOPHYSIOL, V73, P10, DOI 10.1016/j.ijpsycho.2008.12.017; Baker DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069536; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Churchland PS, 2008, NEURON, V60, P409, DOI 10.1016/j.neuron.2008.10.023; Ditto PH, 2010, MACQUARIE MG COG SCI, P23; DITTO PH, 1992, J PERS SOC PSYCHOL, V63, P568, DOI 10.1037/0022-3514.63.4.568; GILOVICH T, 1983, J PERS SOC PSYCHOL, V44, P1110, DOI 10.1037/0022-3514.44.6.1110; Greene E, 2012, BEHAV SCI LAW, V30, P280, DOI 10.1002/bsl.1993; Greene J, 2004, PHILOS T R SOC B, V359, P1775, DOI 10.1098/rstb.2004.1546; Gruber D, 2012, PUBLIC UNDERST SCI, V21, P938, DOI 10.1177/0963662512454072; Gurley JR, 2008, BEHAV SCI LAW, V26, P85, DOI 10.1002/bsl.797; Harris S., 2011, MORAL LANDSCAPE SCI; HASTORF AH, 1954, J ABNORM SOC PSYCH, V49, P129, DOI 10.1037/h0057880; Hook CJ, 2013, J COGNITIVE NEUROSCI, V25, P1397, DOI 10.1162/jocn_a_00407; Jones OD, 2012, INT NEUROLAW, P349, DOI DOI 10.1007/978-3-642-21541-4_19; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; KOEHLER JJ, 1993, ORGAN BEHAV HUM DEC, V56, P28, DOI 10.1006/obhd.1993.1044; Krauss D., 2013, JURIMETRICS, V53, P395; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Lilienfeld SO, 2012, AM PSYCHOL, V67, P111, DOI 10.1037/a0023963; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; LORD CG, 1984, J PERS SOC PSYCHOL, V47, P1231, DOI 10.1037/0022-3514.47.6.1231; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017; Michael RB, 2013, PSYCHON B REV, V20, P720, DOI 10.3758/s13423-013-0391-6; Morse S, 2011, LAW INNOVATION TECH, V3, P209, DOI DOI 10.5235/175799611798204932; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Saks MJ, 2014, J EMPIR LEGAL STUD, V11, P105, DOI 10.1111/jels.12036; Schweitzer NJ, 2011, PSYCHOL PUBLIC POL L, V17, P357, DOI 10.1037/a0023581; Schweitzer NJ, 2011, BEHAV SCI LAW, V29, P592, DOI 10.1002/bsl.995; Simon D, 2013, J EMPIR LEGAL STUD, V10, P797, DOI 10.1111/jels.12028; Simon D, 2011, J EMPIR LEGAL STUD, V8, P709, DOI 10.1111/j.1740-1461.2011.01238.x; Skitka L.J., 2002, ANAL SOC ISS PUB POL, V2, P35, DOI [10.1111/j.1530-2415.2002.00024.x, DOI 10.1111/J.1530-2415.2002.00024.X]; Steinberg L, 2013, NAT REV NEUROSCI, V14, P513, DOI 10.1038/nrn3509; Waldman DA, 2011, ACAD MANAGE PERSPECT, V25, P60, DOI 10.5465/AMP.2011.59198450; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20040; WILSON TD, 1993, PSYCHOL SCI, V4, P322, DOI 10.1111/j.1467-9280.1993.tb00572.x	41	28	29	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107529	10.1371/journal.pone.0107529	http://dx.doi.org/10.1371/journal.pone.0107529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25207921	Green Published, gold			2022-12-27	WOS:000342030300089
J	Bruurs, LJM; Bos, JL				Bruurs, Lucas J. M.; Bos, Johannes L.			Mechanisms of Isoform Specific Rap2 Signaling during Enterocytic Brush Border Formation	PLOS ONE			English	Article							PHOSPHOLIPASE-C-EPSILON; EPIDERMAL-GROWTH-FACTOR; RAS; PALMITOYLATION; ACTIVATION; PROTEINS; DOMAIN; PHOSPHORYLATION; LOCALIZATION; STIMULATION	Brush border formation during polarity establishment of intestinal epithelial cells is uniquely governed by the Rap2A GTPase, despite expression of the other highly similar Rap2 isoforms (Rap2B and Rap2C). We investigated the mechanisms of this remarkable specificity and found that Rap2C is spatially segregated from Rap2A signaling as it is not enriched at the apical membrane after polarization. In contrast, both Rap2A and Rap2B are similarly located at Rab11 positive apical recycling endosomes and inside the brush border. However, although Rap2B localizes similarly it is not equally activated as Rap2A during brush border formation. We reveal that the C-terminal hypervariable region allows selective activation of Rap2A, yet this selectivity does not originate from the known differential lipid modifications of this region. In conclusion, we demonstrate that Rap2 specificity during brush border formation is determined by two distinct mechanisms involving segregated localization and selective activation.	[Bruurs, Lucas J. M.; Bos, Johannes L.] Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res & Canc Genom Netherlands, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Bos, JL (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res & Canc Genom Netherlands, Utrecht, Netherlands.	J.L.Bos@umcutrecht.nl			Netherlands Organization for Scientific Research (NWO TOP grant)	Netherlands Organization for Scientific Research (NWO TOP grant)	This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO TOP grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Chandra A, 2011, NAT CELL BIOL; Dhekne HS, 2014, J CELL SCI; Evellin S, 2002, J BIOL CHEM, V277, P16805, DOI 10.1074/jbc.M112024200; FARRELL FX, 1993, BIOCHEM J, V289, P349, DOI 10.1042/bj2890349; Gloerich M, 2012, NAT CELL BIOL, V14, P793, DOI 10.1038/ncb2537; Gloerich M, 2011, TRENDS CELL BIOL, V21, P615, DOI 10.1016/j.tcb.2011.07.001; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; Popovic M, 2013, J MOL BIOL, V425, P2782, DOI 10.1016/j.jmb.2013.04.031; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Stope MB, 2004, MOL CELL BIOL, V24, P4664, DOI 10.1128/MCB.24.11.4664-4676.2004; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tong JF, 2013, MOL CELL BIOL, V33, P4538, DOI 10.1128/MCB.00822-13; Uechi Y, 2009, BIOCHEM BIOPH RES CO, V378, P732, DOI 10.1016/j.bbrc.2008.11.107; Van Triest M, 2001, METHOD ENZYMOL, V333, P343	19	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106687	10.1371/journal.pone.0106687	http://dx.doi.org/10.1371/journal.pone.0106687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203140	gold, Green Submitted, Green Published			2022-12-27	WOS:000342684500040
J	Burns, RM; Sharp, L; Sullivan, FJ; Deady, SE; Drummond, FJ; O'Neill, C				Burns, Richeal M.; Sharp, Linda; Sullivan, Francis J.; Deady, Sandra E.; Drummond, Frances J.; O'Neill, Ciaran			Factors Driving Inequality in Prostate Cancer Survival: A Population Based Study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; REGRESSION; OUTCOMES; QUALITY; RACE	Purpose: As cancer control strategies have become more successful, issues around survival have become increasingly important to researchers and policy makers. The aim of this study was to examine the role of a range of clinical and sociodemographic variables in explaining variations in survival after a prostate cancer diagnosis, paying particular attention to the role of healthcare provider(s) i.e. private versus public status. Methods: Data were extracted from the National Cancer Registry Ireland, for patients diagnosed with prostate cancer from 1998-2009 (N = 26,183). A series of multivariate Cox and logistic regression models were used to examine the role of healthcare provider and socio-economic status (area-based deprivation) on survival, controlling for age, stage, Gleason grade, marital status and region of residence. Survival was based on all-cause mortality. Results: Older individuals who were treated in a private care setting were more likely to have survived than those who had not, when other factors were controlled for. Differences were evident with respect to marital status, region of residence, clinical stage and Gleason grade. The effect of socio-economic status was modified by healthcare provider, such that risk of death was higher in those men of lower socio-economic status treated by public, but not private providers in the Cox models. The logistic models revealed a socio-economic gradient in risk of death overall; the gradient was larger for those treated by public providers compared to those treated by private providers when controlling for a range of other confounding factors. Conclusion: The role of healthcare provider and socio-economic status in survival of men with prostate cancer may give rise to concerns that warrant further investigation.	[Burns, Richeal M.] Univ Oxford, Hlth Econ Res Ctr, Nuffield Dept Populat Hlth, Oxford, England; [Burns, Richeal M.] Univ Oxford, Surg Intervent Trials Unit, Nuffield Dept Surg Sci, Oxford, England; [Sharp, Linda; Deady, Sandra E.; Drummond, Frances J.] Natl Canc Registry, Cork, Ireland; [Sullivan, Francis J.] NUI Galway, Prostate Canc Inst, Galway, Ireland; [O'Neill, Ciaran] NUI Galway, JE Cairnes Sch Business & Econ, Galway, Ireland	University of Oxford; University of Oxford; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	O'Neill, C (corresponding author), NUI Galway, JE Cairnes Sch Business & Econ, Galway, Ireland.	ciaran.oneill@nuigalway.ie		Frances, Drummond/0000-0002-7802-776X; Sullivan, Francis J./0000-0001-5111-5383	Health Research Board (HRB) in Ireland [HRA_HSR/2010/17]; HRB Research Leader Award [RL/2013/16]	Health Research Board (HRB) in Ireland; HRB Research Leader Award	This work was conducted while Richeal Burns was completing a PhD funded by the Health Research Board (HRB) in Ireland examining the cost-effectiveness of PSA testing [HRA_HSR/2010/17]. Ciaran O'Neill is now funded under a HRB Research Leader Award RL/2013/16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi A, 2011, ASIAN PAC J CANCER P, V12, P3113; American Cancer Society, CANC TREATM SURV FAC; Ata N, 2007, HACET J MATH STAT, V36, P157; Bradburn MJ, 2003, BRIT J CANCER, V89, P431, DOI 10.1038/sj.bjc.6601119; Brenner H, 2005, J CLIN ONCOL, V23, P441, DOI 10.1200/JCO.2005.11.148; Bristow RE, 2013, JNCI-J NATL CANCER I, V105, P823, DOI 10.1093/jnci/djt065; Burns R, 2012, HEALTH POLICY, V108, P268, DOI 10.1016/j.healthpol.2012.08.014; Cancela MD, 2013, BRIT J CANCER, V109, P272, DOI 10.1038/bjc.2013.268; Clarke NW, 2008, BRIT J CANCER, V99, pS78, DOI 10.1038/sj.bjc.6604596; Colombo F., 2004, OECD HEAL WORK PAP, V15, P1; Denvir MA, 2006, J EPIDEMIOL COMMUN H, V60, P1085, DOI 10.1136/jech.2005.044255; Droomers M, 2004, EUR J PUBLIC HEALTH, V14, P311, DOI 10.1093/eurpub/14.3.311; Drummond FJ, 2010, IRISH J MED SCI, V179, P43, DOI 10.1007/s11845-009-0376-7; Eckersberger Elisabeth, 2009, Rev Urol, V11, P127; Economic and Social Research Institute (ESRI), 2011, ACT AC PUBL HOSP IR; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Globocan, 2008, PROST CANC INC MORT; Health Service Executive, 2012, PRIM CAR REIMB SERV; Health Services Executive, 2013, HOSP CANC CONTR; Kelly A, 2007, SAHRU TECHNICAL REPO; Leffondre K, 2003, STAT MED, V22, P3781, DOI 10.1002/sim.1674; Lyratzopoulos G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1928; Morris M, 2007, MED J AUSTRALIA, V186, P296, DOI 10.5694/j.1326-5377.2007.tb00904.x; MOSTOFI FK, 1975, CANCER CHEMOTH REP 1, V59, P111; National Cancer Registry Ireland, CANC TRENDS 3 REC TR; National Cancer Registry Ireland, 2011, CANC IR 2011 ANN REP; NICR/NCRI, CANC IR 1994 2004 CO; Penney KL, 2010, CANCER EPIDEM BIOMAR, V19, P2869, DOI 10.1158/1055-9965.EPI-10-0601; Roach M, 1999, J NATL CANCER I, V91, P801, DOI 10.1093/jnci/91.9.801; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; The National Treatment Purchase Fund, 2006, FREED INF GUID MAN; The Patient Treatment Register, 2010, NAT TREATM PURCH FUN; Walsh B, 2012, HEALTH ECON, V21, P1250, DOI 10.1002/hec.1784	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106456	10.1371/journal.pone.0106456	http://dx.doi.org/10.1371/journal.pone.0106456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IF	25203444	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500024
J	Giudice, E; Di Pietro, S; Alaimo, A; Blanda, V; Lelli, R; Francaviglia, F; Caracappa, S; Torina, A				Giudice, Elisabetta; Di Pietro, Simona; Alaimo, Antonio; Blanda, Valeria; Lelli, Rossella; Francaviglia, Francesco; Caracappa, Santo; Torina, Alessandra			A Molecular Survey of Rickettsia felis in Fleas from Cats and Dogs in Sicily (Southern Italy)	PLOS ONE			English	Article							SPOTTED-FEVER GROUP; CTENOCEPHALIDES-FELIS; 1ST DETECTION; MURINE TYPHUS; INFECTION; TRANSMISSION; HUMANS; SEROPREVALENCE; DISEASE; BOUCHE	Rickettsia felis, the agent of flea-borne spotted fever, has a cosmopolitan distribution. Its pathogenic role in humans has been demonstrated through molecular and serologic tests in several cases. The cat flea (Ctenocephalides felis) is considered the main reservoir and the biological vector. The aim of this study was to assess the presence and occurrence of R. felis in fleas collected from dogs and cats in various sites of Palermo (Sicily). Between August and October 2012, 134 fleas were collected from 42 animals: 37 fleas from 13 dogs and 97 fleas from 29 cats. Two species of fleas were identified: 132 Ctenocephalides felis (98.51%) collected on all animals and only two C. canis (1.49%) on one dog. Out of 132 C. felis, 34 (25.76%), 12 from dogs (32.43%) and 22 (22.68%) from cats, were positive for R. felis DNA by a polymerase chain reaction (PCR), confirmed by sequencing. The only two C. canis fleas were negative. About half of examined animals (47.62%, 20/42) were infested with at least one infected flea; in particular 46.15% of dogs (6/13) and 48.28% of cats (14/29). It seems that in the Palermo district there is a peri-domestic cycle, with a relatively high prevalence of R. felis infection in the cat flea, an insect widely diffused in home environments and which can frequently bite humans. The results also suggest that R. felis should be considered in the human differential diagnosis of any spotted-like fever or febrile illness without a clear source of infection in Sicily, especially if the patient is known to have been exposed to flea bites.	[Giudice, Elisabetta; Di Pietro, Simona; Torina, Alessandra] Univ Messina, Dept Vet Sci, Messina, Italy; [Alaimo, Antonio; Blanda, Valeria; Lelli, Rossella; Caracappa, Santo; Torina, Alessandra] Ist Zooprofilatt Sperimentale Sicilia A Mirri, Palermo, Italy; [Francaviglia, Francesco] ASP Azienda Sanit Prov Palermo, Palermo, Italy	University of Messina; IZS Sicilia	Di Pietro, S (corresponding author), Univ Messina, Dept Vet Sci, Messina, Italy.	dipietros@unime.it	Blanda, Valeria/J-5772-2016; Caracappa, Santo/P-8657-2015; Torina, Alessandra/I-3029-2016; Di Pietro, Simona/L-7817-2015; Giudice, Elisabetta/AAB-9761-2019	Blanda, Valeria/0000-0003-4657-407X; Caracappa, Santo/0000-0002-7218-1408; Torina, Alessandra/0000-0003-1555-8309; Di Pietro, Simona/0000-0003-2224-0833; Giudice, Elisabetta/0000-0002-0604-1765				Abdad Mohammad Yazid, 2011, Emerg Health Threats J, V4, P7168, DOI 10.3402/ehtj.v4i0.7168; ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; Azad AF, 1997, EMERG INFECT DIS, V3, P319, DOI 10.3201/eid0303.970308; Bauer O, 2006, AM J TROP MED HYG, V74, P444, DOI 10.4269/ajtmh.2006.74.444; Beninati T, 2002, EMERG INFECT DIS, V8, P983, DOI 10.3201/eid0809.020600; Bitam I, 2010, INT J INFECT DIS, V14, pE667, DOI 10.1016/j.ijid.2009.11.011; Capelli G, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S8; Chinery M., 1998, GUIDE INSECTS EUROPE; Choi YJ, 2005, EMERG INFECT DIS, V11, P237, DOI 10.3201/eid1102.040603; Ciceroni L, 2006, ANN NY ACAD SCI, V1078, P143, DOI 10.1196/annals.1374.024; Civen R, 2008, CLIN INFECT DIS, V46, P913, DOI 10.1086/527443; Eisen RJ, 2012, ANNU REV ENTOMOL, V57, P61, DOI 10.1146/annurev-ento-120710-100717; Eremeeva ME, 2012, J MED ENTOMOL, V49, P1485, DOI 10.1603/ME11291; Gilles J, 2008, EMERG INFECT DIS, V14, P1294, DOI 10.3201/eid1408.071546; Gilles J, 2008, EMERG INFECT DIS, V14, P684, DOI 10.3201/eid1404.071103; Herms WB, 1923, MED VET ENTOMOLOGY, V2; Hii SF, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-159; Hirunkanokpun S, 2011, MOL ECOL, V20, P4577, DOI 10.1111/j.1365-294X.2011.05289.x; La Scola B, 2002, INT J SYST EVOL MICR, V52, P2035, DOI [10.1099/ijs.0.02070-0, 10.1099/00207713-52-6-2035]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim MY, 2012, EMERG INFECT DIS, V18, P167, DOI 10.3201/eid1801.110996; Maioli G, 2009, CLIN MICROBIOL INFEC, V15, P222, DOI 10.1111/j.1469-0691.2008.02146.x; Mansueto P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/967852; Marquez FJ, 2006, ANN NY ACAD SCI, V1078, P344, DOI 10.1196/annals.1374.067; Nogueras MM, 2006, ANN NY ACAD SCI, V1078, P159, DOI 10.1196/annals.1374.028; Nilsson K, 2014, EUR J NEUROL, V21, P206, DOI 10.1111/ene.12218; Nogueras MM, 2009, CLIN MICROBIOL INFEC, V15, P237, DOI 10.1111/j.1469-0691.2008.02156.x; Nogueras MM, 2011, VECTOR-BORNE ZOONOT, V11, P479, DOI 10.1089/vbz.2010.0008; Oteo JA, 2006, J CLIN MICROBIOL, V44, P2669, DOI 10.1128/JCM.00366-06; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; Perez-Osorio CE, 2008, EMERG INFECT DIS, V14, P1019, DOI 10.3201/eid1407.071656; Reif KE, 2011, VECTOR-BORNE ZOONOT, V11, P963, DOI 10.1089/vbz.2010.0137; Reif KE, 2009, J MED ENTOMOL, V46, P723, DOI 10.1603/033.046.0402; Renvoise A, 2009, EMERG INFECT DIS, V15, P1126, DOI 10.3201/eid1507.090029; Richards AL, 2010, EMERG INFECT DIS, V16, P1081, DOI 10.3201/eid1607.091885; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Shaw SE, 2004, VET MICROBIOL, V102, P183, DOI 10.1016/j.vetmic.2004.06.013; SIKORA H., 1918, Archiv fur Schiffs- und Tropenhygiene, V22, P442; Silaghi C, 2012, VECTOR-BORNE ZOONOT, V12, P76, DOI 10.1089/vbz.2011.0732; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1687, DOI 10.3201/eid1810.120178; Thepparit C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-149; Tijsse-Klasen E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-61; Torina A, 2013, TRANSBOUND EMERG DIS, V60, P125, DOI 10.1111/tbed.12137; Torina A, 2012, EMERG INFECT DIS, V18, P1008, DOI 10.3201/eid1806.110966; TZIANABOS T, 1989, J CLIN MICROBIOL, V27, P2866, DOI 10.1128/JCM.27.12.2866-2868.1989; Wedincamp J, 2002, J VECTOR ECOL, V27, P96; Williams M, 2011, MED J AUSTRALIA, V194, P41, DOI 10.5694/j.1326-5377.2011.tb04145.x	47	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106820	10.1371/journal.pone.0106820	http://dx.doi.org/10.1371/journal.pone.0106820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203839	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500046
J	Hayes, MD; Ovcinnikovs, V; Smith, AG; Kimber, I; Dearman, RJ				Hayes, Mark D.; Ovcinnikovs, Vitalijs; Smith, Andrew G.; Kimber, Ian; Dearman, Rebecca J.			The Aryl Hydrocarbon Receptor: Differential Contribution to T Helper 17 and T Cytotoxic 17 Cell Development	PLOS ONE			English	Article							TC17 CELLS; IN-VIVO; FUNCTIONAL PLASTICITY; CULTURE-MEDIUM; AH RECEPTOR; TH17 CELLS; ACTIVATION; SUPPRESSION; MECHANISMS; EXPRESSION	The aryl hydrocarbon receptor (AhR) has been shown to be required for optimal Thelper (Th) 17 cell activation. Th17 cells provide immunity against extracellular pathogens and are implicated in autoimmune diseases. Herein, the role of the AhR in cytokine production by Th17, and by the analogous population of T cytotoxic (Tc)17 cells, has been examined. Lymph node Tc (CD8(+)) and Th (CD4(+)) cells were isolated by negative selection from naive AhR(+/-) and AhR(-/-) mice and polarised to Tc1/Th1 or Tc17/Th17 phenotypes with appropriate cytokines. Cell differentiation was assessed as a function of mRNA and protein (ELISA and flow cytometry) expression for interferon (IFN)-gamma and for key Th17 cytokines. In AhR(+/-) mice, Th17 cells displayed an exclusive IL-17 profile, which was markedly inhibited by a selective AhR antagonist to levels observed in AhR knockout mice. Addition of the natural AhR agonist 6-formylindolo[3,2-b]carbazole (FICZ) markedly enhanced Th17 cell activity in the heterozygotes. In contrast, Tc17 cells polarised into 3 distinct subsets: producing either IL-17 or IFN-gamma alone, or both cytokines. Blocking AhR was also detrimental to Tc17 development, with reduced responses recorded in AhR(-/-) mice and antagonist-mediated reduction of IL-17 expression in the heterozygotes. However, Tc17 cells were largely refractory to exogenous FICZ, presumably because Tc17 cells express baseline AhR mRNA, but unlike Th17 cells, there is no marked up-regulation during polarisation. Thus, Th17 cell development is more dependent upon AhR activation than is Tc17 cell development, suggesting that endogenous AhR ligands play a much greater role in driving Th17 cell responses.	[Hayes, Mark D.; Ovcinnikovs, Vitalijs; Kimber, Ian; Dearman, Rebecca J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Smith, Andrew G.] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England	University of Manchester; University of Leicester	Hayes, MD (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	mark.hayes1@imperial.ac.uk			medical research council [MR/J500410/1]	medical research council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the medical research council grant number MR/J500410/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Beklen A, 2007, J DENT RES, V86, P347, DOI 10.1177/154405910708600409; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Cerwenka A, 1998, J IMMUNOL, V161, P97; Davies R, 2008, CHEM RES TOXICOL, V21, P330, DOI 10.1021/tx700176r; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Di Meglio P, 2012, J INVEST DERMATOL, V132, pS15; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Evans BR, 2005, ARCH BIOCHEM BIOPHYS, V441, P151, DOI 10.1016/j.abb.2005.07.008; Eysteinsdottir JH, 2013, SCAND J IMMUNOL, V78, P529, DOI 10.1111/sji.12114; Hamada H, 2013, J IMMUNOL, V190, P296, DOI 10.4049/jimmunol.1200571; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Harper PA, 2006, BIOCHEM PHARMACOL, V72, P267, DOI 10.1016/j.bcp.2006.01.007; Henriques A, 2013, RHEUMATOL INT, V33, P2093, DOI 10.1007/s00296-013-2703-6; Hirota K, 2012, EMBO REP, V13, P113, DOI 10.1038/embor.2011.248; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ho PP, 2008, CELL RES, V18, P605, DOI 10.1038/cr.2008.63; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026522; Huber M, 2013, J CLIN INVEST, V123, P247, DOI 10.1172/JCI63681; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Kerkvliet NI, 2002, TOXICOL APPL PHARM, V185, P146, DOI 10.1006/taap.2002.9537; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Ko HSP, 1996, MOL CELL BIOL, V16, P430; Kourilsky P, 2001, TRENDS IMMUNOL, V22, P502, DOI 10.1016/S1471-4906(01)02012-9; McArthur MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038408; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rannug U, 1995, CHEM BIOL, V2, P841, DOI 10.1016/1074-5521(95)90090-X; Satoh T, 2012, EUR J IMMUNOL, V42, P2329, DOI 10.1002/eji.201142240; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Yeh N, 2010, J IMMUNOL, V185, P2089, DOI 10.4049/jimmunol.1000818; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; Zhang LN, 2010, INVEST OPHTH VIS SCI, V51, P2109, DOI 10.1167/iovs.09-3993; Zhang N, 2010, BIOCHEM PHARMACOL, V80, P197, DOI 10.1016/j.bcp.2010.03.023	43	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106955	10.1371/journal.pone.0106955	http://dx.doi.org/10.1371/journal.pone.0106955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203682	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500057
J	Mancuso, P; O'Brien, E; Prano, J; Goel, D; Aronoff, DM				Mancuso, Peter; O'Brien, Edmund; Prano, Joseph; Goel, Deepti; Aronoff, David M.			No Impairment in Host Defense against Streptococcus pneumoniae in Obese CPEfat/fat Mice	PLOS ONE			English	Article							PULMONARY BACTERIAL CLEARANCE; HIGH-FAT DIET; CARBOXYPEPTIDASE-E; H1N1 INFLUENZA; INCREASED MORTALITY; OB/OB MICE; INFECTION; INFLAMMATION; RISK; RESPONSES	In the US and globally, dramatic increases in the prevalence of adult and childhood obesity have been reported during the last 30 years. In addition to cardiovascular disease, type II diabetes, and liver disease, obesity has recently been recognized as an important risk factor for influenza pneumonia. During the influenza pandemic of 2009, obese individuals experienced a greater severity of illness from the H1N1 virus. In addition, obese mice have also been shown to exhibit increased lethality and aberrant pulmonary inflammatory responses following influenza infection. In contrast to influenza, the impact of obesity on bacterial pneumonia in human patients is controversial. In this report, we compared the responses of lean WT and obese CPEfat/fat mice following an intratracheal infection with Streptococcus pneumoniae, the leading cause of community-acquired pneumonia. At 16 weeks of age, CPEfat/fat mice develop severe obesity, hyperglycemia, elevated serum triglycerides and leptin, and increased blood neutrophil counts. There were no differences between lean WT and obese CPEfat/fat mice in survival or lung and spleen bacterial burdens following intratracheal infection with S. pneumoniae. Besides a modest increase in TNF-alpha levels and increased peripheral blood neutrophil counts in CPEfat/fat mice, there were not differences in lung or serum cytokines after infection. These results suggest that obesity, accompanied by hyperglycemia and modestly elevated triglycerides, at least in the case of CPEfat/fat mice, does not impair innate immunity against pneumococcal pneumonia.	[Mancuso, Peter; O'Brien, Edmund; Prano, Joseph; Goel, Deepti] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Mancuso, Peter] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Aronoff, David M.] Vanderbilt Univ, Dept Med, Div Infect Dis, Nashville, TN USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University	Mancuso, P (corresponding author), Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.	pmancuso@umich.edu	Mancuso, Peter/AGZ-3550-2022	Mancuso, Peter/0000-0002-2559-7320; Aronoff, David/0000-0003-4587-6121	National Institutes of Health [HL077417, T32 ES007062]; Flight Attendants Medical Research Institute [CIA-103071]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendants Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by grants from the National Institutes of Health HL077417 (PM), Institutional Training Grant T32 ES007062 (EO), and the Flight Attendants Medical Research Institute CIA-103071(PM and DMA). The funders had not role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Naoe, 2011, Allergology International, V60, P305, DOI 10.2332/allergolint.10-OA-0252; Bartlett JG, 2011, CLIN INFECT DIS, V52, pS296, DOI 10.1093/cid/cir045; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Cecere LM, 2011, COPD, V8, P275, DOI 10.3109/15412555.2011.586660; Cianfarani F, 2013, WOUND REPAIR REGEN, V21, P545, DOI 10.1111/wrr.12051; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Easterbrook JD, 2011, INFLUENZA OTHER RESP, V5, P418, DOI 10.1111/j.1750-2659.2011.00254.x; Faggioni R, 2000, P NATL ACAD SCI USA, V97, P2367, DOI 10.1073/pnas.040561297; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Fuhrman C, 2011, EPIDEMIOL INFECT, V139, P1202, DOI 10.1017/S0950268810002414; Fuhrman C, 2010, EUROSURVEILLANCE, V15, P17; Gidding SS, 2004, J PEDIATR-US, V144, P766, DOI 10.1016/S0022-3476(04)00243-4; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Guo X, 2011, MUCOSAL IMMUNOL, V4, P294, DOI 10.1038/mi.2010.76; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Herishanu Y, 2006, EUR J HAEMATOL, V76, P516, DOI 10.1111/j.1600-0609.2006.00658.x; Hodgson KA, 2013, INFECT IMMUN, V81, P470, DOI 10.1128/IAI.00930-12; Hsu A, 2007, CLIN EXP IMMUNOL, V150, P332, DOI 10.1111/j.1365-2249.2007.03491.x; Ikejima S, 2005, DIABETES, V54, P182, DOI 10.2337/diabetes.54.1.182; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Johnston RA, 2006, AM J PHYSIOL-REG I, V290, pR126, DOI 10.1152/ajpregu.00306.2005; LaRussa P, 2011, SEMIN RESP CRIT CARE, V32, P393, DOI 10.1055/s-0031-1283279; Louriz Maha, 2010, Int Arch Med, V3, P26, DOI 10.1186/1755-7682-3-26; Madan R, 2014, INFECT IMMUN, V82, P341, DOI 10.1128/IAI.00972-13; Mancuso P, 2006, AM J RESP CRIT CARE, V173, P212, DOI 10.1164/rccm.200506-909OC; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Mancuso P, 2013, PULM PHARMACOL THER, V26, P412, DOI 10.1016/j.pupt.2012.04.006; Mancuso P, 2011, J IMMUNOL, V186, P1081, DOI 10.4049/jimmunol.1001470; Marcus JA, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-013-0411-y; Moore SI, 2003, INFECT IMMUN, V71, P4182, DOI 10.1128/IAI.71.7.4182-4185.2003; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; NANJI AA, 1985, AM J CLIN PATHOL, V84, P346, DOI 10.1093/ajcp/84.3.346; O'Brien KB, 2012, J INFECT DIS, V205, P252, DOI 10.1093/infdis/jir729; Ogden Cynthia L, 2013, NCHS Data Brief, P1; Ordway D, 2008, J LEUKOCYTE BIOL, V83, P1502, DOI 10.1189/jlb.1007696; Paich HA, 2013, OBESITY, V21, P2377, DOI 10.1002/oby.20383; Phipps JC, 2010, INFECT IMMUN, V78, P1214, DOI 10.1128/IAI.00963-09; Phung DT, 2013, OBES REV, V14, P839, DOI 10.1111/obr.12055; Rivas-Santiago B, 2012, J DERMATOL SCI, V65, P19, DOI 10.1016/j.jdermsci.2011.09.013; Rueda AM, 2010, J INFECTION, V60, P99, DOI 10.1016/j.jinf.2009.12.003; Seminog OO, 2013, THORAX, V68, P171, DOI 10.1136/thoraxjnl-2012-202480; Sideleva O, 2013, PULM PHARMACOL THER, V26, P455, DOI 10.1016/j.pupt.2012.05.002; Singanayagam A, 2011, J INFECTION, V63, P243, DOI 10.1016/j.jinf.2011.07.014; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tilg H, 2008, CLIN SCI, V114, P275, DOI 10.1042/CS20070196; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Wieland CW, 2005, INT IMMUNOL, V17, P1399, DOI 10.1093/intimm/dxh317; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	52	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106420	10.1371/journal.pone.0106420	http://dx.doi.org/10.1371/journal.pone.0106420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203099	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500021
J	Le, Y; Liu, SL; Peng, MC; Tan, C; Liao, Q; Duan, KM; Ouyang, W; Tong, JB				Le, Yuan; Liu, Shuli; Peng, Mingchao; Tan, Chang; Liao, Qin; Duan, Kaiming; Ouyang, Wen; Tong, Jianbin			Aging Differentially Affects the Loss of Neuronal Dendritic Spine, Neuroinflammation and Memory Impairment at Rats after Surgery	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; AGED RATS; UBIQUITIN AGGREGATION; TRANSGENIC RATS; DECLINE; BRAIN; PLASTICITY; DEFICITS; IMPACT; CORTEX	It is known that age is an important factor for postoperative cognitive dysfunction (POCD) and the patients with POCD suffer from the impairment of multiple brain regions and multiple brain functions. However currently animal studies of POCD mainly focus on hippocampus region, therefore in this study we performed partial hepatectomy in young adult and aged rats to test the questions (1) whether POCD in animals involves other brain areas besides hippocampus; (2) how age influences POCD of young adult and aged animals. We found that (1) in young adult rats, the memory was not significantly affected (P > 0.05) 1d, 3d and 7d after partial hepatectomy, but was significantly impaired (p < 0.001) in aged rats 1d and 3d post-surgery; (2) in young adult rats, the surgery did not significantly affect the densities of dendritic spines of neurons at CA1, dentate gyrus (DG) and cingulate cortex (P > 0.05, respectively) 1d and 3d post-surgery, but the spine densities at CA1 and DG of aged rats were significant reduced 1d and 3d post-surgery (p < 0.001, respectively), however this didn't happen at cingulate cortex (P > 0.05); (3) In young adult rats, surgery didn't affect the activation of microglia and levels of TNF-alpha and IL-1b at hippocampus (P < 0.05), but significantly activated microglia and increased levels of TNF-alpha and IL-1 beta at hippocampus of aged rats (P, 0.05). Our data suggest that (1) partial hepatectomy-induced POCD mainly involves hippocampus impairments, and (2) differential loss of neuronal dendritic spines and neuroinflammation at hippocampus are most likely the mechanism for the formation of POCD in aged rats.	[Le, Yuan; Liu, Shuli; Peng, Mingchao; Tan, Chang; Liao, Qin; Duan, Kaiming; Ouyang, Wen; Tong, Jianbin] Cent S Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China; [Tong, Jianbin] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China	Central South University; Central South University	Ouyang, W (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China.	ouyangwen133@vip.sina.com; jianbintong@aliyun.com			National Natural Science Foundation of China [81371216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81371216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037410; Barrientos RM, 2004, J NEUROIMMUNOL, V155, P119, DOI 10.1016/j.jneuroim.2004.06.009; Bloss EB, 2011, J NEUROSCI, V31, P7831, DOI 10.1523/JNEUROSCI.0839-11.2011; Cao XZ, 2010, PROG NEURO-PSYCHOPH, V34, P1426, DOI 10.1016/j.pnpbp.2010.07.027; Chen MH, 2013, J ANESTH, V27, P487, DOI 10.1007/s00540-012-1548-6; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Fiore M, 1996, BRAIN BEHAV IMMUN, V10, P126, DOI 10.1006/brbi.1996.0013; Harvey Jenni, 2013, Front Synaptic Neurosci, V5, P3, DOI 10.3389/fnsyn.2013.00003; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Hovens IB, 2012, BRAIN BEHAV IMMUN, V26, P1169, DOI 10.1016/j.bbi.2012.06.004; Huang C, 2012, HUM MOL GENET, V21, P4602, DOI 10.1093/hmg/dds299; Hudson AE, 2011, BRIT J ANAESTH, V107, P30, DOI 10.1093/bja/aer122; Kapila AK, 2014, J ALZHEIMERS DIS, V41, P1, DOI 10.3233/JAD-132258; Li SY, 2013, BRAIN RES, V1496, P84, DOI 10.1016/j.brainres.2012.12.025; Matsumoto Y, 2002, J NEUROCHEM, V82, P234, DOI 10.1046/j.1471-4159.2002.00944.x; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Monk TG, 2011, CURR OPIN CRIT CARE, V17, P376, DOI 10.1097/MCC.0b013e328348bece; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Petralia RS, 2014, AGEING RES REV, V14, P31, DOI 10.1016/j.arr.2014.01.003; Ramaiah Ramesh, 2009, Anesthesiol Clin, V27, P485, DOI 10.1016/j.anclin.2009.07.011; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Terrando N, 2011, MAYO CLIN PROC, V86, P885, DOI 10.4065/mcp.2011.0332; Tong JB, 2012, J NEUROCHEM, V123, P406, DOI 10.1111/jnc.12014; Wang JW, 2012, NEUROCHEM RES, V37, P2125, DOI 10.1007/s11064-012-0834-x; Wang Y, 2013, MOL MED REP, V7, P1137, DOI 10.3892/mmr.2013.1322; Wuri G, 2011, ACTA ANAESTH SCAND, V55, P474, DOI 10.1111/j.1399-6576.2011.02402.x; Yan XB, 2012, NEUROSCI LETT, V506, P240, DOI 10.1016/j.neulet.2011.11.015; Yau SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024263; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015	32	32	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106837	10.1371/journal.pone.0106837	http://dx.doi.org/10.1371/journal.pone.0106837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198176	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700058
J	Murakami, K; Kohno, M; Kadoya, M; Nagahara, H; Fujii, W; Seno, T; Yamamoto, A; Oda, R; Fujiwara, H; Kubo, T; Morita, S; Nakada, H; Hla, T; Kawahito, Y				Murakami, Ken; Kohno, Masataka; Kadoya, Masatoshi; Nagahara, Hidetake; Fujii, Wataru; Seno, Takahiro; Yamamoto, Aihiro; Oda, Ryo; Fujiwara, Hiroyoshi; Kubo, Toshikazu; Morita, Satoshi; Nakada, Hiroshi; Hla, Timothy; Kawahito, Yutaka			Knock Out of S1P3 Receptor Signaling Attenuates Inflammation and Fibrosis in Bleomycin-Induced Lung Injury Mice Model	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; IDIOPATHIC PULMONARY-FIBROSIS; SPHINGOSINE 1-PHOSPHATE; VASCULAR LEAK; MURINE; SPHINGOSINE-1-PHOSPHATE; MECHANISMS	Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite involved in many critical cellular processes, including proliferation, migration, and angiogenesis, through interaction with a family of five G protein-coupled receptors (S1P1-5). Some reports have implicated S1P as an important inflammatory mediator of the pathogenesis of airway inflammation, but the role of S1P3 in the pathogenesis of lung diseases is not completely understood. We used S1P3-deficient (knockout (KO)) mice to clarify the role of S1P3 receptor signaling in the pathogenesis of pulmonary inflammation and fibrosis using a bleomycin-induced model of lung injury. On the seventh day after bleomycin administration, S1P3 KO mice exhibited significantly less body weight loss and pulmonary inflammation than wild-type (WT) mice. On the 28th day, there was less pulmonary fibrosis in S1P3 KO mice than in WT mice. S1P3 KO mice demonstrated a 56% reduction in total cell count in bronchoalveolar lavage fluid (BALF) collected on the seventh day compared with WT mice; however, the differential white blood cell profiles were similar. BALF analysis on the seventh day showed that connective tissue growth factor (CTGF) levels were significantly decreased in S1P3 KO mice compared with WT mice, although no differences were observed in monocyte chemotactic protein-1 (MCP-1) or transforming growth factor beta 1 (TGF-beta 1) levels. Finally, S1P levels in BALF collected on the 7th day after treatment were not significantly different between WT and S1P3 KO mice. Our results indicate that S1P3 receptor signaling plays an important role in pulmonary inflammation and fibrosis and that this signaling occurs via CTGF expression. This suggests that this pathway might be a therapeutic target for pulmonary fibrosis.	[Murakami, Ken; Kohno, Masataka; Kadoya, Masatoshi; Nagahara, Hidetake; Fujii, Wataru; Seno, Takahiro; Yamamoto, Aihiro; Kawahito, Yutaka] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan; [Kubo, Toshikazu] Kyoto Prefectural Univ Med, Dept Rheumat Dis & Joint Funct, Kyoto, Japan; [Oda, Ryo; Fujiwara, Hiroyoshi; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthoped, Kyoto, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Nakada, Hiroshi] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 603, Japan; [Hla, Timothy] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto University; Kyoto Sangyo University; Cornell University	Kohno, M (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan.	mkohno@koto.kpu-m.ac.jp	; Hla, Timothy/G-5873-2012	Fujii, Wataru/0000-0002-1633-8255; Kawahito, Yutaka/0000-0002-3860-0488; Hla, Timothy/0000-0001-8355-4065				Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Cooper JAD, 2000, AM J RESP CELL MOL, V22, P520, DOI 10.1165/ajrcmb.22.5.f185; Gellings Lowe N, 2009, CARDIOVASC RES, V82, P303, DOI 10.1093/cvr/cvp056; Gorshkova I, 2012, J LIPID RES, V53, P1553, DOI 10.1194/jlr.M026039; Grotendorst GR, CONNECTIVE TISSUE GR; Huang LS, 2013, FASEB J, V27, P1749, DOI 10.1096/fj.12-219634; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Leask A, 2004, J INVEST DERMATOL, V122, P1, DOI 10.1046/j.0022-202X.2003.22133.x; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li CY, 2009, AM J PATHOL, V175, P1464, DOI 10.2353/ajpath.2009.090037; Manuscript A, 2009, NIH PUBLIC ACCESS, V40, P362; Mathew B, 2011, FASEB J, V25, P3388, DOI 10.1096/fj.11-183970; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Milara J, 2012, THORAX, V67, P147, DOI 10.1136/thoraxjnl-2011-200026; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Qi W, 2007, NEPHROLOGY, V12, P267, DOI 10.1111/j.1440-1797.2007.00788.x; Rahaman M, 2006, AM J RESP CELL MOL, V34, P233, DOI 10.1165/rcmb.2005-0126OC; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sammani S, 2010, AM J RESP CELL MOL, V43, P394, DOI 10.1165/rcmb.2009-0223OC; Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC; Singleton PA, 2007, AM J RESP CELL MOL, V37, P222, DOI 10.1165/rcmb.2006-0327OC; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Sobel K, 2013, J BIOL CHEM, V288, P14839, DOI 10.1074/jbc.M112.426726; Takuwa N, 2010, CARDIOVASC RES, V85, P484, DOI 10.1093/cvr/cvp312; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200	34	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106792	10.1371/journal.pone.0106792	http://dx.doi.org/10.1371/journal.pone.0106792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198418	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700050
J	Shen, DD; Xie, XJ; Zhu, ZJ; Yu, X; Liu, HL; Wang, HZ; Fan, HW; Wang, DW; Jiang, GR; Hong, M				Shen, Dandan; Xie, Xuejian; Zhu, Zhijie; Yu, Xi; Liu, Hailiang; Wang, Huizhu; Fan, Hongwei; Wang, Dawei; Jiang, Guorong; Hong, Min			Screening Active Components from Yu-Ping-Feng-San for Regulating Initiative Key Factors in Allergic Sensitization	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; HUMAN EPITHELIAL-CELLS; INFLAMMATION; EXTRACTION; CYTOKINE	Yu-ping-feng-san (YPFS) is a Chinese medical formula that is used clinically for allergic diseases and characterized by reducing allergy relapse. Our previous studies demonstrated that YPFS efficiently inhibited T helper 2 cytokines in allergic inflammation. The underlying mechanisms of action of YPFS and its effective components remain unclear. In this study, it was shown that YPFS significantly inhibited production of thymic stromal lymphopoietin (TSLP), an epithelial cell-derived initiative factor in allergic inflammation, in vitro and in vivo. A method of human bronchial epithelial cell (16HBE) binding combined with HPLC-MS (named 16HBE-HPLC-MS) was established to explore potential active components of YPFS. The following five components bound to 16HBE cells: calycosin-7-glucoside, ononin, claycosin, sec-o-glucosylhamaudol and formononetin. Serum from YPFS-treated mice was analyzed and three major components were detected claycosin, formononetin and cimifugin. Among these, claycosin and formononetin were detected by 16HBE-HPLC-MS and in the serum of YPFS-treated mice. Claycosin and formononetin decreased the level of TSLP markedly at the initial stage of allergic inflammation in vivo. Nuclear factor (NF)-kappa B, a key transcription factor in TSLP production, was also inhibited by claycosin and formononetin, either in terms of transcriptional activation or its nuclear translocation in vitro. Allergic inflammation was reduced by claycosin and formononetin when they are administered only at the initial stage in a murine model of atopic contact dermatitis. Thus, epithelial cell binding combined with HPLC-MS is a valid method for screening active components from complex mixtures of Chinese medicine. It was demonstrated that the compounds screened from YPFS significantly attenuated allergic inflammation probably by reducing TSLP production via regulating NF-kappa B activation.	[Shen, Dandan; Zhu, Zhijie; Yu, Xi; Liu, Hailiang; Wang, Huizhu; Hong, Min] Nanjing Univ Chinese Med, Natl Stand Lab Pharmacol Chinese Mat Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Jiangsu, Peoples R China; [Xie, Xuejian] Nanjing Mil Command, Nanjing Gen Hosp, Nanjing, Jiangsu, Peoples R China; [Fan, Hongwei] Nanjing Med Univ, Dept Clin Pharmacol Lab, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China; [Jiang, Guorong] Suzhou Hosp Trad Chinese Med, Suzhou, Peoples R China; [Wang, Dawei] Jiangsu Acad Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Shen, Dandan] First Peoples Hosp Taicang, Dept Pharm, Taicang, Peoples R China	Nanjing University of Chinese Medicine; Nanjing General Hospital; Nanjing Medical University	Fan, HW (corresponding author), Nanjing Med Univ, Dept Clin Pharmacol Lab, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	fanhongwei178@sina.com; hongmin72@hotmail.com			National Natural Science Foundation of China [81073121, 81373549, 81102885]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Qing Lan Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Qing Lan Project(Jiangsu Polytech Institute)	This research was funded by Project 81073121, 81373549 and 81102885 supported by National Natural Science Foundation of China, Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and Qing Lan Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Brigadeau F, 2005, J CARDIOVASC ELECTR, V16, P629, DOI 10.1046/j.1540-8167.2005.40584.x; Chen XT, 2006, AM J CHINESE MED, V34, P631, DOI 10.1142/S0192415X06004168; Comeau MR, 2010, MUCOSAL IMMUNOL, V3, P138, DOI 10.1038/mi.2009.134; Dong ZB, 2005, J PHARMACEUT BIOMED, V38, P664, DOI 10.1016/j.jpba.2005.02.008; Fan HW, 2004, CHINESE PHARM J, V41, P63; Gu J, 2005, SHANGHAI J TRADITION, V39, P50; Hong M, 2008, CHINA J CHINESE MAT, V34, P450; Hong M, 2012, MOLECULES, V17, P1468, DOI 10.3390/molecules17021468; Huang C, 2011, CHIN J EXP TRADIT ME, V17, P266, DOI DOI 10.13422/j.cnki.syfjx.2011.10.078; Hulse KE, 2010, J ALLERGY CLIN IMMUN, V125, P247, DOI 10.1016/j.jaci.2009.10.027; Kong XF, 2004, INT IMMUNOPHARMACOL, V4, P975, DOI 10.1016/j.intimp.2004.03.008; Kuang WenJuan, 2011, Tumor, V31, P789; Li Y, 1999, CHINESE LITERATURE, P95; Li Y, 2007, J PHARM BIOMED ANAL, V44, P439; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Shao JH, 2011, CHINA J EXPT TRADITI, V17, P173; Shen CB, 2009, SHANGHAI J TRADITION, V43, P58; Sheng, 2009, ZHEJIANG CHINESE MED, V33, P701; Soumelis V, 2004, SPRINGER SEMIN IMMUN, V25, P325, DOI 10.1007/s00281-003-0152-0; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sun L, 2012, MOL CARDIOLOGY CHINA, V3, P186; Tang D., 1984, CHINESE PHARMACOL B, V19, P43; Tang XH, 1998, TRADITIONAL CHINESE, V11, P7; Wang Hui-Zhu, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1052; Wang YH, 2007, J CLIN INVEST, V117, P3655, DOI 10.1172/JCI34182; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; [王志洁 Wang Zhijie], 2003, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V20, P452; Xia DX, 2009, CHINESE J GERONTOLOG, V29, P2340; Xiao WH, 2008, CHINESE J ANAL CHEM, V36, P1399; Yang, 2009, GUIDING J TRADITIONA, V15, P39; Yesilada E, 2005, J ETHNOPHARMACOL, V96, P71, DOI 10.1016/j.jep.2004.08.036; Yuan XJ, 2009, GUIDING J TRADITIONA, V15, P8; Zeng WJ, 2008, CHIN J DERMATO VENER, V7, P16; Zhang Dan, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P963; Zhang Y, 1995, CHINESE PHARMACOL B, V11, P136; ZHANG Y, 1997, J CHENGDU U TCM, V20, P39; Zhang Z, 2009, IND ROBOT, V36, P36, DOI 10.1108/01439910910924657; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	40	38	42	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107279	10.1371/journal.pone.0107279	http://dx.doi.org/10.1371/journal.pone.0107279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198676	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700102
J	Mayo, CE; Mullens, BA; Reisen, WK; Osborne, CJ; Gibbs, EPJ; Gardner, IA; MacLachlan, NJ				Mayo, Christie E.; Mullens, Bradley A.; Reisen, William K.; Osborne, Cameron J.; Gibbs, E. Paul J.; Gardner, Ian A.; MacLachlan, N. James			Seasonal and Interseasonal Dynamics of Bluetongue Virus Infection of Dairy Cattle and Culicoides sonorensis Midges in Northern California - Implications for Virus Overwintering in Temperate Zones	PLOS ONE			English	Article							EXPERIMENTAL CYCLIC TRANSMISSION; ENCEPHALITIS-VIRUS; RECENT EMERGENCE; BITING MIDGES; DIPTERA; CERATOPOGONIDAE; VARIIPENNIS; VECTOR; ABUNDANCE; CHICKENS	Bluetongue virus (BTV) is the cause of an economically important arboviral disease of domestic and wild ruminants. The occurrence of BTV infection of livestock is distinctly seasonal in temperate regions of the world, thus we determined the dynamics of BTV infection (using BTV-specific real time reverse transcriptase polymerase chain reaction) among sentinel cattle and vector Culicoides sonorensis (C. sonorensis) midges on a dairy farm in northern California throughout both the seasonal and interseasonal (overwintering) periods of BTV activity from August 2012 until March 2014. The data confirmed widespread infection of both sentinel cattle and vector midges during the August - November period of seasonal BTV transmission, however BTV infection of parous female midges captured in traps set during daylight hours also was detected in February of both 2013 and 2014, during the interseasonal period. The finding of BTV-infected vector midges during midwinter suggests that BTV may overwinter in northern California by infection of long-lived female C. sonorensis midges that were infected during the prior seasonal period of virus transmission, and reemerged sporadically during the overwintering period; however the data do not definitively preclude other potential mechanisms of BTV overwintering that are also discussed.	[Mayo, Christie E.; Osborne, Cameron J.; MacLachlan, N. James] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Mullens, Bradley A.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Reisen, William K.] Univ Calif Davis, Ctr Vectorborne Dis, Davis, CA 95616 USA; [Gibbs, E. Paul J.] Univ Florida, Coll Vet Med, Gainesville, FL USA; [Gardner, Ian A.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada	University of California System; University of California Davis; University of California System; University of California Riverside; University of California System; University of California Davis; State University System of Florida; University of Florida; University of Prince Edward Island	Mayo, CE (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	cemayo@ucdavis.edu			Agriculture and Food Research Initiative competitive grant from the USDA National Institute of Food and Agriculture [2012-67015-19527]; Center for Food Animal Health at the University of California Davis; U.S. Department of Agriculture under the Animal Health Act, Public Law [95-113]	Agriculture and Food Research Initiative competitive grant from the USDA National Institute of Food and Agriculture; Center for Food Animal Health at the University of California Davis; U.S. Department of Agriculture under the Animal Health Act, Public Law	These studies were supported by funds provided by the Agriculture and Food Research Initiative competitive grant no. 2012-67015-19527 from the USDA National Institute of Food and Agriculture, the Center for Food Animal Health at the University of California Davis, the U.S. Department of Agriculture under the Animal Health Act, 1977, Public Law 95-113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldet T, 2008, PREV VET MED, V87, P84, DOI 10.1016/j.prevetmed.2008.06.014; Batten C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096049; BELLAMY RE, 1967, AM J EPIDEMIOL, V85, P282, DOI 10.1093/oxfordjournals.aje.a120692; BELLAMY RE, 1968, AM J EPIDEMIOL, V87, P484, DOI 10.1093/oxfordjournals.aje.a120838; Biggerstaff BJ, 2006, MICROSOFT EXCEL ADD; Bonneau KR, 2002, VET MICROBIOL, V88, P115, DOI 10.1016/S0378-1135(02)00106-2; Du Toit R. M., 1944, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V19, P7; ERASMUS BJ, 1975, AUST VET J, V51, P196, DOI 10.1111/j.1751-0813.1975.tb00054.x; FOSTER NM, 1963, AM J VET RES, V24, P1195; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; Holbrook FR, 2000, J MED ENTOMOL, V37, P65, DOI 10.1603/0022-2585-37.1.65; JONES ROBERT HENRY, 1961, ANN ENT SOC AMER, V54, P702, DOI 10.1093/aesa/54.5.702; Lysyk TJ, 2007, J MED ENTOMOL, V44, P741, DOI 10.1603/0022-2585(2007)44[741:EOTOLH]2.0.CO;2; Maan S., 2011, EMERG INFEC IN PRESS; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Maclachlan NJ, 2010, VET CLIN N AM-FOOD A, V26, P163, DOI 10.1016/j.cvfa.2009.10.012; MACLACHLAN NJ, 1994, ARCH VIROL, V136, P1, DOI 10.1007/BF01538812; Mayo CE, 2010, TRANSBOUND EMERG DIS, V57, P277, DOI 10.1111/j.1865-1682.2010.01149.x; Mayo CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089633; Mayo CE, 2012, VET PARASITOL, V187, P295, DOI 10.1016/j.vetpar.2012.01.004; Mayo CE, 2012, VET MICROBIOL, V155, P158, DOI 10.1016/j.vetmic.2011.08.029; MCKERCHER DG, 1953, J AM VET MED ASSOC, V122, P300; Meiswinkel R, 2008, PREV VET MED, V87, P182, DOI 10.1016/j.prevetmed.2008.06.008; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; Mullens BA, 2004, VETER ITAL SER, V40, P160; NEVILL E M, 1971, Onderstepoort Journal of Veterinary Research, V38, P65; Newhouse V F, 1966, J Med Entomol, V3, P340, DOI 10.1093/jmedent/3.3-4.340; NUNAMAKER RA, 1990, COMP BIOCHEM PHYS A, V96, P19, DOI 10.1016/0300-9629(90)90036-R; OSBURN BI, 1981, AM J VET RES, V42, P884; PRICE DA, 1954, J AM VET MED ASSOC, V124, P255; Purse BV, 2006, MED VET ENTOMOL, V20, P335, DOI 10.1111/j.1365-2915.2006.00636.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Singer RS, 2001, J VET DIAGN INVEST, V13, P43, DOI 10.1177/104063870101300109; Spreull J, 1905, J COMP PATHOL, V18, P321, DOI DOI 10.1016/S0368-1742(05)80073-6; STOTT J L, 1985, P571; Takamatsu H-H, 2004, Vet Ital, V40, P456; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070800; Viennet E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-119; White DM, 2005, J GEN VIROL, V86, P453, DOI 10.1099/vir.0.80290-0; Wilson A, 2008, PLOS BIOL, V6, P1612, DOI 10.1371/journal.pbio.0060210; Wirth W.W., 1985, Progress in Clinical and Biological Research, V178, P165	42	28	28	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106975	10.1371/journal.pone.0106975	http://dx.doi.org/10.1371/journal.pone.0106975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215598	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300032
J	Xiao, JS; Su, CM; Zeng, XT				Xiao, Jin-song; Su, Cun-mei; Zeng, Xian-tao			Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Supposed Normal Ovarian Responders Undergoing IVF: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; FOLLICLE-STIMULATING-HORMONE; LEUPROLIDE ACETATE; GONADOTROPIN; CETRORELIX; GANIRELIX; EFFICACY; EMBRYO; SINGLE; GROWTH	Objective: To evaluate the effectiveness and safety of GnRH antagonist and GnRH agonist in supposed normal ovarian responders undergoing IVF. Methods: Data from 6 databases were retrieved for this study. The RCTs of GnRH agonist and GnRH antagonist use during IVF-EF therapy for patients with supposed normal ovarian response were included. A meta-analysis was performed with Revman 5.1software. Results: Twenty-three RCTs met the inclusion criteria. The number of stimulation days (mean difference (MD): -0.66, 95% confidence interval (CI): -1.04 similar to-0.27), Gn amount (MD: -2.92, 95% CI: -5.0 similar to-0.85), E2 values on the day of HCG (MD: -330.39, 95% CI: -510.51 similar to-150.26), Number of oocytes retrieved (MD: -1.33, 95% CI: -2.02 similar to-0.64), clinical pregnancy rate (odds ratio (OR): 0.87, 95% CI: 0.75-1.0), and ovarian hyperstimulation syndrome (OHSS) incidence (OR: 0.59, 95% CI: 0.42 similar to 0.82) were significantly lower in GnRH antagonist protocol than GnRH agonist protocol. However, the endometrial thickness on the day of HCG (MD: -0.04, 95% CI: -0.23 similar to 0.14), the ongoing pregnancy rate (OR: 0.87, 95% CI: 0.74 similar to 1.03), live birth rate (OR: 0.89, 95% CI: 0.64 similar to 1.24), miscarriage rate (OR: 1.17, 95% CI: 0.85 similar to 1.61), and cycle cancellation rate (OR: 1.11, 95% CI: 0.90 similar to 1.37) did not significantly differ between the 2 groups. Conclusions: During IVF treatment for patients with supposed normal responses, the incidence of OHSS were significantly lower, whereas the ongoing pregnancy and live birth rates were similar in the GnRH antagonist compared with the standard long GnRH agonist protocols.	[Xiao, Jin-song] Hubei Univ Med, Taihe Hosp, Reprod Med Ctr, Shiyan City, Hubei Province, Peoples R China; [Su, Cun-mei] Yunnan Prov Populat & Family Planning Sci & Techn, Reprod Med & Treatment Ctr, Kunming, Yunnan, Peoples R China; [Zeng, Xian-tao] Affiliated Taihe Hosp, Hubei Med Coll, Evidence Based Med Ctr, Shiyan City, HuBei, Peoples R China	Hubei University of Medicine	Xiao, JS (corresponding author), Hubei Univ Med, Taihe Hosp, Reprod Med Ctr, Shiyan City, Hubei Province, Peoples R China.	xjs660310@163.com		Zeng, Xian-Tao/0000-0003-1262-725X				Al-Inany H, 2001, COCHRANE DB SYST REV, V4; Al-Inany HG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub2; Al-Inany HG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub3; Albano C, 2000, HUM REPROD, V15, P526, DOI 10.1093/humrep/15.3.526; Baart EB, 2007, HUM REPROD, V22, P980, DOI 10.1093/humrep/del484; Barmat LI, 2005, FERTIL STERIL, V83, P321, DOI 10.1016/j.fertnstert.2004.06.076; Borm G, 2000, HUM REPROD, V15, P1490; Check M L, 2004, Clin Exp Obstet Gynecol, V31, P257; Depalo R, 2009, GYNECOL ENDOCRINOL, V25, P328, DOI 10.1080/09513590802617762; Firouzabadi RD, 2010, ARCH GYNECOL OBSTET, V281, P81, DOI 10.1007/s00404-009-1073-5; Fluker M, 2001, FERTIL STERIL, V75, P38, DOI 10.1016/S0015-0282(00)01638-1; Friedler S, 2006, REPROD BIOMED ONLINE, V12, P27, DOI 10.1016/S1472-6483(10)60976-5; Haouzi D, 2010, BIOL REPROD, V82, P679, DOI 10.1095/biolreprod.109.081299; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hohmann FP, 2003, J CLIN ENDOCR METAB, V88, P166, DOI 10.1210/jc.2002-020788; Hsieh YY, 2008, TAIWAN J OBSTET GYNE, V47, P66, DOI 10.1016/S1028-4559(08)60057-1; Kolibianakis EM, 2006, HUM REPROD UPDATE, V12, P651, DOI 10.1093/humupd/dml038; Kuc P, 2011, GYNECOL ENDOCRINOL, V27, P867, DOI 10.3109/09513590.2010.540602; Lee TH, 2005, FERTIL STERIL, V83, P1700, DOI 10.1016/j.fertnstert.2004.12.037; Loutradis D, 2004, FERTIL STERIL, V82, P1446, DOI 10.1016/j.fertnstert.2004.04.051; Moraloglu O, 2008, ADV THER, V25, P266, DOI 10.1007/s12325-008-0028-8; Olivennes F, 2000, FERTIL STERIL, V73, P314, DOI 10.1016/S0015-0282(99)00524-5; Orvieto R, 2013, REPROD BIOMED ONLINE, V26, P4, DOI 10.1016/j.rbmo.2012.11.001; Papanikolaou EG, 2012, HUM REPROD, V27, P1822, DOI 10.1093/humrep/des066; Pundir J, 2012, REPROD BIOMED ONLINE, V24, P6, DOI 10.1016/j.rbmo.2011.09.017; Qiao J, 2012, GYNECOL ENDOCRINOL, V28, P800, DOI 10.3109/09513590.2012.665103; Rombauts L, 2006, HUM REPROD, V21, P95, DOI 10.1093/humrep/dei302; Sauer MV, 2004, REPROD BIOMED ONLINE, V9, P487, DOI 10.1016/S1472-6483(10)61631-8; Serafini P, 2006, FERTIL STERIL, V86, P830, DOI 10.1016/j.fertnstert.2006.02.110; van Hooren HG, 2001, HUM REPROD, V16, P644; Xavier P, 2005, EUR J OBSTET GYN R B, V120, P185, DOI 10.1016/j.ejogrb.2004.11.005; Xiao JS, 2013, FERTIL STERIL, V100, P1594, DOI 10.1016/j.fertnstert.2013.08.024; Xiao JS, 2013, GYNECOL ENDOCRINOL, V29, P187, DOI 10.3109/09513590.2012.736561; Ye H, 2009, J ASSIST REPROD GEN, V26, P105, DOI 10.1007/s10815-009-9300-3	34	26	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106854	10.1371/journal.pone.0106854	http://dx.doi.org/10.1371/journal.pone.0106854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216031	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300026
J	Wang, YX; Xu, L; Shao, L; Zhang, YQ; Yang, H; Wang, JD; Jonas, JB; Wei, WB				Wang, Ya Xing; Xu, Liang; Shao, Lei; Zhang, Ya Qin; Yang, Hua; Wang, Jin Da; Jonas, Jost B.; Wei, Wen Bin			Subfoveal Choroidal Thickness and Glaucoma. The Beijing Eye Study 2011	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; CLOSURE GLAUCOMA; RETINAL CHANGES; PREVALENCE; PRESSURE; DAMAGE	Purpose: To examine subfoveal choroidal thickness (SFCT) in eyes with glaucoma, using enhanced depth imaging spectral domain optical coherence tomography. Methods: The population-based Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6 +/- 69.8 years (range: 50-93 years). A detailed ophthalmic examination was performed including spectral-domain optical coherence tomography (SD-OCT) with enhanced depth imaging for measurement of SFCT, and assessment of fundus photographs for presence of glaucoma. In addition, the group of patients with chronic angle-closure glaucoma (ACG) from the Beijing Eye Study (n = 37) was merged with a group of patients with chronic ACG from the Tongren hospital (n = 52). Results: Assessments of SFCT and glaucoma were available for 3232 (93.2%) subjects. After adjusting for age, axial length, gender, anterior chamber and lens thickness, SFCT was not significantly associated with presence of glaucoma (P = 0.08; regression coefficient B: -15.7). As a corollary, in logistic regression analysis with adjustment for age, axial length and intraocular pressure, presence of glaucoma was not significantly associated with SFCT (P = 0.20). If only open-angle glaucoma was considered, multivariate analysis revealed no significant association between SFCT and presence of open-angle glaucoma (P = 0.44). As a corollary, in logistic regression analysis, open-angle glaucoma was not significantly associated with SFCT (P = 0.91). In a similar manner if only ACG was taken into account, SFCT was not significantly associated with the presence of ACG (P = 0.27) in multivariate analysis. As a corollary in binary regression analysis, presence of ACG was not significantly associated with SFCT (P = 0.27). Conclusions: In multivariate analysis with adjustment for age, axial length, gender, anterior chamber and lens thickness, neither OAG nor ACG was associated with an abnormal SFCT.	[Wang, Ya Xing; Xu, Liang; Shao, Lei; Zhang, Ya Qin; Yang, Hua; Wang, Jin Da; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Wei, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	wenbing_wei@yahoo.com.cn	wei, wei/HHR-8613-2022; wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing Government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing Government	This work was supported by the State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing Government (7092021, 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora KS, 2012, INVEST OPHTH VIS SCI, V53, P7813, DOI 10.1167/iovs.12-10483; Arora KS, 2012, INVEST OPHTH VIS SCI, V53, P6393, DOI 10.1167/iovs.12-10224; Banitt M, 2013, CURR OPIN OPHTHALMOL; Cennamo G, 2012, OPHTHALMOLOGICA, V228, P47, DOI 10.1159/000336903; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Choi SS, 2011, BRIT J OPHTHALMOL, V95, P131, DOI 10.1136/bjo.2010.183756; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Ehrlich JR, 2011, EXP EYE RES, V92, P189, DOI 10.1016/j.exer.2011.01.002; Fenolland JR, 2011, J FR OPHTALMOL, V34, P313, DOI 10.1016/j.jfo.2011.02.004; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Hayreh SS, 1999, J GLAUCOMA, V8, P56; Hirooka K, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-29; Hirooka K, 2012, CLIN EXP OPHTHALMOL, V40, P576, DOI 10.1111/j.1442-9071.2012.02762.x; Jonas JB, 1999, SURV OPHTHALMOL, V43, P293, DOI 10.1016/S0039-6257(98)00049-6; Kanis MJ, 2010, GRAEF ARCH CLIN EXP, V248, P999, DOI 10.1007/s00417-010-1331-z; KENDELL KR, 1995, INVEST OPHTH VIS SCI, V36, P200; Kim YT, 2011, EYE, V25, P1635, DOI 10.1038/eye.2011.258; KUBOTA T, 1993, BRIT J OPHTHALMOL, V77, P430, DOI 10.1136/bjo.77.7.430; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; McCourt Emily A, 2010, Ophthalmic Surg Lasers Imaging, V41 Suppl, pS28, DOI 10.3928/15428877-20101031-14; Mwanza JC, 2012, INVEST OPHTH VIS SCI, V53, P6695, DOI 10.1167/iovs.12-10388; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P3430, DOI 10.1167/iovs.10-6600; Nork TM, 2000, ARCH OPHTHALMOL-CHIC, V118, P235; PANDA S, 1992, INVEST OPHTH VIS SCI, V33, P2532; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]; Rhew JY, 2012, J GLAUCOMA; Roberts KF, 2012, ARCH OPHTHALMOL-CHIC, V130, P980, DOI 10.1001/archophthalmol.2012.371; Shao L, 2013, INVEST OPHTH VIS SCI, V54, P230, DOI 10.1167/iovs.12-10351; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spraul CW, 2002, VISION RES, V42, P923, DOI 10.1016/S0042-6989(02)00022-6; Usui S, 2012, AM J OPHTHALMOL, V153, P10, DOI 10.1016/j.ajo.2011.05.037; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Werner JS, 2011, EYE, V25, P279, DOI 10.1038/eye.2010.218; Xu J, 2013, OPHTHALMOLO IN PRESS; Yin ZQ, 1997, J GLAUCOMA, V6, P23; Zhou MW, 2013, INVEST OPHTH VIS SCI, V54, P1971, DOI 10.1167/iovs.12-11090	37	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107321	10.1371/journal.pone.0107321	http://dx.doi.org/10.1371/journal.pone.0107321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210857	Green Submitted, gold, Green Published			2022-12-27	WOS:000341855900060
J	Gehara, M; Crawford, AJ; Orrico, VGD; Rodriguez, A; Lotters, S; Fouquet, A; Barrientos, LS; Brusquetti, F; De la Riva, I; Ernst, R; Urrutia, GG; Glaw, F; Guayasamin, JM; Holting, M; Jansen, M; Kok, PJR; Kwet, A; Lingnau, R; Lyra, M; Moravec, J; Pombal, JP; Rojas-Runjaic, FJM; Schulze, A; Senaris, JC; Sole, M; Rodrigues, MT; Twomey, E; Haddad, CFB; Vences, M; Kohler, J				Gehara, Marcelo; Crawford, Andrew J.; Orrico, Victor G. D.; Rodriguez, Ariel; Loetters, Stefan; Fouquet, Antoine; Barrientos, Lucas S.; Brusquetti, Francisco; De la Riva, Ignacio; Ernst, Raffael; Gagliardi Urrutia, Giuseppe; Glaw, Frank; Guayasamin, Juan M.; Hoelting, Monique; Jansen, Martin; Kok, Philippe J. R.; Kwet, Axel; Lingnau, Rodrigo; Lyra, Mariana; Moravec, Jiri; Pombal, Jose P., Jr.; Rojas-Runjaic, Fernando J. M.; Schulze, Arne; Senaris, J. Celsa; Sole, Mirco; Rodrigues, Miguel Trefaut; Twomey, Evan; Haddad, Celio F. B.; Vences, Miguel; Koehler, Joern			High Levels of Diversity Uncovered in a Widespread Nominal Taxon: Continental Phylogeography of the Neotropical Tree Frog Dendropsophus minutus	PLOS ONE			English	Article							LEPTODACTYLUS-FUSCUS SCHNEIDER; ATLANTIC FOREST; MOLECULAR PHYLOGENY; RAIN-FOREST; SPECIES RICHNESS; MITOCHONDRIAL-DNA; CRYPTIC DIVERSITY; DEEP DIVERGENCE; ANDEAN UPLIFT; 1799 ANURA	Species distributed across vast continental areas and across major biomes provide unique model systems for studies of biotic diversification, yet also constitute daunting financial, logistic and political challenges for data collection across such regions. The tree frog Dendropsophus minutus (Anura: Hylidae) is a nominal species, continentally distributed in South America, that may represent a complex of multiple species, each with a more limited distribution. To understand the spatial pattern of molecular diversity throughout the range of this species complex, we obtained DNA sequence data from two mitochondrial genes, cytochrome oxidase I (COI) and the 16S rhibosomal gene (16S) for 407 samples of D. minutus and closely related species distributed across eleven countries, effectively comprising the entire range of the group. We performed phylogenetic and spatially explicit phylogeographic analyses to assess the genetic structure of lineages and infer ancestral areas. We found 43 statistically supported, deep mitochondrial lineages, several of which may represent currently unrecognized distinct species. One major clade, containing 25 divergent lineages, includes samples from the type locality of D. minutus. We defined that clade as the D. minutus complex. The remaining lineages together with the D. minutus complex constitute the D. minutus species group. Historical analyses support an Amazonian origin for the D. minutus species group with a subsequent dispersal to eastern Brazil where the D. minutus complex originated. According to our dataset, a total of eight mtDNA lineages have ranges > 100,000 km(2). One of them occupies an area of almost one million km(2) encompassing multiple biomes. Our results, at a spatial scale and resolution unprecedented for a Neotropical vertebrate, confirm that widespread amphibian species occur in lowland South America, yet at the same time a large proportion of cryptic diversity still remains to be discovered.	[Gehara, Marcelo; Rodriguez, Ariel; Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Evolutionary Biol, Braunschweig, Germany; [Gehara, Marcelo] Univ Fed Rio Grande do Norte, Ctr Biociencias, Posgrad Sistemat & Evolucao, BR-59072970 Natal, RN, Brazil; [Crawford, Andrew J.; Barrientos, Lucas S.] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Crawford, Andrew J.] Smithsonian Trop Res Inst, Panama City, Panama; [Orrico, Victor G. D.; Rodrigues, Miguel Trefaut] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Loetters, Stefan] Univ Trier, Biogeog Dept, Trier, Germany; [Fouquet, Antoine] CNRS Guyane USR3456, Cayenne, French Guiana; [Brusquetti, Francisco] Univ Estadual Paulista, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Brusquetti, Francisco] Inst Invest Biol Paraguay, Asuncion, Paraguay; [De la Riva, Ignacio] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Ernst, Raffael; Hoelting, Monique] Senckenberg Nat Hist Collect Dresden, Museum Zool, Dresden, Germany; [Gagliardi Urrutia, Giuseppe] Peruvian Ctr Biodivers & Conservat, Nanay, Iquitos, Peru; [Glaw, Frank] Zool Staatssammlung Munchen, Munich, Germany; Univ Tecnol Indoamer, Ctr Invest Biodiversidad & Cambio Climat BioCamp, Cotocollao, Quito, Ecuador; [Jansen, Martin] Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Kok, Philippe J. R.] Vrije Univ Brussel, Dept Biol, Amphibian Evolut Lab, Brussels, Belgium; [Kwet, Axel] German Herpetol Soc DGHT, Mannheim, Germany; [Lingnau, Rodrigo] Univ Tecnol Fed Parana, Francisco Beltrao, PR, Brazil; [Lyra, Mariana; Haddad, Celio F. B.] Univ Estadual Paulista, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Moravec, Jiri] Natl Museum, Dept Zool, Prague, Czech Republic; [Pombal, Jose P., Jr.] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Rio De Janeiro, Brazil; [Rojas-Runjaic, Fernando J. M.] Museo Hist Nat La Salle, Fdn La Salle Ciencias Nat, Caracas, Venezuela; [Schulze, Arne; Koehler, Joern] Hess Landesmuseum Darmstadt, Darmstadt, Germany; [Senaris, J. Celsa] Inst Venezolano Invest Cient, Ctr Ecol, Lab Ecol & Genet Poblac, Caracas, Venezuela; [Sole, Mirco] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Twomey, Evan] E Carolina Univ, Dept Biol, Greenville, NC USA	Braunschweig University of Technology; Universidade Federal do Rio Grande do Norte; Universidad de los Andes (Colombia); Smithsonian Institution; Smithsonian Tropical Research Institute; Universidade de Sao Paulo; Universitat Trier; Universidade de Sao Paulo; Universidade Estadual Paulista; Biological Research Institute of Paraguay (IIBP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); Vrije Universiteit Brussel; Universidade Tecnologica Federal do Parana; Universidade de Sao Paulo; Universidade Estadual Paulista; National Museum; Universidade Federal do Rio de Janeiro; Venezuelan Institute Science Research; Universidade Estadual de Santa Cruz; University of North Carolina; East Carolina University	Gehara, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Evolutionary Biol, Pockelsstr 10A, Braunschweig, Germany.	marcelo.gehara@gmail.com	Rodrigues, Miguel T./F-8174-2012; Pombal, Jose P/C-6365-2015; Kok, Philippe/ABE-7834-2020; Lyra, Mariana Lucio/O-6405-2014; Gehara, Marcelo/J-6533-2014; Crawford, Andrew J./G-6365-2012; Haddad, Célio F. B./C-4267-2012; Rojas-Runjaic, Fernando J. M./K-2555-2014; Orrico, Victor G. D./G-9796-2012; Solé, Mirco/A-9722-2008; Lingnau, Rodrigo/F-9035-2010; Gagliardi-Urrutia, Giussepe/AAB-1109-2019; Lingnau, Rodrigo/AAB-9052-2022; Senaris Vazquez, Josefa Celsa/F-1672-2019	Rodrigues, Miguel T./0000-0003-3958-9919; Pombal, Jose P/0000-0003-4900-630X; Lyra, Mariana Lucio/0000-0002-7863-4965; Crawford, Andrew J./0000-0003-3153-6898; Haddad, Célio F. B./0000-0002-7044-5764; Rojas-Runjaic, Fernando J. M./0000-0001-5409-4231; Orrico, Victor G. D./0000-0002-4560-4006; Solé, Mirco/0000-0001-7881-6227; Lingnau, Rodrigo/0000-0001-8406-4439; Gagliardi-Urrutia, Giussepe/0000-0002-6559-3615; Lingnau, Rodrigo/0000-0001-8406-4439; Brusquetti, Francisco/0000-0001-7242-1208; Rodriguez, Ariel/0000-0003-1936-793X; Senaris Vazquez, Josefa Celsa/0000-0001-8673-7385; Barrientos, Lucas/0000-0003-1971-7469; Jansen, Martin/0000-0002-2631-4601; Guayasamin, Juan/0000-0003-0098-978X; Kohler, Jorn/0000-0002-5250-2542; Kok, Philippe/0000-0001-9743-9738; Vences, Miguel/0000-0003-0747-0817	Alexander von Humboldt foundation; FAPESP [2008/50928-1, s 03/10335-8, 10/51071-7, 11/50146-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Nacional de Incentivo a Investigadores (PRONII, Paraguay); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Ministry of Culture of the Czech Republic [DKRVO 2013/14, DKRVO 2012, 00023272]; KAAD; NSF [DEB 1035184, 1120487]; Deutsche Forschungsgemeinschaft [VE247/7-1]; Belgian Directorate-General of Development Cooperation; King Leopold III Fund for Nature Exploration and Conservation; Percy Sladen Memorial Fund; non-profit organization "les Amis de l'Institut Royal des Sciences Naturelles"; German Research Foundation [DFG ER 589/2*1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2012/12500-5]; Ecopetrol [156-09]; Universidad Tecnologica Indoamerica; FAPERJ	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Nacional de Incentivo a Investigadores (PRONII, Paraguay); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Culture of the Czech Republic; KAAD; NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Belgian Directorate-General of Development Cooperation; King Leopold III Fund for Nature Exploration and Conservation; Percy Sladen Memorial Fund; non-profit organization "les Amis de l'Institut Royal des Sciences Naturelles"; German Research Foundation(German Research Foundation (DFG)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ecopetrol; Universidad Tecnologica Indoamerica; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	AR was supported by a Post-Doctoral fellowship of the Alexander von Humboldt foundation. CFBH acknowledges support by FAPESP (proc. 2008/50928-1) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq. FB thanks Programa Nacional de Incentivo a Investigadores (PRONII, Paraguay) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) for financial support. JM was financially supported by the Ministry of Culture of the Czech Republic (DKRVO 2012 and DKRVO 2013/14; 00023272). MG was supported by a PhD fellowship of the KAAD. MTR acknowledges support by FAPESP (# s 03/10335-8, 10/51071-7, and 11/50146-6), CNPq, and NSF (DEB 1035184 and 1120487). MV acknowledges support by the Deutsche Forschungsgemeinschaft (grant VE247/7-1). PJRK was mainly supported by the Belgian Directorate-General of Development Cooperation, the King Leopold III Fund for Nature Exploration and Conservation, and the Percy Sladen Memorial Fund, with additional support by the non-profit organization "les Amis de l'Institut Royal des Sciences Naturelles''. RE and MH were supported by a research grant from the German Research Foundation (DFG ER 589/2*1). VGDO acknowledges support by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (# 2012/12500-5). Laboratory work in Colombia was financed by grant # 156-09 from Ecopetrol. Funding was provided by the Universidad Tecnologica Indoamerica through the project "Patrones de diversidad de los anfibios andinos del Ecuador''. JPP is grateful to CNPq and FAPERJ for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amaro RC, 2012, MOL PHYLOGENET EVOL, V62, P880, DOI 10.1016/j.ympev.2011.11.004; Andrade-Lima D, 1966, VEGETACAO; Angulo A, 2010, SYST BIODIVERS, V8, P357, DOI 10.1080/14772000.2010.507264; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Antonelli A, 2009, MOL STUDIES PHYLOGEO, P386; Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Babik W, 2003, MOL ECOL, V12, P1913, DOI 10.1046/j.1365-294X.2003.01880.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Biju SD, 2011, ZOOTAXA, P1; BOKERMANN WERNER C. A., 1963, AN ACAD BRASIL CIENC, V35, P465; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Cabanne GS, 2008, MOL PHYLOGENET EVOL, V49, P760, DOI 10.1016/j.ympev.2008.09.013; Camargo A, 2006, BIOL J LINN SOC, V87, P325, DOI 10.1111/j.1095-8312.2006.00581.x; Canedo C, 2012, MOL PHYLOGENET EVOL, V65, P610, DOI 10.1016/j.ympev.2012.07.016; CARDOSO A J, 1984, Ciencia e Cultura (Sao Paulo), V36, P1393; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cei JM, 1980, MONITORE ZOOLOGICO I, V2, P609; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; de Sa RO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-241; Donnelly MA, 1991, AM MUS NOVIT, P1; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; DUELLMAN W E, 1982, Amphibia-Reptilia, V3, P153, DOI 10.1163/156853882X00383; Duellman W. E., 1971, Occ Pap Mus nat Hist Univ Kans, VNo. 4, P1; Duellman WE, 1956, FROGS HYLID GENUS PH, P1; Echeverria Dinorah D., 1997, Alytes (Paris), V15, P26; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Etienne RS, 2004, AM NAT, V163, P69, DOI 10.1086/380582; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Fouquet A, 2012, MOL PHYLOGENET EVOL, V62, P826, DOI 10.1016/j.ympev.2011.11.023; Frost DR, 2013, AMPHIBIAN SPECIES WO; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Funk WC, 2008, HERPETOLOGICA, V64, P290, DOI 10.1655/08-019.1; Gehara M, 2013, CONSERV GENET, V14, P973, DOI 10.1007/s10592-013-0488-5; Glaw Frank, 2010, Zootaxa, V2383, P1; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Gomes MdR, 1991, ACTA BIOL LEOPOLDENS, V13, P5; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Hawkins MA, 2007, ZOOTAXA, P61, DOI 10.11646/zootaxa.1540.1.3; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heinicke MP, 2007, P NATL ACAD SCI USA, V104, P10092, DOI 10.1073/pnas.0611051104; HERO JM, 1990, AMAZONIANA, V11, P201; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; Holman JA, 1998, PLEISTOCENE AMPHIBIA, Vvi; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Jansen M, 2011, ZOOL SCR, V40, P567, DOI 10.1111/j.1463-6409.2011.00498.x; KAPLAN M, 1994, J HERPETOL, V28, P79, DOI 10.2307/1564684; Kenny JS, 1969, STUD FAUNA CURACAO, V29, P1, DOI DOI 10.2307/1442340; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Kohler J, 2001, SALAMANDRA, V37, P175; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Ledru MP, 2005, QUATERNARY RES, V64, P444, DOI 10.1016/j.yqres.2005.08.006; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lemmon EM, 2007, EVOLUTION, V61, P2086, DOI 10.1111/j.1558-5646.2007.00181.x; Lescure J, 2000, PATRIMOINES NATURELS, V45, P1; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Maciel DB, 2010, ZOOTAXA, P53; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; MARTINS M, 1987, Revista Brasileira de Biologia, V47, P549; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; McRae BH, 2008, CIRCUITSCAPE; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Morais AR, 2012, HERPETOL J, V22, P249; Motta AP, 2012, ZOOTAXA, P18, DOI 10.11646/zootaxa.3249.1.2; Murphy J.C., 1997, AMPHIBIANS REPTILES; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Noonan BP, 2005, MOL ECOL, V14, P3017, DOI 10.1111/j.1365-294X.2005.02624.x; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL J LINN SOC-LOND, V155, P97, DOI 10.1111/j.1096-3642.2008.00424.x; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Pellegrino KCM, 2011, MOL PHYLOGENET EVOL, V61, P446, DOI 10.1016/j.ympev.2011.07.010; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Por F. D., 1992, Sooretama: the Atlantic rain forest of Brazil.; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Quijada-Mascarenas JA, 2007, J BIOGEOGR, V34, P1296, DOI 10.1111/j.1365-2699.2007.01707.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2007, TRACER V1 4; Reading CJ, 2010, AMPHIBIA-REPTILIA, V31, P483, DOI 10.1163/017353710X521537; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; Rossa-Feres Denise de Cerqueira, 2006, Biota Neotrop., V6, P0, DOI 10.1590/S1676-06032006000100014; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Santos AMM, 2007, J BIOGEOGR, V34, P437, DOI 10.1111/j.1365-2699.2006.01604.x; Santos JC, 2009, PLOS BIOL, V7, P448, DOI 10.1371/journal.pbio.1000056; Scher HD, 2006, SCIENCE, V312, P428, DOI 10.1126/science.1120044; Smith SA, 2005, EVOLUTION, V59, P2433; Symula R, 2003, MOL PHYLOGENET EVOL, V26, P452, DOI 10.1016/S1055-7903(02)00367-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tchaicka L, 2007, MOL ECOL, V16, P819, DOI 10.1111/j.1365-294X.2006.03185.x; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Vallinoto M, 2010, ZOOL SCR, V39, P128, DOI 10.1111/j.1463-6409.2009.00415.x; Vences M, 2008, HYDROBIOLOGIA, V595, P569, DOI 10.1007/s10750-007-9032-2; Vences M, 2012, AMPHIBIA-REPTILIA, V33, P503, DOI 10.1163/15685381-00002856; Vences Miguel, 2011, Herpetology Notes, V4, P239; Vences Miguel, 2010, Bonn Zoological Bulletin, V57, P241; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Werneck FP, 2012, J BIOGEOGR, V39, P1695, DOI 10.1111/j.1365-2699.2012.02715.x; Wielstra B, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-161; Wiens JJ, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234625; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Wiens JJ, 2010, MOL PHYLOGENET EVOL, V55, P871, DOI 10.1016/j.ympev.2010.03.013; Wuster W, 2005, MOL ECOL, V14, P1095, DOI 10.1111/j.1365-294X.2005.02471.x; Wynn A, 2001, TROP ZOOL, V14, P255, DOI 10.1080/03946975.2001.10531157; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30	124	103	106	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e103958	10.1371/journal.pone.0103958	http://dx.doi.org/10.1371/journal.pone.0103958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208078	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300005
J	Ghirlanda, S; Acerbi, A; Herzog, H				Ghirlanda, Stefano; Acerbi, Alberto; Herzog, Harold			Dog Movie Stars and Dog Breed Popularity: A Case Study in Media Influence on Choice	PLOS ONE			English	Article							RANDOM DRIFT; CULTURAL-CHANGE; SELECTION; FASHION; SMOKING; RATES; FADS	Fashions and fads are important phenomena that influence many individual choices. They are ubiquitous in human societies, and have recently been used as a source of data to test models of cultural dynamics. Although a few statistical regularities have been observed in fashion cycles, their empirical characterization is still incomplete. Here we consider the impact of mass media on popular culture, showing that the release of movies featuring dogs is often associated with an increase in the popularity of featured breeds, for up to 10 years after movie release. We also find that a movie's impact on breed popularity correlates with the estimated number of viewers during the movie's opening weekend-a proxy of the movie's reach among the general public. Movies' influence on breed popularity was strongest in the early 20th century, and has declined since. We reach these conclusions through a new, widely applicable method to measure the cultural impact of events, capable of disentangling the event's effect from ongoing cultural trends.	[Ghirlanda, Stefano] CUNY Brooklyn Coll, Dept Psychol, Brooklyn, NY 11210 USA; [Ghirlanda, Stefano; Acerbi, Alberto] Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden; [Acerbi, Alberto] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [Herzog, Harold] Western Carolina Univ, Dept Psychol, Cullowhee, NC 28723 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); Stockholm University; University of Bristol; University of North Carolina; Western Carolina University	Ghirlanda, S (corresponding author), CUNY Brooklyn Coll, Dept Psychol, Brooklyn, NY 11210 USA.	drghirlanda@gmail.com		Acerbi, Alberto/0000-0001-5827-8003	Uniquely Human project - Swedish Research Council; Newton International Fellowship	Uniquely Human project - Swedish Research Council; Newton International Fellowship	AA has been supported by the Uniquely Human project funded by the Swedish Research Council and by a Newton International Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032541; Bentley A, 2011, SIMPLICITY-DES TECHN, P1; Bentley RA, 2007, EVOL HUM BEHAV, V28, P151, DOI 10.1016/j.evolhumbehav.2006.10.002; Bentley RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003057; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Bentley RA, 2003, AM ANTIQUITY, V68, P459, DOI 10.2307/3557104; Berger J, 2012, PSYCHOL SCI; Berger J, 2010, MARKET SCI, V29, P815, DOI 10.1287/mksc.1090.0557; Berger J, 2009, P NATL ACAD SCI USA, V106, P8146, DOI 10.1073/pnas.0812647106; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Caulkins JP, 2007, J ECON DYN CONTROL, V31, P1535, DOI 10.1016/j.jedc.2006.05.008; Dalton MA, 2003, LANCET, V362, P281, DOI 10.1016/S0140-6736(03)13970-0; Dalton MA, 2009, PEDIATRICS, V123, pE551, DOI 10.1542/peds.2008-2102; Ghirlanda S, 2013, DOG MOVIE STARS DOG; Ghirlanda S., 2021, PAVLOVIAN SUMM UNPUB; Ghirlanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074770; Gureckis TM, 2009, TOP COGN SCI, V1, P651, DOI 10.1111/j.1756-8765.2009.01046.x; Hahn MW, 2003, P ROY SOC B-BIOL SCI, V270, pS120, DOI 10.1098/rsbl.2003.0045; Herzog HA, 2004, JAVMA-J AM VET MED A, V225, P365, DOI 10.2460/javma.2004.225.365; Herzog HA, 2004, P ROY SOC B-BIOL SCI, V271, pS353, DOI 10.1098/rsbl.2004.0185; Herzog HA, ANIMAL BEHA IN PRESS; Herzog H, 2006, SOC ANIM, V14, P383, DOI 10.1163/156853006778882448; Kant I., 1798, ANTHR PRAGMATIC POIN; Kroeber AL, 1919, AM ANTHROPOL, V21, P235, DOI 10.1525/aa.1919.21.3.02a00010; Lieberson S., 2000, MATTER TASTE NAMES F; R Core Team, 2021, R LANGUAGE ENV STAT; Rogers DS, 2008, P NATL ACAD SCI USA, V105, P3416, DOI 10.1073/pnas.0711802105; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Simmel G., 1904, INT Q, V10, P130; Smith Adam, 1966, THEORY MORAL SENTIME; Wakefield M, 2003, ADDICTION, V98, P79, DOI 10.1046/j.1360-0443.98.s1.6.x	31	27	27	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106565	10.1371/journal.pone.0106565	http://dx.doi.org/10.1371/journal.pone.0106565			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25208271	Green Published, gold			2022-12-27	WOS:000342030300029
J	Hutson, RA; Trzcinski, E; Kolbe, AR				Hutson, Royce A.; Trzcinski, Eileen; Kolbe, Athena R.			Features of Child Food Insecurity after the 2010 Haiti Earthquake: Results from Longitudinal Random Survey of Households	PLOS ONE			English	Article								Background: Recent commentary on the health consequences of natural disasters has suggested a dearth of research on understanding the antecedents prior to the disaster that are associated with health consequences after the disaster. Utilizing data from a two-wave panel survey of Port-au-Prince, Haiti, conducted just prior to and six weeks after the January 2010 earthquake, we test factors prior to the quake hypothesized to be associated with food insecurity after the quake. Methods: Using random Global Positioning System (GPS) sampling, we re-interviewed 93.1% (N = 1732) of the original 1,800 households interviewed in 2009. Respondents were queried with regard to mortalities, injuries, food security, housing, and other factors after the quake. Findings: Child food insecurity was found to be common on all three indices of food security (17.2%-22.6%). Additionally, only 36.5% of school-aged children were attending school prior to the quake. Findings suggest that prior schooling was associated with a substantial reduction on food insecurity indices (OR 0.62-0.75). Findings further suggest that several household characteristics were associated with food insecurity for children. Prior chronic/acute illnesses, poor living conditions, remittances from abroad, primary respondent mental health, and histories of criminal and other human rights violations committed against family members prior to the quake were associated with food insecurity after the earthquake. Earned household income after the quake was only associated with one of the measures of food insecurity. Interpretation: Food insecurity for children was common after the quake. Those households vulnerable on multiple dimensions prior to the quake were also vulnerable to food insecurity after the quake. Remittances from abroad were leading protective factors for food security. Because Haiti is well known for the potentiality of both hurricanes and earthquakes, reconstruction and redevelopment should focus on ameliorating potential vulnerabilities to poor outcomes in these natural disasters.	[Hutson, Royce A.; Trzcinski, Eileen] Wayne State Univ, Sch Social Work, Detroit, MI USA; [Kolbe, Athena R.] Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA; [Kolbe, Athena R.] Univ Michigan, Dept Polit Sci, Ann Arbor, MI 48109 USA	Wayne State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hutson, RA (corresponding author), Boise State Univ, Sch Social Work, Boise, ID 83725 USA.	roycehutson@boisestate.edu	Kolbe, Athena/AAZ-6768-2021	Kolbe, Athena R./0000-0002-4170-8262; Hutson, Royce/0000-0001-6887-0027	University of Michigan; UNDP (New York); International Development Research Centre (Ottawa); Small Arms Survey (Geneva)	University of Michigan(University of Michigan System); UNDP (New York); International Development Research Centre (Ottawa); Small Arms Survey (Geneva)	This study was supported by the University of Michigan, the UNDP (New York), the International Development Research Centre (Ottawa) and the Small Arms Survey (Geneva). The funders, together with practitioners associated with the World Bank and NGOs in Haiti, were requested to review and comment on the survey instrument prior to fielding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambraseys N, 2011, NATURE, V469, P153, DOI 10.1038/469153a; ANDERSON MB, 1991, DISASTERS, V15, P43, DOI 10.1111/j.1467-7717.1991.tb00426.x; [Anonymous], 2011, LANCET, V377, P439, DOI 10.1016/S0140-6736(11)60141-4; [Anonymous], 2011, EURONEWS; Coates J, 2006, J NUTR, V136, P1438, DOI 10.1093/jn/136.5.1438S; Cohen R, 2011, LESSONS LEARNED RESP; Hutson RA, 2009, SMALL ARMS SURVEY 20; Institut Haitien de Statistique et d'Informatique, 2009, POP 18 ANS PLUS MEN; International Labour Office International Program on the Elimination of Child Labour, 2007, SIMP MOD ESS QUEST C; Kolbe AR, 2006, LANCET, V368, P864, DOI 10.1016/S0140-6736(06)69211-8; Kolbe Athena R, 2010, Med Confl Surviv, V26, P281, DOI 10.1080/13623699.2010.535279; Kristoff M, 2010, HAITI REP NGOS; Logan J. R., 2008, NATURAL DISASTER ANA, P279; Martine G., 2002, ECSP REPORT 8, P45; Melgar-Quinonez HR, 2006, J NUTR, V136, P1431, DOI 10.1093/jn/136.5.1431S; MINUSTAH Human Rights Section, 2010, IDP CAMP JOIN SEC AS; Moszynski J, 2011, BMJ-BRIT MED J, V342, P128; Perez-Escamilla R, 2009, J NUTR, V139, P2132, DOI 10.3945/jn.109.108852; Petterson JS, 2006, AM ANTHROPOL, V108, P643, DOI 10.1525/aa.2006.108.4.643; Schiermeier Q, 2010, NATURE, V467, P1018, DOI 10.1038/4671018a; Sen A.K., 1981, POVERTY FAMINES; Sen Amartya, 1999, A SEN J DREZE OMNIBU; Silove, 2004, MEASURING TRAUMA MEA; Webb P, 2006, J NUTR, V136, P1404	24	10	10	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e104497	10.1371/journal.pone.0104497	http://dx.doi.org/10.1371/journal.pone.0104497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207543	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300006
J	Li, YL; Choi, S; Casey, SC; Felsher, DW				Li, Yulin; Choi, S.; Casey, Stephanie C.; Felsher, Dean W.			Activation of Cre Recombinase Alone Can Induce Complete Tumor Regression	PLOS ONE			English	Article							MAMMALIAN-CELLS; TOXICITY	The Cre/loxP system is a powerful tool for generating conditional genomic recombination and is often used to examine the mechanistic role of specific genes in tumorigenesis. However, Cre toxicity due to its non-specific endonuclease activity has been a concern. Here, we report that tamoxifen-mediated Cre activation in vivo induced the regression of primary lymphomas in p53-/- mice. Our findings illustrate that Cre activation alone can induce the regression of established tumors.	[Li, Yulin; Choi, S.; Casey, Stephanie C.; Felsher, Dean W.] Stanford Univ, Dept Med, Div Oncol, Sch Med, Stanford, CA 94305 USA	Stanford University	Felsher, DW (corresponding author), Stanford Univ, Dept Med, Div Oncol, Sch Med, Stanford, CA 94305 USA.	dfelsher@stanford.edu		Choi, Peter/0000-0002-2820-3032	National Cancer Institute [R01CA170378, U54CA149145]; Leukemia and Lymphoma Society Translational Research grant [R6223-07]; NATIONAL CANCER INSTITUTE [U54CA149145, R01CA170378] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society Translational Research grant(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by grants from National Cancer Institute (R01CA170378, U54CA149145) and the Leukemia and Lymphoma Society Translational Research grant R6223-07 (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2005, MICROBIOL IMMUNOL, V49, P559, DOI 10.1111/j.1348-0421.2005.tb03753.x; Bersell K, 2013, DIS MODEL MECH, V6, P1459, DOI 10.1242/dmm.010447; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Lexow J, 2013, DIS MODEL MECH, V6, P1470, DOI 10.1242/dmm.010470; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665	12	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107589	10.1371/journal.pone.0107589	http://dx.doi.org/10.1371/journal.pone.0107589			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208064	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300091
J	Van Puyvelde, M; Loots, G; Vanfleteren, P; Meys, J; Simcock, D; Pattyn, N				Van Puyvelde, Martine; Loots, Gerrit; Vanfleteren, Pol; Meys, Joris; Simcock, David; Pattyn, Nathalie			Do You Hear the Same? Cardiorespiratory Responses between Mothers and Infants during Tonal and Atonal Music	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; CARDIAC VAGAL TONE; NEUROVISCERAL INTEGRATION; RATE-VARIABILITY; PRETERM INFANTS; CARE-UNIT; EMOTION REGULATION; UNPLEASANT MUSIC; FUNCTIONAL MRI; HUMAN BRAIN	This study examined the effects of tonal and atonal music on respiratory sinus arrhythmia (RSA) in 40 mothers and their 3-month-old infants. The tonal music fragment was composed using the structure of a harmonic series that corresponds with the pitch ratio characteristics of mother-infant vocal dialogues. The atonal fragment did not correspond with a tonal structure. Mother-infant ECG and respiration were registered along with simultaneous video recordings. RR-interval, respiration rate, and RSA were calculated. RSA was corrected for any confounding respiratory and motor activities. The results showed that the infants' and the mothers' RSA-responses to the tonal and atonal music differed. The infants showed significantly higher RSA-levels during the tonal fragment than during the atonal fragment and baseline, suggesting increased vagal activity during tonal music. The mothers showed RSA-responses that were equal to their infants only when the infants were lying close to their bodies and when they heard the difference between the two fragments, preferring the tonal above the atonal fragment. The results are discussed with regard to music-related topics, psychophysiological integration and mother-infant vocal interaction processes.	[Van Puyvelde, Martine; Loots, Gerrit; Vanfleteren, Pol] Vrije Univ Brussel, Fac Psychol & Educ Sci, Discurs & Narrat Studies IDNS, Res Grp Interpersonal, Brussels, Belgium; [Van Puyvelde, Martine; Pattyn, Nathalie] Royal Mil Acad, VIPER Res Unit, Brussels, Belgium; [Loots, Gerrit] Univ Catolica Boliviana San Pablo, La Paz, Bolivia; [Meys, Joris] Univ Ghent, Dept Math Modeling Stat & Bioinformat, Fac Biosci Engn, B-9000 Ghent, Belgium; [Simcock, David] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Simcock, David] James Cook Univ, Fac Med & Biosci, Townsville City, Qld, Australia; [Pattyn, Nathalie] Vrije Univ Brussel, Dept Expt & Appl Psychol, Brussels, Belgium	Vrije Universiteit Brussel; Ghent University; Massey University; James Cook University; Vrije Universiteit Brussel	Van Puyvelde, M (corresponding author), Vrije Univ Brussel, Fac Psychol & Educ Sci, Discurs & Narrat Studies IDNS, Res Grp Interpersonal, Brussels, Belgium.	mvpuyvel@vub.ac.be	Ghiami, Zeinab/G-5492-2016; Simcock, David/J-9676-2014; Van Puyvelde, Martine/AAG-7610-2020	Simcock, David/0000-0001-8959-9889; Van Puyvelde, Martine/0000-0002-6595-7597; Loots, VUB/0000-0001-5015-9202; Pattyn, Nathalie/0000-0002-2690-5479	OZR-Vrije Universiteit Brussel; Royal Military Academy of Brussels	OZR-Vrije Universiteit Brussel; Royal Military Academy of Brussels	This research was granted by OZR-Vrije Universiteit Brussel and the Royal Military Academy of Brussels. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2003, PSYCHOL MUSIC, DOI DOI 10.1177/03057356030314002; [Anonymous], 1981, CARDIOVASCULAR PSYCH, DOI DOI 10.4324/9781315081762; Arnon S, 2006, BIRTH-ISS PERINAT C, V33, P131, DOI 10.1111/j.0730-7659.2006.00090.x; Ball T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000307; Bates D, 2013, IME4 LINEAR MIXED EF; Bazhenova OV, 2001, CHILD DEV, V72, P1314, DOI 10.1111/1467-8624.00350; Berntson GG, 2007, BIOL PSYCHOL, V74, P295, DOI 10.1016/j.biopsycho.2006.08.006; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bidelman GM, 2009, J NEUROSCI, V29, P13165, DOI 10.1523/JNEUROSCI.3900-09.2009; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; BOIK RJ, 1979, PSYCHOL BULL, V86, P1084, DOI 10.1037/0033-2909.86.5.1084; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; BUSH LK, 1993, PSYCHOL BULL, V113, P566, DOI 10.1037/0033-2909.113.3.566; Calkins SD, 1997, DEV PSYCHOBIOL, V31, P125, DOI 10.1002/(SICI)1098-2302(199709)31:2<125::AID-DEV5>3.0.CO;2-M; DAVIS WB, 1989, J MUSIC THER, V26, P168, DOI 10.1093/jmt/26.4.168; De Rosario-Martinez H, 2013, PHIA POSTHOC INTERAC; DoussardRoosevelt JA, 1997, CHILD DEV, V68, P173, DOI 10.2307/1131844; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; Einthoven W, 1913, PFLUG ARCH GES PHYS, V150, P275, DOI 10.1007/BF01697566; Feldman R, 2006, DEV PSYCHOL, V42, P175, DOI 10.1037/0012-1649.42.1.175; Feldman R, 2011, INFANT BEHAV DEV, V34, P569, DOI 10.1016/j.infbeh.2011.06.008; Feldman R, 2010, DEVELOPMENTAL SCI, V13, P271, DOI 10.1111/j.1467-7687.2009.00890.x; Filippa M, 2013, ACTA PAEDIATR, V102, P1017, DOI 10.1111/apa.12356; FINLEY JP, 1983, CAN J PHYSIOL PHARM, V61, P329, DOI 10.1139/y83-050; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Gabrielsson A., 2001, SERIES AFFECTIVE SCI, P431; GIDDENS DP, 1985, J THEOR BIOL, V113, P759, DOI 10.1016/S0022-5193(85)80192-2; Grossman P, 2004, AM J PHYSIOL-HEART C, V287, pH728, DOI 10.1152/ajpheart.00825.2003; GROSSMAN P, 1990, PSYCHOPHYSIOLOGY, V27, P702, DOI 10.1111/j.1469-8986.1990.tb03198.x; GROSSMAN P, 1991, PSYCHOPHYSIOLOGY, V28, P201, DOI 10.1111/j.1469-8986.1991.tb00412.x; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; GUZZETTA CE, 1989, HEART LUNG, V18, P609; Ham J, 2006, ANN NY ACAD SCI, V1094, P297, DOI 10.1196/annals.1376.038; Haslbeck FB, 2012, NORD J MUSIC THER, V21, P203, DOI 10.1080/08098131.2011.648653; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Hofer MA, 1995, ATTACHMENT THEORY, P203; HOLM S, 1979, SCAND J STAT, V6, P65; Iwanaga M, 2005, BIOL PSYCHOL, V70, P61, DOI 10.1016/j.biopsycho.2004.11.015; Iwanaga M, 1997, PERCEPT MOTOR SKILL, V85, P287, DOI 10.2466/pms.1997.85.1.287; Knight AJ, 2011, REHABIL NURS, V36, P200; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Koelsch S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002631; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Lai HL, 2011, J ADV NURS, V67, P2414, DOI 10.1111/j.1365-2648.2011.05670.x; Masataka N, 2006, DEVELOPMENTAL SCI, V9, P46, DOI 10.1111/j.1467-7687.2005.00462.x; McDermott JH, 2010, CURR BIOL, V20, P1035, DOI 10.1016/j.cub.2010.04.019; Mitterschiffthaler MT, 2007, HUM BRAIN MAPP, V28, P1150, DOI 10.1002/hbm.20337; Moore GA, 2009, CHILD DEV, V80, P209, DOI 10.1111/j.1467-8624.2008.01255.x; Morinville A, 2013, PSYCHOL AESTHET CREA, V7, P384, DOI 10.1037/a0034495; Obrist PA, 1982, MEASURING EMOTIONS I, P299; Pallesen KJ, 2005, ANN NY ACAD SCI, V1060, P450, DOI 10.1196/annals.1360.047; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Plantinga J, 2014, J EXP PSYCHOL HUMAN, V40, P40, DOI 10.1037/a0033471; PORGES SW, 1994, DEV PSYCHOBIOL, V27, P289, DOI 10.1002/dev.420270504; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Ritz T, 2002, PSYCHOPHYSIOLOGY, V39, P546, DOI 10.1017/S0048577202010715; Ritz T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052729; ROTHER M, 1989, EARLY HUM DEV, V20, P1, DOI 10.1016/0378-3782(89)90068-6; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; Schafer T, 2010, PSYCHOL AESTHET CREA, V4, P223, DOI 10.1037/a0018374; Schlez A, 2011, ISR MED ASSOC J, V13, P354; Schmidt LA, 2003, BRAIN COGNITION, V52, P27, DOI 10.1016/S0278-2626(03)00006-X; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Standley J, 2012, NEONATAL NETW, V31, P311, DOI 10.1891/0730-0832.31.5.311; Stifter CA, 1999, CHILD DEV, V70, P21, DOI 10.1111/1467-8624.00003; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Tininenko JR, 2012, BIOL PSYCHOL, V89, P562, DOI 10.1016/j.biopsycho.2011.12.022; Trainor LJ, 1998, INFANT BEHAV DEV, V21, P77, DOI 10.1016/S0163-6383(98)90055-8; Trainor LJ, 2002, MUSIC PERCEPT, V20, P187, DOI 10.1525/mp.2002.20.2.187; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084; Trevarthen C, 2001, INFANT MENT HEALTH J, V22, P95, DOI 10.1002/1097-0355(200101/04)22:1<95::AID-IMHJ4>3.0.CO;2-6; Tyrell J, 2001, NEW GROVE DICT MUSIC; Van Puyvelde M, 2010, INFANT BEHAV DEV, V33, P387, DOI 10.1016/j.infbeh.2010.04.003; Van Puyvelde M, 2013, INFANCY, V18, P849, DOI 10.1111/infa.12007; White J M, 1999, Am J Crit Care, V8, P220; WITTE H, 1992, BASIC RES CARDIOL, V87, P193, DOI 10.1007/BF00801966; Zentner MR, 1998, INFANT BEHAV DEV, V21, P483, DOI 10.1016/S0163-6383(98)90021-2	81	9	9	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106920	10.1371/journal.pone.0106920	http://dx.doi.org/10.1371/journal.pone.0106920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25207803	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000342030300048
J	Bour, G; Martel, F; Goffin, L; Bayle, B; Gangloff, J; Aprahamian, M; Marescaux, J; Egly, JM				Bour, Gaetan; Martel, Fernand; Goffin, Laurent; Bayle, Bernard; Gangloff, Jacques; Aprahamian, Marc; Marescaux, Jacques; Egly, Jean-Marc			Design and Development of a Robotized System Coupled to mu CT Imaging for Intratumoral Drug Evaluation in a HCC Mouse Model	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; IN-VIVO; GENE-THERAPY; NEEDLE INSERTION; PARVOVIRUS H-1PV; LIVER-CANCER; TUMOR; EXPRESSION; TRIAL	Hepatocellular carcinoma (HCC) is one of the most common cancer related deaths worldwide. One of the main challenges in cancer treatment is drug delivery to target cancer cells specifically. Preclinical evaluation of intratumoral drugs in orthotopic liver cancer mouse models is difficult, as percutaneous injection hardly can be precisely performed manually. In the present study we have characterized a hepatoma model developing a single tumor nodule by implantation of Hep55.1C cells in the liver of syngeneic C57BL/6J mice. Tumor evolution was followed up by mu CT imaging, and at the histological and molecular levels. This orthotopic, poorly differentiated mouse HCC model expressing fibrosis, inflammation and cancer markers was used to assess the efficacy of drugs. We took advantage of the high precision of a previously developed robotized system for automated, image-guided intratumoral needle insertion, to administer every week in the tumor of the Hep55.1C mouse model. A significant tumor growth inhibition was observed using our robotized system, whereas manual intraperitoneal administration had no effect, by comparison to untreated control mice.	[Bour, Gaetan; Aprahamian, Marc; Marescaux, Jacques; Egly, Jean-Marc] IRCAD, Strasbourg, France; [Martel, Fernand; Egly, Jean-Marc] Univ Strasbourg, Dept Funct Genom & Canc, IGBMC, CNRS,INSERM, Strasbourg, France; [Goffin, Laurent; Bayle, Bernard; Gangloff, Jacques] Univ Strasbourg, ICube Lab UMR, CNRS 7357, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bour, G (corresponding author), IRCAD, Strasbourg, France.	bour.gaetan@gmail.com; egly@igbmc.fr	Bayle, Bernard/N-3859-2015	Bayle, Bernard/0000-0003-4728-8593; Goffin, Laurent/0000-0001-8937-7979	European Research Council Advanced Scientists grants; Institut National du Cancer [INCA-2008-041]; Association de la Recherche contre le Cancer (ARC) [3153]	European Research Council Advanced Scientists grants; Institut National du Cancer(Institut National du Cancer (INCA) France); Association de la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	The work was supported by the following: European Research Council Advanced Scientists grants (JME, http://erc.europa.eu/advanced-grants); Institut National du Cancer (INCA-2008-041, http://www.e-cancer.fr/); and Association de la Recherche contre le Cancer (ARC-No3153, http://www.recherche-cancer.net/) (MA JME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akladios CY, 2011, B CANCER, V98, P120, DOI 10.1684/bdc.2011.1303; Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Angelova AL, 2009, MOL THER, V17, P1164, DOI 10.1038/mt.2009.78; Aprahamian M, 2011, CHEMBIOCHEM, V12, P777, DOI 10.1002/cbic.201000619; Arias JL, 2011, CURR DRUG TARGETS, V12, P1094; Ayadi A, 2007, P ANN INT IEEE EMBS, P194, DOI 10.1109/IEMBS.2007.4352256; BISGAARD HC, 1994, J CELL PHYSIOL, V159, P475, DOI 10.1002/jcp.1041590312; Borovjagin AV, 2010, MOL IMAGING, V9, P59, DOI 10.2310/7290.2010.00003; Bousserouel S, 2012, ANTICANCER RES, V32, P2455; Carpentier A, 2010, NEURO-ONCOLOGY, V12, P401, DOI 10.1093/neuonc/nop047; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; Dan QH, 2001, MOL THER, V4, P427, DOI 10.1006/mthe.2001.0477; DARLINGTON GJ, 1980, J NATL CANCER I, V64, P809; Fasquel JB, 2006, COMPUT METH PROG BIO, V82, P216, DOI 10.1016/j.cmpb.2006.04.004; Fernandes MS, 2009, CLIN CANCER RES, V15, P4847, DOI 10.1158/1078-0432.CCR-09-0451; Goffin L, 2013, IEEE T BIO-MED ENG, V60, P2193, DOI 10.1109/TBME.2013.2243728; Gordon H, 1936, AM J PATHOL, V12, P545; Gotoh M, 2002, PATHOL INT, V52, P19, DOI 10.1046/j.1440-1827.2002.01316.x; GRIGIONI WF, 1989, J PATHOL, V158, P23, DOI 10.1002/path.1711580107; Harrington KJ, 2010, CLIN CANCER RES, V16, P4005, DOI 10.1158/1078-0432.CCR-10-0196; Harrington KJ, 2010, CLIN CANCER RES, V16, P3067, DOI 10.1158/1078-0432.CCR-10-0054; Higashi N, 2002, CLIN EXP METASTAS, V19, P631, DOI 10.1023/A:1020946300690; Huang K, 2013, J GASTROENTEROL HEPA; Kang YM, 2011, BIOMATERIALS, V32, P4556, DOI 10.1016/j.biomaterials.2011.03.007; Kolodkin-Gal D, 2008, J VIROL, V82, P999, DOI 10.1128/JVI.01769-07; KRESS S, 1992, MOL CARCINOGEN, V6, P148, DOI 10.1002/mc.2940060210; Leenders MWH, 2008, WORLD J GASTROENTERO, V14, P6915, DOI 10.3748/wjg.14.6915; Li JW, 2013, EMBO MOL MED, V5, P1537, DOI 10.1002/emmm.201302796; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lun XQ, 2010, MOL THER, V18, P1927, DOI 10.1038/mt.2010.183; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Nakatsuka K, 1999, J HEPATOL, V30, P1119, DOI 10.1016/S0168-8278(99)80268-2; Nie F, 2008, J DRUG TARGET, V16, P389, DOI [10.1080/10611860802088846, 10.1080/10611860802088846 ]; Ohira M, 2006, TRANSPLANTATION, V82, P1712, DOI 10.1097/01.tp.0000250935.41034.2d; Park BH, 2008, LANCET ONCOL, V9, P533, DOI 10.1016/S1470-2045(08)70107-4; Penheiter AR, 2010, AM J ROENTGENOL, V195, P341, DOI 10.2214/AJR.09.3672; Santamaria E, 2009, J PROTEOMICS, V73, P153, DOI 10.1016/j.jprot.2009.06.008; Schwarz M, 2003, TOXICOL PATHOL, V31, P99, DOI 10.1080/01926230390173932; Shiina S, 2005, GASTROENTEROLOGY, V129, P122, DOI 10.1053/j.gastro.2005.04.009; SHOUVAL D, 1988, VIRCHOWS ARCH A, V412, P595, DOI 10.1007/BF00844296; Si S, 2006, GENE THER, V13, P1603, DOI 10.1038/sj.gt.3302823; Soler Luc, 2014, Hepatobiliary Surg Nutr, V3, P73, DOI 10.3978/j.issn.2304-3881.2014.02.03; Suggitt M, 2005, CLIN CANCER RES, V11, P971; Sung MW, 2001, MOL THER, V4, P182, DOI 10.1006/mthe.2001.0444; Tamaki S, 2005, CLIN IMMUNOL, V117, P280, DOI 10.1016/j.clim.2005.08.010; Wang G, 2013, CHINESE J CANCER RES, V25, P646, DOI 10.3978/j.issn.1000-9604.2013.11.07; Weber SM, 2004, J SURG RES, V119, P41, DOI 10.1016/S0022-4804(03)00357-3; Weichert JP, 2000, RADIOLOGY, V216, P865, DOI 10.1148/radiology.216.3.r00se43865; Wu JC, 2010, J CANCER RES CLIN, V136, P595, DOI 10.1007/s00432-009-0695-0; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Zhang BN, 2000, CANCER LETT, V153, P63, DOI 10.1016/S0304-3835(00)00343-8	51	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106675	10.1371/journal.pone.0106675	http://dx.doi.org/10.1371/journal.pone.0106675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203629	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500036
J	da Silva, PCA; Rosembach, TV; Santos, AA; Rocha, MS; Martins, ML				da Silva, Priscila C. A.; Rosembach, Tiago V.; Santos, Anesia A.; Rocha, Marcio S.; Martins, Marcelo L.			Normal and Tumoral Melanocytes Exhibit q-Gaussian Random Search Patterns	PLOS ONE			English	Article							CELL-MIGRATION; LEVY WALKS; MOTILITY; SUCCESS; INFECTION; PROTEINS; MOTION	In multicellular organisms, cell motility is central in all morphogenetic processes, tissue maintenance, wound healing and immune surveillance. Hence, failures in its regulation potentiates numerous diseases. Here, cell migration assays on plastic 2D surfaces were performed using normal (Melan A) and tumoral (B16F10) murine melanocytes in random motility conditions. The trajectories of the centroids of the cell perimeters were tracked through time-lapse microscopy. The statistics of these trajectories was analyzed by building velocity and turn angle distributions, as well as velocity autocorrelations and the scaling of mean-squared displacements. We find that these cells exhibit a crossover from a normal to a super-diffusive motion without angular persistence at long time scales. Moreover, these melanocytes move with non-Gaussian velocity distributions. This major finding indicates that amongst those animal cells supposedly migrating through Levy walks, some of them can instead perform q-Gaussian walks. Furthermore, our results reveal that B16F10 cells infected by mycoplasmas exhibit essentially the same diffusivity than their healthy counterparts. Finally, a q-Gaussian random walk model was proposed to account for these melanocytic migratory traits. Simulations based on this model correctly describe the crossover to super-diffusivity in the cell migration tracks.	[da Silva, Priscila C. A.; Rosembach, Tiago V.; Rocha, Marcio S.; Martins, Marcelo L.] Univ Fed Vicosa, Dept Fis, Vicosa, MG, Brazil; [Santos, Anesia A.] Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil; [Martins, Marcelo L.] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Martins, ML (corresponding author), Univ Fed Vicosa, Dept Fis, Vicosa, MG, Brazil.	mmartins@ufv.br	Rosembach, Tiago Venzel/AAV-9443-2021; Rocha, Márcio S./F-9880-2012; da Silva, Priscila/N-9495-2019; da Silva, Priscila C. A./M-1081-2015	Rocha, Márcio S./0000-0003-0323-3718; da Silva, Priscila/0000-0002-3230-5621; da Silva, Priscila C. A./0000-0002-3230-5621; Venzel Rosembach, Tiago/0000-0001-9805-0951	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco; Fundacao de Apoio a Universidade Federal de Vicosa (FUNARBE-UFV)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Fundacao de Apoio a Universidade Federal de Vicosa (FUNARBE-UFV)	The authors thank the Brazilian supporting agencies Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco, and Fundacao de Apoio a Universidade Federal de Vicosa (FUNARBE-UFV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby WJ, 2012, INTEGR BIOL-UK, V4, P1338, DOI 10.1039/c2ib20154b; Bartumeus F, 2008, J THEOR BIOL, V252, P43, DOI 10.1016/j.jtbi.2008.01.009; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bartumeus F, 2007, FRACTALS, V15, P151, DOI 10.1142/S0218348X07003460; Blitterswijk C.V., 2008, TISSUE ENG; Bray D, 2001, CELL MOVEMENTS MOL M; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Giron JA, 1996, INFECT IMMUN, V64, P197; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Johnson, 1998, APPL MULTIVARIATE ST; Kirchner JW, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066110; Levy P., 1954, THEORIE ADDITION VAR; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li L, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046006; Maska M, 2014, BIOINFORMATICS, V30, P1609, DOI 10.1093/bioinformatics/btu080; Meyer AS, 2012, J CELL BIOL, V197, P721, DOI 10.1083/jcb.201201003; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Potdar AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009636; Reynolds AM, 2009, J THEOR BIOL, V260, P98, DOI 10.1016/j.jtbi.2009.05.033; Reynolds AM, 2009, PHYSICA A, V389, P273; Rieu JP, 2000, BIOPHYS J, V79, P1903, DOI 10.1016/S0006-3495(00)76440-X; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Sokolova IA, 1998, IMMUNOL CELL BIOL, V76, P526, DOI 10.1046/j.1440-1711.1998.00781.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thistleton WJ, 2007, IEEE T INFORM THEORY, V53, P4805, DOI 10.1109/TIT.2007.909173; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Tsallis C, 1999, PHYS LETT A, V257, P93, DOI 10.1016/S0375-9601(99)00270-4; Tsallis C., 2009, SPRINGER; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Upadhyaya A, 2001, PHYSICA A, V293, P549, DOI 10.1016/S0378-4371(01)00009-7; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	40	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e104253	10.1371/journal.pone.0104253	http://dx.doi.org/10.1371/journal.pone.0104253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203532	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500004
J	Hsu, JF; Chou, TC; Lu, J; Chen, SH; Chen, FY; Chen, CC; Chen, JL; Elayda, M; Ballantyne, CM; Shayani, S; Chen, CH				Hsu, Jing-Fang; Chou, Tzu-Chieh; Lu, Jonathan; Chen, Shu-Hua; Chen, Fang-Yu; Chen, Ching-Chu; Chen, Jeffrey L.; Elayda, MacArthur; Ballantyne, Christie M.; Shayani, Steven; Chen, Chu-Huang			Low-Density Lipoprotein Electronegativity Is a Novel Cardiometabolic Risk Factor	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; METABOLIC SYNDROME; CARDIOVASCULAR RISK; ARTERIAL ELASTICITY; LDL; DISEASE; ATHEROSCLEROSIS; SUBFRACTION; MECHANISM; OXIDATION	Background: Low-density lipoprotein (LDL) plays a central role in cardiovascular disease (CVD) development. In LDL chromatographically resolved according to charge, the most electronegative subfraction-L5-is the only subfraction that induces atherogenic responses in cultured vascular cells. Furthermore, increasing evidence has shown that plasma L5 levels are elevated in individuals with high cardiovascular risk. We hypothesized that LDL electronegativity is a novel index for predicting CVD. Methods: In 30 asymptomatic individuals with metabolic syndrome (MetS) and 27 healthy control subjects, we examined correlations between plasma L5 levels and the number of MetS criteria fulfilled, CVD risk factors, and CVD risk according to the Framingham risk score. Results: L5 levels were significantly higher in MetS subjects than in control subjects (21.9 +/- 18.7 mg/dL vs. 11.2 +/- 10.7 mg/dL, P:0.01). The Jonckheere trend test revealed that the percent L5 of total LDL (L5%) and L5 concentration increased with the number of MetS criteria (P<0.001). L5% correlated with classic CVD risk factors, including waist circumference, body mass index, waist-to-height ratio, smoking status, blood pressure, and levels of fasting plasma glucose, triglyceride, and high-density lipoprotein. Stepwise regression analysis revealed that fasting plasma glucose level and body mass index contributed to 28% of L5% variance. The L5 concentration was associated with CVD risk and contributed to 11% of 30-year general CVD risk variance when controlling the variance of waist circumference. Conclusion: Our findings show that LDL electronegativity was associated with multiple CVD risk factors and CVD risk, suggesting that the LDL electronegativity index may have the potential to be a novel index for predicting CVD. Large-scale clinical trials are warranted to test the reliability of this hypothesis and the clinical importance of the LDL electronegativity index.	[Hsu, Jing-Fang; Chen, Fang-Yu; Chen, Chu-Huang] China Med Univ Hosp, Res Ctr L5, Taichung, Taiwan; [Chou, Tzu-Chieh] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chou, Tzu-Chieh] China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan; [Lu, Jonathan; Chen, Shu-Hua; Elayda, MacArthur; Chen, Chu-Huang] Texas Heart Inst, Houston, TX 77025 USA; [Chen, Ching-Chu] China Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Chen, Jeffrey L.] Univ Calif San Diego, Dept Orthoped Surg, San Diego, CA 92103 USA; [Ballantyne, Christie M.; Chen, Chu-Huang] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Shayani, Steven] Mt Sinai Med Ctr, New York, NY 10029 USA; [Shayani, Steven] New York Heart Res Fdn, New York, NY USA; [Chen, Chu-Huang] Kaohsiung Med Univ, Dept Med, Kaohsiung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Texas Heart Institute; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of California System; University of California San Diego; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; Kaohsiung Medical University	Shayani, S (corresponding author), Mt Sinai Med Ctr, New York, NY 10029 USA.	steven.shayani@mountsinai.org; cchen@texasheart.org	Chou, Tzu-Chieh/D-2372-2014; Hsu, Jing-Fang/GZM-0597-2022; Ballantyne, Christie/A-6599-2008	Chou, Tzu-Chieh/0000-0002-9634-0637; Ballantyne, Christie/0000-0002-6432-1730	American Diabetes Association [1-04-RA-13]; National Institutes of Health [HL-63364]; National Science Council of Taiwan [NSC 100-2314-B-039-040-MY3]; China Medical University and Hospital [CMU 100-TS-09]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]; Stroke Biosignature Project Grant of Academia Sinica, Taiwan [BM101100888, BM102021169, BM103010096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063364] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University and Hospital(China Medical University); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Stroke Biosignature Project Grant of Academia Sinica, Taiwan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the American Diabetes Association (1-04-RA-13), the National Institutes of Health (HL-63364), the National Science Council of Taiwan (NSC 100-2314-B-039-040-MY3), China Medical University and Hospital (CMU 100-TS-09), Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004), and the Stroke Biosignature Project Grant of Academia Sinica, Taiwan (BM101100888, BM102021169, and BM103010096). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2007, ATHEROSCLEROSIS, V192, P56, DOI 10.1016/j.atherosclerosis.2006.06.012; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; AVIRAM M, 1983, BIOCHEM MED METAB B, V30, P111, DOI 10.1016/0006-2944(83)90013-3; AVOGARO P, 1988, ARTERIOSCLEROSIS, V8, P79, DOI 10.1161/01.ATV.8.1.79; Benitez S, 2003, CIRCULATION, V108, P92, DOI 10.1161/01.CIR.0000072791.40232.8F; Benitez S, 2007, BBA-MOL CELL BIOL L, V1771, P613, DOI 10.1016/j.bbalip.2007.03.001; CDC, 2011, HEART DIS STROK PREV; Chan HC, 2013, BLOOD, V122, P3632, DOI 10.1182/blood-2013-05-504639; Chang PY, 2013, CARDIOVASC RES, V99, P137, DOI 10.1093/cvr/cvt062; Chen CH, 1997, ARTERIOSCL THROM VAS, V17, P1303, DOI 10.1161/01.ATV.17.7.1303; Chen CH, 2003, CIRCULATION, V107, P2102, DOI 10.1161/01.CIR.0000065220.70220.F7; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Chu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070533; Cziraky MJ, 2009, J MANAGE CARE PHARM, V14, pS3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; De Castellarnau C, 2000, ARTERIOSCL THROM VAS, V20, P2281; Demuth K, 1996, ARTERIOSCL THROM VAS, V16, P773, DOI 10.1161/01.ATV.16.6.773; Fraley AE, 2006, CURR OPIN LIPIDOL, V17, P502, DOI 10.1097/01.mol.0000245255.40634.b5; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Guevara NV, 2001, PHARMACOL RES, V44, P59, DOI 10.1006/phrs.2001.0840; Gupta Sushil, 2013, Indian J Endocrinol Metab, V17, P806, DOI 10.4103/2230-8210.117212; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Kashyap M. L., 1997, Annals Academy of Medicine Singapore, V26, P517; Ke LY, 2011, PURE APPL CHEM, V83, P1731, DOI 10.1351/PAC-CON-10-12-07; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Lee AS, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-64; Lee AS, 2012, APOPTOSIS, V17, P1009, DOI 10.1007/s10495-012-0726-1; Lu J, 2009, CIRC RES, V104, P619, DOI 10.1161/CIRCRESAHA.108.190116; Sanchez-Quesada JL, 2012, CLIN LIPIDOL, V7, P345, DOI 10.2217/CLP.12.26; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Mihic M, 2008, CURR DIABETES REV, V4, P122, DOI 10.2174/157339908784220750; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Organization WH, 2009, GLOB HLTH RISKS MORT; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Pohjantahti-Maaroos H, 2012, ANN MED, V44, P503, DOI 10.3109/07853890.2011.590520; Pohjantahti-Maaroos H, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-41; Sanchez-Quesada JL, 2004, CURR OPIN LIPIDOL, V15, P329, DOI [10.1097/00041433-200406000-00014, 10.1097/01.mol.0000130093.54381.22]; Sanchez-Quesada JL, 2003, ATHEROSCLEROSIS, V166, P261, DOI 10.1016/S0021-9150(02)00374-X; Shimada K, 2004, ATHEROSCLEROSIS, V174, P343, DOI 10.1016/j.atherosclerosis.2004.01.029; Tang D, 2008, J LIPID RES, V49, P33, DOI 10.1194/jlr.M700305-JLR200; Yang CY, 2003, ARTERIOSCL THROM VAS, V23, P1083, DOI 10.1161/01.ATV.0000071350.78872.C4; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624; Ziouzenkova O, 2003, J BIOL CHEM, V278, P39874, DOI 10.1074/jbc.M306786200	46	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107340	10.1371/journal.pone.0107340	http://dx.doi.org/10.1371/journal.pone.0107340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203525	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500085
J	Jiang, Q; Fu, X; Tian, LC; Chen, YQ; Yang, K; Chen, XQ; Zhang, J; Lu, WJ; Wang, J				Jiang, Qian; Fu, Xin; Tian, Lichun; Chen, Yuqin; Yang, Kai; Chen, Xiuqing; Zhang, Jie; Lu, Wenju; Wang, Jian			NOX4 Mediates BMP4-Induced Upregulation of TRPC1 and 6 Protein Expressions in Distal Pulmonary Arterial Smooth Muscle Cells	PLOS ONE			English	Article							RECEPTOR POTENTIAL EXPRESSION; OXIDASE SUBUNIT NOX4; STORE-OPERATED CA2+; NADPH OXIDASE; REACTIVE OXYGEN; INTRACELLULAR CA2+; ENDOTHELIAL-CELLS; HYPERTENSION; HYPOXIA; PROLIFERATION	Rationale: Our previous studies demonstrated that bone morphogenetic protein 4 (BMP4) mediated, elevated expression of canonical transient receptor potential (TRPC) largely accounts for the enhanced proliferation in pulmonary arterial smooth muscle cells (PASMCs). In the present study, we sought to determine the signaling pathway through which BMP4 upregulates TRPC expression. Methods: We employed recombinant human BMP4 (rhBMP4) to determine the effects of BMP4 on NADPH oxidase 4 (NOX4) and reactive oxygen species (ROS) production in rat distal PASMCs. We also designed small interfering RNA targeting NOX4 (siNOX4) and detected whether NOX4 knockdown affects rhBMP4-induced ROS, TRPC1 and 6 expression, cell proliferation and intracellular Ca2+ determination in PASMCs. Results: In rhBMP4 treated rat distal PASMCs, NOX4 expression was (226.73 +/- 11.13) %, and the mean ROS level was (123.65 +/- 1.62) % of that in untreated control cell. siNOX4 transfection significantly reduced rhBMP4-induced elevation of the mean ROS level in PASMCs. Moreover, siNOX4 transfection markedly reduced rhBMP4-induced elevation of TRPC1 and 6 proteins, basal [Ca2+](i) and SOCE. Furthermore, compared with control group (0.21 +/- 0.001), the proliferation of rhBMP4 treated cells was significantly enhanced (0.41 +/- 0.001) (P<0.01). However, such increase was attenuated by knockdown of NOX4. Moreover, external ROS (H2O2 100 mu M, 24 h) rescued the effects of NOX4 knockdown, which included the declining of TRPC1 and 6 expression, basal intracellular calcium concentration ([Ca2+](i)) and store-operated calcium entry (SOCE), suggesting that NOX4 plays as an important mediator in BMP4-induced proliferation and intracellular calcium homeostasis. Conclusion: These results suggest that BMP4 may increase ROS level, enhance TRPC1 and 6 expression and proliferation by up-regulating NOX4 expression in PASMCs.	[Jiang, Qian; Fu, Xin; Tian, Lichun; Chen, Yuqin; Yang, Kai; Chen, Xiuqing; Zhang, Jie; Lu, Wenju; Wang, Jian] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Yang, Kai; Wang, Jian] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA; [Wang, Jian] Inner Mongolia Peoples Hosp, Dept Pulm, Hohhot, Inner Mongolia, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Johns Hopkins University	Wang, J (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	wlu92@yahoo.com; jwang31@jhmi.edu	Yang, Kai/I-6524-2019	Yang, Kai/0000-0003-3044-2240; Chen, Yuqin/0000-0002-7011-7250	NIH [R01-HL093020]; National Natural Science Foundation of China [81173112, 81470246, 81170052, 81220108001]; Guangdong Natural Science Foundation team [1035101200300000]; Guangzhou Department of Education Yangcheng Scholarship [12A001S]; Guangzhou Department of Natural Science [2014Y2-00167]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093020] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation team; Guangzhou Department of Education Yangcheng Scholarship; Guangzhou Department of Natural Science; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH (R01-HL093020), National Natural Science Foundation of China (81173112, 81470246, 81170052, 81220108001), Guangdong Natural Science Foundation team (1035101200300000), Guangzhou Department of Education Yangcheng Scholarship (12A001S), Guangzhou Department of Natural Science (2014Y2-00167) and Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2014, W. Lu), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Dewachter L, 2009, EUR RESPIR J, V34, P1100, DOI 10.1183/09031936.00183008; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Djordjevic T, 2005, ARTERIOSCL THROM VAS, V25, P519, DOI 10.1161/01.ATV.0000154279.98244.eb; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Kim EY, 2012, AM J PHYSIOL-RENAL, V302, pF298, DOI 10.1152/ajprenal.00423.2011; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Li XY, 2013, AM J RESP CELL MOL, V49, P212, DOI 10.1165/rcmb.2012-0051OC; Lin MJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1598, DOI 10.1152/ajplung.00323.2006; Liu D, 2012, EUR RESPIR J, V39, P597, DOI 10.1183/09031936.00072911; Lu WJ, 2008, AM J PHYSIOL-LUNG C, V295, pL104, DOI 10.1152/ajplung.00058.2008; Lu WJ, 2010, AM J PHYSIOL-CELL PH, V299, pC1370, DOI 10.1152/ajpcell.00040.2010; Malczyk M, 2013, AM J RESP CRIT CARE, V188, P1451, DOI 10.1164/rccm.201307-1252OC; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; Ng LC, 2001, CIRC RES, V89, P923, DOI 10.1161/hh2201.100315; Sanders KA, 2007, CIRC RES, V101, P224, DOI 10.1161/CIRCRESAHA.107.158246; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Tabima DM, 2012, FREE RADICAL BIO MED, V52, P1970, DOI 10.1016/j.freeradbiomed.2012.02.041; Tian XY, 2012, J MOL CELL CARDIOL, V52, P237, DOI 10.1016/j.yjmcc.2011.10.013; Wang J, 2005, AM J PHYSIOL-LUNG C, V288, pL1059, DOI 10.1152/ajplung.00448.2004; Wang J, 2004, AM J PHYSIOL-LUNG C, V286, pL848, DOI 10.1152/ajplung.00319.2003; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Wang J, 2014, AM J PHYSIOL-CELL PH, V306, pC364, DOI 10.1152/ajpcell.00048.2013; Wang QS, 2007, FREE RADICAL BIO MED, V42, P642, DOI 10.1016/j.freeradbiomed.2006.12.008; Wang ZY, 2009, CELL PHYSIOL BIOCHEM, V24, P619, DOI 10.1159/000257517; Weigand L, 2005, AM J PHYSIOL-LUNG C, V289, pL5, DOI 10.1152/ajplung.00044.2005; Xia Y, 2014, HYPERTENSION, V63, P173, DOI 10.1161/HYPERTENSIONAHA.113.01902; Yang J, 2013, ARTERIOSCL THROM VAS, V33, P34, DOI 10.1161/ATVBAHA.112.300121; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Zhao Jian-Ping, 2007, Shengli Xuebao, V59, P319	33	22	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107135	10.1371/journal.pone.0107135	http://dx.doi.org/10.1371/journal.pone.0107135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203114	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500072
J	Zhang, YY; Chen, J; Zhang, K; Wang, T; Kong, MY; Chen, RH; Liu, Y; Chen, JP; Wang, ZY; Wang, JF; Huang, H				Zhang, Yinyin; Chen, Jie; Zhang, Kun; Wang, Tong; Kong, Minyi; Chen, Renhua; Liu, Yu; Chen, Jianping; Wang, Zhiyu; Wang, Jingfeng; Huang, Hui			Combination of High Ankle-Brachial Index and Hard Coronary Heart Disease Framingham Risk Score in Predicting the Risk of Ischemic Stroke in General Population	PLOS ONE			English	Article							INCIDENT CARDIOVASCULAR EVENTS; DIABETIC-PATIENTS; ATHEROSCLEROSIS; PREVALENCE; MORTALITY	Our previous study showed that the patients with more metabolic risk factors had higher risk of high ankle-brachial index (ABI), but the relationship between high ABI and the risk of severe cardiovascular and cerebrovascular diseases is still under debate. This study aims to evaluate this association in the general population. 1486 subjects of South China were recruited in the study. 61 subjects were defined as high ABI group (ABI >= 1.3) and 65 subjects were randomly selected as normal ABI group (0.9<ABI<1.3). Biochemical parameters, clinical characteristics and 10-year hard coronary heart disease (HCHD) Framingham Risk Score (FRS) were compared between two groups. The results showed that the 10-year HCHD FRS of high ABI group was significantly higher than normal ABI group (7.87 +/- 6.11 vs. 3.98 +/- 2.90%, P<0.001). There was a positive correlation between ABI value and HCHD FRS in overweight participants (R=0.576, P<0.01). The prevalence of ischemic stroke was higher in high ABI group than normal ABI group (21.3% vs. 6.2%, P<0.05), and it was higher in participants with HCHD FRS >= 6% than those with HCHD FRS<6% (19.1% vs. 6.9%, P<0.05). Moreover, the prevalence of ischemic stroke was higher in participants with high ABI and HCHD FRS >= 6% than those with normal ABI and HCHD FRS<6% (26.7% vs. 4.1%, P<0.05). BMI, hypertension, hsCRP and smoking were proved to be the independent factors and effective predictors for high ABI (P<0.05). In conclusion, high ABI combined with high HCHD FRS should be a potential predictor of ischemic stroke in the general population of South China.	[Zhang, Yinyin; Kong, Minyi; Chen, Renhua; Liu, Yu; Wang, Jingfeng; Huang, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yinyin; Chen, Jie; Zhang, Kun; Wang, Tong; Kong, Minyi; Chen, Renhua; Liu, Yu; Wang, Jingfeng; Huang, Hui] Guangdong Prov Key Lab Arrhythmia & Electrophysio, Guangzhou, Guangdong, Peoples R China; [Chen, Jie; Zhang, Kun] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jianping; Wang, Zhiyu] Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong	Huang, H (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China.	drwjfsums@gmail.com; huanghui765@hotmail.com	wang, jing/GRS-7509-2022		NSFC [81170647, 91029742, 30973207]; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [132030]; Yat-sen Scholarship for Young Scientists; Science & technology star of Zhujiang (Guangzhou); Guangdong Province Key Laboratory of Computational Science at the Sun Yat-sen University	NSFC(National Natural Science Foundation of China (NSFC)); Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China(Fok Ying Tung Education Foundation); Yat-sen Scholarship for Young Scientists; Science & technology star of Zhujiang (Guangzhou); Guangdong Province Key Laboratory of Computational Science at the Sun Yat-sen University	This work was supported in part by NSFC [81170647, 91029742 and 30973207 to Hui Huang], Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [132030], Yat-sen Scholarship for Young Scientists, the Science & technology star of Zhujiang (Guangzhou), and Guangdong Province Key Laboratory of Computational Science at the Sun Yat-sen University to Hui Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2011, ATHEROSCLEROSIS, V214, P169, DOI 10.1016/j.atherosclerosis.2010.10.011; Adragao T, 2012, NEPHROL DIAL TRANSPL, V27, P318, DOI 10.1093/ndt/gfr233; Allison MA, 2008, J AM COLL CARDIOL, V51, P1292, DOI 10.1016/j.jacc.2007.11.064; Allison MA, 2009, J VASC SURG, V50, P1049, DOI 10.1016/j.jvs.2009.05.061; Andrade JL, 2004, INT ANGIOL, V23, P134; Bonny A, 2008, J HYPERTENS, V26, P825, DOI 10.1097/HJH.0b013e3282f857e7; Bouchi R, 2012, ATHEROSCLEROSIS, V222, P490, DOI 10.1016/j.atherosclerosis.2012.02.025; Criqui MH, 2014, JAMA-J AM MED ASSOC, V311, P271, DOI 10.1001/jama.2013.282535; Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060; Hu Da-Yi, 2008, Zhonghua Nei Ke Za Zhi, V47, P723; Ix JH, 2010, J AM COLL CARDIOL, V55, P342, DOI 10.1016/j.jacc.2009.11.010; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Murphy TP, 2011, ATHEROSCLEROSIS, V216, P452, DOI 10.1016/j.atherosclerosis.2011.02.020; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; Pasqualini L, 2012, EUR J INTERN MED, V23, P240, DOI 10.1016/j.ejim.2011.09.004; Power A, 2011, HEMODIAL INT, V15, P256, DOI 10.1111/j.1542-4758.2011.00543.x; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; Wattanakit K, 2007, ATHEROSCLEROSIS, V190, P459, DOI 10.1016/j.atherosclerosis.2006.02.039; Zhang H, 2010, CHINESE MED J-PEKING, V123, P890, DOI 10.3760/cma.j.issn.0366-6999.2010.07.023; Zhang YY, 2013, INT J MED SCI, V10, P183, DOI 10.7150/ijms.5308	22	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106251	10.1371/journal.pone.0106251	http://dx.doi.org/10.1371/journal.pone.0106251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198106	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700027
J	Yoo, RE; Choi, SH; Cho, HR; Jeon, BS; Kwon, E; Kim, EG; Park, J; Myeong, WJ; Won, JK; Lee, YS; Kim, JH; Park, SW; Sohn, CH				Yoo, Roh-Eul; Choi, Seung Hong; Cho, Hye Rim; Jeon, Bong-sik; Kwon, Eunbyul; Kim, Eung-gyu; Park, Juyoung; Myeong, Wan-Jae; Won, Jae-Kyung; Lee, Yun-Sang; Kim, Ji-Hoon; Park, Sun-Won; Sohn, Chul-Ho			Magnetic Resonance Imaging Diagnosis of Metastatic Lymph Nodes in a Rabbit Model: Efficacy of PJY10, a New Ultrasmall Superparamagnetic Iron Oxide Agent, with Monodisperse Iron Oxide Core and Multiple-Interaction Ligands	PLOS ONE			English	Article							CELL LUNG-CANCER; POSITRON-EMISSION-TOMOGRAPHY; RECTAL-CANCER; CONTRAST AGENTS; MR LYMPHOGRAPHY; PROSTATE-CANCER; ENHANCED MRI; USPIO; NANOPARTICLES; CRITERIA	Background: Accurate diagnosis of lymph node metastasis is crucial in treatment planning for cancer patients. Despite the use of various parameters, making correct diagnosis of a small metastatic or a hyperplastic benign node is still a challenge. In this study, we evaluated the feasibility of detecting lymph node metastasis using a new ultrasmall superparamagnetic iron oxide particle, PJY10, in a rabbit model. Methods: To make metastatic and benign lymph nodes, either VX2 carcinoma or fecal material suspension was inoculated into thighs of 56 rabbits three weeks or three days before magnetic resonance (MR) imaging, respectively. T2*-weighted 3T MR imaging was performed before and 24 hours after PJY10 injection (5.2 [n = 15], 7.8 [n = 17], and 10.4 [n = 24] mg Fe/kg). MR images were correlated with pathologic results to calculate sensitivity and specificity. Quantitative analysis of the signal intensity (SI) - number of voxels([low]) (the fraction of the number of voxels with the normalized SI on the postcontrast image lower than that on the precontrast image) and mean SI ratio - was also performed for each lymph node. Results: Sensitivities were 100% at all three dosages, whereas specificity increased with increasing dosage (89% at 10.4 mg Fe/kg). The benign nodes had a significantly higher number of voxels([low]) and a lower mean SI ratio than the metastatic nodes at the dosage of 10.4 mg Fe/kg (P<.001). Az values were 0.905 for the number of voxels([low]) and 0.952 for the mean SI ratio. The number of voxels([low]) (P = .019) and the mean SI ratio (P = .034) had significant correlations with the histopathologic area ratio of metastatic foci in the metastatic nodes at 10.4 mg Fe/kg. Conclusions: PJY10 enabled clear demonstration of lymph node metastasis with high sensitivity and specificity at its optimal dosage of 10.4 mg Fe/kg.	[Yoo, Roh-Eul; Choi, Seung Hong; Cho, Hye Rim; Kim, Ji-Hoon; Park, Sun-Won; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Ctr Nanoparticle Res, Inst Basic Sci, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Cho, Hye Rim] Seoul Natl Univ, Coll Med, Dept Radiat Appl Life Sci, Seoul, South Korea; [Jeon, Bong-sik; Kwon, Eunbyul; Kim, Eung-gyu; Park, Juyoung; Myeong, Wan-Jae] Hanwha Chem Corp, Ctr Res & Dev, Taejon, South Korea; [Won, Jae-Kyung] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Lee, Yun-Sang] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul 151, South Korea; [Park, Sun-Won] Boramae Med Ctr, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Jeon, BS (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	verocay@snuh.org	Sohn, ChulHo/AAV-4565-2021; Kim, Ji-hoon/D-5754-2012	Kim, Ji-hoon/0000-0002-6349-6950; Won, Jae-Kyung/0000-0003-1459-8093	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1120300]; Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs [A112028]; Research Center Program of IBS (Institute for Basic Science) in Korea; Hanwha Chemicals Corp.	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs; Research Center Program of IBS (Institute for Basic Science) in Korea; Hanwha Chemicals Corp.	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1120300), the Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family Affairs (A112028), and the Research Center Program of IBS (Institute for Basic Science) in Korea. S.H.C. acknowledges financial support by Hanwha Chemicals Corp. The funder (Hanwha Chemical Corp.) provided support in the form of salaries for authors [BSJ, EBK, EGK, JP, WJM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598; Anzai Y, 2003, RADIOLOGY, V228, P777, DOI 10.1148/radiol.2283020872; Bellin MF, 2000, EUR J RADIOL, V34, P257, DOI 10.1016/S0720-048X(00)00204-7; Bellin MF, 2002, ABDOM IMAGING, V28, P155, DOI 10.1007/s00261-001-0182-9; Brown G, 2003, RADIOLOGY, V227, P371, DOI 10.1148/radiol.2272011747; Choi EK, 2009, EUR RADIOL, V19, P2024, DOI 10.1007/s00330-009-1350-5; Choi SH, 2006, RADIOLOGY, V241, P753, DOI 10.1148/radiol.2413051979; Choi SH, 2010, J MAGN RESON IMAGING, V31, P134, DOI 10.1002/jmri.22020; Duan HW, 2007, J AM CHEM SOC, V129, P3333, DOI 10.1021/ja068158s; Dunne AA, 2002, ANTICANCER RES, V22, P3273; Dwamena BA, 1999, RADIOLOGY, V213, P530, DOI 10.1148/radiology.213.2.r99nv46530; Fischbein NJ, 2003, AM J NEURORADIOL, V24, P301; Hamilton AM, 2010, J MAGN RESON IMAGING, V31, P110, DOI 10.1002/jmri.22008; Harisinghani MG, 2006, AM J ROENTGENOL, V186, P144, DOI 10.2214/AJR.04.1287; Harisinghani MG, 2004, RADIOGRAPHICS, V24, P867, DOI 10.1148/rg.243035190; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Hauger O, 2000, RADIOLOGY, V217, P819, DOI 10.1148/radiology.217.3.r00dc04819; Islam T, 2009, CANCER BIOMARK, V5, P61, DOI 10.3233/CBM-2009-0578; Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155; Kim JH, 2004, EUR J RADIOL, V52, P78, DOI 10.1016/j.ejrad.2003.12.005; Kitajima K, 2013, ANN NUCL MED, V27, P581, DOI 10.1007/s12149-013-0731-7; Koh DM, 2004, RADIOLOGY, V231, P91, DOI 10.1148/radiol.2311030142; Lahaye MJ, 2008, RADIOLOGY, V246, P804, DOI 10.1148/radiol.2463070221; Lee N, 2012, CHEM SOC REV, V41, P2575, DOI 10.1039/c1cs15248c; Lind K, 2002, J DRUG TARGET, V10, P221, DOI 10.1080/10611860290022651; Ling D, 2011, ANGEW CHEM INT EDIT, V50, P11360, DOI 10.1002/anie.201101521; Misselwitz B, 2006, EUR J RADIOL, V58, P375, DOI 10.1016/j.ejrad.2005.12.044; Morishige K, 2010, CIRCULATION, V122, P1707, DOI 10.1161/CIRCULATIONAHA.109.891804; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Narayanan P, 2009, RADIOGRAPHICS, V29, P1057, DOI 10.1148/rg.294085231; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Shen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094876; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; Torabi M, 2004, J NUCL MED, V45, P1509; Vesselle H, 2002, J THORAC CARDIOV SUR, V124, P511, DOI 10.1067/mtc.2002.123130; WAGNER S, 1994, INVEST RADIOL, V29, P364, DOI 10.1097/00004424-199403000-00021; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Wu LC, 2011, EUR J RADIOL, V80, P582, DOI 10.1016/j.ejrad.2009.11.027	39	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107583	10.1371/journal.pone.0107583	http://dx.doi.org/10.1371/journal.pone.0107583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216040	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300082
J	Pridmore, RW				Pridmore, Ralph W.			Orthogonal Relations and Color Constancy in Dichromatic Colorblindness	PLOS ONE			English	Article							WAVELENGTH DISCRIMINATION; CHROMATIC ADAPTATION; HUE; VISION; POINTS; UNIQUE; PROTANOPES; BRIGHTNESS; SATURATION	This paper employs uniform color space to analyze relations in dichromacy (protanopia, deuteranopia, tritanopia). Fifty percent or less of dichromats represent the classical reduction form of trichromacy, where one of three cones is inoperative but normal trichromatic color mixture such as complementary colors (pairs that mix white) are accepted by the dichromat, whose data can thus be plotted to CIE chromaticity spaces. The remaining dichromats comprise many and varied more-complex gene arrays from mutations, recombinations, etc. Though perhaps a minority, the three reductionist types provide a simple standard, in genotype and phenotype, to which the more complex remainder may be compared. Here, previously published data on dichromacy are plotted and analyzed in CIELUV uniform color space to find spatial relations in terms of color appearance space (e.g., hue angle). Traditional residual (seen) hues for protanopia and deuteranopia (both red-green colorblindness) are yellow and blue, but analysis indicates the protanopic residual hues are more greenish yellow and reddish blue than in tradition. Results for three illuminants (D65, D50, B) imply four principles in the spatial structure of dichromacy: (1) complementarity of confusion hue pairs and of residual hue pairs; (2) orthogonality of confusion locus and residual hues locus at their intersection with the white point, in each dichromatic type; (3) orthogonality of protanopic and tritanopic confusion loci; and (4) inverse relations between protanopic and tritanopic systems generally, such that one's confusion hues are the other's residual hues. Two of the three dichromatic systems do not represent components of normal trichromatic vision as sometimes thought but are quite different. Wavelength shifts between illuminants demonstrate chromatic adaptation correlates exactly with that in trichromatic vision. In theory these results clarify relations in and between types of dichromacy. They also apply in Munsell and CIELAB color spaces but inexactly to the degree they employ inexact complementarity.	Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia	Macquarie University	Pridmore, RW (corresponding author), Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia.	rpridmo@bigpond.net.au		pridmore, ralph/0000-0001-7166-7249				ALPERN M, 1983, J PHYSIOL-LONDON, V335, P683, DOI 10.1113/jphysiol.1983.sp014558; Bosten JM, 2005, CURR BIOL, V15, pR950, DOI 10.1016/j.cub.2005.11.031; Brettel H, 1997, J OPT SOC AM A, V14, P2647, DOI 10.1364/JOSAA.14.002647; Broackes J, 2010, OPHTHAL PHYSL OPT, V30, P672, DOI 10.1111/j.1475-1313.2010.00774.x; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; COX J, 1961, J OPT SOC AM, V51, P992, DOI 10.1364/JOSA.51.000992; Dalton J.S., 1798, MANCHESTER LIT PHILO, V5, P28; FISCHER F P, 1951, Doc Ophthalmol, V5-6, P73, DOI 10.1007/BF00143654; FOSTER DH, 1995, J PHYSIOL-LONDON, V485P, pP23; Hecht S, 1936, J GEN PHYSIOL, V20, P57, DOI 10.1085/jgp.20.1.57; HURVICH LM, 1955, J OPT SOC AM, V45, P602, DOI 10.1364/JOSA.45.000602; Judd D. B., 1975, COLOR BUSINESS SCI I; JUDD DB, 1945, J OPT SOC AM, V35, P199, DOI 10.1364/JOSA.35.000199; Kliegl R, 1983, P S INT RES GROUP CO; Kuehni RG, 2004, COLOR RES APPL, V29, P158, DOI 10.1002/col.10237; Le Grand Y, 1968, LIGHT COLOUR VISION; MACLEOD DIA, 1976, VISION RES, V16, P691, DOI 10.1016/0042-6989(76)90179-6; MASSOFF RW, 1976, VISION RES, V16, P53, DOI 10.1016/0042-6989(76)90076-6; Matthen, 2010, COLOR ONTOLOGY COLOR; Mollon JD, 2001, INVEST OPHTH VIS SCI, V42, pS97; MONTAG ED, 1994, VISION RES, V34, P2137, DOI 10.1016/0042-6989(94)90323-9; Moreira H, 2014, COLOR RES APPL, V39, P372, DOI 10.1002/col.21802; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Neitz M, 2004, VISUAL NEUROSCI, V21, P205, DOI 10.1017/S0952523804213293; Pitt, 1935, CHARACTERISTICS DICH; Pitt FHG, 1945, P R SOC            B, V132, P101; Pridmore RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077134; Pridmore RW, 2010, COLOR RES APPL, V35, P425, DOI 10.1002/col.20572; Pridmore RW, 2009, COLOR RES APPL, V34, P233, DOI 10.1002/col.20490; Pridmore RW, 1999, VISION RES, V39, P3892, DOI 10.1016/S0042-6989(99)00086-3; Ruttiger L, 2001, COLOR RES APPL, V26, pS209, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL44>3.0.CO;2-D; Sharpe L.T., 1999, COLOR VISION GENES P, P3; SLOAN LL, 1955, J OPT SOC AM, V45, P592, DOI 10.1364/JOSA.45.000592; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; VIENOT F, 1995, NATURE, V376, P127, DOI 10.1038/376127a0; Wachtler T, 2004, VISION RES, V44, P2843, DOI 10.1016/j.visres.2004.06.016; WALLS GL, 1964, VISION RES, V4, P3, DOI 10.1016/0042-6989(64)90026-4; WALLS GL, 1956, J OPT SOC AM, V46, P640, DOI 10.1364/JOSA.46.000640; Wong B, 2011, NAT METHODS, V8, P441, DOI 10.1038/nmeth.1618; WRIGHT WD, 1952, J OPT SOC AM, V42, P509, DOI 10.1364/JOSA.42.000509; Wuerger SM, 2005, VISION RES, V45, P3210, DOI 10.1016/j.visres.2005.06.016; Wyszecki G, 1982, COLOR SCI CONCEPTS M, P463	43	6	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107035	10.1371/journal.pone.0107035	http://dx.doi.org/10.1371/journal.pone.0107035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211128	Green Submitted, gold, Green Published			2022-12-27	WOS:000341855900038
J	Rossi, A; Michelini, Z; Leone, P; Borghi, M; Blasi, M; Bona, R; Spada, M; Grasso, F; Gugliotta, A; Klotman, ME; Cara, A; Negri, D				Rossi, Alessandra; Michelini, Zuleika; Leone, Pasqualina; Borghi, Martina; Blasi, Maria; Bona, Roberta; Spada, Massimo; Grasso, Felicia; Gugliotta, Alessio; Klotman, Mary E.; Cara, Andrea; Negri, Donatella			Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector	PLOS ONE			English	Article							SYSTEMIC IMMUNE-RESPONSES; T-CELL; GENE DELIVERY; SUBLINGUAL IMMUNIZATION; NONDIVIDING CELLS; DENDRITIC CELLS; VACCINE; PROTEIN; ENVELOPE; MICE	Many infectious agents infiltrate the host at the mucosal surfaces and then spread systemically. This implies that an ideal vaccine should induce protective immune responses both at systemic and mucosal sites to counteract invasive mucosal pathogens. We evaluated the in vivo systemic and mucosal antigen-specific immune response induced in mice by intramuscular administration of an integrase defective lentiviral vector (IDLV) carrying the ovalbumin (OVA) transgene as a model antigen (IDLV-OVA), either alone or in combination with sublingual adjuvanted OVA protein. Mice immunized intramuscularly with OVA and adjuvant were compared with IDLV-OVA immunization. Mice sublingually immunized only with OVA and adjuvant were used as a positive control of mucosal responses. A single intramuscular dose of IDLV-OVA induced functional antigen-specific CD8+ T cell responses in spleen, draining and distal lymph nodes and, importantly, in the lamina propria of the large intestine. These results were similar to those obtained in a prime-boost regimen including one IDLV immunization and two mucosal boosts with adjuvanted OVA or vice versa. Remarkably, only in groups vaccinated with IDLV-OVA, either alone or in prime-boost regimens, the mucosal CD8+ T cell response persisted up to several months from immunization. Importantly, following IDLV-OVA immunization, the mucosal boost with protein greatly increased the plasma IgG response and induced mucosal antigen-specific IgA in saliva and vaginal washes. Overall, intramuscular administration of IDLV followed by protein boosts using the sublingual route induced strong, persistent and complementary systemic and mucosal immune responses, and represents an appealing prime-boost strategy for immunization including IDLV as a delivery system.	[Rossi, Alessandra; Borghi, Martina; Grasso, Felicia; Negri, Donatella] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Michelini, Zuleika; Leone, Pasqualina; Bona, Roberta; Gugliotta, Alessio; Cara, Andrea] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Blasi, Maria] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Spada, Massimo] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Klotman, Mary E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Duke University	Cara, A (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy.	andrea.cara@iss.it; donatella.negri@iss.it	michelini, zuleika/Q-4383-2019; Rossi, Alessandra/ABH-6468-2020; BORGHI, MARTINA/M-4355-2015; Blasi, Maria/AAX-2293-2021; Spada, Massimo/Z-1345-2019; Spada, Massimo/R-9563-2017; Rossi, Alessandra/K-6601-2016; Bona, Roberta/O-1730-2017; Cara, Andrea/M-4865-2015; Cara, Andrea/AAA-4238-2021; grasso, felicia/B-3399-2013; Michelini, Zuleika/J-9003-2016; Negri, Donatella/M-4362-2015; klotman, mary e/A-1921-2016	michelini, zuleika/0000-0001-6841-7396; Rossi, Alessandra/0000-0001-9042-3549; BORGHI, MARTINA/0000-0001-6313-0273; Spada, Massimo/0000-0003-0751-1893; Spada, Massimo/0000-0003-0751-1893; Rossi, Alessandra/0000-0001-9042-3549; Bona, Roberta/0000-0002-9226-3734; Cara, Andrea/0000-0003-4967-1895; Cara, Andrea/0000-0003-4967-1895; Michelini, Zuleika/0000-0001-6841-7396; Negri, Donatella/0000-0002-3437-9288; Blasi, Maria/0000-0002-7091-0312; Grasso, Felicia/0000-0002-0836-8729	European Union [280873]	European Union(European Commission)	This study was supported by the European Union's Seventh Framework Programme [FP7/2007 2013] under Grant Agreement No: 280873 ADITEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apolonia L, 2007, MOL THER, V15, P1947, DOI 10.1038/sj.mt.6300281; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Bayer M, 2008, MOL THER, V16, P1968, DOI 10.1038/mt.2008.199; Belyakov IM, 2011, CURR MED CHEM, V18, P3953, DOI 10.2174/092986711796957293; Belyakov IM, 2008, VIROLOGY, V381, P106, DOI 10.1016/j.virol.2008.08.019; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Braga CJM, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00487; Buffa V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050529; Cesana D, 2014, MOL THER, V22, P774, DOI 10.1038/mt.2014.3; Chmielewska AM, 2014, J VIROL, V88, P5502, DOI 10.1128/JVI.03574-13; Coutant F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048644; Coutant F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003973; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Cuburu N, 2009, J IMMUNOL, V183, P7851, DOI 10.4049/jimmunol.0803740; Deng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062684; Fontana JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097270; Grasso F, 2013, INT J CANCER, V132, P335, DOI 10.1002/ijc.27676; Hervouet C, 2010, VACCINE, V28, P5582, DOI 10.1016/j.vaccine.2010.06.033; Hu BL, 2011, IMMUNOL REV, V239, P45, DOI 10.1111/j.1600-065X.2010.00967.x; Hu BL, 2010, VACCINE, V28, P6675, DOI 10.1016/j.vaccine.2010.08.012; Huo ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033736; Karwacz K, 2009, J VIROL, V83, P3094, DOI 10.1128/JVI.02519-08; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; Li JY, 2013, VACCINE, V31, P3747, DOI 10.1016/j.vaccine.2013.04.037; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Liu YJ, 2009, J IMMUNOL, V182, P5960, DOI 10.4049/jimmunol.0900008; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Mantis NJ, 2001, VACCINE, V19, P3990, DOI 10.1016/S0264-410X(01)00115-3; Michelini Z, 2009, VACCINE, V27, P4622, DOI 10.1016/j.vaccine.2009.05.070; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negri DRM, 2007, MOL THER, V15, P1716, DOI 10.1038/sj.mt.6300241; Negri DRM, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-69; Negri DRM, 2011, EXPERT OPIN BIOL TH, V11, P739, DOI 10.1517/14712598.2011.571670; Negri DRM, 2010, HUM GENE THER, V21, P1029, DOI 10.1089/hum.2009.200; Negri DRM, 2010, VACCINE, V28, P4175, DOI 10.1016/j.vaccine.2010.04.013; Negri DRM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/534501; Negri DRM, 2010, CURR HIV RES, V8, P274, DOI 10.2174/157016210791208622; Otto P, 1998, PROMEGA NOTES, V69, P19; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Rahim AA, 2009, GENE THER, V16, P509, DOI 10.1038/gt.2008.186; Rappuoli R, 1999, IMMUNOL TODAY, V20, P493, DOI 10.1016/S0167-5699(99)01523-6; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Saenz DT, 2004, J VIROL, V78, P2906, DOI 10.1128/JVI.78.6.2906-2920.2004; Shim Byoung-Shik, 2013, Immune Netw, V13, P81, DOI 10.4110/in.2013.13.3.81; Singh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090001; Sircar P, 2013, MUCOSAL IMMUNOL, V6, P93, DOI 10.1038/mi.2012.52; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Srivastava I, 2008, VACCINE, V26, P2796, DOI 10.1016/j.vaccine.2007.11.083; Wanisch K, 2009, MOL THER, V17, P1316, DOI 10.1038/mt.2009.122; WEISS S, 1992, GENE, V121, P203, DOI 10.1016/0378-1119(92)90123-7; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365	53	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107377	10.1371/journal.pone.0107377	http://dx.doi.org/10.1371/journal.pone.0107377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210766	Green Submitted, Green Published, gold			2022-12-27	WOS:000341855900067
J	Tillman, EJ; Morgan, DA; Rahmouni, K; Swoap, SJ				Tillman, Erik J.; Morgan, Donald A.; Rahmouni, Kamal; Swoap, Steven J.			Three Months of High-Fructose Feeding Fails to Induce Excessive Weight Gain or Leptin Resistance in Mice	PLOS ONE			English	Article							SWEETENED BEVERAGE CONSUMPTION; DIET-INDUCED OBESITY; HIGH-FAT; POMC NEURONS; BODY-FAT; INSULIN SENSITIVITY; ENERGY HOMEOSTASIS; C57BL/6 MICE; MALONYL-COA; FOOD-INTAKE	High-fructose diets have been implicated in obesity via impairment of leptin signaling in humans and rodents. We investigated whether fructose-induced leptin resistance in mice could be used to study the metabolic consequences of fructose consumption in humans, particularly in children and adolescents. Male C57Bl/6 mice were weaned to a randomly assigned diet: high fructose, high sucrose, high fat, or control (sugar-free, low-fat). Mice were maintained on their diets for at least 14 weeks. While fructose-fed mice regularly consumed more kcal and expended more energy, there was no difference in body weight compared to control by the end of the study. Additionally, after 14 weeks, both fructose-fed and control mice displayed similar leptin sensitivity. Fructose-feeding also did not change circulating glucose, triglycerides, or free fatty acids. Though fructose has been linked to obesity in several animal models, our data fail to support a role for fructose intake through food lasting 3 months in altering of body weight and leptin signaling in mice. The lack of impact of fructose in the food of growing mice on either body weight or leptin sensitivity over this time frame was surprising, and important information for researchers interested in fructose and body weight regulation.	[Tillman, Erik J.; Swoap, Steven J.] Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [Morgan, Donald A.; Rahmouni, Kamal] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	Williams College; University of Iowa	Swoap, SJ (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	sswoap@williams.edu	Rahmouni, Kamal/Y-1788-2019; Morgan, Donald A/L-6907-2013	Morgan, Donald A/0000-0003-3167-1643; Rahmouni, Kamal/0000-0001-5136-6748; Tillman, Erik/0000-0003-3599-0297	National Institutes of Health [HL084207, R15AG37959-1]; American Heart Association [14EIA18860041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R15AG037959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	KR is supported by funds from the National Institutes of Health (HL084207) and American Heart Association (14EIA18860041). SJS is supported by funds from the National Institutes of Health (R15AG37959-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attig L, 2010, P NUTR SOC, V69, P221, DOI 10.1017/S002966511000008X; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Banks WA, 2004, DIABETES, V53, P1253, DOI 10.2337/diabetes.53.5.1253; Beigy M, 2013, J ANIM PHYSL ANIM NU; Bocarsly ME, 2010, PHARMACOL BIOCHEM BE, V97, P101, DOI 10.1016/j.pbb.2010.02.012; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bray GA, 2010, CURR OPIN LIPIDOL, V21, P51, DOI 10.1097/MOL.0b013e3283346ca2; Bremer AA, 2009, ARCH PEDIAT ADOL MED, V163, P328, DOI 10.1001/archpediatrics.2009.21; Bryant CD, 2008, J NEUROGENET, V22, P315, DOI 10.1080/01677060802357388; Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105; Chang HYS, 2012, J AM ASSOC LAB ANIM, V51, P401; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cummings BP, 2010, AM J PHYSIOL-REG I, V298, pR1343, DOI 10.1152/ajpregu.00468.2009; D'Angelo G, 2005, HYPERTENSION, V46, P806, DOI 10.1161/01.HYP.0000182697.39687.34; DeBosch BJ, 2013, MOL ENDOCRINOL, V27, P1887, DOI 10.1210/me.2013-1137; Denova-Gutierrez E, 2008, ANN NUTR METAB, V53, P245, DOI 10.1159/000189127; Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Haring SJ, 2011, PHYSIOL BEHAV, V104, P914, DOI 10.1016/j.physbeh.2011.05.032; Harrington S, 2008, J SCH NURS, V24, P3, DOI [10.1177/10598405080240010201, 10.1622/1059-8405(2008)024[0003:TROSBC]2.0.CO;2]; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Huang BW, 2004, DIABETES OBES METAB, V6, P120, DOI 10.1111/j.1462-8902.2004.00323.x; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Juergens H, 2003, OBES RES, V11, pA19; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; Lane MD, 2009, BIOCHEM BIOPH RES CO, V382, P1, DOI 10.1016/j.bbrc.2009.02.145; Le KA, 2006, AM J CLIN NUTR, V84, P1374, DOI 10.1093/ajcn/84.6.1374; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Ma X, 2008, P NATL ACAD SCI USA, V105, P9811, DOI 10.1073/pnas.0800952105; Meyer CW, 2007, NATURWISSENSCHAFTEN, V94, P401, DOI 10.1007/s00114-006-0203-1; MICHAELIS OE, 1984, AM J CLIN NUTR, V39, P612, DOI 10.1093/ajcn/39.4.612; Muller CJ, 2009, GENES BRAIN BEHAV, V8, P481, DOI 10.1111/j.1601-183X.2009.00490.x; Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975; Rikke BA, 2003, MECH AGEING DEV, V124, P663, DOI 10.1016/S0047-6374(03)00003-4; Sahu A, 2003, FRONT NEUROENDOCRIN, V24, P225, DOI 10.1016/j.yfrne.2003.10.001; Schaefer EJ, 2009, J NUTR, V139, pS1257, DOI 10.3945/jn.108.098186; SCHEMMEL RA, 1982, AM J PHYSIOL, V243, pR347, DOI 10.1152/ajpregu.1982.243.3.R347; Shafrir E, 2000, DIABETES-METAB RES, V16, P94, DOI 10.1002/(SICI)1520-7560(200003/04)16:2<94::AID-DMRR82>3.0.CO;2-U; Shapiro A, 2008, AM J PHYSIOL-REG I, V295, pR1370, DOI 10.1152/ajpregu.00195.2008; Shapiro A, 2011, BRIT J NUTR, V106, P390, DOI 10.1017/S000711451100033X; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Ushio M, 2013, AM J PHYSIOL-ENDOC M, V305, pE293, DOI 10.1152/ajpendo.00442.2012; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; WELLE S, 1981, METABOLISM, V30, P953, DOI 10.1016/0026-0495(81)90092-5; Zhang Y, 2006, PHYSIOL BEHAV, V88, P249, DOI 10.1016/j.physbeh.2006.05.038	51	45	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107206	10.1371/journal.pone.0107206	http://dx.doi.org/10.1371/journal.pone.0107206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211467	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900049
J	Cano, RJ; Rivera-Perez, J; Toranzos, GA; Santiago-Rodriguez, TM; Narganes-Storde, YM; Chanlatte-Baik, L; Garcia-Roldan, E; Bunkley-Williams, L; Massey, SE				Cano, Raul J.; Rivera-Perez, Jessica; Toranzos, Gary A.; Santiago-Rodriguez, Tasha M.; Narganes-Storde, Yvonne M.; Chanlatte-Baik, Luis; Garcia-Roldan, Erileen; Bunkley-Williams, Lucy; Massey, Steven E.			Paleomicrobiology: Revealing Fecal Microbiomes of Ancient Indigenous Cultures	PLOS ONE			English	Article							PROFILES; PATTERNS	Coprolites are fossilized feces that can be used to provide information on the composition of the intestinal microbiota and, as we show, possibly on diet. We analyzed human coprolites from the Huecoid and Saladoid cultures from a settlement on Vieques Island, Puerto Rico. While more is known about the Saladoid culture, it is believed that both societies co-existed on this island approximately from 5 to 1170 AD. By extracting DNA from the coprolites, followed by metagenomic characterization, we show that both cultures can be distinguished from each other on the basis of their bacterial and fungal gut microbiomes. In addition, we show that parasite loads were heavy and also culturally distinct. Huecoid coprolites were characterized by maize and Basidiomycetes sequences, suggesting that these were important components of their diet. Saladoid coprolite samples harbored sequences associated with fish parasites, suggesting that raw fish was a substantial component of their diet. The present study shows that ancient DNA is not entirely degraded in humid, tropical environments, and that dietary and/or host genetic differences in ancient populations may be reflected in the composition of their gut microbiome. This further supports the hypothesis that the two ancient cultures studied were distinct, and that they retained distinct technological/cultural differences during an extended period of close proximity and peaceful coexistence. The two populations seemed to form the later-day Tainos, the Amerindians present at the point of Columbian contact. Importantly, our data suggest that paleomicrobiomics can be a powerful tool to assess cultural differences between ancient populations.	[Cano, Raul J.] Calif Polytech State Univ San Luis Obispo, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA; [Rivera-Perez, Jessica; Toranzos, Gary A.; Garcia-Roldan, Erileen; Bunkley-Williams, Lucy; Massey, Steven E.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Santiago-Rodriguez, Tasha M.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Narganes-Storde, Yvonne M.; Chanlatte-Baik, Luis] Univ Puerto Rico, Ctr Archaeol Res, San Juan, PR 00931 USA	California State University System; California Polytechnic State University San Luis Obispo; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of California System; University of California San Diego; University of Puerto Rico	Cano, RJ (corresponding author), Calif Polytech State Univ San Luis Obispo, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA.	rcano@calpoly.edu			NIH RISE Program (NIH) [5R25GM061151-12]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061151] Funding Source: NIH RePORTER	NIH RISE Program (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was partially funded by NIH RISE Program (NIH Grant No. 5R25GM061151-12). The authors also would like to thank Mark Brolaski of Mo Bio Laboratories for providing the necessary supplies and support for the extraction of fossil DNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AJ, 1996, ENVIRON TOXIC WATER, V11, P21, DOI 10.1002/(SICI)1098-2256(1996)11:1<21::AID-TOX4>3.0.CO;2-B; Alvarez AJ, 1996, ENVIRON TOXIC WATER, V11, P129, DOI 10.1002/(SICI)1098-2256(1996)11:2<129::AID-TOX8>3.0.CO;2-B; Appelt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088376; CALLEN E. O., 1960, New Scientist, V8, P35; CANO RJ, 1995, SCIENCE, V268, P1060, DOI 10.1126/science.7538699; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carneiro S, 2011, ADV INTEL SOFT COMPU, V93, P313; Casula G, 2002, APPL ENVIRON MICROB, V68, P2344, DOI 10.1128/AEM.68.5.2344-2352.2002; Chanlatte LA, 2005, CULTURA HUECA MUSEO, P101; Chanlatte LA, 2002, CULTURASALADOIDE PUE, P55; Chanlatte-Baik LA, 2013, HDB CARRIBBEAN ARCHA; Chastanet A, 2003, MOL MICROBIOL, V47, P1061, DOI 10.1046/j.1365-2958.2003.03355.x; Crespo E, 2010, TRIBES PEOPLE POWER; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Fugassa MH, 2006, J PARASITOL, V92, P1110, DOI 10.1645/GE-876R1.1; Garcia SL, 1993, DIAGNOSTIC MED PARAS, P309; Goncalves MLC, 2003, MEM I OSWALDO CRUZ, V98, P103, DOI 10.1590/S0074-02762003000900016; Han ET, 2003, MEM I OSWALDO CRUZ, V98, P123, DOI 10.1590/S0074-02762003000900018; Hert DG, 2008, ELECTROPHORESIS, V29, P4618, DOI 10.1002/elps.200800456; KAPRELYANTS AS, 1993, FEMS MICROBIOL LETT, V104, P271, DOI 10.1016/0378-1097(93)90600-7; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Koltunov V, 2010, MICROB ECOL, V59, P296, DOI 10.1007/s00248-009-9573-1; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lu K, 2014, CHEM RES TOXICOL, V27, P172, DOI 10.1021/tx400454z; Narganes Y, 1991, P 30 INT C INT ASS C, P628; Narganes Y, 2007, P 21 C INT ASS CAR A, P275; Narganes-Storde Y, 1982, VERTEBRATE FAUNAL RE; Pagan-Jimenez JR, 2007, AM ARCHEOLOGY PARIS; Pal A, 2007, J PHOTOCH PHOTOBIO A, V186, P335, DOI 10.1016/j.jphotochem.2006.09.002; Rodriguez M, 1997, INDIGENOUS PEOPLE CA; Rodriguez-Ramos RR., 2010, RETHINKING PUERTO RI; Rouse I, 1992, TAINOS RISE DECLINE; SAITO T, 1991, J NUTR SCI VITAMINOL, V37, P493, DOI 10.3177/jnsv.37.493; Santiago-Rodriguez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065191; Schwartz K, 2012, NEURO-ONCOLOGY, V14, P55; Sharma N, 2005, MICROPALEONTOLOGY, V51, P73, DOI 10.2113/51.1.73; Wilson SM, 2007, ARCHEOLOGY CARIBBEAN; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zaremba-Niedzwiedzka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062799	40	45	46	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106833	10.1371/journal.pone.0106833	http://dx.doi.org/10.1371/journal.pone.0106833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207979	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300042
J	Chen, F; Yuan, YJ				Chen, Feng; Yuan, Yujiang			May-June Maximum Temperature Reconstruction from Mean Earlywood Density in North Central China and Its Linkages to the Summer Monsoon Activities	PLOS ONE			English	Article							TREE-RING DENSITY; WIDTH; PRECIPITATION; CHRONOLOGIES; VARIABILITY; PARAMETERS; COLUMBIA; SIGNALS; SITES	Cores of Pinus tabulaformis from Tianshui were subjected to densitometric analysis to obtain mean earlywood density data. Climate response analysis indicates that May-June maximum temperature is the main factor limiting the mean earlywood density (EWD) of Chinese pine trees in the Shimen Mountains. Based on the EWD chronology, we have reconstructed May-June maximum temperature 1666 to 2008 for Tianshui, north central China. The reconstruction explains 40.1% of the actual temperature variance during the common period 1953-2008. The temperature reconstruction is representative of temperature conditions over a large area to the southeast and northwest of the sampling site. Preliminary analysis of links between large-scale climatic variation and the temperature reconstruction shows that there is a relationship between extremes in spring temperature and anomalous atmospheric circulation in the region. It is thus revealed that the mean earlywood density chronology of Pinus tabulaformis has enough potential to reconstruct the temperature variability further into the past.	[Chen, Feng; Yuan, Yujiang] China Meteorol Adm, Inst Desert Meteorol, Xinjiang Lab Tree Ring Ecol, Key Lab Tree Ring Phys & Chem Res, Urumqi, Xinjiang, Peoples R China	China Meteorological Administration	Chen, F (corresponding author), China Meteorol Adm, Inst Desert Meteorol, Xinjiang Lab Tree Ring Ecol, Key Lab Tree Ring Phys & Chem Res, Urumqi, Xinjiang, Peoples R China.	feng653@163.com	Chen, Feng/C-5859-2013	Chen, Feng/0000-0002-2551-8653	National Basic Research Program of China [2010CB951001]; Basic Research Operating Expenses of the Central-level Non-profit Research Institutes [IDM201105]	National Basic Research Program of China(National Basic Research Program of China); Basic Research Operating Expenses of the Central-level Non-profit Research Institutes	This work was supported by supported by the National Basic Research Program of China (2010CB951001), The Basic Research Operating Expenses of the Central-level Non-profit Research Institutes (IDM201105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Blasing T. J., 1981, Tree-Ring Bulletin, V41, P37; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Buntgen U, 2005, CLIM DYNAM, V25, P141, DOI 10.1007/s00382-005-0028-1; Chen F, 2012, INT J CLIMATOL, V32, P1089, DOI 10.1002/joc.2327; Chen F, 2013, QUATERN INT, V283, P36, DOI 10.1016/j.quaint.2012.05.047; Chen F, 2012, THEOR APPL CLIMATOL, V107, P633, DOI 10.1007/s00704-011-0512-y; Chen F, 2012, INT J BIOMETEOROL, V56, P765, DOI 10.1007/s00484-011-0431-8; Chen F, 2010, GEOCHRONOMETRIA, V36, P17, DOI 10.2478/v10003-010-0014-4; Cook ER, 1990, METHODS DENDROCHRONO, DOI DOI 10.1007/978-94-015-7879-0; Cook ER, 1985, THESIS U ARIZONA TUC; CREBER GT, 1984, BOT REV, V50, P357, DOI 10.1007/BF02862630; D'Arrigo R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019756; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; Davi N, 2002, CLIMATIC CHANGE, V52, P201, DOI 10.1023/A:1013085624162; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Fan ZX, 2009, GLOBAL PLANET CHANGE, V65, P1, DOI 10.1016/j.gloplacha.2008.10.001; Fang KY, 2010, INT J CLIMATOL, V30, P1137, DOI 10.1002/joc.1974; Fritts H.C, 1976, TREE RINGS CLIMATE; Grudd H, 2008, CLIM DYNAM, V31, P843, DOI 10.1007/s00382-007-0358-2; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; HUGHES MK, 1994, QUATERNARY RES, V42, P88, DOI 10.1006/qres.1994.1056; HUGHES MK, 1984, NATURE, V308, P341, DOI 10.1038/308341a0; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Li Q, 2013, QUATERN INT, V283, P11, DOI 10.1016/j.quaint.2012.03.017; Luckman BH, 1997, HOLOCENE, V7, P375, DOI 10.1177/095968369700700401; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Ninomiya K, 1999, J METEOROL SOC JPN, V77, P77, DOI 10.2151/jmsj1965.77.1_77; Pant GB, 2000, CAN J FOREST RES, V30, P1127, DOI 10.1139/cjfr-30-7-1127; Schweingruber F. H., 1978, Tree-Ring Bulletin, V38, P61; SCHWEINGRUBER FH, 1988, BOREAS, V17, P559; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; [王劲松 WANG Jinsong], 2008, [高原气象, Plateau Meteorology], V27, P84; Wang LiLi, 2005, Acta Phytoecologica Sinica, V29, P380; Wang L, 2010, INT J CLIMATOL, V30, P972, DOI 10.1002/joc.2000; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilson RJS, 2003, HOLOCENE, V13, P851, DOI 10.1191/0959683603hl663rp; Wu RG, 2002, J CLIMATE, V15, P3266, DOI 10.1175/1520-0442(2002)015<3266:ACOTEA>2.0.CO;2; Zhou TJ, 2009, METEOROL Z, V18, P455, DOI 10.1127/0941-2948/2009/0396; Zhou TJ, 2009, J CLIMATE, V22, P2199, DOI 10.1175/2008JCLI2527.1	40	13	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107501	10.1371/journal.pone.0107501	http://dx.doi.org/10.1371/journal.pone.0107501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207554	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300086
J	Oeste, CL; Pinar, M; Schink, KO; Martinez-Turrion, J; Stenmark, H; Penalva, MA; Perez-Sala, D				Oeste, Clara L.; Pinar, Mario; Schink, Kay O.; Martinez-Turrion, Javier; Stenmark, Harald; Penalva, Miguel A.; Perez-Sala, Dolores			An Isoprenylation and Palmitoylation Motif Promotes Intraluminal Vesicle Delivery of Proteins in Cells from Distant Species	PLOS ONE			English	Article							ESCRT MACHINERY; ENDOCYTIC PATHWAY; RAB CONVERSION; LATE ENDOSOMES; FISSION YEAST; LIVE CELLS; TRAFFICKING; LOCALIZATION; DEGRADATION; GTPASES	The C-terminal ends of small GTPases contain hypervariable sequences which may be posttranslationally modified by defined lipid moieties. The diverse structural motifs generated direct proteins towards specific cellular membranes or organelles. However, knowledge on the factors that determine these selective associations is limited. Here we show, using advanced microscopy, that the isoprenylation and palmitoylation motif of human RhoB (-CINCCKVL) targets chimeric proteins to intraluminal vesicles of endolysosomes in human cells, displaying preferential co-localization with components of the late endocytic pathway. Moreover, this distribution is conserved in distant species, including cells from amphibians, insects and fungi. Blocking lipidic modifications results in accumulation of CINCCKVL chimeras in the cytosol, from where they can reach endolysosomes upon release of this block. Remarkably, CINCCKVL constructs are sorted to intraluminal vesicles in a cholesterol-dependent process. In the lower species, neither the C-terminal sequence of RhoB, nor the endosomal distribution of its homologs are conserved; in spite of this, CINCCKVL constructs also reach endolysosomes in Xenopus laevis and insect cells. Strikingly, this behavior is prominent in the filamentous ascomycete fungus Aspergillus nidulans, in which GFP-CINCCKVL is sorted into endosomes and vacuoles in a lipidation-dependent manner and allows monitoring endosomal movement in live fungi. In summary, the isoprenylated and palmitoylated CINCCKVL sequence constitutes a specific structure which delineates an endolysosomal sorting strategy operative in phylogenetically diverse organisms.	[Oeste, Clara L.; Martinez-Turrion, Javier; Perez-Sala, Dolores] CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain; [Pinar, Mario; Penalva, Miguel A.] CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, Madrid, Spain; [Schink, Kay O.; Stenmark, Harald] Oslo Univ Hosp, Ctr Canc Biomed, Fac Med, Oslo, Norway	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Oslo	Perez-Sala, D (corresponding author), CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain.	dperezsala@cib.csic.es	Stenmark, Harald/B-8868-2008; Penalva, Miguel A/G-2295-2015; Perez-Sala, Dolores/L-5969-2014; Oeste, Clara/O-2873-2014	Penalva, Miguel A/0000-0002-3102-2806; Perez-Sala, Dolores/0000-0003-0600-665X; Oeste, Clara/0000-0002-7035-132X; Schink, Kay Oliver/0000-0002-5903-4059; Pinar, Mario/0000-0002-2415-8721	MINECO [SAF2009-11642, SAF2012-36519, BIO2012-30695, EEBB-I-12-04482]; RETIC [RD12/0013/0008]; Comunidad de Madrid [S2010/BMD-2414]; Norwegian Cancer Society; South-Eastern Norway Regional Health Authority; CSIC; FPI program from MINECO [BES-2010-033718]	MINECO(Spanish Government); RETIC; Comunidad de Madrid(Comunidad de Madrid); Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority; CSIC; FPI program from MINECO(Spanish Government)	This work was supported by grants SAF2009-11642 and SAF2012-36519 from MINECO and RETIC RD12/0013/0008 to DPS, grants BIO2012-30695 from MINECO and S2010/BMD-2414 from Comunidad de Madrid to MAP, and grants from the Norwegian Cancer Society and the South-Eastern Norway Regional Health Authority to HS. CLO is supported by the FPI program from MINECO (BES-2010-033718). The stay of CLO at HS laboratory was supported by the short stay grant EEBB-I-12-04482 from MINECO. J. Martinez Turrion has been the recipient of a JAE Intro Fellowship from CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2012, MOL BIOL CELL, V23, P1889, DOI 10.1091/mbc.E11-11-0925; ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Amiya E, 2013, J BIOL CHEM, V288, P14497, DOI 10.1074/jbc.M112.448522; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Canto I, 2013, J BIOL CHEM, V288, P15900, DOI 10.1074/jbc.M113.469866; Coutinho MF, 2012, MOL GENET METAB, V107, P257, DOI 10.1016/j.ymgme.2012.07.012; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Elias M, 2012, J CELL SCI, V125, P2500, DOI 10.1242/jcs.101378; Flannery AR, 2010, J CELL BIOL, V191, P599, DOI 10.1083/jcb.201003021; Fortwendel JR, 2012, EUKARYOT CELL, V11, P966, DOI 10.1128/EC.00091-12; Gharbi S, 2007, J MASS SPECTROM, V42, P1474, DOI 10.1002/jms.1291; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gilk SD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003107; Hirata D, 1998, J CELL SCI, V111, P149; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Klopper TH, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-71; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Koga H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1393; Lambou K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-63; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McCormick PJ, 2008, TRAFFIC, V9, P1984, DOI 10.1111/j.1600-0854.2008.00814.x; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mobius W, 2003, TRAFFIC, V4, P222; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Oeste CL, 2013, HISTOCHEM CELL BIOL, V139, P659, DOI 10.1007/s00418-012-1057-6; Pantazopoulou A, 2009, MOL BIOL CELL, V20, P4335, DOI 10.1091/mbc.E09-03-0254; Peng YT, 2006, TRAFFIC, V7, P1378, DOI 10.1111/j.1600-0854.2006.00472.x; Perez-Sala D, 2007, FRONT BIOSCI-LANDMRK, V12, P4456, DOI 10.2741/2401; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Schweizer A, 1996, J CELL BIOL, V132, P577, DOI 10.1083/jcb.132.4.577; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Stamatakis K, 2002, J BIOL CHEM, V277, P49389, DOI 10.1074/jbc.M204049200; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Toulmay A, 2013, J CELL BIOL, V202, P35, DOI 10.1083/jcb.201301039; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Valero RA, 2010, TRAFFIC, V11, P1221, DOI 10.1111/j.1600-0854.2010.01091.x; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Wang DA, 2005, J BIOL CHEM, V280, P19243, DOI 10.1074/jbc.M411472200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	51	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107190	10.1371/journal.pone.0107190	http://dx.doi.org/10.1371/journal.pone.0107190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207810	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300064
J	Pilcher, W; Miles, S; Tang, S; Mayer, G; Whitehead, A				Pilcher, Whitney; Miles, Scott; Tang, Song; Mayer, Greg; Whitehead, Andrew			Genomic and Genotoxic Responses to Controlled Weathered-Oil Exposures Confirm and Extend Field Studies on Impacts of the Deepwater Horizon Oil Spill on Native Killifish	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; SALMON ONCORHYNCHUS-GORBUSCHA; PRINCE-WILLIAM-SOUND; DNA STRAND BREAKS; CRUDE-OIL; FUNDULUS-HETEROCLITUS; SALT MARSHES; GENE-EXPRESSION; NEKTON USE; TOXICITY	To understand the ecotoxicological impacts of the Deepwater Horizon oil spill, field studies provide a context for ecological realism but laboratory-based studies offer power for connecting biological effects with specific causes. As a complement to field studies, we characterized genome-wide gene expression responses of Gulf killifish (Fundulus grandis) to oil-contaminated waters in controlled laboratory exposures. Transcriptional responses to the highest concentrations of oiled water in the laboratory were predictive of field-observed responses that coincided with the timing and location of major oiling. The transcriptional response to the low concentration (similar to 10-fold lower than the high concentration) was distinct from the high concentration and was not predictive of major oiling in the field. The high concentration response was characterized by activation of the molecular signaling pathway that facilitates oil metabolism and oil toxicity. The high concentration also induced DNA damage. The low concentration invoked expression of genes that may support a compensatory response, including genes associated with regulation of transcription, cell cycle progression, RNA processing, DNA damage, and apoptosis. We conclude that the gene expression response detected in the field was a robust indicator of exposure to the toxic components of contaminating oil, that animals in the field were exposed to relatively high concentrations that are especially damaging to early life stages, and that such exposures can damage DNA.	[Pilcher, Whitney] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Miles, Scott] Louisiana State Univ, Dept Environm Sci, Baton Rouge, LA 70803 USA; [Tang, Song; Mayer, Greg] Texas Tech Univ, Dept Environm Toxicol, Lubbock, TX 79409 USA; [Whitehead, Andrew] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Texas Tech University System; Texas Tech University; University of California System; University of California Davis	Whitehead, A (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.	awhitehead@ucdavis.edu	Mayer, Gregory D/A-8459-2017; Mayer, Gregory/N-1401-2019; Tang, Song/E-9843-2013	Mayer, Gregory D/0000-0002-2652-9856; Mayer, Gregory/0000-0002-2652-9856; Tang, Song/0000-0003-3219-1422	National Science Foundation [DEB-1120512, DEB-1048206]; Gulf of Mexico Research Initiative	National Science Foundation(National Science Foundation (NSF)); Gulf of Mexico Research Initiative	This research was supported by funding from the National Science Foundation (www.NSF.gov) (DEB-1120512 and DEB-1048206 to A. W.) and the Gulf of Mexico Research Initiative (http://gulfresearchinitiative.org/) (to A. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackleh AS, 2012, J ACOUST SOC AM, V131, P2306, DOI 10.1121/1.3682042; Adams SM, 2005, MAR POLLUT BULL, V51, P649, DOI 10.1016/j.marpolbul.2004.11.040; Andrew AS, 2003, ENVIRON HEALTH PERSP, V111, P825, DOI 10.1289/ehp.111-1241504; [Anonymous], 2011, DEEP WAT GULF OIL DI; Antkiewicz DS, 2006, TOXICOL SCI, V94, P175, DOI 10.1093/toxsci/kfl093; Balk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019735; Carls MG, 2005, MAR ECOL PROG SER, V301, P253, DOI 10.3354/meps301253; Carlson DB, 2002, J BIOCHEM MOL TOXIC, V16, P317, DOI 10.1002/jbt.10051; Carmichael RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041155; Chesire DR, 2004, CANCER RES, V64, P2523, DOI 10.1158/0008-5472.CAN-03-3309; Clark BW, 2010, AQUAT TOXICOL, V99, P232, DOI 10.1016/j.aquatox.2010.05.004; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Culp JM, 2000, ENVIRON TOXICOL CHEM, V19, P1167, DOI 10.1002/etc.5620190450; Dubansky B, 2013, ENVIRON SCI TECHNOL, V47, P5074, DOI 10.1021/es400458p; Fernandez-Tajes J, 2011, J TOXICOL ENV HEAL A, V74, P1067, DOI 10.1080/15287394.2011.582312; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Heintz RA, 2000, MAR ECOL PROG SER, V208, P205, DOI 10.3354/meps208205; Holth TF, 2009, ENVIRON SCI TECHNOL, V43, P3329, DOI 10.1021/es803479p; Hose JE, 1996, CAN J FISH AQUAT SCI, V53, P2355, DOI 10.1139/cjfas-53-10-2355; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Jin MH, 2010, ENVIRON TOXICOL, V25, P1, DOI 10.1002/tox.20466; Kawajiri K, 2009, P NATL ACAD SCI USA, V106, P13481, DOI 10.1073/pnas.0902132106; Kennedy CJ, 2006, ENVIRON TOXICOL CHEM, V25, P2715, DOI 10.1897/05-504R.1; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; KNEIB RT, 1994, MAR ECOL PROG SER, V106, P227, DOI 10.3354/meps106227; Kosmehl T, 2008, MUTAT RES-GEN TOX EN, V650, P1, DOI 10.1016/j.mrgentox.2007.09.009; La Point TW, 2000, ENVIRON TOXICOL CHEM, V19, P14, DOI [10.1002/etc.5620190103, 10.1897/1551-5028(2000)019&lt;0014:FAICWW&gt;2.3.CO;2]; Large AT, 2002, MAR ENVIRON RES, V54, P493, DOI 10.1016/S0141-1136(02)00139-3; Lerebours A, 2010, ENVIRON SCI TECHNOL, V44, P1438, DOI 10.1021/es902550x; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Lim W, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2854; LOTRICH VA, 1975, ECOLOGY, V56, P191, DOI 10.2307/1935311; Luoma SN, 1996, J EXP MAR BIOL ECOL, V200, P29, DOI 10.1016/S0022-0981(96)02679-2; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Marty GD, 1997, CAN J FISH AQUAT SCI, V54, P1846, DOI 10.1139/cjfas-54-8-1846; Mathieu MC, 2001, J BIOL CHEM, V276, P4819, DOI 10.1074/jbc.M008495200; MEREDITH WH, 1979, ESTUAR COAST MAR SCI, V8, P99, DOI 10.1016/0302-3524(79)90066-5; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Nahrgang J, 2010, AQUAT TOXICOL, V97, P234, DOI 10.1016/j.aquatox.2009.11.003; Norcross BL, 1996, CAN J FISH AQUAT SCI, V53, P2376, DOI 10.1139/cjfas-53-10-2376; Park JH, 2009, J BIOL CHEM, V284, P29725, DOI 10.1074/jbc.M109.042143; Planchart A, 2010, CHEM RES TOXICOL, V23, P480, DOI 10.1021/tx9003165; Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6250, DOI 10.1021/es8010783; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; ROZAS LP, 1993, MAR ECOL PROG SER, V96, P147, DOI 10.3354/meps096147; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schmitt RJ, 1996, DETECTING ECOLOGICAL, Vxx; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Singer MM, 2000, MAR POLLUT BULL, V40, P1007, DOI 10.1016/S0025-326X(00)00045-X; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; SUBRAHMANYAM CB, 1980, B MAR SCI, V30, P790; Taban IC, 2004, MAR ENVIRON RES, V58, P701, DOI 10.1016/j.marenvres.2004.03.018; Teo SLH, 2003, ESTUARIES, V26, P720, DOI 10.1007/BF02711983; Thomas RE, 2007, MAR POLLUT BULL, V54, P726, DOI 10.1016/j.marpolbul.2007.01.009; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Van Veld Peter A., 2008, P597, DOI 10.1201/9780203647295.ch13; Weber L, 2013, ECOTOXICOLOGY, V22, P642, DOI 10.1007/s10646-013-1055-z; Whitehead A, INTEGRATIVE IN PRESS; Whitehead A, 2013, INTEGRATIVE COMP BIO; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Whitehead A, 2012, P ROY SOC B-BIOL SCI, V279, P427, DOI 10.1098/rspb.2011.0847	63	31	31	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106351	10.1371/journal.pone.0106351	http://dx.doi.org/10.1371/journal.pone.0106351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208076	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300019
J	Qiao, F; Cong, HQ; Jiang, XF; Wang, RX; Yin, JM; Qian, D; Wang, ZN; Nick, P				Qiao, Fei; Cong, Hanqing; Jiang, Xuefei; Wang, Rongxiang; Yin, Junmei; Qian, Dan; Wang, Zhunian; Nick, Peter			De Novo Characterization of a Cephalotaxus hainanensis Transcriptome and Genes Related to Paclitaxel Biosynthesis	PLOS ONE			English	Article							HARRINGTONIA VAR DRUPACEA; FUNCTIONAL GENOMICS; PRIMER DESIGN; VAR. NANA; ALKALOIDS; PLANTS; TAXOL; TOOL; RNA	Cephalotaxus hainanensis, an endangered plant, is known to contain several metabolites with anti-cancer activity. Despite its clinical impact, the alkaloid metabolism of this species has remained largely uncharacterized. The potential of Cephalotaxus for metabolic engineering of medically interesting compounds has, so far, not been exploited, due to the almost complete lack of molecular information. We have therefore performed a high throughput RNA-seq analysis and assembled the transcriptome de novo. Raw reads comprising 4.3 Gbp were assembled de novo into 39,416 unique sequences (unigenes) with a mean length of 1,089.8 bp and a total assembly size of 45.8 Mbp, which equals to more than 50 times the number of Cephalotaxaceae sequences currently deposited in the GenBank (as of August 2013). As proof of principle for medically interesting pathways, gene fragments related to paclitaxel biosynthesis were searched and detected. To verify their functionality, the metabolic product paclitaxel, and its precursor baccatin III, were identified in the leaves of C. hainanensis by HPLC, and shown to be induced by MeJA. This finding demonstrates exemplarily the potential of the annotated transcriptome as information resource for the biotechnological exploitation of plant secondary metabolism.	[Qiao, Fei; Cong, Hanqing; Wang, Rongxiang; Yin, Junmei; Wang, Zhunian] Chinese Acad Trop Agr Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China; [Jiang, Xuefei; Qian, Dan] Hainan Univ, Coll Hort & Landscape Architecture, Minist Educ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Haikou, Hainan, Peoples R China; [Nick, Peter] Karlsruhe Inst Technol, Inst Bot, D-76021 Karlsruhe, Germany	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hainan University; Helmholtz Association; Karlsruhe Institute of Technology	Cong, HQ (corresponding author), Chinese Acad Trop Agr Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China.	hanqing.cong@hotmail.com; hnjiangxuefei@gmail.com			Hainan University Young Scientist Fund [qnjj1217]; Special Fund for Agro-scientific Research in the Public Interest [201303117]	Hainan University Young Scientist Fund; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by Hainan University Young Scientist Fund (qnjj1217) and Special Fund for Agro-scientific Research in the Public Interest (201303117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkafi H, 2012, NAT PROD REP, V29, P845, DOI 10.1039/c2np20037f; Bocar M, 2003, J NAT PROD, V66, P152, DOI 10.1021/np0203178; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daniell H, 2001, TRENDS PLANT SCI, V6, P219, DOI 10.1016/S1360-1385(01)01922-7; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Goodman J., 2001, STORY TAXOL NATURE P; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hudlicky Ts, 2007, EVOLUTION DESIGN MET, V574; Jaakola L, 2001, MOL BIOTECHNOL, V19, P201, DOI 10.1385/MB:19:2:201; Jin J, 2013, LANCET ONCOL, V14, P599, DOI 10.1016/S1470-2045(13)70152-9; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Mugdha Sharma, 2011, Asian Journal of Home Science, V6, P50, DOI 10.3923/ajpp.2011.50.71; Morita H, 2002, TETRAHEDRON, V58, P5489, DOI 10.1016/S0040-4020(02)00521-5; Morita H, 2010, HETEROCYCLES, V81, P441, DOI 10.3987/COM-09-11870; Namdeo A. G., 2007, Pharmacognosy Reviews, V1, P69; POWELL RG, 1972, PHYTOCHEMISTRY, V11, P1467, DOI 10.1016/S0031-9422(00)90102-X; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Takano I, 1996, J NAT PROD, V59, P1192, DOI 10.1021/np9605044; Takano I, 1997, PHYTOCHEMISTRY, V44, P735, DOI 10.1016/S0031-9422(96)00574-2; Takano I, 1996, J NAT PROD, V59, P965, DOI 10.1021/np9604543; Walker K, 2001, PHYTOCHEMISTRY, V58, P1, DOI 10.1016/S0031-9422(01)00160-1; WALL ME, 1954, J AM PHARM ASSOC SCI, V43, P503, DOI 10.1002/jps.3030430819; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshinaga M, 2004, TETRAHEDRON, V60, P7861, DOI 10.1016/j.tet.2004.06.070; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Yukimune Y, 2000, PHYTOCHEMISTRY, V54, P13, DOI 10.1016/S0031-9422(00)00006-6; Zhou XW, 2010, APPL MICROBIOL BIOT, V86, P1707, DOI 10.1007/s00253-010-2546-y; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	32	19	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106900	10.1371/journal.pone.0106900	http://dx.doi.org/10.1371/journal.pone.0106900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203398	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500054
J	Eddy, JL; Gielda, LM; Caulfield, AJ; Rangel, SM; Lathem, WW				Eddy, Justin L.; Gielda, Lindsay M.; Caulfield, Adam J.; Rangel, Stephanie M.; Lathem, Wyndham W.			Production of Outer Membrane Vesicles by the Plague Pathogen Yersinia pestis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR PLA; HEAT-LABILE ENTEROTOXIN; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; ENVELOPE STRESS; PSEUDOMONAS-AERUGINOSA; SURFACE PROTEASE; SECRETION; EXPRESSION; VIRULENCE	Many Gram-negative bacteria produce outer membrane vesicles (OMVs) during cell growth and division, and some bacterial pathogens deliver virulence factors to the host via the release of OMVs during infection. Here we show that Yersinia pestis, the causative agent of the disease plague, produces and releases native OMVs under physiological conditions. These OMVs, approximately 100 nm in diameter, contain multiple virulence-associated outer membrane proteins including the adhesin Ail, the F1 outer fimbrial antigen, and the protease Pla. We found that OMVs released by Y. pestis contain catalytically active Pla that is competent for plasminogen activation and alpha 2-antiplasmin degradation. The abundance of OMV-associated proteins released by Y. pestis is significantly elevated at 37 degrees C compared to 26 degrees C and is increased in response to membrane stress and mutations in RseA, Hfq, and the major Braun lipoprotein (Lpp). In addition, we show that Y. pestis OMVs are able to bind to components of the extracellular matrix such as fibronectin and laminin. These data suggest that Y. pestis may produce OMVs during mammalian infection and we propose that dispersal of Pla via OMV release may influence the outcome of infection through interactions with Pla substrates such as plasminogen and Fas ligand.	[Eddy, Justin L.; Gielda, Lindsay M.; Caulfield, Adam J.; Rangel, Stephanie M.; Lathem, Wyndham W.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Lathem, WW (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	lathem@northwestern.edu		Lathem, Wyndham/0000-0003-4347-089X	National Institutes of Health [P30 CA060553, R01 AI093727]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health P30 CA060553 to RHLCCC; National Institutes of Health R01 AI093727 to WWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; BEESLEY ED, 1967, J BACTERIOL, V94, P19, DOI 10.1128/JB.94.1.19-26.1967; Bellows LE, 2012, MOL MICROBIOL, V86, P661, DOI 10.1111/mmi.12011; Bjerre A, 2000, J ENDOTOXIN RES, V6, P437, DOI 10.1179/096805100101532397; BURROWS TW, 1956, NATURE, V177, P426, DOI 10.1038/177426b0; Butler T, 2013, AM J TROP MED HYG, V89, P788, DOI 10.4269/ajtmh.13-0191; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Caulfield AJ, 2014, CELL HOST MICROBE, V15, P424, DOI 10.1016/j.chom.2014.03.005; Caulfield AJ, 2012, ADV EXP MED BIOL, V954, P253, DOI 10.1007/978-1-4614-3561-7_32; Chutkan Halima, 2013, Methods Mol Biol, V966, P259, DOI 10.1007/978-1-62703-245-2_16; Cornelis GR, 2002, INT J MED MICROBIOL, V291, P455; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Avila-Calderon ED, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/352493; Davis JM, 2006, INFECT IMMUN, V74, P4401, DOI 10.1128/IAI.00637-06; DORWARD DW, 1991, J CLIN MICROBIOL, V29, P1162, DOI 10.1128/JCM.29.6.1162-1170.1991; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Eren E, 2012, J BIOL CHEM, V287, P23971, DOI 10.1074/jbc.M112.376418; Eren E, 2010, STRUCTURE, V18, P809, DOI 10.1016/j.str.2010.03.013; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; Galindo CL, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/342168; GANKEMA H, 1980, INFECT IMMUN, V29, P704; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Hellman J, 2001, J ENDOTOXIN RES, V7, P69, DOI 10.1177/09680519010070010101; Hinnebusch BJ, 1998, J INFECT DIS, V178, P1406, DOI 10.1086/314456; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Houppert AS, 2013, INFECT IMMUN, V81, P1186, DOI 10.1128/IAI.01417-12; Ismail S, 2003, INFECT IMMUN, V71, P5670, DOI 10.1128/IAI.71.10.5670-5675.2003; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kesty NC, 2004, J BIOL CHEM, V279, P2069, DOI 10.1074/jbc.M307628200; KIENLE Z, 1992, J GEN MICROBIOL, V138, P1679, DOI 10.1099/00221287-138-8-1679; Kolodziejek AM, 2013, APPL ENVIRON MICROB, V79, P4509, DOI 10.1128/AEM.00675-13; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kukkonen M, 2001, MOL MICROBIOL, V40, P1097, DOI 10.1046/j.1365-2958.2001.02451.x; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lahteenmaki K, 1998, INFECT IMMUN, V66, P5755; LAI CH, 1981, J PERIODONTAL RES, V16, P379, DOI 10.1111/j.1600-0765.1981.tb00989.x; Lane MC, 2013, J MED MICROBIOL, V62, P1124, DOI 10.1099/jmm.0.056275-0; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lathem WW, 2014, MBIO, V5, DOI 10.1128/mBio.01038-13; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; MacDonald IA, 2013, J BACTERIOL, V195, P2971, DOI 10.1128/JB.02267-12; Manning AJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-258; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; NIKAIDO H, 1977, J BACTERIOL, V132, P1045, DOI 10.1128/JB.132.3.1045-1047.1977; Park SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017629; Parker H, 2012, MICROBES INFECT, V14, P9, DOI 10.1016/j.micinf.2011.08.007; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Pieper R, 2009, MICROBIOL-SGM, V155, P498, DOI 10.1099/mic.0.022160-0; Pieper R, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-5; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Pouillot F, 2005, MICROBIOL-SGM, V151, P3759, DOI 10.1099/mic.0.28274-0; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Saunders NB, 1998, INFECT IMMUN, V66, P3218, DOI 10.1128/IAI.66.7.3218-3222.1998; Schertzer JW, 2012, MBIO, V3, DOI 10.1128/mBio.00297-11; Schiano CA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00129; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06; Schwechheimer C, 2013, J BACTERIOL, V195, P4161, DOI 10.1128/JB.02192-12; Schwechheimer C, 2013, BIOCHEMISTRY-US, V52, P3031, DOI 10.1021/bi400164t; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Shah S, 1998, CHEST, V113, P1190, DOI 10.1378/chest.113.5.1190; SODEINDE OA, 1988, INFECT IMMUN, V56, P2749, DOI 10.1128/IAI.56.10.2749-2752.1988; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; SODEINDE OA, 1989, INFECT IMMUN, V57, P1517, DOI 10.1128/IAI.57.5.1517-1523.1989; Tan TT, 2007, J INFECT DIS, V195, P1661, DOI 10.1086/517611; Tsang TM, 2010, INFECT IMMUN, V78, P3358, DOI 10.1128/IAI.00238-10; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; Yonezawa H, 2011, ANAEROBE, V17, P388, DOI 10.1016/j.anaerobe.2011.03.020	74	42	45	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107002	10.1371/journal.pone.0107002	http://dx.doi.org/10.1371/journal.pone.0107002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198697	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700072
J	Hua, RH; Huo, H; Li, YN; Xue, Y; Wang, XL; Guo, LP; Zhou, B; Song, Y; Bu, ZG				Hua, Rong-Hong; Huo, Hong; Li, Ye-Nan; Xue, Yao; Wang, Xiao-Lei; Guo, Li-Ping; Zhou, Bin; Song, Yong; Bu, Zhi-Gao			Generation and Efficacy Evaluation of Recombinant Classical Swine Fever Virus E2 Glycoprotein Expressed in Stable Transgenic Mammalian Cell Line	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; SUBUNIT MARKER VACCINE; HOG-CHOLERA VIRUS; PREGNANT SOWS; DIAGNOSTIC-TEST; PROTECTS PIGS; INSECT CELLS; CHALLENGE; STRAIN; TRANSMISSION	Classical swine fever virus (CSFV) is the causative agent of classical swine fever (CSF), which is a highly contagious swine disease that causes significant economic loses to the pig industry worldwide. The envelope E2 glycoprotein of CSFV is the most important viral antigen in inducing protective immune response against CSF. In this study, we generated a mammalian cell clone (BCSFV-E2) that could stably produce a secreted form of CSFV E2 protein (mE2). The mE2 protein was shown to be N-linked glycosylated and formed a homodimer. The vaccine efficacy of mE2 was evaluated by immunizing pigs. Twenty-five 6-week-old Landrace piglets were randomly divided into five groups. Four groups were intramuscularly immunized with mE2 emulsified in different adjuvants twice at four-week intervals. One group was used as the control group. All mE2-vaccinated pigs developed CSFV-neutralizing antibodies two weeks after the first vaccination with neutralizing antibody titers ranging from 1: 40 to 1: 320. Two weeks after the booster vaccination, the neutralizing antibody titers increased greatly and ranged from 1: 10,240 to 1: 81,920. At 28 weeks after the booster vaccine was administered, the neutralizing antibody titers ranged from 1: 80 to 1: 10240. At 32 weeks after the first vaccination, pigs in all the groups were challenged with a virulent CSFV strain at a dose of 1 x 10(5) TCID50. At two weeks after the challenge, all the mE2-immunized pigs survived and exhibited no obvious symptoms of CSF. The neutralizing antibody titer at this time was 20,480. Unvaccinated pigs in the control group exhibited symptoms of CSF 3-4 days after challenge and were euthanized from 7-9 days after challenge when the pigs became moribund. These results indicate that the mE2 is a good candidate for the development of a safe and effective CSFV subunit vaccine.	[Hua, Rong-Hong; Huo, Hong; Li, Ye-Nan; Xue, Yao; Wang, Xiao-Lei; Guo, Li-Ping; Bu, Zhi-Gao] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Heilongjiang, Peoples R China; [Xue, Yao; Song, Yong] Heilongjiang Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Zhou, Bin] Nanjing Agr Univ, Coll Vet Med, Key Lab Anim Dis Diag & Immunol, Minist Agr, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Heilongjiang University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Hua, RH (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Heilongjiang, Peoples R China.	huaronghong@163.com; buzhigao@caas.cn		Hua, Rong-Hong/0000-0001-7034-5766; Zhou, Bin/0000-0001-7279-9489	Special Fund from Agro-scientific Research in the Public Interest of China [201203082]	Special Fund from Agro-scientific Research in the Public Interest of China	This work was supported by grants from the Special Fund from Agro-scientific Research in the Public Interest of China (201203082). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens U, 2000, VET MICROBIOL, V77, P83, DOI 10.1016/S0378-1135(00)00265-0; BIRONT P, 1987, VET MICROBIOL, V14, P105, DOI 10.1016/0378-1135(87)90002-2; Bouma A, 2000, VACCINE, V18, P1374, DOI 10.1016/S0264-410X(99)00398-9; Bouma A, 1999, VET MICROBIOL, V66, P101, DOI 10.1016/S0378-1135(99)00003-6; Chen ZhenShi, 2011, Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine, V33, P920; de Smit AJ, 2000, VET QUART, V22, P150, DOI 10.1080/01652176.2000.9695045; de Smit AJ, 2001, VET MICROBIOL, V78, P307, DOI 10.1016/S0378-1135(00)00306-0; de Smit AJ, 2000, VET QUART, V22, P182, DOI 10.1080/01652176.2000.9695054; de Smit AJ, 2000, VACCINE, V18, P2351, DOI 10.1016/S0264-410X(00)00027-X; Depner KR, 2001, VET MICROBIOL, V83, P107, DOI 10.1016/S0378-1135(01)00410-2; Graham SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029310; Hua RH, 2014, VIRUS RES, V185, P103, DOI 10.1016/j.virusres.2014.03.001; Hua RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067553; Hua RH, 2011, HYBRIDOMA, V30, P451, DOI 10.1089/hyb.2011.0027; HULST MM, 1993, J VIROL, V67, P5435, DOI 10.1128/JVI.67.9.5435-5442.1993; Hulst MM, 1996, CYTOTECHNOLOGY, V20, P271, DOI 10.1007/BF00350406; Klinkenberg D, 2002, VACCINE, V20, P3005, DOI 10.1016/S0042-207X(02)00283-X; Kojima A, 2003, J VIROL, V77, P8745, DOI 10.1128/JVI.77.16.8745-8755.2003; Konishi E, 2001, J VIROL, V75, P2204, DOI 10.1128/JVI.75.5.2204-2212.2001; Lin GJ, 2009, VET MICROBIOL, V139, P369, DOI 10.1016/j.vetmic.2009.06.027; Lipowski A, 2000, VET MICROBIOL, V77, P99, DOI 10.1016/S0378-1135(00)00266-2; Moennig V, 2003, VET J, V165, P11, DOI 10.1016/S1090-0233(02)00112-0; Moormann RJM, 2000, VET MICROBIOL, V73, P209, DOI 10.1016/S0378-1135(00)00146-2; Sun YK, 2013, RES VET SCI, V94, P354, DOI 10.1016/j.rvsc.2012.09.012; Sun Y, 2010, RES VET SCI, V88, P77, DOI 10.1016/j.rvsc.2009.06.005; TERPSTRA C, 1984, VET MICROBIOL, V9, P113, DOI 10.1016/0378-1135(84)90026-9; Tyborowska J, 2007, ACTA BIOCHIM POL, V54, P813, DOI 10.18388/abp.2007_3172; van Oirschot JT, 2003, VET MICROBIOL, V96, P367, DOI 10.1016/j.vetmic.2003.09.008; van Rijn PA, 1999, VACCINE, V17, P433, DOI 10.1016/S0264-410X(98)00215-1; vanRijn PA, 1996, J GEN VIROL, V77, P2737, DOI 10.1099/0022-1317-77-11-2737; VANRIJN PA, 1993, J GEN VIROL, V74, P2053, DOI 10.1099/0022-1317-74-10-2053; WEILAND E, 1992, J VIROL, V66, P3677, DOI 10.1128/JVI.66.6.3677-3682.1992; Yu XL, 2001, VACCINE, V19, P1520, DOI 10.1016/S0264-410X(00)00334-0	33	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106891	10.1371/journal.pone.0106891	http://dx.doi.org/10.1371/journal.pone.0106891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198669	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700062
J	Moller, Y; Siegemund, M; Beyes, S; Herr, R; Lecis, D; Delia, D; Kontermann, R; Brummer, T; Pfizenmaier, K; Olayioye, MA				Moeller, Yvonne; Siegemund, Martin; Beyes, Sven; Herr, Ricarda; Lecis, Daniele; Delia, Domenico; Kontermann, Roland; Brummer, Tilman; Pfizenmaier, Klaus; Olayioye, Monilola A.			EGFR-Targeted TRAIL and a Smac Mimetic Synergize to Overcome Apoptosis Resistance in KRAS Mutant Colorectal Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; ANTITUMORAL ACTIVITY; COLON-CARCINOMA; UP-REGULATION; K-RAS; GROWTH; DEATH; INHIBITORS; RECEPTORS; PATHWAYS	TRAIL is a death receptor ligand that induces cell death preferentially in tumor cells. Recombinant soluble TRAIL, however, performs poorly as an anti-cancer therapeutic because oligomerization is required for potent biological activity. We previously generated a diabody format of tumor-targeted TRAIL termed Db(alpha EGFR)-scTRAIL, comprising single-stranded TRAIL molecules (scTRAIL) and the variable domains of a humanized variant of the EGFR blocking antibody Cetuximab. Here we define the bioactivity of Db(alpha EGFR)-scTRAIL with regard to both EGFR inhibition and TRAIL receptor activation in 3D cultures of Caco-2 colorectal cancer cells, which express wild-type K-Ras. Compared with conventional 2D cultures, Caco-2 cells displayed strongly enhanced sensitivity toward Db(alpha EGFR)-scTRAIL in these 3D cultures. We show that the antibody moiety of Db(alpha EGFR)-scTRAIL not only efficiently competed with ligand-induced EGFR function, but also determined the apoptotic response by specifically directing Db(alpha EGFR)-scTRAIL to EGFR-positive cells. To address how aberrantly activated K-Ras, which leads to Cetuximab resistance, affects Db(alpha EGFR)-scTRAIL sensitivity, we generated stable Caco-2tet cells inducibly expressing oncogenic K-Ras(G12V). In the presence of doxycycline, these cells showed increased resistance to Db(alpha EGFR)-scTRAIL, associated with the elevated expression of the anti-apoptotic proteins cIAP2, Bcl-xL and FlipS. Co-treatment of cells with the Smac mimetic SM83 restored the Db(alpha EGFR)-scTRAIL-induced apoptotic response. Importantly, this synergy between Db(alpha EGFR)-scTRAIL and SM83 also translated to 3D cultures of oncogenic K-Ras expressing HCT-116 and LoVo colorectal cancer cells. Our findings thus support the notion that Db(alpha EGFR)-scTRAIL therapy in combination with apoptosis-sensitizing agents may be promising for the treatment of EGFR-positive colorectal cancers, independently of their KRAS status.	[Moeller, Yvonne; Siegemund, Martin; Beyes, Sven; Kontermann, Roland; Pfizenmaier, Klaus; Olayioye, Monilola A.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70174 Stuttgart, Germany; [Herr, Ricarda; Brummer, Tilman] Univ Freiburg, Inst Mol Med & Cell Res IMMZ, Fac Med, D-79106 Freiburg, Germany; [Herr, Ricarda] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Brummer, Tilman] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany; [Lecis, Daniele; Delia, Domenico] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol, Milan, Italy	University of Stuttgart; University of Freiburg; University of Freiburg; University of Freiburg; Fondazione IRCCS Istituto Nazionale Tumori Milan	Olayioye, MA (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, D-70174 Stuttgart, Germany.	monilola.olayioye@izi.uni-stuttgart.de	Brummer, Tilman/B-6218-2016; Lecis, Daniele/C-2113-2017; Brummer, Tilman/AAA-9428-2020	Brummer, Tilman/0000-0003-4387-7905; Lecis, Daniele/0000-0002-0564-0563; Brummer, Tilman/0000-0003-4387-7905; Siegemund, Martin/0000-0003-4088-6734; Griffin, Ricarda/0000-0003-1368-2832	Bundesministerium fur Bildung und Forschung (BMBF); Deutsche Forschungsgemeinschaft (DFG) via the Collaborative Research Centre 850; Excellence Initiative of the BMBF via EXC 294 BIOSS; DFG	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG) via the Collaborative Research Centre 850(German Research Foundation (DFG)); Excellence Initiative of the BMBF via EXC 294 BIOSS; DFG(German Research Foundation (DFG))	This work was funded by the Bundesministerium fur Bildung und Forschung (BMBF; http://www.bmbf.de/) e:Bio grant 'PREDICT' to MAO, RK and KP. RH and TB are supported by the Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de/) via the Collaborative Research Centre 850 and the Excellence Initiative of the BMBF via EXC 294 BIOSS. TB and MAO are supported by Heisenberg program of the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP WP, 1994, AM J PHYSIOL-GASTR L, V267, pG892, DOI 10.1152/ajpgi.1994.267.5.G892; Brand Toni M, 2012, Small GTPases, V3, P34, DOI 10.4161/sgtp.18751; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Darding M, 2011, CELL DEATH DIFFER, V18, P1376, DOI 10.1038/cdd.2011.10; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; Drosopoulos KG, 2005, J BIOL CHEM, V280, P22856, DOI 10.1074/jbc.M412483200; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Fulda S, 2002, NAT MED; Gibson EM, 2002, CANCER RES, V62, P488; Guerrero S, 2000, CANCER RES, V60, P6750; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Herr R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-17; Huang SY, 2011, CANCER PREV RES, V4, P666, DOI 10.1158/1940-6207.CAPR-10-0235; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kriegl L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051654; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Lecis D, 2010, BRIT J CANCER, V102, P1707, DOI 10.1038/sj.bjc.6605687; Lecis D, 2012, BIOORGAN MED CHEM, V20, P6709, DOI 10.1016/j.bmc.2012.09.041; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Magudia K, 2012, J CELL BIOL, V198, P185, DOI 10.1083/jcb.201202108; Manzoni L, 2012, BIOORGAN MED CHEM, V20, P6687, DOI 10.1016/j.bmc.2012.09.020; Miura K, 2009, EXPERT OPIN THER TAR, V13, P1333, DOI 10.1517/14728220903277256; Oikonomou E, 2013, BIOFACTORS, V39, P343, DOI 10.1002/biof.1112; Overmeyer JH, 2011, FRONT BIOSCI-LANDMRK, V16, P1693, DOI 10.2741/3814; Psahoulia FH, 2007, MOL CANCER THER, V6, P2591, DOI 10.1158/1535-7163.MCT-07-0001; Roring M, 2012, EMBO J, V31, P2629, DOI 10.1038/emboj.2012.100; Schneider B, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.45; Siegemund M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.29; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Stagg J, 2008, P NATL ACAD SCI USA, V105, P16254, DOI 10.1073/pnas.0806849105; Strater J, 2002, CLIN CANCER RES, V8, P3734; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Vaculova A, 2006, FEBS LETT, V580, P6565, DOI 10.1016/j.febslet.2006.11.004; van Geelen CMM, 2003, BRIT J CANCER, V89, P363, DOI 10.1038/sj.bjc.6601065; Van Schaeybroeck S, 2008, CANCER RES, V68, P8312, DOI 10.1158/0008-5472.CAN-07-6736; Van Schaeybroeck S, 2011, CANCER RES, V71, P1071, DOI 10.1158/0008-5472.CAN-10-0714; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zeestraten ECM, 2013, BIC, V13	51	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107165	10.1371/journal.pone.0107165	http://dx.doi.org/10.1371/journal.pone.0107165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198428	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700090
J	Zhan, L; Liu, HX; Fang, YP; Kong, B; He, YQ; Zhong, XB; Fang, JW; Wan, YJY; Guo, GL				Zhan, Le; Liu, Hui-Xin; Fang, Yaping; Kong, Bo; He, Yuqi; Zhong, Xiao-bo; Fang, Jianwen; Wan, Yu-Jui Yvonne; Guo, Grace L.			Genome-Wide Binding and Transcriptome Analysis of Human Farnesoid X Receptor in Primary Human Hepatocytes	PLOS ONE			English	Article							BILE-ACID BIOSYNTHESIS; NUCLEAR RECEPTOR; MOUSE-LIVER; GENE; FXR; IDENTIFICATION; EXPRESSION; MICE; ACTIVATION; REVEALS	Background & Aims: Farnesoid X receptor (FXR, NR1H4) is a ligand-activated transcription factor, belonging to the nuclear receptor superfamily. FXR is highly expressed in the liver and is essential in regulating bile acid homeostasis. FXR deficiency is implicated in numerous liver diseases and mice with modulation of FXR have been used as animal models to study liver physiology and pathology. We have reported genome-wide binding of FXR in mice by chromatin immunoprecipitation - deep sequencing (ChIP-seq), with results indicating that FXR may be involved in regulating diverse pathways in liver. However, limited information exists for the functions of human FXR and the suitability of using murine models to study human FXR functions. Methods: In the current study, we performed ChIP-seq in primary human hepatocytes (PHHs) treated with a synthetic FXR agonist, GW4064 or DMSO control. In parallel, RNA deep sequencing (RNA-seq) and RNA microarray were performed for GW4064 or control treated PHHs and wild type mouse livers, respectively. Results: ChIP-seq showed similar profiles of genome-wide FXR binding in humans and mice in terms of motif analysis and pathway prediction. However, RNA-seq and microarray showed more different transcriptome profiles between PHHs and mouse livers upon GW4064 treatment. Conclusions: In summary, we have established genome-wide human FXR binding and transcriptome profiles. These results will aid in determining the human FXR functions, as well as judging to what level the mouse models could be used to study human FXR functions.	[Zhan, Le; Kong, Bo; Guo, Grace L.] Rutgers State Univ, Dept Pharmacol & Toxicol, Sch Pharm, Piscataway, NJ 08854 USA; [Zhan, Le; Guo, Grace L.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Liu, Hui-Xin; He, Yuqi; Wan, Yu-Jui Yvonne] Univ Calif, Davis Hlth Syst, Dept Med Pathol & Lab Med, Sacramento, CA USA; [Fang, Yaping] Huazhong Agr Univ, Coll Sci, Inst Comp Applicat, Wuhan, Hubei, Peoples R China; [Zhong, Xiao-bo] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT USA; [Fang, Jianwen] NCI, Biometr Res Branch, Rockville, MD USA	Rutgers State University New Brunswick; University of Kansas; University of Kansas Medical Center; Huazhong Agricultural University; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Guo, GL (corresponding author), Rutgers State Univ, Dept Pharmacol & Toxicol, Sch Pharm, Piscataway, NJ 08854 USA.	guo@eohsi.rutgers.edu	Kong, Bo/G-7650-2014	Kong, Bo/0000-0002-8200-7817; Liu, Hui-Xin/0000-0002-8981-9981; Fang, Yaping/0000-0001-6075-0768	NIH fund [DK081343, DK090036, GM104037]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK090036, R01DK081343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104037] Funding Source: NIH RePORTER	NIH fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the NIH fund, grants DK081343, DK090036 and GM104037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Chong HK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-51; Chong HK, 2010, NUCLEIC ACIDS RES, V38, P6007, DOI 10.1093/nar/gkq397; Deng YJ, 2013, ENDOCRINOLOGY, V154, P1794, DOI 10.1210/en.2012-2126; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El Kasmi KC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006898; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gao H, 2008, MOL ENDOCRINOL, V22, P10, DOI 10.1210/me.2007-0121; Gardes C, 2013, J LIPID RES, V54, P1283, DOI 10.1194/jlr.M033423; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huang L, 2003, J BIOL CHEM, V278, P51085, DOI 10.1074/jbc.M308321200; Jia L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003645; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kong B, 2012, HEPATOLOGY, V56, P1034, DOI 10.1002/hep.25740; Kostrubsky VE, 1999, DRUG METAB DISPOS, V27, P887; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2012, HEPATOLOGY, V56, P108, DOI 10.1002/hep.25609; Li D, 2012, MOL PHARMACOL, V81, P86, DOI 10.1124/mol.111.074393; Li GD, 2010, MOL ENDOCRINOL, V24, P1404, DOI 10.1210/me.2010-0014; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Maglich JM, 2003, NUCLEIC ACIDS RES, V31, P4051, DOI 10.1093/nar/gkg444; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Qin P, 2005, AM J PHYSIOL-GASTR L, V289, pG267, DOI 10.1152/ajpgi.00043.2005; Ryan KK, 2014, NATURE; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Thomas AM, 2013, PHARM RES-DORDR, V30, P2188, DOI 10.1007/s11095-013-1006-7; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Williams JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043961; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200	37	38	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e105930	10.1371/journal.pone.0105930	http://dx.doi.org/10.1371/journal.pone.0105930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198545	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700021
J	Dominguez, LJ; Martinez-Gonzalez, MA; Basterra-Gortari, FJ; Gea, A; Barbagallo, M; Bes-Rastrollo, M				Dominguez, Ligia J.; Martinez-Gonzalez, Miguel A.; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Barbagallo, Mario; Bes-Rastrollo, Maira			Fast Food Consumption and Gestational Diabetes Incidence in the SUN Project	PLOS ONE			English	Article							WEIGHT-GAIN; SEGUIMIENTO-UNIVERSIDAD; MEDITERRANEAN DIET; FREQUENCY QUESTIONNAIRE; LIFE-STYLE; RISK; MELLITUS; POPULATION; ADHERENCE; PATTERNS	Background: Gestational diabetes prevalence is increasing, mostly because obesity among women of reproductive age is continuously escalating. We aimed to investigate the incidence of gestational diabetes according to the consumption of fast food in a cohort of university graduates. Methods: The prospective dynamic "Seguimiento Universidad de Navarra" (SUN) cohort included data of 3,048 women initially free of diabetes or previous gestational diabetes who reported at least one pregnancy between December 1999 and March 2011. Fast food consumption was assessed through a validated 136-item semi-quantitative food frequency questionnaire. Fast food was defined as the consumption of hamburgers, sausages, and pizza. Three categories of fast food were established: low (0-3 servings/month), intermediate (>3 servings/month and <= 2 servings/week) and high (>2 servings/week). Non-conditional logistic regression models were used to adjust for potential confounders. Results: We identified 159 incident cases of gestational diabetes during follow-up. After adjusting for age, baseline body mass index, total energy intake, smoking, physical activity, family history of diabetes, cardiovascular disease/hypertension at baseline, parity, adherence to Mediterranean dietary pattern, alcohol intake, fiber intake, and sugar-sweetened soft drinks consumption, fast food consumption was significantly associated with a higher risk of incident gestational diabetes, with multivariate adjusted OR of 1.31 (95% conficence interval [CI]: 0.81-2.13) and 1.86 (95% CI: 1.13-3.06) for the intermediate and high categories, respectively, versus the lowest category of baseline fast food consumption (p for linear trend: 0.007). Conclusion: Our results suggest that pre-pregnancy higher consumption of fast food is an independent risk factor for gestational diabetes.	[Dominguez, Ligia J.; Barbagallo, Mario] Univ Palermo, Dept Internal Med & Specialties, Geriatr Unit, Palermo, Sicily, Italy; [Martinez-Gonzalez, Miguel A.; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Bes-Rastrollo, Maira] Univ Navarra, Dept Prevent Med & Publ Hlth, Navarra, Spain; [Martinez-Gonzalez, Miguel A.; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Bes-Rastrollo, Maira] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Javier Basterra-Gortari, Francisco] Hosp Reina Sofia, Dept Internal Med Endocrinol, Navarra, Spain	University of Palermo; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Dominguez, LJ (corresponding author), Univ Palermo, Dept Internal Med & Specialties, Geriatr Unit, Palermo, Sicily, Italy.	ligia.dominguez@unipa.it; mbes@unav.es	Bes-Rastrollo, Maira/A-1329-2009; BARBAGALLO, MARIO/K-4794-2017; Martinez-Gonzalez, Miguel A./AAE-7669-2019	Bes-Rastrollo, Maira/0000-0002-9139-4206; BARBAGALLO, MARIO/0000-0002-1349-6530; dominguez, ligia j/0000-0003-1466-8610; Gea, Alfredo/0000-0002-2229-4690	Spanish Ministry of Health Government [PI10/02658, PI10/02293, RD06/0045, G03/140, PI13/00615]; Navarra Regional Government [45/2011]; University of Navarra; FPU fellowship from the Spanish Government	Spanish Ministry of Health Government; Navarra Regional Government; University of Navarra; FPU fellowship from the Spanish Government(Spanish Government)	The SUN Study has received funding from the Spanish Ministry of Health Government (current grants PI10/02658, PI10/02293, RD06/0045, G03/140 and PI13/00615), the Navarra Regional Government (45/2011) and the University of Navarra. AG is supported by a FPU fellowship from the Spanish Government. Funding sources had no role in the design, collection, analysis, and interpretation of the data; in the writing, and in the decision to submit the paper for publication.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Albrecht SS, 2010, DIABETES CARE, V33, P768, DOI 10.2337/dc09-1801; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Bao W, 2013, DIABETES CARE, V36, P2001, DOI 10.2337/dc12-2018; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bes-Rastrollo M, 2006, AM J CLIN NUTR, V83, P362; Bes-Rastrollo M., 2005, REV ESP OBES, V3, P352; Bes-Rastrollo M, 2010, PUBLIC HEALTH NUTR, V13, P1356, DOI 10.1017/S1368980009992783; Bowers K, 2012, AM J CLIN NUTR, V95, P446, DOI 10.3945/ajcn.111.026294; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x; Cuadrado C., 2013, TABLAS COMPOSICION A, V16th; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; GREENLAND S, 1980, INT J EPIDEMIOL, V9, P361, DOI 10.1093/ije/9.4.361; HARRIS M, 1979, DIABETES, V28, P1039; Horvath K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1395; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Lopez S, 2011, AM J CLIN NUTR, V93, P494, DOI 10.3945/ajcn.110.003251; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Martinez-Gonzalez MA, 2002, NUTR NEUROSCI, V5, P65, DOI 10.1080/10284150290007047; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Mataix Verdu J., 2009, TABLA COMPOSICION AL, V5th; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; NICE, 2008, CLIN GUID; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Odegaard AO, 2012, CIRCULATION, V126, P182, DOI 10.1161/CIRCULATIONAHA.111.084004; Pan A, 2012, CIRCULATION, V126, P163, DOI 10.1161/CIRCULATIONAHA.112.115923; Park S, 2013, EUR J CLIN NUTR, V67, P196, DOI 10.1038/ejcn.2012.207; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Tobias DK, 2012, AM J CLIN NUTR, V96, P289, DOI 10.3945/ajcn.111.028266; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Uusitalo U, 2009, PUBLIC HEALTH NUTR, V12, P2392, DOI 10.1017/S136898000900528X; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P496, DOI 10.1097/EDE.0b013e3181a82f12; Willett W., 2012, NUTR EPIDEMIOLOGY; Zhang C, 2006, DIABETOLOGIA, V49, P2604, DOI 10.1007/s00125-006-0422-1; Zhang CL, 2006, DIABETES CARE, V29, P2223, DOI 10.2337/dc06-0266; Zhang CL, 2011, AM J CLIN NUTR, V94, p1975S, DOI 10.3945/ajcn.110.001032	45	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106627	10.1371/journal.pone.0106627	http://dx.doi.org/10.1371/journal.pone.0106627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215961	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300018
J	Huang, SK; Scruggs, AM; McEachin, RC; White, ES; Peters-Golden, M				Huang, Steven K.; Scruggs, Anne M.; McEachin, Richard C.; White, Eric S.; Peters-Golden, Marc			Lung Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis Exhibit Genome-Wide Differences in DNA Methylation Compared to Fibroblasts from Nonfibrotic Lung	PLOS ONE			English	Article							PROSTAGLANDIN E-2 RESISTANCE; HYPERMETHYLATION; APOPTOSIS; RECEPTOR; PROLIFERATION; CONTRIBUTES; EXPRESSION; DIAGNOSIS; GENDER	Excessive fibroproliferation is a central hallmark of idiopathic pulmonary fibrosis (IPF), a chronic, progressive disorder that results in impaired gas exchange and respiratory failure. Fibroblasts are the key effector cells in IPF, and aberrant expression of multiple genes contributes to their excessive fibroproliferative phenotype. DNA methylation changes are critical to the development of many diseases, but the DNA methylome of IPF fibroblasts has never been characterized. Here, we utilized the HumanMethylation 27 array, which assays the DNA methylation level of 27,568 CpG sites across the genome, to compare the DNA methylation patterns of IPF fibroblasts (n = 6) with those of nonfibrotic patient controls (n = 3) and commercially available normal lung fibroblast cell lines (n = 3). We found that multiple CpG sites across the genome are differentially methylated (as defined by P value less than 0.05 and fold change greater than 2) in IPF fibroblasts compared to fibroblasts from nonfibrotic controls. These methylation differences occurred both in genes recognized to be important in fibroproliferation and extracellular matrix generation, as well as in genes not previously recognized to participate in those processes (including organ morphogenesis and potassium ion channels). We used bisulfite sequencing to independently verify DNA methylation differences in 3 genes (CDKN2B, CARD10, and MGMT); these methylation changes corresponded with differences in gene expression at the mRNA and protein level. These differences in DNA methylation were stable throughout multiple cell passages. DNA methylation differences may thus help to explain a proportion of the differences in gene expression previously observed in studies of IPF fibroblasts. Moreover, significant variability in DNA methylation was observed among individual IPF cell lines, suggesting that differences in DNA methylation may contribute to fibroblast heterogeneity among patients with IPF. These results demonstrate that IPF fibroblasts exhibit global differences in DNA methylation that may contribute to the excessive fibroproliferation associated with this disease.	[Huang, Steven K.; Scruggs, Anne M.; White, Eric S.; Peters-Golden, Marc] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [McEachin, Richard C.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Huang, SK (corresponding author), Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.	stehuang@umich.edu			American Thoracic Society Coalition for Pulmonary Fibrosis Foundation Research Grant; Nathan Shock Center Functional Assessment Core; National Heart, Lung, and Blood Institute [HL094657, HL094311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085083, R01HL127203, K08HL094657, T32HL007749, R56HL119289, R01HL094311] Funding Source: NIH RePORTER	American Thoracic Society Coalition for Pulmonary Fibrosis Foundation Research Grant; Nathan Shock Center Functional Assessment Core; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an American Thoracic Society Coalition for Pulmonary Fibrosis Foundation Research Grant, the Nathan Shock Center Functional Assessment Core, and grants HL094657 (to SKH) and HL094311 (to MP-G) from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi IO, 2013, AM J RESP CELL MOL, V49, P86, DOI 10.1165/rcmb.2012-0224OC; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Bonner JC, 1998, AM J PHYSIOL-LUNG C, V274, pL72, DOI 10.1152/ajplung.1998.274.1.L72; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Buhling F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-37; Choi MR, 2012, EXP MOL MED, V44, P503, DOI 10.3858/emm.2012.44.8.057; Cisneros J, 2012, AM J PHYSIOL-LUNG C, V303, pL295, DOI 10.1152/ajplung.00332.2011; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Emblom-Callahan MC, 2010, GENOMICS, V96, P134, DOI 10.1016/j.ygeno.2010.04.005; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Grombacher T, 1998, ONCOGENE, V17, P845, DOI 10.1038/sj.onc.1202000; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Han MLK, 2010, RESP MED, V104, P724, DOI 10.1016/j.rmed.2009.11.019; Hogaboam CM, 2005, METH MOLEC MED, V117, P209; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2008, AM J RESP CRIT CARE, V177, P66, DOI 10.1164/rccm.200706-963OC; Huang SK, 2012, FASEB J, V26, P3703, DOI 10.1096/fj.11-203323; Huang SK, 2010, AM J PATHOL, V177, P2245, DOI 10.2353/ajpath.2010.100446; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; JORDANA M, 1988, AM REV RESPIR DIS, V137, P579, DOI 10.1164/ajrccm/137.3.579; Katzenstein ALA, 2008, HUM PATHOL, V39, P1275, DOI 10.1016/j.humpath.2008.05.009; Kaz AM, 2014, EPIGENETICS-US, V9, P492, DOI 10.4161/epi.27650; Lindahl GE, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-80; Lovinsky-Desir S, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-9; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Mene P, 2010, NEPHROL DIAL TRANSPL, V25, P353, DOI 10.1093/ndt/gfp634; Meuten T, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-62; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; QUELLE DE, 1995, ONCOGENE, V11, P635; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; RAGHU G, 1988, AM REV RESPIR DIS, V138, P703, DOI 10.1164/ajrccm/138.3.703; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Redaelli S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt138; Sanders YY, 2008, AM J RESP CELL MOL, V39, P610, DOI 10.1165/rcmb.2007-0322OC; Sanders YY, 2007, AM J RESP CELL MOL, V36, P226, DOI 10.1165/rcmb.2006-0178OC; Sanders YY, 2012, AM J RESP CRIT CARE, V186, P525, DOI 10.1164/rccm.201201-0077OC; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Sisson Thomas H, 2012, Adv Biosci Biotechnol, V3, P657; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Trujillo G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001510; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866	50	62	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107055	10.1371/journal.pone.0107055	http://dx.doi.org/10.1371/journal.pone.0107055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215577	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300040
J	Silva, DR; Muller, AM; Tomasini, KD; Dalcin, PDR; Golub, JE; Conde, MB				Silva, Denise Rossato; Mueller, Alice Manica; Tomasini, Karina da Silva; Roth Dalcin, Paulo de Tarso; Golub, Jonathan E.; Conde, Marcus Barreto			Active Case Finding of Tuberculosis (TB) in an Emergency Room in a Region with High Prevalence of TB in Brazil	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; FIBEROPTIC BRONCHOSCOPY; DIAGNOSIS; SMEAR; SPUTUM; MORTALITY; TIME; CITY	Setting: Public hospital emergency room (ER) in Porto Alegre, Brazil, a setting with high prevalence of tuberculosis (TB) and human immunodeficiency virus (HIV) infection. Objective: To determine the prevalence of PTB, using a symptom based active case finding (ACF) strategy in the ER of a public hospital in an area with high prevalence of TB and HIV, as well as variables associated with pulmonary TB diagnosis. Methods: Cross sectional study. All patients >= 18 years seeking care at the ER were screened for respiratory symptoms and those with cough >= 2 weeks were invited to provide a chest radiograph and two unsupervised samples of sputum for acid-fast bacilli smear and culture. Results: Among 31,267 admissions, 6,273 (20.1%) reported respiratory symptoms; 197 reported cough >= 2 weeks, of which pulmonary TB was diagnosed in 30. In multivariate analysis, the variables associated with a pulmonary tuberculosis diagnosis were: age (OR 0.94, 95% CI: 0.92-0.97; p < 0.0001), sputum production (OR 0.18, 95% CI 0.06-0.56; p = 0.003), and radiographic findings typical of TB (OR 12.11, 95% CI 4.45-32.93; p < 0.0001). Conclusions: This study identified a high prevalence of pulmonary TB among patients who sought care at the emergency department of a tertiary hospital, emphasizing the importance of regular screening of all comers for active TB in this setting.	[Silva, Denise Rossato; Roth Dalcin, Paulo de Tarso] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Fac Med, Dept Pulmonol, Porto Alegre, RS, Brazil; [Silva, Denise Rossato; Mueller, Alice Manica; Tomasini, Karina da Silva; Roth Dalcin, Paulo de Tarso] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Pneumol, Porto Alegre, RS, Brazil; [Golub, Jonathan E.] Johns Hopkins Sch Med, Dept Epidemiol, Baltimore, MD USA; [Conde, Marcus Barreto] Univ Fed Rio de Janeiro, Inst Doencas Torax, Rio De Janeiro, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Johns Hopkins University; Johns Hopkins Medicine; Universidade Federal do Rio de Janeiro	Silva, DR (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Fac Med, Dept Pulmonol, Porto Alegre, RS, Brazil.	denise.rossato@terra.com.br	Conte, Marcus B/A-2501-2013; Dalcin, Paulo T. R./E-6009-2013	Conte, Marcus B/0000-0002-7249-4455; Dalcin, Paulo T. R./0000-0002-9774-9135; Rossato Silva, Denise/0000-0003-0230-2734	Fundo de Incentivo a Pesquisa - Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [300414/2010-2]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E26/101491/2010]	Fundo de Incentivo a Pesquisa - Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the Fundo de Incentivo a Pesquisa - Hospital de Clinicas de Porto Alegre (FIPE-HCPA). Marcus B. Conde is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 300414/2010-2) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; E26/101491/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOB TUB CONTR SURV; Bastos LGV, 2007, INT J TUBERC LUNG D, V11, P156; Conde MB, 2000, AM J RESP CRIT CARE, V162, P2238, DOI 10.1164/ajrccm.162.6.2003125; Desalu OO, 2011, PAN AFR MED J, V9; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Gaeta TJ, 1997, ACAD EMERG MED, V4, P138, DOI 10.1111/j.1553-2712.1997.tb03721.x; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Long R, 2002, INT J TUBERC LUNG D, V6, P332; MacPherson P, 2011, INT J TUBERC LUNG D, V15, P1390, DOI 10.5588/ijtld.11.0056; Maior MD, 2012, J BRAS PNEUMOL, V38, P202, DOI 10.1590/S1806-37132012000200009; McWilliams T, 2002, THORAX, V57, P1010, DOI 10.1136/thorax.57.12.1010; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; Ministerio da Saude, 2011, PROGR NAC CONTR TUB; Ministerio da Saude - Brasil, 2012, ESP TUB, V43; Redd JT, 1997, AM J PUBLIC HEALTH, V87, P1543, DOI 10.2105/AJPH.87.9.1543; Rothman RE, 2006, EMERG MED CLIN N AM, V24, P989, DOI 10.1016/j.emc.2006.06.006; Silva DR, 2010, LUNG, V188, P33, DOI 10.1007/s00408-009-9224-9; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tamura A, 2010, INTERNAL MED, V49, P95, DOI 10.2169/internalmedicine.49.2686; Tsai TC, 2008, AM J EMERG MED, V26, P888, DOI 10.1016/j.ajem.2007.11.036; Valença Laércio Moreira, 2006, J. bras. pneumol., V32, P284, DOI 10.1590/S1806-37132006000400005; Wisnivesky JP, 2000, ARCH INTERN MED, V160, P2471, DOI 10.1001/archinte.160.16.2471; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, TREATM TUB	27	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107576	10.1371/journal.pone.0107576	http://dx.doi.org/10.1371/journal.pone.0107576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211158	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900085
J	Tsai, PC; Huang, SW; Tsai, HL; Ma, CJ; Hou, MF; Yang, IP; Wang, YS; Juo, SHH; Wang, JY				Tsai, Pei-Chien; Huang, Szu-Wei; Tsai, Hsiang-Lin; Ma, Cheng-Jen; Hou, Ming-Feng; Yang, I-Ping; Wang, Yung-Song; Juo, Suh-Hang Hank; Wang, Jaw-Yuan			The Association between DNA Copy Number Aberrations at Chromosome 5q22 and Gastric Cancer	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; GENETIC ALTERATIONS; PHENOTYPE; CARCINOMA; APC	Background: Gastric cancer is common cancer. Discovering novel genetic biomarkers might help to identify high-risk individuals. Copy number variation (CNV) has recently been shown to influence risk for several cancers. The aim of the present study was sought to test the association between copy number at a variant region and GC. Methods: A total of 110 gastric cancer patients and 325 healthy volunteers were enrolled in this study. We searched for a CNV and found a CNV (Variation 7468) containing part of the APC gene, the SRP19 gene and the REEP5 gene. We chose four probes targeting at APC-intron8, APC-exon9, SRP19 and REEP5 to interrogate this CNV. Specific Taqman probes labeled by different reporter fluorophores were used in a real-time PCR platform to obtain copy number. Both the original non-integer data and transformed integer data on copy number were used for analyses. Results: Gastric caner patients had a lower non-integer copy number than controls for the APC-exon9 probe (Adjusted p = 0.026) and SRP19 probe (Adjusted p = 0.002). The analysis of integer copy number yielded a similar pattern although less significant (Adjusted p = 0.07 for APC-exon9 probe and Adjusted p = 0.02 for SRP19 probe). Conclusions: Losses of a CNV at 5q22, especially in the DNA region surrounding APC-exon 9, may be associated with a higher risk of gastric cancer.	[Tsai, Pei-Chien] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Szu-Wei; Wang, Yung-Song; Juo, Suh-Hang Hank; Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Tsai, Hsiang-Lin] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Tsai, Hsiang-Lin; Ma, Cheng-Jen; Hou, Ming-Feng; Juo, Suh-Hang Hank; Wang, Jaw-Yuan] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Tsai, Hsiang-Lin; Hou, Ming-Feng; Wang, Jaw-Yuan] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Ma, Cheng-Jen; Hou, Ming-Feng; Wang, Jaw-Yuan] Kaohsiung Med Univ Hosp, Dept Surg, Div Gastrointestinal & Gen Surg, Kaohsiung, Taiwan; [Yang, I-Ping] Shu Zen Coll Med & Management, Dept Nursing, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Juo, SHH (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan.	hjuo@kmu.edu.tw; cy614112@ms14.hinet.net	Jaw-Yuan, Wang/AFS-8845-2022; Juo, Suh-Hang/C-9545-2009	Jaw-Yuan, Wang/0000-0002-7705-2621; Hou, Ming-Feng/0000-0001-6030-9702; Tsai, Pei-Chien/0000-0002-5044-6727; Yang, I-Ping/0000-0001-7051-3328	Kaohsiung Medical University Hospital [KMUH98-8I04, KMUH98-8G05, KMUH99-9R03]; Excellence for Cancer Research Center Grant through Department of Health, Executive Yuan, Taiwan, Republic of China [MOHW103-TD-B-111-05]; National Science Council of the Republic of China [NSC 99-2320-B-037-014-MY3, NSC 94-2314B037-104]	Kaohsiung Medical University Hospital; Excellence for Cancer Research Center Grant through Department of Health, Executive Yuan, Taiwan, Republic of China; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Kaohsiung Medical University Hospital (KMUH98-8I04, KMUH98-8G05, KMUH99-9R03), Excellence for Cancer Research Center Grant through the funding from the Department of Health, Executive Yuan, Taiwan, Republic of China (MOHW103-TD-B-111-05), and the National Science Council of the Republic of China (NSC 99-2320-B-037-014-MY3, NSC 94-2314B037-104). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAER M, 1990, NUCLEIC ACIDS RES, V18, P97, DOI 10.1093/nar/18.1.97; Buffart TE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-345; Carvalho CMB, 2010, P NATL ACAD SCI USA, V107, P1765, DOI 10.1073/pnas.0906222107; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Fang DC, 2002, WORLD J GASTROENTERO, V8, P787, DOI 10.3748/wjg.v8.i5.787; Fearnhead NS, 2002, BRIT MED BULL, V64, P27, DOI 10.1093/bmb/64.1.27; Gavert Nancy, 2002, Hum Mutat, V19, P664, DOI 10.1002/humu.9037; Gumus-Akay G, 2009, ARCH MED RES, V40, P551, DOI 10.1016/j.arcmed.2009.07.004; HERMANEK P, 1989, LEBER MAGEN DARM, V19, P169; Hong SJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-138; Ionita-Laza I, 2009, GENOMICS, V93, P22, DOI 10.1016/j.ygeno.2008.08.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khan A, 2010, THYROID, V20, P795, DOI 10.1089/thy.2009.0216; Kimura Y, 2004, MODERN PATHOL, V17, P1328, DOI 10.1038/modpathol.3800180; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Liu MM, 2011, INVEST OPHTH VIS SCI, V52, P3129, DOI 10.1167/iovs.10-6735; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morohara K, 2005, CANCER GENET CYTOGEN, V161, P57, DOI 10.1016/j.cancergencyto.2005.01.007; Nieuwenhuis MH, 2007, CRIT REV ONCOL HEMAT, V61, P153, DOI 10.1016/j.critrevonc.2006.07.004; Nishimura T, 2008, TUMOR BIOL, V29, P343, DOI 10.1159/000176044; Nobili S, 2011, WORLD J GASTROENTERO, V17, P290, DOI 10.3748/wjg.v17.i3.290; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Stock M, 2005, GENE, V360, P1, DOI 10.1016/j.gene.2005.06.026; Telang N, 2011, ONCOL REP, V25, P1195, DOI 10.3892/or.2011.1215; Tsugane S, 2007, GASTRIC CANCER, V10, P75, DOI 10.1007/s10120-007-0420-0; Uchida M, 2010, J PATHOL, V221, P96, DOI 10.1002/path.2686; van Dekken H, 1999, CANCER RES, V59, P748; Vauhkonen Matti, 2005, Gastric Cancer, V8, P238, DOI 10.1007/s10120-005-0346-3; Walsh KM, 2010, MUTAT RES-FUND MOL M, V690, P89, DOI 10.1016/j.mrfmmm.2010.05.005; Weiss MM, 2004, CELL ONCOL, V26, P307; Wu CW, 2002, GENE CHROMOSOME CANC, V35, P219, DOI 10.1002/gcc.10106; Wu MS, 2001, GENE CHROMOSOME CANC, V30, P80, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1062>3.0.CO;2-R; Yaghoobi M, 2010, BRIT J CANCER, V102, P237, DOI 10.1038/sj.bjc.6605380	34	7	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106624	10.1371/journal.pone.0106624	http://dx.doi.org/10.1371/journal.pone.0106624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210923	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900020
J	Bouetard, A; Cote, J; Besnard, AL; Collinet, M; Coutellec, MA				Bouetard, Anthony; Cote, Jessica; Besnard, Anne-Laure; Collinet, Marc; Coutellec, Marie-Agnes			Environmental versus Anthropogenic Effects on Population Adaptive Divergence in the Freshwater Snail Lymnaea stagnalis	PLOS ONE			English	Article							INBREEDING DEPRESSION; GENETIC DIFFERENTIATION; EVOLUTIONARY PRINCIPLES; Q(ST)-F-ST COMPARISONS; PESTICIDE TOLERANCE; NATURAL-POPULATIONS; SELFING RATE; DRIFT LOAD; F-ST; SELECTION	Repeated pesticide contaminations of lentic freshwater systems located within agricultural landscapes may affect population evolution in non-target organisms, especially in species with a fully aquatic life cycle and low dispersal ability. The issue of evolutionary impact of pollutants is therefore conceptually important for ecotoxicologists. The impact of historical exposure to pesticides on genetic divergence was investigated in the freshwater gastropod Lymnaea stagnalis, using a set of 14 populations from contrasted environments in terms of pesticide and other anthropogenic pressures. The hypothesis of population adaptive divergence was tested on 11 life-history traits, using Q(ST) -F-ST comparisons. Despite strong neutral differentiation (mean F-ST = 0.291), five adult traits or parameters were found to be under divergent selection. Conversely, two early expressed traits showed a pattern consistent with uniform selection or trait canalization, and four adult traits appeared to evolve neutrally. Divergent selection patterns were mostly consistent with a habitat effect, opposing pond to ditch and channel populations. Comparatively, pesticide and other human pressures had little correspondence with evolutionary patterns, despite hatching rate impairment associated with global anthropogenic pressure. Globally, analyses revealed high genetic variation both at neutral markers and fitness-related traits in a species used as model in ecotoxicology, providing empirical support for the need to account for genetic and evolutionary components of population response in ecological risk assessment.	[Bouetard, Anthony; Cote, Jessica; Besnard, Anne-Laure; Collinet, Marc; Coutellec, Marie-Agnes] INRA, Agrocampus Ouest, UMR ESE Ecol & Ecosyst Hlth 0985, F-35042 Rennes, France	INRAE; Institut Agro; Agrocampus Ouest	Coutellec, MA (corresponding author), INRA, Agrocampus Ouest, UMR ESE Ecol & Ecosyst Hlth 0985, CS84215, F-35042 Rennes, France.	marie-agnes.coutellec@rennes.inra.fr			French National Institute for Agricultural Research (INRA: CJS Contrat Jeune Scientifique); French National Institute for Agricultural research (INRA: AIP Bioressources); French National Institute for Agricultural research (INRA: EFPA Department PI)	French National Institute for Agricultural Research (INRA: CJS Contrat Jeune Scientifique); French National Institute for Agricultural research (INRA: AIP Bioressources); French National Institute for Agricultural research (INRA: EFPA Department PI)	AB had a PhD fellowship from the French National Institute for Agricultural Research (INRA: CJS Contrat Jeune Scientifique). Experiment and data acquisition were funded by the French National Institute for Agricultural research (INRA: AIP Bioressources and EFPA Department PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger-Deschenes S, 2013, ECOTOXICOLOGY, V22, P938, DOI 10.1007/s10646-013-1083-8; Belkhir K, 1996, 5171 CNRS UMR U MONT; Besnard A-L, 2013, MOL ECOL RESOUR, V13; Bickham JW, 2000, MUTAT RES-REV MUTAT, V463, P33, DOI 10.1016/S1383-5742(00)00004-1; Bijlsma R, 2012, EVOL APPL, V5, P117, DOI 10.1111/j.1752-4571.2011.00214.x; Bonnin I, 1996, GENETICS, V143, P1795; Bourret V, 2008, AQUAT TOXICOL, V86, P76, DOI 10.1016/j.aquatox.2007.10.003; Breitholtz M, 2006, ECOTOX ENVIRON SAFE, V63, P324, DOI 10.1016/j.ecoenv.2005.12.009; Bridges CM, 2000, CONSERV BIOL, V14, P1490, DOI 10.1046/j.1523-1739.2000.99343.x; Brown CD, 2007, ENVIRON TOXICOL CHEM, V26, P1818, DOI 10.1897/06-498R.1; Brown CD, 2009, ENVIRON POLLUT, V157, P3314, DOI 10.1016/j.envpol.2009.06.029; Chapuis E, 2007, MOL ECOL, V16, P3484, DOI 10.1111/j.1365-294X.2007.03386.x; Chapuis E, 2008, GENETICS, V180, P2151, DOI 10.1534/genetics.108.092452; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Coors A, 2009, AQUAT TOXICOL, V95, P71, DOI 10.1016/j.aquatox.2009.08.004; Cothran RD, 2013, EVOL APPL, V6, P832, DOI 10.1111/eva.12069; Coutellec MA, 2011, J EVOLUTION BIOL, V24, P2248, DOI 10.1111/j.1420-9101.2011.02355.x; Coutellec M-A, 2008, DEMOGRAPHIC TOXICITY, P152; Coutellec MA, 2006, ECOTOXICOLOGY, V15, P199, DOI 10.1007/s10646-005-0049-x; Coutellec MA, 2011, ECOTOXICOLOGY, V20, P524, DOI 10.1007/s10646-011-0611-7; Coutellec MA, 2013, ECOTOXICOLOGY, V22, P879, DOI 10.1007/s10646-013-1082-9; David P, 2007, MOL ECOL, V16, P2474, DOI 10.1111/j.1365-294X.2007.03330.x; de Zwart D, 2005, INTEGR ENVIRON ASSES, V1, P123, DOI 10.1897/IEAM_2004-015.1; Declerck S, 2006, BIOL CONSERV, V131, P523, DOI 10.1016/j.biocon.2006.02.024; DEPLEDGE MH, 1994, ENVIRON HEALTH PERSP, V102, P101, DOI 10.1289/ehp.94102s12101; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edelaar P, 2011, MOL ECOL, V20, P1805, DOI 10.1111/j.1365-294X.2011.05051.x; Escobar JS, 2011, EVOLUTION, V65, P1233, DOI 10.1111/j.1558-5646.2011.01218.x; Escobar JS, 2008, GENETICS, V180, P1593, DOI 10.1534/genetics.108.092718; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Gordo I, 2001, CURR BIOL, V11, pR684, DOI 10.1016/S0960-9822(01)00408-0; Goudet J, 2006, GENETICS, V172, P1337, DOI 10.1534/genetics.105.050583; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Goudet J, 2007, GENETICS, V176, P1371, DOI 10.1534/genetics.106.067173; Guillaume F, 2011, EVOLUTION, V65, P1723, DOI 10.1111/j.1558-5646.2011.01248.x; Guillemaud T, 1998, EVOLUTION, V52, P443, DOI [10.2307/2411080, 10.1111/j.1558-5646.1998.tb01644.x]; HABDIJA I, 1995, INT REV GES HYDROBIO, V80, P103, DOI 10.1002/iroh.19950800113; Haddrill PR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r18; Hangartner S, 2012, EVOLUTION, V66, P867, DOI 10.1111/j.1558-5646.2011.01472.x; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hendry AP, 2011, EVOL APPL, V4, P159, DOI 10.1111/j.1752-4571.2010.00165.x; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hoffmann AA, 2000, BIOSCIENCE, V50, P217, DOI 10.1641/0006-3568(2000)050[0217:ESAAEF]2.3.CO;2; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Jimenez-Ambriz G, 2007, NEW PHYTOL, V173, P199, DOI 10.1111/j.1469-8137.2006.01923.x; Johansson M, 2007, MOL ECOL, V16, P2693, DOI 10.1111/j.1365-294X.2007.03357.x; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Klerks PL, 2002, HUM ECOL RISK ASSESS, V8, P971, DOI 10.1080/1080-700291905774; Knott KE, 2003, MOL ECOL NOTES, V3, P333, DOI 10.1046/j.1471-8286.2003.00444.x; Koene JM, 2004, BELG J ZOOL, V134, P41; Koene JM, 2009, EVOL ECOL, V23, P533, DOI 10.1007/s10682-008-9253-5; Kopp KC, 2007, LYMNAEA STAGNALIS MI; Kopp KC, 2012, EVOL ECOL, V26, P483, DOI 10.1007/s10682-011-9504-8; Lamy JB, 2012, MOL ECOL, V21, P5646, DOI 10.1111/mec.12017; Lankau R, 2011, EVOL APPL, V4, P315, DOI 10.1111/j.1752-4571.2010.00171.x; Le Corre V, 2012, MOL ECOL, V21, P1548, DOI 10.1111/j.1365-294X.2012.05479.x; LEBLANC GA, 1994, ENVIRON HEALTH PERSP, V102, P266, DOI 10.1289/ehp.94102266; Leinonen T, 2013, NAT REV GENET, V14, P179, DOI 10.1038/nrg3395; Long TAF, 2013, AM NAT, V181, P532, DOI 10.1086/669675; Lopez-Fanjul C, 2003, GENETICS, V164, P1627; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Lynch M., 1998, GENETICS ANAL QUANTI; Matson CW, 2006, ENVIRON HEALTH PERSP, V114, P547, DOI 10.1289/ehp.8404; Medina MH, 2007, CHEMOSPHERE, V67, P2105, DOI 10.1016/j.chemosphere.2006.12.024; Memmott J, 2009, PHILOS T R SOC B, V364, P1693, DOI 10.1098/rstb.2008.0255; Morgan AJ, 2007, ENVIRON SCI TECHNOL, V41, P1085, DOI 10.1021/es061992x; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Oleksiak MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-263; Orsini L, 2012, MOL ECOL, V21, P2160, DOI 10.1111/j.1365-294X.2011.05429.x; Palo JU, 2003, MOL ECOL, V12, P1963, DOI 10.1046/j.1365-294X.2003.01865.x; Pelletier F, 2009, TRENDS ECOL EVOL, V24, P263, DOI 10.1016/j.tree.2008.11.013; Pinheiro J. C., 2002, MIXED EFFECTS MODELS; Pomati F, 2013, ECOTOXICOLOGY, V22, P779, DOI 10.1007/s10646-013-1068-7; Pritchard JK, 2000, GENETICS, V155, P945; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Puurtinen M, 2007, J EVOLUTION BIOL, V20, P901, DOI 10.1111/j.1420-9101.2007.01312.x; Puurtinen M, 2004, EVOLUTION, V58, P749, DOI 10.1111/j.0014-3820.2004.tb00408.x; Rasanen K, 2003, EVOLUTION, V57, P352, DOI 10.1554/0014-3820(2003)057[0352:GVIAST]2.0.CO;2; Rattner BA, 2009, ECOTOXICOLOGY, V18, P773, DOI 10.1007/s10646-009-0354-x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schwarzenbach RP, 2010, ANNU REV ENV RESOUR, V35, P109, DOI 10.1146/annurev-environ-100809-125342; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Smith TB, 2008, MOL ECOL, V17, P1, DOI 10.1111/j.1365-294X.2007.03607.x; SPITZE K, 1993, GENETICS, V135, P367; Varian-Ramos CW, 2013, ENVIRON POLLUT, V182, P316, DOI 10.1016/j.envpol.2013.07.044; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; VIA S, 1990, ANNU REV ENTOMOL, V35, P421, DOI 10.1146/annurev.en.35.010190.002225; Volis S, 2005, HEREDITY, V95, P466, DOI 10.1038/sj.hdy.6800745; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitehead A, 2011, P NATL ACAD SCI USA, V108, P6193, DOI 10.1073/pnas.1017542108; Whitlock MC, 2000, HEREDITY, V84, P452, DOI 10.1046/j.1365-2540.2000.00693.x; Whitlock MC, 2009, GENETICS, V183, P1055, DOI 10.1534/genetics.108.099812; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Wolf JB, 2000, EVOLUTION, V54, P1882, DOI 10.1111/j.0014-3820.2000.tb01235.x; Yuan JS, 2007, TRENDS PLANT SCI, V12, P6, DOI 10.1016/j.tplants.2006.11.001	99	15	15	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106670	10.1371/journal.pone.0106670	http://dx.doi.org/10.1371/journal.pone.0106670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207985	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300035
J	Du, HJ; Wu, KL; Didoronkute, A; Levy, MVA; Todi, N; Shchelokova, A; Massiah, MA				Du, Haijuan; Wu, Kuanlin; Didoronkute, Alma; Levy, Marcus V. A.; Todi, Nimish; Shchelokova, Anna; Massiah, Michael A.			MID1 Catalyzes the Ubiquitination of Protein Phosphatase 2A and Mutations within Its Bbox1 Domain Disrupt Polyubiquitination of Alpha4 but Not of PP2Ac	PLOS ONE			English	Article							OPITZ-G/BBB SYNDROME; REGULATORY SUBUNIT ALPHA-4; SYNDROME GENE-PRODUCT; SERINE/THREONINE PHOSPHATASES; BINDING DOMAINS; GBBB SYNDROME; ZINC FINGERS; LIGASE MID1; MICROTUBULES; PHOSPHORYLATION	MID1 is a microtubule-associated protein that belongs to the TRIM family. MID1 functions as an ubiquitin E3 ligase, and recently was shown to catalyze the polyubiquitination of, alpha4, a protein regulator of protein phosphatase 2A (PP2A). It has been hypothesized that MID1 regulates PP2A, requiring the intermediary interaction with alpha4. Here we report that MID1 catalyzes the in vitro ubiquitination of the catalytic subunit of PP2A (PP2Ac) in the absence of alpha4. In the presence of alpha4, the level of PP2Ac ubiquitination is reduced. Using the MID1 RING-Bbox1-Bbox2 (RB1B2) construct containing the E3 ligase domains, we investigate the functional effects of mutations within the Bbox domains that are identified in patients with X-linked Opitz G syndrome (XLOS). The RB1B2 proteins harboring the C142S, C145T, A130V/T mutations within the Bbox1 domain and C195F mutation within the Bbox2 domain maintain auto-polyubiquitination activity. Qualitatively, the RB1B2 proteins containing these mutations are able to catalyze the ubiquitination of PP2Ac. In contrast, the RB1B2 proteins with mutations within the Bbox1 domain are unable to catalyze the polyubiquitination of alpha4. These results suggest that unregulated alpha4 may be the direct consequence of these natural mutations in the Bbox1 domain of MID1, and hence alpha4 could play a greater role to account for the increased amount of PP2A observed in XLOS-derived fibroblasts.	[Du, Haijuan; Wu, Kuanlin; Didoronkute, Alma; Levy, Marcus V. A.; Todi, Nimish; Shchelokova, Anna; Massiah, Michael A.] George Washington Univ, Dept Chem, Washington, DC 20052 USA	George Washington University	Massiah, MA (corresponding author), George Washington Univ, Dept Chem, Washington, DC 20052 USA.	massiah@gwu.edu			The National Science Foundation [1052520]; Direct For Biological Sciences [1052520] Funding Source: National Science Foundation	The National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding provided by Award 1052520, nsf.gov. The National Science Foundation had no role in the design, data collection, analysis, decision to publish or preparation of this manuscript.	Aranda-Orgilles B, 2008, HUM GENET, V123, P163, DOI 10.1007/s00439-007-0456-6; Aranda-Orgilles B, 2011, J BIOL CHEM, V286, P39945, DOI 10.1074/jbc.M111.224451; Aranda-Orgilles B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003507; BERG JM, 1990, J BIOL CHEM, V265, P6513; BERG JM, 1988, P NATL ACAD SCI USA, V85, P99, DOI 10.1073/pnas.85.1.99; Buchner G, 1999, HUM MOL GENET, V8, P1397, DOI 10.1093/hmg/8.8.1397; Cox TC, 2000, HUM MOL GENET, V9, P2553, DOI 10.1093/hmg/9.17.2553; De Falco F, 2003, AM J MED GENET A, V120A, P222, DOI 10.1002/ajmg.a.10265; Du HJ, 2013, J BIOL CHEM, V288, P21341, DOI 10.1074/jbc.M113.481093; Du HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028877; Everett AD, 2002, DEV DYNAM, V224, P461, DOI 10.1002/dvdy.10125; Ferrentino R, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9480; Fontanella B, 2008, HUM MUTAT, V29, P584, DOI 10.1002/humu.20706; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Han XF, 2011, J MOL BIOL, V407, P505, DOI 10.1016/j.jmb.2011.01.048; Hu CH, 2012, AM J MED GENET A, V158A, P726, DOI 10.1002/ajmg.a.35216; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Ji X, 2014, GENE, V537, P140, DOI 10.1016/j.gene.2013.12.018; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Liu EB, 2011, P NATL ACAD SCI USA, V108, P8680, DOI 10.1073/pnas.1100131108; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Massiah MA, 2006, J MOL BIOL, V358, P532, DOI 10.1016/j.jmb.2006.02.009; Massiah MA, 1998, NUCL ACID INTERACTIV; Massiah MA, 2007, J MOL BIOL, V369, P1, DOI 10.1016/j.jmb.2007.03.017; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; McDonald WJ, 2014, MOL CELL ENDOCRINOL, V382, P254, DOI 10.1016/j.mce.2013.09.033; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Perry J, 1999, GENOMICS, V62, P385, DOI 10.1006/geno.1999.6043; Ruiter M, 2010, CLIN DYSMORPHOL, V19, P195, DOI 10.1097/MCD.0b013e32833dc5ee; Schweiger S, 1999, P NATL ACAD SCI USA, V96, P2794, DOI 10.1073/pnas.96.6.2794; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; So J, 2005, AM J MED GENET A, V132A, P1, DOI 10.1002/ajmg.a.30407; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Turowski P, 1997, EUR J BIOCHEM, V248, P200, DOI 10.1111/j.1432-1033.1997.t01-1-00200.x; Wang XJ, 2012, FEBS LETT, V586, P1390, DOI 10.1016/j.febslet.2012.02.049; Watkins GR, 2012, J BIOL CHEM, V287, P24207, DOI 10.1074/jbc.M112.368613; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Zhan XZ, 2013, J BIOL CHEM, V288, P28535, DOI 10.1074/jbc.M113.508085	54	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107428	10.1371/journal.pone.0107428	http://dx.doi.org/10.1371/journal.pone.0107428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207814	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300080
J	Su, PH; Chen, JY; Lin, CY; Chen, HY; Liao, PC; Ying, TH; Wang, SL				Su, Pen-Hua; Chen, Jia-Yuh; Lin, Ching-Yi; Chen, Hsiao-Yen; Liao, Pao-Chi; Ying, Tsung-Ho; Wang, Shu-Li			Sex Steroid Hormone Levels and Reproductive Development of Eight-Year-Old Children following In Utero and Environmental Exposure to Phthalates	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; INTERNAL EXPOSURE; PUBERTAL CHANGES; HUMAN URINE; METABOLITES; ESTERS; DEHP; BOYS; INFANTS; PATTERN	In utero exposure to phthalates may adversely affect reproductive development in children due to the anti-androgenic properties of the pthalates. Accordingly, we aimed to determine the effects of in utero and environmental phthalate exposure on the reproductive development of eight-year-old children. We recruited 180 children in central Taiwan during November 2001 and followed them until August 2009 when all children became eight years old. Birth outcomes were collected. Bone age, hormone concentrations, and reproductive developmental stages were determined. Phthalate metabolite levels, including mono-2-ethylhexyl phthalate [MEHP], mono-n-butyl phthalate [MnBP], and mono-benzyl phthalate [MBzP], were assessed. No significant gender differences were found in in utero phthalate exposure. Maternal urinary levels of phthalate metabolites did not correlate significantly with birth outcomes, physical characteristics, and reproductive hormones of the eight-year-old children. Regarding the urinary phthalate metabolite levels of the eight-year-old children, MEHP correlated significantly with serum progesterone levels. MEHP levels in girls correlated significantly with serum progesterone levels. MnBP correlated significantly with serum FSH in all children. In girls, MnBP correlated with serum FSH, and MBzP correlated with serum progesterone and FSH levels. Urinary phthalate metabolite levels did not correlate with female developmental stages or the development of female reproductive organs. Phthalate metabolites did not correlate with the physical characteristics and reproductive hormones in boys. Therefore, environmental exposure to phthalates, as determined by urinary phthalate metabolite levels of eight-year-old children, may affect reproductive hormone levels in children, indicating that further studies on the environmental health effects of phthalates are warranted.	[Su, Pen-Hua; Chen, Jia-Yuh] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Su, Pen-Hua; Chen, Jia-Yuh] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Su, Pen-Hua; Chen, Hsiao-Yen; Wang, Shu-Li] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan; [Lin, Ching-Yi; Ying, Tsung-Ho] Chung Shan Med Univ, Sch Med, Dept Obstet & Gynecol, Taichung, Taiwan; [Lin, Ching-Yi; Ying, Tsung-Ho] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Liao, Pao-Chi] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Liao, Pao-Chi] Natl Cheng Kung Univ, Sustainable Environm Res Ctr, Tainan 70101, Taiwan; [Wang, Shu-Li] Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; National Health Research Institutes - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Cheng Kung University; National Cheng Kung University; Chung Shan Medical University	Wang, SL (corresponding author), Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan.	slwang@nhri.org.tw	Wang, Shu-Li/C-1367-2010	Wang, Shu-Li/0000-0002-0686-4729	Chung Shan Medical University Hospital, Taiwan [CSH-2013-C-013]	Chung Shan Medical University Hospital, Taiwan	This study was supported by a research grant from Chung Shan Medical University Hospital, Taiwan (CSH-2013-C-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berberoglu Merih, 2009, J Clin Res Pediatr Endocrinol, V1, P164, DOI 10.4274/jcrpe.v1i4.3; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187; Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802; Huang PC, 2010, HUM REPROD, V25, P986, DOI 10.1093/humrep/deq015; Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2; Just AC, 2012, ENVIRON HEALTH PERSP, V120, P1475, DOI 10.1289/ehp.1104544; Kasper-Sonnenberg M, 2012, INT J HYG ENVIR HEAL, V215, P373, DOI 10.1016/j.ijheh.2011.09.004; Kobrosly RW, 2014, ENVIRON HEALTH PERSP, V122, P521, DOI 10.1289/ehp.1307063; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270; Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7; Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073; Lomenick JP, 2010, J PEDIATR-US, V156, P221, DOI 10.1016/j.jpeds.2009.09.047; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Moore NP, 2000, REPROD TOXICOL, V14, P183, DOI 10.1016/S0890-6238(00)00068-X; Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048; Rey RA, 2013, ANDROLOGY-US, V1, P3, DOI 10.1111/j.2047-2927.2012.00008.x; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Tanner JM, 2001, GOV OPPOS, V3rd, DOI DOI 10.1111/1477-7053.00052; Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007	27	16	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e102788	10.1371/journal.pone.0102788	http://dx.doi.org/10.1371/journal.pone.0102788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207995	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300004
J	Fodah, RA; Scott, JB; Tam, HH; Yan, P; Pfeffer, TL; Bundschuh, R; Warawa, JM				Fodah, Ramy A.; Scott, Jacob B.; Tam, Hok-Hei; Yan, Pearlly; Pfeffer, Tia L.; Bundschuh, Ralf; Warawa, Jonathan M.			Correlation of Klebsiella pneumoniae Comparative Genetic Analyses with Virulence Profiles in a Murine Respiratory Disease Model	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; COMPLETE GENOME SEQUENCE; HUMAN EPITHELIAL-CELLS; LIVER-ABSCESS; REQUIRING HOSPITALIZATION; BURKHOLDERIA PSEUDOMALLEI; CAPSULAR SEROTYPES; HIGH PREVALENCE; IN-VITRO; RESISTANT	Klebsiella pneumoniae is a bacterial pathogen of worldwide importance and a significant contributor to multiple disease presentations associated with both nosocomial and community acquired disease. ATCC 43816 is a well-studied K. pneumoniae strain which is capable of causing an acute respiratory disease in surrogate animal models. In this study, we performed sequencing of the ATCC 43816 genome to support future efforts characterizing genetic elements required for disease. Furthermore, we performed comparative genetic analyses to the previously sequenced genomes from NTUH-K2044 and MGH 78578 to gain an understanding of the conservation of known virulence determinants amongst the three strains. We found that ATCC 43816 and NTUH-K2044 both possess the known virulence determinant for yersiniabactin, as well as a Type 4 secretion system (T4SS), CRISPR system, and an acetonin catabolism locus, all absent from MGH 78578. While both NTUH-K2044 and MGH 78578 are clinical isolates, little is known about the disease potential of these strains in cell culture and animal models. Thus, we also performed functional analyses in the murine macrophage cell lines RAW264.7 and J774A. 1 and found that MGH 78578 (K52 serotype) was internalized at higher levels than ATCC 43816 (K2) and NTUH-K2044 (K1), consistent with previous characterization of the antiphagocytic properties of K1 and K2 serotype capsules. We also examined the three K. pneumoniae strains in a novel BALB/c respiratory disease model and found that ATCC 43816 and NTUH-K2044 are highly virulent (LD50<100 CFU) while MGH 78578 is relatively avirulent.	[Fodah, Ramy A.; Pfeffer, Tia L.; Warawa, Jonathan M.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Warawa, Jonathan M.] Univ Louisville, Ctr Predict Med, Louisville, KY 40292 USA; [Scott, Jacob B.] Univ Louisville, Sch Dent, Louisville, KY 40292 USA; [Tam, Hok-Hei] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Scott, Jacob B.] Ohio State Univ, Coll Dent, Columbus, OH 43210 USA; [Yan, Pearlly; Bundschuh, Ralf] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Yan, Pearlly; Bundschuh, Ralf] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Yan, Pearlly; Bundschuh, Ralf] Ohio State Univ, Dept Internal Med, Solove Res Inst, Div Hematol, Columbus, OH 43210 USA; [Yan, Pearlly; Bundschuh, Ralf] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Yan, Pearlly; Bundschuh, Ralf] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Yan, Pearlly; Bundschuh, Ralf] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University of Louisville; University of Louisville; University of Louisville; Massachusetts Institute of Technology (MIT); University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Warawa, JM (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	jonathan.warawa@louisville.edu	Yan, Pearlly S/E-4339-2011; Bundschuh, Ralf A/B-9623-2008	Yan, Pearlly S/0000-0003-1965-4920; Bundschuh, Ralf A/0000-0002-6699-8614	University of Louisville	University of Louisville	This work was supported by internal funding at the University of Louisville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; BAGLEY ST, 1985, INFECT CONT HOSP EP, V6, P52, DOI 10.1017/S0195941700062603; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Brett PJ, 1997, EPIDEMIOL INFECT, V118, P137, DOI 10.1017/S095026889600739X; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Cano V, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-156; Chou HC, 2004, INFECT IMMUN, V72, P3783, DOI 10.1128/IAI.72.7.3783-3792.2004; Chung DR, 2011, AM J RESP CRIT CARE, V184, P1409, DOI 10.1164/rccm.201102-0349OC; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Doyle T, 2008, SURVEY HOSP MICROBIO, P9; FANG GD, 1990, MEDICINE, V69, P307, DOI 10.1097/00005792-199009000-00004; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Fumagalli O, 1997, INFECT IMMUN, V65, P4445, DOI 10.1128/IAI.65.11.4445-4451.1997; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; HIGHSMITH AK, 1985, INFECT CONT HOSP EP, V6, P75, DOI 10.1017/S0195941700062640; Hsieh PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033155; Izquierdo L, 2003, J BACTERIOL, V185, P7213, DOI 10.1128/JB.185.24.7213-7221.2003; KABHA K, 1995, INFECT IMMUN, V63, P847, DOI 10.1128/IAI.63.3.847-852.1995; Kesteman AS, 2010, ANTIMICROB AGENTS CH, V54, P2960, DOI 10.1128/AAC.01612-09; Keynan Y, 2007, INT J ANTIMICROB AG, V30, P385, DOI 10.1016/j.ijantimicag.2007.06.019; Lau HY, 2007, MICROB PATHOGENESIS, V42, P148, DOI 10.1016/j.micpath.2007.01.001; Lavender HF, 2004, INFECT IMMUN, V72, P4888, DOI 10.1128/IAI.72.8.4888-4890.2004; Lawlor MS, 2007, INFECT IMMUN, V75, P1463, DOI 10.1128/IAI.00372-06; Lawlor MS, 2005, MOL MICROBIOL, V58, P1054, DOI 10.1111/j.1365-2958.2005.04918.x; Lawrenz MB, 2014, JOVE IN PRESS; Liao CH, 2011, EMERG INFECT DIS, V17, P1113, DOI [10.3201/eid1706.100811, 10.3201/eid/1706.100811]; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Liu PL, 2012, J BACTERIOL, V194, P1841, DOI 10.1128/JB.00043-12; Lledo W., 2009, Morbidity and Mortality Weekly Report, V58, P256; Insua JL, 2013, INFECT IMMUN, V81, P3552, DOI 10.1128/IAI.00391-13; March C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056847; March C, 2011, J BIOL CHEM, V286, P9956, DOI 10.1074/jbc.M110.181008; Marquez P, 2010, SPECIAL STUDIES REPO, P25; MARRIE TJ, 1989, REV INFECT DIS, V11, P586; Marston Barbara J., 1997, Archives of Internal Medicine, V157, P1709, DOI 10.1001/archinte.157.15.1709; MEYER KS, 1993, ANN INTERN MED, V119, P353, DOI 10.7326/0003-4819-119-5-199309010-00001; Oelschlaeger TA, 1997, INFECT IMMUN, V65, P2950, DOI 10.1128/IAI.65.7.2950-2958.1997; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Paganin F, 2004, EUR RESPIR J, V24, P779, DOI 10.1183/09031936.04.00119503; Pan PC, 2011, EXP BIOL MED, V236, P219, DOI 10.1258/ebm.2010.010193; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; Pan YJ, 2011, INFECT IMMUN, V79, P997, DOI 10.1128/IAI.00906-10; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Sahly H, 2000, INFECT IMMUN, V68, P6744, DOI 10.1128/IAI.68.12.6744-6749.2000; Scott JB, 2013, GENETIC CHARACTERIZA; Shin SH, 2012, J BACTERIOL, V194, P2736, DOI 10.1128/JB.00027-12; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Srinivasan VB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033777; Struve C, 2003, FEMS MICROBIOL LETT, V218, P149, DOI 10.1016/S0378-1097(02)01117-5; Warawa JM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00133; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Yadav V, 2003, INDIAN J MED RES, V118, P47; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	58	40	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107394	10.1371/journal.pone.0107394	http://dx.doi.org/10.1371/journal.pone.0107394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203254	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500093
J	Huet, S; Cony-Makhoul, P; Heiblig, M; Tigaud, I; Gazzo, S; Belhabri, A; Souche, D; Michallet, M; Magaud, JP; Hayette, S; Nicolini, F				Huet, Sarah; Cony-Makhoul, Pascale; Heiblig, Mael; Tigaud, Isabelle; Gazzo, Sophie; Belhabri, Amine; Souche, Denis; Michallet, Mauricette; Magaud, Jean-Pierre; Hayette, Sandrine; Nicolini, Franck			Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; RESIDUAL DISEASE DETECTION; POLYMERASE-CHAIN-REACTION; CHRONIC PHASE; TRANSCRIPT LEVELS; IMATINIB; SURVIVAL; EUROPE	Recent studies demonstrate that early molecular response to tyrosine-kinase inhibitors is strongly predictive of outcome in chronic myeloid leukemia patients and that early response landmarks may identify patients at higher risk for transformation who would benefit from an early switch to second-line therapy. In this study, we evaluated the ability of the control gene GUS to identify relevant thresholds for known therapeutic decision levels (BCR-ABL1/ABL1(IS) = 10% and 0.1%). We then defined the most relevant cut-offs for early molecular response markers (transcript level at 3 months, halving time and log reduction between diagnosis and 3 months of treatment) using GUS or ABL1. We demonstrated that, although both control genes could be used (in an equivalent way) to accurately assess early molecular response, the BCR-ABL1/GUS level at diagnosis is impacted by the higher GUS copy number over-expressed in CML cells, thus negatively impacting its ability to completely replace ABL1 at diagnosis. Furthermore, we pointed out, for the first time, that it would be helpful to monitor BCR-ABL1 levels at an earlier time point than that currently performed, in order to assess response to first-line tyrosine-kinase inhibitors and consider a potential switch of therapy as early as possible. We evaluated this optimal time point as being 19 days after the start of treatment in our cohort.	[Huet, Sarah; Tigaud, Isabelle; Gazzo, Sophie; Souche, Denis; Magaud, Jean-Pierre; Hayette, Sandrine] Ctr Hosp Lyon Sud, Lab Hematol, Ctr Biol Sud, F-69310 Pierre Benite, France; [Huet, Sarah; Magaud, Jean-Pierre; Hayette, Sandrine] CNRS, Fac Med Lyon Sud, UMR 5239, Oullins, France; [Cony-Makhoul, Pascale] Ctr Hosp Annecy, Serv Clin Hematol, Pringy, France; [Heiblig, Mael; Michallet, Mauricette; Nicolini, Franck] Ctr Hosp Lyon Sud, Serv Clin Hematol 1G, F-69310 Pierre Benite, France; [Belhabri, Amine] Ctr Reg Lutte Canc Leon Berard, Serv Clin Hematol, Lyon, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Centre Hospitalier Annecy Genevois; CHU Lyon; UNICANCER; Centre Leon Berard	Huet, S (corresponding author), Ctr Hosp Lyon Sud, Lab Hematol, Ctr Biol Sud, F-69310 Pierre Benite, France.	sarah.huet@chu-lyon.fr	HAYETTE, sandrine/Z-2283-2019	Heiblig, Mael/0000-0003-1682-8657	MSD; Astellas; Novartis; Pfizer; Bristol-Myers Squibb; Genzyme	MSD; Astellas(Astellas Pharmaceuticals); Novartis(Novartis); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Genzyme(Sanofi-AventisGenzyme Corporation)	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: Cony-Makhoul P: BMS: Honoraria. Michallet M: MSD: consultancy, Honoraria, Research Funding; Astellas: Consultancy, Honoraria, Research Funding; Novartis: Consultancy, Honoraria, Research Funding; Pfizer: Consultancy, Honoraria, Research Funding; Bristol-Myers Squibb: Consultancy, Honoraria, Research Funding; Genzyme: consultancy, Honoraria, Research Funding. Nicolini FE: Ariad, Teva, BMS and Pfizer: Honoraria. Novartis: Honoraria and grants. Huet S, Heiblig M, Tigaud I, Gazzo S, Belhabri A, Souche D, Magaud JP, and Hayette S have declared that no competing interests exist. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Branford S, 2008, BLOOD, V112, P3330, DOI 10.1182/blood-2008-04-150680; Branford S, 2013, BLOOD, V122; Branford S, 2012, J CLIN ONCOL, V30, P4323, DOI 10.1200/JCO.2011.40.5217; Branford S, 2012, BLOOD, V119, P4264, DOI 10.1182/blood-2011-11-393041; Brummendorf TH, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.69.69; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Hanfstein B, 2014, LEUKEMIA, V28, P1988, DOI 10.1038/leu.2014.153; Hanfstein B, 2012, LEUKEMIA, V26, P2096, DOI 10.1038/leu.2012.85; Hehlmann R, 2014, J CLIN ONCOL, V32, P415, DOI 10.1200/JCO.2013.49.9020; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Hughes TP, 2014, BLOOD, V123, P1353, DOI 10.1182/blood-2013-06-510396; Hughes TP, 2010, BLOOD, V116, P3758, DOI 10.1182/blood-2010-03-273979; Jabbour E, 2014, BLOOD, V123, P494, DOI 10.1182/blood-2013-06-511592; Jain P, 2013, BLOOD, V121, P4867, DOI 10.1182/blood-2013-03-490128; Marin D, 2012, BLOOD, V120, P291, DOI 10.1182/blood-2012-01-407486; Marin D, 2012, J CLIN ONCOL, V30, P232, DOI 10.1200/JCO.2011.38.6565; Marin D, 2008, BLOOD, V112, P4437, DOI 10.1182/blood-2008-06-162388; Neelakantan P, 2013, BLOOD, V121, P2739, DOI 10.1182/blood-2012-11-466037; Rousselot P, 2012, ASH ANN M, V120, P168; Vigneri PG, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.1495.1495	23	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106250	10.1371/journal.pone.0106250	http://dx.doi.org/10.1371/journal.pone.0106250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203717	gold, Green Submitted, Green Published			2022-12-27	WOS:000342684500016
J	Yeo, KJ; Hong, YS; Jee, JG; Lee, JK; Kim, HJ; Park, JW; Kim, EH; Hwang, E; Kim, SY; Lee, EG; Kwon, O; Cheong, HK				Yeo, Kwon Joo; Hong, Young-Soo; Jee, Jun-Goo; Lee, Jae Kyoung; Kim, Hyo Jeong; Park, Jin-Wan; Kim, Eun-Hee; Hwang, Eunha; Kim, Sang-Yoon; Lee, Eun-Gyeong; Kwon, Ohsuk; Cheong, Hae-Kap			Mechanism of the pH-Induced Conformational Change in the Sensor Domain of the DraK Histidine Kinase via the E83, E105, and E107 Residues	PLOS ONE			English	Article							TORSION ANGLE DYNAMICS; STREPTOMYCES-COELICOLOR; SECONDARY METABOLISM; 2-COMPONENT; SYSTEM; PROTEIN; BIOSYNTHESIS; ACTINORHODIN; PHASE; POLYKETIDE	The DraR/DraK two-component system was found to be involved in the differential regulation of antibiotic biosynthesis in a medium-dependent manner; however, its function and signaling and sensing mechanisms remain unclear. Here, we describe the solution structure of the extracellular sensor domain of DraK and suggest a mechanism for the pH-dependent conformational change of the protein. The structure contains a mixed alpha-beta fold, adopting a fold similar to the ubiquitous sensor domain of histidine kinase. A biophysical study demonstrates that the E83, E105, and E107 residues have abnormally high pKa values and that they drive the pH-dependent conformational change for the extracellular sensor domain of DraK. We found that a triple mutant (E83L/E105L/E107A) is pH independent and mimics the low pH structure. An in vivo study showed that DraK is essential for the recovery of the pH of Streptomyces coelicolor growth medium after acid shock. Our findings suggest that the DraR/DraK two-component system plays an important role in the pH regulation of S. coelicolor growth medium. This study provides a foundation for the regulation and the production of secondary metabolites in Streptomyces.	[Yeo, Kwon Joo; Park, Jin-Wan; Kim, Eun-Hee; Hwang, Eunha; Cheong, Hae-Kap] Korea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang, Chungbuk, South Korea; [Hong, Young-Soo; Lee, Jae Kyoung; Kim, Hyo Jeong] Korea Res Inst Biosci & Biotechnol KRIBB, Chem Biol Res Ctr, Ochang, Chungbuk, South Korea; [Jee, Jun-Goo] Kyungpook Natl Univ, Coll Pharm, Kyungpook, South Korea; [Kim, Sang-Yoon; Lee, Eun-Gyeong; Kwon, Ohsuk] KRIBB, Biochem & Synthet Biol Res Ctr, Taejon, South Korea	Korea Basic Science Institute (KBSI); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyungpook National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Cheong, HK (corresponding author), Korea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang, Chungbuk, South Korea.	oskwon@kribb.re.kr; haekap@kbsi.re.kr	; Kim, Sang-Yoon/Q-1259-2015	Hong, Young-Soo/0000-0001-7768-2239; Kim, Sang-Yoon/0000-0002-6918-0607	KBSI grant [T34410]; Pioneer Research Center Program through the National Research Foundation of Korea [2008-2000225]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT & Future Planning [20110031947]; KRIBB Research Initiative Program	KBSI grant; Pioneer Research Center Program through the National Research Foundation of Korea(National Research Foundation of Korea); Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT & Future Planning; KRIBB Research Initiative Program	This study was supported by a KBSI grant (T34410) to C. H. K. by the Pioneer Research Center Program through the National Research Foundation of Korea (2008-2000225) and the Intelligent Synthetic Biology Center of Global Frontier Project (20110031947), which is funded by the Ministry of Science, ICT & Future Planning, and a grant from the KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; DAVOODI J, 1995, EUR J BIOCHEM, V232, P839, DOI 10.1111/j.1432-1033.1995.tb20881.x; GRAMAJO HC, 1993, MOL MICROBIOL, V7, P837, DOI 10.1111/j.1365-2958.1993.tb01174.x; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hong YS, 2004, J AM CHEM SOC, V126, P11142, DOI 10.1021/ja047769m; Hopwood DA, 1999, MICROBIOL-UK, V145, P2183, DOI 10.1099/00221287-145-9-2183; Hutchings MI, 2004, MICROBIOL-SGM, V150, P2795, DOI 10.1099/mic.0.27181-0; INOUE M, 1992, BIOCHEMISTRY-US, V31, P8816, DOI 10.1021/bi00152a018; ISHIZUKA H, 1992, J BACTERIOL, V174, P7585, DOI 10.1128/JB.174.23.7585-7594.1992; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kim YJ, 2007, APPL MICROBIOL BIOT, V76, P1119, DOI 10.1007/s00253-007-1083-9; Koteva K, 2010, NAT CHEM BIOL, V6, P327, DOI 10.1038/nchembio.350; Lu YH, 2007, APPL MICROBIOL BIOT, V77, P625, DOI 10.1007/s00253-007-1184-5; McKenzie NL, 2007, J BACTERIOL, V189, P5284, DOI 10.1128/JB.00305-07; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Mongan J, 2007, J CHEM THEORY COMPUT, V3, P156, DOI 10.1021/ct600085e; Montelione GT, 2013, STRUCTURE, V21, P1563, DOI 10.1016/j.str.2013.07.021; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Perry J, 2011, MOL BIOSYST, V7, P1388, DOI 10.1039/c0mb00329h; Ragona L, 2003, J BIOL CHEM, V278, P38840, DOI 10.1074/jbc.M306269200; Rozas D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031760; Ryding NJ, 2002, J BACTERIOL, V184, P794, DOI 10.1128/JB.184.3.794-805.2002; Santos-Beneit F, 2009, MOL MICROBIOL, V72, P53, DOI 10.1111/j.1365-2958.2009.06624.x; SHRAGER RI, 1972, BIOCHEMISTRY-US, V11, P541, DOI 10.1021/bi00754a010; Shu D, 2009, APPL MICROBIOL BIOT, V81, P1149, DOI 10.1007/s00253-008-1738-1; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; Sola-Landa A, 2005, MOL MICROBIOL, V56, P1373, DOI 10.1111/j.1365-2958.2005.04631.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; TAKANO E, 1992, MOL MICROBIOL, V6, P2797, DOI 10.1111/j.1365-2958.1992.tb01459.x; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yeo KJ, 2013, BIOCHEM BIOPH RES CO, V431, P554, DOI 10.1016/j.bbrc.2013.01.018; Yepes A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019980; Yu ZY, 2012, MOL MICROBIOL, V85, P535, DOI 10.1111/j.1365-2958.2012.08126.x; Zhang Z, 2010, J MOL BIOL, V400, P335, DOI 10.1016/j.jmb.2010.04.049; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	45	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107168	10.1371/journal.pone.0107168	http://dx.doi.org/10.1371/journal.pone.0107168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203403	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500074
J	Ashwell, M; Mayhew, L; Richardson, J; Rickayzen, B				Ashwell, Margaret; Mayhew, Les; Richardson, Jon; Rickayzen, Ben			Waist-to-Height Ratio Is More Predictive of Years of Life Lost than Body Mass Index	PLOS ONE			English	Article							SCREENING TOOL; RISK-FACTORS; MORTALITY; OBESITY; CIRCUMFERENCE; ASSOCIATION; DISEASE	Objective: Our aim was to compare the effect of central obesity (measured by waist-to-height ratio, WHtR) and total obesity (measured by body mass index, BMI) on life expectancy expressed as years of life lost (YLL), using data on British adults. Methods: A Cox proportional hazards model was applied to data from the prospective Health and Lifestyle Survey (HALS) and the cross sectional Health Survey for England (HSE). The number of years of life lost (YLL) at three ages (30, 50, 70 years) was found by comparing the life expectancies of obese lives with those of lives at optimum levels of BMI and WHtR. Results: Mortality risk associated with BMI in the British HALS survey was similar to that found in US studies. However, WHtR was a better predictor of mortality risk. For the first time, YLL have been quantified for different values of WHtR. This has been done for both sexes separately and for three representative ages. Conclusion: This study supports the simple message "Keep your waist circumference to less than half your height". The use of WHtR in public health screening, with appropriate action, could help add years to life.	[Ashwell, Margaret] Ashwell Associates, Ashwell, Herts, England; [Ashwell, Margaret] Oxford Brookes Univ, Oxford OX3 0BP, England; [Mayhew, Les; Richardson, Jon; Rickayzen, Ben] City Univ London, Fac Actuarial Sci & Insurance, Cass Business Sch, London EC1V 0HB, England	Oxford Brookes University; City University London	Ashwell, M (corresponding author), Ashwell Associates, Ashwell, Herts, England.	margaret@ashwell.uk.com			Institute and Faculty of Actuaries in the UK	Institute and Faculty of Actuaries in the UK	The initial work on this project was funded by a research grant from the Institute and Faculty of Actuaries in the UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, WHO TECH REP SER, P894; Ashwell M, 2012, CLIN OBES, V2, P3, DOI 10.1111/j.1758-8111.2012.00037.x; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 1996, BRIT MED J, V312, P377; Ashwell M., 2011, OPEN OBESITY J, V3, P78, DOI [10.2174/1876823701103010078, DOI 10.2174/1876823701103010078]; Bender R, 1998, AM J EPIDEMIOL, V147, P42; Bodenant M, 2011, STROKE, V42, P2872, DOI 10.1161/STROKEAHA.111.614099; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cox BD, 1996, BRIT MED J, V313, P1487, DOI 10.1136/bmj.313.7070.1487; Cox BD, 1988, HLTH LIFESTYLE SURVE, DOI 10.5255/UKDA-SN-2218-1; Department of Health (DoH), 2011, HLTH LIV HLTH PEOPL; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Heo M, 2003, STAT MED, V22, P1911, DOI 10.1002/sim.1218; HSIEH SD, 1995, INT J OBESITY, V19, P585; Krakauer NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088793; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Lee J S, 1995, Sangyo Eiseigaku Zasshi, V37, P9; McPherson K, 2007, LANCET, V370, P1755, DOI 10.1016/S0140-6736(07)61740-1; National Centre for Social Research and University College London. Department of Epidemiology and Public Health, 2008, HLTH SURV ENGL 2006; National Institute for Health and Clinical Excellence, 2012, NICE DRAFT SCOP ASS; National Institute for Health and Clinical Excellence, 2006, NICE CLIN GUID 43 OB; NHS Information Centre, 2011, STAT OB PHYS ACT DIE; Peeters A, 2003, JAMA-J AM MED ASSOC, V289, P2941, DOI 10.1001/jama.289.22.2941-a; Preston S. H., 2014, WILL MORE OBESITY LE; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Song X, 2013, EUR J CLIN NUTR, V67, P1298, DOI 10.1038/ejcn.2013.203; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Stevens J, 2001, AM J EPIDEMIOL, V153, P946, DOI 10.1093/aje/153.10.946; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; The NHS Information Centre for Health and Social Care, 2011, HLTH SURV ENGL 2010; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zamboni M, 1998, INT J OBESITY, V22, P655, DOI 10.1038/sj.ijo.0800643; Zhang XL, 2009, STROKE, V40, P1098, DOI 10.1161/STROKEAHA.108.539692	36	85	89	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e103483	10.1371/journal.pone.0103483	http://dx.doi.org/10.1371/journal.pone.0103483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198730	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000341304700004
J	Curl, P; Vujic, I; van 't Veer, LJ; Ortiz-Urda, S; Kahn, JG				Curl, Patti; Vujic, Igor; van 't Veer, Laura J.; Ortiz-Urda, Susana; Kahn, James G.			Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma	PLOS ONE			English	Article							ADJUSTED LIFE-YEAR; PHASE-III; MALIGNANT-MELANOMA; IMPROVED SURVIVAL; MEK INHIBITION; DACARBAZINE; TEMOZOLOMIDE; MULTICENTER; VEMURAFENIB; IPILIMUMAB	Purpose: Genetically-targeted therapies are both promising and costly advances in the field of oncology. Several treatments for metastatic melanoma with a mutation in the BRAF gene have been approved. They extend life but are more expensive than the previous standard of care (dacarbazine). Vemurafenib, the first drug in this class, costs $13,000 per month ($207,000 for a patient with median survival). Patients failing vemurafenib are often given ipilimumab, an immunomodulator, at $150,000 per course. Assessment of cost-effectiveness is a valuable tool to help navigate the transition toward targeted cancer therapy. Methods: We performed a cost-utility analysis to compare three strategies for patients with BRAF+ metastatic melanoma using a deterministic expected-value decision tree model to calculate the present value of lifetime costs and quality-adjusted life years (QALYs) for each strategy. We performed sensitivity analyses on all variables. Results: In the base case, the incremental cost-effectiveness ratio (ICER) for vemurafenib compared with dacarbazine was $353,993 per QALY gained (0.42 QALYs added, $156,831 added). The ICER for vemurafenib followed by ipilimumab compared with vemurafenib alone was $158,139. In sensitivity analysis, treatment cost had the largest influence on results: the ICER for vemurafenib versus dacarbazine dropped to $100,000 per QALY gained with a treatment cost of $3600 per month. Conclusion: The cost per QALY gained for treatment of BRAF+ metastatic melanoma with vemurafenib alone or in combination exceeds widely-cited thresholds for cost-effectiveness. These strategies may become cost-effective with lower drug prices or confirmation of a durable response without continued treatment.	[Curl, Patti; Vujic, Igor; Kahn, James G.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Vujic, Igor] Rudolfstiftung Hosp, Vienna, Austria; [van 't Veer, Laura J.; Ortiz-Urda, Susana] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; Rudolfstiftung Hospital; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Curl, P (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	patti.curl@ucsf.edu			NATIONAL CANCER INSTITUTE [K08CA155035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; NCI NIH HHS [K08CA155035, K08 CA155035] Funding Source: Medline; NIMH NIH HHS [P30 MH062246] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], RED BOOK ONL; Avril MF, 2004, J CLIN ONCOL, V22, P1118, DOI 10.1200/JCO.2004.04.165; Beusterien KM, 2009, BRIT J CANCER, V101, P387, DOI 10.1038/sj.bjc.6605187; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Centers for Disease Control and Prevention/National Center for Health Statistics, 2013, FAST STATS LIF EXP; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Eggermont A, 2014, ONCOIMMUNOLOGY, V3; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gandhi SK, 2001, PHARMACOTHERAPY, V21, P684, DOI 10.1592/phco.21.7.684.34568; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hillner BE, 2000, J CLIN ONCOL, V18, P1474, DOI 10.1200/JCO.2000.18.7.1474; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Ray T, 2014, ZELBORAF SHOW STRONG; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Shahabi V, 2012, CANCER IMMUNOL IMMUN, V61, P733, DOI 10.1007/s00262-012-1227-3; Slominski AT, 2014, MAYO CLIN PROC, V89, P429, DOI 10.1016/j.mayocp.2014.02.009; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253	22	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107255	10.1371/journal.pone.0107255	http://dx.doi.org/10.1371/journal.pone.0107255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198196	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700098
J	Laszkiewicz, A; Bzdzion, L; Kasztura, M; Sniezewski, L; Janik, S; Kisielow, P; Cebrat, M				Laszkiewicz, Agnieszka; Bzdzion, Lukasz; Kasztura, Monika; Sniezewski, Lukasz; Janik, Sylwia; Kisielow, Pawel; Cebrat, Malgorzata			Ikaros and RAG-2-Mediated Antisense Transcription Are Responsible for Lymphocyte-Specific Inactivation of NWC Promoter	PLOS ONE			English	Article							RECOMBINATION ACTIVATING GENE; V(D)J RECOMBINATION; RAG LOCUS; DNA-BINDING; CELLS; EXPRESSION; PROTEINS; ELEMENTS; MICE; RNA	Recombination activating gene-2 (RAG-2) and NWC are strongly evolutionarily conserved overlapping genes which are convergently transcribed. In non-lymphoid cells the NWC promoter is active whereas in lymphocytes it is inactive due to the DNA methylation. Analysing the mechanism responsible for lymphocyte-specific methylation and inactivation of NWC promoter we found that Ikaros, a lymphocyte-specific transcription factor, acts as a repressor of NWC promoter - thus identifying a new Ikaros target - but is insufficient for inducing its methylation which depends on the antisense transcription driven by RAG-2 promoter. Possible implications of these observations for understanding evolutionary mechanisms leading to lymphocyte specific expression of RAG genes are discussed.	[Laszkiewicz, Agnieszka; Bzdzion, Lukasz; Kasztura, Monika; Sniezewski, Lukasz; Janik, Sylwia; Kisielow, Pawel; Cebrat, Malgorzata] Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Tumor Immunol, Lab Mol & Cellular Immunol, PL-53114 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Cebrat, M (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Tumor Immunol, Lab Mol & Cellular Immunol, PL-53114 Wroclaw, Poland.	cebrat@iitd.pan.wroc.pl		Cebrat, Malgorzata/0000-0003-4544-3289; Laszkiewicz, Agnieszka/0000-0002-0317-4255	Polish Ministry of Science and Higher Education/National Science Centre [N N401 049138]	Polish Ministry of Science and Higher Education/National Science Centre	This work was supported by the Polish Ministry of Science and Higher Education/National Science Centre (grant N N401 049138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Cebrat M, 2005, EUR J IMMUNOL, V35, P2230, DOI 10.1002/eji.200526225; Cebrat M, 2008, MOL IMMUNOL, V45, P2297, DOI 10.1016/j.molimm.2007.11.009; Cichocki F, 2010, J IMMUNOL, V185, P2009, DOI 10.4049/jimmunol.1000855; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kisielow P, 2008, INT J IMMUNOGENET, V35, P395, DOI 10.1111/j.1744-313X.2008.00791.x; Laszkiewicz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044807; Laszkiewicz A, 2011, IMMUNOGENETICS, V63, P183, DOI 10.1007/s00251-011-0511-2; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moskalev EA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr213; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; THOMPSON CB, 1995, IMMUNITY, V3, P531, DOI 10.1016/1074-7613(95)90124-8; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Tufarelli C, 2006, PHILOS T R SOC B, V361, P67, DOI 10.1098/rstb.2005.1732; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wei XC, 2002, J IMMUNOL, V169, P873, DOI 10.4049/jimmunol.169.2.873; Yannoutsos N, 2004, NAT IMMUNOL, V5, P443, DOI 10.1038/ni1053; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106927	10.1371/journal.pone.0106927	http://dx.doi.org/10.1371/journal.pone.0106927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198102	gold, Green Submitted, Green Published			2022-12-27	WOS:000341304700067
J	Stahli, A; Bosshardt, D; Sculean, A; Gruber, R				Staehli, Alexandra; Bosshardt, Dieter; Sculean, Anton; Gruber, Reinhard			Emdogain-Regulated Gene Expression in Palatal Fibroblasts Requires TGF-beta RI Kinase Signaling	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT CELLS; ENAMEL MATRIX PROTEINS; GROWTH-FACTOR-BETA; CONNECTIVE-TISSUE GRAFT; IN-VITRO; GINGIVAL FIBROBLASTS; DERIVATIVE PROTEIN; INTERLEUKIN-11; TGF-BETA-1; PROLIFERATION	Genome-wide microarrays have suggested that Emdogain regulates TGF-beta target genes in gingival and palatal fibroblasts. However, definitive support for this contention and the extent to which TGF-beta signaling contributes to the effects of Emdogain has remained elusive. We therefore studied the role of the TGF-beta receptor I (TGF-beta RI) kinase to mediate the effect of Emdogain on palatal fibroblasts. Palatal fibroblasts were exposed to Emdogain with and without the inhibitor for TGF-beta RI kinase, SB431542. Emdogain caused 39 coding genes to be differentially expressed in palatal fibroblasts by microarray analysis (p<0.05; >10-fold). Importantly, in the presence of the TGF-beta RI kinase inhibitor SB431542, Emdogain failed to cause any significant changes in gene expression. Consistent with this mechanism, three independent TGF-beta RI kinase inhibitors and a TGF-beta neutralizing antibody abrogated the increased expression of IL-11, a selected Emdogain target gene. The MAPK inhibitors SB203580 and U0126 lowered the impact of Emdogain on IL-11 expression. The data support that TGF-beta RI kinase activity is necessary to mediate the effects of Emdogain on gene expression in vitro.	[Staehli, Alexandra; Bosshardt, Dieter; Sculean, Anton; Gruber, Reinhard] Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland; [Staehli, Alexandra; Gruber, Reinhard] Univ Bern, Sch Dent Med, Lab Oral Cell Biol, Bern, Switzerland; [Bosshardt, Dieter] Univ Bern, Sch Dent Med, Robert K Schenk Lab Oral Histol, Bern, Switzerland	University of Bern; University of Bern; University of Bern	Gruber, R (corresponding author), Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland.	reinhard.gruber@zmk.unibe.ch	Bosshardt, Dieter D/C-9442-2012	Gruber, Reinhard/0000-0001-5400-9009	regular budget of the Department for Periodontology	regular budget of the Department for Periodontology	The study was funded by the regular budget of the Department for Periodontology.	Agis H, 2010, J DENT RES, V89, P40, DOI 10.1177/0022034509354298; Al-Hezaimi K, 2012, INT WOUND J, V9, P436, DOI 10.1111/j.1742-481X.2011.00904.x; Anderson GJ, 2008, NAT CHEM BIOL, V4, P15, DOI 10.1038/nchembio0108-15; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Baello S, 2014, ENDOCRINOLOGY, V155, P475, DOI 10.1210/en.2013-1472; Bamba S, 2003, AM J PHYSIOL-GASTR L, V285, pG529, DOI 10.1152/ajpgi.00050.2003; Bosshardt DD, 2008, J CLIN PERIODONTOL, V35, P87, DOI 10.1111/j.1600-051X.2008.01264.x; Brett PM, 2002, J DENT RES, V81, P776, DOI 10.1177/154405910208101111; Carinci F, 2006, ORAL DIS, V12, P329, DOI 10.1111/j.1601-0825.2005.01204.x; ELIAS JA, 1994, J IMMUNOL, V152, P2421; Garbers C, 2013, BIOL CHEM, V394, P1145, DOI 10.1515/hsz-2013-0166; Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]; Gruber R, 2014, J PERIODONTAL RES; Gruber R, 2013, CLIN ORAL INVESTIG; Gruber R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071046; Gunay H, 2008, INT J PERIODONT REST, V28, P497; Gupta J, 2011, CANCER BIOL THER, V11, P311, DOI 10.4161/cbt.11.3.14096; Heng NHM, 2007, J PERIODONTOL, V78, P2369, DOI 10.1902/jop.2007.070130; Henriques Paulo S G, 2010, J Oral Sci, V52, P463; Hong CC, 2009, CYTOKINE GROWTH F R, V20, P409, DOI 10.1016/j.cytogfr.2009.10.021; Jinno K, 2009, J DENT RES, V88, P757, DOI 10.1177/0022034509341798; Johnson DL, 2009, J PERIODONTOL, V80, P648, DOI 10.1902/jop.2009.070420; Johnson RB, 2004, J PERIODONTOL, V75, P37, DOI 10.1902/jop.2004.75.1.37; Kapferer I, 2011, J PERIODONTAL RES, V46, P118, DOI 10.1111/j.1600-0765.2010.01321.x; Kawamura I, 2012, J BIOL CHEM, V287, P29101, DOI 10.1074/jbc.M112.349415; Kawase T, 2002, J PERIODONTAL RES, V37, P255, DOI 10.1034/j.1600-0765.2002.01615.x; Kawase T, 2001, J PERIODONTAL RES, V36, P367, DOI 10.1034/j.1600-0765.2001.360604.x; Khedmat S, 2011, J PERIODONTAL RES, V46, P67, DOI 10.1111/j.1600-0765.2010.01313.x; Kim SS, 2013, J DENT RES, V92, P1022, DOI 10.1177/0022034513503659; Koop R, 2012, J PERIODONTOL, V83, P707, DOI 10.1902/jop.2011.110266; Lee YC, 2011, PULM PHARMACOL THER, V24, P23, DOI 10.1016/j.pupt.2010.10.016; Lees JD, 2013, ARCH ORAL BIOL, V58, P348, DOI 10.1016/j.archoralbio.2012.08.003; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Lyngstadaas SP, 2001, J CLIN PERIODONTOL, V28, P181, DOI 10.1034/j.1600-051x.2001.028002181.x; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; McCarthy TL, 2010, MOL ENDOCRINOL, V24, P587, DOI 10.1210/me.2009-0379; Mirastschijski U, 2004, WOUND REPAIR REGEN, V12, P100, DOI 10.1111/j.1524-475X.2004.tb00001.x; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mrozik KM, 2012, CLIN ORAL INVEST, V16, P867, DOI 10.1007/s00784-011-0558-3; Nokhbehsaim M, 2011, J PERIODONTAL RES, V46, P374, DOI 10.1111/j.1600-0765.2011.01357.x; Nokhbehsaim M, 2011, J PERIODONTOL, V82, P1725, DOI 10.1902/jop.2011.100678; Okubo K, 2003, J PERIODONTAL RES, V38, P1, DOI 10.1034/j.1600-0765.2003.01607.x; Parkar MH, 2004, J PERIODONTOL, V75, P1539, DOI 10.1902/jop.2004.75.11.1539; Peng J, 2014, CLIN IMPLANT DENT RE; Pollari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037361; Rasperini G, 2011, INT J PERIODONT REST, V31, P133; Remst DFG, 2014, CELL TISSUE RES, V355, P163, DOI 10.1007/s00441-013-1740-5; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Schedlich LJ, 2013, MOL CELL ENDOCRINOL, V377, P56, DOI 10.1016/j.mce.2013.06.033; Sculean A, 2011, CLIN ADV PERIODONTIC, V1, P101, DOI 10.1902/cap.2011.110047; Shaker OG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/174764; Song ZC, 2010, CELL PROLIFERAT, V43, P84, DOI 10.1111/j.1365-2184.2009.00656.x; Stout BM, 2014, J PERIODONTOL, V85, pE9, DOI 10.1902/jop.2013.130264; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Verardi Simone, 2012, J Evid Based Dent Pract, V12, P127, DOI 10.1016/S1532-3382(12)70024-6; Voloshenyuk TG, 2011, CYTOKINE, V55, P90, DOI 10.1016/j.cyto.2011.03.024; Wei J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013778; Weishaupt P, 2008, ORAL SURG ORAL MED O, V106, P304, DOI 10.1016/j.tripleo.2008.02.033; Yashiro R, 2006, J CLIN PERIODONTOL, V33, P165, DOI 10.1111/j.1600-051X.2006.00898.x; Yucel OO, 2008, J CLIN PERIODONTOL, V35, P365, DOI 10.1111/j.1600-051X.2008.01212.x; Zilm PS, 2011, J PERIODONTAL RES, V46, P111, DOI 10.1111/j.1600-0765.2010.01320.x	61	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e105672	10.1371/journal.pone.0105672	http://dx.doi.org/10.1371/journal.pone.0105672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197981	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700016
J	Martinez-Larrad, MT; Anchuelo, AC; Del Prado, N; Rueda, JMI; Gabriel, R; Serrano-Rios, M				Teresa Martinez-Larrad, Maria; Corbaton Anchuelo, Arturo; Del Prado, Nayade; Ibarra Rueda, Jose Maria; Gabriel, Rafael; Serrano-Rios, Manuel			Profile of Individuals Who Are Metabolically Healthy Obese Using Different Definition Criteria. A Population-Based Analysis in the Spanish Population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; NORMAL-WEIGHT; ALCOHOL-CONSUMPTION; INSULIN-RESISTANCE; PREVALENCE; RISK; ADIPONECTIN; PHENOTYPES; DETERMINANTS	Background: Obesity is associated with numerous metabolic complications such as diabetes mellitus type 2, dyslipidemia, hypertension, cardiovascular diseases and several forms of cancer. Our goal was to compare different criteria to define the metabolically healthy obese (MHO) with metabolically unhealthy obese (MUHO) subjects. We applied Wildman (W), Wildman modified (WM) with insulin resistance (IR) with cut-off point >= 3.8 and levels of C-Reactive Protein (CRP) >= 3 mg/l; and Consensus Societies (CS) criteria. In these subjects cardiovascular-risk (CV-risk) was estimated by Framingham score and SCORE for MHO and MUHO. Methods: A cross-sectional study was conducted in Spanish Caucasian adults. A total of 3,844 subjects completed the study, 45% males, aged 35-74 years. Anthropometric/biochemical variables were measured. Obesity was defined as BMI: >= 30 Kg/m(2). Results: The overall prevalence of obesity in our population was 27.5%, (23.7%/males and 30.2%/females). MHO prevalence according to W, WM, and CS definition criteria were: 9.65%, 16.29%, 39.94% respectively in obese participants. MHO has lower waist circumference (WC) measurements than MUHO. The estimated CV-risks by Framingham and SCORE Project charts were lower in MHO than MUHO subjects. WC showed high specificity and sensitivity in detecting high estimated CV risk by Framingham. However, WHR showed high specificity and sensitivity in detecting CV risk according to SCORE Project. MHO subjects as defined by any of the three criteria had higher adiponectin levels after adjustment by sex, age, WC, HOMA IR and Framingham or SCORE risks. This relationship was not found for CRP circulating levels neither leptin levels. Conclusions: MHO prevalence is highly dependent on the definition criteria used to define those individuals. Results showed that MHO subjects had less WC, and a lower estimated CV-risk than MUHO subjects. Additionally, the high adiponectin circulating levels in MHO may suggest a protective role against developing an unhealthy metabolic state.	[Teresa Martinez-Larrad, Maria; Corbaton Anchuelo, Arturo; Serrano-Rios, Manuel] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Teresa Martinez-Larrad, Maria; Corbaton Anchuelo, Arturo; Del Prado, Nayade; Ibarra Rueda, Jose Maria; Serrano-Rios, Manuel] Inst Invest Sanitaria Hosp Clin San Carlos IdiSSC, Madrid, Spain; [Gabriel, Rafael] Hosp La Paz, Clin Epidemiol Res Unit, Madrid, Spain	Hospital Universitario La Paz	Martinez-Larrad, MT (corresponding author), Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain.	mserrano.hcsc@salud.madrid.org	Serrano Ríos, Manuel/E-4625-2019; Corbatón-Anchuelo, Arturo/I-4390-2013	Serrano Ríos, Manuel/0000-0002-3214-1444; Corbatón-Anchuelo, Arturo/0000-0002-8775-4766	Fondo Europeo para el Desarrollo Regional [FEDER 2FD 1997/2309]; Red de Centros RCMN [C03/08]; Instituto de Salud Carlos III-RETIC, Madrid, Spain [FIS 03/1618, RD06/0015/0012]; Eli Lilly Lab, Spain; Bayer Pharmaceutical Co., Spain; Fundacion Mutua Madrilena, Spain	Fondo Europeo para el Desarrollo Regional; Red de Centros RCMN; Instituto de Salud Carlos III-RETIC, Madrid, Spain; Eli Lilly Lab, Spain(Eli Lilly); Bayer Pharmaceutical Co., Spain; Fundacion Mutua Madrilena, Spain	This work was supported by grants FEDER 2FD 1997/2309 from the Fondo Europeo para el Desarrollo Regional, Red de Centros RCMN (C03/08), FIS 03/1618, from Instituto de Salud Carlos III-RETIC RD06/0015/0012, Madrid, Spain. The authors also acknowledge CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion) and Madrid Autonomous Community (MOIR S2010/BMD-2423). Partial support also came from Educational Grants from Eli Lilly Lab, Spain, Bayer Pharmaceutical Co., Spain and Fundacion Mutua Madrilena 2008, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino Sr RB, 2008, CIRCULATION, V18, P499; Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Ascaso JF, 2001, MED CLIN-BARCELONA, V117, P530, DOI 10.1016/S0025-7753(01)72168-9; Basati G, 2011, CLINICS, V66, P1129, DOI 10.1590/S1807-59322011000700002; Bluher M, 2012, CURR OPIN ENDOCRINOL, V19, P341, DOI 10.1097/MED.0b013e328357f0a3; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Bray GA, 2003, ENDOCRIN METAB CLIN, V32, P787, DOI 10.1016/S0889-8529(03)00067-7; Buja A, 2010, EUR J CLIN NUTR, V64, P297, DOI 10.1038/ejcn.2009.136; Calori G, 2011, DIABETES CARE, V34, P210, DOI 10.2337/dc10-0665; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Flint AJ, 2010, OBESITY, V18, P377, DOI 10.1038/oby.2009.223; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Iacobellis G, 2005, OBES RES, V13, P1116, DOI 10.1038/oby.2005.130; Jennings CL, 2008, OBESITY, V16, P1602, DOI 10.1038/oby.2008.233; Juge-Aubry CE, 2005, BEST PRACT RES CL EN, V19, P547, DOI 10.1016/j.beem.2005.07.009; Koenig W, 2006, J AM COLL CARDIOL, V48, P1369, DOI 10.1016/j.jacc.2006.06.053; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280; Lopez-Garcia E, 2013, ATHEROSCLEROSIS, V231, P152, DOI 10.1016/j.atherosclerosis.2013.09.003; Lorenzo C, 2002, HYPERTENSION, V39, P203, DOI 10.1161/hy0202.103439; Marques-Vidal P, 2012, EUR J CLIN NUTR, V66, P426, DOI 10.1038/ejcn.2011.170; Martinez-Larrad MT, 2005, MED CLIN-BARCELONA, V125, P481; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ogorodnikova AD, 2012, OBESITY, V20, P651, DOI 10.1038/oby.2011.243; Pajunen P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-754; Pataky Z, 2010, INT J OBESITY, V34, pS18, DOI 10.1038/ijo.2010.235; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Shin MJ, 2006, INT J OBESITY, V30, P1529, DOI 10.1038/sj.ijo.0803304; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Soriguer F, 2013, J CLIN ENDOCR METAB, V98, P2318, DOI 10.1210/jc.2012-4253; Martinez-Larrad MT, 2011, AV DIABETOL, V27, P168, DOI 10.1016/j.avdiab.2011.09.003; Ukkola O, 2002, J MOL MED, V80, P696, DOI 10.1007/s00109-002-0378-7; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; World Health Organization, 1990, MONICA MAN; Yoon YS, 2004, AM J CLIN NUTR, V80, P217	43	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106641	10.1371/journal.pone.0106641	http://dx.doi.org/10.1371/journal.pone.0106641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198070	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700037
J	Wang, HX; Shi, H; Li, YY; Wang, YH				Wang, Huixia; Shi, Hui; Li, Yangyang; Wang, Yanhui			The Effects of Leaf Roughness, Surface Free Energy and Work of Adhesion on Leaf Water Drop Adhesion	PLOS ONE			English	Article							CONTACT ANGLES; WETTABILITY; REPELLENCY; RETENTION; PLANTS; LOTUS; SIZE	The adhesion of water droplets to leaves is important in controlling rainfall interception, and affects a variety of hydrological processes. Leaf water drop adhesion (hereinafter, adhesion) depends not only on droplet formulation and parameters but also on the physical (leaf roughness) and physico-chemical (surface free energy, its components, and work-of-adhesion) properties of the leaf surface. We selected 60 plant species from Shaanxi Province, NW China, as experimental materials with the goal of gaining insight into leaf physical and physico-chemical properties in relation to the adhesion of water droplets on leaves. Adhesion covered a wide range of area, from 4.09 to 88.87 g/m(2) on adaxial surfaces and 0.72 to 93.35 g/m(2) on abaxial surfaces. Distinct patterns of adhesion were observed among species, between adaxial and abaxial surfaces, and between leaves with wax films and wax crystals. Adhesion decreased as leaf roughness increased (r = -0.615, p = 0.000), but there were some outliers, such as Salix psammophila and Populus simonii with low roughness and low adhesion, and the abaxial surface of Hyoscyamus pusillus and the adaxial surface of Vitex negundo with high roughness and high adhesion. Meanwhile, adhesion was positively correlated with surface free energy (r = 0.535, p = 0.000), its dispersive component (r = 0.526, p = 0.000), and work of adhesion for water (r = 0.698, p = 0.000). However, a significant power correlation was observed between adhesion and the polar component of surface free energy (p = 0.000). These results indicated that leaf roughness, surface free energy, its components, and work-of-adhesion for water played important roles in hydrological characteristics, especially work-of-adhesion for water.	[Wang, Huixia; Wang, Yanhui] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Wang, Huixia; Shi, Hui] Xian Univ Architecture & Technol, Sch Environm & Municipal Engn, Xian, Peoples R China; [Li, Yangyang] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Xi'an University of Architecture & Technology; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Wang, YH (corresponding author), Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.	dasenlin-80@163.com			National Natural Science Foundation of China [41230852]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 41230852); http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens S, 2011, WATER AIR SOIL POLL, V219, P43, DOI 10.1007/s11270-010-0682-8; Aryal B, 2010, OECOLOGIA, V162, P1, DOI 10.1007/s00442-009-1437-3; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bhushan B, 2011, PROG MATER SCI, V56, P1, DOI 10.1016/j.pmatsci.2010.04.003; BOYCE RL, 1991, NEW PHYTOL, V117, P543, DOI 10.1111/j.1469-8137.1991.tb00959.x; Bradley DJ, 2003, AM J BOT, V90, P857, DOI 10.3732/ajb.90.6.857; Brewer CA, 1997, PLANT CELL ENVIRON, V20, P1, DOI 10.1046/j.1365-3040.1997.d01-15.x; BREWER CA, 1991, PLANT CELL ENVIRON, V14, P955, DOI 10.1111/j.1365-3040.1991.tb00965.x; Calder IR, 1996, J HYDROL, V185, P379, DOI 10.1016/0022-1694(95)02999-0; Fernandez V, 2014, PLANT PHYSL IN PRESS, DOI [10.1104/114.242040, DOI 10.1104/114.242040]; Fernandez V, 2014, PLANT SOIL, V384, P7, DOI 10.1007/s11104-014-2052-6; Fernandez V, 2011, PLANT PHYSIOL, V156, P2098, DOI 10.1104/pp.111.176305; FOWKES FM, 1962, J PHYS CHEM-US, V66, P382, DOI 10.1021/j100808a524; Gao JinHui, 2007, Journal of Beijing Forestry University, V29, P94; Gindl M, 2001, COLLOID SURFACE A, V181, P279, DOI 10.1016/S0927-7757(00)00795-0; HAINES BL, 1985, NEW PHYTOL, V99, P407, DOI 10.1111/j.1469-8137.1985.tb03668.x; Holder CD, 2007, J HYDROL, V336, P147, DOI 10.1016/j.jhydrol.2006.12.018; Holder CD, 2013, ECOHYDROLOGY, V6, P483, DOI 10.1002/eco.1278; HOLLOWAY P. J., 1970, Pesticide Science, V1, P156, DOI 10.1002/ps.2780010411; Khayet M, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-45; Knoll D, 1998, NEW PHYTOL, V140, P271, DOI 10.1046/j.1469-8137.1998.00269.x; Koch K, 2009, PROG MATER SCI, V54, P137, DOI 10.1016/j.pmatsci.2008.07.003; Massinon M, 2012, BIOSYST ENG, V112, P56, DOI 10.1016/j.biosystemseng.2012.02.005; MONSON RK, 1992, ENVIRON EXP BOT, V32, P319, DOI 10.1016/0098-8472(92)90044-3; Muller C, 2005, J CHEM ECOL, V31, P2621, DOI 10.1007/s10886-005-7617-7; Nairn JJ, 2011, PEST MANAG SCI, V67, P1562, DOI 10.1002/ps.2213; Nanko K, 2013, AGR FOREST METEOROL, V169, P74, DOI 10.1016/j.agrformet.2012.09.018; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Packham DE, 1996, INT J ADHES ADHES, V16, P121, DOI 10.1016/0143-7496(95)00034-8; Puente DWM, 2011, PEST MANAG SCI, V67, P798, DOI 10.1002/ps.2116; Raupach M., 1997, SCAM SOIL CANOPY ATM, P81; Saebo A, 2012, SCI TOTAL ENVIRON, V427, P347, DOI 10.1016/j.scitotenv.2012.03.084; Sikalo S, 2006, EXP THERM FLUID SCI, V31, P97, DOI 10.1016/j.expthermflusci.2006.03.028; Szechynska-Hebda M, 2013, PLANT PATHOL, V62, P867, DOI 10.1111/ppa.12001; Tanakamaru Shigemi, 1998, Journal of Agricultural Meteorology, V54, P155; Wagner P, 2003, J EXP BOT, V54, P1295, DOI 10.1093/jxb/erg127; Wohlfahrt G, 2006, J HYDROL, V319, P383, DOI 10.1016/j.jhydrol.2005.06.036; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]; Zorba V, 2008, ADV MATER, V20, P4049, DOI 10.1002/adma.200800651	40	51	54	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107062	10.1371/journal.pone.0107062	http://dx.doi.org/10.1371/journal.pone.0107062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198355	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700079
J	Martinez, AC; Hernandez, M; Novella, S; Martinez, MP; Pagan, RM; Hermenegildo, C; Garcia-Sacristan, A; Prieto, D; Benedito, S				Cristina Martinez, Ana; Hernandez, Medardo; Novella, Susana; Pilar Martinez, Maria; Maria Pagan, Rosa; Hermenegildo, Carlos; Garcia-Sacristan, Albino; Prieto, Dolores; Benedito, Sara			Diminished Neurogenic Femoral Artery Vasoconstrictor Response in a Zucker Obese Rat Model: Differential Regulation of NOS and COX Derivatives	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; PENILE ARTERIES; NORADRENERGIC VASOCONSTRICTION; CARDIOVASCULAR-SYSTEM; MESENTERIC-ARTERIES; INSULIN-RESISTANCE; METABOLIC SYNDROME; BLOOD-PRESSURE	Objective: Peripheral arterial disease is one of the macrovascular complications of type 2 diabetes mellitus. This study addresses femoral artery regulation in a prediabetic model of obese Zucker rats (OZR) by examining cross-talk between endothelial and neural factors. Methods and Results: Arterial preparations from lean (LZR) and OZR were subjected to electrical field stimulation (EFS) on basal tone. Nitric oxide synthase (NOS) and cyclooxygenase (COX) isoform expression patterns were determined by immunohistochemical labelling and Western blotting. Results indicate significantly reduced noradrenergic contractions in preparations from OZR compared with those of LZR. Functional inhibition of endothelial NOS (eNOS) indicated a predominant role of this isoform in LZR and its modified activity in OZR. Neural (nNOS) and inducible NOS (iNOS) were activated and their expression was higher in femoral arteries from OZR. Neurotransmission modulated by large-conductance Ca2+-activated (BKCa) or voltage-dependent (K-V) K+ channels did not seem compromised in the obese animals. Endothelial COX-1 and COX-2 were expressed in LZR and an additional adventitial location of COX-2 was also observed in OZR, explaining the higher COX-2 protein levels detected in this group. Prostanoids derived from both isoforms helped maintain vasoconstriction in LZR while in OZR only COX-2 was active. Superoxide anion inhibition reduced contractions in endothelium-intact arteries from OZR. Conclusions: Endothelial dysfunction led to reduced neurogenic vasoconstriction in femoral arteries from OZR. In a setting of obesity, NO-dependent nNOS and iNOS dilation activity could be an alternative mechanism to offset COX-2- and reactive oxygen species-mediated vasoconstriction, along with impaired endothelial NO relaxation.	[Cristina Martinez, Ana; Hernandez, Medardo; Maria Pagan, Rosa; Garcia-Sacristan, Albino; Prieto, Dolores; Benedito, Sara] Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain; [Novella, Susana; Hermenegildo, Carlos] Univ Valencia, Fac Med, Dept Fisiol, Valencia, Spain; [Pilar Martinez, Maria] Univ Complutense Madrid, Fac Vet, Dept Anat & Anat Patol Comparadas, Madrid, Spain	Complutense University of Madrid; University of Valencia; Complutense University of Madrid	Benedito, S (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain.	sbenedi@ucm.es	Hermenegildo, Carlos/C-5995-2008; Martínez, Ana Cristina/H-9795-2015; Pilar Martinez, P Martinez/E-8591-2016; BENEDITO, SARA/H-9730-2015; Novella, Susana/A-7406-2017; PRIETO, DOLORES/S-8172-2018	Martínez, Ana Cristina/0000-0002-2829-0914; Pilar Martinez, P Martinez/0000-0001-9063-3191; BENEDITO, SARA/0000-0001-9660-2409; Novella, Susana/0000-0001-8303-7252; PRIETO, DOLORES/0000-0001-7049-5991; Hermenegildo, Carlos/0000-0002-4015-2645	Ministerio de Economia y Competitividad (Spain) [SAF2009-10448, SAF 2012-31631]	Ministerio de Economia y Competitividad (Spain)	This study was supported by grant SAF2009-10448 and SAF 2012-31631 from Ministerio de Economia y Competitividad (Spain) (http://www.mineco.gob.es/). Authors who received the funding include DP (lead researcher), ACM and SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfranca A, 2006, CARDIOVASC RES, V70, P446, DOI 10.1016/j.cardiores.2005.12.020; Barton M, 2003, INT J BIOCHEM CELL B, V35, P826, DOI 10.1016/S1357-2725(02)00307-2; Blanco-Rivero J, 2011, BRIT J PHARMACOL, V162, P271, DOI 10.1111/j.1476-5381.2010.01030.x; Chadha PS, 2010, J PHARMACOL EXP THER, V335, P284, DOI 10.1124/jpet.110.167593; Cohen RA, 2010, J CARDIOVASC PHARM, V55, P308, DOI 10.1097/FJC.0b013e3181d89670; Contreras C, 2013, J SEX MED, V10, P2141, DOI 10.1111/jsm.12234; Contreras C, 2010, BRIT J PHARMACOL, V161, P350, DOI 10.1111/j.1476-5381.2010.00825.x; Martinez AC, 2009, J PHARMACOL SCI, V111, P299, DOI 10.1254/jphs.09135FP; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Erdos B, 2004, AM J PHYSIOL-REG I, V287, pR1456, DOI 10.1152/ajpregu.00279.2004; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Feletou M, 2011, BRIT J PHARMACOL, V164, P894, DOI 10.1111/j.1476-5381.2011.01276.x; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Hernanz R, 2014, CLIN SCI, V126, P111, DOI 10.1042/CS20120651; Hopfner RL, 1999, DIABETOLOGIA, V42, P1383, DOI 10.1007/s001250051308; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Icks A, 2009, EXP CLIN ENDOCR DIAB, V117, P500, DOI 10.1055/s-0029-1225333; Joseph BK, 2013, PHARMACOL RES, V70, P126, DOI 10.1016/j.phrs.2013.01.008; KASISKE BL, 1992, HYPERTENSION, V19, pI110, DOI 10.1161/01.HYP.19.1_Suppl.I110; Linton MF, 2004, CURR OPIN PHARMACOL, V4, P116, DOI 10.1016/j.coph.2003.12.003; Macarthur H, 2011, ACTA PHYSIOL, V203, P37, DOI 10.1111/j.1748-1716.2010.02242.x; Pagan RM, 2012, BIOCHEM PHARMACOL, V83, P882, DOI 10.1016/j.bcp.2011.12.038; Pagan RM, 2009, EUR J PHARMACOL, V616, P166, DOI 10.1016/j.ejphar.2009.06.002; Oltman CL, 2005, AM J PHYSIOL-ENDOC M, V289, pE113, DOI 10.1152/ajpendo.00594.2004; Pannirselvam M, 2005, BRIT J PHARMACOL, V144, P953, DOI 10.1038/sj.bjp.0706121; Sanchez A, 2010, BRIT J PHARMACOL, V159, P604, DOI 10.1111/j.1476-5381.2009.00553.x; Sanchez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036027; Sanchez A, 2010, ATHEROSCLEROSIS, V213, P392, DOI 10.1016/j.atherosclerosis.2010.09.022; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Shi Y, 2008, BRIT J PHARMACOL, V154, P639, DOI 10.1038/bjp.2008.110; Soskic SS, 2011, OPEN CARDIOVASC MED, V5, P153, DOI 10.2174/1874192401105010153; Straznicky NE, 2008, CURR HYPERTENS REP, V10, P440, DOI 10.1007/s11906-008-0083-1; Subramanian R, 2003, EUR J PHARMACOL, V477, P143, DOI 10.1016/j.ejphar.2003.08.003; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Tsutsui Masato, 2004, J Atheroscler Thromb, V11, P41; Tsutsui M, 2010, PHARMACOL THERAPEUT, V128, P499, DOI 10.1016/j.pharmthera.2010.08.010; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Velkoska E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1236, DOI 10.1152/ajpendo.00505.2004; Villalba N, 2009, AM J PHYSIOL-HEART C, V297, pH696, DOI 10.1152/ajpheart.01308.2008; Weil BR, 2011, AM J PHYSIOL-HEART C, V301, pH689, DOI 10.1152/ajpheart.00206.2011; Wise H, 2002, NEUROSIGNALS, V11, P20, DOI 10.1159/000057318; Wu SQ, 2000, CARDIOVASC RES, V45, P994, DOI 10.1016/S0008-6363(99)00417-4; Zacharia J, 2004, BRIT J PHARMACOL, V141, P915, DOI 10.1038/sj.bjp.0705690	45	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106372	10.1371/journal.pone.0106372	http://dx.doi.org/10.1371/journal.pone.0106372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216050	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300010
J	Jia, J; Zhang, W; Wang, J; Wang, PL; Zhu, RH				Jia, Jing; Zhang, Wei; Wang, Jing; Wang, Peilong; Zhu, Ruohua			Selectively Adsorptive Extraction of Phenylarsonic Acids in Chicken Tissue by Carboxymethyl alpha-Cyclodextrin Immobilized Fe3O4 Magnetic Nanoparticles Followed Ultra Performance Liquid Chromatography Coupled Tandem Mass Spectrometry Detection	PLOS ONE			English	Article							BETA-CYCLODEXTRIN; ARSENIC SPECIATION; ARSANILIC ACID; ROXARSONE; REMOVAL; WATER; RESIN; ADSORBENTS; SAMPLES; LIVER	Carboxymethyl alpha-cyclodextrin immobilized Fe3O4 magnetic nanoparticles (CM-alpha-CD-Fe3O4) were synthesized for the selectively adsorptive extraction of five phenylarsonic acids including p-amino phenylarsonic acid, p-nitro phenylarsonic acid, p-hydroxy phenylarsonic acid, p-acylamino phenylarsonic acid and p-hydroxy-3-nitro phenylarsonic acid in chicken tissue. Using ultra performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS), a highly sensitive analytical method was proposed for the determination of five phenylarsonic acids. It was shown that CM-alpha-CDFe3O4 could extract the five phenylarsonic acids in complex chicken tissue samples with high extraction efficiency. Under the optimal conditions, a high enrichment factor, ranging from 349 to 606 fold, was obtained. The limits of detection (LODs) (at a signal-to-noise ratio of 3) were in the range of 0.05-0.11 mu g/kg for the five phenylarsonic acids. The proposed method was applied for the determination of five target phenylarsonic acids in chicken muscle and liver samples. Recoveries for the spiked samples with 0.2 mu g/kg, 2.0 mu g/kg and 20 mu g/kg of each phenylarsonic acids were in the range of 77.2%-110.2%, with a relative standard deviation (RSD) of less than 12.5%.	[Zhang, Wei; Wang, Jing; Wang, Peilong; Zhu, Ruohua] Minist Agr, Key Lab Agrifood Safety & Qual, Beijing, Peoples R China; [Jia, Jing; Zhu, Ruohua] Capital Normal Univ, Dept Chem, Beijing, Peoples R China; [Zhang, Wei; Wang, Jing; Wang, Peilong] China Agr Acad Sci, Inst Qual Stand & Testing Technol Agr Prod, Beijing, Peoples R China	Ministry of Agriculture & Rural Affairs; Capital Normal University; Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Wang, PL (corresponding author), Minist Agr, Key Lab Agrifood Safety & Qual, Beijing, Peoples R China.	wplcon99@163.com; zhurh@mail.cnu.edu.cn	Wang, Peilong/R-4412-2016	Wang, Peilong/0000-0003-1585-2727	NSFC [31201832]; Special Fund for Agro-scientific Research in the Public Interest [201203094]; National International cooperation program [2012DFA31140]	NSFC(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National International cooperation program	The authors would like to thank the NSFC (No. 31201832), Special Fund for Agro-scientific Research in the Public Interest (No. 201203094), and National International cooperation program (No. 2012DFA31140) for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin I, 2012, J HAZARD MATER, V235, P62, DOI [10.1016/j.jhazmat2012.06.024, 10.1016/j.jhazmat.2012.06.024]; Atia AA, 2008, SEP PURIF TECHNOL, V61, P348, DOI 10.1016/j.seppur.2007.11.008; Atia AA, 2007, SEP SCI TECHNOL, V42, P403, DOI 10.1080/01496390601069978; Badruddoza AZM, 2011, J HAZARD MATER, V185, P1177, DOI 10.1016/j.jhazmat.2010.10.029; Badruddoza AZM, 2010, COLLOID SURFACE A, V367, P85, DOI 10.1016/j.colsurfa.2010.06.018; Badruddoza AZM, 2010, J COLLOID INTERF SCI, V346, P337, DOI 10.1016/j.jcis.2010.03.004; Bartel M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/373141; Bednar AJ, 2004, WATER RES, V38, P355, DOI 10.1016/j.watres.2003.09.034; CHEN SL, 1995, BIOL TRACE ELEM RES, V48, P263, DOI 10.1007/BF02789408; Chen WR, 2012, J HAZARD MATER, V227, P378, DOI 10.1016/j.jhazmat.2012.05.078; Chiou PWS, 1997, J SCI FOOD AGR, V74, P229, DOI 10.1002/(SICI)1097-0010(199706)74:2&lt;229::AID-JSFA793&gt;3.0.CO;2-F; Conklin SD, 2012, J AGR FOOD CHEM, V60, P9394, DOI 10.1021/jf302366a; FDA, 2011, STUD 275 30 ARS SPEC; Jaafar J., 2001, TEKNOL, V35, P71, DOI [10.11113/jt.v35.604, DOI 10.11113/JT.V35.604]; Zhi JG, 2008, J COLLOID INTERF SCI, V319, P270, DOI 10.1016/j.jcis.2007.11.031; Kan XW, 2010, J PHYS CHEM B, V114, P3999, DOI 10.1021/jp910060c; Krachler M, 1996, FRESEN J ANAL CHEM, V355, P120; Kuehnelt D., 2003, ORGANOMET COMPD ENV, P223; Li PJ, 2011, J CHROMATOGR A, V1218, P4779, DOI 10.1016/j.chroma.2011.05.058; Li RX, 2011, CHINESE CHEM LETT, V22, P217, DOI 10.1016/j.cclet.2010.09.014; Liu JJ, 2008, J ENVIRON MONITOR, V10, P975, DOI 10.1039/b803210f; Liu ZG, 2010, CHEM ENG J, V160, P57, DOI 10.1016/j.cej.2010.03.003; Ma MS, 2000, J ANAL SCI, V16, P89; Mao XJ, 2011, J CHROMATOGR A, V1218, P1, DOI 10.1016/j.chroma.2010.10.103; Mayo JT, 2007, SCI TECHNOL ADV MAT, V8, P71, DOI 10.1016/j.stam.2006.10.005; Mohan D, 2007, J HAZARD MATER, V142, P1, DOI 10.1016/j.jhazmat.2007.01.006; Pergantis SA, 1997, J ANAL ATOM SPECTROM, V12, P531, DOI 10.1039/a606416g; Roerdink AR, 2004, J CHROMATOGR A, V1057, P177, DOI 10.1016/j.chroma.2004.09.071; Rosal CG, 2005, ELECTROPHORESIS, V26, P1606, DOI 10.1002/elps.200406198; Samanta G, 1999, MICROCHEM J, V62, P174, DOI 10.1006/mchj.1999.1713; Thirunavukkarasu O., 2002, URBAN WATER, P415, DOI [10.1016/S1462-0758(02)00029-8, DOI 10.1016/S1462-0758(02)00029-8]; Wang PL, 2010, J AGR FOOD CHEM, V58, P5263, DOI 10.1021/jf1001205; Wu W, 2008, NANOSCALE RES LETT, V3, P397, DOI 10.1007/s11671-008-9174-9; Wu YP, 2009, NANOSCALE RES LETT, V4, P738, DOI 10.1007/s11671-009-9314-x; Zhang CC, 2001, J APPL POLYM SCI, V82, P1587, DOI 10.1002/app.1997	35	5	6	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107147	10.1371/journal.pone.0107147	http://dx.doi.org/10.1371/journal.pone.0107147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215503	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300046
J	Mizunami, M; Nemoto, Y; Terao, K; Hamanaka, Y; Matsumoto, Y				Mizunami, Makoto; Nemoto, Yuko; Terao, Kanta; Hamanaka, Yoshitaka; Matsumoto, Yukihisa			Roles of Calcium/Calmodulin-Dependent Kinase II in Long-Term Memory Formation in Crickets	PLOS ONE			English	Article							PROTEIN-KINASE; ADENYLYL-CYCLASE; MUSHROOM BODIES; DEVELOPMENTAL-CHANGES; OLFACTORY MEMORY; CAMKII FUNCTION; CALMODULIN; NEURONS; HONEYBEE; INHIBITION	Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) is a key molecule in many systems of learning and memory in vertebrates, but roles of CaMKII in invertebrates have not been characterized in detail. We have suggested that serial activation of NO/cGMP signaling, cyclic nucleotide-gated channel, Ca2+/CaM and cAMP signaling participates in long-term memory (LTM) formation in olfactory conditioning in crickets, and here we show participation of CaMKII in LTM formation and propose its site of action in the biochemical cascades. Crickets subjected to 3-trial conditioning to associate an odor with reward exhibited memory that lasts for a few days, which is characterized as protein synthesis-dependent LTM. In contrast, animals subjected to 1-trial conditioning exhibited memory that lasts for only several hours (mid-term memory, MTM). Injection of a CaMKII inhibitor prior to 3-trial conditioning impaired 1-day memory retention but not 1-hour memory retention, suggesting that CaMKII participates in LTM formation but not in MTM formation. Animals injected with a cGMP analogue, calcium ionophore or cAMP analogue prior to 1-trial conditioning exhibited 1-day retention, and co-injection of a CaMKII inhibitor impaired induction of LTM by the cGMP analogue or that by the calcium ionophore but not that by the cAMP analogue, suggesting that CaMKII is downstream of cGMP production and Ca2+ influx and upstream of cAMP production in biochemical cascades for LTM formation. Animals injected with an adenylyl cyclase (AC) activator prior to 1-trial conditioning exhibited 1-day retention. Interestingly, a CaMKII inhibitor impaired LTM induction by the AC activator, although AC is expected to be a downstream target of CaMKII. The results suggest that CaMKII interacts with AC to facilitate cAMP production for LTM formation. We propose that CaMKII serves as a key molecule for interplay between Ca2+ signaling and cAMP signaling for LTM formation, a new role of CaMKII in learning and memory.	[Mizunami, Makoto; Hamanaka, Yoshitaka; Matsumoto, Yukihisa] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 060, Japan; [Nemoto, Yuko] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Terao, Kanta] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Matsumoto, Yukihisa] Tokyo Med & Dent Univ, Fac Liberal Arts, Ichikawa, Japan	Hokkaido University; Tohoku University; Hokkaido University; Tokyo Medical & Dental University (TMDU)	Mizunami, M (corresponding author), Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 060, Japan.	mizunami@sci.hokudai.ac.jp		Mizunami, Makoto/0000-0003-4168-2610; TERAO, Kanta/0000-0002-2037-2464	Ministry of Education, Science, Culture, Sports and Technology of Japan	Ministry of Education, Science, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in Aid for Scientific Research, The Ministry of Education, Science, Culture, Sports and Technology of Japan. The websiteis:http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Antonov I, 2010, J NEUROSCI, V30, P5781, DOI 10.1523/JNEUROSCI.4947-09.2010; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Balfanz S, 2012, INSECT BIOCHEM MOLEC, V42, P435, DOI 10.1016/j.ibmb.2012.02.005; Burkert P, 2006, EUR J NEUROSCI, V23, P335, DOI 10.1111/j.1460-9568.2005.04562.x; Cann MJ, 2002, METHOD ENZYMOL, V345, P150; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; Chen CC, 2012, SCIENCE, V335, P678, DOI 10.1126/science.1212735; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Gunosewoyo H, 2007, CURR MED CHEM, V14, P1505, DOI 10.2174/092986707780831023; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kamikouchi A, 2000, J COMP NEUROL, V417, P501, DOI 10.1002/(SICI)1096-9861(20000221)417:4&lt;501::AID-CNE8&gt;3.0.CO;2-4; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Lent DD, 2007, DEV NEUROBIOL, V67, P740, DOI 10.1002/dneu.20374; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Luk CC, 2011, EUR J NEUROSCI, V34, P569, DOI 10.1111/j.1460-9568.2011.07784.x; Malik BR, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00052; Matsumoto CS, 2013, NEUROSCI LETT, V541, P4, DOI 10.1016/j.neulet.2013.01.010; Matsumoto Y, 2003, ZOOL SCI, V20, P409, DOI 10.2108/zsj.20.409; Matsumoto Y, 2002, J EXP BIOL, V205, P1429; Matsumoto Y, 2006, LEARN MEMORY, V13, P35, DOI 10.1101/lm.130506; Matsumoto Y, 2014, LEARN MEMORY, V21, P272, DOI 10.1101/lm.032037.113; Matsumoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068538; Matsumoto Y, 2009, NEUROSCI LETT, V467, P81, DOI 10.1016/j.neulet.2009.10.008; Mehren JE, 2004, J NEUROSCI, V24, P10584, DOI 10.1523/JNEUROSCI.3560-04.2004; Mehren JE, 2006, LEARN MEMORY, V13, P686, DOI 10.1101/lm.317806; Mizunami M, 2013, HBK BEHAV NEUROSCI, V22, P549, DOI 10.1016/B978-0-12-415823-8.00041-1; Mizunami M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-46; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Pasch E, 2011, J COMP NEUROL, V519, P3700, DOI 10.1002/cne.22683; Shanavas A, 1998, J NEUROCHEM, V70, P1644; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Takahashi T, 2009, J NEUROSCI METH, V179, P9, DOI 10.1016/j.jneumeth.2009.01.002; Takamatsu Y, 2003, BRAIN RES, V974, P99, DOI 10.1016/S0006-8993(03)02562-9; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Wan HM, 2010, J NEUROSCI, V30, P56, DOI 10.1523/JNEUROSCI.2577-09.2010; Wei J, 1996, J BIOL CHEM, V271, P24231, DOI 10.1074/jbc.271.39.24231; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	48	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107442	10.1371/journal.pone.0107442	http://dx.doi.org/10.1371/journal.pone.0107442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215889	Green Published, gold			2022-12-27	WOS:000341774300065
J	Murakami, Y; Tanahashi, T; Okada, R; Toyoda, H; Kumada, T; Enomoto, M; Tamori, A; Kawada, N; Taguchi, YH; Azuma, T				Murakami, Yoshiki; Tanahashi, Toshihito; Okada, Rina; Toyoda, Hidenori; Kumada, Takashi; Enomoto, Masaru; Tamori, Akihiro; Kawada, Norifumi; Taguchi, Y-h; Azuma, Takeshi			Comparison of Hepatocellular Carcinoma miRNA Expression Profiling as Evaluated by Next Generation Sequencing and Microarray	PLOS ONE			English	Article							SUPPRESSES CELL-PROLIFERATION; MICRORNA EXPRESSION; LIVER; DEEP; RNAS; EPIDEMIOLOGY; PROGNOSIS; PATTERNS; GENOMICS; REVEALS	MicroRNA (miRNA) expression profiling has proven useful in diagnosing and understanding the development and progression of several diseases. Microarray is the standard method for analyzing miRNA expression profiles; however, it has several disadvantages, including its limited detection of miRNAs. In recent years, advances in genome sequencing have led to the development of next-generation sequencing (NGS) technologies, which significantly advance genome sequencing speed and discovery. In this study, we compared the expression profiles obtained by next generation sequencing (NGS) with the profiles created using microarray to assess if NGS could produce a more accurate and complete miRNA profile. Total RNA from 14 hepatocellular carcinoma tumors (HCC) and 6 matched non-tumor control tissues were sequenced with Illumina MiSeq 50-bp single-end reads. Micro RNA expression profiles were estimated using miRDeep2 software. As a comparison, miRNA expression profiles for 11 out of 14 HCCs were also established by microarray (Agilent human microRNA microarray). The average total sequencing exceeded 2.2 million reads per sample and of those reads, approximately 57% mapped to the human genome. The average correlation for miRNA expression between microarray and NGS and subtraction were 0.613 and 0.587, respectively, while miRNA expression between technical replicates was 0.976. The diagnostic accuracy of HCC, p-value, and AUC were 90.0%, 7.22x10(-4), and 0.92, respectively. In summary, NGS created an miRNA expression profile that was reproducible and comparable to that produced by microarray. Moreover, NGS discovered novel miRNAs that were otherwise undetectable by microarray. We believe that miRNA expression profiling by NGS can be a useful diagnostic tool applicable to multiple fields of medicine.	[Murakami, Yoshiki; Enomoto, Masaru; Tamori, Akihiro; Kawada, Norifumi] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan; [Tanahashi, Toshihito] Kobe Pharmaceut Univ, Dept Med Pharmaceut, Kobe, Hyogo 658, Japan; [Tanahashi, Toshihito; Okada, Rina; Azuma, Takeshi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan; [Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan; [Taguchi, Y-h] Chuo Univ, Dept Phys, Tokyo 112, Japan	Osaka Metropolitan University; Kobe Pharmaceutical University; Kobe University; Ogaki Municipal Hospital; Chuo University	Murakami, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan.	m2079633@med.osaka-cu.ac.jp	kawada, norifumi/AAS-1367-2020; ENOMOTO, Masaru/I-3864-2019; Taguchi, Y-h./E-1474-2011	ENOMOTO, Masaru/0000-0002-4028-4381; Taguchi, Y-h./0000-0003-0867-8986; Tanahashi, Toshihito/0000-0002-9308-210X				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bjork JK, 2010, DEVELOPMENT, V137, P3177, DOI 10.1242/dev.050955; Braconi C, 2008, HEPATOLOGY, V47, P1807, DOI 10.1002/hep.22326; Burroughs AM, 2012, NUCLEIC ACIDS RES, V40, P1424, DOI 10.1093/nar/gkr903; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Law PTY, 2013, J HEPATOL, V58, P1165, DOI 10.1016/j.jhep.2013.01.032; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; McCormick Kevin P, 2011, Silence, V2, P2, DOI 10.1186/1758-907X-2-2; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Murakami Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-99; Murakami Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048366; Taguchi YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066714; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wittmann J, 2010, THESCIENTIFICWORLDJO, V10, P1239, DOI 10.1100/tsw.2010.101; Xu J, 2012, LIVER INT, V32, P752, DOI 10.1111/j.1478-3231.2011.02750.x; Yan Y, 2013, HEPATOLOGY, V57, P667, DOI 10.1002/hep.26071; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895	29	60	63	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106314	10.1371/journal.pone.0106314	http://dx.doi.org/10.1371/journal.pone.0106314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215888	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300009
J	Yue, X; Gao, XQ; Wang, F; Dong, YX; Li, XG; Zhang, XS				Yue, Xun; Gao, Xin-Qi; Wang, Fang; Dong, YuXiu; Li, XingGuo; Zhang, Xian Sheng			Transcriptional Evidence for Inferred Pattern of Pollen Tube-Stigma Metabolic Coupling during Pollination	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; GENE-EXPRESSION; ARABIDOPSIS POLLEN; PETUNIA-HYBRIDA; ETHANOLIC FERMENTATION; BIOLOGICAL NETWORKS; PISTIL INTERACTIONS; PLANT-METABOLISM; MALE GAMETOPHYTE; TOBACCO POLLEN	It is difficult to derive all qualitative proteomic and metabolomic experimental data in male (pollen tube) and female (pistil) reproductive tissues during pollination because of the limited sensitivity of current technology. In this study, genome-scale enzyme correlation network models for plants (Arabidopsis/maize) were constructed by analyzing the enzymes and metabolic routes from a global perspective. Then, we developed a data-driven computational pipeline using the "guilt by association" principle to analyze the transcriptional coexpression profiles of enzymatic genes in the consecutive steps for metabolic routes in the fast-growing pollen tube and stigma during pollination. The analysis identified an inferred pattern of pollen tube-stigma ethanol coupling. When the pollen tube elongates in the transmitting tissue (TT) of the pistil, this elongation triggers the mobilization of energy from glycolysis in the TT cells of the pistil. Energy-rich metabolites (ethanol) are secreted that can be taken up by the pollen tube, where these metabolites are incorporated into the pollen tube's tricarboxylic acid (TCA) cycle, which leads to enhanced ATP production for facilitating pollen tube growth. In addition, our analysis also provided evidence for the cooperation of kaempferol, dTDP-alpha-L-rhamnose and cell-wall-related proteins; phosphatidic-acid-mediated Ca2+ oscillations and cytoskeleton; and glutamate degradation IV for gamma-aminobutyric acid (GABA) signaling activation in Arabidopsis and maize stigmas to provide the signals and materials required for pollen tube tip growth. In particular, the "guilt by association" computational pipeline and the genome-scale enzyme correlation network models (GECN) developed in this study was initiated with experimental "omics" data, followed by data analysis and data integration to determine correlations, and could provide a new platform to assist inachieving a deeper understanding of the co-regulation and inter-regulation model in plant research.	[Yue, Xun] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Yue, Xun; Gao, Xin-Qi; Wang, Fang; Dong, YuXiu; Li, XingGuo; Zhang, Xian Sheng] Shandong Agr Univ, Coll Informat Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Yue, X (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	yuexun@sdau.edu.cn	zhang, xian/GYA-0290-2022; Gao, Xin-Qi/AAM-4887-2021	gao, xin qi/0000-0002-2530-7776	National Major Program of Transgenic Research in China [2013CB945100]; National Natural Science Foundation, China [31171475, 31170293]; State Key Laboratory of Crop Science, China [2013KF15]	National Major Program of Transgenic Research in China; National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Crop Science, China	This study was supported by the National Major Program of Transgenic Research in China (Grant No. 2013CB945100), the National Natural Science Foundation, China (Grant Nos. 31171475 and 31170293), and the State Key Laboratory of Crop Science, China (Grant No. 2013KF15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Boavida LC, 2011, PLANT PHYSIOL, V155, P2066, DOI 10.1104/pp.110.169813; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Chalivendra SC, 2013, J EXP BOT, V64, P265, DOI 10.1093/jxb/ers324; Chapman LA, 2011, SEX PLANT REPROD, V24, P319, DOI 10.1007/s00497-011-0172-1; Colaco R, 2012, J MICROSC-OXFORD, V247, P106, DOI 10.1111/j.1365-2818.2012.03628.x; Coronas S, 2007, BIOCHEM SOC SYMP, V74, P117, DOI 10.1042/BSS2007c11; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Crawford BCW, 2008, CURR BIOL, V18, pR972, DOI 10.1016/j.cub.2008.08.010; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; Dal'Molin CGD, 2010, PLANT PHYSIOL, V154, P1871, DOI 10.1104/pp.110.166488; Diet A, 2006, PLANT CELL, V18, P1630, DOI 10.1105/tpc.105.038653; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Dresselhaus T, 2011, ANN BOT-LONDON, V108, P727, DOI 10.1093/aob/mcr017; ELLEMAN CJ, 1992, NEW PHYTOL, V121, P413, DOI 10.1111/j.1469-8137.1992.tb02941.x; Gao X. Q., 2010, FRONT BIOL, V5, P156, DOI [10.1007/s11515-010-0024-7, DOI 10.1007/S11515-010-0024-7]; Gass N, 2005, PLANT CELL, V17, P2355, DOI 10.1105/tpc.105.033290; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Han B, 2010, J INTEGR PLANT BIOL, V52, P1043, DOI 10.1111/j.1744-7909.2010.00996.x; Helling D, 2006, PLANT CELL, V18, P3519, DOI 10.1105/tpc.106.047373; Higashiyama T, 2008, SEX PLANT REPROD, V21, P17, DOI 10.1007/s00497-007-0064-6; Higashiyama T, 2010, PLANT CELL PHYSIOL, V51, P177, DOI 10.1093/pcp/pcq008; Hill K, 2013, PLANT PHYSIOL, V163, P1487, DOI 10.1104/pp.113.227215; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Ischebeck T, 2008, PLANT CELL, V20, P3312, DOI 10.1105/tpc.108.059568; Jensen PA, 2011, BIOINFORMATICS, V27, P541, DOI 10.1093/bioinformatics/btq702; Kerhoas L, 2006, J AGR FOOD CHEM, V54, P6603, DOI 10.1021/jf061043n; KOOIJMAN EE, 2010, PLANT LIPID SIGNALIN; LABARCA C, 1973, PLANT PHYSIOL, V52, P87, DOI 10.1104/pp.52.2.87; Lee JY, 2003, PLANT PHYSIOL, V132, P517, DOI 10.1104/pp.103.020511; Lee Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002769; Li MN, 2007, PLANT PHYSIOL, V144, P1797, DOI 10.1104/pp.107.101600; Ling Y, 2013, PLANTA, V238, P831, DOI 10.1007/s00425-013-1938-5; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Magistretti PJ, 2011, EXP PHYSIOL, V96, P407, DOI 10.1113/expphysiol.2010.053157; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Mellema S, 2002, PLANT J, V30, P329, DOI 10.1046/j.1365-313X.2002.01293.x; Miller KD, 1999, J BIOL CHEM, V274, P34011, DOI 10.1074/jbc.274.48.34011; Mintz-Oron S, 2012, P NATL ACAD SCI USA, V109, P339, DOI 10.1073/pnas.1100358109; MO YY, 1992, P NATL ACAD SCI USA, V89, P7213, DOI 10.1073/pnas.89.15.7213; Monteiro D, 2005, J EXP BOT, V56, P1665, DOI 10.1093/jxb/eri163; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; Obermeyer G, 2013, PLANT PHYSIOL, V162, P1822, DOI 10.1104/pp.113.219857; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; OKELLEY JC, 1955, AM J BOT, V42, P322, DOI 10.2307/2438569; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Pleskot R, 2012, FRONT PLANT SCI, V19, P3; Poolman MG, 2009, PLANT PHYSIOL, V151, P1570, DOI 10.1104/pp.109.141267; Potocky M, 2003, PLANTA, V217, P122, DOI 10.1007/s00425-002-0965-4; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Saha R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021784; Sebastian S, 2012, ARABIDOPSIS BOOK, V10, pe0160; Sivitz AB, 2008, PLANT PHYSIOL, V147, P92, DOI 10.1104/pp.108.118992; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sousa E, 2008, PLANT CELL, V20, P3050, DOI 10.1105/tpc.108.058826; Stitt M, 2013, CURR OPIN PLANT BIOL, V16, P381, DOI 10.1016/j.pbi.2013.02.012; Swanson R, 2005, SEX PLANT REPROD, V18, P163, DOI 10.1007/s00497-005-0009-x; Swanson R, 2004, ANNU REV GENET, V38, P793, DOI 10.1146/annurev.genet.38.072902.092356; Tadege M, 1999, TRENDS PLANT SCI, V4, P320, DOI 10.1016/S1360-1385(99)01450-8; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; TAYLOR LP, 1992, J HERED, V83, P11, DOI 10.1093/oxfordjournals.jhered.a111149; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Tung CW, 2005, PLANT PHYSIOL, V138, P977, DOI 10.1104/pp.105.060558; Veit M, 1999, J NAT PROD, V62, P1301, DOI 10.1021/np990080o; VOGT T, 1995, PHYTOCHEMISTRY, V38, P589, DOI 10.1016/0031-9422(94)00703-V; Wang JF, 2009, PLANT PHYSIOL BIOCH, V47, P86, DOI 10.1016/j.plaphy.2008.10.011; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Wen WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4438; Xu P, 1997, PLANTA, V202, P257, DOI 10.1007/s004250050127; Xu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053545; Xue HW, 2009, BIOCHEM J, V421, P145, DOI 10.1042/BJ20090300; YLSTRA B, 1994, PLANT J, V6, P201, DOI 10.1046/j.1365-313X.1994.6020201.x; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040	78	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107046	10.1371/journal.pone.0107046	http://dx.doi.org/10.1371/journal.pone.0107046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215523	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300039
J	Ishizuya-Oka, A; Kajita, M; Hasebe, T				Ishizuya-Oka, Atsuko; Kajita, Mitsuko; Hasebe, Takashi			Thyroid Hormone-Regulated Wnt5a/Ror2 Signaling Is Essential for Dedifferentiation of Larval Epithelial Cells into Adult Stem Cells in the Xenopus laevis Intestine	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; AMPHIBIAN METAMORPHOSIS; PROGENITOR CELLS; GELATINASE-A; EXPRESSION; MOUSE; PROTEIN; GENES; MUSASHI-1; PATHWAY	Background and Aims: Amphibian intestinal remodeling, where thyroid hormone (T3) induces some larval epithelial cells to become adult stem cells analogous to the mammalian intestinal ones, serves as a unique model for studying how the adult stem cells are formed. To clarify its molecular mechanisms, we here investigated roles of non-canonical Wnt signaling in the larval-to-adult intestinal remodeling during Xenopus laevis metamorphosis. Methods/Findings: Our quantitative RT-PCR (qRT-PCR) and immunohistochemical analyses indicated that the expressions of Wnt5a and its receptors, frizzled 2 (Fzd2) and receptor tyrosine kinase-like orphan receptor 2 (Ror2) are up-regulated by T3 and are spatiotemporally correlated with adult epithelial development in the X. laevis intestine. Notably, changes in morphology of larval absorptive epithelial cells expressing Ror2 coincide well with formation of the adult stem cells during metamorphosis. In addition, by using organ cultures of the tadpole intestine, we have experimentally shown that addition of exogenous Wnt5a protein to the culture medium causes morphological changes in the larval epithelium expressing Ror2 even in the absence of T3. In contrast, in the presence of T3 where the adult stem cells are formed in vitro, inhibition of endogenous Wnt5a by an anti-Wnt5a antibody suppressed the epithelial morphological changes, leading to the failure of stem cell formation. Significance: Our findings strongly suggest that the adult stem cells originate from the larval absorptive cells expressing Ror2, which require Wnt5a/Ror2 signaling for their dedifferentiation accompanied by changes in cell morphology.	[Ishizuya-Oka, Atsuko; Hasebe, Takashi] Nippon Med Sch, Dept Biol, Musashino, Tokyo, Japan; [Kajita, Mitsuko] Nippon Med Sch, Inst Dev & Aging Sci, Kawasaki, Kanagawa, Japan	Nippon Medical School; Nippon Medical School	Ishizuya-Oka, A (corresponding author), Nippon Med Sch, Dept Biol, Kyonan Cho, Musashino, Tokyo, Japan.	a-oka@nms.ac.jp		Hasebe, Takashi/0000-0001-7200-8173	Japan Society for the Promotion of Science [24570078]; Grants-in-Aid for Scientific Research [25440160] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (C) (No. 24570078 to AI-O) http://www.jsps.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgeier SH, 2008, DEV BIOL, V324, P10, DOI 10.1016/j.ydbio.2008.08.018; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Buchholz DR, 2007, DEV BIOL, V303, P576, DOI 10.1016/j.ydbio.2006.11.037; CHENG H, 1985, ANAT REC, V211, P420, DOI 10.1002/ar.1092110408; Cheung R, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00058; Das B, 2009, J BIOL CHEM, V284, P34167, DOI 10.1074/jbc.M109.066084; Dodd M.H.I., 1976, P467; EDWARDS DR, 1992, EMBO J, V11, P2415, DOI 10.1002/j.1460-2075.1992.tb05306.x; Ford CE, 2013, INT J CANCER, V133, P779, DOI 10.1002/ijc.27984; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Harper J, 2011, P NATL ACAD SCI USA, V108, P10585, DOI 10.1073/pnas.1105852108; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Hasebe T, 2008, DEV DYNAM, V237, P3006, DOI 10.1002/dvdy.21698; Hasebe T, 2007, MECH DEVELOP, V124, P11, DOI 10.1016/j.mod.2006.09.001; Hasebe T, 2011, STEM CELLS, V29, P154, DOI 10.1002/stem.560; Heimeier RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r55; Hourdry J., 1977, INT REV CYTOL      S, V5, P337; Ishizuya-Oka A, 1997, DEV BIOL, V192, P149, DOI 10.1006/dbio.1997.8749; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; Ishizuya-Oka A, 2003, J CELL SCI, V116, P3157, DOI 10.1242/jcs.00616; Ishizuya-Oka A, 2008, MOL CELL ENDOCRINOL, V288, P71, DOI 10.1016/j.mce.2008.02.020; Ishizuya-Oka A, 2007, DEV DYNAM, V236, P3358, DOI 10.1002/dvdy.21291; Ishizuya-Oka A, 2013, CURR TOP DEV BIOL, V103, P305, DOI 10.1016/B978-0-12-385979-2.00011-3; Ishizuya-Oka A, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-37; Ishizuya-Oka A, 2009, FASEB J, V23, P2568, DOI 10.1096/fj.08-128124; Ishizuya-Oka A, 2006, DEV DYNAM, V235, P3240, DOI 10.1002/dvdy.20969; IshizuyaOka A, 1996, CELL TISSUE RES, V286, P467, DOI 10.1007/s004410050716; ISHIZUYAOKA A, 1991, IN VITRO CELL DEV B, V27, P853; KANAMORI A, 1992, J BIOL CHEM, V267, P739; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; KIKUYAMA S, 1993, INT REV CYTOL, V145, P105, DOI 10.1016/S0074-7696(08)60426-X; Kress E, 2009, J BIOL CHEM, V284, P1234, DOI 10.1074/jbc.M806548200; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lara E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-170; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Lickert H, 2001, MECH DEVELOP, V105, P181, DOI 10.1016/S0925-4773(01)00390-2; Listyorini D, 2006, DEV GROWTH DIFFER, V48, P243, DOI [10.1111/j.1440-169x.2006.00861.x, 10.1111/j.1440-169X.2006.00861.x]; MARSHALL JA, 1978, J ANAT, V126, P133; MCAVOY JW, 1977, J EXP ZOOL, V202, P129, DOI 10.1002/jez.1402020115; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Muncan V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1463; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Rankin SA, 2011, DEV DYNAM, V240, P1467, DOI 10.1002/dvdy.22642; Rankin SA, 2009, DEV DYNAM, V238, P2401, DOI 10.1002/dvdy.22043; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; SHI YB, 1994, BBA-GENE STRUCT EXPR, V1217, P227, DOI 10.1016/0167-4781(94)90042-6; Shi YB, 2013, CURR TOP DEV BIOL, V105, P275, DOI 10.1016/B978-0-12-396968-2.00010-5; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sun GH, 2013, ENDOCRINOLOGY, V154, P4396, DOI 10.1210/en.2013-1432; Sun GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013605; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Wu J, 2009, TRENDS CELL BIOL, V19, P295, DOI 10.1016/j.tcb.2009.04.003; Yamada M, 2010, DEV DYNAM, V239, P941, DOI 10.1002/dvdy.22212	61	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107611	10.1371/journal.pone.0107611	http://dx.doi.org/10.1371/journal.pone.0107611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211363	Green Submitted, Green Published, gold			2022-12-27	WOS:000341855900087
J	Fagan, JK; Dollar, G; Lu, QH; Barnett, A; Jorge, JP; Schlosser, A; Pfleger, C; Adler, P; Jenny, A				Fagan, Jeremy K.; Dollar, Gretchen; Lu, Qiuheng; Barnett, Austen; Jorge, Joaquin Pechuan; Schlosser, Andreas; Pfleger, Cathie; Adler, Paul; Jenny, Andreas			Combover/CG10732, a Novel PCP Effector for Drosophila Wing Hair Formation	PLOS ONE			English	Article							PLANAR CELL POLARITY; RHO-ASSOCIATED KINASE; CONVERGENT EXTENSION MOVEMENTS; ROK-ALPHA; PROTEIN; PHOSPHORYLATION; ACTIN; GENE; MORPHOGENESIS; LOCALIZATION	The polarization of cells is essential for the proper functioning of most organs. Planar Cell Polarity (PCP), the polarization within the plane of an epithelium, is perpendicular to apical-basal polarity and established by the non-canonical Wnt/Fz-PCP signaling pathway. Within each tissue, downstream PCP effectors link the signal to tissue specific readouts such as stereocilia orientation in the inner ear and hair follicle orientation in vertebrates or the polarization of ommatidia and wing hairs in Drosophila melanogaster. Specific PCP effectors in the wing such as Multiple wing hairs (Mwh) and Rho Kinase (Rok) are required to position the hair at the correct position and to prevent ectopic actin hairs. In a genome-wide screen in vitro, we identified Combover (Cmb)/CG10732 as a novel Rho kinase substrate. Overexpression of Cmb causes the formation of a multiple hair cell phenotype (MHC), similar to loss of rok and mwh. This MHC phenotype is dominantly enhanced by removal of rok or of other members of the PCP effector gene family. Furthermore, we show that Cmb physically interacts with Mwh, and cmb null mutants suppress the MHC phenotype of mwh alleles. Our data indicate that Cmb is a novel PCP effector that promotes to wing hair formation, a function that is antagonized by Mwh.	[Fagan, Jeremy K.; Dollar, Gretchen; Barnett, Austen; Jenny, Andreas] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA; [Fagan, Jeremy K.; Dollar, Gretchen; Barnett, Austen; Jenny, Andreas] Albert Einstein Coll Med, Dept Genet, New York, NY USA; [Lu, Qiuheng; Adler, Paul] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Jorge, Joaquin Pechuan] Albert Einstein Coll Med, Dept Syst & Computat Biol, New York, NY USA; [Schlosser, Andreas] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Pfleger, Cathie] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA	Yeshiva University; Yeshiva University; University of Virginia; Yeshiva University; University of Wurzburg; Icahn School of Medicine at Mount Sinai	Jenny, A (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA.	andreas.jenny@einstein.yu.edu	Pechuan, Joaquin/H-7327-2015	Pechuan, Joaquin/0000-0001-8938-7931; Barnett, Austen/0000-0003-4290-7594	National Institutes of Health (NIH) [GM088202]; NIH [5 T32 GM007491-35, GM037163, R01CA140451]; DOD [W81XWH-14-1-0059]; NSF [1257939]; NATIONAL CANCER INSTITUTE [R01CA140451, P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037163, R01GM088202, T32GM007491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health (NIH) grant GM088202 (to AJ), NIH 5 T32 GM007491-35 (to JKF; PI Kielian), NIH GM037163 (to PNA), NIH R01CA140451(to CP), DOD W81XWH-14-1-0059 (to CP) and NSF 1257939 (to CP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2005, AD DEV BIOL, V14, P1, DOI 10.1016/S1574-3349(04)14001-5; Adler PN, 2004, CURR BIOL, V14, P2046, DOI 10.1016/j.cub.2004.11.007; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Collier S, 2005, GENETICS, V169, P2035, DOI 10.1534/genetics.104.033381; Collier S, 1997, DEVELOPMENT, V124, P4029; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Dickinson WJ, 1997, CELL MOTIL CYTOSKEL, V38, P9; Dunlop JA, 2010, ARTHROPOD STRUCT DEV, V39, P124, DOI 10.1016/j.asd.2010.01.003; EATON S, 1995, J CELL BIOL, V131, P151, DOI 10.1083/jcb.131.1.151; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Gray RS, 2011, DEV CELL, V21, P120, DOI 10.1016/j.devcel.2011.06.011; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Guild GM, 2005, MOL BIOL CELL, V16, P3620, DOI 10.1091/mbc.E05-03-0185; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Huang J, 2008, GENETICS, V180, P703, DOI 10.1534/genetics.108.090563; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Kang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022699; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khandekar SS, 2006, PROTEIN PEPTIDE LETT, V13, P369, DOI 10.2174/092986606775974357; Kim GH, 2005, DEV DYNAM, V232, P958, DOI 10.1002/dvdy.20262; Lee H, 2002, GENETICS, V160, P1535; Lee LA, 2005, DEV CELL, V8, P435, DOI 10.1016/j.devcel.2004.12.008; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Lu QH, 2010, GENETICS, V185, P549, DOI 10.1534/genetics.110.114066; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Maung SMTW, 2011, ORGANOGENESIS, V7, P165, DOI 10.4161/org.7.3.18143; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Regier JC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058568, 10.1371/journal.pone.0072678]; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Riechmann V, 2004, DEVELOPMENT, V131, P5897, DOI 10.1242/dev.01515; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Schlosser A, 2005, ANAL CHEM, V77, P5243, DOI 10.1021/ac050232m; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Strutt D, 2008, DEVELOPMENT, V135, P3103, DOI 10.1242/dev.025205; Strutt H, 2009, SEMIN CELL DEV BIOL, V20, P957, DOI 10.1016/j.semcdb.2009.03.006; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Turner CM, 1998, MECH DEVELOP, V70, P181, DOI 10.1016/S0925-4773(97)00194-9; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wan X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042056; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; Yan J, 2008, GENETICS, V180, P219, DOI 10.1534/genetics.108.091314; Yan J, 2009, DEV BIOL, V333, P186, DOI 10.1016/j.ydbio.2009.06.027; Yun UJ, 1999, DEV GENET, V25, P297, DOI 10.1002/(SICI)1520-6408(1999)25:4<297::AID-DVG3>3.3.CO;2-C	64	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107311	10.1371/journal.pone.0107311	http://dx.doi.org/10.1371/journal.pone.0107311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207969	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300074
J	Jacob, MS; Duffy, CJ				Jacob, Michael S.; Duffy, Charles J.			Might Cortical Hyper-Responsiveness in Aging Contribute to Alzheimer's Disease?	PLOS ONE			English	Article							SELECTIVE ATTENTION; VISUAL-CORTEX; FUNCTIONAL DEGRADATION; RHESUS-MONKEYS; BRAIN ACTIVITY; SELF-MOVEMENT; AMYLOID-BETA; PERCEPTION; DYNAMICS; STATE	Our goal is to understand the neural basis of functional impairment in aging and Alzheimer's disease (AD) to be able to characterize clinically significant decline and assess therapeutic efficacy. We used frequency-tagged ERPs to word and motion stimuli to study the effects of stimulus conditions and selective attention. ERPs to word or motion increase when a task-irrelevant 2nd stimulus is added, but decrease when the task is moved to that 2nd stimulus. Spectral analyses show task effects on response power without 2nd stimulus effects. However, phase coherence shows both 2nd stimulus and task effects. Thus, power and coherence are dissociably modulated by stimulus and task effects. Task-dependent phase coherence successively declines in aging and AD. In contrast, task-dependent spectral power increases in aging, only to decrease in AD. We hypothesize that age-related declines in signal coherence, associated with increased power generation, stresses neurons and contributes to the loss of response power and the development of functional impairment in AD.	[Jacob, Michael S.; Duffy, Charles J.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Jacob, Michael S.; Duffy, Charles J.] Univ Rochester, Med Ctr, Ctr Visual Sci, Rochester, NY 14642 USA; [Jacob, Michael S.] Univ Calif San Francisco, Med Ctr, Dept Psychiat, San Francisco, CA USA	University of Rochester; University of Rochester; University of California System; University of California San Francisco	Duffy, CJ (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.	Charles_Duffy@urmc.rochester.edu			National Eye Institute [R01-EY022062, P30-EY01319]; National Institute on Aging [R01-AG17596]; Office of Naval Research [N000141110525]; University of Rochester Center for Translational Science [RR024135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024135] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022062, P30EY001319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017596] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office of Naval Research(Office of Naval Research); University of Rochester Center for Translational Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Eye Institute (R01-EY022062, P30-EY01319), National Institute on Aging (R01-AG17596), Office of Naval Research (N000141110525), and University of Rochester Center for Translational Science (RR024135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Attar CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037186; Besle J, 2011, J NEUROSCI, V31, P3176, DOI 10.1523/JNEUROSCI.4518-10.2011; Binetti G, 1996, ANN NY ACAD SCI, V777, P221, DOI 10.1111/j.1749-6632.1996.tb34422.x; Bledowski C, 2004, NEUROIMAGE, V22, P530, DOI 10.1016/j.neuroimage.2003.12.034; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Cohen JY, 2009, J NEUROPHYSIOL, V102, P2375, DOI 10.1152/jn.00680.2009; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Dolev I, 2013, NAT NEUROSCI, V16, P587, DOI 10.1038/nn.3376; Eimer M, 1996, PSYCHOPHYSIOLOGY, V33, P13, DOI 10.1111/j.1469-8986.1996.tb02104.x; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Fernandez R, 2013, J ALZHEIMERS DIS; Fernandez R, 2007, NEUROLOGY, V68, P2066, DOI 10.1212/01.wnl.0000264873.62313.81; Fernandez R, 2012, NEUROBIOL AGING, V33, P2551, DOI 10.1016/j.neurobiolaging.2011.12.031; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fu Y, 2013, CEREB CORTEX, V23, P2923, DOI 10.1093/cercor/bhs282; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Heitz RP, 2010, J NEUROPHYSIOL, V104, P2433, DOI 10.1152/jn.00604.2010; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P599, DOI 10.1152/jn.1965.28.3.599; Hesselmann G, 2006, VISION RES, V46, P1048, DOI 10.1016/j.visres.2005.10.007; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopfinger JB, 2001, NEUROPSYCHOLOGIA, V39, P1277, DOI 10.1016/S0028-3932(01)00117-8; Hua TM, 2006, NEUROBIOL AGING, V27, P155, DOI 10.1016/j.neurobiolaging.2004.11.012; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jagust WJ, 2011, TRENDS COGN SCI, V15, P520, DOI 10.1016/j.tics.2011.09.004; Jardanhazy A, 2008, EUR J NEUROL, V15, P150, DOI 10.1111/j.1468-1331.2007.02016.x; Kavcic V, 2003, BRAIN, V126, P1173, DOI 10.1093/brain/awg105; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; Kishore S, 2012, CEREB CORTEX, V22, P201, DOI 10.1093/cercor/bhr115; Klimesch W, 2007, NEUROSCI BIOBEHAV R, V31, P1003, DOI 10.1016/j.neubiorev.2007.03.005; Kuba M, 2007, VISION RES, V47, P189, DOI 10.1016/j.visres.2006.09.020; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Li L, 2013, NEUROBIOL AGING, V34, P477, DOI 10.1016/j.neurobiolaging.2012.02.025; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Mamelak M, 2007, NEUROBIOL AGING, V28, P1340, DOI 10.1016/j.neurobiolaging.2006.06.008; Mapstone M, 2010, BRAIN, V133, P2690, DOI 10.1093/brain/awq140; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Michael L, 2011, VISION RES, V51, P1781, DOI 10.1016/j.visres.2011.06.007; Money J., 1965, STANDARDIZED ROAD MA; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Morrison JH, 2007, INT REV NEUROBIOL, V81, P41, DOI 10.1016/S0074-7742(06)81004-4; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Neufang S, 2011, J ALZHEIMERS DIS, V25, P309, DOI 10.3233/JAD-2011-102154; Ng BSW, 2012, J NEUROSCI, V32, P12268, DOI 10.1523/JNEUROSCI.1877-12.2012; Niedeggen M, 2012, J COGNITIVE NEUROSCI, V24, P1294, DOI 10.1162/jocn_a_00177; Oh H, 2013, J NEUROSCI, V33, P18425, DOI 10.1523/JNEUROSCI.2775-13.2013; Oh H, 2011, NEUROIMAGE, V54, P1887, DOI 10.1016/j.neuroimage.2010.10.027; Palomares M, 2012, J VISION, V12, DOI [10.1167/12.10.15, 10.1167/12.10.18]; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Parks NA, 2011, J COGNITIVE NEUROSCI, V23, P1113, DOI 10.1162/jocn.2010.21460; Pei F, 2002, J VISION, V2, DOI 10.1167/2.9.1; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Prvulovic D, 2005, PSYCHIAT RES-NEUROIM, V140, P97, DOI 10.1016/j.pscychresns.2005.06.006; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rousselet GA, 2007, NEUROIMAGE, V36, P843, DOI 10.1016/j.neuroimage.2007.02.052; Sawaki R, 2012, J NEUROSCI, V32, P10725, DOI 10.1523/JNEUROSCI.1864-12.2012; Scheef L, 2012, NEUROLOGY, V79, P1332, DOI 10.1212/WNL.0b013e31826c1a8d; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Terada S, 2013, PSYCHIAT RES-NEUROIM, V213, P249, DOI 10.1016/j.pscychresns.2013.03.006; Tumeh PC, 2007, SEMIN NUCL MED, V37, P69, DOI 10.1053/j.semnuclmed.2006.10.002; ULLSPERGER P, 1987, INT J PSYCHOPHYSIOL, V5, P145, DOI 10.1016/0167-8760(87)90018-3; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Varney N. R., 1983, CONTRIBUTIONS NEUROP, P44; Velasco ME, 1998, BRAIN RES, V813, P329, DOI 10.1016/S0006-8993(98)01034-8; Wechsler D, 1997, WECSHLER MEMORY SACL; Zhao GA, 2011, NEUROSCI LETT, V491, P68, DOI 10.1016/j.neulet.2010.12.066	76	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e105962	10.1371/journal.pone.0105962	http://dx.doi.org/10.1371/journal.pone.0105962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208332	Green Published, gold			2022-12-27	WOS:000342030300013
J	Li, XS; Xu, Q; Fu, XY; Luo, WS				Li, Xiao-shan; Xu, Qing; Fu, Xiang-yang; Luo, Wei-sheng			Heat Shock Protein 60 Overexpression Is Associated with the Progression and Prognosis in Gastric Cancer	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; HSP60; CARCINOGENESIS; TUMORIGENESIS; CHEMOTHERAPY; EXPRESSION; BIOMARKER; SURGERY; HSP10	Background: Heat shock protein 60 (HSP60) is a chaperonin with essential functions for cell physiology and survival, and its expression correlates with prognosis in a number of malignancies. The aim of this study is to determine the relationship of HSP60 status with clinicopathological parameters and prognosis in gastric cancer. Methods: The levels of HSP60 and matrix metallopeptidase 9 (MMP-9) antigen was evaluated by immunohistochemistry in 223 gastric carcinoma samples. The association between HSP60 and MMP-9, clinicopathological parameters, and prognosis of gastric cancer was examined. Results: The level of HSP60 protein was significantly associated with depth invasion, lymph node metastasis and stage of disease (all P<0.05). Both univariate and multivariate analyses revealed that HSP60 was an independent prognostic factor for both overall survival (OS) and recurrence-free survival (RFS) (both P<0.05). Furthermore, HSP60 overexpression was associated with a poor prognosis in patients with advanced gastric cancer in different risk groups. Moreover, HSP60 was significantly correlated with MMP-9 among 223 gastric cancer tissues (P<0.001). Patients who had HSP60 overexpression, in which tumor cells displayed high invasiveness, had poor OS and shorter RFS. Conclusion: HSP60 plays an important role on tumor aggressiveness and prognosis, and may act as a promising target for prognostic prediction.	[Li, Xiao-shan; Fu, Xiang-yang; Luo, Wei-sheng] Guilin Med Univ, Affiliated Hosp, Dept Gastroenterol, Guilin, Guangxi Zhuang, Peoples R China; [Xu, Qing] Guilin Med Univ, Guilin, Guangxi Zhuang, Peoples R China; [Luo, Wei-sheng] Guangxi Univ Chinese Med, Affiliated Hosp 1, Nanning, Guangxi Zhuang, Peoples R China	Guilin Medical University; Guilin Medical University; Guangxi University of Chinese Medicine	Luo, WS (corresponding author), Guilin Med Univ, Affiliated Hosp, Dept Gastroenterol, Guilin, Guangxi Zhuang, Peoples R China.	wsluo58@126.com						Bornschein J, 2011, HELICOBACTER, V16, P45, DOI 10.1111/j.1523-5378.2011.00880.x; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Cappello F, 2005, LANCET ONCOL, V6, P816, DOI 10.1016/S1470-2045(05)70393-4; Cappello F, 2006, CANCER-AM CANCER SOC, V107, P2417, DOI 10.1002/cncr.22265; Cappello F, 2014, EXPERT OPIN THER TAR, V18, P185, DOI 10.1517/14728222.2014.856417; Chu DK, 2011, INT J CANCER, V129, P887, DOI 10.1002/ijc.25734; Compare D, 2010, EUR REV MED PHARMACO, V14, P302; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dikken JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-329; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Faried A, 2004, EUR J CANCER, V40, P2804, DOI 10.1016/j.ejca.2004.08.013; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gupta Radhey S, 2008, Novartis Found Symp, V291, P59; Hamelin C, 2011, FEBS J, V278, P4845, DOI 10.1111/j.1742-4658.2011.08385.x; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Khalil AA, 2007, CANCER SCI, V98, P201, DOI 10.1111/j.1349-7006.2007.00374.x; Kim HJ, 2007, MOL CELLS, V23, P123; Lin CS, 2010, BIOCHEM BIOPH RES CO, V392, P183, DOI 10.1016/j.bbrc.2010.01.010; Myung Jae-Kyung, 2004, Proteome Sci, V2, P8, DOI 10.1186/1477-5956-2-8; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Nobili S, 2011, WORLD J GASTROENTERO, V17, P290, DOI 10.3748/wjg.v17.i3.290; Pace A, 2013, CURR PHARM DESIGN, V19, P2757, DOI 10.2174/1381612811319150011; Tanaka A, 2009, PATHOL RES PRACT, V205, P690, DOI 10.1016/j.prp.2009.04.008; Wang JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062876, 10.1371/journal.pone.0080980]; Yasui W, 2011, PATHOL RES PRACT, V207, P608, DOI 10.1016/j.prp.2011.09.006; Zhao FJ, 2010, MED ONCOL, V27, P774, DOI 10.1007/s12032-009-9285-x	27	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107507	10.1371/journal.pone.0107507	http://dx.doi.org/10.1371/journal.pone.0107507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207654	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300087
J	Sarkar, P; Bosneaga, E; Yap, EG; Das, J; Tsai, WT; Cabal, A; Neuhaus, E; Maji, D; Kumar, S; Joo, M; Yakovlev, S; Csencsits, R; Yu, ZY; Bajaj, C; Downing, KH; Auer, M				Sarkar, Purbasha; Bosneaga, Elena; Yap, Edgar G., Jr.; Das, Jyotirmoy; Tsai, Wen-Ting; Cabal, Angelo; Neuhaus, Erica; Maji, Dolonchampa; Kumar, Shailabh; Joo, Michael; Yakovlev, Sergey; Csencsits, Roseann; Yu, Zeyun; Bajaj, Chandrajit; Downing, Kenneth H.; Auer, Manfred			Electron Tomography of Cryo-Immobilized Plant Tissue: A Novel Approach to Studying 3D Macromolecular Architecture of Mature Plant Cell Walls In Situ	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; RAPID FREEZING SPRF; CRYOELECTRON MICROSCOPY; CELLULOSE MICROFIBRILS; SPECIMEN PREPARATION; ANCHORED PROTEIN; FINE-STRUCTURE; CROSS-LINKS; GROWTH; EXPANSION	Cost-effective production of lignocellulosic biofuel requires efficient breakdown of cell walls present in plant biomass to retrieve the wall polysaccharides for fermentation. In-depth knowledge of plant cell wall composition is therefore essential for improving the fuel production process. The precise spatial three-dimensional (3D) organization of cellulose, hemicellulose, pectin and lignin within plant cell walls remains unclear to date since the microscopy techniques used so far have been limited to two-dimensional, topographic or low-resolution imaging, or required isolation or chemical extraction of the cell walls. In this paper we demonstrate that by cryo-immobilizing fresh tissue, then either cryo-sectioning or freeze-substituting and resin embedding, followed by cryo-or room temperature (RT) electron tomography, respectively, we can visualize previously unseen details of plant cell wall architecture in 3D, at macromolecular resolution (similar to 2 nm), and in near-native state. Qualitative and quantitative analyses showed that wall organization of cryo-immobilized samples were preserved remarkably better than conventionally prepared samples that suffer substantial extraction. Lignin-less primary cell walls were well preserved in both self-pressurized rapidly frozen (SPRF), cryo-sectioned samples as well as high-pressure frozen, freeze-substituted and resin embedded (HPF-FS-resin) samples. Lignin-rich secondary cell walls appeared featureless in HPF-FS-resin sections presumably due to poor stain penetration, but their macromolecular features could be visualized in unprecedented details in our cryo-sections. While cryo-tomography of vitreous tissue sections is currently proving to be instrumental in developing 3D models of lignin-rich secondary cell walls, here we confirm that the technically easier method of RT-tomography of HPF-FS-resin sections could be used immediately for routine study of low-lignin cell walls. As a proof of principle, we characterized the primary cell walls of a mutant (cob-6) and wild type Arabidopsis hypocotyl parenchyma cells by RT-tomography of HPF-FS-resin sections, and detected a small but significant difference in spatial organization of cellulose microfibrils in the mutant walls.	[Sarkar, Purbasha; Bosneaga, Elena; Das, Jyotirmoy; Cabal, Angelo; Maji, Dolonchampa; Kumar, Shailabh; Auer, Manfred] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Sarkar, Purbasha; Bosneaga, Elena; Yap, Edgar G., Jr.; Tsai, Wen-Ting; Neuhaus, Erica; Joo, Michael; Csencsits, Roseann; Downing, Kenneth H.; Auer, Manfred] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Yakovlev, Sergey] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Yu, Zeyun] Univ Wisconsin, Dept Comp Sci, Milwaukee, WI 53201 USA; [Bajaj, Chandrajit] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Bajaj, Chandrajit] Univ Texas Austin, Inst Computat Engn & Sci, Austin, TX 78712 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Milwaukee; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Auer, M (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	mauer@lbl.gov	Kumar, Shailabh/ABE-9452-2021	Kumar, Shailabh/0000-0001-5383-3282; Bajaj, Chandrajit/0000-0002-9619-3278; Maji, Dolonchampa/0000-0003-3208-2883	Energy Biosciences Institute [007G18]; National Institutes of Health [P01-GM051487-15, R01-EB004873]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB004873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM051487] Funding Source: NIH RePORTER	Energy Biosciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was primarily funded by the Energy Biosciences Institute (http://www.energybiosciencesinstitute.org), grant number 007G18 (MA). The LBNL electron microscopes used in this study were supported by National Institutes of Health (http://www.nih.gov); grant number P01-GM051487-15 (KHD, MA). The automated segmentation done at UT Austin was supported by National Institutes of Health (http://www.nih.gov); grant R01-EB004873 (CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010; Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366; ALBERSHEIM P, 2011, PLANT CELL WALLS, P1; Anderson CT, 2010, PLANT PHYSIOL, V152, P787, DOI 10.1104/pp.109.150128; Bajaj CL, 1997, VISUALIZATION '97 - PROCEEDINGS, P167, DOI 10.1109/VISUAL.1997.663875; Banerjee G, 2010, BIOENERG RES, V3, P82, DOI 10.1007/s12155-009-9067-5; Baskin TI, 1999, PLANT PHYSIOL, V119, P681, DOI 10.1104/pp.119.2.681; Chundawat SPS, 2011, ENERG ENVIRON SCI, V4, P973, DOI 10.1039/c0ee00574f; Ciesielski PN, 2013, ACS NANO, V7, P8011, DOI 10.1021/nn4031542; Cosgrove DJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00204; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2000, PLANT PHYSIOL BIOCH, V38, P109, DOI 10.1016/S0981-9428(00)00164-9; Davies LM, 2003, PLANTA, V217, P283, DOI 10.1007/s00425-003-0979-6; Dick-Perez M, 2011, BIOCHEMISTRY-US, V50, P989, DOI 10.1021/bi101795q; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; Donohoe BS, 2007, P NATL ACAD SCI USA, V104, P163, DOI 10.1073/pnas.0609818104; Donohoe BS, 2006, METHODS, V39, P154, DOI 10.1016/j.ymeth.2006.05.013; El Mansouri NE, 2011, BIORESOURCES, V6, P2647; Elkins JG, 2010, CURR OPIN BIOTECH, V21, P657, DOI 10.1016/j.copbio.2010.05.008; Eltsov M, 2005, J BACTERIOL, V187, P8047, DOI 10.1128/JB.187.23.8047-8054.2005; Fernandez JJ, 2003, J STRUCT BIOL, V144, P152, DOI 10.1016/j.jsb.2003.09.010; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; FREYWYSS.A, 1968, WOOD SCI TECHNOL, V2, P73, DOI 10.1007/BF00394956; FUJINO T, 1994, PROTOPLASMA, V180, P39, DOI 10.1007/BF01379222; Fujino T, 2000, PLANT CELL PHYSIOL, V41, P486, DOI 10.1093/pcp/41.4.486; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; Han HM, 2012, J STRUCT BIOL, V178, P84, DOI 10.1016/j.jsb.2012.04.001; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P4; HEYN ANJ, 1969, J ULTRA MOL STRUCT R, V26, P52; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HUMPHREY E, 2006, MICROSC MICROANAL S2, V12, P194; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krishnamurthy KV, 1999, METHODS CELL WALL CY, P29; Lee KJD, 2011, MOL PLANT, V4, P212, DOI 10.1093/mp/ssq075; Leroux O, 2012, ANN BOT-LONDON, V110, P1083, DOI 10.1093/aob/mcs186; Leunissen JLM, 2009, J MICROSC-OXFORD, V235, P25, DOI 10.1111/j.1365-2818.2009.03178.x; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; MacKinnon IM, 2006, PLANTA, V224, P438, DOI 10.1007/s00425-005-0208-6; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McCann MC, 2008, CURR OPIN PLANT BIOL, V11, P314, DOI 10.1016/j.pbi.2008.04.001; MCCANN MC, 1990, J CELL SCI, V96, P323; McCann MC, 1991, CYTOSKELETAL BASIS P, P109; McDonald KL, 2011, J MICROSC-OXFORD, V243, P227, DOI 10.1111/j.1365-2818.2011.03526.x; McDonald KL, 2014, MICROSC MICROANAL, V20, P152, DOI 10.1017/S1431927613013846; McDonald KL, 2014, PROTOPLASMA, V251, P429, DOI 10.1007/s00709-013-0575-y; McDonald KL, 2006, BIOTECHNIQUES, V41, P137, DOI 10.2144/000112226; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Nemeth G, 2011, INT J IMAG SYST TECH, V21, P37, DOI 10.1002/ima.20272; Newman RH, 2013, PLANT PHYSIOL, V163, P1558, DOI 10.1104/pp.113.228262; OHAD I, 1964, J CELL BIOL, V22, P302, DOI 10.1083/jcb.22.1.302; Otegui MS, 2001, PLANT CELL, V13, P2033, DOI 10.1105/tpc.13.9.2033; Park YB, 2012, PLANT PHYSIOL, V158, P1933, DOI 10.1104/pp.111.192880; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pierson J, 2010, J STRUCT BIOL, V169, P219, DOI 10.1016/j.jsb.2009.10.001; Popper ZA, 2008, CURR OPIN PLANT BIOL, V11, P286, DOI 10.1016/j.pbi.2008.02.012; PRESTON RD, 1948, NATURE, V162, P665, DOI 10.1038/162665a0; Radotic K, 2012, BIOPHYS J, V103, P386, DOI 10.1016/j.bpj.2012.06.046; Ragauskas A. J., 2006, Industrial biotechnology, V2, P55, DOI 10.1089/ind.2006.2.55; Resch Guenter P, 2011, Cold Spring Harb Protoc, V2011, P778, DOI 10.1101/pdb.top118; ROLAND JC, 1975, J CELL SCI, V19, P239; Rose JKC, 1999, TRENDS PLANT SCI, V4, P176, DOI 10.1016/S1360-1385(99)01405-3; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Segui-Simarro JM, 2004, PLANT CELL, V16, P836, DOI 10.1105/tpc.017749; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Taylor NG, 2008, NEW PHYTOL, V178, P239, DOI 10.1111/j.1469-8137.2008.02385.x; Thimm JC, 2000, PLANTA, V212, P25, DOI 10.1007/s004250000359; Thomas LH, 2013, PLANT PHYSIOL, V161, P465, DOI 10.1104/pp.112.206359; Verbelen JP, 2000, J MICROSC-OXFORD, V198, P101, DOI 10.1046/j.1365-2818.2000.00691.x; Xin ZY, 2011, ROUTES TO CELLULOSIC ETHANOL, P181, DOI 10.1007/978-0-387-92740-4_12; Xu P, 2007, WOOD SCI TECHNOL, V41, P101, DOI 10.1007/s00226-006-0088-3; Xu P, 2011, J MATER SCI, V46, P534, DOI 10.1007/s10853-010-5000-8; Yakovlev S, 2011, J MICROSC-OXFORD, V244, P235, DOI 10.1111/j.1365-2818.2011.03530.x; Yakovlev S, 2010, MICROSC MICROANAL S2, V16, P860; Yu ZY, 2008, IEEE ACM T COMPUT BI, V5, P568, DOI 10.1109/TCBB.2007.70226; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001; Zhang Q, 2012, BIOPOLYMERS, V97, P709, DOI 10.1002/bip.22052	87	17	17	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106928	10.1371/journal.pone.0106928	http://dx.doi.org/10.1371/journal.pone.0106928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207917	Green Submitted, gold, Green Published			2022-12-27	WOS:000342030300049
J	Singh, H; Shukla, MR; Chary, KVR; Rao, BJ				Singh, Himanshu; Shukla, Manish R.; Chary, Kandala V. R.; Rao, Basuthkar J.			Acetate and Bicarbonate Assimilation and Metabolite Formation in Chlamydomonas reinhardtii: A C-13-NMR Study	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; NMR; GROWTH; OIL; BIOSYNTHESIS; ACCUMULATION; EXPRESSION	Cellular metabolite analyses by C-13-NMR showed that C. reinhardtii cells assimilate acetate at a faster rate in heterotrophy than in mixotrophy. While heterotrophic cells produced bicarbonate and CO2aq, mixotrophy cells produced bicarbonate alone as predominant metabolite. Experiments with singly C-13-labelled acetate ((CH3)-C-13-COOH or CH3-(COOH)-C-13) supported that both the C-13 nuclei give rise to bicarbonate and CO2aq. The observed metabolite(s) upon further incubation led to the production of starch and triacylglycerol (TAG) in mixotrophy, whereas in heterotrophy the TAG production was minimal with substantial accumulation of glycerol and starch. Prolonged incubation up to eight days, without the addition of fresh acetate, led to an increased TAG production at the expense of bicarbonate, akin to that of nitrogen-starvation. However, such TAG production was substantially high in mixotrophy as compared to that in heterotrophy. Addition of mitochondrial un-coupler blocked the formation of bicarbonate and CO2aq in heterotrophic cells, even though acetate uptake ensued. Addition of PSII-inhibitor to mixotrophic cells resulted in partial conversion of bicarbonate into CO2aq, which were found to be in equilibrium. In an independent experiment, we have monitored assimilation of bicarbonate via photoautotrophy and found that the cells indeed produce starch and TAG at a much faster rate as compared to that in mixotrophy and heterotrophy. Further, we noticed that the accumulation of starch is relatively more as compared to TAG. Based on these observations, we suggest that acetate assimilation in C. reinhardtii does not directly lead to TAG formation but via bicarbonate/CO2aq pathways. Photoautotrophic mode is found to be the best growth condition for the production of starch and TAG and starch in C. reinhardtii.	[Singh, Himanshu; Chary, Kandala V. R.] Tata Inst Fundamental Res, Dept Chem, Bombay 400005, Maharashtra, India; [Shukla, Manish R.; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Shukla, Manish R.; Chary, Kandala V. R.] Tata Inst Fundamental Res, Ctr Interdisciplinary Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR)	Rao, BJ (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	bjrao@tifr.res.in	Singh, Himanshu/M-6619-2019	Singh, Himanshu/0000-0002-2819-6282	Department of Science and Technology, New Delhi; Department of Biotechnology, New Delhi; Council of Scientific and Industrial Research, New Delhi; Tata Institute of Fundamental Research (TIFR), Mumbai	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Tata Institute of Fundamental Research (TIFR), Mumbai(Tata Institute of Fundamental Research (TIFR))	The facilities provided by the National Facility for High Field NMR, supported by the Department of Science and Technology, New Delhi, Department of Biotechnology, New Delhi, Council of Scientific and Industrial Research, New Delhi, and Tata Institute of Fundamental Research (TIFR), Mumbai, are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWORTH DJ, 1985, ANAL CHEM, V57, P710, DOI 10.1021/ac00280a030; Bligny R, 2001, CURR OPIN PLANT BIOL, V4, P191, DOI 10.1016/S1369-5266(00)00160-6; Boyle NR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-4; Cakmak T, 2012, BIOTECHNOL BIOENG, V109, P1947, DOI 10.1002/bit.24474; Chary KVR, 2008, NMR BIOL SYSTEMS MOL, V6; Cheng YS, 2011, LIPIDS, V46, P95, DOI 10.1007/s11745-010-3494-0; COMBRES C, 1994, PHYSIOL PLANTARUM, V91, P729, DOI 10.1111/j.1399-3054.1994.tb03012.x; Dominguez H, 1998, EUR J BIOCHEM, V254, P96, DOI 10.1046/j.1432-1327.1998.2540096.x; FETT JP, 1994, PLANT PHYSIOL, V106, P103, DOI 10.1104/pp.106.1.103; FOLCH J, 1957, J BIOL CHEM, V226, P497; Grivet J P, 2001, Curr Issues Mol Biol, V3, P7; Harris EH, 2009, LIFE ACETATE FLAGELL; Harris EH, 2009, CHLAMYDOMONAS LAB AM; Johnson X, 2013, EUKARYOT CELL, V12, P776, DOI 10.1128/EC.00318-12; Kim HK, 2011, TRENDS BIOTECHNOL, V29, P267, DOI 10.1016/j.tibtech.2011.02.001; Kovacs H, 2005, PROG NUCL MAG RES SP, V46, P131, DOI 10.1016/j.pnmrs.2005.03.001; Krishnan P, 2005, J EXP BOT, V56, P255, DOI 10.1093/jxb/eri010; Lv HX, 2013, GENOMICS, V101, P229, DOI 10.1016/j.ygeno.2013.01.004; Marty D, 1997, PLANT SCI, V122, P11, DOI 10.1016/S0168-9452(96)04534-7; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; MORELAND DE, 1967, ANN REV PLANT PHYSIO, V18, P365, DOI 10.1146/annurev.pp.18.060167.002053; Moroney JV, 2011, PHOTOSYNTH RES, V109, P133, DOI 10.1007/s11120-011-9635-3; MURPHY DJ, 1979, PLANT PHYSIOL, V63, P328, DOI 10.1104/pp.63.2.328; Perez-Garcia O, 2011, WATER RES, V45, P11, DOI 10.1016/j.watres.2010.08.037; Ran CQ, 2006, BIOTECHNOL PROGR, V22, P438, DOI 10.1021/bp050289u; Ratcliffe RG, 2001, PROG NUCL MAG RES SP, V39, P267, DOI 10.1016/S0079-6565(01)00035-8; ROBITAILLE PML, 1993, J BIOL CHEM, V268, P26296; Shachar-Hill Y, 2002, METAB ENG, V4, P90, DOI 10.1006/mben.2001.0215; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Sijtsma L, 2005, ALTERNATIVE CARBON S, P107; Spalding MH, 2009, CHLAMYDOMONAS SOURCE, V2, P257; STROM ET, 1981, J AM CHEM SOC, V103, P1255, DOI 10.1021/ja00395a062; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Wang ST, 2011, BOT STUD, V52, P305; Ward JL, 2007, FEBS J, V274, P1126, DOI 10.1111/j.1742-4658.2007.05675.x; Work VH, 2010, EUKARYOT CELL, V9, P1251, DOI 10.1128/EC.00075-10	36	18	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106457	10.1371/journal.pone.0106457	http://dx.doi.org/10.1371/journal.pone.0106457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207648	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300023
J	Cantrell, CL; Zheljazkov, VD; Carvalho, CR; Astatkie, T; Jeliazkova, EA; Rosa, LH				Cantrell, Charles L.; Zheljazkov, Valtcho D.; Carvalho, Camila R.; Astatkie, Tess; Jeliazkova, Ekaterina A.; Rosa, Luiz H.			Dual Extraction of Essential Oil and Podophyllotoxin from Creeping Juniper (Juniperus horizontalis)	PLOS ONE			English	Article							BIG HORN MOUNTAINS; LEAVES; YIELD	Juniperus horizontalis Moench (Family Cupressaceae), commonly called creeping juniper, is a widely distributed species in the United States and much of Canada. It is potentially a source for two important chemical products, the anticancer drug synthetic precursor, podophyllotoxin and essential oils. The objectives of this study were to ascertain the likelihood of utilizing J. horizontalis needles for the simultaneous production of both (-)-podophyllotoxin and essential oil components and to determine the optimum distillation time (DT) needed for the production of essential oil containing a specific ratio of constituents. Eleven different distillation times were tested in this study: 20, 40, 80, 160, 180, 240, 480, 600, 720, 840, and 960 min. Total essential oil content increased with increasing distillation time from a minimum of 0.023% at 20 min to a maximum of 1.098% at 960 min. The major constituents present in the oil were alpha-pinene, sabinene, and limonene. The percent concentration of sabinene in the essential oil varied from a high of 46.6% at 80 min to a low of 30.2% at 960 min, that of limonene changed very little as a result of distillation time and remained near 30% for all distillation times, whereas the concentration of alpha-pinene was 9.6% at 20 min DT and decreased to 4.2% at 960 min. Post distillation analysis of needles revealed elevated amounts of (-)-podophyllotoxin remaining in the tissue varied in the amount of podophyllotoxin present, from a low of 0.281% to a high of 0.364% as compared to undistilled needles which gave 0.217% podophyllotoxin. As a result of this study, specific essential oil components can now be targeted in J. horizontalis by varying the distillation time. Furthermore, needles can be successfully utilized as a source of both essential oil and podophyllotoxin, consecutively.	[Cantrell, Charles L.; Carvalho, Camila R.] ARS, Nat Prod Utilizat Res Unit, USDA, University, MS 38677 USA; [Zheljazkov, Valtcho D.; Jeliazkova, Ekaterina A.] Univ Wyoming, Sheridan Res & Extens Ctr, Sheridan, WY USA; [Carvalho, Camila R.; Rosa, Luiz H.] Sci Fed Univ Minas Gerais, Inst Biol, Dept Microbiol, Lab Systemat & Biomol Fungi, Belo Horizonte, MG, Brazil; [Astatkie, Tess] Dalhousie Univ, Fac Agr, Truro, NS, Canada	United States Department of Agriculture (USDA); University of Wyoming; Dalhousie University	Cantrell, CL (corresponding author), ARS, Nat Prod Utilizat Res Unit, USDA, University, MS 38677 USA.	charles.cantrell@ars.usda.gov	Jeliazkova, Ekaterina/AAT-7069-2020; Astatkie, Tessema/J-7231-2012	Astatkie, Tessema/0000-0002-9779-8789; Jeliazkova, Ekaterina/0000-0003-2740-9925	University of Wyoming; Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	University of Wyoming; Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was partially funded by the University of Wyoming startup funding awarded to Dr. Zheljazkov. C. R. Carvalho was supported by Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG) and L. H. Rosa by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P, 2009, PHYTOLOGIA, V91, P31; Adams R.P., 2008, JUNIPERS WORLD GENUS; ADAMS RP, 1981, PHYTOCHEMISTRY, V20, P2501, DOI 10.1016/0031-9422(81)83081-6; Canel C, 2001, PLANTA MED, V67, P97, DOI 10.1055/s-2001-10636; Cantrell CL, 2013, IND CROP PROD, V43, P668, DOI 10.1016/j.indcrop.2012.07.075; Gawde AJ, 2009, IND CROP PROD, V30, P276, DOI 10.1016/j.indcrop.2009.05.005; Gawde AJ, 2009, IND CROP PROD, V30, P59, DOI 10.1016/j.indcrop.2009.01.010; Imbert TF, 1998, BIOCHIMIE, V80, P207, DOI 10.1016/S0300-9084(98)80004-7; Koulman A., 2004, BIOTECHNOLOGY MED PL; Kusari S, 2011, PHYTOCHEM ANALYSIS, V22, P128, DOI 10.1002/pca.1258; Marques JV, 2013, J BIOL CHEM, V288, P466, DOI 10.1074/jbc.M112.400689; Montgomery D.C., 2013, DESIGN ANAL EXPT; Mourad A. K., 2005, Communications in Agricultural and Applied Biological Sciences, V70, P601; Nadeem M, 2000, BIOL CONSERV, V92, P121, DOI 10.1016/S0006-3207(99)00059-2; PALMAOTAL M, 1983, CAN J BOT, V61, P2733, DOI 10.1139/b83-301; Panten J, 2004, CHEM BIODIVERS, V1, P1936, DOI 10.1002/cbdv.200490148; SAS Institute Inc, 2010, SAS STAT 9 3 US GUID; STAHELIN HF, 1991, CANCER RES, V51, P5; Zheljazkov VD, 2012, HORTSCIENCE, V47, P1696, DOI 10.21273/HORTSCI.47.12.1696; Zheljazkov VD, 2013, J ESSENT OIL RES, V25, P62, DOI 10.1080/10412905.2012.744704; Zheljazkov VD, 2013, IND CROP PROD, V43, P787, DOI 10.1016/j.indcrop.2012.08.024; Zheljazkov VD, 2012, J OLEO SCI, V61, P537, DOI 10.5650/jos.61.537	22	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106057	10.1371/journal.pone.0106057	http://dx.doi.org/10.1371/journal.pone.0106057			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203255	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500012
J	Choi, SH; Lee, HY; Lee, KS; Chung, MP; Kwon, OJ; Han, J; Kim, N; Seo, JB				Choi, Seung Hee; Lee, Ho Yun; Lee, Kyung Soo; Chung, Man Pyo; Kwon, O. Jung; Han, Joungho; Kim, Namkug; Seo, Joon Beom			The Value of CT for Disease Detection and Prognosis Determination in Combined Pulmonary Fibrosis and Emphysema (CPFE)	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; IDIOPATHIC INTERSTITIAL PNEUMONIAS; SURVIVAL; ALVEOLITIS; DIAGNOSIS; EXTENT; INDEX	Background and Purpose: Several imaging-based indices were constructed quantitatively using the emphysema index (EI) and fibrosis score (FS) on high-resolution computed tomography (HRCT). We evaluated the ability of these indices to predict mortality compared to physiologic results. Additionally, prognostic predictive factors were compared among subgroups with biopsy-proven fibrotic idiopathic interstitial pneumonia (IIP) (biopsy-proven CPFE) and in a separate cohort with subclinical CPFE. Materials and Methods: Three chest radiologists independently determined FS. EI was automatically quantified. PFTs, smoking history, and composite physiologic index (CPI) were reviewed. Predictors of time to death were determined based on clinico-physiologic factors and CT-based CPFE indices. Results: The prevalence of biopsy-proven CPFE was 26% (66/254), with an EI of 9.1 +/- 7.1 and a FS of 19.3 +/- 14.2. In patients with CPFE, median survival and 5-year survival rates were 6.0 years and 34.8%, respectively, whereas those in fibrotic IIP without emphysema were 10.0 years and 60.9% (p = 0.013). However, the extent of fibrosis did not differ significantly between the two cohorts. In subclinical CPFE, prevalence was 0.04% (93/20,372), EI was 11.3 +/- 10.4, and FS was 9.1 +/- 7.1. FVC and a fibrosis-weighted CT index were independent predictors of survival in the biopsy-proven CPFE cohort, whereas only the fibrosis-weighted CT index was a significant prognostic factor in the subclinical CPFE cohort. Conclusions: Recognition and stratification using CT quantification can be utilized as a prognostic predictor. Prognostic factors vary according to fibrosis severity and among cohorts of patients with biopsy-proven and subclinical CPFE.	[Choi, Seung Hee; Lee, Ho Yun; Lee, Kyung Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Choi, Seung Hee; Lee, Ho Yun; Lee, Kyung Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea; [Chung, Man Pyo; Kwon, O. Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Resp & Crit Med,Dept Internal Med, Seoul, South Korea; [Han, Joungho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Kim, Namkug; Seo, Joon Beom] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Namkug; Seo, Joon Beom] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Lee, HY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.	hoyunlee96@gmail.com	Kim, Namkug/E-3843-2012; Seo, Joon Beom/AAQ-5445-2021; Lee, Ho Yun/D-6086-2012	Kim, Namkug/0000-0002-3438-2217; Seo, Joon Beom/0000-0003-0271-7884; 				Akagi T, 2009, RESP MED, V103, P1209, DOI 10.1016/j.rmed.2009.02.001; Antoniou KM, 2008, AM J RESP CRIT CARE, V177, P190, DOI 10.1164/rccm.200612-1759OC; BERGIN C, 1986, AM REV RESPIR DIS, V133, P541; Chae EJ, 2010, AM J ROENTGENOL, V194, pW248, DOI 10.2214/AJR.09.2672; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; Doherty MJ, 1997, THORAX, V52, P998, DOI 10.1136/thx.52.11.998; Doyle TJ, 2012, AM J RESP CRIT CARE, V185, P1147, DOI 10.1164/rccm.201108-1420PP; Flaherty KR, 2006, AM J RESP CRIT CARE, V174, P803, DOI 10.1164/rccm.200604-488OC; Flaherty KR, 2003, AM J RESP CRIT CARE, V168, P543, DOI 10.1164/rccm.200209-1112OC; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; Kurashima K, 2010, RESPIROLOGY, V15, P843, DOI 10.1111/j.1440-1843.2010.01778.x; Lee HY, 2012, CHEST, V142, P1577, DOI 10.1378/chest.11-2812; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Park YS, 2008, INVEST RADIOL, V43, P395, DOI 10.1097/RLI.0b013e31816901c7; Ryerson CJ, 2013, CHEST; Schmidt SL, 2011, EUR RESPIR J, V38, P176, DOI 10.1183/09031936.00114010; Shin KM, 2008, RADIOLOGY, V249, P328, DOI 10.1148/radiol.2483071378; Todd NW, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-6; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Wells AU, 1997, AM J RESP CRIT CARE, V155, P1367, DOI 10.1164/ajrccm.155.4.9105081; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; WIGGINS J, 1990, RESP MED, V84, P365, DOI 10.1016/S0954-6111(08)80070-4	26	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107476	10.1371/journal.pone.0107476	http://dx.doi.org/10.1371/journal.pone.0107476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203455	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500104
J	Moller, KL; Thygesen, LC; Schipperijn, J; Loft, S; Bonde, JP; Mikkelsen, S; Brauer, C				Moller, Karina Lauenborg; Thygesen, Lau Caspar; Schipperijn, Jasper; Loft, Steffen; Bonde, Jens Peter; Mikkelsen, Sigurd; Brauer, Charlotte			Occupational Exposure to Ultrafine Particles among Airport Employees - Combining Personal Monitoring and Global Positioning System	PLOS ONE			English	Article							AIR-POLLUTION; PARTICULATE MATTER; TERM EXPOSURE; DISEASE; TIME	Background: Exposure to ultrafine particles (UFP) has been linked to cardiovascular and lung diseases. Combustion of jet fuel and diesel powered handling equipment emit UFP resulting in potentially high exposure levels among employees working at airports. High levels of UFP have been reported at several airports, especially on the apron, but knowledge on individual exposure profiles among different occupational groups working at an airport is lacking. Purpose: The aim of this study was to compare personal exposure to UFP among five different occupational groups working at Copenhagen Airport (CPH). Method: 30 employees from five different occupational groups (baggage handlers, catering drivers, cleaning staff and airside and landside security) at CPH were instructed to wear a personal monitor of particle number concentration in real time and a GPS device. The measurements were carried out on 8 days distributed over two weeks in October 2012. The overall differences between the groups were assessed using linear mixed model. Results: Data showed significant differences in exposure levels among the groups when adjusted for variation within individuals and for effect of time and date (p < 0.01). Baggage handlers were exposed to 7 times higher average concentrations (geometric mean, GM: 37 x 10(3) UFP/cm(3), 95% CI: 25-55 x 10(3) UFP/cm(3)) than employees mainly working indoors (GM: 5 x 10(3) UFP/cm(3), 95% CI: 2-11 x 10(3) UFP/cm(3)). Furthermore, catering drivers, cleaning staff and airside security were exposed to intermediate concentrations (GM: 12 to 20 x 10(3) UFP/cm(3)). Conclusion: The study demonstrates a strong gradient of exposure to UFP in ambient air across occupational groups of airport employees.	[Moller, Karina Lauenborg; Thygesen, Lau Caspar] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Schipperijn, Jasper] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Loft, Steffen] Univ Copenhagen, Dept Publ Hlth, Environm Hlth Sect, Copenhagen, Denmark; [Bonde, Jens Peter; Mikkelsen, Sigurd; Brauer, Charlotte] Copenhagen Univ Hosp Bispebjerg, Dept Occupat & Environm Med, Copenhagen, Denmark	University of Southern Denmark; University of Southern Denmark; University of Copenhagen; Aarhus University; University of Copenhagen; Bispebjerg Hospital	Moller, KL (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.	Kalm@si-folkesundhed.dk	Schipperijn, Jasper/AAF-5426-2020; Thygesen, Lau/W-9096-2019	Schipperijn, Jasper/0000-0002-6558-7610; Thygesen, Lau/0000-0001-8375-5211; Loft, Steffen/0000-0001-9552-8518; Brauer, Charlotte/0000-0002-2109-3264; Moller, Karina/0000-0002-1430-5580	Danish Working Environment Research Fund [20110081336]; Center for Indoor air and Health in dwellings (CISBO)	Danish Working Environment Research Fund; Center for Indoor air and Health in dwellings (CISBO)	This study was supported by a grant from The Danish Working Environment Research Fund (Journal no: 20110081336). The three Nano Tracers were purchased with funds from Center for Indoor air and Health in dwellings (CISBO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ZJ, 2011, AM J RESP CRIT CARE, V183, P455, DOI 10.1164/rccm.201006-0937OC; Andersen ZJ, 2010, EUR HEART J, V31, P2034, DOI 10.1093/eurheartj/ehq188; Asbach C, 2012, ANN OCCUP HYG, V56, P606, DOI 10.1093/annhyg/mes033; Beko G, 2013, ENVIRON SCI TECHNOL, V47, P10240, DOI 10.1021/es402429h; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Buonanno G, 2012, ENVIRON POLLUT, V170, P78, DOI 10.1016/j.envpol.2012.05.027; Cavallo D, 2006, TOXICOLOGY, V223, P26, DOI 10.1016/j.tox.2006.03.003; Donaldson K, 2001, ENVIRON HEALTH PERSP, V109, P523, DOI 10.2307/3454663; Duncan S, 2013, AM J PREV MED, V44, pE19, DOI 10.1016/j.amepre.2012.10.013; Fang SC, 2010, INT J ENV RES PUB HE, V7, P1773, DOI 10.3390/ijerph7041773; Franck U, 2011, SCI TOTAL ENVIRON, V409, P4217, DOI 10.1016/j.scitotenv.2011.05.049; Kerr J, 2012, MED SCI SPORT EXER; Kerr J, 2011, AM J PREV MED, V41, P532, DOI 10.1016/j.amepre.2011.07.017; Krenn PJ, 2011, AM J PREV MED, V41, P508, DOI 10.1016/j.amepre.2011.06.046; Morabia A, 2009, AM J PREV MED, V37, P72, DOI 10.1016/j.amepre.2009.03.014; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Raaschou-Nielsen O, 2011, ENVIRON HEALTH PERSP, V119, P860, DOI 10.1289/ehp.1002353; Tandon PS, 2013, AM J PREV MED, V44, P85, DOI 10.1016/j.amepre.2012.09.052; Thomas Ellermann AM, 2011, MEASUREMENT ULTRAFIN; Touri L, 2013, EUR RESPIR REV, V22, P124, DOI 10.1183/09059180.00005712; Tunnicliffe WS, 1999, OCCUP ENVIRON MED, V56, P118, DOI 10.1136/oem.56.2.118; Weichenthal S, 2012, ENVIRON RES, V115, P26, DOI 10.1016/j.envres.2012.03.001; Wu J, 2010, ENVIRON HEALTH INSIG, V4, P93, DOI 10.4137/EHI.S6246; Yang CY, 2003, J TOXICOL ENV HEAL A, V66, P799, DOI 10.1080/15287390306383	24	21	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106671	10.1371/journal.pone.0106671	http://dx.doi.org/10.1371/journal.pone.0106671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203510	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500035
J	Tron, L; Lert, F; Spire, B; Dray-Spira, R				Tron, Laure; Lert, France; Spire, Bruno; Dray-Spira, Rosemary		ANRS-Vespa2 Study Grp	Tobacco Smoking in HIV-Infected versus General Population in France: Heterogeneity across the Various Groups of People Living with HIV	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; CIGARETTE-SMOKING; MORTALITY; COMORBIDITIES; INDIVIDUALS; PREVALENCE; MORBIDITY; BEHAVIOR; BURDEN	Background: Although the various groups of people living with HIV (PLWHIV) considerably differ regarding socioeconomic and behavioral characteristics, their specificities regarding tobacco smoking have been poorly investigated. We aimed to assess patterns of tobacco consumption across the various groups of PLWHIV and to compare them to the general population, accounting for the specific socioeconomic profile of PLWHIV. Methods: We used data of the ANRS-Vespa2 study, a national representative survey on PLWHIV conducted in France in 2011. Prevalence of past and current tobacco consumption, heavy smoking and strong nicotine dependence were assessed among the various groups of PLWHIV as defined by transmission category, gender and geographic origin, and compared to the French general population using direct standardization and multivariate Poisson regression models, accounting for gender, age, education and geographic origin. Results: Among the 3,019 participants aged 18-85 years (median time since HIV diagnosis: 12 years), 37.5% were current smokers and 22.1% were past smokers, with marked differences across the various groups of PLWHIV. Compared to the general population, the prevalence of regular smoking was increased among HIV-infected men who have sex with men (MSM) (adjusted prevalence rate ratio (aPRR): 1.19, 95% confidence interval (95% CI): 1.07-1.32), French-native women (aPRR: 1.32, 95% CI: 1.10-1.57), and heterosexual French-native men (although not significantly, aPRR: 1.19, 95% CI: 0.98-1.45). Additionally, HIV-infected MSM were significantly less likely to be ex-smokers (aPRR: 0.73, 95% CI: 0.64-0.82) than the general population and similar trends were observed among heterosexual French-native men (aPRR: 0.89, 95% CI: 0.78-1.02) and women (aPRR: 0.84, 95% CI: 0.70-1.01). HIV-infected sub-Saharan African migrants were less likely to be regular smokers than the general population. Conclusions: Smoking constitutes a major concern in various groups of PLWHIV in France including MSM and heterosexual French-natives, probably resulting from PLWHIV being less likely to quit smoking than their counterparts in the general population.	[Tron, Laure; Dray-Spira, Rosemary] INSERM, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, UMR 1136 S, Paris, France; [Tron, Laure; Dray-Spira, Rosemary] Univ Paris 06, Sorbonne Univ, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol,UMR 1136 S, Paris, France; [Lert, France] INSERM, Ctr Res Epidemiol & Populat Hlth, Dept Epidemiol Occupat & Social Determinants Hlth, U1018, Villejuif, France; [Lert, France] Versailles St Quentin En Yvelines Univ, Villejuif, France; [Spire, Bruno] INSERM, Econ & Social Sci Appl Hlth & Anal Med Informat S, F-13258 Marseille, France; [Spire, Bruno] Aix Marseille Univ, IRD, UMR S912, Marseille, France; [Lert, France] Southeastern Hlth Reg Observ, ORS PACA, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Tron, L (corresponding author), INSERM, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, UMR 1136 S, Paris, France.	laure.tron@inserm.fr	Spire, Bruno/F-5546-2013; Tron, Laure/ABD-8890-2020	Spire, Bruno/0000-0002-3546-8020; Tron, Laure/0000-0002-2091-6652; Carrieri, Patrizia/0000-0002-6794-4837; Lelievre, Jean-Daniel/0000-0002-8182-3628; Alvarez, Mario Moises/0000-0002-9131-5344; Chen, Xinguang/0000-0001-8263-643X; Dray-Spira, Rosemary/0000-0001-7646-3667; DENES, Eric/0000-0001-5321-3171	ANRS (Agence Nationale de Recherche sur le Sida et les Hepatites Virales), Paris, France	ANRS (Agence Nationale de Recherche sur le Sida et les Hepatites Virales), Paris, France(ANRS)	The Vespa2 study was sponsored and funded by the ANRS (Agence Nationale de Recherche sur le Sida et les Hepatites Virales), Paris, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang C, 2009, GLOBAL HLTH, V5, P1744; Bajos N, 2008, SEXUALITY FRANCE PRA; Balsam KF, 2012, AM J ORTHOPSYCHIAT, V82, P482, DOI 10.1111/j.1939-0025.2012.01186.x; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; BECK F, 2013, HLTH BAROMETER 2010; Benard A, 2006, INT J TUBERC LUNG D, V10, P378; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Cockerham L, 2010, JAIDS-J ACQ IMM DEF, V53, P102, DOI 10.1097/QAI.0b013e3181b79d22; Costes J-M, 2009, TENDANCES; Crothers K, 2009, AIDS EDUC PREV, V21, P40, DOI 10.1521/aeap.2009.21.3_supp.40; De Socio GV, 2014, AIDS, V28, P609, DOI 10.1097/QAD.0000000000000181; De Socio GVL, 2007, SCAND J INFECT DIS, V39, P805, DOI 10.1080/00365540701230884; Dray-Spira R., 2013, Bulletin Epidemiologique Hebdomadaire, P285; Dray-Spira R., 2013, Bulletin Epidemiologique Hebdomadaire, P321; Dray-Spira R, 2012, AIDS, V26, P207, DOI 10.1097/QAD.0b013e32834dcf61; Duval X, 2008, ANTIVIR THER, V13, P389; Glass TR, 2006, HIV MED, V7, P404, DOI 10.1111/j.1468-1293.2006.00400.x; Gritz ER, 2004, NICOTINE TOB RES, V6, P71, DOI 10.1080/14622200310001656885; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Hemkens LG, 2014, EUR HEART J, V9, P9; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Lert F., 2013, Bulletin Epidemiologique Hebdomadaire, P293; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Licht AS, 2012, AM J PUBLIC HEALTH, V102, P1868, DOI 10.2105/AJPH.2012.300717; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Marshall MM, 2011, ADDICT BEHAV, V36, P61, DOI 10.1016/j.addbeh.2010.08.022; McKirnan DJ, 2006, SUBST USE MISUSE, V41, P1197, DOI 10.1080/10826080500514503; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Morlat P., 2013, PRISE CHARGE MED PER; Nadal J-M, 1997, B EPIDEMIOL HEBD, V23, P107; National Institute of Statistics and Economic Studies (INSEE), 2010, 2010 POP CENS; Oh John Y, 2012, Open AIDS J, V6, P177, DOI 10.2174/1874613601206010177; Palella FJ, 2011, CURR OPIN HIV AIDS, V6, P266, DOI 10.1097/COH.0b013e328347876c; Peretti-Watel P, 2006, DRUG ALCOHOL DEPEN, V82, pS71, DOI 10.1016/S0376-8716(06)80012-8; Peretti-Watel P, 2009, ADDICTION, V104, P1718, DOI 10.1111/j.1360-0443.2009.02682.x; Rahmanian Shiva, 2011, Proc Am Thorac Soc, V8, P313, DOI 10.1513/pats.201009-058WR; Reinsch N, 2012, EUR J PREV CARDIOL, V19, P267, DOI 10.1177/1741826711398431; Rodriguez-Penney AT, 2013, AIDS PATIENT CARE ST, V27, P5, DOI 10.1089/apc.2012.0329; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Shirley DK, 2013, CLIN INFECT DIS, V57, P275, DOI 10.1093/cid/cit207; Spilka S, 2012, TENDANCES; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195; World Health Organization, 2008, WHO REP GLOB TOB EP	50	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107451	10.1371/journal.pone.0107451	http://dx.doi.org/10.1371/journal.pone.0107451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IF	25202968	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500099
J	Khan, JA; Mustafa, M; Hayat, T; Alsaedi, A				Khan, Junaid Ahmad; Mustafa, Meraj; Hayat, Tasawar; Alsaedi, Ahmed			On Three-Dimensional Flow and Heat Transfer over a Non-Linearly Stretching Sheet: Analytical and Numerical Solutions	PLOS ONE			English	Article							HOMOTOPY ANALYSIS METHOD; BOUNDARY-LAYER-FLOW; FREE-CONVECTION; MAGNETIC-FIELD; SERIES SOLUTIONS; PERMEABLE SHEET; MASS-TRANSFER; VISCOUS-FLOW; MHD FLOW; NANOFLUID	This article studies the viscous flow and heat transfer over a plane horizontal surface stretched non-linearly in two lateral directions. Appropriate wall conditions characterizing the non-linear variation in the velocity and temperature of the sheet are employed for the first time. A new set of similarity variables is introduced to reduce the boundary layer equations into self-similar forms. The velocity and temperature distributions are determined by two methods, namely (i) optimal homotopy analysis method (OHAM) and (ii) fourth-fifth-order Runge-Kutta integration based shooting technique. The analytic and numerical solutions are compared and these are found in excellent agreement. Influences of embedded parameters on momentum and thermal boundary layers are sketched and discussed.	[Khan, Junaid Ahmad] NUST, RCMS, Islamabad, Pakistan; [Mustafa, Meraj] NUST, SNS, Islamabad, Pakistan; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah 21413, Saudi Arabia	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University	Mustafa, M (corresponding author), NUST, SNS, Islamabad, Pakistan.	meraj_mm@hotmail.com	Mustafa Hashmi, Meraj/P-1769-2014; Ahmad, Junaid/AAE-8872-2019; Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/E-9449-2015; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasbandy S, 2011, COMMUN NONLINEAR SCI, V16, P4268, DOI 10.1016/j.cnsns.2011.03.031; Bhargava R., 2007, Nonlinear Analysis Modelling and Control, V12, P45; Cortell R, 2008, PHYS LETT A, V372, P631, DOI 10.1016/j.physleta.2007.08.005; Cortell R, 2007, APPL MATH COMPUT, V184, P864, DOI 10.1016/j.amc.2006.06.077; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Farooq U, 2014, SCI WORLD J, DOI 10.1155/2014/158269; Hayat T, 2008, PHYS LETT A, V372, P637, DOI 10.1016/j.physleta.2007.08.006; Hayat T, 2012, COMMUN NONLINEAR SCI, V17, P699, DOI 10.1016/j.cnsns.2011.05.042; Hayat T, 2011, APPL MATH MECH-ENGL, V32, P167, DOI 10.1007/s10483-011-1403-7; Hayat T, 2009, NONLINEAR ANAL-REAL, V10, P966, DOI 10.1016/j.nonrwa.2007.11.020; Kechil SA, 2008, PHYS LETT A, V372, P2258, DOI 10.1016/j.physleta.2007.11.027; Khan JA, 2014, J MOL LIQ, V194, P41, DOI 10.1016/j.molliq.2013.12.045; LAKSHMISHA KN, 1988, J HEAT TRANS-T ASME, V110, P590, DOI 10.1115/1.3250533; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Liu IC, 2008, INT J HEAT MASS TRAN, V51, P4018, DOI 10.1016/j.ijheatmasstransfer.2007.10.041; Liu IC, 2013, CHEM ENG COMMUN, V200, P253, DOI 10.1080/00986445.2012.703148; Marinca V, 2008, INT COMMUN HEAT MASS, V35, P710, DOI 10.1016/j.icheatmasstransfer.2008.02.010; Mukhopadhyay S, 2013, ALEX ENG J, V52, P563, DOI 10.1016/j.aej.2013.07.004; Mukhopadhyay S, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/7/074701; Mushtaq A, 2013, Z NATURFORSCH A, V68, P791, DOI 10.5560/ZNA.2013-0063; Mustafa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061859; Niu Z, 2010, COMMUN NONLINEAR SCI, V15, P2026, DOI 10.1016/j.cnsns.2009.08.014; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Rashidi MM, 2014, MECCANICA, V49, P469, DOI 10.1007/s11012-013-9805-9; Rashidi MM, 2010, NONLINEAR ANAL-MODEL, V15, P83, DOI 10.15388/NA.2010.15.1.14366; Rashidi MM, 2010, MATH PROBL ENG, V2010, P14, DOI DOI 10.1155/2010/491319; Rashidi MM, 2011, INT J NUMER METHOD H, V21, P864, DOI 10.1108/09615531111162837; Shahzad A, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/8/084705; Sheikholeslami M, 2014, J MOL LIQ, V194, P179, DOI 10.1016/j.molliq.2014.01.022; Sheikholeslami M, 2014, COMPUT FLUIDS, V94, P147, DOI 10.1016/j.compfluid.2014.01.036; Sheikholeslami M, 2014, J MOL LIQ, V194, P13, DOI 10.1016/j.molliq.2014.01.003; Sheikholeslami M, 2014, POWDER TECHNOL, V254, P82, DOI 10.1016/j.powtec.2013.12.054; Sheikholeslami M, 2014, J TAIWAN INST CHEM E, V45, P795, DOI 10.1016/j.jtice.2013.09.018; Sheikholeslami M, 2014, SCI IRAN, V21, P203; Sheikholeslami M, 2014, POWDER TECHNOL, V256, P490, DOI 10.1016/j.powtec.2014.01.079; Takhar HS, 2001, ACTA MECH, V146, P59, DOI 10.1007/BF01178795; Vajravelu K, 2001, APPL MATH COMPUT, V124, P281, DOI 10.1016/S0096-3003(00)00062-X; WANG CY, 1984, PHYS FLUIDS, V27, P1915, DOI 10.1063/1.864868; Xu H, 2007, EUR J MECH B-FLUID, V26, P15, DOI 10.1016/j.euromechflu.2005.12.003; Zhao YL, 2014, ADV HOMOTOPY ANAL ME; Ziabakhsh Z, 2010, J TAIWAN INST CHEM E, V41, P22, DOI 10.1016/j.jtice.2009.04.011	41	58	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107287	10.1371/journal.pone.0107287	http://dx.doi.org/10.1371/journal.pone.0107287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198696	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700103
J	Gong, Z; Luna, Y; Yu, P; Fan, HZ				Gong, Zheng; Luna, Yesmin; Yu, Ping; Fan, Huizhou			Lactobacilli Inactivate Chlamydia trachomatis through Lactic Acid but Not H2O2	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; BACTERIAL VAGINOSIS; GENOME SEQUENCE; ARGININE DECARBOXYLASE; VAGINAL LACTOBACILLI; GRAM STAIN; WOMEN; RESISTANCE; INFECTION; IDENTIFICATION	Lactobacillus species dominate the microbiome in the lower genital tract of most reproductive-age women. Producing lactic acid and H2O2, lactobacilli are believed to play an important role in prevention of colonization by and growth of pathogens. However, to date, there have been no reported studies characterizing how lactobacilli interact with Chlamydia trachomatis, a leading sexually transmitted bacterium. In this report, we demonstrate inactivation of C. trachomatis infectivity by culture media conditioned by Lactobacillus crispatus, L. gasseri and L. jensenii, known to be dominating organisms in the human vaginal microbiome. Lactobacillus still cultures produced lactic acid, leading to time-and concentration-dependent killing of C. trachomatis. Neutralization of the acidic media completely reversed chlamydia killing. Addition of lactic acid into Lactobacillus-unconditioned growth medium recapitulated the chlamydiacidal activity of conditioned media. The H2O2 concentrations in the still cultures were found to be comparable to those reported for the cervicovaginal fluid, but insufficient to inactivate chlamydiae. Aeration of Lactobacillus cultures by shaking markedly induced H2O2 production, but strongly inhibited Lactobacillus growth and lactic acid production, and thus severely affected acidification, leading to significantly reduced chlamydiacidal efficiency. These observations indicate lactobacilli inactivate chlamydiae primarily through maintaining acidity in a relatively hypoxic environment in the vaginal lumen with limited H2O2, which is consistent with the notion that women with higher vaginal pH are more prone to sexually transmitted C. trachomatis infection. In addition to lactic acid, formic acid and acetic acid also exhibited potent chlamydiacidal activities. Taken together, our findings imply that lowering the vaginal pH through engineering of the vaginal microbiome and other means will make women less susceptible to C. trachomatis infection.	[Gong, Zheng; Luna, Yesmin; Fan, Huizhou] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Gong, Zheng; Yu, Ping] Cent South Univ, Xiangya Med Sch, Dept Immunol, Changsha, Hunan, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Central South University	Fan, HZ (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	fanhu@rutgers.edu		FAN, HUIZHOU/0000-0002-4903-926X	National Institutes of Health [AI071954]; New Jersey Health Foundation [PC7-13]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071954, R33AI071954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Health Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (AI071954) and a grant from the New Jersey Health Foundation (PC7-13) to HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2006, DERMATOLOGY, V212, P41, DOI 10.1159/000089021; Aldunate M, 2013, J ANTIMICROB CHEMOTH, V68, P2015, DOI 10.1093/jac/dkt156; Allsworth JE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.060; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Bao XF, 2012, P NATL ACAD SCI USA, V109, P16870, DOI 10.1073/pnas.1207300109; Barlow REL, 2001, J MED MICROBIOL, V50, P902, DOI 10.1099/0022-1317-50-10-902; Beatty Wandy L., 1994, Trends in Microbiology, V2, P94, DOI 10.1016/0966-842X(94)90542-8; Beigi RH, 2005, J INFECT DIS, V191, P924, DOI 10.1086/428288; Bliven KA, 2012, FEMS MICROBIOL LETT, V337, P140, DOI 10.1111/1574-6968.12021; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; CDC, 2013, MMWR-MORBID MORTAL W, V62, P424; CDC, 2013, CDC FACT SHEET STD T; Chang TLY, 2003, P NATL ACAD SCI USA, V100, P11672, DOI 10.1073/pnas.1934747100; Cohen CR, 1999, SEX TRANSM INFECT, V75, P21, DOI 10.1136/sti.75.1.21; den Hartog JE, 2006, HUM REPROD UPDATE, V12, P719, DOI 10.1093/humupd/dml030; Ding HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080534; Doerflinger SY, 2014, J INFECT DIS, V209, P1989, DOI 10.1093/infdis/jiu004; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gharsallah H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-333; Giles TN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-166; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; HINTON M, 1988, VET REC, V123, P416, DOI 10.1136/vr.123.16.416; Jin L, 2007, J APPL MICROBIOL, V102, P1107, DOI 10.1111/j.1365-2672.2006.03147.x; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94; Martin R, 2010, APPL ENVIRON MICROB, V76, P400, DOI 10.1128/AEM.01631-09; Martinez RCR, 2009, LETT APPL MICROBIOL, V48, P269, DOI 10.1111/j.1472-765X.2008.02477.x; MARTIUS J, 1988, OBSTET GYNECOL, V71, P89; Mastromarino P, 2014, INT J MED MICROBIOL, V304, P654, DOI 10.1016/j.ijmm.2014.04.006; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; O'Hanlon DE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-120; Ocana VS, 1999, CURR MICROBIOL, V38, P279, DOI 10.1007/PL00006802; Pridmore RD, 2008, FEMS MICROBIOL LETT, V283, P210, DOI 10.1111/j.1574-6968.2008.01176.x; Pybus V, 1999, MICROBES INFECT, V1, P285, DOI 10.1016/S1286-4579(99)80024-0; Quatravaux S, 2006, J APPL MICROBIOL, V101, P903, DOI 10.1111/j.1365-2672.2006.02955.x; Rabe LK, 2003, J CLIN MICROBIOL, V41, P3260, DOI 10.1128/JCM.41.7.3260-3264.2003; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reid G, 2002, MICROBES INFECT, V4, P319, DOI 10.1016/S1286-4579(02)01544-7; Rizzo A, 2013, IMMUNOL LETT, V156, P102, DOI 10.1016/j.imlet.2013.08.013; Sachse K, 2014, SYST APPL MICROBIOL, V37, P79, DOI 10.1016/j.syapm.2013.12.004; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Stamm WE, 2005, CHLAMYDIA TRACHOMATI; Stephens RS, 2009, FEMS IMMUNOL MED MIC, V55, P115, DOI 10.1111/j.1574-695X.2008.00516.x; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Teixeira GS, 2012, J MED MICROBIOL, V61, P1074, DOI 10.1099/jmm.0.041962-0; Thompson JL, 1997, BRIT POULTRY SCI, V38, P59, DOI 10.1080/00071669708417941; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Vajdic Claire M, 2005, Sex Health, V2, P169, DOI 10.1071/SH05018; Van Lent S, 2012, J BACTERIOL, V194, P6930, DOI 10.1128/JB.01828-12; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wilks M, 2004, J CLIN MICROBIOL, V42, P713, DOI 10.1128/JCM.42.2.713-717.2004; Xu Shuang, 2013, BMC Res Notes, V6, P377, DOI 10.1186/1756-0500-6-377; Yasir M, 2011, INFECT IMMUN, V79, P4019, DOI 10.1128/IAI.05308-11	58	90	96	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107758	10.1371/journal.pone.0107758	http://dx.doi.org/10.1371/journal.pone.0107758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215504	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300094
J	Reddy, R; Fahiminiya, S; El Zir, E; Mansour, A; Megarbane, A; Majewski, J; Slim, R				Reddy, Ramesh; Fahiminiya, Somayyeh; El Zir, Elie; Mansour, Ahmad; Megarbane, Andre; Majewski, Jacek; Slim, Rima			Molecular Genetics of the Usher Syndrome in Lebanon: Identification of 11 Novel Protein Truncating Mutations by Whole Exome Sequencing	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; SYNDROME TYPE-3; HEARING-LOSS; FAMILY; GENES; DEAFNESS; PROTOCADHERIN-15; CADHERIN-23; PREVALENCE; POPULATION	Background: Usher syndrome (USH) is a genetically heterogeneous condition with ten disease-causing genes. The spectrum of genes and mutations causing USH in the Lebanese and Middle Eastern populations has not been described. Consequently, diagnostic approaches designed to screen for previously reported mutations were unlikely to identify the mutations in 11 unrelated families, eight of Lebanese and three of Middle Eastern origins. In addition, six of the ten USH genes consist of more than 20 exons, each, which made mutational analysis by Sanger sequencing of PCR-amplified exons from genomic DNA tedious and costly. The study was aimed at the identification of USH causing genes and mutations in 11 unrelated families with USH type I or II. Methods: Whole exome sequencing followed by expanded familial validation by Sanger sequencing. Results: We identified disease-causing mutations in all the analyzed patients in four USH genes, MYO7A, USH2A, GPR98 and CDH23. Eleven of the mutations were novel and protein truncating, including a complex rearrangement in GPR98. Conclusion: Our data highlight the genetic diversity of Usher syndrome in the Lebanese population and the time and cost-effectiveness of whole exome sequencing approach for mutation analysis of genetically heterogeneous conditions caused by large genes.	[Reddy, Ramesh; Slim, Rima] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada; [Reddy, Ramesh; Slim, Rima] McGill Univ, Ctr Hlth, Dept Obstet Gynecol, Montreal, PQ, Canada; [Fahiminiya, Somayyeh; Majewski, Jacek] McGill Univ, Montreal, PQ, Canada; [Fahiminiya, Somayyeh; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Fahiminiya, Somayyeh; Majewski, Jacek] Dept Human Genet, Montreal, PQ, Canada; [El Zir, Elie] Hop Sacre Coeur, Dept Otorhinolaryngol, Baabda, Lebanon; [Mansour, Ahmad] Amer Univ Beirut, Dept Ophthalmol, Beirut, Lebanon; [Megarbane, Andre] Univ St Joseph, Fac Med, Unite Genet Med, Beirut, Lebanon	McGill University; McGill University; McGill University; American University of Beirut; Saint Joseph University Beirut	Slim, R (corresponding author), McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada.	rima.slim@muhc.mcgill.ca	Slim, Rima/J-4104-2019; Guggilla, Ramesh Reddy/I-3679-2016; Megarbane, Andre/ABD-5574-2021	Slim, Rima/0000-0002-4060-2159; Guggilla, Ramesh Reddy/0000-0002-6457-966X; 	Canadian Institutes of Health Research [86546]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (86546). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Akoury E, 2011, OPHTHALMIC GENET, V32, P245, DOI 10.3109/13816810.2011.587083; Besnard T, 2014, MOL GENET GENOM MED, V2, P30, DOI 10.1002/mgg3.25; Besnard T, 2012, HUM MUTAT, V33, P504, DOI 10.1002/humu.22004; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Burland T G, 2000, Methods Mol Biol, V132, P71; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Di Leva F, 2006, AUDIOL NEURO-OTOL, V11, P157, DOI 10.1159/000091199; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Eisenberger T, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-59; Eng L, 2004, HUM MUTAT, V23, P67, DOI 10.1002/humu.10295; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Fahiminiya S, 2014, J BONE MINER RES; Fahiminiya S, 2013, BONE, V57, P41, DOI 10.1016/j.bone.2013.07.020; Ganapathy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084773; Glockle N, 2014, EUR J HUM GENET, V22, P99, DOI 10.1038/ejhg.2013.72; Hilgert N, 2009, J MED GENET, V46, P272, DOI 10.1136/jmg.2008.060947; Huang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063832; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Khan MI, 2011, OPHTHALMOLOGY, V118, P1444, DOI 10.1016/j.ophtha.2010.10.047; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mendez-Vidal C, 2013, MOL VIS, V19, P2187; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; Mouglabey YB, 1998, CLIN GENET, V54, P155; Nakanishi H, 2010, J HUM GENET, V55, P796, DOI 10.1038/jhg.2010.115; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Saouda M, 1998, HUM GENET, V103, P193, DOI 10.1007/s004390050806; Shi YH, 2013, BIOINFORMATICS, V29, P1461, DOI 10.1093/bioinformatics/btt151; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Spandau UHM, 2002, GRAEF ARCH CLIN EXP, V240, P495, DOI 10.1007/s00417-002-0485-8; Stabej PL, 2012, J MED GENET, V49, P27, DOI 10.1136/jmedgenet-2011-100468; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VERNON M, 1969, J CHRON DIS, V22, P133, DOI 10.1016/0021-9681(69)90055-1; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Yoshimura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090688; Zheng QY, 2005, HUM MOL GENET, V14, P103, DOI 10.1093/hmg/ddi010	50	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107326	10.1371/journal.pone.0107326	http://dx.doi.org/10.1371/journal.pone.0107326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211151	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900062
J	Remis, RS; Alary, M; Liu, J; Kaul, R; Palmer, RWH				Remis, Robert S.; Alary, Michel; Liu, Juan; Kaul, Rupert; Palmer, Robert W. H.			HIV Transmission among Men Who Have Sex with Men due to Condom Failure	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; HOMOSEXUAL-MEN; RISK REDUCTION; SAN-FRANCISCO; UNITED-STATES; INFECTION; BEHAVIOR; PREVENTION; FREQUENCY; PARTNERS	Background: Despite preventive efforts, HIV incidence remains high among men who have sex with men (MSM) in industrialized countries. Condoms are an important element in prevention but, given the high frequency of condom use and their imperfect effectiveness, a substantial number and proportion of HIV transmissions may occur despite condoms. We developed a model to examine this hypothesis. Methods: We used estimates of annual prevalent and incident HIV infections for MSM in Ontario. For HIV-negative men, we applied frequencies of sexual episodes and per-contact HIV transmission risks of receptive and insertive anal sex with and without a condom and oral sex without a condom. We factored in the proportion of HIV-infected partners receiving antiretroviral therapy and its impact in reducing transmissibility. We used Monte-Carlo simulation to determine the plausible range for the proportion of HIV transmissions for each sexual practice. Results: Among Ontario MSM in 2009, an estimated 92,963 HIV-negative men had 1,184,343 episodes of anal sex with a condom and 117,133 anal sex acts without a condom with an HIV-positive partner. Of the 693 new HIV infections, 51% were through anal sex with a condom, 33% anal sex without a condom and 16% oral sex. For anal sex with a condom, the 95% confidence limits were 17% and 77%. Conclusions: The proportion of HIV infections related to condom failure appears substantial and higher than previously thought. That 51% of transmissions occur despite condom use may be conservative (i.e. low) since we used a relatively high estimate (87.1%) for condom effectiveness. If condom effectiveness were closer to 70%, a value estimated from a recent CDC study, the number and proportion of HIV transmissions occurring despite condom use would be much higher. Therefore, while condom use should continue to be promoted and enhanced, this alone is unlikely to stem the tide of HIV infection among MSM.	[Remis, Robert S.; Liu, Juan; Palmer, Robert W. H.] Univ Toronto, Dalla Lana Sch Publ Hlth, Ontario HIV Epidemiol Monitoring Unit, Toronto, ON, Canada; [Alary, Michel] CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Alary, Michel] Univ Laval, Fac Med, Dept Med Sociale & Prevent, Quebec City, PQ G1K 7P4, Canada; [Alary, Michel] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Kaul, Rupert] Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON, Canada	University of Toronto; Laval University; Laval University; Institut national de sante publique du Quebec (INSPQ); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Palmer, RWH (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Ontario HIV Epidemiol Monitoring Unit, Toronto, ON, Canada.	r.palmer@utoronto.ca		Kaul, Rupert/0000-0002-1586-4093				[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Baggaley RF, 2008, INT J EPIDEMIOL, V37, P1255, DOI 10.1093/ije/dyn151; Calzavara L, 2003, AM J EPIDEMIOL, V157, P210, DOI 10.1093/aje/kwf195; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P430; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Centre for Communicable Diseases and Infection Control Public Health Agency of Canada, 2012, EST HIV PREV INC CAN; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; D'Anna LH, 2012, AIDS CARE, V24, P1028, DOI 10.1080/09540121.2012.668285; George C, 2006, JAIDS-J ACQ IMM DEF, V42, P207, DOI 10.1097/01.qai.0000200664.24968.4c; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hogg RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047260; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Katz MH, 1997, J ACQ IMMUN DEF SYND, V14, pS38, DOI 10.1097/00042560-199700002-00008; LAU RKW, 1992, INT J STD AIDS, V3, P267, DOI 10.1177/095646249200300407; Livingston KA, 2014, VACCINE, V32, P369, DOI 10.1016/j.vaccine.2013.11.021; Marcus U, 2006, SEX TRANSM DIS, V33, P11, DOI 10.1097/01.olq.0000187224.10428.31; Mastro T D, 1996, AIDS, V10 Suppl A, pS75, DOI 10.1097/00002030-199601001-00011; MORRIS M, 1994, AM J EPIDEMIOL, V140, P217, DOI 10.1093/oxfordjournals.aje.a117241; Myers T, 2008, TECHNICAL REPORT LAM; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Remis RS, 2013, CAN J INFECT DIS SA, V24, p76A; Remis RS, 2012, REPORT HIV AIDS ONTA; Rodger A BT, 2014, TOP ANTIVIR MED, V22, P24; Silverman BG, 1997, SEX TRANSM DIS, V24, P11, DOI 10.1097/00007435-199701000-00004; Smith D, 2013, 20 C RETR OPP INF AT; Statistics Canada, TABL 109 5325 EST PO; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; van Sighem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044819; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Volk JE, 2012, JAIDS-J ACQ IMM DEF, V61, P112, DOI 10.1097/QAI.0b013e31825bd87d; Wall KM, 2013, J HOMOSEXUAL, V60, P1520, DOI 10.1080/00918369.2013.819256; World Health Organization, 2014, POL BRIEF CONS GUID	36	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107540	10.1371/journal.pone.0107540	http://dx.doi.org/10.1371/journal.pone.0107540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211493	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900081
J	Ricceri, F; Trevisan, M; Fiano, V; Grasso, C; Fasanelli, F; Scoccianti, C; De Marco, L; Tos, AG; Vineis, P; Sacerdote, C				Ricceri, Fulvio; Trevisan, Morena; Fiano, Valentina; Grasso, Chiara; Fasanelli, Francesca; Scoccianti, Chiara; De Marco, Laura; Tos, Anna Gillio; Vineis, Paolo; Sacerdote, Carlotta			Seasonality Modifies Methylation Profiles in Healthy People	PLOS ONE			English	Article							DNA METHYLATION; PROMOTER METHYLATION; GLOBAL METHYLATION; GENE-EXPRESSION; AIR-POLLUTION; HEAVY SMOKERS; CANCER; BLOOD; EXPOSURE; MECHANISMS	DNA methylation is a well-characterized epigenetic modification that plays an important role in the regulation of gene expression. There is growing evidence on the involvement of epigenetic mechanisms in disease onset, including cancer. Environmental factors seem to induce changes in DNA methylation affecting human health. However, little is known about basal methylation levels in healthy people and about the correlation between environmental factors and different methylation profiles. We investigated the effect of seasonality on basal methylation by testing methylation levels in the long interspersed nucleotide element-1 (LINE-1) and in two cancer-related genes (RASSF1A and MGMT) of 88 healthy male heavy smokers involved in an Italian randomized study; at enrolment the subjects donated a blood sample collected in different months. Methylation analyses were performed by pyrosequencing. Mean methylation percentage was higher in spring and summer for the LINE1, RASSF1A and MGMT genes (68.26%, 2.35%, and 9.52% respectively) compared with autumn and winter (67.43%, 2.17%, and 8.60% respectively). In particular, LINE-1 was significantly hypomethylated (p=0.04 or 0.05 depending on the CpG island involved) in autumn and winter compared with spring and summer. Seasonality seems to be a modifier of methylation levels and this observation should be taken into account in future analyses.	[Ricceri, Fulvio; Trevisan, Morena; Fiano, Valentina; Grasso, Chiara; Fasanelli, Francesca; De Marco, Laura; Tos, Anna Gillio; Sacerdote, Carlotta] Univ Turin, Dept Med Sci, Unit Canc Epidemiol CERMS, Turin, Italy; [Ricceri, Fulvio; Trevisan, Morena; Fiano, Valentina; Grasso, Chiara; Fasanelli, Francesca; De Marco, Laura; Tos, Anna Gillio; Sacerdote, Carlotta] Citta Salute & Sci Hosp, Turin, Italy; [Ricceri, Fulvio] Univ Turin, Dept Math, Turin, Italy; [Scoccianti, Chiara] IARC, Lyon, France; [Vineis, Paolo] Human Genet Fdn HUGEF, Turin, Italy; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, London, England	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; World Health Organization; International Agency for Research on Cancer (IARC); Imperial College London	Ricceri, F (corresponding author), Univ Turin, Dept Med Sci, Unit Canc Epidemiol CERMS, Turin, Italy.	fulvio.ricceri@unito.it	Ricceri, Fulvio/I-9910-2018; De Marco, Laura/J-7254-2016; Trevisan, Morena/J-9088-2016	Ricceri, Fulvio/0000-0001-8749-9737; De Marco, Laura/0000-0003-2167-9270; Trevisan, Morena/0000-0001-7982-7411; Sacerdote, Carlotta/0000-0002-8008-5096; DEI TOS, ANGELO/0000-0002-1228-8940; FIANO, VALENTINA/0000-0001-7978-372X	World Cancer Research Fund; Compagnia di San Paolo (Torino); Piedmont Region	World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Compagnia di San Paolo (Torino)(Compagnia di San Paolo); Piedmont Region(Regione Piemonte)	This work has been made possible by grants from the World Cancer Research Fund and Compagnia di San Paolo (Torino) to PV, and partially supported by Piedmont Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado S, 2014, INTEGR COMP BIOL, V54, P68, DOI 10.1093/icb/icu034; Arita A, 2012, J TRACE ELEM MED BIO, V26, P174, DOI 10.1016/j.jtemb.2012.03.012; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Azzi A, 2014, NAT NEUROSCI, V17, P377, DOI 10.1038/nn.3651; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bauer AK, 2010, ANN NY ACAD SCI, V1203, P113, DOI 10.1111/j.1749-6632.2010.05606.x; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bell ML, 2008, AM J EPIDEMIOL, V167, P986, DOI 10.1093/aje/kwm396; Biggeri Annibale, 2004, Epidemiol Prev, V28, P4; Bujko M, 2012, ONCOL LETT, V4, P551, DOI 10.3892/ol.2012.771; Campaner S, 2010, CELL CYCLE, V9, P3655, DOI 10.4161/cc.9.18.13049; Coustham V, 2012, SCIENCE, V337, P584, DOI 10.1126/science.1221881; De Prins S, 2013, ENVIRON INT, V59, P418, DOI 10.1016/j.envint.2013.07.007; DeMarini DM, 2013, MUTAGENESIS, V28, P485, DOI 10.1093/mutage/get042; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Fahrer J, 2013, CARCINOGENESIS, V34, P2435, DOI 10.1093/carcin/bgt275; Fang MZ, 2005, CLIN CANCER RES, V11, P7033, DOI 10.1158/1078-0432.CCR-05-0406; Fujii G, 2006, BIOCHEM J, V395, P203, DOI 10.1042/BJ20051802; Gsur A, 2001, INT J CANCER, V95, P152, DOI 10.1002/1097-0215(20010520)95:3<152::AID-IJC1026>3.0.CO;2-S; Guarrera S, 2007, BRIT J NUTR, V98, P525, DOI 10.1017/S0007114507725151; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kurian Joseph R, 2013, Front Endocrinol (Lausanne), V4, P61, DOI 10.3389/fendo.2013.00061; Li YY, 2009, INT J CANCER, V125, P286, DOI 10.1002/ijc.24398; Lim Unhee, 2012, Methods Mol Biol, V863, P359, DOI 10.1007/978-1-61779-612-8_23; Maekawa F, 2012, EPIGENETICS-US, V7, P1046, DOI 10.4161/epi.21539; Malaveille C, 1998, MUTAT RES-FUND MOL M, V402, P219, DOI 10.1016/S0027-5107(97)00300-X; Park JY, 2012, BRIT J NUTR, V108, P552, DOI 10.1017/S0007114511005733; Pinto R, 2005, FEBS LETT, V579, P5553, DOI 10.1016/j.febslet.2005.09.019; Pisani P, 1997, INT J EPIDEMIOL, V26, pS152, DOI 10.1093/ije/26.suppl_1.S152; Pogribny IP, 2012, CANC LETT; Ricceri F, 2010, CANC EPIDEMIOL BIOMA; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Rietjens IMCM, 2013, MOL NUTR FOOD RES, V57, P100, DOI 10.1002/mnfr.201200439; Samoli E, 2006, EUR RESPIR J, V27, P1129, DOI 10.1183/09031936.06.00143905; Schulz WA, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/83672; Scoccianti C, 2011, EPIGENETICS-US, V6, P1114, DOI 10.4161/epi.6.9.16515; Sherman JD, 2002, GENOME, V45, P253, DOI 10.1139/g01-147; Shi FQ, 2013, ENVIRON MOL MUTAGEN, V54, P406, DOI 10.1002/em.21790; Stevenson TJ, 2013, P NATL ACAD SCI USA, V110, P16651, DOI 10.1073/pnas.1310643110; Talaska G, 2006, MUTAGENESIS, V21, P179, DOI 10.1093/mutage/gel021; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Vineis P, 2005, CARCINOGENESIS, V26, P1846, DOI 10.1093/carcin/bgi216; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391; Zhang FF, 2012, EPIGENETICS-US, V7, P606, DOI 10.4161/epi.20236; Zhu Y, 2011, CHRONOBIOL INT, V28, P852, DOI 10.3109/07420528.2011.618896	48	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106846	10.1371/journal.pone.0106846	http://dx.doi.org/10.1371/journal.pone.0106846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210735	Green Submitted, gold, Green Published			2022-12-27	WOS:000341855900026
J	Tseng, M; Myers, JH				Tseng, Michelle; Myers, Judith H.			The Relationship between Parasite Fitness and Host Condition in an Insect - Virus System	PLOS ONE			English	Article							CALIFORNICA-MULTIPLE-NUCLEOPOLYHEDROVIRUS; NUCLEAR POLYHEDROSIS-VIRUS; TRICHOPLUSIA-NI; POPULATION-CYCLES; GENETIC-VARIATION; DISEASE DYNAMICS; FOOD LIMITATION; CABBAGE-LOOPER; TRICHURIS-SUIS; LIFE-HISTORY	Research in host-parasite evolutionary ecology has demonstrated that environmental variation plays a large role in mediating the outcome of parasite infection. For example, crowding or low food availability can reduce host condition and make them more vulnerable to parasite infection. This observation that poor-condition hosts often suffer more from parasite infection compared to healthy hosts has led to the assumption that parasite productivity is higher in poor-condition hosts. However, the ubiquity of this negative relationship between host condition and parasite fitness is unknown. Moreover, examining the effect of environmental variation on parasite fitness has been largely overlooked in the host-parasite literature. Here we investigate the relationship between parasite fitness and host condition by using a laboratory experiment with the cabbage looper Trichoplusia ni and its viral pathogen, AcMNPV, and by surveying published host-parasite literature. Our experiments demonstrated that virus productivity was positively correlated with host food availability and the literature survey revealed both positive and negative relationships between host condition and parasite fitness. Together these data demonstrate that contrary to previous assumptions, parasite fitness can be positively or negatively correlated with host fitness. We discuss the significance of these findings for host-parasite population biology.	[Tseng, Michelle; Myers, Judith H.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia	Tseng, M (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	mtseng@zoology.ubc.ca			Natural Sciences and Engineering Research Council (NSERC) Discovery Grant; NSERC Postdoctoral Fellowship	Natural Sciences and Engineering Research Council (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Postdoctoral Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by an Natural Sciences and Engineering Research Council (NSERC) Discovery Grant to JHM and an NSERC Postdoctoral Fellowship to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2007, J ANIM ECOL, V76, P1004, DOI 10.1111/j.1365-2656.2007.01263.x; ABRAHAMSON WG, 1988, OECOLOGIA, V77, P302, DOI 10.1007/BF00378034; Agrios G.N., 2005, PLANT PATHOL, V5th; ANDERSON R M, 1991; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Barber I, 2008, BEHAVIOUR, V145, P647, DOI 10.1163/156853908792451403; Bedhomme S, 2004, P ROY SOC B-BIOL SCI, V271, P739, DOI 10.1098/rspb.2003.2657; Beldomenico PM, 2008, P ROY SOC B-BIOL SCI, V275, P1753, DOI 10.1098/rspb.2008.0147; Beldomenico PM, 2010, TRENDS ECOL EVOL, V25, P21, DOI 10.1016/j.tree.2009.06.015; Beldomenico PM, 2009, EPIDEMICS-NETH, V1, P162, DOI 10.1016/j.epidem.2009.05.002; Benesh DP, 2010, INT J PARASITOL, V40, P487, DOI 10.1016/j.ijpara.2009.10.001; Bickford CP, 2005, OECOLOGIA, V146, P179, DOI 10.1007/s00442-005-0215-0; Bize P, 2008, AM NAT, V171, P107, DOI 10.1086/523943; Blanford S, 2003, ECOL LETT, V6, P2, DOI 10.1046/j.1461-0248.2003.00387.x; BOOTH DT, 1993, P ROY SOC B-BIOL SCI, V253, P125, DOI 10.1098/rspb.1993.0091; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Burden JP, 2000, J INVERTEBR PATHOL, V75, P226, DOI 10.1006/jipa.1999.4921; Cory JS, 2004, ECOL LETT, V7, P632, DOI 10.1111/j.1461-0248.2004.00617.x; Cory JS, 2004, FUNCT ECOL, V18, P443, DOI 10.1111/j.0269-8463.2004.00853.x; Cory JS, 2003, ANNU REV ECOL EVOL S, V34, P239, DOI 10.1146/annurev.ecolsys.34.011802.132402; CROMPTON DWT, 1987, MAMMAL REV, V17, P117, DOI 10.1111/j.1365-2907.1987.tb00057.x; de Roode JC, 2008, P NATL ACAD SCI USA, V105, P7489, DOI 10.1073/pnas.0710909105; de Roode JC, 2009, OECOLOGIA, V161, P67, DOI 10.1007/s00442-009-1361-6; Duncan AB, 2011, P ROY SOC B-BIOL SCI, V278, P3412, DOI 10.1098/rspb.2011.0287; Dwyer G, 2005, AM NAT, V165, P16, DOI 10.1086/426603; Dwyer G, 1997, AM NAT, V150, P685, DOI 10.1086/286089; Ebert D, 2000, OECOLOGIA, V122, P200, DOI 10.1007/PL00008847; Ebert D, 2004, AM NAT, V164, pS19, DOI 10.1086/424606; Erlandson M, 2007, BIOL CONTROL, V41, P256, DOI 10.1016/j.biocontrol.2007.01.011; Fellous S, 2009, AM NAT, V173, pE177, DOI 10.1086/598490; Franklin MT, 2010, MOL ECOL, V19, P1122, DOI 10.1111/j.1365-294X.2010.04548.x; Fuxa JR, 2004, AGR ECOSYST ENVIRON, V103, P27, DOI 10.1016/j.agee.2003.10.013; Garamszegi LZ, 2011, GLOBAL CHANGE BIOL, V17, P1751, DOI 10.1111/j.1365-2486.2010.02346.x; Glatzel G, 2009, BOTANY, V87, P10, DOI 10.1139/B08-096; Gouagna LC, 2004, PARASITOLOGY, V128, P235, DOI 10.1017/S003118200300444X; Guinnee MA, 2003, PARASITOLOGY, V127, P507, DOI 10.1017/S0031182003003998; Hall MD, 2012, P ROY SOC B-BIOL SCI, V279, P3176, DOI 10.1098/rspb.2012.0509; Hall SR, 2009, AM NAT, V174, P149, DOI 10.1086/600086; Hall SR, 2009, ECOL LETT, V12, P118, DOI 10.1111/j.1461-0248.2008.01264.x; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Harrison RL, 2012, J INVERTEBR PATHOL, V110, P33, DOI 10.1016/j.jip.2012.02.002; Hernandez-Crespo P, 1999, BIOL CONTROL, V16, P119, DOI 10.1006/bcon.1999.0753; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; JAENIKE J, 1978, Evolutionary Theory, V3, P191; JAQUES RP, 1967, CAN ENTOMOL, V99, P820, DOI 10.4039/Ent99820-8; Johansen MV, 1997, PARASITOLOGY, V115, P257, DOI 10.1017/S0031182097001327; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; Klemola N, 2010, ECOLOGY, V91, P2506, DOI 10.1890/09-2076.1; Krasnov BR, 2005, FUNCT ECOL, V19, P625, DOI 10.1111/j.1365-2435.2005.01015.x; Krist AC, 2004, J EVOLUTION BIOL, V17, P33, DOI 10.1046/j.1420-9101.2003.00661.x; Laine AL, 2007, J EVOLUTION BIOL, V20, P2371, DOI 10.1111/j.1420-9101.2007.01406.x; Lecompte F, 2010, PLANT PATHOL, V59, P891, DOI 10.1111/j.1365-3059.2010.02320.x; Lively CM, 1995, ECOLOGY; Mitchell ER, 1984, BIOL BEHAV DISPERASA, P10; Mitchell SE, 2005, EVOLUTION, V59, P70, DOI 10.1111/j.0014-3820.2005.tb00895.x; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Murray DL, 1998, ECOLOGY, V79, P1209, DOI 10.1890/0012-9658(1998)079[1209:DPANSI]2.0.CO;2; Myers JH, 2011, OECOLOGIA, V167, P647, DOI 10.1007/s00442-011-2023-z; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Pedersen S, 2001, PARASITOLOGY, V122, P589, DOI 10.1017/S0031182001007582; PRUSSUSTUN A, 2006, PREVENTING DIS THROU; Raymond B, 2002, OECOLOGIA, V131, P533, DOI 10.1007/s00442-002-0926-4; Refardt D, 2007, J EVOLUTION BIOL, V20, P921, DOI 10.1111/j.1420-9101.2007.01307.x; Rosario C, 1999, J HELMINTHOL, V73, P167, DOI 10.1017/S0022149X99000256; Rueesch S, 2012, PARASITOL RES, V111, P1193, DOI 10.1007/s00436-012-2953-3; Ryder JJ, 2007, OIKOS, V116, P578, DOI [10.1111/j.2007.0030-1299.15574.x, 10.1111/j.0030-1299.2007.15574.x]; Sadd BM, 2011, EVOLUTION, V65, P2995, DOI 10.1111/j.1558-5646.2011.01345.x; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Scott ME., 1994, PARASITIC INFECT DIS; Seppala O, 2008, OIKOS, V117, P749, DOI 10.1111/j.0030-1299.2008.16396.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shostak AW, 2008, PARASITOLOGY, V135, P1019, DOI 10.1017/S0031182008004459; SMILEY JT, 1982, ANN ENTOMOL SOC AM, V75, P616, DOI 10.1093/aesa/75.6.616; Stjernman M, 2011, J EVOLUTION BIOL, V24, P2357, DOI 10.1111/j.1420-9101.2011.02363.x; Studer A, 2012, J EXP MAR BIOL ECOL, V412, P110, DOI 10.1016/j.jembe.2011.11.008; Tschirren B, 2007, FUNCT ECOL, V21, P372, DOI 10.1111/j.1365-2435.2007.01235.x; Tseng M, 2006, AM NAT, V168, P565, DOI 10.1086/507997; Vale PF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1145; Vale PF, 2011, AM NAT, V177, P510, DOI 10.1086/659002; Vicente J, 2007, OECOLOGIA, V152, P655, DOI 10.1007/s00442-007-0690-6; Volkman LE, 1997, ADV VIRUS RES, V48, P313, DOI 10.1016/S0065-3527(08)60291-2; Wilson KR, 2000, BIOL CONTROL, V19, P57, DOI 10.1006/bcon.2000.0841; Winternitz JC, 2012, CAN J ZOOL, V90, P1149, DOI [10.1139/Z2012-083, 10.1139/z2012-083]; Yih W, 2000, J EUKARYOT MICROBIOL, V47, P504, DOI 10.1111/j.1550-7408.2000.tb00082.x; Zanette L, 2010, J ANIM ECOL, V79, P1172, DOI 10.1111/j.1365-2656.2010.01724.x; Zwart MP, 2010, BIOL CONTROL, V52, P77, DOI 10.1016/j.biocontrol.2009.10.002	86	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106401	10.1371/journal.pone.0106401	http://dx.doi.org/10.1371/journal.pone.0106401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208329	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300021
J	Distrutti, E; O'Reilly, JA; McDonald, C; Cipriani, S; Renga, B; Lynch, MA; Fiorucci, S				Distrutti, Eleonora; O'Reilly, Julie-Ann; McDonald, Claire; Cipriani, Sabrina; Renga, Barbara; Lynch, Marina A.; Fiorucci, Stefano			Modulation of Intestinal Microbiota by the Probiotic VSL#3 Resets Brain Gene Expression and Ameliorates the Age-Related Deficit in LTP	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GUT MICROBIOTA; STRESS; DISEASE; IMPACT; NEUROINFLAMMATION; NEUROPROTECTION; INTERLEUKIN-4; DYSFUNCTION; ACTIVATION	The intestinal microbiota is increasingly recognized as a complex signaling network that impacts on many systems beyond the enteric system modulating, among others, cognitive functions including learning, memory and decision-making processes. This has led to the concept of a microbiota-driven gut-brain axis, reflecting a bidirectional interaction between the central nervous system and the intestine. A deficit in synaptic plasticity is one of the many changes that occurs with age. Specifically, the archetypal model of plasticity, long-term potentiation (LTP), is reduced in hippocampus of middle-aged and aged rats. Because the intestinal microbiota might change with age, we have investigated whether the age-related deficit in LTP might be attenuated by changing the composition of intestinal microbiota with VSL#3, a probiotic mixture comprising 8 Gram-positive bacterial strains. Here, we report that treatment of aged rats with VSL#3 induced a robust change in the composition of intestinal microbiota with an increase in the abundance of Actinobacteria and Bacterioidetes, which was reduced in control-treated aged rats. VSL#3 administration modulated the expression of a large group of genes in brain tissue as assessed by whole gene expression, with evidence of a change in genes that impact on inflammatory and neuronal plasticity processes. The age-related deficit in LTP was attenuated in VSL#3-treated aged rats and this was accompanied by a modest decrease in markers of microglial activation and an increase in expression of BDNF and synapsin. The data support the notion that intestinal microbiota can be manipulated to positively impact on neuronal function.	[Distrutti, Eleonora] Azienda Osped Perugia, SC Gastroenterol & Epatol, Perugia, Italy; [O'Reilly, Julie-Ann; McDonald, Claire; Lynch, Marina A.] Trinity Coll Dublin, Dept Physiol, Inst Neurosci, Dublin, Ireland; [Cipriani, Sabrina] Univ Perugia, Dipartimento Med, I-06100 Perugia, Italy; [Renga, Barbara; Fiorucci, Stefano] Univ Perugia, Dipartimento Sci Chirurg & Biomed, I-06100 Perugia, Italy	University of Perugia; Azienda Ospedaliera di Perugia; Trinity College Dublin; University of Perugia; University of Perugia	Distrutti, E (corresponding author), Azienda Osped Perugia, SC Gastroenterol & Epatol, Perugia, Italy.	eleonoradistrutti@katamail.com		Lynch, Marina/0000-0002-4631-0499; McDonald, Claire/0000-0002-0583-742X	CD Investments s.r.l, Rome, Italy	CD Investments s.r.l, Rome, Italy	The authors declare that they received funding from a commercial source (CD Investments s.r.l, Rome, Italy). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aisa B, 2007, PSYCHONEUROENDOCRINO, V32, P256, DOI 10.1016/j.psyneuen.2006.12.013; Baba H, 1997, DEV NEUROSCI-BASEL, V19, P49, DOI 10.1159/000111185; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; BENNO Y, 1992, J VET MED SCI, V54, P703, DOI 10.1292/jvms.54.703; Bhatia S, 2012, BIOCHEM J, V442, P713, DOI 10.1042/BJ20111166; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Claes IJJ, 2011, MOL NUTR FOOD RES, V55, P1441, DOI 10.1002/mnfr.201100139; Clarke RM, 2008, J BIOL CHEM, V283, P1808, DOI 10.1074/jbc.M707442200; Costello DA, 2011, J NEUROSCI, V31, P3871, DOI 10.1523/JNEUROSCI.6676-10.2011; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Dai C, 2013, MOL CELL BIOCHEM, V374, P1, DOI 10.1007/s11010-012-1488-3; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Dharmani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058671; Distrutti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063893; Edelmann E, 2014, NEUROPHARMACOLOGY, V76, P610, DOI 10.1016/j.neuropharm.2013.05.043; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; Ewaschuk J, 2007, HEPATOLOGY, V46, P841, DOI 10.1002/hep.21750; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Glezer I, 2006, FASEB J, V20, P750, DOI 10.1096/fj.05-5234fje; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Hawkes CA, 2013, AGING CELL, V12, P224, DOI 10.1111/acel.12045; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Honjo K, 2009, ALZHEIMERS DEMENT, V5, P348, DOI 10.1016/j.jalz.2008.12.001; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Jobin C, 2010, GUT MICROBES, V1, P196, DOI 10.4161/gmic.1.3.12485; Kelly L, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.001; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; Kim HJ, 2003, ALIMENT PHARM THER, V17, P895, DOI 10.1046/j.1365-2036.2003.01543.x; Kumar A, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00007; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Loane DJ, 2009, NEUROBIOL AGING, V30, P920, DOI 10.1016/j.neurobiolaging.2007.09.001; Lynch AM, 2007, NEUROBIOL AGING, V28, P845, DOI 10.1016/j.neurobiolaging.2006.04.006; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Lynch MA, 2010, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.006.2009; Lyons A, 2007, J NEUROCHEM, V101, P771, DOI 10.1111/j.1471-4159.2006.04370.x; Lyons A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-27; Mamdani F, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.12; Martinez-Garcia A, 2010, J ALZHEIMERS DIS, V22, P1181, DOI 10.3233/JAD-2010-101348; Mencarelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022978; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Moore ME, 2005, BIOCHEM SOC T, V33, P573, DOI 10.1042/BST0330573; Moore M, 2007, SYNAPSE, V61, P851, DOI 10.1002/syn.20433; O'Callaghan RM, 2009, HIPPOCAMPUS, V19, P1019, DOI 10.1002/hipo.20591; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002; Reber SO, 2012, PSYCHONEUROENDOCRINO, V37, P1, DOI 10.1016/j.psyneuen.2011.05.014; Reiff C, 2009, INFLAMM BOWEL DIS, V15, P1721, DOI 10.1002/ibd.20999; Rex CS, 2006, J NEUROPHYSIOL, V96, P677, DOI 10.1152/jn.00336.2006; Rosenthal Samantha L, 2012, Am J Neurodegener Dis, V1, P191; Simpson S, 2012, MULT SCLER J, V18, P799, DOI 10.1177/1352458511428081; Suri D, 2013, BIOL PSYCHIAT, V73, P658, DOI 10.1016/j.biopsych.2012.10.023; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; Viladomiu M, 2013, J NUTR BIOCHEM, V24, P929, DOI 10.1016/j.jnutbio.2013.01.006; Wang L, 2011, PSYCHOPHARMACOLOGY, V216, P207, DOI 10.1007/s00213-011-2209-4; Yamada K, 2003, PHYSIOL BEHAV, V78, P303, DOI 10.1016/S0031-9384(02)00979-4; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao Y, 2013, CELLS MOL NEURO 1129	64	140	143	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106503	10.1371/journal.pone.0106503	http://dx.doi.org/10.1371/journal.pone.0106503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202975	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500029
J	Pritchard, AL; White, OJ; Burel, JG; Carroll, ML; Phipps, S; Upham, JW				Pritchard, Antonia L.; White, Olivia J.; Burel, Julie G.; Carroll, Melanie L.; Phipps, Simon; Upham, John W.			Asthma Is Associated with Multiple Alterations in Anti-Viral Innate Signalling Pathways	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; TIME RT-PCR; ALLERGIC RHINITIS; INTERFERON-ALPHA; IMMUNE-RESPONSES; EPITHELIAL-CELLS; RHINOVIRUS; RECEPTOR; INFECTION; EXPRESSION	Background: Human rhinovirus (HRV) infection is a major trigger for asthma exacerbations. Anti-viral immunity appears to be abnormal in asthma, with immune dysfunction reported in both airway structural cells and migratory, bone marrow derived cells. Though decreased capacity to produce anti-viral interferons (IFNs) has been reported in asthma, a detailed analysis of the molecular events involved has not been undertaken. Objective: To compare the molecular pathway controlling type I IFN synthesis in HRV-stimulated peripheral blood mononuclear cells (PBMC) from asthmatic and healthy subjects. Methods: PBMC from 22 allergic asthmatics and 20 healthy donors were cultured with HRV for 24 hours. Multiple components of the Toll-like receptor (TLR), IFN regulatory and NF kappa beta pathways were compared at the mRNA and protein level. Results: Multiple deficiencies in the innate immune response to HRV were identified in asthma, with significantly lower expression of IFN alpha, IFN beta and interferon stimulated genes than in healthy subjects. This was accompanied by reduced expression of intra-cellular signalling molecules including interferon regulatory factors (IRF1, IRF7), NF-kappa B family members (p50, p52, p65 and I kappa K alpha) and STAT1, and by reduced responsiveness to TLR7/TLR8 activation. These observations could not be attributed to alterations in the numbers of dendritic cell (DC) subsets in asthma or baseline expression of the viral RNA sensing receptors TLR7/TLR8. In healthy subjects, blocking the activity of type-I IFN or depleting plasmacytoid DC recapitulated many of the abnormalities observed in asthma. Conclusions: Multiple abnormalities in innate anti-viral signalling pathways were identified in asthma, with deficiencies in both IFN-dependent and IFN-independent molecules identified.	[Pritchard, Antonia L.; White, Olivia J.; Burel, Julie G.; Carroll, Melanie L.] Univ Queensland, Sch Med, TRI, Lung & Allergy Res Grp, Brisbane, Qld, Australia; [Phipps, Simon] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Upham, John W.] Princess Alexandra Hosp, Dept Resp Med, Brisbane, Qld 4102, Australia	University of Queensland; University of Queensland	Upham, JW (corresponding author), Univ Queensland, Sch Med, TRI, Lung & Allergy Res Grp, Brisbane, Qld, Australia.	j.upham@uq.edu.au	Phipps, Simon/F-9170-2010; Upham, John/F-4420-2010; Pritchard, Antonia/F-4288-2010	Phipps, Simon/0000-0002-7388-3612; Upham, John/0000-0002-0017-3433; Pritchard, Antonia/0000-0001-5336-0454	National Health and Medical Research Council, Australia; Princess Alexandra Hospital Foundation; Asthma Foundation of Queensland	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Princess Alexandra Hospital Foundation; Asthma Foundation of Queensland	National Health and Medical Research Council, Australia (JWU, SP), the Princess Alexandra Hospital Foundation (JWU) and the Asthma Foundation of Queensland (JWU).(http://www.nhmrc.gov.au) (http://www.pafoundation.org.au) (http://www.asthmaaustralia.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bufe A, 2002, INT ARCH ALLERGY IMM, V127, P82, DOI 10.1159/000048173; Cakebread JA, 2011, J ALLERGY CLIN IMMUN, V127, P1148, DOI 10.1016/j.jaci.2011.01.023; Carroll ML, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-184; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Durrani SR, 2012, J ALLERGY CLIN IMMUN, V130, P489, DOI 10.1016/j.jaci.2012.05.023; Gehlhar K, 2006, CLIN EXP ALLERGY, V36, P331, DOI 10.1111/j.1365-2222.2006.02450.x; Gern JE, 1996, J IMMUNOL, V156, P621; Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Lynch JP, 2014, EUR RESPIR J, V43, P264, DOI 10.1183/09031936.00203412; Moller-Larsen S, 2008, THORAX, V63, P1064, DOI 10.1136/thx.2007.094128; Nilsson D, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-66; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilette C, 2013, ALLERGY, V68, P312, DOI 10.1111/all.12090; Pritchard AL, 2012, IMMUNOL CELL BIOL, V90, P974, DOI 10.1038/icb.2012.39; Pritchard AL, 2012, J IMMUNOL, V188, P5898, DOI 10.4049/jimmunol.1103507; Roponen M, 2010, EUR RESPIR J, V35, P64, DOI 10.1183/09031936.00172008; Saba TG, 2014, AM J RESP CELL MOL, V50, P974, DOI 10.1165/rcmb.2013-0354OC; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; Seo YJ, 2010, ADV APPL MICROBIOL, V73, P83, DOI 10.1016/S0065-2164(10)73004-5; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Spears M, 2011, CLIN EXP ALLERGY, V41, P665, DOI 10.1111/j.1365-2222.2010.03692.x; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Tversky JR, 2008, CLIN EXP ALLERGY, V38, P781, DOI 10.1111/j.1365-2222.2008.02954.x; Upham JW, 2009, J ALLERGY CLIN IMMUN, V124, P707, DOI 10.1016/j.jaci.2009.07.009; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Zambrano JC, 2003, J ALLERGY CLIN IMMUN, V111, P1008, DOI 10.1067/mai.2003.1396	37	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106501	10.1371/journal.pone.0106501	http://dx.doi.org/10.1371/journal.pone.0106501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203745	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500027
J	Tantoso, E; Wong, LP; Li, BW; Saw, WY; Xu, WT; Little, P; Ong, RTH; Teo, YY				Tantoso, Erwin; Wong, Lai-Ping; Li, Bowen; Saw, Woei-Yuh; Xu, Wenting; Little, Peter; Ong, Rick Twee-Hee; Teo, Yik-Ying			Evaluating the Coverage and Potential of Imputing the Exome Microarray with Next-Generation Imputation Using the 1000 Genomes Project	PLOS ONE			English	Article							WIDE ASSOCIATION; GENOTYPE IMPUTATION; GENETIC-VARIATION; RARE VARIANTS; POPULATIONS; COMMON; MAP; CHALLENGES; DISEASES; TRAITS	Next-generation genotyping microarrays have been designed with insights from large-scale sequencing of exomes and whole genomes. The exome genotyping arrays promise to query the functional regions of the human genome at a fraction of the sequencing cost, thus allowing large number of samples to be genotyped. However, two pertinent questions exist: firstly, how representative is the content of the exome chip for populations not involved in the design of the chip; secondly, can the content of the exome chip be imputed with the reference data from the 1000 Genomes Project (1KGP). By deep whole-genome sequencing two Asian populations that are not part of the 1KGP, comprising 96 Southeast Asian Malays and 36 South Asian Indians for which the same samples have also been genotyped on both the Illumina 2.5 M and exome microarrays, we discovered the exome chip is a poor representation of exonic content in our two populations. However, up to 94.1% of the variants on the exome chip that are polymorphic in our populations can be confidently imputed with existing non-exome-centric microarrays using the 1KGP panel. The coverage further increases if there exists population-specific reference data from whole-genome sequencing. There is thus limited gain in using the exome chip for populations not involved in the microarray design. Instead, for the same cost of genotyping 2,000 samples on the exome chip, performing whole-genome sequencing of at least 35 samples in that population to complement the 1KGP may yield a higher coverage of the exonic content from imputation instead.	[Tantoso, Erwin; Wong, Lai-Ping; Li, Bowen; Saw, Woei-Yuh; Xu, Wenting; Ong, Rick Twee-Hee; Teo, Yik-Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Little, Peter; Teo, Yik-Ying] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik-Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Teo, YY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	statyy@nus.edu.sg		Tantoso, Erwin/0000-0002-7946-6297	Saw Swee Hock School of Public Health; Yong Loo Lin School of Medicine; National University Health System; Life Science Institute; Office of Deputy President (Research and Technology) from the National University of Singapore; National Research Foundation, Prime Minister's Office, Singapore [NRF-RF-2010-05]	Saw Swee Hock School of Public Health; Yong Loo Lin School of Medicine(National University of Singapore); National University Health System; Life Science Institute; Office of Deputy President (Research and Technology) from the National University of Singapore(National University of Singapore); National Research Foundation, Prime Minister's Office, Singapore(National Research Foundation, Singapore)	This project acknowledges the support of the Saw Swee Hock School of Public Health, the Yong Loo Lin School of Medicine, the National University Health System, the Life Science Institute and the Office of Deputy President (Research and Technology) from the National University of Singapore. LPW, BL, RTHO and YYT additionally acknowledge support by the National Research Foundation, Prime Minister's Office, Singapore under its Research Fellowship (NRF-RF-2010-05) and administered by the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jallow M, 2009, NAT GENET; Li Y, 2010, GENET EPIDEMIOL; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2008, AM J HUM GENET, V83, P535, DOI 10.1016/j.ajhg.2008.09.007; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106681	10.1371/journal.pone.0106681	http://dx.doi.org/10.1371/journal.pone.0106681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203698	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500037
J	Davis, MA; Gilbert-Diamond, D; Karagas, MR; Li, ZG; Moore, JH; Williams, SM; Frost, HR				Davis, Matthew A.; Gilbert-Diamond, Diane; Karagas, Margaret R.; Li, Zhigang; Moore, Jason H.; Williams, Scott M.; Frost, H. Robert			A Dietary-Wide Association Study (DWAS) of Environmental Metal Exposure in US Children and Adults	PLOS ONE			English	Article							CANCER RISK; ARSENIC CONCENTRATIONS; RICE CONSUMPTION; CELL CARCINOMA; LEAD; CADMIUM; METHYLMERCURY; TRANSPORTERS; BIOMARKERS; SPECIATION	Background: A growing body of evidence suggests that exposure to toxic metals occurs through diet but few studies have comprehensively examined dietary sources of exposure in US populations. Purpose: Our goal was to perform a novel dietary-wide association study (DWAS) to identify specific dietary sources of lead, cadmium, mercury, and arsenic exposure in US children and adults. Methods: We combined data from the National Health and Nutrition Examination Survey with data from the US Department of Agriculture's Food Intakes Converted to Retail Commodities Database to examine associations between 49 different foods and environmental metal exposure. Using blood and urinary biomarkers for lead, cadmium, mercury, and arsenic, we compared sources of dietary exposure among children to that of adults. Results: Diet accounted for more of the variation in mercury and arsenic than lead and cadmium. For instance we estimate 4.5% of the variation of mercury among children and 10.5% among adults is explained by diet. We identified a previously unrecognized association between rice consumption and mercury in a US study population - adjusted for other dietary sources such as seafood, an increase of 10 g/day of rice consumption was associated with a 4.8% (95% CI: 3.6, 5.2) increase in blood mercury concentration. Associations between diet and metal exposure were similar among children and adults, and we recapitulated other known dietary sources of exposure. Conclusion: Utilizing this combination of data sources, this approach has the potential to identify and monitor dietary sources of metal exposure in the US population.	[Davis, Matthew A.; Gilbert-Diamond, Diane; Karagas, Margaret R.; Li, Zhigang; Moore, Jason H.] Childrens Environm Hlth & Dis Prevent Res Ctr Dar, Hanover, NH USA; [Davis, Matthew A.; Gilbert-Diamond, Diane; Karagas, Margaret R.; Li, Zhigang; Moore, Jason H.; Williams, Scott M.; Frost, H. Robert] Dartmouth Coll, Inst Quantitat Biomed Sci, Hanover, NH 03755 USA; [Davis, Matthew A.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Davis, Matthew A.; Gilbert-Diamond, Diane; Karagas, Margaret R.; Li, Zhigang; Moore, Jason H.; Frost, H. Robert] Geisel Sch Med Dartmouth, Dept Community & Family Med, Sect Biostat & Epidemiol, Hanover, NH USA; [Moore, Jason H.; Williams, Scott M.; Frost, H. Robert] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH USA	Dartmouth College; University of Michigan System; University of Michigan; Dartmouth College; Dartmouth College	Davis, MA (corresponding author), Childrens Environm Hlth & Dis Prevent Res Ctr Dar, Hanover, NH USA.	mattadav@umich.edu	Moore, Jason H./AAV-9645-2021; Williams, Scott/Q-4812-2019	Moore, Jason H./0000-0002-5015-1099; Williams, Scott/0000-0002-4835-9544	National Institutes of Health (NIH) [LM009012, LM010098, GM103534]; NIH [K01AT006162]; NIH NIEHS [P01 ES022832]; EPA [RD-83544201]; NIH NIGMS [P20 GM104416]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K01AT006162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES022832, P42ES007373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534, P20GM104416] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012, R01LM010098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EPA(United States Environmental Protection Agency); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research project was supported by grants LM009012, LM010098, and GM103534 by the National Institutes of Health (NIH). Davis was supported by Award Number K01AT006162 from the NIH. Karagas and Gilbert-Diamond were supported by NIH NIEHS P01 ES022832 and EPA RD-83544201. Gilbert-Diamond was further supported by NIH NIGMS P20 GM104416. The NIH was not involved in the design and conduct of the study or collection, management, analysis, and interpretation of the data.	Adams SV, 2014, J EXPO SCI ENV EPID, V24, P163, DOI 10.1038/jes.2013.55; Amaral AFS, 2012, GUT, V61, P1583, DOI 10.1136/gutjnl-2011-301086; Barbosa F, 2005, ENVIRON HEALTH PERSP, V113, P1669, DOI 10.1289/ehp.7917; BARRY PSI, 1981, BRIT J IND MED, V38, P61; Batista BL, 2011, J HAZARD MATER, V191, P342, DOI 10.1016/j.jhazmat.2011.04.087; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berglund Marika, 2005, Environ Health, V4, P20, DOI 10.1186/1476-069X-4-20; Borchers A, 2010, CLIN REV ALLERG IMMU, V39, P95, DOI 10.1007/s12016-009-8176-4; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; *CDCP, 2010, 2000 GROWTH CHARTS; Chen CL, 2004, JAMA-J AM MED ASSOC, V292, P2984, DOI 10.1001/jama.292.24.2984; Cho YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075087, 10.1371/journal.pone.0081560]; Davis MA, 2012, ENVIRON HEALTH PERSP, V120, P1418, DOI 10.1289/ehp.1205014; Drewnowski A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-59; *EUR FOOD SAF AUTH, 2009, PAN CONT FOOD CHAIN; Fang Y, 2014, FOOD CHEM, V147, P147, DOI 10.1016/j.foodchem.2013.09.116; Gamble MV, 2007, AM J CLIN NUTR, V86, P1202, DOI 10.1093/ajcn/86.4.1202; Gidlow DA, 2004, OCCUP MED-OXFORD, V54, P76, DOI 10.1093/occmed/kqh019; Gilbert-Diamond D, 2013, ENVIRON HEALTH PERSP, V121, P1154, DOI 10.1289/ehp.1206178; Gilbert-Diamond D, 2011, P NATL ACAD SCI USA, V108, P20656, DOI 10.1073/pnas.1109127108; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Gulson BL, 1996, B ENVIRON CONTAM TOX, V56, P543; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Huang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075007; International Agency for Research on Cancer World Health Organization, 2004, SOM DRINK WAT DIS CO, P1017; Islam Ejaz Ul, 2007, Journal of Zhejiang University-Science B, V8, P1, DOI 10.1631/jzus.2007.B0001; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Karagas MR, 2004, CANCER CAUSE CONTROL, V15, P465, DOI 10.1023/B:CACO.0000036452.55199.a3; Karagas MR, 2001, AM J EPIDEMIOL, V153, P559, DOI 10.1093/aje/153.6.559; Leonardi G, 2012, ENVIRON HEALTH PERSP, V120, P721, DOI 10.1289/ehp.1103534; Lindberg A, 2004, ENVIRON RES, V96, P28, DOI 10.1016/j.envres.2003.09.005; Lioy PJ, 2011, ENVIRON HEALTH PERSP, V119, pA466, DOI 10.1289/ehp.1104387; Llobett JM, 2003, J AGR FOOD CHEM, V51, P838, DOI 10.1021/jf020734q; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; Meacher DM, 2002, HUM ECOL RISK ASSESS, V8, P1697, DOI 10.1080/20028091057565; Meharg AA, 2008, ENVIRON SCI TECHNOL, V42, P1051, DOI 10.1021/es702212p; Mitani N, 2009, PLANT CELL, V21, P2133, DOI 10.1105/tpc.109.067884; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; *NAT HLTH NUTR EX, 2007 2008 DAT DOC CO; Nathan Vincent R., 2006, Journal of Water and Health, V4, P67; Navas-Acien A, 2011, ENVIRON RES, V111, P110, DOI 10.1016/j.envres.2010.10.009; Orloff K, 2009, J TOXICOL ENV HEAL B, V12, P509, DOI 10.1080/10937400903358934; Patel CJ, 2012, INT J EPIDEMIOL, V41, P828, DOI 10.1093/ije/dys003; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Prozialeck WC, 2010, BIOMETALS, V23, P793, DOI 10.1007/s10534-010-9288-2; Rothenberg SE, 2013, ENVIRON POLLUT, V180, P291, DOI 10.1016/j.envpol.2013.05.037; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Slotnick MJ, 2006, ENVIRON RES, V102, P125, DOI 10.1016/j.envres.2005.12.001; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Tzoulaki I, 2012, CIRCULATION, V126, P2456, DOI 10.1161/CIRCULATIONAHA.112.114058; *US DEP AGR, FOOD INT CONV RET CO; Wakefield Julie, 2002, Environ Health Perspect, V110, pA574, DOI 10.1289/ehp.110-a574; Watanabe T, 2004, SCI TOTAL ENVIRON, V329, P17, DOI 10.1016/j.scitotenv.2004.03.010; *WHO, 2013, WHO 2006 CHILD GROWT; Xue JP, 2010, ENVIRON HEALTH PERSP, V118, P345, DOI 10.1289/ehp.0901205; Yost LJ, 2004, HUM ECOL RISK ASSESS, V10, P473, DOI 10.1080/10807030490452151	56	31	31	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e104768	10.1371/journal.pone.0104768	http://dx.doi.org/10.1371/journal.pone.0104768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198543	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700011
J	Zhao, XK; Hu, SX; Wang, L; Zhang, Q; Zhu, XD; Zhao, H; Wang, CQ; Tao, RY; Guo, SP; Wang, J; Xu, JJ; He, Y; Gao, YZ				Zhao, Xiankun; Hu, Shuxiang; Wang, Lu; Zhang, Qing; Zhu, Xiaodan; Zhao, Hua; Wang, Chaoqun; Tao, Ruiyang; Guo, Siping; Wang, Jing; Xu, Jiejie; He, Yan; Gao, Yuzhen			Functional Short Tandem Repeat Polymorphism of PTPN11 and Susceptibility to Hepatocellular Carcinoma in Chinese Populations	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE SHP2; MUTATIONS; CANCER; RISK; GENE; CARCINOGENESIS; EPIDEMIOLOGY; EXPRESSION	Background: PTPN11, which encodes tyrosine phosphatase Shp2, is a critical gene mediating cellular responses to hormones and cytokines. Loss of Shp2 promotes hepatocellular carcinoma (HCC), suggesting that PTPN11 functions as a tumor suppressor in HCC tumorgenesis. The aim of this study was to evaluate the effects of the short tandem repeat (STR) polymorphism (rs199618935) within 3'UTR of PTPN11 on HCC susceptibility in Chinese populations. Methodology/Principal Findings: We analyzed the associations in 400 patients from Jiangsu province of China, validating the findings in an additional 305 patients from Shanghai of China. Unconditional logistic regression was used to analyze the association between rs199618935 and HCC risk. Additional biochemical investigations and in-silico studies were used to evaluate the possible functional significance of this polymorphism. Logistic regression analysis showed that compared with individuals carrying shorter alleles (11 and 12 repeats), those subjects who carry longer alleles (13 and 14 repeats) had a significantly decreased risk of HCC [adjusted odds ratio (OR) = 0.63, 95% confidence interval (CI) = 0.53-0.76, P = 2.00 x 10(-7)], with the risk decreased even further in those carrying allele 15 and 16 (adjusted OR = 0.46, 95% CI = 0.34-0.62, P = 1.00 x 10(-7)). Biochemical investigations showed that longer alleles of rs199618935 conferred higher PTPN11 expression in vivo and in vitro. The altered luciferase activities in reporter gene system suggested that STR regulation of PTPN11 expression could be a transcriptional event. Finally, in-silico prediction revealed that different alleles of rs199618935 could alter the local structure of PTPN11 mRNA. Conclusions/Significance: Taken together, our findings suggested that the STR polymorphism within PTPN11 contributes to hepatocarcinogenesis, possibly by affecting PTPN11 expression through a structure-dependent mechanism. The replication of our studies and further functional studies are needed to validate our findings.	[Zhao, Xiankun; Hu, Shuxiang; Wang, Lu; Zhang, Qing; Zhu, Xiaodan; Wang, Chaoqun; Tao, Ruiyang; Guo, Siping; Wang, Jing; Gao, Yuzhen] Soochow Univ, Coll Med, Dept Forens Med, Suzhou, Jiangsu, Peoples R China; [Zhao, Hua] Soochow Univ, Dept Gen Surg, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China; [Xu, Jiejie] Fudan Univ, Sch Basic Med Sci, Shanghai Med Coll, Key Lab Med Mol Virol,MOE, Shanghai 200433, Peoples R China; [Xu, Jiejie] Fudan Univ, Sch Basic Med Sci, Shanghai Med Coll, MOH, Shanghai 200433, Peoples R China; [He, Yan] Soochow Univ, Coll Med, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Fudan University; Fudan University; Soochow University - China	He, Y (corresponding author), Soochow Univ, Coll Med, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China.	yhe@suda.edu.cn; yuzhengao@suda.edu.cn			National Natural Science Foundation of China [81171893, 81201574]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Hui-Chun Chin and Tsung-Dao Lee Chinese Undergraduate Research Endowment (CURE)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Hui-Chun Chin and Tsung-Dao Lee Chinese Undergraduate Research Endowment (CURE)	This study is supported by grants from National Natural Science Foundation of China (No. 81171893 and No. 81201574), Priority Academic Program Development of Jiangsu Higher Education Institutions as well as Hui-Chun Chin and Tsung-Dao Lee Chinese Undergraduate Research Endowment (CURE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1989, BIOTECHNIQUES, V7, P736; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chang WJ, 2014, GUT, V63, P1457, DOI 10.1136/gutjnl-2013-305475; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Feng GS, 2012, CANCER CELL, V21, P150, DOI 10.1016/j.ccr.2012.01.001; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; He CY, 2013, CARCINOGENESIS, V34, P1450, DOI 10.1093/carcin/bgt079; Jiang CY, 2012, J CANCER RES CLIN, V138, P637, DOI 10.1007/s00432-011-1143-5; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Leibowitz MS, 2013, CLIN CANCER RES, V19, P798, DOI 10.1158/1078-0432.CCR-12-1517; Lincoln PJ, 1997, FORENSIC SCI INT, V87, P179, DOI 10.1016/S0379-0738(97)00110-2; Liu X, 2012, CANCER RES, V72, P5296, DOI 10.1158/0008-5472.CAN-12-1495; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Monto A, 2001, SEMIN ONCOL, V28, P441, DOI 10.1053/sonc.2001.26947; Mooers BHM, 2005, P NATL ACAD SCI USA, V102, P16626, DOI 10.1073/pnas.0505873102; Schneeberger VE, 2014, CARCINOGENE IN PRESS; Tartaglia M, 2005, EUR J MED GENET, V48, P81, DOI 10.1016/j.ejmg.2005.03.001; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wan J, 2013, DNA CELL BIOL, V32, P628, DOI 10.1089/dna.2013.2118; Xu J, 2013, BIOCHEM BIOPH RES CO, V439, P586, DOI 10.1016/j.bbrc.2013.09.028; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; Zhu ZS, 2012, CANCER RES, V72, P6163, DOI 10.1158/0008-5472.CAN-12-0010	31	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106841	10.1371/journal.pone.0106841	http://dx.doi.org/10.1371/journal.pone.0106841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198338	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700059
J	Hou, LN; Li, F; Zeng, QC; Su, L; Chen, PA; Xu, ZH; Zhu, DJ; Liu, CH; Xu, DL				Hou, Li-na; Li, Fei; Zeng, Qing-chun; Su, Liang; Chen, Ping-an; Xu, Zhi-hao; Zhu, Din-ji; Liu, Chang-hua; Xu, Ding-li			Excretion of Urinary Orosomucoid 1 Protein Is Elevated in Patients with Chronic Heart Failure	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; ANGIOGENIC FACTORS; BLADDER-CANCER; IDENTIFICATION; BIOMARKERS; DIAGNOSIS; ENDOMETRIOSIS; GLYCOPROTEIN; INFLAMMATION	Easily screening markers for early detection of chronic heart failure (CHF) are lacking. We identified twenty differently expressed proteins including orosomucoid 1(ORM1) in urine between patients with CHF and normal controls by proteomic methods. Bioinformatics analyses suggested ORM1 could be used for further analysis. After verification by western blotting, the urinary levels of ORM1 were quantified with enzyme-linked immunosorbent assay (ELISA) by correcting for creatinine expression. The ORM1-Cr was significantly elevated in CHF patients than normal controls (6498.83 +/- 4300.21 versus 2102.26 +/- 1069.24 ng/mg). Furthermore, a Spearman analysis indicated that the urinary ORM1 levels had a high positive correlation with the classification of CHF, and the multivariate analysis suggested that the urinary ORM1 content was associated with the plasma amino-terminal pro-brain natriuretic peptide (NT-proBNP) (OR: 2.106, 95% CI: 1.213-3.524, P=0.002) and the New York Heart Association (NYHA) classification (OR: 3.019, 95% CI: 1.329-4.721, P<0.001). In addition, receiving operating curve (ROC) analyses suggested that an optimum cut-off value of 2484.98 ng/mg with 90.91% sensitivity and 85.48% specificity, respectively, could be used for the diagnosis of CHF. To sum up, our findings indicate that ORM1 could be a potential novel urinary biomarker for the early detection of CHF.	[Hou, Li-na; Zeng, Qing-chun; Su, Liang; Chen, Ping-an; Xu, Zhi-hao; Zhu, Din-ji; Liu, Chang-hua; Xu, Ding-li] Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Hou, Li-na] Southern Med Univ, Nanfang Hosp, Dept Hlth Management, Guangzhou, Guangdong, Peoples R China; [Li, Fei] Southern Med Univ, Nanfang Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Xu, DL (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	dinglixu@fimmu.com	Xu, Dingli/AAA-6176-2019					ANDERSSON LC, 1979, MOL CELL BIOCHEM, V27, P117; Bozkurt B, 2010, HEART FAIL REV, V15, P331, DOI 10.1007/s10741-009-9140-3; Buhimschi CS, 2005, AM J OBSTET GYNECOL, V192, P734, DOI 10.1016/j.ajog.2004.12.052; Cho SH, 2007, AM J REPROD IMMUNOL, V58, P497, DOI 10.1111/j.1600-0897.2007.00535.x; Cho S, 2012, HUM REPROD, V27, P515, DOI 10.1093/humrep/der345; Christiansen MS, 2010, DIABETES RES CLIN PR, V89, P16, DOI 10.1016/j.diabres.2010.03.018; Christiansen MS, 2009, SCAND J CLIN LAB INV, V69, P272, DOI 10.1080/00365510802531100; Christiansen MS, 2010, J DIABETES COMPLICAT, V24, P28, DOI 10.1016/j.jdiacomp.2008.08.001; Christiansen MS, 2005, DIABETOLOGIA, V48, P386, DOI 10.1007/s00125-004-1630-1; Christiansen MS, 2002, DIABETOLOGIA, V45, P115, DOI 10.1007/s125-002-8251-3; Dawson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035879; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; GAHMBERG CG, 1978, J EXP MED, V148, P507, DOI 10.1084/jem.148.2.507; Guha K, 2013, CURR CARDIOL REV, V9, P123, DOI 10.2174/1573403X11309020005; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Irmak S, 2005, PROTEOMICS, V5, P4296, DOI 10.1002/pmic.200402005; ITO S, 1989, ACTA ENDOCRINOL-COP, V120, P584, DOI 10.1530/acta.0.1200584; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Jiang HJ, 2009, DIABETES-METAB RES, V25, P232, DOI 10.1002/dmrr.940; Jou YJ, 2010, ANAL CHIM ACTA, V681, P41, DOI 10.1016/j.aca.2010.09.030; Kaiser T, 2004, ELECTROPHORESIS, V25, P2044, DOI 10.1002/elps.200305788; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Li F, 2012, J PROTEOMICS, V77, P225, DOI 10.1016/j.jprot.2012.09.002; Li JP, 2012, J PROTEOMICS, V75, P2879, DOI 10.1016/j.jprot.2011.12.040; Lisowska-Myjak B, 2011, NEPHROLOGY, V16, P403, DOI 10.1111/j.1440-1797.2011.01444.x; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Logdberg L, 2000, BBA-PROTEIN STRUCT M, V1482, P284, DOI 10.1016/S0167-4838(00)00164-3; Maekawa Y, 2002, J AM COLL CARDIOL, V39, P241, DOI 10.1016/S0735-1097(01)01721-1; Nakagomi A, 2010, J CARD FAIL, V16, P562, DOI 10.1016/j.cardfail.2010.02.003; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; Schocken Douglas D, 2008, Prev Cardiol, V11, P127; Smith ER, 2008, CLIN CANCER RES, V14, P2378, DOI 10.1158/1078-0432.CCR-07-1253; Snell-Bergeon JK, 2009, DIABETES TECHNOL THE, V11, P1, DOI 10.1089/dia.2008.0040; Sorensson J, 1999, AM J PHYSIOL-HEART C, V276, pH530, DOI 10.1152/ajpheart.1999.276.2.H530; Wrigley BJ, 2011, EUR J HEART FAIL, V13, P1161, DOI 10.1093/eurjhf/hfr122; Ye B, 2006, CLIN CANCER RES, V12, P432, DOI 10.1158/1078-0432.CCR-05-0461; Yin WH, 2004, AM HEART J, V147, P931, DOI 10.1016/j.ahj.2003.11.021; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739; Zimmerli LU, 2008, MOL CELL PROTEOMICS, V7, P290, DOI 10.1074/mcp.M700394-MCP200	42	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107550	10.1371/journal.pone.0107550	http://dx.doi.org/10.1371/journal.pone.0107550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215505	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300078
J	Maeto, C; Rodriguez, AM; Holgado, MP; Falivene, J; Gherardi, MM				Maeto, Cynthia; Rodriguez, Ana Maria; Holgado, Maria Pia; Falivene, Juliana; Gherardi, Maria Magdalena			Novel Mucosal DNA-MVA HIV Vaccination in Which DNA-IL-12 Plus Cholera Toxin B Subunit (CTB) Cooperates to Enhance Cellular Systemic and Mucosal Genital Tract Immunity	PLOS ONE			English	Article							VACCINIA VIRUS ANKARA; CD8(+) T-CELLS; MEMORY STEM-CELLS; RESPONSES; IMMUNIZATION; INFECTION; AVIDITY; BOOST; INTERLEUKIN-12; VECTOR	Induction of local antiviral immune responses at the mucosal portal surfaces where HIV-1 and other viral pathogens are usually first encountered remains a primary goal for most vaccines against mucosally acquired viral infections. Exploring mucosal immunization regimes in order to find optimal vector combinations and also appropriate mucosal adjuvants in the HIV vaccine development is decisive. In this study we analyzed the interaction of DNA-IL-12 and cholera toxin B subunit (CTB) after their mucosal administration in DNA prime/MVA boost intranasal regimes, defining the cooperation of both adjuvants to enhance immune responses against the HIV-1 Env antigen. Our results demonstrated that nasal mucosal DNA/MVA immunization schemes can be effectively improved by the co-delivery of DNA-IL-12 plus CTB inducing elevated HIV-specific CD8 responses in spleen and more importantly in genital tract and genito-rectal draining lymph nodes. Remarkably, these CTL responses were of superior quality showing higher avidity, polyfunctionality and a broader cytokine profile. After IL-12+CTB co-delivery, the cellular responses induced showed an enhanced breadth recognizing with higher efficiency Env peptides from different subtypes. Even more, an in vivo CTL cytolytic assay demonstrated the higher specific CD8 T-cell performance after the IL-12+CTB immunization showing in an indirect manner its potential protective capacity. Improvements observed were maintained during the memory phase where we found higher proportions of specific central memory and T memory stem-like cells T-cell subpopulations. Together, our data show that DNA-IL-12 plus CTB can be effectively employed acting as mucosal adjuvants during DNA prime/MVA boost intranasal vaccinations, enhancing magnitude and quality of HIV-specific systemic and mucosal immune responses.	[Maeto, Cynthia; Rodriguez, Ana Maria; Holgado, Maria Pia; Falivene, Juliana; Gherardi, Maria Magdalena] Consejo Nacl Invest Cient & Tecn, Univ Buenos Aires, Inst Invest Biomed Retrovirus & SIDA INBIRS, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Gherardi, MM (corresponding author), Consejo Nacl Invest Cient & Tecn, Univ Buenos Aires, Inst Invest Biomed Retrovirus & SIDA INBIRS, RA-1033 Buenos Aires, DF, Argentina.	mgherardi@fmed.uba.ar	Rodríguez, Ana/GQR-0554-2022	Falivene, Juliana/0000-0003-3437-4863	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) [2008/0549, 2011/1658]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT)	This research was funded by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT; grant numbers 2008/0549 and 2011/1658) to M.M.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu DI, 2003, J VIROL, V77, P5589, DOI 10.1128/JVI.77.10.5589-5597.2003; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Andre S, 1998, J VIROL, V72, P1497; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Arulanandam BP, 1999, VACCINE, V17, P252, DOI 10.1016/S0264-410X(98)00157-1; Belyakov IM, 2000, J IMMUNOL, V165, P6454, DOI 10.4049/jimmunol.165.11.6454; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; BERGMANN C, 1993, EUR J IMMUNOL, V23, P2777, DOI 10.1002/eji.1830231109; Bertley FMN, 2004, J IMMUNOL, V172, P3745, DOI 10.4049/jimmunol.172.6.3745; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Cripps AW, 2001, VACCINE, V19, P2513, DOI 10.1016/S0264-410X(00)00481-3; DALLO S, 1987, VIROLOGY, V159, P408, DOI 10.1016/0042-6822(87)90480-6; DeBenedette MA, 2008, J IMMUNOL, V181, P5296, DOI 10.4049/jimmunol.181.8.5296; Durward M, 2010, J VIS EXP; Ferko B, 1998, J INFECT DIS, V178, P1359, DOI 10.1086/314445; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Genesca M, 2009, J INTERN MED, V265, P67, DOI 10.1111/j.1365-2796.2008.02051.x; Gherardi MM, 2005, J GEN VIROL, V86, P2925, DOI 10.1099/vir.0.81181-0; Gherardi MM, 2004, J IMMUNOL, V172, P6209, DOI 10.4049/jimmunol.172.10.6209; Gherardi MM, 2001, HISTOL HISTOPATHOL, V16, P655, DOI 10.14670/HH-16.655; Gherardi MM, 2000, J VIROL, V74, P6278, DOI 10.1128/JVI.74.14.6278-6286.2000; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hervouet C, 2010, VACCINE, V28, P5582, DOI 10.1016/j.vaccine.2010.06.033; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Kipnis A, 2005, INFECT IMMUN, V73, P7759, DOI 10.1128/IAI.73.11.7759-7764.2005; Li G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067401; Li ZX, 2008, J IMMUNOL, V180, P2504, DOI 10.4049/jimmunol.180.4.2504; Lopalco L, 2011, EXPERT REV VACCINES, V10, P1253, DOI [10.1586/ERV.11.98, 10.1586/erv.11.98]; Luci C, 2006, J IMMUNOL, V176, P2749, DOI 10.4049/jimmunol.176.5.2749; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Manrique M, 2009, MUCOSAL IMMUNOL, V2, P536, DOI 10.1038/mi.2009.103; Manrique M, 2011, J IMMUNOL, V186, P3581, DOI 10.4049/jimmunol.1002594; Rodriguez AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037801; Markiewicz MA, 2009, J IMMUNOL, V182, P1351, DOI 10.4049/jimmunol.182.3.1351; Matoba N, 2006, VACCINE, V24, P5047, DOI 10.1016/j.vaccine.2006.03.045; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Ramirez JC, 2000, J VIROL, V74, P7651, DOI 10.1128/JVI.74.16.7651-7655.2000; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Ranasinghe C, 2013, MUCOSAL IMMUNOL, V6, P1068, DOI 10.1038/mi.2013.1; Ranasinghe C, 2007, J IMMUNOL, V178, P2370, DOI 10.4049/jimmunol.178.4.2370; Rodriguez AM, 2009, VIRUS RES, V146, P1, DOI 10.1016/j.virusres.2009.08.004; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Staats HF, 2001, J IMMUNOL, V167, P5386, DOI 10.4049/jimmunol.167.9.5386; Tapia E, 2003, MICROBES INFECT, V5, P73, DOI 10.1016/S1286-4579(02)00077-1; Turk G, 2013, J VIROL, V87, P7445, DOI 10.1128/JVI.00865-13; Vingert B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000780; Wick WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044778; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11; Wright AKA, 2008, VACCINE, V26, P4893, DOI 10.1016/j.vaccine.2008.06.058; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326	55	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107524	10.1371/journal.pone.0107524	http://dx.doi.org/10.1371/journal.pone.0107524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215887	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300073
J	Zhang, L; Tang, RH; Bai, S; Connors, NK; Lua, LHL; Chuan, YP; Middelberg, APJ; Sun, Y				Zhang, Lin; Tang, Ronghong; Bai, Shu; Connors, Natalie K.; Lua, Linda H. L.; Chuan, Yap P.; Middelberg, Anton P. J.; Sun, Yan			Energetic Changes Caused by Antigenic Module Insertion in a Virus-Like Particle Revealed by Experiment and Molecular Dynamics Simulations	PLOS ONE			English	Article							PLATELET-ADHESION INHIBITORS; BIOMIMETIC DESIGN; VACCINE; BINDING; LIGAND; CARBOXYBETAINE; RECOGNITION; DIFFERENCE; CAPSOMERE; PEPTIDES	The success of recombinant virus-like particles (VLPs) for human papillomavirus and hepatitis B demonstrates the potential of VLPs as safe and efficacious vaccines. With new modular designs emerging, the effects of antigen module insertion on the self-assembly and structural integrity of VLPs should be clarified so as to better enabling improved design. Previous work has revealed insights into the molecular energetics of a VLP subunit, capsomere, comparing energetics within various solution conditions known to drive or inhibit self-assembly. In the present study, molecular dynamics (MD) simulations coupled with the molecular mechanics-Poisson-Boltzmann surface area (MM-PBSA) method were performed to examine the molecular interactions and energetics in a modular capsomere of a murine polyomavirus (MPV) VLP designed to protect against influenza. Insertion of an influenza antigenic module is found to lower the binding energy within the capsomere, and a more active state is observed in Assembly Buffer as compared with that in Stabilization Buffer, which has been experimentally validated through measurements using differential scanning calorimetry. Further in-depth analysis based on free-energy decomposition indicates that destabilized binding can be attributed to electrostatic interaction induced by the chosen antigen module. These results provide molecular insights into the conformational stability of capsomeres and their abilities to be exploited for antigen presentation, and are expected to be beneficial for the biomolecular engineering of VLP vaccines.	[Zhang, Lin; Tang, Ronghong; Bai, Shu; Sun, Yan] Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300072, Peoples R China; [Zhang, Lin; Tang, Ronghong; Bai, Shu; Sun, Yan] Tianjin Univ, Sch Chem Engn & Technol, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Zhang, Lin; Sun, Yan] Collaborat Innovat Ctr Chem Sci & Engn, Tianjin, Peoples R China; [Connors, Natalie K.; Chuan, Yap P.; Middelberg, Anton P. J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Lua, Linda H. L.] Univ Queensland, Brisbane, Qld, Australia	Tianjin University; Tianjin University; University of Queensland; University of Queensland	Sun, Y (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300072, Peoples R China.	ysun@tju.edu.cn	Connors, Natalie/J-7171-2013; Lua, Linda/B-4879-2010	Connors, Natalie/0000-0003-4866-4757; Lua, Linda/0000-0002-9756-7083; Sun, Yan/0000-0001-5256-9571; Middelberg, Anton/0000-0001-5922-5704	Natural Science Foundation of China [21236005]; Natural Science Foundation of Tianjin [13JCZDJC31100]; Key Technologies R&D Program of International Cooperation of Tianjin, China [11ZCGHHZ00600]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130032110028]; Innovation Foundation of Tianjin University; Queensland Government's "National and International Research Alliances'' Program; Australian Research Council (Federation Fellowship); Queensland Smart Futures Fund (Premier's Fellowship)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Key Technologies R&D Program of International Cooperation of Tianjin, China; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Innovation Foundation of Tianjin University; Queensland Government's "National and International Research Alliances'' Program; Australian Research Council (Federation Fellowship)(Australian Research Council); Queensland Smart Futures Fund (Premier's Fellowship)	This work was supported by the Natural Science Foundation of China (Nos. 21236005), the Natural Science Foundation of Tianjin (13JCZDJC31100), the Key Technologies R&D Program of International Cooperation of Tianjin, China (11ZCGHHZ00600), the Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) (No. 20130032110028), the Innovation Foundation of Tianjin University, and Queensland Government's "National and International Research Alliances'' Program. Experimental constructs were initially generated using funding provided by the Australian Research Council (Federation Fellowship to APJM) and the Queensland Smart Futures Fund (Premier's Fellowship to APJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Anggraeni MR, 2013, VACCINE, V31, P4428, DOI 10.1016/j.vaccine.2013.06.087; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brown AM, 2014, ARCH BIOCHEM BIOPHYS, V545, P44, DOI 10.1016/j.abb.2014.01.002; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caldeira JC, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-22; Chuan YP, 2013, BIOTECHNOL BIOENG, V110, P2343, DOI 10.1002/bit.24907; Chuan YP, 2010, J R SOC INTERFACE, V7, P409, DOI 10.1098/rsif.2009.0175; Daggett V, 2006, CHEM REV, V106, P1898, DOI 10.1021/cr0404242; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Echeverria I, 2014, J AM CHEM SOC, V136, P8708, DOI 10.1021/ja503069k; Gorfe AA, 2003, BIOCHEMISTRY-US, V42, P11568, DOI 10.1021/bi026937p; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang B, 2011, J PHYS CHEM B, V115, P4168, DOI 10.1021/jp111216g; Joshi H, 2013, VACCINE, V31, P4841, DOI 10.1016/j.vaccine.2013.07.075; Joshi M, 2009, PROTEINS, V75, P323, DOI 10.1002/prot.22241; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Lafont V, 2007, PROTEINS, V67, P418, DOI 10.1002/prot.21259; Li J, 2012, J MOL GRAPH MODEL, V37, P49, DOI 10.1016/j.jmgm.2012.04.002; Li YY, 2014, LANGMUIR, V30, P8500, DOI 10.1021/la5017438; Lin DQ, 2012, J PHYS CHEM B, V116, P1393, DOI 10.1021/jp206817b; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; MCALEER WJ, 1984, NATURE, V307, P178, DOI 10.1038/307178a0; Mohr J, 2013, METHODS, V60, P248, DOI 10.1016/j.ymeth.2013.04.019; Pattenden LK, 2005, TRENDS BIOTECHNOL, V23, P523, DOI 10.1016/j.tibtech.2005.07.011; Peabody DS, 2008, J MOL BIOL, V380, P252, DOI 10.1016/j.jmb.2008.04.049; RICHARDSON MJ, 1977, POLYMER, V18, P413, DOI 10.1016/0032-3861(77)90095-7; Shao Q, 2012, J CHEM PHYS, V136; Shao Q, 2014, J PHYS CHEM B, V118, P189, DOI 10.1021/jp410224w; Shao Q, 2013, J PHYS CHEM B, V117, P1357, DOI 10.1021/jp3094534; Shao Q, 2011, J PHYS CHEM B, V115, P8358, DOI 10.1021/jp204046f; Shao Q, 2010, J PHYS CHEM B, V114, P16625, DOI 10.1021/jp107272n; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; Takahashi R, 2008, J BIOTECHNOL, V135, P385, DOI 10.1016/j.jbiotec.2008.05.012; Tan M, 2011, J VIROL, V85, P753, DOI 10.1128/JVI.01835-10; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Wang RZ, 2014, J MOL RECOGNIT, V27, P250, DOI 10.1002/jmr.2356; Yu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020575, 10.1371/journal.pone.0028680]; Zhang L, 2014, LANGMUIR, V30, P4734, DOI 10.1021/la4046012; Zhang L, 2014, LANGMUIR, V30, P4725, DOI 10.1021/la404599s; Zhang L, 2013, J PHYS CHEM B, V117, P5411, DOI 10.1021/jp311170w; Zhao QJ, 2013, TRENDS BIOTECHNOL, V31, P654, DOI 10.1016/j.tibtech.2013.09.002; Zhou J, 2004, J PHYS CHEM B, V108, P17418, DOI 10.1021/jp038048x	48	8	9	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107313	10.1371/journal.pone.0107313	http://dx.doi.org/10.1371/journal.pone.0107313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215874	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300057
J	Barre, O; Dufour, A; Eckhard, U; Kappelhoff, R; Beliveau, F; Leduc, R; Overall, CM				Barre, Olivier; Dufour, Antoine; Eckhard, Ulrich; Kappelhoff, Reinhild; Beliveau, Francois; Leduc, Richard; Overall, Christopher M.			Cleavage Specificity Analysis of Six Type II Transmembrane Serine Proteases (TTSPs) Using PICS with Proteome-Derived Peptide Libraries	PLOS ONE			English	Article							PROATRIAL NATRIURETIC PEPTIDE; HEPATOCYTE GROWTH-FACTOR; MATRIPTASE-2 TMPRSS6; CATALYTIC DOMAIN; SUBSTRATE-SPECIFICITY; PROTEOLYTIC-ENZYMES; CRYSTAL-STRUCTURE; HUMAN-LIVER; TRYPSIN; HEPSIN	Background: Type II transmembrane serine proteases (TTSPs) are a family of cell membrane tethered serine proteases with unclear roles as their cleavage site specificities and substrate degradomes have not been fully elucidated. Indeed just 52 cleavage sites are annotated in MEROPS, the database of proteases, their substrates and inhibitors. Methodology/Principal Finding: To profile the active site specificities of the TTSPs, we applied Proteomic Identification of protease Cleavage Sites (PICS). Human proteome-derived database searchable peptide libraries were assayed with six human TTSPs (matriptase, matriptase-2, matriptase-3, HAT, DESC and hepsin) to simultaneously determine sequence preferences on the N-terminal non-prime (P) and C-terminal prime (P') sides of the scissile bond. Prime-side cleavage products were isolated following biotinylation and identified by tandem mass spectrometry. The corresponding non-prime side sequences were derived from human proteome databases using bioinformatics. Sequencing of 2,405 individual cleaved peptides allowed for the development of the family consensus protease cleavage site specificity revealing a strong specificity for arginine in the P1 position and surprisingly a lysine in P1' position. TTSP cleavage between R down arrow K was confirmed using synthetic peptides. By parsing through known substrates and known structures of TTSP catalytic domains, and by modeling the remainder, structural explanations for this strong specificity were derived. Conclusions: Degradomics analysis of 2,405 cleavage sites revealed a similar and characteristic TTSP family specificity at the P1 and P1' positions for arginine and lysine in unfolded peptides. The prime side is important for cleavage specificity, thus making these proteases unusual within the tryptic-enzyme class that generally has overriding non-prime side specificity.	[Barre, Olivier; Dufour, Antoine; Eckhard, Ulrich; Kappelhoff, Reinhild; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada; [Beliveau, Francois; Leduc, Richard] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1K 2R1, Canada; [Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of Sherbrooke; University of British Columbia	Overall, CM (corresponding author), Univ British Columbia, Dept Oral Biol & Med Sci, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada.	chris.overall@ubc.ca	Dufour, Antoine/AAB-7886-2019; Eckhard, Ulrich/L-3733-2016	Eckhard, Ulrich/0000-0001-5863-4514; Beliveau, Francois/0000-0001-6324-2363	Proteolytic Signatures in Breast Cancer C.I.H.R [M.O.P. 111058]; Swiss National Science Foundation (SNF); Canadian Institutes of Health Research (CIHR); CIHR; Michael Smith Foundation for Health Research (MSFHR); Canadian Cancer Society; Canada Foundation for Innovation (CFI); MSFHR; Canada Research Chair in Metalloproteinase Proteomics and Systems Biology	Proteolytic Signatures in Breast Cancer C.I.H.R; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); MSFHR(Michael Smith Foundation for Health Research); Canada Research Chair in Metalloproteinase Proteomics and Systems Biology(Canada Research Chairs)	This study was funded by Proteolytic Signatures in Breast Cancer C.I.H.R. Grant M.O.P. 111058. O.B. was supported by the Swiss National Science Foundation (SNF) and a post-doctoral fellowship by the Canadian Institutes of Health Research (CIHR). A.D. and U.E. were supported by post-doctoral fellowships from CIHR and the Michael Smith Foundation for Health Research (MSFHR), respectively. A Canada Research Chair in Metalloproteinase Proteomics and Systems Biology supports C.M.O. This work was supported by grants to C.M.O. and R.L. from the CIHR and the Canadian Cancer Society. The University of British Columbia, Centre for Blood Research Mass Spectrometry Suite is supported by the Canada Foundation for Innovation (CFI) and MSFHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2006, FEBS J, V273, P615, DOI 10.1111/j.1742-4658.2005.05094.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beaufort N, 2007, AM J PHYSIOL-LUNG C, V292, pL1263, DOI 10.1152/ajplung.00191.2006; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bugge TH, 2007, FRONT BIOSCI-LANDMRK, V12, P5060, DOI 10.2741/2448; Cal S, 2003, P NATL ACAD SCI USA, V100, P9185, DOI 10.1073/pnas.1633392100; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Eckhard U, 2014, J PROTEOMICS, V100, P102, DOI 10.1016/j.jprot.2013.10.004; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Hobson JP, 2004, J BIOL CHEM, V279, P46981, DOI 10.1074/jbc.M403299200; Hooper JD, 2000, EUR J BIOCHEM, V267, P6931, DOI 10.1046/j.1432-1327.2000.01806.x; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; HUBER R, 1974, J MOL BIOL, V89, P73, DOI 10.1016/0022-2836(74)90163-6; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Kappelhoff R, 2001, CLIP CHIP OLIGONUCLE, DOI [10.1002/0471140864.ps2119s56, DOI 10.1002/0471140864.PS2119S56]; Kappelhoff R, 2010, METHODS MOL BIOL, V622, P175, DOI 10.1007/978-1-60327-299-5_10; Katz BA, 2004, J MOL BIOL, V344, P527, DOI 10.1016/j.jmb.2004.09.032; KAZAMA Y, 1995, J BIOL CHEM, V270, P66, DOI 10.1074/jbc.270.1.66; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Kyrieleis OJP, 2007, FEBS J, V274, P2148, DOI 10.1111/j.1742-4658.2007.05756.x; Lang JC, 2001, BRIT J CANCER, V84, P237, DOI 10.1054/bjoc.2000.1586; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; LEYTUS SP, 1988, BIOCHEMISTRY-US, V27, P1067, DOI 10.1021/bi00403a032; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marino G, 2014, BIOCHEM J, V457, P335, DOI 10.1042/BJ20130196; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Moran P, 2006, J BIOL CHEM, V281, P30439, DOI 10.1074/jbc.M605440200; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Sales KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023261; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2011, BIOL CHEM, V392, P1031, DOI 10.1515/BC.2011.158; Schilling O, 2011, NAT PROTOC, V6, P111, DOI 10.1038/nprot.2010.178; Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Starr AE, 2012, J BIOL CHEM, V287, P13382, DOI 10.1074/jbc.M111.314179; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Tripathi M, 2008, J BIOL CHEM, V283, P30576, DOI 10.1074/jbc.M802312200; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wu F, 2002, J BIOL CHEM, V277, P16900, DOI 10.1074/jbc.M201503200; Wysocka M, 2010, BIOORGAN MED CHEM, V18, P5504, DOI 10.1016/j.bmc.2010.06.059; Xu D, 2014, BIOINFORMATICS, V30, P660, DOI 10.1093/bioinformatics/btt578; Yamaoka K, 1998, J BIOL CHEM, V273, P11895, DOI 10.1074/jbc.273.19.11895; Yasuoka S, 1997, AM J RESP CELL MOL, V16, P300, DOI 10.1165/ajrcmb.16.3.9070615; Yuan C, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-30	78	45	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e105984	10.1371/journal.pone.0105984	http://dx.doi.org/10.1371/journal.pone.0105984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211023	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900005
J	Gao, SH; Li, SQ; Liu, LP; Wang, Y; Ding, H; Li, LL; Zhong, XW				Gao, Shaohui; Li, Saiqun; Liu, Liangping; Wang, Yong; Ding, Hui; Li, Lili; Zhong, Xingwu			Early Changes in Ocular Surface and Tear Inflammatory Mediators after Small-Incision Lenticule Extraction and Femtosecond Laser-Assisted Laser In Situ Keratomileusis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DRY EYE; CONTACT-LENSES; PHOTOREFRACTIVE KERATECTOMY; CORNEAL SENSATION; MYOPIA; LASIK; EXPRESSION; CYTOKINES; COMPLICATIONS	Purpose: To characterize the early ocular-surface changes or tear inflammatory-mediators levels following small-incision lenticule extraction (ReLEx smile) and femtosecond laser-assisted laser in situ keratomileusis (FS-LASIK). Methods: Forty-seven myopic subjects were recruited for this prospective study. Fifteen underwent ReLEx smile and thirty-two underwent FS-LASIK. Corneal fluorescein (FL) staining, tear break-up time (TBUT), Schirmer I test (SIT), ocular surface disease index (OSDI) and central corneal sensitivity were evaluated in all participants. Tears were collected and analyzed for interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), nerve growth factor (NGF) and intercellular adhesion molecule-1 (ICAM-1) levels using multiplex magnetic beads. All measurements were preformed preoperatively and 1 day, 1 week, 1 month and 3 months postoperatively. Results: FL scores in ReLEx smile group were lower than those of FS-LASIK group 1 week postoperatively (P = 0.010). Compared to the FS-LASIK group, longer TBUT were observed in ReLEx smile group 1 month (P = 0.029) and 3 months (P = 0.045) postoperatively. No significant differences were found in tear secretion for the two groups (P > 0.05). OSDI scores were higher in FS-LASIK group 1 month after surgery (P = 0.020). Higher central corneal sensitivity was observed in ReLEx smile group 1 week, 1 month and 3 months (P < 0.05) postoperatively. Compared to FS-LASIK group, lower and faster recovery of IL-6 and NGF levels in tears was observed in ReLEx smile group postoperatively (P < 0.05). Tears TNF-alpha and ICAM-1 concentrations were not significantly different between the two groups at any follow-up time (P > 0.05). Moreover, IL-6 and NGF levels correlated with ocular surface changes after ReLEx smile or FS-LASIK. Conclusions: In the early postoperative period, ReLEx smile results in milder ocular surface changes than FS-LASIK. Furthermore, the tear inflammatory mediators IL-6 and NGF may play a crucial role in the ocular surface healing process following ReLEx smile and FS-LASIK.	[Gao, Shaohui; Li, Saiqun; Liu, Liangping; Wang, Yong; Li, Lili; Zhong, Xingwu] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Shaohui; Li, Saiqun; Liu, Liangping; Wang, Yong; Li, Lili; Zhong, Xingwu] Sun Yat Sen Univ, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Shaohui] Zhengzhou Univ, Peoples Hosp, Henan Eye Hosp, Zhengzhou, Henan Province, Peoples R China; [Gao, Shaohui] Zhengzhou Univ, Peoples Hosp, Henan Eye Inst, Zhengzhou, Henan Province, Peoples R China; [Ding, Hui; Zhong, Xingwu] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Hainan Eye Hosp, Haikou, Hainan Province, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Zhengzhou University; Zhengzhou University; Sun Yat Sen University	Zhong, XW (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhongxwu@mail.sysu.edu.cn			National Natural Science Foundation of China [81371046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81371046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albietz JM, 2004, J CATARACT REFR SURG, V30, P675, DOI 10.1016/j.jcrs.2003.07.003; Ang M, 2012, INVEST OPHTH VIS SCI, V53, P1414, DOI 10.1167/iovs.11-8808; Blanco-Mezquita T, 2013, INVEST OPHTH VIS SCI, V54, P3880, DOI 10.1167/iovs.12-10816; Blum M, 2010, KLIN MONATSBL AUGENH, V227, P961, DOI 10.1055/s-0029-1245894; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Byeseda SE, 2009, AM J PATHOL, V175, P571, DOI 10.2353/ajpath.2009.090112; Chao C, 2014, OCUL SURF, V12, P32, DOI 10.1016/j.jtos.2013.09.001; Dong ZX, 2014, BRIT J OPHTHALMOL, V98, P263, DOI 10.1136/bjophthalmol-2013-303415; Ebihara N, 2011, INVEST OPHTH VIS SCI, V52, P8549, DOI 10.1167/iovs.11-7956; Gao SH, 2013, CURR EYE RES, V38, P1118, DOI 10.3109/02713683.2013.809768; Gonzalez-Perez J, 2012, INVEST OPHTH VIS SCI, V53, P5301, DOI 10.1167/iovs.11-9155; Gonzalez-Perez J, 2012, BRIT J OPHTHALMOL, V96, P1092, DOI 10.1136/bjophthalmol-2012-301527; He JC, 2010, EXP EYE RES, V91, P513, DOI 10.1016/j.exer.2010.07.007; Hjortdal JO, 2012, J REFRACT SURG, V28, P865, DOI 10.3928/1081597X-20121115-01; Huang JCC, 2012, J REFRACT SURG, V28, P625, DOI 10.3928/1081597X-20120815-07; Iwata M, 2003, BRIT J OPHTHALMOL, V87, P203, DOI 10.1136/bjo.87.2.203; Kamiya K, 2012, J CATARACT REFR SURG, V38, P1996, DOI 10.1016/j.jcrs.2012.06.052; Kim P, 2011, CURR OPIN OPHTHALMOL, V22, P238, DOI 10.1097/ICU.0b013e3283477c9c; Lee HK, 2005, AM J OPHTHALMOL, V139, P965, DOI 10.1016/j.ajo.2004.12.051; Li MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081435; Li MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077797; Massingale ML, 2009, CORNEA, V28, P1023, DOI 10.1097/ICO.0b013e3181a16578; Melki SA, 2001, SURV OPHTHALMOL, V46, P95, DOI 10.1016/S0039-6257(01)00254-5; Micera A, 2006, EXP EYE RES, V83, P747, DOI 10.1016/j.exer.2006.03.010; Moshirfar M, 2010, J CATARACT REFR SURG, V36, P1925, DOI 10.1016/j.jcrs.2010.05.027; Mrochen M, 2006, OPHTHALMOLOGE, V103, P1005, DOI 10.1007/s00347-006-1450-4; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Na KS, 2012, INVEST OPHTH VIS SCI, V53, P5443, DOI 10.1167/iovs.11-9417; Nakamura Y, 1998, CURR EYE RES, V17, P673, DOI 10.1080/02713689808951242; Nejima R, 2005, AM J OPHTHALMOL, V139, P64, DOI 10.1016/j.ajo.2004.08.039; Netto MV, 2007, J REFRACT SURG, V23, P667; O'Brien TP, 1998, ARCH OPHTHALMOL-CHIC, V116, P1470, DOI 10.1001/archopht.116.11.1470; Okada Y, 2007, MOL VIS, V13, P1428; Reim M, 2001, EUR J OPHTHALMOL, V11, P105, DOI 10.1177/112067210101100201; Riau AK, 2011, INVEST OPHTH VIS SCI, V52, P6213, DOI 10.1167/iovs.11-7439; Salomao MQ, 2010, J CATARACT REFR SURG, V36, P1024, DOI 10.1016/j.jcrs.2010.03.025; Sekundo W, 2008, J CATARACT REFR SURG, V34, P1513, DOI 10.1016/j.jcrs.2008.05.033; Sornelli F, 2010, MOL VIS, V16, P1439; Sutton G, 2008, J REFRACT SURG, V24, P802, DOI 10.3928/1081597X-20081001-06; Toda I, 2001, AM J OPHTHALMOL, V132, P1, DOI 10.1016/S0002-9394(01)00959-X; Toda I, 2008, CORNEA, V27, pS70, DOI 10.1097/ICO.0b013e31817f42c0; Turu L, 2012, J Med Life, V5, P82; Vesaluoma M, 1997, BRIT J OPHTHALMOL, V81, P145, DOI 10.1136/bjo.81.2.145; Wilson SE, 2001, AM J OPHTHALMOL, V132, P405, DOI 10.1016/S0002-9394(01)00995-3; Yoon KC, 2007, CORNEA, V26, P431, DOI 10.1097/ICO.0b013e31803dcda2	45	51	58	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107370	10.1371/journal.pone.0107370	http://dx.doi.org/10.1371/journal.pone.0107370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211490	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900065
J	Mbah, H; Negedu-Momoh, OR; Adedokun, O; Ikani, PA; Balogun, O; Sanwo, O; Ochei, K; Ekanem, M; Torpey, K				Mbah, Henry; Negedu-Momoh, Olubunmi Ruth; Adedokun, Oluwasanmi; Ikani, Patrick Anibbe; Balogun, Oluseyi; Sanwo, Olusola; Ochei, Kingsley; Ekanem, Maurice; Torpey, Kwasi			Implementing and Measuring the Level of Laboratory Service Integration in a Program Setting in Nigeria	PLOS ONE			English	Article							PRESIDENTS EMERGENCY PLAN; HEALTH-SERVICES; CARE SERVICES; AIDS RELIEF; HIV CARE; SCALE-UP; SYSTEMS	Background: The surge of donor funds to fight HIV&AIDS epidemic inadvertently resulted in the setup of laboratories as parallel structures to rapidly respond to the identified need. However these parallel structures are a threat to the existing fragile laboratory systems. Laboratory service integration is critical to remedy this situation. This paper describes an approach to quantitatively measure and track integration of HIV-related laboratory services into the mainstream laboratory services and highlight some key intervention steps taken, to enhance service integration. Method: A quantitative before-and-after study conducted in 122 Family Health International (FHI360) supported health facilities across Nigeria. A minimum service package was identified including management structure; trainings; equipment utilization and maintenance; information, commodity and quality management for laboratory integration. A check list was used to assess facilities at baseline and 3 months follow-up. Level of integration was assessed on an ordinal scale (0 = no integration, 1 = partial integration, 2 = full integration) for each service package. A composite score grading expressed as a percentage of total obtainable score of 14 was defined and used to classify facilities (<= 80% FULL, 25% to 79% PARTIAL and <25% NO integration). Weaknesses were noted and addressed. Results: We analyzed 9 (7.4%) primary, 104 (85.2%) secondary and 9 (7.4%) tertiary level facilities. There were statistically significant differences in integration levels between baseline and 3 months follow-up period (p<0.01). Baseline median total integration score was 4 (IQR 3 to 5) compared to 7 (IQR 4 to 9) at 3 months follow-up (p = 0.000). Partial and fully integrated laboratory systems were 64 (52.5%) and 0 (0.0%) at baseline, compared to 100 (82.0%) and 3 (2.4%) respectively at 3 months follow-up (p = 0.000). Discussion: This project showcases our novel approach to measure the status of each laboratory on the integration continuum.	[Mbah, Henry; Negedu-Momoh, Olubunmi Ruth; Adedokun, Oluwasanmi; Ikani, Patrick Anibbe; Balogun, Oluseyi; Sanwo, Olusola; Ochei, Kingsley; Ekanem, Maurice; Torpey, Kwasi] Family Hlth Int FHI 360, Garki Abuja, Nigeria		Mbah, H (corresponding author), Family Hlth Int FHI 360, Garki Abuja, Nigeria.	hmbah@ng.fhi360.org		Adedokun, Oluwasanmi/0000-0002-4678-9735; Torpey, Kwasi/0000-0003-1628-2922	FHI360 Nigeria; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID)	FHI360 Nigeria; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Support for this paper was provided by FHI360 Nigeria with funds from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchak S., 2018, STUDY FAMILY PLANNIN; Briggs CJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub2; Browne G, 2001, SOC SCI MED, V53, P1697, DOI 10.1016/S0277-9536(00)00455-X; Centers for Disease Control and Prevention, 2009, PROGR COLL SERV INT; Coggin WL, 2010, CLIN INFECT DIS, V50, pS255, DOI 10.1086/651499; El-Sadr WM, 2008, NEW ENGL J MED, V359, P553, DOI 10.1056/NEJMp0803762; El-Sadr WM, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000298105.79484.62; Gershy-Damet GM, 2010, AM J CLIN PATHOL, V134, P393, DOI 10.1309/AJCPTUUC2V1WJQBM; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Grepin KA, 2011, JAIDS-J ACQ IMM DEF, V57, pS77, DOI 10.1097/QAI.0b013e31821f6afa; Johnson K, 2012, INTEGRATION HIV FAMI; Justman JE, 2009, JAIDS-J ACQ IMM DEF, V52, pS30, DOI 10.1097/QAI.0b013e3181bbc9f5; Kuhlmann AS, 2010, INT PERSPECT SEX R H, V36, P189, DOI 10.1363/3618910; Lloyd J WS, 2005, ALLIANCE HEAL FUTUR, V6, P2302; Nkengasong JN, 2010, AM J CLIN PATHOL, V134, P368, DOI 10.1309/AJCPMPSINQ9BRMU6; Nkengasong JN, 2009, AM J CLIN PATHOL, V131, P852, DOI 10.1309/AJCPC51BLOBBPAKC; Odeny TA, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/485715; Parsons LM, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.11; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Ringheim BK, 2009, SUPPORTING INTEGRATI; Sherr L, 2012, 1 AIDSTARONE, P1; Strandberg-Larsen M, 2009, INT J INTEGR CARE, V9, P1; Sweeney S, 2012, SEX TRANSM INFECT, V88, P85, DOI 10.1136/sextrans-2011-050199; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522; Vo BN, 2012, AIDS CARE, V24, P1442, DOI 10.1080/09540121.2011.652357; Winestone LE, 2012, GLOB PUBLIC HEALTH, V7, P149, DOI 10.1080/17441692.2011.621964; World Health Organization, 2010, INT LAB STRENGHT HIG	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107277	10.1371/journal.pone.0107277	http://dx.doi.org/10.1371/journal.pone.0107277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211131	gold, Green Submitted, Green Published			2022-12-27	WOS:000341855900054
J	Osumi, M; Imai, R; Ueta, K; Nobusako, S; Morioka, S				Osumi, Michihiro; Imai, Ryota; Ueta, Kozo; Nobusako, Satoshi; Morioka, Shu			Negative Body Image Associated with Changes in the Visual Body Appearance Increases Pain Perception	PLOS ONE			English	Article							RUBBER HAND ILLUSION; INDUCED ANALGESIA; MIRROR THERAPY; PHANTOM PAIN; REDUCES PAIN; SKIN COLOR; FEEDBACK; OWNERSHIP; CORTEX; SIZE	Changing the visual body appearance by use of as virtual reality system, funny mirror, or binocular glasses has been reported to be helpful in rehabilitation of pain. However, there are interindividual differences in the analgesic effect of changing the visual body image. We hypothesized that a negative body image associated with changing the visual body appearance causes interindividual differences in the analgesic effect although the relationship between the visual body appearance and analgesic effect has not been clarified. We investigated whether a negative body image associated with changes in the visual body appearance increased pain. Twenty-five healthy individuals participated in this study. To evoke a negative body image, we applied the method of rubber hand illusion. We created an "injured rubber hand'' to evoke unpleasantness associated with pain, a "hairy rubber hand'' to evoke unpleasantness associated with embarrassment, and a "twisted rubber hand'' to evoke unpleasantness associated with deviation from the concept of normality. We also created a "normal rubber hand'' as a control. The pain threshold was measured while the participant observed the rubber hand using a device that measured pain caused by thermal stimuli. Body ownership experiences were elicited by observation of the injured rubber hand and hairy rubber hand as well as the normal rubber hand. Participants felt more unpleasantness by observing the injured rubber hand and hairy rubber hand than the normal rubber hand and twisted rubber hand (p<0.001). The pain threshold was lower under the injured rubber hand condition than with the other conditions (p<0.001). We conclude that a negative body appearance associated with pain can increase pain sensitivity.	[Osumi, Michihiro; Imai, Ryota; Ueta, Kozo; Nobusako, Satoshi; Morioka, Shu] Kio Univ, Grad Sch Hlth Sci, Dept Neurorehabil, Nara, Japan; [Osumi, Michihiro] Setsunan Gen Hosp, Neurocognit Rehabil Ctr, Osaka, Japan		Osumi, M (corresponding author), Kio Univ, Grad Sch Hlth Sci, Dept Neurorehabil, Nara, Japan.	p0511109@univ.kio.ac.jp	Imai, Ryota/B-6390-2019; Morioka, Shu/AAH-9229-2019	Imai, Ryota/0000-0002-0276-6419; Morioka, Shu/0000-0003-2853-1789; nobusako, satoshi/0000-0001-7183-5054	Sasakawa Scientific Research Grant from The Japan Science Society;  [25-613]	Sasakawa Scientific Research Grant from The Japan Science Society; 	This work was supported by the Sasakawa Scientific Research Grant from The Japan Science Society. http://www.jss.or.jp/ikusei/sasakawa/. MO received the funding. Grant Agreement Number 25-613. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bingel U, 2007, CURR OPIN NEUROL, V20, P424, DOI 10.1097/WCO.0b013e328259c34d; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Cacchio A, 2009, NEUROREHAB NEURAL RE, V23, P792, DOI 10.1177/1545968309335977; Capelari EDP, 2009, PERCEPTION, V38, P92, DOI 10.1068/p5892; Chan BL, 2007, NEW ENGL J MED, V357, P2206, DOI 10.1056/NEJMc071927; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Darnall BD, 2012, J REHABIL MED, V44, P254, DOI 10.2340/16501977-0933; Diers M, 2013, PAIN, V154, P890, DOI 10.1016/j.pain.2013.02.022; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Eisenberger NI, 2006, PAIN, V126, P132, DOI 10.1016/j.pain.2006.06.024; Farmer H, 2012, CONSCIOUS COGN, V21, P1242, DOI 10.1016/j.concog.2012.04.011; Gallagher S., 2005, BODY SHAPES MIND, P17; Gonzalez-Franco M, 2014, EXP BRAIN RES, V232, P875, DOI 10.1007/s00221-013-3800-1; Hansel A, 2011, EUR J PAIN, V15, P874, DOI 10.1016/j.ejpain.2011.03.013; Hagenberg A, 2014, PM R; Hegedus G, 2014, EUR J PAIN; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Lewis E, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00600; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2012, J NEUROSCI, V32, P2601, DOI 10.1523/JNEUROSCI.4031-11.2012; Longo MR, 2009, J NEUROSCI, V29, P12125, DOI 10.1523/JNEUROSCI.3072-09.2009; Maister L, 2013, COGNITION, V128, P170, DOI 10.1016/j.cognition.2013.04.002; Mancini F, 2013, PAIN, V154, P1906, DOI 10.1016/j.pain.2013.06.029; Mancini F, 2011, PSYCHOL SCI, V22, P325, DOI 10.1177/0956797611398496; Martini M, 2014, EUR J PAIN; Martini M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00438; McCabe CS, 2005, RHEUMATOLOGY, V44, P509, DOI 10.1093/rheumatology/keh529; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; Moguillansky CV, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00659; Mohan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052400; Moseley GL, 2008, CURR BIOL, V18, pR1047, DOI 10.1016/j.cub.2008.09.031; Nishigami T, 2014, RHEUMATOLOGY OXFORD; Osumi Michihiro, 2014, Front Hum Neurosci, V8, P137, DOI 10.3389/fnhum.2014.00137; Preston C, 2011, RHEUMATOLOGY, V50, P2314, DOI 10.1093/rheumatology/ker104; Ramachandran VS, 2009, NEUROCASE, V15, P357, DOI 10.1080/13554790903081767; Romano D, 2014, NEUROPSYCHOLOGIA, V57, P93, DOI 10.1016/j.neuropsychologia.2014.03.002; Romano D, 2014, BEHAV BRAIN RES, V261, P275, DOI 10.1016/j.bbr.2013.12.049; Schweinhardt P, 2008, NEUROIMAGE, V40, P759, DOI 10.1016/j.neuroimage.2007.12.016; Senkowski D, 2014, TRENDS COGN SCI, V18, P319, DOI 10.1016/j.tics.2014.03.005; Senkowski D, 2011, J NEUROSCI, V31, P14542, DOI 10.1523/JNEUROSCI.6002-10.2011; Spangler DL, 2012, INT J EAT DISORDER, V45, P17, DOI 10.1002/eat.20899; Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; YARNITSKY D, 1995, PAIN, V60, P329, DOI 10.1016/0304-3959(94)00132-X; Yoshino A, 2012, J PAIN, V13, P628, DOI 10.1016/j.jpain.2011.12.005	48	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107376	10.1371/journal.pone.0107376	http://dx.doi.org/10.1371/journal.pone.0107376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1UA	25210738	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900066
J	Bao, CJ; Liu, WW; Zhu, YF; Liu, WD; Hu, JL; Liang, Q; Cheng, YJ; Wu, Y; Yu, RB; Zhou, MH; Shen, HB; Chen, F; Tang, FY; Peng, ZH				Bao, Changjun; Liu, Wanwan; Zhu, Yefei; Liu, Wendong; Hu, Jianli; Liang, Qi; Cheng, Yuejia; Wu, Ying; Yu, Rongbin; Zhou, Minghao; Shen, Hongbing; Chen, Feng; Tang, Fenyang; Peng, Zhihang			The Spatial Analysis on Hemorrhagic Fever with Renal Syndrome in Jiangsu Province, China Based on Geographic Information System	PLOS ONE			English	Article							LIAONING PROVINCE; CLIMATE; EPIDEMIC	Background: Hemorrhagic fever with renal syndrome (HFRS) is endemic in mainland China, accounting for 90% of total reported cases worldwide, and Jiangsu is one of the most severely affected provinces. In this study, the authors conducted GIS-based spatial analyses in order to determine the spatial distribution of the HFRS cases, identify key areas and explore risk factors for public health planning and resource allocation. Methods: Interpolation maps by inverse distance weighting were produced to detect the spatial distribution of HFRS cases in Jiangsu from 2001 to 2011. Spatio-temporal clustering was applied to identify clusters at the county level. Spatial correlation analysis was conducted to detect influencing factors of HFRS in Jiangsu. Results: HFRS cases in Jiangsu from 2001 to 2011 were mapped and the results suggested that cases in Jiangsu were not distributed randomly. Cases were mainly distributed in northeastern and southwestern Jiangsu, especially in Dafeng and Sihong counties. It was notable that prior to this study, Sihong county had rarely been reported as a high-risk area of HFRS. With the maximum spatial size of 50% of the total population and the maximum temporal size of 50% of the total population, spatio-temporal clustering showed that there was one most likely cluster (LLR = 624.52, P < 0.0001, RR = 8.19) and one second-most likely cluster (LLR = 553.97, P < 0.0001, RR = 8.25), and both of these clusters appeared from 2001 to 2004. Spatial correlation analysis showed that the incidence of HFRS in Jiangsu was influenced by distances to highways, railways, rivers and lakes. Conclusion: The application of GIS together with spatial interpolation, spatio-temporal clustering and spatial correlation analysis can effectively identify high-risk areas and factors influencing HFRS incidence to lay a foundation for researching its pathogenesis.	[Liu, Wanwan; Cheng, Yuejia; Yu, Rongbin; Shen, Hongbing; Chen, Feng; Peng, Zhihang] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Bao, Changjun; Zhu, Yefei; Liu, Wendong; Hu, Jianli; Liang, Qi; Wu, Ying; Zhou, Minghao; Tang, Fenyang] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention	Tang, FY (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	tfyepi@163.com; zhihangpeng@njmu.edu.cn	zhou, minghao/GZA-7244-2022		Natural Science Foundation Key Project of Jiangsu Province, China [BK2010079]; National S&T Major Project Foundation of China [2011ZX10004-902]; Jiangsu Province Health Development Project with Science and Education [ZX201109]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation Key Project of Jiangsu Province, China; National S&T Major Project Foundation of China; Jiangsu Province Health Development Project with Science and Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported in part by Natural Science Foundation Key Project of Jiangsu Province, China (BK2010079), 'National S&T Major Project Foundation of China' (2011ZX10004-902). Jiangsu Province Health Development Project with Science and Education (NO. ZX201109), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admi, 2007, REP LAND US CHANG SI; Chaput EK, 2002, EMERG INFECT DIS, V8, P943, DOI 10.3201/eid0809.020103; CHEN HX, 1994, CHINESE MED J-PEKING, V107, P107; Cheng YJ, 2012, GEOSPATIAL HEALTH, V7, P63, DOI 10.4081/gh.2012.105; [成月佳 Cheng Yuejia], 2011, [中国卫生统计, Chinese Journal of Health Statistics], V28, P632; Clement J, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-1; Dijigu, 2008, REP LAND US CHANG SI; [丁克琴 DING Keqin], 2011, [中国公共卫生, China Public Health], V27, P1097; Fang Li-qun, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P929; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; [方立群 Fang Liqun], 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P265; Han SS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-347; LAHDEVIRTA J, 1971, ANN CLIN RES, V3, P1; Lin HL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-207; Lin JL, 2010, CHIN J EPIDEMIOL, V31, P1434; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Qian HaiKun, 2011, Disease Surveillance, V26, P435; Schmaljohn CS, 2012, EXPERT REV VACCINES, V11, P511, DOI [10.1586/ERV.12.15, 10.1586/erv.12.15]; [唐咸艳 Tang Xianyan], 2011, [中华流行病学杂志, Chinese Journal of Epidemiology], V32, P274; [汪旸 WANG Yang], 2009, [中国地方病学杂志, Chinese Journal of Endemiology], V28, P97; Wei L, 2011, AM J TROP MED HYG, V84, P497, DOI 10.4269/ajtmh.2011.10-0314; Wu W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-229; Yang Shengmei, 2006, Acta Theriologica Sinica, V26, P267; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470; Zu Rong-qiang, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P109; Zuo SQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000945	27	8	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e83848	10.1371/journal.pone.0083848	http://dx.doi.org/10.1371/journal.pone.0083848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207806	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300001
J	Chen, YY; Chen, S; Kang, J; Fang, H; Dao, H; Guo, WZ; Lai, CH; Lai, MY; Fan, JH; Fu, LC; Andrieu, JM; Lu, W				Chen, Yingyu; Chen, Song; Kang, Jun; Fang, Hua; Dao, Hong; Guo, Weizhong; Lai, Chunhui; Lai, Mingyue; Fan, Jianhua; Fu, Linchun; Andrieu, Jean-Marie; Lu, Wei			Evolving Molecular Epidemiological Profile of Human Immunodeficiency Virus 1 in the Southwest Border of China	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; YUNNAN; TRANSMISSION	Background: We have previously reported in Xishuangbanna (Banna) Dai Autonomous Prefecture, a well-developed tourist destination in the southwest border of China, that HIV-1 transmitted dominantly through heterosexual contact with less divergent genotypes and few drug resistant mutations [1]. Due to the rapid increase of newly diagnosed HIV-1 cases per year in Banna in recent years, it's important to evaluate the evolution of HIV-1 molecular epidemiology for the better understanding of ongoing HIV-1 outbreak in this region. Methodology/Principal Findings: By sequencing of HIV-1 pol genes and phylogenetic analysis, we conducted a molecular epidemiologic study in 352 HIV-1-seropositive highly active antiretroviral treatment (HAART)-naive individuals newly diagnosed at the Banna Center for Disease Control and Prevention between 2009 and 2011. Of 283 samples (84.1% taken from heterosexually acquired adults, 10.6% from needle-sharing drug users, 2.8% from men who have sex with men, 0.4% from children born from HIV-1-infected mothers, and 2.1% remained unknown) with successful sequencing for pol gene, we identified 108 (38.2%) HIV-1 subtype CRF08_BC, 101 (35.7%) CRF01_AE, 49 (17.3%) CRF07_BC, 5 (1.8%) C/CRF57_BC, 3 (1.1%) B', 1 (0.4%) B/CRF51_01B, and 16 (5.7%) unique recombinants forms. Among these infected individuals, 104 (36.7%) cases showed drug resistant or resistance-relevant mutations, and 4 of them conferring high-level resistance to 3TC/FTC, EFV/NVP or NFV. Phylogenetic analysis revealed 21 clusters (2-7 sequences) with only 21.2% (60/283) sequences involved. Conclusion/Significance: In contrast to our previous findings, CRF08_BC, replaced CRF01_AE, became the dominant genotype of HIV-1 in Banna prefecture. The viral strains with drug resistance mutations were detected frequently in newly diagnosed HIV-1-infected individuals in this region.	[Chen, Yingyu; Chen, Song; Guo, Weizhong; Lai, Chunhui; Fu, Linchun; Lu, Wei] Guangzhou Univ Chinese Med, Inst Trop Med, Sino French Collaborat Lab, Guangzhou, Guangdong, Peoples R China; [Chen, Song; Andrieu, Jean-Marie; Lu, Wei] Univ Paris 05, Inst Rech Dev, Inst Rech Vaccins & Immunol Canc & Sida, Paris, France; [Kang, Jun; Fang, Hua; Dao, Hong; Lai, Mingyue; Fan, Jianhua] Xishuangbanna Ctr Dis Control & Prevent, Jinghong, Yunnan, Peoples R China	Guangzhou University of Chinese Medicine; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Lu, W (corresponding author), Guangzhou Univ Chinese Med, Inst Trop Med, Sino French Collaborat Lab, Guangzhou, Guangdong, Peoples R China.	louis.luwei@ird.fr	chen, ying/HHS-8254-2022; Delaporte, Eric/J-5397-2018	Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS)	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS)	This work was supported by the Institut de Recherche pour le Developpement (IRD) and the Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GENOME ANNOUNC; Bao LL, 2008, AIDS RES HUM RETROV, V24, P733, DOI 10.1089/aid.2007.0269; Chen LL, 2011, AIDS RES HUM RETROV, V27, P693, DOI [10.1089/aid.2010.0264, 10.1089/AID.2010.0264]; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060101; Chen M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-382; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Chu Xiao-Gang, 2012, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V26, P460; Deng W, 2009, AIDS, V23, P977, DOI 10.1097/QAD.0b013e328329217d; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng Y, 2013, AIDS RES HUM RETROV; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hsi JH, 2013, AIDS RES HUM RETROV; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046777; Li X, 2013, GENOME ANNOUNC, V1; Liu YJ, 2011, AIDS RES HUM RETROV, V27, P445, DOI 10.1089/aid.2010.0212; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Ng OT, 2012, AIDS RES HUM RETROV, V28, P527, DOI [10.1089/aid.2011.0177, 10.1089/AID.2011.0177]; Su YZ, 2013, EPIDEMIOL INFECT, P1; Wei H, 2013, AIDS RES HUM RETROV; Yao Y, 2009, INT J INFECT DIS, V13, P154, DOI 10.1016/j.ijid.2008.05.1228; Yu XF, 2003, AIDS RES HUM RETROV, V19, P1051, DOI 10.1089/088922203322588422	23	14	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107578	10.1371/journal.pone.0107578	http://dx.doi.org/10.1371/journal.pone.0107578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207977	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300090
J	Skotte, NH; Southwell, AL; Ostergaard, ME; Carroll, JB; Warby, SC; Doty, CN; Petoukhov, E; Vaid, K; Kordasiewicz, H; Watt, AT; Freier, SM; Hung, G; Seth, PP; Bennett, CF; Swayze, EE; Hayden, MR				Skotte, Niels H.; Southwell, Amber L.; Ostergaard, Michael E.; Carroll, Jeffrey B.; Warby, Simon C.; Doty, Crystal N.; Petoukhov, Eugenia; Vaid, Kuljeet; Kordasiewicz, Holly; Watt, Andrew T.; Freier, Susan M.; Hung, Gene; Seth, Punit P.; Bennett, C. Frank; Swayze, Eric E.; Hayden, Michael R.			Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SELECTIVE INHIBITION; CAG REPEATS; MOLECULAR-MECHANISMS; EMBRYONIC LETHALITY; NUCLEIC-ACID; RNA DUPLEXES; MOUSE MODEL; EXPRESSION; ATAXIN-3	Huntington disease (HD) is an inherited, fatal neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene. The mutant protein causes neuronal dysfunction and degeneration resulting in motor dysfunction, cognitive decline, and psychiatric disturbances. Currently, there is no disease altering treatment, and symptomatic therapy has limited benefit. The pathogenesis of HD is complicated and multiple pathways are compromised. Addressing the problem at its genetic root by suppressing mutant huntingtin expression is a promising therapeutic strategy for HD. We have developed and evaluated antisense oligonucleotides (ASOs) targeting single nucleotide polymorphisms that are significantly enriched on HD alleles (HD-SNPs). We describe our structure-activity relationship studies for ASO design and find that adjusting the SNP position within the gap, chemical modifications of the wings, and shortening the unmodified gap are critical for potent, specific, and well tolerated silencing of mutant huntingtin. Finally, we show that using two distinct ASO drugs targeting the two allelic variants of an HD-SNP could provide a therapeutic option for all persons with HD; allele-specifically for roughly half, and non-specifically for the remainder.	[Skotte, Niels H.; Southwell, Amber L.; Doty, Crystal N.; Petoukhov, Eugenia; Vaid, Kuljeet; Hayden, Michael R.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Ostergaard, Michael E.; Kordasiewicz, Holly; Watt, Andrew T.; Freier, Susan M.; Hung, Gene; Seth, Punit P.; Bennett, C. Frank; Swayze, Eric E.] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Carroll, Jeffrey B.] Western Washington Univ, Dept Psychol, Behav Neurosci Program, Bellingham, WA 98225 USA; [Warby, Simon C.] McGill Univ, Dept Psychiat, Ctr Adv Res Sleep Med, Montreal, PQ, Canada	Child & Family Research Institute; University of British Columbia; Isis Pharmaceuticals Inc; Western Washington University; McGill University; Universite de Montreal	Hayden, MR (corresponding author), Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada.	mrh@cmmt.ubc.ca	Skotte, Niels Henning/AFK-2715-2022; Skotte, Niels Henning/AAG-1023-2022; Hayden, Michael R/D-8581-2011; Seth, Punit/M-2205-2019	Hayden, Michael R/0000-0001-5159-1419; Seth, Punit/0000-0002-1783-7806; Southwell, Amber/0000-0002-6353-5008; Swayze, Eric/0000-0001-6430-6576; Skotte, Niels Henning/0000-0001-7027-7193	ISIS Pharmaceuticals; Canadian Institutes of Health Research (CIHR) [20R90174]; Ph.D. School for Genetic Medicine, University of Copenhagen, Denmark; Stadslage Svend Ahrend Larsen og grosserer Jon Johannesons Fond; CIHR; Pfizer Ripples of Hope; The Huntington Society of Canada; The Michael Smith Foundation for Health Research	ISIS Pharmaceuticals; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ph.D. School for Genetic Medicine, University of Copenhagen, Denmark; Stadslage Svend Ahrend Larsen og grosserer Jon Johannesons Fond; CIHR(Canadian Institutes of Health Research (CIHR)); Pfizer Ripples of Hope; The Huntington Society of Canada; The Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by grants from ISIS Pharmaceuticals and the Canadian Institutes of Health Research (CIHR) (20R90174), and fellowships from the Ph.D. School for Genetic Medicine, University of Copenhagen, Denmark (NHS), Stadslage Svend Ahrend Larsen og grosserer Jon Johannesons Fond (NHS), CIHR (ALS and NHS), Pfizer Ripples of Hope (ALS and NHS), The Huntington Society of Canada (ALS), and The Michael Smith Foundation for Health Research (ALS). MRH is a Killam University Professor and holds a Canada Research Chair. ISIS Pharmaceuticals synthesized and provided the ASOs used in this study and took part in the data generation, analysis, and manuscript preparation. None of the other funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2013, BIOCHEMISTRY-US, V52, P9329, DOI 10.1021/bi4014209; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Boado RJ, 2000, J PHARMACOL EXP THER, V295, P239; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Fisher ER, 2014, MOVEMENT DISORD, V29, P105, DOI 10.1002/mds.25717; Frank S, 2010, NEUROPSYCH DIS TREAT, V6, P657, DOI 10.2147/NDT.S6430; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Graham RK, 2006, NEUROBIOL DIS, V21, P444, DOI 10.1016/j.nbd.2005.08.007; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Hu JX, 2014, NUCLEIC ACID THER, V24, P199, DOI 10.1089/nat.2013.0476; Hu JX, 2010, CHEM BIOL, V17, P1183, DOI 10.1016/j.chembiol.2010.10.013; Hu JX, 2009, ANN NY ACAD SCI, V1175, P24, DOI 10.1111/j.1749-6632.2009.04975.x; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Kauffmann AD, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp587; Kay C, 2014, CLIN GENET, V86, P29, DOI 10.1111/cge.12385; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lima WF, 1997, J BIOL CHEM, V272, P18191, DOI 10.1074/jbc.272.29.18191; Lindow M, 2012, NAT BIOTECHNOL, V30, P920, DOI 10.1038/nbt.2376; Liu J, 2013, NUCLEIC ACIDS RES, V41, P9570, DOI 10.1093/nar/gkt693; Liu J, 2013, NUCLEIC ACIDS RES, V41, P8788, DOI 10.1093/nar/gkt594; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; MONIA BP, 1993, J BIOL CHEM, V268, P14514; Murray S, 2012, NUCLEIC ACIDS RES, V40, P6135, DOI 10.1093/nar/gks273; Nance MA, 2007, BRAIN RES BULL, V72, P175, DOI 10.1016/j.brainresbull.2006.10.027; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Nellemann C, 2000, MOL CELL NEUROSCI, V16, P313, DOI 10.1006/mcne.2000.0872; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Ostergaard ME, 2013, NUCLEIC ACIDS RES, V41, P9634, DOI 10.1093/nar/gkt725; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Quarrell Oliver, 2012, PLoS Curr, V4, pe4f8606b742ef3, DOI 10.1371/4f8606b742ef3; Rigo F, 2014, J PHARMACOL EXP THER, V350, P46, DOI 10.1124/jpet.113.212407; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Semaka A, 2013, J MED GENET, V50, P696, DOI 10.1136/jmedgenet-2013-101796; Seth PP, 2009, J MED CHEM, V52, P10, DOI 10.1021/jm801294h; Smirnova IV, 1998, J NEUROBIOL, V36, P64, DOI 10.1002/(SICI)1097-4695(199807)36:1<64::AID-NEU6>3.0.CO;2-8; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Southwell AL, 2013, HUM MOL GENET, V22, P18, DOI 10.1093/hmg/dds397; Southwell AL, 2012, TRENDS MOL MED, V18, P634, DOI 10.1016/j.molmed.2012.09.001; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; Sun X, 2014, HUM MOL GENET, V23, P6302, DOI 10.1093/hmg/ddu349; Teplova M, 1999, NAT STRUCT BIOL, V6, P535; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; VANDIJK JG, 1986, HUM GENET, V73, P235, DOI 10.1007/BF00401235; Videnovic A, 2013, CURR TREAT OPTION NE, V15, P424, DOI 10.1007/s11940-013-0219-8; Warby SC, 2009, AM J HUM GENET, V84, P351, DOI 10.1016/j.ajhg.2009.02.003; Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993; Weir DW, 2011, LANCET NEUROL, V10, P573, DOI 10.1016/S1474-4422(11)70070-9; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	66	84	97	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107434	10.1371/journal.pone.0107434	http://dx.doi.org/10.1371/journal.pone.0107434			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207939	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300081
J	Tschauner, K; Hornschemeyer, P; Muller, VS; Hunke, S				Tschauner, Karolin; Hoernschemeyer, Patrick; Mueller, Volker Steffen; Hunke, Sabine			Dynamic Interaction between the CpxA Sensor Kinase and the Periplasmic Accessory Protein CpxP Mediates Signal Recognition in E-coli	PLOS ONE			English	Article							ENVELOPE STRESS-RESPONSE; COMPLETE GENOME SEQUENCE; MEMBRANE-PROTEINS; 2-COMPONENT; TRANSDUCTION; SYSTEM; ACTIVATION; PATHWAY; EXPRESSION; SUPPRESSES	Two-component systems, consisting of an inner membrane sensor kinase and a cytosolic response regulator, allow bacteria to respond to changes in the environment. Some two-component systems are additionally orchestrated by an accessory protein that integrates additional signals. It is assumed that spatial and temporal interaction between an accessory protein and a sensor kinase modifies the activity of a two-component system. However, for most accessory proteins located in the bacterial envelope the mechanistic details remain unclear. Here, we analyzed the interaction between the periplasmic accessory protein CpxP and the sensor kinase CpxA in Escherichia coli in dependency of three specific stimuli. The Cpx two-component system responds to envelope stress and plays a pivotal role for the quality control of multisubunit envelope structures, including type three secretion systems and pili of different pathogens. In unstressed cells, CpxP shuts off the Cpx response by a yet unknown mechanism. We show for the first time the physical interaction between CpxP and CpxA in unstressed cells using bacterial two-hybrid system and membrane-Strep-tagged protein interaction experiments. In addition, we demonstrate that a high salt concentration and the misfolded pilus subunit PapE displace CpxP from the sensor kinase CpxA in vivo. Overall, this study provides clear evidence that CpxP modulates the activity of the Cpx system by dynamic interaction with CpxA in response to specific stresses.	[Tschauner, Karolin; Hoernschemeyer, Patrick; Hunke, Sabine] Univ Osnabruck, Osnabruck, Germany; [Mueller, Volker Steffen; Hunke, Sabine] Humboldt Univ, Dept Biol, D-10099 Berlin, Germany	University Osnabruck; Humboldt University of Berlin	Hunke, S (corresponding author), Univ Osnabruck, FB5, Osnabruck, Germany.	sabine.hunke@uos.de			Deutsche Forschungsgemeinschaft [Hu1011/3-1, SFB944]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding to SH, funding by the Deutsche Forschungsgemeinschaft (Hu1011/3-1 and SFB944) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Buelow DR, 2005, J BACTERIOL, V187, P6622, DOI 10.1128/JB.187.19.6622-6630.2005; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; COSMA CL, 1995, MOL MICROBIOL, V18, P491, DOI 10.1111/j.1365-2958.1995.mmi_18030491.x; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; Debnath I, 2013, INFECT IMMUN, V81, P1450, DOI 10.1128/IAI.01213-12; Fleischer R, 2007, J BIOL CHEM, V282, P8583, DOI 10.1074/jbc.M605785200; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Graf S, 2014, J BACTERIOL, V196, P1084, DOI 10.1128/JB.01154-13; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Herzberg C, 2007, PROTEOMICS, V7, P4032, DOI 10.1002/pmic.200700491; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Humphreys S, 2004, INFECT IMMUN, V72, P4654, DOI 10.1128/IAI.72.8.4654-4661.2004; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; Hunke S, 2003, MOL MICROBIOL, V50, P1579, DOI 10.1046/j.1365-2958.2003.03785.x; Hunke S, 2012, FEMS MICROBIOL LETT, V326, P12, DOI 10.1111/j.1574-6968.2011.02436.x; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; Jones CH, 1997, EMBO J, V16, P6394, DOI 10.1093/emboj/16.21.6394; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; KENNEY LJ, 1995, P NATL ACAD SCI USA, V92, P8866, DOI 10.1073/pnas.92.19.8866; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kwon E, 2012, PROTEIN SCI, V21, P1334, DOI 10.1002/pro.2120; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lee SK, 2007, APPL ENVIRON MICROB, V73, P5711, DOI 10.1128/AEM.00791-07; Lee YM, 2004, J BACTERIOL, V186, P4326, DOI 10.1128/JB.186.13.4326-4337.2004; Liu JF, 2012, RES MICROBIOL, V163, P518, DOI 10.1016/j.resmic.2012.07.010; Liu JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023314; Mahoney TF, 2013, J BACTERIOL, V195, P1869, DOI 10.1128/JB.02197-12; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; Meyer FM, 2011, METAB ENG, V13, P18, DOI 10.1016/j.ymben.2010.10.001; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miot M, 2007, PROTEIN SCI, V16, P2445, DOI 10.1110/ps.073047807; Muller VS, 2011, PROTEOMICS, V11, P2124, DOI 10.1002/pmic.201000558; Muller VS, 2013, JOVE-J VIS EXP, DOI 10.3791/50810; Raivio TL, 1997, J BACTERIOL, V179, P7724, DOI 10.1128/jb.179.24.7724-7733.1997; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Raivio TL, 2000, MOL MICROBIOL, V37, P1186, DOI 10.1046/j.1365-2958.2000.02074.x; Raivio TL, 2013, J BACTERIOL, V195, P2755, DOI 10.1128/JB.00105-13; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; SNYDER WB, 1995, J BACTERIOL, V177, P953, DOI 10.1128/jb.177.4.953-963.1995; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Thede GL, 2011, J BACTERIOL, V193, P2149, DOI 10.1128/JB.01296-10; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wong ETC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003192; Xu D, 1997, J MOL BIOL, V265, P68, DOI 10.1006/jmbi.1996.0712; Zhou XH, 2011, J BIOL CHEM, V286, P9805, DOI 10.1074/jbc.M110.194092	58	32	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107383	10.1371/journal.pone.0107383	http://dx.doi.org/10.1371/journal.pone.0107383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207645	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300079
J	Forbes, SC; Willcocks, RJ; Triplett, WT; Rooney, WD; Lott, DJ; Wang, DJ; Pollaro, J; Senesac, CR; Daniels, MJ; Finkel, RS; Russman, BS; Byrne, BJ; Finanger, EL; Tennekoon, GI; Walter, GA; Sweeney, HL; Vandenborne, K				Forbes, Sean C.; Willcocks, Rebecca J.; Triplett, William T.; Rooney, William D.; Lott, Donovan J.; Wang, Dah-Jyuu; Pollaro, Jim; Senesac, Claudia R.; Daniels, Michael J.; Finkel, Richard S.; Russman, Barry S.; Byrne, Barry J.; Finanger, Erika L.; Tennekoon, Gihan I.; Walter, Glenn A.; Sweeney, H. Lee; Vandenborne, Krista			Magnetic Resonance Imaging and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne Muscular Dystrophy: A Multicenter Cross Sectional Study	PLOS ONE			English	Article							DIAGNOSTIC PROCESS; STIMULATED ECHOES; RELAXATION-TIMES; MRI; TISSUE; T2; QUANTIFICATION; QUANTITATION; METABOLITES; EXERCISE	Introduction: Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder that results in functional deficits. However, these functional declines are often not able to be quantified in clinical trials for DMD until after age 7. In this study, we hypothesized that (H2OT2)-H-1 derived using H-1-MRS and MRI-T-2 will be sensitive to muscle involvement at a young age (5-7 years) consistent with increased inflammation and muscle damage in a large cohort of DMD subjects compared to controls. Methods: MR data were acquired from 123 boys with DMD (ages 5-14 years; mean 8.6 SD 2.2 years) and 31 healthy controls (age 9.7 SD 2.3 years) using 3-Tesla MRI instruments at three institutions (University of Florida, Oregon Health & Science University, and Children's Hospital of Philadelphia). T-2-weighted multi-slice spin echo (SE) axial images and single voxel H-1-MRS were acquired from the lower leg and thigh to measure lipid fraction and (H2OT2)-H-1. Results: MRI-T-2, (H2OT2)-H-1, and lipid fraction were greater (p<0.05) in DMD compared to controls. In the youngest age group, DMD values were different (p<0.05) than controls for the soleus MRI-T-2, (H2OT2)-H-1 and lipid fraction and vastus lateralis MRI-T-2 and (H2OT2)-H-1. In the boys with DMD, MRI-T-2 and lipid fraction were greater (p<0.05) in the oldest age group (11-14 years) than the youngest age group (5-6.9 years), while (H2OT2)-H-1 was lower in the oldest age group compared to the young age group. Discussion: Overall, MR measures of T-2 and lipid fraction revealed differences between DMD and Controls. Furthermore, MRI-T-2 was greater in the older age group compared to the young age group, which was associated with higher lipid fractions. Overall, MR measures of T-2 and lipid fraction show excellent sensitivity to DMD disease pathologies and potential therapeutic interventions in DMD, even in the younger boys.	[Forbes, Sean C.; Willcocks, Rebecca J.; Triplett, William T.; Lott, Donovan J.; Senesac, Claudia R.; Vandenborne, Krista] Univ Florida, Dept Phys Therapy, Gainesville, FL 32603 USA; [Rooney, William D.; Pollaro, Jim; Russman, Barry S.; Finanger, Erika L.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Wang, Dah-Jyuu; Finkel, Richard S.; Tennekoon, Gihan I.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Daniels, Michael J.] Univ Texas Austin, Dept Stat & Data Sci, Austin, TX 78712 USA; [Daniels, Michael J.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Finkel, Richard S.] Nemours Childrens Hosp, Orlando, FL USA; [Byrne, Barry J.] Univ Florida, Powell Gene Therapy Ctr, Dept Pediat & Mol Genet & Microbiol, Gainesville, FL USA; [Walter, Glenn A.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Sweeney, H. Lee] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	State University System of Florida; University of Florida; Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Pennsylvania	Forbes, SC (corresponding author), Univ Florida, Dept Phys Therapy, Gainesville, FL 32603 USA.	scforbes@ufl.edu		Byrne, Barry J./0000-0002-7302-1756; Triplett, William/0000-0002-9546-1306	National Institute of Arthritis and Musculosketetal and Skin Diseases/National Institute of Neurological Disorders and Stroke [R01AR056973/R01AR065943]; Wellstone Muscular Dystrophy Center [1U54AR052646]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646, R01AR065943, R01AR056973] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculosketetal and Skin Diseases/National Institute of Neurological Disorders and Stroke; Wellstone Muscular Dystrophy Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by National Institute of Arthritis and Musculosketetal and Skin Diseases/National Institute of Neurological Disorders and Stroke R01AR056973/R01AR065943 and Wellstone Muscular Dystrophy Center 1U54AR052646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpan I, NEUROLOGY IN PRESS; Arpan I, 2013, NMR BIOMED, V26, P320, DOI 10.1002/nbm.2851; Azzabou N, J MAGN RESO IN PRESS; BRUHN H, 1991, MAGN RESON MED, V17, P82, DOI 10.1002/mrm.1910170113; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Carlier PG, 2014, NEUROMUSCULAR DISORD, V24, P390, DOI 10.1016/j.nmd.2014.02.009; Connolly AM, 2013, NEUROMUSCULAR DISORD, V23, P529, DOI 10.1016/j.nmd.2013.04.005; Daack-Hirsch S, 2013, AM J MED GENET A, V161A, P687, DOI 10.1002/ajmg.a.35810; Elliott MA, 1999, MAGN RESON MED, V41, P450, DOI 10.1002/(SICI)1522-2594(199903)41:3<450::AID-MRM4>3.0.CO;2-9; Foley JM, 1999, J APPL PHYSIOL, V87, P2311, DOI 10.1152/jappl.1999.87.6.2311; Forbes SC, 2013, RADIOLOGY, V269, P198, DOI 10.1148/radiol.13121948; Forbes SC, 2012, NEUROMUSCULAR DISORD, V22, pS111, DOI 10.1016/j.nmd.2012.05.013; FRAHM J, 1989, MAGNET RESON MED, V9, P79, DOI 10.1002/mrm.1910090110; Friedman SD, 2014, MUSCLE NERVE, V49, P257, DOI 10.1002/mus.23911; Friedman SD, 2012, MUSCLE NERVE, V45, P500, DOI 10.1002/mus.22342; Frisullo G, 2011, J CLIN IMMUNOL, V31, P155, DOI 10.1007/s10875-010-9474-6; Gloor M, 2011, J MAGN RESON IMAGING, V33, P203, DOI 10.1002/jmri.22431; Gold GE, 2004, AM J ROENTGENOL, V183, P343, DOI 10.2214/ajr.183.2.1830343; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Henricson EK, 2012, PLOS CURR; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman EP, 2013, DISCOV MED, V16, P233; Holtzer C, 2011, GENET MED, V13, P942, DOI 10.1097/GIM.0b013e31822623f1; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Krssak M, 2004, MAGN RESON MATER PHY, V16, P155, DOI 10.1007/s10334-003-0029-1; Loganathan R, 2006, INT J CARDIOVAS IMAG, V22, P81, DOI 10.1007/s10554-005-5386-6; Lott DJ, 2014, NEUROMUSCULAR DISORD, V24, P574, DOI 10.1016/j.nmd.2014.03.013; Maier CF, 2003, J MAGN RESON IMAGING, V17, P358, DOI 10.1002/jmri.10263; Marden FA, 2005, SKELETAL RADIOL, V34, P140, DOI 10.1007/s00256-004-0825-3; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; Mayhew AG, 2013, DEV MED CHILD NEUROL, V55, P1046, DOI 10.1111/dmcn.12220; Mazzone ES, 2009, NEUROMUSCULAR DISORD, V19, P458, DOI 10.1016/j.nmd.2009.06.368; Mazzone E, 2010, NEUROMUSCULAR DISORD, V20, P712, DOI 10.1016/j.nmd.2010.06.014; Petrof BJ, 2002, AM J PHYS MED REHAB, V81, pS162, DOI 10.1097/00002060-200211001-00017; Rooney WD, 2013, P INT SOC MAG RESON, V21, P0689; Torriani M, 2012, SKELETAL RADIOL, V41, P437, DOI 10.1007/s00256-011-1240-1; Triplett WT, 2014, MAGN RESON MED, V72, P8, DOI 10.1002/mrm.24917; Weber MA, 2012, J NEUROL, V259, P2385, DOI 10.1007/s00415-012-6512-8; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Willis TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070993; Wokke BH, 2014, NEUROMUSCULAR DISORD, V24, P409, DOI 10.1016/j.nmd.2014.01.015; Wren TAL, 2008, AM J ROENTGENOL, V190, pW8, DOI 10.2214/AJR.07.2732	43	78	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106435	10.1371/journal.pone.0106435	http://dx.doi.org/10.1371/journal.pone.0106435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203313	Green Published, gold			2022-12-27	WOS:000342684500023
J	Gopalsamy, A; Hagen, T; Swaminathan, K				Gopalsamy, Anupriya; Hagen, Thilo; Swaminathan, Kunchithapadam			Investigating the Molecular Basis of Siah1 and Siah2 E3 Ubiquitin Ligase Substrate Specificity	PLOS ONE			English	Article							HUMAN HOMOLOG; CELL-GROWTH; SINA GENE; C-ELEGANS; CANCER; EXPRESSION; ABSENTIA; HYPOXIA; TUMORIGENESIS; DEGRADATION	The Siah1 and Siah2 E3 ubiquitin ligases play an important role in diverse signaling pathways and have been shown to be deregulated in cancer. The human Siah1 and Siah2 isoforms share high sequence similarity but possess contrary roles in cancer, with Siah1 more often acting as a tumor suppressor while Siah2 functions as a proto-oncogene. The different function of Siah1 and Siah2 in cancer is likely due to the ubiquitination of distinct substrates. Hence, we decided to investigate the molecular basis of the substrate specificity, utilizing the well-characterized Siah2 substrate PHD3. Using chimeric and mutational approaches, we identified critical residues in Siah2 that promote substrate specificity. Thus, we have found that four residues in the N-terminal region of the Siah2 substrate binding domain (SBD) (Ser132, His150, Pro155, Tyr163) are critical for substrate specificity. In the C-terminal region of the SBD, a single residue, Leu250, was identified to promote the specific binding of Siah2 SBD to PHD3. Our study may help to overcome the challenges in the identification of Siah2 specific inhibitors.	[Gopalsamy, Anupriya] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Singapore 117595, Singapore; [Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Hagen, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchth@nus.edu.sg; dbsks@nus.edu.sg		Gopalsamy, Anupriya/0000-0002-2774-5454	Department of Obstetrics and Gynecology, National University of Singapore, Singapore [R174-000-001-731]	Department of Obstetrics and Gynecology, National University of Singapore, Singapore	This work was funded by a grant from the Department of Obstetrics and Gynecology, National University of Singapore (Grant Number R174-000-001-731), Singapore for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AU, 2008, JNCI-J NATL CANCER I, V100, P1606, DOI 10.1093/jnci/djn365; Behling KC, 2011, BREAST CANCER RES TR, V129, P717, DOI 10.1007/s10549-010-1254-8; Brauckhoff A, 2007, Verh Dtsch Ges Pathol, V91, P269; Buchwald M, 2013, ONCOGENE, V32, P4913, DOI 10.1038/onc.2012.515; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Confalonieri S, 2009, ONCOGENE, V28, P2959, DOI 10.1038/onc.2009.156; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dinkel H, 2011, NUCL ACIDS RES; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Frasor J, 2005, P NATL ACAD SCI USA, V102, P13153, DOI 10.1073/pnas.0502782102; Frew IJ, 2003, MOL CELL BIOL, V23, P9150, DOI 10.1128/MCB.23.24.9150-9161.2003; Garber K, 2005, J NATL CANCER I, V97, P166, DOI 10.1093/jnci/97.3.166; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; House CM, 2009, CANCER RES, V69, P8835, DOI 10.1158/0008-5472.CAN-09-1676; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Kim CJ, 2004, ONCOGENE, V23, P8591, DOI 10.1038/sj.onc.1208113; Kramer OH, 2013, LEUKEMIA, V27, P792, DOI 10.1038/leu.2012.284; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Liu M, 2012, MOL CELL, V46, P325, DOI 10.1016/j.molcel.2012.03.007; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Malz M, 2012, INT J CANCER, V131, P2016, DOI 10.1002/ijc.27473; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Qi J, 2013, CELL BIOCH BIOPHYS; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sarkar TR, 2012, MOL CELL BIOL, V32, P320, DOI 10.1128/MCB.05790-11; Schmidt RL, 2007, CANCER RES, V67, P11798, DOI 10.1158/0008-5472.CAN-06-4471; Schrodinger L., 2020, PYMOL; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shah M, 2009, PIGM CELL MELANOMA R, V22, P799, DOI 10.1111/j.1755-148X.2009.00628.x; Stebbins JL, 2013, CHEM BIOL, V20, P973, DOI 10.1016/j.chembiol.2013.06.008; Wen YY, 2010, MOL CARCINOGEN, V49, P440, DOI 10.1002/mc.20615; Wong CSF, 2013, CANCER RES, V73, P2400, DOI 10.1158/0008-5472.CAN-12-4348; Wong CSF, 2012, CANCER RES, V72, P1694, DOI 10.1158/0008-5472.CAN-11-3310; Yoshibayashi H, 2007, ONCOL REP, V17, P549; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	47	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106547	10.1371/journal.pone.0106547	http://dx.doi.org/10.1371/journal.pone.0106547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202994	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500030
J	Lin, YS; Liu, YF; Chou, YE; Yang, SF; Chien, MH; Wu, CH; Chou, CH; Cheng, CW; Wang, PH				Lin, Yue-Shan; Liu, Yu-Fan; Chou, Ying-Erh; Yang, Shun-Fa; Chien, Ming-Hsien; Wu, Chih-Hsien; Chou, Chi-Hung; Cheng, Chao-Wen; Wang, Po-Hui			Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms and Haplotypes with Uterine Cervical Cancer in Taiwanese Women	PLOS ONE			English	Article							REDUCTASE M2 SUBUNIT; SERUM YKL-40; PROMOTER POLYMORPHISMS; CARTILAGE GP-39; CHI3L1; CELLS; MARKER; RRM2; OVEREXPRESSION; SUSCEPTIBILITY	Background: This study aimed to investigate the relationships of chitinase 3-like 1 (CHI3L1) single nucleotide polymorphisms (SNPs) and haplotypes with the development of uterine cervical cancer in Taiwanese women. The SNPs frequencies and haplotypes were also correlated with the clinicopathologic variables of cervical cancer, cancer recurrence, and patient survival. Methodology and Principal Findings: Ninety-nine patients with invasive cancer and 61 with pre-cancerous lesions of the uterine cervix were compared to 310 healthy control subjects. Three SNPs rs6691378 (-1371, G/A), rs10399805 (-247, G/A) and rs4950928 (-131, C/G) in the promoter region, and one SNP rs880633 (+2950, T/C) in exon 5 were analyzed by real time polymerase chain reaction and genotyping. The results showed that the mutant homozygous genotype AA of CHI3L1 SNP rs6691378 and AA of rs10399805, and haplotypes AACC and AACT increased the risk of developing pre-cancerous lesions and invasive cancer. The patients with these risk haplotypes had higher than stage I tumors, larger tumors, and vaginal invasion. In logistic regression model, they also tended to have poor survival event [p = 0.078; odds ratio (OR): 2.99, 95% confidence interval (CI): 0.89-10.08] and a higher probability of recurrence event (p = 0.081; OR: 3.07, 95% CI: 0.87-10.81). There was a significant association between the CHI3L1 risk haplotypes and probability of recurrence (p = 0.002; hazard ratio: 6.21, 95% CI: 1.90-20.41), and a marginal association between the risk haplotypes and overall survival (p = 0.051; hazard ratio: 3.76, 95% CI: 0.99-14.29) in the patients with SCC, using Cox proportional hazard model. Conclusion: The CHI3L1 SNPs rs6691378 and rs10399805 and CHI3L1 haplotypes all correlated with the development of cervical pre-cancerous lesions and invasive cancer. The cervical cancer patients with the CHI3L1 haplotypes AACC or AACT had poor clinicopathologic characteristics and poor recurrence and survival events. These risk haplotypes were associated with higher recurrence, especially in the patients with SCC.	[Lin, Yue-Shan] Chi Mei Fdn, Med Ctr, Dept Obstet & Gynecol, Tainan, Taiwan; [Liu, Yu-Fan] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Chou, Ying-Erh; Yang, Shun-Fa; Wu, Chih-Hsien; Chou, Chi-Hung; Wang, Po-Hui] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chien, Ming-Hsien; Cheng, Chao-Wen] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan; [Chou, Chi-Hung] Yuan Sheng Hosp, Dept Internal Med, Div Cardiol, Yuanlin, Taiwan; [Chou, Chi-Hung] Changhua Christian Hosp, Yuanlin Branch, Yuanlin, Taiwan; [Wang, Po-Hui] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wang, Po-Hui] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Wang, PH (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	wang082160@yahoo.com.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	Chung Shan Medical University Hospital [CSH-2013-D-001, CSH-2014-D-003]; Taiwan National Science Council [NSC 102-2314-B-040-014-MY3]; Chi-Mei Foundation Medical Center [CSMU-CMMC-102-02]; Chung Shan Medical University Hospital	Chung Shan Medical University Hospital; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Chi-Mei Foundation Medical Center; Chung Shan Medical University Hospital	This study was supported by research grants from Chung Shan Medical University Hospital (CSH-2013-D-001, CSH-2014-D-003), the Taiwan National Science Council (NSC 102-2314-B-040-014-MY3) and Chung Shan Medical University Hospital and Chi-Mei Foundation Medical Center (CSMU-CMMC-102-02). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; De Ceuninck F, 2001, BIOCHEM BIOPH RES CO, V285, P926, DOI 10.1006/bbrc.2001.5253; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duff GW, 2007, NUTR REV, V65, pS177, DOI [10.1111/j.1753-4887.2007.tb00359.x, 10.1301/nr.2007.dec.S177-S181]; Duxbury MS, 2007, BIOCHEM BIOPH RES CO, V354, P190, DOI 10.1016/j.bbrc.2006.12.177; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; FULLER AF, 1989, GYNECOL ONCOL, V33, P34, DOI 10.1016/0090-8258(89)90598-2; Grisaru DA, 2003, CANCER, V97, P1904, DOI 10.1002/cncr.11269; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011; Junker N, 2005, LUNG CANCER, V48, P223, DOI 10.1016/j.lungcan.2004.11.011; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kjaergaard AD, 2013, J MED GENET, V50, P831, DOI 10.1136/jmedgenet-2013-101908; Kruit A, 2007, RESP MED, V101, P1563, DOI 10.1016/j.rmed.2006.12.006; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lee H, 2010, CLIN BIOCHEM, V43, P1195, DOI 10.1016/j.clinbiochem.2010.07.017; Liu XY, 2007, CLIN COLORECTAL CANC, V6, P374, DOI 10.3816/CCC.2007.n.007; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Mitsuhashi A, 2009, ANN ONCOL, V20, P71, DOI 10.1093/annonc/mdn552; Morikawa T, 2010, HISTOPATHOLOGY, V57, P885, DOI 10.1111/j.1365-2559.2010.03725.x; Morikawa T, 2010, HUM PATHOL, V41, P1742, DOI 10.1016/j.humpath.2010.06.001; Nielsen KR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3391; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; Sapp H, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.028; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Schorge JO, 1996, GYNECOL ONCOL, V63, P34, DOI 10.1006/gyno.1996.0274; SEVIN BU, 1995, CANCER-AM CANCER SOC, V76, P1978, DOI 10.1002/1097-0142(19951115)76:10+<1978::AID-CNCR2820761313>3.0.CO;2-K; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Sohn MH, 2009, AM J RESP CRIT CARE, V179, P449, DOI 10.1164/rccm.200809-1422OC; Thomsen SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047094; Tiret L, 2002, P NUTR SOC, V61, P457, DOI 10.1079/PNS2002178; Verlaan DJ, 2012, J ALLERGY CLIN IMMUN, V130, P533, DOI 10.1016/j.jaci.2012.03.015; Wang LM, 2012, CHINESE MED J-PEKING, V125, P2151, DOI 10.3760/cma.j.issn.0366-6999.2012.12.013; Zhang KQ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-11; Zhao XZ, 2007, AM J HUM GENET, V80, P12, DOI 10.1086/510438; Zheng JL, 2011, CYTOKINE, V54, P51, DOI 10.1016/j.cyto.2010.12.018	42	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e104038	10.1371/journal.pone.0104038	http://dx.doi.org/10.1371/journal.pone.0104038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203433	Green Submitted, gold, Green Published			2022-12-27	WOS:000342684500003
J	Ohinata, Y; Tsukiyama, T				Ohinata, Yasuhide; Tsukiyama, Tomoyuki			Establishment of Trophoblast Stem Cells under Defined Culture Conditions in Mice	PLOS ONE			English	Article							EXPRESSION; FGF-4; GENE; DIFFERENTIATION; INHIBITION; DERIVATION	The inner cell mass (ICM) and trophoblast cell lineages duet early embryonic development in mammals. After implantation, the ICM forms the embryo proper as well as some extraembryonic tissues, whereas the trophoectoderm (TE) exclusively forms the fetal portion of the placenta and the trophoblast giant cells. Although embryonic stem (ES) cells can be derived from ICM in cultures of mouse blastocysts in the presence of LIF and/or combinations of small-molecule chemical compounds, and the undifferentiated pluripotent state can be stably maintained without use of serum and feeder cells, defined culture conditions for derivation and maintenance of undifferentiated trophoblast stem (TS) cells have not been established. Here, we report that addition of FGF2, activin A, XAV939, and Y27632 are necessary and sufficient for derivation of TS cells from both of E3.5 blastocysts and E6.5 early postimplantation extraembryonic ectoderm. Moreover, the undifferentiated TS cell state can be stably maintained in chemically defined culture conditions. Cells derived in this manner expressed TS cell marker genes, including Eomes, Elf5, Cdx2, Klf5, Cdh1, Esrrb, Sox2, and Tcfap2c; differentiated into all trophoblast subtypes (trophoblast giant cells, spongiotrophoblast, and labyrinthine trophoblast) in vitro; and exclusively contributed to trophoblast lineages in chimeric animals. This delineation of minimal requirements for derivation and self-renewal provides a defined platform for precise description and dissection of the molecular state of TS cells.	[Ohinata, Yasuhide] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Ohinata, Yasuhide] Univ Yamanashi, Life Sci Expt Facil, Dept Biotechnol, Fac Life & Environm Sci, Kofu, Yamanashi, Japan; [Ohinata, Yasuhide; Tsukiyama, Tomoyuki] RIKEN Kobe Inst, Lab Pluripotent Stem Cell Studies, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan	Japan Science & Technology Agency (JST); University of Yamanashi; RIKEN	Ohinata, Y (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.	yasuhideohinata@gmail.com	TSUKIYAMA, Tomoyuki/AAI-3082-2020	TSUKIYAMA, Tomoyuki/0000-0002-2657-7719	JST PRESTO; Japan Society for the Promotion of Science	JST PRESTO(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from the JST PRESTO to Y.O., and the Japan Society for the Promotion of Science (Research Fellowship Program) to Y.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Haffner-Krausz R, 1999, MECH DEVELOP, V85, P167, DOI 10.1016/S0925-4773(99)00082-9; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Kubaczka C, 2014, STEM CELL REP, V2, P232, DOI 10.1016/j.stemcr.2013.12.013; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; NAGY A, 1990, DEVELOPMENT, V110, P815; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; RAPPOLEE DA, 1994, DEVELOPMENT, V120, P2259; ROGERS MB, 1991, DEVELOPMENT, V113, P815; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sumi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063378; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xu XL, 1998, DEVELOPMENT, V125, P753; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	28	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107308	10.1371/journal.pone.0107308	http://dx.doi.org/10.1371/journal.pone.0107308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203285	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500083
J	Qureshi, H; Genesca, M; Fritts, L; McChesney, MB; Robert-Guroff, M; Miller, CJ				Qureshi, Huma; Genesca, Meritxell; Fritts, Linda; McChesney, Michael B.; Robert-Guroff, Marjorie; Miller, Christopher J.			Infection with Host-Range Mutant Adenovirus 5 Suppresses Innate Immunity and Induces Systemic CD4+T Cell Activation in Rhesus Macaques	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODIES TARGET; PLASMACYTOID DENDRITIC CELLS; BLOOD MONONUCLEAR-CELLS; T-CELLS; GAG/POL/NEF VACCINE; IFN-GAMMA; RESPONSES; HEXON; EXPRESSION	Ad5 is a common cause of respiratory disease and an occasional cause of gastroenteritis and conjunctivitis, and seroconversion before adolescence is common in humans. To gain some insight into how Ad5 infection affects the immune system of rhesus macaques (RM) 18 RM were infected with a host-range mutant Ad5 (Ad5hr) by 3 mucosal inoculations. There was a delay of 2 to 6 weeks after the first inoculation before plasmacytoid dendritic cell (pDC) frequency and function increased in peripheral blood. Primary Ad5hr infection suppressed IFN-gamma mRNA expression, but the second Ad5hr exposure induced a rapid increase in IFN-gamma mRNA in peripheral blood mononuclear cells (PBMC). Primary Ad5hr infection suppressed CCL20, TNF and IL-1 mRNA expression in PBMC, and subsequent virus exposures further dampened expression of these pro-inflammatory cytokines. Primary, but not secondary, Ad5hr inoculation increased the frequency of CXCR3+ CD4+ T cells in blood, while secondary, but not primary, Ad5hr infection transiently increased the frequencies of Ki67+, HLADR+ and CD95+/CCR5+ CD4+ T cells in blood. Ad5hr infection induced polyfunctional CD4 and CD8+ T cells specific for the Ad5 hexon protein in all of the animals. Thus, infection with Ad5hr induced a complex pattern of innate and adaptive immunity in RM that included transient systemic CD4+ T cell activation and suppressed innate immunity on re-exposure to the virus. The complex effects of adenovirus infection on the immune system may help to explain the unexpected results of testing Ad5 vector expressing HIV antigens in Ad5 seropositive people.	[Qureshi, Huma; Genesca, Meritxell; Fritts, Linda; McChesney, Michael B.; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Qureshi, Huma; Genesca, Meritxell; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Robert-Guroff, Marjorie] NCI, Vaccine Branch, NIH, Bethesda, MD 20892 USA	University of California System; University of California Davis; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Miller, CJ (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	cjmiller@ucdavis.edu	Genescà, Meritxell/AAF-9074-2020; Genescà, Meritxell/AFT-2336-2022	Genescà, Meritxell/0000-0001-6413-3812	National Institutes of Health, National Institute of Allergy and Infectious Disease [P01 AI82278-01]; NATIONAL CANCER INSTITUTE [ZIABC011062, ZIABC011063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082278] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	P01 AI82278-01 from the National Institutes of Health, National Institute of Allergy and Infectious Disease to CJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2005, CLIN DIAGN LAB IMMUN, V12, P606, DOI 10.1128/CDLI.12.5.606-621.2005; Abel K, 2004, J VIROL, V78, P841, DOI 10.1128/JVI.78.2.841-854.2004; Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Alkhalaf MA, 2013, J MED VIROL, V85, P1947, DOI 10.1002/jmv.23678; Baden LR, 2014, J INFECT DIS; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bradley RR, 2012, J VIROL, V86, P1267, DOI 10.1128/JVI.06165-11; Bradley RR, 2012, J VIROL, V86, P625, DOI 10.1128/JVI.06254-11; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; BUIMOVICIKLEIN E, 1988, J MED VIROL, V25, P371, DOI 10.1002/jmv.1890250402; Calcedo R, 2009, J VIROL, V83, P2623, DOI 10.1128/JVI.02160-08; CHANY C, 1958, AM J HYG, V67, P367, DOI 10.1093/oxfordjournals.aje.a119941; Cheng C, 2007, PLOS PATHOG, V3, P239, DOI 10.1371/journal.ppat.0030025; Cheng C, 2010, J VIROL, V84, P630, DOI 10.1128/JVI.00866-09; Chung E, 2005, CLIN DIAGN LAB IMMUN, V12, P426, DOI 10.1128/CDLI.12.3.426-435.2005; Cinek O, 2006, J CLIN VIROL, V35, P33, DOI 10.1016/j.jcv.2005.03.007; Curlin ME, 2011, AIDS, V25, P153, DOI 10.1097/QAD.0b013e328342115c; EDWARDS KM, 1985, PEDIATRICS, V76, P420; EVANS AS, 1958, NEW ENGL J MED, V259, P464, DOI 10.1056/NEJM195809042591002; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Friedman JM, 2002, J VIROL, V76, P5515, DOI 10.1128/JVI.76.11.5515-5521.2002; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; GIOVARELLI M, 1988, J IMMUNOL, V141, P2831; Higginbotham JN, 2002, HUM GENE THER, V13, P129, DOI 10.1089/10430340152712683; HILLIS WD, 1973, INDIAN J MED RES, V61, P980; Hutnick NA, 2010, VACCINE, V28, P1932, DOI 10.1016/j.vaccine.2009.10.091; JEFFERIES WA, 1990, J EXP MED, V172, P1653, DOI 10.1084/jem.172.6.1653; Kessler T, 2010, J GEN VIROL, V91, P1150, DOI 10.1099/vir.0.013920-0; KLESSIG DF, 1979, CELL, V17, P957, DOI 10.1016/0092-8674(79)90335-0; Leen AM, 2008, J VIROL, V82, P546, DOI 10.1128/JVI.01689-07; Lesokhin AM, 2002, J VIROL, V76, P8236, DOI 10.1128/JVI.76.16.8236-8243.2002; LEW JF, 1991, J INFECT DIS, V164, P673, DOI 10.1093/infdis/164.4.673; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lore K, 2007, J IMMUNOL, V179, P1721, DOI 10.4049/jimmunol.179.3.1721; MARASKOVSKY E, 1989, J IMMUNOL, V143, P1210; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Onion D, 2007, J GEN VIROL, V88, P2417, DOI 10.1099/vir.0.82867-0; Patterson LJ, 2012, CLIN VACCINE IMMUNOL, V19, P629, DOI 10.1128/CVI.00010-12; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Pine SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018526; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; Reinhart TA, 2002, BLOOD, V99, P3119, DOI 10.1182/blood.V99.9.3119; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Roy S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024859; Rozis G, 2005, EUR J IMMUNOL, V35, P2617, DOI 10.1002/eji.200425939; Schaack J, 2004, P NATL ACAD SCI USA, V101, P3124, DOI 10.1073/pnas.0303709101; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Sun Y, 2009, J VIROL, V83, P10596, DOI 10.1128/JVI.01170-09; Tai X, 2012, BLOOD; Tang J, 2004, GENE THER, V11, P1408, DOI 10.1038/sj.gt.3302316; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Varnavski AN, 2002, J VIROL, V76, P5711, DOI 10.1128/JVI.76.11.5711-5719.2002; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wong S, 2008, J MED VIROL, V80, P856, DOI 10.1002/jmv.21136; Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109	63	10	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106004	10.1371/journal.pone.0106004	http://dx.doi.org/10.1371/journal.pone.0106004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203111	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500011
J	Li, CG; Hao, LG; Li, Y; Wang, SG; Chen, H; Zhang, LM; Ke, B; Yin, YS; Suo, HJ; Sun, BS; Zhang, B; Wang, CL				Li, Chenguang; Hao, Ligang; Li, Yue; Wang, Shengguang; Chen, Hui; Zhang, Lianmin; Ke, Bin; Yin, Yuesong; Suo, Haijin; Sun, Bingsheng; Zhang, Bin; Wang, Changli			Prognostic Value Analysis of Mutational and Clinicopathological Factors in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; CARCINOMA; SPECTRUM	Introduction: Targeting activating oncogenic driver mutations in lung adenocarcinoma has led to prolonged survival in patients harboring these specific genetic alterations. The prognostic value of these mutations has not yet been elucidated. The prevalence of recently uncovered non-coding somatic mutation in promoter region of TERT gene is also to be validated in lung cancer. The purpose of this study is to show the prevalence, association with clinicalpathological features and prognostic value of these factors. Methods: In a cohort of patients with non-small cell lung cancer (NSCLC) (n = 174, including 107 lung adenocarcinoma and 67 lung squamous cell carcinoma), EGFR, KRAS, HER2 and BRAF were directly sequenced in lung adeoncarcinoma, ALK fusions were screened using FISH (Fluorescence in situ Hybridization). TERT promoter region was sequenced in all of the 174 NSCLC samples. Associations of these somatic mutations and clinicopathological features, as well as prognostic factors were evaluated. Results: EGFR, KRAS, HER2, BRAF mutation and ALK fusion were mutated in 25.2%, 6.5%, 1.9%, 0.9% and 3.7% of lung adenocarcinomas. No TERT promoter mutation was validated by reverse-sided sequencing. Lung adenocarcinoma with EGFR and KRAS mutations showed no significant difference in Disease-free Survival (DFS) and Overall Survival (OS). Cox Multi-variate analysis revealed that only N stage and HER2 mutation were independent predictors of worse overall survival (HR = 1.653, 95% CI 1.219-2.241, P = 0.001; HR = 12.344, 95% CI 2.615-58.275, P = 0.002). Conclusions: We have further confirmed that TERT promoter mutation may only exist in a very small fraction of NSCLCs. These results indicate that dividing lung adenocarcinoma into molecular subtypes according to oncogenic driver mutations doesn't predict survival difference of the disease.	[Li, Chenguang; Hao, Ligang; Li, Yue; Wang, Shengguang; Chen, Hui; Zhang, Lianmin; Yin, Yuesong; Suo, Haijin; Sun, Bingsheng; Zhang, Bin; Wang, Changli] Tianjin Med Univ, Dept Lung Canc, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Li, Chenguang; Hao, Ligang; Li, Yue; Wang, Shengguang; Chen, Hui; Zhang, Lianmin; Ke, Bin; Yin, Yuesong; Suo, Haijin; Sun, Bingsheng; Zhang, Bin; Wang, Changli] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Li, Chenguang; Hao, Ligang; Li, Yue; Wang, Shengguang; Chen, Hui; Zhang, Lianmin; Yin, Yuesong; Suo, Haijin; Sun, Bingsheng; Zhang, Bin; Wang, Changli] Tianjin Lung Canc Ctr, Tianjin, Peoples R China; [Ke, Bin] Tianjin Med Univ Canc Inst & Hosp, Dept Gastr Canc, Tianjin, Peoples R China; [Suo, Haijin] Tianjin Beichen Hosp, Dept Surg, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Wang, CL (corresponding author), Tianjin Med Univ, Dept Lung Canc, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin, Peoples R China.	wangchangli@medmail.com.cn			National Natural Science Foundation of China [81302001, 81201649]; China Postdoctoral Science Foundation [2014M550147]; Key Program for Anti-cancer Research of Tianjin Municipal Science and Technology Commission [12ZCDZSY15400]; Key Program of Application Foundation, Tianjin Municipal Science and Technology Commission [12JCYBJC17800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Key Program for Anti-cancer Research of Tianjin Municipal Science and Technology Commission; Key Program of Application Foundation, Tianjin Municipal Science and Technology Commission	This work was supported by the National Natural Science Foundation of China (81302001 to CG Li and 81201649 to BS Sun, http://www.nsfc.gov.cn), China Postdoctoral Science Foundation (2014M550147 to CG Li, http://res.chinapostdoctor.org.cn/BshWeb/index.shtml), Key Program for Anti-cancer Research of Tianjin Municipal Science and Technology Commission (12ZCDZSY15400 to CL Wang, http://www.tstc.gov.cn/) and Key Program of Application Foundation, Tianjin Municipal Science and Technology Commission (12JCYBJC17800 to CL Wang, http://www.tstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Bucheit AD, 2013, CANCER-AM CANCER SOC, V119, P3821, DOI 10.1002/cncr.28306; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Gao B, 2010, J THORAC ONCOL, V5, P1130, DOI 10.1097/JTO.0b013e3181e05016; Gold KA, 2012, CLIN CANCER RES, V18, P3002, DOI 10.1158/1078-0432.CCR-11-2055; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hurst CD, 2014, EUR UROL, V65, P367, DOI 10.1016/j.eururo.2013.08.057; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeon JH, 2014, EUR J CARDIOTHORAC S; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Li CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028204; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Perez-Moreno P, 2012, CLIN CANCER RES, V18, P2443, DOI 10.1158/1078-0432.CCR-11-2370; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038	21	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107276	10.1371/journal.pone.0107276	http://dx.doi.org/10.1371/journal.pone.0107276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198510	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700100
J	Uckermann, O; Galli, R; Tamosaityte, S; Leipnitz, E; Geiger, KD; Schackert, G; Koch, E; Steiner, G; Kirsch, M				Uckermann, Ortrud; Galli, Roberta; Tamosaityte, Sandra; Leipnitz, Elke; Geiger, Kathrin D.; Schackert, Gabriele; Koch, Edmund; Steiner, Gerald; Kirsch, Matthias			Label-Free Delineation of Brain Tumors by Coherent Anti-Stokes Raman Scattering Microscopy in an Orthotopic Mouse Model and Human Glioblastoma	PLOS ONE			English	Article							HUMAN GLIOMAS; IN-VIVO; CARS; TISSUE; METASTASES	Background Coherent anti-Stokes Raman scattering (CARS) microscopy provides fine resolution imaging and displays morphochemical properties of unstained tissue. Here, we evaluated this technique to delineate and identify brain tumors. Methods Different human tumors (glioblastoma, brain metastases of melanoma and breast cancer) were induced in an orthotopic mouse model. Cryosections were investigated by CARS imaging tuned to probe C-H molecular vibrations, thereby addressing the lipid content of the sample. Raman microspectroscopy was used as reference. Histopathology provided information about the tumor's localization, cell proliferation and vascularization. Results The morphochemical contrast of CARS images enabled identifying brain tumors irrespective of the tumor type and properties: All tumors were characterized by a lower CARS signal intensity than the normal parenchyma. On this basis, tumor borders and infiltrations could be identified with cellular resolution. Quantitative analysis revealed that the tumor-related reduction of CARS signal intensity was more pronounced in glioblastoma than in metastases. Raman spectroscopy enabled relating the CARS intensity variation to the decline of total lipid content in the tumors. The analysis of the immunohistochemical stainings revealed no correlation between tumor-induced cytological changes and the extent of CARS signal intensity reductions. The results were confirmed on samples of human glioblastoma. Conclusions CARS imaging enables label-free, rapid and objective identification of primary and secondary brain tumors. Therefore, it is a potential tool for diagnostic neuropathology as well as for intraoperative tumor delineation. [GRAPHICS] .						Koch, Edmund/0000-0003-0554-2178	German Ministry for Education, Research and Technology (BMBF); Association of German Engineers (VDI) (mediCARS-CARS microscopy in medicine) [13N10777]	German Ministry for Education, Research and Technology (BMBF)(Federal Ministry of Education & Research (BMBF)); Association of German Engineers (VDI) (mediCARS-CARS microscopy in medicine)	This work was supported by the German Ministry for Education, Research and Technology (BMBF) and The Association of German Engineers (VDI) (mediCARS-CARS microscopy in medicine, A.Z. 13N10777). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov D, 2009, J RAMAN SPECTROSC, V40, P941, DOI 10.1002/jrs.2205; Belanger E, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021107; Beleites C, 2011, ANAL BIOANAL CHEM, V400, P2801, DOI 10.1007/s00216-011-4985-4; Beljebbar A, 2008, ANAL CHEM, V80, P8406, DOI 10.1021/ac800990y; Berghoff AS, 2013, NEURO-ONCOLOGY, V15, P1664, DOI 10.1093/neuonc/not112; Bergner N, 2012, CHEMOMETR INTELL LAB, V117, P224, DOI 10.1016/j.chemolab.2012.02.008; Burkacky O, 2006, OPT LETT, V31, P3656, DOI 10.1364/OL.31.003656; Chaichana KL, 2014, NEURO-ONCOLOGY, V16, P113, DOI 10.1093/neuonc/not137; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Evans CL, 2007, OPT EXPRESS, V15, P12076, DOI 10.1364/OE.15.012076; Fu Y, 2008, OPT EXPRESS, V16, P19396, DOI 10.1364/OE.16.019396; Galeffi Francesca, 2012, Curr Drug Discov Technol, V9, P280; Galli R, 2013, PROC SPIE, V8797, DOI 10.1117/12.2031729; Galli R, 2012, ANAL CHEM, V84, P8707, DOI 10.1021/ac301938m; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Kamp MA, 2012, ACTA NEUROCHIR, V154, P223, DOI 10.1007/s00701-011-1200-5; Kirsch M, 2005, CLIN CANCER RES, V11, P1259; Kirsch M, 1998, CANCER RES, V58, P4654; Koljenovic S, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922307; Krafft C, 2005, ANALYST, V130, P1070, DOI 10.1039/b419232j; Krafft C, 2004, ANALYST, V129, P921, DOI 10.1039/b408934k; Krafft C, 2007, ANAL BIOANAL CHEM, V387, P1669, DOI 10.1007/s00216-006-0892-5; Krafft C, 2006, BIOPOLYMERS, V82, P301, DOI 10.1002/bip.20492; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Legare F, 2006, OPT EXPRESS, V14, P4427, DOI 10.1364/OE.14.004427; Lei M, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533707; Martin DD, 1996, LIPIDS, V31, P1283, DOI 10.1007/BF02587914; Meyer T, 2013, ANAL CHEM, V85, P6703, DOI 10.1021/ac400570w; Meyer T, 2012, J BIOPHOTONICS, V5, P729, DOI 10.1002/jbio.201200104; Meyer T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533268; Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202; Murugkar S, 2010, OPT EXPRESS, V18, P23796, DOI 10.1364/OE.18.023796; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Pohling C, 2011, BIOMED OPT EXPRESS, V2, P2110, DOI 10.1364/BOE.2.002110; Rivera DR, 2011, P NATL ACAD SCI USA, V108, P17598, DOI 10.1073/pnas.1114746108; Saar BG, 2011, OPT LETT, V36, P2396, DOI 10.1364/OL.36.002396; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shi YZ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3641988; Somerset HL, 2011, ADV ANAT PATHOL, V18, P446, DOI 10.1097/PAP.0b013e3182169934; Steiner G, 2003, BIOPOLYMERS, V72, P464, DOI 10.1002/bip.10487; Uckermann O, 2013, EUR ASS NEUROONC MAG, V4, P20; Wang HW, 2009, VIB SPECTROSC, V50, P160, DOI 10.1016/j.vibspec.2008.11.007; YATES AJ, 1979, J LIPID RES, V20, P428	44	59	59	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107115	10.1371/journal.pone.0107115	http://dx.doi.org/10.1371/journal.pone.0107115			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198698	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700083
J	Zhai, YF; Lin, QC; Zhou, XH; Zhang, XY; Liu, TL; Yu, Y				Zhai, Yifan; Lin, Qingcai; Zhou, Xianhong; Zhang, Xiaoyan; Liu, Tingli; Yu, Yi			Identification and Validation of Reference Genes for Quantitative Real-Time PCR in Drosophila suzukii (Diptera: Drosophilidae)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HOUSEKEEPING GENES; RT-PCR; BROWN PLANTHOPPER; EXPRESSION; SELECTION; NORMALIZATION; HEMIPTERA; HEAD	To accurately evaluate gene expression levels and obtain more accurate quantitative real-time RT-PCR (qRT-PCR) data, normalization relative to reliable reference gene(s) is required. Drosophila suzukii, is an invasive fruit pest native to East Asia, and recently invaded Europe and North America, the stability of its reference genes have not been previously investigated. In this study, ten candidate reference genes (RPL18, RPS3, AK, EF-1 beta, TBP, NADH, HSP22, GAPDH, Actin, alpha-Tubulin), were evaluated for their suitability as normalization genes under different biotic (developmental stage, tissue and population), and abiotic (photoperiod, temperature) conditions. The three statistical approaches (geNorm, NormFinder and BestKeeper) and one web-based comprehensive tool (RefFinder) were used to normalize analysis of the ten candidate reference genes identified alpha-Tubulin, TBP and AK as the most stable candidates, while HSP22 and Actin showed the lowest expression stability. We used three most stable genes (alpha-Tubulin, TBP and AK) and one unstably expressed gene to analyze the expression of P-glycoprotein in abamectin-resistant and sensitive strains, and the results were similar to reference genes alpha-Tubulin, TBP and AK, which show good stability, while the result of HSP22 has a certain bias. The three validated reference genes can be widely used for quantification of target gene expression with qRT-PCR technology in D. suzukii.	[Zhai, Yifan; Zhou, Xianhong; Liu, Tingli; Yu, Yi] Shandong Acad Agr Sci, Inst Plant Protect, Jinan, Peoples R China; [Lin, Qingcai] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China; [Zhang, Xiaoyan] Yunnan Agr Univ, Coll Plant Protect, Kunming, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Agricultural University; Yunnan Agricultural University	Zhai, YF (corresponding author), Shandong Acad Agr Sci, Inst Plant Protect, Jinan, Peoples R China.	zyifan@saas.ac.cn; robertyuyi@163.com			Shandong Provincial Modern Agricultural Industry Technology System Innovation Team Foundation, China [SDAIT-03-022-08]; Ministry of Agriculture Agricultural Research Exceptional Talents and Innovation Team Foundation, China	Shandong Provincial Modern Agricultural Industry Technology System Innovation Team Foundation, China; Ministry of Agriculture Agricultural Research Exceptional Talents and Innovation Team Foundation, China	Shandong Provincial Modern Agricultural Industry Technology System Innovation Team Foundation, China (SDAIT-03-022-08) and Ministry of Agriculture Agricultural Research Exceptional Talents and Innovation Team Foundation, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bansal R, 2012, J ECON ENTOMOL, V105, P1432, DOI 10.1603/EC12095; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Dong MT, 2012, CURR GENET, V58, P13, DOI 10.1007/s00294-011-0361-3; Dong XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067723; Dong XL, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-53; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Logan J., 2009, REAL TIME PCR CURREN; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032288; Luo L, 2013, INSECT BIOCHEM MOLEC, V43, P627, DOI 10.1016/j.ibmb.2013.04.006; Mamidala P, 2011, J MED ENTOMOL, V48, P947, DOI 10.1603/ME10262; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Paim Rafaela M., 2012, BMC Research Notes, V5, DOI 10.1186/1756-0500-5-128; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Ram KR, 2009, P NATL ACAD SCI USA, V106, P15384, DOI 10.1073/pnas.0902923106; Rota-Stabelli O, 2013, CURR BIOL, V23, pR8, DOI 10.1016/j.cub.2012.11.021; Sanghavi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080605; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Smits Katrien, 2009, BMC Res Notes, V2, P246, DOI 10.1186/1756-0500-2-246; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Sun W, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20801; Swarup S, 2011, P NATL ACAD SCI USA, V108, P9887, DOI 10.1073/pnas.1017548108; Taki FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094311; Tatsumi K, 2008, BIOCHEM BIOPH RES CO, V374, P106, DOI 10.1016/j.bbrc.2008.06.103; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tunbridge EM, 2011, BIOL PSYCHIAT, V69, P173, DOI 10.1016/j.biopsych.2010.05.023; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xie W, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4601; Zhai YF, 2013, J PROTEOME RES, V12, P5199, DOI 10.1021/pr400561c; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	32	48	50	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106800	10.1371/journal.pone.0106800	http://dx.doi.org/10.1371/journal.pone.0106800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198611	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700052
J	Hoare, DJ; Van Labeke, N; McCormack, A; Sereda, M; Smith, S; Al Taher, H; Kowalkowski, VL; Sharples, M; Hall, DA				Hoare, Derek J.; Van Labeke, Nicolas; McCormack, Abby; Sereda, Magdalena; Smith, Sandra; Al Taher, Hala; Kowalkowski, Victoria L.; Sharples, Mike; Hall, Deborah A.			Gameplay as a Source of Intrinsic Motivation in a Randomized Controlled Trial of Auditory Training for Tinnitus	PLOS ONE			English	Article							DISCRIMINATION THERAPY ADT; HEARING-LOSS; FREQUENCY DISCRIMINATION; PRIMARY-CARE; PLASTICITY; COMPUTER; MEMORY	Background: Previous studies of frequency discrimination training (FDT) for tinnitus used repetitive task-based training programmes relying on extrinsic factors to motivate participation. Studies reported limited improvement in tinnitus symptoms. Purpose: To evaluate FDT exploiting intrinsic motivations by integrating training with computer-gameplay. Methods: Sixty participants were randomly assigned to train on either a conventional task-based training, or one of two interactive game-based training platforms over six weeks. Outcomes included assessment of motivation, tinnitus handicap, and performance on tests of attention. Results: Participants reported greater intrinsic motivation to train on the interactive game-based platforms, yet compliance of all three groups was similar (similar to 70%) and changes in self-reported tinnitus severity were not significant. There was no difference between groups in terms of change in tinnitus severity or performance on measures of attention. Conclusion: FDT can be integrated within an intrinsically motivating game. Whilst this may improve participant experience, in this instance it did not translate to additional compliance or therapeutic benefit.	[Hoare, Derek J.; McCormack, Abby; Sereda, Magdalena; Smith, Sandra; Al Taher, Hala; Hall, Deborah A.] Natl Inst Hlth Res Nottingham, Hearing Biomed Res Unit, Nottingham, England; [Hoare, Derek J.; McCormack, Abby; Sereda, Magdalena; Smith, Sandra; Hall, Deborah A.] Univ Nottingham, Sch Med, Div Clin Neurosci, Otol & Hearing Grp, Nottingham NG7 2RD, England; [Van Labeke, Nicolas; Sharples, Mike] Open Univ, Inst Educ Technol, Milton Keynes MK7 6AA, Bucks, England; [Kowalkowski, Victoria L.] Inst Hearing Res, Med Res Council, Nottingham, England	University of Nottingham; University of Nottingham; Open University - UK; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Hoare, DJ (corresponding author), Natl Inst Hlth Res Nottingham, Hearing Biomed Res Unit, Nottingham, England.	derek.hoare@nottingham.ac.uk		Hunter, Abby/0000-0002-6533-6918; Van Labeke, Nicolas/0000-0001-5073-799X; Hall, Deborah/0000-0002-3804-1452; Sereda, Magdalena/0000-0002-2792-8496; Hoare, Derek/0000-0002-8768-1392	National Institute for Health Research (NIHR) Biomedical Research Unit Programme; NIHR or the Department of Health; Medical Research Council [1202016] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Unit Programme(National Institute for Health Research (NIHR)); NIHR or the Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the National Institute for Health Research (NIHR) Biomedical Research Unit Programme, however, the views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Altman DG, 2005, BMJ-BRIT MED J, V330, P384; Amitay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009816; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Barry J. G., 2010, JOVE-J VIS EXP, V44, P2139, DOI [10.3791/2139, DOI 10.3791/2139]; Beck AT, 1997, ASSESSMENT, V4, P211, DOI 10.1177/107319119700400301; Benedek J., 2002, P US PROF ASS C ORL; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cima RFF, 2012, LANCET, V379, P1951, DOI 10.1016/S0140-6736(12)60469-3; Clark KB, 1999, NAT NEUROSCI, V2, P94, DOI 10.1038/4600; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1998, STAT POWER ANAL BEHA; David SV, 2012, P NATL ACAD SCI USA, V109, P2144, DOI 10.1073/pnas.1117717109; Davis A., 2000, TINNITUS HDB, P1; Delb W, 2002, HNO, V50, P997, DOI 10.1007/s00106-002-0645-5; Delb W, 2008, APPL PSYCHOPHYS BIOF, V33, P211, DOI 10.1007/s10484-008-9065-y; Dietrich V, 2001, HEARING RES, V158, P95, DOI 10.1016/S0378-5955(01)00282-9; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; El-Shunnar SK, 2011, J EVAL CLIN PRACT, V17, P684, DOI 10.1111/j.1365-2753.2011.01696.x; Elgoyhen AB, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00001; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Flor H, 2004, APPL PSYCHOPHYS BIOF, V29, P113, DOI 10.1023/B:APBI.0000026637.77671.f4; Fu Qian-Jie, 2007, Seminars in Hearing, V28, P142, DOI 10.1055/s-2007-973440; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Henry, 1998, Int Tinnitus J, V4, P114; Herraiz C, 2006, ACTA OTO-LARYNGOL, V126, P80, DOI 10.1080/03655230600895614; Herraiz C, 2007, PROG BRAIN RES, V166, P467, DOI 10.1016/S0079-6123(07)66045-2; Herraiz C, 2010, EUR ARCH OTO-RHINO-L, V267, P1067, DOI 10.1007/s00405-009-1182-6; Hoare DJ, 2012, JARO-J ASSOC RES OTO, V13, P543, DOI 10.1007/s10162-012-0323-6; Hoare DJ, 2012, J EVAL CLIN PRACT, V18, P326, DOI 10.1111/j.1365-2753.2010.01566.x; Hoare DJ, 2010, ANN BEHAV MED, V40, P313, DOI 10.1007/s12160-010-9213-5; Joffe H, 2004, RES METHODS CLIN HLT, P56, DOI DOI 10.4135/9781849209793; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; KUK FK, 1990, EAR HEARING, V11, P434, DOI 10.1097/00003446-199012000-00005; Malone T.W., 1987, APTITUDE LEARNING IN, V1st ed., P223, DOI [10.4324/9781003163244, DOI 10.4324/9781003163244]; Meikle Mary B, 2008, Trends Amplif, V12, P223, DOI 10.1177/1084713808319943; Melcher JR, 2013, HEARING RES, V295, P79, DOI 10.1016/j.heares.2012.03.013; Moller A R, 2000, J Am Acad Audiol, V11, P115; Newman C W, 1998, J Am Acad Audiol, V9, P153; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Nilsson CN, 2009, PRESENCE, V21, P69, DOI DOI 10.1162/PRES_; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2003, JARO-J ASSOC RES OTO, V4, P312, DOI 10.1007/s10162-002-3039-1; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Papastergiou M, 2009, COMPUT EDUC, V53, P603, DOI 10.1016/j.compedu.2009.04.001; Pierce KJ, 2012, J CLIN EXP NEUROPSYC, V34, P126, DOI 10.1080/13803395.2011.623120; Przybylski AK, 2010, REV GEN PSYCHOL, V14, P154, DOI 10.1037/a0019440; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Schaette R, 2006, EUR J NEUROSCI, V23, P3124, DOI 10.1111/j.1460-9568.2006.04774.x; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; SULLIVAN M, 1993, ARCH INTERN MED, V153, P2251, DOI 10.1001/archinte.153.19.2251; Sweetow Robert W, 2007, Trends Amplif, V11, P101, DOI 10.1177/1084713807301321; Tass PA, 2012, RESTOR NEUROL NEUROS, V30, P137, DOI 10.3233/RNN-2012-110218; Thai-Van H, 2003, BRAIN, V126, P2235, DOI 10.1093/brain/awg228; Thai-Van H, 2002, BRAIN, V125, P524, DOI 10.1093/brain/awf044; Tyler RS, 2012, J AM ACAD AUDIOL, V23, P115, DOI 10.3766/jaaa.23.2.6; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Williams GC, 2007, HEALTH PSYCHOL, V26, P728, DOI 10.1037/0278-6133.26.6.728	66	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107430	10.1371/journal.pone.0107430	http://dx.doi.org/10.1371/journal.pone.0107430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP0SM	25215617	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000341774300064
J	Piek, S; Wang, ZR; Ganguly, J; Lakey, AM; Bartley, SN; Mowlaboccus, S; Anandan, A; Stubbs, KA; Scanlon, MJ; Vrielink, A; Azadi, P; Carlson, RW; Kahler, CM				Piek, Susannah; Wang, Zhirui; Ganguly, Jhuma; Lakey, Adam M.; Bartley, Stephanie N.; Mowlaboccus, Shakeel; Anandan, Anandhi; Stubbs, Keith A.; Scanlon, Martin J.; Vrielink, Alice; Azadi, Parastoo; Carlson, Russell W.; Kahler, Charlene M.			The Role of Oxidoreductases in Determining the Function of the Neisserial Lipid A Phosphoethanolamine Transferase Required for Resistance to Polymyxin	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; MENINGITIDIS; GONORRHOEAE; LIPOOLIGOSACCHARIDE; DSBA; PROTEIN; IDENTIFICATION; BIOSYNTHESIS; SUSCEPTIBILITY	The decoration of the lipid A headgroups of the lipooligosaccharide (LOS) by the LOS phosphoethanolamine (PEA) transferase (LptA) in Neisseria spp. is central for resistance to polymyxin. The structure of the globular domain of LptA shows that the protein has five disulphide bonds, indicating that it is a potential substrate of the protein oxidation pathway in the bacterial periplasm. When neisserial LptA was expressed in Escherichia coli in the presence of the oxidoreductase, EcDsbA, polymyxin resistance increased 30-fold. LptA decorated one position of the E. coli lipid A headgroups with PEA. In the absence of the EcDsbA, LptA was degraded in E. coli. Neisseria spp. express three oxidoreductases, DsbA1, DsbA2 and DsbA3, each of which appear to donate disulphide bonds to different targets. Inactivation of each oxidoreductase in N. meningitidis enhanced sensitivity to polymyxin with combinatorial mutants displaying an additive increase in sensitivity to polymyxin, indicating that the oxidoreductases were required for multiple pathways leading to polymyxin resistance. Correlates were sought between polymyxin sensitivity, LptA stability or activity and the presence of each of the neisserial oxidoreductases. Only meningococcal mutants lacking DsbA3 had a measurable decrease in the amount of PEA decoration on lipid A headgroups implying that LptA stability was supported by the presence of DsbA3 but did not require DsbA1/2 even though these oxidoreductases could oxidise the protein. This is the first indication that DsbA3 acts as an oxidoreductase in vivo and that multiple oxidoreductases may be involved in oxidising the one target in N. meningitidis. In conclusion, LptA is stabilised by disulphide bonds within the protein. This effect was more pronounced when neisserial LptA was expressed in E. coli than in N. meningitidis and may reflect that other factors in the neisserial periplasm have a role in LptA stability.	[Piek, Susannah; Lakey, Adam M.; Bartley, Stephanie N.; Mowlaboccus, Shakeel; Kahler, Charlene M.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Piek, Susannah; Lakey, Adam M.; Bartley, Stephanie N.; Mowlaboccus, Shakeel; Kahler, Charlene M.] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Perth, WA 6009, Australia; [Wang, Zhirui; Ganguly, Jhuma; Azadi, Parastoo; Carlson, Russell W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Anandan, Anandhi; Stubbs, Keith A.; Vrielink, Alice] Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia; [Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic 3004, Australia; [Scanlon, Martin J.] Monash Univ, ARC Ctr Excellence Coherent Xray Sci, Melbourne, Vic 3004, Australia	University of Western Australia; University of Western Australia; University System of Georgia; University of Georgia; University of Western Australia; Monash University; Monash University	Kahler, CM (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia.	Charlene.Kahler@uwa.edu.au	Ganguly, Jhuma/AAY-2927-2020; Stubbs, Keith/H-5909-2014; Kahler, Charlene M/H-5159-2014; Vrielink, Alice/D-3652-2013	Ganguly, Jhuma/0000-0001-5119-6144; Kahler, Charlene M/0000-0003-4322-3055; Mowlaboccus, Shakeel/0000-0001-9408-6068; Scanlon, Martin/0000-0002-9230-7506; Vrielink, Alice/0000-0001-8197-3725; Anandan, Anandhi/0000-0003-4743-2831; Stubbs, Keith/0000-0001-6899-402X	National Health and Medical Research Council [1003697, 572656]; Department of Energy [DE-FG-02-93ER20097]; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Department of Energy(United States Department of Energy (DOE)); Australian Research Council(Australian Research Council)	MJS, AV, RWC and CMK were funded by the National Health and Medical Research Council (APP 1003697 and 572656). Structural analysis was also supported, in part, by a Department of Energy Grant (DE-FG-02-93ER20097) to the Complex Carbohydrate Research Center. KAS is supported by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysuriya SD, 2010, COMMUN DIS INTELL, V34, P342; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Anandan A, 2012, ACTA CRYSTALLOGRAP F; Balthazar JT, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00030; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; CHUNG CT, 1988, NUCLEIC ACIDS RES, V16, P3580, DOI 10.1093/nar/16.8.3580; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; du Plessis M, 2010, J ANTIMICROB CHEMOTH, V65, P2258, DOI 10.1093/jac/dkq291; Hobbs MM, 2013, MBIO, V4, DOI 10.1128/mBio.00892-13; John CM, 2012, INFECT IMMUN, V80, P4014, DOI 10.1128/IAI.00506-12; Johnson MB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00077; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kahler CM, 1998, CRIT REV MICROBIOL, V24, P281, DOI 10.1080/10408419891294216; Kahler CM, 1996, J BACTERIOL, V178, P1265, DOI 10.1128/jb.178.5.1265-1273.1996; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; KULSHIN VA, 1992, J BACTERIOL, V174, P1793, DOI 10.1128/jb.174.6.1793-1800.1992; Kumar P, 2011, MOL MICROBIOL, V79, P1557, DOI 10.1111/j.1365-2958.2011.07546.x; Lafaye C, 2009, J MOL BIOL, V392, P952, DOI 10.1016/j.jmb.2009.07.056; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; MENARD R, 1993, J BACTERIOL, V175, P5899; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; Neri A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-246; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; Piek S, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00162; Qu XD, 1996, INFECT IMMUN, V64, P1240, DOI 10.1128/IAI.64.4.1240-1245.1996; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rahman MM, 2000, MICROBIOL-UK, V146, P1901, DOI 10.1099/00221287-146-8-1901; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Sampson TR, 2012, ANTIMICROB AGENTS CH, V56, P5642, DOI 10.1128/AAC.00756-12; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Shafer WM, 2001, J MOL MICROB BIOTECH, V3, P219; Sinha S, 2004, MICROBIOL-SGM, V150, P2993, DOI 10.1099/mic.0.27216-0; Sinha S, 2008, MICROBIOL-SGM, V154, P217, DOI 10.1099/mic.0.2007/010496-0; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; STEPHENS DS, 1991, INFECT IMMUN, V59, P4097, DOI 10.1128/IAI.59.11.4097-4102.1991; Takahashi H, 2008, INFECT IMMUN, V76, P5777, DOI 10.1128/IAI.00676-08; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tinsley CR, 2004, J BIOL CHEM, V279, P27078, DOI 10.1074/jbc.M313404200; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Tzeng YL, 2002, J BIOL CHEM, V277, P24103, DOI 10.1074/jbc.M200931200; Unemo M, 2011, EURO SURVEILL, V16; Unemo M, 2011, ANN NY ACAD SCI, V1230, pE19, DOI 10.1111/j.1749-6632.2011.06215.x; Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h; Vivian JP, 2008, J BIOL CHEM, V283, P32452, DOI 10.1074/jbc.M803990200; Wanty C, 2013, J MOL BIOL, V425, P3389, DOI 10.1016/j.jmb.2013.06.029; Webb SAR, 2001, METH MOLEC MED, V67, P663, DOI 10.1385/1-59259-149-3:663; Westphal O, 1965, METHODS CARBOHYDR CH, V5, P83; World Helath Organization, 2012, NEISS GON, P1; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yount NY, 2013, ANN NY ACAD SCI, V1277, P127, DOI 10.1111/nyas.12005	51	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106513	10.1371/journal.pone.0106513	http://dx.doi.org/10.1371/journal.pone.0106513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215579	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300016
J	Guillaud, M; Buys, TPH; Carraro, A; Korbelik, J; Follen, M; Scheurer, M; Storthz, KA; van Niekerk, D; MacAulay, CE				Guillaud, Martial; Buys, Timon P. H.; Carraro, Anita; Korbelik, Jagoda; Follen, Michele; Scheurer, Michael; Storthz, Karen Adler; van Niekerk, Dirk; MacAulay, Calum E.			Evaluation of HPV Infection and Smoking Status Impacts on Cell Proliferation in Epithelial Layers of Cervical Neoplasia	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS; CIGARETTE-SMOKING; EARLY CIN; TOBACCO SMOKING; LOW-RISK; GRADE; KI-67; EXPRESSION; BEHAVIOR	Accurate cervical intra-epithelial neoplasia (CIN) lesion grading is needed for effective patient management. We applied computer-assisted scanning and analytic approaches to immuno-stained CIN lesion sections to more accurately delineate disease states and decipher cell proliferation impacts from HPV and smoking within individual epithelial layers. A patient cohort undergoing cervical screening was identified (n = 196) and biopsies of varying disease grades and with intact basement membranes and epithelial layers were obtained (n = 261). Specimens were sectioned, stained (Mib1), and scanned using a high-resolution imaging system. We achieved semi-automated delineation of proliferation status and epithelial cell layers using Otsu segmentation, manual image review, Voronoi tessellation, and immuno-staining. Data were interrogated against known status for HPV infection, smoking, and disease grade. We observed increased cell proliferation and decreased epithelial thickness with increased disease grade (when analyzing the epithelium at full thickness). Analysis within individual cell layers showed a >= 50% increase in cell proliferation for CIN2 vs. CIN1 lesions in higher epithelial layers (with minimal differences seen in basal/parabasal layers). Higher rates of proliferation for HPV-positive vs. -negative cases were seen in epithelial layers beyond the basal/parabasal layers in normal and CIN1 tissues. Comparing smokers vs. non-smokers, we observed increased cell proliferation in parabasal (low and high grade lesions) and basal layers (high grade only). In sum, we report CIN grade-specific differences in cell proliferation within individual epithelial layers. We also show HPV and smoking impacts on cell layer-specific proliferation. Our findings yield insight into CIN progression biology and demonstrate that rigorous, semi-automated imaging of histopathological specimens may be applied to improve disease grading accuracy.	[Guillaud, Martial; Buys, Timon P. H.; Carraro, Anita; Korbelik, Jagoda; MacAulay, Calum E.] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Follen, Michele] Texas Tech Univ Hlth Sci Ctr El Paso, Paul L Foster Sch Med, Dept Obstet & Gynecol, El Paso, TX USA; [Scheurer, Michael] Baylor Coll Med, Dept Pediat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Storthz, Karen Adler] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost Sci, Houston, TX 77030 USA; [van Niekerk, Dirk] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC V5Z 4E6, Canada	British Columbia Cancer Agency; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; British Columbia Cancer Agency	Guillaud, M (corresponding author), British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada.	mguillau@bccrc.ca	MacAulay, Calum/K-1795-2016	Scheurer, Michael/0000-0002-8379-6088; guillaud, martial/0000-0001-8982-2489; MacAulay, Calum/0000-0003-4440-2792	National Cancer Institute [P01-CA-82710]; NATIONAL CANCER INSTITUTE [P01CA082710] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, grant number P01-CA-82710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baak JPA, 2006, J CLIN PATHOL, V59, P1017, DOI 10.1136/jcp.2005.027839; Baak JPA, 2006, CELL ONCOL, V28, P63; Baak JPA, 2005, CELL ONCOL, V27, P277; BARTON SE, 1988, LANCET, V2, P652; Broekema M, 2009, AM J RESP CRIT CARE, V180, P1170, DOI 10.1164/rccm.200906-0828OC; Calleja-Macias IE, 2009, INT J CANCER, V124, P1090, DOI 10.1002/ijc.24053; Campaner AB, 2011, ARCH GYNECOL OBSTET, V284, P119, DOI 10.1007/s00404-010-1586-y; Collins S, 2010, EUR J CANCER, V46, P405, DOI 10.1016/j.ejca.2009.09.015; Deacon JM, 2000, BRIT J CANCER, V83, P1565, DOI 10.1054/bjoc.2000.1523; Graflund M, 2004, ONCOL REP, V12, P169; Gultekin SE, 2008, J PERIODONTOL, V79, P1444, DOI [10.1902/jop.2008.070645, 10.1902/jop.2008.070645 ]; Guillaud M, 2006, CELL ONCOL, V28, P61; Harris TG, 2004, AM J EPIDEMIOL, V159, P834, DOI 10.1093/aje/kwh115; Hildesheim A, 2001, BRIT J CANCER, V84, P1219, DOI 10.1054/bjoc.2001.1779; Ho GYF, 1998, INT J CANCER, V78, P281, DOI 10.1002/(SICI)1097-0215(19981029)78:3&lt;281::AID-IJC3&gt;3.0.CO;2-R; HONDA H, 1983, INT REV CYTOL, V81, P191, DOI 10.1016/S0074-7696(08)62339-6; Kamalov R, 2005, COMPUT METH PROG BIO, V77, P99, DOI 10.1016/j.cmpb.2004.04.003; Keating JT, 2001, AM J SURG PATHOL, V25, P884, DOI 10.1097/00000478-200107000-00006; Kruse AJ, 2003, J PATHOL, V199, P462, DOI 10.1002/path.1316; Kruse AJ, 2004, CELL ONCOL, V26, P13; Kruse AJ, 2004, INT J GYNECOL PATHOL, V23, P100, DOI 10.1097/00004347-200404000-00003; Kruse AJ, 2002, AM J SURG PATHOL, V26, P1501, DOI 10.1097/00000478-200211000-00013; Kruse AJ, 2001, J PATHOL, V195, P557, DOI 10.1002/path.998; Kruse AJ, 2001, J PATHOL, V193, P48; Lapperre TS, 2006, THORAX, V61, P115, DOI 10.1136/thx.2005.040519; Lieberman JA, 2008, CLIN VACCINE IMMUNOL, V15, P49, DOI 10.1128/CVI.00216-07; Lorenzato M, 2005, HUM PATHOL, V36, P1101, DOI 10.1016/j.humpath.2005.07.016; Maeda M. Y. S., 2001, Pathologica (Genoa), V93, P189; Malpica A, 2005, GYNECOL ONCOL, V99, pS38, DOI 10.1016/j.ygyno.2005.07.040; Matsumoto K, 2010, CANCER SCI, V101, P2065, DOI 10.1111/j.1349-7006.2010.01642.x; Moore TO, 2001, J CUTAN MED SURG, V5, P323, DOI 10.1007/s102270000029; Olsen AO, 1998, EPIDEMIOLOGY, V9, P346, DOI 10.1097/00001648-199805000-00022; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rahkola-Soisalo P, 2013, ACTA OBSTET GYN SCAN, V92, P711, DOI 10.1111/aogs.12119; Rahkola-Soisalo P, 2013, ANN MED, V45, P79, DOI 10.3109/07853890.2012.665472; Tolstrup J, 2006, ACTA OBSTET GYN SCAN, V85, P1114, DOI 10.1080/00016340600677027; Van Niekerk D, 2007, GYNECOL ONCOL, V107, pS233, DOI 10.1016/j.ygyno.2007.07.064; You JX, 2010, BBA-GENE REGUL MECH, V1799, P192, DOI 10.1016/j.bbagrm.2009.09.009	38	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107088	10.1371/journal.pone.0107088	http://dx.doi.org/10.1371/journal.pone.0107088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210770	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900043
J	Ali, S; Littlewood, E; McMillan, D; Delgadillo, J; Miranda, A; Croudace, T; Gilbody, S				Ali, Shehzad; Littlewood, Elizabeth; McMillan, Dean; Delgadillo, Jaime; Miranda, Alfonso; Croudace, Tim; Gilbody, Simon			Heterogeneity in Patient-Reported Outcomes following Low-Intensity Mental Health Interventions: A Multilevel Analysis	PLOS ONE			English	Article							COLLABORATIVE RESEARCH-PROGRAM; NATIONAL-INSTITUTE; THERAPISTS; PSYCHOTHERAPY; VARIABILITY; SEVERITY; FEEDBACK	Background: Variability in patient-reported outcomes of psychological treatments has been partly attributed to therapists a phenomenon commonly known as therapist effects. Meta-analytic reviews reveal wide variation in therapist-attributable variability in psychotherapy outcomes, with most studies reporting therapist effects in the region of 5% to 10% and some finding minimal to no therapist effects. However, all except one study to date have been conducted in high-intensity or mixed intervention groups; therefore, there is scarcity of evidence on therapist effects in brief low-intensity psychological interventions. Objective: To examine therapist effects in low-intensity interventions for depression and anxiety in a naturalistic setting. Data and Analysis: Session-by-session data on patient-reported outcome measures were available for a cohort of 1,376 primary care psychotherapy patients treated by 38 therapists. Outcome measures included PHQ-9 (sensitive to depression) and GAD-7 (sensitive to general anxiety disorder) measures. Three-level hierarchical linear modelling was employed to estimate therapist-attributable proportion of variance in clinical outcomes. Therapist effects were evaluated using the intracluster correlation coefficient (ICC) and Bayesian empirical predictions of therapist random effects. Three sensitivity analyses were conducted: 1) using both treatment completers and non-completers; 2) a sub-sample of cases with baseline scores above the conventional clinical thresholds for PHQ-9 and GAD-7; and 3) a two-level model (using patient-level pre- and post-treatment scores nested within therapists). Results: The ICC estimates for all outcome measures were very small, ranging between 0% and 1.3%, although most were statistically significant. The Bayesian empirical predictions showed that therapist random effects were not statistically significantly different from each other. Between patient variability explained most of the variance in outcomes. Conclusion: Consistent with the only other study to date in low intensity interventions, evidence was found to suggest minimal to no therapist effects in patient-reported outcomes. This draws attention to the more prominent source of variability which is found at the between-patient level.	[Ali, Shehzad; Littlewood, Elizabeth; McMillan, Dean; Croudace, Tim; Gilbody, Simon] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Ali, Shehzad] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Delgadillo, Jaime] Leeds Community Healthcare NHS Trust, Primary Care Mental Hlth Serv, Leeds, W Yorkshire, England; [Miranda, Alfonso] Ctr Invest & Docencia Econ, Mexico City, DF, Mexico	University of York - UK; University of York - UK; Centro de Investigacion y Docencia Economicas A.C. (CIDE)	Ali, S (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	shehzad.ali@york.ac.uk	Miranda, Alfonso/AHC-1802-2022; Croudace, Tim/ABC-9681-2021; Gilbody, Simon/AAY-3720-2021	Miranda, Alfonso/0000-0002-8176-0946; Gilbody, Simon/0000-0002-8236-6983; Croudace, Tim/0000-0001-8346-7463; Delgadillo, Jaime/0000-0001-5349-230X				Allen JP, 1998, PSYCHOTHER RES, V8, P455; Almlov J, 2011, BEHAV COGN PSYCHOTH, V39, P311, DOI 10.1017/S135246581000069X; Baldwin S. A., 2013, BERGIN GARFIELDS HDB; Beutler L.E., 2004, BERGIN GARFIELDS HDB, V5th ed., P227; Blatt SJ, 1996, J CONSULT CLIN PSYCH, V64, P1276, DOI 10.1037/0022-006X.64.6.1276; Cella M, 2011, PSYCHOTHER RES, V21, P168, DOI 10.1080/10503307.2010.535571; Christensen H, 2010, OXFORD GUIDE LOW INT; Clark DM, 2009, BEHAV RES THER, V47, P910, DOI 10.1016/j.brat.2009.07.010; Crits-Christoph P., 1991, PSYCHOTHER RES, V1, P2, DOI [DOI 10.1080/10503309112331335511, 10.1080/10503309112331335511]; Crits-Christoph P, 2006, PSYCHOTHER RES, V16, P178, DOI 10.1080/10503300500265025; CRITSCHRISTOPH P, 1991, J CONSULT CLIN PSYCH, V59, P20, DOI 10.1037/0022-006X.59.1.20; Delgadillo J, 2012, BEHAV COGN PSYCHOTH, V1, P1; Elkin I, 1999, CLIN PSYCHOL-SCI PR, V6, P10, DOI 10.1093/clipsy/6.1.10; Elkin I, 2006, PSYCHOTHER RES, V16, P144, DOI 10.1080/10503300500268540; Huppert JD, 2001, J CONSULT CLIN PSYCH, V69, P747, DOI 10.1037//0022-006X.69.5.747; Kim DM, 2006, PSYCHOTHER RES, V16, P161, DOI 10.1080/10503300500264911; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lambert MJ, 2001, PSYCHOTHER RES, V11, P49, DOI 10.1080/713663852; LUBORSKY L, 1986, AM J ORTHOPSYCHIAT, V56, P501, DOI 10.1111/j.1939-0025.1986.tb03483.x; Luborsky L, 1997, CLIN PSYCHOL-SCI PR, V4, P53, DOI 10.1111/j.1468-2850.1997.tb00099.x; Lutz W, 2007, J COUNS PSYCHOL, V54, P32, DOI 10.1037/0022-0167.54.1.32; NHS Improving Access to Psychological Therapies (IAPT) Programme, 2011, NAT CURR ED PSYCH WE; NICE, 2007, ANX AM MAN ANX PAN D; NICE, 2010, DEPR TREATM MAN DEPR; Okiishi J, 2003, CLIN PSYCHOL PSYCHOT, V10, P361, DOI 10.1002/cpp.383; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Richards D. A., 2011, REACH OUT NATL PROGR; Rodgers M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16280; Saxon D, 2012, J CONSULT CLIN PSYCH, V80, P535, DOI 10.1037/a0028898; Slade K, 2008, CLIN PSYCHOL PSYCHOT, V15, P287, DOI 10.1002/cpp.594; Soldz S, 2006, PSYCHOTHER RES, V16, P173, DOI 10.1080/10503300500264937; Turpin G, 2011, IAPT SUPERVISION GUI; Wampold B., 2001, GREAT PSYCHOTHERAPY, P1; Wampold BE, 2000, PSYCHOL METHODS, V5, P425, DOI 10.1037/1082-989X.5.4.425; Wampold BE, 2006, PSYCHOTHER RES, V16, P184, DOI 10.1080/10503300500265181; Wampold BE, 2005, J CONSULT CLIN PSYCH, V73, P914, DOI 10.1037/0022-006X.73.5.914	38	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e99658	10.1371/journal.pone.0099658	http://dx.doi.org/10.1371/journal.pone.0099658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25207881	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000342030300002
J	Kroghsbo, S; Andersen, NB; Rasmussen, TF; Jacobsen, S; Madsen, CB				Kroghsbo, Stine; Andersen, Nanna B.; Rasmussen, Tina F.; Jacobsen, Susanne; Madsen, Charlotte B.			Acid Hydrolysis of Wheat Gluten Induces Formation of New Epitopes but Does Not Enhance Sensitizing Capacity by the Oral Route: A Study in "Gluten Free'' Brown Norway Rats	PLOS ONE			English	Article							EXERCISE-INDUCED ANAPHYLAXIS; CONTROLLED FOOD CHALLENGE; BINDING EPITOPES; IMMUNE-RESPONSE; DOUBLE-BLIND; BALB/C MICE; ALLERGY; PROTEIN; IGE; TOLERANCE	Background: Acid hydrolyzed wheat proteins (HWPs) are used in the food and cosmetic industry as emulsifiers. Cases of severe food allergic reactions caused by HWPs have been reported. Recent data suggest that these reactions are caused by HWPs produced by acid hydrolysis. Objectives: To examine the sensitizing capacity of gluten proteins per se when altered by acid or enzymatic hydrolysis relative to unmodified gluten in rats naive to gluten. Methods: High IgE-responder Brown Norway (BN) rats bred on a gluten-free diet were sensitized without the use of adjuvant to three different gluten products (unmodified, acid hydrolyzed and enzymatic hydrolyzed). Rats were sensitized by intraperitoneal (i.p.) immunization three times with 200 mu g gluten protein/rat or by oral dosing for 35 days with 0.2, 2 or 20 mg gluten protein/rat/day. Sera were analyzed for specific IgG and IgE and IgG-binding capacity by ELISA. IgE functionality was measured by rat basophilic leukemia (RBL) assay. Results: Regardless of the route of dosing, all products had sensitizing capacity. When sensitized i.p., all three gluten products induced a strong IgG1 response in all animals. Acid hydrolyzed gluten induced the highest level of specific IgE but with a low functionality. Orally all three gluten products induced specific IgG1 and IgE but with different dose-response relations. Sensitizing rats i. p. or orally with unmodified or enzymatic hydrolyzed gluten induced specific IgG1 responses with similar binding capacity which was different from that of acid hydrolyzed gluten indicating that acid hydrolysis of gluten proteins induces formation of 'new' epitopes. Conclusions: In rats not tolerant to gluten acid hydrolysis of gluten enhances the sensitizing capacity by the i. p. but not by the oral route. In addition, acid hydrolysis induces formation of new epitopes. This is in contrast to the enzymatic hydrolyzed gluten having an epitope pattern similar to unmodified gluten.	[Kroghsbo, Stine; Andersen, Nanna B.; Rasmussen, Tina F.; Madsen, Charlotte B.] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Jacobsen, Susanne] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Madsen, CB (corresponding author), Tech Univ Denmark, Natl Food Inst, Soborg, Denmark.	charm@food.dtu.dk		Madsen, Charlotte Bernhard/0000-0002-9086-7120	Danish Research Council [0603-00199B]; Danish Veterinary and Food Administration	Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Veterinary and Food Administration	This work was financially supported by Tereos Syral, Aalst, Belgium who also provided the gluten proteins used, Danish Veterinary and Food Administration, and the Danish Research Council grant 0603-00199B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi R, 2012, ALLERGY, V67, P1392, DOI 10.1111/all.12018; BARKHOLT V, 1989, ANAL BIOCHEM, V177, P318, DOI 10.1016/0003-2697(89)90059-6; Battais F, 2005, ALLERGY, V60, P815, DOI 10.1111/j.1398-9995.2005.00795.x; Belitz H. D., 2004, FOOD CHEM, V3rd, DOI [DOI 10.1007/978-3-540-69934-7, 10.1007/978-3-540-69934-7]; Berin MC, 2011, CURR OPIN IMMUNOL, V23, P794, DOI 10.1016/j.coi.2011.08.010; Bohle B, 2004, MOL NUTR FOOD RES, V48, P424, DOI 10.1002/mnfr.200400003; Bouchez-Mahiout I, 2010, J AGR FOOD CHEM, V58, P4207, DOI 10.1021/jf903973x; Brix S, 2005, INT ARCH ALLERGY IMM, V136, P250, DOI 10.1159/000083951; Chinuki Y, 2011, CONTACT DERMATITIS, V65, P55, DOI 10.1111/j.1600-0536.2011.01917.x; Christensen HR, 2004, BRIT J NUTR, V91, P725, DOI 10.1079/BJN20041093; Cianferoni Antonella, 2009, Allergology International, V58, P457, DOI 10.2332/allergolint.09-RAI-0138; de Jonge JD, 2007, METHODS, V41, P99, DOI 10.1016/j.ymeth.2006.09.004; Denery-Papini S, 2012, ALLERGY, V67, P1023, DOI 10.1111/j.1398-9995.2012.02860.x; Denery-Papini S, 2011, CLIN EXP ALLERGY, V41, P1478, DOI 10.1111/j.1365-2222.2011.03808.x; Finley JW, 1985, DIGESTIBILITY AMINO; Fukutomi Y, 2014, EAACI COP; Fukutomi Y, 2011, J ALLERGY CLIN IMMUN, V127, P531, DOI 10.1016/j.jaci.2010.09.035; Gourbeyre P, 2012, MOL NUTR FOOD RES, V56, P336, DOI 10.1002/mnfr.201100353; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; Kroghsbo S, 2011, INT ARCH ALLERGY IMM, V155, P212, DOI 10.1159/000321200; Kumagai H, 2007, BIOSCI BIOTECH BIOCH, V71, P977, DOI 10.1271/bbb.60645; Lauriere M, 2007, ALLERGY, V62, P890, DOI 10.1111/j.1398-9995.2007.01456.x; Lauriere M, 2006, CONTACT DERMATITIS, V54, P283, DOI 10.1111/j.0105-1873.2006.00830.x; Leduc V, 2003, J ALLERGY CLIN IMMUN, V111, P897, DOI 10.1067/mai.2003.1345; Mills ENC, 2009, MOL NUTR FOOD RES, V53, P963, DOI 10.1002/mnfr.200800236; Mittag D, 2004, MOL NUTR FOOD RES, V48, P380, DOI 10.1002/mnfr.200400016; Nakamura R, 2013, J ALLERGY CLIN IMMUN, V132, P1436, DOI 10.1016/j.jaci.2013.07.017; Palosuo K, 2003, CURR OPIN ALLERGY CL, V3, P205, DOI [10.1097/00130832-200306000-00009, 10.1097/01.all.0000072717.82112.cc]; Pastorello EA, 2007, INT ARCH ALLERGY IMM, V144, P10, DOI 10.1159/000102609; Pecquet C, 2004, CONTACT DERMATITIS, V50, P182; Pelkonen AS, 2011, ANN ALLERG ASTHMA IM, V106, P343, DOI 10.1016/j.anai.2011.01.003; Pilegaard K, 2004, TOXICOLOGY, V196, P247, DOI 10.1016/j.tox.2003.11.010; Shils ME, 2006, MODERN NUTR HLTH DIS, V10th; Shinoda J, 2012, J DERMATOL, V39, P724, DOI 10.1111/j.1346-8138.2011.01397.x; Shreffler WG, 2004, J ALLERGY CLIN IMMUN, V113, P776, DOI 10.1016/j.jaci.2003.12.588; Strid J, 2005, CLIN EXP ALLERGY, V35, P757, DOI 10.1111/j.1365-2222.2005.02260.x; Tatham AS, 2008, CLIN EXP ALLERGY, V38, P1712, DOI 10.1111/j.1365-2222.2008.03101.x; Varjonen E, 2000, ALLERGY, V55, P294, DOI 10.1034/j.1398-9995.2000.00516.x; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004	39	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107137	10.1371/journal.pone.0107137	http://dx.doi.org/10.1371/journal.pone.0107137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207551	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300062
J	Chen, Z; Liu, HB; Yu, CH; Wang, Y; Wang, L; Song, Y				Chen, Zi; Liu, Hong-bing; Yu, Chun-hua; Wang, Ying; Wang, Li; Song, Yong			Diagnostic Value of Mutation-Specific Antibodies for Immunohistochemical Detection of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							ACTIVATING EGFR MUTATIONS; SYSTEMATIC REVIEWS; TEST ACCURACY; ODDS RATIO; ADENOCARCINOMA; GENE; GEFITINIB; SENSITIVITY; PERFORMANCE; THERAPY	Background: Various studies have assessed the diagnostic accuracy of EGFR mutation-specific antibodies in non-small cell lung cancer (NSCLC). We performed a meta-analysis of existing data to investigate the diagnostic value of mutation-specific antibodies for detection of EGFR mutations in NSCLC. Methods: We systematically retrieved relevant studies from PubMed, Web of Knowledge, and Google Scholar. Data from studies that met the inclusion criteria were extracted for further exploration of heterogeneity, including calculation of the average sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and analysis of SROC(summary receiver operating characteristic) curves. Results: Fifteen studies met our inclusion criteria. A summary of the meta-analysis of the efficacy of the anti-E746-A750 antibody was as follows: sensitivity, 0.60 (95% CI, 0.55-0.64); specificity, 0.98 (95% CI, 0.97-0.98); PLR, 33.50 (95% CI, 13.96-80.39); NLR, 0.39 (95% CI, 0.30-0.51) and DOR, 111.17 (95% CI, 62.22-198.63). A similar meta-analysis was performed for the anti-L858R antibody with results as follows: sensitivity, 0.76 (95% CI, 0.71-0.79); specificity, 0.96 (95% CI, 0.95-0.97); PLR, 24.42 (95% CI, 11.66-51.17); NLR, 0.22 (95% CI, 0.12-0.39) and DOR, 126.66 (95% CI, 54.60-293.82). Conclusion: Immunohistochemistry alone is sufficient for the detection of EGFR mutations if the result is positive. Molecular-based analyses are necessary only if the anti-E746-A750 antibody results are negative. Immunohistochemistry seems more suitable for clinical screening for EGFR mutations prior to molecular-based analysis.	[Chen, Zi; Liu, Hong-bing; Wang, Li; Song, Yong] Nanjing Univ, Sch Med, Dept Resp Med, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Yu, Chun-hua] Second Mil Med Univ, Dept Med Engn, Jinling Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Ying] Yijishan Hosp, Wannan Med Collage, Dept Resp Med, Wuhu, Peoples R China	Nanjing University; Naval Medical University; Wannan Medical College	Song, Y (corresponding author), Nanjing Univ, Sch Med, Dept Resp Med, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China.	yong_song6310@yahoo.com						Ambrosini-Spaltro A, 2012, APPL IMMUNOHISTO M M, V20, P356, DOI 10.1097/PAI.0b013e31823e064b; Angulo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043842; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Cooper WA, 2013, J CLIN PATHOL, V66, P744, DOI 10.1136/jclinpath-2013-201607; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gallagher EJ, 1998, ANN EMERG MED, V31, P391, DOI 10.1016/S0196-0644(98)70352-X; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Hasanovic A, 2012, LUNG CANCER, V77, P299, DOI 10.1016/j.lungcan.2012.04.004; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofman P, 2012, ANN ONCOL, V23, P1738, DOI 10.1093/annonc/mdr535; Ilie MI, 2010, VIRCHOWS ARCH, V457, P483, DOI 10.1007/s00428-010-0963-z; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Kato Y, 2010, J THORAC ONCOL, V5, P1551, DOI 10.1097/JTO.0b013e3181e9da60; Kawahara A, 2010, CLIN CANCER RES, V16, P3163, DOI 10.1158/1078-0432.CCR-09-3239; Kitamura A, 2010, CLIN CANCER RES, V16, P3349, DOI 10.1158/1078-0432.CCR-10-0129; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kozu Y, 2011, LUNG CANCER, V73, P45, DOI 10.1016/j.lungcan.2010.11.003; Lau J, 2001, ANN EMERG MED, V37, P453, DOI 10.1067/mem.2001.114903; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Simonetti S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-135; Suzuki S, 2004, J CLIN EPIDEMIOL, V57, P461, DOI 10.1016/j.jclinepi.2003.09.017; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wu SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023303; Xiong Y, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-27; Yatabe Y, 2007, PATHOL INT, V57, P233, DOI 10.1111/j.1440-1827.2007.02098.x; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739	35	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e105940	10.1371/journal.pone.0105940	http://dx.doi.org/10.1371/journal.pone.0105940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203004	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500010
J	Wen, YX; Li, J; Tan, Y; Qin, J; Xie, XF; Wang, LL; Mei, QB; Wang, H; Magdalou, J; Chen, LB				Wen, Yinxian; Li, Jing; Tan, Yang; Qin, Jun; Xie, Xianfei; Wang, Linlong; Mei, Qibing; Wang, Hui; Magdalou, Jacques; Chen, Liaobin			Angelica Sinensis Polysaccharides Stimulated UDP-Sugar Synthase Genes through Promoting Gene Expression of IGF-1 and IGF1R in Chondrocytes: Promoting Anti-Osteoarthritic Activity	PLOS ONE			English	Article							CHONDROITIN SULFATE; ARTICULAR CHONDROCYTES; GLUCOSE DEHYDROGENASE; HYALURONAN PRODUCTION; OSTEOARTHRITIS; GROWTH; KNEE; INTERLEUKIN-1-BETA; GLYCOSAMINOGLYCANS; CHROMATOGRAPHY	Background: Osteoarthritis (OA) is a chronic joints disease characterized by progressive degeneration of articular cartilage due to the loss of cartilage matrix. Previously, we found, for the first time, that an acidic glycan from Angelica Sinensis Polysaccharides (APSs), namely the APS-3c, could protect rat cartilage from OA due to promoting glycosaminoglycan (GAG) synthesis in chondrocytes. In the present work, we tried to further the understanding of ASP-3c's anti-OA activity. Methodology/Principal Findings: Human primary chondrocytes were treated with APS-3c or/and recombinant human interleukin 1 beta (IL-1 beta). It turned out that APS-3c promoted synthesis of UDP-xylose and GAG, as well as the gene expression of UDP-sugar synthases (USSs), insulin like growth factor 1 (IGF1) and IGF1 receptor (IGF1R), and attenuated the degenerative phenotypes, suppressed biosynthesis of UDP-sugars and GAG, and inhibited the gene expression of USSs, IGF1 and IGF1R induced by IL-1 beta. Then, we induced a rat OA model with papain, and found that APS-3c also stimulated GAG synthesis and gene expression of USSs, IGF1 and IGF1R in vivo. Additionally, recombinant human IGF1 and IGF1R inhibitor NP-AEW541 were applied to figure out the correlation between stimulated gene expression of USSs, IGF1 and IGF1R induced by APS-3c. It tuned out that the promoted GAG synthesis and USSs gene expression induced by APS-3c was mediated by the stimulated IGF1 and IGF1R gene expression, but not through directly activation of IGF1R signaling pathway. Conclusions/Significances: We demonstrated for the first time that APS-3c presented anti-OA activity through stimulating IGF-1 and IGF1R gene expression, but not directly activating the IGF1R signaling pathway, which consequently promoted UDP-sugars and GAG synthesis due to up-regulating gene expression of USSs. Our findings presented a better understanding of APS-3c's anti-OA activity and suggested that APS-3c could potentially be a novel therapeutic agent for OA.	[Wen, Yinxian; Tan, Yang; Qin, Jun; Wang, Linlong; Chen, Liaobin] Wuhan Univ, Zhongnan Hosp, Dept Orthoped Surg, Wuhan 430072, Peoples R China; [Li, Jing; Xie, Xianfei; Wang, Hui] Wuhan Univ, Basic Med Sch, Dept Pharmacol, Wuhan 430072, Peoples R China; [Mei, Qibing] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Wang, Hui; Chen, Liaobin] Hubei Prov Key Lab Dev Originated Dis, Wuhan, Peoples R China; [Magdalou, Jacques] Univ Lorraine, CNRS, Fac Med, UMR 7365, Vandoeuvre Les Nancy, France	Wuhan University; Wuhan University; Air Force Military Medical University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine	Chen, LB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Orthoped Surg, Wuhan 430072, Peoples R China.	lbchen@whu.edu.cn			National Natural Science Foundation of China [81220108026, 81430089, 81371940, 81001617, 81401832]; Hubei province [2012IHA01202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei province	This work was supported by Grants from the National Natural Science Foundation of China (No. 81220108026, 81430089, 81371940, 81001617, 81401832), International science and technology cooperation projects of Hubei province (2012IHA01202).	Adatia A, 2012, J PHARM PHARMACOL, V64, P617, DOI 10.1111/j.2042-7158.2012.01458.x; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Berenbaum F, 2011, OSTEOARTHR CARTILAGE, V19, P361, DOI 10.1016/j.joca.2011.01.019; Cao W, 2006, CARBOHYD RES, V341, P1870, DOI 10.1016/j.carres.2006.04.017; Cao W, 2010, INT J BIOL MACROMOL, V46, P115, DOI 10.1016/j.ijbiomac.2009.11.005; Caterson B, 2000, MATRIX BIOL, V19, P333, DOI 10.1016/S0945-053X(00)00078-0; Chao WW, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-29; Chao WW, 2010, J ETHNOPHARMACOL, V129, P244, DOI 10.1016/j.jep.2010.03.022; Clarkin CE, 2011, J CELL PHYSIOL, V226, P749, DOI 10.1002/jcp.22393; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; David-Raoudi M, 2009, ARTHRITIS RHEUM-US, V60, P760, DOI 10.1002/art.24302; Eames BF, 2010, DEV BIOL, V341, P400, DOI 10.1016/j.ydbio.2010.02.035; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Gaissmaier C, 2008, INJURY, V39, pS88, DOI 10.1016/j.injury.2008.01.035; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Gouze JN, 2001, ARTHRITIS RHEUM, V44, P351, DOI 10.1002/1529-0131(200102)44:2<351::AID-ANR53>3.3.CO;2-D; Haisa M, 2013, J INT MED RES, V41, P253, DOI 10.1177/0300060513476585; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Henrotin Y, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0361-z; Hochberg M, 2013, CURR MED RES OPIN, V29, P259, DOI 10.1185/03007995.2012.753430; Hochberg MC, 2010, OSTEOARTHR CARTILAGE, V18, pS28, DOI 10.1016/j.joca.2010.02.016; Hui Marco K C, 2006, Int J Med Sci, V3, P1; HULL SR, 1994, ANAL BIOCHEM, V222, P49, DOI 10.1006/abio.1994.1452; Jerosch J, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/969012; Khair M, 2013, J BIOL CHEM, V288, P1774, DOI 10.1074/jbc.M112.419887; Lee JG, 2012, J ETHNOPHARMACOL, V139, P739, DOI 10.1016/j.jep.2011.11.049; Li RS, 2009, J MED CHEM, V52, P4981, DOI 10.1021/jm9002395; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Maneix L, 2008, RHEUMATOLOGY, V47, P281, DOI 10.1093/rheumatology/kem323; Metz HE, 2011, CLIN CANCER RES, V17, P206, DOI 10.1158/1078-0432.CCR-10-0434; Montaseri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028663; Naumann A, 2002, J HISTOCHEM CYTOCHEM, V50, P1049, DOI 10.1177/002215540205000807; Porter RM, 2006, J CELL PHYSIOL, V209, P542, DOI 10.1002/jcp.20762; Prydz K, 2000, J CELL SCI, V113, P193; Qin J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/794761; Schwartz NB, 2000, FRONT BIOSCI, V5, pD649; Shakibaei M, 2006, BIOCHEM PHARMACOL, V72, P1382, DOI 10.1016/j.bcp.2006.08.022; Shelton JG, 2004, CELL CYCLE, V3, P372; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Tan Y, 2012, TOXICOL LETT, V214, P279, DOI 10.1016/j.toxlet.2012.09.007; Tomiya N, 2001, ANAL BIOCHEM, V293, P129, DOI 10.1006/abio.2001.5091; Wong V. K. C., 2008, Inflammopharmacology, V16, P162, DOI 10.1007/s10787-007-0026-5; YAMADA H, 1984, PLANTA MED, V50, P163, DOI 10.1055/s-2007-969661; Yang TH, 2006, INT J BIOL MACROMOL, V39, P179, DOI 10.1016/j.ijbiomac.2006.02.013; Ye YN, 2001, LIFE SCI, V69, P637, DOI 10.1016/S0024-3205(01)01153-5; Zhang M, 2009, OSTEOARTHR CARTILAGE, V17, P100, DOI 10.1016/j.joca.2008.05.007	51	14	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107024	10.1371/journal.pone.0107024	http://dx.doi.org/10.1371/journal.pone.0107024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202993	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500060
J	Zlosnik, JEA; Mori, PY; To, D; Leung, J; Hird, TJ; Speert, DP				Zlosnik, James E. A.; Mori, Paul Y.; To, Derek; Leung, James; Hird, Trevor J.; Speert, David P.			Swimming Motility in a Longitudinal Collection of Clinical Isolates of Burkholderia cepacia Complex Bacteria from People with Cystic Fibrosis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; LUNG INFECTION; EXOPOLYSACCHARIDE PRODUCTION; CENOCEPACIA; ADAPTATION; VIRULENCE; HOST; EPIDEMIOLOGY; IDENTIFICATION; COLONIZATION	Chronic bacterial lung infections in cystic fibrosis (CF) are the leading cause of morbidity and mortality. While a range of bacteria are known to be capable of establishing residence in the CF lung, only a small number have a clearly established link to deteriorating clinical status. The two bacteria with the clearest roles in CF lung disease are Pseudomonas aeruginosa and bacteria belonging to the Burkholderia cepacia complex (BCC). A number of common adaptations by P. aeruginosa strains to chronic lung infection in CF have been well described. Typically, initial isolates of P. aeruginosa are nonmucoid and display a range of putative virulence determinants. Upon establishment of chronic infection, subsequent isolates ultimately show a reduction in putative virulence determinants, including swimming motility, along with an acquisition of the mucoid phenotype and increased levels of antimicrobial resistance. Infections by BCC are marked by an unpredictable, but typically worse, clinical outcome. However, in contrast to P. aeruginosa infections in CF, studies describing adaptive changes in BCC bacterial phenotype during chronic lung infections are far more limited. To further enhance our understanding of chronic lung infections by BCC bacteria in CF, we assessed the swimming motility phenotype in 551 isolates of BCC bacteria from cystic fibrosis (CF) lung infections between 1981 and 2007. These data suggest that swimming motility is not typically lost by BCC during chronic infection, unlike as seen in P. aeruginosa infections. Furthermore, while we observed a statistically significant link between mucoidy and motility, we did not detect any link between motility phenotype and clinical outcome. These studies highlight the need for further work to understand the adaptive changes of BCC bacteria during chronic infection in the CF lung.	[Zlosnik, James E. A.; Mori, Paul Y.; To, Derek; Leung, James; Hird, Trevor J.; Speert, David P.] Univ British Columbia, Dept Pediat, Fac Med, Ctr Understanding & Preventing Infect Children, Vancouver, BC V6T 1W5, Canada	University of British Columbia	Zlosnik, JEA (corresponding author), Univ British Columbia, Dept Pediat, Fac Med, Ctr Understanding & Preventing Infect Children, Vancouver, BC V6T 1W5, Canada.	jzlosnik@cfri.ubc.ca		Zlosnik, James/0000-0002-9708-9034	Cystic Fibrosis Canada [20R32976]	Cystic Fibrosis Canada	This work was supported by a Cystic Fibrosis Canada (www.cysticfibrosis.ca) operating grant to DPS (20R32976) and a fellowship to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; BRETT PJ, 1994, INFECT IMMUN, V62, P1914, DOI 10.1128/IAI.62.5.1914-1919.1994; Chung JW, 2007, MICROBIOL-SGM, V153, P206, DOI 10.1099/mic.0.2006/000455-0; Chung JW, 2003, INFECT IMMUN, V71, P904, DOI 10.1128/IAI.71.2.904-909.2003; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Ciofu O, 2012, FEMS IMMUNOL MED MIC, V65, P215, DOI 10.1111/j.1574-695X.2012.00983.x; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; Coutinho CP, 2011, INFECT IMMUN, V79, P2950, DOI 10.1128/IAI.01366-10; Drevinek P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-121; Ellis CN, 2010, APPL ENVIRON MICROB, V76, P2387, DOI 10.1128/AEM.01930-09; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; Hales BA, 1998, J BACTERIOL, V180, P1110, DOI 10.1128/JB.180.5.1110-1118.1998; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Huse HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082621; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Kalish LA, 2006, AM J RESP CRIT CARE, V173, P421, DOI 10.1164/rccm.200503-344OC; LARSEN GY, 1993, J CLIN MICROBIOL, V31, P788, DOI 10.1128/JCM.31.4.788-792.1993; Leitao JH, 2008, EUR J CLIN MICROBIOL, V27, P1101, DOI 10.1007/s10096-008-0552-0; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; LIPUMA JJ, 1990, LANCET, V336, P1094, DOI 10.1016/0140-6736(90)92571-X; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Madeira A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083065; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 1996, J CLIN MICROBIOL, V34, P2914, DOI 10.1128/JCM.34.12.2914-2920.1996; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; McKeon SA, 2011, J INFECT DIS, V203, P383, DOI 10.1093/infdis/jiq054; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; MONTIE TC, 1983, J CLIN MICROBIOL, V18, P452, DOI 10.1128/JCM.18.3.452-456.1983; Nash EF, 2011, PEDIATR PULM, V46, P512, DOI 10.1002/ppul.21404; O'Grady EP, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00015; Peeters C, 2013, SYST APPL MICROBIOL, V36, P483, DOI 10.1016/j.syapm.2013.06.003; Pessi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072939; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; Silva IN, 2011, MICROBIOL-SGM, V157, P3124, DOI 10.1099/mic.0.050989-0; SIMPSON DA, 1992, INFECT IMMUN, V60, P3771, DOI 10.1128/IAI.60.9.3771-3779.1992; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Smith K, 2003, POETRY REV, V93, P5; Tomich M, 2002, INFECT IMMUN, V70, P1799, DOI 10.1128/IAI.70.4.1799-1806.2002; Traverse CC, 2012, TANGLED BANK EXPT EV, V110, DOI [10.1073/pnas.1207025110, DOI 10.1073/PNAS.1207025110]; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Urban TA, 2005, INFECT IMMUN, V73, P5426, DOI 10.1128/IAI.73.9.5426-5437.2005; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Ventura GMDC, 2008, FEMS IMMUNOL MED MIC, V54, P37, DOI 10.1111/j.1574-695X.2008.00453.x; Zlosnik JEA, 2008, J CLIN MICROBIOL, V46, P1470, DOI 10.1128/JCM.02273-07; Zlosnik JEA, 2011, AM J RESP CRIT CARE, V183, P67, DOI 10.1164/rccm.201002-0203OC; Zlosnik JEA, 2010, J INFECT DIS, V202, P770, DOI 10.1086/655663	50	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106428	10.1371/journal.pone.0106428	http://dx.doi.org/10.1371/journal.pone.0106428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203161	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500022
J	Cahill, S; Singal, R; Grasso, C; King, D; Mayer, K; Baker, K; Makadon, H				Cahill, Sean; Singal, Robbie; Grasso, Chris; King, Dana; Mayer, Kenneth; Baker, Kellan; Makadon, Harvey			Do Ask, Do Tell: High Levels of Acceptability by Patients of Routine Collection of Sexual Orientation and Gender Identity Data in Four Diverse American Community Health Centers	PLOS ONE			English	Article							CARE; GAY	Background: The Institute of Medicine and The Joint Commission have recommended asking sexual orientation and gender identity (SOGI) questions in clinical settings and including such data in Electronic Health Records (EHRs). This is increasingly viewed as a critical step toward systematically documenting and addressing health disparities affecting lesbian, gay, bisexual, and transgender (LGBT) people. The U. S. government is currently considering whether to include SOGI data collection in the Stage 3 guidelines for the incentive program promoting meaningful use of EHR. However, some have questioned whether acceptable standard measures to collect SOGI data in clinical settings exist. Methods: In order to better understand how a diverse group of patients would respond if SOGI questions were asked in primary care settings, 301 randomly selected patients receiving primary care at four health centers across the U. S. were asked SOGI questions and then asked follow-up questions. This sample was mainly heterosexual, racially diverse, and geographically and regionally broad. Results: There was a strong consensus among patients surveyed about the importance of asking SOGI questions. Most of the LGBT respondents thought that the questions presented on the survey allowed them to accurately document their SOGI. Most respondents-heterosexual and LGBT-answered the questions, and said that they would answer such questions in the future. While there were some age-related differences, respondents of all ages overwhelmingly expressed support for asking SOGI questions and understood the importance of providers' knowing their patients' SOGI. Conclusions: Given current deliberations within national health care regulatory bodies and the government's increased attention to LGBT health disparities, the finding that patients can and will answer SOGI questions has important implications for public policy. This study provides evidence that integrating SOGI data collection into the meaningful use requirements is both acceptable to diverse samples of patients, including heterosexuals, and feasible.	[Cahill, Sean] Northeastern Univ, Fenway Inst, Dept Polit Sci, Boston, MA 02115 USA; [Cahill, Sean] NYU, Wagner Sch, New York, NY USA; [Singal, Robbie; Grasso, Chris; King, Dana] Fenway Inst, Boston, MA USA; [Mayer, Kenneth] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Fenway Inst, Boston, MA 02215 USA; [Baker, Kellan] Ctr Amer Progress, Washington, DC USA; [Makadon, Harvey] Harvard Univ, Sch Med, Fenway Inst, Boston, MA USA	Northeastern University; New York University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Cahill, S (corresponding author), Northeastern Univ, Fenway Inst, Dept Polit Sci, Boston, MA 02115 USA.	scahill@fenwayhealth.org			Health Resources Services Administration, HIV/AIDS Bureau [UB2HA20233]; Center for American Progress	Health Resources Services Administration, HIV/AIDS Bureau; Center for American Progress	This research was made possible by the research infrastructure of the Community Health Applied Research Network (CHARN). CHARN is a network of community health centers and universities established to conduct patient-centered outcome research among underserved populations. It was funded by the Health Resources Services Administration, HIV/AIDS Bureau (grant # UB2HA20233). This specific four health center study was funded by a grant from the Center for American Progress. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, FED REG, V77; Bradford J, 2012, ASK SEXUAL ORIENTATI; Centers for Disease Control and Prevention, 2011, HIV INF TRANSG PEOPL; Clements-Nolle K, 2006, J HOMOSEXUAL, V51, P53, DOI 10.1300/J082v51n03_04; Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities Board on the Health of Select Populations & Institute of Medicine, 2011, HLTH LESB GAY BIS TR; Conron KJ, 2010, AM J PUBLIC HEALTH, V100, P1953, DOI 10.2105/AJPH.2009.174169; Deutsch M, 2013, JNL AM MED INFORM AS, V0, P1, DOI [10.1136/amianjnl-2012-001472, DOI 10.1136/AMIANJNL-2012-001472]; Futterweit W, 1998, ARCH SEX BEHAV, V27, P209, DOI 10.1023/A:1018638715498; GENIUSS Group (Gender identity in U.S. surveillance), 2013, GEND REL MEAS OV; Grant J.M., 2011, INJUSTICE EVERY TURN; Jeffries WL, 2013, AIDS BEHAV, V17, P1442, DOI 10.1007/s10461-012-0189-y; Kann Laura, 2011, Morbidity and Mortality Weekly Report, V60, P1; Kerker BD, 2006, J URBAN HEALTH, V83, P970, DOI 10.1007/s11524-006-9096-8; Klitzman RL, 2002, J HOMOSEXUAL, V42, P65, DOI 10.1300/J082v42n04_04; Lambda Legal, 2010, HLTH CAR ISNT CAR LA; Lombardi E, 2002, J HOMOSEX, V42; Makadon HJ, 2011, CLEV CLIN J MED, V78, P220, DOI 10.3949/ccjm.78gr.10006; Mayer KH, 2008, AM J PUBLIC HEALTH, V98, P989, DOI 10.2105/AJPH.2007.127811; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Smith DM, 2007, J HOMOSEXUAL, V52, P1, DOI 10.1300/J082v52n03_01; Tate CC, 2013, J SEX RES, V50, P767, DOI 10.1080/00224499.2012.690110; The Joint Commission, 2011, ADV EFF COMM CULT CO; US. Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL 2020; Valanis BG, 2000, ARCH FAM MED, V9, P843, DOI 10.1001/archfami.9.9.843	24	144	144	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107104	10.1371/journal.pone.0107104	http://dx.doi.org/10.1371/journal.pone.0107104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JX	25198577	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700081
J	Chan, PKS; Ngai, KLK; Lao, TT; Wong, MCS; Cheung, T; Yeung, ACM; Chan, MCW; Luk, SWC				Chan, Paul K. S.; Ngai, Karry L. K.; Lao, Terence T.; Wong, Martin C. S.; Cheung, Theresa; Yeung, Apple C. M.; Chan, Martin C. W.; Luk, Scotty W. C.			Response to Booster Doses of Hepatitis B Vaccine among Young Adults Who Had Received Neonatal Vaccination	PLOS ONE			English	Article							VIRUS-INFECTION; ENDEMICITY; IMMUNITY; INFANTS; PROGRAM; MOTHERS; TAIWAN; HBSAG	Background: Newborns who have received hepatitis B immunization in 1980s are now young adults joining healthcare disciplines. The need for booster, pre- and post-booster checks becomes a practical question. Aims: The aim of this study is to refine the HBV vaccination policy for newly admitted students in the future. Methods: A prospective study on medical and nursing school entrants to evaluate hepatitis B serostatus and the response to booster doses among young adults. Findings: Among 212 students, 17-23-year-old, born after adoption of neonatal immunization, 2 (0.9%) were HBsAg positive, 40 (18.9%) were anti-HBs positive. At 1 month after a single-dose booster for anti-HBs-negative students, 14.5% had anti-HBs <10 mIU/mL, 29.0% and 56.5% were 10-100 and >100 mIU/mL, respectively. The anti-HBs levels were significantly higher for females than males (mean [SD]: 431 [418] vs. 246 [339] mIU/mL, P = 0.047). At 2-4 month after the third booster dose, 97.1% had anti-HBs >100 mIU/mL and 2.9% had 10-100 mIU/mL. Conclusions: Pre-booster check is still worthwhile to identify carriers among newly recruited healthcare workers born after adoption of neonatal immunization. A 3-dose booster, rather than a single dose, is required for the majority to achieve an anti-HBs level >100 mIU/mL, as memory immunity has declined in a substantial proportion of individuals. Cost-effectiveness of post-booster check for anti-HBs is low and should be further evaluated based on contextual specific utilization of results.	[Chan, Paul K. S.; Ngai, Karry L. K.; Yeung, Apple C. M.; Chan, Martin C. W.] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Lao, Terence T.; Cheung, Theresa] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Wong, Martin C. S.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Luk, Scotty W. C.] Chinese Univ Hong Kong, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Luk, Scotty W. C.] Chinese Univ Hong Kong, Univ Hlth Serv, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, PKS (corresponding author), Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk	Wong, Martin/L-4568-2014; Chan, Paul KS/J-9360-2013; Chan, Martin/B-3588-2009	Wong, Martin/0000-0001-7706-9370; Chan, Paul KS/0000-0002-6360-4608; Chan, Martin/0000-0002-1568-1596				Boxall EH, 2004, J INFECT DIS, V190, P1264, DOI 10.1086/423818; CHEN D-S, 1987, Journal of the American Medical Association, V257, P2597, DOI 10.1001/jama.257.19.2597; Chien YC, 2006, EPIDEMIOL REV, V28, P126, DOI 10.1093/epirev/mxj010; Dumolard L., 2008, Morbidity and Mortality Weekly Report, V57, P1249; Hammitt LL, 2007, VACCINE, V25, P6958, DOI 10.1016/j.vaccine.2007.06.059; Henderson DK, 2010, INFECT CONT HOSP EP, V31, P203, DOI 10.1086/650298; Hong Kong Department of Health Special Prevention Program, 2010, SURV VIR HEP HONG KO; Lu JJY, 2009, VACCINE, V27, P6613, DOI 10.1016/j.vaccine.2009.08.007; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Salisbury D, 1996, IMMUNISATION INFECT; Scientific Working Group on Viral Hepatitis Prevention Department of Health Hong Kong SAR Government, 2004, REC HEP B VACC REG H; Wang LY, 2007, VACCINE, V25, P7160, DOI 10.1016/j.vaccine.2007.07.022; WONG VCW, 1984, LANCET, V1, P921; World Health O, 2009, WKLY EPIDEMIOL REC, V84, P405, DOI DOI 10.1016/J.VACCINE.2009.10.110; World Health Organization Publication, 2010, VACCINE, V28, P589, DOI DOI 10.1016/J.VACCINE.2009.10.110	16	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107163	10.1371/journal.pone.0107163	http://dx.doi.org/10.1371/journal.pone.0107163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198289	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700089
J	Obr, A; Roselova, P; Grebenova, D; Kuzelova, K				Obr, Adam; Roeselova, Pavla; Grebenova, Dana; Kuzelova, Katerina			Real-Time Analysis of Imatinib- and Dasatinib-Induced Effects on Chronic Myelogenous Leukemia Cell Interaction with Fibronectin	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITORS; BCR-ABL; INTEGRIN FUNCTION; CANCER-CELLS; SRC; ADHESION; HEMATOPOIESIS; EXPRESSION; RESISTANCE	Attachment of stem leukemic cells to the bone marrow extracellular matrix increases their resistance to chemotherapy and contributes to the disease persistence. In chronic myelogenous leukemia (CML), the activity of the fusion BCR-ABL kinase affects adhesion signaling. Using real-time monitoring of microimpedance, we studied in detail the kinetics of interaction of human CML cells (JURL-MK1, MOLM-7) and of control BCR-ABL-negative leukemia cells (HEL, JURKAT) with fibronectin-coated surface. The effect of two clinically used kinase inhibitors, imatinib (a relatively specific c-ABL inhibitor) and dasatinib (dual ABL/SRC family kinase inhibitor), on cell binding to fibronectin is described. Both imatinib and low-dose (several nM) dasatinib reinforced CML cell interaction with fibronectin while no significant change was induced in BCR-ABL-negative cells. On the other hand, clinically relevant doses of dasatinib (100 nM) had almost no effect in CML cells. The efficiency of the inhibitors in blocking the activity of BCR-ABL and SRC-family kinases was assessed from the extent of phosphorylation at autophosphorylation sites. In both CML cell lines, SRC kinases were found to be transactivated by BCR-ABL. In the intracellular context, EC50 for BCR-ABL inhibition was in subnanomolar range for dasatinib and in submicromolar one for imatinib. EC50 for direct inhibition of LYN kinase was found to be about 20 nM for dasatinib and more than 10 mu M for imatinib. Cells pretreated with 100 nM dasatinib were still able to bind to fibronectin and SRC kinases are thus not necessary for the formation of cell-matrix contacts. However, a minimal activity of SRC kinases might be required to mediate the increase in cell adhesivity induced by BCR-ABL inhibition. Indeed, active (autophosphorylated) LYN was found to localize in cell adhesive structures which were visualized using interference reflection microscopy.	[Obr, Adam; Roeselova, Pavla; Grebenova, Dana; Kuzelova, Katerina] Inst Hematol & Blood Transfus, Dept Cellular Biochem, CR-12820 Prague, Czech Republic; [Obr, Adam] Charles Univ Prague, Dept Cell Biol, Fac Sci, Prague, Czech Republic	Institute of Hematology Prague; Charles University Prague	Kuzelova, K (corresponding author), Inst Hematol & Blood Transfus, Dept Cellular Biochem, CR-12820 Prague, Czech Republic.	Katerina.Kuzelova@uhkt.cz	Kuzelova, Katerina/ADE-8303-2022	Kuzelova, Katerina/0000-0002-9628-6255; Obr, Adam/0000-0003-0057-076X	Ministry of Health of the Czech Republic [00023736]; European Union [ERDF OPPK CZ.2.16/3.1.00/24001, CZ.2.16/3.1.00/28007]; Grant Agency of Charles University [498214]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); European Union(European Commission); Grant Agency of Charles University	The work was supported by the Ministry of Health of the Czech Republic (Project for conceptual development of research organization No. 00023736) and by European Union (grants ERDF OPPK CZ.2.16/3.1.00/24001 and CZ.2.16/3.1.00/28007). AO acknowledges the support of the Grant Agency of Charles University (grant No. 498214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2005, INT J HEMATOL, V82, P371, DOI 10.1532/IJH97.05100; Barnes DJ, 2006, CELL CYCLE, V5, P2862, DOI 10.4161/cc.5.24.3573; Bazzoni G, 1996, J CLIN INVEST, V98, P521, DOI 10.1172/JCI118820; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Burgess MR, 2005, P NATL ACAD SCI USA, V102, P3395, DOI 10.1073/pnas.0409770102; Cassuto O, 2012, ONCOTARGET, V3, P1557; Chen H, 2013, TALANTA, V107, P88, DOI 10.1016/j.talanta.2012.12.046; Deguchi Y, 2008, LEUKEMIA RES, V32, P980, DOI 10.1016/j.leukres.2007.11.008; Dubreuil P, PLOS ONE, pe7258; Fumagalli L, 2007, J IMMUNOL, V178, P3874, DOI 10.4049/jimmunol.178.6.3874; Grebenova D, 2012, J PROTEOMICS, V77, P406, DOI 10.1016/j.jprot.2012.09.014; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Imagawa J, 2012, INT J HEMATOL, V96, P194, DOI 10.1007/s12185-012-1138-2; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Kimura S, 2006, CURR PHARM BIOTECHNO, V7, P371, DOI 10.2174/138920106778521532; Kuzelova K, 2010, J CELL BIOCHEM, V111, P1413, DOI 10.1002/jcb.22868; Kuzelova K, 2010, J CELL BIOCHEM, V109, P184, DOI 10.1002/jcb.22397; Maia V, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-9; Manley PW, 2005, BBA-PROTEINS PROTEOM, V1754, P3, DOI 10.1016/j.bbapap.2005.07.040; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; Martinelli G, 2005, LEUKEMIA, V19, P1872, DOI 10.1038/sj.leu.2403950; Mauro MJ, 2013, LEUKEMIA RES, V37, P1395, DOI 10.1016/j.leukres.2013.07.029; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mocsai A, 1999, J IMMUNOL, V162, P1120; Nakata Y, 2006, BLOOD, V107, P4234, DOI 10.1182/blood-2005-08-3343; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Niwa T, 2007, ANAL CHEM INSIGHTS, V2, P93; O'Hare T, 2005, CLIN CANCER RES, V11, P6987, DOI 10.1158/1078-0432.CCR-05-0622; Obr A, 2013, CELL ADHES MIGR, V7, P275, DOI 10.4161/cam.24531; Pereira S, 2003, J IMMUNOL, V171, P1319, DOI 10.4049/jimmunol.171.3.1319; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Salgia R, 1997, J CLIN INVEST, V100, P46, DOI 10.1172/JCI119520; Salgia R, 1996, J BIOL CHEM, V271, P25198, DOI 10.1074/jbc.271.41.25198; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Suen PW, 1999, J CELL SCI, V112, P4067; Tsuji-Takayama K, 1994, Hum Cell, V7, P167; Vainstein V, 2013, BLOOD, V122, P3331, DOI 10.1182/blood-2012-08-452409; Verfaillie CM, 1997, ACTA HAEMATOL-BASEL, V97, P40; Weisberg E, 2012, LEUKEMIA, V26, P985, DOI 10.1038/leu.2011.360; Wertheim JA, 2002, BLOOD, V99, P4122, DOI 10.1182/blood.V99.11.4122; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330	43	8	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107367	10.1371/journal.pone.0107367	http://dx.doi.org/10.1371/journal.pone.0107367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198091	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700107
J	Ochi, R; Chettimada, S; Gupte, SA				Ochi, Rikuo; Chettimada, Sukrutha; Gupte, Sachin A.			Poly(Ethylene Glycol)-Cholesterol Inhibits L-Type Ca2+ Channel Currents and Augments Voltage-Dependent Inactivation in A7r5 Cells	PLOS ONE			English	Article							MEMBRANE CHOLESTEROL CONTENT; SMOOTH-MUSCLE; BILAYER THICKNESS; CALCIUM-CHANNELS; IN-VITRO; DOMAINS; ELEVATION; TRANSPORT	Cholesterol distributes at a high density in the membrane lipid raft and modulates ion channel currents. Poly(ethylene glycol) cholesteryl ether (PEG-cholesterol) is a nonionic amphipathic lipid consisting of lipophilic cholesterol and covalently bound hydrophilic PEG. PEG-cholesterol is used to formulate lipoplexes to transfect cultured cells, and liposomes for encapsulated drug delivery. PEG-cholesterol is dissolved in the external leaflet of the lipid bilayer, and expands it to flatten the caveolae and widen the gap between the two leaflets. We studied the effect of PEG-cholesterol on whole cell L-type Ca2+ channel currents (I-Ca,I-L) recorded from cultured A7r5 arterial smooth muscle cells. The pretreatment of cells with PEG-cholesterol decreased the density of I-Ca,I-L and augmented the voltage-dependent inactivation with acceleration of time course of inactivation and negative shift of steady-state inactivation curve. Methyl-beta-cyclodextrin (M beta CD) is a cholesterol-binding oligosaccharide. The enrichment of cholesterol by the M beta CD: cholesterol complex (cholesterol (M beta CD)) caused inhibition of I-Ca,I-L but did not augment voltage-dependent inactivation. Incubation with M beta CD increased I-Ca,I-L, slowed the time course of inactivation and shifted the inactivation curve to a positive direction. Additional pretreatment by a high concentration of M beta CD of the cells initially pretreated with PEG-cholesterol, increased I-Ca,I-L to a greater level than the control, and removed the augmented voltage-dependent inactivation. Due to the enhancement of the voltage-dependent inactivation, PEG-cholesterol inhibited window I-Ca,I-L more strongly as compared with cholesterol (M beta CD). Poly(ethylene glycol) conferred to cholesterol the efficacy to induce sustained augmentation of voltage-dependent inactivation of I-Ca,I-L.	[Ochi, Rikuo; Chettimada, Sukrutha; Gupte, Sachin A.] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA	University of South Alabama	Ochi, R (corresponding author), New York Med Coll, Dept Pharmacol, New York, NY 10595 USA.	rikuoochi@yahoo.com; s_gupte@nymc.edu		Chettimada, Sukrutha/0000-0002-2224-9988	 [ROI-HL085352]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085352] Funding Source: NIH RePORTER	; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grant ROI-HL085352 to SAG (http://www.nhlbi.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Baba T, 2004, HISTOCHEM CELL BIOL, V122, P587, DOI 10.1007/s00418-004-0723-8; Baba T, 2001, TRAFFIC, V2, P501, DOI 10.1034/j.1600-0854.2001.20707.x; Bannister JP, 2009, CIRC RES, V105, P948, DOI 10.1161/CIRCRESAHA.109.203620; Bowles DK, 2004, J APPL PHYSIOL, V96, P2240, DOI 10.1152/japplphysiol.01229.2003; Choubey A, 2013, BIOPHYS J, V104, P2429, DOI 10.1016/j.bpj.2013.04.036; COHEN NM, 1987, J PHYSIOL-LONDON, V391, P169, DOI 10.1113/jphysiol.1987.sp016732; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Dopico AM, 2010, PHARMACOL THERAPEUT, V135, P133; Felix R, 1997, J NEUROSCI, V17, P6884; FLEISCHMANN BK, 1994, P NATL ACAD SCI USA, V91, P11914, DOI 10.1073/pnas.91.25.11914; Garg S, 2011, BIOPHYS J, V101, P370, DOI 10.1016/j.bpj.2011.06.014; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Ishiwata H, 1997, BBA-MOL CELL RES, V1359, P123, DOI 10.1016/S0167-4889(97)00061-X; Jennings LJ, 1999, AM J PHYSIOL-GASTR L, V277, pG1017, DOI 10.1152/ajpgi.1999.277.5.G1017; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Lee AK, 2011, ENDOCRINOLOGY, V152, P3351, DOI 10.1210/en.2011-0124; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107; Narang D, 2013, CAN J PHYSIOL PHARM, V91, P316, DOI 10.1139/cjpp-2012-0257; Naylor J, 2010, CIRC RES, V106, P1507, DOI 10.1161/CIRCRESAHA.110.219329; Nie Y, 2012, THERANOSTICS, V2, P1092, DOI 10.7150/thno.4949; Purcell EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026289; Sanders KM, 2001, J APPL PHYSIOL, V91, P1438, DOI 10.1152/jappl.2001.91.3.1438; Sato SB, 2004, J BIOL CHEM, V279, P23790, DOI 10.1074/jbc.M313568200; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Tulenko TN, 1998, J LIPID RES, V39, P947; Villalain J, 1996, EUR J BIOCHEM, V241, P586, DOI 10.1111/j.1432-1033.1996.00586.x; Xu L, 2011, THER DELIV, V2, P451, DOI [10.4155/TDE.11.13, 10.4155/tde.11.13]; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yuan CB, 2004, BIOPHYS J, V86, P3620, DOI 10.1529/biophysj.103.029678; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	34	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107049	10.1371/journal.pone.0107049	http://dx.doi.org/10.1371/journal.pone.0107049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197984	gold, Green Submitted, Green Published			2022-12-27	WOS:000341304700076
J	Xiao, DD; Nie, X; Wang, WY; Zhou, J; Zhang, M; Zhou, Z; Zhao, Y; Gu, M; Wang, Z; Lu, MJ				Xiao, Dongdong; Nie, Xin; Wang, Wenyue; Zhou, Juan; Zhang, Ming; Zhou, Zhe; Zhao, Yang; Gu, Meng; Wang, Zhong; Lu, Mujun			Comparison of Transverse Island Flap Onlay and Tubularized Incised-Plate Urethroplasties for Primary Proximal Hypospadias: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							OBJECTIVE SCORING SYSTEM; URETHRAL PLATE; REPAIR; DISTAL; PRESERVATION; PERCEPTION; OUTCOMES; BIAS	Purpose: This meta-analysis was conducted to compare postoperative outcomes between transverse island flap (TVIF) onlay and tubularized incised-plate (TIP) urethroplasties for primary proximal hypospadias. Materials and Methods: A comprehensive literature search updated to 21st May 2014 was carried out for relevant studies. After literature identification and data extraction, odds ratio (OR) with 95% confidential interval (CI) was calculated to compare postoperative complication rate between TVIF onlay and TIP. Meta-regression and subgroup analyses were applied to find potential affective factors. Results: A total of 6 studies including 309 patients receiving TVIF onlay and 262 individuals subjected to TIP met inclusion criteria. The synthetic data suggested that TVIF onlay and TIP were comparable in terms of total complication rate (OR 0.85, 95% CI 0.56-1.30, p = 0.461), fistula (OR 0.68, 95% CI 0.38-1.21, p = 0.194), recurrent curvature (OR 1.16, 95% CI 0.43-3.12, p = 0.766), dehiscence (OR 0.95, 95% CI 0.33-2.74, p = 0.920), diverticulum (OR 1.90, 95% CI 0.53-6.78, p = 0.321), meatal stenosis (OR 0.74, 95% CI 0.20-2.77, p = 0.651) and urethral stricture (OR 1.49, 95% CI 0.41-5.50, p = 0.545), without significant heterogeneity for each comparison group. Meta-regression and subgroup analyses revealed no significant findings. One-way sensitivity analysis indicated that the results were stable. No publication bias was detected using both funnel plot and Egger's test. Also, there were no obvious differences observed in cosmetic and functional outcomes. Conclusions: This meta-analysis suggests that TVIF onlay and TIP urethroplasties are clinically equivalent. Given the inherent limitations of included studies, this conclusion should be interpreted with caution and wait to be confirmed by more well-designed randomized controlled trials with high quality in the future.	[Xiao, Dongdong; Zhou, Juan; Zhang, Ming; Zhou, Zhe; Zhao, Yang; Gu, Meng; Wang, Zhong; Lu, Mujun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Urol, Shanghai 200030, Peoples R China; [Nie, Xin; Wang, Wenyue] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Gen Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, Z (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Urol, Shanghai 200030, Peoples R China.	zhongwang2010@sina.com; lumujun@163.com	Xiao, Dongdong/I-3730-2019; Xiao, Dongdong/O-4344-2017; Lu, Mujun/AFV-7941-2022	Xiao, Dongdong/0000-0002-7962-3846; Xiao, Dongdong/0000-0002-7962-3846; Lu, Mujun/0000-0002-3404-1260	National Natural Science Foundation of China [81070605, 81370860]; Shanghai Jiao Tong University [YG2011MS14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University	This work was supported by the General Programs of the National Natural Science Foundation of China (No. 81070605 & No. 81370860) and the Biomedical Engineering Research Fund of Shanghai Jiao Tong University (No. YG2011MS14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braga LHP, 2007, J UROLOGY, V178, P1451, DOI 10.1016/j.juro.2007.05.170; Castagnetti M, 2013, J UROLOGY, V189, P1508, DOI 10.1016/j.juro.2012.11.013; Chen SC, 2000, BJU INT, V86, P1050, DOI 10.1046/j.1464-410x.2000.00966.x; DeLair SM, 2008, J UROLOGY, V179, P1102, DOI 10.1016/j.juro.2007.10.090; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUCKETT JW, 1980, UROL CLIN N AM, V7, P423; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELDER JS, 1987, J UROLOGY, V138, P376, DOI 10.1016/S0022-5347(17)43152-1; Erol A, 2000, BJU INT, V85, P728, DOI 10.1046/j.1464-410x.2000.00486.x; Esposito C, 2014, J PEDIATR UROL, V10, P294, DOI 10.1016/j.jpurol.2013.09.003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holland AJA, 2000, J UROLOGY, V164, P489, DOI 10.1016/S0022-5347(05)67408-3; HOLLOWELL JG, 1990, J UROLOGY, V143, P98, DOI 10.1016/S0022-5347(17)39878-6; Hollowell JG, 1990, J UROLOGY, V143, P100; Holmdahl Gundela, 2006, J Pediatr Urol, V2, P304, DOI 10.1016/j.jpurol.2005.11.018; Mizuno K, 2002, INT J UROL, V9, P88, DOI 10.1046/j.1442-2042.2002.00426.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moursy EE, 2010, J PEDIATR UROL, V6, P45, DOI 10.1016/j.jpurol.2009.04.013; Prat D, 2012, UROLOGY, V79, P1350, DOI 10.1016/j.urology.2011.11.085; Samuel M, 2003, BJU INT, V92, P783, DOI 10.1046/j.1464-410X.2003.04478.x; SANTANELLI F, 1994, ANN PLAS SURG, V33, P305, DOI 10.1097/00000637-199409000-00012; SANTANELLI F, 1990, SCAND J PLAST RECONS, V24, P67, DOI 10.3109/02844319009004523; Sarhan O, 2009, J UROLOGY, V182, P682, DOI 10.1016/j.juro.2009.04.034; SNODGRASS W, 1994, J UROLOGY, V151, P464, DOI 10.1016/S0022-5347(17)34991-1; Snodgrass W, 2007, J UROLOGY, V177, P698, DOI 10.1016/j.juro.2006.09.104; Standoli L, 1979, RASS ITAL CHIR PEDIA, V21, P82; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Sujijantararat P, 2009, ASIAN J SURG, V32, P229, DOI 10.1016/S1015-9584(09)60399-7; Tobias A., 1999, STATA TECHNICAL B, V8, P15; van der Toorn F, 2013, J PEDIATR UROL, V9, P1006, DOI 10.1016/j.jpurol.2013.01.015; Weber DM, 2008, J UROLOGY, V180, P1080, DOI 10.1016/j.juro.2008.05.060; Wells G, 2000, NEWCASTLE OTTAWA SCA; Xu N, 2014, INT UROL NEPHROL, V46, P487, DOI 10.1007/s11255-013-0567-z	33	11	13	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106917	10.1371/journal.pone.0106917	http://dx.doi.org/10.1371/journal.pone.0106917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197970	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700066
J	Adams, EJ; Goad, M; Sahlqvist, S; Bull, FC; Cooper, AR; Ogilvie, D				Adams, Emma J.; Goad, Mary; Sahlqvist, Shannon; Bull, Fiona C.; Cooper, Ashley R.; Ogilvie, David		iConnect Consortium	Reliability and Validity of the Transport and Physical Activity Questionnaire (TPAQ) for Assessing Physical Activity Behaviour	PLOS ONE			English	Article							CRITERION-RELATED VALIDITY; SHORT-FORM; WALKING; ADULTS; ACCELEROMETER; IPAQ	Background: No current validated survey instrument allows a comprehensive assessment of both physical activity and travel behaviours for use in interdisciplinary research on walking and cycling. This study reports on the test-retest reliability and validity of physical activity measures in the transport and physical activity questionnaire (TPAQ). Methods: The TPAQ assesses time spent in different domains of physical activity and using different modes of transport for five journey purposes. Test-retest reliability of eight physical activity summary variables was assessed using intra-class correlation coefficients (ICC) and Kappa scores for continuous and categorical variables respectively. In a separate study, the validity of three survey-reported physical activity summary variables was assessed by computing Spearman correlation coefficients using accelerometer-derived reference measures. The Bland-Altman technique was used to determine the absolute validity of survey-reported time spent in moderate-to-vigorous physical activity (MVPA). Results: In the reliability study, ICC for time spent in different domains of physical activity ranged from fair to substantial for walking for transport (ICC = 0.59), cycling for transport (ICC = 0.61), walking for recreation (ICC = 0.48), cycling for recreation (ICC = 0.35), moderate leisure-time physical activity (ICC = 0.47), vigorous leisure-time physical activity (ICC = 0.63), and total physical activity (ICC = 0.56). The proportion of participants estimated to meet physical activity guidelines showed acceptable reliability (k = 0.60). In the validity study, comparison of survey-reported and accelerometer-derived time spent in physical activity showed strong agreement for vigorous physical activity (r = 0.72, p<0.001), fair but non-significant agreement for moderate physical activity (r = 0.24, p = 0.09) and fair agreement for MVPA (r = 0.27, p = 0.05). Bland-Altman analysis showed a mean overestimation of MVPA of 87.6 min/week (p = 0.02) (95% limits of agreement -447.1 to +622.3 min/week). Conclusion: The TPAQ provides a more comprehensive assessment of physical activity and travel behaviours and may be suitable for wider use. Its physical activity summary measures have comparable reliability and validity to those of similar existing questionnaires.	[Adams, Emma J.; Goad, Mary] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Natl Ctr Phys Act & Hlth, British Heart Fdn, Loughborough, Leics, England; [Sahlqvist, Shannon] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res C PAN, Geelong, Vic 3217, Australia; [Bull, Fiona C.] Univ Western Australia, Ctr Built Environm & Hlth, Sch Populat Hlth, Perth, WA 6009, Australia; [Cooper, Ashley R.] Univ Bristol, Ctr Exercise Nutr & Hlth Sci, Sch Policy Studies, Bristol, Avon, England; [Ogilvie, David] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; [Ogilvie, David] Univ Cambridge, UKCRC Ctr Diet & Act Res CEDAR, Cambridge, England	Loughborough University; Deakin University; University of Western Australia; University of Bristol; University of Cambridge; University of Cambridge	Adams, EJ (corresponding author), Univ Loughborough, Sch Sport Exercise & Hlth Sci, Natl Ctr Phys Act & Hlth, British Heart Fdn, Loughborough, Leics, England.	e.j.adams@lboro.ac.uk	Cooper, Ashley/D-9956-2014	Cooper, Ashley/0000-0001-8644-3870; Ogilvie, David/0000-0002-0270-4672; Adams, Emma J/0000-0002-5444-6951; Rutter, Harry/0000-0002-9322-0656; Sahlqvist, Shannon/0000-0002-3714-9533	Engineering and Physical Sciences Research Council [EP/G00059X/1]; Medical Research Council [MC_UU_12015/6]; Centre for Diet and Activity Research (CEDAR); British Heart Foundation; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1, MC_UP_1001/1] Funding Source: researchfish; EPSRC [EP/G00059X/1] Funding Source: UKRI; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1, MC_UU_12015/6, MC_UP_1001/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for Diet and Activity Research (CEDAR); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The iConnect consortium is funded by the Engineering and Physical Sciences Research Council (grant reference EP/G00059X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DO is also supported by the Medical Research Council [Unit Programme number MC_UU_12015/6] and the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence that is funded by the British Heart Foundation, Economic and Social Research Council, Medical Research Council, National Institute for Health Research and the Wellcome Trust. The views expressed in this paper are those of the authors and do not necessarily reflect those of the study funders, the NIHR, or the Department of Health.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Badland H, 2006, RES Q EXERCISE SPORT, V77, P386; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Craig R, 2009, HLTH SURVEY ENGLAND; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; De Vries SI, 2011, MED SCI SPORT EXER, V43, P1994, DOI 10.1249/MSS.0b013e318219d939; Department of Health, 2011, START ACT STAY ACT R; Department of Health and Department for Transport, 2010, ACT TRAV STRAT; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Forsyth A, 2010, CAMTI102907; Forsyth A, 2012, TRANSPORT RES REC, P22, DOI 10.3141/2299-03; Giles-Corti B, 2006, PREV MED, V42, P455, DOI 10.1016/j.ypmed.2006.01.019; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Herrmann SD, 2013, MEAS PHYS EDUC EXERC, V17, P221, DOI 10.1080/1091367X.2013.805139; Krizek KJ, 2009, ENVIRON PLANN B, V36, P725, DOI 10.1068/b34023; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; National Institute for Health and Care Excellence, 2012, WALK CYCL LOC MEAS P, V41; Office for National Statistics, 2011, 2011 CENS ENGL WAL; Ogilvie D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000694; Ogilvie D, 2011, AM J PUBLIC HEALTH, V101, P473, DOI 10.2105/AJPH.2010.198002; Sahlqvist S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-62; Slootmaker SM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-17; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000	29	31	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107039	10.1371/journal.pone.0107039	http://dx.doi.org/10.1371/journal.pone.0107039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP0SM	25215510	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300038
J	Kwak, Y; Pearson, J; Huettel, SA				Kwak, Youngbin; Pearson, John; Huettel, Scott A.			Differential Reward Learning for Self and Others Predicts Self-Reported Altruism	PLOS ONE			English	Article							IOWA GAMBLING TASK; DECISION-MAKING; INDIVIDUAL-DIFFERENCES; SOCIAL EVALUATION; NEURAL RESPONSES; EMPATHY; ACTIVATION; SIGNALS; INSENSITIVITY; PERSONALITY	In social environments, decisions not only determine rewards for oneself but also for others. However, individual differences in pro-social behaviors have been typically studied through self-report. We developed a decision-making paradigm in which participants chose from card decks with differing rewards for themselves and charity; some decks gave similar rewards to both, while others gave higher rewards for one or the other. We used a reinforcement-learning model that estimated each participant's relative weighting of self versus charity reward. As shown both in choices and model parameters, individuals who showed relatively better learning of rewards for charity - compared to themselves - were more likely to engage in pro-social behavior outside of a laboratory setting indicated by self-report. Overall rates of reward learning, however, did not predict individual differences in pro-social tendencies. These results support the idea that biases toward learning about social rewards are associated with one's altruistic tendencies.	[Kwak, Youngbin] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA; [Pearson, John; Huettel, Scott A.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; [Huettel, Scott A.] Duke Univ, Duke Ctr Interdisciplinary Decis Sci, Durham, NC USA; [Huettel, Scott A.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	University of Massachusetts System; University of Massachusetts Amherst; Duke University; Duke University; Duke University	Huettel, SA (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA.	scott.huettel@duke.edu		Pearson, John/0000-0002-9876-7837	National Institute on Drug Abuse (NIDA) Grant [P30 DA023026]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA023026] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA) Grant; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institute on Drug Abuse (NIDA) Grant P30 DA023026. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ARCHER RL, 1981, J PERS SOC PSYCHOL, V40, P786, DOI 10.1037/0022-3514.40.4.786; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Becker G., 1976, EC APPROACH HUMAN BE; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Brand M, 2005, PSYCHIAT RES, V133, P91, DOI 10.1016/j.psychres.2004.10.003; Brogan A, 2010, J INT NEUROPSYCH SOC, V16, P711, DOI 10.1017/S1355617710000354; Busemeyer JR, 2002, PSYCHOL ASSESSMENT, V14, P253, DOI 10.1037//1040-3590.14.3.253; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; CARLO G, 1991, J PERS SOC PSYCHOL, V61, P450, DOI 10.1037/0022-3514.61.3.450; Carter RM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.021.2009; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chan RCK, 2010, PSYCHIAT RES, V175, P181, DOI 10.1016/j.psychres.2009.01.020; CIALDINI RB, 1987, J PERS SOC PSYCHOL, V52, P749, DOI 10.1037/0022-3514.52.4.749; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Desmeules R, 2008, J BEHAV DECIS MAKING, V21, P211, DOI 10.1002/bdm.583; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; EDWARDS AWF, 1972, LIKELIHOOD; Fehr E., 2003, ADV EC EC THEORY APP, VI, P208, DOI [10.1017/CBO9780511610240.008, DOI 10.1017/CBO9780511610240.008]; Fehr E, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P215, DOI 10.1016/B978-0-12-374176-9.00015-4; Franken IHA, 2006, PERS INDIV DIFFER, V40, P1497, DOI 10.1016/j.paid.2005.12.005; Franken IHA, 2005, PERS INDIV DIFFER, V39, P991, DOI 10.1016/j.paid.2005.04.004; FULTZ J, 1986, J PERS SOC PSYCHOL, V50, P761, DOI 10.1037/0022-3514.50.4.761; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hauser DJ, 2013, J EXPT PSYCHOL GEN; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; HOMANS GC, 1958, AM J SOCIOL, V63, P597, DOI 10.1086/222355; Huynh H., 1970, J AM STAT ASSOC, V65, P1582, DOI DOI 10.1080/01621459.1970.10481187; Janowski V, 2013, SOC COGN AFFECT NEUR, V8, P201, DOI 10.1093/scan/nsr086; Kishida KT, 2010, NEURON, V67, P543, DOI 10.1016/j.neuron.2010.07.021; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; Nicolle A, 2012, NEURON, V75, P1114, DOI 10.1016/j.neuron.2012.07.023; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Poletti M, 2011, J CLIN EXP NEUROPSYC, V33, P395, DOI 10.1080/13803395.2010.524150; Putman P, 2004, EMOTION, V4, P305, DOI 10.1037/1528-3542.4.3.305; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; ROMER D, 1986, J PERS SOC PSYCHOL, V51, P1001, DOI 10.1037/0022-3514.51.5.1001; Smith Adam, 1976, WEALTH NATIONS; SMITH VL, 1982, AM ECON REV, V72, P923; SMITH VL, 1962, J POLIT ECON, V70, P111, DOI 10.1086/258609; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Thibaut J., 1959, SOCIAL PSYCHOL GROUP; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x; Yokum D, 2009, NEUROCOGNITIVE PERSP; Zaki J, 2011, P NATL ACAD SCI USA, V108, P19761, DOI 10.1073/pnas.1112324108; Zhu LS, 2012, P NATL ACAD SCI USA, V109, P1419, DOI 10.1073/pnas.1116783109	56	15	15	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107621	10.1371/journal.pone.0107621	http://dx.doi.org/10.1371/journal.pone.0107621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP0SM	25215883	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300089
J	Sha, Y; Zhou, W; Yang, ZY; Zhu, XL; Xiang, YP; Li, TD; Zhu, DX; Yang, XY				Sha, Yan; Zhou, Wei; Yang, Zhenyu; Zhu, Xiaoling; Xiang, Yingping; Li, Tiandi; Zhu, Dexiang; Yang, Xinyue			Changes in Poly(ADP-Ribosyl)ation Patterns in Workers Exposed to BTX	PLOS ONE			English	Article							BENZENE; TOLUENE; GENOTOXICITY; METHYLATION; METABOLISM; PROMOTER; CANCER; DNMT1; CYTOTOXICITY; MODULATION	Occupational exposure to (benzene, toluene and xylene, BTX is common in the Chinese workplace. Chronic occupational exposure to benzene is associated with an increased risk of hematological malignancies such as acute myeloid leukemia (AML), but the underlying mechanisms are still unclear. This study investigates changes in poly(ADP-ribosyl)ation and DNA methylation in subjects occupationally exposed to a BTX. Blood DNA samples and exposure data were obtained from subjects with different levels of exposure, including 132 decorators, 129 painters, and 130 unexposed referents in a container-manufacturing factory in Shenzhen, China. Occupational exposure assessment included personal monitoring of airborne benzene, toluene and xylene. Hematological parameters were measured and the cytokinesis-block micronucleus (CBMN) assay was used to detect DNA damage in peripheral lymphocytes. Quantitative real-time PCR was used to detect the mRNA expression of poly(ADP-ribose) polymerase 1 (PARP1) and poly(ADP-ribose) glycohydrolase (PARG), DNA methyltransferases (DNMTs) including DNMT1, DNMT3a and DNMT3b, methyl-CpG-binding domain protein 2(MBD2). PARP1 assay was used to measure PARP activity. Airborne levels of benzene, toluene and xylene in the two exposed groups were significantly higher than those of controls (P<0.001). The two exposed groups (decorators, painters) showed decreased PARP1, DNMTs and MBD2 expression relative to controls (P<0.05), and PARP activity was also decreased (P<0.05). Decreased PARP1, DNMT1, DNMT3a, DNMT3b and MBD2 mRNA expression was correlated with increased airborne BTX (Pearson's r: -0.587, -0.314, -0.636, -0.567 and -0.592 respectively, P<0.001). No significant differences in hematological parameters and CBMN were found among the three groups. Together, these results suggest that decreased DNMTs, MBD2 and PARP1 might be involved in the global hypomethylation associated with BTX exposure, and the imbalance of PARP/PARG might participate in the down-regulation of DNMTs. This is the first human study to link altered poly(ADP-ribosyl) ation patterns, which reproduce the aberrant epigenetic patterns found in benzene-treated cells, to chronic occupational exposure to BTX.	[Sha, Yan; Yang, Xinyue] Shenzhen Prevent & Treatment Ctr Occupat Dis, Dept Educ & Res, Shenzhen, Guangdong, Peoples R China; [Zhou, Wei; Yang, Zhenyu; Zhu, Xiaoling; Xiang, Yingping] Shenzhen Prevent & Treatment Ctr Occupat Dis, Dept Occupat Hazard Assessment, Shenzhen, Guangdong, Peoples R China; [Li, Tiandi] Shenzhen Prevent & Treatment Ctr Occupat Dis, Physicochem Lab, Shenzhen, Guangdong, Peoples R China; [Zhu, Dexiang] Shenzhen Prevent & Treatment Ctr Occupat Dis, Dept Integrated Serv, Shenzhen, Guangdong, Peoples R China		Sha, Y (corresponding author), Shenzhen Prevent & Treatment Ctr Occupat Dis, Dept Educ & Res, Shenzhen, Guangdong, Peoples R China.	sandyee123@126.com			Natural Science Foundation of China [81202247]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant 81202247 from the Natural Science Foundation of China, (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; ANDREWS LS, 1977, BIOCHEM PHARMACOL, V26, P293, DOI 10.1016/0006-2952(77)90180-0; [Anonymous], 1982, IARC Monogr Eval Carcinog Risk Chem Hum, V29, P93; [Anonymous], GBZ212007; ATSDR, 2004, INT PROF BENZ TOL ET; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird MG, 2010, CHEM-BIOL INTERACT, V184, P233, DOI 10.1016/j.cbi.2010.01.012; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Delaney CA, 2000, CLIN CANCER RES, V6, P2860; DOSEMECI M, 1994, AM J IND MED, V26, P401, DOI 10.1002/ajim.4700260313; FENECH M, 1993, ENVIRON HEALTH PERSP, V101, P101, DOI 10.2307/3431708; Fenech M, 2010, HEALTH PHYS, V98, P234, DOI 10.1097/HP.0b013e3181b85044; Gao A, 2010, TOXICOL LETT, V195, P114, DOI 10.1016/j.toxlet.2010.03.005; Gong CM, 2012, TOXICOL LETT, V209, P264, DOI 10.1016/j.toxlet.2012.01.007; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Khalade A, 2010, ENV HLTH, V28, P9; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kuang SR, 2005, CHEM-BIOL INTERACT, V153, P129, DOI 10.1016/j.cbi.2005.03.038; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; LUBBERT M, 1992, BLOOD, V80, P2066; Maffei F, 2005, MUTAT RES-GEN TOX EN, V583, P1, DOI 10.1016/j.mrgentox.2005.01.011; Nishikawa T, 2011, J OCCUP HEALTH, V53, P84, DOI 10.1539/joh.10-002-OA; Qu QS, 2002, AM J IND MED, V42, P275, DOI 10.1002/ajim.10121; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Ross D, 2000, J TOXICOL ENV HEAL A, V61, P357, DOI 10.1080/00984100050166361; Seow WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050471; Singh MP, 2009, TOXICOL APPL PHARM, V235, P226, DOI 10.1016/j.taap.2008.12.002; Smith MT, 2010, ANNU REV PUBL HEALTH, V31, P133, DOI 10.1146/annurev.publhealth.012809.103646; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang LM, 2006, REGUL TOXICOL PHARM, V46, P149, DOI 10.1016/j.yrtph.2006.06.009; Wetmore BA, 2008, CHEM-BIOL INTERACT, V173, P166, DOI 10.1016/j.cbi.2008.03.012; WONG O, 1989, AM J IND MED, V15, P283, DOI 10.1002/ajim.4700150305; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717	37	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106146	10.1371/journal.pone.0106146	http://dx.doi.org/10.1371/journal.pone.0106146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215535	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300007
J	Godbole, S; Sane, S; Kamble, P; Raj, Y; Dulhani, N; Venkatesh, S; Reddy, DCS; Chavan, L; Bhattacharya, M; Bindoria, S; Kadam, D; Thakur, S; Narwani, P; Pereira, E; Paranjape, R; Risbud, A				Godbole, Sheela; Sane, Suvarna; Kamble, Pranil; Raj, Yujwal; Dulhani, Nisha; Venkatesh, Srinivasan; Reddy, D. C. S.; Chavan, Laxmikant; Bhattacharya, Madhulekha; Bindoria, Suchitra; Kadam, Dilip; Thakur, Savita; Narwani, Prakash; Pereira, Elmira; Paranjape, Ramesh; Risbud, Arun			Predictors of Bisexual Behaviour among MSM Attending Intervention Sites May Help in Prevention Interventions for This Bridge to the Heterosexual Epidemic in India: Data from HIV Sentinel Surveillance	PLOS ONE			English	Article							HIDDEN POPULATIONS; SEX BEHAVIOR; MEN; PREVALENCE; RISK; CHENNAI	Background: Indian cultural tradition demanding marriage, many MSM howsoever they self-identify are likely to be married or have sex with women. To consolidate India's HIV prevention gains, it is important to understand and address the interaction between the MSM and heterosexual epidemics in India and create specific interventions for bisexual MSM. The challenge is to identify and intervene this hard to reach population. Data from HIV Sentinel Surveillance 2011 among MSM in four Indian states were analyzed to assess predictors and prevalence of bisexual behaviour in MSM. Methods: Between March-May 2011, 4682 men (15-49 years) who had anal/oral sex with a male partner in the past month, attending intervention sites and consenting for an un-linked anonymous survey answered an 11- item questionnaire and provided blood for HIV test by finger stick at 19 designated surveillance sites. Results: Of 4682 MSM tested overall, 5% were illiterate, 51% reported only receptive anal intercourse, 21% only penetrative and 28% both. 36% MSM had ever received money for sex. Overall 6.8% were HIV infected. 44% MSM were bisexual in the last six months. On multivariate analysis, 'being bisexual' was found to be independently associated with 'older age': 26-30 years [AOR = 3.1, 95% CI(2.7, 3.7)], >30 years [AOR = 6.5, 95% CI(5.5, 7.7)]; 'reporting penetrative behaviour alone' with other men [AOR = 5.8, 95% CI(4.8, 7.0), p<0.01] and 'reporting both penetrative and receptive behaviour' [AOR = 2.7, 95% CI(2.3, 3.1) p<0.01]. Those who both paid and received money for sex [AOR = 0.49, 95% CI (0.38, 0.62)] were significantly less likely to be bisexual. Conclusions: A substantial proportion of men receiving services from Targeted Intervention programs are bisexual and the easy opportunity for intervention in this setting should be capitalised upon. Focusing on older MSM, as well as MSM who show penetrative behaviour with other men, could help in reaching this population.	[Godbole, Sheela; Sane, Suvarna; Kamble, Pranil; Dulhani, Nisha; Paranjape, Ramesh; Risbud, Arun] Indian Council Med Res, Natl AIDS Res Inst, Pune, Maharashtra, India; [Raj, Yujwal; Venkatesh, Srinivasan] Govt India, Minist Hlth & Family Welf, Dept AIDS Control, New Delhi, India; [Reddy, D. C. S.] WHO India, New Delhi, India; [Bindoria, Suchitra] Maharashtra State AIDS Control Soc, Mumbai, Maharashtra, India; [Kadam, Dilip] Mumbai Dist AIDS Control Soc, Bombay, Maharashtra, India; [Thakur, Savita] Madhya Pradesh State AIDS Control Soc, Bhopal, Madhya Pradesh, India; [Narwani, Prakash] Rajasthan State AIDS Control Soc, Jaipur, Rajasthan, India; [Chavan, Laxmikant] Gujarat State AIDS Control Soc, Ahmadabad, Gujarat, India; [Pereira, Elmira] Goa State AIDS Control Soc, Panaji, Goa, India; [Bhattacharya, Madhulekha] Natl Inst Hlth & Family Welfare, Dept Community Hlth Adm, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Godbole, S (corresponding author), Indian Council Med Res, Natl AIDS Res Inst, Pune, Maharashtra, India.	sgodbole@nariindia.org	Godbole, Sheela/ABG-4942-2020; Sane, Suvarna/AAN-5475-2021; Godbole, Sheela/K-4177-2017; Bhattacharya, Madhulekha/ABU-4692-2022	Paranjape, Ramesh/0000-0003-2948-9148; Godbole, Sheela/0000-0001-6537-9064	Department of AIDS Control, Ministry of Health and Family Welfare, Govt of India	Department of AIDS Control, Ministry of Health and Family Welfare, Govt of India	HIV sentinel surveillance (source of data) is funded through the Department of AIDS Control, Ministry of Health and Family Welfare, Govt of India as part of the National AIDS Control Programme. Url: http://naco.gov.in/NACO/. Employees of the funding organisation, some of whom are coauthors, have been involved in either design, implementation or monitoring of the survey.	Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; Go VF, 2004, JAIDS-J ACQ IMM DEF, V35, P314, DOI 10.1097/00126334-200403010-00014; Government of India Ministry of Health and Family Welfare, 1999, NAT OP GUID ART SER; Gupta A, 2006, JAIDS-J ACQ IMM DEF, V43, P483; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Khan S, 2005, MALE TO MALE SEX HIV; Kumta S, 2010, JAIDS-J ACQ IMM DEF, V53, P227, DOI 10.1097/QAI.0b013e3181c354d8; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; NACO, 2011, STRAT APPR TARG INT; NACO, 2007, TARG INT NACP 3 OPER; NACO, 2013, TECHN REP IND HIV ES; National Summary Report - India, 2011, NAT SUMM REP IND; Patel VV, 2012, INDIAN J MED RES, V136, P563; Prudden HJ, 2012, 19 INT AIDS C; Safren SA, 2006, AIDS EDUC PREV, V18, P323, DOI 10.1521/aeap.2006.18.4.323; Setia Maninder Singh, 2006, Indian J Dermatol Venereol Leprol, V72, P425; Setia Maninder Singh, 2008, J LGBT Health Res, V4, P51; Solomon Sunil S, 2010, J Int AIDS Soc, V13 Suppl 2, pS7, DOI 10.1186/1758-2652-13-S2-S7; Solomon SS, 2010, AIDS BEHAV, V14, P1001, DOI 10.1007/s10461-010-9711-2; Verma RK, 2004, AIDS, V18, P1845, DOI 10.1097/00002030-200409030-00014	22	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107439	10.1371/journal.pone.0107439	http://dx.doi.org/10.1371/journal.pone.0107439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1UA	25211511	Green Submitted, Green Published, gold			2022-12-27	WOS:000341855900073
J	Grossschadl, F; Freidl, W; Rasky, E; Burkert, N; Muckenhuber, J; Stronegger, WJ				Grossschaedl, Franziska; Freidl, Wolfgang; Rasky, Eva; Burkert, Nathalie; Muckenhuber, Johanna; Stronegger, Willibald J.			A 35-Year Trend Analysis for Back Pain in Austria: The Role of Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; GENERAL-POPULATION; GLOBAL BURDEN; PREVALENCE; ASSOCIATION; DISORDERS; PATTERNS; WOMEN; COHORT; WORLD	Background: The prevalence of back pain is constantly increasing and a public health problem of high priority. In Austria there is a lack of empirical evidence for the development of back pain and its related factors. The present study aims to investigate trends in the prevalence of back pain across different subpopulations (sex, age, obesity). Methods: A secondary data analysis based on five nationally representative cross-sectional health surveys (1973-2007) was carried out. Face-to-face interviews were conducted in private homes in Austria. Subjects aged 20 years and older were included in the study sample (n = 178,818). Obesity was defined as BMI >= 30 kg/m(2) and adjusted for self-report bias. Back pain was measured as the self-reported presence of the disorder. Results: The age-standardized prevalence of back pain was 32.9% in 2007; it was higher among women than men (p<0.001), higher in older than younger subjects (p<0.001) and higher in obese than non-obese individuals (p<0.001). During the investigation period the absolute change in the prevalence of back pain was +19.4%. Among all subpopulations the prevalence steadily increased. Obese men showed the highest increase of and the greatest risk for back pain. Conclusion: These results help to understand the development of back pain in Austria and can be used to plan controlled promotion programs. Further monitoring is recommended in order to control risk groups and plan target group-specific prevention strategies. In Austria particular emphasis should be on obese individuals. We recommend conducting prospective studies to confirm our results and investigate causal relationships.	[Grossschaedl, Franziska; Freidl, Wolfgang; Rasky, Eva; Burkert, Nathalie; Stronegger, Willibald J.] Med Univ Graz, Inst Social Med & Epidemiol, Graz, Austria; [Muckenhuber, Johanna] Graz Univ, Inst Sociol, Graz, Austria	Medical University of Graz; University of Graz	Grossschadl, F (corresponding author), Med Univ Graz, Inst Social Med & Epidemiol, Graz, Austria.	franziska.grossschaedl@medunigraz.at	Stronegger, Willibald J./C-2425-2018	Stronegger, Willibald J./0000-0003-3496-1208; Grossschadl, Franziska/0000-0002-6726-0443				Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Ali SM, 2006, EUR J PUBLIC HEALTH, V16, P324, DOI 10.1093/eurpub/cki187; Buchbinder R, 2013, BEST PRACT RES CL RH, V27, P575, DOI 10.1016/j.berh.2013.10.007; Carmona L, 2001, ANN RHEUM DIS, V60, P1040, DOI 10.1136/ard.60.11.1040; Demyttenaere K, 2007, PAIN, V129, P332, DOI 10.1016/j.pain.2007.01.022; Dionne CE, 2006, AGE AGEING, V35, P229, DOI 10.1093/ageing/afj055; Espelt A, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112698; Fejer R, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-24; Grossschadl F, 2013, EUR J PUBLIC HEALTH, V23, P306, DOI 10.1093/eurpub/cks033; Grossschadl F, 2012, PUBLIC HEALTH NUTR, V15, P20, DOI 10.1017/S1368980011001911; Han TS, 1997, INT J OBESITY, V21, P600, DOI 10.1038/sj.ijo.0800448; Harkness EF, 2005, RHEUMATOLOGY, V44, P890, DOI 10.1093/rheumatology/keh599; Hershkovich O, 2013, AM J EPIDEMIOL, V178, P603, DOI 10.1093/aje/kwt019; Hoy D, 2010, ARTHRITIS RHEUM, V64, P2028; Hoy D, 2010, BEST PRACT RES CL RH, V24, P155, DOI 10.1016/j.berh.2009.11.002; Hunter G. R., 2005, International Journal of Body Composition Research, V3, P55; Kopec JA, 2004, SPINE, V29, P70, DOI 10.1097/01.BRS.0000103942.81227.7F; Kostova V, 2001, J NEUROL SCI, V192, P17, DOI 10.1016/S0022-510X(01)00585-8; Lake JK, 2000, J CLIN EPIDEMIOL, V53, P245, DOI 10.1016/S0895-4356(99)00155-9; Leijon M, 2004, SCAND J PUBLIC HEALT, V32, P94, DOI 10.1080/14034940310006195; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; Melissas J, 2003, OBES SURG, V13, P389, DOI 10.1381/096089203765887714; Nilsen TIL, 2011, AM J EPIDEMIOL, V174, P267, DOI 10.1093/aje/kwr087; Organization W. H., 1992, WORLD HLTH STAT ANN; Schneider S, 2006, CLIN J PAIN, V22, P738, DOI 10.1097/01.ajp.0000210920.03289.93; Shiely F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-560; Shiri R, 2008, AM J EPIDEMIOL, V167, P1110, DOI 10.1093/aje/kwn007; Shiri R, 2013, SEMIN ARTHRITIS RHEU, V42, P640, DOI 10.1016/j.semarthrit.2012.09.002; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; SKOVRON ML, 1994, SPINE, V19, P129, DOI 10.1097/00007632-199401001-00002; Stranjalis G, 2004, SPINE, V29, P1355, DOI 10.1097/01.BRS.0000127181.59012.1C; Thelin A, 2008, J REHABIL MED, V40, P555, DOI 10.2340/16501977-0205; van der Windt DA, 2013, BEST PRACT RES CL RH, V27, P699, DOI 10.1016/j.berh.2013.11.001; Volinn E, 1997, SPINE, V22, P1747, DOI 10.1097/00007632-199708010-00013; Waddell G, 2002, BACK PAIN INCAPACITY; WHO, 2014, OB OV; Wijnhoven HAH, 2006, CLIN J PAIN, V22, P717, DOI 10.1097/01.ajp.0000210912.95664.53	38	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107436	10.1371/journal.pone.0107436	http://dx.doi.org/10.1371/journal.pone.0107436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207972	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300082
J	Sarkar, TS; Biswas, P; Ghosh, SK; Ghosh, S				Sarkar, Tuhin Subhra; Biswas, Pranjal; Ghosh, Subrata Kumar; Ghosh, Sanjay			Nitric Oxide Production by Necrotrophic Pathogen Macrophomina phaseolina and the Host Plant in Charcoal Rot Disease of Jute: Complexity of the Interplay between Necrotroph-Host Plant Interactions	PLOS ONE			English	Article							PHOSPHATIDIC-ACID PRODUCTION; GLUTATHIONE-REDUCTASE; NITROSATIVE STRESS; SYNTHASE; PURIFICATION; RESISTANCE; ACCUMULATION; PROTEIN; FUNGUS	M. phaseolina, a global devastating necrotrophic fungal pathogen causes charcoal rot disease in more than 500 host plants. With the aim of understanding the plant-necrotrophic pathogen interaction associated with charcoal rot disease of jute, biochemical approach was attempted to study cellular nitric oxide production under diseased condition. This is the first report on M. phaseolina infection in Corchorus capsularis (jute) plants which resulted in elevated nitric oxide, reactive nitrogen species and S nitrosothiols production in infected tissues. Time dependent nitric oxide production was also assessed with 4-Amino-5-Methylamino-2',7'-Difluorofluorescein Diacetate using single leaf experiment both in presence of M. phaseolina and xylanases obtained from fungal secretome. Cellular redox status and redox active enzymes were also assessed during plant fungal interaction. Interestingly, M. phaseolina was found to produce nitric oxide which was detected in vitro inside the mycelium and in the surrounding medium. Addition of mammalian nitric oxide synthase inhibitor could block the nitric oxide production in M. phaseolina. Bioinformatics analysis revealed nitric oxide synthase like sequence with conserved amino acid sequences in M. phaseolina genome sequence. In conclusion, the production of nitric oxide and reactive nitrogen species may have important physiological significance in necrotrophic host pathogen interaction.	[Sarkar, Tuhin Subhra; Biswas, Pranjal; Ghosh, Sanjay] Univ Calcutta, Dept Biochem, Kolkata, India; [Ghosh, Sanjay] Univ Calcutta, Ctr Res Nanosci & Nanotechnol, Kolkata, India; [Ghosh, Subrata Kumar] Cent Res Inst Jute & Allied Fibres CRIJAF, Div Crop Protect, Kolkata, India	University of Calcutta; University of Calcutta; Indian Council of Agricultural Research (ICAR); ICAR - Central Research Institute for Jute & Allied Fibres	Ghosh, S (corresponding author), Univ Calcutta, Dept Biochem, Kolkata, India.	ghoshs71@hotmail.com	Biswas, Pranjal/AGG-8515-2022	Biswas, Pranjal/0000-0003-4173-4214; Ghosh, Sanjay/0000-0001-8624-1494	Indian Council of Agricultural Research under Technology Mission on Jute (TMJ) [MM1.6]; University Grants Commission (UGC), Govt. of India	Indian Council of Agricultural Research under Technology Mission on Jute (TMJ); University Grants Commission (UGC), Govt. of India(University Grants Commission, India)	The work was supported by Indian Council of Agricultural Research under Technology Mission on Jute (TMJ) MM1.6. Research fellowship of Tuhin Subhra Sarkar was supported by University Grants Commission (UGC), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aly Aly A., 2007, Journal of Plant Protection Research, V47, P91; Azevedo H, 2008, PLANT CELL PHYSIOL, V49, P386, DOI 10.1093/pcp/pcn015; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Conrath U, 2004, PLANT J, V38, P1015, DOI 10.1111/j.1365-313X.2004.02096.x; Corpas FJ, 2004, PLANT PHYSIOL, V136, P2722, DOI 10.1104/pp.104.042812; Crane BR, 2010, ANNU REV BIOCHEM, V79, P445, DOI 10.1146/annurev-biochem-062608-103436; Crous PW, 2006, STUD MYCOL, P235, DOI 10.3114/sim.55.1.235; De B. K., 1992, Journal of Mycopathological Research, V30, P51; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Floryszak-Wieczorek J, 2007, NEW PHYTOL, V175, P718, DOI 10.1111/j.1469-8137.2007.02142.x; Golderer G, 2001, GENE DEV, V15, P1299, DOI 10.1101/gad.890501; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI DOI 10.1002/CBER.187901201117; Gupta GK, 2005, TECHNICAL B NATL RES, V10; Hong IS, 2003, FEMS MICROBIOL LETT, V222, P177, DOI 10.1016/S0378-1097(03)00254-4; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Islam MS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-493; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lanteri ML, 2011, PLANTA, V234, P845, DOI 10.1007/s00425-011-1446-4; Laxalt AM, 2007, J BIOL CHEM, V282, P21160, DOI 10.1074/jbc.M701212200; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mandal R. K., 2000, Environment and Ecology, V18, P814; Mandels M, 2010, BIOTECHNOL BIOENG, V105, P3, DOI 10.1002/bit.22603; Mayek-Perez N., 2001, AGROCIENCIA-MEXICO, V46, P649; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Messner S, 2009, BIOCHEM J, V418, P691, DOI 10.1042/BJ20080192; MIYAKE C, 1992, PLANT CELL PHYSIOL, V33, P541; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; Prats E, 2005, MOL PLANT PATHOL, V6, P65, DOI 10.1111/j.1364-3703.2004.00266.x; Prats E, 2008, RES MICROBIOL, V159, P476, DOI 10.1016/j.resmic.2008.04.001; Raguchander T., 1993, Indian Phytopathology, V46, P379; Raho N, 2011, J PLANT PHYSIOL, V168, P534, DOI 10.1016/j.jplph.2010.09.004; Rodriguez-Serrano M, 2006, PLANT CELL ENVIRON, V29, P1532, DOI 10.1111/j.1365-3040.2006.01531.x; Sahoo R, 2006, FREE RADICAL BIO MED, V40, P625, DOI 10.1016/j.freeradbiomed.2005.09.029; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Su G, 2001, PHYTOPATHOLOGY, V91, P120, DOI 10.1094/PHYTO.2001.91.2.120; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Tseng MJ, 2002, ENZYME MICROB TECH, V30, P590, DOI 10.1016/S0141-0229(02)00018-2; Turrion-Gomez JL, 2011, MOL PLANT PATHOL, V12, P606, DOI [10.1111/j.1364-3703.2010.00695.x, 10.1111/J.1364-3703.2010.00695.X]; Valderrama R, 2007, FEBS LETT, V581, P453, DOI 10.1016/j.febslet.2007.01.006; Van Baarlen P, 2004, MOL PLANT PATHOL, V5, P559, DOI [10.1111/j.1364-3703.2004.00253.x, 10.1111/J.1364-3703.2004.00253.X]; Wang J, 2005, FUNGAL GENET BIOL, V42, P284, DOI 10.1016/j.fgb.2004.12.006; Wrather JA, 2003, PLANT HLTH PROGR, DOI [10.1094/PHP-2003-0325-01-RV, DOI 10.1094/PHP-2003-0325-01-RV]; Wyllie TD, 1998, CHARCOAL ROT SOYBEAN, P106	48	29	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107348	10.1371/journal.pone.0107348	http://dx.doi.org/10.1371/journal.pone.0107348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208092	gold, Green Submitted, Green Published			2022-12-27	WOS:000342030300076
J	Tan, F; Xia, YX; Zhu, BY				Tan, Fei; Xia, Yongxiang; Zhu, Boyao			Link Prediction in Complex Networks: A Mutual Information Perspective	PLOS ONE			English	Article								Topological properties of networks are widely applied to study the link-prediction problem recently. Common Neighbors, for example, is a natural yet efficient framework. Many variants of Common Neighbors have been thus proposed to further boost the discriminative resolution of candidate links. In this paper, we reexamine the role of network topology in predicting missing links from the perspective of information theory, and present a practical approach based on the mutual information of network structures. It not only can improve the prediction accuracy substantially, but also experiences reasonable computing complexity.	[Tan, Fei; Xia, Yongxiang; Zhu, Boyao] Zhejiang Univ, Dept Informat Sci & Elect Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Xia, YX (corresponding author), Zhejiang Univ, Dept Informat Sci & Elect Engn, Hangzhou 310003, Zhejiang, Peoples R China.	xiayx@zju.edu.cn	Tan, Fei/AAF-7698-2019; Xia, Yongxiang/D-2439-2015		National Natural Science Foundation of China [61174153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge the support from the National Natural Science Foundation of China under Grant No. 61174153. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Al Hasan M, 2006, SDM06 WORKSH LINK AN; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Benchettara N, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P326, DOI 10.1109/ASONAM.2010.87; Cannistraci CV, 2013, SCI REP-UK, V3, DOI 10.1038/srep01613; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Huang Z, 2005, ACM-IEEE J CONF DIG, P141, DOI 10.1145/1065385.1065415; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kleinberg J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0378; Kumar R, 2010, LINK MINING: MODELS, ALGORITHMS, AND APPLICATIONS, P337, DOI 10.1007/978-1-4419-6515-8_13; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Leskovec J., 2010, P 19 INT C WORLD WID, P641, DOI [10.1145/1772690.1772756, DOI 10.1145/1772690.1772756]; Leskovec J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1361; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Liu HF, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/18004; Liu Z, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48007; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pavlov M., 2007, FEWS, V290, P42, DOI DOI 10.5555/2889513.2889517; Piraveenan M, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/28002; Piraveenan M, 2010, ALIFE 12 C, P329; Sa H.R., 2010, 3 INT WORKSH WEB TEX; Sarukkai RR, 2000, COMPUT NETW, V33, P377, DOI 10.1016/S1389-1286(00)00044-X; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Soundarajan S., 2012, ADV DATA MINING APPL, P395; Spring N, 2002, ACM SIGCOMM COMP COM, V32, P133, DOI 10.1145/964725.633039; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang WQ, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/28004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zeng A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036101; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055437; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8; Zhu J., 2002, P 13 ACM C HYPERTEXT, P169, DOI [DOI 10.1145/513338.513381, 10.1145/513338.513381]	44	77	84	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107056	10.1371/journal.pone.0107056	http://dx.doi.org/10.1371/journal.pone.0107056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207920	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300057
J	Beattie, BJ; Pentlow, KS; O'Donoghue, J; Humm, JL				Beattie, Bradley J.; Pentlow, Keith S.; O'Donoghue, Joseph; Humm, John L.			A Recommendation for Revised Dose Calibrator Measurement Procedures for Zr-89 and I-124	PLOS ONE			English	Article							PET	Because of their chemical properties and multiday half lives, iodine-124 and zirconium-89 are being used in a growing number of PET imaging studies. Some aspects of their quantitation, however, still need attention. For Zr-89 the PET images should, in principle, be as quantitatively accurate as similarly reconstructed F-18 measurements. We found, however, that images of a 20 cm well calibration phantom containing Zr-89 underestimated the activity by approximately 10% relative to a dose calibrator measurement (Capintec CRC-15R) using a published calibration setting number of 465. PET images of I-124, in contrast, are complicated by the contribution of decays in cascade that add spurious coincident events to the PET data. When these cascade coincidences are properly accounted for, quantitatively accurate images should be possible. We found, however, that even with this correction we still encountered what appeared to be a large variability in the accuracy of the PET images when compared to dose calibrator measurements made using the calibration setting number, 570, recommended by Capintec. We derive new calibration setting numbers for Zr-89 and I-124 based on their 511 keV photon peaks as measured on an HPGe detector. The peaks were calibrated relative to an F-18 standard, the activity level of which was precisely measured in a dose calibrator under well-defined measurement conditions. When measuring Zr-89 on a Capintec CRC-15R we propose the use of calibration setting number 517. And for I-124, we recommend the use of a copper filter surrounding the sample and the use of calibration setting number 494. The new dose calibrator measurement procedures we propose will result in more consistent and accurate radioactivity measurements of Zr-89 and I-124. These and other positron emitting radionuclides can be accurately calibrated relative to F-18 based on measurements of their 511 keV peaks and knowledge of their relative positron abundances.	[Beattie, Bradley J.; Pentlow, Keith S.; O'Donoghue, Joseph; Humm, John L.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Beattie, BJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	beattieb@mskcc.org		O'Donoghue, Joseph A/0000-0002-2761-0015	National Cancer Institute [P30 CA08748, P50 CA086438-12]; NATIONAL CANCER INSTITUTE [P30CA008748, P50CA086438] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by the National Cancer Institute P30 CA08748 [http://www.cancer.gov/] and National Cancer Institute P50 CA086438-12 [http://www.cancer.gov/] to BJB and JLH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], STOPP POW RANG TABL; Avila-Rodriguez MA, 2006, AIP CONF PROC, V854, P45, DOI 10.1063/1.2356397; Beattie BJ, 2003, MED PHYS, V30, P2410, DOI 10.1118/1.1595599; Capintec, 2001, CRC 15R RAD DOS CAL, pA1; Cessna JT, 2008, APPL RADIAT ISOTOPES, V66, P988, DOI 10.1016/j.apradiso.2008.02.046; Eckerman K., 2008, Annals of the ICRP, V38, P9, DOI 10.1016/j.icrp.2008.10.004; Eckerman Keith F, 2008, Ann ICRP, V38, P3, DOI 10.1016/j.icrp.2009.02.001; HINRICHSEN PF, 1968, NUCL PHYS A, VA118, P538, DOI 10.1016/0375-9474(68)90438-7; Holland JP, 2009, NUCL MED BIOL, V36, P729, DOI 10.1016/j.nucmedbio.2009.05.007; Jentzen W, 2010, PHYS MED BIOL, V55, P2365, DOI 10.1088/0031-9155/55/8/016; Pentlow KS, 1996, J NUCL MED, V37, P1557; Verel I, 2003, J NUCL MED, V44, P1271; WIARDA KS, 1984, J NUCL MED, V25, P633; XCOM, PHOT CROSS SECT DAT	14	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106868	10.1371/journal.pone.0106868	http://dx.doi.org/10.1371/journal.pone.0106868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202987	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500050
J	Handke, B; Szabad, J; Lidsky, PV; Hafen, E; Lehner, CF				Handke, Bjoern; Szabad, Janos; Lidsky, Peter V.; Hafen, Ernst; Lehner, Christian F.			Towards Long Term Cultivation of Drosophila Wing Imaginal Discs In Vitro	PLOS ONE			English	Article							CELL-CYCLE; EXTRACELLULAR-MATRIX; DNA-REPLICATION; GROWTH-CONTROL; MELANOGASTER; DISKS; DIFFERENTIATION; CULTURE; GENE; VIVO	The wing imaginal disc of Drosophila melanogaster is a prominent experimental system for research on control of cell growth, proliferation and death, as well as on pattern formation and morphogenesis during organogenesis. The precise genetic methodology applicable in this system has facilitated conceptual advances of fundamental importance for developmental biology. Experimental accessibility and versatility would gain further if long term development of wing imaginal discs could be studied also in vitro. For example, culture systems would allow live imaging with maximal temporal and spatial resolution. However, as clearly demonstrated here, standard culture methods result in a rapid cell proliferation arrest within hours of cultivation of dissected wing imaginal discs. Analysis with established markers for cells in S-and M phase, as well as with RGB cell cycle tracker, a novel reporter transgene, revealed that in vitro cultivation interferes with cell cycle progression throughout interphase and not just exclusively during G1. Moreover, quantification of EGFP expression from an inducible transgene revealed rapid adverse effects of disc culture on basic cellular functions beyond cell cycle progression. Disc transplantation experiments confirmed that these detrimental consequences do not reflect fatal damage of imaginal discs during isolation, arguing clearly for a medium insufficiency. Alternative culture media were evaluated, including hemolymph, which surrounds imaginal discs during growth in situ. But isolated larval hemolymph was found to be even less adequate than current culture media, presumably as a result of conversion processes during hemolymph isolation or disc culture. The significance of prominent growth-regulating pathways during disc culture was analyzed, as well as effects of insulin and disc co-culture with larval tissues as potential sources of endocrine factors. Based on our analyses, we developed a culture protocol that prolongs cell proliferation in cultured discs.	[Handke, Bjoern; Lidsky, Peter V.; Lehner, Christian F.] Univ Zurich, Inst Mol Life Sci IMLS, Zurich, Switzerland; [Szabad, Janos] Univ Szeged, Fac Med, Dept Biol, Szeged, Hungary; [Hafen, Ernst] ETH, Dept Biol, Inst Mol Syst Biol IMSB, Zurich, Switzerland	University of Zurich; Szeged University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lehner, CF (corresponding author), Univ Zurich, Inst Mol Life Sci IMLS, Zurich, Switzerland.	christian.lehner@imls.uzh.ch	Lidsky, Peter/AAX-7079-2021	Lidsky, Peter/0000-0001-8976-6800	SystemsX.ch; Swiss National Science Foundation [31003A_152667]	SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The research was supported as a part of the WingX project by SystemsX.ch (www.systemsx.ch) and by a grant (31003A_152667) from the Swiss National Science Foundation (www.snf.ch) to CFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER PN, 1981, EXP CELL RES, V133, P452, DOI 10.1016/0014-4827(81)90340-2; Aldaz S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2763; Aldaz S, 2010, P NATL ACAD SCI USA, V107, P14217, DOI 10.1073/pnas.1008623107; BARNES D, 1980, CELL, V22, P649, DOI 10.1016/0092-8674(80)90540-1; Beadle GW, 1936, GENETICS, V21, P225; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062; CURRIE DA, 1988, DEVELOPMENT, V102, P805; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; DAVIS KT, 1977, SCIENCE, V196, P438, DOI 10.1126/science.403606; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; DURONIO RJ, 1995, GENE DEV, V9, P1456, DOI 10.1101/gad.9.12.1456; Dushay MS, 2009, CELL MOL LIFE SCI, V66, P2643, DOI 10.1007/s00018-009-0036-0; ECHALIER G, 1969, CR ACAD SCI D NAT, V268, P1771; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; FAIN MJ, 1982, DEV BIOL, V92, P247, DOI 10.1016/0012-1606(82)90169-5; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Fristrom D, 1993, DEV DROSOPHILA MELAN, P843; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; Ghannad-Rezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029869; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Glatter T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.79; Gonzalez M, 2011, SCI REPORTS, V1; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; GRAVES BJ, 1982, DEV BIOL, V93, P104, DOI 10.1016/0012-1606(82)90243-3; Guha A, 2009, DEV BIOL, V335, P317, DOI 10.1016/j.ydbio.2009.09.005; HADORN E, 1963, DEV BIOL, V7, P617, DOI 10.1016/0012-1606(63)90146-5; Halfar K, 2001, DEVELOPMENT, V128, P1687; Handke B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067208; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Heemskerk I, 2014, DEVELOPMENT, V141, P2339, DOI 10.1242/dev.109264; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; JAMES AA, 1981, DEV BIOL, V85, P39, DOI 10.1016/0012-1606(81)90234-7; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Karim FD, 1998, DEVELOPMENT, V125, P1; Karim FD, 1996, GENETICS, V143, P315; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917; MADHAVAN MM, 1977, ROUX ARCH DEV BIOL, V183, P269, DOI 10.1007/BF00848459; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; MARTIN PF, 1982, J EXP ZOOL, V222, P97, DOI 10.1002/jez.1402220113; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McClure KD, 2005, DEVELOPMENT, V132, P5033, DOI 10.1242/dev.02092; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Morris LX, 2011, DEVELOPMENT, V138, P2207, DOI 10.1242/dev.065508; Nakajima Y, 2013, NATURE, V500, P359, DOI 10.1038/nature12335; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; NG M, 1995, DEVELOPMENT, V121, P589; Nienhaus U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047594; Nijhout HF, 2007, DEV BIOL, V302, P569, DOI 10.1016/j.ydbio.2006.10.023; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; Oh H, 2009, ONCOGENE, V28, P1916, DOI 10.1038/onc.2009.43; Ohsawa S, 2012, METHOD ENZYMOL, V506, P407, DOI 10.1016/B978-0-12-391856-7.00044-5; OZTURK SS, 1990, BIOTECHNOL PROGR, V6, P437, DOI 10.1021/bp00006a006; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Restrepo S, 2014, CURR BIOL, V24, pR245, DOI 10.1016/j.cub.2014.01.055; RIZKI TM, 1985, MOL GEN GENET, V201, P7, DOI 10.1007/BF00397978; RIZKI TM, 1980, ROUX ARCH DEV BIOL, V188, P91, DOI 10.1007/BF00848799; ROBB JA, 1969, J CELL BIOL, V41, P876, DOI 10.1083/jcb.41.3.876; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHUBIGER M, 1987, DEV BIOL, V123, P145, DOI 10.1016/0012-1606(87)90436-2; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Simcox A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000142; Stronach B, 2005, DEV DYNAM, V232, P575, DOI 10.1002/dvdy.20283; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; UI K, 1987, IN VITRO CELL DEV B, V23, P707; UI K, 1987, JPN J GENET, V62, P563; Ursprung H, 1962, DEV BIOL, V22-39; Vincent JP, 2013, NAT REV MOL CELL BIO, V14, P581, DOI 10.1038/nrm3639; Widmann TJ, 2009, J CELL SCI, V122, P1362, DOI 10.1242/jcs.044271; WIESCHAUS E, 1978, ROUX ARCH DEV BIOL, V184, P75, DOI 10.1007/BF00848670; Willecke M, 2011, ONCOGENE, V30, P4067, DOI 10.1038/onc.2011.125; WOODRUFF RC, 1979, GENETICS, V92, P117; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; YOFFE KB, 1995, DEV BIOL, V170, P636, DOI 10.1006/dbio.1995.1243; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zartman J, 2013, DEVELOPMENT, V140, P667, DOI 10.1242/dev.088872	103	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107333	10.1371/journal.pone.0107333	http://dx.doi.org/10.1371/journal.pone.0107333			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203426	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500084
J	Lane, EP; de Wet, M; Thompson, P; Siebert, U; Wohlsein, P; Plon, S				Lane, Emily P.; de Wet, Morne; Thompson, Peter; Siebert, Ursula; Wohlsein, Peter; Ploen, Stephanie			A Systematic Health Assessment of Indian Ocean Bottlenose (Tursiops aduncus) and Indo-Pacific Humpback (Sousa plumbea) Dolphins Incidentally Caught in Shark Nets off the KwaZulu-Natal Coast, South Africa	PLOS ONE			English	Article							PORPOISES PHOCOENA-PHOCOENA; TOXOPLASMA-GONDII; MORBILLIVIRUS INFECTIONS; POSTMORTEM FINDINGS; EAST-COAST; TRUNCATUS; DISEASES; PARASITES; MAMMALS; SEALS	Coastal dolphins are regarded as indicators of changes in coastal marine ecosystem health that could impact humans utilizing the marine environment for food or recreation. Necropsy and histology examinations were performed on 35 Indian Ocean bottlenose dolphins (Tursiops aduncus) and five Indo-Pacific humpback dolphins (Sousa plumbea) incidentally caught in shark nets off the KwaZulu-Natal coast, South Africa, between 2010 and 2012. Parasitic lesions included pneumonia (85%), abdominal and thoracic serositis (75%), gastroenteritis (70%), hepatitis (62%), and endometritis (42%). Parasitic species identified were Halocercus sp. (lung), Crassicauda sp. (skeletal muscle) and Xenobalanus globicipitis (skin). Additional findings included bronchiolar epithelial mineralisation (83%), splenic filamentous tags (45%), non-suppurative meningoencephalitis (39%), and myocardial fibrosis (26%). No immunohistochemically positive reaction was present in lesions suggestive of dolphin morbillivirus, Toxoplasma gondii and Brucella spp. The first confirmed cases of lobomycosis and sarcocystosis in South African dolphins were documented. Most lesions were mild, and all animals were considered to be in good nutritional condition, based on blubber thickness and muscle mass. Apparent temporal changes in parasitic disease prevalence may indicate a change in the host/parasite interface. This study provided valuable baseline information on conditions affecting coastal dolphin populations in South Africa and, to our knowledge, constitutes the first reported systematic health assessment in incidentally caught dolphins in the Southern Hemisphere. Further research on temporal disease trends as well as disease pathophysiology and anthropogenic factors affecting these populations is needed.	[Lane, Emily P.] Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa; [de Wet, Morne; Thompson, Peter] Univ Pretoria, Fac Vet Sci, Dept Prod Anim Studies, Epidemiol Sect, ZA-0002 Pretoria, South Africa; [Siebert, Ursula] Univ Vet Med, Inst Terr & Aquat Wildlife Res, Hannover, Germany; [Wohlsein, Peter] Univ Vet Med, Dept Pathol, Hannover, Germany; [Ploen, Stephanie] Port Elizabeth Museum Bayworld, South African Inst Aquat Biodivers, Port Elizabeth, South Africa	National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of Pretoria; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity	Lane, EP (corresponding author), Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa.	emily@nzg.ac.za	Ploen, Stephanie/HGU-2443-2022; Thompson, Peter N/J-2534-2013	Thompson, Peter/0000-0002-2268-9748; Lane, Emily/0000-0003-0379-3790	German Science Foundation [SI 1542/4-1]; South African National Research Foundation [707140]; National Research Foundation SEAChange grant [74241]	German Science Foundation(German Research Foundation (DFG)); South African National Research Foundation(National Research Foundation - South Africa); National Research Foundation SEAChange grant	Pathological investigations on cetaceans caught in shark nets in South Africa was funded by the German Science Foundation (SI 1542/4-1) as part of a Research Cooperation Programme with the South African National Research Foundation (Grant number 707140), as well as by a National Research Foundation SEAChange grant (Grant number 74241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BM, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P237; Alton G.G., 1975, LAB TECHNIQUES BRUCE; [Anonymous], [No title captured]; Atkins S, 2013, BIOL CONSERV, V159, P442, DOI 10.1016/j.biocon.2012.10.007; Aznar FJ, 2006, PARASITOLOGY, V133, P369, DOI 10.1017/S0031182006000321; Bar K, 1999, CONSERVATION ADVISOR, V229, P5; de Quiros YB, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00177; Best P, 2007, WHALES DOLPHINS SO A; Bock P., 1989, ROMEIS MIKROSKOPISCH; Bossart GD, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P383, DOI 10.1201/9781420041637.sec4; Bossart Gregory D., 2006, Oceanography, V19, P134; Brown CC, 2007, JUBB KENNEDY PALMERS, P279; CALZADA N, 1994, MAR MAMMAL SCI, V10, P299, DOI 10.1111/j.1748-7692.1994.tb00484.x; Caswell JL, 2007, JUBB KENNEDY PALMERS, P540; Clark LS, 2006, J COMP PATHOL, V135, P208, DOI 10.1016/j.jcpa.2006.07.005; Cockcroft V.G., 1994, Reports of the International Whaling Commission Special Issue, V15, P541; Cockcroft V.G., 1990, P295; COCKCROFT VG, 1990, FISH B-NOAA, V88, P289; COCKCROFT VG, 1990, S AFR J MARINE SCI, V9, P1; COCKCROFT VG, 1992, J ZOOL, V226, P123, DOI 10.1111/j.1469-7998.1992.tb06131.x; Cornaglia E, 2000, J VET MED A, V47, P129, DOI 10.1046/j.1439-0442.2000.00268.x; DAILEY M, 1978, J WILDLIFE DIS, V14, P503, DOI 10.7589/0090-3558-14.4.503; de la Riva GT, 2009, J WILDLIFE DIS, V45, P109, DOI 10.7589/0090-3558-45.1.109; de Quiros YB, 2011, SCI REP-UK, V1, DOI 10.1038/srep00193; De Wet M, 2013, THESIS U PRETORIA PR; Di Guardo G, 2005, J VET MED A, V52, P88, DOI 10.1111/j.1439-0442.2005.00693.x; Di Guardo G, 2010, VET PATHOL, V47, P245, DOI 10.1177/0300985809358036; DOMINGO M, 1992, VET PATHOL, V29, P1, DOI 10.1177/030098589202900101; Dubey JP, 2005, J PARASITOL, V91, P1074, DOI 10.1645/GE-582R.1; Dubey JP, 2003, VET PARASITOL, V116, P275, DOI 10.1016/S0304-4017(03)00263-2; Duignan PJ, 2003, DEP CONSERVATION SCI; Epstein RP, 1998, MARINE ECOSYSTEMS EM; Fauquier D. A., 2010, Diseases of Aquatic Organisms, V88, P85; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; Foster G, 2002, VET MICROBIOL, V90, P563, DOI 10.1016/S0378-1135(02)00236-5; Geraci J.R., 2005, MARINE MAMMALS ASHOR, P176; Geraci JR, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P546; GERACI JR, 1987, INT J PARASITOL, V17, P407, DOI 10.1016/0020-7519(87)90116-0; Gulland FMD, 2007, ECOHEALTH, V4, P135, DOI 10.1007/s10393-007-0097-1; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Higgins R, 2000, CAN VET J, V41, P105; Jauniaux T, 2002, J COMP PATHOL, V126, P243, DOI 10.1053/jcpa.2001.0547; Jefferson TA, 2012, MAR MAMMAL SCI, V28, P84, DOI 10.1111/j.1748-7692.2010.00462.x; Kaiser SML, 2012, THESIS N MANDELA MET; Karczmarski L, 2000, MAR MAMMAL SCI, V16, P65, DOI 10.1111/j.1748-7692.2000.tb00904.x; Keck N, 2010, VET REC, V166, P654, DOI 10.1136/vr.b4837; Kennedy S, 1998, J COMP PATHOL, V119, P201, DOI 10.1016/S0021-9975(98)80045-5; Kiszka J, 2009, DIS AQUAT ORGAN, V84, P151, DOI 10.3354/dao02037; KUIKEN T, 1994, VET REC, V134, P81, DOI 10.1136/vr.134.4.81; KwaZulu-Natal Sharks Board, 2009, CATCH STAT; KwaZulu-Natal Sharks Board, 2011, SHARK NETS DRUML SAF; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lehnert K, 2007, HELGOLAND MAR RES, V61, P239, DOI 10.1007/s10152-007-0072-9; Lehnert K, CHANGE PARA IN PRESS; Lipscomb TP, 1996, J VET DIAGN INVEST, V8, P283, DOI 10.1177/104063879600800302; LIPSCOMB TP, 1994, J WILDLIFE DIS, V30, P567, DOI 10.7589/0090-3558-30.4.567; Maxie MG., 2007, JUBB KENNEDY PALMERS, V2, P425; Miller MA, 2002, INT J PARASITOL, V32, P997, DOI 10.1016/S0020-7519(02)00069-3; Moore MJ, 2009, VET PATHOL, V46, P536, DOI 10.1354/vp.08-VP-0065-M-FL; MUNDAY BL, 1978, J WILDLIFE DIS, V14, P417, DOI 10.7589/0090-3558-14.4.417; Natoli A, 2008, CONSERV GENET, V9, P627, DOI 10.1007/s10592-007-9379-y; NORRIS KENNETH S., 1961, JOUR MAMMAL, V42, P471, DOI 10.2307/1377364; O'Shea TJ, 2003, N P TOX ENV, P595; Peddemors V. M., 1999, Journal of Cetacean Research and Management, V1, P157; Peddemors VM, 1995, THESIS U PORT ELIZAB; Raga JA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P821; Raga JA, 2008, EMERG INFECT DIS, V14, P471, DOI 10.3201/eid1403.071230; Reddy ML, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P3; Reif JS, 2009, MED MYCOL, V47, P125, DOI 10.1080/13693780802178493; Reif JS, 2006, JAVMA-J AM VET MED A, V228, P104, DOI 10.2460/javma.228.1.104; Resendes AR, 2002, J PARASITOL, V88, P206, DOI 10.1645/0022-3395(2002)088[0206:HSIASD]2.0.CO;2; Roe WD, 2012, VET J, V194, P326, DOI 10.1016/j.tvjl.2012.03.028; Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223; Siebert U, 2006, J COMP PATHOL, V134, P134, DOI 10.1016/j.jcpa.2005.09.002; Siebert U, 1999, MAR POLLUT BULL, V38, P285, DOI 10.1016/S0025-326X(98)00147-7; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Stimmer L, 2010, VET MICROBIOL, V145, P23, DOI 10.1016/j.vetmic.2010.02.034; Torchin ME, 2002, PARASITOLOGY, V124, pS137, DOI 10.1017/S0031182002001506; Tsai MS, 2008, INT J INFECT DIS, V12, pE119, DOI 10.1016/j.ijid.2008.03.020; Turnbull BS, 1998, J COMP PATHOL, V118, P317, DOI 10.1016/S0021-9975(07)80007-7; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Van Bressem MF, 2001, VET MICROBIOL, V81, P287, DOI 10.1016/S0378-1135(01)00368-6; Van Dijk JE, 2007, COLOUR ATLAS VET PAT; Venter K, 2009, DIET HUMPBACK DOLPHI; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; WOODARD JC, 1969, PATHOL VET, V6, P257, DOI 10.1177/030098586900600307; Young DD, 1998, THESIS RHODES U GRAH; Zappulli V, 2005, J VET DIAGN INVEST, V17, P617, DOI 10.1177/104063870501700620	90	28	28	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107038	10.1371/journal.pone.0107038	http://dx.doi.org/10.1371/journal.pone.0107038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203143	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500062
J	Lai, QL; Liu, Y; Yuan, J; Du, J; Wang, LP; Sun, FQ; Shao, ZZ				Lai, Qiliang; Liu, Yang; Yuan, Jun; Du, Juan; Wang, Liping; Sun, Fengqin; Shao, Zongze			Multilocus Sequence Analysis for Assessment of Phylogenetic Diversity and Biogeography in Thalassospira Bacteria from Diverse Marine Environments	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; GENOME SEQUENCE; SP NOV.; DEEP-SEA; GENETIC-RELATIONSHIPS; TAXONOMIC EVALUATION; DEGRADING BACTERIA; STREPTOMYCES; SEDIMENT; SURFACE	Thalassospira bacteria are widespread and have been isolated from various marine environments. Less is known about their genetic diversity and biogeography, as well as their role in marine environments, many of them cannot be discriminated merely using the 16S rRNA gene. To address these issues, in this report, the phylogenetic analysis of 58 strains from seawater and deep sea sediments were carried out using the multilocus sequence analysis (MLSA) based on acsA, aroE, gyrB, mutL, rpoD and trpB genes, and the DNA-DNA hybridization (DDH) and average nucleotide identity (ANI) based on genome sequences. The MLSA analysis demonstrated that the 58 strains were clearly separated into 15 lineages, corresponding to seven validly described species and eight potential novel species. The DDH and ANI values further confirmed the validity of the MLSA analysis and eight potential novel species. The MLSA interspecies gap of the genus Thalassospira was determined to be 96.16-97.12% sequence identity on the basis of the combined analyses of the DDH and MLSA, while the ANIm interspecies gap was 95.76-97.20% based on the in silico DDH analysis. Meanwhile, phylogenetic analyses showed that the Thalassospira bacteria exhibited distribution pattern to a certain degree according to geographic regions. Moreover, they clustered together according to the habitats depth. For short, the phylogenetic analyses and biogeography of the Thalassospira bacteria were systematically investigated for the first time. These results will be helpful to explore further their ecological role and adaptive evolution in marine environments.	[Lai, Qiliang; Liu, Yang; Yuan, Jun; Du, Juan; Wang, Liping; Sun, Fengqin; Shao, Zongze] State Key Lab Breeding Base Marine Genet Resource, Xiamen, Peoples R China; [Lai, Qiliang; Liu, Yang; Yuan, Jun; Du, Juan; Wang, Liping; Sun, Fengqin; Shao, Zongze] SOA, Key Lab Marine Genet Resources, Inst Oceanog 3, Xiamen, Peoples R China; [Lai, Qiliang; Liu, Yang; Yuan, Jun; Du, Juan; Wang, Liping; Sun, Fengqin; Shao, Zongze] Key Lab Marine Genet Resources Fujian Prov, Xiamen, Peoples R China; [Lai, Qiliang; Liu, Yang; Yuan, Jun; Du, Juan; Wang, Liping; Sun, Fengqin; Shao, Zongze] Collaborat Innovat Ctr Deep Sea Biol, Xiamen, Peoples R China; [Lai, Qiliang; Liu, Yang; Yuan, Jun; Du, Juan; Wang, Liping; Sun, Fengqin; Shao, Zongze] Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China	State Oceanic Administration	Shao, ZZ (corresponding author), State Key Lab Breeding Base Marine Genet Resource, Xiamen, Peoples R China.	shaozz@163.com	Shao, Zongze/T-6682-2017; Liu, Yang/H-6618-2014	Shao, Zongze/0000-0002-4784-090X; Liu, Yang/0000-0002-2362-9501	COMRA program [DY125-15-R-01]; Public Welfare Project of SOA [201005032]; National Natural Science Foundation of China [41176154/41276005]; National Infrastructure of Microbial Resources [NIMR-2013-9, NIMR-2014-9]	COMRA program; Public Welfare Project of SOA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Infrastructure of Microbial Resources	This work was financially supported by COMRA program (No. DY125-15-R-01) (http://www.comra.org/), Public Welfare Project of SOA (201005032) (http://www.soa.gov.cn/), National Natural Science Foundation of China (41176154/41276005) (http://www.nsfc.gov.cn/) and National Infrastructure of Microbial Resources (No. NIMR-2013-9 and NIMR-2014-9) (http://www.nstic.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Perez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075797; Bassey DE, 2011, TOXICOL ENVIRON CHEM, V93, P44, DOI 10.1080/02772248.2010.504357; Brady C, 2013, SYST APPL MICROBIOL, V36, P309, DOI 10.1016/j.syapm.2013.03.005; Cui ZS, 2008, ENVIRON MICROBIOL, V10, P2138, DOI 10.1111/j.1462-2920.2008.01637.x; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Ghosh M, 2012, WORLD J MICROB BIOT, V28, P2859, DOI 10.1007/s11274-012-1097-z; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hutz A, 2011, APPL ENVIRON MICROB, V77, P4412, DOI 10.1128/AEM.00490-11; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ivars-Martinez E, 2008, MOL ECOL, V17, P4092, DOI 10.1111/j.1365-294X.2008.03883.x; Khan NH, 2008, APPL ENVIRON MICROB, V74, P6194, DOI 10.1128/AEM.02322-07; Kim BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051846; Kim W, 2002, FEMS MICROBIOL LETT, V207, P21, DOI 10.1111/j.1574-6968.2002.tb11022.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klochko VV, 2012, J GEN APPL MICROBIOL, V58, P129; Kodama Y, 2008, INT J SYST EVOL MICR, V58, P711, DOI 10.1099/ijs.0.65476-0; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Lai OL, 2009, INT J SYST EVOL MICR, V59, P1278, DOI 10.1099/ijs.0.003889-0; Lai QL, 2012, J BACTERIOL, V194, P6957, DOI 10.1128/JB.01904-12; Lai QL, 2012, J BACTERIOL, V194, P6956, DOI 10.1128/JB.01903-12; Lanoot B, 2004, SYST APPL MICROBIOL, V27, P84, DOI 10.1078/0723-2020-00257; Liu CL, 2007, INT J SYST EVOL MICR, V57, P316, DOI 10.1099/ijs.0.64544-0; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079417, 10.1371/journal.pone.0082678, 10.1371/journal.pone.0061031, 10.1371/journal.pone.0072930, 10.1371/journal.pone.0055221, 10.1371/journal.pone.0075318, 10.1371/journal.pone.0080097]; Liu ZF, 2013, MICROBIOLOGYOPEN, V2, P492, DOI 10.1002/mbo3.89; Lopez-Lopez A, 2002, INT J SYST EVOL MICR, V52, P1277, DOI 10.1099/ijs.0.01928-0; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Martinez-Murcia AJ, 2011, SYST APPL MICROBIOL, V34, P189, DOI 10.1016/j.syapm.2010.11.014; Meier-Kolthoff JP, 2013, ARCH MICROBIOL, V195, P413, DOI 10.1007/s00203-013-0888-4; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Nogi Y, 2014, INT J SYST EVOL MICR, V64, P1149, DOI 10.1099/ijs.0.058321-0; Plotnikova EG, 2011, MICROBIOLOGY+, V80, P703, DOI 10.1134/S0026261711050109; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rizzo C, 2013, MAR POLLUT BULL, V70, P125, DOI 10.1016/j.marpolbul.2013.02.020; Rong XY, 2012, SYST APPL MICROBIOL, V35, P7, DOI 10.1016/j.syapm.2011.10.004; Ross AC, 2013, J AM CHEM SOC, V135, P1155, DOI 10.1021/ja3119674; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Theethakaew C, 2013, APPL ENVIRON MICROB, V79, P2358, DOI 10.1128/AEM.03067-12; Thomas S, 2010, ISME J, V4, P459, DOI 10.1038/ismej.2009.129; Thompson FL, 2005, APPL ENVIRON MICROB, V71, P5107, DOI 10.1128/AEM.71.9.5107-5115.2005; Tsubouchi T, 2014, INT J SYST EVOL MICR, V64, P107, DOI 10.1099/ijs.0.056028-0; Um S, 2013, MAR DRUGS, V11, P611, DOI 10.3390/md11030611; Wang BJ, 2008, ENVIRON MICROBIOL, V10, P1948, DOI 10.1111/j.1462-2920.2008.01611.x; Wang LP, 2010, ENVIRON MICROBIOL, V12, P1230, DOI 10.1111/j.1462-2920.2010.02165.x; Winkelmann N, 2010, APPL ENVIRON MICROB, V76, P776, DOI 10.1128/AEM.01525-09; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Yamamoto S, 1999, INT J SYST BACTERIOL, V49, P87, DOI 10.1099/00207713-49-1-87; Yang MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036987; Zhang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044936; Zhao BS, 2010, INT J SYST EVOL MICR, V60, P1125, DOI 10.1099/ijs.0.013201-0	52	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106353	10.1371/journal.pone.0106353	http://dx.doi.org/10.1371/journal.pone.0106353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198177	gold, Green Submitted, Green Published			2022-12-27	WOS:000341304700028
J	Marti, S; Thibault, L; Dehaene, S				Marti, Sebastien; Thibault, Louis; Dehaene, Stanislas			How Does the Extraction of Local and Global Auditory Regularities Vary with Context?	PLOS ONE			English	Article							TOP-DOWN PROCESSES; MISMATCH NEGATIVITY; ELECTROPHYSIOLOGICAL EVIDENCE; PRESERVED FEEDFORWARD; POTENTIALS REVEAL; STIMULUS DEVIANCE; LONG-TERM; BRAIN; ATTENTION; MEMORY	How does the human brain extract regularities from its environment? There is evidence that short range or 'local' regularities (within seconds) are automatically detected by the brain while long range or 'global' regularities (over tens of seconds or more) require conscious awareness. In the present experiment, we asked whether participants' attention was needed to acquire such auditory regularities, to detect their violation or both. We designed a paradigm in which participants listened to predictable sounds. Subjects could be distracted by a visual task at two moments: when they were first exposed to a regularity or when they detected violations of this regularity. MEG recordings revealed that early brain responses (100-130 ms) to violations of short range regularities were unaffected by visual distraction and driven essentially by local transitional probabilities. Based on global workspace theory and prior results, we expected that visual distraction would eliminate the long range global effect, but unexpectedly, we found the contrary, i.e. late brain responses (300-600 ms) to violations of long range regularities on audio-visual trials but not on auditory only trials. Further analyses showed that, in fact, visual distraction was incomplete and that auditory and visual stimuli interfered in both directions. Our results show that conscious, attentive subjects can learn the long range dependencies present in auditory stimuli even while performing a visual task on synchronous visual stimuli. Furthermore, they acquire a complex regularity and end up making different predictions for the very same stimulus depending on the context (i.e. absence or presence of visual stimuli). These results suggest that while short-range regularity detection is driven by local transitional probabilities between stimuli, the human brain detects and stores long-range regularities in a highly flexible, context dependent manner.	[Marti, Sebastien; Dehaene, Stanislas] INSERM, U992, Cognit Neuroimaging Unit, Gif Sur Yvette, France; [Marti, Sebastien; Dehaene, Stanislas] CEA, DSV I2BM, NeuroSpin Ctr, Gif Sur Yvette, France; [Dehaene, Stanislas] Coll France, F-75231 Paris, France; [Thibault, Louis] Univ Paris 05, Lab Psychol Percept, UMR 8242, Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Marti, S (corresponding author), INSERM, U992, Cognit Neuroimaging Unit, Gif Sur Yvette, France.	sebastien.marti@yahoo.fr			Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA); Institut National de la Sante et de la Recherche Medicale (INSERM); European Research Council - the NeuroConsc program; INSERM; CEA; Fondation pour la Recherche Medicale (FRM); Bettencourt-Schueller Foundation; Region Ile-de-France	Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Research Council - the NeuroConsc program; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Bettencourt-Schueller Foundation; Region Ile-de-France(Region Ile-de-France)	The present work was supported by the Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA), the Institut National de la Sante et de la Recherche Medicale (INSERM), and a senior grant of the European Research Council - the NeuroConsc program - to S. D. The Neurospin MEG facility was sponsored by grants from INSERM, CEA, Fondation pour la Recherche Medicale (FRM), the Bettencourt-Schueller Foundation, and the Region Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Arnott SR, 2002, NEUROREPORT, V13, P2209, DOI 10.1097/00001756-200212030-00009; Atas A, 2014, PSYCHOL SCI, V25, P113, DOI 10.1177/0956797613499591; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Boh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021458; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; Chennu S, 2013, J NEUROSCI, V33, P11194, DOI 10.1523/JNEUROSCI.0114-13.2013; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; DUNCANJOHNSON CC, 1982, BIOL PSYCHOL, V14, P1, DOI 10.1016/0301-0511(82)90016-3; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; GIARD MH, 1994, ELECTROEN CLIN NEURO, V92, P238, DOI 10.1016/0168-5597(94)90067-1; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Isreal J B, 1980, Prog Brain Res, V54, P416, DOI 10.1016/S0079-6123(08)61653-2; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; Jones SJ, 2002, NEUROPHYSIOL CLIN, V32, P241, DOI 10.1016/S0987-7053(02)00309-X; Kim R, 2009, NEUROSCI LETT, V461, P145, DOI 10.1016/j.neulet.2009.06.030; King JR, 2013, NEUROIMAGE, V83, P726, DOI 10.1016/j.neuroimage.2013.07.013; King JR, 2011, SCIENCE, V334, DOI 10.1126/science.1210012; KING JR, 2014, TRENDS COGN SCI; Kolossa A, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00359; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Lappe C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00260; Liebenthal E, 2003, NEUROIMAGE, V19, P1395, DOI 10.1016/S1053-8119(03)00228-3; MANTYSALO S, 1987, BIOL PSYCHOL, V24, P183, DOI 10.1016/0301-0511(87)90001-9; Mars RB, 2008, J NEUROSCI, V28, P12539, DOI 10.1523/JNEUROSCI.2925-08.2008; Marti S, 2012, NEUROIMAGE, V59, P2883, DOI 10.1016/j.neuroimage.2011.09.063; Mill RW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002925; Mullens D, 2014, PSYCHOPHYSIOLOGY, V51, P437, DOI 10.1111/psyp.12190; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1982, BIOL PSYCHOL, V14, P53, DOI 10.1016/0301-0511(82)90017-5; NAATANEN R, 1993, PSYCHOPHYSIOLOGY, V30, P436, DOI 10.1111/j.1469-8986.1993.tb02067.x; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Paavilainen P, 2007, NEUROREPORT, V18, P159, DOI 10.1097/WNR.0b013e328010e2ac; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pegado F, 2010, NEUROPSYCHOLOGIA, V48, P3145, DOI 10.1016/j.neuropsychologia.2010.06.030; Qin PM, 2008, NEUROSCI LETT, V448, P24, DOI 10.1016/j.neulet.2008.10.029; Restuccia D, 2005, COGNITIVE BRAIN RES, V25, P891, DOI 10.1016/j.cogbrainres.2005.09.023; Rinne T, 2005, NEUROIMAGE, V26, P66, DOI 10.1016/j.neuroimage.2005.01.017; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1997, PSYCHOL SCI, V8, P101, DOI 10.1111/j.1467-9280.1997.tb00690.x; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; Schonwiesner M, 2007, J NEUROPHYSIOL, V97, P2075, DOI 10.1152/jn.01083.2006; SCHROGER E, 2013, BRAIN TOPOGR; Schurger A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-122; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; Sussman E, 2001, COGNITIVE BRAIN RES, V12, P431, DOI 10.1016/S0926-6410(01)00067-2; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Sussman ES, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00333; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Tervaniemi M, 2001, ANN NY ACAD SCI, V930, P259, DOI 10.1111/j.1749-6632.2001.tb05737.x; Todd J, 2013, J NEUROPHYSIOL, V109, P99, DOI 10.1152/jn.00581.2012; Todd J, 2011, NEUROPSYCHOLOGIA, V49, P3399, DOI 10.1016/j.neuropsychologia.2011.08.016; Trainor LJ, 2002, J COGNITIVE NEUROSCI, V14, P430, DOI 10.1162/089892902317361949; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; Wacongne C, 2011, P NATL ACAD SCI USA, V108, P20754, DOI 10.1073/pnas.1117807108; Wetter S, 2004, INT J PSYCHOPHYSIOL, V54, P263, DOI 10.1016/j.ijpsycho.2004.04.008; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Winkler I, 1998, NEUROREPORT, V9, P3809, DOI 10.1097/00001756-199812010-00008; Winkler I, 2005, EXP PSYCHOL, V52, P3, DOI 10.1027/1618-3169.52.1.3; Winkler I, 2005, COGNITIVE BRAIN RES, V25, P291, DOI 10.1016/j.cogbrainres.2005.06.005; Winkler I, 1996, BRAIN RES, V742, P239, DOI 10.1016/S0006-8993(96)01008-6; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Yaron A, 2012, NEURON, V76, P603, DOI 10.1016/j.neuron.2012.08.025	80	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107227	10.1371/journal.pone.0107227	http://dx.doi.org/10.1371/journal.pone.0107227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197987	Green Published, gold			2022-12-27	WOS:000341304700096
J	Seiffert-Sinha, K; Yang, RG; Fung, CK; Lai, KW; Patterson, KC; Payne, AS; Xi, N; Sinha, AA				Seiffert-Sinha, Kristina; Yang, Ruiguo; Fung, Carmen K.; Lai, King W.; Patterson, Kevin C.; Payne, Aimee S.; Xi, Ning; Sinha, Animesh A.			Nanorobotic Investigation Identifies Novel Visual, Structural and Functional Correlates of Autoimmune Pathology in a Blistering Skin Disease Model	PLOS ONE			English	Article							PEMPHIGUS-VULGARIS; HUMAN EPIDERMIS; CANCER-CELLS; APOPTOSIS; AUTOANTIBODIES; IGG; KERATINOCYTES; ACANTHOLYSIS; DESMOSOMES; DESMOGLEIN	There remain major gaps in our knowledge regarding the detailed mechanisms by which autoantibodies mediate damage at the tissue level. We have undertaken novel strategies at the interface of engineering and clinical medicine to integrate nanoscale visual and structural data using nanorobotic atomic force microscopy with cell functional analyses to reveal previously unattainable details of autoimmune processes in real-time. Pemphigus vulgaris is a life-threatening autoimmune blistering skin condition in which there is disruption of desmosomal cell-cell adhesion structures that are associated with the presence of antibodies directed against specific epithelial proteins including Desmoglein (Dsg) 3. We demonstrate that pathogenic (blister-forming) anti-Dsg3 antibodies, distinct from non-pathogenic (non-blister forming) anti-Dsg3 antibodies, alter the structural and functional properties of keratinocytes in two sequential steps - an initial loss of cell adhesion and a later induction of apoptosis-related signaling pathways, but not full apoptotic cell death. We propose a "2-Hit" model for autoimmune disruption associated with skin-specific pathogenic autoantibodies. These data provide unprecedented details of autoimmune processes at the tissue level and offer a novel conceptual framework for understanding the action of self-reactive antibodies.	[Seiffert-Sinha, Kristina; Sinha, Animesh A.] SUNY Buffalo, Clin & Translat Res Ctr, Dept Dermatol, Buffalo, NY 14260 USA; [Yang, Ruiguo; Fung, Carmen K.; Xi, Ning] Michigan State Univ, Dept Elect & Comp Engn, Robot & Automat Lab, E Lansing, MI 48824 USA; [Lai, King W.] City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Patterson, Kevin C.] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA; [Payne, Aimee S.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Michigan State University; City University of Hong Kong; Michigan State University; Michigan State University College of Human Medicine; University of Pennsylvania	Sinha, AA (corresponding author), SUNY Buffalo, Clin & Translat Res Ctr, Dept Dermatol, Buffalo, NY 14260 USA.	aasinha@buffalo.edu	Yang, Ruiguo/A-7374-2015	Yang, Ruiguo/0000-0002-1361-4277; Patterson, Kevin/0000-0002-8883-0855; Lai, King Wai Chiu/0000-0001-5002-2273	NSF [IIS-0713346, DMI-0500372]; ONR [N00014-04-1-0799, N00014-07-1-0935]; NIH [R43 GM084520]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM084520] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); ONR(Office of Naval Research); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF Grants IIS-0713346 and DMI-0500372, ONR Grants N00014-04-1-0799 and N00014-07-1-0935, and NIH Grant R43 GM084520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANHALT GJ, 1982, NEW ENGL J MED, V306, P1189, DOI 10.1056/NEJM198205203062001; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; BECKER BA, 1993, DERMATOL CLIN, V11, P429, DOI 10.1016/S0733-8635(18)30241-9; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brancolini C, 1998, CELL DEATH DIFFER, V5, P1042, DOI 10.1038/sj.cdd.4400443; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Demchenko AP, 2013, CYTOTECHNOLOGY, V65, P157, DOI 10.1007/s10616-012-9481-y; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Garrod D, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/212439; Grando SA, 2009, EXP DERMATOL, V18, P764, DOI 10.1111/j.1600-0625.2009.00934.x; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; James KA, 2011, DERMATOL CLIN, V29, P405, DOI 10.1016/j.det.2011.03.012; Kimura TE, 2007, J INVEST DERMATOL, V127, P775, DOI 10.1038/sj.jid.5700643; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; Lee HE, 2009, J BIOL CHEM, V284, P12524, DOI 10.1074/jbc.M808204200; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Mao XM, 2011, J BIOL CHEM, V286, P1283, DOI 10.1074/jbc.M110.172874; Nguyen VT, 2000, J CLIN INVEST, V106, P1467, DOI 10.1172/JCI10305; ODLAND GF, 1958, J BIOPHYS BIOCHEM CY, V4, P529; Pacheco-Tovar MG, 2009, J EUR ACAD DERMATOL, V23, P697, DOI 10.1111/j.1468-3083.2009.03162.x; Payne AS, 2007, J INVEST DERMATOL, V127, P1681, DOI 10.1038/sj.jid.5700790; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Pelacho B, 2004, FEBS LETT, V566, P6, DOI 10.1016/j.febslet.2004.03.107; Pelling AE, 2009, CELL MOTIL CYTOSKEL, V66, P409, DOI 10.1002/cm.20391; Puviani M, 2003, J INVEST DERMATOL, V120, P164, DOI 10.1046/j.1523-1747.2003.12014.x; Schmidt E, 2009, AUTOIMMUN REV, V8, P533, DOI 10.1016/j.autrev.2009.01.011; Schmidt E, 2009, AM J PHYSIOL-CELL PH, V296, pC162, DOI 10.1152/ajpcell.00161.2008; Scothern A, 2008, METHOD CELL BIOL, V88, P347, DOI 10.1016/S0091-679X(08)00418-4; Shimizu A, 2004, J INVEST DERMATOL, V122, P1145, DOI 10.1111/j.0022-202X.2004.22426.x; SHIMIZU H, 1995, J INVEST DERMATOL, V105, P153, DOI 10.1111/1523-1747.ep12316695; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; TAKAHASHI Y, 1985, J INVEST DERMATOL, V84, P41, DOI 10.1111/1523-1747.ep12274679; Tang HL, 2009, BRIT J CANCER, V100, P118, DOI 10.1038/sj.bjc.6604802; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; WATT FM, 1984, J CELL BIOL, V99, P2211, DOI 10.1083/jcb.99.6.2211; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; Yokouchi M, 2009, J INVEST DERMATOL, V129, P2156, DOI 10.1038/jid.2009.61	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106895	10.1371/journal.pone.0106895	http://dx.doi.org/10.1371/journal.pone.0106895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198693	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700063
J	DiFrancesco, ML; Hansen, UP; Thiel, G; Moroni, A; Schroeder, I				DiFrancesco, Mattia L.; Hansen, Ulf-Peter; Thiel, Gerhard; Moroni, Anna; Schroeder, Indra			Effect of Cytosolic pH on Inward Currents Reveals Structural Characteristics of the Proton Transport Cycle in the Influenza A Protein M2 in Cell-Free Membrane Patches of Xenopus oocytes	PLOS ONE			English	Article							CURRENT-VOLTAGE RELATIONSHIPS; REACTION-KINETIC-ANALYSIS; ION-CHANNEL PROTEIN; CONDUCTION MECHANISM; IV CURVE; VIRUS; SELECTIVITY; ACTIVATION; PORE; INHIBITION	Transport activity through the mutant D44A of the M2 proton channel from influenza virus A was measured in excised inside-out macro-patches of Xenopus laevis oocytes at cytosolic pH values of 5.5, 7.5 and 8.2. The current-voltage relationships reveal some peculiarities: 1. "Transinhibition'', i.e., instead of an increase of unidirectional outward current with increasing cytosolic H+ concentration, a decrease of unidirectional inward current was found. 2. Strong inward rectification. 3. Exponential rise of current with negative potentials. In order to interpret these findings in molecular terms, different kinetic models have been tested. The transinhibition basically results from a strong binding of H+ to a site in the pore, presumably His37. This assumption alone already provides inward rectification and exponential rise of the IV curves. However, it results in poor global fits of the IV curves, i.e., good fits were only obtained for cytosolic pH of 8.2, but not for 7.5. Assuming an additional transport step as e.g. caused by a constriction zone at Val27 resulted in a negligible improvement. In contrast, good global fits for cytosolic pH of 7.5 and 8.2 were immediately obtained with a cyclic model. A "recycling step'' implies that the protein undergoes conformational changes (assigned to Trp41 and Val27) during transport which have to be reset before the next proton can be transported. The global fit failed at the low currents at pH(cyt) = 5.5, as expected from the interference of putative transport of other ions besides H+. Alternatively, a regulatory effect of acidic cytosolic pH may be assumed which strongly modifies the rate constants of the transport cycle.	[DiFrancesco, Mattia L.; Moroni, Anna] Univ Milan, Dept Biosci, Milan, Italy; [DiFrancesco, Mattia L.; Moroni, Anna] Univ Milan, CNR IBF, Milan, Italy; [Thiel, Gerhard; Schroeder, Indra] Tech Univ Darmstadt, Darmstadt, Germany; [Hansen, Ulf-Peter] Univ Kiel, Dept Biol Struct, Kiel, Germany	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; Technical University of Darmstadt; University of Kiel	Schroeder, I (corresponding author), Tech Univ Darmstadt, Darmstadt, Germany.	schroeder@bio.tu-darmstadt.de	moroni, anna/H-2097-2014; DiFrancesco, Mattia Lorenzo/AAC-1029-2022	moroni, anna/0000-0002-1860-406X; DiFrancesco, Mattia Lorenzo/0000-0002-7511-4438; Schroeder, Indra/0000-0002-7875-983X; Thiel, Gerhard/0000-0002-2335-1351	German Israeli Foundation for Scientific Research and Development [1086-13.11/2010]; Programmi di Ricerca di Rilevante Interesse Nazionale [2010CSJX4F]; Ministero Affari Esteri [01467532013-06-27]; Cariplo [2009-3519]	German Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Programmi di Ricerca di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero Affari Esteri; Cariplo(Fondazione Cariplo)	d This study was supported by German Israeli Foundation for Scientific Research and Development (www.gif.org.il), grant #1086-13.11/2010 to GT, Programmi di Ricerca di Rilevante Interesse Nazionale (http://prin.miur.it/), grant #2010CSJX4F to AM, Ministero Affari Esteri (http://www.esteri.it/MAE/IT), grant #01467532013-06-27 to AM, Cariplo (http://www.fondazionecariplo.it/en/the-foundation/index.html) grant #2009-3519 to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenavoli A, 2009, J GEN PHYSIOL, V134, P219, DOI 10.1085/jgp.200910266; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; Balannik V, 2010, BIOCHEMISTRY-US, V49, P696, DOI 10.1021/bi901799k; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Chizhmakov IV, 2003, J PHYSIOL-LONDON, V546, P427, DOI 10.1113/jphysiol.2002.028910; Chizhmakov IV, 1996, J PHYSIOL-LONDON, V494, P329, DOI 10.1113/jphysiol.1996.sp021495; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; DENCHER NA, 1989, P NATL ACAD SCI USA, V86, P7876, DOI 10.1073/pnas.86.20.7876; FISAHN J, 1986, J MEMBRANE BIOL, V94, P245, DOI 10.1007/BF01869720; GRADMANN D, 1987, BIOPHYS J, V51, P569, DOI 10.1016/S0006-3495(87)83382-9; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; GRAMBAS S, 1992, VIROLOGY, V191, P541, DOI 10.1016/0042-6822(92)90229-I; Hansen U-P, 1986, ABSTRACTS LECT POSTE, pL13; HANSEN UP, 1981, J MEMBRANE BIOL, V63, P165, DOI 10.1007/BF01870979; HANSEN UP, 1983, J MEMBRANE BIOL, V75, P141, DOI 10.1007/BF01995634; HAY AJ, 1979, J GEN VIROL, V42, P189, DOI 10.1099/0022-1317-42-1-189; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; Hiller S, 2013, BIOPHYS J, V104, P1639, DOI 10.1016/j.bpj.2013.03.020; Hladky SB, 1995, BIOPHYS J, V69, P1758, DOI 10.1016/S0006-3495(95)80046-9; Hong M, 2012, PROTEIN SCI, V21, P1620, DOI 10.1002/pro.2158; Hu F, 2010, SCIENCE, V330, P39880; Hu FH, 2012, J AM CHEM SOC, V134, P3703, DOI 10.1021/ja2081185; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Ivanovic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031566; Jing XH, 2008, P NATL ACAD SCI USA, V105, P10967, DOI 10.1073/pnas.0804958105; Khurana E, 2009, P NATL ACAD SCI USA, V106, P1069, DOI 10.1073/pnas.0811720106; KOCH MHJ, 1991, EMBO J, V10, P521, DOI 10.1002/j.1460-2075.1991.tb07978.x; Lamb R.A., 1994, RECEPTOR MEDIATED VI, P303; Lear JD, 2003, FEBS LETT, V552, P17, DOI 10.1016/s0014-5793(03)00778-6; Leiding T, 2010, P NATL ACAD SCI USA, V107, P15409, DOI 10.1073/pnas.1009997107; Leonov H, 2009, J MOL MODEL, V15, P1317, DOI 10.1007/s00894-009-0493-2; Lin TI, 2001, J VIROL, V75, P3647, DOI 10.1128/JVI.75.8.3647-3656.2001; Ma CL, 2013, STRUCTURE, V21, P2033, DOI 10.1016/j.str.2013.08.029; Moffat JC, 2008, BIOPHYS J, V94, P434, DOI 10.1529/biophysj.107.109082; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; Nguyen PA, 2008, BIOCHEMISTRY-US, V47, P9934, DOI 10.1021/bi801315m; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pielak RM, 2010, J AM CHEM SOC, V132, P17695, DOI 10.1021/ja108458u; Pielak RM, 2010, BIOCHEM BIOPH RES CO, V401, P58, DOI 10.1016/j.bbrc.2010.09.008; Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; Polishchuk AL, 2010, BIOCHEMISTRY-US, V49, P10061, DOI 10.1021/bi101229m; SANDERS D, 1981, J MEMBRANE BIOL, V58, P139, DOI 10.1007/BF01870976; Sansom MSP, 1997, VIROLOGY, V233, P163, DOI 10.1006/viro.1997.8578; Schneider F, 2013, BIOPHYS J, V105, P91, DOI 10.1016/j.bpj.2013.05.042; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schroeder I, 2007, J GEN PHYSIOL, V130, P83, DOI 10.1085/jgp.200709802; Schroeder I, 2013, J GEN PHYSIOL, V141, P499, DOI 10.1085/jgp.201210956; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Shimbo K, 1996, BIOPHYS J, V70, P1335, DOI 10.1016/S0006-3495(96)79690-X; Shrivastava IH, 2006, BIOPHYS J, V90, P3929, DOI 10.1529/biophysj.105.080093; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Vijayvergiya V, 2004, BIOPHYS J, V87, P1697, DOI 10.1529/biophysj.104.043018; WANG C, 1995, BIOPHYS J, V69, P1363, DOI 10.1016/S0006-3495(95)80003-2; Wei CY, 2013, BIOPHYS J, V105, P2036, DOI 10.1016/j.bpj.2013.08.030; Williams JK, 2013, J AM CHEM SOC, V135, P9885, DOI 10.1021/ja4041412; Yi M, 2008, J PHYS CHEM B, V112, P7977, DOI 10.1021/jp800171m; Zhou HX, 2011, J MEMBRANE BIOL, V244, P93, DOI 10.1007/s00232-011-9402-6; Zhou HX, 2011, BIOPHYS J, V100, P912, DOI 10.1016/j.bpj.2011.01.002	67	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107406	10.1371/journal.pone.0107406	http://dx.doi.org/10.1371/journal.pone.0107406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211283	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900071
J	Moker, EA; Bateman, LA; Kraus, WE; Pescatello, LS				Moker, Emily A.; Bateman, Lori A.; Kraus, William E.; Pescatello, Linda S.			The Relationship between the Blood Pressure Responses to Exercise following Training and Detraining Periods	PLOS ONE			English	Article							RISK REDUCTION INTERVENTION; METABOLIC SYNDROME; DEFINED EXERCISE; HYPERTENSION; INTENSITY; PREHYPERTENSION; STRRIDE; DISEASE	Background: Exercise training lowers blood pressure (BP), while BP increases and returns to pre-training values with detraining. Yet, there is considerable variability in these BP responses. We examined the relationship between the BP responses after 6 months of training followed by 2 weeks of detraining among the same people. Methodology/Principal Findings: Subjects (n = 75) (X +/- SD, 50.2 +/- 10.6 yr) were sedentary, obese, and had prehypertension. They completed an aerobic (n = 34); resistance (n = 28); or aerobic + resistance or concurrent (n = 13) exercise training program. We calculated a metabolic syndrome z score (MetSz). Subjects were classified as BP responders (BP decreased) or non-responders (BP increased) to training and detraining. Linear and multivariable regression tested the BP response. Chi Square tested the frequency of responders and non-responders. The systolic BP (SBP, r = -0.474) and diastolic (DBP, r = -0.540) response to training negatively correlated with detraining (p< 0.01), independent of modality (p>0.05). Exercise responders reduced SBP 11.5 +/- 7.8 (n = 29) and DBP 9.8 +/- 6.2 mmHg (n = 31); non-responders increased SBP 7.9.+/- 10.9 (n = 46) and DBP 4.9 +/- 7.1 mmHg (n = 44) (p<0.001). We found 65.5% of SBP training responders were SBP detraining non-responders; while 60.9% of SBP training non-responders were SBP detraining responders (p = 0.034). Similarly, 80.6% of DBP training responders were DBP detraining non-responders; while 59.1% of DBP training non-responders were DBP detraining responders (p<0.001). The SBP detraining response (r = -0.521), resting SBP (r = -0.444), and MetSz (r = 0.288) explained 44.8% of the SBP training response (p<0.001). The DBP detraining response (r = -0.553), resting DBP (r = -0.450), and MetSz (r = 0.463) explained 60.1% of the DBP training response (p<0.001). Conclusions/Significance: As expected most subjects that decreased BP after exercise training, increased BP after detraining. An unanticipated finding was most subjects that increased BP after exercise training, decreased BP after detraining. Reasons why the negative effects of exercise training on BP maybe reversed with detraining among some people should be explored further.	[Moker, Emily A.; Pescatello, Linda S.] Univ Connecticut, Dept Kinesiol, Storrs, CT 06269 USA; [Bateman, Lori A.; Kraus, William E.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA	University of Connecticut; Duke University	Pescatello, LS (corresponding author), Univ Connecticut, Dept Kinesiol, Storrs, CT 06269 USA.	Linda.Pescatello@uconn.edu			Studies of a Targeted Risk Reduction through Defined Exercise (STRRIDE-AT/RT) [1R01HL57354]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057354] Funding Source: NIH RePORTER	Studies of a Targeted Risk Reduction through Defined Exercise (STRRIDE-AT/RT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the Studies of a Targeted Risk Reduction through Defined Exercise (STRRIDE-AT/RT) 1R01HL57354; 2003-2008; NCT00275145. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, 3 REP NAT CHOLEST ED; Ash I, 2013, CURR HYPERTENS REV, V9, P130, DOI 10.2174/15734021113099990010; Bateman LA, 2011, AM J CARDIOL, V108, P838, DOI 10.1016/j.amjcard.2011.04.037; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bouchard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037887; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Eicher JD, 2010, AM HEART J, V160, P513, DOI 10.1016/j.ahj.2010.06.005; Erdogan D, 2012, J HYPERTENS, V30, P1639, DOI 10.1097/HJH.0b013e3283550faa; Ferreira I, 2012, HYPERTENSION, V60, P542, DOI 10.1161/HYPERTENSIONAHA.112.194738; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Hagberg JM, 2000, SPORTS MED, V30, P193, DOI 10.2165/00007256-200030030-00004; Johnson JL, 2007, AM J CARDIOL, V100, P1759, DOI 10.1016/j.amjcard.2007.07.027; Kraus WE, 2001, MED SCI SPORT EXER, V33, P1774, DOI 10.1097/00005768-200110000-00025; MEREDITH IT, 1990, J HYPERTENS, V8, P859, DOI 10.1097/00004872-199009000-00010; Murray A, 2006, J HUM HYPERTENS, V20, P193, DOI 10.1038/sj.jhh.1001970; Olson KM, 2012, ATHEROSCLEROSIS, V222, P202, DOI 10.1016/j.atherosclerosis.2012.01.027; Pescatello LS, 2008, APPL CLIN GENET, V1, P7, DOI 10.2147/TACG.S3813; Pescatello LS, 2001, MED SCI SPORT EXER, V33, P1855, DOI 10.1097/00005768-200111000-00009; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Pescatello LS, 2013, ACSMAS GUIDELINES EX; Pescatello LS, 2008, BMC CARDIOVASC DISOR, V8, DOI DOI 10.1186/1471-2261-8-12; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Shephard RJ, 2003, SPORTS MED, V33, P575, DOI 10.2165/00007256-200333080-00003; Slentz CA, 2007, J APPL PHYSIOL, V103, P432, DOI 10.1152/japplphysiol.01314.2006; Wang G, 2013, AM J HYPERTENS; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126	28	32	33	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e105755	10.1371/journal.pone.0105755	http://dx.doi.org/10.1371/journal.pone.0105755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208075	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300011
J	Deng, CY; Yang, H; Kuang, SJ; Rao, F; Xue, YM; Zhou, ZL; Liu, XY; Shan, ZX; Li, XH; Lin, QX; Wu, SL; Yu, XY				Deng, Chun-Yu; Yang, Hui; Kuang, Su-Juan; Rao, Fang; Xue, Yu-Mei; Zhou, Zhi-Ling; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Lin, Qiu-Xiong; Wu, Shu-Lin; Yu, Xi-Yong			Upregulation of 5-Hydroxytryptamine Receptor Signaling in Coronary Arteries after Organ Culture	PLOS ONE			English	Article							ENDOTHELIN ETB RECEPTORS; RAT MESENTERIC-ARTERY; CEREBRAL-ARTERIES; SUBARACHNOID HEMORRHAGE; SEROTONIN; DISEASE; 5-HT2A; VASOCONSTRICTION; SARPOGRELATE; ANTAGONIST	Background: 5-Hydroxytryptamine (5-HT) is a powerful constrictor of coronary arteries and is considered to be involved in the pathophysiological mechanisms of coronary-artery spasm. However, the mechanism of enhancement of coronary-artery constriction to 5-HT during the development of coronary artery disease remains to be elucidated. Organ culture of intact blood-vessel segments has been suggested as a model for the phenotypic changes of smooth muscle cells in cardiovascular disease. Methodology/Principal Findings: We wished to characterize 5-HT receptor-induced vasoconstriction and quantify expression of 5-HT receptor signaling in cultured rat coronary arteries. Cumulative application of 5-HT produced a concentration-dependent vasoconstriction in fresh and 24 h-cultured rat coronary arteries without endothelia. 5-HT induced greater constriction in cultured coronary arteries than in fresh coronary arteries. U46619- and CaCl2-induced constriction in the two groups was comparable. 5-HT stimulates the 5-HT2A receptor and cascade of phospholipase C to induce coronary vasoconstriction. Calcium influx through L-type calcium channels and non-L-type calcium channels contributed to the coronary-artery constrictions induced by 5-HT. The contractions mediated by non-L-type calcium channels were significantly enhanced in cultured coronary arteries compared with fresh coronary arteries. The vasoconstriction induced by thapsigargin was also augmented in cultured coronary arteries. The decrease in Orai1 expression significantly inhibited 5-HT-evoked entry of Ca2+ in coronary artery cells. Expression of the 5-HT2A receptor, Orai1 and STIM1 were augmented in cultured coronary arteries compared with fresh coronary arteries. Conclusions: An increased contraction in response to 5-HT was mediated by the upregulation of 5-HT2A receptors and downstream signaling in cultured coronary arteries.	[Deng, Chun-Yu; Yang, Hui; Kuang, Su-Juan; Rao, Fang; Xue, Yu-Mei; Zhou, Zhi-Ling; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Lin, Qiu-Xiong; Wu, Shu-Lin; Yu, Xi-Yong] Guangdong Gen Hosp, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Deng, Chun-Yu; Yang, Hui; Kuang, Su-Juan; Rao, Fang; Xue, Yu-Mei; Zhou, Zhi-Ling; Liu, Xiao-Ying; Shan, Zhi-Xin; Li, Xiao-Hong; Lin, Qiu-Xiong; Wu, Shu-Lin; Yu, Xi-Yong] Guangdong Acad Med Sci, Guangdong Prov Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Wu, SL (corresponding author), Guangdong Gen Hosp, Med Res Ctr, Guangzhou, Guangdong, Peoples R China.	doctorwushulin@163.com; xiyong.yu@gmail.com			National Natural Science Foundation of China [81273516, 81270222, 81330007, 81302779]; Guangdong Provincial Natural Science Foundation [S2013010014762, S2013040014689]; National Key Basic Research Program of China [2012CB526600]; Guangdong Provincial Medical Science Foundation [A2012006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Key Basic Research Program of China(National Basic Research Program of China); Guangdong Provincial Medical Science Foundation	This work was supported by the National Natural Science Foundation of China (No. 81273516, No. 81270222, No. 81330007, No. 81302779), by Guangdong Provincial Natural Science Foundation (No. S2013010014762, No. S2013040014689), National Key Basic Research Program of China (No. 2012CB526600) and by Guangdong Provincial Medical Science Foundation (No. A2012006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YX, 2005, BASIC CLIN PHARMACOL, V96, P282, DOI 10.1111/j.1742-7843.2005.pto960402.x; Dominguez-Rodriguez A, 2012, ARTERIOSCL THROM VAS, V32, P1325, DOI 10.1161/ATVBAHA.111.243014; Giachini FRC, 2009, HYPERTENSION, V53, P409, DOI 10.1161/HYPERTENSIONAHA.108.124404; Hansen-Schwartz J, 2003, J NEUROSURG, V99, P115, DOI 10.3171/jns.2003.99.1.0115; Hansen-Schwartz J, 2008, FRONT BIOSCI-LANDMRK, V13, P2160, DOI 10.2741/2831; Hara K, 2004, J LAB CLIN MED, V144, P31, DOI 10.1016/j.lab.2004.03.014; Hoel NL, 2001, NEUROREPORT, V12, P1605, DOI 10.1097/00001756-200106130-00019; Huang Y, 2002, BRIT J PHARMACOL, V135, P1467, DOI 10.1038/sj.bjp.0704587; Johnsson E, 2008, EUR J PHARMACOL, V582, P94, DOI 10.1016/j.ejphar.2007.12.030; Kwan HY, 2010, J VASC RES, V47, P148, DOI 10.1159/000235969; Luo GG, 2004, BASIC CLIN PHARMACOL, V95, P280, DOI 10.1111/j.1742-7843.2004.t01-1-pto950506.x; Miyata K, 2000, J CARDIOVASC PHARM, V35, P294, DOI 10.1097/00005344-200002000-00018; Nagatomo T, 2004, PHARMACOL THERAPEUT, V104, P59, DOI 10.1016/j.pharmthera.2004.08.005; Nakamura E, 2011, BIOL PHARM BULL, V34, P82, DOI 10.1248/bpb.34.82; Nilsson D, 2008, EUR J PHARMACOL, V579, P233, DOI 10.1016/j.ejphar.2007.09.031; Nishihira K, 2006, J THROMB HAEMOST, V4, P247, DOI 10.1111/j.1538-7836.2005.01702.x; NYBORG NCB, 1991, BRIT J PHARMACOL, V102, P282, DOI 10.1111/j.1476-5381.1991.tb12167.x; Povlsen GK, 2012, EXP BRAIN RES, V219, P507, DOI 10.1007/s00221-012-3108-6; Raote I, 2007, FRONT NEUROSCI, P105; Robich MP, 2010, J THORAC CARDIOV SUR, V139, P1033, DOI 10.1016/j.jtcvs.2009.05.032; Sakamoto K, 2005, ARTERIOSCL THROM VAS, V25, P327, DOI 10.1161/01.ATV.0000152611.50953.e2; Satomura K, 2002, CLIN CARDIOL, V25, P28, DOI 10.1002/clc.4950250108; Skovsted GF, 2012, LIFE SCI, V91, P593, DOI 10.1016/j.lfs.2012.02.009; Tanaka N, 2008, CLIN EXP PHARMACOL P, V35, P836, DOI 10.1111/j.1440-1681.2008.04933.x; Vikenes K, 1999, CIRCULATION, V100, P483, DOI 10.1161/01.CIR.100.5.483; Wackenfors A, 2004, EUR J PHARMACOL, V503, P147, DOI 10.1016/j.ejphar.2004.09.039; Watts SW, 2011, CARDIOVASC THER, V29, P54, DOI 10.1111/j.1755-5922.2010.00173.x; Yamada K, 2012, J PHARMACOL SCI, V119, P243, DOI 10.1254/jphs.12009FP	28	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107128	10.1371/journal.pone.0107128	http://dx.doi.org/10.1371/journal.pone.0107128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202989	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500070
J	Melsom, CB; Orstavik, O; Osnes, JB; Skomedal, T; Levy, FO; Krobert, KA				Melsom, Caroline Bull; Orstavik, Oivind; Osnes, Jan-Bjorn; Skomedal, Tor; Levy, Finn Olav; Krobert, Kurt Allen			G(i) Proteins Regulate Adenylyl Cyclase Activity Independent of Receptor Activation	PLOS ONE			English	Article							MEDIATED INOTROPIC RESPONSE; ENDOGENOUS RGS PROTEINS; MUSCARINIC RECEPTORS; PERTUSSIS-TOXIN; CONSTITUTIVE ACTIVITY; RAT CARDIOMYOCYTES; INVERSE AGONISTS; INHIBITION; KINASE; BETA(2)-ADRENOCEPTOR	Background and purpose: Despite the view that only beta(2)- as opposed to beta(1)-adrenoceptors (beta ARs) couple to G(i), some data indicate that the beta(1)AR-evoked inotropic response is also influenced by the inhibition of G(i). Therefore, we wanted to determine if G(i) exerts tonic receptor-independent inhibition upon basal adenylyl cyclase (AC) activity in cardiomyocytes. Experimental approach: We used the G(s)-selective (R,R)- and the G(s)- and G(i)-activating (R,S)-fenoterol to selectively activate beta(2)ARs (beta(1)AR blockade present) in combination with G(i) inactivation with pertussis toxin (PTX). We also determined the effect of PTX upon basal and forskolin-mediated responses. Contractility was measured ex vivo in left ventricular strips and cAMP accumulation was measured in isolated ventricular cardiomyocytes from adult Wistar rats. Key results: PTX amplified both the (R,R)- and (R,S)-fenoterol-evoked maximal inotropic response and concentration-dependent increases in cAMP accumulation. The EC50 values of fenoterol matched published binding affinities. The PTX enhancement of the G(s)-selective (R,R)-fenoterol-mediated responses suggests that G(i) regulates AC activity independent of receptor coupling to G(i) protein. Consistent with this hypothesis, forskolin-evoked cAMP accumulation was increased and inotropic responses to forskolin were potentiated by PTX treatment. In non-PTX-treated tissue, phosphodiesterase (PDE) 3 and 4 inhibition or removal of either constitutive muscarinic receptor activation of G(i) with atropine or removal of constitutive adenosine receptor activation with CGS 15943 had no effect upon contractility. However, in PTX-treated tissue, PDE3 and 4 inhibition alone increased basal levels of cAMP and accordingly evoked a large inotropic response. Conclusions and implications: Together, these data indicate that G(i) exerts intrinsic receptor-independent inhibitory activity upon AC. We propose that PTX treatment shifts the balance of intrinsic G(i) and G(s) activity upon AC towards G(s), enhancing the effect of all cAMP-mediated inotropic agents.	[Melsom, Caroline Bull; Orstavik, Oivind; Osnes, Jan-Bjorn; Skomedal, Tor; Levy, Finn Olav; Krobert, Kurt Allen] Univ Oslo, Dept Pharmacol, Fac Med, Oslo, Norway; [Melsom, Caroline Bull; Orstavik, Oivind; Osnes, Jan-Bjorn; Skomedal, Tor; Levy, Finn Olav; Krobert, Kurt Allen] Oslo Univ Hosp, Oslo, Norway; [Melsom, Caroline Bull; Orstavik, Oivind; Osnes, Jan-Bjorn; Skomedal, Tor; Levy, Finn Olav; Krobert, Kurt Allen] Univ Oslo, Fac Med, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Melsom, Caroline Bull; Orstavik, Oivind; Osnes, Jan-Bjorn; Skomedal, Tor; Levy, Finn Olav; Krobert, Kurt Allen] Univ Oslo, Fac Med, Ctr Heart Failure Res, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Levy, FO (corresponding author), Univ Oslo, Dept Pharmacol, Fac Med, Oslo, Norway.	f.o.levy@medisin.uio.no			Norwegian Council on Cardiovascular Disease; Research Council of Norway; South-Eastern Norway Regional Health Authority; Stiftelsen Kristian Gerhard Jebsen; Anders Jahre's Foundation for the Promotion of Science; Family Blix foundation; Simon Fougner Hartmann foundation; University of Oslo	Norwegian Council on Cardiovascular Disease; Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority; Stiftelsen Kristian Gerhard Jebsen; Anders Jahre's Foundation for the Promotion of Science; Family Blix foundation; Simon Fougner Hartmann foundation; University of Oslo	The present work was supported by The Norwegian Council on Cardiovascular Disease, The Research Council of Norway, South-Eastern Norway Regional Health Authority, Stiftelsen Kristian Gerhard Jebsen, Anders Jahre's Foundation for the Promotion of Science, The Family Blix foundation, The Simon Fougner Hartmann foundation and grants at the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen GO, 2004, AM J PHYSIOL-HEART C, V286, pH1354, DOI 10.1152/ajpheart.00549.2003; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Chakir K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001909; Chen-Goodspeed M, 2005, J BIOL CHEM, V280, P1808, DOI 10.1074/jbc.M409172200; DAVENPORT CW, 1987, J ANDROL, V8, P314; Dessauer CW, 2002, J BIOL CHEM, V277, P28823, DOI 10.1074/jbc.M203962200; Dhein S, 2001, PHARMACOL RES, V44, P161, DOI 10.1006/phrs.2001.0835; El-Armouche A, 2003, CARDIOVASC RES, V60, P478, DOI 10.1016/j.cardiores.2003.09.014; ESCHENHAGEN T, 1993, CELL BIOL INT, V17, P723, DOI 10.1006/cbir.1993.1135; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gong HB, 2000, BRIT J PHARMACOL, V131, P594, DOI 10.1038/sj.bjp.0703591; Graham TE, 2004, BIOCHEM BIOPH RES CO, V316, P307, DOI 10.1016/j.bbrc.2004.02.049; GRIFFIN MT, 1985, J NEUROCHEM, V45, P1585, DOI 10.1111/j.1471-4159.1985.tb07230.x; HANF R, 1993, J PHYSIOL-LONDON, V461, P743, DOI 10.1113/jphysiol.1993.sp019539; Harvey RD, 2003, BRIT J PHARMACOL, V139, P1074, DOI 10.1038/sj.bjp.0705338; Heubach UF, 2002, BRIT J PHARMACOL, V136, P217, DOI 10.1038/sj.bjp.0704700; Hippe HJ, 2007, CIRC RES, V100, P1191, DOI 10.1161/01.RES.0000264058.28808.cc; Hippe HJ, 2013, N-S ARCH PHARMACOL, V386, P459, DOI 10.1007/s00210-013-0876-x; Hippe HJ, 2009, P NATL ACAD SCI USA, V106, P16269, DOI 10.1073/pnas.0901679106; Hippe HJ, 2003, J BIOL CHEM, V278, P7227, DOI 10.1074/jbc.M210305200; HSIA JA, 1984, BIOCHEM BIOPH RES CO, V119, P1068, DOI 10.1016/0006-291X(84)90883-0; Hussain RI, 2013, J MOL CELL CARDIOL, V56, P129, DOI 10.1016/j.yjmcc.2012.11.015; Jakubik J, 1995, FEBS LETT, V377, P275, DOI 10.1016/0014-5793(95)01360-1; Jozwiak K, 2007, J MED CHEM, V50, P2903, DOI 10.1021/jm070030d; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Kuschel M, 1999, J BIOL CHEM, V274, P22048, DOI 10.1074/jbc.274.31.22048; Levy FO, 2013, N-S ARCH PHARMACOL, V386, P665, DOI 10.1007/s00210-013-0874-z; LEVY MN, 1971, CIRC RES, V29, P437, DOI 10.1161/01.RES.29.5.437; Lutz S, 2002, N-S ARCH PHARMACOL, V365, P50, DOI 10.1007/s00210-001-0500-3; MALAISSE WJ, 1984, BIOCHEM BIOPH RES CO, V124, P190, DOI 10.1016/0006-291X(84)90935-5; Melsom CB, 2014, N-S ARCH PHARMACOL, V387, P1177, DOI 10.1007/s00210-014-1036-7; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Piacentini L, 1996, BBA-BIOMEMBRANES, V1282, P11, DOI 10.1016/0005-2736(96)00029-6; Qvigstad E, 2005, CARDIOVASC RES, V65, P869, DOI 10.1016/j.cardiores.2004.11.017; Ranu HK, 2000, AM J PHYSIOL-HEART C, V278, pH1807, DOI 10.1152/ajpheart.2000.278.6.H1807; Rau T, 2003, FASEB J, V17, P523, DOI 10.1096/fj.02-0660fje; REITHMANN C, 1995, N-S ARCH PHARMACOL, V351, P27; Ricny J, 2002, PHYSIOL RES, V51, P131; SCHERER NM, 1987, ARCH BIOCHEM BIOPHYS, V259, P431, DOI 10.1016/0003-9861(87)90509-1; Shryock JC, 1998, MOL PHARMACOL, V53, P886; Sjaastad I, 2003, ACTA PHYSIOL SCAND, V177, P449, DOI 10.1046/j.1365-201X.2003.01063.x; SKOMEDAL T, 1982, ACTA PHARMACOL TOX, V50, P1; SKOMEDAL T, 1980, ACTA PHARMACOL TOX, V46, P200; Skomedal T, 1997, J PHARMACOL EXP THER, V280, P721; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; Waterson RE, 2011, CARDIOVASC RES, V91, P45, DOI 10.1093/cvr/cvr054; Woo AYH, 2014, J BIOL CHEM, V289, P19351, DOI 10.1074/jbc.M114.558882; Woo AYH, 2009, MOL PHARMACOL, V75, P158, DOI 10.1124/mol.108.051078; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Xiao RP, 2003, CIRCULATION, V108, P1633, DOI 10.1161/01.CIR.0000087595.17277.73; Xiao RP, 1999, CIRC RES, V84, P43; XIAO RP, 1995, MOL PHARMACOL, V47, P322	54	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106608	10.1371/journal.pone.0106608	http://dx.doi.org/10.1371/journal.pone.0106608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203113	Green Published, gold			2022-12-27	WOS:000342684500032
J	Zhao, K; Wei, LB; Hui, H; Dai, QS; You, QD; Guo, QL; Lu, N				Zhao, Kai; Wei, Libin; Hui, Hui; Dai, Qinsheng; You, Qi-Dong; Guo, Qing-Long; Lu, Na			Wogonin Suppresses Melanoma Cell B16-F10 Invasion and Migration by Inhibiting Ras-Medicated Pathways	PLOS ONE			English	Article							CANCER-CELLS; MATRIX METALLOPROTEINASES; EXPRESSION; GROWTH	The patients diagnosed with melanoma have a bad prognosis for early regional invasion and distant metastases. Wogonin (5,7-dihydroxy-8-methoxyflavone) is one of the active components of flavonoids that extracts from Scutellariae radix. Several previous studies reported that wogonin possesses antitumor effect against leukemia, gastrointestinal cancer and breast cancer. In this study, we used melanoma cell B16-F10 to further investigate the anti-invasive and anti-migratory activity of wogonin. Our date showed that wogonin caused suppression of cell migration, adhesion, invasion and actin remodeling by inhibiting the expression of matrix metalloproteinase-2 and Rac1 in vitro. Wogonin also reduced the number of the tumor nodules on the whole surface of the lung in vivo. Furthermore, the examination of mechanism revealed that wogonin inhibited Extracellular Regulated protein Kinases and Protein Kinase B pathways, which are both medicated by Ras. Insulin-like growth factor-1-induced or tumor necrosis factor-alpha-induced invasion was also inhibited by wogonin. Therefore, the inhibitory mechanism of melanoma cell invasion by wogonin might be elucidated.	[Zhao, Kai; Wei, Libin; Hui, Hui; Dai, Qinsheng; You, Qi-Dong; Guo, Qing-Long; Lu, Na] China Pharmaceut Univ, Key Lab Drug Qual Control & Pharmacovigilance, Jiangsu Key Lab Carcinogenesis & Intervent, State Key Lab Nat Med,Minist Educ, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	You, QD (corresponding author), China Pharmaceut Univ, Key Lab Drug Qual Control & Pharmacovigilance, Jiangsu Key Lab Carcinogenesis & Intervent, State Key Lab Nat Med,Minist Educ, Nanjing, Jiangsu, Peoples R China.	youqidong@gmail.com; anticancer_drug@163.com; luna555@163.com			National Natural Science Foundation of China [91029744]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1193]; Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University [JKGZ201101, SKLNMZZ201210, SKLNMZZCX201303, SKLNMZZJQ201302]; Fundamental Research Funds for the Central Universities [JKP2011003]; National Science & Technology Major Project [2012ZX09304-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science & Technology Major Project	This work was supported by the National Natural Science Foundation of China (No. 91029744), Program for Changjiang Scholars and Innovative Research Team in University (IRT1193), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. JKGZ201101, SKLNMZZ201210, SKLNMZZCX201303 and SKLNMZZJQ201302), Fundamental Research Funds for the Central Universities (No. JKP2011003), and The National Science & Technology Major Project (No. 2012ZX09304-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Aladowicz E, 2013, FUTURE ONCOL, V9, P713, DOI [10.2217/fon.13.9, 10.2217/FON.13.9]; Anisimov VN, 2013, CRIT REV ONCOL HEMAT, V87, P201, DOI 10.1016/j.critrevonc.2013.01.005; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chen P, 2011, TOXICOLOGY, V282, P122, DOI 10.1016/j.tox.2011.01.018; Chen XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079201; Dye DE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00252; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Frohlich E, 2010, CELL MOL LIFE SCI, V67, P3947, DOI 10.1007/s00018-010-0469-5; Giltnane JM, 2014, DISCOV MED, V17, P275; Hui KM, 2002, BIOCHEM PHARMACOL, V64, P1415, DOI 10.1016/S0006-2952(02)01347-3; Ikemoto S, 2000, UROLOGY, V55, P951, DOI 10.1016/S0090-4295(00)00467-2; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Lu N, 2008, EXP BIOL MED, V233, P1013, DOI 10.3181/0801-RM-7; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Nagase H, 1998, Cell Res, V8, P179; Pai SY, 2010, DIS MARKERS, V29, P177, DOI [10.1155/2010/380291, 10.3233/DMA-2010-0738]; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Price John T, 2002, Expert Opin Ther Targets, V6, P217; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Shtivelman E, 2014, ONCOTARGET, V5, P1701, DOI 10.18632/oncotarget.1892; Virtanen SS, 2002, CANCER RES, V62, P2708; Wang S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-81; Xu LJ, 2006, J BIOL CHEM, V281, P4457, DOI 10.1074/jbc.M510721200; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang BC, 2000, LAB INVEST, V80, P529, DOI 10.1038/labinvest.3780058; Yoon SO, 2001, J BIOL CHEM, V276, P20085, DOI 10.1074/jbc.M101143200; Zidi I, 2010, MED ONCOL, V27, P185, DOI 10.1007/s12032-009-9190-3	28	30	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106458	10.1371/journal.pone.0106458	http://dx.doi.org/10.1371/journal.pone.0106458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203554	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500025
J	Park, J; Cho, SY; Lee, YJ; Lee, SB; Son, H; Jeong, H				Park, Juhyun; Cho, Sung Yong; Lee, Young Ju; Lee, Seung Bae; Son, Hwancheol; Jeong, Hyeon			Poor Glycemic Control of Diabetes Mellitus Is Associated with Higher Risk of Prostate Cancer Detection in a Biopsy Population	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; TESTOSTERONE; METAANALYSIS; LEVEL; NG/ML; MEN	Objectives: To evaluate the impact of glycemic control of diabetes mellitus (DM) on prostate cancer detection in a biopsy population. Patients and Methods: We retrospectively reviewed the records of 1,368 men who underwent prostate biopsy at our institution. We divided our biopsy population into three groups according to their history of DM, and their Hemoglobin A1c (HbA1c) level: a no-DM (DM-) group; a good glycemic control (DM+GC) group (HbA1c<6.5%); and a poor glycemic control (DM+PC) group (HbA1c >= 6.5%). For sub-analyses, the DM+PC group was divided into a moderately poor glycemic control (DM+mPC) group (6.5 <= HbA1c <7.5%) and a severely poor glycemic control (DM+sPC) group (HbA1c >= 7.5%). Results: Among 1,368 men, 338 (24.7%) had a history of DM, and 393 (28.7%) had a positive biopsy. There was a significant difference in prostatic specific antigen density (PSAD) (P = 0.037) and the frequency of abnormal DRE findings (P = 0.031) among three groups. The occurrence rate of overall prostate cancer (P<0.001) and high-grade prostate cancer (P = 0.016) also presented with a significantly difference. In the multivariate analysis, the DM+PC group was significantly associated with a higher rate of overall prostate cancer detection in biopsy subjects compared to the DM- group (OR = 2.313, P = 0.001) but the DM+PC group was not associated with a higher rate of high-grade (Gleason score >= 7) diseases detected during the biopsy (OR = 1.297, P = 0.376). However, in subgroup analysis, DM+sPC group was significantly related to a higher risk of high-grade diseases compared to the DM- group (OR = 2.446, P = 0.048). Conclusions: Poor glycemic control of DM was associated with a higher risk of prostate cancer detection, including high-grade disease, in the biopsy population.	[Park, Juhyun; Cho, Sung Yong; Lee, Seung Bae; Son, Hwancheol; Jeong, Hyeon] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Urol, Seoul, South Korea; [Lee, Young Ju] Seoul Natl Univ, Hosp 101, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Jeong, H (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Urol, Seoul, South Korea.	drjh@brm.co.kr		Park, Juhyun/0000-0002-5549-9756	Seoul National University Hospital (SNUH) Research Fund [03-2014-5]	Seoul National University Hospital (SNUH) Research Fund	This study was supported by Grant No. 03-2014-5 from the Seoul National University Hospital (SNUH) Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyeke T, 2013, CARCINOGENESIS, V34, P2823, DOI 10.1093/carcin/bgt307; [Anonymous], 2010, DIABETES CARE S1, V33, pS11; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Bonovas S, 2004, DIABETOLOGIA, V47, P1071, DOI 10.1007/s00125-004-1415-6; Brand JS, 2011, CLIN ENDOCRINOL, V74, P572, DOI 10.1111/j.1365-2265.2010.03951.x; Carignan A, 2012, EUR UROL, V62, P453, DOI 10.1016/j.eururo.2012.04.044; Chan JM, 2005, CANCER CAUSE CONTROL, V16, P789, DOI 10.1007/s10552-005-3301-z; de Beer JC, 2014, BRIT J CANCER, V110, P2361, DOI 10.1038/bjc.2014.150; Fall K, 2013, CANCER EPIDEM BIOMAR, V22, P1102, DOI 10.1158/1055-9965.EPI-12-1046; Fukushima H, 2012, UROLOGY, V79, P1329, DOI 10.1016/j.urology.2012.01.070; Grossmann M, 2010, CURR OPIN ENDOCRINOL, V17, P247, DOI 10.1097/MED.0b013e32833919cf; Hong SK, 2012, PROSTATE, V72, P51, DOI 10.1002/pros.21405; Hong SK, 2009, PROSTATE, V69, P820, DOI 10.1002/pros.20932; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Kim HS, 2010, PROSTATE, V70, P1540, DOI 10.1002/pros.21189; Kim HJ, 2012, KOREAN J UROL, V53, P9, DOI 10.4111/kju.2012.53.1.9; Leitzmann MF, 2008, CANCER CAUSE CONTROL, V19, P1267, DOI 10.1007/s10552-008-9198-6; Li QA, 2010, CANCER CAUSE CONTROL, V21, P1025, DOI 10.1007/s10552-010-9530-9; Margel D, 2013, J CLIN ONCOL, V31, P3069, DOI 10.1200/JCO.2012.46.7043; Moreira DM, 2011, CANCER CAUSE CONTROL, V22, P977, DOI 10.1007/s10552-011-9770-3; Naito M, 2012, NAGOYA J MED SCI, V74, P285; Onitilo AA, 2013, EUR J CANC PREV; Ozbek E, 2014, ASIAN PAC J CANCER P, V15, P2555, DOI 10.7314/APJCP.2014.15.6.2555; Pierce BL, 2012, UROL ONCOL-SEMIN ORI, V30, P735, DOI 10.1016/j.urolonc.2012.07.008; Roddam AW, 2008, ANN INTERN MED, V149, P461, DOI 10.7326/0003-4819-149-7-200810070-00006; Salonia A, 2012, CLIN CANCER RES, V18, P3648, DOI 10.1158/1078-0432.CCR-11-2799; Teloken C, 2005, J UROLOGY, V174, P2178, DOI 10.1097/01.ju.0000181818.51977.29; Tsilidis KK, 2014, DIABETES CARE; Xylinas E, 2011, BJU INT, V107, P1400, DOI 10.1111/j.1464-410X.2010.09816.x; Yamamoto S, 2007, EUR UROL, V52, P696, DOI 10.1016/j.eururo.2007.03.052	30	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e104789	10.1371/journal.pone.0104789	http://dx.doi.org/10.1371/journal.pone.0104789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198675	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700012
J	Patel, M; Gleason, A; O'Malley, S; Connolly, B; Suresch, D; Virostko, J; Phillips, N; Lin, SA; Chen, TB; Klimas, M; Hargreaves, RJ; Sur, C; Williams, DL; Powers, AC; Bednar, B				Patel, Manishkumar; Gleason, Alexa; O'Malley, Stacey; Connolly, Brett; Suresch, Donna; Virostko, John; Phillips, Neil; Lin, Shu-An; Chen, Tsing-Bau; Klimas, Michael; Hargreaves, Richard J.; Sur, Cyrille; Williams, David L., Jr.; Powers, Alvin C.; Bednar, Bohumil			Non-Invasive Bioluminescence Imaging of beta-Cell Function in Obese-Hyperglycemic [ob/ob] Mice	PLOS ONE			English	Article							EXPRESSION; APOPTOSIS; ISLETS; MOUSE	Background: Type 2 diabetes results from failure of the beta-cells to compensate for increased insulin demand due to abnormal levels of metabolic factors. The ob/ob(lep-/-) mouse has been extensively studied as an animal model of type 2 diabetes. Previous studies have shown a correlation between beta-cell function and bioluminescent imaging in lean genetically engineered mice. The ability to noninvasively monitor beta-cell function in ob/ob mice could provide new information on beta-cell regulation in type 2 diabetes. Methods: To create the B6 Albino ob/ob MIP-luc mice (ob/ob-luc), the ob/ob mouse was crossed with the CD1 MIP-luc mouse. All mice were backcrossed over multiple generations to ensure the genetic background of the transgenic mice was over 96% similar to the background of the original ob/ob mouse. Animal weight, blood glucose levels, insulin in plasma, and in vivo bioluminescence (BLI) were monitored weekly or biweekly for up to 70 weeks of age. BL imaging was performed using IVIS Spectrum (Perkin Elmer) and calculated by integrating the bioluminescence signal between 5 and 10 min after i.v. injection of D-luciferin. Insulin immunohistochemistry determined islet beta cell count and insulin secretion assay determined islet insulin function. Results: There were significant increases in BLI and insulin levels as the ob/ob-luc mice aged while glucose levels gradually decreased. Ob/ob-luc were sacrificed at different time points to determine ex vivo BLI, islet function and total beta-cell numbers using a cell counting training algorithm developed for the Vectra image analysis system (Perkin Elmer). The number of beta-cells increased as the mice aged and all three ex vivo measurements correlated with BLI. Conclusions: The ob/ob-luc mice can serve as a model of metabolic stress, similar to human type 2 diabetes using BLI as a surrogate marker for beta-cell function.	[Patel, Manishkumar; Gleason, Alexa; O'Malley, Stacey; Connolly, Brett; Suresch, Donna; Lin, Shu-An; Chen, Tsing-Bau; Klimas, Michael; Hargreaves, Richard J.; Sur, Cyrille; Williams, David L., Jr.; Bednar, Bohumil] Merck & Co Inc, Merck Res Labs, Dept Imaging, West Point, PA 19486 USA; [Virostko, John] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Phillips, Neil; Powers, Alvin C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Powers, Alvin C.] Vanderbilt Univ, Dept Med, Div Endocrinol Diabet & Metab, Nashville, TN USA; [Powers, Alvin C.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Merck & Company; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Patel, M (corresponding author), Merck & Co Inc, Merck Res Labs, Dept Imaging, West Point, PA 19486 USA.	manishkumar_patel@merck.com	Virostko, Jack/AAR-5947-2021; Sur, Cyrille/G-1154-2010	Virostko, Jack/0000-0003-3413-8801; 	Merck Co.; Juvenile Diabetes Research Foundation; VA Research Service [BX000666]; National Institutes of Health [DK094199, DK089572, DK072473, DK68764]; South-Eastern Center for small animal imaging [U24CA126588]; Vanderbilt Mouse Metabolic Phenotyping Center [DK59637]; Vanderbilt Diabetes Research and Training Center [DK20593]; NATIONAL CANCER INSTITUTE [U24CA126588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089572, R01DK094199, U24DK059637, P60DK020593, U2CDK059637, R01DK068764, P30DK020593] Funding Source: NIH RePORTER	Merck Co.(Merck & Company); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); VA Research Service(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South-Eastern Center for small animal imaging; Vanderbilt Mouse Metabolic Phenotyping Center; Vanderbilt Diabetes Research and Training Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly funded by Merck & Co. Merck & Co. provided support in the form of salaries for authors MP, AG, SO, BC, DS, SAL, TBC, MK, RJH, CS, DLW and BB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.'' Work by Drs. Virostko, Phillips, and Powers was supported by grants from the Juvenile Diabetes Research Foundation, the VA Research Service (BX000666), the National Institutes of Health (DK094199, DK089572, DK072473, DK68764), the South-Eastern Center for small animal imaging (U24CA126588), the Vanderbilt Mouse Metabolic Phenotyping Center (DK59637), and the Vanderbilt Diabetes Research and Training Center (DK20593). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros CC, 2009, INT J OBESITY, V33, P938, DOI 10.1038/ijo.2009.95; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004-0219; HUMMEL KP, 1972, BIOCHEM GENET, V7, P1, DOI 10.1007/BF00487005; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Keyaerts M, 2008, EUR J NUCL MED MOL I, V35, P999, DOI 10.1007/s00259-007-0664-2; Leckstrom A, 1999, PANCREAS, V18, P266, DOI 10.1097/00006676-199904000-00008; LEMARCHAND Y, 1977, DIABETES, V26, P355; LIN PY, 1977, J NUTR, V107, P1715, DOI 10.1093/jn/107.9.1715; Lindstrom P, 2010, ADV EXP MED BIOL, V654, P463, DOI 10.1007/978-90-481-3271-3_20; LOTEN EG, 1976, AM J PHYSIOL, V230, P602, DOI 10.1152/ajplegacy.1976.230.3.602; Marchetti P, 2004, J CLIN ENDOCR METAB, V89, P5535, DOI 10.1210/jc.2004-0150; Marchetti P, 2010, ADV EXP MED BIOL, V654, P501, DOI 10.1007/978-90-481-3271-3_22; Park SY, 2009, HORM METAB RES, V41, P1, DOI 10.1055/s-0028-1087209; Park SY, 2005, GENESIS, V43, P80, DOI 10.1002/gene.20157; Paroo Z, 2004, MOL IMAGING, V3, P117, DOI 10.1162/1535350041464865; Virostko J., 2009, MOL IMAGING BIOL, V12, P42; Virostko John, 2006, Curr Diab Rep, V6, P328, DOI 10.1007/s11892-006-0069-9; Virostko J, 2007, APPL OPTICS, V46, P2540, DOI 10.1364/AO.46.002540; Virostko J, 2004, MOL IMAGING, V3, P333, DOI 10.1162/1535350042973508; Virostko J, 2009, GASTROENTEROLOGY, V136, P407, DOI 10.1053/j.gastro.2008.12.024; Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358; Westman S, 1968, Diabetologia, V4, P141, DOI 10.1007/BF01219435; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735	29	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106693	10.1371/journal.pone.0106693	http://dx.doi.org/10.1371/journal.pone.0106693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198535	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700041
J	Shen, N; Gong, J; Wang, Y; Tian, J; Qian, JM; Zou, L; Chen, W; Zhu, BB; Lu, XH; Zhong, R; Guo, AY; Wang, L; Miao, XP				Shen, Na; Gong, Jing; Wang, Ying; Tian, Jing; Qian, Jiaming; Zou, Li; Chen, Wei; Zhu, Beibei; Lu, Xinghua; Zhong, Rong; Guo, Anyuan; Wang, Li; Miao, Xiaoping			Integrative Genomic Analysis Identifies That SERPINA6-rs1998056 Regulated by FOXA/ER alpha Is Associated with Female Hepatocellular Carcinoma	PLOS ONE			English	Article							CORTICOSTEROID-BINDING GLOBULIN; GENETIC-VARIATIONS; ANDROGEN RECEPTOR; CORTISOL; RISK; CANCER; EPIDEMIOLOGY; RESISTANCE; PROSTATE; ELEMENT	The human forkhead box A1 (FOXA1) and A2 (FOXA2) transcription factors have been found to control estrogen and androgen signaling through co-regulating target genes with sex hormone receptors. Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 binding elements may be associated with sexual dimorphism of hepatocellular carcinoma (HCC) risk. Firstly we extracted chromatin immunoprecipitation-sequencing (ChIP-seq) data of FOXA1, FOXA2 and estrogen receptor 1(ER alpha) from ENCODE database to obtain dual target regions of FOXA/ER alpha, and further intersected these regions with genes' promoters. Then we used MATCH program to predict FOXA binding elements, in which genetic variants were retrieved by dbSNP database (NCBI, build 134). A total of 15 candidate variants were identified in this stage. Secondly we performed a case-control study with 1,081 HCC patients and 2,008 matched controls and found a significant association of SERPINA6-rs1998056 with female HCC risk under common genetic models (e. g. GG versus CC: OR = 2.03, 95% CI = 1.26-3.27, P = 0.004). Moreover, results from our real-time quantitative polymerase chain reaction (qPCR) using 72 normal liver tissues adjacent to the tumors showed that SERPINA6 expression was significantly different among different genotypes of this variant (GG versus CC: P = 0.032; Group test: P = 0.060). In summary, our study suggested that SERPINA6-rs1998056 regulated by FOXA/ER alpha might be associated with female HCC risk.	[Shen, Na; Gong, Jing; Zou, Li; Chen, Wei; Zhu, Beibei; Zhong, Rong; Miao, Xiaoping] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat, MOE Minist Educ, Key Lab Environm & Hlth,Minist Environm Protect K, Wuhan 430074, Peoples R China; [Shen, Na; Gong, Jing; Zou, Li; Chen, Wei; Zhu, Beibei; Zhong, Rong; Miao, Xiaoping] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Shen, Na; Tian, Jing; Wang, Li] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Beijing 100730, Peoples R China; [Shen, Na; Wang, Ying; Wang, Li] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Wang, Ying] Wuhan Ctr Dis Prevent & Control, Wuhan, Peoples R China; [Qian, Jiaming; Lu, Xinghua] Chinese Acad Med Sci, Div Gastroenterol, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China; [Guo, Anyuan] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Dept Syst Biol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Huazhong University of Science & Technology	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat, MOE Minist Educ, Key Lab Environm & Hlth,Minist Environm Protect K, Wuhan 430074, Peoples R China.	liwang@ibms.pumc.edu.cn; miaoxp@mail.hust.edu.cn	miao, xiaoping/C-4336-2011; Zhong, Rong/Q-1813-2019	miao, xiaoping/0000-0002-6818-9722; 	National Natural Science Foundation of China [NSCF-81273182]; Beijing Innovative Talent Development Project [2012D009008000004]; China Postdoctoral Science Foundation [2014M550395]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Innovative Talent Development Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Natural Science Foundation of China (NSCF-81273182 to W. L.), Beijing Innovative Talent Development Project (2012D009008000004 to W. L.), Wuhan Innovative Talent Development Project for Ying Wang and General Financial Grant from the China Postdoctoral Science Foundation [2014M550395 to R.Z.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Bucossi S, 2013, J ALZHEIMERS DIS, V37, P453, DOI 10.3233/JAD-130431; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chen JG, 2011, SEMIN CANCER BIOL, V21, P59, DOI 10.1016/j.semcancer.2010.11.002; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; de Ronde JJ, 2013, BREAST CANCER RES TR, V137, P213, DOI 10.1007/s10549-012-2340-x; Eggert T, 2013, GUT, V62, P1667, DOI 10.1136/gutjnl-2013-305164; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez-Real JM, 2002, J CLIN ENDOCR METAB, V87, P4686, DOI 10.1210/jc.2001-011843; Fernandez-Real JM, 1999, J CLIN ENDOCR METAB, V84, P3192, DOI 10.1210/jc.84.9.3192; Galbois A, 2010, J HEPATOL, V52, P839, DOI 10.1016/j.jhep.2010.01.026; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katoh M, 2004, INT J ONCOL, V25, P1495; Kawase M, 2013, BREAST CANC; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Lin L, 2002, CANCER RES, V62, P5273; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Ming L, 2002, HEPATOLOGY, V36, P1214, DOI 10.1053/jhep.2002.36366; Mirosevich J, 2006, PROSTATE, V66, P1013, DOI 10.1002/pros.20299; Nucera C, 2009, CLIN CANCER RES, V15, P3680, DOI 10.1158/1078-0432.CCR-08-3155; Qureshi AC, 2007, CLIN ENDOCRINOL, V66, P632, DOI 10.1111/j.1365-2265.2007.02784.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Trifan A, 2013, WORLD J GASTROENTERO, V19, P445, DOI 10.3748/wjg.v19.i4.445; Tsuge M, 2005, NAT GENET, V37, P1104, DOI 10.1038/ng1638; Vincent RP, 2009, ANN CLIN BIOCHEM, V46, P505, DOI 10.1258/acb.2009.009030; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; White T, 2006, CONTRACEPTION, V74, P293, DOI 10.1016/j.contraception.2006.04.005; Wolf I, 2007, INT J CANCER, V120, P1013, DOI 10.1002/ijc.22389; Yu XP, 2005, ANN NY ACAD SCI, V1061, P77, DOI 10.1196/annals.1336.009; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017; Zhong R, 2013, MOL CARCINOGEN, V52, P118, DOI 10.1002/mc.22043; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	37	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107246	10.1371/journal.pone.0107246	http://dx.doi.org/10.1371/journal.pone.0107246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198130	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700097
J	Amrani, A; Bergon, A; Holota, H; Tamburini, C; Garel, M; Ollivier, B; Imbert, J; Dolla, A; Pradel, N				Amrani, Amira; Bergon, Aurelie; Holota, Helene; Tamburini, Christian; Garel, Marc; Ollivier, Bernard; Imbert, Jean; Dolla, Alain; Pradel, Nathalie			Transcriptomics Reveal Several Gene Expression Patterns in the Piezophile Desulfovibrio hydrothermalis in Response to Hydrostatic Pressure	PLOS ONE			English	Article							DEEP-SEA; PHOTOBACTERIUM-PROFUNDUM; VULGARIS HILDENBOROUGH; SHEWANELLA-VIOLACEA; ENERGY-METABOLISM; GENOME SEQUENCE; CYTOCHROME-C; MICROBIOLOGY; ADAPTATION; BACTERIA	RNA-seq was used to study the response of Desulfovibrio hydrothermalis, isolated from a deep-sea hydrothermal chimney on the East-Pacific Rise at a depth of 2,600 m, to various hydrostatic pressure growth conditions. The transcriptomic datasets obtained after growth at 26, 10 and 0.1 MPa identified only 65 differentially expressed genes that were distributed among four main categories: aromatic amino acid and glutamate metabolisms, energy metabolism, signal transduction, and unknown function. The gene expression patterns suggest that D. hydrothermalis uses at least three different adaptation mechanisms, according to a hydrostatic pressure threshold (HPt) that was estimated to be above 10 MPa. Both glutamate and energy metabolism were found to play crucial roles in these mechanisms. Quantitation of the glutamate levels in cells revealed its accumulation at high hydrostatic pressure, suggesting its role as a piezolyte. ATP measurements showed that the energy metabolism of this bacterium is optimized for deep-sea life conditions. This study provides new insights into the molecular mechanisms linked to hydrostatic pressure adaptation in sulfate-reducing bacteria.	[Amrani, Amira; Tamburini, Christian; Garel, Marc; Ollivier, Bernard; Pradel, Nathalie] Aix Marseille Univ, Univ Sud Toulon Var, CNRS INSU, IRD,MIO,UM110, Marseille, France; [Bergon, Aurelie; Holota, Helene; Imbert, Jean] INSERM, TGML, TAGC, U1090, Marseille, France; [Bergon, Aurelie; Holota, Helene; Imbert, Jean] Aix Marseille Univ, TGML, TAGC, UMR S 1090, Marseille, France; [Dolla, Alain] Aix Marseille Univ, CNRS, LCB UMR7283, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Dolla, A (corresponding author), Aix Marseille Univ, CNRS, LCB UMR7283, Marseille, France.	dolla@imm.cnrs.fr; nathalie.pradel@ird.fr	Imbert, Jean/G-3248-2013; Tamburini, Christian/AAO-8577-2020; Tamburini, Christian/I-7821-2012; Ollivier, Bernard/I-6150-2016; Imbert, Jean/AAG-1165-2020; Bergon, Aurélie/M-4977-2016	Imbert, Jean/0000-0002-0478-9593; Tamburini, Christian/0000-0003-3752-7423; Tamburini, Christian/0000-0003-3752-7423; Imbert, Jean/0000-0002-0478-9593; Bergon, Aurélie/0000-0003-1518-4562; Garel, Marc/0000-0002-4374-5905	Inserm; GIS IBiSA; Aix-Marseille Universite;  [ANR-10-INBS-0009-10]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); GIS IBiSA; Aix-Marseille Universite; 	High-throughput sequencing was performed at the TGML Platform. The platform is supported by grants from Inserm, GIS IBiSA, Aix-Marseille Universite, and ANR-10-INBS-0009-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazard D, 2003, INT J SYST EVOL MICR, V53, P173, DOI 10.1099/ijs.0.02323-0; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bienhold C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053590; Boonyaratanakornkit BB, 2007, EXTREMOPHILES, V11, P495, DOI 10.1007/s00792-007-0063-4; BRUSCHI M, 1992, BIOCHEMISTRY-US, V31, P3281, DOI 10.1021/bi00127a033; Campanaro S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-122; Campanaro S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-313; Pereira IAC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00069; Chaudhuri RR, 2011, MICROBIOL-SGM, V157, P2922, DOI 10.1099/mic.0.050278-0; Haveman SA, 2003, J BACTERIOL, V185, P4345, DOI 10.1128/JB.185.15.4345-4353.2003; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Ikegami A, 2000, FEMS MICROBIOL LETT, V192, P91, DOI 10.1111/j.1574-6968.2000.tb09364.x; JANNASCH HW, 1984, ANNU REV MICROBIOL, V38, P487, DOI 10.1146/annurev.mi.38.100184.002415; Ji BY, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00226-12; Keller KL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00135; Khelaifia S, 2011, INT J SYST EVOL MICR, V61, P2706, DOI 10.1099/ijs.0.028670-0; Le Bihan T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060897; Martin DD, 2002, EXTREMOPHILES, V6, P507, DOI 10.1007/s00792-002-0288-1; Meyer B, 2013, J BACTERIOL, V195, P990, DOI 10.1128/JB.01959-12; Ohke Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1522, DOI 10.1271/bbb.130197; Orcutt BN, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00189; Pradel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055130; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Simonato F, 2006, J BIOTECHNOL, V126, P11, DOI 10.1016/j.jbiotec.2006.03.038; Suszynski TM, 2008, TRANSPL P, V40, P346, DOI 10.1016/j.transproceed.2008.01.061; Tamegai H, 2012, BIOSCI BIOTECH BIOCH, V76, P1506, DOI 10.1271/bbb.120237; van Heeswijk WC, 2013, MICROBIOL MOL BIOL R, V77, P628, DOI 10.1128/MMBR.00025-13; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Vossmeyer A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00253; YAYANOS AA, 1995, ANNU REV MICROBIOL, V49, P777, DOI 10.1146/annurev.mi.49.100195.004021; Zhang YP, 2009, J BACTERIOL, V191, P5526, DOI 10.1128/JB.00585-09	34	31	32	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106831	10.1371/journal.pone.0106831	http://dx.doi.org/10.1371/journal.pone.0106831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215865	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300025
J	Dhasmana, A; Jamal, QMS; Mir, SS; Bhatt, MLB; Rahman, Q; Gupta, R; Siddiqui, MH; Lohani, M				Dhasmana, Anupam; Jamal, Qazi Mohd. Sajid; Mir, Snober Shabnam; Bhatt, Madan Lal Bramha; Rahman, Qamar; Gupta, Richa; Siddiqui, Mohd. Haris; Lohani, Mohtashim			Titanium Dioxide Nanoparticles As Guardian against Environmental Carcinogen Benzo[alpha]Pyrene	PLOS ONE			English	Article								Polycyclic aromatic hydrocarbons (PAH), like Benzo[alpha]Pyrene (BaP) are known to cause a number of toxic manifestations including lung cancer. As Titanium dioxide Nanoparticles (TiO2 NPs) have recently been shown to adsorb a number of PAHs from soil and water, we investigated whether TiO2 NPs could provide protection against the BaP induced toxicity in biological system. A549 cells when co-exposed with BaP (25 mu M, 50 mu M and 75 mu M) along with 0.1 mu g/ml, 0.5 mu g/ml and 1 mu g/ml of TiO2 NPs, showed significant reduction in the toxic effects of BaP, as measured by Micronucleus Assay, MTT Assay and ROS Assay. In order to explore the mechanism of protection by TiO2 NP against BaP, we performed in silico studies. BaP and other PAHs are known to enter the cell via aromatic hydrocarbon receptor (AHR). TiO2 NP showed a much higher docking score with AHR (12074) as compared to the docking score of BaP with AHR (4600). This indicates a preferential binding of TiO2 NP with the AHR, in case if both the TiO2 NP and BaP are present. Further, we have done the docking of BaP with the TiO2 NP bound AHR-complex (score 4710), and observed that BaP showed strong adsorption on TiO2 NP itself, and not at its original binding site (at AHR). TiO2 NPs thereby prevent the entry of BaP in to the cell via AHR and hence protect cells against the deleterious effects induced by BaP.	[Dhasmana, Anupam; Jamal, Qazi Mohd. Sajid; Mir, Snober Shabnam; Siddiqui, Mohd. Haris; Lohani, Mohtashim] Integral Univ, Dept Bioengn & Biosci, Environm Carcinogenesis & Toxicoinformat Lab, Lucknow, Uttar Pradesh, India; [Bhatt, Madan Lal Bramha] Ram Manohar Lohia Inst Med Sci, Dept Radiat Oncol, Lucknow, Uttar Pradesh, India; [Rahman, Qamar] Amity Univ Campus, Lucknow, Uttar Pradesh, India; [Gupta, Richa] CSIR, Indian Inst Toxicol Res, Div Dev Toxicol, Lucknow, Uttar Pradesh, India	Integral University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Lohani, M (corresponding author), Integral Univ, Dept Bioengn & Biosci, Environm Carcinogenesis & Toxicoinformat Lab, Lucknow, Uttar Pradesh, India.	mlohani@rediffmail.com	Lohani, Mohtashim/AAR-3394-2021; Dhasmana, Anupam/K-6043-2019; Rahman, Qamar/AAF-7026-2022; Rahman, Qamar/AFJ-9953-2022; Jamal, Qazi Mohammad Sajid/A-8438-2015	Dhasmana, Anupam/0000-0002-8042-940X; Jamal, Qazi Mohammad Sajid/0000-0001-5525-708X; Lohani, Mohtashim/0000-0001-9414-4539	Indian Council of Medical Research, New Delhi, India [45/20/2013NAN-BMS]	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	Indian Council of Medical Research, New Delhi, India provided a Senior Research Fellowship to Mr. Anupam Dhasmana (45/20/2013NAN-BMS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Deng QX, 2011, CHEM COMMUN, V47, P6153, DOI 10.1039/c1cc10794a; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hsu GW, 2005, J BIOL CHEM, V280, P3764, DOI 10.1074/jbc.M411276200; International Agency for Research on Cancer (IARC), 2010, IARC MON EV CARC RIS, V92, P773; Jacimovic J, 2010, MATERIALS, V3, P1509, DOI 10.3390/ma3031509; Karnchanasest B., 2007, Journal of Applied Sciences, V7, P3317; Kefi BB, 2011, J ENVIRON SCI, V23, P860, DOI 10.1016/S1001-0742(10)60481-0; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Petry T, 1996, CHEMOSPHERE, V32, P639, DOI 10.1016/0045-6535(95)00348-7; PHILLIPS DH, 1983, NATURE, V303, P468, DOI 10.1038/303468a0; Rahman Q, 2002, ENVIRON HEALTH PERSP, V110, P797, DOI 10.1289/ehp.02110797; Rahman Q, 2000, ENV HLTH, V110, P8; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Siddiqui MA, 2008, TOXICOL IN VITRO, V22, P1681, DOI 10.1016/j.tiv.2008.07.001; Srivastava RK, 2010, TOXICOL IND HEALTH, V26, P575, DOI 10.1177/0748233710374464; Srivastava RK, 2012, HUM EXP TOXICOL, P1; Synowczynski J., 2007, ARLTR4047 WEAP MAT R; Wu XJ, 2003, TOXICOL LETT, V144, P143, DOI 10.1016/S0378-4274(03)00198-X; Yasuhito S, 1999, PNAS, V97, P779; Yoichi N, 2000, AM J RESP CELL MOL B, V22, P747	23	31	33	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107068	10.1371/journal.pone.0107068	http://dx.doi.org/10.1371/journal.pone.0107068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215666	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300041
J	Zhao, BJ; Lin, Y; Xu, J; Ni, BX; Da, M; Ding, CY; Hu, YL; Zhang, K; Yang, SW; Wang, XW; Yu, SQ; Chen, YJ; Mo, XM; Liu, JY; Shen, HB; Sha, JH; Ma, HX				Zhao, Bijun; Lin, Yuan; Xu, Jing; Ni, Bixian; Da, Min; Ding, Chenyue; Hu, Yuanli; Zhang, Kai; Yang, Shiwei; Wang, Xiaowei; Yu, Shiqiang; Chen, Yijiang; Mo, Xuming; Liu, Jiayin; Shen, Hongbing; Sha, Jiahao; Ma, Hongxia			Replication of the 4p16 Susceptibility Locus in Congenital Heart Disease in Han Chinese Populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HB-EGF; MSX1; PREVALENCE; GENETICS; MUTATION; DEFECTS	Congenital heart disease (CHD) is the most common form of congenital human birth anomalies and a leading cause of perinatal and infant mortality. Some studies including our published genome-wide association study (GWAS) of CHD have indicated that genetic variants may contribute to the risk of CHD. Recently, Cordell et al. published a GWAS of multiple CHD phenotypes in European Caucasians and identified 3 susceptibility loci (rs870142, rs16835979 and rs6824295) for ostium secundum atrial septal defect (ASD) at chromosome 4p16. However, whether these loci at 4p16 confer the predisposition to CHD in Chinese population is unclear. In the current study, we first analyzed the associations between these 3 single nucleotide polymorphisms (SNPs) at 4p16 and CHD risk by using our existing genome-wide scan data and found all of the 3 SNPs showed significant associations with ASD in the same direction as that observed in Cordell's study, but not with other subtypes-ventricular septal defect (VSD) and ASD combined VSD. As these 3 SNPs were in high linkage disequilibrium (LD) in Chinese population, we selected one SNP with the lowest P value in our GWAS scan (rs16835979) to perform a replication study with additional 1,709 CHD cases with multiple phenotypes and 1,962 controls. The significant association was also observed only within the ASD subgroup, which was heterogeneous from other disease groups. In combined GWAS and replication samples, the minor allele of rs16835979 remained significant association with the risk of ASD (OR = 1.22, 95% CI = 1.08-1.38, P = 0.001). Our findings suggest that susceptibility loci of ASD identified from Cordell's European GWAS are generalizable to Chinese population, and such investigation may provide new insights into the roles of genetic variants in the etiology of different CHD phenotypes.	[Zhao, Bijun; Yu, Shiqiang] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China; [Lin, Yuan; Zhang, Kai; Shen, Hongbing; Sha, Jiahao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Lin, Yuan; Ni, Bixian; Zhang, Kai; Shen, Hongbing; Ma, Hongxia] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Lin, Yuan; Ni, Bixian; Zhang, Kai; Shen, Hongbing; Ma, Hongxia] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Xu, Jing; Wang, Xiaowei; Chen, Yijiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Thorac & Cardiovasc Surg, Nanjing, Jiangsu, Peoples R China; [Da, Min; Hu, Yuanli; Mo, Xuming] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Ding, Chenyue; Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Ctr Clin Reprod Med, Nanjing, Jiangsu, Peoples R China; [Yang, Shiwei] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, Nanjing, Jiangsu, Peoples R China	Air Force Military Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Ma, HX (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	hongxiama@njmu.edu.cn		Yu, Shiqiang/0000-0003-3519-0943	National Key Basic Research Program Grant [2011CB944300, 2013CB911400, 2012CB944902]; National Science Foundation for Distinguished Young Scholars of China [81225020]; New Century Excellent Talents in University [NCET-10-0178]; Organization Department of the CPC Central Committee; Jiangsu Outstanding Youth Science Foundation [BK2012042]; Jiangsu Province Clinical Science and Technology Projects [BL2012008]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province	National Key Basic Research Program Grant(National Basic Research Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Organization Department of the CPC Central Committee; Jiangsu Outstanding Youth Science Foundation; Jiangsu Province Clinical Science and Technology Projects; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province	This work was supported by the following sources: National Key Basic Research Program Grant (2011CB944300, 2013CB911400 and 2012CB944902), the National Science Foundation for Distinguished Young Scholars of China (81225020), the New Century Excellent Talents in University (NCET-10-0178), the Organization Department of the CPC Central Committee, the Jiangsu Outstanding Youth Science Foundation (BK2012042), Jiangsu Province Clinical Science and Technology Projects (BL2012008), the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine) and Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bei M, 1998, DEVELOPMENT, V125, P4325; Blanco R, 2001, HUM BIOL, V73, P81, DOI 10.1353/hub.2001.0002; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Chen YH, 2007, DEV BIOL, V308, P421, DOI 10.1016/j.ydbio.2007.05.037; Chen YH, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-75; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Cordell HJ, 2013, NAT GENET, V45, P822, DOI 10.1038/ng.2637; DAVIDSON D, 1995, TRENDS GENET, V11, P405, DOI 10.1016/S0168-9525(00)89124-6; Hatsuzawa K, 2000, J BIOL CHEM, V275, P13713, DOI 10.1074/jbc.275.18.13713; Hu Z, 2014, J THORAC CARDIOV SUR, V148, P596, DOI 10.1016/j.jtcvs.2013.08.067; Hu ZB, 2013, NAT GENET, V45, P818, DOI 10.1038/ng.2636; Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Shen HB, 2013, J BIOMED RES, V27, P167, DOI 10.7555/JBR.27.20130040; Soemedi R, 2012, HUM MOL GENET, V21, P1513, DOI 10.1093/hmg/ddr589; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Ware SM, 2012, J CLIN EXP CARDIOL S, pS8; Weismann CG, 2007, CURR OPIN CARDIOL, V22, P200, DOI 10.1097/HCO.0b013e3280f629c7; Wessels MW, 2010, CLIN GENET, V78, P103, DOI 10.1111/j.1399-0004.2010.01435.x	25	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107411	10.1371/journal.pone.0107411	http://dx.doi.org/10.1371/journal.pone.0107411			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215500	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300062
J	Falcon, BL; Swearingen, M; Gough, WH; Lee, LD; Foreman, R; Uhlik, M; Hanson, JC; Lee, JA; McClure, DB; Chintharlapalli, S				Falcon, Beverly L.; Swearingen, Michelle; Gough, Wendy H.; Lee, Linda; Foreman, Robert; Uhlik, Mark; Hanson, Jeff C.; Lee, Jonathan A.; McClure, Don B.; Chintharlapalli, Sudhakar			An In Vitro Cord Formation Assay Identifies Unique Vascular Phenotypes Associated with Angiogenic Growth Factors	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; ENDOTHELIAL-CELLS; VEGF INHIBITION; GENE-EXPRESSION; ACTIVATION; RESISTANCE; THERAPY; BETA; ANGIOPOIETIN-2; HOMEOSTASIS	Vascular endothelial growth factor (VEGF) plays a dominant role in angiogenesis. While inhibitors of the VEGF pathway are approved for the treatment of a number of tumor types, the effectiveness is limited and evasive resistance is common. One mechanism of evasive resistance to inhibition of the VEGF pathway is upregulation of other pro-angiogenic factors such as fibroblast growth factor (FGF) and epidermal growth factor (EGF). Numerous in vitro assays examine angiogenesis, but many of these assays are performed in media or matrix with multiple growth factors or are driven by VEGF. In order to study angiogenesis driven by other growth factors, we developed a basal medium to use on a co-culture cord formation system of adipose derived stem cells (ADSCs) and endothelial colony forming cells (ECFCs). We found that cord formation driven by different angiogenic factors led to unique phenotypes that could be differentiated and combination studies indicate dominant phenotypes elicited by some growth factors. VEGF-driven cords were highly covered by smooth muscle actin, and bFGF-driven cords had thicker nodes, while EGF-driven cords were highly branched. Multiparametric analysis indicated that when combined EGF has a dominant phenotype. In addition, because this assay system is run in minimal medium, potential proangiogenic molecules can be screened. Using this assay we identified an inhibitor that promoted cord formation, which was translated into in vivo tumor models. Together this study illustrates the unique roles of multiple anti-angiogenic agents, which may lead to improvements in therapeutic angiogenesis efforts and better rational for anti-angiogenic therapy.	[Falcon, Beverly L.; Swearingen, Michelle; Lee, Linda; Uhlik, Mark; Chintharlapalli, Sudhakar] Eli Lilly & Co, Lilly Corp Ctr, Dept Canc Angiogenesis, Indianapolis, IN 46285 USA; [Gough, Wendy H.; Lee, Jonathan A.] Eli Lilly & Co, Lilly Corp Ctr, Dept Quantitat Biol, Indianapolis, IN 46285 USA; [Foreman, Robert] Eli Lilly & Co, Lilly Corp Ctr, Dept In Vivo Pharmacol, Indianapolis, IN 46285 USA; [Hanson, Jeff C.] Eli Lilly & Co, Lilly Corp Ctr, Dept Informat Capabil, Indianapolis, IN 46285 USA; [McClure, Don B.] Eli Lilly & Co, Lilly Corp Ctr, Dept BioTDR, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly	Chintharlapalli, S (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Dept Canc Angiogenesis, Indianapolis, IN 46285 USA.	chintharlapalli_sudhakar@lilly.com			Lilly Research Laboratories; Eli Lilly and Company	Lilly Research Laboratories(Eli Lilly); Eli Lilly and Company(Eli Lilly)	All of the authors are employed with Eli Lilly and Company. The funder provided support in the form of salaries for all the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section.	Allen E, 2011, CLIN CANCER RES, V17, P5299, DOI 10.1158/1078-0432.CCR-10-2847; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cascone T, 2011, J CLIN INVEST, V121, P1313, DOI 10.1172/JCI42405; Chen YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-264; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; Falcon BL, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-31; Falcon BL, 2011, AM J PATHOL, V178, P2920, DOI 10.1016/j.ajpath.2011.02.019; Gerald D, 2013, CANCER RES, V73, P1649, DOI 10.1158/0008-5472.CAN-12-4697; Giavazzi R, 2003, AM J PATHOL, V162, P1913, DOI 10.1016/S0002-9440(10)64325-8; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Gourlaouen M, 2013, J BIOL CHEM, V288, P7467, DOI 10.1074/jbc.M112.446401; Kawai-Kowase K, 2004, ARTERIOSCL THROM VAS, V24, P1384, DOI 10.1161/01.ATV.0000136548.17816.07; Lee JA, 2013, J BIOMOL SCREEN; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Merfeld-Clauss S, 2010, TISSUE ENG PT A, V16, P2953, DOI [10.1089/ten.tea.2009.0635, 10.1089/ten.TEA.2009.0635]; MULLER G, 1987, P NATL ACAD SCI USA, V84, P5600, DOI 10.1073/pnas.84.16.5600; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Petit AMV, 1997, AM J PATHOL, V151, P1523; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; TAKEHARA K, 1987, CELL, V49, P415, DOI 10.1016/0092-8674(87)90294-7; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130	25	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106901	10.1371/journal.pone.0106901	http://dx.doi.org/10.1371/journal.pone.0106901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210890	Green Submitted, gold, Green Published			2022-12-27	WOS:000341855900028
J	Lin, CJ; Amano, T; Tang, Y; Tian, XC				Lin, Chih-Jen; Amano, Tomokazu; Tang, Yong; Tian, Xiuchun			Improved Derivation Efficiency and Pluripotency of Stem Cells from the Refractory Inbred C57BL/6 Mouse Strain by Small Molecules	PLOS ONE			English	Article							VENTRAL BODY-WALL; NUCLEAR TRANSFER; FERTILIZED BLASTOCYSTS; TETRAPLOID EMBRYOS; SELF-RENEWAL; IPS CELLS; ROCK-I; MICE; LINES; GENE	The ability of small molecules to maintain self-renewal and to inhibit differentiation of pluripotent stem cells has been well-demonstrated. Two widely used molecules are PD 98059 (PD), an inhibitor of extracellular-signal-regulated kinase 1 (ERK), and SC1 (Pluripotin), which inhibits the RasGAP and ERK pathways. However, no studies have been conducted to compare their effects on the pluripotency and derivation of embryonic stem (ES) cells from inbred mice C57BL/6, an important mouse strain frequently used to model behavior, cognitive functions, immune system, and metabolic disorders in humans and also the first mouse strain chosen to be sequenced for its entire genome. We found significantly increased derivation efficiency of ES cells from in vivo fertilized embryos (fES) of C57BL/6 with the use of PD (71.4% over the control of 35.3%). Because fES and ES from cloned embryos (ntES) are not distinguishable in transcription or translation profiles, we used ntES cells to compare the effect of small molecules on their in vitro characteristics, in vitro differentiation ability, and the ability to generate full-term ntES-4N pups by tetraploid complementation. NtES cells exhibited typical ES characteristics and up-regulated Sox2 expression in media with either small-molecule. Higher rates of full term ntES-4N pup were generated by the supplementation of PD or SC1. We obtained the highest efficiency of ntES-4N pup generation ever reported from this strain by supplementing ES medium with SC1. Lastly, we compared the pluripotency of fES, ntES and induced pluripotent stem (iPS) cells of C57BL/6 background using the tetraploid complementation assay. A significant increase in implantation sites and the number of full-term pups were obtained when fES, ntES, and iPS cells were cultured with SC1 compared to the control ES medium. In conclusion, supplementing ES cell culture medium with PD and SC1 increases the derivation efficiency and pluripotency, respectively, of stem cells derived from the refractory inbred C57BL/6 strain.	[Lin, Chih-Jen; Tang, Yong; Tian, Xiuchun] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; [Lin, Chih-Jen; Amano, Tomokazu; Tang, Yong; Tian, Xiuchun] Univ Connecticut, Stem Cell Inst, Storrs, CT USA	University of Connecticut; University of Connecticut	Tian, XC (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA.	xiuchun.tian@uconn.edu		Lin, Chih-Jen/0000-0003-4684-8747	USDA grant [1265-31000-091-02S]; USDA Regional Project [W2171]	USDA grant(United States Department of Agriculture (USDA)); USDA Regional Project	This study was supported by USDA grant (1265-31000-091-02S) and USDA Regional Project W2171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2009, CLONING STEM CELLS, V11, P77, DOI 10.1089/clo.2008.0059; Andang M, 2008, NAT PROTOC, V3, P1013, DOI 10.1038/nprot.2008.65; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Baharvand H, 2004, IN VITRO CELL DEV-AN, V40, P76, DOI 10.1290/1543-706X(2004)040<0076:CCDFEO>2.0.CO;2; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Chang CC, 2010, CELL REPROGRAM, V12, P43, DOI 10.1089/cell.2009.0043; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Ding JJ, 2009, PROTEOMICS, V9, P2711, DOI 10.1002/pmic.200800824; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; Huang J, 2011, CELL RES; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; KAWASE E, 1994, INT J DEV BIOL, V38, P385; Kim C, 2009, CLONING STEM CELLS, V11, P89, DOI 10.1089/clo.2008.0053; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lin CJ, 2010, BIOL REPROD, V83, P177, DOI 10.1095/biolreprod.110.084707; McWhir J, 1996, NAT GENET, V14, P223, DOI 10.1038/ng1096-223; Ohta H, 2008, REPRODUCTION, V136, P581, DOI 10.1530/REP-08-0184; Ohta H, 2008, BIOL REPROD, V79, P486, DOI 10.1095/biolreprod.107.067116; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Sharova LV, 2007, DEV BIOL, V307, P446, DOI 10.1016/j.ydbio.2007.05.004; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanimoto Y, 2008, COMPARATIVE MED, V58, P347; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Williams T, 2008, AM J MED GENET C, V148C, P186, DOI 10.1002/ajmg.c.30179; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yang W, 2009, STEM CELLS, V27, P383, DOI 10.1634/stemcells.2008-0974; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	37	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106916	10.1371/journal.pone.0106916	http://dx.doi.org/10.1371/journal.pone.0106916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211343	gold, Green Submitted, Green Published			2022-12-27	WOS:000341855900032
J	Young, S; Whitehorn, P; Berger, L; Skerratt, LF; Speare, R; Garland, S; Webb, R				Young, Sam; Whitehorn, Paul; Berger, Lee; Skerratt, Lee F.; Speare, Rick; Garland, Stephen; Webb, Rebecca			Defects in Host Immune Function in Tree Frogs with Chronic Chytridiomycosis	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; DEADLY CHYTRID FUNGUS; XENOPUS-LAEVIS; POPULATION DECLINES; AMPHIBIAN DECLINES; INFECTIOUS-DISEASE; SHEEP ERYTHROCYTES; EMERGING DISEASE; CLAWED TOAD; DEFENSES	The amphibian chytrid fungus Batrachochytrium dendrobatidis (Bd) has caused mass mortality leading to population declines and extinctions in many frog species worldwide. The lack of host resistance may be due to fungal immunosuppressive effects that have been observed when Bd is incubated with cultured lymphocytes, but whether in vivo host immunosuppression occurs is unknown. We used a broad range of hematologic and protein electrophoresis biomarkers, along with various functional tests, to assess immune competence in common green (Litoria caerulea) and white-lipped (L. infrafrenata) tree frogs experimentally infected with Bd. Compared with uninfected frogs, Bd infection in L. caerulea caused a reduction in immunoglobulin and splenic lymphocyte responses to antigenic stimulation with sheep red blood cells, along with decreased white blood cell and serum protein concentrations, indicating possible impaired immune response capability of Bd-infected frogs. This is the first in vivo study suggesting that infection with Bd causes multiple defects in systemic host immune function, and this may contribute to disease development in susceptible host species. Although L. infrafrenata failed to maintain Bd infection after exposure, white blood cell and serum globulin concentrations were lower in recovered frogs compared with unexposed frogs, but antigen-specific serum and splenic antibody, and splenic cellular, responses were similar in both recovered and unexposed frogs. This may indicate potential systemic costs associated with infection clearance and/or redirection of host resources towards more effective mechanisms to overcome infection. No clear mechanism for resistance was identified in L. infrafrenata, suggesting that localized and/or innate immune defense mechanisms may be important factors involved in disease resistance in this species.	[Young, Sam; Berger, Lee; Skerratt, Lee F.; Speare, Rick; Garland, Stephen; Webb, Rebecca] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia; [Young, Sam; Whitehorn, Paul] Mogo Zoo, Mogo, NSW, Australia	James Cook University	Young, S (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia.	sam.young@my.jcu.edu.au	Webb, Rebecca/GQZ-5902-2022	Webb, Rebecca/0000-0002-2539-2755; Speare, Rick/0000-0002-9993-1213; Skerratt, Lee/0000-0003-3471-7512; Berger, Lee/0000-0001-9227-5439	Australian Government Department of the Environment, Water, Heritage and the Arts [60776]; Australian Research Council [FT100100375, LP110200240]	Australian Government Department of the Environment, Water, Heritage and the Arts(Australian Government); Australian Research Council(Australian Research Council)	Funding was provided by the Australian Government Department of the Environment, Water, Heritage and the Arts (grant number 60776, www.environment.gov.au) and the Australian Research Council (grant numbers FT100100375 and LP110200240, www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEHLING UH, 1976, J IMMUNOL, V117, P847; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L., 1999, DECLINES DISAPPEARAN, V1999, P23; BLOMBERG B, 1980, EUR J IMMUNOL, V10, P869, DOI 10.1002/eji.1830101112; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Boyle DG, 2003, DIS AQUAT ORGAN, V56, P59, DOI 10.3354/dao056059; Brem FMR, 2008, DIS AQUAT ORGAN, V81, P189, DOI 10.3354/dao01960; Brown GP, 2011, METHODS ECOL EVOL, V2, P341, DOI 10.1111/j.2041-210X.2011.00090.x; Campbell T. W., 2007, AVIAN EXOTIC ANIMAL; Cashins SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056747; Chai LYA, 2009, MED MYCOL, V47, P227, DOI 10.1080/13693780802209082; CUNNINGHAM AJ, 1968, IMMUNOLOGY, V14, P599; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Davis A. K., 2010, Comparative Clinical Pathology, V19, P49, DOI 10.1007/s00580-009-0914-8; Dean JH, 1989, PRINCIPLES METHODS T, P741; Dhabhar FS, 1996, J IMMUNOL, V157, P1638; DRABKIN DL, 1945, AM J MED SCI, V209, P268; Du Pasquier L, 2000, IMMUNOL REV, V175, P201, DOI 10.1034/j.1600-065X.2000.017501.x; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; FAIRBROTHER A, 1990, ARCH ENVIRON CON TOX, V19, P836, DOI 10.1007/BF01055048; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; GARRIDO E, 1987, DEV COMP IMMUNOL, V11, P375, DOI 10.1016/0145-305X(87)90081-4; GEARING AJH, 1984, J EMBRYOL EXP MORPH, V84, P287; Gilbertson MK, 2003, ENVIRON TOXICOL CHEM, V22, P101, DOI [10.1002/etc.5620220113, 10.1897/1551-5028(2003)022&lt;0101:IITNLF&gt;2.0.CO;2]; Grasman KA, 2002, INTEGR COMP BIOL, V42, P34, DOI 10.1093/icb/42.1.34; HORTON JD, 1976, J EXP ZOOL, V196, P243, DOI 10.1002/jez.1401960211; Jackway RJ, 2011, PEPTIDES, V32, P161, DOI 10.1016/j.peptides.2010.09.019; JERNE NK, 1963, SCIENCE, V140, P405, DOI 10.1126/science.140.3565.405; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Kinney KS, 2005, DEV COMP IMMUNOL, V29, P287, DOI 10.1016/j.dci.2004.08.001; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; McDonald K. R., 2005, PAC CONSERV BIOL, V11, P114, DOI DOI 10.1071/PC050114; MELROSE WD, 1995, COMP HAEMATOL INT, V5, P7, DOI 10.1007/BF00214484; NATT MP, 1952, POULTRY SCI, V31, P735, DOI 10.3382/ps.0310735; Pappenheimer AM, 1917, J EXP MED, V25, P633, DOI 10.1084/jem.25.5.633; Peterson JD, 2011, INTEGR COMP BIOL, V51, pE108; Peterson JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062146; PFEIFFER CJ, 1990, J ZOO WILDLIFE MED, V21, P56; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; ROLLINSSMITH LA, 1984, IMMUNOLOGY, V52, P491; ROLLINSSMITH LA, 1993, DIFFERENTIATION, V54, P155, DOI 10.1111/j.1432-0436.1993.tb01598.x; Rosenberg CE, 2002, J PHARMACOL TOXICOL, V47, P121, DOI 10.1016/S1056-8719(02)00216-2; Rosenblum EB, 2012, MOL ECOL, V21, P3110, DOI 10.1111/j.1365-294X.2012.05481.x; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Speare R, 2004, AUST VET J, V82, P300, DOI 10.1111/j.1751-0813.2004.tb12710.x; STADECKER MJ, 1977, J IMMUNOL, V118, P1564; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Strober W., 1997, CURR PROTOC IMMUNOL, V21, DOI DOI 10.1002/0471142735.IMA03AS21/FULL; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Whittington RJ, 1996, DIS AQUAT ORGAN, V26, P59, DOI 10.3354/dao026059; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Wright K. M., 2001, Amphibian medicine and captive husbandry, P129; Wright Kevin M., 2001, P309; Young S, 2012, THESIS J COOK U; Young S, 2012, VET CLIN PATH, V41, P478, DOI 10.1111/j.1939-165X.2012.00470.x; Young S, 2012, J ZOO WILDLIFE MED, V43, P330, DOI 10.1638/2011-0231.1; Zaalberg OB, 1964, NATURE, V202, P1213; Zaias Julia, 2002, Journal of Herpetological Medicine and Surgery, V12, P30; ZETTERGREN LD, 1991, TOXICOL LETT, V55, P11, DOI 10.1016/0378-4274(91)90022-X	72	14	14	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107284	10.1371/journal.pone.0107284	http://dx.doi.org/10.1371/journal.pone.0107284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211333	gold, Green Published, Green Accepted			2022-12-27	WOS:000341855900056
J	Francischetti, IMB; Ma, DY; Andersen, JF; Ribeiro, JMC				Francischetti, Ivo M. B.; Ma, Dongying; Andersen, John F.; Ribeiro, Jose M. C.			Evidence for a Lectin Specific for Sulfated Glycans in the Salivary Gland of the Malaria Vector, Anopheles gambiae	PLOS ONE			English	Article							BAT DESMODUS-ROTUNDUS; PLATELET-AGGREGATION; INFLAMMATORY RESPONSE; RHODNIUS-PROLIXUS; IMMUNE-RESPONSE; BRUGIA-MALAYI; HEMAGGLUTININS; PROTEINS; MOSQUITO; BINDING	Salivary gland homogenate (SGH) from the female mosquitoes Anopheles gambiae, An. stephensi, An. freeborni, An. dirus and An. albimanus were found to exhibit hemagglutinating (lectin) activity. Lectin activity was not found for male An. gambiae, or female Ae aegypti, Culex quinquefasciatus, Phlebotomus duboscqi, and Lutzomyia longipalpis. With respect to species-specificity, An. gambiae SGH agglutinates red blood cells (RBC) from humans, horse, sheep, goat, pig, and cow; it is less active for rats RBC, and not detectable for guinea-pigs or chicken RBC. Notably, lectin activity was inhibited by low concentrations of dextran sulfate 50-500 K, fucoidan, heparin, laminin, heparin sulfate proteoglycan, sialyl-containing glycans (e.g. 3'-sialyl Lewis X, and 6'-sialyl lactose), and gangliosides (e.g. GM3, GD1, GD1b, GTB1, GM1, GQ1B), but not by simple sugars. These results imply that molecule(s) in the salivary gland target sulfated glycans. SGH from An. gambiae was also found to promote agglutination of HL-60 cells which are rich in sialyl Lewis X, a glycan that decorates PSGL-1, the neutrophils receptor that interacts with endothelial cell P-selectin. Accordingly, SGH interferes with HL-60 cells adhesion to immobilized P-selectin. Because An. gambiae SGH expresses galectins, one member of this family (herein named Agalectin) was expressed in E. coli. Recombinant Agalectin behaves as a non-covalent homodimer. It does not display lectin activity, and does not interact with 500 candidates tested in a Glycan microarray. Gel-filtration chromatography of the SGH of An. gambiae identified a fraction with hemagglutinating activity, which was analyzed by 1D PAGE followed by in-gel tryptic digestion, and nano-LC MS/MS. This approach identified several genes which emerge as candidates for a lectin targeting sulfated glycans, the first with this selectivity to be reported in the SGH of a blood-sucking arthropod. The role of salivary molecules (sialogenins) with lectin activity is discussed in the context of inflammation, and parasite-vector-host interactions.	[Francischetti, Ivo M. B.; Ma, Dongying; Andersen, John F.; Ribeiro, Jose M. C.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Francischetti, IMB (corresponding author), NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ivofrancischetti@gmail.com		Ribeiro, Jose/0000-0002-9107-0818	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RN, 2009, J INSECT PHYSIOL, V55, P862, DOI 10.1016/j.jinsphys.2009.06.002; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Assumpcao TCF, 2013, J BIOL CHEM, V288, P14341, DOI 10.1074/jbc.M113.466995; Assumpcao TCF, 2010, J BIOL CHEM, V285, P39001, DOI 10.1074/jbc.M110.152835; Basseri HR, 2002, EXP PARASITOL, V100, P226, DOI 10.1016/S0014-4894(02)00026-7; Brennan JDG, 2000, P NATL ACAD SCI USA, V97, P13859, DOI 10.1073/pnas.250472597; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Choumet V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050464; Clemetson KJ, 2010, TOXICON, V56, P1236, DOI 10.1016/j.toxicon.2010.03.011; Demeure CE, 2005, J IMMUNOL, V174, P3932, DOI 10.4049/jimmunol.174.7.3932; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Francischetti IMB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087140; Francischetti IMB, 2013, J PROTEOMICS, V82, P288, DOI 10.1016/j.jprot.2013.01.009; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Ghosh AK, 2009, CURR OPIN MICROBIOL, V12, P394, DOI 10.1016/j.mib.2009.06.010; Grubhoffer L, 1997, PARASITE, V4, P203, DOI 10.1051/parasite/1997043203; HUDSON A, 1964, CAN J ZOOLOG, V42, P113, DOI 10.1139/z64-011; Jacobs T, 2010, EUR J CELL BIOL, V89, P113, DOI 10.1016/j.ejcb.2009.10.006; James AA, 2003, J EXP BIOL, V206, P3817, DOI 10.1242/jeb.00616; Koh CY, 2009, THROMB HAEMOSTASIS, V102, P437, DOI 10.1160/TH09-04-0221; Liu FT, 2012, ANN NY ACAD SCI, V1253, P80, DOI 10.1111/j.1749-6632.2011.06386.x; Ma DY, 2013, BLOOD, V122, P4094, DOI 10.1182/blood-2013-08-517474; Matuschewski K, 2006, CELL MICROBIOL, V8, P1547, DOI 10.1111/j.1462-5822.2006.00778.x; Metcalf R. L., 1945, JOUR NATION MALARIA SOC, V4, P271; MOHAMED HA, 1992, MED VET ENTOMOL, V6, P217, DOI 10.1111/j.1365-2915.1992.tb00609.x; Nayar JK, 1997, COMP BIOCHEM PHYS A, V118, P1321, DOI 10.1016/S0300-9629(97)00246-6; Nayar JK, 1997, COMP BIOCHEM PHYS B, V116, P109, DOI 10.1016/S0305-0491(96)00211-8; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Owhashi M, 2001, PARASITOL RES, V87, P376, DOI 10.1007/s004360000355; Ribeiro JMC, 1999, J EXP BIOL, V202, P809; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIEU P, 1994, J CELL BIOL, V127, P2081, DOI 10.1083/jcb.127.6.2081; SHUTE P. G., 1935, JOUR TROP MED AND HYG, V38, P277; Soares AC, 2014, PARASITOL INT, V63, P229, DOI 10.1016/j.parint.2013.07.001; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Yoshida S, 2007, PLOS PATHOG, V3, P1962, DOI 10.1371/journal.ppat.0030192; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566	40	16	16	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107295	10.1371/journal.pone.0107295	http://dx.doi.org/10.1371/journal.pone.0107295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207644	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300071
J	Jin, X; Deng, M; Kaps, SR; Zhu, XW; Holken, I; Mess, K; Adelung, R; Mishra, YK				Jin, Xin; Deng, Mao; Kaps, Soeren; Zhu, Xinwei; Hoelken, Iris; Mess, Kristin; Adelung, Rainer; Mishra, Yogendra Kumar			Study of Tetrapodal ZnO-PDMS Composites: A Comparison of Fillers Shapes in Stiffness and Hydrophobicity Improvements	PLOS ONE			English	Article							POLYMER COMPOSITES; PARTICLE-SIZE; SURFACES; ADHESION; NANO; NANOSTRUCTURES; NANOCOMPOSITES; FABRICATION; NETWORKS; RESISTANCE	ZnO particles of different size and structures were used as fillers to modify the silicone rubber, in order to reveal the effect of the filler shape in the polymer composites. Tetrapodal shaped microparticles, short microfibers/whiskers, and nanosized spherical particles from ZnO have been used as fillers to fabricate the different ZnO-Silicone composites. The detailed microstructures of the fillers as well as synthesized composites using scanning electron microscopy have been presented here. The tensile elastic modulus and water contact angle, which are important parameters for bio-mimetic applications, of fabricated composites with different fillers have been measured and compared. Among all three types of fillers, tetrapodal shaped ZnO microparticles showed the best performance in terms of increase in hydrophobicity of material cross-section as well as the stiffness of the composites. It has been demonstrated that the tetrapodal shaped microparticles gain their advantage due to the special shape, which avoids agglomeration problems as in the case for nanoparticles, and the difficulty of achieving truly random distribution for whisker fillers.	[Jin, Xin; Deng, Mao; Kaps, Soeren; Zhu, Xinwei; Hoelken, Iris; Mess, Kristin; Adelung, Rainer; Mishra, Yogendra Kumar] Univ Kiel, Inst Mat Sci, Kiel, Germany	University of Kiel	Mishra, YK (corresponding author), Univ Kiel, Inst Mat Sci, Kiel, Germany.	ykm@tf.uni-kiel.de	Mishra, Yogendra Kumar/G-6241-2010; Adelung, Rainer/AAU-1027-2021	Mishra, Yogendra Kumar/0000-0002-8786-9379; Adelung, Rainer/0000-0002-2617-678X	German Research Foundation (DFG) [SFB 677-C10, SFB 855-A5, Ad/183/10-1]; EU	German Research Foundation (DFG)(German Research Foundation (DFG)); EU(European Commission)	This research was sponsored by the German Research Foundation (DFG) under the schemes SFB 677-C10, SFB 855-A5, Ad/183/10-1. Furthermore the financial support from EU Graphene Flagship is also appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Boesel LF, 2010, ADV MATER, V22, P2125, DOI 10.1002/adma.200903200; Breuer O, 2004, POLYM COMPOSITE, V25, P630, DOI 10.1002/pc.20058; Cadek M, 2004, NANO LETT, V4, P353, DOI 10.1021/nl035009o; Devan RS, 2012, ADV FUNCT MATER, V22, P3326, DOI 10.1002/adfm.201201008; Fiedler B, 2006, COMPOS SCI TECHNOL, V66, P3115, DOI 10.1016/j.compscitech.2005.01.014; Fu SY, 2008, COMPOS PART B-ENG, V39, P933, DOI 10.1016/j.compositesb.2008.01.002; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; Genzer J, 2008, MRS BULL, V33, P742, DOI 10.1557/mrs2008.159; Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104; Gorrasi G, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40441; Hu GS, 2009, MAT SCI ENG A-STRUCT, V504, P8, DOI 10.1016/j.msea.2008.12.025; Hussain F, 2006, J COMPOS MATER, V40, P1511, DOI 10.1177/0021998306067321; ISAYEV AI, 1987, POLYM COMPOSITE, V8, P158, DOI 10.1002/pc.750080305; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Jin X, 2012, ADV MATER, V24, P5676, DOI 10.1002/adma.201201780; Jones R.M., 1999, MECH COMPOS MATER, V2nd, DOI DOI 10.1201/9781498711067; Lee J, 2008, J R SOC INTERFACE, V5, P835, DOI 10.1098/rsif.2007.1308; Li J, 2011, COLLOID SURFACE A, V384, P109, DOI 10.1016/j.colsurfa.2011.03.024; Lipatov Y. S., 1995, POLYM REINFORCEMENT; Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105; Mannov E, 2013, COMPOS SCI TECHNOL, V87, P36, DOI 10.1016/j.compscitech.2013.07.019; Menon C, 2004, GECKO INSPIRED SURFA, P431; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Mishra YK, 2013, PART PART SYST CHAR, V30, P775, DOI 10.1002/ppsc.201300197; Mishra YK, 2014, KONA POWDER PART J, P92; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Moczo J, 2008, J IND ENG CHEM, V14, P535, DOI 10.1016/j.jiec.2008.06.011; Murphy MP, 2009, ACS APPL MATER INTER, V1, P849, DOI 10.1021/am8002439; Pantani R, 2013, EUR POLYM J, V49, P3471, DOI 10.1016/j.eurpolymj.2013.08.005; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Paul DR, 2008, POLYMER, V49, P3187, DOI 10.1016/j.polymer.2008.04.017; Pavlidou S, 2008, PROG POLYM SCI, V33, P1119, DOI 10.1016/j.progpolymsci.2008.07.008; Potschke P, 2013, COMPOS SCI TECHNOL, V74, P78, DOI 10.1016/j.compscitech.2012.10.010; Raquez JM, 2013, PROG POLYM SCI, V38, P1504, DOI 10.1016/j.progpolymsci.2013.05.014; Reddy S, 2007, ADV MATER, V19, P3833, DOI 10.1002/adma.200700733; Reimer T, 2014, ACS APPL MATER INTER, V6, P7806, DOI 10.1021/am5010877; Ronning C, 2005, J APPL PHYS, V98, DOI 10.1063/1.1997290; Wagner HD, 2007, NAT NANOTECHNOL, V2, P742, DOI 10.1038/nnano.2007.401; Wagner HD, 2013, COMPOS SCI TECHNOL, V83, P27, DOI 10.1016/j.compscitech.2013.04.017; Wang ZL, 2009, MAT SCI ENG R, V64, P33, DOI 10.1016/j.mser.2009.02.001; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Wichmann MHG, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/47/475503; Wong M, 2003, POLYMER, V44, P7757, DOI 10.1016/j.polymer.2003.10.011; Xia F, 2008, ADV MATER, V20, P2842, DOI 10.1002/adma.200800836; Zeng HB, 2010, ADV FUNCT MATER, V20, P561, DOI 10.1002/adfm.200901884; Zhou WY, 2007, J APPL POLYM SCI, V104, P1312, DOI 10.1002/app.25789; Zhou ZW, 2005, MATER SCI FORUM, V475-479, P1033, DOI 10.4028/www.scientific.net/MSF.475-479.1033; Zhou ZW, 1999, J MATER PROCESS TECH, V90, P415, DOI 10.1016/S0924-0136(99)00003-5; Zhou ZW, 2001, J APPL POLYM SCI, V80, P1520, DOI 10.1002/app.1243	51	39	40	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106991	10.1371/journal.pone.0106991	http://dx.doi.org/10.1371/journal.pone.0106991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208080	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300052
J	Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Leithner, A; Pichler, M				Szkandera, Joanna; Gerger, Armin; Liegl-Atzwanger, Bernadette; Stotz, Michael; Samonigg, Hellmut; Ploner, Ferdinand; Stojakovic, Tatjana; Leithner, Andreas; Pichler, Martin			Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients	PLOS ONE			English	Article							SERUM HEMOGLOBIN LEVEL; TUMOR OXYGENATION; CANCER-PATIENTS; SURVIVAL; PREDICTS; RATIO	Background: Anemia refers to low hemoglobin (Hb) levels, represents a common symptom and complication in cancer patients and was reported to negatively influence survival in patients with various malignancies. In the present study, we aimed to explore the prognostic impact of pre-operative Hb levels on clinical outcome in a large cohort of soft tissue sarcoma (STS) patients after curative surgery. Methods: Retrospective data from 367 STS patients, which were operated between 1998 and 2013, were included in the study. Cut-off levels for anemia were defined as Hb<13 g/dl in males and Hb<12 g/dl in females according to the current WHO guidelines. The impact of pre-operative Hb levels on cancer-specific survival (CSS) and overall survival (OS) was assessed using Kaplan-Meier curves. Additionally, Hb levels were compared for the prognostic influence on CSS and OS applying univariate and multivariate Cox proportional models. Results: Hb level was associated with established prognostic factors, including age, tumor grade, size and depth (p<0.05). Kaplan-Meier curves showed that low Hb levels were significantly associated with decreased CSS and OS in STS patients (p<0.001 for both endpoints, log-rank test). In multivariate analysis, we found an independent association between low Hb levels and poor CSS and OS (HR = 0.46, CI 95% = 0.25-0.85, p = 0.012; HR = 0.34, CI 95% = 0.23-0.51, p<0.001). Conclusion: The present data underline a negative prognostic impact of low pre-operative Hb levels on clinical outcome in STS patients. Thus, Hb levels may provide an additional and cost-effective tool to discriminate between STS patients that are at high risk of mortality.	[Szkandera, Joanna; Gerger, Armin; Stotz, Michael; Samonigg, Hellmut; Ploner, Ferdinand; Pichler, Martin] Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria; [Liegl-Atzwanger, Bernadette] Med Univ Graz, Inst Pathol, Graz, Austria; [Stojakovic, Tatjana] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Leithner, Andreas] Med Univ Graz, Dept Orthopaed Surg, Graz, Austria; [Szkandera, Joanna; Gerger, Armin; Stotz, Michael] Med Univ Graz, Dept Med, Div Clin Oncol, Res Unit Genet Epidemiol & Pharmacogenet, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Pichler, M (corresponding author), Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria.	martin.pichler@medunigraz.at		Szkandera, Joanna/0000-0002-2217-893X; Pichler, Martin/0000-0002-8701-9462				Adamson John W, 2008, Hematology Am Soc Hematol Educ Program, P159, DOI 10.1182/asheducation-2008.1.159; Aoe K, 2005, INTERNAL MED, V44, P800, DOI 10.2169/internalmedicine.44.800; Brizel DM, 1996, CANCER RES, V56, P941; Coindre JM, 2006, ARCH PATHOL LAB MED, V130, P1448; Cormier JN, 2004, CA-CANCER J CLIN, V54, P94, DOI 10.3322/canjclin.54.2.94; De Benoist B., 2008, WORLDWIDE PREVALENCE, V4; Dicato M, 2010, ANN ONCOL, V21, P167, DOI 10.1093/annonc/mdq284; Kattan MW, 2002, J CLIN ONCOL, V20, P791, DOI 10.1200/JCO.2002.20.3.791; Knight K, 2004, AM J MED, V116, P11, DOI 10.1016/j.amjmed.2003.12.008; Liegl-Atzwanger B, 2009, EUR SURG, V41, P143, DOI 10.1007/s10353-009-0474-9; Ludwig H, 1998, SEMIN ONCOL, V25, P2; MILLER CB, 1990, NEW ENGL J MED, V322, P1689, DOI 10.1056/NEJM199006143222401; Nakamura T, 2013, J ORTHOP SCI, V18, P987, DOI 10.1007/s00776-013-0454-6; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; NIEKEN J, 1995, BLOOD, V86, P900, DOI 10.1182/blood.V86.3.900.bloodjournal863900; Nordsmark M, 1996, INT J RADIAT ONCOL, V35, P701, DOI 10.1016/0360-3016(96)00132-0; Obermair A, 1998, CANCER-AM CANCER SOC, V83, P726, DOI 10.1002/(SICI)1097-0142(19980815)83:4<726::AID-CNCR14>3.0.CO;2-U; Ruiz-Tovar J, 2011, CIR CIR, V79, P313; Rutkowski P, 2002, INT J CANCER, V100, P463, DOI 10.1002/ijc.10496; Steensma DP, 2008, J CLIN ONCOL, V26, P1022, DOI 10.1200/JCO.2007.15.3874; Stotz M, 2014, BRIT J CANCER, V110, P435, DOI 10.1038/bjc.2013.785; Szkandera J, 2013, BRIT J CANCER, V109, P2316, DOI 10.1038/bjc.2013.595; Szkandera J, 2013, BRIT J CANCER, V108, P1677, DOI 10.1038/bjc.2013.135; Vaupel P, 2006, STRAHLENTHER ONKOL, V182, P63, DOI 10.1007/s00066-006-1543-7; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10	26	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107297	10.1371/journal.pone.0107297	http://dx.doi.org/10.1371/journal.pone.0107297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207808	Green Submitted, gold, Green Published			2022-12-27	WOS:000342030300072
J	Zhu, XY; Bouffanais, R; Yue, DKP				Zhu, Xiaoying; Bouffanais, Roland; Yue, Dick K. P.			Persistent Cellular Motion Control and Trapping Using Mechanotactic Signaling	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM CELLS; FLUID SHEAR-STRESS; SOLID SUBSTRATE; MOVEMENT; CHEMOTAXIS; MECHANICS; MOTILITY; CALCIUM; LEUKOCYTES; PSEUDOPOD	Chemotactic signaling and the associated directed cell migration have been extensively studied owing to their importance in emergent processes of cellular aggregation. In contrast, mechanotactic signaling has been relatively overlooked despite its potential for unique ways to artificially signal cells with the aim to effectively gain control over their motile behavior. The possibility of mimicking cellular mechanotactic signals offers a fascinating novel strategy to achieve targeted cell delivery for in vitro tissue growth if proven to be effective with mammalian cells. Using (i) optimal level of extracellular calcium ([Ca2+](ext)=3 mM) we found, (ii) controllable fluid shear stress of low magnitude (sigma < 0.5 Pa), and (iii) the ability to swiftly reverse flow direction (within one second), we are able to successfully signal Dictyostelium discoideum amoebae and trigger migratory responses with heretofore unreported control and precision. Specifically, we are able to systematically determine the mechanical input signal required to achieve any predetermined sequences of steps including straightforward motion, reversal and trapping. The mechanotactic cellular trapping is achieved for the first time and is associated with a stalling frequency of 0: 06 similar to 0: 1 Hz for a reversing direction mechanostimulus, above which the cells are effectively trapped while maintaining a high level of directional sensing. The value of this frequency is very close to the stalling frequency recently reported for chemotactic cell trapping [Meier B, et al. (2011) Proc Natl Acad Sci USA 108:11417-11422], suggesting that the limiting factor may be the slowness of the internal chemically-based motility apparatus.	[Zhu, Xiaoying; Bouffanais, Roland] Singapore Univ Technol & Design, Singapore, Singapore; [Zhu, Xiaoying; Bouffanais, Roland; Yue, Dick K. P.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Singapore University of Technology & Design; Massachusetts Institute of Technology (MIT)	Bouffanais, R (corresponding author), Singapore Univ Technol & Design, Singapore, Singapore.	bouffanais@sutd.edu.sg	Bouffanais, Roland/L-3460-2013	Bouffanais, Roland/0000-0002-2507-4642; Yue, Dick/0000-0003-1273-9964	SUTD-MIT International Design Centre (IDC) Grant [IDG31400104]	SUTD-MIT International Design Centre (IDC) Grant	Funding provided by SUTD-MIT International Design Centre (IDC) Grant IDG31400104 (XZ & RB). http://idc.sutd.edu.sg/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnadottir J, ANN REV BIOPHYS, P111; Bouffanais R, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052716; Coughlin MF, 2004, BIOPHYS J, V87, P2035, DOI 10.1529/biophysj.104.042192; Dalous J, 2008, BIOPHYS J, V94, P1063, DOI 10.1529/biophysj.107.114702; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Decave E, 2003, J CELL SCI, V116, P4331, DOI 10.1242/jcs.00726; Decave E, 2002, BIOPHYS J, V82, P2383, DOI 10.1016/S0006-3495(02)75583-5; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Fache S, 2005, J CELL SCI, V118, P3445, DOI 10.1242/jcs.02461; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Hardin J, 2004, CURR OPIN GENET DEV, V14, P399, DOI 10.1016/j.gde.2004.06.008; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Kamm RD, 2002, ANNU REV FLUID MECH, V34, P211, DOI 10.1146/annurev.fluid.34.082401.165302; Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lombardi ML, 2008, EXP CELL RES, V314, P1850, DOI 10.1016/j.yexcr.2008.02.001; Lusche DF, 2009, CELL MOTIL CYTOSKEL, V66, P567, DOI 10.1002/cm.20367; Makino A, 2006, AM J PHYSIOL-CELL PH, V290, pC1633, DOI 10.1152/ajpcell.00576.2005; McLaughlin SB, 1999, CALCIUM PHYSL TERRES; Meier B, 2011, P NATL ACAD SCI USA, V108, P11417, DOI 10.1073/pnas.1014853108; Moraes C, 2012, ANN BIOMED ENG, V40, P1211, DOI 10.1007/s10439-011-0455-6; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]; Polacheck WJ, 2011, P NATL ACAD SCI USA, V108, P11115, DOI 10.1073/pnas.1103581108; Riviere C, 2007, J BIOMECH, V40, P64, DOI 10.1016/j.jbiomech.2005.11.012; Scherer A, 2010, J CELL SCI, V123, P3756, DOI 10.1242/jcs.068619; Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304; Thery M, 2011, WORLD CELL RACE; Van der Heiden K, 2006, DEV DYNAM, V235, P19, DOI 10.1002/dvdy.20557; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Wilhelm C, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041906	32	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e105406	10.1371/journal.pone.0105406	http://dx.doi.org/10.1371/journal.pone.0105406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207940	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300009
J	Chinello, C; Cazzaniga, M; De Sio, G; Smith, AJ; Gianazza, E; Grasso, A; Rocco, F; Signorini, S; Grasso, M; Bosari, S; Zoppis, I; Dakna, M; van der Burgt, YEM; Mauri, G; Magni, F				Chinello, Clizia; Cazzaniga, Marta; De Sio, Gabriele; Smith, Andrew James; Gianazza, Erica; Grasso, Angelica; Rocco, Francesco; Signorini, Stefano; Grasso, Marco; Bosari, Silvano; Zoppis, Italo; Dakna, Mohammed; van der Burgt, Yuri E. M.; Mauri, Giancarlo; Magni, Fulvio			Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches	PLOS ONE			English	Article							METALLOPROTEASES MEPRIN-ALPHA; PROTEIN-COUPLED RECEPTORS; BIOMARKER DISCOVERY; TOF-MS; KIDNEY-DISEASE; SELDI-TOF; CANCER; EXPRESSION; IDENTIFICATION; OSTEOPONTIN	Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's lifespan only for early stage tumours. Moreover, solid renal masses cannot be confidently differentiated from RCC. Therefore, markers to distinguish malignant kidney tumours and for their detection are needed. Two different peptide signatures were obtained by a MALDI-TOF profiling approach based on urine pre-purification by C8 magnetic beads. One cluster of 12 signals could differentiate malignant tumours (n = 137) from benign renal masses and controls (n = 153) with sensitivity of 76% and specificity of 87% in the validation set. A second cluster of 12 signals distinguished clear cell RCC (n = 118) from controls (n = 137) with sensitivity and specificity values of 84% and 91%, respectively. Most of the peptide signals used in the two models were observed at higher abundance in patient urines and could be identified as fragments of proteins involved in tumour pathogenesis and progression. Among them: the Meprin 1 alpha with a pro-angiogenic activity, the Probable G-protein coupled receptor 162, belonging to the GPCRs family and known to be associated with several key functions in cancer, the Osteopontin that strongly correlates to tumour stages and invasiveness, the Phosphorylase b kinase regulatory subunit alpha and the SeCreted and TransMembrane protein 1.	[Chinello, Clizia; Cazzaniga, Marta; De Sio, Gabriele; Smith, Andrew James; Gianazza, Erica; Magni, Fulvio] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy; [Grasso, Angelica; Rocco, Francesco] Osped Maggiore Policlin Fdn, Dept Specialist Surg Sci, Urol unit, Milan, Italy; [Signorini, Stefano] Hosp Desio, Dept Lab Med, Desio, Italy; [Grasso, Marco] Azienda Osped San Gerardo, Dept Surg Pathol Cytol Med Genet & Nephropathol, Monza, Italy; [Bosari, Silvano] Osped Maggiore Policlin Fdn Milano, Dept Med Surg & Dent Sci, Pathol Unit, Milan, Italy; [Zoppis, Italo; Mauri, Giancarlo] Univ Milano Bicocca, Dept Informat Syst & Commun, Milan, Italy; [Dakna, Mohammed] Mosa Diagnost GmbH, Hannover, Germany; [van der Burgt, Yuri E. M.] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands	University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milano-Bicocca; Modular Open Systems Approach (MOSA) Solutions; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Chinello, C (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy.	clizia.chinello@unimib.it	Bosari, Silvano/K-7744-2016; van der Burgt, Yuri/I-1149-2016; Mauri, Giancarlo/M-3258-2013; SMITH, ANDREW JAMES/AAF-7926-2020; Magni, Fulvio/A-7340-2014; GIANAZZA, ERICA/G-5249-2018	Bosari, Silvano/0000-0002-9744-6951; van der Burgt, Yuri/0000-0003-0556-5564; Mauri, Giancarlo/0000-0003-3520-4022; SMITH, ANDREW JAMES/0000-0001-6530-6113; Magni, Fulvio/0000-0002-8663-0374; GIANAZZA, ERICA/0000-0003-2370-947X; Chinello, Clizia/0000-0002-7921-7768; CAZZANIGA, MARTA/0000-0003-2240-5466; ZOPPIS, ITALO FRANCESCO/0000-0001-7312-7123	Italian Ministry of University and Research: FIRB [RBRN07BMCT_11]; Fondi Ateneo; EuroKUP COST Action Mass Spectrometry Imaging: New Tools for Healthcare Research [BM1104]; European Union [FP7-PEOPLE-2013-ITN-608332]	Italian Ministry of University and Research: FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Fondi Ateneo; EuroKUP COST Action Mass Spectrometry Imaging: New Tools for Healthcare Research; European Union(European Commission)	FM was supported by grants from the Italian Ministry of University and Research: FIRB 2007 (Rete nazionale per lo studio del proteoma umano, no. RBRN07BMCT_11; http://www.ihpnet.it), Fondi Ateneo 2010-2013 (http://www.unimib.it/), and in part by the EuroKUP COST Action (BM1104) Mass Spectrometry Imaging: New Tools for Healthcare Research (http://www.maldi-msi.org/). The research leading to these results has also received funding from the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement FP7-PEOPLE-2013-ITN-608332 (http://www.imodeckd.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2011, EXPERT REV PROTEOMIC, V8, P615, DOI [10.1586/EPR.11.46, 10.1586/epr.11.46]; Algaba F, 2011, EUR UROL, V60, P634, DOI 10.1016/j.eururo.2011.06.047; Alves G, 2013, INT BRAZ J UROL, V39, P228, DOI 10.1590/S1677-5538.IBJU.2013.02.12; Anborgh PH, 2010, J CELL MOL MED, V14, P2037, DOI 10.1111/j.1582-4934.2010.01115.x; Balog CI, 2009, CLIN CHEM, V55, P117, DOI 10.1373/clinchem.2008.108795; Banyra Oleg, 2014, Cent European J Urol, V66, P394, DOI 10.5173/ceju.2013.04.art2; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Bleyer AJ, 2004, KIDNEY INT, V66, P974, DOI 10.1111/j.1523-1755.2004.00845.x; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Bosso N, 2008, PROTEOM CLIN APPL, V2, P1036, DOI 10.1002/prca.200780139; Boulatnikov IG, 2009, BIOCHEMISTRY-US, V48, P10183, DOI 10.1021/bi901429y; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Bylander J, 2008, AM J PHYSIOL-RENAL, V294, pF480, DOI 10.1152/ajprenal.00214.2007; Cava C., 2013, COPY NUMBER ALTERATI, P104; Chinello C, 2010, UROLOGY, V75, P842, DOI 10.1016/j.urology.2009.09.050; Cifola I, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-6; Coppola D, 2004, CLIN CANCER RES, V10, P184, DOI 10.1158/1078-0432.CCR-1405-2; Cosgrove S, 2011, J BIOL CHEM, V286, P7692, DOI 10.1074/jbc.M110.183863; CRAIG SS, 1987, AM J PHYSIOL, V253, pC535, DOI 10.1152/ajpcell.1987.253.4.C535; Del Boccio P, 2012, ELECTROPHORESIS, V33, P689, DOI 10.1002/elps.201100375; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dziuda DM, 2010, DATA MINING GENOMICS; Echaniz-Laguna A, 2010, NEUROMUSCULAR DISORD, V20, P125, DOI 10.1016/j.nmd.2009.11.004; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Frantzi M, 2014, J PROTEOMICS, V98, P44, DOI 10.1016/j.jprot.2013.12.010; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; Gianazza E, 2010, J PROTEOMICS, V73, P593, DOI 10.1016/j.jprot.2009.07.006; Gianazza E, 2012, J PROTEOMICS, V76, P125, DOI 10.1016/j.jprot.2012.07.032; Han WK, 2005, J AM SOC NEPHROL, V16, P1126, DOI 10.1681/ASN.2004070530; Heinzelmann-Schwarz VA, 2007, J CLIN PATHOL, V60, P622, DOI 10.1136/jcp.2005.034223; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Kaya K, 2005, SCAND J UROL NEPHROL, V39, P25, DOI 10.1080/00365590410002500; Klein J, 2014, ELECTROPHORESIS, V35, P1060, DOI 10.1002/elps.201300327; Kuk C, 2009, MOL CELL PROTEOMICS, V8, P661, DOI 10.1074/mcp.M800313-MCP200; Lapolla A, 2009, J MASS SPECTROM, V44, P419, DOI 10.1002/jms.1520; Lewis G., 2012, PRACTITIONER, V256, P12; Lewis Gareth, 2012, Practitioner, V256, P13; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026450; Lucin K, 2004, CROAT MED J, V45, P703; M'Koma AE, 2007, BIOCHEM BIOPH RES CO, V353, P829, DOI 10.1016/j.bbrc.2006.12.111; Mainini V, 2012, MOL BIOSYST, V8, P959, DOI 10.1039/c1mb05377a; Matters GL, 2005, CLIN EXP METASTAS, V22, P331, DOI 10.1007/s10585-005-0660-5; Mierswa I, 2006, YALE RAPID PROTOTYPI, P935; Minamida S, 2011, ANAL BIOANAL CHEM, V401, P245, DOI 10.1007/s00216-011-5057-5; Minder P, 2012, J BIOL CHEM, V287, P35201, DOI 10.1074/jbc.M112.368910; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Molin L, 2012, J PROTEOMICS; Morrissey JJ, 2014, UROLOGY, V83, DOI 10.1016/j.urology.2013.09.026; Murphy G, 2011, EXPERT REV ANTICANC, V11, P1871, DOI [10.1586/ERA.11.122, 10.1586/era.11.122]; Ramana Jayashree, 2012, BMC Res Notes, V5, P246, DOI 10.1186/1756-0500-5-246; Ramankulov A, 2007, J CANCER RES CLIN, V133, P643, DOI 10.1007/s00432-007-0215-z; Rogers MA, 2003, CANCER RES, V63, P6971; Ross H, 2012, ARCH PATHOL LAB MED, V136, P391, DOI 10.5858/arpa.2011-0479-RA; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Santucci L, 2012, PROTEOMICS, V12, P509, DOI 10.1002/pmic.201100404; Savino R, 2012, DRUG DISCOV TODAY, V17, P143, DOI 10.1016/j.drudis.2011.10.002; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Siwy J, 2011, PROTEOM CLIN APPL, V5, P367, DOI 10.1002/prca.201000155; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Terracciano R, 2009, BIOCONJUGATE CHEM, V20, P913, DOI 10.1021/bc800510f; Wai-Hoe L, 2009, APPL BIOCHEM BIOTECH, V159, P221, DOI 10.1007/s12010-008-8503-x; Wang T, 2014, J INVEST DERMATOL, V134, P1108, DOI 10.1038/jid.2013.437; Wu DL, 2008, TECHNOL CANCER RES T, V7, P155, DOI 10.1177/153303460800700301; Wu J, 2010, RAPID COMMUN MASS SP, V24, P1971, DOI 10.1002/rcm.4601; Ye B, 2006, CLIN CANCER RES, V12, P432, DOI 10.1158/1078-0432.CCR-05-0461; Yusenko MV, 2009, INT J BIOL SCI, V5, P517; Zoppis I, 2011, IEEE ACM T COMPUT BI; Zurbig P, 2009, PROTEOMICS, V9, P2108, DOI 10.1002/pmic.200800560	73	24	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106684	10.1371/journal.pone.0106684	http://dx.doi.org/10.1371/journal.pone.0106684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202906	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500038
J	Keitel, A; Prinz, W; Daum, MM				Keitel, Anne; Prinz, Wolfgang; Daum, Moritz M.			Perception of Individual and Joint Action in Infants and Adults	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUAL TRACKING; EFFECT SIZE; OBJECT; CHILDREN; GOAL; INFORMATION; ANTICIPATE; ATTENTION; SEARCH	Infants and adults frequently observe actions performed jointly by more than one person. Research in action perception, however, has focused largely on actions performed by an individual person. Here, we explore how 9- and 12-month-old infants and adults perceive a block-stacking action performed by either one agent (individual condition) or two agents (joint condition). We used eye tracking to measure the latency of participants' gaze shifts towards action goals. Adults anticipated goals in both conditions significantly faster than infants, and their gaze latencies did not differ between conditions. By contrast, infants showed faster anticipation of goals in the individual condition than in the joint condition. This difference was more pronounced in 9-month-olds. Further analyses of fixations examined the role of visual attention in action perception. These findings are cautiously interpreted in terms of low-level processing in infants and higher-level processing in adults. More precisely, our results suggest that adults are able to infer the overarching joint goal of two agents, whereas infants are not yet able to do so and might rely primarily on visual cues to infer the respective sub-goals. In conclusion, our findings indicate that the perception of joint action in infants develops differentially from that of individual action.	[Keitel, Anne] Univ Glasgow, Ctr Cognit Neuroimaging, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Keitel, Anne; Daum, Moritz M.] Max Planck Inst Human Cognit & Brain Sci, Res Grp Infant Cognit & Act, Leipzig, Germany; [Prinz, Wolfgang] Max Planck Inst Human Cognit & Brain Sci, Dept Psychol, Leipzig, Germany; [Daum, Moritz M.] Univ Zurich, Dept Psychol, Zurich, Switzerland	University of Glasgow; Max Planck Society; Max Planck Society; University of Zurich	Keitel, A (corresponding author), Univ Glasgow, Ctr Cognit Neuroimaging, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	anne.keitel@glasgow.ac.uk	Daum, Moritz/A-1441-2013; Keitel, Anne/I-4992-2019	Daum, Moritz/0000-0002-4032-4574; Keitel, Anne/0000-0003-4498-0146	Deutsche Forschungsgemeinschaft, Graduate School "Function of Attention in Cognition" [GRK 1182]; Freistaat Sachsen through the University of Leipzig	Deutsche Forschungsgemeinschaft, Graduate School "Function of Attention in Cognition"; Freistaat Sachsen through the University of Leipzig	AK acknowledges financial support from the Deutsche Forschungsgemeinschaft, Graduate School "Function of Attention in Cognition" (GRK 1182), URL: http://uni-leipzig.de/similar to gkattent/index.php?lang = en. AK further acknowledges financial support from a Wiedereinstiegsstipendium fellowship from the Freistaat Sachsen through the University of Leipzig (no grant number available), URL: http://www.zv.uni-leipzig.de/studium/angebot/foerderung/finanzierungsmoeglichkeiten/landesgraduiertenfoerderung/wiedereinstiegsstipendium.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport FH, 1920, J EXP PSYCHOL, V3, P159, DOI 10.1037/h0067891; Altmann EM, 2011, J EXP PSYCHOL LEARN, V37, P935, DOI 10.1037/a0022931; Ambrosini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067916; Ambrosini E, 2012, J EXP PSYCHOL HUMAN, V38, P263, DOI 10.1037/a0026570; Atmaca S, 2011, EXP BRAIN RES, V211, P371, DOI 10.1007/s00221-011-2709-9; BAKEMAN R, 1984, CHILD DEV, V55, P1278, DOI 10.2307/1129997; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; BECKER W, 1969, VISION RES, V9, P1247, DOI 10.1016/0042-6989(69)90112-6; Bigelow AE, 2009, INFANCY, V14, P526, DOI 10.1080/15250000903144181; Brownell CA, 2011, REV PHILOS PSYCHOL, V2, P193, DOI 10.1007/s13164-011-0056-1; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Chapman PR, 1998, PERCEPTION, V27, P951, DOI 10.1068/p270951; Costantini M, 2012, Q J EXP PSYCHOL, V65, P848, DOI 10.1080/17470218.2012.679945; Daum MM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00370; Daum MM, 2009, DEVELOPMENTAL SCI, V12, P854, DOI 10.1111/j.1467-7687.2009.00831.x; Elsner C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00120; Eshuis R, 2009, PSYCHOL SCI, V20, P438, DOI 10.1111/j.1467-9280.2009.02317.x; Falck-Ytter T, 2006, NAT NEUROSCI, V9, P878, DOI 10.1038/nn1729; Fawcett C, 2013, DEVELOPMENTAL SCI, V16, P841, DOI 10.1111/desc.12074; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Gredeback G, 2006, EXP BRAIN RES, V173, P159, DOI 10.1007/s00221-006-0376-z; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; HAITH MM, 1988, CHILD DEV, V59, P467, DOI 10.2307/1130325; Hayashi M, 2009, ANIM COGN, V12, pS49, DOI 10.1007/s10071-009-0273-5; Henderson AME, 2013, INFANCY, V18, P10, DOI 10.1111/j.1532-7078.2012.00126.x; Henderson AME, 2011, COGNITION, V121, P12, DOI 10.1016/j.cognition.2011.05.008; Henrichs I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00391; Hunnius S, 2010, DEV PSYCHOL, V46, P446, DOI 10.1037/a0016543; Johnson SP, 2003, P NATL ACAD SCI USA, V100, P10568, DOI 10.1073/pnas.1630655100; Kanakogi Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1342; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Keitel A, 2013, J EXP CHILD PSYCHOL, V116, P264, DOI 10.1016/j.jecp.2013.06.005; Keitel C, 2013, NEUROIMAGE, V70, P240, DOI 10.1016/j.neuroimage.2012.12.046; Kochukhova O, 2010, CHILD DEV, V81, P1729, DOI 10.1111/j.1467-8624.2010.01506.x; Kourtis D, 2013, SOC NEUROSCI-UK, V8, P31, DOI 10.1080/17470919.2012.694823; Liszkowski U, 2006, J COGN DEV, V7, P173, DOI 10.1207/s15327647jcd0702_2; MEICLER M, 1980, INFANT BEHAV DEV, V3, P265, DOI 10.1016/S0163-6383(80)80032-4; Melzer A, 2012, INFANT BEHAV DEV, V35, P570, DOI 10.1016/j.infbeh.2012.05.003; MIURA T, 1990, EYE MIND INFORMATION, P119; NELSON KE, 1971, J EXP CHILD PSYCHOL, V12, P182, DOI 10.1016/0022-0965(71)90003-8; NELSON KE, 1974, MERRILL PALMER QUART, V20, P3; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; ROBINSON GH, 1972, HUM FACTORS, V14, P315, DOI 10.1177/001872087201400404; Rosander K, 2007, PROG BRAIN RES, V164, P105, DOI 10.1016/S0079-6123(07)64006-0; Rosetti Y., 2007, ATTENTION PERFORM, P435, DOI DOI 10.1093/ACPROF:OSO/9780199231447.003.0020; ROSS RG, 1993, J AM ACAD CHILD PSY, V32, P783, DOI 10.1097/00004583-199307000-00012; Rotman G, 2006, J NEUROPHYSIOL, V96, P1358, DOI 10.1152/jn.00227.2006; Sailer U, 2005, J NEUROSCI, V25, P8833, DOI 10.1523/JNEUROSCI.2658-05.2005; Schmitow C, 2013, INFANT BEHAV DEV, V36, P223, DOI 10.1016/j.infbeh.2013.01.002; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Thorgrimsson GB, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00321; von Hofsten C, 2004, TRENDS COGN SCI, V8, P266, DOI 10.1016/j.tics.2004.04.002; von Hofsten C, 2009, RES AUTISM SPECT DIS, V3, P556, DOI 10.1016/j.rasd.2008.12.003; Warneken F, 2006, CHILD DEV, V77, P640, DOI 10.1111/j.1467-8624.2006.00895.x; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; WHITE BL, 1964, CHILD DEV, V35, P349, DOI 10.1111/j.1467-8624.1964.tb05944.x; Woodward Amanda L, 2001, INTENTIONS INTENTION, P149; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269	60	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107450	10.1371/journal.pone.0107450	http://dx.doi.org/10.1371/journal.pone.0107450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IF	25202914	Green Accepted, Green Published, gold			2022-12-27	WOS:000342684500098
J	Kvist, T; Sondt-Marcussen, L; Mikkelsen, MJ				Kvist, Thomas; Sondt-Marcussen, Line; Mikkelsen, Marie Just			Partition Enrichment of Nucleotide Sequences (PINS) - A Generally Applicable, Sequence Based Method for Enrichment of Complex DNA Samples	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; RAPID AMPLIFICATION; PCR	The dwindling cost of DNA sequencing is driving transformative changes in various biological disciplines including medicine, thus resulting in an increased need for routine sequencing. Preparation of samples suitable for sequencing is the starting point of any practical application, but enrichment of the target sequence over background DNA is often laborious and of limited sensitivity thereby limiting the usefulness of sequencing. The present paper describes a new method, Probability directed Isolation of Nucleic acid Sequences (PINS), for enrichment of DNA, enabling the sequencing of a large DNA region surrounding a small known sequence. A 275,000 fold enrichment of a target DNA sample containing integrated human papilloma virus is demonstrated. Specifically, a sample containing 0.0028 copies of target sequence per ng of total DNA was enriched to 786 copies per ng. The starting concentration of 0.0028 target copies per ng corresponds to one copy of target in a background of 100,000 complete human genomes. The enriched sample was subsequently amplified using rapid genome walking and the resulting DNA sequence revealed not only the sequence of a the truncated virus, but also 1026 base pairs 5' and 50 base pairs 3' to the integration site in chromosome 8. The demonstrated enrichment method is extremely sensitive and selective and requires only minimal knowledge of the sequence to be enriched and will therefore enable sequencing where the target concentration relative to background is too low to allow the use of other sample preparation methods or where significant parts of the target sequence is unknown.	[Kvist, Thomas; Sondt-Marcussen, Line; Mikkelsen, Marie Just] Samplix ApS, Ballerup, Denmark		Mikkelsen, MJ (corresponding author), Samplix ApS, Ballerup, Denmark.	mjm@samplix.com			Samplix ApS	Samplix ApS	The authors received no specific funding for this work. All authors are employed by Samplix ApS. Samplix ApS provided support in the form of salaries for authors TK, LS-M and MJM but did not have any additional role in the study design, data collection analysis, decision to publish, or preparation of the manuscript.	Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bidard FC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006305; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Han T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-217; Kilstrup M, 2000, Nucleic Acids Res, V28, pE55, DOI 10.1093/nar/28.11.e55; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lasken R., 2005, METHODS EXPRESS WHOL, P99; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Milbury CA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq899; MYERS LE, 1994, J CLIN MICROBIOL, V32, P732, DOI 10.1128/JCM.32.3.732-739.1994; OBLINGER JL, 1975, J MILK FOOD TECHNOL, V38, P540, DOI 10.4315/0022-2747-38.9.540; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Schneider UV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038451; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Woyke T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026161	21	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106817	10.1371/journal.pone.0106817	http://dx.doi.org/10.1371/journal.pone.0106817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203653	gold, Green Submitted, Green Published			2022-12-27	WOS:000342684500044
J	Zhu, JF; Feng, XY; Zhang, XW; Wen, YS; Lin, P; Rong, TH; Cai, L; Zhang, LJ				Zhu, Jian-fei; Feng, Xing-yu; Zhang, Xue-wen; Wen, Ying-sheng; Lin, Peng; Rong, Tie-hua; Cai, Ling; Zhang, Lan-jun			Time-Varying Pattern of Postoperative Recurrence Risk of Early-Stage (T1a-T2bN0M0) Non-Small Cell Lung Cancer (NSCLC): Results of a Single-Center Study of 994 Chinese Patients	PLOS ONE			English	Article							VINORELBINE PLUS CISPLATIN; PROGNOSTIC-FACTORS; ADJUVANT CHEMOTHERAPY; BREAST-CANCER; TNM CLASSIFICATION; SURGICAL RESECTION; PREDICT SURVIVAL; TUMOR DORMANCY; 7TH EDITION; SURGERY	Background: The aim of this study was to analyze the time-varying pattern of recurrence risk of early-stage (T1a-T2bN0M0) non-small cell lung cancer (NSCLC) after surgery using the hazard function and identify patients who might benefit from adjuvant chemotherapy. Patients and Methods: This retrospective study enrolled 994 patients with early-stage NSCLC who underwent radical surgical resection between January 1999 and October 2009. Survival curves were generated using the Kaplan-Meier method, and the annual recurrence hazard was estimated using the hazard function. Results: The median recurrence-free survival (RFS) was 8.8 years. The life table survival analysis showed that the 1-year, 3-year, 5-year and 10-year recurrence rates were 82.0%, 67.0%, 59.0% and 48.0%, respectively. Approximately 256 (25.7%) patients experienced relapse [locoregional: 32 (3.2%) and distant: 224 (22.5%)], and 162 patients died from cancer. The annual recurrence hazard curve for the entire population showed that the first major recurrence surge reached a maximum 1.6 years after surgery. The curve subsequently declined until reaching a nadir at 7.2 years. A second peak occurred at 8.8 years. An analysis of clinical-pathological factors demonstrated that this double-peaked pattern was present in several subgroups. Conclusions: The presence of a double-peaked pattern indicates that there is a predictable temporal distribution of the recurrence hazard of early-stage NSCLC. The annual recurrence hazard may be an effective method of selecting patients at high risk of recurrence, who may benefit from adjuvant therapy.	[Zhu, Jian-fei; Wen, Ying-sheng; Lin, Peng; Rong, Tie-hua; Zhang, Lan-jun] Sun Yat Sen Univ, Dept Thorac Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Jian-fei] Shaanxi Prov Peoples Hosp, Xian, Shaanxi, Peoples R China; [Feng, Xing-yu] Sun Yat Sen Univ, Dept Gastropancreat Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xue-wen] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Ling] Sun Yat Sen Univ, Dept Radiat Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Xi'an Medical University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Cai, L (corresponding author), Sun Yat Sen Univ, Dept Radiat Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	cailing@sysucc.org.cn; zhanglj@sysucc.org.cn	Zhu, Jianfei/AAP-4683-2020		national and provincial Science and technology projects [2012AA021502, 2012B031800295]	national and provincial Science and technology projects	This research was supported by national and provincial Science and technology projects (No. 2012AA021502 and No. 2012B031800295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2010, LUNG CANCER, V68, P398, DOI 10.1016/j.lungcan.2009.08.008; AlKattan K, 1997, EUR J CARDIO-THORAC, V12, P380, DOI 10.1016/S1010-7940(97)00198-X; Amini A, 2013, ANN SURG ONCOL, V20, P1934, DOI 10.1245/s10434-012-2800-x; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Demicheli R, 2007, NAT CLIN PRACT ONCOL, V4, P699, DOI 10.1038/ncponc0999; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Feng XY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0514-y; Gaspar MJ, 2003, ANTICANCER RES, V23, P3427; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Ignatius SH, 2008, CHEST, V133, P662, DOI 10.1378/chest.07-1306; Ishigaki T, 2013, ANN THORAC CARDIOVAS, V19, P341, DOI 10.5761/atcs.oa.12.01921; Janssen-Heijnen MLG, 2005, CRIT REV ONCOL HEMAT, V55, P231, DOI 10.1016/j.critrevonc.2005.04.008; Jin Y, 2013, CLINICS, V68, P686, DOI 10.6061/clinics/2013(05)17; Jones DR, 2006, ANN THORAC SURG, V81, P1958, DOI 10.1016/j.athoracsur.2005.12.054; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Kobayashi N, 2007, J THORAC ONCOL, V2, P808, DOI 10.1097/JTO.0b013e31814617c7; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Li CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028204; Lou F, 2013, J THORAC CARDIOV SUR, V145, P75, DOI 10.1016/j.jtcvs.2012.09.030; Maeda R, 2011, CHEST, V139, P855, DOI 10.1378/chest.10-1535; Mery CM, 2005, CHEST, V128, P237, DOI 10.1378/chest.128.1.237; Molina R, 2003, TUMOR BIOL, V24, P209, DOI 10.1159/000074432; Nakagawa T, 2008, EUR J CARDIO-THORAC, V34, P499, DOI 10.1016/j.ejcts.2008.05.016; Nakagawa T, 2007, ANN THORAC SURG, V83, P204, DOI 10.1016/j.athoracsur.2006.07.035; Ou SHI, 2007, CANCER-AM CANCER SOC, V110, P1532, DOI 10.1002/cncr.22938; Park SY, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-151; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Shimada Y, 2012, J THORAC ONCOL, V7, P1263, DOI 10.1097/JTO.0b013e31825cca6e; Shimizu K, 2005, J THORAC CARDIOV SUR, V130, P160, DOI 10.1016/j.jtcvs.2004.11.021; SIMES RJ, 1985, J CLIN ONCOL, V3, P1418, DOI 10.1200/JCO.1985.3.10.1418; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Sun ZF, 2006, J THORAC CARDIOV SUR, V131, P1014, DOI 10.1016/j.jtcvs.2005.12.057; Tantraworasin Apichat, 2013, Cancer Manag Res, V5, P77, DOI 10.2147/CMAR.S45642; VARANI J, 1981, J SURG ONCOL, V17, P9, DOI 10.1002/jso.2930170103; Wang WL, 2011, CHINESE J CANCER RES, V23, P265, DOI 10.1007/s11670-011-0265-2; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Yamamoto K, 2003, EUR J CARDIO-THORAC, V23, P21, DOI 10.1016/S1010-7940(02)00661-9; Yin WJ, 2009, BREAST CANCER RES TR, V114, P527, DOI 10.1007/s10549-008-0022-5; Zhu ZH, 2009, J CLIN ONCOL, V27, P1091, DOI 10.1200/JCO.2008.16.6991	49	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106668	10.1371/journal.pone.0106668	http://dx.doi.org/10.1371/journal.pone.0106668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203402	gold, Green Submitted, Green Published			2022-12-27	WOS:000342684500034
J	An, LL; Pookhao, N; Jiang, HM; Xu, JN				An, Lingling; Pookhao, Nauromal; Jiang, Hongmei; Xu, Jiannong			Statistical Approach of Functional Profiling for a Microbial Community	PLOS ONE			English	Article								Background: Metagenomics is a relatively new but fast growing field within environmental biology and medical sciences. It enables researchers to understand the diversity of microbes, their functions, cooperation, and evolution in a particular ecosystem. Traditional methods in genomics and microbiology are not efficient in capturing the structure of the microbial community in an environment. Nowadays, high-throughput next-generation sequencing technologies are powerfully driving the metagenomic studies. However, there is an urgent need to develop efficient statistical methods and computational algorithms to rapidly analyze the massive metagenomic short sequencing data and to accurately detect the features/functions present in the microbial community. Although several issues about functions of metagenomes at pathways or subsystems level have been investigated, there is a lack of studies focusing on functional analysis at a low level of a hierarchical functional tree, such as SEED subsystem tree. Results: A two-step statistical procedure (metaFunction) is proposed to detect all possible functional roles at the low level from a metagenomic sample/community. In the first step a statistical mixture model is proposed at the base of gene codons to estimate the abundances for the candidate functional roles, with sequencing error being considered. As a gene could be involved in multiple biological processes the functional assignment is therefore adjusted by utilizing an error distribution in the second step. The performance of the proposed procedure is evaluated through comprehensive simulation studies. Compared with other existing methods in metagenomic functional analysis the new approach is more accurate in assigning reads to functional roles, and therefore at more general levels. The method is also employed to analyze two real data sets. Conclusions: metaFunction is a powerful tool in accurate profiling functions in a metagenomic sample.	[An, Lingling; Pookhao, Nauromal] Univ Arizona, Dept Agr & Biosyst Engn, Tucson, AZ 85721 USA; [An, Lingling] Univ Arizona, Interdisciplinary Programs Stat, Tucson, AZ USA; [Jiang, Hongmei] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [Xu, Jiannong] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	University of Arizona; University of Arizona; Northwestern University; New Mexico State University	An, LL (corresponding author), Univ Arizona, Dept Agr & Biosyst Engn, Tucson, AZ 85721 USA.	anling@email.arizona.edu	Xu, Jiannong/N-1583-2019; Jiang, Hongmei/AAU-2911-2021	Xu, Jiannong/0000-0001-7332-4370; An, Lingling/0000-0001-8273-0776	National Science Foundation [DMS-1043080, DMS-1222592]; National Institutes of Health [P30 ES006694]; The Cecil Miller Endowment at University of Arizona Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM092789] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Cecil Miller Endowment at University of Arizona Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation [DMS-1043080 to HJ and LA] and [DMS-1222592 to LA, HJ, JX], and partially supported by National Institutes of Health [P30 ES006694 to LA] and by The Cecil Miller Endowment at University of Arizona Foundation to NP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, JACKKNIFE BOOTSTRAP; Belda-Ferre P, 2011, ISME J; Clemente JC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-8; DEMPSTER A, 1977, J ROYAL STAT SOC B, V39, P39; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; ENGEMAN RM, 1994, ECOLOGY, V75, P1769, DOI 10.2307/1939636; Fozo EM, 2007, INFECT IMMUN, V75, P1537, DOI 10.1128/IAI.01938-06; Hoff KJ, 2009, NUCLEIC ACIDS RES, V37, pW101, DOI 10.1093/nar/gkp327; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jiang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046450; Karlsson C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2297; Lindner MS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks803; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Markowitz VM, 2011, NUCL ACIDS RES; Mea Sohn, 2014, BMC BIOINFORMATICS, V15; Meinicke P, 2011, BIOINFORMATICS, V27, P1618, DOI 10.1093/bioinformatics/btr266; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Park SN, 2012, J BACTERIOL, V194, P6322, DOI 10.1128/JB.01600-12; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Prakash T, 2012, BRIEF BIOINFORM, V13, P711, DOI 10.1093/bib/bbs033; Ready D, 2006, ANTIMICROB AGENTS CH, V50, P2866, DOI 10.1128/AAC.00217-06; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rosen GL, 2009, CURR GENOMICS, V10, P493, DOI 10.2174/138920209789208255; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; Sharon I, 2011, J COMPUT BIOL, V18, P495, DOI 10.1089/cmb.2010.0260; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Xia LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027992; Yooseph S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-182; Yoshimura M, 2000, INFECT IMMUN, V68, P6912, DOI 10.1128/IAI.68.12.6912-6916.2000	34	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106588	10.1371/journal.pone.0106588	http://dx.doi.org/10.1371/journal.pone.0106588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198674	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700032
J	Emeville, E; Broquere, C; Brureau, L; Ferdinand, S; Blanchet, P; Multigner, L; Romana, M				Emeville, Elise; Broquere, Cedric; Brureau, Laurent; Ferdinand, Severine; Blanchet, Pascal; Multigner, Luc; Romana, Marc			Copy Number Variation of GSTT1 and GSTM1 and the Risk of Prostate Cancer in a Caribbean Population of African Descent	PLOS ONE			English	Article							GLUTATHIONE; GENE; POLYMORPHISMS; GENOTYPE; ALCOHOL; EPIDEMIOLOGY; METAANALYSIS; EXPOSURE; CLUSTER	Background: Deletions of the glutathione S-transferase genes M1 and T1 (GSTM1 and GSTT1) have been studied as potential risk factors for prostate cancer. Conflicting results have been obtained. Moreover, most such studies could not discriminate heterozygous from homozygous carriers of the non-deleted alleles. Objective: We investigated whether copy number variation (CNV) of the GSTM1 and/or GSTT1 genes contribute to the risk of prostate cancer in the Caribbean population of African descent of Guadeloupe. Methods: In a population-based case-control study, we compared 629 prostate cancer patients and 622 control subjects. Logistic regression was used to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI). Exact copy numbers of GSTM1 and GSTT1 were determined by real-time PCR. Results: A higher copy number of GSTM1 was marginally associated with prostate cancer risk. Men with 2 and 3 or more GSTT1 genes were at higher risk of prostate cancer (OR: 1.55, 95% CI: 1.11-2.16 and OR: 4.89, 95% CI: 1.71-13.99, respectively; P-trend <0.001). Men with 3, 4 and 5 or more copies of both GSTM1 and GSTT1 genes were at higher risk of prostate cancer (OR: 2.18, 95% CI: 1.21-3.91, OR: 3.24, 95% CI: 1.63-6.46, and OR: 5.77, 95% CI: 1.40-23.84, respectively; P-trend <0.001). Conclusions: Copy number of GSTT1 and combined GSTM1/GSTT1 appear to be associated with prostate cancer risk in our population study with gene dose relationship. Our results support the hypothesis that variations in copy number of GSTT1 modulate the risk of prostate cancer.	[Emeville, Elise; Blanchet, Pascal; Multigner, Luc] IRSET, INSERM, U1085, Pointe A Pitre, Guadeloupe, France; [Emeville, Elise; Multigner, Luc] Univ Rennes 1, Rennes, France; [Broquere, Cedric; Ferdinand, Severine; Romana, Marc] INSERM, U1134, Pointe A Pitre, Guadeloupe, France; [Broquere, Cedric; Ferdinand, Severine; Blanchet, Pascal; Romana, Marc] Univ Antilles Guyane, Pointe A Pitre, Guadeloupe, France; [Brureau, Laurent; Blanchet, Pascal] Ctr Hosp Univ Pointe A Pitre, Serv Urol, Pointe A Pitre, Guadeloupe, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite des Antilles; CHU Guadeloupe	Multigner, L (corresponding author), IRSET, INSERM, U1085, Pointe A Pitre, Guadeloupe, France.	luc.multigner@inserm.fr	Blanchet, Pascal/K-3532-2015; Romana, Marc/K-6442-2017; Multigner, Luc/I-2926-2015; Multigner, Luc/AAA-6214-2020	Romana, Marc/0000-0002-8715-9836; Multigner, Luc/0000-0003-3205-8568; Multigner, Luc/0000-0003-3205-8568; FERDINAND, Severine/0000-0001-8258-5089	French National Health Directorate; Ligue Nationale Contre le Cancer; French National Health Directorate; Ligue Nationale Contre le Cancer	French National Health Directorate; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); French National Health Directorate; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the French National Health Directorate. E. Emeville is supported by a Ph.D. fellowship from the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen K, 2002, PROSTATE, V52, P297, DOI 10.1002/pros.10120; Arruda VR, 1998, CLIN GENET, V54, P210; Bruhn C, 1998, BIOCHEM PHARMACOL, V56, P1189, DOI 10.1016/S0006-2952(98)00191-9; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chen C, 2001, EPIDEMIOL REV, V23, P30, DOI 10.1093/oxfordjournals.epirev.a000793; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Dennis LK, 2001, EPIDEMIOL REV, V23, P110, DOI 10.1093/oxfordjournals.epirev.a000775; Dubuisson C, 2007, REGUL TOXICOL PHARM, V49, P5, DOI 10.1016/j.yrtph.2007.04.008; Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239; Gong MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050587; Guengerich FP, 2003, J BIOCHEM MOL BIOL, V36, P20; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hsing AW, 2006, FRONT BIOSCI-LANDMRK, V11, P1388, DOI 10.2741/1891; Josephy PD, 2010, PROTEOMICS, V876940; McLellan RA, 1997, MOL PHARMACOL, V52, P958, DOI 10.1124/mol.52.6.958; Minelli C, 2010, INT J EPIDEMIOL, V39, P539, DOI 10.1093/ije/dyp337; Mo ZN, 2009, PROSTATE, V69, P662, DOI 10.1002/pros.20907; MONKS TJ, 1990, TOXICOL APPL PHARM, V106, P1, DOI 10.1016/0041-008X(90)90100-9; Morgan TO, 1996, NEW ENGL J MED, V335, P304, DOI 10.1056/NEJM199608013350502; Multigner L, 2010, J CLIN ONCOL, V28, P3457, DOI 10.1200/JCO.2009.27.2153; Norskov MS, 2011, PHARMACOGENOMICS J, V11, P292, DOI 10.1038/tpj.2010.38; Ntais C, 2005, CANCER EPIDEM BIOMAR, V14, P176; Rebbeck TR, 1997, CANCER EPIDEM BIOMAR, V6, P733; Rudolph A, 2012, INT J CANCER, V131, pE841, DOI 10.1002/ijc.27428; Rundle A, 2003, CANCER EPIDEM BIOMAR, V12, P911; Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009; Taioli E, 2011, CARCINOGENESIS, V32, P1361, DOI 10.1093/carcin/bgr119; Timofeeva M, 2009, CLIN BIOCHEM, V42, P500, DOI 10.1016/j.clinbiochem.2008.12.011; Wei BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046982; Xu SJ, 1998, J BIOL CHEM, V273, P3517, DOI 10.1074/jbc.273.6.3517; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053700	31	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107275	10.1371/journal.pone.0107275	http://dx.doi.org/10.1371/journal.pone.0107275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198353	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700099
J	Hudelson, P; Dao, MD; Perneger, T; Durieux-Paillard, S				Hudelson, Patricia; Dao, Melissa Dominice; Perneger, Thomas; Durieux-Paillard, Sophie			A "Migrant Friendly Hospital'' Initiative in Geneva, Switzerland: Evaluation of the Effects on Staff Knowledge and Practices	PLOS ONE			English	Article							HEALTH-CARE; RESPONSE RATE; DIVERSITY; ATTITUDES; QUALITY; EUROPE; VIEWS	Background: International migration poses important challenges to European health care systems. The development of "migrant friendly hospitals'' has been identified as a priority in both Europe and Switzerland. Methods: A multi-pronged initiative was developed at Geneva University Hospitals (HUG) to improve staff knowledge and use of existing "migrant friendly'' resources. A self-administered questionnaire was sent pre and post-intervention to random samples of 4 major professional groups with direct patient contact at the HUG. The questionnaire assessed staff knowledge, attitudes and reported practices regarding the care of migrant patients. Results: Overall response rate was 51% (N = 1460) in 2010 but only 19% (N = 761) in 2013 owing to an institutionally imposed change in survey method. Despite these difficulties, and after adjusting for sample differences, we found that respondents in 2013 were significantly more likely to have received training in how to organize an appointment with an interpreter, how to work with an interpreter and about health and social services available for migrant patients. Respondents were also significantly more likely to have used several Migrant Friendly structures at the HUG. Use of, preference for and perceived skill at working with professional interpreters all improved, and respondents were both more likely to be encouraged by their supervisors to use professional interpreters, and less likely to be encouraged to look for alternative solutions for communicating with non francophone patients. Finally, 2013 respondents encountered fewer difficulties caring for migrant patients, although lack of time and language barriers continued to be the most important sources of difficulty. Conclusion: Our results suggest that an institution-wide information campaign may contribute to increased awareness and use of migrant friendly resources by clinical staff. Hospital commitment and financing, along with inter-departmental participation in all activities were important in creating and maintaining project visibility, and in contributing to a migrant friendly institutional culture.	[Hudelson, Patricia] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Dao, Melissa Dominice] Univ Hosp Geneva, Primary Care Serv, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Perneger, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Durieux-Paillard, Sophie] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Programme Sante Migrants, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva	Hudelson, P (corresponding author), Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland.	Patricia.Hudelson@hcuge.ch	Dominicé Dao, Melissa/AAZ-3032-2020	Dominicé Dao, Melissa/0000-0002-0839-277X; Hudelson, Patricia/0000-0003-2601-7479	Swiss Federal Office of Public Health; Geneva University Hospitals	Swiss Federal Office of Public Health; Geneva University Hospitals	This project was jointly funded by the Swiss Federal Office of Public Health (http://www.bag.admin.ch/themen/gesundheitspolitik/07685/index.html?lang = fr) and the Geneva University Hospitals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 2012, MIGRATION OBSERVATOR; [Anonymous], SANTE PRECARITE RESE; Betancourt JR, 2006, ACAD MED, V81, P499, DOI 10.1097/01.ACM.0000225211.77088.cb; Bhopal RS, 2007, EUR J PUBLIC HEALTH, V17, P238, DOI 10.1093/eurpub/ckm039; Bischoff Alexander, 2009, World Hosp Health Serv, V45, P7; Dao MD, 2014, INT CULT PSYCHOL, P313, DOI 10.1007/978-1-4614-7615-3_15; Diamond LC, 2009, J GEN INTERN MED, V24, P256, DOI 10.1007/s11606-008-0875-7; Dogra N, 2009, MED TEACH, V31, P990, DOI 10.3109/01421590902960326; Hardigan PC, 2012, J COMMUN HEALTH, V37, P383, DOI 10.1007/s10900-011-9455-6; Hudelson P, 2008, QUAL SAF HEALTH CARE, V17, P31, DOI 10.1136/qshc.2006.021311; Hudelson P, 2013, INT J QUAL HLTH CARE; Hudelson P, 2010, EVAL HEALTH PROF, V33, P452, DOI 10.1177/0163278710370157; Hudelson P, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-187; Hudelson PM, 2004, INT J QUAL HEALTH C, V16, P345, DOI 10.1093/intqhc/mzh076; Jensen NK, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-154; Knipper Michael, 2010, GMS Z Med Ausbild, V27, pDoc26, DOI 10.3205/zma000663; Kongsved SM, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e25; Locatis C, 2010, J GEN INTERN MED, V25, P345, DOI 10.1007/s11606-009-1236-x; Mayr A, 2012, J CLIN EPIDEMIOL, V65, P970, DOI 10.1016/j.jclinepi.2012.03.005; Mladovsky P, 2012, CLIN MED, V12, P248, DOI 10.7861/clinmedicine.12-3-248; Mladovsky P, 2012, HEALTH POLICY, V105, P1, DOI 10.1016/j.healthpol.2012.01.007; Norredam M, 2010, EUR J PUBLIC HEALTH, V20, P555, DOI 10.1093/eurpub/ckp195; O'Donnell C, 2013, LANCET, V382, P393, DOI 10.1016/S0140-6736(13)61666-9; Perron NJ, 2005, SWISS MED WKLY, V135, P475; Priebe S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-187; Puebla Fortier J, 2010, GLOBAL CONSULTATION; Rechel B., 2011, MIGRATION HLTH EUROP; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Rechel B, 2012, HEALTH POLICY, V105, P10, DOI 10.1016/j.healthpol.2012.01.003; Sandhu S, 2012, SOC PSYCH PSYCH EPID, V48, P105; Swiss Federal Office of Public Health, 2002, MIGR PUBL HLTH CONF; United Nations Department of Economic and Social Affairs, 1998, REC STAT INT MIGR RE	32	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106758	10.1371/journal.pone.0106758	http://dx.doi.org/10.1371/journal.pone.0106758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JX	25198063	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700047
J	Toor, JS; Singh, S; Sharma, A; Arora, SK				Toor, Jaideep S.; Singh, Sukhvinder; Sharma, Aman; Arora, Sunil K.			Mycobacterium tuberculosis Modulates the Gene Interactions to Activate the HIV Replication and Faster Disease Progression in a Co-Infected Host	PLOS ONE			English	Article							REGULATORY T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; HEME OXYGENASE-1; IMMUNE ACTIVATION; TYPE-1 INFECTION; FOXP3 ISOFORMS; NUCLEAR FACTOR	Understanding of the chronic immune activation, breakdown of immune defense and synergistic effect between HIV and Mycobacterium tuberculosis (Mtb) may provide essential information regarding key factors involved in the pathogenesis of HIV disease. In this study, we aimed to highlight a few of the immunological events that may influence and accelerate the progression of HIV disease in the presence of co-infecting Mtb. A cross-sectional study was performed on cohorts, including anti-tubercular therapy (ATT) naive active pulmonary tuberculosis (PTB) patients, antiretroviral therapy (ART) naive HIV-1 infected individuals at different stages of disease, ATT and ART naive HIV-PTB co-infected individuals and healthy controls. A significantly higher T-regulatory cell (Treg) frequency coupled with the high FoxP3 expression in the CD4 T-cells indicated an immunosuppressive environment in the advance stage of HIV-1 infection. This is further substantiated by high HO-1 expression favoring TB co-infection. Functionally, this change in Treg frequency in HIV-1 infected individuals correlated well with suppression of T-cell proliferation. Mtb infection seems to facilitate the expansion of the Treg pool along with increased expression of FoxP3, specifically the variant-1, as evident from the data in HIV-1 co-infected as well as in patients with only PTB. A significantly lower expression of HO-1 in co-infected individuals compared to patients with only HIV-infection having comparable CD4 count correlated well with increased expression of CCR5 and CxCR4 as well as NF-kappa B and inflammatory cytokines IL-6 and TNF-alpha, which collectively may contribute to enhanced viral replication and increased cell death, hence faster disease progression in co-infected individuals.	[Toor, Jaideep S.; Singh, Sukhvinder; Arora, Sunil K.] Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India; [Sharma, Aman] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Arora, SK (corresponding author), Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India.	arora.sunil@pgimer.edu.in	Singh, Sukhvinder/I-8846-2019; Arora, Sunil K/V-9083-2019		Department of Biotechnology, Govt. of India [BT/PR8497/Med/14/1258/2006]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This study was supported by Grant No. BT/PR8497/Med/14/1258/2006 from Department of Biotechnology, Govt. of India; (URL: www.dbt.nic.in) Project entitled: 'MECHANISMS INVOLVED IN THE DOWN REGULATION OF EFFECTOR T-CELL ACTIVITY IN TUBERCULOSIS AND HIV CO-INFECTIONS.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Aarts-Riemens T, 2008, EUR J IMMUNOL, V38, P1381, DOI 10.1002/eji.200737590; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Apoil PA, 2005, JAIDS-J ACQ IMM DEF, V39, P381, DOI 10.1097/01.qai.0000169662.30783.2d; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Burt TD, 2010, J IMMUNOL, V185, P5279, DOI 10.4049/jimmunol.0903127; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Carrion F, 2010, LUPUS, V19, P317, DOI 10.1177/0961203309348983; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; George JF, 2008, AM J PATHOL, V173, P154, DOI 10.2353/ajpath.2008.070963; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; GREENE WC, 1991, NEW ENGL J MED, V324, P308, DOI 10.1056/NEJM199101313240506; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; LANDER HM, 1993, J IMMUNOL, V150, P1509; Lee SS, 2007, FASEB J, V21, P3450, DOI 10.1096/fj.07-8472com; Liu R, 1998, AIDS RES HUM RETROV, V14, P1509, DOI 10.1089/aid.1998.14.1509; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Mougiakakos D, 2011, BLOOD, V117, P4826, DOI 10.1182/blood-2010-12-324038; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; PACE GW, 1995, FREE RADICAL BIO MED, V19, P523, DOI 10.1016/0891-5849(95)00047-2; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Pyo CW, 2008, BIOCHEM BIOPH RES CO, V376, P180, DOI 10.1016/j.bbrc.2008.08.114; Sternfeld T, 2009, HIV MED, V10, P512, DOI 10.1111/j.1468-1293.2009.00723.x; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Xia ZW, 2007, AM J PATHOL, V171, P1904, DOI 10.2353/ajpath.2007.070096; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	37	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106815	10.1371/journal.pone.0106815	http://dx.doi.org/10.1371/journal.pone.0106815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198707	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700053
J	Foure, A; Nosaka, K; Wegrzyk, J; Duhamel, G; Le Troter, A; Boudinet, H; Mattei, JP; Vilmen, C; Jubeau, M; Bendahan, D; Gondin, J				Foure, Alexandre; Nosaka, Kazunori; Wegrzyk, Jennifer; Duhamel, Guillaume; Le Troter, Arnaud; Boudinet, Helene; Mattei, Jean-Pierre; Vilmen, Christophe; Jubeau, Marc; Bendahan, David; Gondin, Julien			Time Course of Central and Peripheral Alterations after Isometric Neuromuscular Electrical Stimulation-Induced Muscle Damage	PLOS ONE			English	Article							EXERCISE-INDUCED MUSCLE; SHORTENING CYCLE EXERCISE; HUMAN SKELETAL-MUSCLE; ECCENTRIC EXERCISE; VOLUNTARY ACTIVATION; QUADRICEPS MUSCLE; CREATINE-KINASE; CELLULAR MECHANISMS; INTERPOLATED TWITCH; REPEATED BOUTS	Isometric contractions induced by neuromuscular electrostimulation (NMES) have been shown to result in a prolonged force decrease but the time course of the potential central and peripheral factors have never been investigated. This study examined the specific time course of central and peripheral factors after isometric NMES-induced muscle damage. Twenty-five young healthy men were subjected to an NMES exercise consisting of 40 contractions for both legs. Changes in maximal voluntary contraction force of the knee extensors (MVC), peak evoked force during double stimulations at 10 Hz (Db(10)) and 100 Hz (Db(100)), its ratio (10:100), voluntary activation, muscle soreness and plasma creatine kinase activity were assessed before, immediately after and throughout four days after NMES session. Changes in knee extensors volume and T-2 relaxation time were also assessed at two (D2) and four (D4) days post-exercise. MVC decreased by 29% immediately after NMES session and was still 19% lower than the baseline value at D4. The decrease in Db(10) was higher than in Db(100) immediately and one day post-exercise resulting in a decrease (-12%) in the 10:100 ratio. On the contrary, voluntary activation significantly decreased at D2 (-5%) and was still depressed at D4 (-5%). Muscle soreness and plasma creatine kinase activity increased after NMES and peaked at D2 and D4, respectively. T-2 was also increased at D2 (6%) and D4 (9%). Additionally, changes in MVC and peripheral factors (e.g., Db(100)) were correlated on the full recovery period, while a significant correlation was found between changes in MVC and VA only from D2 to D4. The decrease in MVC recorded immediately after the NMES session was mainly due to peripheral changes while both central and peripheral contributions were involved in the prolonged force reduction. Interestingly, the chronological events differ from what has been reported so far for voluntary exercise-induced muscle damage.	[Foure, Alexandre; Wegrzyk, Jennifer; Duhamel, Guillaume; Le Troter, Arnaud; Mattei, Jean-Pierre; Vilmen, Christophe; Bendahan, David; Gondin, Julien] Aix Marseille Univ, CNRS, CRMBM UMR 7339, Marseille, France; [Nosaka, Kazunori] Edith Cowan Univ, Sch Exercise & Hlth Sci, Joondalup, WA 6027, Australia; [Boudinet, Helene] La Timone Hosp, APHM, CEMEREM, Imaging Ctr, Marseille, France; [Mattei, Jean-Pierre] La Concept Hosp, APHM, Dept Rheumatol, Marseille, France; [Jubeau, Marc] Univ Nantes, UFR STAPS, Lab Motricite Interact Performance EA 4334, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Edith Cowan University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Nantes Universite	Foure, A (corresponding author), Aix Marseille Univ, CNRS, CRMBM UMR 7339, Marseille, France.	alexandre.foure@hotmail.fr	Fouré, Alexandre/AAI-9587-2020; Nosaka, Kazunori/H-4412-2011; GONDIN, Julien/D-6877-2019; Bendahan, David/AAU-1420-2020; Duhamel, Guillaume/AAP-2780-2020	Fouré, Alexandre/0000-0002-9678-8773; Nosaka, Kazunori/0000-0001-7373-4994; Duhamel, Guillaume/0000-0001-5704-8513; Wegrzyk, Jennifer/0000-0003-2140-6061; le troter, arnaud/0000-0002-7897-9672	Centre National de la Recherche Scientifique (CNRS) [UMR 7339]; Ajinomoto	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ajinomoto	This study was supported by Centre National de la Recherche Scientifique (CNRS UMR 7339) and Ajinomoto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GR, 1992, J APPL PHYSIOL, V73, P1578, DOI 10.1152/jappl.1992.73.4.1578; ADAMS GR, 1993, J APPL PHYSIOL, V74, P532, DOI 10.1152/jappl.1993.74.2.532; Aldayel A, 2010, J APPL PHYSIOL, V109, P735, DOI 10.1152/japplphysiol.00189.2010; Aldayel A, 2010, EUR J APPL PHYSIOL, V108, P709, DOI 10.1007/s00421-009-1278-0; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allen DG, 2001, ACTA PHYSIOL SCAND, V171, P311, DOI 10.1046/j.1365-201x.2001.00833.x; ALLEN DG, 1992, SPORTS MED, V13, P116, DOI 10.2165/00007256-199213020-00007; ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Avela J, 2006, EUR J APPL PHYSIOL, V97, P486, DOI 10.1007/s00421-006-0209-6; Behrens M, 2012, INT J SPORTS MED, V33, P600, DOI 10.1055/s-0032-1304642; Black CD, 2008, MED SCI SPORT EXER, V40, P1605, DOI 10.1249/MSS.0b013e3181788dbe; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; CLARKSON PM, 1988, CLIN SCI, V75, P257, DOI 10.1042/cs0750257; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Crameri RM, 2007, J PHYSIOL-LONDON, V583, P365, DOI 10.1113/jphysiol.2007.128827; de Haan A, 2009, J APPL PHYSIOL, V107, P355, DOI 10.1152/japplphysiol.91220.2008a; Deley G, 2006, INT J SPORTS MED, V27, P475, DOI 10.1055/s-2005-865837; DUHAMEL G, 2012, TRANSVERSE RELAXATIO, P446; FISHER MJ, 1990, INVEST RADIOL, V25, P480, DOI 10.1097/00004424-199005000-00003; Foley JM, 1999, J APPL PHYSIOL, V87, P2311, DOI 10.1152/jappl.1999.87.6.2311; Gold GE, 2004, AM J ROENTGENOL, V183, P343, DOI 10.2214/ajr.183.2.1830343; Gondin J, 2011, EUR J APPL PHYSIOL, V111, P2473, DOI 10.1007/s00421-011-2101-2; Green MA, 2012, NMR BIOMED, V25, P852, DOI 10.1002/nbm.1801; Guilhem G, 2013, AM J SPORT MED, V41, P1942, DOI 10.1177/0363546513490648; Hill CA, 2001, J PHYSIOL-LONDON, V531, P871, DOI 10.1111/j.1469-7793.2001.0871h.x; Hoheisel U, 2005, PAIN, V114, P168, DOI 10.1016/j.pain.2004.12.020; HULTMAN E, 1983, PFLUG ARCH EUR J PHY, V398, P139, DOI 10.1007/BF00581062; Jubeau M, 2008, J APPL PHYSIOL, V104, P75, DOI 10.1152/japplphysiol.00335.2007; Jubeau M, 2012, EUR J APPL PHYSIOL, V112, P429, DOI 10.1007/s00421-011-1991-3; Khalsa PS, 2004, J ELECTROMYOGR KINES, V14, P109, DOI 10.1016/j.jelekin.2003.09.020; Lacourpaille L, 2014, ACTA PHYSIOL, V211, P135, DOI 10.1111/apha.12272; Laurin J, 2012, SCAND J MED SCI SPOR, V22, P534, DOI 10.1111/j.1600-0838.2010.01279.x; LeBlanc A D, 1993, Clin J Sport Med, V3, P26, DOI 10.1097/00042752-199301000-00006; Mackey AL, 2008, J APPL PHYSIOL, V105, P1620, DOI 10.1152/japplphysiol.90952.2008; Mackey AL, 2011, FASEB J, V25, P1943, DOI 10.1096/fj.10-176487; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Marqueste T, 2008, J APPL PHYSIOL, V105, P299, DOI 10.1152/japplphysiol.00738.2007; Martin PG, 2008, J PHYSIOL-LONDON, V586, P1277, DOI 10.1113/jphysiol.2007.140426; Martin V, 2004, MED SCI SPORT EXER, V36, P1907, DOI 10.1249/01.MSS.0000145526.43208.08; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Nordez A, 2009, J MAGN RESON IMAGING, V30, P1116, DOI 10.1002/jmri.21867; Nosaka K, 2002, J SCI MED SPORT, V5, P204, DOI 10.1016/S1440-2440(02)80005-6; Nosaka K, 2002, SCAND J MED SCI SPOR, V12, P337, DOI 10.1034/j.1600-0838.2002.10178.x; Nosaka K, 2001, MED SCI SPORT EXER, V33, P22; Nosaka K, 2011, EUR J APPL PHYSIOL, V111, P2427, DOI 10.1007/s00421-011-2086-x; Prasartwuth O, 2005, J PHYSIOL-LONDON, V567, P337, DOI 10.1113/jphysiol.2005.087767; Racinais S, 2008, EUR J APPL PHYSIOL, V102, P439, DOI 10.1007/s00421-007-0604-7; Sheffler LR, 2007, MUSCLE NERVE, V35, P562, DOI 10.1002/mus.20758; Sorichter S, 2001, J SPORT SCI, V19, P687, DOI 10.1080/02640410152475810; Strojnik V, 1998, J APPL PHYSIOL, V84, P344, DOI 10.1152/jappl.1998.84.1.344; Taylor JL, 2009, J APPL PHYSIOL, V107, P354, DOI 10.1152/japplphysiol.91220.2008; Vanderthommen M, 2003, J APPL PHYSIOL, V94, P1012, DOI 10.1152/japplphysiol.00887.2001; Verges S, 2009, J APPL PHYSIOL, V106, P701, DOI 10.1152/japplphysiol.01051.2007; Warren GL, 1999, SPORTS MED, V27, P43, DOI 10.2165/00007256-199927010-00004; WESTERBLAD H, 1991, AM J PHYSIOL, V261, pC195, DOI 10.1152/ajpcell.1991.261.2.C195; Zory R, 2005, INT J SPORTS MED, V26, P847, DOI 10.1055/s-2005-837459	56	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107298	10.1371/journal.pone.0107298	http://dx.doi.org/10.1371/journal.pone.0107298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215511	gold, Green Published			2022-12-27	WOS:000341774300054
J	Abenza, JF; Chessel, A; Raynaud, WG; Carazo-Salas, RE				Abenza, Juan F.; Chessel, Anatole; Raynaud, William G.; Carazo-Salas, Rafael E.			Dynamics of Cell Shape Inheritance in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; POLARIZED GROWTH; SACCHAROMYCES-CEREVISIAE; MICROTUBULE NUCLEATION; SIGNALING NETWORKS; SELF-ORGANIZATION; STEM-CELLS; PROTEIN; MORPHOGENESIS; CYCLE	Every cell has a characteristic shape key to its fate and function. That shape is not only the product of genetic design and of the physical and biochemical environment, but it is also subject to inheritance. However, the nature and contribution of cell shape inheritance to morphogenetic control is mostly ignored. Here, we investigate morphogenetic inheritance in the cylindrically-shaped fission yeast Schizosaccharomyces pombe. Focusing on sixteen different 'curved' mutants - a class of mutants which often fail to grow axially straight - we quantitatively characterize their dynamics of cell shape inheritance throughout generations. We show that mutants of similar machineries display similar dynamics of cell shape inheritance, and exploit this feature to show that persistent axial cell growth in S. pombe is secured by multiple, separable molecular pathways. Finally, we find that one of those pathways corresponds to the swc2-swr1-vps71 SWR1/SRCAP chromatin remodelling complex, which acts additively to the known mal3-tip1-mto1-mto2 microtubule and tea1-tea2-tea4-pom1 polarity machineries.	[Abenza, Juan F.; Chessel, Anatole; Raynaud, William G.; Carazo-Salas, Rafael E.] Univ Cambridge, Gurdon Inst, Cambridge, England	University of Cambridge	Abenza, JF (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.	jfa27@cam.ac.uk; cre20@cam.ac.uk	Chessel, Anatole/O-8902-2019; Abenza, Juan Francisco/AAH-4930-2019	Chessel, Anatole/0000-0002-1326-6305; Abenza, Juan Francisco/0000-0003-1685-1013; Carazo-Salas, Rafael E/0000-0002-5943-3981	European Research Council (ERC); Ramon Areces Foundation Postdoctoral Fellowship; Herchel Smith Postdoctoral Fellowship; Human Frontier Science Program (HFSP) [RGY0066/2009-C]; Biological Sciences Research Council (BBSRC) [BB/K006320/1]; Biotechnology and Biological Sciences Research Council [BB/K006320/1] Funding Source: researchfish; BBSRC [BB/K006320/1] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)); Ramon Areces Foundation Postdoctoral Fellowship; Herchel Smith Postdoctoral Fellowship; Human Frontier Science Program (HFSP)(Human Frontier Science Program); Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a European Research Council (ERC) Starting Researcher Investigator Grant (SYSGRO; R.E.C.-S. and J.F.A.), a Ramon Areces Foundation Postdoctoral Fellowship (J.F.A.), a Herchel Smith Postdoctoral Fellowship (J.F.A.), a Human Frontier Science Program (HFSP) Young Investigator Grant (RGY0066/2009-C; R.E.C.-S., A. C.), and a Biological Sciences Research Council (BBSRC) Responsive Mode grant (BB/K006320/1; R.E.C.-S., A.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam J, 2012, MOL BIOL CELL, V23, P2878, DOI 10.1091/mbc.E12-03-0205; Alvarez-Tabares I, 2007, J CELL SCI, V120, P3589, DOI 10.1242/jcs.007567; Anders A, 2008, YEAST, V25, P913, DOI 10.1002/yea.1639; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Becam AM, 2001, MOL GENET GENOMICS, V266, P454, DOI 10.1007/s004380100548; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Buchanan L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000726; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; CHAIET L, 1964, ARCH BIOCHEM BIOPHYS, V106, P1, DOI 10.1016/0003-9861(64)90150-X; Chang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001347; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Costa P, 2012, INT J BIOCHEM CELL B, V44, P2233, DOI 10.1016/j.biocel.2012.09.003; Cuadrado A, 2010, EMBO J, V29, P2014, DOI 10.1038/emboj.2010.85; Das M, 2012, SCIENCE, V337, P239, DOI 10.1126/science.1218377; Fernandes PMB, 2004, FEBS LETT, V556, P153, DOI 10.1016/S0014-5793(03)01396-6; Gebert M, 2012, J CELL BIOL, V197, P595, DOI 10.1083/jcb.201110047; Georgieva M, 2008, J CELL BIOCHEM, V104, P59, DOI 10.1002/jcb.21600; Hachet O, 2011, CELL, V145, P1116, DOI 10.1016/j.cell.2011.05.014; Harold FM, 2005, MICROBIOL MOL BIOL R, V69, P544, DOI 10.1128/MMBR.69.4.544-564.2005; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Hayles J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130053; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070; La Carbona S, 2006, BIOL CELL, V98, P619, DOI 10.1042/BC20060048; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Markowetz F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000655; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Martin SG, 2005, CELL CYCLE, V4, P1046, DOI 10.4161/cc.4.8.1853; Martin SG, 2009, CELL CYCLE, V8, P3643, DOI 10.4161/cc.8.22.9891; Martin SG, 2009, TRENDS CELL BIOL, V19, P447, DOI 10.1016/j.tcb.2009.06.003; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Minc N, 2009, CURR BIOL, V19, P1096, DOI 10.1016/j.cub.2009.05.031; MITCHISON JM, 1957, EXP CELL RES, V13, P244, DOI 10.1016/0014-4827(57)90005-8; MITCHISON JM, 1985, J CELL SCI, V75, P357; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nern A, 2000, MOL CELL, V5, P853, DOI 10.1016/S1097-2765(00)80325-1; Niccoli T, 2003, YEAST, V20, P1349, DOI 10.1002/yea.1054; Piel M, 2009, CURR BIOL, V19, pR823, DOI 10.1016/j.cub.2009.08.012; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Rojas ER, 2011, BIOPHYS J, V101, P1844, DOI 10.1016/j.bpj.2011.08.016; Roubinet C, 2012, CYTOSKELETON, V69, P957, DOI 10.1002/cm.21086; Samejima I, 2005, MOL BIOL CELL, V16, P3040, DOI 10.1091/mbc.e04-11-1003; Samejima I, 2010, CURR BIOL, V20, P1959, DOI 10.1016/j.cub.2010.10.006; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; SERAPHIN B, 1989, NATURE, V337, P84, DOI 10.1038/337084a0; SNELL V, 1994, EMBO J, V13, P2066, DOI 10.1002/j.1460-2075.1994.tb06481.x; Sumner JB, 1936, J BACTERIOL, V32, P227, DOI 10.1128/JB.32.2.227-237.1936; Tatebe H, 2005, CURR BIOL, V15, P1006, DOI 10.1016/j.cub.2005.04.061; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Terenna CR, 2008, CURR BIOL, V18, P1748, DOI 10.1016/j.cub.2008.09.047; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529; Vignaud T, 2012, TRENDS CELL BIOL, V22, P671, DOI 10.1016/j.tcb.2012.08.012; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100	65	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106959	10.1371/journal.pone.0106959	http://dx.doi.org/10.1371/journal.pone.0106959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210736	gold, Green Submitted, Green Published			2022-12-27	WOS:000341855900034
J	Gouba, N; Raoult, D; Drancourt, M				Gouba, Nina; Raoult, Didier; Drancourt, Michel			Eukaryote Culturomics of the Gut Reveals New Species	PLOS ONE			English	Article							FECAL FUNGAL FLORA; HEALTHY-VOLUNTEERS; MICROBIOTA; DIVERSITY; COMMUNITY; YEASTS; IMPACT; WATER	The repertoire of microeukaryotes in the human gut has been poorly explored, mainly in individuals living in northern hemisphere countries. We further explored this repertoire using PCR-sequencing and culture in seven individuals living in four tropical countries. A total of 41 microeukaryotes including 38 different fungal species and three protists were detected. Four fungal species, Davidiella tassiana, Davidiella sp., Corticiaceae sp., and Penicillium sp., were uniquely detected by culture; 27 fungal species were uniquely detected using PCR-sequencing and Candida albicans, Candida glabrata, Trichosporon asahii, Clavispora lusitaniae, Debaryomyces hansenii, Malassezia restricta, and Malassezia sp. were detected using both molecular and culture methods. Fourteen microeukaryotes were shared by the seven individuals, whereas 27 species were found in only one individual, including 11 species in Amazonia, nine species in Polynesia, five species in India, and two species in Senegal. These data support a worldwide distribution of Malassezia sp., Trichosporon sp., and Candida sp. in the gut mycobiome. Here, 13 fungal species and two protists, Stentor roeseli and Vorticella campanula, were observed for first time in the human gut. This study revealed a previously unsuspected diversity in the repertoire of human gut microeukaryotes, suggesting spots for further exploring this repertoire.	[Gouba, Nina; Raoult, Didier; Drancourt, Michel] Aix Marseille Univ, URMITE, UMR63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Drancourt, M (corresponding author), Aix Marseille Univ, URMITE, UMR63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France.	michel.drancourt@univ-amu.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Agirbasli H, 2005, MYCOPATHOLOGIA, V159, P515, DOI 10.1007/s11046-005-3451-2; ALKHESRAJI TO, 1980, T BRIT MYCOL SOC, V75, P397, DOI 10.1016/S0007-1536(80)80119-7; Bhattacharya K, 2002, MYCOPATHOLOGIA, V155, P135, DOI 10.1023/A:1020475411125; Chen Y, 2011, DIAGN MICR INFEC DIS, V70, P492, DOI 10.1016/j.diagmicrobio.2010.04.005; Classen AT, 2003, FEMS MICROBIOL ECOL, V44, P319, DOI 10.1016/S0168-6496(03)00068-0; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Duran A, 2009, FEMS MICROBIOL LETT, V298, P99, DOI 10.1111/j.1574-6968.2009.01700.x; Erb Downward John R, 2013, Sci Rep, V3, P2191, DOI 10.1038/srep02191; Figel IC, 2013, MYCOPATHOLOGIA, V175, P413, DOI 10.1007/s11046-013-9633-4; Firmesse O, 2008, INT J FOOD MICROBIOL, V125, P176, DOI 10.1016/j.ijfoodmicro.2008.03.044; Foissner W, 2009, ACTA PROTOZOOL, V48, P291; Goncalves VN, 2012, FEMS MICROBIOL ECOL, V82, P459, DOI 10.1111/j.1574-6941.2012.01424.x; Gong YC, 2007, J EUKARYOT MICROBIOL, V54, P45, DOI 10.1111/j.1550-7408.2006.00147.x; Gouba Nina, 2014, BMC Res Notes, V7, P33, DOI 10.1186/1756-0500-7-33; Gouba N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059474; Hamad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040888; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Keszthelyi A, 2008, MICROBIOL RES, V163, P267, DOI 10.1016/j.micres.2008.01.002; Khatib R, 2001, MYCOSES, V44, P151, DOI 10.1046/j.1439-0507.2001.00639.x; Kitagaki H, 2013, ANNU REV FOOD SCI T, V4, P215, DOI 10.1146/annurev-food-030212-182545; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; LEEMING JP, 1987, J CLIN MICROBIOL, V25, P2017, DOI 10.1128/JCM.25.10.2017-2019.1987; Li QR, 2012, HUM PATHOL, V43, P1273, DOI 10.1016/j.humpath.2011.09.017; McCormick MA, 2013, MYCOLOGIA, V105, P1524, DOI 10.3852/12-336; Najafzadeh MJ, 2013, J MED MICROBIOL, V62, P797, DOI 10.1099/jmm.0.057406-0; Nam YD, 2008, J MICROBIOL, V46, P491, DOI 10.1007/s12275-008-0199-7; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Pandey PK, 2012, J BIOSCIENCES, V37, P221, DOI 10.1007/s12038-012-9197-3; Pereira E, 2013, MICROBIOL RES, V168, P1, DOI 10.1016/j.micres.2012.06.008; Rohrig J, 2013, CURR GENET, V59, P55, DOI 10.1007/s00294-013-0387-9; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Takahashi T, 1997, MYCOPATHOLOGIA, V139, P23, DOI 10.1023/A:1006831111595; Vallini G, 1997, INT J SYST BACTERIOL, V47, P336, DOI 10.1099/00207713-47-2-336; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	36	53	55	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106994	10.1371/journal.pone.0106994	http://dx.doi.org/10.1371/journal.pone.0106994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210972	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900037
J	Hernandez-Cuevas, NA; Weber, C; Hon, CC; Guillen, N				Hernandez-Cuevas, Nora Adriana; Weber, Christian; Hon, Chung-Chau; Guillen, Nancy			Gene Expression Profiling in Entamoeba histolytica Identifies Key Components in Iron Uptake and Metabolism	PLOS ONE			English	Article							D-PHOSPHOGLYCERATE DEHYDROGENASE; PROTOZOAN PARASITE; PROTEIN; BIOSYNTHESIS; ACQUISITION; ACTIVATION; REDUCTION; POSSESSES; INVASION; EHADH2	Entamoeba histolytica is an ameboid parasite that causes colonic dysentery and liver abscesses in humans. The parasite encounters dramatic changes in iron concentration during its invasion of the host, with relatively low levels in the intestinal lumen and then relatively high levels in the blood and liver. The liver notably contains sources of iron; therefore, the parasite's ability to use these sources might be relevant to its survival in the liver and thus the pathogenesis of liver abscesses. The objective of the present study was to identify factors involved in iron uptake, use and storage in E. histolytica. We compared the respective transcriptomes of E. histolytica trophozoites grown in normal medium (containing around 169 mu M iron), low-iron medium (around 123 mu M iron), iron-deficient medium (around 91 mu M iron), and iron-deficient medium replenished with hemoglobin. The differentially expressed genes included those coding for the ATP-binding cassette transporters and major facilitator transporters (which share homology with bacterial siderophores and heme transporters) and genes involved in heme biosynthesis and degradation. Iron deficiency was associated with increased transcription of genes encoding a subset of cell signaling molecules, some of which have previously been linked to adaptation to the intestinal environment and virulence. The present study is the first to have assessed the transcriptome of E. histolytica grown under various iron concentrations. Our results provide insights into the pathways involved in iron uptake and metabolism in this parasite.	[Hernandez-Cuevas, Nora Adriana; Weber, Christian; Hon, Chung-Chau; Guillen, Nancy] Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France; [Hernandez-Cuevas, Nora Adriana; Weber, Christian; Hon, Chung-Chau; Guillen, Nancy] INSERM, U786, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hernandez-Cuevas, NA (corresponding author), Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France.	noraahc@gmail.com	Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714; Hon, Chung-Chau/0000-0002-3741-7577	French National Research Agency [ANR-MIE-08 Intestinalamibe]	French National Research Agency(French National Research Agency (ANR))	The work was funded by the French National Research Agency through grants to NG (ANR-MIE-08 Intestinalamibe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali V, 2004, EUR J BIOCHEM, V271, P2670, DOI 10.1111/j.1432-1033.2004.04195.x; Ali V, 2004, J BIOL CHEM, V279, P16863, DOI 10.1074/jbc.M313314200; Bera T, 2006, J BIOENERG BIOMEMBR, V38, P299, DOI 10.1007/s10863-006-9047-9; Biller L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-63; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Campillos M, 2010, NUCLEIC ACIDS RES, V38, pW360, DOI 10.1093/nar/gkq371; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Crouch MLV, 2008, MOL MICROBIOL, V67, P971, DOI 10.1111/j.1365-2958.2007.06089.x; Cruz-Castaneda A, 2011, BIOCHEM J, V434, P105, DOI 10.1042/BJ20100897; Delmar P, 2005, BIOINFORMATICS, V21, P502, DOI 10.1093/bioinformatics/bti023; DIAMOND LS, 1961, SCIENCE, V134, P336, DOI 10.1126/science.134.3475.336; Draskovic I, 2005, MOL MICROBIOL, V55, P881, DOI 10.1111/j.1365-2958.2004.04430.x; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Espinosa A, 2009, J ANTIMICROB CHEMOTH, V63, P675, DOI 10.1093/jac/dkp015; Evstatiev R, 2012, GUT, V61, P933, DOI 10.1136/gut.2010.214312; Flannery AR, 2013, CURR OPIN MICROBIOL, V16, P716, DOI 10.1016/j.mib.2013.07.018; Frankenberg N, 2003, APPL MICROBIOL BIOT, V63, P115, DOI 10.1007/s00253-003-1432-2; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Husain A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-275; Jeelani G, 2010, J BIOL CHEM, V285, P26889, DOI 10.1074/jbc.M110.106310; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Kim HP, 2011, BIOCHEM BIOPH RES CO, V404, P1, DOI 10.1016/j.bbrc.2010.11.067; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Krucken J, 2004, GENE, V341, P291, DOI 10.1016/j.gene.2004.07.005; Lee J, 2008, KOREAN J PARASITOL, V46, P37, DOI 10.3347/kjp.2008.46.1.37; Leipuviene R, 2007, CELL MOL LIFE SCI, V64, P2945, DOI 10.1007/s00018-007-7198-4; Levican G, 2007, P NATL ACAD SCI USA, V104, P3135, DOI 10.1073/pnas.0611611104; Lopez-Soto F, 2009, INFECT GENET EVOL, V9, P1038, DOI 10.1016/j.meegid.2009.05.018; Loyevsky M, 2003, MOL BIOCHEM PARASIT, V126, P231, DOI 10.1016/S0166-6851(02)00278-5; Maralikova B, 2010, CELL MICROBIOL, V12, P331, DOI 10.1111/j.1462-5822.2009.01397.x; Mi-ichi F, 2009, P NATL ACAD SCI USA, V106, P21731, DOI 10.1073/pnas.0907106106; Mishra V, 2012, MOL BIOCHEM PARASIT, V181, P117, DOI 10.1016/j.molbiopara.2011.10.008; Olivos-Garcia A, 2009, INFECT GENET EVOL, V9, P1033, DOI 10.1016/j.meegid.2009.04.005; Page WJ, 2003, FEMS MICROBIOL LETT, V228, P211, DOI 10.1016/S0378-1097(03)00753-5; Park SJ, 2001, MOL BIOCHEM PARASIT, V114, P257, DOI 10.1016/S0166-6851(01)00264-X; Penuliar GM, 2012, J ANTIMICROB CHEMOTH, V67, P375, DOI 10.1093/jac/dkr484; Puntarulo Susana, 2005, Molecular Aspects of Medicine, V26, P299, DOI 10.1016/j.mam.2005.07.001; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Ralston KS, 2011, TRENDS PARASITOL, V27, P253, DOI 10.1016/j.pt.2011.02.006; Reimmann C, 2001, J BACTERIOL, V183, P813, DOI 10.1128/JB.183.3.813-820.2001; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Reyes-Lopez M, 2011, MICROBIOL-SGM, V157, P209, DOI 10.1099/mic.0.040063-0; Richardson DR, 2010, J MOL MED, V88, P323, DOI 10.1007/s00109-009-0565-x; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Sabaty M, 2010, J BACTERIOL, V192, P1238, DOI 10.1128/JB.01342-09; Santi-Rocca J, 2008, CELL MICROBIOL, V10, P202, DOI 10.1111/j.1462-5822.2007.01030.x; Santi-Rocca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031777; Calla-Choque JS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/424767; Sato J, 2010, BIOSCI BIOTECH BIOCH, V74, P854, DOI 10.1271/bbb.90798; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Solano-Gonzalez E, 2007, FEBS LETT, V581, P2919, DOI 10.1016/j.febslet.2007.05.056; TANNICH E, 1991, MOL BIOCHEM PARASIT, V49, P61, DOI 10.1016/0166-6851(91)90130-X; Tronel C, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/264935; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wang ZJ, 2009, PLANT SIGNAL BEHAV, V4, P165, DOI 10.4161/psb.4.3.7722; Weber C, 2006, EUKARYOT CELL, V5, P871, DOI 10.1128/EC.5.5.871-875.2006; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Zhao T, 2001, J BACTERIOL, V183, P6225, DOI 10.1128/JB.183.21.6225-6233.2001	60	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107102	10.1371/journal.pone.0107102	http://dx.doi.org/10.1371/journal.pone.0107102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210888	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900044
J	Sridhar, S; Guruprasad, K				Sridhar, Settu; Guruprasad, Kunchur			Can Natural Proteins Designed with 'Inverted' Peptide Sequences Adopt Native-Like Protein Folds?	PLOS ONE			English	Article							SIMILARITY	We have carried out a systematic computational analysis on a representative dataset of proteins of known three-dimensional structure, in order to evaluate whether it would possible to 'swap' certain short peptide sequences in naturally occurring proteins with their corresponding 'inverted' peptides and generate 'artificial' proteins that are predicted to retain native-like protein fold. The analysis of 3,967 representative proteins from the Protein Data Bank revealed 102,677 unique identical inverted peptide sequence pairs that vary in sequence length between 5-12 and 18 amino acid residues. Our analysis illustrates with examples that such 'artificial' proteins may be generated by identifying peptides with 'similar structural environment' and by using comparative protein modeling and validation studies. Our analysis suggests that natural proteins may be tolerant to accommodating such peptides.	[Sridhar, Settu; Guruprasad, Kunchur] Ctr Cellular & Mol Biol, Hyderabad, Telangana, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Guruprasad, K (corresponding author), Ctr Cellular & Mol Biol, Hyderabad, Telangana, India.	guru@ccmb.res.in			Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The authors thank Department of Biotechnology, Government of India for research grant support and Ms. Shruti Krishnan Rao for technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPH SYST; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Gayatri M, 2010, PROTEIN PEPTIDE LETT, V17, P1459, DOI 10.2174/0929866511009011459; Griep S, 2010, NUCLEIC ACIDS RES, V38, pD318, DOI 10.1093/nar/gkp786; Guruprasad K, 2005, INT J BIOL MACROMOL, V36, P259, DOI 10.1016/j.ijbiomac.2005.06.005; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krishna N, 2011, INT J BIOL MACROMOL, V49, P218, DOI 10.1016/j.ijbiomac.2011.04.017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lorenzen S, 2003, FEBS LETT, V545, P105, DOI 10.1016/S0014-5793(03)00450-2; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Nebel JC, 2010, PROTEIN PEPTIDE LETT, V17, P854, DOI 10.2174/092986610791306698; Olszewski KA, 1996, PROTEIN ENG, V9, P5, DOI 10.1093/protein/9.1.5; Pornillos O, 2006, FEBS LETT, V580, P358, DOI 10.1016/j.febslet.2005.12.054; Preissner R, 1997, FEBS LETT, V414, P425, DOI 10.1016/S0014-5793(97)00907-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WUILMART C, 1975, J MOL EVOL, V5, P259, DOI 10.1007/BF01732214	18	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107647	10.1371/journal.pone.0107647	http://dx.doi.org/10.1371/journal.pone.0107647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210740	Green Submitted, gold, Green Published			2022-12-27	WOS:000341855900090
J	Zhang, S; Hu, LQ; Chen, J; Xu, BY; Zhou, YH; Hu, YL				Zhang, Shu; Hu, Lingqing; Chen, Jie; Xu, Biyun; Zhou, Yi-Hua; Hu, Yali			Cytomegalovirus Seroprevalence in Pregnant Women and Association with Adverse Pregnancy/Neonatal Outcomes in Jiangsu Province, China	PLOS ONE			English	Article							CMV IGG; INFECTION; DIAGNOSIS; PREVALENCE; MANAGEMENT; BIRTH	Background: In this study, we aimed to determine the provincial population-based seroprevalence in pregnant women and to further explore the association of maternal CMV infection status and adverse pregnancy/neonatal/growth outcomes in Jiangsu, China. Methods: In this case-control study, the sera from 527 pregnant women with adverse pregnancy/neonatal outcomes and 496 mothers of healthy infants in Jiangsu Province, collected at gestation age of 15-20 weeks, were tested for anti-CMV IgG, IgM and IgG avidity. Adverse pregnancy/neonatal outcomes were identified based on pregnancy/neonatal outcomes. Results: The overall seroprevalence of anti-CMV IgG was 98.7%, with 99.4% and 98.0% in the case and control groups, respectively (P = 0.039). The prevalence of anti-CMV IgG+/IgM+, was higher in the case group than that in the control group (3.8% vs. 1.6%, P = 0.033). Anti-CMV IgG avidity assay showed that none in the control group were primarily infected, but five (0.9%) in the case group underwent primary infection (P = 0.084); all five infants of these women presented severe adverse neonatal/growth outcomes. Exact logistic regression analysis showed that anti-CMV IgG+/IgM+ was associated with adverse pregnancy/neonatal/growth outcomes (aOR = 2.44, 95% CI 1.01-6.48, P = 0.047). Maternal low education level and prior abnormal pregnancies also were risk factors for adverse pregnancy/neonatal outcomes. Conclusions: In populations with very high prevalence of latent CMV infection, active maternal CMV infection during pregnancy might be a risk factor for adverse pregnancy/neonatal outcomes.	[Zhang, Shu; Chen, Jie; Hu, Yali] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China; [Hu, Lingqing] Wuxi Maternal & Child Hlth Hosp, Dept Obstet & Gynecol, Wuxi, Jiangsu, Peoples R China; [Xu, Biyun] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Biostat, Nanjing, Jiangsu, Peoples R China; [Zhou, Yi-Hua] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Expt Med, Nanjing, Jiangsu, Peoples R China; [Zhou, Yi-Hua] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Zhou, Yi-Hua; Hu, Yali] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Zhou, YH (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Expt Med, Nanjing, Jiangsu, Peoples R China.	zgr03summer@126.com; dtylhu@126.com	hu, ling/GWC-1104-2022		National Key Basic Research Project, China [2010CB945104]; National Natural Science Foundation of China [81300514]; Department of Health, Jiangsu Province [XK201102]; Nanjing Medical Science and Technique Development Foundation, Nanjing, China [2011024]	National Key Basic Research Project, China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Health, Jiangsu Province; Nanjing Medical Science and Technique Development Foundation, Nanjing, China	This study was supported by a Grant (2010CB945104) from National Key Basic Research Project, China (973 Planning), a National Natural Science Foundation of China (No. 81300514), a Special Research Grant (XK201102) for the Key Laboratory from the Department of Health, Jiangsu Province, and by Nanjing Medical Science and Technique Development Foundation (2011024), Nanjing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri L, 2012, J RES HEALTH SCI, V12, P38; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Chen J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-304; Chen MH, 2008, J PAEDIATR CHILD H, V44, P166, DOI 10.1111/j.1440-1754.2007.01215.x; De Paschale M, 2009, INFECT DIS OBSTET GY, V2009, P206; Enders G, 2013, J CLIN VIROL, V56, P102, DOI 10.1016/j.jcv.2012.09.015; Enders G, 2012, MED MICROBIOL IMMUN, V201, P303, DOI 10.1007/s00430-012-0232-7; Fang FQ, 2009, CLIN VACCINE IMMUNOL, V16, P1700, DOI 10.1128/CVI.00385-08; Guo T, 1992, Zhonghua Liu Xing Bing Xue Za Zhi, V13, P76; Johnson JM, 2013, AM J PERINAT, V30, P121, DOI 10.1055/s-0032-1333133; Kouri V, 2010, PEDIATR INFECT DIS J, V29, P1105, DOI 10.1097/INF.0b013e3181eb7388; Lazzarotto T, 2011, CLIN MICROBIOL INFEC, V17, P1285, DOI 10.1111/j.1469-0691.2011.03564.x; Lazzarotto T, 2008, J CLIN VIROL, V41, P192, DOI 10.1016/j.jcv.2007.10.015; Li ZY, 2009, CLIN CHIM ACTA, V403, P212, DOI 10.1016/j.cca.2009.03.027; Munro SC, 2005, J CLIN MICROBIOL, V43, P4713, DOI 10.1128/JCM.43.9.4713-4718.2005; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; Neirukh T, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-528; Numazaki Kei, 2002, International Journal of Infectious Diseases, V6, P147, DOI 10.1016/S1201-9712(02)90078-0; Ornoy A, 2006, REPROD TOXICOL, V21, P399, DOI 10.1016/j.reprotox.2005.02.002; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; Tabatabaee M, 2009, J MATERN-FETAL NEO M, V22, P517, DOI 10.1080/14767050902801678; Uysal A, 2012, ARCH GYNECOL OBSTET, V286, P605, DOI 10.1007/s00404-012-2353-z; Wu Guo-jun, 2001, Hunan Yike Daxue Xuebao, V26, P23; [吴少亘 WU Shaogen], 2009, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V27, P217; Yamamoto AY, 2013, EPIDEMIOL INFECT, V141, P2187, DOI 10.1017/S0950268812002695; Yamamoto AY, 2011, PEDIATR INFECT DIS J, V30, P1043, DOI 10.1097/INF.0b013e31822d9640; Zhong X Y, 1993, J Tongji Med Univ, V13, P60; 无, 2007, [江苏医药, Jiangsu Medical Journal], V33, P1218	28	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107645	10.1371/journal.pone.0107645	http://dx.doi.org/10.1371/journal.pone.0107645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211647	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900089
J	Nenzen, HK; Montoya, D; Varela, S				Nenzen, Hedvig K.; Montoya, Daniel; Varela, Sara			The Impact of 850,000 Years of Climate Changes on the Structure and Dynamics of Mammal Food Webs	PLOS ONE			English	Article							PLEISTOCENE; COMMUNITIES; EXTINCTION; NETWORKS; SIZE; PLIOPLEISTOCENE; ARCHITECTURE; NESTEDNESS; COMPLEXITY; STABILITY	Most evidence of climate change impacts on food webs comes from modern studies and little is known about how ancient food webs have responded to climate changes in the past. Here, we integrate fossil evidence from 71 fossil sites, body-size relationships and actualism to reconstruct food webs for six large mammal communities that inhabited the Iberian Peninsula at different times during the Quaternary. We quantify the long-term dynamics of these food webs and study how their structure changed across the Quaternary, a period for which fossil data and climate changes are well known. Extinction, immigration and turnover rates were correlated with climate changes in the last 850 kyr. Yet, we find differences in the dynamics and structural properties of Pleistocene versus Holocene mammal communities that are not associated with glacial-interglacial cycles. Although all Quaternary mammal food webs were highly nested and robust to secondary extinctions, general food web properties changed in the Holocene. These results highlight the ability of communities to reorganize with the arrival of phylogenetically similar species without major structural changes, and the impact of climate change and super-generalist species (humans) on Iberian Holocene mammal communities.	[Nenzen, Hedvig K.] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Montoya, Daniel] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Varela, Sara] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic	University of Quebec; University of Quebec Montreal; University of Bristol; Charles University Prague	Nenzen, HK (corresponding author), Univ Quebec, Dept Sci Biol, CP 8888, Montreal, PQ H3C 3P8, Canada.	hedvig.nenzen@gmail.com	Montoya, Daniel/L-2266-2019; Varela, Sara/J-7725-2016	Montoya, Daniel/0000-0002-5521-5282; Varela, Sara/0000-0002-5756-5737; Nenzen, Hedvig/0000-0002-0189-4283	UQAM; NSERC-Discovery; NSERC-Create; Canada Research Chairs; Support of establishment, development and mobility of quality research teams at the Charles University (European Science Foundation) [CZ.1.07/2.3.00/30.0022]; European Commission [301124]; Support of establishment, development and mobility of quality research teams at the Charles University (Czech Republic) [CZ.1.07/2.3.00/30.0022]	UQAM; NSERC-Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC-Create; Canada Research Chairs(Canada Research ChairsCGIAR); Support of establishment, development and mobility of quality research teams at the Charles University (European Science Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Support of establishment, development and mobility of quality research teams at the Charles University (Czech Republic)	H.N. was supported by: UQAM, NSERC-Discovery, NSERC-Create, Canada Research Chairs. S. V. was supported by 'Support of establishment, development and mobility of quality research teams at the Charles University' (CZ.1.07/2.3.00/30.0022, European Science Foundation and Czech Republic). D. M. was supported by the European Commission (MODELECORESTORATION- FP7 Marie Curie Intra-European Fellowship for Career Development [301124]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2001, QUATERNARY RES, V56, P411, DOI 10.1006/qres.2001.2269; Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bascompte J, 2009, PHILOS T R SOC B, V364, P1781, DOI 10.1098/rstb.2008.0226; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baskerville EB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002321; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Bosl C, 2006, INT J OSTEOARCHAEOL, V16, P296, DOI 10.1002/oa.834; Bon C, 2012, P ROY SOC B-BIOL SCI, V279, P2825, DOI 10.1098/rspb.2012.0358; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Ceballos G, 2010, QUATERNARY RES, V73, P464, DOI 10.1016/j.yqres.2010.02.006; de Visser SN, 2011, J ANIM ECOL, V80, P484, DOI 10.1111/j.1365-2656.2010.01787.x; Dormann C.F., 2008, R NEWS, V8, P8; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Harnik PG, 2012, TRENDS ECOL EVOL, V27, P608, DOI 10.1016/j.tree.2012.07.010; Jablonski D, 2008, EVOLUTION, V62, P715, DOI 10.1111/j.1558-5646.2008.00317.x; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kageyama M, 2006, QUATERNARY SCI REV, V25, P2082, DOI 10.1016/j.quascirev.2006.02.010; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Martinez ND, 1999, ECOLOGY, V80, P1044, DOI 10.1890/0012-9658(1999)080[1044:EOSEOC]2.0.CO;2; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Montoya D, 2007, ECOGRAPHY, V30, P173, DOI 10.1111/j.0906-7590.2007.04873.x; Newsome SD, 2010, P NATL ACAD SCI USA, V107, P9246, DOI 10.1073/pnas.0913011107; Olesen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026455; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Palombo MR, 2005, GEOL SOC SPEC PUBL, V247, P251, DOI 10.1144/GSL.SP.2005.247.01.14; Pascual M., 2005, ECOLOGICAL NETWORKS; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Pope KS, 2013, GLOBAL CHANGE BIOL, V19, P1518, DOI 10.1111/gcb.12130; Raia P, 2005, PALAEOGEOGR PALAEOCL, V221, P293, DOI 10.1016/j.palaeo.2005.02.014; Rodriguez JS, 2004, PALAEOGEOGR PALAEOCL, V207, P1, DOI 10.1016/j.palaeo.2003.12.016; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Roopnarine P., 2010, NAT PREC, DOI [10.1038/npre.2010.4433.2, DOI 10.1038/NPRE.2010.4433.2]; Roopnarine PD, 2006, PALEOBIOLOGY, V32, P1; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; SELVAGGIO MM, 1994, J HUM EVOL, V27, P215, DOI 10.1006/jhev.1994.1043; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stouffer DB, 2012, SCIENCE, V335, P1489, DOI 10.1126/science.1216556; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson RM, 2012, TRENDS ECOL EVOL, V27, P689, DOI 10.1016/j.tree.2012.08.005; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; van der Made J., 2005, HOMINIDOS PRIMERAS O, P394; Varela S, 2011, PALAEOGEOGR PALAEOCL, V310, P451, DOI 10.1016/j.palaeo.2011.07.021; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Yeakel JD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0239; Zarnetske PL, 2012, SCIENCE, V336, P1516, DOI 10.1126/science.1222732	63	10	10	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106651	10.1371/journal.pone.0106651	http://dx.doi.org/10.1371/journal.pone.0106651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207754	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300032
J	Nicol, LE; O'Brien, TD; Dumesic, DA; Grogan, T; Tarantal, AF; Abbott, DH				Nicol, Lindsey E.; O'Brien, Timothy D.; Dumesic, Daniel A.; Grogan, Tristan; Tarantal, Alice F.; Abbott, David H.			Abnormal Infant Islet Morphology Precedes Insulin Resistance in PCOS-Like Monkeys	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; FEMALE RHESUS-MONKEYS; BETA-CELL PROLIFERATION; METABOLIC DYSFUNCTION; FETAL; PREGNANCY; EXPOSURE; CONSEQUENCES; SECRETION; PANCREAS	Polycystic ovary syndrome (PCOS) is prevalent in reproductive-aged women and confounded by metabolic morbidities, including insulin resistance and type 2 diabetes. Although the etiology of PCOS is undefined, contribution of prenatal androgen (PA) exposure has been proposed in a rhesus monkey model as premenopausal PA female adults have PCOS-like phenotypes in addition to insulin resistance and decreased glucose tolerance. PA female infants exhibit relative hyperinsulinemia, suggesting prenatal sequelae of androgen excess on glucose metabolism and an antecedent to future metabolic disease. We assessed consequences of PA exposure on pancreatic islet morphology to identify evidence of programming on islet development. Islet counts and size were quantified and correlated with data from intravenous glucose tolerance tests (ivGTT) obtained from dams and their offspring. Average islet size was decreased in PA female infants along with corresponding increases in islet number, while islet fractional area was preserved. Infants also demonstrated an increase in both the proliferation marker Ki67 within islets and the beta to alpha cell ratio suggestive of enhanced beta cell expansion. PA adult females have reduced proportion of small islets without changes in proliferative or apoptotic markers, or in beta to alpha cell ratios. Together, these data suggest in utero androgen excess combined with mild maternal glucose intolerance alter infant and adult islet morphology, implicating deviant islet development. Marked infant, but subtle adult, morphological differences provide evidence of islet post-natal plasticity in adapting to changing physiologic demands: from insulin sensitivity and relative hypersecretion to insulin resistance and diminished insulin response to glucose in the mature PCOS-like phenotype.	[Nicol, Lindsey E.] Wisconsin Sch Med & Publ Hlth, Madison, WI 53726 USA; [O'Brien, Timothy D.] Univ Minnesota, St Paul, MN 55108 USA; [Dumesic, Daniel A.] Univ Calif Los Angeles, Los Angeles, CA USA; [Grogan, Tristan] Univ Calif Los Angeles, Sch Med, Dept Med Stat Core, Los Angeles, CA USA; [Tarantal, Alice F.] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Abbott, David H.] Univ Wisconsin, Madison, WI USA; [Abbott, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Nicol, LE (corresponding author), Wisconsin Sch Med & Publ Hlth, Madison, WI 53726 USA.	nicol@ohsu.edu		O'Brien, Timothy/0000-0001-9742-0930; Dumesic, Daniel/0000-0003-0387-1277	Endocrine Fellows Foundation; NIH [T32 DK07786, P50 HD044405, P51 OD011106, P51 OD011107]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NIH/NCATS/UCLA CTSI [UL1TR000124]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD044405] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015459, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007786] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106, P51OD011107] Funding Source: NIH RePORTER	Endocrine Fellows Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NCATS/UCLA CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by The Endocrine Fellows Foundation Grant and NIH grants T32 DK07786 (postdoctoral fellows training grant), P50 HD044405, P51 OD011106 (WNPRC base operating grant) and P51 OD011107 (CNPRC base operating grant), and was partly conducted at a facility (WNPRC) constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. Statistical analysis for the frequency distribution curves was funded by NIH/NCATS/UCLA CTSI Grant UL1TR000124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2008, BIOL REPROD, V79, P154, DOI 10.1095/biolreprod.108.067702; Abbott DH, 2013, MOL CELL ENDOCRINOL, V373, P21, DOI 10.1016/j.mce.2013.01.013; Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Abbott DH, 2009, AM J PRIMATOL, V71, P776, DOI 10.1002/ajp.20679; Abbott DH, 2005, HUM REPROD UPDATE, V11, P357, DOI 10.1093/humupd/dmi013; AERTS L, 1990, DIABETES METAB REV, V6, P147, DOI 10.1002/dmr.5610060303; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Bruns CM, 2007, INT J OBESITY, V31, P1579, DOI 10.1038/sj.ijo.0803638; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Clark A, 2001, DIABETES, V50, pS169, DOI 10.2337/diabetes.50.2007.S169; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Costes S, 2013, DIABETES, V62, P327, DOI 10.2337/db12-1326; Demissie M, 2008, AM J PHYSIOL-ENDOC M, V295, pE262, DOI 10.1152/ajpendo.90208.2008; Dumesic DA, 2009, HUM REPROD, V24, P3188, DOI 10.1093/humrep/dep324; Dumesic DA, 1997, FERTIL STERIL, V67, P155, DOI 10.1016/S0015-0282(97)81873-0; Eisner JR, 2000, J CLIN ENDOCR METAB, V85, P1206, DOI 10.1210/jc.85.3.1206; HANSEN BC, 1990, AM J PHYSIOL, V259, pR612, DOI 10.1152/ajpregu.1990.259.3.R612; Hogg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024877; Li R, 2008, MAR GEOD, V31, P1, DOI 10.1080/01490410701860856; Luense LJ, 2011, ENDOCRINOLOGY, V152, P4974, DOI 10.1210/en.2011-1182; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Padmanabhan V, 2010, INT J ANDROL, V33, P394, DOI 10.1111/j.1365-2605.2009.01024.x; Rae M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056263; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Robles-Diaz G, 2001, ISRAEL MED ASSOC J, V3, P364; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Tarantal AF, 2005, MOL THER, V12, P87, DOI 10.1016/j.ymthe.2005.01.019; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Van Assche FA, 2001, BRIT MED BULL, V60, P173, DOI 10.1093/bmb/60.1.173; Weir GC, 2007, J CLIN INVEST, V117, P81, DOI 10.1172/JCI30862; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Winborn WB, 1987, GASTROENTEROLOGY, V92, P23, DOI 10.1016/0016-5085(87)90835-3; Xu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027286; Zhou R, 2007, REPROD TOXICOL, V23, P438, DOI 10.1016/j.reprotox.2006.12.009	35	29	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106527	10.1371/journal.pone.0106527	http://dx.doi.org/10.1371/journal.pone.0106527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207967	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300026
J	Wattanapanitch, M; Klincumhom, N; Potirat, P; Amornpisutt, R; Lorthongpanich, C; U-pratya, Y; Laowtammathron, C; Kheolamai, P; Poungvarin, N; Issaragrisil, S				Wattanapanitch, Methichit; Klincumhom, Nuttha; Potirat, Porntip; Amornpisutt, Rattaya; Lorthongpanich, Chanchao; U-pratya, Yaowalak; Laowtammathron, Chuti; Kheolamai, Pakpoom; Poungvarin, Niphon; Issaragrisil, Surapol			Dual Small-Molecule Targeting of SMAD Signaling Stimulates Human Induced Pluripotent Stem Cells toward Neural Lineages	PLOS ONE			English	Article							DIRECTED DIFFERENTIATION; DEFINED CONDITIONS; SPEMANN ORGANIZER; SELF-RENEWAL; IN-VITRO; INDUCTION; INHIBITION; SURVIVAL; NEURONS; DISEASE	Incurable neurological disorders such as Parkinson's disease (PD), Huntington's disease (HD), and Alzheimer's disease (AD) are very common and can be life-threatening because of their progressive disease symptoms with limited treatment options. To provide an alternative renewable cell source for cell-based transplantation and as study models for neurological diseases, we generated induced pluripotent stem cells (iPSCs) from human dermal fibroblasts (HDFs) and then differentiated them into neural progenitor cells (NPCs) and mature neurons by dual SMAD signaling inhibitors. Reprogramming efficiency was improved by supplementing the histone deacethylase inhibitor, valproic acid (VPA), and inhibitor of p160-Rho associated coiled-coil kinase (ROCK), Y-27632, after retroviral transduction. We obtained a number of iPS colonies that shared similar characteristics with human embryonic stem cells in terms of their morphology, cell surface antigens, pluripotency-associated gene and protein expressions as well as their in vitro and in vivo differentiation potentials. After treatment with Noggin and SB431542, inhibitors of the SMAD signaling pathway, HDF-iPSCs demonstrated rapid and efficient differentiation into neural lineages. Six days after neural induction, neuroepithelial cells (NEPCs) were observed in the adherent monolayer culture, which had the ability to differentiate further into NPCs and neurons, as characterized by their morphology and the expression of neuron-specific transcripts and proteins. We propose that our study may be applied to generate neurological disease patient-specific iPSCs allowing better understanding of disease pathogenesis and drug sensitivity assays.	[Wattanapanitch, Methichit; Klincumhom, Nuttha; Potirat, Porntip; Amornpisutt, Rattaya; Lorthongpanich, Chanchao; Laowtammathron, Chuti; Issaragrisil, Surapol] Mahidol Univ, Fac Med, Siriraj Ctr Excellence Stem Cell Res, Siriraj Hosp, Bangkok, Thailand; [U-pratya, Yaowalak; Issaragrisil, Surapol] Mahidol Univ, Fac Med, Siriraj Hosp, Div Hematol,Dept Med, Bangkok, Thailand; [Kheolamai, Pakpoom] Thammasat Univ, Fac Med, Dept Preclin Sci, Div Cell Biol, Pathum Thani, Thailand; [Poungvarin, Niphon] Mahidol Univ, Fac Med, Siriraj Hosp, Div Neurol,Dept Med, Bangkok, Thailand	Mahidol University; Mahidol University; Thammasat University; Mahidol University	Issaragrisil, S (corresponding author), Mahidol Univ, Fac Med, Siriraj Ctr Excellence Stem Cell Res, Siriraj Hosp, Bangkok, Thailand.	surapolsi@gmail.com	Wattanapanitch, Methichit/X-5942-2019; Kheolamai, Pakpoom/R-8575-2019	Wattanapanitch, Methichit/0000-0003-2508-5760; Kheolamai, Pakpoom/0000-0002-4113-7172	Thailand Research Fund (DBG) [RTA 488-0007, 4980014]; Commission on Higher Education [CHE-RES-RG-49]	Thailand Research Fund (DBG)(Thailand Research Fund (TRF)); Commission on Higher Education	This study was supported by grant from the Thailand Research Fund (RTA 488-0007 to S.I. and DBG no. 4980014 to N.P.), and the Commission on Higher Education (grant no. CHE-RES-RG-49 to S.I.). S.I. is a Senior Research Scholar of Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MC, 2012, CELL STEM CELL, V11, P253, DOI 10.1016/j.stem.2012.04.026; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chayosumrit M, 2010, BIOMATERIALS, V31, P505, DOI 10.1016/j.biomaterials.2009.09.071; Claassen DA, 2009, MOL REPROD DEV, V76, P722, DOI 10.1002/mrd.21021; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Clarke DL, 2003, BONE MARROW TRANSPL, V32, pS13, DOI 10.1038/sj.bmt.1703937; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Davila JC, 2004, TOXICOL SCI, V79, P214, DOI 10.1093/toxsci/kfh100; Dottori Mirella, 2008, V438, P19, DOI 10.1007/978-1-59745-133-8_3; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; Hsu Yi-Chao, 2013, Biomed J, V36, P98, DOI 10.4103/2319-4170.113226; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Li XY, 2008, STEM CELLS DEV, V17, P1079, DOI 10.1089/scd.2007.0247; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Matulka K, 2013, CELL STEM CELL, V13, P706, DOI 10.1016/j.stem.2013.09.016; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Pruksananonda K, 2012, BIORESEARCH OPEN ACC, V1, P166, DOI 10.1089/biores.2012.0242; Rolletschek A, 2004, TOXICOL LETT, V149, P361, DOI 10.1016/j.toxlet.2003.12.064; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	37	29	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106952	10.1371/journal.pone.0106952	http://dx.doi.org/10.1371/journal.pone.0106952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207966	Green Submitted, gold, Green Published			2022-12-27	WOS:000342030300050
J	Lokhov, PG; Trifonova, OP; Maslov, DL; Balashova, EE; Archakov, AI; Shestakova, EA; Shestakova, MV; Dedov, II				Lokhov, Petr G.; Trifonova, Oxana P.; Maslov, Dmitry L.; Balashova, Elena E.; Archakov, Alexander I.; Shestakova, Ekaterina A.; Shestakova, Marina V.; Dedov, Ivan I.			Diagnosing Impaired Glucose Tolerance Using Direct Infusion Mass Spectrometry of Blood Plasma	PLOS ONE			English	Article							METABOLOMICS; RISK; REPRODUCIBILITY; OBESITY; ASSOCIATION; DATABASE; DISEASE	The goal of this study was to evaluate the capacity for mass spectrometry of blood plasma to diagnose impaired glucose tolerance (IGT). For this study, blood plasma samples from control subjects (n = 30) and patients with IGT (n = 20) were treated with methanol and low molecular weight fraction were then analyzed by direct infusion mass spectrometry. A total of 51 metabolite ions strongly associated with IGT were detected. The area under a receiver operating characteristic (ROC) curve (AUC) for diagnosing IGT that was based on an analysis of all these metabolites was 0.93 (accuracy 90%, specificity 90%, and sensitivity 90%). The associated reproducibility was 85%. The metabolites identified were also consistent with risk factors previously associated with the development of diabetes. Thus, direct infusion mass spectrometry of blood plasma metabolites represents a rapid, single-step, and reproducible method for the analysis of metabolites. Moreover, this method has the potential to serve as a prototype for clinical analyses that could replace the currently used glucose tolerance test with a more patient-friendly assay.	[Lokhov, Petr G.; Trifonova, Oxana P.; Maslov, Dmitry L.; Balashova, Elena E.; Archakov, Alexander I.] Inst Biomed Chem RAMS, Moscow, Russia; [Shestakova, Ekaterina A.; Shestakova, Marina V.; Dedov, Ivan I.] Endocrinol Sci Ctr, Moscow, Russia	Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; Russian Academy of Medical Sciences; Endocrinology Research Centre	Lokhov, PG (corresponding author), Inst Biomed Chem RAMS, Moscow, Russia.	lokhovpg@rambler.ru	Lokhov, Petr G./F-2942-2017; Trifonova, Oxana P/I-9373-2014; Shestakova, Marina/D-9123-2012; Lokhov, Petr G./AAZ-2108-2020; Maslov, Dmitry/ABD-2497-2020; Dedov, Ivan I/D-3729-2014; Shestakova, Ekaterina/N-8409-2014	Lokhov, Petr G./0000-0002-0730-1725; Shestakova, Marina/0000-0002-5057-127X; Lokhov, Petr G./0000-0002-0730-1725; Maslov, Dmitry/0000-0003-3003-7595; Dedov, Ivan I/0000-0002-8175-7886; Trifonova, Oxana/0000-0002-5803-2529; Balashova, Elena/0000-0002-5314-5727; Shestakova, Ekaterina/0000-0001-6612-6851	Russian Academy of Medical Science; Russian Academy of Science	Russian Academy of Medical Science; Russian Academy of Science(Russian Academy of Sciences)	This work was supported by the Russian Academy of Medical Science ('Human Proteome Program, Medical Addendum') and Russian Academy of Science (grant 'Metabolomics-based diagnostics of impaired glucose tolerance'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balion CM, 2007, CLIN CHEM LAB MED, V45, P1180, DOI 10.1515/CCLM.2007.250; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Bavenholm PN, 2003, J CLIN ENDOCR METAB, V88, P82, DOI 10.1210/jc.2002-020330; Crews B, 2009, ANAL CHEM, V81, P8538, DOI 10.1021/ac9014947; de Luis DA, 2010, DIABETES RES CLIN PR, V88, P76, DOI 10.1016/j.diabres.2009.12.019; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Ellis DI, 2007, PHARMACOGENOMICS, V8, P1243, DOI 10.2217/14622416.8.9.1243; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Fonseca Vivian A, 2005, Clin Cornerstone, V7, P61, DOI 10.1016/S1098-3597(05)80069-9; Geckil H, 2004, BIOPROC BIOSYST ENG, V26, P325, DOI 10.1007/s00449-004-0373-1; Gowda GAN, 2008, EXPERT REV MOL DIAGN, V8, P617, DOI 10.1586/14737159.8.5.617; Inouye M, 2000, ATHEROSCLEROSIS, V148, P197, DOI 10.1016/S0021-9150(99)00263-4; Kashyap SR, 2008, DIABETES CARE, V31, P134, DOI 10.2337/dc07-1198; Ko GTC, 1998, ANN CLIN BIOCHEM, V35, P62, DOI 10.1177/000456329803500107; Koulman A, 2007, RAPID COMMUN MASS SP, V21, P421, DOI 10.1002/rcm.2854; Lin L, 2010, ANALYST, V135, P2970, DOI 10.1039/c0an00265h; Lokhov PG, 2013, EUR J CANCER PREV, V22, P335, DOI 10.1097/CEJ.0b013e32835b3898; Lokhov PG, 2012, INT J MASS SPECTROM, V309, P200, DOI 10.1016/j.ijms.2011.10.002; Lokhov PG, 2010, METABOLOMICS, V6, P156, DOI 10.1007/s11306-009-0187-x; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Martens HA, 1998, CHEMOMETR INTELL LAB, V44, P99, DOI 10.1016/S0169-7439(98)00167-1; MCDONALD GW, 1965, DIABETES, V14, P473, DOI 10.2337/diab.14.8.473; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Raina Elley C, 2008, Evid Based Med, V13, P173, DOI 10.1136/ebm.13.6.173; SAGEL J, 1973, JAMA-J AM MED ASSOC, V226, P667, DOI 10.1001/jama.226.6.667; Sipe JC, 2005, INT J OBESITY, V29, P755, DOI 10.1038/sj.ijo.0802954; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Strathmann FG, 2011, AM J CLIN PATHOL, V136, P609, DOI 10.1309/AJCPW0TA8OBBNGCK; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; US Department of Health and Human Services, 2001, GUID IND BIOAN METH; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; WHO, 1999, DEF DIAGN CLASS DIAB, DOI [10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S]; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923	38	21	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e105343	10.1371/journal.pone.0105343	http://dx.doi.org/10.1371/journal.pone.0105343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202985	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500009
J	Yin, L; Zhang, XT; Bian, XW; Guo, YM; Wang, ZY				Yin, Li; Zhang, Xin-Tian; Bian, Xiu-Wu; Guo, Yu-Ming; Wang, Zhao-Yi			Disruption of the ER-alpha 36-EGFR/HER2 Positive Regulatory Loops Restores Tamoxifen Sensitivity in Tamoxifen Resistance Breast Cancer Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; STEM-CELLS; ENDOCRINE RESISTANCE; ER-ALPHA; GROWTH; ANTIESTROGEN; EXPRESSION; VARIANT; MECHANISMS; RECEPTOR-ALPHA-36	Tamoxifen provided a successful treatment for ER-positive breast cancer for many years. However, most breast tumors develop tamoxifen resistance and are eventually refractory to tamoxifen therapy. The molecular mechanisms underlying development of tamoxifen resistance have not been well established. Recently, we reported that breast cancer cells with high levels of ER-alpha 36, a variant of ER-alpha, were resistant to tamoxifen and knockdown of ER-alpha 36 expression in tamoxifen resistant cells with the shRNA method restored tamoxifen sensitivity, indicating that gained ER-alpha 36 expression is one of the underlying mechanisms of tamoxifen resistance. Here, we found that tamoxifen induced expression of ER-alpha 36-EGFR/HER2 positive regulatory loops and tamoxifen resistant MCF7 cells (MCF7/TAM) expressed enhanced levels of the loops. Disruption of the ER-alpha 36-EGFR/HER2 positive regulatory loops with the dual tyrosine kinase inhibitor Lapatinib or ER-alpha 36 down-regulator Broussoflavonol B in tamoxifen resistant MCF7 cells restored tamoxifen sensitivity. In addition, we also found both Lapatinib and Broussoflavonol B increased the growth inhibitory activity of tamoxifen in tumorsphere cells derived from MCF7/TAM cells. Our results thus demonstrated that elevated expression of the ER-alpha 36-EGFR/HER2 loops is one of the mechanisms by which ER-positive breast cancer cells escape tamoxifen therapy. Our results thus provided a rational to develop novel therapeutic approaches for tamoxifen resistant patients by targeting the ER-alpha 36-EGFR/HER2 loops.	[Yin, Li; Zhang, Xin-Tian; Guo, Yu-Ming; Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Med Microbiol, Omaha, NE 68178 USA; [Yin, Li; Zhang, Xin-Tian; Guo, Yu-Ming; Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Immunol, Omaha, NE 68178 USA; [Yin, Li; Bian, Xiu-Wu] Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China; [Yin, Li; Bian, Xiu-Wu] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China	Creighton University; Creighton University; Army Medical University; Army Medical University	Wang, ZY (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol, Omaha, NE 68178 USA.	zywang@creighton.edu	Bian, Xiu-Wu/D-4736-2017	Bian, Xiu-Wu/0000-0003-4383-0197	Department of Defense [DAMD 11-1-0497]; Nebraska Tobacco Settlement Biomedical Research Program Awards [LB-595]	Department of Defense(United States Department of Defense); Nebraska Tobacco Settlement Biomedical Research Program Awards	This work was supported by Department of Defense grant DAMD 11-1-0497 and Nebraska Tobacco Settlement Biomedical Research Program Awards (LB-595) to Z.Y. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry DA, 2000, J CLIN ONCOL, V18, P3471, DOI 10.1200/JCO.2000.18.20.3471; Bianco AR, 1998, P AN M AM SOC CLIN, V17, p97a; BORG A, 1994, CANCER LETT, V81, P137, DOI 10.1016/0304-3835(94)90194-5; Carlomagno C, 1996, J CLIN ONCOL, V14, P2702, DOI 10.1200/JCO.1996.14.10.2702; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chu I, 2005, CANCER RES, V65, P18; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Clarke R, 2001, PHARMACOL REV, V53, P25; Deng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088034; Dontu G, 2010, GENE DEV, V17, P1253; Elledge RM, 1998, CLIN CANCER RES, V4, P7; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guo MX, 2013, EUR J PHARMACOL, V714, P56, DOI 10.1016/j.ejphar.2013.05.047; Guo MX, 2013, ANTICANCER RES, V33, P1873; Han JS, 2009, INT J ONCOL, V34, P1449, DOI 10.3892/ijo_00000273; Kang LG, 2011, J STEROID BIOCHEM, V127, P262, DOI 10.1016/j.jsbmb.2011.08.011; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kunisue H, 2000, BRIT J CANCER, V82, P46; Kurokawa H, 2000, CANCER RES, V60, P5887; Leary AF, 2010, CLIN CANCER RES, V16, P1486, DOI 10.1158/1078-0432.CCR-09-1764; LEITZEL K, 1995, J CLIN ONCOL, V13, P1129, DOI 10.1200/JCO.1995.13.5.1129; Li GL, 2013, MOL ONCOL, V7, P611, DOI 10.1016/j.molonc.2013.02.001; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; MCCANN AH, 1991, CANCER RES, V51, P3296; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; O'Brien CS, 2009, J MAMMARY GLAND BIOL, V14, P45, DOI 10.1007/s10911-009-9115-y; Oliveira LR, 2010, HISTOL HISTOPATHOL, V25, P371, DOI 10.14670/HH-25.371; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Piva M, 2013, EMBO MOL MED, V5, P1; Ravdin P, 1998, P AN M AM SOC CLIN, V17, p97a; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Witters LM, 1997, BREAST CANC RES TREA, V42, P0167; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Yamauchi H, 1997, J CLIN ONCOL, V15, P2518, DOI 10.1200/JCO.1997.15.7.2518; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zhang XT, 2013, ENDOCRINOLOGY, V154, P1990, DOI 10.1210/en.2013-1116; Zhang XT, 2014, J STEROID BIOCHEM, V143, P434, DOI 10.1016/j.jsbmb.2014.06.009; Zhang XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030174; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	48	27	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107369	10.1371/journal.pone.0107369	http://dx.doi.org/10.1371/journal.pone.0107369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203051	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500091
J	Chen, B; Shen, JG; Zhang, XC; Pan, FS; Yang, XE; Feng, Y				Chen, Bao; Shen, Jianguo; Zhang, Xincheng; Pan, Fengshan; Yang, Xiaoe; Feng, Ying			The Endophytic Bacterium, Sphingomonas SaMR12, Improves the Potential for Zinc Phytoremediation by Its Host, Sedum alfredii	PLOS ONE			English	Article							WEIGHT ORGANIC-ACIDS; ROOT MORPHOLOGY; CITRIC-ACID; CONTAMINATED SOIL; HEAVY-METALS; DURUM-WHEAT; PLANT; GROWTH; RHIZOSPHERE; HYPERACCUMULATOR	The endophytic bacterium, Sphingomonas SaMR12, isolated from Sedum alfredii Hance, appears to increase plant biomass and zinc-extraction from contaminated soil; however, the mechanism by which this occurs is not clear. Here, the ability of SaMR12 to promote zinc extraction and its effects on root morphology and exudation were examined in hydroponics. Zinc treatment increased shoot biomass by 30 to 45%, and by a further 10 to 19% when combined with SaMR12 inoculation. Zinc treatment also increased zinc accumulation modestly and this too was enhanced with SaMR12. Both biomass and zinc levels increased in a dose-dependent manner with significant effects seen at 50 mu M zinc and apparent saturation at 500 mu M. Zinc and the endophyte also increased levels of auxin but not at 50 mu M and zinc increased levels of superoxide and hydrogen peroxide but mainly at 500 mu M. As for root morphology, SaMR12 increased root branching, the number of root tips, and surface area. Zinc and SaMR12 also increased the exudation of oxalic acid. For most assays the effects of the endophyte and zinc were additive, with the notable exception of SaMR12 strongly reducing the production of reactive oxygen species at 500 mu M zinc. Taken together, these results suggest that the promotion of growth and zinc uptake by exposure to zinc and to SaMR12 are independent of reactive oxygen and do not involve increases in auxin.	[Chen, Bao; Zhang, Xincheng; Pan, Fengshan; Yang, Xiaoe; Feng, Ying] Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Jianguo] Agr Ecol & Plant Protect Management Stn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Feng, Y (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	yfeng@zju.edu.cn	Pan, Peter/ADX-3362-2022		Ministry of Science and Technology of China [2012AA100605]; Natural Science Foundation of China [21177107]; Ministry of Education of China [310003]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the projects from the "863" project from the Ministry of Science and Technology of China (No. 2012AA100605), Natural Science Foundation of China (No. 21177107), and the Ministry of Education of China (No. 310003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen-Jonnarth U, 2000, NEW PHYTOL, V146, P557, DOI 10.1046/j.1469-8137.2000.00653.x; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Berkelaar E, 2000, CAN J BOT, V78, P381, DOI 10.1139/cjb-78-3-381; Bonnet M, 2000, J EXP BOT, V51, P945, DOI 10.1093/jexbot/51.346.945; Burd GI, 2000, CAN J MICROBIOL, V46, P237, DOI 10.1139/cjm-46-3-237; Chen LA, 2010, APPL SOIL ECOL, V46, P383, DOI 10.1016/j.apsoil.2010.10.003; Chen Y, 2013, MICROB ECOL, V65, P161, DOI 10.1007/s00248-012-0093-z; Cieslinski G, 1998, PLANT SOIL, V203, P109, DOI 10.1023/A:1004325817420; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Harish S, 2009, BIOL CONTROL, V51, P16, DOI 10.1016/j.biocontrol.2009.06.002; Hinsinger P, 2003, PLANT SOIL, V248, P43, DOI 10.1023/A:1022371130939; Hou SJ, 2008, TALANTA, V76, P798, DOI 10.1016/j.talanta.2008.04.041; Islam MR, 2013, J BASIC MICROB, V53, P1004, DOI 10.1002/jobm.201200141; Jha P, 2009, MICROB ECOL, V58, P179, DOI 10.1007/s00248-009-9485-0; Jones DL, 1996, PLANT SOIL, V180, P57, DOI 10.1007/BF00015411; Kochian L.V., 2000, BIOCH MOL BIOL PLANT, V20, P1204; KOTHARI SK, 1990, NEW PHYTOL, V116, P303, DOI 10.1111/j.1469-8137.1990.tb04718.x; Li TQ, 2013, ENVIRON POLLUT, V182, P248, DOI 10.1016/j.envpol.2013.07.025; Li TQ, 2009, J HAZARD MATER, V169, P734, DOI 10.1016/j.jhazmat.2009.04.004; Li TQ, 2005, J INTEGR PLANT BIOL, V47, P927, DOI 10.1111/j.1744-7909.2005.00117.x; Liu D, 2007, B ENVIRON CONTAM TOX, V78, P280, DOI 10.1007/s00128-007-9121-y; Lu LL, 2013, J ZHEJIANG UNIV-SC B, V14, P106, DOI 10.1631/jzus.B1200211; Ma JF, 1997, PLANT CELL PHYSIOL, V38, P1019, DOI 10.1093/oxfordjournals.pcp.a029266; Malinowski DP, 1999, J AGRON CROP SCI, V183, P53, DOI 10.1046/j.1439-037x.1999.00321.x; Marques APGC, 2010, SOIL BIOL BIOCHEM, V42, P1229, DOI 10.1016/j.soilbio.2010.04.014; MEHARG AA, 1995, PLANT SOIL, V170, P345, DOI 10.1007/BF00010488; Nag S, 2000, PLANT SCI, V157, P157, DOI 10.1016/S0168-9452(00)00281-8; Oliveira ALM, 2002, PLANT SOIL, V242, P205, DOI 10.1023/A:1016249704336; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Poschenrieder C., 2003, CONTRIB SCI, V2, P333; Prasad AS, 2007, AM J CLIN NUTR, V85, P837, DOI 10.1093/ajcn/85.3.837; PRIKRYL Z, 1980, PLANT SOIL, V57, P69, DOI 10.1007/BF02139643; Rajkumar M, 2009, CHEMOSPHERE, V77, P153, DOI 10.1016/j.chemosphere.2009.06.047; Saber NE, 1999, BIOL PLANTARUM, V42, P65, DOI 10.1023/A:1002115425544; Shi YW, 2010, PHOTOSYNTH RES, V105, P5, DOI 10.1007/s11120-010-9547-7; Smit CE, 1996, APPL SOIL ECOL, V3, P127, DOI 10.1016/0929-1393(95)00078-X; Splivallo R, 2009, PLANT PHYSIOL, V150, P2018, DOI 10.1104/pp.109.141325; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Tang B, 2004, ANAL CHIM ACTA, V502, P125, DOI 10.1016/j.aca.2003.09.052; Tripathi BN, 2004, PLANTA, V219, P397, DOI 10.1007/s00425-004-1237-2; Wang SL, 2013, ENVIRON GEOCHEM HLTH, V35, P111, DOI 10.1007/s10653-012-9461-3; Wu LH, 2004, AGR ECOSYST ENVIRON, V102, P307, DOI 10.1016/j.agee.2003.09.002; Wu LH, 2003, CHEMOSPHERE, V50, P819, DOI 10.1016/S0045-6535(02)00225-4; Yang JY, 2006, ENVIRON POLLUT, V143, P9, DOI 10.1016/j.envpol.2005.11.010; Yang XE, 2005, INT J PHYTOREMEDIAT, V7, P69, DOI 10.1080/16226510590915855; Yang XE, 2004, PLANT SOIL, V259, P181, DOI 10.1023/B:PLSO.0000020956.24027.f2; Yang X, 2006, PLANTA, V224, P185, DOI 10.1007/s00425-005-0194-8; Yuttavanichakul W, 2012, BIOL CONTROL, V63, P87, DOI 10.1016/j.biocontrol.2012.06.008; Zhang XC, 2013, INT J PHYTOREMEDIAT, V15, P51, DOI 10.1080/15226514.2012.670315; Zhang XX, 2010, J HAZARD MATER, V175, P703, DOI 10.1016/j.jhazmat.2009.10.066; Zhang YF, 2011, J HAZARD MATER, V186, P1720, DOI 10.1016/j.jhazmat.2010.12.069; Zhu XF, 2011, PLANT CELL ENVIRON, V34, P1055, DOI 10.1111/j.1365-3040.2011.02304.x	53	51	56	5	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106826	10.1371/journal.pone.0106826	http://dx.doi.org/10.1371/journal.pone.0106826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198772	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700054
J	Cooper, AE; Ahonen, S; Rowlan, JS; Duncan, A; Seppala, EH; Vanhapelto, P; Lohi, H; Komaromy, AM				Cooper, Ann E.; Ahonen, Saija; Rowlan, Jessica S.; Duncan, Alison; Seppala, Eija H.; Vanhapelto, Paivi; Lohi, Hannes; Komaromy, Andras M.			A Novel Form of Progressive Retinal Atrophy in Swedish Vallhund Dogs	PLOS ONE			English	Article							CANINE MULTIFOCAL RETINOPATHY; VITAMIN-E-DEFICIENCY; CONE-ROD DYSTROPHY; RETINITIS-PIGMENTOSA; GENE-THERAPY; NONSENSE MUTATION; ANIMAL-MODEL; DEGENERATION; DELETION; ACHROMATOPSIA	Inherited retinal degenerations, such as retinitis pigmentosa (RP) and age-related macular degeneration (AMD), represent leading causes of incurable blindness in humans. This is also true in dogs, where the term progressive retinal atrophy (PRA) is used to describe inherited photoreceptor degeneration resulting in progressive vision loss. Because of the similarities in ocular anatomy, including the presence of a cone photoreceptor-rich central retinal region, and the close genotype-phenotype correlation, canine models contribute significantly to the understanding of retinal disease mechanisms and the development of new therapies. The screening of the pure-bred dog population for new forms of PRA represents an important strategy to establish new large animal models. By examining 324 dogs of the Swedish vallhund breed in seven countries and across three continents, we were able to describe a new and unique form of PRA characterized by the multifocal appearance of red and brown discoloration of the tapetal fundus followed over time by thinning of the retina. We propose three stages of the disease based on the appearance of the ocular fundus and associated visual deficits. Electroretinography revealed a gradual loss of both rod and cone photoreceptor-mediated function in Stages 2 and 3 of the disease. In the few dogs that suffered from pronounced vision loss, night-blindness occurred first in late Stage 2, followed by decreased day-vision in Stage 3. Histologic examinations confirmed the loss of photoreceptor cells at Stage 3, which was associated with the accumulation of autofluorescent material in the adjacent retinal pigment epithelium. Pedigree analysis was suggestive of an autosomal-recessive mode of inheritance. Mutations in six known canine retinal degeneration genes as well as hypovitaminosis E were excluded as causes of the disease. The observed variability in the age of disease onset and rate of progression suggest the presence of genetic and/or environmental disease modifiers.	[Cooper, Ann E.; Komaromy, Andras M.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Cooper, Ann E.; Rowlan, Jessica S.; Duncan, Alison; Komaromy, Andras M.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA; [Cooper, Ann E.] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA USA; [Ahonen, Saija; Seppala, Eija H.; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Ahonen, Saija; Seppala, Eija H.; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Ahonen, Saija; Seppala, Eija H.; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Rowlan, Jessica S.] Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA; [Vanhapelto, Paivi] Vet Clin Vetset, Kyrkslatt, Finland	Michigan State University; University of Pennsylvania; University of California System; University of California Irvine; University of Helsinki; University of Helsinki; University of Washington; University of Washington Seattle	Komaromy, AM (corresponding author), Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA.	komaromy@cvm.msu.edu	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532; Ahonen, Saija/0000-0003-3313-784X	NIH [K12-EY15398, R01-EY019304, R01-EY06855]; Academy of Finland; Sigrid Juselius Foundation; Biocentrum Helsinki; Jane and Aatos Erkko Foundation; University of Helsinki Research Funds; Folkhalsan Research Centre; NATIONAL EYE INSTITUTE [K12EY015398, R01EY019304, R01EY006855] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Jane and Aatos Erkko Foundation; University of Helsinki Research Funds; Folkhalsan Research Centre; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH grants K12-EY15398, R01-EY019304, R01-EY06855, Academy of Finland, Sigrid Juselius Foundation, Biocentrum Helsinki, Jane and Aatos Erkko Foundation, University of Helsinki Research Funds and Folkhalsan Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2004, VET OPHTHALMOL, V7, P439; Aguirre G D, 1998, Mol Vis, V4, P23; AGUIRRE GD, 1988, EXP EYE RES, V46, P663, DOI 10.1016/S0014-4835(88)80055-1; Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; American College of Veterinary Ophthalmologists, 2013, OC DIS PRES BE INH P; Balicki I, 2013, VET OPHTHALMOL, V16, P397, DOI 10.1111/vop.12007; Beltran WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090390; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; Cideciyan AV, 2004, HUM MOL GENET, V13, P525, DOI 10.1093/hmg/ddh048; CLEMENTS PJM, 1993, CURR EYE RES, V12, P861, DOI 10.3109/02713689309020391; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Davidson MG, 1998, J AM VET MED ASSOC, V213, P645; Ekesten B, 2013, DOC OPHTHALMOL, V127, P79, DOI 10.1007/s10633-013-9388-8; Guyon R, 2007, MOL VIS, V13, P1094; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Guziewicz KE, 2011, INVEST OPHTH VIS SCI, V52, P4497, DOI 10.1167/iovs.10-6385; HUGHES PL, 1987, VET PATHOL, V24, P22, DOI 10.1177/030098588702400105; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Klein R, 2013, INVEST OPHTHALMOL VI, V54, pORSF5; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; KOOIJMAN AC, 1980, INVEST OPHTH VIS SCI, V19, P315; Lheriteau E, 2014, MOL THER, V22, P265, DOI 10.1038/mt.2013.232; Miyadera K, 2012, MAMM GENOME, V23, P212, DOI 10.1007/s00335-011-9384-9; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Mowat FM, 2008, MOL VIS, V14, P2518; MuLellan GJ, 2002, VET REC, V151, P663, DOI 10.1136/vr.151.22.663; Narfstrom KN., 2013, VET OPHTHALMOL, V5th ed., P1303; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; Petit L, 2012, MOL THER, V20, P2019, DOI 10.1038/mt.2012.134; RAY K, 1994, INVEST OPHTH VIS SCI, V35, P4291; RIIS RC, 1981, AM J VET RES, V42, P74; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Storey ES, 2005, VET OPHTHALMOL, V8, P337, DOI 10.1111/j.1463-5224.2005.00423.x; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; Veske A, 1999, GENOMICS, V57, P57, DOI 10.1006/geno.1999.5754; Wiik AC, 2008, GENOME RES, V18, P1415, DOI 10.1101/gr.074302.107; Yeh CY, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-27; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007; Zangerl B, 2010, MOL VIS, V16, P2791	43	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106610	10.1371/journal.pone.0106610	http://dx.doi.org/10.1371/journal.pone.0106610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198798	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700034
J	d'Eeckenbrugge, GC; Lacape, JM				d'Eeckenbrugge, Geo Coppens; Lacape, Jean-Marc			Distribution and Differentiation of Wild, Feral, and Cultivated Populations of Perennial Upland Cotton (Gossypium hirsutum L.) in Mesoamerica and the Caribbean	PLOS ONE			English	Article							GENETIC DIVERSITY; TEHUACAN VALLEY; GERMPLASM; EVOLUTION; NICHE; IDENTIFICATION; DOMESTICATION; CONSERVATISM; MUSTELINUM; CACTACEAE	Perennial forms of Gossypium hirsutum are classified under seven races. Five Mesoamerican races would have been derived from the wild race 'yucatanense' from northern Yucatan. 'Marie-Galante', the main race in the Caribbean, would have developed from introgression with G. barbadense. The racial status of coastal populations from the Caribbean has not been clearly defined. We combined Ecological Niche Modeling with an analysis of SSR marker diversity, to elucidate the relationships among cultivated, feral and wild populations of perennial cottons. Out of 954 records of occurrence in Mesoamerica and the Caribbean, 630 were classified into four categories cultivated, feral (disturbed and secondary habitats), wild/feral (protected habitats), and truly wild cotton (TWC) populations. The widely distributed three first categories cannot be differentiated on ecological grounds, indicating they mostly belong to the domesticated pool. In contrast, TWC are restricted to the driest and hottest littoral habitats, in northern Yucatan and in the Caribbean (from Venezuela to Florida), as confirmed by their climatic envelope in the factorial analysis. Extrapolating this TWC climatic model to South America and the Pacific Ocean points towards places where other wild representatives of tetraploid Gossypium species have been encountered. The genetic analysis sample comprised 42 TWC accessions from 12 sites and 68 feral accessions from 18 sites; at nine sites, wild and feral accessions were collected in close vicinity. Principal coordinate analysis, neighbor joining, and STRUCTURE consistently showed a primary divergence between TWC and feral cottons, and a secondary divergence separating 'Marie-Galante' from all other feral accessions. This strong genetic structure contrasts strikingly with the absence of geographic differentiation. Our results show that TWC populations of Mesoamerica and the Caribbean constitute a homogenous gene pool. Furthermore, the relatively low genetic divergence between the Mesoamerican and Caribbean domesticated pools supports the hypothesis of domestication of G. hirsutum in northern Yucatan.	[d'Eeckenbrugge, Geo Coppens] CIRAD, UMR CEFE 5175, Montpellier, France; [Lacape, Jean-Marc] CIRAD, UMR AGAP, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; CIRAD; Universite de Montpellier	d'Eeckenbrugge, GC (corresponding author), CIRAD, UMR CEFE 5175, Campus CNRS, Montpellier, France.	geo.coppens@cirad.fr	Lacape, JM/Y-1806-2019; Lacape, Jean-Marc/B-4326-2008	Lacape, Jean-Marc/0000-0003-0891-8329; Coppens d'Eeckenbrugge, Geo/0000-0002-1970-0627				Alves MF, 2013, GENET MOL RES, V12, P597, DOI 10.4238/2013.February.27.9; Alves MF, 2009, REV CIENC AGRON, V40, P406; ANO G, 1983, COTON FIBRES TROP, V38, P201; Ano G, 1981, RAPPORT MISSION GUYA; Ano G, 1982, COT FIB TROP, P327; Ano G, 1983, PLANT GENETIC RESOUR, V54; Ano G, 1982, RAPPORT MISSION MEXI; Bakineti T, 1999, STATE FOREST TREE GE; Britton N., 1920, THE BAHAMA FLORA; Britton N.L, 1918, FLORA BERMUDA; Brubaker C.L., 1999, COTTON ORIGIN HIST T, P3; BRUBAKER CL, 1994, AM J BOT, V81, P1309, DOI 10.2307/2445407; Butterworth KM, 2009, INT J PLANT SCI, V170, P561, DOI 10.1086/597817; Casas A, 2007, ANN BOT-LONDON, V100, P1101, DOI 10.1093/aob/mcm126; Chan WL, 2011, GEOSCI MODEL DEV, V4, P1035, DOI 10.5194/gmd-4-1035-2011; Coville F V, 1908, Science, V27, P664, DOI 10.1126/science.27.695.664; Darwin-Foundation, GOSS DARW GAL SPEC C; Degener O, 1959, ATOLL RES B, V64, P24; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fleming K, 1998, EARTH PLANET SC LETT, V163, P327, DOI 10.1016/S0012-821X(98)00198-8; FOSBERG FR, 1969, ATOLL RES B, V123; Fosberg FR, 1994, ATOLL RES B, V393, P61; Fosberg FR, 1959, ATOLL RES B, V67; FOSBERG FR, 1987, ATOLL RES B, V295; FRYXELL P. A., 1963, Empire Cotton Growing Review, V40, P289; Fryxell P.A, 1979, NATURAL HIST COTTON; FRYXELL PAUL A., 1965, ADVANCING FRONTIERS PLANT SCI, V10, P31; Grover CE, 2012, PLANT SYST EVOL, V298, P1177, DOI 10.1007/s00606-012-0615-7; Guillen S, 2011, GENET RESOUR CROP EV, V58, P409, DOI 10.1007/s10722-010-9586-0; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON J. B., 1943, Tropical Agriculture, V20, P235; Hutchinson J. B., 1944, JOUR AGRIC UNIV PUERTO RICO, V28, P35; HUTCHINSON JB, 1951, HEREDITY, V5, P161, DOI 10.1038/hdy.1951.19; HUTCHINSON JB, 1954, HEREDITY, V8, P225, DOI 10.1038/hdy.1954.20; HUTCHINSON JB, 1947, EVOLUTION GOSSYPIUM; Kaufman Terrance, 1990, U PITTSBURGH WORKING, P91; Krapovickas A., 2008, BONPLANDIA, V17, P55, DOI [10.30972/bon.1711361, DOI 10.30972/BON.1711361]; Lacape JM, 2007, MOL BREEDING, V19, P45, DOI 10.1007/s11032-006-9042-1; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Liu S, 2000, CROP SCI, V40, P1459, DOI 10.2135/cropsci2000.4051459x; Lubbers Edward L., 2009, V3, P23, DOI 10.1007/978-0-387-70810-2_2; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Mc Stewart J, 2008, WILD GOSSYPIUM HIRSU, P833; McCarty JC, 2006, EUPHYTICA, V148, P283, DOI 10.1007/s10681-005-9027-x; McCarty JC, 2004, CROP SCI, V44, P1231, DOI 10.2135/cropsci2004.1231; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; Metcalfe SE, 2006, ANN MO BOT GARD, V93, P258, DOI 10.3417/0026-6493(2006)93[258:LQEOTN]2.0.CO;2; Miller AJ, 2006, AM J BOT, V93, P1757, DOI 10.3732/ajb.93.12.1757; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; MORTON J, 1987, FRUITS WARM CLIMATES, P242; Nickrent DL, 2008, VASCULAR FLORA ANDRO; Ortiz F, 2010, J ARID ENVIRON, V74, P897, DOI 10.1016/j.jaridenv.2010.01.009; Parra F, 2010, ANN BOT-LONDON, V106, P483, DOI 10.1093/aob/mcq143; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Percival A. E., 1990, Advances in Agronomy, V44, P225, DOI 10.1016/S0065-2113(08)60823-8; Perrier X., 2006, DARWIN SOFTWARE; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PICKERSGILL B, 1975, Biotropica, V7, P42, DOI 10.2307/2989799; de Menezes IPP, 2014, GENETICA, V142, P99, DOI 10.1007/s10709-014-9757-6; Pritchard JK, 2000, GENETICS, V155, P945; Proctor G., 1980, ATOLL RES B, V241, P71; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; QUISENBERRY JE, 1981, CROP SCI, V21, P889, DOI 10.2135/cropsci1981.0011183X002100060022x; Rapp RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-139; Rensch C. R, 1976, COMP OTOMANGUEAN PHO; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer J., 1967, GEOGRAPHIC RECONNAIS; SAUER JD, 1982, CAYMAN ISLANDS SEASH; Schwendiman J, 1986, COTTON COLLECTING CA; SMITH CE, 1971, ECON BOT, V25, P160, DOI 10.1007/BF02860076; Stephens S G, 1973, Basic Life Sci, V2, P239; STEPHENS S. G., 1963, ANN MISSOURI BOT GARD, V50, P1, DOI 10.2307/2394914; STEPHENS S. G., 1967, CIENC CULT [SAO PAULO], V19, P118; STEPHENS SG, 1966, AM NAT, V100, P199, DOI 10.1086/282413; Stephens SG, 1971, MAN SEA, P401; Stephens SG, 1965, AM NAT, V94, P365; Stephens SG, 1966, COTTON COLLECTION CO; Stewart J. M., 1994, CHALLENGING FUTURE, P313; Stoddart DR, 1991, ATOLL RES B, V352, P24; Stoddart DR, 1980, ATOLL RES B, V241, P53; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Ulloa M, 2006, GENET RESOUR CROP EV, V53, P653, DOI 10.1007/s10722-004-2988-0; Barroso PAV, 2010, GENET RESOUR CROP EV, V57, P343, DOI 10.1007/s10722-009-9472-9; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Wegier A, 2011, MOL ECOL, V20, P4182, DOI 10.1111/j.1365-294X.2011.05258.x; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1990, BIOCHEM SYST ECOL, V18, P517, DOI 10.1016/0305-1978(90)90123-W; Wendel JF, 2012, INT COTT GEN IN ICGI; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; Wendel Jonathan F., 2009, V3, P3, DOI 10.1007/978-0-387-70810-2_1; Whistler A, 2011, LESSONS LEARNED TECH; Wu TT, 2014, PLANT BREEDING, V133, P250, DOI 10.1111/pbr.12139	96	46	46	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107458	10.1371/journal.pone.0107458	http://dx.doi.org/10.1371/journal.pone.0107458			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198534	Green Published, gold			2022-12-27	WOS:000341304700111
J	Handeland, K; Tengs, T; Kokotovic, B; Vikoren, T; Ayling, RD; Bergsjo, B; Sigurdardottir, OG; Bretten, T				Handeland, Kjell; Tengs, Torstein; Kokotovic, Branko; Vikoren, Turid; Ayling, Roger D.; Bergsjo, Bjarne; Sigurdardottir, Olof G.; Bretten, Tord			Mycoplasma ovipneumoniae - A Primary Cause of Severe Pneumonia Epizootics in the Norwegian Muskox (Ovibos moschatus) Population	PLOS ONE			English	Article							BIGHORN SHEEP; RESPIRATORY-DISEASE; BOVIS; OUTBREAK; LAMBS; POLYARTHRITIS; INFECTION	The Norwegian muskox (Ovibos moschatus) population lives on the high mountain plateau of Dovre and originates from animals introduced from Greenland. In the late summers of 2006 and 2012, severe outbreaks of pneumonia with mortality rates of 25-30% occurred. During the 2012 epidemic high quality samples from culled sick animals were obtained for microbiological and pathological examinations. High throughput sequencing (pyrosequencing) of pneumonic lung tissue revealed high concentrations of Mycoplasma ovipneumoniae in all six animals examined by this method and Pasteurella multocida subsp. multocida in four animals, whereas no virus sequences could be identified. Mycoplasma ovipneumoniae and P. multocida multocida were also isolated by culture. Using real time PCR on lung swabs, M. ovipneumoniae was detected in all of the 19 pneumonic lungs examined. Gross pathological examination revealed heavy consolidations primarily in the cranial parts of the lungs and it also identified one case of otitis media. Histologically, lung lesions were characterized as acute to subacute mixed exudative and moderately proliferative bronchoalveolar pneumonia. Immunohistochemical (IHC) examination revealed high load of M. ovipneumoniae antigens within lung lesions, with particularly intensive staining in the neutrophils. Similar IHC finding were observed in archived lung tissue blocks from animals examined during the 2006 epidemic. An M. ovipneumoniae specific ELISA was applied on bio-banked muskox sera from stray muskoxen killed in the period 2004-2013 and sick muskoxen culled, as well as sera from wild reindeer (Rangifer tarandus tarandus) on Dovre and muskoxen from Greenland. Serology and mycoplasma culturing was also carried out on sheep that had been on pasture in the muskox area during the outbreak in 2012. Our findings indicated separate introductions of M. ovipneumoniae infection in 2006 and 2012 from infected co-grazing sheep. Salt licks shared by the two species were a possible route of transmitting infection.	[Handeland, Kjell; Tengs, Torstein; Vikoren, Turid; Bergsjo, Bjarne] Norwegian Vet Inst, Oslo, Norway; [Kokotovic, Branko] Natl Vet Inst, Copenhagen, Denmark; [Ayling, Roger D.] Anim Hlth & Vet Labs Agcy Weybridge, Addlestone, Surrey, England; [Sigurdardottir, Olof G.] Univ Iceland, Inst Expt Pathol, Keldur, Iceland; [Bretten, Tord] Norwegian Nat Inspectorate, Oppdal, Norway	Norwegian Veterinary Institute; Technical University of Denmark; Veterinary Laboratories Agency; University of Iceland	Handeland, K (corresponding author), Norwegian Vet Inst, Oslo, Norway.	kjell.handeland@vetinst.no	Ayling, Roger D/C-7567-2011		Norwegian Environment Agency	Norwegian Environment Agency	The study was carried out within the frame of the Health Surveillance Programme for Wild Cervids and Muskox that is financed by the Norwegian Environment Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALENDAL E, 1983, Fauna Norvegica Series A, V4, P41; Alley MR, 1999, NEW ZEAL VET J, V47, P155, DOI 10.1080/00480169.1999.36135; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayling R, 2005, VET REC, V156, P391, DOI 10.1136/vr.156.12.391-b; Ayling RD, 2004, VET REC, V155, P413, DOI 10.1136/vr.155.14.413; BAKKE T, 1982, ACTA VET SCAND, V23, P235; Baseman JB, 1997, EMERG INFECT DIS, V3, P21, DOI 10.3201/eid0301.970103; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; BLACK SR, 1988, J WILDLIFE DIS, V24, P627, DOI 10.7589/0090-3558-24.4.627; Bretten S, 1990, NORGES DYR PATTEDYRE, V2, P171; Caswell J.L., 2007, JUBB KENNEDY PALMERS, V2, P523; Citti C, 2013, TRENDS MICROBIOL, V21, P196, DOI 10.1016/j.tim.2013.01.003; Cuyler C, 2009, 75 GREENL I NAT RES; DAMASSA AJ, 1991, SMALL RUMINANT RES, V4, P85, DOI 10.1016/0921-4488(91)90055-U; Dyer N, 2008, J VET DIAGN INVEST, V20, P369, DOI 10.1177/104063870802000321; Gunn A, 2013, MUSKOXEN; Hervas J, 1996, J VET MED B, V43, P221, DOI 10.1111/j.1439-0450.1996.tb00309.x; IONAS G, 1991, VET MICROBIOL, V29, P339, DOI 10.1016/0378-1135(91)90141-2; Janardhan KS, 2010, J VET DIAGN INVEST, V22, P797, DOI 10.1177/104063871002200528; Kobisch M, 1996, REV SCI TECH OIE, V15, P1669; Lin YC, 2008, RES VET SCI, V84, P367, DOI 10.1016/j.rvsc.2007.06.004; Maeda T, 2003, J COMP PATHOL, V129, P100, DOI 10.1016/S0021-9975(03)00009-4; Maunsell FP, 2011, J VET INTERN MED, V25, P772, DOI 10.1111/j.1939-1676.2011.0750.x; MEW AJ, 1985, VET MICROBIOL, V10, P541, DOI 10.1016/0378-1135(85)90063-X; NAYAK NC, 1990, PREV VET MED, V9, P259, DOI 10.1016/0167-5877(90)90071-O; Nicholas R., 2000, Cattle Practice, V8, P115; Nicholas RAJ, 2008, SMALL RUMINANT RES, V76, P92, DOI 10.1016/j.smallrumres.2007.12.014; NOSTVOLD S, 1982, ACTA VET SCAND, V23, P259; Parham K, 2006, VET MICROBIOL, V118, P83, DOI 10.1016/j.vetmic.2006.07.005; Pitcher DG, 2005, VET J, V170, P300, DOI 10.1016/j.tvjl.2004.08.011; Register KB, 2013, J VET DIAGN INVEST, V25, P541, DOI 10.1177/1040638713495029; Sack, 1979, VISCERA DOMESTIC MAM, P211; Sheehan M, 2007, VET J, V173, P630, DOI 10.1016/j.tvjl.2006.01.013; Smith T, 2008, ALASKA WILDLIFE NOTE; TERLAAK EA, 1993, VET MICROBIOL, V34, P175, DOI 10.1016/0378-1135(93)90171-3; THIRKELL D, 1990, VET MICROBIOL, V24, P143, DOI 10.1016/0378-1135(90)90062-Z; Vikoren T, 2008, VET MICROBIOL, V127, P10, DOI 10.1016/j.vetmic.2007.07.029; Weber G, 2002, NAT GENET, V30, P141, DOI 10.1038/ng818; Ytrehus B, 2008, ECOHEALTH, DOI 10.10007/s10393-008-0166-0; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	42	28	31	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106116	10.1371/journal.pone.0106116	http://dx.doi.org/10.1371/journal.pone.0106116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198695	Green Published, gold			2022-12-27	WOS:000341304700023
J	Ke, XX; Zhang, DK; Zhu, SQ; Xia, QY; Xiang, ZH; Cui, HJ				Ke, Xiao-Xue; Zhang, Dunke; Zhu, Shunqin; Xia, Qingyou; Xiang, Zhonghuai; Cui, Hongjuan			Inhibition of H3K9 Methyltransferase G9a Repressed Cell Proliferation and Induced Autophagy in Neuroblastoma Cells	PLOS ONE			English	Article							DRUG-INDUCED APOPTOSIS; DNA METHYLATION; HISTONE METHYLATION; LC3B; INACTIVATION; PROGRESSION; MECHANISMS; EXPRESSION; INTERACTS; INVASION	Histone methylation plays an important role in gene transcription and chromatin organization and is linked to the silencing of a number of critical tumor suppressor genes in tumorigenesis. G9a is a histone methyltransferase (HMTase) for histone H3 lysine 9. In this study, we investigated the role of G9a in neuroblastoma tumor growth together with the G9a inhibitor BIX01294. The exposure of neuroblastoma cells to BIX01294 resulted in the inhibition of cell growth and proliferation, and BIX01294 treatment resulted in the inhibition of the tumorigenicity of neuroblastoma cells in NOD/SCID mice. Therefore, G9a may be a potential therapeutic target in neuroblastoma. Moreover, we found several specific characteristics of autophagy after BIX01294 treatment, including the appearance of membranous vacuoles and microtubule-associated protein light chain 3 (LC3B). Similar results were observed in G9a-knockdown cells. In conclusion, our results demonstrated that G9a is a prognostic marker in neuroblastoma, and revealed a potential role of G9a in regulating the autophagy signaling pathway in neuroblastoma.	[Ke, Xiao-Xue; Zhang, Dunke; Zhu, Shunqin; Xia, Qingyou; Xiang, Zhonghuai; Cui, Hongjuan] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Xiang, ZH (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xbxzh@swu.edu.cn; hongjuan.cui@gmail.com			National Basic Research Program of China [2012CB114603]; National Natural Science Foundation of China [31172268, 81201551]; Ph.D. Start-up Foundation of Southwest University [SWU112033, SWU111014]; Science and Technology Project of Chongqing (Academician Foundation) [cstc2013jcyjys0007]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Start-up Foundation of Southwest University; Science and Technology Project of Chongqing (Academician Foundation)	This work was supported by the National Basic Research Program of China (No. 2012CB114603), the National Natural Science Foundation of China (Nos. 31172268 and 81201551), the Ph.D. Start-up Foundation of Southwest University (Nos. SWU112033 and SWU111014), and the Science and Technology Project of Chongqing (Academician Foundation No. cstc2013jcyjys0007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askin FB, 1998, AM J CLIN PATHOL, V109, pS23; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Barta T, 2013, EXP BIOL MED, V238, P271, DOI 10.1177/1535370213480711; Berardi DE, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/595092; Bessho F, 1999, LANCET, V353, P70, DOI 10.1016/S0140-6736(05)74838-8; Calcagno DQ, 2013, WORLD J GASTROENTERO, V19, P1182, DOI 10.3748/wjg.v19.i8.1182; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Chen QR, 2008, GENOMICS, V92, P195, DOI 10.1016/j.ygeno.2008.05.014; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; de Narvajas AAM, 2013, MOL CELL BIOL, V33, P3983, DOI 10.1128/MCB.00813-13; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fimia GM, 2013, CELL DEATH DIFFER, V20, P1, DOI 10.1038/cdd.2012.97; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Goyama S, 2010, LEUKEMIA, V24, P81, DOI 10.1038/leu.2009.202; Hale AN, 2013, AUTOPHAGY, V9, P951, DOI 10.4161/auto.24273; Huang X, 2010, J CLIN NEUROSCI, V17, P1515, DOI 10.1016/j.jocn.2010.03.051; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kim Y, 2013, AUTOPHAGY, V9, P2126, DOI 10.4161/auto.26308; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lee IH, 2013, CURRENT OPINION CELL; Lee Kyung-Min, 2013, Exp Neurobiol, V22, P133, DOI 10.5607/en.2013.22.3.133; Li T, 2012, CELL BIOL INT, V36, P331, DOI 10.1042/CBI20110231; Li T, 2011, DNA CELL BIOL, V30, P1045, DOI 10.1089/dna.2011.1255; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Liu F, 2011, J MED CHEM, V54, P6139, DOI 10.1021/jm200903z; Liu F, 2010, J MED CHEM, V53, P5844, DOI 10.1021/jm100478y; Lu ZY, 2013, ANTI-CANCER DRUG, V24, P484, DOI 10.1097/CAD.0b013e32835ffdbb; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Mai S, 2012, AUTOPHAGY, V8, P47, DOI 10.4161/auto.8.1.18174; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Meyer G, 2013, CURRENT PHARM DESIGN; Mezentseva NV, 2013, STEM CELLS DEV, V22, P654, DOI 10.1089/scd.2012.0181; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Ohhata T, 2004, GENESIS, V40, P151, DOI 10.1002/gene.20077; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Shah Sanjay, 1998, Indian Journal of Pediatrics, V65, P691, DOI 10.1007/BF02731044; Sharp SE, 2011, SEMIN NUCL MED, V41, P345, DOI 10.1053/j.semnuclmed.2011.05.001; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Simon T, 2013, J CLIN ONCOL, V31, P752, DOI 10.1200/JCO.2012.45.9339; Sridhar S, 2013, MOL DIAGN THER, V17, P63, DOI 10.1007/s40291-013-0019-6; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Thomas LR, 2008, J IMMUNOL, V181, P485, DOI 10.4049/jimmunol.181.1.485; Wu H, 2013, GENE CHROMOSOME CANC, V52, P644, DOI 10.1002/gcc.22060; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Zhao H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0475-1; Zhu SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079332, 10.1371/journal.pone.0071555]	51	53	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106962	10.1371/journal.pone.0106962	http://dx.doi.org/10.1371/journal.pone.0106962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198515	Green Published, gold			2022-12-27	WOS:000341304700070
J	Owens, RA; Hammel, S; Sheridan, KJ; Jones, GW; Doyle, S				Owens, Rebecca A.; Hammel, Stephen; Sheridan, Kevin J.; Jones, Gary W.; Doyle, Sean			A Proteomic Approach to Investigating Gene Cluster Expression and Secondary Metabolite Functionality in Aspergillus fumigatus	PLOS ONE			English	Article							INTRACELLULAR PROTEINS; MASS-SPECTROMETRY; OXIDATIVE STRESS; IDENTIFICATION; GLIOTOXIN; EXPOSURE; VIRULENCE; PATHOGEN; BIOSYNTHESIS; MECHANISMS	A combined proteomics and metabolomics approach was utilised to advance the identification and characterisation of secondary metabolites in Aspergillus fumigatus. Here, implementation of a shotgun proteomic strategy led to the identification of non-redundant mycelial proteins (n = 414) from A. fumigatus including proteins typically under-represented in 2-D proteome maps: proteins with multiple transmembrane regions, hydrophobic proteins and proteins with extremes of molecular mass and pI. Indirect identification of secondary metabolite cluster expression was also achieved, with proteins (n = 18) from LaeA-regulated clusters detected, including GliT encoded within the gliotoxin biosynthetic cluster. Biochemical analysis then revealed that gliotoxin significantly attenuates H2O2-induced oxidative stress in A. fumigatus (p > 0.0001), confirming observations from proteomics data. A complementary 2-D/LC-MS/MS approach further elucidated significantly increased abundance (p < 0.05) of proliferating cell nuclear antigen (PCNA), NADH-quinone oxidoreductase and the gliotoxin oxidoreductase GliT, along with significantly attenuated abundance (p < 0.05) of a heat shock protein, an oxidative stress protein and an autolysis-associated chitinase, when gliotoxin and H2O2 were present, compared to H2O2 alone. Moreover, gliotoxin exposure significantly reduced the abundance of selected proteins (p < 0.05) involved in de novo purine biosynthesis. Significantly elevated abundance (p < 0.05) of a key enzyme, xanthine-guanine phosphoribosyl transferase Xpt1, utilised in purine salvage, was observed in the presence of H2O2 and gliotoxin. This work provides new insights into the A. fumigatus proteome and experimental strategies, plus mechanistic data pertaining to gliotoxin functionality in the organism.	[Owens, Rebecca A.; Hammel, Stephen; Sheridan, Kevin J.; Jones, Gary W.; Doyle, Sean] Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland	Maynooth University	Doyle, S (corresponding author), Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland.	sean.doyle@nuim.ie	Owens, Rebecca/V-2362-2019	Owens, Rebecca A./0000-0001-6545-1978; Doyle, Sean/0000-0003-1679-3247; Jones, Gary/0000-0002-7565-934X	Science Foundation Ireland Principal Investigator Award [PI/11/1188]; Irish Research Council for Science Engineering and Technology Embark PhD Fellowships; competitive award from the Irish Higher Education Authority; 3U Partnership (DCU/NUIM/RCSI)	Science Foundation Ireland Principal Investigator Award(Science Foundation Ireland); Irish Research Council for Science Engineering and Technology Embark PhD Fellowships(Irish Research Council for Science, Engineering and Technology); competitive award from the Irish Higher Education Authority; 3U Partnership (DCU/NUIM/RCSI)	This work was funded in part by a Science Foundation Ireland Principal Investigator Award to SD (PI/11/1188). RAO and SH were recipients of Irish Research Council for Science Engineering and Technology Embark PhD Fellowships. LC-MS facilities were funded by a competitive award from the Irish Higher Education Authority. Funding from the 3U Partnership (DCU/NUIM/RCSI) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Albrecht D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-32; Alcazar-Fuoli L, 2011, FUNGAL GENET BIOL, V48, P418, DOI 10.1016/j.fgb.2010.12.007; Arnaud M, ASPERGILLUS GENOME D; Asif AR, 2006, J PROTEOME RES, V5, P954, DOI 10.1021/pr0504586; Barker BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-62; Baumer M, 2000, J BIOL CHEM, V275, P38929, DOI 10.1074/jbc.M007925200; Brace JL, 2005, YEAST, V22, P641, DOI 10.1002/yea.1235; Burkovics P, 2009, NUCLEIC ACIDS RES, V37, P4247, DOI 10.1093/nar/gkp357; Cagas SE, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010108, 10.1074/mcp.M110.004606]; Carberry S, 2006, BIOCHEM BIOPH RES CO, V341, P1096, DOI 10.1016/j.bbrc.2006.01.078; Carberry S, 2012, FUNGAL GENET BIOL, V49, P302, DOI 10.1016/j.fgb.2012.02.003; Choi HS, 2007, BIOCHEM BIOPH RES CO, V359, P523, DOI 10.1016/j.bbrc.2007.05.139; Collins C, 2013, J PROTEOME RES, V12, P2552, DOI 10.1021/pr301131t; Davis C, 2011, CHEM BIOL, V18, P542, DOI 10.1016/j.chembiol.2010.12.022; Fallon JP, 2010, J MED MICROBIOL, V59, P625, DOI 10.1099/jmm.0.018192-0; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fraczek Marcin G, 2010, Clin Mol Allergy, V8, P15, DOI 10.1186/1476-7961-8-15; Franzosa EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028211; Gallagher L, 2012, EUKARYOT CELL, V11, P1226, DOI 10.1128/EC.00113-12; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; Gautam P, 2008, ANTIMICROB AGENTS CH, V52, P4220, DOI 10.1128/AAC.01431-07; Gautam P, 2011, MYCOPATHOLOGIA, V172, P331, DOI 10.1007/s11046-011-9445-3; Grundmann A, 2005, MICROBIOL-SGM, V151, P2199, DOI 10.1099/mic.0.27962-0; Gubbens J, 2014, CHEM BIOL, V21, P707, DOI 10.1016/j.chembiol.2014.03.011; Guetsova ML, 1999, J BACTERIOL, V181, P2984, DOI 10.1128/JB.181.9.2984-2986.1999; Hartl L, 2012, APPL MICROBIOL BIOT, V93, P533, DOI 10.1007/s00253-011-3723-3; Kato N, 2011, CHEMBIOCHEM, V12, P711, DOI 10.1002/cbic.201000562; Khoufache K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-5; Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9; Kniemeyer O, 2011, INT J MED MICROBIOL, V301, P368, DOI 10.1016/j.ijmm.2011.04.001; Lessing F, 2007, EUKARYOT CELL, V6, P2290, DOI 10.1128/EC.00267-07; Lin HC, 2013, J AM CHEM SOC, V135, P4616, DOI 10.1021/ja312503y; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Mabey JE, 2004, NUCLEIC ACIDS RES, V32, pD401, DOI 10.1093/nar/gkh009; MacKenzie DA, 2005, MOL GENET GENOMICS, V274, P410, DOI 10.1007/s00438-005-0034-3; Maiya S, 2007, CHEMBIOCHEM, V8, P1736, DOI 10.1002/cbic.200700202; Maiya S, 2006, CHEMBIOCHEM, V7, P1062, DOI 10.1002/cbic.200600003; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Hanlon KA, 2012, APPL ENVIRON MICROB, V78, P3166, DOI 10.1128/AEM.07249-11; O'Hanlon KA, 2011, INFECT IMMUN, V79, P3978, DOI 10.1128/IAI.00192-11; O'Keeffe G, 2013, PROTEIN SCI, V22, P1612, DOI 10.1002/pro.2367; Ouyang HM, 2010, MOL BIOTECHNOL, V44, P177, DOI 10.1007/s12033-009-9224-2; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; Priebe S, 2011, FUNGAL GENET BIOL, V48, P353, DOI 10.1016/j.fgb.2010.11.001; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Scharf DH, 2010, J AM CHEM SOC, V132, P10136, DOI 10.1021/ja103262m; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000952; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sienko M, 2007, FUNGAL GENET BIOL, V44, P691, DOI 10.1016/j.fgb.2006.12.002; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; Singh S, 2012, J PROTEOME RES, V11, P3259, DOI 10.1021/pr300006j; Stack D, 2007, MICROBIOL-SGM, V153, P1297, DOI 10.1099/mic.0.2006/006908-0; Steffan N, 2009, ORG BIOMOL CHEM, V7, P4082, DOI 10.1039/b908392h; Suh MJ, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-30; Teutschbein J, 2010, J PROTEOME RES, V9, P3427, DOI 10.1021/pr9010684; Tsunematsu Y, 2013, NAT CHEM BIOL, V9, P818, DOI [10.1038/NCHEMBIO.1366, 10.1038/nchembio.1366]; Valerius O, 2001, FUNGAL GENET BIOL, V32, P21, DOI 10.1006/fgbi.2000.1244; Vodisch M, 2011, J PROTEOME RES, V10, P2508, DOI 10.1021/pr1012812; Vodisch M, 2009, PROTEOMICS, V9, P1407, DOI 10.1002/pmic.200800394; Wartenberg D, 2011, INT J MED MICROBIOL, V301, P602, DOI 10.1016/j.ijmm.2011.04.016; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wiedner SD, 2012, J BIOL CHEM, V287, P33447, DOI 10.1074/jbc.M112.394106; Wiemann P, 2013, J IND MICROBIOL BIOT; Wiemann P, 2013, P NATL ACAD SCI USA, V110, P17065, DOI 10.1073/pnas.1313258110; Yamazaki H, 2007, CURR GENET, V51, P89, DOI 10.1007/s00294-006-0109-7; Zamir L, 2012, P NATL ACAD SCI USA, V109, pE406, DOI 10.1073/pnas.1108633109	70	31	31	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106942	10.1371/journal.pone.0106942	http://dx.doi.org/10.1371/journal.pone.0106942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198175	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000341304700068
J	Sethi, A; Delatte, J; Foil, L; Husseneder, C				Sethi, Amit; Delatte, Jennifer; Foil, Lane; Husseneder, Claudia			Protozoacidal Trojan-Horse: Use of a Ligand-Lytic Peptide for Selective Destruction of Symbiotic Protozoa within Termite Guts	PLOS ONE			English	Article							VARIANT SURFACE GLYCOPROTEIN; TRYPANOSOMA-BRUCEI; COPTOTERMES-FORMOSANUS; ENTEROBACTER-CLOACAE; AFRICAN TRYPANOSOMES; PLASMA-MEMBRANE; BORNE DISEASES; PROTEINS; BACTERIA; CELLS	For novel biotechnology-based termite control, we developed a cellulose bait containing freeze-dried genetically engineered yeast which expresses a protozoacidal lytic peptide attached to a protozoa-recognizing ligand. The yeast acts as a 'Trojan-Horse' that kills the cellulose-digesting protozoa in the termite gut, which leads to the death of termites, presumably due to inefficient cellulose digestion. The ligand targets the lytic peptide specifically to protozoa, thereby increasing its protozoacidal efficiency while protecting non-target organisms. After ingestion of the bait, the yeast propagates in the termite's gut and is spread throughout the termite colony via social interactions. This novel paratransgenesis-based strategy could be a good supplement for current termite control using fortified biological control agents in addition to chemical insecticides. Moreover, this ligand-lytic peptide system could be used for drug development to selectively target disease-causing protozoa in humans or other vertebrates.	[Sethi, Amit; Delatte, Jennifer; Foil, Lane; Husseneder, Claudia] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Sethi, A (corresponding author), DuPont Pioneer Agr Biotechnol, Johnston, IA 50131 USA.	amit.sethi@pioneer.com; chusseneder@agcenter.lsu.edu		Husseneder, Claudia/0000-0001-5962-9354	Biotechnology Agricultural Center Interdisciplinary Team Program at Louisiana State University Agricultural Center; state of Louisiana	Biotechnology Agricultural Center Interdisciplinary Team Program at Louisiana State University Agricultural Center; state of Louisiana	Funding was provided by the Biotechnology Agricultural Center Interdisciplinary Team Program at Louisiana State University Agricultural Center, and the state of Louisiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadias M, 2001, INT J FOOD MICROBIOL, V65, P173, DOI 10.1016/S0168-1605(00)00513-4; ALEY SB, 1980, J EXP MED, V152, P391, DOI 10.1084/jem.152.2.391; Bechinger B, 2004, CRIT REV PLANT SCI, V23, P271, DOI 10.1080/07352680490452825; Bell A, 2011, CURR PHARM DESIGN, V17, P2719, DOI 10.2174/138161211797416057; Boer E, 2009, APPL MICROBIOL BIOT, V84, P583, DOI 10.1007/s00253-009-2167-5; BOMAN HG, 1989, J BIOL CHEM, V264, P5852; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Chouvenc T, 2011, BIOL CONTROL, V59, P69, DOI 10.1016/j.biocontrol.2011.06.015; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; CLARKE BJ, 1988, J PROTOZOOL, V35, P408, DOI 10.1111/j.1550-7408.1988.tb04118.x; Cleveland LR, 1923, P NATL ACAD SCI USA, V9, P424, DOI 10.1073/pnas.9.12.424; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; Crotti E, 2012, MICROB BIOTECHNOL, V5, P307, DOI 10.1111/j.1751-7915.2011.00312.x; Dandekar AM, 2012, P NATL ACAD SCI USA, V109, P3721, DOI 10.1073/pnas.1116027109; De Baetselier P, 2002, NATO SCI SER I LIFE, V343, P157; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115; Gomes-Solecki MJC, 2006, VACCINE, V24, P4440, DOI 10.1016/j.vaccine.2005.08.089; Grunfelder CG, 2003, MOL BIOL CELL, V14, P2029, DOI 10.1091/mbc.E02-10-0640; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Hajek AE, 2010, BIOL INVASIONS, V12, P2895, DOI 10.1007/s10530-010-9735-6; Hansel W, 2007, MOL CELL ENDOCRINOL, V260, P183, DOI 10.1016/j.mce.2005.12.056; Hares MC, 2008, MICROBIOL-SGM, V154, P3503, DOI 10.1099/mic.0.2008/018440-0; Higashiguchi DT, 2006, INT J SYST EVOL MICR, V56, P15, DOI 10.1099/ijs.0.63543-0; Hurwitz I, 2011, INT J BIOL SCI, V7, P1334, DOI 10.7150/ijbs.7.1334; Husseneder C, 2005, APPL MICROBIOL BIOT, V68, P360, DOI 10.1007/s00253-005-1914-5; Husseneder C, 2005, CURR MICROBIOL, V50, P119, DOI 10.1007/s00284-004-4428-y; Husseneder C, 2009, INSECT SYMBIOSIS, V3, P361; Husseneder Claudia, 2010, J Vis Exp, DOI 10.3791/2190; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; Koumandou VL, 2013, EUKARYOT CELL, V12, P330, DOI 10.1128/EC.00273-12; Kreil G, 1980, Ann N Y Acad Sci, V343, P338, DOI 10.1111/j.1749-6632.1980.tb47262.x; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; Leuschner C, 2004, CURR PHARM DESIGN, V10, P2299, DOI 10.2174/1381612043383971; Manna PT, 2014, TRENDS PARASITOL, V30, P251, DOI 10.1016/j.pt.2014.03.004; Manzoni C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024909; Mehlert A, 1998, MOL BIOCHEM PARASIT, V91, P145, DOI 10.1016/S0166-6851(97)00187-4; Miller TA, 2011, J APPL ENTOMOL, V135, P474, DOI 10.1111/j.1439-0418.2010.01600.x; Mutwiri GK, 2000, J PARASITOL, V86, P1355, DOI 10.1645/0022-3395(2000)086[1355:EOTAPD]2.0.CO;2; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Ramirez JL, 2008, J ECON ENTOMOL, V101, P1519, DOI 10.1603/0022-0493(2008)101[1519:FOAGMB]2.0.CO;2; Rasgon JL, 2011, FUTURE MICROBIOL, V6, P851, DOI 10.2217/FMB.11.71; Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135; Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002; SAKANE T, 1997, MICROBIOL CULT COLL, V13, P1; Saran RK, 2008, J ECON ENTOMOL, V101, P873, DOI 10.1603/0022-0493(2008)101[873:PSEUAH]2.0.CO;2; SENNETT C, 1981, ANNU REV BIOCHEM, V50, P1053, DOI 10.1146/annurev.bi.50.070181.005201; Sethi A, 2008, ENTOMOL EXP APPL, V128, P410, DOI 10.1111/j.1570-7458.2008.00732.x; Sethi A, 2013, ARCH INSECT BIOCHEM, V84, P175, DOI 10.1002/arch.21135; Sethi A, 2011, COMP BIOCHEM PHYS A, V159, P261, DOI 10.1016/j.cbpa.2011.03.012; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Valderrama MJ, 1999, J FOOD PROTECT, V62, P189, DOI 10.4315/0362-028X-62.2.189; VANSTERKENBURG ELM, 1993, ACTA TROP, V54, P237, DOI 10.1016/0001-706X(93)90096-T; Vooght LD, 2012, MICROB CELL FACT, V11, P23; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; WATANABE F, 1988, J GEN MICROBIOL, V134, P67; Yates C, 2011, BIOCHEM PHARMACOL, V81, P104, DOI 10.1016/j.bcp.2010.09.015; Zhao RH, 2008, APPL ENVIRON MICROB, V74, P7219, DOI 10.1128/AEM.00977-08	59	11	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106199	10.1371/journal.pone.0106199	http://dx.doi.org/10.1371/journal.pone.0106199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198727	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700024
J	Tokarz, D; Cisek, R; El-Ansari, O; Espie, GS; Fekl, U; Barzda, V				Tokarz, Danielle; Cisek, Richard; El-Ansari, Omar; Espie, George S.; Fekl, Ulrich; Barzda, Virginijus			Organization of Astaxanthin within Oil Bodies of Haematococcus pluvialis Studied with Polarization-Dependent Harmonic Generation Microscopy	PLOS ONE			English	Article							MOLECULAR 2ND HYPERPOLARIZABILITY; OPTICAL 2ND-HARMONIC MICROSCOPY; GREEN-ALGA; 3RD-HARMONIC GENERATION; BIOLOGICAL TISSUE; COLLAGEN; STRESS; LASER; CAROTENOGENESIS; BIOSYNTHESIS	Nonlinear optical microscopy was used to image the localization of astaxanthin accumulation in the green alga, Haematococcus pluvialis. Polarization-in, polarization-out (PIPO) second harmonic generation (SHG) and third harmonic generation (THG) microscopy was applied to study the crystalline organization of astaxanthin molecules in light-stressed H. pluvialis in vivo. Since astaxanthin readily forms H- and J-aggregates in aqueous solutions, PIPO THG studies of astaxanthin aggregates contained in red aplanospores were compared to PIPO THG of in vitro self-assembled H- and J-aggregates of astaxanthin. The PIPO THG data clearly showed an isotropic organization of astaxanthin in red aplanospores of H. pluvialis. This is in contrast to the highly anisotropic organization of astaxanthin in synthetic H- and J-aggregates, which showed to be uniaxial. Since carotenoids in vitro preferentially form H- and J-aggregates, but in vivo form a randomly organized structure, this implies that astaxanthin undergoes a different way of packing in biological organisms, which is either due to the unique physical environment of the alga or is controlled enzymatically.	[Tokarz, Danielle; Cisek, Richard; Fekl, Ulrich; Barzda, Virginijus] Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada; [Fekl, Ulrich; Barzda, Virginijus] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada; [Barzda, Virginijus] Univ Toronto, Dept Phys, Toronto, ON, Canada; [Barzda, Virginijus] Univ Toronto, Inst Opt Sci, Toronto, ON, Canada; [Espie, George S.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [El-Ansari, Omar; Espie, George S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Mississauga; University of Toronto	Barzda, V (corresponding author), Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada.	virgis.barzda@utoronto.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors acknowledge funding from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzda Virginijus, 2008, V26, P35; Boussiba S, 2000, PHYSIOL PLANTARUM, V108, P111, DOI 10.1034/j.1399-3054.2000.108002111x./; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Chu SW, 2004, BIOPHYS J, V86, P3914, DOI 10.1529/biophysj.103.034595; Chu SW, 2001, OPT LETT, V26, P1909, DOI 10.1364/OL.26.001909; Cisek R, 2012, THESIS U TORONTO; Cisek R, 2009, PHOTOSYNTH RES, V102, P111, DOI 10.1007/s11120-009-9500-9; Collins AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024302; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; ELSTNER EF, 1982, ANNU REV PLANT PHYS, V33, P73, DOI 10.1146/annurev.pp.33.060182.000445; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Giovannetti R, 2009, SPECTROCHIM ACTA A, V73, P157, DOI 10.1016/j.saa.2009.02.017; Greenhalgh C, 2007, APPL OPTICS, V46, P1852, DOI 10.1364/AO.46.001852; Grunewald K, 2001, J BIOL CHEM, V276, P6023, DOI 10.1074/jbc.M006400200; Harker M, 1996, BIORESOURCE TECHNOL, V55, P207, DOI 10.1016/0960-8524(95)00002-X; Kaczor A, 2011, ANAL CHEM, V83, P7763, DOI 10.1021/ac201302f; KOBAYASHI M, 1992, J FERMENT BIOENG, V74, P61, DOI 10.1016/0922-338X(92)90271-U; Koehn Sonja, 2008, V4, P53, DOI 10.1007/978-3-7643-7499-0_5; Lemoine Y, 2010, PHOTOSYNTH RES, V106, P155, DOI 10.1007/s11120-010-9583-3; Li Y, 2008, J PLANT PHYSIOL, V165, P1783, DOI 10.1016/j.jplph.2007.12.007; Major A, 2009, LASER PHYS LETT, V6, P272, DOI 10.1002/lapl.200810127; Millard AC, 1999, APPL OPTICS, V38, P7393, DOI 10.1364/AO.38.007393; Mizutani G, 2000, J LUMIN, V87-9, P824, DOI 10.1016/S0022-2313(99)00428-7; Muller M, 1998, J MICROSC-OXFORD, V191, P266, DOI 10.1046/j.1365-2818.1998.00399.x; OSVATH S, 1994, J PHOTOCH PHOTOBIO B, V26, P287, DOI 10.1016/1011-1344(94)07053-9; RAMAZANOV Z, 1994, PLANTA, V195, P210; SANTOS MF, 1984, CYTOLOGIA, V49, P215; Sarada R, 2002, PROCESS BIOCHEM, V37, P623, DOI 10.1016/S0032-9592(01)00246-1; Squier J, 2001, REV SCI INSTRUM, V72, P2855, DOI 10.1063/1.1379598; Squier JA, 1998, OPT EXPRESS, V3, P315, DOI 10.1364/OE.3.000315; Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7; TJAHJONO AE, 1994, BIOTECHNOL LETT, V16, P133, DOI 10.1007/BF01021659; Tokarz D, 2014, J PHYS CHEM B, V118, P3814, DOI 10.1021/jp411387p; Tokarz D, 2013, J PHYS CHEM B, V117, P11069, DOI 10.1021/jp400739v; Tokarz D, 2012, ANAL CHIM ACTA, V755, P86, DOI 10.1016/j.aca.2012.09.049; Tokarz D, 2012, PHYS CHEM CHEM PHYS, V14, P10653, DOI 10.1039/c2cp41583f; Tuer AE, 2012, BIOPHYS J, V103, P2093, DOI 10.1016/j.bpj.2012.10.019; Tuer AE, 2011, J PHYS CHEM B, V115, P12759, DOI 10.1021/jp206308k; Wayama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053618	40	9	9	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107804	10.1371/journal.pone.0107804	http://dx.doi.org/10.1371/journal.pone.0107804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215522	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300095
J	Cooper, MA; Nguyen, TD; Spincemaille, P; Prince, MR; Weinsaft, JW; Wang, Y				Cooper, Mitchell A.; Nguyen, Thanh D.; Spincemaille, Pascal; Prince, Martin R.; Weinsaft, Jonathan W.; Wang, Yi			How Accurate Is MOLLI T1 Mapping In Vivo? Validation by Spin Echo Methods	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; DIFFUSE MYOCARDIAL FIBROSIS; INVERSION-RECOVERY MOLLI; CARDIAC AMYLOIDOSIS; PULSE SEQUENCE; QUANTIFICATION; HEART; T-1; CARDIOMYOPATHY; RESOLUTION	T-1 mapping is a promising quantitative tool for assessing diffuse cardiomyopathies. The purpose of this study is to quantify in vivo accuracy of the Modified Look-Locker Inversion Recovery (MOLLI) cardiac T-1 mapping sequence against the spin echo gold standard, which has not been done previously. T-1 accuracy of MOLLI was determined by comparing with the gold standard inversion recovery spin echo sequence in the calf muscle, and with a rapid inversion recovery fast spin echo sequence in the heart. T-1 values were obtained with both conventional MOLLI fitting and MOLLI fitting with inversion efficiency correction. In the calf (n = 6), conventional MOLLI fitting produced inconsistent T-1 values with error ranging from 8.0% at 90 degrees to 17.3% at 30 degrees. Modified MOLLI fitting with inversion efficiency correction improved error to under 7.4% at all flip angles. In the heart (n = 5), modified MOLLI fitting with inversion correction reduced T-1 error to 5.5% from 14.0% by conventional MOLLI fitting. This study shows that conventional MOLLI fitting can lead to significant in vivo T-1 errors when not accounting for the lower adiabatic inversion efficiency often experienced in vivo.	[Cooper, Mitchell A.; Wang, Yi] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Cooper, Mitchell A.; Nguyen, Thanh D.; Spincemaille, Pascal; Prince, Martin R.; Weinsaft, Jonathan W.; Wang, Yi] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Weinsaft, Jonathan W.] Weill Cornell Med Coll, Dept Med, Div Cardiol, New York, NY USA	Cornell University; Cornell University; Cornell University	Cooper, MA (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	mac453@cornell.edu	Prince, Martin R./S-6850-2016; Wang, Yi/GRS-4287-2022	Prince, Martin R./0000-0002-9883-0584; Spincemaille, Pascal/0000-0002-8821-1341	National Science Foundation Graduate Research Fellowship [DGE-0707428]; National Institutes of Health [HL064647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064647] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by a National Science Foundation Graduate Research Fellowship (nsf.gov, DGE-0707428) and National Institutes of Health (nih.gov, grant HL064647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broberg CS, 2010, CIRC-CARDIOVASC IMAG, V3, P727, DOI 10.1161/CIRCIMAGING.108.842096; DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A; Ehses P, 2013, MAGN RESON MED, V69, P71, DOI 10.1002/mrm.24225; Fitts M, 2013, MAGN RESON MED, V70, P1274, DOI 10.1002/mrm.24586; Gai ND, 2013, MAGN RESON MED, V69, P329, DOI 10.1002/mrm.24251; Giri S, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-56; Gloor M, 2008, MAGN RESON MED, V60, P691, DOI 10.1002/mrm.21705; Gloor M, 2012, P 20 ANN M ISMRM MEL, P4262; Iles L, 2008, J AM COLL CARDIOL, V52, P1574, DOI 10.1016/j.jacc.2008.06.049; Kellman P, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-2; Kellman P, 2014, MAGN RESON MED, V71, P1428, DOI 10.1002/mrm.24793; Kellman P, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-63; Kim D, 2005, MAGNET RESON MED, V54, P1423, DOI 10.1002/mrm.20704; Krombach GA, 2007, J MAGN RESON IMAGING, V25, P1283, DOI 10.1002/jmri.20917; Lu MJ, 2013, EUR J RADIOL, V82, pE225, DOI 10.1016/j.ejrad.2012.12.014; Maceira AM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-54; Maceira AM, 2005, CIRCULATION, V111, P186, DOI 10.1161/01.CIR.0000152819.97857.9D; Messroghli DR, 2007, J MAGN RESON IMAGING, V26, P1081, DOI 10.1002/jmri.21119; Messroghli DR, 2006, RADIOLOGY, V238, P1004, DOI 10.1148/radiol.2382041903; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Moon JC, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-92; NEKOLLA S, 1992, J COMPUT ASSIST TOMO, V16, P327, DOI 10.1097/00004728-199203000-00031; Nguyen TD, 2013, P 21 ANN M ISMRM SAL, P262; Nguyen TD, 2006, MAGN RESON MED, V56, P210, DOI 10.1002/mrm.20938; Piechnik SK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-69; Robson MD, 2013, MAGN RESON MED; Rodgers CT, 2012, MAGN RESON MED, DOI 10.1002/mrm.24548; Sibley CT, 2012, RADIOLOGY, V265, P724, DOI 10.1148/radiol.12112721; Sparrow Patrick, 2006, AJR Am J Roentgenol, V187, pW630, DOI 10.2214/AJR.05.1264; Weingartner S, 2013, MAGN RESON MED; Xue H, 2012, MAGN RESON MED, V67, P1644, DOI 10.1002/mrm.23153	31	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107327	10.1371/journal.pone.0107327	http://dx.doi.org/10.1371/journal.pone.0107327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211243	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900063
J	Ding, YW; Qu, JW; Yu, XS; Wang, S				Ding, Yanwei; Qu, Jianwei; Yu, Xiaosong; Wang, Shuang			The Mediating Effects of Burnout on the Relationship between Anxiety Symptoms and Occupational Stress among Community Healthcare Workers in China: A Cross-Sectional Study	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; MENTAL-HEALTH; NATIONAL-SURVEY; JOB BURNOUT; DISORDERS; NURSES; PROFESSIONALS; DEPRESSION; STAFF; LIFE	Background: Several occupational stress studies of healthcare workers have predicted a high prevalence of anxiety symptoms, which can affect their quality of life and the care that they provide. However, few studies have been conducted among community healthcare workers in China. We attempted to explore whether burnout mediates the association between occupational stress and anxiety symptoms. Methods: A cross-sectional survey was completed in Liaoning Province, China from November to December 2012. A total of 1,752 healthcare workers from 52 Community Health Centers participated in this study, and all participants were given self-administered questionnaires. These questionnaires addressed the following aspects: the Zung Self-Rating Anxiety Scale, the Chinese version of the effort-reward imbalance scale and the Maslach Burnout Inventory-General Survey. Finally, the study included 1,243 effective respondents (effective response rate, 70.95%). Hierarchical linear regression analysis, performed with SPSS 17.0, was used to estimate the effect of burnout. Results: The prevalence of anxiety symptoms among the community healthcare workers was 38.0%. After adjusting for demographic characteristics, the effort-reward ratio and overcommitment positively predicted anxiety symptoms. Meanwhile, the effort-reward ratio and overcommitment were positively related to the emotional exhaustion and cynicism subscales of burnout. In addition, the emotional exhaustion and cynicism subscales were positively related to anxiety symptoms. Thus, there is a link between burnout, occupational stress and anxiety symptoms. Conclusions: Burnout mediates the effect of occupational stress on anxiety symptoms. To effectively reduce the impact of occupational stress on anxiety symptoms, burnout management should be considered.	[Ding, Yanwei; Qu, Jianwei; Yu, Xiaosong; Wang, Shuang] China Med Univ, Affiliated Hosp 1, Dept Gen Practice, Shenyang, Liaoning, Peoples R China	China Medical University	Yu, XS (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gen Practice, Shenyang, Liaoning, Peoples R China.	xsyu@mail.cmu.edu.cn						Ahmed I, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.06.003; Ajdary H., 2011, INTERDISCIPLINARY J, V3, P101; Bargellini A, 2000, OCCUP ENVIRON MED, V57, P453, DOI 10.1136/oem.57.7.453; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Begat Ingrid, 2005, J Nurs Manag, V13, P221, DOI 10.1111/j.1365-2834.2004.00527.x; Boudrias JS, 2012, NURS HEALTH SCI, V14, P8, DOI 10.1111/j.1442-2018.2011.00650.x; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Chor D, 2008, CAD SAUDE PUBLICA, V24, P219, DOI 10.1590/S0102-311X2008000100022; Dai JM, 2008, J OCCUP ENVIRON MED, V50, P785, DOI 10.1097/JOM.0b013e318167750a; Dib HH, 2010, HEALTH PLACE, V16, P477, DOI 10.1016/j.healthplace.2009.12.005; DiGiacomo M, 2001, J Allied Health, V30, P106; Dudek D, 2013, KARDIOL POL, V71, P781, DOI 10.5603/KP.2013.0188; Fiabane E, 2013, J CLIN NURS, V22, P2614, DOI 10.1111/jocn.12084; Gao YQ, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-141; Gilbert S, 2010, J NURS MANAGE, V18, P339, DOI 10.1111/j.1365-2834.2010.01074.x; Gomez-Gascon T, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-173; Haynes C, 2000, PSYCHOLOGIST, V13, P128; Jiang HL, 2009, HEALTH ECON, V18, pS107, DOI 10.1002/hec.1517; Li J, 2005, INT ARCH OCC ENV HEA, V78, P198, DOI 10.1007/s00420-004-0581-7; Lin QH, 2013, J OCCUP HEALTH, V55, P458, DOI 10.1539/joh.12-0287-OA; Liu XC, 1997, SOC PSYCH PSYCH EPID, V32, P63, DOI 10.1007/BF00788922; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Maina G, 2009, INT ARCH OCC ENV HEA, V82, P1141, DOI 10.1007/s00420-009-0439-0; Mark G, 2012, BRIT J HEALTH PSYCH, V17, P505, DOI 10.1111/j.2044-8287.2011.02051.x; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C, 2008, J APPL PSYCHOL, V93, P498, DOI 10.1037/0021-9010.93.3.498; McEvoy PM, 2011, AUST NZ J PSYCHIAT, V45, P957, DOI 10.3109/00048674.2011.624083; Nakao M, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-4; Nordang K, 2010, BMC NURS, V9, DOI 10.1186/1472-6955-9-8; Patel V, 2011, BRIT J PSYCHIAT, V199, P459, DOI 10.1192/bjp.bp.111.092155; Pavlakis A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-63; Peplinska A, 2013, INT MARIT HEALTH, V64, P221, DOI 10.5603/IMH.2013.0008; Peterson U, 2008, J ADV NURS, V62, P84, DOI 10.1111/j.1365-2648.2007.04580.x; Piko BF, 2006, INT J NURS STUD, V43, P311, DOI 10.1016/j.ijnurstu.2005.05.003; Ruitenburg MM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-292; Schwarz R, 2001, DEUT MED WOCHENSCHR, V126, P611, DOI 10.1055/s-2001-14420; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Sun W, 2012, J OCCUP HEALTH, V54, P1, DOI 10.1539/joh.11-0169-OA; Tsai YC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-199; Tsutsumi A, 2012, INT ARCH OCC ENV HEA, V85, P153, DOI 10.1007/s00420-011-0656-1; Turnipseed DL, 1998, PSYCHOL REP, V82, P627, DOI 10.2466/PR0.82.2.627-642; Wang XQ, 2007, INT NURS REV, V54, P271, DOI 10.1111/j.1466-7657.2007.00562.x; Wang Y, 2012, J OCCUP HEALTH, V54, P232, DOI 10.1539/joh.11-0243-OA; Wang Z.Y., 1984, J SHANGHAI PSYCHIAT, V2, P73; Wu SY, 2011, IND HEALTH, V49, P158, DOI 10.2486/indhealth.MS1160; Wu SY, 2012, IND HEALTH, V50, P279, DOI 10.2486/indhealth.MS1250; Xie ZY, 2011, J ADV NURS, V67, P1537, DOI 10.1111/j.1365-2648.2010.05576.x; Zhang X, 2011, WORK, V40, P239, DOI 10.3233/WOR-2011-1224; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	51	53	54	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107130	10.1371/journal.pone.0107130	http://dx.doi.org/10.1371/journal.pone.0107130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1UA	25211025	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900045
J	Shin, NY; Kim, KE; Park, M; Kim, YD; Kim, DJ; Ahn, SJ; Heo, JH; Lee, SK				Shin, Na-Young; Kim, Kyung-eun; Park, Mina; Kim, Young Dae; Kim, Dong Joon; Ahn, Sung Jun; Heo, Ji Hoe; Lee, Seung-Koo			Dual-Phase CT Collateral Score: A Predictor of Clinical Outcome in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							PERFUSION-COMPUTED-TOMOGRAPHY; ANGIOGRAPHY SOURCE IMAGES; THROMBOLYTIC THERAPY; FLOW; CIRCULATION; OCCLUSION; TRIAL; HYPOPERFUSION; INFARCT	Background and Purpose: The presence of good collaterals on CT angiography (CTA) is a well-known predictor for favorable outcome in acute ischemic stroke. Recently, multiphase CT has been introduced as a more accurate method in assessing collaterals. The aim of this study was to assess the ability of dual-phase CT to evaluate collateral status and predict clinical outcome. Methods: Forty-three patients who underwent both dual-phase CT and transfemoral cerebral angiography (TFCA) for occluded intracranial internal carotid artery (ICA) and/or middle cerebral artery (M1 segment) were recruited from a prospectively collected database. The collateral status on dual-phase CT was graded by using a 4-point scale: grade 0 = no collaterals; 1 = some collaterals with persistence of some defects; 2 = slow but complete collaterals; and 3 = fast and complete collaterals. Univariate and multivariate analysis were performed to define the independent predictors for favorable outcome at 3 months. Results: Dual-phase CT collateral status (rho = 0.744) showed higher correlation with TFCA collateral status than CTA collateral status (rho = 0.596) and substantial interobserver agreement (weighted kappa = 0.776). In the univariate analysis, age, history of hypertension, collateral scores on CTA, dual-phase CT, and TFCA, occlusion in intracranial ICA, final infarct volume, and symptomatic hemorrhage were significantly associated with outcome. Among them, only the dual-phase CT collateral score was an independent predictor for favorable outcome (OR = 26.342 (2.788-248.864); P = 0.004) in the multivariate analysis. Conclusions: The collateral status on dual-phase CT can be a useful predictor for clinical outcome in acute stroke patients, especially when advanced CT techniques are not available in emergent situations.	[Shin, Na-Young; Kim, Kyung-eun; Park, Mina; Kim, Dong Joon; Ahn, Sung Jun; Lee, Seung-Koo] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea; [Kim, Young Dae; Heo, Ji Hoe] Yonsei Univ, Coll Med, Severance Hosp, Dept Neurol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SK (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea.	slee@yuhs.ac	Kim, Dong Joon/AAH-2257-2021	Kim, Dong Joon/0000-0002-7035-087X; Kim, Young Dae/0000-0001-5750-2616; Ahn, Sung Jun/0000-0003-0075-2432; Heo, Ji Hoe/0000-0001-9898-3321; Lee, Seung-Koo/0000-0001-5646-4072; PARK, MINA/0000-0002-2005-7560				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bang OY, 2008, NEUROLOGY, V71, P1804, DOI 10.1212/01.wnl.0000335929.06390.d3; Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Calleja AI, 2013, EUR J NEUROL, V20, P795, DOI 10.1111/ene.12063; Campbell BCV, 2012, ARCH NEUROL-CHICAGO, V69, P46, DOI 10.1001/archneurol.2011.232; Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475; Choi JY, 2011, CEREBROVASC DIS, V31, P346, DOI 10.1159/000322602; Frolich AMJ, 2014, EUR RADIOL, V24, P390, DOI 10.1007/s00330-013-3024-6; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Jung SL, 2011, J NEUROIMAGING, V21, P225, DOI 10.1111/j.1552-6569.2010.00496.x; Kim SJ, 2012, EUR NEUROL, V67, P252, DOI 10.1159/000334867; Knauth M, 1997, AM J NEURORADIOL, V18, P1001; Kucinski T, 2003, NEURORADIOLOGY, V45, P11, DOI 10.1007/s00234-002-0881-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee KH, 2000, ARCH NEUROL-CHICAGO, V57, P990, DOI 10.1001/archneur.57.7.990; Lee SJ, 2004, ARCH NEUROL-CHICAGO, V61, P505, DOI 10.1001/archneur.61.4.505; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Lima FO, 2010, STROKE, V41, P2316, DOI 10.1161/STROKEAHA.110.592303; Maas MB, 2009, STROKE, V40, P3001, DOI 10.1161/STROKEAHA.109.552513; McVerry F, 2012, AM J NEURORADIOL, V33, P576, DOI 10.3174/ajnr.A2794; Miteff F, 2009, BRAIN, V132, P2231, DOI 10.1093/brain/awp155; Mortimer AM, 2013, J NEUROINTERV SURG; Rosenthal ES, 2008, AM J NEURORADIOL, V29, P1471, DOI 10.3174/ajnr.A1153; Schramm P, 2002, STROKE, V33, P2426, DOI 10.1161/01.STR.0000032244.03134.37; Soares BP, 2010, STROKE, V41, pE34, DOI 10.1161/STROKEAHA.109.568766; Tan IYL, 2009, AM J NEURORADIOL, V30, P525, DOI 10.3174/ajnr.A1408; Tan JC, 2007, ANN NEUROL, V61, P533, DOI 10.1002/ana.21130; Wildermuth S, 1998, STROKE, V29, P935, DOI 10.1161/01.STR.29.5.935; Yoo AJ, 2012, J NEUROIMAGING, V22, P329, DOI 10.1111/j.1552-6569.2011.00627.x	31	15	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107379	10.1371/journal.pone.0107379	http://dx.doi.org/10.1371/journal.pone.0107379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210853	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900068
J	Basso, F; Robert-Demontrond, P; Hayek, M; Anton, JL; Nazarian, B; Roth, M; Oullier, O				Basso, Frederic; Robert-Demontrond, Philippe; Hayek, Maryvonne; Anton, Jean-Luc; Nazarian, Bruno; Roth, Muriel; Oullier, Olivier			Why People Drink Shampoo? Food Imitating Products Are Fooling Brains and Endangering Consumers for Marketing Purposes	PLOS ONE			English	Article							DENAMIC PROJECT DESCRIPTION; ORBITOFRONTAL CORTEX; ACCIDENTAL MISUSE; APPETIZING FOODS; METAPHOR; ACTIVATION; IMAGES; REWARD; RESPONSES; INSIGHTS	A Food Imitating Product (FIP) is a household cleaner or a personal care product that exhibits food attributes in order to enrich consumption experience. As revealed by many cases worldwide, such a marketing strategy led to unintentional self-poisonings and deaths. FIPs therefore constitute a very serious health and public policy issue. To understand why FIPs are a threat, we first conducted a qualitative analysis on real-life cases of household cleaners and personal care products-related phone calls at a poison control center followed by a behavioral experiment. Unintentional self-poisoning in the home following the accidental ingestion of a hygiene product by a healthy adult is very likely to result from these products being packaged like foodstuffs. Our hypothesis is that FIPs are non-verbal food metaphors that could fool the brain of consumers. We therefore conducted a subsequent functional neuroimaging (fMRI) experiment that revealed how visual processing of FIPs leads to cortical taste inferences. Considered in the grounded cognition perspective, the results of our studies reveal that healthy adults can unintentionally categorize a personal care product as something edible when a food-like package is employed to market nonedible and/or dangerous products. Our methodology combining field (qualitative) and laboratory (behavioral and functional neuroimaging) findings could be of particular relevance for policy makers, as it can help screening products prior to their market release - e.g. the way they are packaged and how they can potentially confuse the mind of consumers - and therefore save lives.	[Basso, Frederic] Univ London London Sch Econ & Polit Sci, Psychol LSE, London WC2A 2AE, England; [Basso, Frederic; Robert-Demontrond, Philippe] Univ Rennes 1, Grad Sch Management, Rennes, France; [Basso, Frederic; Robert-Demontrond, Philippe] CNRS, Ctr Res Econ & Management, UMR 6211, Rennes, France; [Basso, Frederic; Oullier, Olivier] Aix Marseille Univ, CNRS, LPC UMR 7290, Cognit Psychol Lab,Federat Rech 3C, FR-3512 Marseille, France; [Hayek, Maryvonne] Hop Salvator, Poison Control Ctr, Marseille, France; [Anton, Jean-Luc; Nazarian, Bruno; Roth, Muriel] Aix Marseille Univ, Inst Neurosci Timone, Ctr IRM Fonct Cerebrale, CNRS,UMR 7289, Marseille, France	University of London; London School Economics & Political Science; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Oullier, O (corresponding author), Aix Marseille Univ, CNRS, LPC UMR 7290, Cognit Psychol Lab,Federat Rech 3C, FR-3512 Marseille, France.	olivier.oullier@univ-amu.fr			French Ministry of Research; Aix-Marseille University and the Centre National de la Recherche Scientifique; Center for Research in Economics and Management [UMR CNRS 6211]; French Ministry for Research; Graduate School of Management Grant; University of Rennes 1	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Aix-Marseille University and the Centre National de la Recherche Scientifique; Center for Research in Economics and Management; French Ministry for Research(Ministry of Research, France); Graduate School of Management Grant; University of Rennes 1	Funding was provided by the French Ministry of Research (FB's full fellowship), Aix-Marseille University and the Centre National de la Recherche Scientifique (OO) and the Center for Research in Economics and Management, UMR CNRS 6211 (PRD). Competitive doctoral fellowship, French Ministry for Research, Graduate School of Management Grant, University of Rennes 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1956, AM J PUBLIC HEALTH N, V46, P951; [Anonymous], 2002, PURITY DANGER ANAL C; Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Bambini V, 2011, BRAIN RES BULL, V86, P203, DOI 10.1016/j.brainresbull.2011.07.015; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2010, TOP COGN SCI, V2, P322, DOI 10.1111/j.1756-8765.2010.01104.x; Basso F., 2010, IMPROVING PUBLIC HLT, P94; Basso F, 2011, AM J PUBLIC HEALTH, V101, P203, DOI 10.2105/AJPH.2010.197996; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Bouille J, 2014, RECH APPL MARKET-ENG, V29, P72, DOI 10.1177/2051570714526960; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bremer K, 1997, ADV CONSUM RES, V24, P419; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Camerer CF, 2006, U CHICAGO LAW REV, V73, P87; Caraccio T, 2006, CLIN TOXICOL, V44, P745; Cardillo ER, 2012, NEUROIMAGE, V59, P3212, DOI 10.1016/j.neuroimage.2011.11.079; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHRISTESEN HBT, 1994, J TOXICOL-CLIN TOXIC, V32, P557, DOI 10.3109/15563659409011060; consumerreports.org, 2006, CONS REP SAF FAB BET; consumerunion.org, 2012, DET PODS SHOULDNT LO; Corballis MC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001767; Cornelissen JP, 2003, PSYCHOL MARKET, V20, P209, DOI 10.1002/mar.10068; Cornier MA, 2007, AM J CLIN NUTR, V86, P965, DOI 10.1093/ajcn/86.4.965; Cornier MA, 2009, PHYSIOL BEHAV, V97, P525, DOI 10.1016/j.physbeh.2009.03.019; Cotte J, 2004, J CONSUM RES, V31, P333, DOI 10.1086/422112; Coulson S, 2008, CAMB HANDB PSYCHOL, P177; Coulter RA, 2006, ADV CONSUM RES, V33, P453; Coveney CM, 2009, SOC SCI MED, V68, P487, DOI 10.1016/j.socscimed.2008.11.016; Creusen MEH, 2005, J PROD INNOVAT MANAG, V22, P63, DOI 10.1111/j.0737-6782.2005.00103.x; Cristofari J-F, 2008, MARK MAG, P61; Davids S, 2010, INT J OBESITY, V34, P94, DOI 10.1038/ijo.2009.193; Diaz MT, 2011, J COGNITIVE NEUROSCI, V23, P3586, DOI 10.1162/jocn_a_00053; Dietvorst RC, 2009, J MARKETING RES, V46, P653, DOI 10.1509/jmkr.46.5.653; Directorate General for Health and Consumers, 2008, KEEP EUR CONS SAF AN; dolceta.eu, 2011, ONL CONS ED DANG IM; Falk EB, 2010, J NEUROSCI, V30, P8421, DOI 10.1523/JNEUROSCI.0063-10.2010; FISCHLER C, 1988, SOC SCI INFORM, V27, P275, DOI 10.1177/053901888027002005; Forceville Charles J., 2007, PUBLIC J SEMIOTICS, V1, P15, DOI DOI 10.37693/PJOS.2007.1.8812; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Fuehrer D, 2008, OBESITY, V16, P945, DOI 10.1038/oby.2008.33; Gagnon L, 2003, BRAIN LANG, V87, P217, DOI 10.1016/S0093-934X(03)00057-9; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Ger G, 2004, ADV CONSUM RES, V31, P462; Gibbs RW, 2006, MIND LANG, V21, P434, DOI 10.1111/j.1468-0017.2006.00285.x; Gibbs RW, 2010, STUD HIST PHILOS SCI, V41, P305, DOI 10.1016/j.shpsa.2010.07.004; Gibbs RW, 2008, CAMB HANDB PSYCHOL, P161; Giora R., 2000, METAPHOR SYMBOL, V15, P63, DOI [10.1080/10926488.2000.9678865, DOI 10.1080/10926488.2000.9678865]; Gold R, 2012, LATERALITY, V17, P602, DOI 10.1080/1357650X.2011.599936; Goldstone AP, 2009, EUR J NEUROSCI, V30, P1625, DOI 10.1111/j.1460-9568.2009.06949.x; Gonzalez J, 2006, NEUROIMAGE, V32, P906, DOI 10.1016/j.neuroimage.2006.03.037; HADDON W, 1970, AM J PUBLIC HEALTH N, V60, P2229, DOI 10.2105/AJPH.60.12.2229-b; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Heiland A, 2009, CLIN TOXICOL, V47, P478; Hirschman EC., 2007, MARKETING THEOR, V7, P227, DOI DOI 10.1177/1470593107080343; HOLBROOK MB, 1982, J CONSUM RES, V9, P132, DOI 10.1086/208906; HOLBROOK MB, 1983, J RETAILING, V59, P4; HOLBROOK MB, 1984, J CONSUM RES, V11, P728, DOI 10.1086/209009; ISKRANT AP, 1962, AM J PUBLIC HEALTH N, V52, P1708, DOI 10.2105/AJPH.52.10.1708; Jahiel RI, 2008, J URBAN HEALTH, V85, P517, DOI 10.1007/s11524-008-9283-x; Joy A, 2003, J CONSUM RES, V30, P259, DOI 10.1086/376802; Joy A, 2009, J CONSUM PSYCHOL, V19, P556, DOI 10.1016/j.jcps.2009.05.013; Joy A, 2009, J BUS RES, V62, P39, DOI 10.1016/j.jbusres.2007.11.015; Kay M, 2009, CURR OPIN PEDIATR, V21, P651, DOI 10.1097/MOP.0b013e32832e2764; Killgore WDS, 2005, DEV PSYCHOBIOL, V47, P377, DOI 10.1002/dev.20099; Kobayashi M, 2004, NEUROIMAGE, V23, P1271, DOI 10.1016/j.neuroimage.2004.08.002; Kopjar B, 1996, AM J PUBLIC HEALTH, V86, P400, DOI 10.2105/AJPH.86.3.400; Kosslyn S. M., 1980, IMAGE MIND; Kosslyn S. M., 1994, IMAGE BRAIN; Krieger N, 2008, AM J PUBLIC HEALTH, V98, P221, DOI 10.2105/AJPH.2007.111278; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Lacey S, 2012, BRAIN LANG, V120, P416, DOI 10.1016/j.bandl.2011.12.016; Lakoff G., 1999, PHILOS FLESH; Lakoff G., 2003, METAPHORS WE LIVE BY, DOI [10.7208/chicago/9780226470993.001.0001, DOI 10.7208/CHICAGO/9780226470993.001.0001]; Lakoff G, 2012, TOP COGN SCI, V4, P773, DOI 10.1111/j.1756-8765.2012.01222.x; Lakoff G, 2008, CAMB HANDB PSYCHOL, P17; Lakoff George, 2003, METAPHOR WE LIVE BY; Lakoff George, 1987, WOMEN FIRE, DOI DOI 10.7208/CHICAGO/9780226471013.001.0001; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Loken B., 2008, HDB CONSUMER PSYCHOL, P133; MACINNIS DJ, 1987, J CONSUM RES, V13, P473, DOI 10.1086/209082; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; Martens L., 2006, HOME CULT, V3, P39, DOI DOI 10.2752/174063106778053255; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Mashal N, 2009, LATERALITY, V14, P30, DOI 10.1080/13576500802049433; McFarland RA, 1955, AM J PUBLIC HEALTH N, V45, P1302, DOI 10.2105/AJPH.45.10.1302; McKenzie LB, 2010, PEDIAT PEDS, P2009; McParland M, 2008, CHEM HAZARS POISONS, P42; Miller MA, 2006, ANN EMERG MED, V48, pS81; Moreau CP, 2001, J CONSUM RES, V27, P489, DOI 10.1086/319623; Nielsen JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071275; Norman D., 2013, DESIGN EVERYDAY THIN; Oliveri M, 2004, J COGN NEUROSCI; Oullier O., 2010, IMPROVING PUBLIC HLT; Oullier O, 2013, NATURE, V501, P463, DOI 10.1038/501463a; Oullier O, 2012, NATURE, V483, P7, DOI 10.1038/483007a; Paivio, 1986, MENTAL REPRESENTATIO; Papagno C, 2004, BRAIN LANG, V89, P226, DOI 10.1016/S0093-934X(03)00398-5; Passamonti L, 2009, J NEUROSCI, V29, P43, DOI 10.1523/JNEUROSCI.4966-08.2009; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Petit O, 2011, M S-MED SCI, V27, P1000, DOI 10.1051/medsci/201127111000; Phillips BJ, 2009, J ADVERTISING, V38, P49, DOI 10.2753/JOA0091-3367380104; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; Rajagopal P, 2009, J CONSUM RES, V36, P232, DOI 10.1086/596721; Rapp AM, 2004, COGNITIVE BRAIN RES, V20, P395, DOI 10.1016/j.cogbrainres.2004.03.017; Ratneshwar S, 2001, J CONSUM PSYCHOL, V10, P147, DOI 10.1207/s15327663jcp1003_3; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Rees CE, 2007, SOC SCI MED, V65, P725, DOI 10.1016/j.socscimed.2007.03.044; Reimann M, 2011, PSYCHOL MARKET, V28, P608, DOI 10.1002/mar.20403; Reimann M, 2010, J CONSUM PSYCHOL, V20, P431, DOI 10.1016/j.jcps.2010.06.009; Ross BH, 1999, COGNITIVE PSYCHOL, V38, P495, DOI 10.1006/cogp.1998.0712; Russell, 1974, APPROACH ENV PSYCHOL; Santel S, 2006, BRAIN RES, V1114, P138, DOI 10.1016/j.brainres.2006.07.045; Schienle A, 2009, BIOL PSYCHIAT, V65, P654, DOI 10.1016/j.biopsych.2008.09.028; SCHNEIDER KC, 1977, J CONSUM RES, V4, P67, DOI 10.1086/208681; Scientific Committee on Consumer Safety, 2011, EXPL NOT MOD SCCS OP; Scientific Committee on Consumer Safety, 2011, OP POT HLTH RISKS PO; Silverman D., 2011, QUALITATIVE METHODOL; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Smyth RL, 2001, BRIT MED J, V322, P1377, DOI 10.1136/bmj.322.7299.1377; Societe Generale de Surveillance, 2008, SGS PUBLICATION; Soriano A, 2013, M S-MED SCI, V29, P1042, DOI 10.1051/medsci/20132911022; SPIGGLE S, 1994, J CONSUM RES, V21, P491, DOI 10.1086/209413; St-Onge MP, 2005, J NUTR, V135, P1014, DOI 10.1093/jn/135.5.1014; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Subramaniam K, 2012, NEUROPSYCHOLOGIA, V50, P2705, DOI 10.1016/j.neuropsychologia.2012.07.020; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Tempowski J, 2009, CLIN TOXICOL, V47, P445; THOMPSON CJ, 1994, J CONSUM RES, V21, P432, DOI 10.1086/209409; Thompson CJ, 1997, J MARKETING RES, V34, P438, DOI 10.2307/3151963; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Van der Laan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041738; van Rompay T, 2005, ACTA PSYCHOL, V119, P315, DOI 10.1016/j.actpsy.2005.02.001; Wagner R, 2009, CLIN TOXICOL, V47, P475; Wallis P, 2005, SOC SCI MED, V60, P2629, DOI 10.1016/j.socscimed.2004.11.031; Wallner-Liebmann S, 2010, OBESITY, V18, P1552, DOI 10.1038/oby.2010.26; World Health Organization, 2008, WORLD REPORT CHILD I; Wyke S, 2009, TOXICOL LETT, V189, pS47, DOI 10.1016/j.toxlet.2009.06.113; Yang FG, 2009, BRAIN LANG, V111, P114, DOI 10.1016/j.bandl.2009.08.006; Yoon C, 2006, J CONSUM RES, V33, P31, DOI 10.1086/504132; ZALTMAN G, 1995, J ADVERTISING RES, V35, P35; Zaltman G., 2008, MARKETING METAPHORIA	151	25	25	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e100368	10.1371/journal.pone.0100368	http://dx.doi.org/10.1371/journal.pone.0100368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25207971	Green Published, Green Accepted, gold			2022-12-27	WOS:000342030300003
J	Murray, JM; Watson, GJ				Murray, Joanna M.; Watson, Gordon J.			A Critical Assessment of Marine Aquarist Biodiversity Data and Commercial Aquaculture: Identifying Gaps in Culture Initiatives to Inform Local Fisheries Managers	PLOS ONE			English	Article							MITHRACULUS-FORCEPS EDWARDS,A.MILNE; SABELLASTARTE-SPECTABILIS; ENTACMAEA-QUADRICOLOR; LARVAL DEVELOPMENT; HETERACTIS-CRISPA; 1875 DECAPODA; SEA-ANEMONES; CORAL-REEFS; TRADE; BRACHYURA	It is widely accepted that if well managed, the marine aquarium trade could provide socio-economic stability to local communities while incentivising the maintenance of coral reefs. However, the trade has also been implicated as having potentially widespread environmental impacts that has in part driven developments in aquaculture to relieve wild collection pressures. This study investigates the biodiversity in hobbyist aquaria (using an online survey) and those species currently available from an aquaculture source (commercial data and hobbyist initiatives) in the context of a traffic light system to highlight gaps in aquaculture effort and identify groups that require fisheries assessments. Two hundred and sixty nine species including clown fish, damsels, dotty backs, angelfish, gobies, sea horses and blennies, have reported breeding successes by hobbyists, a pattern mirrored by the European and US commercial organisations. However, there is a mismatch (high demand and low/non-existent aquaculture) for a number of groups including tangs, starfish, anemones and hermit crabs, which we recommend are priority candidates for local stock assessments. Hobbyist perception towards the concept of a sustainable aquarium trade is also explored with results demonstrating that only 40% of respondents were in agreement with industry and scientists who believe the trade could be an exemplar of a sustainable use of coral reefs. We believe that a more transparent evidence base, including the publication of the species collected and cultured, will go some way to align the concept of a sustainable trade across industry stakeholders and better inform the hobbyist when purchasing their aquaria stock. We conclude by proposing that a certification scheme established with government support is the most effective way to move towards a self-regulating industry. It would prevent industry "greenwashing'' from multiple certification schemes, alleviate conservation concerns, and, ultimately, support aquaculture initiatives alongside well managed ornamental fisheries.	[Murray, Joanna M.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Murray, Joanna M.; Watson, Gordon J.] Sch Biol Sci, Inst Marine Sci, Portsmouth, Hants, England	Centre for Environment Fisheries & Aquaculture Science; University of Portsmouth	Murray, JM (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England.	Joanna.Murray@cefas.co.uk		Watson, Gordon/0000-0001-8274-7658	Leverhulme Trust grant;  [F/00 678/9]	Leverhulme Trust grant(Leverhulme Trust); 	This work was supported by a Leverhulme Trust grant to G. Watson and a studentship for J. Murray (grant number F/00 678/9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencastro LA, 2004, THESIS U FLORIDA; Amos AM, 2009, TURNSTONE CONSULTING, P51; Bell JD, 1999, AQUACULT INT, V7, P207, DOI 10.1023/A:1009245612050; Bell JD, 1997, AQUAC RES, V28, P121; Bowden-Kerby A, 2001, B MAR SCI, V69, P915; Bunting BW, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P109; Bybee DR, 2006, SCI MAR, V70, P279, DOI 10.3989/scimar.2006.70s3279; Bybee DR, 2007, MAR BIOL, V151, P639, DOI 10.1007/s00227-006-0504-0; Calado R, 2003, J CRUSTACEAN BIOL, V23, P963, DOI 10.1651/C-2409; Calfo A., 2007, BOOK CORAL PROPAGATI, V1; Centurion Fernandez C, 2009, PROPAGATION GIANT AN, P291; Cohen FPA, 2013, REV FISH SCI, V21, P98, DOI 10.1080/10641262.2012.760522; Evans JR, 2005, INTERNET RES, V15, P195, DOI 10.1108/10662240510590360; Feldheim KA, 2010, J HERED, V101, P374, DOI 10.1093/jhered/esp129; Froese R, 2013, FISHBASE; Fujita R, 2012, FISH FISH, P1; Green E, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P31; Green E, 1999, GLOBAL TRADE CORAL W, V9; Gutierrez NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043765; HESLINGA GA, 1981, AQUACULTURE, V22, P35, DOI 10.1016/0044-8486(81)90131-9; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jaffry S, 2004, FOOD POLICY, V29, P215, DOI 10.1016/j.foodpol.2004.04.001; Kaiser MJ, 2006, CONSERV BIOL, V20, P392, DOI 10.1111/j.1523-1739.2006.00319.x; Kolm N, 2003, CONSERV BIOL, V17, P910, DOI 10.1046/j.1523-1739.2003.01522.x; Moorhead JA, 2010, REV FISH SCI, V18, P315, DOI 10.1080/10641262.2010.516035; Muir J, 2005, PHILOS T R SOC B, V360, P191, DOI 10.1098/rstb.2004.1572; Murakioshi M, 1993, JAPAN AQUACULTURE SO, V14, P299; Murray JM, 2013, AQUACULTURE, V410, P129, DOI 10.1016/j.aquaculture.2013.06.019; Murray JM, 2010, THESIS U PORTSMOUTH; Murray JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029543; Olivier K, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P49, DOI 10.1002/9780470752722.ch4; Olivotto I, 2011, J WORLD AQUACULT SOC, V42, P135, DOI 10.1111/j.1749-7345.2011.00453.x; Parks JE, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P185; Penha-Lopes G, 2006, AQUAC RES, V37, P398, DOI 10.1111/j.1365-2109.2006.01447.x; Penha-Lopes G, 2005, AQUAC RES, V36, P1313, DOI 10.1111/j.1365-2109.2005.01349.x; Pomeroy R, 2004, ASIAN FISH SCI, V17, P365; Rajee R, 2013, BIOL CONSERV, V164, P158; Rhyne AL, 2005, AQUACULTURE, V245, P183, DOI 10.1016/j.aquaculture.2004.11.016; Rhyne AL, 2012, AQUACULTURE AQUARIUM, V5, P99; Rhyne AL, 2014, CURR OPIN ENV SUST, V7, P101, DOI 10.1016/j.cosust.2013.12.001; Rhyne AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035808; Rhyne ARR, 2009, PUBLIC LIB SCI ONLIN, V4, P1; Schlapfer F, 2004, ECOL ECON, V51, P1, DOI 10.1016/j.ecolecon.2004.04.006; Scott A, 2007, INVERTEBR REPROD DEV, V50, P163, DOI 10.1080/07924259.2007.9652241; Scott A, 2007, BIOL BULL-US, V213, P110, DOI 10.2307/25066627; Scott A, 2009, MAR BIOL, V156, P1659, DOI 10.1007/s00227-009-1201-6; Shuman CS, 2005, CORAL REEFS, V24, P564, DOI 10.1007/s00338-005-0027-z; Tamaru C, 2008, REGIONAL NOTES CTR T, V19, P6; Tamaru CS, 2011, J WORLD AQUACULT SOC, V42, P12, DOI 10.1111/j.1749-7345.2010.00439.x; TISSOT B, 1999, SECRETARIAT PACIFIC, V6, P16; Tissot BN, 2010, MAR POLICY, V34, P1385, DOI 10.1016/j.marpol.2010.06.002; Tlusty M, 2002, AQUACULTURE, V205, P203, DOI 10.1016/S0044-8486(01)00683-4; Wabnitz C, 2003, OCEAN AQUARIUM; Watson GJ, 2012, AQUAT CONSERV, V22, P731, DOI 10.1002/aqc.2264; Whitmarsh D, 2011, AQUAC RES, V42, P142, DOI 10.1111/j.1365-2109.2010.02672.x; WoRMS Editorial Board, 2013, WORLD REGISTER MARIN	56	26	27	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e105982	10.1371/journal.pone.0105982	http://dx.doi.org/10.1371/journal.pone.0105982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207538	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300014
J	Zhou, SS; Chen, QC; Wang, XL				Zhou, Shusen; Chen, Qingcai; Wang, Xiaolong			Active Semi-Supervised Learning Method with Hybrid Deep Belief Networks	PLOS ONE			English	Article								In this paper, we develop a novel semi-supervised learning algorithm called active hybrid deep belief networks (AHD), to address the semi-supervised sentiment classification problem with deep learning. First, we construct the previous several hidden layers using restricted Boltzmann machines (RBM), which can reduce the dimension and abstract the information of the reviews quickly. Second, we construct the following hidden layers using convolutional restricted Boltzmann machines (CRBM), which can abstract the information of reviews effectively. Third, the constructed deep architecture is fine-tuned by gradient-descent based supervised learning with an exponential loss function. Finally, active learning method is combined based on the proposed deep architecture. We did several experiments on five sentiment classification datasets, and show that AHD is competitive with previous semi-supervised learning algorithm. Experiments are also conducted to verify the effectiveness of our proposed method with different number of labeled reviews and unlabeled reviews respectively.	[Zhou, Shusen] Ludong Univ, Sch Informat & Elect Engn, Yantai, Shandong, Peoples R China; [Chen, Qingcai; Wang, Xiaolong] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China	Ludong University; Harbin Institute of Technology; University Town of Shenzhen	Zhou, SS (corresponding author), Ludong Univ, Sch Informat & Elect Engn, Yantai, Shandong, Peoples R China.	zhoushusen@gmail.com			National Natural Science Foundation of China [61300155]; Scientific Research Fund of Ludong University [LY2013004]; Scientific Research Fund of Ludong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Ludong University; Scientific Research Fund of Ludong University	This work is supported in part by National Natural Science Foundation of China (No. 61300155), and Scientific Research Fund of Ludong University (LY2013004). Shusen Zhou received the funding from Scientific Research Fund of Ludong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blitzer J., 2007, ANN M ASS COMP LING, P440, DOI DOI 10.1109/IRPS.2011.5784441; Chapelle O., 2006, IEEE T NEURAL NETWOR, V20, P542; Dasgupta S, 2009, P JOINT C 47 ANN M A, V2, P701; Desjardins G., 2008, TECHNICAL REPORT; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Kamvar S. D., 2003, P 18 INT JOINT C ART, P561; Kusy B, 2009, 2009 INTERNATIONAL CONFERENCE ON INFORMATION PROCESSING IN SENSOR NETWORKS (IPSN 2009), P109; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee H., 2009, P ANN INT C MACH LEA, P609; Li SS, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P414; LIU Y, 2010, INT ACM SIGIR C RES, P873; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Pang B., 2008, FDN TRENDS INFORM RE, V2; Ranzato M., 2008, P 25 INT C MACHINE L, P792, DOI DOI 10.1145/1390156.1390256; Salakhutdinov R., 2007, P ART INT STAT, P412; Sindhwani V, 2008, IEEE DATA MINING, P1025, DOI 10.1109/ICDM.2008.113; Socher R., 2011, P 2011 C EMPIRICAL M, P151; Socher Richard, 2013, P 2013 C EMPIRICALME, P1631, DOI DOI 10.1371/JOURNAL.PONE.0073791; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Wei W, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P404; Zhen Y, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P299; Zhou S, 2010, P 23 INT C COMPUTATI, P1515; Zhu X., 2007, TECHNICAL REPORT	24	7	9	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107122	10.1371/journal.pone.0107122	http://dx.doi.org/10.1371/journal.pone.0107122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208128	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300060
J	den Besten, G; Havinga, R; Bleeker, A; Rao, S; Gerding, A; van Eunen, K; Groen, AK; Reijngoud, DJ; Bakker, BM				den Besten, Gijs; Havinga, Rick; Bleeker, Aycha; Rao, Shodhan; Gerding, Albert; van Eunen, Karen; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.			The Short-Chain Fatty Acid Uptake Fluxes by Mice on a Guar Gum Supplemented Diet Associate with Amelioration of Major Biomarkers of the Metabolic Syndrome	PLOS ONE			English	Article							INSULIN SENSITIVITY; PERFECT ADAPTATION; SMALL-INTESTINE; INDUCED OBESITY; PROPIONIC-ACID; MICROBIOTA; HYPERGLYCEMIA; IMPROVEMENT; RESISTANCE; CAPACITY	Studies with dietary supplementation of various types of fibers have shown beneficial effects on symptoms of the metabolic syndrome. Short-chain fatty acids (SCFAs), the main products of intestinal bacterial fermentation of dietary fiber, have been suggested to play a key role. Whether the concentration of SCFAs or their metabolism drives these beneficial effects is not yet clear. In this study we investigated the SCFA concentrations and in vivo host uptake fluxes in the absence or presence of the dietary fiber guar gum. C57Bl/6J mice were fed a high-fat diet supplemented with 0%, 5%, 7.5% or 10% of the fiber guar gum. To determine the effect on SCFA metabolism, C-13-labeled acetate, propionate or butyrate were infused into the cecum of mice for 6 h and the isotopic enrichment of cecal SCFAs was measured. The in vivo production, uptake and bacterial interconversion of acetate, propionate and butyrate were calculated by combining the data from the three infusion experiments in a single steady-state isotope model. Guar gum treatment decreased markers of the metabolic syndrome (body weight, adipose weight, triglycerides, glucose and insulin levels and HOMA-IR) in a dose-dependent manner. In addition, hepatic mRNA expression of genes involved in gluconeogenesis and fatty acid synthesis decreased dose-dependently by guar gum treatment. Cecal SCFA concentrations were increased compared to the control group, but no differences were observed between the different guar gum doses. Thus, no significant correlation was found between cecal SCFA concentrations and metabolic markers. In contrast, in vivo SCFA uptake fluxes by the host correlated linearly with metabolic markers. We argue that in vivo SCFA fluxes, and not concentrations, govern the protection from the metabolic syndrome by dietary fibers.	[den Besten, Gijs; Havinga, Rick; Bleeker, Aycha; Rao, Shodhan; van Eunen, Karen; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9700 AB Groningen, Netherlands; [den Besten, Gijs; Havinga, Rick; Bleeker, Aycha; Rao, Shodhan; van Eunen, Karen; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Syst Biol Ctr Energy Metab & Ageing, NL-9700 AB Groningen, Netherlands; [Gerding, Albert; Groen, Albert K.; Reijngoud, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9700 AB Groningen, Netherlands; [den Besten, Gijs; van Eunen, Karen; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Bleeker, Aycha; van Eunen, Karen] Top Inst Food & Nutr, Wageningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Top Institute Food & Nutrition	Bakker, BM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9700 AB Groningen, Netherlands.	B.M.Bakker01@umcg.nl		Reijngoud, Dirk-Jan/0000-0003-1157-4491; Rao, Shodhan/0000-0001-8840-6950; Bakker, Barbara/0000-0001-6274-3633	Netherlands Genomics Initiative via the Netherlands Consortium for Systems Biology	Netherlands Genomics Initiative via the Netherlands Consortium for Systems Biology	This work was funded by the Netherlands Genomics Initiative via the Netherlands Consortium for Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blouin JM, 2011, INT J CANCER, V128, P2591, DOI 10.1002/ijc.25599; Butt MS, 2007, CRIT REV FOOD SCI, V47, P389, DOI 10.1080/10408390600846267; Cicero AFG, 2010, MEDITERR J NUTR META, V3, P47, DOI 10.1007/s12349-009-0056-1; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; Dall'Alba V, 2013, BRIT J NUTR, V110, P1601, DOI 10.1017/S0007114513001025; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; den Besten G, 2013, AM J PHYSIOL-GASTR L, V305, pG900, DOI 10.1152/ajpgi.00265.2013; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; EBIHARA K, 1989, J NUTR, V119, P1100, DOI 10.1093/jn/119.8.1100; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Hu GX, 2010, MED HYPOTHESES, V74, P123, DOI 10.1016/j.mehy.2009.07.022; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; LANDIN K, 1992, AM J CLIN NUTR, V56, P1061, DOI 10.1093/ajcn/56.6.1061; Lasdon L. S., 1978, ACM Transactions on Mathematical Software, V4, P34, DOI 10.1145/355769.355773; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; LEVRAT MA, 1991, J NUTR, V121, P1730, DOI 10.1093/jn/121.11.1730; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Misra A, 2010, J AM COLL NUTR, V29, p289S, DOI 10.1080/07315724.2010.10719844; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Ott SJ, 2004, DIAGN MICR INFEC DIS, V50, P237, DOI 10.1016/j.diagmicrobio.2004.08.012; Papathanasopoulos A, 2010, GASTROENTEROLOGY, V138, P65, DOI 10.1053/j.gastro.2009.11.045; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Sakakibara S, 2006, BIOCHEM BIOPH RES CO, V344, P597, DOI 10.1016/j.bbrc.2006.03.176; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sellin JH, 1999, NEWS PHYSIOL SCI, V14, P58; Tang Y, 2011, INT J CANCER, V128, P847, DOI 10.1002/ijc.25638; Teixeira TFS, 2013, BRIT J NUTR, V109, P914, DOI 10.1017/S0007114512002723; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; Yamashita H, 2007, BIOSCI BIOTECH BIOCH, V71, P1236, DOI 10.1271/bbb.60668; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	43	55	55	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107392	10.1371/journal.pone.0107392	http://dx.doi.org/10.1371/journal.pone.0107392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203112	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500092
J	Glass-Kaastra, SK; Finley, R; Hutchinson, J; Patrick, DM; Weiss, K; Conly, J				Glass-Kaastra, Shiona K.; Finley, Rita; Hutchinson, Jim; Patrick, David M.; Weiss, Karl; Conly, John			Does Variation among Provincial Drug Formulary Antimicrobial Listings in Canada Influence Prescribing Rates?	PLOS ONE			English	Article							IMPACT	Background: The financial accessibility of antimicrobial drugs to the outpatient community in Canada is governed at the provincial level through formularies. Each province may choose to list particular drugs or impose restriction criteria on products in order to guide prescribing and/or curtail costs. Although changes to formularies have been shown to change patterns in the use of individual products and alter costs, no comparison has been made among the provincial antimicrobial formularies with regards to flexibility/stringency, or an assessment of how these formularies impact overall antimicrobial use in the provinces. Objectives: To summarize provincial antimicrobial formularies and assess whether their relative flexibility/stringency had a statistical impact upon provincial prescription volume during a one year period. Methods: Provincial drug plan formularies were accessed and summarized for all prescribed antimicrobials in Canada during 2010. The number of general and restricted benefits for each plan was compiled by antimicrobial classification. Population-adjusted prescription rates for all individual antimicrobials and by antimicrobial class were obtained from the Canadian Integrated Program for Antimicrobial Resistance Surveillance. Correlations between the number of general benefits, restricted benefits, and total benefits with the prescription rate in the provinces were assessed by Spearman rank correlation coefficients. Results: Formularies varied considerably among the Canadian provinces. Quebec had the most flexible formulary, offering the greatest number of general benefits and fewest restrictions. In contrast, Saskatchewan's formulary displayed the lowest number of general benefits and most restrictions. Correlation analyses detected a single significant result; macrolide prescription rates decreased as the number of general macrolide benefits increased. All other rates of provincial antimicrobial prescribing and measures of flexibility/stringency revealed no significant correlations. Conclusions: Although antimicrobial formulary listings are used to guide prescribing rates within a province, our analysis of one year's data of the impact of the antimicrobial formulary structure did not correlate with antimicrobial prescribing rates, and other factors are likely to be at play.	[Glass-Kaastra, Shiona K.; Finley, Rita] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Hutchinson, Jim] Univ British Columbia, Div Med Microbiol, Isl Med Program, Victoria, BC, Canada; [Patrick, David M.] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Patrick, David M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Weiss, Karl] Univ Montreal, Hop Maison Neuve Rosemont, Dept Infect Dis & Microbiol, Montreal, PQ, Canada; [Conly, John] Univ Calgary, Dept Med, Calgary, AB, Canada; [Conly, John] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Conly, John] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Conly, John] Univ Calgary, Synder Inst Chron Dis, Calgary, AB, Canada	Public Health Agency of Canada; University of British Columbia; University of British Columbia; Universite de Montreal; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Finley, R (corresponding author), Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Guelph, ON, Canada.	Rita.Finley@phac-aspc.gc.ca			Abbott; Bayer; Gilead; Merck; Pfizer; Optimer Pharma; Roche; Vertex; Alberta Heritage Foundation for Medical Research; Canadian Institutes for Health Research; PHAC; NCCID; Alberta Advanced Education Technology	Abbott(Abbott Laboratories); Bayer(Bayer AG); Gilead(Gilead Sciences); Merck(Merck & Company); Pfizer(Pfizer); Optimer Pharma; Roche(Roche Holding); Vertex(Vertex Pharmaceuticals); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); PHAC; NCCID; Alberta Advanced Education Technology	The authors have read the journal's policy and have identified the following conflicts: KW has received research funds and/or has been on the advisory board from Abbott, Bayer, Gilead, Merck, Pfizer, Optimer Pharma, Roche, Vertex. JC has received honoraria from the Canadian Agency for Drugs and Technologies in Health for work as an expert reviewer and clinical expert, respectively, for projects on the role of rapid PCR testing for MRSA in hospitalized patients and the use of vancomycin or metronidazole for treatment of Clostridium difficile colitis within the last 3 years. He has also received speaker's honoraria related to new anti-bacterial agents from Janssen-Ortho and Pfizer within the past 3 years. He has received financial support for research activities from the Alberta Heritage Foundation for Medical Research, the Canadian Institutes for Health Research, PHAC, NCCID, Alberta Advanced Education & Technology and Pfizer. RF, SGK, DP and JH do not have any conflict of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data or materials.	Alberta Health and Wellness, 2012, ALB HLTH WELLN DRUG; Anis AH, 2001, MED CARE, V39, P315, DOI 10.1097/00005650-200104000-00003; [Anonymous], ATC DDD IND; British Columbia Ministry of Health, 2011, LTD COV DRUG PLAN CR; British Columbia Ministry of Health Services, 2011, PHARMACARE FORM SEAR; Burke JP, 1998, JAMA-J AM MED ASSOC, V280, P1270, DOI 10.1001/jama.280.14.1270; Canadian Agency for Drugs and Technologies in Health (CADTH), 2012, COMM DRUG REV; Finley R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076398; Glass-Kaastra SK, 2014, CAN J INFECT DIS MED, V25, P95, DOI 10.1155/2014/703898; Government of Alberta Health and Wellness, 2011, ALB HLTH WELLN DRUG; Government of Manitoba, 2012, MAN DRUG BEN INT F 3; Health PEI, 2011, FORMULARY; Health Prince Edward Island, 2012, P E I PHARM FORM; Mamdani M, 2007, AM J MED, V120, P893, DOI 10.1016/j.amjmed.2007.02.028; Manitoba Health, 2011, MAN PHARM PROGR DRUG; Marshall DA, 2006, CAN J PUBLIC HEALTH, V97, P126, DOI 10.1007/BF03405330; Mckay RM, 2011, CAN J INFECT DIS MED, V22, P19, DOI 10.1155/2011/745090; New Brunswick Department of Health, 2012, PRESCR DRUG PROGR SP; New Brunswick Department of Health, 2011, PRESCR DRUG PROGR FO; Newfoundland and Labrador Department of Health and Community Services, 2011, PRESCR DRUG PROGR NL; Newfoundland and Labrador Department of Health and Community Services, 2012, NEWF LABR PRESCR DRU; Nova Scotia Pharmacare, 2011, DRUG FORM; Nova Scotia Pharmacare, 2012, CRIT EXC STAT COV; Ontario Ministry of Health and Long-Term Care, 2011, ONT DRUG BEN FORM CO; Ontario Ministry of Health and Long-Term Care, 2011, ONT DRUG BEN PROGR L; Pomey MP, 2020, J HLTH POLIT POLICY, V35, P705; Quebec Regie de L'assurance maladie, 2011, DEM AUT PAIEM MED EX; Regie de l'assurance maladie Quebec, 2011, LIST MED; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Saskatchewan Ministry of Health, 2011, DRUG PLAN FORM; Weiss K, 2011, CLIN INFECT DIS, V53, P433, DOI 10.1093/cid/cir409	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107515	10.1371/journal.pone.0107515	http://dx.doi.org/10.1371/journal.pone.0107515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203557	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500105
J	Kuwahara, G; Nishinakamura, H; Kojima, D; Tashiro, T; Kodama, S				Kuwahara, Go; Nishinakamura, Hitomi; Kojima, Daibo; Tashiro, Tadashi; Kodama, Shohta			GM-CSF Treated F4/80(+) BMCs Improve Murine Hind Limb Ischemia Similar to M-CSF Differentiated Macrophages	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; PERIPHERAL ARTERIAL-DISEASE; THERAPEUTIC ANGIOGENESIS; NEOVASCULARIZATION; POLARIZATION; PROFILES; SUBSETS; HYPOXIA; ORIGIN	Novel cell therapy is required to treat critical limb ischemia (CLI) as many current approaches require repeated aspiration of bone marrow cells (BMCs). The use of cultured BMCs can reduce the total number of injections required and were shown to induce therapeutic angiogenesis in a murine model of hind limb ischemia. Blood flow recovery was significantly improved in mice treated with granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent BMCs that secreted inflammatory cytokines. Angiogenesis, lymphangiogenesis, and blood flow recovery ratio were significantly higher in the GM-CSF-cultured F4/80(+) macrophage (GM-Mo)-treated group compared with controls. Furthermore, Foxp3(+) cell numbers and tissue IL-10 concentrations were significantly increased compared with controls. There was no significant difference in blood flow recovery between GM-Mo and M-CSF-cultured F4/80(+) macrophages (M-Mo). Thus, GM-Mo were associated with improved blood flow in hind limb ischemia similar to M-Mo. The selective methods of culturing and treating GM-Mo cells similar to M-Mo cells could be used clinically to help resolve the large number of cells required for BMC treatment of CLI. This study demonstrates a novel cell therapy for CLI that can be used in conjunction with conventional therapy including percutaneous intervention and surgical bypass.	[Kuwahara, Go; Tashiro, Tadashi] Fukuoka Univ, Fac Med, Dept Cardiovasc Surg, Fukuoka 81401, Japan; [Kuwahara, Go; Nishinakamura, Hitomi; Kojima, Daibo; Kodama, Shohta] Fukuoka Univ, Fac Med, Dept Regenerat Med & Transplantat, Fukuoka 81401, Japan	Fukuoka University; Fukuoka University	Kodama, S (corresponding author), Fukuoka Univ, Fac Med, Dept Regenerat Med & Transplantat, Fukuoka 81401, Japan.	skodama@fukuoka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Fukuoka University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fukuoka University	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by intramural funds of Fukuoka University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Cai ZQ, 2013, P NATL ACAD SCI USA, V110, P17462, DOI 10.1073/pnas.1317158110; Chauhan SK, 2011, BLOOD, V118, P4630, DOI 10.1182/blood-2011-01-332049; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Gehling UM, 2000, BLOOD, V95, P3106; Hellingman AA, 2012, J CELL MOL MED, V16, P328, DOI 10.1111/j.1582-4934.2011.01300.x; Ito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076943; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Jetten N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068811; Jiang H, 2004, J CLIN INVEST, V114, P1198, DOI 10.1172/JCI200423411; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Kuwahara G, 2013, J VASC SURG, V57, P1090, DOI 10.1016/j.jvs.2012.08.121; la Sala A, 2012, TRENDS MOL MED, V18, P494, DOI 10.1016/j.molmed.2012.06.007; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lawall H, 2011, J VASC SURG, V53, P445, DOI 10.1016/j.jvs.2010.08.060; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2009, BLOOD, V114, P3135, DOI 10.1182/blood-2009-07-231795; Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565; Sharir R, 2014, CARDIOVASC RES, V103, P585, DOI 10.1093/cvr/cvu159; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Troidl C, 2013, CURR VASC PHARMACOL, V11, P5, DOI 10.2174/157016113804547629; Zouggari Y, 2009, CIRCULATION, V120, P1415, DOI 10.1161/CIRCULATIONAHA.109.875583	34	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106987	10.1371/journal.pone.0106987	http://dx.doi.org/10.1371/journal.pone.0106987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202910	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500058
J	Ludwig, Y; Berendzen, KW; Xu, CZ; Piepho, HP; Hochholdinger, F				Ludwig, Yvonne; Berendzen, Kenneth W.; Xu, Changzheng; Piepho, Hans-Peter; Hochholdinger, Frank			Diversity of Stability, Localization, Interaction and Control of Downstream Gene Activity in the Maize Aux/IAA Protein Family	PLOS ONE			English	Article							OF-FUNCTION MUTATION; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; LATERAL ROOT INITIATION; TRANSCRIPTIONAL REPRESSION; ARABIDOPSIS-THALIANA; AUXIN RESPONSE; PLANT-GROWTH; IAA PROTEIN; CELL-DEATH; DOMAIN-II	AUXIN/INDOLE-3-ACETIC ACID (Aux/IAA) proteins are central regulators of auxin signal transduction. They control many aspects of plant development, share a conserved domain structure and are localized in the nucleus. In the present study, five maize Aux/IAA proteins (ZmIAA2, ZmIAA11, ZmIAA15, ZmIAA20 and ZmIAA33) representing the evolutionary, phylogenetic and expression diversity of this gene family were characterized. Subcellular localization studies revealed that ZmIAA2, ZmIAA11 and ZmIAA15 are confined to the nucleus while ZmIAA20 and ZmIAA33 are localized in both the nucleus and the cytoplasm. Introduction of specific point mutations in the degron sequence (VGWPPV) of domain II by substituting the first proline by serine or the second proline by leucine stabilized the Aux/IAA proteins. While protein half-life times between similar to 11 min (ZmIAA2) to similar to 120 min (ZmIAA15) were observed in wild-type proteins, the mutated forms of all five proteins were almost as stable as GFP control proteins. Moreover, all five maize Aux/IAA proteins repressed downstream gene expression in luciferase assays to different degrees. In addition, bimolecular fluorescence complementation (BiFC) analyses demonstrated interaction of all five Aux/IAA proteins with RUM1 (ROOTLESS WITH UNDETECTABLE MERISTEM 1, ZmIAA10) while only ZmIAA15 and ZmIAA33 interacted with the RUM1 paralog RUL1 (RUM-LIKE 1, ZmIAA29). Moreover, ZmIAA11, ZmIAA15 ZmIAA33 displayed homotypic interaction. Hence, despite their conserved domain structure, maize Aux/IAA proteins display a significant variability in their molecular characteristics which is likely associated with the wide spectrum of their developmental functions.	[Ludwig, Yvonne; Xu, Changzheng; Hochholdinger, Frank] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany; [Berendzen, Kenneth W.] Univ Tubingen, Cent Facil, Ctr Plant Mol Biol ZMBP, Tubingen, Germany; [Piepho, Hans-Peter] Univ Hohenheim, Inst Crop Sci, Bioinformat Unit, Stuttgart, Germany; [Xu, Changzheng] Southwest Univ, Coll Resources & Environm RCBB, Chongqing, Peoples R China	University of Bonn; Eberhard Karls University of Tubingen; University Hohenheim; Southwest University - China	Hochholdinger, F (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany.	hochholdinger@uni-bonn.de	Xu, Changzheng/AAD-4043-2021	Xu, Changzheng/0000-0002-4048-3620; Piepho, Hans-Peter/0000-0001-7813-2992; Berendzen, Kenneth/0000-0001-9870-6164; Hochholdinger, Frank/0000-0002-5155-0884	University of Bonn; University of Hohenheim	University of Bonn; University of Hohenheim	This study was supported by the University of Bonn and the University of Hohenheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; ABEL S, 1995, PLANT J, V8, P87, DOI 10.1046/j.1365-313X.1995.08010087.x; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Arase F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043414; Berendzen KW, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-25; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; EDWARDS D, 1987, BIOMETRICS, V43, P913, DOI 10.2307/2531545; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; GUILFOYLE TJ, 1999, BIOCH MOL BIOL PLANT; Guilfoyle TJ, 2012, PLANT SCI, V190, P82, DOI 10.1016/j.plantsci.2012.04.003; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P47, DOI 10.1007/s10142-005-0005-0; Kagale S, 2011, EPIGENETICS-US, V6, P141, DOI 10.4161/epi.6.2.13627; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kitomi Y, 2012, PLANT SCI, V190, P116, DOI 10.1016/j.plantsci.2012.04.005; Korasick DA, 2014, P NATL ACAD SCI US; Li M, 2010, EUR J CELL BIOL, V89, P126, DOI 10.1016/j.ejcb.2009.10.012; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Ludwig Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078859; Muto H, 2007, PLANT PHYSIOL, V144, P187, DOI 10.1104/pp.107.096628; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Nakamura A, 2006, PLANT J, V46, P297, DOI 10.1111/j.1365-313X.2006.02693.X; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Overvoorde P, 2010, COLD SPRING HARBOR P; Padmanabhan MS, 2005, J VIROL, V79, P2549, DOI 10.1128/JVI.79.4.2549-2558.2005; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Rinaldi MA, 2012, PLANT MOL BIOL, V79, P359, DOI 10.1007/s11103-012-9917-y; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Sheen J., 2002, TRANSIENT EXPRESSION; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tao LZ, 2005, PLANT CELL, V17, P2369, DOI 10.1105/tpc.105.032987; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Tian Q, 1999, DEVELOPMENT, V126, P711; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Uehara T, 2008, PLANT CELL PHYSIOL, V49, P1025, DOI 10.1093/pcp/pcn079; von Behrens I, 2011, PLANT J, V66, P341, DOI 10.1111/j.1365-313X.2011.04495.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Went FW., 1937, PHYTOHORMONES; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x; Yang XQ, 2004, PLANT J, V40, P772, DOI 10.1111/j.1365-313X.2004.02254.x	52	13	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107346	10.1371/journal.pone.0107346	http://dx.doi.org/10.1371/journal.pone.0107346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203637	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500086
J	Fields, PD; Taylor, DR				Fields, Peter D.; Taylor, Douglas R.			Determinants of Genetic Structure in a Nonequilibrium Metapopulation of the Plant Silene latifolia	PLOS ONE			English	Article							POPULATION-STRUCTURE; CHLOROPLAST DNA; INBREEDING DEPRESSION; ENVIRONMENTAL-FACTORS; NATURAL-POPULATIONS; LOCAL-POPULATIONS; F-MODEL; DIFFERENTIATION; EXTINCTION; DYNAMICS	Population genetic differentiation will be influenced by the demographic history of populations, opportunities for migration among neighboring demes and founder effects associated with repeated extinction and recolonization. In natural populations, these factors are expected to interact with each other and their magnitudes will vary depending on the spatial distribution and age structure of local demes. Although each of these effects has been individually identified as important in structuring genetic variance, their relative magnitude is seldom estimated in nature. We conducted a population genetic analysis in a metapopulation of the angiosperm, Silene latifolia, from which we had more than 20 years of data on the spatial distribution, demographic history, and extinction and colonization of demes. We used hierarchical Bayesian methods to disentangle which features of the populations contributed to among population variation in allele frequencies, including the magnitude and direction of their effects. We show that population age, long-term size and degree of connectivity all combine to affect the distribution of genetic variance; small, recently-founded, isolated populations contributed most to increase FST in the metapopulation. However, the effects of population size and population age are best understood as being modulated through the effects of connectivity to other extant populations, i.e. F-ST diminishes as populations age, but at a rate that depends how isolated the population is. These spatial and temporal correlates of population structure give insight into how migration, founder effect and within-deme genetic drift have combined to enhance and restrict genetic divergence in a natural metapopulation.	[Fields, Peter D.; Taylor, Douglas R.] Univ Virginia, Dept Biol, Charlottesville, VA USA	University of Virginia	Fields, PD (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	peter.fields@unibas.ch			National Science Foundation (NSF), DEB [0919335]	National Science Foundation (NSF), DEB(National Science Foundation (NSF))	This work was funded by the National Science Foundation (NSF), DEB #0919335 (http://www.nsf.gov/) to Douglas R. Taylor and Janis Antonovics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoullaye D, 2010, MOL ECOL RESOUR, V10, P232, DOI 10.1111/j.1755-0998.2009.02796.x; Alexander HM, 2012, J ECOL, V100, P88, DOI 10.1111/j.1365-2745.2011.01917.x; ALEXANDER HM, 1990, J ECOL, V78, P166, DOI 10.2307/2261043; Antonovics J., 2004, ECOLOGY GENETICS EVO, P471, DOI DOI 10.1016/B978-012323448-3/50021-0; Antonovics J., 1998, SPATIAL ECOLOGY ROLE, P158; Antonovics Janis, 1994, P146; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Barluenga M, 2011, HEREDITY, V106, P13, DOI 10.1038/hdy.2010.38; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bernasconi G, 2009, HEREDITY, V103, P5, DOI 10.1038/hdy.2009.34; Bhatia G, 2013, GENOME RES; Cosentino BJ, 2012, P ROY SOC B-BIOL SCI, V279, P1575, DOI 10.1098/rspb.2011.1880; Edelaar P, 2011, MOL ECOL, V20, P4830, DOI 10.1111/j.1365-294X.2011.05333.x; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Freville H, 2013, J ECOL, V101, P1572, DOI 10.1111/1365-2745.12141; Gaggiotti OE, 2004, MOL ECOL, V13, P811, DOI 10.1046/j.1365-294X.2003.02028.x; Gaggiotti OE, 2010, MOL ECOL RESOUR, V10, P821, DOI 10.1111/j.1755-0998.2010.02873.x; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Giles BE, 1997, AM NAT, V149, P507, DOI 10.1086/286002; Giles BE, 1998, HEREDITY, V80, P715, DOI 10.1046/j.1365-2540.1998.00348.x; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Haag CR, 2005, GENETICS, V170, P1809, DOI 10.1534/genetics.104.036814; Hanski I., 2001, INTEGRATING ECOLOGY, P139; Hanski I, 2004, ECOLOGY GENETICS EVO; Hanski Ilkka, 1997, P5, DOI 10.1016/B978-012323445-2/50003-1; Ingvarsson PK, 2000, P ROY SOC B-BIOL SCI, V267, P1321, DOI 10.1098/rspb.2000.1145; Ingvarsson PK, 1999, EVOLUTION, V53, P605, DOI 10.2307/2640796; Jolivet C, 2007, ANN BOT-LONDON, V100, P119, DOI 10.1093/aob/mcm088; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Juillet N, 2003, MOL ECOL NOTES, V3, P358, DOI 10.1046/j.1471-8286.2003.00449.x; Karhunen M, 2012, GENETICS, V192, P609, DOI 10.1534/genetics.112.140871; Keller SR, 2012, MOL ECOL, V21, P4721, DOI 10.1111/j.1365-294X.2012.05751.x; Lamy T, 2012, MOL ECOL, V21, P1394, DOI 10.1111/j.1365-294X.2012.05478.x; Lamy T, 2013, AM NAT, V181, P479, DOI 10.1086/669676; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; McCauley DE, 1997, J HERED, V88, P257, DOI 10.1093/oxfordjournals.jhered.a023103; McCauley DE, 1996, AM J BOT, V83, P727, DOI 10.2307/2445849; MCCAULEY DE, 1994, P NATL ACAD SCI USA, V91, P8127, DOI 10.1073/pnas.91.17.8127; McCauley DE, 1995, HEREDITY, V75, P630, DOI 10.1038/hdy.1995.182; MCCAULEY DE, 1995, TRENDS ECOL EVOL, V10, P198, DOI 10.1016/S0169-5347(00)89052-7; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Moody-Weis J, 2008, ECOGRAPHY, V31, P61, DOI 10.1111/j.2008.0906-7590.05282.x; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Pannell JR, 2014, NEW PHYTOL, V201, P417, DOI 10.1111/nph.12495; Peroni PA, 2001, J TORREY BOT SOC, V128, P400, DOI 10.2307/3088672; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richards CM, 2000, AM NAT, V155, P383, DOI 10.1086/303324; Richards CM, 2003, HEREDITY, V90, P181, DOI 10.1038/sj.hdy.6800214; Richards CM, 1999, EVOLUTION, V53, P63, DOI [10.2307/2640920, 10.1111/j.1558-5646.1999.tb05333.x]; Robinson JD, 2013, MOL ECOL, V22, P2627, DOI 10.1111/mec.12283; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; Teixeira S, 2007, MOL ECOL, V16, P4370, DOI 10.1111/j.1365-294X.2007.03493.x; THRALL PH, 1995, CAN J BOT, V73, pS1249, DOI 10.1139/b95-385; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; Whitlock MC, 2000, HEREDITY, V84, P452, DOI 10.1046/j.1365-2540.2000.00693.x; WHITLOCK MC, 1992, AM NAT, V139, P952, DOI 10.1086/285368; Whitlock MC, 2002, GENETICS, V160, P1191; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Wood CW, 2013, ECOL EVOL, V3, P1484, DOI 10.1002/ece3.560; Wright S, 1931, GENETICS, V16, P0097	64	10	11	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e104575	10.1371/journal.pone.0104575	http://dx.doi.org/10.1371/journal.pone.0104575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198341	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700009
J	Petr, M; St'astny, P; Pecha, O; Steffl, M; Seda, O; Kohlikova, E				Petr, Miroslav; St'astny, Petr; Pecha, Ondrej; Steffl, Michal; Seda, Ondrej; Kohlikova, Eva			PPARA Intron Polymorphism Associated with Power Performance in 30-s Anaerobic Wingate Test	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; ALPHA GENE VARIATION; TISSUE DISTRIBUTION; MUSCLE STRENGTH; ICE HOCKEY; GAMMA; WOMEN; MEN; METABOLISM; PHYSIOLOGY	To date, polymorphisms in several genes have been associated with a strength/power performance including alpha 3 actinin, ciliary neurotrophic factor, vitamin D receptor, or angiotensin I converting enzyme, underlining the importance of genetic component of the multifactorial strength/power-related phenotypes. The single nucleotide variation in peroxisome proliferator-activated receptor alpha gene (PPARA) intron 7 G/C (rs4253778; g. 46630634G>C) has been repeatedly found to play a significant role in response to different types of physical activity. We investigated the effect of PPARA intron 7 G/C polymorphism specifically on anaerobic power output in a group of 77 elite male Czech ice hockey players (18-36 y). We determined the relative peak power per body weight (P-max.kg(-1)) and relative peak power per fat free mass (W.kg(-1) (FFM)) during the 30-second Wingate Test (WT30) on bicycle ergometer (Monark 894E Peak bike, MONARK, Sweden). All WT30s were performed during the hockey season. Overall genotype frequencies were 50.6% GG homozygotes, 40.3% CG heterozygotes, and 9.1% CC homozygotes. We found statistically significant differences in P-max.kg(-1) and marginally significant differences in P-max.kg(-1) FFM values in WT30 between carriers and non-carriers for C allele (14.6 +/- 0.2 vs. 13.9 +/- 0.3 W.kg(-1) and 15.8 +/- 0.2 vs. 15.2 +/- 0.3 W.kg(-1) (FFM), P = 0.036 and 0.12, respectively). Furthermore, P-max.kg(-1) (FFM) strongly positively correlated with the body weight only in individuals with GG genotypes (R = 0.55; p<0.001). Our results indicate that PPARA 7C carriers exhibited higher speed strength measures in WT30. We hypothesize that C allele carriers within the cohort of trained individuals may possess a metabolic advantage towards anaerobic metabolism.	[Petr, Miroslav; Steffl, Michal; Kohlikova, Eva] Charles Univ Prague, Dept Physiol & Biochem, Fac Phys Educ & Sport, Prague, Czech Republic; [St'astny, Petr] Charles Univ Prague, Dept Sport Games, Fac Phys Educ & Sport, Prague, Czech Republic; [Pecha, Ondrej] Charles Univ Prague, Dept Kinanthropol & Humanities, Fac Phys Educ & Sport, Prague, Czech Republic; [Seda, Ondrej] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic; [Seda, Ondrej] Gen Teaching Hosp, Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; General University Hospital Prague	Petr, M (corresponding author), Charles Univ Prague, Dept Physiol & Biochem, Fac Phys Educ & Sport, Prague, Czech Republic.	petr@ftvs.cuni.cz	Steffl, Michal/P-6804-2016; Kohlikova, Eva/N-6346-2017; Petr, Miroslav/C-3648-2015; Pecha, Ondrej/M-2568-2016; Stastny, Petr/S-3467-2016; Seda, Ondrej/A-2058-2008	Steffl, Michal/0000-0001-7297-8145; Kohlikova, Eva/0000-0003-3981-088X; Petr, Miroslav/0000-0001-8735-1935; Pecha, Ondrej/0000-0002-9096-1432; Stastny, Petr/0000-0003-2841-374X; Seda, Ondrej/0000-0001-8498-5895	Ministry of Education Youth and Sport [MSM 002160864, SVV 2012-265603, 38]	Ministry of Education Youth and Sport(Ministry of Education, Youth & Sports - Czech Republic)	The authors report the following sources of funding: MSM 002160864 (Ministry of Education Youth and Sport), SVV 2012-265603 (Ministry of Education Youth and Sport), PRVOUK n. 38 (Ministry of Education Youth and Sport). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmetov II, 2006, EUR J APPL PHYSIOL, V97, P103, DOI 10.1007/s00421-006-0154-4; Ahmetov II, 2006, ROS FIZIOL ZH, V92, P883; Ahmetov II, 2009, HUM GENET, V126, P751, DOI 10.1007/s00439-009-0728-4; Akhmetov I I, 2007, Ross Fiziol Zh Im I M Sechenova, V93, P837; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Broos S, 2011, SCAND J MED SCI SPOR; Cabrero A., 2002, Current Drug Targets - Inflammation and Allergy, V1, P243, DOI 10.2174/1568010023344616; COX MH, 1995, SPORTS MED, V19, P184, DOI 10.2165/00007256-199519030-00004; Cresci S, 2008, PHARMACOGENOMICS, V9, P1403, DOI 10.2217/14622416.9.10.1403; Cresci S, 2008, PPAR RES, V2008, DOI 10.1155/2008/374549; De Mars G, 2007, J APPL PHYSIOL, V102, P1824, DOI 10.1152/japplphysiol.00692.2006; Druzhevskaya AM, 2008, EUR J APPL PHYSIOL, V103, P631, DOI 10.1007/s00421-008-0763-1; Dubuquoy L, 2002, LANCET, V360, P1410, DOI 10.1016/S0140-6736(02)11395-X; Eynon N, 2009, INT J SPORTS MED, V30, P888, DOI 10.1055/s-0029-1238291; Eynon N, 2010, SCAND J MED SCI SPOR, V20, pE145, DOI 10.1111/j.1600-0838.2009.00930.x; Farlinger CM, 2007, J STRENGTH COND RES, V21, P915; Flavell DM, 2005, DIABETES, V54, P582, DOI 10.2337/diabetes.54.2.582; Ginevi V., 2010, ACTA MED LITU, V17, P1, DOI DOI 10.2478/V10140-010-0001-0; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Horowitz JF, 2000, AM J PHYSIOL-ENDOC M, V279, pE348, DOI 10.1152/ajpendo.2000.279.2.E348; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Jamshidi Y, 2002, CIRCULATION, V105, P950, DOI 10.1161/hc0802.104535; Jelen K, 2008, NEUROENDOCRINOL LETT, V29, P454; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Maciejewska A, 2011, J SCI MED SPORT, V14, P58, DOI 10.1016/j.jsams.2010.05.006; MONTGOMERY DL, 1988, SPORTS MED, V5, P99, DOI 10.2165/00007256-198805020-00003; Mukherjee R, 1997, J BIOL CHEM, V272, P8071, DOI 10.1074/jbc.272.12.8071; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Seda O, 2007, PHARMACOGENOMICS, V8, P587, DOI 10.2217/14622416.8.6.587; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Windelinckx A, 2007, OSTEOPOROSIS INT, V18, P1235, DOI 10.1007/s00198-007-0374-4	34	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107171	10.1371/journal.pone.0107171	http://dx.doi.org/10.1371/journal.pone.0107171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198533	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700091
J	Turner, CR; Nielsen, M; Collier-Baker, E				Turner, Cameron R.; Nielsen, Mark; Collier-Baker, Emma			Groups' Actions Trump Injunctive Reaction in an Incidental Observation by Young Children	PLOS ONE			English	Article							NORMATIVE CONDUCT; OVER-IMITATION; FOCUS THEORY; EMOTION; NORMS; CONFORMITY; RESPONSES; MAJORITY; BEHAVIOR; CULTURE	Children's ability to use social information to direct their behavior is key to their survival and development. However, in observing adult behavior, children are confronted with multiple forms of social information that may vary in reliability and adaptiveness. Two of the most well established biases influencing human behavior are: (1) following the majority (majority influence or conformity); and (2) the use of emotional signals. The current experiment aimed to evaluate how children respond when both information about the majority behavior of a group (descriptive norm) and attitudes of the group towards a behavior (injunctive norm, expressed through an emotional reaction) are present and what happens when they are in conflict. We used a method designed to mimic the manner in which children might observe group members' behavior during development. Novel apparatuses were constructed for which there were two discrete actions that could be performed to retrieve a reward. Three-year-olds observed four adults demonstrating one set of actions, followed by a fifth adult who presented an alternative set of actions. The first four adults' injunctive responses to this fifth adult's actions were manipulated between-groups: positive, negative, or neutral. It was found that children preferred to copy the majority action, regardless of the injunctive reaction of the group. We argue that this affirms the adaptive utility of copying the majority.	[Turner, Cameron R.] Univ Durham, Sch Educ, Durham, England; [Nielsen, Mark; Collier-Baker, Emma] Univ Queensland, Sch Psychol, Early Cognit Dev Ctr, Brisbane, Qld, Australia; [Nielsen, Mark] Univ KwaZulu Natal, Sch Appl Human Sci, Durban, South Africa	Durham University; University of Queensland; University of Kwazulu Natal	Turner, CR (corresponding author), Univ Durham, Sch Educ, Durham, England.	cameron.turner@durham.ac.uk	Nielsen, Mark/A-6792-2013	Nielsen, Mark/0000-0002-0402-8372; Turner, Cameron/0000-0002-3413-7860	Australian Research Council [DP 110100602]; STFC [ST/J001465/1] Funding Source: UKRI	Australian Research Council(Australian Research Council); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This study was supported by an Australian Research Council Discovery Project Grant (DP 110100602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Atkisson C, 2012, EVOL PSYCHOL-US, V10, P519, DOI 10.1177/147470491201000309; Borsari B, 2003, J STUD ALCOHOL, V64, P331, DOI 10.15288/jsa.2003.64.331; Buchsbaum D, 2011, COGNITION, V120, P331, DOI 10.1016/j.cognition.2010.12.001; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chudek M, 2012, EVOL HUM BEHAV, V33, P46, DOI 10.1016/j.evolhumbehav.2011.05.005; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Claidiere N, 2012, PSYCHOL BULL, V138, P126, DOI 10.1037/a0025868; Corriveau KH, 2013, J COGN CULT, V13, P367, DOI 10.1163/15685373-12342099; Corriveau KH, 2010, DEV PSYCHOL, V46, P437, DOI 10.1037/a0017553; Corriveau KH, 2009, PSYCHOL SCI, V20, P372, DOI 10.1111/j.1467-9280.2009.02291.x; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Dimberg U, 1996, MOTIV EMOTION, V20, P149, DOI 10.1007/BF02253869; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Elam KK, 2010, EVOL PSYCHOL-US, V8, P754, DOI 10.1177/147470491000800415; FEINMAN S, 1992, SOCIAL REFERENCING S; Flom R, 2011, BRIT J DEV PSYCHOL, V29, P64, DOI 10.1348/026151010X512088; Flynn E, 2012, SOC PSYCHOL-GERMANY, V43, P185, DOI 10.1027/1864-9335/a000119; Fusaro M, 2008, DEVELOPMENTAL SCI, V11, P771, DOI 10.1111/j.1467-7687.2008.00728.x; Fusaro M, 2013, DEV PSYCHOL, V49, P514, DOI 10.1037/a0030580; Gardiner AK, 2011, J COGN DEV, V12, P355, DOI 10.1080/15248372.2010.542216; Gendron M, 2014, PSYCHOL SCI, V25, P911, DOI 10.1177/0956797613517239; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Haun DBM, 2013, DEV COGN NEUROS-NETH, V3, P61, DOI 10.1016/j.dcn.2012.09.003; Haun DBM, 2012, CURR BIOL, V22, P727, DOI 10.1016/j.cub.2012.03.006; Haun DBM, 2011, CHILD DEV, V82, P1759, DOI 10.1111/j.1467-8624.2011.01666.x; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Herrmann PA, 2013, COGNITION, V129, P536, DOI 10.1016/j.cognition.2013.08.010; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; HORNIK R, 1987, CHILD DEV, V58, P937, DOI 10.2307/1130534; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Kallgren CA, 2000, PERS SOC PSYCHOL B, V26, P1002, DOI 10.1177/01461672002610009; Kenward B, 2011, P ROY SOC B-BIOL SCI, V278, P1239, DOI 10.1098/rspb.2010.1399; Kim G, 2011, INFANT CHILD DEV, V20, P449, DOI 10.1002/icd.708; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Lyons DE, 2007, P NATL ACAD SCI USA, V104, P19751, DOI 10.1073/pnas.0704452104; McGuigan N, 2011, BRIT J PSYCHOL, V102, P1, DOI 10.1348/000712610X493115; Montague DPF, 2001, DEV PSYCHOL, V37, P826, DOI 10.1037//0012-1649.37.6.826; Mumme DL, 1996, CHILD DEV, V67, P3219, DOI 10.1111/j.1467-8624.1996.tb01910.x; Mumme DL, 2003, CHILD DEV, V74, P221, DOI 10.1111/1467-8624.00532; Nielsen M, 2006, DEV PSYCHOL, V42, P555, DOI 10.1037/0012-1649.42.3.555; Nielsen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034066; Nielsen M, 2011, DEV PSYCHOL, V47, P1050, DOI 10.1037/a0023866; Nielsen M, 2010, PSYCHOL SCI, V21, P729, DOI 10.1177/0956797610368808; Over H, 2012, J COMP PSYCHOL, V126, P182, DOI 10.1037/a0024555; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; Rakoczy H, 2013, CHILD DEV PERSPECT, V7, P17, DOI 10.1111/cdep.12010; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Rendell L, 2011, TRENDS COGN SCI, V15, P68, DOI 10.1016/j.tics.2010.12.002; RENO RR, 1993, J PERS SOC PSYCHOL, V64, P104, DOI 10.1037/0022-3514.64.1.104; Repacholi BM, 2007, CHILD DEV, V78, P503, DOI 10.1111/j.1467-8624.2007.01012.x; Schillaci RS, 2014, J COGN DEV, V15, P569, DOI 10.1080/15248372.2013.784973; Shariff AF, 2011, CURR DIR PSYCHOL SCI, V20, P395, DOI 10.1177/0963721411424739; Sherif M., 1935, ARCH PSYCHOL, V27, P23; Smith JR, 2008, BRIT J SOC PSYCHOL, V47, P647, DOI 10.1348/014466607X269748; Steiner I.D., 1965, CURR STUD SOC PSYCH, P301; Striano T, 2006, BRIT J DEV PSYCHOL, V24, P753, DOI 10.1348/026151005X70319; UZGIRIS IC, 1981, INT J BEHAV DEV, V4, P1, DOI 10.1177/016502548100400101; Vaillant-Molina M, 2012, DEV PSYCHOL, V48, P1, DOI 10.1037/a0025263; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011; Walker MB, 1996, J SOC PSYCHOL, V136, P367, DOI 10.1080/00224545.1996.9714014	67	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107375	10.1371/journal.pone.0107375	http://dx.doi.org/10.1371/journal.pone.0107375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JX	25198163	Green Accepted, Green Published, gold			2022-12-27	WOS:000341304700108
J	Bon, J; Kahloon, R; Zhang, YZ; Xue, JM; Fuhrman, CR; Tan, JN; Burger, M; Kass, DJ; Csizmadia, E; Otterbein, L; Chandra, D; Bhargava, A; Pilewski, JM; Roodman, GD; Sciurba, FC; Duncan, SR				Bon, Jessica; Kahloon, Rehan; Zhang, Yingze; Xue, Jianmin; Fuhrman, Carl R.; Tan, Jiangning; Burger, Mathew; Kass, Daniel J.; Csizmadia, Eva; Otterbein, Leo; Chandra, Divay; Bhargava, Arpit; Pilewski, Joseph M.; Roodman, G. David; Sciurba, Frank C.; Duncan, Steven R.			Autoreactivity to Glucose Regulated Protein 78 Links Emphysema and Osteoporosis in Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RADIOGRAPHIC EMPHYSEMA; UNFOLDED PROTEIN; RITUXIMAB; COPD; AUTOIMMUNITY; ASSOCIATION; ANTIBODIES; LUNG	Rationale: Emphysema and osteoporosis are epidemiologically associated diseases of cigarette smokers. The causal mechanism(s) linking these illnesses is unknown. We hypothesized autoimmune responses may be involved in both disorders. Objectives: To discover an antigen-specific autoimmune response associated with both emphysema and osteoporosis among smokers. Methods: Replicate nonbiased discovery assays indicated that autoimmunity to glucose regulated protein 78 (GRP78), an endoplasmic reticulum chaperone and cell surface signaling receptor, is present in many smokers. Subject assessments included spirometry, chest CT scans, dual x-ray absorptiometry, and immunoblots for anti-GRP78 IgG. Anti-GRP78 autoantibodies were isolated from patient plasma by affinity chromatography, leukocyte functions assessed by flow cytometry, and soluble metabolites and mediators measured by immunoassays. Measurements and Main Results: Circulating anti-GRP78 IgG autoantibodies were detected in plasma specimens from 86 (32%) of the 265 smoking subjects. Anti-GRP78 autoantibodies were singularly prevalent among subjects with radiographic emphysema (OR 3.1, 95%CI 1.7-5.7, p = 0.003). Anti-GRP78 autoantibodies were also associated with osteoporosis (OR 4.7, 95%CI 1.7-13.3, p = 0.002), and increased circulating bone metabolites (p = 0.006). Among emphysematous subjects, GRP78 protein was an autoantigen of CD4 T-cells, stimulating lymphocyte proliferation (p = 0.0002) and IFN-gamma production (p = 0.03). Patient-derived anti-GRP78 autoantibodies had avidities for osteoclasts and macrophages, and increased macrophage NFkB phosphorylation (p = 0.005) and productions of IL-8, CCL-2, and MMP9 (p = 0.005, 0.007, 0.03, respectively). Conclusions: Humoral and cellular GRP78 autoimmune responses in smokers have numerous biologically-relevant pro-inflammatory and other deleterious actions, and are associated with emphysema and osteoporosis. These findings may have relevance for the pathogenesis of smoking-associated diseases, and development of biomarker immunoassays and/or novel treatments for these disorders.	[Bon, Jessica; Kahloon, Rehan; Zhang, Yingze; Xue, Jianmin; Tan, Jiangning; Burger, Mathew; Kass, Daniel J.; Chandra, Divay; Bhargava, Arpit; Pilewski, Joseph M.; Sciurba, Frank C.; Duncan, Steven R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Fuhrman, Carl R.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Csizmadia, Eva; Otterbein, Leo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Roodman, G. David] Indiana Sch Med, Dept Med, Indianapolis, IN USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Indiana University System; Indiana University Bloomington	Zhang, YZ (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	duncsr@upmc.edu	Sciurba, Frank/AAZ-9339-2021; Bon, Jessica/AAK-6714-2021; Pilewski, Joseph/AAF-5149-2021	sciurba, frank/0000-0001-7468-2225; Zhang, YIngze/0000-0001-8042-6105	U.S. NIH [HL084948, HL107172, AR57308, HL007563]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084948, T32HL007563, P50HL107172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. NIH grants HL084948, HL107172, AR57308, and HL007563. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Bon J, 2011, AM J RESP CRIT CARE, V183, P885, DOI 10.1164/rccm.201004-0666OC; Borie R, 2009, EUR RESPIR J, V33, P1503, DOI 10.1183/09031936.00160908; Brandsma CA, 2011, EUR RESPIR J, V37, P1289, DOI 10.1183/09031936.00116710; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Chandra D, 2012, CHEST, V142, P655, DOI 10.1378/chest.11-1456; Duncan SR, 2012, NATURE, V489, pS15, DOI 10.1038/489S15a; ERICKSON SB, 1979, MAYO CLIN PROC, V54, P714; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Feghali-Bostwick CA, 2007, J IMMUNOL, V179, P2592, DOI 10.4049/jimmunol.179.4.2592; Franks AL, 2012, ANTICANCER RES, V32, P1119; Fu SM, 2011, J AUTOIMMUN, V37, P104, DOI 10.1016/j.jaut.2011.05.004; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Gosselink JV, 2010, AM J RESP CRIT CARE, V181, P1329, DOI 10.1164/rccm.200812-1902OC; Greene CM, 2010, AM J RESP CRIT CARE, V181, P31, DOI 10.1164/rccm.200904-0545OC; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Kahloon RA, 2013, AM J RESP CRIT CARE, V187, P768, DOI 10.1164/rccm.201203-0506OC; Keir GJ, 2012, EUR RESPIR J, V40, P641, DOI 10.1183/09031936.00163911; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Kurzius-Spencer M, 2001, AM J RESP CRIT CARE, V164, P1261, DOI 10.1164/ajrccm.164.7.2010051; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lu MC, 2010, ARTHRITIS RHEUM-US, V62, P1213, DOI 10.1002/art.27386; Mannino DM, 2002, CHEST, V121, p121S, DOI 10.1378/chest.121.5_suppl.121S; Monaco Claudia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P35, DOI 10.2174/1568010043483881; Pordeus V, 2008, CLIN REV ALLERG IMMU, V34, P283, DOI 10.1007/s12016-007-8048-8; Purcell AW, 2003, CLIN EXP IMMUNOL, V132, P193, DOI 10.1046/j.1365-2249.2003.02153.x; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; Rinaldi M, 2012, THORAX, V67, P694, DOI 10.1136/thoraxjnl-2011-200690; Sem M, 2009, RHEUMATOLOGY, V48, P968, DOI 10.1093/rheumatology/kep157; Shields AM, 2011, CLIN EXP IMMUNOL, V165, P292, DOI 10.1111/j.1365-2249.2011.04433.x; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; van Kempen LCL, 2002, CANCER CELL, V2, P251, DOI 10.1016/S1535-6108(02)00157-5; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Washko GR, 2008, COPD, V5, P177, DOI 10.1080/15412550802093025; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC	40	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e105066	10.1371/journal.pone.0105066	http://dx.doi.org/10.1371/journal.pone.0105066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216103	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000341774300002
J	Sole, X; Crous-Bou, M; Cordero, D; Olivares, D; Guino, E; Sanz-Pamplona, R; Rodriguez-Moranta, F; Sanjuan, X; de Oca, J; Salazar, R; Moreno, V				Sole, Xavier; Crous-Bou, Marta; Cordero, David; Olivares, David; Guino, Elisabet; Sanz-Pamplona, Rebeca; Rodriguez-Moranta, Francisco; Sanjuan, Xavier; de Oca, Javier; Salazar, Ramon; Moreno, Victor			Discovery and Validation of New Potential Biomarkers for Early Detection of Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; GENE-EXPRESSION; PCR DATA; MOLECULAR BIOMARKERS; DIAGNOSTIC-ACCURACY; PROBE LEVEL; BLOOD; TIME; DNA; NORMALIZATION	Background: Accurate detection of characteristic proteins secreted by colon cancer tumor cells in biological fluids could serve as a biomarker for the disease. The aim of the present study was to identify and validate new serum biomarkers and demonstrate their potential usefulness for early diagnosis of colon cancer. Methods: The study was organized in three sequential phases: 1) biomarker discovery, 2) technical and biological validation, and 3) proof of concept to test the potential clinical use of selected biomarkers. A prioritized subset of the differentially-expressed genes between tissue types (50 colon mucosa from cancer-free individuals and 100 normal-tumor pairs from colon cancer patients) was validated and further tested in a series of serum samples from 80 colon cancer cases, 23 patients with adenoma and 77 cancer-free controls. Results: In the discovery phase, 505 unique candidate biomarkers were identified, with highly significant results and high capacity to discriminate between the different tissue types. After a subsequent prioritization, all tested genes (N = 23) were successfully validated in tissue, and one of them, COL10A1, showed relevant differences in serum protein levels between controls, patients with adenoma (p = 0.0083) and colon cancer cases (p = 3.2e-6). Conclusion: We present a sequential process for the identification and further validation of biomarkers for early detection of colon cancer that identifies COL10A1 protein levels in serum as a potential diagnostic candidate to detect both adenoma lesions and tumor. Impact: The use of a cheap serum test for colon cancer screening should improve its participation rates and contribute to decrease the burden of this disease.	[Sole, Xavier; Crous-Bou, Marta; Cordero, David; Olivares, David; Guino, Elisabet; Sanz-Pamplona, Rebeca; Moreno, Victor] Hosp Llobregat, Catalan Inst Oncol ICO, Canc Prevent & Control Program, Unit Biomarkers & Susceptibil, Barcelona, Spain; [Sole, Xavier; Crous-Bou, Marta; Cordero, David; Olivares, David; Guino, Elisabet; Sanz-Pamplona, Rebeca; Moreno, Victor] Hosp Llobregat, CIBERESP, Barcelona, Spain; [Sole, Xavier; Crous-Bou, Marta; Cordero, David; Olivares, David; Guino, Elisabet; Sanz-Pamplona, Rebeca; Rodriguez-Moranta, Francisco; Sanjuan, Xavier; de Oca, Javier; Salazar, Ramon; Moreno, Victor] Hosp Llobregat, Bellvitge Biomed Res Inst IDIBELL, Colorectal Canc Grp, Barcelona, Spain; [Rodriguez-Moranta, Francisco] Univ Hosp Bellvitge, Hosp Llobregat, Dept Gastroenterol, Barcelona, Spain; [Sanjuan, Xavier] Univ Hosp Bellvitge, Hosp Llobregat, Dept Pathol, Barcelona, Spain; [de Oca, Javier; Moreno, Victor] Univ Barcelona, Fac Med, Dept Clin Sci, Barcelona 7, Spain; [de Oca, Javier] Univ Hosp Bellvitge, Hosp Llobregat, Dept Gen & Digest Surg, Colorectal Unit, Barcelona, Spain; [Salazar, Ramon] Hosp Llobregat, Catalan Inst Oncol ICO, Dept Med Oncol, Barcelona, Spain	Catalan Institute of Oncology; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Catalan Institute of Oncology; University of Barcelona	Moreno, V (corresponding author), Hosp Llobregat, Catalan Inst Oncol ICO, Canc Prevent & Control Program, Unit Biomarkers & Susceptibil, Barcelona, Spain.	v.moreno@iconcologia.net	Solé, Xavier/AAF-3015-2019; Cordero, David/D-1650-2019; RODRIGUEZ MORANTA, FRANCISCO/H-9333-2015; Crous-Bou, Marta/A-9499-2019; Rodriguez-Moranta, Francisco/AAB-8082-2019; Moreno, Victor/A-1697-2010	Solé, Xavier/0000-0002-2197-3325; Cordero, David/0000-0003-1470-2356; RODRIGUEZ MORANTA, FRANCISCO/0000-0003-4025-5510; Crous-Bou, Marta/0000-0003-1493-4288; Rodriguez-Moranta, Francisco/0000-0003-4025-5510; Moreno, Victor/0000-0002-2818-5487; Guino, Elisabet/0000-0003-0093-2652; Sanz-Pamplona, Rebeca/0000-0002-2187-3527	Catalan Institute of Oncology (ICO); Private Foundation of the Biomedical Research Institute of Bellvitge (IDIBELL); Instituto de Salud Carlos III [PI08-1635, PI08-1359, PS09-1037, PI11-1439]; CIBERESP [CB06/02/2005]; Accion Transversal del Cancer; Catalan Government DURSI [2009SGR1489]; Fundacio Privada Olga Torres (FOT); Spanish Association Against Cancer (AECC) Scientific Foundation; European Commission [FP7-COOP-Health-2007-B]; Xarxa de Bancs de Tumors de Catalunya - Pla Director d'Oncologia de Catalunya (XBTC)	Catalan Institute of Oncology (ICO); Private Foundation of the Biomedical Research Institute of Bellvitge (IDIBELL); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBERESP; Accion Transversal del Cancer(Instituto de Salud Carlos III); Catalan Government DURSI; Fundacio Privada Olga Torres (FOT); Spanish Association Against Cancer (AECC) Scientific Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Xarxa de Bancs de Tumors de Catalunya - Pla Director d'Oncologia de Catalunya (XBTC)	This work was supported by the Catalan Institute of Oncology (ICO) and the Private Foundation of the Biomedical Research Institute of Bellvitge (IDIBELL), the Instituto de Salud Carlos III [grants PI08-1635, PI08-1359, PS09-1037, PI11-1439], CIBERESP CB06/02/2005 and the "Accion Transversal del Cancer'', the Catalan Government DURSI [grant 2009SGR1489], the Fundacio Privada Olga Torres (FOT), the Spanish Association Against Cancer (AECC) Scientific Foundation, the European Commission [grant FP7-COOP-Health-2007-B HiPerDART], and Xarxa de Bancs de Tumors de Catalunya sponsored by Pla Director d'Oncologia de Catalunya (XBTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist DA, 2010, GASTROENTEROLOGY, V138, P2127, DOI 10.1053/j.gastro.2010.01.055; Almaawi A, 2013, TISSUE ENG PT A, V19, P1039, DOI [10.1089/ten.TEA.2012.0129, 10.1089/ten.tea.2012.0129]; Alvarez-Chaver P, 2014, WORLD J GASTROENTERO, V20, P3804, DOI 10.3748/wjg.v20.i14.3804; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Binefa G, 2014, WORLD J GASTROENTERO, V20, P6786, DOI 10.3748/wjg.v20.i22.6786; Bossuyt PM, 2003, LANCET, V361, P71, DOI 10.1016/S0140-6736(03)12122-8; Bujanda L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051810; Burt RW, 2010, CURR OPIN GASTROEN, V26, P466, DOI 10.1097/MOG.0b013e32833d1733; Chapman KB, 2012, FUTURE ONCOL, V8, P1031, DOI [10.2217/FON.12.79, 10.2217/fon.12.79]; Chen WD, 2005, JNCI-J NATL CANCER I, V97, P1124, DOI 10.1093/jnci/dji204; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gough MJ, 2008, CANCER RES, V68, P5206, DOI 10.1158/0008-5472.CAN-07-6484; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Han QF, 2006, CANCER LETT, V231, P129, DOI 10.1016/j.canlet.2005.01.026; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Hundt S, 2007, CANCER EPIDEM BIOMAR, V16, P1935, DOI 10.1158/1055-9965.EPI-06-0994; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jung K, 2008, BRIT J CANCER, V99, P553, DOI 10.1038/sj.bjc.6604491; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Kim HJ, 2008, BMB REP, V41, P685, DOI 10.5483/BMBRep.2008.41.10.685; Kim HJ, 2010, J CERAM PROCESS RES, V11, P11; Korner H, 2007, ANN SURG ONCOL, V14, P417, DOI 10.1245/s10434-006-9060-6; LaPointe LC, 2008, PHYSIOL GENOMICS, V33, P50, DOI 10.1152/physiolgenomics.00185.2006; Lascorz J, 2010, CARCINOGENESIS, V31, P1612, DOI 10.1093/carcin/bgq146; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Miller S, 2012, J SURG ONCOL, V105, P459, DOI 10.1002/jso.21704; Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363; Newton K, 2010, COLORECTAL DIS, V12, P706, DOI 10.1111/j.1463-1318.2010.02220.x; Newton KF, 2012, COLORECTAL DIS, V14, P3, DOI 10.1111/j.1463-1318.2010.02439.x; Parra-Blanco A, 2010, J GASTROENTEROL, V45, P703, DOI 10.1007/s00535-010-0214-8; Pawa N, 2011, NAT REV GASTRO HEPAT, V8, P711, DOI 10.1038/nrgastro.2011.205; Peris M, 2007, J MED SCREEN, V14, P81, DOI 10.1258/096914107781261936; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Ransohoff DF, 2009, ANN INTERN MED, V150, P50, DOI 10.7326/0003-4819-150-1-200901060-00308; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Safran M, 2010, DATABASE, V2010, DOI DOI 10.1093/DATABASE/BAQ020; Sanz-Pamplona R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-46; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tanaka T, 2010, INT J MOL SCI, V11, P3209, DOI 10.3390/ijms11093209; Team RDC, 2012, R LANG ENV STAT COMP; Tjalsma H, 2010, EXPERT REV PROTEOMIC, V7, P879, DOI 10.1586/EPR.10.81; von Karsa L, 2013, ENDOSCOPY, V45, P51, DOI 10.1055/s-0032-1325997; WARMAN ML, 1993, NAT GENET, V5, P79, DOI 10.1038/ng0993-79; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhou BY, 2010, P NATL ACAD SCI USA, V107, P9923, DOI 10.1073/pnas.1002757107	57	71	75	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106748	10.1371/journal.pone.0106748	http://dx.doi.org/10.1371/journal.pone.0106748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215506	gold, Green Submitted, Green Published			2022-12-27	WOS:000341774300022
J	Eli, K				Eli, Karin			Between Difference and Belonging: Configuring Self and Others in Inpatient Treatment for Eating Disorders	PLOS ONE			English	Article							ANOREXIA-NERVOSA; LIMINALITY; EXPERIENCES; ILLNESS; DROPOUT; VIEWS	Dedicated inpatient care for eating disorders has profound impact on patients' embodied practices and lived realities. Analyses of inpatients' accounts have shown that participants endorse complex and conflicting attitudes toward their experiences in eating disorders wards, yet the apparent ambivalence that characterizes inpatient experiences has not been subject to critical examination. This paper examines the narrated experiences of 13 participants (12 women and one man; age 18-38 years at first interview) with past or present anorexia nervosa, bulimia nervosa, or eating disorder not otherwise specified, who had been hospitalized in an inpatient eating disorders ward for adults in central Israel. The interviews, which took place in 2005-2006, and again in 2011, were part of a larger longitudinal study exploring the subjective experiences of eating disorders and recovery among Israeli adults. Employing qualitative analysis, this study finds that the participants' accounts were concerned with dynamics of difference and belonging, as they played out in various aspects of inpatient care, including diagnosis, treatment, relationships with fellow patients and staff, and everyday life in hospital. Notably, participants simultaneously defined themselves as connected to, but also distinct from, the eating disordered others who formed their reference group at the ward. Through negotiating a protectively ambivalent positioning, participants recognized their eating disordered identities and connected with others on the ward, while also asserting their non-disordered individuality and distancing themselves from the potential dangers posed by 'excessive' belonging. The paper suggests that this ambivalent positioning can usefully be understood through the anthropological concept of liminality: being both a part of and apart from one's community.	Univ Oxford, Inst Social & Cultural Anthropol, Unit Biocultural Variat & Obes, Oxford, England	University of Oxford	Eli, K (corresponding author), Univ Oxford, Inst Social & Cultural Anthropol, Unit Biocultural Variat & Obes, Oxford, England.	Karin.eli@anthro.ox.ac.uk		Eli, Karin/0000-0001-9132-8404	Oxford University Press John Fell Research Fund	Oxford University Press John Fell Research Fund	This research was funded in part by an award from the Oxford University Press John Fell Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Charmaz K., 2002, QUAL INQ, V8, P302, DOI DOI 10.1177/107780040200800307; Colton A, 2004, EUR EAT DISORD REV, V12, P307, DOI 10.1002/erv.587; Dias K., 2003, J INT WOMENS STUDIES, V4, P31; Eli K, 2014, MIL BEHAV HLTH, V2, P89, DOI DOI 10.1080/21635781.2013.838140; Frank A., 2010, WOUNDED STORYTELLER; Gennep Arnold van, 1960, RITES PASSAGE; Gooldin S., 2002, ISRAELI SOCIOLOGY, V4, P105; Gremillion H, 2002, SIGNS, V27, P381, DOI 10.1086/495691; Griffiths R, 1998, INT J EAT DISORDER, V23, P443; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hope T, 2011, HASTINGS CENT REP, V41, P19; Jackson JE, 2005, AM ETHNOL, V32, P332, DOI 10.1525/ae.2005.32.3.332; Kahn C, 2001, INT J EAT DISORDER, V30, P237, DOI 10.1002/eat.1080; Lavis A, 2011, THESIS GOLDSMITHS; Lester RJ, 2007, MED ANTHROPOL Q, V21, P369, DOI [10.1525/maq.2007.21.4.369, 10.1525/MAQ.2007.21.4.369]; Little M, 1998, SOC SCI MED, V47, P1485, DOI 10.1016/S0277-9536(98)00248-2; Long D, 2008, ANTHROPOL MED, V15, P71, DOI 10.1080/13648470802121844; Long S, 2012, J HEALTH PSYCHOL, V17, P419, DOI 10.1177/1359105311419270; Malson H, 2004, J COMMUNITY APPL SOC, V14, P473, DOI 10.1002/casp.804; Nordbo RHS, 2012, EUR EAT DISORD REV, V20, P60, DOI 10.1002/erv.1097; Offord A, 2006, EUR EAT DISORD REV, V14, P377, DOI 10.1002/erv.687; Reid M, 2008, J HEALTH PSYCHOL, V13, P956, DOI 10.1177/1359105308095070; Rice Tom, 2003, ANTHROPOL TODAY, V19, P4, DOI [10.1111/1467-8322.00201, DOI 10.1111/1467-8322.00201]; Rich E, 2006, SOCIOL HEALTH ILL, V28, P284, DOI 10.1111/j.1467-9566.2006.00493.x; Smith J. A., 2008, DOING SOCIAL PSYCHOL, P229, DOI [10.1002/9780470776278.ch10, DOI 10.1002/9780470776278.CH10, DOI 10.4135/9781848607927.N11]; Smith JA., 1999, QUALITATIVE HLTH PSY, P218, DOI [10.4135/9781446217870.n14, DOI 10.4135/9781446217870.N14]; Smith V, 2012, THESIS U EDINBURGH; Surgenor LJ, 2004, EUR EAT DISORD REV, V12, P94, DOI 10.1002/erv.539; Tierney S, 2013, INT J NURS STUD, V50, P738, DOI 10.1016/j.ijnurstu.2012.04.014; Tierney Stephanie, 2008, J Am Psychiatr Nurses Assoc, V13, P368, DOI 10.1177/1078390307309215; Turner Victor, 1967, FOREST SYMBOLS; van der Geest S, 2004, SOC SCI MED, V59, P1995, DOI 10.1016/j.socscimed.2004.03.004; Wallier J, 2009, INT J EAT DISORDER, V42, P636, DOI 10.1002/eat.20609; Warin Megan, 2005, BODY SOC, V11, P97, DOI 10.1177/1357034X05056193; Williams S, 2010, PSYCHOL HEALTH, V25, P551, DOI 10.1080/08870440802617629	37	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e105452	10.1371/journal.pone.0105452	http://dx.doi.org/10.1371/journal.pone.0105452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1UA	25210886	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900004
J	Louis, C; Tinant, G; Mignolet, E; Thome, JP; Debier, C				Louis, Caroline; Tinant, Gilles; Mignolet, Eric; Thome, Jean-Pierre; Debier, Cathy			PCB-153 Shows Different Dynamics of Mobilisation from Differentiated Rat Adipocytes during Lipolysis in Comparison with PCB-28 and PCB-118	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; ADIPOSE-TISSUE SAMPLES; ELEPHANT SEAL PUPS; POST-WEANING FAST; POLYCHLORINATED-BIPHENYLS; MEMBRANE-FLUIDITY; ORGANOCHLORINE PESTICIDES; MIROUNGA-ANGUSTIROSTRIS; OBESE INDIVIDUALS; TOXIC POLLUTANTS	Background: Polychlorinated biphenyls (PCBs) are persistent organic pollutants. Due to their lipophilic character, they are preferentially stored within the adipose tissue. During the mobilisation of lipids, PCBs might be released from adipocytes into the bloodstream. However, the mechanisms associated with the release of PCBs have been poorly studied. Several in vivo studies followed their dynamics of release but the complexity of the in vivo situation, which is characterised by a large range of pollutants, does not allow understanding precisely the behaviour of individual congeners. The present in vitro experiment studied the impact of (i) the number and position of chlorine atoms of PCBs on their release from adipocytes and (ii) the presence of other PCB congeners on the mobilisation rate of such molecules. Methodology/Principal Findings: Differentiated rat adipocytes were used to compare the behaviour of PCB-28, -118 and -153. Cells were contaminated with the three congeners, alone or in cocktail, and a lipolysis was then induced with isoproterenol during 12 hours. Our data indicate that the three congeners were efficiently released from adipocytes and accumulated in the medium during the lipolysis. Interestingly, for a same level of cell lipids, PCB-153, a hexa-CB with two chlorine atoms in ortho-position, was mobilised slower than PCB-28, a tri-CB, and PCB-118, a penta-CB, which are both characterised by one chlorine atom in ortho-position. It suggests an impact of the chemical properties of pollutants on their mobilisation during periods of negative energy balance. Moreover, the mobilisation of PCB congeners, taken individually, did not seem to be influenced by the presence of other congeners within adipocytes. Conclusion/Significance: These results not only highlight the obvious mobilisation of PCBs from adipocytes during lipolysis, in parallel to lipids, but also demonstrate that the structure of congeners defines their rate of release from adipocytes.	[Louis, Caroline; Tinant, Gilles; Mignolet, Eric; Debier, Cathy] Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium; [Thome, Jean-Pierre] Univ Liege, Lab Ecol Anim & Ecotoxicol, Liege, Belgium	Universite Catholique Louvain; University of Liege	Debier, C (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium.	cathy.debier@uclouvain.be						Arrebola JP, 2012, ENVIRON RES, V112, P40, DOI 10.1016/j.envres.2011.10.006; BECKER MM, 1982, J TOXICOL ENV HEALTH, V9, P225, DOI 10.1080/15287398209530157; Bourez S, 2013, TOXICOL LETT, V216, P40, DOI 10.1016/j.toxlet.2012.09.027; Bourez S, 2012, TOXICOL LETT, V214, P243, DOI 10.1016/j.toxlet.2012.08.018; Bourez S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031834; Campbell AS, 2008, ENVIRON SCI TECHNOL, V42, P7496, DOI 10.1021/es8011063; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Chevrier J, 2000, INT J OBESITY, V24, P1272, DOI 10.1038/sj.ijo.0801380; De Saeger S, 2005, CHEMOSPHERE, V58, P953, DOI 10.1016/j.chemosphere.2004.09.069; Debier C, 2005, ENVIRON TOXICOL CHEM, V24, P629, DOI 10.1897/04-033R.1; Debier C, 2004, AQUAT TOXICOL, V68, P179, DOI 10.1016/j.aquatox.2004.03.010; Debier C, 2003, MAR ECOL PROG SER, V247, P237, DOI 10.3354/meps247237; Debier C, 2006, AQUAT TOXICOL, V80, P149, DOI 10.1016/j.aquatox.2006.08.002; Debier C, 2012, COMP BIOCHEM PHYS A, V162, P323, DOI 10.1016/j.cbpa.2012.04.001; Dirinck E, 2011, OBESITY, V19, P709, DOI 10.1038/oby.2010.133; Dirtu AC, 2013, ENVIRON SCI TECHNOL, V47, P12441, DOI 10.1021/es400657t; EC, 2002, OFFICIAL J EUROPEAN, V262, P8; EDENS NK, 1990, J LIPID RES, V31, P1423; GALLENBERG LA, 1987, J TOXICOL ENV HEALTH, V20, P163, DOI 10.1080/15287398709530969; Gonzalez A, 2013, AQUAT TOXICOL, V144, P11, DOI 10.1016/j.aquatox.2013.09.018; Gupta C, 2000, P SOC EXP BIOL MED, V224, P61, DOI 10.1046/j.1525-1373.2000.22402.x; Hue O, 2006, OBES SURG, V16, P1145, DOI 10.1381/096089206778392356; Imbeault P, 2002, AM J PHYSIOL-ENDOC M, V282, pE574, DOI 10.1152/ajpendo.00394.2001; Irigaray P, 2005, FOOD CHEM TOXICOL, V43, P457, DOI 10.1016/j.fct.2004.11.016; Katynski AL, 2004, COMP BIOCHEM PHYS C, V137, P81, DOI 10.1016/j.cca.2003.11.004; Kester MHA, 2000, ENDOCRINOLOGY, V141, P1897, DOI 10.1210/en.141.5.1897; Kim MJ, 2011, ENVIRON HEALTH PERSP, V119, P377, DOI 10.1289/ehp.1002848; KOPPE JG, 1995, EUR J OBSTET GYN R B, V61, P73, DOI 10.1016/0028-2243(95)02156-M; La Merrill M, 2013, ENVIRON HEALTH PERSP, V121, P162, DOI 10.1289/ehp.1205485; Lee DH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015977, 10.1371/journal.pone.0026172]; Liem AKD, 2000, FOOD ADDIT CONTAM, V17, P241, DOI 10.1080/026520300283324; LopezAparicio P, 1997, PESTIC BIOCHEM PHYS, V57, P54, DOI 10.1006/pest.1997.2256; Louis C, 2014, IN VITRO CELL DEV-AN, V50, P507, DOI 10.1007/s11626-014-9733-6; Louis C, 2014, ENVIRON RES, V132, P438, DOI 10.1016/j.envres.2014.04.016; Malarvannan G, 2013, ENVIRON INT, V55, P33, DOI 10.1016/j.envint.2013.02.012; MATTHEWS HB, 1984, FUND APPL TOXICOL, V4, P420, DOI 10.1016/0272-0590(84)90199-4; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1010, DOI 10.1289/ehp.1002922; Moon HB, 2012, ARCH ENVIRON CON TOX, V62, P176, DOI 10.1007/s00244-011-9679-6; Robertson LW, 2001, PCBS RECENT ADV ENV; Sbarbati A, 2010, EUR J HISTOCHEM, V54, P226, DOI 10.4081/ejh.2010.e48; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; SPINDLERVOMACHKA M, 1984, TOXICOL APPL PHARM, V74, P70, DOI 10.1016/0041-008X(84)90271-0; Van QCD, 2011, ANIM FEED SCI TECH, V169, P1, DOI 10.1016/j.anifeedsci.2011.05.002; Vanden Berghe M, 2012, ENVIRON INT, V46, P6, DOI 10.1016/j.envint.2012.04.011; Vanden Berghe M, 2010, ENVIRON POLLUT, V158, P1570, DOI 10.1016/j.envpol.2009.12.012; Wang N, 2010, ENVIRON SCI TECHNOL, V44, P4334, DOI 10.1021/es9038775; Wassermann M, 1979, Ann N Y Acad Sci, V320, P69; Yilmaz B, 2006, TOXICOLOGY, V217, P184, DOI 10.1016/j.tox.2005.09.008; Zhou LB, 2011, BBA-MOL BASIS DIS, V1812, P527, DOI 10.1016/j.bbadis.2010.10.001	49	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106495	10.1371/journal.pone.0106495	http://dx.doi.org/10.1371/journal.pone.0106495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211159	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900014
J	Na, KS; Jee, DH; Han, K; Park, YG; Kim, MS; Kim, EC				Na, Kyung-Sun; Jee, Dong Hyun; Han, Kyungdo; Park, Yong-Gyu; Kim, Man Soo; Kim, Eun Chul			The Ocular Benefits of Estrogen Replacement Therapy: A Population-Based Study in Postmenopausal Korean Women	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; BLUE MOUNTAINS EYE; BEAVER DAM EYE; INTRAOCULAR-PRESSURE; HORMONE-THERAPY; REPRODUCTIVE FACTORS; PTERYGIUM; PREVALENCE; EXPOSURES; CATARACT	Purpose: To elucidate the prevalence of cataract, glaucoma, pterygia, and diabetic retinopathy among Korean postmenopausal women with or without estrogen replacement therapy (ERT). Methods: A cross-sectional, nationally representative sample from the 4th Korea National Health and Nutrition Examination Survey (KNHANES IV) (2007-2009) was used. Participants were interviewed for the determination of socioeconomic and gynecologic factors. Each woman also underwent an ophthalmologic examination and provided a blood sample for risk factor assessment. Results: Of 3968 postmenopausal women enrolled, 3390 had never received estrogen, and 578 were undergoing estrogen treatment. After adjusting for age, diabetes, hypertension, high cholesterol levels, and high low-density lipoprotein levels, the prevalence of anterior polar cataract, retinal nerve fiber layer (RNFL) defect, and flesh pterygium was higher in the non-ERT group (OR, 3.24; 95% CI, 1.12-9.35, OR 1.70; 95% CI, 1.04-2.78, OR 3.725; 95% CI, 1.21-11.45, respectively). Further, the prevalence of atrophic pterygium was lower in the non-ERT group compared to that in the ERT group (OR, 0.21, 95% CI, 0.07-0.63). Conclusions: These data suggest that ERT has a protective effect against the development of anterior polar cataract, flesh pterygium, and RNFL defect.	[Na, Kyung-Sun; Jee, Dong Hyun; Kim, Man Soo; Kim, Eun Chul] Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Han, Kyungdo; Park, Yong-Gyu] Catholic Univ Korea, Dept Biostat, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, EC (corresponding author), Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul, South Korea.	eunchol@hanmail.net		Park, Yong Gyu/0000-0002-8721-3230	National Research Foundation of Korea Grant [201238648]	National Research Foundation of Korea Grant(National Research Foundation of Korea)	This study is supported by National Research Foundation of Korea Grant founded by the Korean Government (201238648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov Y, 2005, J GLAUCOMA, V14, P271, DOI 10.1097/01.ijg.0000169390.17427.b7; Abramov Y, 2004, MENOPAUSE, V11, P62, DOI 10.1097/01.GME.0000074701.19603.11; Ang M, 2012, OPHTHALMOLOGY, V119, P1509, DOI 10.1016/j.ophtha.2012.02.009; Craig MC, 2010, ANN NY ACAD SCI, V1205, P245, DOI 10.1111/j.1749-6632.2010.05673.x; Cumming RG, 1997, AM J EPIDEMIOL, V145, P242; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Deschenes MC, 2010, INVEST OPHTH VIS SCI, V51, P2587, DOI 10.1167/iovs.09-3710; Gabriel SR, 2005, COCHRANE DB SYST REV, V18; Gagliano C, 2014, BRIT J OPHTHALMOL, V98, P371, DOI 10.1136/bjophthalmol-2012-302705; GERHARD M, 1995, CIRCULATION, V92, P5, DOI 10.1161/01.CIR.92.1.5; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Hayashi T, 2011, NITRIC OXIDE-BIOL CH, V24, P199, DOI 10.1016/j.niox.2011.04.002; Kanthan GL, 2010, ACTA OPHTHALMOL, V88, P773, DOI 10.1111/j.1755-3768.2009.01565.x; Khurana RN, 2006, AM J OPHTHALMOL, V142, P494, DOI 10.1016/j.ajo.2006.04.018; Klein BEK, 2000, AM J OPHTHALMOL, V130, P322, DOI 10.1016/S0002-9394(00)00474-8; KLEIN BEK, 1994, ARCH OPHTHALMOL-CHIC, V112, P85, DOI 10.1001/archopht.1994.01090130095025; Klein BEK, 1999, DIABETES CARE, V22, P1984, DOI 10.2337/diacare.22.12.1984; Li ZJ, 2013, CORNEA, V32, P806, DOI 10.1097/ICO.0b013e31826dff30; Maki PM, 2012, CLIMACTERIC, V15, P256, DOI 10.3109/13697137.2012.660613; Ogueta SB, 1999, INVEST OPHTH VIS SCI, V40, P1906; Pasquale LR, 2013, MOL VIS, V19, P1471; Rosano G, 2012, CLIMACTERIC, V15, P299, DOI 10.3109/13697137.2012.658899; Sator MO, 1998, MATURITAS, V29, P93, DOI 10.1016/S0378-5122(97)00091-1; Sator MO, 1997, MATURITAS, V28, P55, DOI 10.1016/S0378-5122(97)00060-1; Saw S M, 1999, Ophthalmic Epidemiol, V6, P219, DOI 10.1076/opep.6.3.219.1504; Schaumberg DA, 2001, JAMA-J AM MED ASSOC, V286, P2114, DOI 10.1001/jama.286.17.2114; Tan DTH, 1997, ARCH OPHTHALMOL-CHIC, V115, P1235, DOI 10.1001/archopht.1997.01100160405001; Tint NL, 2010, MENOPAUSE, V17, P157, DOI 10.1097/gme.0b013e3181b82fb4; Tostes RC, 2003, BRAZ J MED BIOL RES, V36, P1143, DOI 10.1590/S0100-879X2003000900002; Uncu G, 2006, GYNECOL ENDOCRINOL, V22, P501, DOI 10.1080/09513590600917919	30	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106473	10.1371/journal.pone.0106473	http://dx.doi.org/10.1371/journal.pone.0106473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210892	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900012
J	Pugh, SD; MacDougall, DA; Agarwal, SR; Harvey, RD; Porter, KE; Calaghan, S				Pugh, Sara D.; MacDougall, David A.; Agarwal, Shailesh R.; Harvey, Robert D.; Porter, Karen E.; Calaghan, Sarah			Caveolin Contributes to the Modulation of Basal and beta-Adrenoceptor Stimulated Function of the Adult Rat Ventricular Myocyte by Simvastatin: A Novel Pleiotropic Effect	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; STATIN THERAPY; CARDIAC MYOCYTES; ADRENERGIC STIMULATION; UP-REGULATION; CHOLESTEROL; CAMP; ACTIVATION; INHIBITION; OVEREXPRESSION	The number of people taking statins is increasing across the globe, highlighting the importance of fully understanding statins' effects on the cardiovascular system. The beneficial impact of statins extends well beyond regression of atherosclerosis to include direct effects on tissues of the cardiovascular system ('pleiotropic effects'). Pleiotropic effects on the cardiac myocyte are often overlooked. Here we consider the contribution of the caveolin protein, whose expression and cellular distribution is dependent on cholesterol, to statin effects on the cardiac myocyte. Caveolin is a structural and regulatory component of caveolae, and is a key regulator of cardiac contractile function and adrenergic responsiveness. We employed an experimental model in which inhibition of myocyte HMG CoA reductase could be studied in the absence of paracrine influences from non-myocyte cells. Adult rat ventricular myocytes were treated with 10 mu M simvastatin for 2 days. Simvastatin treatment reduced myocyte cholesterol, caveolin 3 and caveolar density. Negative inotropic and positive lusitropic effects (with corresponding changes in [Ca2+](i)) were seen in statin-treated cells. Simvastatin significantly potentiated the inotropic response to beta 2-, but not beta 1-, adrenoceptor stimulation. Under conditions of beta 2-adrenoceptor stimulation, phosphorylation of phospholamban at Ser(16) and troponin I at Ser(23/24) was enhanced with statin treatment. Simvastatin increased NO production without significant effects on eNOS expression or phosphorylation (Ser(1177)), consistent with the reduced expression of caveolin 3, its constitutive inhibitor. In conclusion, statin treatment can reduce caveolin 3 expression, with functional consequences consistent with the known role of caveolae in the cardiac cell. These data are likely to be of significance, particularly during the early phases of statin treatment, and in patients with heart failure who have altered beta-adrenoceptor signalling. In addition, as caveolin is ubiquitously expressed and has myriad tissue-specific functions, the impact of statin-dependent changes in caveolin is likely to have many other functional sequelae.	[Pugh, Sara D.; MacDougall, David A.; Calaghan, Sarah] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Porter, Karen E.] Univ Leeds, Div Cardiovasc & Diabet Res, Leeds, W Yorkshire, England; [Agarwal, Shailesh R.; Harvey, Robert D.] Univ Nevada, Dept Pharmacol, Reno, NV 89557 USA	University of Leeds; University of Leeds; Nevada System of Higher Education (NSHE); University of Nevada Reno	Calaghan, S (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England.	s.c.calaghan@leeds.ac.uk	Harvey, Robert D/L-8496-2016; Stefanadis, Christodoulos/ABH-2232-2020	Harvey, Robert D/0000-0002-8499-8765; Stefanadis, Christodoulos/0000-0001-5974-6454; Calaghan, Sarah/0000-0002-9145-2576; MacDougall, David/0000-0003-1811-288X	British Heart Foundation [PG/09/051/27828]; Heart Research United Kingdom [RG2546/07/09]; National Institute of Health [R01GM101928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101928] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Heart Research United Kingdom; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The majority (approximate to 55%) of this work was funded by the British Heart Foundation (PG/09/051/27828; http://www.bhf.org.uk). The remainder was funded by Heart Research United Kingdom (approximate to 30%, RG2546/07/09; http://heartresearch.org.uk/grant), and the National Institute of Health (approximate to 15%, R01GM101928; http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SR, 2011, J MOL CELL CARDIOL, V50, P500, DOI 10.1016/j.yjmcc.2010.11.015; Aravamudan B, 2003, HUM MOL GENET, V12, P2777, DOI 10.1093/hmg/ddg313; BALLIGAND JL, 1995, J BIOL CHEM, V270, P14582, DOI 10.1074/jbc.270.24.14582; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Bountioukos M, 2003, AM J CARDIOL, V92, P613, DOI 10.1016/S0002-9149(03)00737-9; BRISTOW MR, 1993, J AM COLL CARDIOL, V22, pA61, DOI 10.1016/0735-1097(93)90465-D; Burkard N, 2007, CIRC RES, V100, pE32, DOI 10.1161/01.RES.0000259042.04576.6a; Calaghan S, 2006, CARDIOVASC RES, V69, P816, DOI 10.1016/j.cardiores.2005.10.006; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Calaghan SC, 1998, PFLUG ARCH EUR J PHY, V436, P948, DOI 10.1007/s004240050728; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; Chan PS, 2007, CIRCULATION, V115, P2398, DOI 10.1161/CIRCULATIONAHA.106.667683; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Feron O, 2001, CIRCULATION, V103, P113; Feron O, 1998, J BIOL CHEM, V273, P30249, DOI 10.1074/jbc.273.46.30249; Foerster K, 2003, P NATL ACAD SCI USA, V100, P14475, DOI 10.1073/pnas.1936026100; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; GERMERSHAUSEN JI, 1989, BIOCHEM BIOPH RES CO, V158, P667, DOI 10.1016/0006-291X(89)92773-3; Graham G, 2008, BIOPHYS J, V94, P501; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Harvey RD, 2012, J MOL CELL CARDIOL, V52, P366, DOI 10.1016/j.yjmcc.2011.07.007; Hatcher CJ, 1999, PFLUG ARCH EUR J PHY, V438, P307, DOI 10.1007/s004240050914; Ikonen E, 2004, BIOCHEM SOC T, V32, P121, DOI 10.1042/BST0320121; Jo SH, 2002, CIRC RES, V91, P46, DOI 10.1161/01.RES.0000024115.67561.54; Kozera L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008312; Kuschel M, 1999, J BIOL CHEM, V274, P22048, DOI 10.1074/jbc.274.31.22048; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Leach RN, 2005, CELL CALCIUM, V38, P515, DOI 10.1016/j.ceca.2005.07.006; Li L, 1998, AM J PHYSIOL-HEART C, V274, pH1335, DOI 10.1152/ajpheart.1998.274.4.H1335; MacDougall DA, 2012, J MOL CELL CARDIOL, V52, P388, DOI 10.1016/j.yjmcc.2011.06.014; Massion PB, 2004, CIRCULATION, V110, P2666, DOI 10.1161/01.CIR.0000145608.80855.BC; MASTERS BA, 1995, TOXICOL APPL PHARM, V131, P163, DOI 10.1006/taap.1995.1058; Mizuguchi Y, 2008, CIRC J, V72, P538; Muhlhauser U, 2006, FASEB J, V20, P785, DOI 10.1096/fj.05-5067fje; Muller-Strahl G, 2000, J PHYSIOL-LONDON, V522, P311, DOI 10.1111/j.1469-7793.2000.00311.x; Nakagami H, 2003, ANN MED, V35, P398, DOI 10.1080/07853890310001294; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; NORMAN AW, 1972, J BIOL CHEM, V247, P1918; Nussler AK, 2006, NAT PROTOC, V1, P2223, DOI 10.1038/nprot.2006.341; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Porter KE, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001931; Reboulleau A, 2012, J MOL CELL CARDIOL, V53, P196, DOI 10.1016/j.yjmcc.2012.05.015; Rubinstein J, 2009, CLIN CARDIOL, V32, P684, DOI 10.1002/clc.20644; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Sadowitz B, 2010, VASC ENDOVASC SURG, V44, P241, DOI 10.1177/1538574410362922; Seddon M, 2007, CARDIOVASC RES, V75, P315, DOI 10.1016/j.cardiores.2007.04.031; SHMEEDA H, 1995, AM J PHYSIOL-HEART C, V268, pH759, DOI 10.1152/ajpheart.1995.268.2.H759; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Talini E, 2008, ATHEROSCLEROSIS, V197, P346, DOI 10.1016/j.atherosclerosis.2007.05.024; To QT, 2010, CELL BIOCHEM FUNCT, V28, P480, DOI 10.1002/cbf.1680; Tousoulis D, 2007, INT J CARDIOL, V115, P144, DOI 10.1016/j.ijcard.2006.03.094; Uray IP, 2003, CARDIOVASC RES, V59, P57, DOI 10.1016/S0008-6363(03)00352-3; Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8; Wang H, 2008, AM J PHYSIOL-HEART C, V294, pH1473, DOI 10.1152/ajpheart.01249.2007; Werner N, 2002, BASIC RES CARDIOL, V97, P105, DOI 10.1007/s003950200000; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798; Zhang YH, 2012, J MOL CELL CARDIOL, V52, P341, DOI 10.1016/j.yjmcc.2011.09.006; Zheng X, 2005, ACTA PHARMACOL SIN, V26, P696, DOI 10.1111/j.1745-7254.2005.00105.x; Ziolo MT, 2008, J MOL CELL CARDIOL, V45, P625, DOI 10.1016/j.yjmcc.2008.07.015; Ziviani L, 2001, BRIT J CLIN PHARMACO, V51, P147, DOI 10.1111/j.1365-2125.2001.bcp119.x	63	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106905	10.1371/journal.pone.0106905	http://dx.doi.org/10.1371/journal.pone.0106905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211146	Green Published, gold			2022-12-27	WOS:000341855900030
J	Rikiishi, K; Maekawa, M				Rikiishi, Kazuhide; Maekawa, Masahiko			Seed Maturation Regulators Are Related to the Control of Seed Dormancy in Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							ARABIDOPSIS LEAFY COTYLEDON1; LATE EMBRYO DEVELOPMENT; TRANSCRIPTION FACTOR; GENE-EXPRESSION; LATE EMBRYOGENESIS; FUS3 GENE; FUSCA3; GERMINATION; THALIANA; GIBBERELLIN	In Arabidopsis, the regulation network of the seed maturation program controls the induction of seed dormancy. Wheat EST sequences showing homology with the master regulators of seed maturation, LEAFY COTYLEDON1 (LEC1), LEC2 and FUSCA3 (FUS3), were searched from databases and designated respectively as TaL1L (LEC1-LIKE), TaL2L (LEC2-LIKE), and TaFUS3. TaL1LA, TaL2LA and TaFUS3 mainly expressed in seeds or embryos, with the expression limited to the early stages of seed development. Results show that tissue-specific and developmental-stage-dependent expressions are similar to those of seed maturation regulators in Arabidopsis. In wheat cultivars, the expression level of TaL1LA is correlated significantly with the germination index (GI) of whole seeds at 40 days after pollination (DAP) (r = -0.83**). Expression levels of TaFUS3 and TaL2LA are significantly correlated respectively with GIs at 40 DAP and 50 DAP, except for dormant cultivars. No correlation was found between the expression level of TaVP1, orthologue of ABA INSENSITIVE3 (ABI3), and seed dormancy. DELAY OF GERMINATION1 (DOG1) was identified as a quantitative trait locus (QTL) for the regulation of seed dormancy in Arabidopsis. Its promoter has RY motif, which is a target sequence of LEC2. Significant correlation was found between the expression of TaDOG1 and seed dormancy except for dormant cultivars. These results indicate that TaL1LA, TaL2LA, and TaFUS3 are wheat orthologues of seed maturation regulators. The expressions of these genes affect the level of seed dormancy. Furthermore, the pathways, which involve seed maturation regulators and TaDOG1, are important for regulating seed dormancy in wheat.	[Rikiishi, Kazuhide; Maekawa, Masahiko] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan	Okayama University	Rikiishi, K (corresponding author), Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan.	riki@rib.okayama-u.ac.jp			Ohara Foundation for Agricultural Research	Ohara Foundation for Agricultural Research	This work was supported by a grant from the Ohara Foundation for Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2003, GENETICS, V164, P711; Baumbusch LO, 2004, J EXP BOT, V55, P77, DOI 10.1093/jxb/erh014; BAUMLEIN H, 1994, PLANT J, V6, P379, DOI 10.1046/j.1365-313X.1994.06030379.x; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; Chiang GCK, 2011, MOL ECOL, V20, P3336, DOI 10.1111/j.1365-294X.2011.05181.x; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Gazzarrini S, 2004, DEV CELL, V7, P373, DOI 10.1016/j.devcel.2004.06.017; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; Guo XL, 2013, PLANT J, V75, P403, DOI 10.1111/tpj.12209; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Jones HD, 1997, PLANT J, V12, P911, DOI 10.1046/j.1365-313X.1997.12040911.x; Junker A, 2012, PLANT J, V71, P427, DOI 10.1111/j.1365-313X.2012.04999.x; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; KEITH K, 1994, PLANT CELL, V6, P589, DOI 10.1105/tpc.6.5.589; Kroj T, 2003, DEVELOPMENT, V130, P6065, DOI 10.1242/dev.00814; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Liu AH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056536, 10.1371/journal.pone.0057359, 10.1371/journal.pone.0056570, 10.1371/journal.pone.0054001]; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Luerssen K, 1998, PLANT J, V15, P755, DOI 10.1046/j.1365-313X.1998.00259.x; McKibbin RS, 2002, P NATL ACAD SCI USA, V99, P10203, DOI 10.1073/pnas.152318599; MEINKE DW, 1992, SCIENCE, V258, P1647, DOI 10.1126/science.258.5088.1647; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Moreno-Risueno MA, 2008, PLANT J, V53, P882, DOI 10.1111/j.1365-313X.2007.03382.x; Nakabayashi K, 2012, PLANT CELL, V24, P2826, DOI 10.1105/tpc.112.100214; Nambara E, 2003, TRENDS PLANT SCI, V8, P213, DOI 10.1016/S1360-1385(03)00060-8; Nambara E, 2000, DEV BIOL, V220, P412, DOI 10.1006/dbio.2000.9632; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; PARCY F, 1994, PLANT CELL, V6, P1567, DOI 10.1105/tpc.6.11.1567; Parcy F, 1997, PLANT CELL, V9, P1265, DOI 10.1105/tpc.9.8.1265; Peng LT, 2008, J PLANT PHYSIOL, V165, P876, DOI 10.1016/j.jplph.2007.07.010; Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139; Raz V, 2001, DEVELOPMENT, V128, P243; Reidt W, 2000, PLANT J, V21, P401, DOI 10.1046/j.1365-313x.2000.00686.x; Rikiishi K, 2010, J CEREAL SCI, V52, P236, DOI 10.1016/j.jcs.2010.05.012; Rikiishi K, 2010, J CEREAL SCI, V51, P292, DOI 10.1016/j.jcs.2010.01.003; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Seo M, 2006, PLANT J, V48, P354, DOI 10.1111/j.1365-313X.2006.02881.x; Shen B, 2010, PLANT PHYSIOL, V153, P980, DOI 10.1104/pp.110.157537; Sreenivasulu N, 2013, ANNU REV PLANT BIOL, V64, P189, DOI 10.1146/annurev-arplant-050312-120215; Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; To A, 2006, PLANT CELL, V18, P1642, DOI 10.1105/tpc.105.039925; Tsuchiya Y, 2004, PLANT J, V37, P73, DOI 10.1046/j.1365-313X.2003.01939.x; Vicient CM, 2000, J EXP BOT, V51, P995, DOI 10.1093/jexbot/51.347.995; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x	55	18	18	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107618	10.1371/journal.pone.0107618	http://dx.doi.org/10.1371/journal.pone.0107618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211528	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900088
J	Lerman, G; Sharon, M; Leibowitz-Amit, R; Sidi, Y; Avni, D				Lerman, Galya; Sharon, Moran; Leibowitz-Amit, Raya; Sidi, Yechezkel; Avni, Dror			The Crosstalk between IL-22 Signaling and miR-197 in Human Keratinocytes	PLOS ONE			English	Article							GENE-EXPRESSION; PSORIASIFORM DERMATOSIS; T-CELL; SKIN; MICRORNA; DIFFERENTIATION; PATHOGENESIS; EPIGENETICS; DISTINCT; SITES	The interaction between the immune system and epithelial cells is tightly regulated. Aberrations of this balance may result in inflammatory diseases such as psoriasis, inflammatory bowel disease and rheumatoid arthritis. IL-22 is produced by Th17, Th22 and Th1 cells. Putative targets for IL-22 are cells in the skin, kidney, digestive and respiratory systems. The highest expression of IL-22 receptor is found in the skin. IL-22 plays an important role in the pathogenesis of T cell-mediated inflammatory diseases such as psoriasis, inflammatory bowel disease and rheumatoid arthritis. Recently, we found that miR-197 is down regulated in psoriatic lesions. In the present work we show that miR-197 over expression inhibits keratinocytes proliferation induced by IL-22 and keratinocytes migration. In addition, we found that IL-22 activates miR-197 expression through the binding of phosphorylated STAT3 to sequences in the putative promoter of miR-197. Finally we found that IL-22 receptor subunit IL22RA1 is a direct target of miR-197. Hence, we identified a novel feedback loop controlling IL-22 signaling, in which IL-22 induces miR-197, which in turn, negatively regulates IL-22 receptor and attenuates the biological outcome of such signaling. Regulation of this pathway may be important in inflammatory skin disorders such a psoriasis and in wound healing.	[Lerman, Galya; Leibowitz-Amit, Raya; Sidi, Yechezkel; Avni, Dror] Chaim Sheba Med Ctr, Ctr Canc Res, Mol Cell Biol Lab, IL-52621 Tel Hashomer, Israel; [Lerman, Galya; Leibowitz-Amit, Raya; Sidi, Yechezkel; Avni, Dror] Chaim Sheba Med Ctr, Dept Med C, IL-52621 Tel Hashomer, Israel; [Leibowitz-Amit, Raya] Chaim Sheba Med Ctr, Inst Oncol, IL-52621 Tel Hashomer, Israel; [Sharon, Moran; Sidi, Yechezkel] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Sidi, Y (corresponding author), Chaim Sheba Med Ctr, Ctr Canc Res, Mol Cell Biol Lab, IL-52621 Tel Hashomer, Israel.	Yehezkel.Sidi@sheba.health.gov.il; droravni@msn.com	Avni, Dror/GRE-8325-2022	Avni, Dror/0000-0002-8738-1840; Sharon, Michal/0000-0003-3933-0595	Chief Scientist Office of Israel Ministry of Health [4898, 10132]; Israel Cancer Association [20110076]; Weizmann Institute of Science - Chaim Sheba Medical Center Collaborative Grant Project; Tel Aviv University	Chief Scientist Office of Israel Ministry of Health; Israel Cancer Association; Weizmann Institute of Science - Chaim Sheba Medical Center Collaborative Grant Project; Tel Aviv University	This research was supported by grants from the Chief Scientist Office of Israel Ministry of Health, (Grant No. 4898 and Grant No. 10132), the Israel Cancer Association (Grant No. 20110076), the Weizmann Institute of Science - Chaim Sheba Medical Center Collaborative Grant Project (2010-2012) to D. Avni and Y. Sidi, and 2012 Tel Aviv University: Garnt in memory of Professor Y. Kacenelenbogen for research in dermatology to Y. Sidi. The authors also thank the Shalvi family and Nathan Hetz for generous donations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Back SJ, 2012, ANN DERMATOL, V24, P261, DOI 10.5021/ad.2012.24.3.261; Belleudi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024194; Boniface K, 2005, EUR CYTOKINE NETW, V16, P309; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Botchkarev VA, 2012, J INVEST DERMATOL, V132, P2505, DOI 10.1038/jid.2012.182; Bowcock AM, 2005, ANNU REV GENOM HUM G, V6, P93, DOI 10.1146/annurev.genom.6.080604.162324; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Dai YM, 2011, HEAD NECK-J SCI SPEC, V33, P786, DOI 10.1002/hed.21540; Furney SJ, 2012, PIGM CELL MELANOMA R, V25, P488, DOI 10.1111/j.1755-148X.2012.01016.x; Gervin K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002454; Ghosh D, 2000, NUCLEIC ACIDS RES, V28, P308, DOI 10.1093/nar/28.1.308; GROSS TL, 1986, VET PATHOL, V23, P76, DOI 10.1177/030098588602300113; Gudjonsson JE, 2012, J INVEST DERMATOL, V132, P506, DOI 10.1038/jid.2011.364; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Ichihara A, 2011, BRIT J DERMATOL, V165, P1003, DOI 10.1111/j.1365-2133.2011.10497.x; JAYO MJ, 1988, VET PATHOL, V25, P282, DOI 10.1177/030098588802500406; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kiezun Adam, 2012, BMC Res Notes, V5, P92, DOI 10.1186/1756-0500-5-92; Kohanbash G, 2012, SEMIN CANCER BIOL, V22, P70, DOI 10.1016/j.semcancer.2011.12.010; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lai R, 2003, BIOTECHNIQUES, V34, P52, DOI 10.2144/03341bm07; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Lena AM, 2008, CELL DEATH DIFFER; Lerman G, 2011, BR J DERMATOL; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LOWE NJ, 1981, J INVEST DERMATOL, V76, P141, DOI 10.1111/1523-1747.ep12525484; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; MASON KV, 1986, J AM VET MED ASSOC, V189, P897; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Nickoloff BJ, 2000, EXP DERMATOL, V9, P359, DOI 10.1034/j.1600-0625.2000.009005359.x; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Roberson EDO, 2012, J INVEST DERMATOL, V132, P583, DOI 10.1038/jid.2011.348; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Sadagurski M, 2006, MOL CELL BIOL, V26, P2675, DOI 10.1128/MCB.26.7.2675-2687.2006; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Sestito R, 2011, FASEB J, V25, P916, DOI 10.1096/fj.10-172288; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; Trowbridge RM, 2014, J DRUGS DERMATOL, V13, P111; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Weber F, 2006, J CLIN ENDOCR METAB, V91, P3584, DOI 10.1210/jc.2006-0693; Wei TL, 2010, EXP DERMATOL, V19, P854, DOI 10.1111/j.1600-0625.2010.01118.x; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Xu N, 2011, J INVEST DERMATOL; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang P, 2012, J EUR ACAD DERMATOL, V26, P399, DOI 10.1111/j.1468-3083.2011.04261.x; Zhang P, 2013, J AUTOIMMUN, V41, P17, DOI 10.1016/j.jaut.2013.01.001; Zhang P, 2011, EUR J DERMATOL, V21, P552, DOI 10.1684/ejd.2011.1383; Zhang P, 2010, J DERMATOL SCI, V60, P40, DOI 10.1016/j.jdermsci.2010.07.011	67	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107467	10.1371/journal.pone.0107467	http://dx.doi.org/10.1371/journal.pone.0107467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208211	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300084
J	Miniotis, MF; Mukwaya, A; Wingren, AG				Miniotis, Maria Falck; Mukwaya, Anthonny; Wingren, Anette Gjorloff			Digital Holographic Microscopy for Non-Invasive Monitoring of Cell Cycle Arrest in L929 Cells	PLOS ONE			English	Article							RESISTANCE	Digital holographic microscopy (DHM) has emerged as a powerful non-invasive tool for cell analysis. It has the capacity to analyse multiple parameters simultaneously, such as cell-number, confluence and phase volume. This is done while cells are still adhered and growing in their culture flask. The aim of this study was to investigate whether DHM was able to monitor drug-induced cell cycle arrest in cultured cells and thus provide a non-disruptive alternative to flow cytometry. DHM parameters from G1 and G2/M cell cycle arrested L929 mouse fibroblast cells were collected. Cell cycle arrest was verified with flow cytometry. This study shows that DHM is able to monitor phase volume changes corresponding to either a G1 or G2/M cell cycle arrest. G1-phase arrest with staurosporine correlated with a decrease in the average cell phase volume and G2/M-phase arrest with colcemid and etoposide correlated with an increase in the average cell phase volume. Importantly, DHM analysis of average cell phase volume was of comparable accuracy to flow cytometric measurement of cell cycle phase distribution as recorded following dose-dependent treatment with etoposide. Average cell phase volume changes in response to treatment with cell cycle arresting compounds could therefore be used as a DHM marker for monitoring cell cycle arrest in cultured mammalian cells.	[Miniotis, Maria Falck] Malmo Univ, Dept Biomed Lab Sci Hlth & Soc, Malmo, Sweden; Malmo Univ Hosp, Malmo, Sweden	Malmo University; Lund University; Skane University Hospital	Miniotis, MF (corresponding author), Malmo Univ, Dept Biomed Lab Sci Hlth & Soc, Malmo, Sweden.	maria.falck@mah.se	Mukwaya, Anthony/K-2335-2019; Wingren, Anette Gjörloff/AAN-2439-2020	Mukwaya, Anthony/0000-0002-9645-8942; Wingren, Anette Gjörloff/0000-0002-2993-0354	Lars Hierta foundation [FO2012-0399, FO2013-0080]; Ake Wiberg foundation [171916142]; Swedish Institute scholarship [04471/2012]; Malmo University	Lars Hierta foundation; Ake Wiberg foundation; Swedish Institute scholarship; Malmo University	MFM acknowledges funding from The Lars Hierta foundation (grants: FO2012-0399 and FO2013-0080) and Ake Wiberg foundation (grant nr: 171916142). AM acknowledges funding from a Swedish Institute scholarship (04471/2012). AGW acknowledges funding from Malmo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.larshiertasminne.se/, http://ake-wiberg.se/, http://studyinsweden.se/scholarship/swedish-institute-study-scholarships/, http://mah.se/.	Alm K., 2013, HOLOGRAPHY BASIC PRI, P335, DOI DOI 10.5772/54505; Chalut KJ, 2012, INTEGR BIOL-UK, V4, P280, DOI 10.1039/c2ib00129b; Charriere F, 2006, OPT EXPRESS, V14, P7005, DOI 10.1364/OE.14.007005; Ekpenyong AE, 2013, J BIOPHOTONICS, V6, P393, DOI 10.1002/jbio.201200113; Girshovitz P, 2012, BIOMED OPT EXPRESS, V3, P1757, DOI 10.1364/BOE.3.001757; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kemper B, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3431712; Khmaladze A, 2012, J STRUCT BIOL, V178, P270, DOI 10.1016/j.jsb.2012.03.008; Kuhn J, 2013, ASSAY DRUG DEV TECHN, V11, P101, DOI 10.1089/adt.2012.476; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; LIN Y, 1992, J CELL PHYSIOL, V152, P646, DOI 10.1002/jcp.1041520325; Mir M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089000; Pan F, 2012, OPT EXPRESS, V20, P11496, DOI 10.1364/OE.20.011496; Pavillon N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030912; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Rudolf E., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P421, DOI 10.2174/1568011033482242; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Shaked NT, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3420179; URBANI L, 1995, EXP CELL RES, V219, P159, DOI 10.1006/excr.1995.1216; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Workman P, 2008, CURR OPIN PHARMACOL, V8, P359, DOI 10.1016/j.coph.2008.07.007; Zhu H, 2009, NEOPLASIA, V11, P1226, DOI 10.1593/neo.09986	23	42	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106546	10.1371/journal.pone.0106546	http://dx.doi.org/10.1371/journal.pone.0106546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208094	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300028
J	Young, VJ; Brown, JK; Saunders, PTK; Duncan, WC; Horne, AW				Young, Vicky J.; Brown, Jeremy K.; Saunders, Philippa T. K.; Duncan, W. Colin; Horne, Andrew W.			The Peritoneum Is Both a Source and Target of TGF-beta in Women with Endometriosis	PLOS ONE			English	Article							GROWTH-FACTOR; PELVIC ENDOMETRIOSIS; MESOTHELIAL CELLS; EPITHELIAL-CELLS; ACTIVATION; FLUID; PROMOTES; CANCER; MODEL; BAD	Transforming growth factor-beta (TGF-beta) is believed to play a major role in the aetiology of peritoneal endometriosis. We aimed to determine if the peritoneum is a source of TGF-beta and if peritoneal TGF-beta expression, reception or target genes are altered in women with endometriosis. Peritoneal fluid, peritoneal bushings and peritoneal biopsies were collected from women with and without endometriosis. TGF-beta 1, 2 and 3 protein concentrations were measured in the peritoneal fluid. TGF-beta 1 was measured in mesothelial cell conditioned media. Control peritoneum and peritoneum prone to endometriosis (within Pouch of Douglas) from women without disease (n = 16) and peritoneum distal and adjacent to endometriosis lesions in women with endometriosis (n = 15) and were analysed for TGF-beta expression, reception and signalling by immunohistochemistry, qRT-PCR and a TGF-beta signalling PCR array. TGF-beta 1 was increased in the peritoneal fluid of women with endometriosis compared to those without disease (P<0.05) and peritoneal mesothelial cells secrete TGF-beta 1 in-vitro. In women with endometriosis, peritoneum from sites adjacent to endometriosis lesions expressed higher levels of TGFB1 mRNA when compared to distal sites (P<0.05). The TGF-beta-stimulated Smad 2/3 signalling pathway was active in the peritoneum and there were significant increases (P<0.05) in expression of genes associated with tumorigenesis (MAPK8, CDC6), epithelial-mesenchymal transition (NOTCH1), angiogenesis (ID1, ID3) and neurogenesis (CREB1) in the peritoneum of women with endometriosis. In conclusion, the peritoneum, and in particular, the peritoneal mesothelium, is a source of TGF-beta 1 and this is enhanced around endometriosis lesions. The expression of TGF-beta-regulated genes is altered in the peritoneum of women with endometriosis and this may promote an environment favorable to lesion formation.	[Young, Vicky J.; Brown, Jeremy K.; Saunders, Philippa T. K.; Duncan, W. Colin; Horne, Andrew W.] Univ Edinburgh, MRC, Queens Med Res Inst, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh	Horne, AW (corresponding author), Univ Edinburgh, MRC, Queens Med Res Inst, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	andrew.horne@ed.ac.uk	Saunders, Philippa TK/C-7489-2013	Saunders, Philippa TK/0000-0001-9051-9380; Horne, Andrew/0000-0002-9656-493X	Wellbeing of Women research grant [R42533]; Federation of Women Graduates [134225]; College of Medicine and Veterinary Medicine at the University of Edinburgh; MRC [G0802808, G1002033, G1100356] Funding Source: UKRI; Medical Research Council [G1100356, G0802808, G1002033] Funding Source: researchfish; Wellbeing of Women [RG1436] Funding Source: researchfish; Chief Scientist Office [SCD/02] Funding Source: researchfish	Wellbeing of Women research grant(Wellbeing of Women (WoW)); Federation of Women Graduates; College of Medicine and Veterinary Medicine at the University of Edinburgh; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellbeing of Women(Wellbeing of Women (WoW)); Chief Scientist Office	This work was funded by a Wellbeing of Women research grant (R42533) awarded to AWH, PTKS, JKB and WCD (http://www.wellbeingofwomen.org.uk). VJY receives grant support from Federation of Women Graduates (134225) and a PhD studentship from the College of Medicine and Veterinary Medicine at the University of Edinburgh (http://www.bfwg.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley J, 2013, ARCH GYNECOLOGY OBST; CANDIANI GB, 1991, OBSTET GYNECOL, V77, P421; D'Hooghe TM, 2001, AM J OBSTET GYNECOL, V184, P917, DOI 10.1067/mob.2001.111715; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Deng HB, 2008, J BIOL CHEM, V283, P20754, DOI 10.1074/jbc.M800024200; Dunselman GAJ, 2001, HUM REPROD, V16, P605, DOI 10.1093/humrep/16.4.605; Espinoza I, 2013, CANCER LETT, V341, P41, DOI 10.1016/j.canlet.2013.08.027; Fegan KS, 2008, J ENDOCRINOL, V196, P369, DOI 10.1677/JOE-07-0419; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Ho HN, 1997, HUM REPROD, V12, P2528, DOI 10.1093/humrep/12.11.2528; Hull ML, 2008, AM J PATHOL, V173, P700, DOI 10.2353/ajpath.2008.071128; Hull ML, 2012, AM J PATHOL, V180, P880, DOI 10.1016/j.ajpath.2011.11.013; Hull ML, 2003, J CLIN ENDOCR METAB, V88, P2889, DOI 10.1210/jc.2002-021912; Ishimaru T, 2004, FERTIL STERIL, V81, P810, DOI 10.1016/j.fertnstert.2003.09.037; Johnson MC, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-45; Kobayashi H, 2014, ARCH GYNECOL OBSTET, V289, P13, DOI 10.1007/s00404-013-3049-8; Komiyama SI, 2007, J REPROD MED, V52, P306; Kuohung W, 2002, FERTIL STERIL, V78, P767, DOI 10.1016/S0015-0282(02)03342-3; Kupker W, 1998, HUM REPROD UPDATE, V4, P719, DOI 10.1093/humupd/4.5.719; Kyama C, 2006, ENDOMETRIAL PERITONE; Ling MT, 2005, CARCINOGENESIS, V26, P1668, DOI 10.1093/carcin/bgi128; Lucidi RS, 2005, FERTIL STERIL, V84, P16, DOI 10.1016/j.fertnstert.2004.10.058; MAHMOOD TA, 1991, HUM REPROD, V6, P544, DOI 10.1093/oxfordjournals.humrep.a137377; Matsuzaki S, 2012, HUM REPROD, V27, P712, DOI 10.1093/humrep/der442; Mizumoto Y, 1996, Nihon Sanka Fujinka Gakkai Zasshi, V48, P379; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; Nisolle M, 2000, FERTIL STERIL, V74, P306, DOI 10.1016/S0015-0282(00)00601-4; Offner FA, 1996, AM J PATHOL, V148, P1679; Omwandho COA, 2010, HUM REPROD, V25, P101, DOI 10.1093/humrep/dep382; OOSTERLYNCK DJ, 1993, FERTIL STERIL, V59, P778; OOSTERLYNCK DJ, 1994, OBSTET GYNECOL, V83, P287; Petrakis TG, 2012, TRANSCR-AUSTIN, V3, P124, DOI 10.4161/trns.20301; Pizzo A, 2002, GYNECOL OBSTET INVES, V54, P82, DOI 10.1159/000067717; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sabapathy K, 2012, PROG MOL BIOL TRANSL, V106, P145, DOI 10.1016/B978-0-12-396456-4.00013-4; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Song MQ, 2003, FERTIL STERIL, V79, P789, DOI 10.1016/S0015-0282(02)04836-7; Sotnikova NY, 2010, FERTIL STERIL, V93, P2701, DOI 10.1016/j.fertnstert.2009.11.024; Suen JL, 2014, AM J PATHOL, V184, P464, DOI 10.1016/j.ajpath.2013.10.023; Sun RJ, 2011, CELL BIOCHEM FUNCT, V29, P636, DOI 10.1002/cbf.1799; Tagashira Y, 2009, FERTIL STERIL, V91, P2185, DOI 10.1016/j.fertnstert.2008.04.052; Taniguchi F, 2009, MOL CELL ENDOCRINOL, V307, P196, DOI 10.1016/j.mce.2009.04.012; Taylor RN, 2002, ANN NY ACAD SCI, V955, P89, DOI 10.1111/j.1749-6632.2002.tb02769.x; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Witz CA, 2003, FERTIL STERIL, V79, P770, DOI 10.1016/S0015-0282(02)04834-3; Wong YC, 2004, APOPTOSIS, V9, P279, DOI 10.1023/B:APPT.0000025804.25396.79; Wu RJ, 2004, HUM REPROD UPDATE, V10, P119, DOI 10.1093/humupd/dmh011; Young VJ, 2013, HUM REPROD UPDATE, V19, P558, DOI 10.1093/humupd/dmt024; Young VJ, 2014, J CLIN ENDOCRINOL ME; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0	51	69	79	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106773	10.1371/journal.pone.0106773	http://dx.doi.org/10.1371/journal.pone.0106773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207642	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300039
J	Bai, BY; Yegnasubramanian, S; Wheelan, SJ; Laiho, M				Bai, Baoyan; Yegnasubramanian, Srinivasan; Wheelan, Sarah J.; Laiho, Marikki			RNA-Seq of the Nucleolus Reveals Abundant SNORD44-Derived Small RNAs	PLOS ONE			English	Article							REGULATORY NONCODING RNAS; BOX C/D SNORNAS; RIBOSOMAL-RNA; BIOGENESIS; LOCALIZATION; PROTEINS; PARTICLE; CRM1; RIBONUCLEOPROTEINS; IDENTIFICATION	Small non-coding RNAs represent RNA species that are not translated to proteins, but which have diverse and broad functional activities in physiological and pathophysiological states. The knowledge of these small RNAs is rapidly expanding in part through the use of massive parallel (deep) sequencing efforts. We present here the first deep sequencing of small RNomes in subcellular compartments with particular emphasis on small RNAs (sRNA) associated with the nucleolus. The vast majority of the cellular, cytoplasmic and nuclear sRNAs were identified as miRNAs. In contrast, the nucleolar sRNAs had a unique size distribution consisting of 19-20 and 25 nt RNAs, which were predominantly composed of small snoRNA-derived box C/D RNAs (termed as sdRNA). Sequences from 47 sdRNAs were identified, which mapped to both 59 and 39 ends of the snoRNAs, and retained conserved box C or D motifs. SdRNA reads mapping to SNORD44 comprised 74% of all nucleolar sdRNAs, and were confirmed by Northern blotting as comprising both 20 and 25 nt RNAs. A novel 120 nt SNORD44 form was also identified. The expression of the SNORD44 sdRNA and 120 nt form was independent of Dicer/Drosha-mediated processing pathways but was dependent on the box C/D snoRNP proteins/sno-ribonucleoproteins fibrillarin and NOP58. The 120 nt SNORD44-derived RNA bound to fibrillarin suggesting that C/D sno-ribonucleoproteins are involved in regulating the stability or processing of SNORD44. This study reveals sRNA cell-compartment specific expression and the distinctive unique composition of the nucleolar sRNAs.	[Bai, Baoyan; Laiho, Marikki] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA; [Yegnasubramanian, Srinivasan; Wheelan, Sarah J.; Laiho, Marikki] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Laiho, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA.	mlaiho1@jhmi.edu			National Institutes of Health [P30 CA006973]; Johns Hopkins University; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University(Johns Hopkins University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [P30 CA006973] and Johns Hopkins University start-up funds (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai BY, 2014, FEBS OPEN BIO, V4, P441, DOI 10.1016/j.fob.2014.04.010; Bai BY, 2013, NUCLEUS-PHILA, V4, P315, DOI 10.4161/nucl.25342; Bai BY, 2012, PROTEOMICS, V12, P3044, DOI 10.1002/pmic.201200071; Bertrand E, 1998, GENE DEV, V12, P2463, DOI 10.1101/gad.12.16.2463; Boulon S, 2004, MOL CELL, V16, P777, DOI 10.1016/j.molcel.2004.11.013; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Cahill NM, 2002, EMBO J, V21, P3816, DOI 10.1093/emboj/cdf376; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Dunbar DA, 2000, NUCLEIC ACIDS RES, V28, P2855, DOI 10.1093/nar/28.15.2855; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Falaleeva M, 2013, BIOESSAYS, V35, P46, DOI 10.1002/bies.201200117; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gerbi SA, 2002, MOL BIOL CELL, V13, P3123, DOI 10.1091/mbc.01-12-0596; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V126, P135, DOI 10.1007/s00418-006-0212-3; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Kishore S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r45; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kiss T, 2006, MOL CELL, V23, P775, DOI 10.1016/j.molcel.2006.08.023; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Lafontaine DLJ, 1999, RNA, V5, P455, DOI 10.1017/S135583829998192X; Lange TS, 2000, MOL BIOL CELL, V11, P2419, DOI 10.1091/mbc.11.7.2419; Langenberger D, 2013, J EXP ZOOL PART B, V320B, P35, DOI 10.1002/jez.b.22481; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Li ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070869; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Lin J, 2004, GENE DEV, V18, P387, DOI 10.1101/gad.1171804; Narayanan A, 2003, J CELL SCI, V116, P177, DOI 10.1242/jcs.00176; Ono M, 2011, NUCLEIC ACIDS RES, V39, P3879, DOI 10.1093/nar/gkq1355; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Pradet-Balade B, 2011, EMBO J, V30, P2205, DOI 10.1038/emboj.2011.128; Samarsky DA, 1998, EMBO J, V17, P3747, DOI 10.1093/emboj/17.13.3747; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Scott MS, 2012, NUCLEIC ACIDS RES, V40, P3676, DOI 10.1093/nar/gkr1233; Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026; Scott MS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000507; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Verheggen C, 2002, EMBO J, V21, P2736, DOI 10.1093/emboj/21.11.2736; Verheggen C, 2001, EMBO J, V20, P5480, DOI 10.1093/emboj/20.19.5480; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Xue S, 2010, MOL CELL, V39, P939, DOI 10.1016/j.molcel.2010.08.022	51	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107519	10.1371/journal.pone.0107519	http://dx.doi.org/10.1371/journal.pone.0107519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203660	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500106
J	Oblak, A; Jerala, R				Oblak, Alja; Jerala, Roman			Species-Specific Activation of TLR4 by Hypoacylated Endotoxins Governed by Residues 82 and 122 of MD-2	PLOS ONE			English	Article							ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; LARGE VIRULENCE PLASMID; COMPLETE DNA-SEQUENCE; STRUCTURAL BASIS; YERSINIA-PESTIS; RECEPTOR 4; LIPID-A; ACYLATION; LPS; ANTAGONIST	The Toll-like receptor 4/MD-2 receptor complex recognizes endotoxin, a Gram-negative bacterial cell envelope component. Recognition of the most potent hexaacylated form of endotoxin is mediated by the sixth acyl chain that protrudes from the MD-2 hydrophobic pocket and bridges TLR4/MD-2 to the neighboring TLR4 ectodomain, driving receptor dimerization via hydrophobic interactions. In hypoacylated endotoxins all acyl chains could be accommodated within the binding pocket of the human hMD-2. Nevertheless, tetra-and pentaacylated endotoxins activate the TLR4/MD-2 receptor of several species. We observed that amino acid residues 82 and 122, located at the entrance to the endotoxin binding site of MD-2, have major influence on the species-specific endotoxin recognition. We show that substitution of hMD-2 residue V82 with an amino acid residue with a bulkier hydrophobic side chain enables activation of TLR4/MD-2 by pentaacylated and tetraacylated endotoxins. Interaction of the lipid A phosphate group with the amino acid residue 122 of MD-2 facilitates the appropriate positioning of the hypoacylated endotoxin. Moreover, mouse TLR4 contributes to the agonistic effect of pentaacylated msbB endotoxin. We propose a molecular model that explains how the molecular differences between the murine or equine MD-2, which both have sufficiently large hydrophobic pockets to accommodate all five or four acyl chains, influence the positioning of endotoxin so that one of the acyl chains remains outside the pocket and enables hydrophobic interactions with TLR4, leading to receptor activation.	[Oblak, Alja; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia; [Oblak, Alja; Jerala, Roman] Ctr Excellence EN FIST, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Jerala, R (corresponding author), Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia.	roman.jerala@ki.si	Jerala, Roman/H-9850-2015	Jerala, Roman/0000-0002-6337-5251	Research Programme (Molecular Biotechnology) [P4-0176]; Centre of Excellence ENFIST; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	Research Programme (Molecular Biotechnology); Centre of Excellence ENFIST; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AO and RJ were supported by Research Programme P4-0176 (Molecular Biotechnology) and by the Centre of Excellence ENFIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Anisimov AP, 2007, J MED MICROBIOL, V56, P443, DOI 10.1099/jmm.0.46880-0; Beutler B, 2003, ANNU REV PHARMACOL, V43, P609, DOI 10.1146/annurev.pharmtox.43.100901.135729; Burland V, 1998, NUCLEIC ACIDS RES, V26, P4196, DOI 10.1093/nar/26.18.4196; Clements A, 2007, J BIOL CHEM, V282, P15569, DOI 10.1074/jbc.M701454200; Clementz T, 1997, J BIOL CHEM, V272, P10353; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Coats SR, 2003, INFECT IMMUN, V71, P6799, DOI 10.1128/IAI.71.12.6799-6807.2003; Coats SR, 2011, INFECT IMMUN, V79, P203, DOI 10.1128/IAI.00937-10; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; KAWASAKI S, 1994, J BACTERIOL, V176, P284, DOI 10.1128/JB.176.2.284-290.1994; Keck M, 2011, J BIOL CHEM, V286, P12850, DOI 10.1074/jbc.M110.194209; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; Kim SH, 2004, INFECT IMMUN, V72, P1174, DOI 10.1128/IAI.72.2.1174-1180.2004; Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Oblak A, 2015, MOL IMMUNOL, V63, P134, DOI 10.1016/j.molimm.2014.06.034; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Post DMB, 2002, INFECT IMMUN, V70, P909, DOI 10.1128/IAI.70.2.909-920.2002; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Vasl J, 2009, J IMMUNOL, V183, P5138, DOI 10.4049/jimmunol.0901544; Venkatesan MM, 2001, INFECT IMMUN, V69, P3271, DOI 10.1128/IAI.69.5.3271-3285.2001; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245	39	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107520	10.1371/journal.pone.0107520	http://dx.doi.org/10.1371/journal.pone.0107520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203747	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500107
J	Raj, A; McDougal, L; Silverman, JG; Rusch, MLA				Raj, Anita; McDougal, Lotus; Silverman, Jay G.; Rusch, Melanie L. A.			Cross-Sectional Time Series Analysis of Associations between Education and Girl Child Marriage in Bangladesh, India, Nepal and Pakistan, 1991-2011	PLOS ONE			English	Article								Background: Girl education is believed to be the best means of reducing girl child marriage (marriage <18 years) globally. However, in South Asia, where the majority of girl child marriages occur, substantial improvements in girl education have not corresponded to equivalent reductions in child marriage. This study examines the levels of education associated with female age at marriage over the previous 20 years across four South Asian nations with high rates (>20%) of girl child marriage-Bangladesh, India, Nepal and Pakistan. Methods: Cross-sectional time series analyses were conducted on Demographic and Health Surveys (DHS) from 1991 to 2011 in the four focal nations. Analyses were restricted to ever-married women aged 20-24 years. Multinomial logistic regression models were used to assess the effect of highest level of education received (none, primary, secondary or higher) on age at marriage (<14, 14-15, 16-17, 18 and older). Results: In Bangladesh and Pakistan, primary education was not protective against girl child marriage; in Nepal, it was protective against marriage at <14 years (AOR = 0.42) but not for older adolescents. Secondary education was protective across minor age at marriage categories in Bangladesh (, 14 years AOR = 0.10; 14-15 years AOR =.25; 16-17 years AOR = 0.64) and Nepal (<14 years AOR = 0.21; 14-15 years AOR = 0.25; 16-17 years AOR = 0.57), but protective against marriage of only younger adolescents in Pakistan (<14 years AOR = 0.19; 14-15 years AOR = 0.23). In India, primary and secondary education were respectively protective across all age at marriage categories (<14 years AOR = 0.34, AOR = 0.05; 14-15 years AOR = 0.52, AOR = 0.20; 16-17 years AOR = 0.71, AOR = 0.48). Conclusion: Primary education is likely insufficient to reduce girl child marriage in South Asia, outside of India. Secondary education may be a better protective strategy against this practice for the region, but may be less effective for prevention of marriage among older relative to younger adolescents.	[Raj, Anita; McDougal, Lotus; Silverman, Jay G.] Univ Calif San Diego, Dept Med, Sch Med, Div Global Publ Hlth, San Diego, CA 92103 USA; [Raj, Anita; McDougal, Lotus; Silverman, Jay G.] Univ Calif San Diego, Ctr Gender Equ & Hlth, San Diego, CA 92103 USA; [Raj, Anita] Boston Univ, Sch Med, Dept Med, Boston Med Ctr,Sect Gen Internal Med Clin Addict, Boston, MA 02118 USA; [Rusch, Melanie L. A.] Vancouver Isl Hlth Author, Vancouver, BC, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; Boston Medical Center; Boston University; Vancouver Island Health Authority	Raj, A (corresponding author), Univ Calif San Diego, Dept Med, Sch Med, Div Global Publ Hlth, San Diego, CA 92103 USA.	anitaraj@ucsd.edu			David and Lucile Packard Foundation [2011-37366]; National Institutes of Health [R01HD061115]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061115] Funding Source: NIH RePORTER	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	A grant from the David and Lucile Packard Foundation (Grant #2011-37366; Principal Investigator: Anita Raj) funded work from Ms. McDougal and Dr. Rusch for data analysis, interpretation of study findings, and manuscript development. This same grant, as well as a grant from the National Institutes of Health (Grant Number R01HD061115; Joint Principal Investigator: Anita Raj), supported time from Dr. Raj to lead study design and development of the manuscript and time from Dr. Silverman to support interpretation of study findings and substantial revisions of the manuscript. Mr. Lester Coutinho, our Program Manager from the David and Lucile Packard Foundation, contributed to the conceptualization and interpretation of study findings. He did not participate in data collection, analysis, the decision to publish, or preparation of the manuscript, nor did he receive any financial support from our grant to provide his input. The authors' Packard grant funding was not contingent on his participation in this paper.	[Anonymous], MEAS DHS DHS METH; Brown G., 2012, OUT WEDLOCK SCH COMB; Chitrakar Roshan, 2009, OVERCOMING BARRIERS; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; IIPS & ORC Macro, 1995, NATL FAMILY HLTH SUR; IIPS & ORC Macro, 2000, NATL FAMILY HLTH SUR; Jain S, 2007, NEW INSIGHTS PREVENT; Khanna T., 2013, CHILD MARRIAGE S ASI; Malhotra A., 2011, SOLUTIONS END CHILD; Malhotra A, 2003, IMPACT INVESTMENTS F; Ministry of Health and Population (MOHP) [Nepal] New ERA ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health and Population (MOHP) [Nepal] New ERA Macro International Inc, 2007, NEP DEM HLTH SURV 20; Ministry of Health [Nepal] New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20; MITRA S, 1997, BANGLADESH DEMOGRAPH; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; National Institute of Population Studies (NIPS) [Pakistan] aIMII, 1992, PAK DEM HLTH SURV 19; National Institute of Population Studies (NIPS) [Pakistan] Macro International Inc, 2008, PAK DEM HLTH SURV 20; NIPORT Mitra and Associates ORC Macro, 2005, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ORC Macro, 2001, BANGL DEM HLTH SURV; Pradhan A., 1997, NEPAL FAMILY HLTH SU; Raj A, 2012, JAMA-J AM MED ASSOC, V307, P2027, DOI 10.1001/jama.2012.3497; Raj A, 2010, ARCH DIS CHILD, V95, P931, DOI 10.1136/adc.2009.178707; Raj A, 2009, LANCET, V373, P1883, DOI 10.1016/S0140-6736(09)60246-4; Rowan, 2011, BREAKING VOWS EARLY; Rutstein S. O., 2004, DHS WEALTH INDEX; Rutstein SO, 2006, GUIDE DHS STAT; The World Bank, 2009, COUNTR PROF SEL BANG; The World Bank, 2012, BRIEF ED S AS; UNFPA RAHNUMA, 2007, CHILD MARR PAK TAB; UNICEF, 2012, CHILD MARR IND AN AV; UNICEF, 2012, CHILD MARR PROGR BRI; United Nation, 2012, MILL DEV GOALS REP; United Nations News Centre, 2012, UN NEWS UN CHIEF UNV; United States Census Bureau, 2012, INT DAT BAS IDB; United States Department of State: Office of Global Women's Issues, 2012, SECR CLINT LAUNCH NE	35	35	35	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106210	10.1371/journal.pone.0106210	http://dx.doi.org/10.1371/journal.pone.0106210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203635	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500015
J	MacPherson, H; Newbronner, L; Chamberlain, R; Richmond, SJ; Lansdown, H; Perren, S; Hopton, A; Spilsbury, K				MacPherson, Hugh; Newbronner, Liz; Chamberlain, Ruth; Richmond, Stewart J.; Lansdown, Harriet; Perren, Sara; Hopton, Ann; Spilsbury, Karen			Practitioner Perspectives on Strategies to Promote Longer-Term Benefits of Acupuncture or Counselling for Depression: A Qualitative Study	PLOS ONE			English	Article							SYMPTOMS; CARE	Background: Non-pharmacological interventions for depression may help patients manage their condition. Evidence from a recent large-scale trial (ACUDep) suggests that acupuncture and counselling can provide longer-term benefits for many patients with depression. This paper describes the strategies practitioners reported using to promote longer-term benefits for their patients. Methods: A qualitative sub-study of practitioners (acupuncturists and counsellors) embedded in a randomised controlled trial. Using topic guides, data was collected from telephone interviews and a focus group, altogether involving 19 counsellors and 17 acupuncturists. Data were audio recorded, transcribed verbatim and analysed using thematic content analysis. Results: For longer-term impact, both acupuncturists and counsellors encouraged insight into root causes of depression on an individual basis and saw small incremental changes as precursors to sustained benefit. Acupuncturists stressed the importance of addressing concurrent physical symptoms, for example helping patients relax or sleep better in order to be more receptive to change, and highlighted the importance of Chinese medicine theory-based lifestyle change for lasting benefit. Counsellors more often highlighted the importance of the therapeutic relationship, emphasising the need for careful "pacing'' such that the process and tools employed were tailored and timed for each individual, depending on the "readiness'' to change. Our data is limited to acupuncture practitioners using the principles of traditional Chinese medicine, and counsellors using a humanistic, non-directive and person-centred approach. Conclusions: Long-term change appears to be an important focus within the practices of both acupuncturists and counsellors. To achieve this, practitioners stressed the need for an individualised approach with a focus on root causes.	[MacPherson, Hugh; Newbronner, Liz; Richmond, Stewart J.; Lansdown, Harriet; Perren, Sara; Hopton, Ann; Spilsbury, Karen] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Newbronner, Liz; Chamberlain, Ruth] Firefly Res & Evaluat, Malton, N Yorkshire, England	University of York - UK	MacPherson, H (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	hugh.macpherson@york.ac.uk		Spilsbury, Karen/0000-0002-6908-0032; MacPherson, Hugh/0000-0003-4255-4768	National Institute for Health Research (NIHR) under Programme Grants for Applied Research [RP-PG-0707-10186]; National Institute for Health Research [RP-PG-0707-10186] Funding Source: researchfish	National Institute for Health Research (NIHR) under Programme Grants for Applied Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This research is supported by the National Institute for Health Research (NIHR) under Programme Grants for Applied Research (Grant No. RP-PG-0707-10186). The views expressed in this presentation are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, BERG GARF HDB PSYCH, P495; Bower P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001025.pub3; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Centre for Outcomes Research & Effectiveness (CORE), HUM PSYCH THER COMP; Hannes K, 2011, GUIDANCE INCLUSION S; Katona C, 2005, CLIN MED, V5, P390, DOI 10.7861/clinmedicine.5-4-390; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; MacPherson H, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/286048; MacPherson H, 2006, J ALTERN COMPLEM MED, V12, P873, DOI 10.1089/acm.2006.12.873; MacPherson H, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001518; MacPherson H, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-209; Mind, 2002, MY CHOIC SURV; Parker G, 2009, BRIT J PSYCHIAT, V194, P1, DOI 10.1192/bjp.bp.108.054767; Perren S, 2009, COUNS PSYCHOTHER RES, V9, P241, DOI 10.1080/14733140903150745; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Roth A.D., 2009, COMPETENCES REQUIRED; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Smith CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004046.pub3	18	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e104077	10.1371/journal.pone.0104077	http://dx.doi.org/10.1371/journal.pone.0104077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198108	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700007
J	Place, DE; Muse, SJ; Kirimanjeswara, GS; Harvill, ET				Place, David E.; Muse, Sarah J.; Kirimanjeswara, Girish S.; Harvill, Eric T.			Caspase-1-Independent Interleukin-1 beta Is Required for Clearance of Bordetella pertussis Infections and Whole-Cell Vaccine-Mediated Immunity	PLOS ONE			English	Article							ADENYLATE-CYCLASE TOXIN; IN-VIVO; NEUTROPHIL RECRUITMENT; CASPASE-1 ACTIVATION; FUNGAL PATHOGENS; DEFICIENT MICE; T-CELLS; INFLAMMASOME; IL-1-BETA; IL-1	Whooping cough remains a significant disease worldwide and its re-emergence in highly vaccinated populations has been attributed to a combination of imperfect vaccines and evolution of the pathogen. The focus of this study was to examine the role of IL-1 alpha/beta and the inflammasome in generation of the interleukin-1 (IL-1) response, which is required for the clearance of Bordetella pertussis. We show that IL-1 beta but not IL-1 alpha is required for mediating the clearance of B. pertussis from the lungs of mice. We further found that IL-1 beta and IL-1R deficient mice, compared to wild-type, have similar but more persistent levels of inflammation, characterized by immune cell infiltration, with significantly increased IFN gamma and a normal IL-17A response during B. pertussis infection. Contrary to expectations, the cleavage of precursor IL-1 beta to its mature form did not require caspase-1 during primary infections within the lung despite being required by bone marrow-derived macrophages exposed to live bacteria. We also found that the caspase-1 inflammasome was not required for protective immunity against a B. pertussis challenge following vaccination with heat-killed whole cell B. pertussis, despite IL-1R signaling being required. These findings demonstrate that caspase-1-independent host factors are involved in the processing of protective IL-1 beta responses that are critical for bacterial clearance and vaccine-mediated immunity.	[Place, David E.; Muse, Sarah J.; Kirimanjeswara, Girish S.; Harvill, Eric T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Place, David E.] Penn State Univ, Grad Program Immunol & Infect Dis, University Pk, PA 16802 USA; [Muse, Sarah J.] Penn State Univ, Grad Program Biochem Microbiol & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Harvill, ET (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	harvill@psu.edu	Place, David/ABD-6703-2021	Place, David/0000-0002-1904-4164; Harvill, Eric/0000-0001-8893-2133	National Institutes of Health [GM083113, AI077917]; NIH [T32AI074551]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074551, K99AI077917, R56AI107016, R21AI116186, R01AI053075, R00AI077917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113681, R01GM083113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health through grants to ETH (GM083113) and GSK (AI077917). Sarah J Muse was funded by an NIH Training Grant (T32AI074551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheim K, 1997, P NATL ACAD SCI USA, V94, P2681, DOI 10.1073/pnas.94.6.2681; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; BEVILACQUA MP, 1985, J CLIN INVEST, V76, P2003, DOI 10.1172/JCI112200; Buryskova M, 2004, J BIOL CHEM, V279, P4017, DOI 10.1074/jbc.M306342200; Calkins CM, 2002, J ENDOTOXIN RES, V8, P59, DOI 10.1179/096805102125000092; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; Cypowyj S, 2012, EUR J IMMUNOL, V42, P2246, DOI 10.1002/eji.201242605; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dunne A, 2010, J IMMUNOL, V185, P1711, DOI 10.4049/jimmunol.1000105; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Flak TA, 2000, INFECT IMMUN, V68, P1235, DOI 10.1128/IAI.68.3.1235-1242.2000; Forsyth K, 2007, CLIN INFECT DIS, V45, P1487, DOI 10.1086/522660; Gill S, 2010, ANAT REC, V293, P968, DOI 10.1002/ar.21094; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Higgs R, 2012, MUCOSAL IMMUNOLOGY; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kamanova J, 2008, J IMMUNOL, V181, P5587, DOI 10.4049/jimmunol.181.8.5587; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; KAVITA U, 1995, J BIOL CHEM, V270, P27758, DOI 10.1074/jbc.270.46.27758; Kawaguchi Y, 2006, P NATL ACAD SCI USA, V103, P14501, DOI 10.1073/pnas.0603545103; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lavine JS, 2011, PNAS; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; MARTIN S, 1988, IMMUNOLOGY, V64, P301; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Skeldon A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00015; STIBITZ S, 1991, J BACTERIOL, V173, P4288, DOI 10.1128/JB.173.14.4288-4296.1991; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Unlu S, 2007, MOL IMMUNOL, V44, P3364, DOI 10.1016/j.molimm.2007.02.016; van de Veerdonk Frank L, 2011, Trends Immunol, V32, P110, DOI 10.1016/j.it.2011.01.003; van Gent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046407; VONKOENIG CHW, 1988, J CLIN MICROBIOL, V26, P2558, DOI 10.1128/JCM.26.12.2558-2560.1988; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Wolters P J, 2000, Respir Res, V1, P170, DOI 10.1186/rr29; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang XQ, 2011, J IMMUNOL, V186, P4895, DOI 10.4049/jimmunol.1000594; Zhang XQ, 2011, INFECT IMMUN, V79, P527, DOI 10.1128/IAI.00590-10	55	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107188	10.1371/journal.pone.0107188	http://dx.doi.org/10.1371/journal.pone.0107188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198773	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700094
J	Takahashi, H; Ohshima, C; Nakagawa, M; Thanatsang, K; Phraephaisarn, C; Chaturongkasumrit, Y; Keeratipibul, S; Kuda, T; Kimura, B				Takahashi, Hajime; Ohshima, Chihiro; Nakagawa, Miku; Thanatsang, Krittaporn; Phraephaisarn, Chirapiphat; Chaturongkasumrit, Yuphakhun; Keeratipibul, Suwimon; Kuda, Takashi; Kimura, Bon			Development of New Multilocus Variable Number of Tandem Repeat Analysis (MLVA) for Listeria innocua and Its Application in a Food Processing Plant	PLOS ONE			English	Article							TYPING METHOD; MONOCYTOGENES; ELECTROPHORESIS; PREVALENCE; DIVERSITY; STRAINS; MEAT	Listeria innocua is an important hygiene indicator bacterium in food industries because it behaves similar to Listeria monocytogenes, which is pathogenic to humans. PFGE is often used to characterize bacterial strains and to track contamination source. However, because PFGE is an expensive, complicated, time-consuming protocol, and poses difficulty in data sharing, development of a new typing method is necessary. MLVA is a technique that identifies bacterial strains on the basis of the number of tandem repeats present in the genome varies depending on the strains. MLVA has gained attention due to its high reproducibility and ease of data sharing. In this study, we developed a MLVA protocol to assess L. innocua and evaluated it by tracking the contamination source of L. innocua in an actual food manufacturing factory by typing the bacterial strains isolated from the factory. Three VNTR regions of the L. innocua genome were chosen for use in the MLVA. The number of repeat units in each VNTR region was calculated based on the results of PCR product analysis using capillary electrophoresis (CE). The calculated number of repetitions was compared with the results of the gene sequence analysis to demonstrate the accuracy of the CE repeat number analysis. The developed technique was evaluated using 60 L. innocua strains isolated from a food factory. These 60 strains were classified into 11 patterns using MLVA. Many of the strains were classified into ST-6, revealing that this MLVA strain type can contaminate each manufacturing process in the factory. The MLVA protocol developed in this study for L. innocua allowed rapid and easy analysis through the use of CE. This technique was found to be very useful in hygiene control in factories because it allowed us to track contamination sources and provided information regarding whether the bacteria were present in the factories.	[Takahashi, Hajime; Ohshima, Chihiro; Nakagawa, Miku; Chaturongkasumrit, Yuphakhun; Kuda, Takashi; Kimura, Bon] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Dept Food Sci & Technol, Tokyo, Japan; [Thanatsang, Krittaporn; Keeratipibul, Suwimon] Chulalongkorn Univ, Fac Sci, Dept Food Technol, Bangkok, Thailand; [Phraephaisarn, Chirapiphat] Chulalongkorn Univ, Fac Sci, Program Biotechnol, Bangkok, Thailand	Tokyo University of Marine Science & Technology; Chulalongkorn University; Chulalongkorn University	Takahashi, H (corresponding author), Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Dept Food Sci & Technol, Tokyo, Japan.	hajime@kaiyodai.ac.jp	KUDA, Takashi/O-1974-2014; Kimbo, Bon/O-1879-2014	Kimbo, Bon/0000-0002-3071-1343; keeratipibul, suwimon/0000-0001-7708-3084	Ministry of Education, Science, Sports and Culture of Japan [24380115]; Towa Foundation for Food Research; Chulalongkorn University's Graduate scholarship	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Towa Foundation for Food Research; Chulalongkorn University's Graduate scholarship	This work was supported by Grant-in-Aid for Scientific Research (B 24380115) from the Ministry of Education, Science, Sports and Culture of Japan and The Towa Foundation for Food Research. One of the authors KT was supported by the Chulalongkorn University's Graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chenal-Francisque V, 2013, J CLIN MICROBIOL, V51, P1868, DOI 10.1128/JCM.00606-13; Fox E, 2011, INT J FOOD MICROBIOL, V145, pS39, DOI 10.1016/j.ijfoodmicro.2010.10.012; Fox E, 2009, J FOOD PROTECT, V72, P1450, DOI 10.4315/0362-028X-72.7.1450; Gonzalez D, 2013, FOOD MICROBIOL, V36, P374, DOI 10.1016/j.fm.2013.06.023; Guillet C, 2010, EMERG INFECT DIS, V16, P136, DOI 10.3201/eid1601.091155; Jadhav S, 2012, J MICROBIOL METH, V88, P327, DOI 10.1016/j.mimet.2012.01.002; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keys C, 2005, J APPL MICROBIOL, V98, P928, DOI 10.1111/j.1365-2672.2004.02532.x; Kimura B, 2008, J MICROBIOL METH, V72, P313, DOI 10.1016/j.mimet.2007.12.014; Larsson JT, 2009, EURO SURVEILL, V14; Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; Miya S, 2008, INT J FOOD MICROBIOL, V124, P239, DOI 10.1016/j.ijfoodmicro.2008.03.023; Miya S, 2012, J MICROBIOL METH, V90, P285, DOI 10.1016/j.mimet.2012.05.023; Miya S, 2010, APPL ENVIRON MICROB, V76, P3383, DOI 10.1128/AEM.01456-09; Ochiai Y, 2010, J FOOD PROTECT, V73, P1688, DOI 10.4315/0362-028X-73.9.1688; Oliveira M, 2011, FOOD MICROBIOL, V28, P590, DOI 10.1016/j.fm.2010.11.004; Sauders BD, 2012, APPL ENVIRON MICROB, V78, P4420, DOI 10.1128/AEM.00282-12; Suwimon Keeratipibul, 2012, Food Control, V27, P64; Swaminathan B., 2001, FOOD MICROBIOLOGY FU, P383; Thimothe J, 2004, J FOOD PROTECT, V67, P328, DOI 10.4315/0362-028X-67.2.328; Vongkamjan K, 2012, APPL ENVIRON MICROB, V78, P8666, DOI 10.1128/AEM.01859-12; Williams SK, 2011, J FOOD PROTECT, V74, P63, DOI 10.4315/0362-028X.JFP-10-097	23	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e105803	10.1371/journal.pone.0105803	http://dx.doi.org/10.1371/journal.pone.0105803			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198191	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700018
J	Wortham, M; Guo, CC; Zhang, M; Song, LY; Lee, BK; Iyer, VR; Furey, TS; Crawford, GE; Yan, H; He, YP				Wortham, Matthew; Guo, Changcun; Zhang, Monica; Song, Lingyun; Lee, Bum-Kyu; Iyer, Vishwanath R.; Furey, Terrence S.; Crawford, Gregory E.; Yan, Hai; He, Yiping			Chromatin Accessibility Mapping Identifies Mediators of Basal Transcription and Retinoid-Induced Repression of OTX2 in Medulloblastoma	PLOS ONE			English	Article							PHOTORECEPTOR CELL FATE; REGULATORY ELEMENTS; GENE-EXPRESSION; ANTERIOR NEUROECTODERM; HUMAN GENOME; CYCLE GENES; REVEALS; SITES; ACID; DIFFERENTIATION	Despite an emerging understanding of the genetic alterations giving rise to various tumors, the mechanisms whereby most oncogenes are overexpressed remain unclear. Here we have utilized an integrated approach of genomewide regulatory element mapping via DNase-seq followed by conventional reporter assays and transcription factor binding site discovery to characterize the transcriptional regulation of the medulloblastoma oncogene Orthodenticle Homeobox 2 (OTX2). Through these studies we have revealed that OTX2 is differentially regulated in medulloblastoma at the level of chromatin accessibility, which is in part mediated by DNA methylation. In cell lines exhibiting chromatin accessibility of OTX2 regulatory regions, we found that autoregulation maintains OTX2 expression. Comparison of medulloblastoma regulatory elements with those of the developing brain reveals that these tumors engage a developmental regulatory program to drive OTX2 transcription. Finally, we have identified a transcriptional regulatory element mediating retinoid-induced OTX2 repression in these tumors. This work characterizes for the first time the mechanisms of OTX2 overexpression in medulloblastoma. Furthermore, this study establishes proof of principle for applying ENCODE datasets towards the characterization of upstream trans-acting factors mediating expression of individual genes.	[Wortham, Matthew; Guo, Changcun; Zhang, Monica; Yan, Hai; He, Yiping] Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Wortham, Matthew; Guo, Changcun; Zhang, Monica; Yan, Hai; He, Yiping] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC USA; [Song, Lingyun; Crawford, Gregory E.] Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC USA; [Lee, Bum-Kyu; Iyer, Vishwanath R.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Furey, Terrence S.] Univ N Carolina, Dept Biol, Dept Genet, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Furey, Terrence S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Crawford, Gregory E.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA	Duke University; Duke University; Duke University; University of Texas System; University of Texas Austin; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Yan, H (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA.	hai.yan@dm.duke.edu; yiping.he@duke.edu	song, ling/GQZ-5934-2022	Lee, Bum Kyu/0000-0001-7835-419X; Furey, Terry/0000-0001-5546-9672	National Institutes of Health [R01CA118822, U54HG004563, R01CA130075]; Pediatric Brain Tumor Foundation; American Association for Cancer Research-Aflac; Cancer Prevention and Research Institute of Texas [RP120194]; NATIONAL CANCER INSTITUTE [R01CA118822, P30CA014236, R01CA130075] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; American Association for Cancer Research-Aflac; Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health (www.nih.gov) grants R01CA118822 to H.Y., U54HG004563 to G. E. C., and R01CA130075 to V.R.I., the Pediatric Brain Tumor Foundation (www.curethekids.org) for H.Y. and Y.H., the American Association for Cancer Research-Aflac (www.aacr.org) Career Development Award for Pediatric Cancer Research to Y.H., and the Cancer Prevention and Research Institute of Texas (www.cprit.state.tx.us) grant RP120194 to V.R.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331; Bai RY, 2010, NEURO-ONCOLOGY, V12, P655, DOI 10.1093/neuonc/nop062; Boon K, 2005, CANCER RES, V65, P703; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bunt J, 2012, INT J CANCER, V131, pE21, DOI 10.1002/ijc.26474; Bunt J, 2010, MOL CANCER RES, V8, P1344, DOI 10.1158/1541-7786.MCR-09-0546; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Di CH, 2005, CANCER RES, V65, P919; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emerson MM, 2011, DEV BIOL, V360, P241, DOI 10.1016/j.ydbio.2011.09.012; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fossat N, 2005, DEV DYNAM, V233, P154, DOI 10.1002/dvdy.20287; Fossat N, 2006, EMBO REP, V7, P824, DOI 10.1038/sj.embor.7400751; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Gheldof N, 2010, NUCLEIC ACIDS RES, V38, P4325, DOI 10.1093/nar/gkq175; Haeussler M, 2011, DEV BIOL, V350, P239, DOI 10.1016/j.ydbio.2010.11.026; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Inoue F, 2012, MOL CELL BIOL, V32, P2618, DOI 10.1128/MCB.00083-12; Jia SJ, 2009, DEV BIOL, V333, P273, DOI 10.1016/j.ydbio.2009.06.037; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Kimura-Yoshida C, 2004, DEVELOPMENT, V131, P57, DOI 10.1242/dev.00877; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Kurokawa D, 2004, DEVELOPMENT, V131, P3319, DOI 10.1242/dev.01220; Kurokawa D, 2004, DEVELOPMENT, V131, P3307, DOI 10.1242/dev.01219; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sato T, 2009, DEVELOPMENT, V136, P3617, DOI 10.1242/dev.041210; Schumacher A, 1996, NATURE, V384, P648, DOI 10.1038/384648a0; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SIMEONE A, 1995, MECH DEVELOP, V51, P83, DOI 10.1016/0925-4773(95)96241-M; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Takasaki N, 2007, EMBO J, V26, P1649, DOI 10.1038/sj.emboj.7601619; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wortham M, 2009, CNS CANC MODELS MARK, P1077; Wortham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036211	61	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107156	10.1371/journal.pone.0107156	http://dx.doi.org/10.1371/journal.pone.0107156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198066	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700087
J	Wu, D; Luo, HQ; Zhou, WX; Qian, JM; Li, JN				Wu, Dong; Luo, Han-Qing; Zhou, Wei-Xun; Qian, Jia-Ming; Li, Jing-Nan			The Performance of Three-Sample Qualitative Immunochemical Fecal Test to Detect Colorectal Adenoma and Cancer in Gastrointestinal Outpatients: An Observational Study	PLOS ONE			English	Article							OCCULT BLOOD-TESTS; COST-EFFECTIVENESS; AMERICAN-COLLEGE; TASK-FORCE; NEOPLASIA; COLONOSCOPY; POPULATION	Background: Repeated qualitative fecal immunochemical test (qlFIT) is a clinical strategy widely used to detect lower gastrointestinal lesions, but its diagnostic power has not been assessed in opportunistic screening for colorectal neoplasia. Objective: This study aimed to determine the performance of three-sample qlFIT in screening for colorectal cancer and its precursors in high-risk participants. Methods: 513 gastrointestinal outpatients yielded three qlFITs before a standard colonoscopy. We evaluated the diagnostic value of one, two, and three positive qlFITs serving as the positivity threshold. The risk factors of colorectal neoplasia to yield positive qlFITs were also determined. Results: 52 patients were diagnosed with colorectal cancer and 70 with advanced adenomatous polyp. For colorectal cancer, the sensitivity and specificity of one positive qlFIT were 90.4% and 53.8%, of two were 80.8% and 75.1%, and of three were 53.9% and 88.5%, respectively. For advanced adenomatous polyp, the sensitivity and specificity of one positive qlFIT were 81.4% and 54.2%, of two were 50.0% and 72.5%, and of three were 28.6% and 86.2%. Left-sided location (OR 2.50, 95%CI 1.26-4.95) and advanced histology of tumors (OR 3.08, 95%CI 1.58-6.01) were independently associated with positive qlFITs. Conclusions: Three-sample qlFIT is a reasonably good method to detect colorectal neoplasia in high-risk population. Tumors in the left side or with advanced pathological features are more likely to produce positive qlFITs.	[Wu, Dong; Luo, Han-Qing; Qian, Jia-Ming; Li, Jing-Nan] Chinese Acad Med Sci, Dept Gastroenterol, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhou, Wei-Xun] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Li, JN (corresponding author), Chinese Acad Med Sci, Dept Gastroenterol, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China.	lijn2008@126.com	Wu, Dong/AAT-8892-2021; Wu, Dong/GQZ-7113-2022	Wu, Dong/0000-0001-9430-9874; Wu, Dong/0000-0001-9430-9874	Beijing Municipal Government, China [2011-4001-01]	Beijing Municipal Government, China	The special funding of capital health research and development, No. 2011-4001-01, Beijing Municipal Government, China, funded this study. The website was www.bjhbkj.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Chen WQ, 2013, CHIN J CANCER, V32, P106, DOI 10.5732/cjc.013.10018; Chiang TH, 2011, CAN MED ASSOC J, V183, P1474, DOI 10.1503/cmaj.101248; de Wijkerslooth TR, 2012, AM J GASTROENTEROL, V107, P1570, DOI 10.1038/ajg.2012.249; Deng Shang-xin, 2010, Zhonghua Yi Xue Za Zhi, V90, P2679; Digby J, 2013, J CLIN PATHOL, V66, P415, DOI 10.1136/jclinpath-2013-201445; Doubeni CA, 2010, ANN FAM MED, V8, P299, DOI 10.1370/afm.1112; Faivre J, 2012, EUR J CANCER, V48, P2969, DOI 10.1016/j.ejca.2012.04.007; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goede SL, 2013, GUT, V62, P727, DOI 10.1136/gutjnl-2011-301917; Haug U, 2011, BRIT J CANCER, V104, P1779, DOI 10.1038/bjc.2011.160; Haug U, 2010, AM J GASTROENTEROL, V105, P682, DOI 10.1038/ajg.2009.668; Hazazi R, 2010, ALIMENT PHARM THER, V31, P523, DOI 10.1111/j.1365-2036.2009.04202.x; Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005; Levi Z, 2007, ANN INTERN MED, V146, P244, DOI 10.7326/0003-4819-146-4-200702200-00003; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lindholm E, 2008, BRIT J SURG, V95, P1029, DOI 10.1002/bjs.6136; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Ou CH, 2013, J DIGEST DIS, V14, P474, DOI 10.1111/1751-2980.12077; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Raginel T, 2013, GASTROENTEROLOGY, V144, P918, DOI 10.1053/j.gastro.2013.01.042; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Rozen P, 2009, ALIMENT PHARM THER, V29, P906, DOI 10.1111/j.1365-2036.2009.03946.x; Senore C, 2013, GUT, V62, P735, DOI 10.1136/gutjnl-2011-301013; Wilschut JA, 2011, GASTROENTEROLOGY, V141, P1648, DOI 10.1053/j.gastro.2011.07.020; Xie WC, 2012, ASIAN PAC J CANCER P, V13, P3911, DOI 10.7314/APJCP.2012.13.8.3911; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	27	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106648	10.1371/journal.pone.0106648	http://dx.doi.org/10.1371/journal.pone.0106648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198288	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700039
J	Gavin, MC; Stepp, JR				Gavin, Michael C.; Stepp, John Richard			Rapoport's Rule Revisited: Geographical Distributions of Human Languages	PLOS ONE			English	Article							SPECIES RICHNESS; LATITUDINAL GRADIENT; LINGUISTIC DIVERSITY; RANGE-SIZE; PATTERNS; SCALE	One of the most well studied ecological patterns is Rapoport's rule, which posits that the geographical extent of species ranges increases at higher latitudes. However, studies to date have been limited in their geographic scope and results have been equivocal. In turn, much debate exists over potential links between Rapoport's rule and latitudinal patterns in species richness. Humans collectively speak nearly 7000 different languages, which are spread unevenly across the globe, with loci in the tropics. Causes of this skewed distribution have received only limited study. We analyze the extent of Rapoport's rule in human languages at a global scale and within each region of the globe separately. We test the relationship between Rapoport's rule and the richness of languages spoken in different regions. We also explore the frequency distribution of language-range sizes. The language-range area distribution is strongly right-skewed, with 87% of languages having range areas less than 10,000 km(2), and only nine languages with range areas over 1,000,000 km(2). At a global scale, language-range extents and areas are positively correlated with latitude. At a global scale and in five of the six regions examined, language-range extent and language-range area are strongly correlated with language richness. Our results point to group boundary formation as a critical mediator of the relationship between Rapoport's rule and diversity patterns. Where strong group boundaries limit range overlap, as is the case with human languages, and range sizes increase with latitude, latitudinal richness gradients may result.	[Gavin, Michael C.] Colorado State Univ, Dept Human Dimens Nat Resources, Ft Collins, CO 80523 USA; Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA	Colorado State University; State University System of Florida; University of Florida	Gavin, MC (corresponding author), Colorado State Univ, Dept Human Dimens Nat Resources, Ft Collins, CO 80523 USA.	michael.gavin@colostate.edu		Stepp, John Richard/0000-0001-9594-9187; Gavin, Michael/0000-0002-2169-4668	International Science and Technology Linkages Fund of the Royal Society of New Zealand; Christensen Fund through grant entitled "Developing a Global GIS Database for Biocultural Diversity"; Christensen Fund through grant entitled "Development and Outreach with GIS to Assess Biocultural Diversity"; National Evolutionary Synthesis Center (NESCent), NSF [EF-0905606]	International Science and Technology Linkages Fund of the Royal Society of New Zealand; Christensen Fund through grant entitled "Developing a Global GIS Database for Biocultural Diversity"; Christensen Fund through grant entitled "Development and Outreach with GIS to Assess Biocultural Diversity"; National Evolutionary Synthesis Center (NESCent), NSF(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this research was provided in part by a grant from the International Science and Technology Linkages Fund of the Royal Society of New Zealand and from The Christensen Fund through grants entitled "Developing a Global GIS Database for Biocultural Diversity" and "Development and Outreach with GIS to Assess Biocultural Diversity." Additional support was provided by the National Evolutionary Synthesis Center (NESCent), NSF #EF-0905606. Institutional support was provided by the Ethnobiology Laboratory and the Land Use and Environmental Change Institute at the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, GUNS GERMS STEEL; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; CAMPBELL L, 2002, EXAMINING FARMING LA, P49; Collard IF, 2002, EVOL ECOL RES, V4, P371; Colwell R., 2011, THEORY ECOLOGY, P309; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Crosby A.W., 1986, ECOLOGICAL IMPERIALI, DOI DOI 10.1017/CBO9780511805554; Currie TE, 2009, P NATL ACAD SCI USA, V106, P7339, DOI 10.1073/pnas.0804698106; Dimmendaal GJ, 2008, LANG LINGUIST COMPAS, V2, P840, DOI 10.1111/j.1749-818x.2008.00085.x; Esri, 2009, ARCGIS 9 2; Foley R. A., 2004, TRACES ANCESTRY STUD, P61; Gaston KJ, 1999, OIKOS, V84, P309, DOI 10.2307/3546727; Gaston KJ, 1998, TRENDS ECOL EVOL, V13, P70, DOI 10.1016/S0169-5347(97)01236-6; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gavin MC, 2013, BIOSCIENCE, V63, P524, DOI 10.1525/bio.2013.63.7.6; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Graves GR, 2005, P NATL ACAD SCI USA, V102, P7871, DOI 10.1073/pnas.0500424102; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Jansen DH, 1967, AM NAT, V101, P233; JULIANO S A, 1983, Coleopterists Bulletin, V37, P232; KRAUSS M, 1992, LANGUAGE, V68, P4, DOI 10.1353/lan.1992.0075; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; MACE R, 1995, P ROY SOC B-BIOL SCI, V261, P117, DOI 10.1098/rspb.1995.0125; Nettle D, 1996, J ANTHROPOL ARCHAEOL, V15, P403, DOI 10.1006/jaar.1996.0015; Nettle D, 2000, ECON DEV CULT CHANGE, V48, P335, DOI 10.1086/452461; Nettle D, 1998, J ANTHROPOL ARCHAEOL, V17, P354, DOI 10.1006/jaar.1998.0328; NETTLE DANIEL, 1999, LINGUISTIC DIVERSITY; Nichols Johanna, 1992, LINGUISTIC DIVERSITY; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; PAGEL MD, 1991, AM NAT, V137, P791, DOI 10.1086/285194; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rangel TFLVB, 2007, AM NAT, V170, P602, DOI 10.1086/521315; Rapoport E. H., 1982, AREOGRAPHY GEOGRAPHI, P269; RENFREW C, 1992, MAN, V27, P445, DOI 10.2307/2803924; Renfrew C, 1998, CAMB ARCHAEOL J, V8, P294, DOI 10.1017/S095977430000189X; Renfrew C, 1991, CAMB ARCHAEOL J, V1, P3, DOI DOI 10.1017/S0959774300000238; Renfrew Cohn, 2002, EXAMINING FARMING LA; ROHDE K, 1993, AM NAT, V142, P1, DOI 10.1086/285526; Rohde Klaus, 1996, Biodiversity Letters, V3, P10, DOI 10.2307/2999704; Ruggiero A, 2007, GLOBAL ECOL BIOGEOGR, V16, P401, DOI 10.1111/j.1466-8238.2006.00303.x; Stepp JR, 2005, MT RES DEV, V25, P223, DOI 10.1659/0276-4741(2005)025[0223:MABD]2.0.CO;2; Stepp JR, 2004, POLICY MATTERS, V13, P267; STEVENS G, 1992, SYSTEMATICS, ECOLOGY, AND THE BIODIVERSITY CRISIS, P40; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Sutherland WJ, 2003, NATURE, V423, P276, DOI 10.1038/nature01607; Taylor PH, 1999, ECOLOGY, V80, P2474, DOI 10.1890/0012-9658(1999)080[2474:CRSRBR]2.0.CO;2; Turner NJ, 2003, HUM ECOL, V31, P439, DOI 10.1023/A:1025023906459; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032	49	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107623	10.1371/journal.pone.0107623	http://dx.doi.org/10.1371/journal.pone.0107623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP0SM	25216049	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300090
J	Rabinovich, S; Powell, RLR; Lindsay, RWB; Yuan, M; Carpov, A; Wilson, A; Lopez, M; Coleman, JW; Wagner, D; Sharma, P; Kemelman, M; Wright, KJ; Seabrook, JP; Arendt, H; Martinez, J; DeStefano, J; Chiuchiolo, MJ; Parks, CL				Rabinovich, Svetlana; Powell, Rebecca L. R.; Lindsay, Ross W. B.; Yuan, Maoli; Carpov, Alexei; Wilson, Aaron; Lopez, Mary; Coleman, John W.; Wagner, Denise; Sharma, Palka; Kemelman, Marina; Wright, Kevin J.; Seabrook, John P.; Arendt, Heather; Martinez, Jennifer; DeStefano, Joanne; Chiuchiolo, Maria J.; Parks, Christopher L.			A Novel, Live-Attenuated Vesicular Stomatitis Virus Vector Displaying Conformationally Intact, Functional HIV-1 Envelope Trimers That Elicits Potent Cellular and Humoral Responses in Mice	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; PROVIDES COMPLETE PROTECTION; BOOST VACCINE REGIMEN; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; ENV TRIMERS; CODON USAGE; TYPE-1 ENV; GENE TRANSLOCATIONS	Though vaccination with live-attenuated SIV provides the greatest protection from progressive disease caused by SIV challenge in rhesus macaques, attenuated HIV presents safety concerns as a vaccine; therefore, live viral vectors carrying HIV immunogens must be considered. We have designed a replication-competent vesicular stomatitis virus (VSV) displaying immunogenic HIV-1 Env trimers and attenuating quantities of the native surface glycoprotein (G). The clade B Env immunogen is an Env-VSV G hybrid (EnvG) in which the transmembrane and cytoplasmic tail regions are derived from G. Relocation of the G gene to the 5'terminus of the genome and insertion of EnvG into the natural G position induced a similar to 1 log reduction in surface G, significant growth attenuation compared to wild-type, and incorporation of abundant EnvG. Western blot analysis indicated that similar to 75% of incorporated EnvG was a mature proteolytically processed form. Flow cytometry showed that surface EnvG bound various conformationally- and trimer-specific antibodies (Abs), and in-vitro growth assays on CD4+CCR5+ cells demonstrated EnvG functionality. Neither intranasal (IN) or intramuscular (IM) administration in mice induced any observable pathology and all regimens tested generated potent Env-specific ELISA titers of 10(4)-10(5), with an IM VSV prime/IN VSV boost regimen eliciting the highest binding and neutralizing Ab titers. Significant quantities of Env-specific CD4+ T cells were also detected, which were augmented as much as 70-fold by priming with IM electroporated plasmids encoding EnvG and IL-12. These data suggest that our novel vector can achieve balanced safety and immunogenicity and should be considered as an HIV vaccine platform.	[Rabinovich, Svetlana; Powell, Rebecca L. R.; Lindsay, Ross W. B.; Yuan, Maoli; Carpov, Alexei; Wilson, Aaron; Lopez, Mary; Coleman, John W.; Wagner, Denise; Sharma, Palka; Kemelman, Marina; Wright, Kevin J.; Seabrook, John P.; Arendt, Heather; Martinez, Jennifer; DeStefano, Joanne; Chiuchiolo, Maria J.; Parks, Christopher L.] Int AIDS Vaccine Initiat, Design & Dev Lab, Brooklyn, NY USA; [Rabinovich, Svetlana; Chiuchiolo, Maria J.; Parks, Christopher L.] Suny Downstate Med Ctr, Sch Grad Studies, Mol & Cellular Biol Program, Brooklyn, NY USA	International AIDS Vaccine Initiative; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Powell, RLR (corresponding author), Int AIDS Vaccine Initiat, Design & Dev Lab, Brooklyn, NY USA.	RPowell@iavi.org			Bill and Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); National Institute of Allergy and Infectious Diseases [R01AI084840]; The Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084840] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); The Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	IAVI's work is made possible by generous support from many donors including: the Bill and Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. Award Number R01AI084840 from the National Institute of Allergy and Infectious Diseases and The Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) supported this research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; [Anonymous], 2012, IAVI INS POL BRIEF, V29; Ball LA, 1999, J VIROL, V73, P4705, DOI 10.1128/JVI.73.6.4705-4712.1999; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bogard E, 2002, J ACQ IMMUN DEF SYND, V29, P132, DOI 10.1097/00042560-200202010-00004; BOVARNICK MR, 1950, J BACTERIOL, V59, P509, DOI 10.1128/JB.59.4.509-522.1950; Brown D, 2002, INT J MED MICROBIOL, V291, P433; CHEN SSL, 1991, INTERVIROLOGY, V32, P193, DOI 10.1159/000150199; Clarke DK, 2007, J VIROL, V81, P2056, DOI 10.1128/JVI.01911-06; Clarke DK, 2006, SPRINGER SEMIN IMMUN, V28, P239, DOI 10.1007/s00281-006-0042-3; Coleman JW, 2007, J VIROL METHODS, V143, P55, DOI 10.1016/j.jviromet.2007.02.007; Cooper D, 2008, J VIROL, V82, P207, DOI 10.1128/JVI.01515-07; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doan LX, 2005, REV MED VIROL, V15, P75, DOI 10.1002/rmv.449; DOMS RW, 1988, J CELL BIOL, V107, P89, DOI 10.1083/jcb.107.1.89; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Egan MA, 2005, AIDS RES HUM RETROV, V21, P629, DOI 10.1089/aid.2005.21.629; Egan MA, 2004, AIDS RES HUM RETROV, V20, P989, DOI 10.1089/aid.2004.20.989; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; FIELDS BN, 1967, NEW ENGL J MED, V277, P889, DOI 10.1056/NEJM196711092771901; Flanagan EB, 2000, J VIROL, V74, P7895, DOI 10.1128/JVI.74.17.7895-7902.2000; Flanagan EB, 2003, J VIROL, V77, P5740, DOI 10.1128/JVI.77.10.5740-5748.2003; GALLIONE CJ, 1983, J VIROL, V46, P162, DOI 10.1128/JVI.46.1.162-169.1983; Gherardi MM, 2000, J VIROL, V74, P6278, DOI 10.1128/JVI.74.14.6278-6286.2000; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hastie E, 2013, VIRUS RES, V176, P16, DOI 10.1016/j.virusres.2013.06.003; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; IVERSON LE, 1981, CELL, V23, P477, DOI 10.1016/0092-8674(81)90143-4; Jalah R, 2013, J BIOL CHEM, V288, P6763, DOI 10.1074/jbc.M112.436675; Johnson JE, 2007, VIROLOGY, V360, P36, DOI 10.1016/j.virol.2006.10.026; Johnson JE, 2009, VACCINE, V27, P2930, DOI 10.1016/j.vaccine.2009.03.006; Johnson JE, 1997, J VIROL, V71, P5060, DOI 10.1128/JVI.71.7.5060-5068.1997; Johnson JE, 1998, VIROLOGY, V251, P244, DOI 10.1006/viro.1998.9429; Johnson RP, 1998, CURR OPIN IMMUNOL, V10, P436, DOI 10.1016/S0952-7915(98)80118-0; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; Lasarte JJ, 1999, J IMMUNOL, V162, P5270; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Lee K, 2000, J INTERF CYTOK RES, V20, P589; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Loret S, 2012, CYTOM PART A, V81A, P950, DOI 10.1002/cyto.a.22107; Maloy KJ, 2000, J EXP MED, V191, P2159, DOI 10.1084/jem.191.12.2159; McCluskie MJ, 2002, FEMS IMMUNOL MED MIC, V32, P179, DOI 10.1016/S0928-8244(01)00305-4; MOORE JP, 1994, J VIROL, V68, P8350, DOI 10.1128/JVI.68.12.8350-8364.1994; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Natuk RJ, 2006, J VIROL, V80, P4447, DOI 10.1128/JVI.80.9.4447-4457.2006; Olitsky PK, 1936, J EXP MED, V64, P723, DOI 10.1084/jem.64.5.723; OWENS RJ, 1993, J VIROL, V67, P360, DOI 10.1128/JVI.67.1.360-365.1993; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Parks CL, 2013, CURR OPIN HIV AIDS, V8, P402, DOI 10.1097/COH.0b013e328363d389; Parks CL, 2006, HIV VACC KEYST S KEY; Parren PWHI, 1998, J VIROL, V72, P10270, DOI 10.1128/JVI.72.12.10270-10274.1998; PESSIN JE, 1980, J BIOL CHEM, V255, P9044; PLOTKIN SA, 2004, VACCINES; Publicover J, 2005, J VIROL, V79, P13231, DOI 10.1128/JVI.79.21.13231-13238.2005; Publicover J, 2004, J VIROL, V78, P9317, DOI 10.1128/JVI.78.17.9317-9324.2004; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; REIF JS, 1987, AM J TROP MED HYG, V36, P177, DOI 10.4269/ajtmh.1987.36.177; Reuter JD, 2002, J VIROL, V76, P8900, DOI 10.1128/JVI.76.17.8900-8909.2002; Richman Douglas D, 2004, Trans Am Clin Climatol Assoc, V115, P289; Roberts A, 1998, J VIROL, V72, P4704, DOI 10.1128/JVI.72.6.4704-4711.1998; Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; ROOST HP, 1995, P NATL ACAD SCI USA, V92, P1257, DOI 10.1073/pnas.92.5.1257; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; ROSE JK, 1981, J VIROL, V39, P519, DOI 10.1128/JVI.39.2.519-528.1981; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; Rose NF, 2000, J VIROL, V74, P10903, DOI 10.1128/JVI.74.23.10903-10910.2000; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; Schell J, 2009, VACCINE, V27, P979, DOI 10.1016/j.vaccine.2008.12.017; Schnell MJ, 1998, EMBO J, V17, P1289, DOI 10.1093/emboj/17.5.1289; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Tong T, 2012, J VIROL, V86, P3574, DOI 10.1128/JVI.06938-11; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Turner PE, 2000, GENETICS, V156, P1465; Ugozzoli M, 2011, ANAL BIOCHEM, V418, P224, DOI 10.1016/j.ab.2011.07.012; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watson J C, 1998, MMWR Recomm Rep, V47, P1; WEBB PA, 1987, AM J TROP MED HYG, V36, P183, DOI 10.4269/ajtmh.1987.36.183; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0; Wertz GW, 1998, P NATL ACAD SCI USA, V95, P3501, DOI 10.1073/pnas.95.7.3501; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11; Witko SE, 2006, J VIROL METHODS, V135, P91, DOI 10.1016/j.jviromet.2006.02.006; Xu R, 2008, VACCINE, V26, P4819, DOI 10.1016/j.vaccine.2008.06.103; ZAVADA J, 1982, J GEN VIROL, V63, P15, DOI 10.1099/0022-1317-63-1-15; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	104	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106597	10.1371/journal.pone.0106597	http://dx.doi.org/10.1371/journal.pone.0106597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215861	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300017
J	Li, BR; Ding, LH; Yang, CR; Kang, BL; Liu, L; Story, MD; Pace, BS				Li, Biaoru; Ding, Lianghao; Yang, Chinrang; Kang, Baolin; Liu, Li; Story, Michael D.; Pace, Betty S.			Characterization of Transcription Factor Networks Involved in Umbilical Cord Blood CD34(+) Stem Cells-Derived Erythropoiesis	PLOS ONE			English	Article							GLOBIN GENE-EXPRESSION; FETAL-HEMOGLOBIN INDUCTION; PRIMARY ERYTHROID-CELLS; HUMAN GAMMA-GLOBIN; DIFFERENTIATION; BCL11A; DISEASE; TRANSPLANTATION; KLF1; IDENTIFICATION	Fetal stem cells isolated from umbilical cord blood (UCB) possess a great capacity for proliferation and differentiation and serve as a valuable model system to study gene regulation. Expanded knowledge of the molecular control of hemoglobin synthesis will provide a basis for rational design of therapies for beta-hemoglobinopathies. Transcriptome data are available for erythroid progenitors derived from adult stem cells, however studies to define molecular mechanisms controlling globin gene regulation during fetal erythropoiesis are limited. Here, we utilize UCB-CD34(+) stem cells induced to undergo erythroid differentiation to characterize the transcriptome and transcription factor networks (TFNs) associated with the gamma/beta-globin switch during fetal erythropoiesis. UCB-CD34(+) stem cells grown in the one-phase liquid culture system displayed a higher proliferative capacity than adult CD34(+) stem cells. The gamma/beta-globin switch was observed after day 42 during fetal erythropoiesis in contrast to adult progenitors where the switch occurred around day 21. To gain insights into transcription factors involved in globin gene regulation, microarray analysis was performed on RNA isolated from UCB-CD34(+) cell-derived erythroid progenitors harvested on day 21, 42, 49 and 56 using the HumanHT-12 Expression BeadChip. After data normalization, Gene Set Enrichment Analysis identified transcription factors (TFs) with significant changes in expression during the gamma/beta-globin switch. Forty-five TFs were silenced by day 56 (Profile-1) and 30 TFs were activated by day 56 (Profile-2). Both GSEA datasets were analyzed using the MIMI Cytoscape platform, which discovered TFNs centered on KLF4 and GATA2 (Profile-1) and KLF1 and GATA1 for Profile-2 genes. Subsequent shRNA studies in KU812 leukemia cells and human erythroid progenitors generated from UCB-CD34(+) cells supported a negative role of MAFB in gamma-globin regulation. The characteristics of erythroblasts derived from UCB-CD34(+) stem cells including prolonged gamma-globin expression combined with unique TFNs support novel mechanisms controlling the gamma/beta-globin switch during UCB-derived erythropoiesis.	[Li, Biaoru; Kang, Baolin; Pace, Betty S.] Georgia Regents Univ, Dept Pediat, Div Hematol Oncol, Augusta, GA 30901 USA; [Ding, Lianghao; Yang, Chinrang; Story, Michael D.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Ding, Lianghao; Yang, Chinrang; Story, Michael D.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Liu, Li] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA	University System of Georgia; Augusta University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas	Pace, BS (corresponding author), Georgia Regents Univ, Dept Pediat, Div Hematol Oncol, Augusta, GA 30901 USA.	bpace@gru.edu	Story, Michael/AAX-2864-2021	Story, Michael/0000-0001-6522-4169; Li, Biaoru/0000-0002-5626-9557; Pace, Betty/0000-0002-1275-4112	National Heart Lung Blood Institute [HL069234]; National Cancer Institute [1P30 CA142543]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069234] Funding Source: NIH RePORTER	National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the following: National Heart Lung Blood Institute - HL069234 (BSP) and National Cancer Institute - 1P30 CA142543 (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2014, BLOOD, V123, P3466, DOI 10.1182/blood-2014-01-548305; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bolanos-Meade J, 2009, CURR OPIN ONCOL, V21, P158, DOI 10.1097/CCO.0b013e328324ba04; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Brognara E, 2011, EUR J PHARMACOL, V672, P30, DOI 10.1016/j.ejphar.2011.09.024; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Ding LH, 2008, NUCLEIC ACIDS RES, V36, P1; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Fibach E, 2005, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.im22f07s69, DOI 10.1002/0471142735.IM22F07S69]; FISCHKOFF SA, 1987, LEUKEMIA RES, V11, P1105, DOI 10.1016/0145-2126(87)90164-0; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gekas C, 2010, INT J DEV BIOL, V54, P1089, DOI 10.1387/ijdb.103070cg; He YY, 2011, PEDIATR HEMAT ONCOL, V28, P708, DOI 10.3109/08880018.2011.616573; Hung HL, 2001, J BIOL CHEM, V276, P10715, DOI 10.1074/jbc.M007846200; Kalra IS, 2011, BRIT J HAEMATOL, V154, P248, DOI 10.1111/j.1365-2141.2011.08710.x; Keefer JR, 2006, EXP HEMATOL, V34, P1151, DOI 10.1016/j.exphem.2006.03.018; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kim A, 2007, NUCLEIC ACIDS RES, V35, P5831, DOI 10.1093/nar/gkm620; Kindwall-Keller TL, 2012, BONE MARROW TRANSPL, V47, P924, DOI 10.1038/bmt.2011.195; Landry JR, 2008, BLOOD, V111, P3005, DOI 10.1182/blood-2007-07-098830; Li BR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-153; Liu PC, 2011, PHYSIOL GENOMICS, V43, P1117, DOI 10.1152/physiolgenomics.00099.2011; Mankidy R, 2006, BLOOD, V108, P3179, DOI 10.1182/blood-2005-12-010934; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Peller S, 2009, BLOOD CELL MOL DIS, V43, P74, DOI 10.1016/j.bcmd.2009.01.020; PETERSON KR, 1993, MOL CELL BIOL, V13, P4836, DOI 10.1128/MCB.13.8.4836; Pierik A, 2012, LAB CHIP, V12, P1897, DOI 10.1039/c2lc20740k; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Ramakrishnan V, 2011, BLOOD CELL MOL DIS, V47, P12, DOI 10.1016/j.bcmd.2011.03.003; Ramanathan P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-197; Robert A, 2012, METHODS MOL BIOL, V788, P219, DOI 10.1007/978-1-61779-307-3_16; Ruggeri A, 2011, BIOL BLOOD MARROW TR, V17, P1375, DOI 10.1016/j.bbmt.2011.01.012; Sangerman J, 2006, BLOOD, V108, P3590, DOI 10.1182/blood-2006-01-023713; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Satoh Y, 2004, J BIOL CHEM, V279, P24986, DOI 10.1074/jbc.M400407200; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Sieweke Michael H., 1997, Leukemia (Basingstoke), V11, P486; Stamatoyannopoulos G, 1990, ANN N Y ACAD SCI, V612, P127; Stamatoyannopoulos G., 2001, MOL BASIS BLOOD DIS, Vthird, P135; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Zein S, 2010, EXP BIOL MED, V235, P1385, DOI 10.1258/ebm.2010.010129; Zhang P, 2005, BLOOD CELL MOL DIS, V35, P227, DOI 10.1016/j.bcmd.2005.04.009; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	51	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107133	10.1371/journal.pone.0107133	http://dx.doi.org/10.1371/journal.pone.0107133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211130	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900046
J	Sedegah, M; Hollingdale, MR; Farooq, F; Ganeshan, H; Belmonte, M; Kim, Y; Peters, B; Sette, A; Huang, J; McGrath, S; Abot, E; Limbach, K; Shi, M; Soisson, L; Diggs, C; Chuang, I; Tamminga, C; Epstein, JE; Villasante, E; Richie, TL				Sedegah, Martha; Hollingdale, Michael R.; Farooq, Fouzia; Ganeshan, Harini; Belmonte, Maria; Kim, Yohan; Peters, Bjoern; Sette, Alessandro; Huang, Jun; McGrath, Shannon; Abot, Esteban; Limbach, Keith; Shi, Meng; Soisson, Lorraine; Diggs, Carter; Chuang, Ilin; Tamminga, Cindy; Epstein, Judith E.; Villasante, Eileen; Richie, Thomas L.			Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes	PLOS ONE			English	Article							CD8(+) T-CELLS; APICAL MEMBRANE ANTIGEN-1; LIVER STAGES; VACCINE; RESPONSES; PROTECTION; IMMUNOGENICITY; PROTEIN; CANDIDATE; SAFETY	Background: Fifteen volunteers were immunized with three doses of plasmid DNA encoding P. falciparum circumsporozoite protein (CSP) and apical membrane antigen-1 (AMA1) and boosted with human adenovirus-5 (Ad) expressing the same antigens (DNA/Ad). Four volunteers (27%) demonstrated sterile immunity to controlled human malaria infection and, overall, protection was statistically significantly associated with ELISpot and CD8+ T cell IFN-gamma activities to AMA1 but not CSP. DNA priming was required for protection, as 18 additional subjects immunized with Ad alone (AdCA) did not develop sterile protection. Methodology/Principal Findings: We sought to identify correlates of protection, recognizing that DNA-priming may induce different responses than AdCA alone. Among protected volunteers, two and three had higher ELISpot and CD8+ T cell IFN-gamma responses to CSP and AMA1, respectively, than non-protected volunteers. Unexpectedly, non-protected volunteers in the AdCA trial showed ELISpot and CD8+ T cell IFN-gamma responses to AMA1 equal to or higher than the protected volunteers. T cell functionality assessed by intracellular cytokine staining for IFN-gamma, TNF-alpha and IL-2 likewise did not distinguish protected from non-protected volunteers across both trials. However, three of the four protected volunteers showed higher effector to central memory CD8+ T cell ratios to AMA1, and one of these to CSP, than non-protected volunteers for both antigens. These responses were focused on discrete regions of CSP and AMA1. Class I epitopes restricted by A*03 or B*58 supertypes within these regions of AMA1 strongly recalled responses in three of four protected volunteers. We hypothesize that vaccine-induced effector memory CD8+ T cells recognizing a single class I epitope can confer sterile immunity to P. falciparum in humans. Conclusions/Significance: We suggest that better understanding of which epitopes within malaria antigens can confer sterile immunity and design of vaccine approaches that elicit responses to these epitopes will increase the potency of next generation gene-based vaccines.	[Sedegah, Martha; Hollingdale, Michael R.; Farooq, Fouzia; Ganeshan, Harini; Belmonte, Maria; Huang, Jun; McGrath, Shannon; Abot, Esteban; Limbach, Keith; Chuang, Ilin; Tamminga, Cindy; Epstein, Judith E.; Villasante, Eileen; Richie, Thomas L.] Naval Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD 20910 USA; [Kim, Yohan; Peters, Bjoern; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Shi, Meng] Walter Reed Army Inst Res, Div Med Audio Visual Lib & Stat Serv, Silver Spring, MD USA; [Soisson, Lorraine; Diggs, Carter] USAID, Washington, DC USA	Naval Medical Research Center (NMRC); La Jolla Institute for Immunology; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Agency for International Development (USAID)	Sedegah, M (corresponding author), Naval Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD 20910 USA.	Martha.Sedegah@med.navy.mil	Sette, Alessandro/AFO-8916-2022	Richie, Thomas/0000-0002-2946-5456; Farooq, Fouzia/0000-0001-6491-6323	USAID [GHA-P-00-03-00006-01, 936-3118]; Congressionally Directed Medical Research Program [W81XWH-05-2-0041]; Military Infectious Research Program [62787A 870 F 1432]	USAID(United States Agency for International Development (USAID)); Congressionally Directed Medical Research Program(United States Department of Defense); Military Infectious Research Program	This work was supported by USAID "Development of Adenovirus-Vectored Malaria Vaccines'' Grant # GHA-P-00-03-00006-01, Project Number 936-3118; and the Congressionally Directed Medical Research Program "Development of Recombinant Adenoviral-based Vaccines against Malaria'' Grant # W81XWH-05-2-0041. Website https://cdmrp.org; Military Infectious Research Program "Phase 1/2a clinical trials assessing the safety, tolerability, immunogenicity & protective efficacy of Ad5-CA, a two-antigen, adenovirus-vectored Plasmodium falciparum malaria vaccine, in healthy, malaria-naive adults work unit number 62787A 870 F 1432. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bejon P, 2006, VACCINE, V24, P4709, DOI 10.1016/j.vaccine.2006.03.029; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Cockburn IA, 2008, J IMMUNOL, V180, P64, DOI 10.4049/jimmunol.180.1.64; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; De Rosa SC, 2011, J IMMUNOL, V187, P3391, DOI 10.4049/jimmunol.1101421; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Epstein JE, 2011, SCIENCE; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Hafalla JCR, 2003, J IMMUNOL, V171, P964, DOI 10.4049/jimmunol.171.2.964; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; HOFFMAN SL, 1990, IMMUNOL LETT, V25, P33, DOI 10.1016/0165-2478(90)90087-7; Huaman MC, 2009, VACCINE, V27, P5239, DOI 10.1016/j.vaccine.2009.06.066; Jiang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006559; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kirman JR, 2003, CURR OPIN IMMUNOL, V15, P471, DOI 10.1016/S0952-7915(03)00068-2; Krzych U, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00370; Lumsden JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020775; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Bouillet LEM, 2011, INFECT IMMUN, V79, P3642, DOI 10.1128/IAI.05048-11; Miao J, 2006, VACCINE, V24, P6187, DOI 10.1016/j.vaccine.2006.05.099; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NUSSENZWEIG V, 1985, CELL, V42, P401, DOI 10.1016/0092-8674(85)90093-5; Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Penaloza-MacMaster P, 2013, J VIROL, V87, P1373, DOI 10.1128/JVI.02058-12; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Porter DW, 2011, VACCINE, V29, P7514, DOI 10.1016/j.vaccine.2011.03.083; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Quinn KM, 2013, J IMMUNOL, V190, P2720, DOI 10.4049/jimmunol.1202861; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; Sedegah M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-185; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sedegah M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-241; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Steffensen MA, 2013, J VIROL, V87, P6283, DOI 10.1128/JVI.00465-13; Tamminga C, 2013, HUM VACC IMMUNOTHER, V9, P2165, DOI 10.4161/hv.24941; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Tan WG, 2013, J VIROL, V87, P1359, DOI 10.1128/JVI.02055-12; Todryk SM, 2009, IMMUNOLOGY, V128, P83, DOI 10.1111/j.1365-2567.2009.03073.x; Tse SW, 2013, GENES IMMUN, V14, P302, DOI 10.1038/gene.2013.20; Vasconcelos JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00358; Vuola JM, 2005, J IMMUNOL, V174, P449, DOI 10.4049/jimmunol.174.1.449; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1989, J IMMUNOL, V143, P4263; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yang SH, 2006, GENE THER, V13, P1110, DOI 10.1038/sj.gt.3302751	63	48	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106241	10.1371/journal.pone.0106241	http://dx.doi.org/10.1371/journal.pone.0106241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211344	gold, Green Submitted, Green Published			2022-12-27	WOS:000341855900008
J	Qian, ZM; Cheng, XE; Chen, YQ				Qian, Zhi-Ming; Cheng, Xi En; Chen, Yan Qiu			Automatically Detect and Track Multiple Fish Swimming in Shallow Water with Frequent Occlusion	PLOS ONE			English	Article							SYSTEM; QUANTIFICATION	Due to its universality, swarm behavior in nature attracts much attention of scientists from many fields. Fish schools are examples of biological communities that demonstrate swarm behavior. The detection and tracking of fish in a school are of important significance for the quantitative research on swarm behavior. However, different from other biological communities, there are three problems in the detection and tracking of fish school, that is, variable appearances, complex motion and frequent occlusion. To solve these problems, we propose an effective method of fish detection and tracking. In this method, first, the fish head region is positioned through extremum detection and ellipse fitting; second, The Kalman filtering and feature matching are used to track the target in complex motion; finally, according to the feature information obtained by the detection and tracking, the tracking problems caused by frequent occlusion are processed through trajectory linking. We apply this method to track swimming fish school of different densities. The experimental results show that the proposed method is both accurate and reliable.	[Qian, Zhi-Ming; Cheng, Xi En; Chen, Yan Qiu] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China; [Qian, Zhi-Ming] Chuxiong Normal Univ, Chuxiong, Peoples R China	Fudan University; Chuxiong Normal University	Chen, YQ (corresponding author), Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China.	chenyq@fudan.edu.cn			National Natural Science Foundation of China [61175036, 61363023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research work presented in this paper is supported by National Natural Science Foundation of China ( Grant No. 61175036 and No. 61363023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Shalom Y., 1987, TRACKING DATA ASS; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; Bisazza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015516; Butail S, 2012, J R SOC INTERFACE, V9, P77, DOI 10.1098/rsif.2011.0113; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Delcourt J, 2013, FISH FISH, V14, P186, DOI 10.1111/j.1467-2979.2012.00462.x; Delcourt J, 2009, BEHAV RES METHODS, V41, P228, DOI 10.3758/BRM.41.1.228; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; FORTMANN TE, 1983, IEEE J OCEANIC ENG, V8, P173, DOI 10.1109/JOE.1983.1145560; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kato S, 2004, J NEUROSCI METH, V134, P1, DOI 10.1016/j.jneumeth.2003.09.028; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Miller N, 2013, P NATL ACAD SCI USA, V110, P5263, DOI 10.1073/pnas.1217513110; Mussulini BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054515; Otsu N, 1975, AUTOMATICA, V11, P285; Perera A. A., 2006, 2006 IEEE COMPUTER S, V1, P666; Sims DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007351; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; Weissbrod A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3018; Witt MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001111; Wu HS, 2011, OPT EXPRESS, V19, P7646, DOI 10.1364/OE.19.007646; Ylieff MY, 2003, FISH PHYSIOL BIOCHEM, V28, P281, DOI 10.1023/B:FISH.0000030555.92215.08; Yu LL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000014	26	47	49	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106506	10.1371/journal.pone.0106506	http://dx.doi.org/10.1371/journal.pone.0106506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207811	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300024
J	Cao, WL; Yan, WS; Xiang, XH; Chen, K; Xia, SH				Cao, Wei-Li; Yan, Wen-Shan; Xiang, Xiao-Hui; Chen, Kai; Xia, Shi-Hai			Prevention Effect of Allopurinol on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Meta-Analysis of Prospective Randomized Controlled Trials	PLOS ONE			English	Article							ERCP PANCREATITIS; ORAL ALLOPURINOL; XANTHINE-OXIDASE; FREE-RADICALS; PROPHYLAXIS; PATHOGENESIS; GABEXATE	Background: Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP) which can be severe and cause death in approximately 10% of cases. Up to now, six randomized controlled trials (RCTs) have been found relevant to the effect of allopurinol on prevention of Post-ERCP pancreatitis (PEP). However, these results remained controversial. Objective: To conduct a meta-analysis with RCTs published in full text to determine the effectiveness of prophylactic allopurinol of different dosages and administration time in the incidence and severity of PEP. Methods: Literature search was performed in PubMed, Embase, Web of Science and Cochrane Library from databases inception to May 2014. RCTs comparing the effect of allopurinol with placebo on prevention of PEP were included. Statistical heterogeneity was quantitatively evaluated by chi(2) test with the significance set P<0.10 or I-2>50%. Results: Six RCTs consisting of 1974 participants were eventually included. The incidences of PEP in allopurinol group and placebo group were 8.4%(83/986) and 9.9%(98/988) respectively. Meta-analysis showed no evident prevention effect of allopurinol on the incidence of PEP (RR 0.75, 95% CI 0.39-1.42) with significant heterogeneity (I-2 = 70.4%, P = 0.005). When studies were stratified according to the dosages and administration time of allopurinol they applied, there was still no evident prevention effect of allopurinol on mild, moderate or severe PEP. However, statistically substantial heterogeneity was presented in the subgroup of moderate PEP when the effect of high dose of allopurinol was analyzed (I-moderate(2) = 82.3%, P-moderate = 0.018). Statistically significant heterogeneity was also observed in subgroup of mild PEP, when the effect of long adminstration time of allopurinol was investigated (I-mild(2) = 62.8%, P-mild = 0.068). Conclusion: The prophylactic use of allopurinol in different dosages and administration time had no effect in preventing incidence and severity of PEP.	[Cao, Wei-Li; Yan, Wen-Shan; Xia, Shi-Hai] Liaoning Med Univ, Postgrad Training Base, Chinese Peoples Armed Police Forces, Affiliated Hosp,Logist Univ, Jinzhou, Peoples R China; [Cao, Wei-Li; Xiang, Xiao-Hui; Chen, Kai; Xia, Shi-Hai] Chinese Peoples Armed Police Forces, Logist Univ, Affiliated Hosp, Dept Hepatopancreatobiliary & Splen Med, Tianjin, Peoples R China; [Yan, Wen-Shan] Chinese Peoples Armed Police Forces, Logist Univ, Affiliated Hosp, Dept Endem Area Orthoped Ctr Sect 3, Tianjin, Peoples R China	Jinzhou Medical University	Xia, SH (corresponding author), Liaoning Med Univ, Postgrad Training Base, Chinese Peoples Armed Police Forces, Affiliated Hosp,Logist Univ, Jinzhou, Peoples R China.	xiash2014@sina.com	Xiang, Xiaohui/D-8093-2015	Xiang, Xiaohui/0000-0002-5762-5007; Yan, Wen-Shan/0000-0001-8197-0137; Chen, Kai/0000-0001-6844-2671; Xia, Shihai/0000-0002-3748-4841				Abbasinazari Mohammad, 2011, Acta Med Iran, V49, P579; Arata S, 2010, J HEPATO-BIL-PAN SCI, V17, P70, DOI 10.1007/s00534-009-0220-5; Bai Y, 2008, ALIMENT PHARM THER, V28, P557, DOI 10.1111/j.1365-2036.2008.03756.x; Budzynska A, 2001, ENDOSCOPY, V33, P766, DOI 10.1055/s-2001-16520; Cavallini G, 1996, NEW ENGL J MED, V335, P919, DOI 10.1056/NEJM199609263351302; Cheung J, 2009, GASTROINTEST ENDOSC, V70, P1211, DOI 10.1016/j.gie.2009.08.007; Dumonceau JM, 2010, ENDOSCOPY, V42, P503, DOI 10.1055/s-0029-1244208; Fathallah N, 2010, JCR-J CLIN RHEUMATOL, V16, P170, DOI 10.1097/RHU.0b013e3181dfbaf7; Freeman ML, 2004, GASTROINTEST ENDOSC, V59, P845, DOI 10.1016/S0016-5107(04)00353-0; Freeman ML, 2004, GASTROINTEST ENDOSC, V59, P8, DOI 10.1016/S0016-5107(03)02530-6; Guan WP, 2003, J CARDIOVASC PHARM, V41, P699, DOI 10.1097/00005344-200305000-00005; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Katsinelos P, 2005, GASTROINTEST ENDOSC, V61, P407, DOI 10.1016/S0016-5107(04)02647-1; Kountouras J, 2001, HEPATO-GASTROENTEROL, V48, P743; Martinez-Torres H, 2009, WORLD J GASTROENTERO, V15, P1600, DOI 10.3748/wjg.15.1600; Masci E, 2003, AM J GASTROENTEROL, V98, P2182, DOI 10.1016/S0002-9270(03)00704-4; Mosler P, 2005, GASTROINTEST ENDOSC, V62, P245, DOI 10.1016/S0016-5107(05)01572-5; NORDBACK IH, 1993, SURGERY, V113, P90; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Romagnuolo J, 2008, CLIN GASTROENTEROL H, V6, P465, DOI 10.1016/j.cgh.2007.12.032; SANFEY H, 1985, ANN SURG, V201, P633, DOI 10.1097/00000658-198505000-00013; SANFEY H, 1984, SURGERY, V96, P485; SANFEY H, 1984, ANN SURG, V200, P405, DOI 10.1097/00000658-198410000-00003; Sofuni A, 2007, CLIN GASTROENTEROL H, V5, P1339, DOI 10.1016/j.cgh.2007.07.008; Zheng MH, 2008, PANCREAS, V37, P247, DOI 10.1097/MPA.0b013e31816857e3	25	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107350	10.1371/journal.pone.0107350	http://dx.doi.org/10.1371/journal.pone.0107350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202907	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500088
J	Michie, KA; Boysen, A; Low, HH; Moller-Jensen, J; Lowe, J				Michie, Katharine A.; Boysen, Anders; Low, Harry H.; Moller-Jensen, Jakob; Loewe, Jan			LeoA, B and C from Enterotoxigenic Escherichia coli (ETEC) Are Bacterial Dynamins	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; CRYSTAL-STRUCTURE; CHROMOSOMAL GENES; PROTEIN; OLIGOMERIZATION; REFINEMENT; SECRETION; SOFTWARE; DOMAIN; MODEL	Escherichia coli (ETEC) strain H10407 contains a GTPase virulence factor, LeoA, which is encoded on a pathogenicity island and has been shown to enhance toxin release, potentially through vesicle secretion. By sequence comparisons and X-ray structure determination we now identify LeoA as a bacterial dynamin-like protein (DLP). Proteins of the dynamin family remodel membranes and were once thought to be restricted to eukaryotes. In ETEC H10407 LeoA localises to the periplasm where it forms a punctate localisation pattern. Bioinformatic analyses of leoA and the two upstream genes leoB and leoC suggest that LeoA works in concert with a second dynamin-like protein, made up of LeoB and LeoC. Disruption of the leoAB genes leads to a reduction in secretion of periplasmic Tat-GFP and outer membrane OmpA. Our data suggest a role for LeoABC dynamin-like proteins in potentiating virulence through membrane vesicle associated toxin secretion.	[Michie, Katharine A.; Low, Harry H.; Loewe, Jan] MRC Lab Mol Biol, Struct Studies Div, Cambridge, England; [Boysen, Anders; Moller-Jensen, Jakob] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark	MRC Laboratory Molecular Biology; University of Southern Denmark	Lowe, J (corresponding author), MRC Lab Mol Biol, Struct Studies Div, Cambridge, England.	jyl@mrc-lmb.cam.ac.uk	Low, Harry/T-4482-2019; Löwe, Jan/X-6998-2019; Michie, Katharine A/B-3858-2011; Møller-Jensen, Jakob/AAO-8480-2020	Michie, Katharine A/0000-0002-2133-2237; Møller-Jensen, Jakob/0000-0002-6008-3771; Lowe, Jan/0000-0002-5218-6615; Boysen, Anders/0000-0001-9171-6669	Medical Research Council [U105184326]; Wellcome Trust [095514/Z/11/Z]; Lundbeck Foundation [R31-A2459]; MRC [MC_U105184326] Funding Source: UKRI; Medical Research Council [MC_U105184326] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Lundbeck Foundation(Lundbeckfonden); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (U105184326 to JL), the Wellcome Trust (095514/Z/11/Z to JL) and the Lundbeck Foundation (R31-A2459 to JMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alland D, 2000, J BACTERIOL, V182, P1802, DOI 10.1128/JB.182.7.1802-1811.2000; Beis K, 2006, INT J BIOL MACROMOL, V39, P10, DOI 10.1016/j.ijbiomac.2005.12.008; Bramkamp M, 2012, BIOL CHEM, V393, P1203, DOI 10.1515/hsz-2012-0185; Brown EA, 2007, MICROBIOL-SGM, V153, P3776, DOI 10.1099/mic.0.2007/009084-0; Burmann F, 2011, MOL MICROBIOL, V79, P1294, DOI 10.1111/j.1365-2958.2011.07523.x; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Fleckenstein JM, 2000, INFECT IMMUN, V68, P2766, DOI 10.1128/IAI.68.5.2766-2774.2000; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; French C, 1996, ENZYME MICROB TECH, V19, P332, DOI 10.1016/S0141-0229(96)00003-8; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Low HH, 2010, CURR OPIN STRUC BIOL, V20, P791, DOI 10.1016/j.sbi.2010.09.011; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ozaki S, 2013, CELL REP, V4, P985, DOI 10.1016/j.celrep.2013.07.040; Perez-Cruz C, 2013, APPL ENVIRON MICROB, V79, P1874, DOI 10.1128/AEM.03657-12; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stock D, 2005, PROG BIOPHYS MOL BIO, V88, P311, DOI 10.1016/j.pbiomolbio.2004.07.009; Turk D, 2013, ACTA CRYSTALLOGR D, V69, P1342, DOI 10.1107/S0907444913008408; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; van den Ent F, 1999, STRUCTURE, V7, P1181, DOI 10.1016/S0969-2126(00)80052-0; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	37	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107211	10.1371/journal.pone.0107211	http://dx.doi.org/10.1371/journal.pone.0107211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203511	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500075
J	Tang, DL; Liu, XH; Song, M; Yu, HL				Tang, Delin; Liu, Xianghua; Song, Meng; Yu, Hailiang			Experimental and Theoretical Study on Minimum Achievable Foil Thickness during Asymmetric Rolling	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; SENDZIMIR MILL; SHEET; DEFORMATION; PREDICTION; PRESSURE; AL	Parts produced by microforming are becoming ever smaller. Similarly, the foils required in micro-machines are becoming ever thinner. The asymmetric rolling technique is capable of producing foils that are thinner than those produced by the conventional rolling technique. The difference between asymmetric rolling and conventional rolling is the 'cross-shear' zone. However, the influence of the cross-shear zone on the minimum achievable foil thickness during asymmetric rolling is still uncertain. In this paper, we report experiments designed to understand this critical influencing factor on the minimum achievable thickness in asymmetric rolling. Results showed that the minimum achievable thickness of rolled foils produced by asymmetric rolling with a rolling speed ratio of 1.3 can be reduced to about 30% of that possible by conventional rolling technique. Furthermore, the minimum achievable thickness during asymmetric rolling could be correlated to the cross-shear ratio, which, in turn, could be related to the rolling speed ratio. From the experimental results, a formula to calculate the minimum achievable thickness was established, considering the parameters cross-shear ratio, friction coefficient, work roll radius, etc. in asymmetric rolling.	[Tang, Delin; Liu, Xianghua; Song, Meng] Northeastern Univ, State Key Lab Rolling & Automat, Shenyang, Peoples R China; [Yu, Hailiang] Univ Wollongong, Sch Mech Mat & Mechatron Engn, Wollongong, NSW, Australia; [Yu, Hailiang] Shenyang Agr Univ, Sch Mech Engn, Shenyang 110161, Peoples R China	Northeastern University - China; University of Wollongong; Shenyang Agricultural University	Yu, HL (corresponding author), Univ Wollongong, Sch Mech Mat & Mechatron Engn, Wollongong, NSW, Australia.	yuhailiang1980@tom.com	YU, Hailiang/B-5977-2009	YU, Hailiang/0000-0001-7959-0717	National Science Foundation of China [51374069]; Vice-Chancellor's Fellowship Grant at the University of Wollongong; URC Small Grant at the University of Wollongong	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Vice-Chancellor's Fellowship Grant at the University of Wollongong; URC Small Grant at the University of Wollongong	Support was provided by the National Science Foundation of China through Grant 51374069 and the Vice-Chancellor's Fellowship Grant and URC Small Grant at the University of Wollongong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cui Q., 2002, Journal of Japan Institute of Light Metals, V52, P185, DOI 10.2464/jilm.52.185; Fu MW, 2013, INT J ADV MANUF TECH, V67, P2411, DOI 10.1007/s00170-012-4661-7; Hao L, 2013, J IRON STEEL RES INT, V20, P34, DOI 10.1016/S1006-706X(13)60094-1; Hugh F, 1948, P I MECH ENG, V159, P115; Ji YH, 2008, MAT SCI ENG A-STRUCT, V485, P299, DOI 10.1016/j.msea.2007.07.089; Jin H, 2004, METALL MATER TRANS A, V35A, P997, DOI 10.1007/s11661-004-0026-7; Kawalek A, 2011, METALURGIJA, V50, P163; Kim KH, 2001, ACTA MATER, V49, P2583, DOI 10.1016/S1359-6454(01)00036-2; Kim WJ, 2009, MAT SCI ENG A-STRUCT, V506, P71, DOI 10.1016/j.msea.2008.11.029; Lian J.C., 1979, HEAVY MACH 1, P20; Longtin R, 2011, ADV MATER, V23, P5812, DOI 10.1002/adma.201103275; Ma D, 1983, CENTRAL IRON STEEL R, V3, P43; Overhagen C, 2013, IRON STEEL TECHNOL, V10, P97; Roberts WL, 1978, COLD ROLLING STEEL; Singh P, 2008, J MATER PROCESS TECH, V200, P238, DOI 10.1016/j.jmatprotec.2007.09.010; Stone MD, 1953, IRON STEEL ENG, V30, P61; Tzou GY, 2000, J MATER PROCESS TECH, V105, P344, DOI 10.1016/S0924-0136(00)00574-4; Wronski S, 2011, MATER CHARACT, V62, P22, DOI 10.1016/j.matchar.2010.10.002; Yole D, 2013, MEMS MARKETS STATUS; Yu HL, 2008, J MATER PROCESS TECH, V208, P42, DOI 10.1016/j.jmatprotec.2007.12.124; Yu HL, 2008, J IRON STEEL RES INT, V15, P30, DOI 10.1016/S1006-706X(08)60007-2; Yu HL, 2007, ISIJ INT, V47, P996, DOI 10.2355/isijinternational.47.996; Yu HL, 2013, MAT SCI ENG A-STRUCT, V568, P212, DOI 10.1016/j.msea.2013.01.048; Yu HL, 2014, METALL MATER TRANS A, V45A, P4038, DOI 10.1007/s11661-014-2311-4; Yu HL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05017; Yu HL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02373; Yu HL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00772; Zhang SH, 2012, INT J MECH SCI, V65, P168, DOI 10.1016/j.ijmecsci.2012.09.015; Zhu Q, 1988, J NE U TECHNOL, V57, P420; Zuo FQ, 2008, T NONFERR METAL SOC, V18, P774, DOI 10.1016/S1003-6326(08)60133-8	30	20	22	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106637	10.1371/journal.pone.0106637	http://dx.doi.org/10.1371/journal.pone.0106637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203265	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500033
J	Wang, B; Zhang, LS; Qiu, FM; Fang, WX; Deng, JQ; Zhou, YF; Lu, JC; Yang, L				Wang, Bo; Zhang, Lisha; Qiu, Fuman; Fang, Wenxiang; Deng, Jieqiong; Zhou, Yifeng; Lu, Jiachun; Yang, Lei			A Newfound Association between MDC1 Functional Polymorphism and Lung Cancer Risk in Chinese	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; GENOME-WIDE ASSOCIATION; COPY-NUMBER VARIATION; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; SUSCEPTIBILITY LOCI; CELLULAR-RESPONSE; IDENTIFIES 2; CHECKPOINT; GENE	Mediator of DNA damage checkpoint protein 1 (MDC1) plays an early and core role in Double-Strand Break Repair (DDR) and ataxia telangiectasia-mutated (ATM) mediated response to DNA double-strand breaks (DSBs), and thus involves the pathogenesis of several DNA damage-related diseases such as cancer. We hypothesized that the single nucleotide polymorphisms (SNPs) of MDC1 which have potencies on affecting MDC1 expression or function were associated with risk of lung cancer. In a two-stage case-control study, we tested the association between 5 putatively functional SNPs of MDC1 and lung cancer risk in a southern Chinese population, and validated the promising association in an eastern Chinese population. We found the SNP rs4713354A > C that is located in the 5'-untranslated region of MDC1 was significantly associated with lung cancer risk in both populations (P = 0.024), with an odds ratio as 1.23(95% confidence interval = 1.35-1.26) for the rs4713354C (CA+CC) genotypes compared to the rs4713354AA genotype. However, no significant association was observed between other SNPs and lung cancer risk. The gene-based analysis rested with these SNPs suggested the MDC1 as a susceptible gene for lung cancer (P = 0.009). Moreover, by querying the gene expression database, we further found that the rs4713354C genotypes confer a significantly lower mRNA expression of MDC1 than the rs4713354AA genotype in 260 cases of lymphoblastoid cells (P = 0.002). Our data suggested that the SNP rs4713354A>C of MDC1 may be a functional genetic biomarker for susceptibility to lung cancer in Chinese.	[Wang, Bo; Zhang, Lisha; Qiu, Fuman; Fang, Wenxiang; Lu, Jiachun; Yang, Lei] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Deng, Jieqiong; Zhou, Yifeng] Soochow Univ, Coll Med, Lab Canc Mol Genet, Suzhou, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Soochow University - China	Yang, L (corresponding author), Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	leiyang@gzhmu.com.cn			National Natural Scientific Foundation of China [30671813, 30872178, 81072366, 81273149, 81001278, 81171895, 81271350]; Guangdong Provincial Scientific Research Grants [8251018201000005]; Guangdong Provincial High Level Experts Grants [2010-79]; Changjiang Scholars and Innovative Research Team in University [IRT0961]; Guangdong natural science foundation team grant [10351012003000000]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Scientific Research Grants; Guangdong Provincial High Level Experts Grants; Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong natural science foundation team grant	This study was supported by the National Natural Scientific Foundation of China grants 30671813, 30872178, 81072366, 81273149 (JCL), and partly by 81001278 and 81171895 (YFZ), 81271350 (WJ); the Guangdong Provincial Scientific Research Grants 8251018201000005 (JCL), Guangdong Provincial High Level Experts Grants 2010-79, Changjiang Scholars and Innovative Research Team in University grant IRT0961 and Guangdong natural science foundation team grant 10351012003000000 (JCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2007, ONCOGENE, V26, P7414, DOI 10.1038/sj.onc.1210553; Belgnaoui SM, 2010, J BIOL CHEM, V285, P32897, DOI 10.1074/jbc.M110.146373; Bohgaki T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001381; Brooks JD, 2012, HUM MUTAT, V33, P158, DOI 10.1002/humu.21604; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Ermolaeva MA, 2014, TRENDS GENET, V30, P95, DOI 10.1016/j.tig.2013.12.001; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hsia TC, 2014, ENV TOXICOL; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Liu B, 2012, AM J HUM GENET, V91, P384, DOI 10.1016/j.ajhg.2012.07.003; Liu B, 2010, CARCINOGENESIS, V31, P1405, DOI 10.1093/carcin/bgq126; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lou Zhenkun, 2004, Methods Mol Biol, V281, P179; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lu JC, 2011, HUM MUTAT, V32, P1299, DOI 10.1002/humu.21574; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Min Y, 2011, ONCOGENE, V30, P4901, DOI 10.1038/onc.2011.187; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Nakanishi M, 2007, J BIOL CHEM, V282, P22993, DOI 10.1074/jbc.M611412200; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Patel AN, 2011, BREAST CANCER RES TR, V126, P601, DOI 10.1007/s10549-010-0960-6; Peng AM, 2005, CANCER RES, V65, P1158, DOI 10.1158/0008-5472.CAN-04-2508; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Pugh TJ, 2009, CLIN CANCER RES, V15, P5008, DOI 10.1158/1078-0432.CCR-08-3357; Rai Rekha, 2007, Cancer Genomics & Proteomics, V4, P99; Safe S, 2014, MOL ENDOCRINOL, V28, P157, DOI 10.1210/me.2013-1291; Sato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057013; Shahar OD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078472; Shen GP, 2011, INT J CANCER, V129, P1459, DOI 10.1002/ijc.25759; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Townsend K, 2009, J BIOL CHEM, V284, P33939, DOI 10.1074/jbc.M109.009191; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wilson K, 2011, BRIT DENT J, V210, P53, DOI 10.1038/sj.bdj.2011.13; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Yang L, 2014, AM J RESP CRIT CARE, V189, P139, DOI 10.1164/rccm.201307-1355OC; Yang L, 2013, HUM MOL GENET, V22, P1886, DOI 10.1093/hmg/ddt019; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026944; Yang ZM, 2010, MOL CELL BIOCHEM, V342, P1, DOI 10.1007/s11010-010-0460-3; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991; Zhang ZZ, 2013, WORLD J GASTROENTERO, V19, P1968, DOI 10.3748/wjg.v19.i12.1968	48	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106794	10.1371/journal.pone.0106794	http://dx.doi.org/10.1371/journal.pone.0106794			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198518	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700051
J	Akcakaya, M; Nam, S; Basha, TA; Kawaji, K; Tarokh, V; Nezafat, R				Akcakaya, Mehmet; Nam, Seunghoon; Basha, Tamer A.; Kawaji, Keigo; Tarokh, Vahid; Nezafat, Reza			An Augmented Lagrangian Based Compressed Sensing Reconstruction for Non-Cartesian Magnetic Resonance Imaging without Gridding and Regridding at Every Iteration	PLOS ONE			English	Article							GRAPHICS PROCESSING UNIT; HEART CORONARY MRA; MOTION; ANGIOGRAPHY; ACQUISITION; ALGORITHM; MINIMIZATION; TRANSFORM; SPIRALS; KERNEL	Background: Non-Cartesian trajectories are used in a variety of fast imaging applications, due to the incoherent image domain artifacts they create when undersampled. While the gridding technique is commonly utilized for reconstruction, the incoherent artifacts may be further removed using compressed sensing (CS). CS reconstruction is typically done using conjugate-gradient (CG) type algorithms, which require gridding and regridding to be performed at every iteration. This leads to a large computational overhead that hinders its applicability. Methods: We sought to develop an alternative method for CS reconstruction that only requires two gridding and one regridding operation in total, irrespective of the number of iterations. This proposed technique is evaluated on phantom images and whole-heart coronary MRI acquired using 3D radial trajectories, and compared to conventional CS reconstruction using CG algorithms in terms of quantitative vessel sharpness, vessel length, computation time, and convergence rate. Results: Both CS reconstructions result in similar vessel length (P = 0.30) and vessel sharpness (P = 0.62). The per-iteration complexity of the proposed technique is approximately 3-fold lower than the conventional CS reconstruction (17.55 vs. 52.48 seconds in C++). Furthermore, for in-vivo datasets, the convergence rate of the proposed technique is faster (60 +/- 13 vs. 455 +/- 320 iterations) leading to a similar to 23-fold reduction in reconstruction time. Conclusions: The proposed reconstruction provides images of similar quality to the conventional CS technique in terms of removing artifacts, but at a much lower computational complexity.	[Akcakaya, Mehmet; Nam, Seunghoon; Basha, Tamer A.; Kawaji, Keigo; Nezafat, Reza] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Cardiovasc, Boston, MA 02138 USA; [Nam, Seunghoon] Medtronic Inc, Surg Technol, Littleton, MA USA; [Kawaji, Keigo] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; [Tarokh, Vahid] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Medtronic; University of Chicago; Harvard University	Akcakaya, M (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Cardiovasc, Boston, MA 02138 USA.	makcakay@bidmc.harvard.edu	Kawaji, Keigo/J-5501-2018; Poor, H. Vincent/S-5027-2016; Basha, Tamer/AAN-4033-2020	Kawaji, Keigo/0000-0002-4813-3414; Poor, H. Vincent/0000-0002-2062-131X; Basha, Tamer/0000-0003-4431-8646; Akcakaya, Mehmet/0000-0001-6400-7736	NIH [R01EB008743-01A2, K99HL111410-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL111410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The project described was supported by NIH R01EB008743-01A2 and NIH K99HL111410-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adluru G, 2011, J MAGN RESON IMAGING, V34, P1465, DOI 10.1002/jmri.22808; Akcakaya M, 2011, MAGN RESON MED, V66, P756, DOI 10.1002/mrm.22841; Barger AV, 2002, MAGN RESON MED, V48, P297, DOI 10.1002/mrm.10212; Becker SR, 2011, MATH PROGRAM COMPUT, V3, P165, DOI 10.1007/s12532-011-0029-5; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; Bertsekas D., 1996, CONSTRAINED OPTIMIZA; Bhat H, 2011, MAGN RESON MED, V65, P1269, DOI 10.1002/mrm.22717; Blaimer M, 2009, MAY HAW P 17 SCI M I, P2713; Buchgraber G, 2010, MAY STOCKH P 18 SCI, P4959; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan RW, 2012, MAGN RESON MED, V67, P363, DOI 10.1002/mrm.23008; Chartrand R, 2013, NOV AS P 47 AS C SIG, P1; DERICHE R, 1990, IEEE T PATTERN ANAL, V12, P78, DOI 10.1109/34.41386; Doneva M, 2010, MAGN RESON MED, V64, P1114, DOI 10.1002/mrm.22483; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; Fischer A, 2009, COMBINATION NONCONVE, P2813; GLOVER GH, 1992, MAGNET RESON MED, V28, P275, DOI 10.1002/mrm.1910280209; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Johnson KO, 2009, MAGN RESON MED, V61, P439, DOI 10.1002/mrm.21840; Katoh M, 2006, J MAGN RESON IMAGING, V23, P757, DOI 10.1002/jmri.20569; Knoll F, 2010, MAGN RESON MATER PHY, V23, P103, DOI 10.1007/s10334-010-0207-x; Lee GR, 2012, MAGN RESON MED; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; MEYER CH, 1992, MAGNET RESON MED, V28, P202, DOI 10.1002/mrm.1910280204; Mistretta CA, 2006, MAGN RESON MED, V55, P30, DOI 10.1002/mrm.20772; Mistretta CA, 2009, J MAGN RESON IMAGING, V29, P501, DOI 10.1002/jmri.21683; Nam S, 2013, MAGN RESON MED, V69, P91, DOI 10.1002/mrm.24234; O'Sullivan JD, 1985, MED IMAGING IEEE T, V4, P200; Peters DC, 2000, MAGNET RESON MED, V43, P91, DOI 10.1002/(SICI)1522-2594(200001)43:1<91::AID-MRM11>3.0.CO;2-4; Pipe JG, 1999, MAGNET RESON MED, V41, P179, DOI 10.1002/(SICI)1522-2594(199901)41:1<179::AID-MRM25>3.0.CO;2-V; Ramani S, 2011, IEEE T MED IMAGING, V30, P694, DOI 10.1109/TMI.2010.2093536; Rasche V, 1999, IEEE T MED IMAGING, V18, P385, DOI 10.1109/42.774166; Santos JM, 2006, MAGN RESON MED, V55, P371, DOI 10.1002/mrm.20765; Scott AD, 2009, RADIOLOGY, V250, P331, DOI 10.1148/radiol.2502071998; Seiberlich N, 2007, MAGN RESON MED, V58, P1257, DOI 10.1002/mrm.21435; Sorensen TS, 2008, IEEE T MED IMAGING, V27, P538, DOI 10.1109/TMI.2007.909834; Sorensen TS, 2009, IEEE T MED IMAGING, V28, P1974, DOI 10.1109/TMI.2009.2027118; Stehning C, 2005, MAGN RESON MED, V54, P476, DOI 10.1002/mrm.20557; Stehning C, 2004, MAGNET RESON MED, V52, P197, DOI 10.1002/mrm.20128; Stone SS, 2008, J PARALLEL DISTR COM, V68, P1307, DOI 10.1016/j.jpdc.2008.05.013; Thedens DR, 1999, MAGN RESON MED, V41, P1170, DOI 10.1002/(SICI)1522-2594(199906)41:6<1170::AID-MRM13>3.0.CO;2-J; Trouard TP, 1996, JMRI-J MAGN RESON IM, V6, P925, DOI 10.1002/jmri.1880060614; van den Berg E, 2008, SIAM J SCI COMPUT, V31, P890, DOI 10.1137/080714488; Wajer F, 2001, MAY GLASG P 8 SCI M, P1798; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Yang JF, 2010, IEEE J-STSP, V4, P288, DOI 10.1109/JSTSP.2010.2042333; Yeh EN, 2005, MAGN RESON MED, V54, P1, DOI 10.1002/mrm.20517; Zwart NR, 2012, MAGN RESON MED, V67, P701, DOI 10.1002/mrm.23041	50	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107107	10.1371/journal.pone.0107107	http://dx.doi.org/10.1371/journal.pone.0107107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215945	Green Submitted, gold, Green Published			2022-12-27	WOS:000341774300042
J	Todorov, I; Del Missier, F; Mantyla, T				Todorov, Ivo; Del Missier, Fabio; Mantyla, Timo			Age-Related Differences in Multiple Task Monitoring	PLOS ONE			English	Article							ADULT LIFE-SPAN; DUAL-TASK; GENDER-DIFFERENCES; OLDER-ADULTS; VIRTUAL ENVIRONMENT; EXECUTIVE FUNCTIONS; SEX-DIFFERENCES; FRONTAL LOBES; MULTITASKING; PERFORMANCE	Coordinating multiple tasks with narrow deadlines is particularly challenging for older adults because of age related decline in cognitive control functions. We tested the hypothesis that multiple task performance reflects age- and gender-related differences in executive functioning and spatial ability. Young and older adults completed a multitasking session with four monitoring tasks as well as separate tasks measuring executive functioning and spatial ability. For both age groups, men exceeded women in multitasking, measured as monitoring accuracy. Individual differences in executive functioning and spatial ability were independent predictors of young adults' monitoring accuracy, but only spatial ability was related to sex differences. For older adults, age and executive functioning, but not spatial ability, predicted multitasking performance. These results suggest that executive functions contribute to multiple task performance across the adult life span and that reliance on spatial skills for coordinating deadlines is modulated by age.	[Todorov, Ivo; Del Missier, Fabio; Mantyla, Timo] Stockholm Univ, S-10691 Stockholm, Sweden; [Del Missier, Fabio] Univ Trieste, Trieste, Italy	Stockholm University; University of Trieste	Todorov, I (corresponding author), Stockholm Univ, S-10691 Stockholm, Sweden.	ivo.todorov@psychology.su.se	Del Missier, Fabio/B-3195-2009; Del Missier, Fabio/AAV-4160-2021	Del Missier, Fabio/0000-0003-4681-5857; Del Missier, Fabio/0000-0003-4681-5857; Todorov, Ivo/0000-0003-2100-1443	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was funded by a grant from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin MS, 1996, ADAPT BEHAV, V4, P125, DOI 10.1177/105971239600400202; BARNES CA, 1980, CAN J PSYCHOL, V34, P29, DOI 10.1037/h0081022; Boff K. R., 1986, HDB PERCEPTION HUMAN, P1; Bonato M, 2012, NEUROSCI BIOBEHAV R, V36, P2257, DOI 10.1016/j.neubiorev.2012.08.007; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Carell Maria G, 2011, Adv Cogn Psychol, V7, P49, DOI 10.2478/v10053-008-0101-5; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Craik FIM, 2006, MEM COGNITION, V34, P1236, DOI 10.3758/BF03193268; De Bruin WB, 2012, J BEHAV DECIS MAKING, V25, P352, DOI 10.1002/bdm.712; Dehaene Stanislas, 2011, SPACE TIME NUMBER BR; Del Missier F, 2013, J EXP PSYCHOL LEARN, V39, P1344, DOI 10.1037/a0032379; Del Missier F, 2012, J BEHAV DECIS MAKING, V25, P331, DOI 10.1002/bdm.731; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dror IE, 2005, EXP AGING RES, V31, P409, DOI 10.1080/03610730500206725; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Federal Aviation Administration, 2003, HRPM EMP 1 20 MAX EN; FEINGOLD A, 1988, AM PSYCHOL, V43, P95, DOI 10.1037/0003-066X.43.2.95; Forman H, 2011, J EXP CHILD PSYCHOL, V108, P170, DOI 10.1016/j.jecp.2010.07.004; Fuster J M, 1993, Curr Opin Neurobiol, V3, P160, DOI 10.1016/0959-4388(93)90204-C; Gothe K, 2007, PSYCHOL AGING, V22, P596, DOI 10.1037/0882-7974.22.3.596; Hambrick DZ, 2010, APPL COGNITIVE PSYCH, V24, P1149, DOI 10.1002/acp.1624; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hoffman M, 2011, P NATL ACAD SCI USA, V108, P14786, DOI 10.1073/pnas.1015182108; INGRAM DK, 1988, NEUROBIOL AGING, V9, P475, DOI 10.1016/S0197-4580(88)80101-5; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Law AS, 2013, Q J EXP PSYCHOL, V66, P1241, DOI 10.1080/17470218.2012.748813; Levy J, 2008, APPL COGNITIVE PSYCH, V22, P507, DOI 10.1002/acp.1378; Logie RH, 2011, MEM COGNITION, V39, P1561, DOI 10.3758/s13421-011-0120-1; Loukopoulos L.D., 2009, AEROSAFETY WORLD, V4, P18; Lovden M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.013; Mantyla T, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P191, DOI 10.1142/9789812707123_0008; Mantyla T, 2007, J EXP CHILD PSYCHOL, V96, P1, DOI 10.1016/j.jecp.2006.08.003; Mantyla T, 2013, PSYCHOL SCI, V24, P811, DOI 10.1177/0956797612475319; Mantyla T, 2013, PSYCHOL SCI, V24, P514, DOI 10.1177/0956797612459660; Mayr U., 2001, AGEING EXECUTIVE CON; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Munro CA, 2012, AGING NEUROPSYCHOL C, V19, P759, DOI 10.1080/13825585.2012.690366; Neider MB, 2011, PSYCHOL AGING, V26, P260, DOI 10.1037/a0021566; Nunes A, 2009, J EXP PSYCHOL-APPL, V15, P12, DOI 10.1037/a0014947; Nunez RE, 2006, COGNITIVE SCI, V30, P401, DOI 10.1207/s15516709cog0000_62; Offer S, 2011, AM SOCIOL REV, V76, P809, DOI 10.1177/0003122411425170; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Park DC, 1996, PSYCHOL AGING, V11, P621, DOI 10.1037/0882-7974.11.4.621; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; PETERS M, 1995, BRAIN COGNITION, V28, P39, DOI 10.1006/brcg.1995.1032; Piaget J., 1969, CHILDS CONCEPTION TI; Rodgers M Kirk, 2012, Neurobiol Aging, V33, DOI 10.1016/j.neurobiolaging.2010.07.021; Ronnlund M, 2006, INTELLIGENCE, V34, P63, DOI 10.1016/j.intell.2005.06.004; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Salthouse T, 2012, ANNU REV PSYCHOL, V63, P201, DOI 10.1146/annurev-psych-120710-100328; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; Schaie KW, 1998, PSYCHOL AGING, V13, P8, DOI 10.1037/0882-7974.13.1.8; Stoet G., 2013, BMC PSYCHOL, V1, DOI [10.1186/2050-7283-1-18, DOI 10.1186/2050-7283-1-18]; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Thilers PP, 2010, PSYCHONEUROENDOCRINO, V35, P516, DOI 10.1016/j.psyneuen.2009.08.018; Todorov I, 2014, DEADLINES SPAC UNPUB; TVERSKY B, 1991, COGNITIVE PSYCHOL, V23, P515, DOI 10.1016/0010-0285(91)90005-9; Vallesi A, 2008, COGNITION, V107, P501, DOI 10.1016/j.cognition.2007.10.011; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Wickens CD, 2008, HUM FACTORS, V50, P449, DOI 10.1518/001872008X288394	63	15	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107619	10.1371/journal.pone.0107619	http://dx.doi.org/10.1371/journal.pone.0107619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP0SM	25215609	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300088
J	Bogren, LK; Murphy, CJ; Johnston, EL; Sinha, N; Serkova, NJ; Drew, KL				Bogren, Lori K.; Murphy, Carl J.; Johnston, Erin L.; Sinha, Neeraj; Serkova, Natalie J.; Drew, Kelly L.			H-1-NMR Metabolomic Biomarkers of Poor Outcome after Hemorrhagic Shock are Absent in Hibernators	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ARCTIC GROUND-SQUIRREL; FUNCTION IMPROVING AGENT; BETA-HYDROXYBUTYRATE; KETOGENIC DIET; CARDIAC-ARREST; QUANTITATIVE-ANALYSIS; CEREBRAL-ISCHEMIA; NMR-SPECTROSCOPY; TRAUMA PATIENTS	Background: Hemorrhagic shock (HS) following trauma is a leading cause of death among persons under the age of 40. During HS the body undergoes systemic warm ischemia followed by reperfusion during medical intervention. Ischemia/reperfusion (I/R) results in a disruption of cellular metabolic processes that ultimately lead to tissue and organ dysfunction or failure. Resistance to I/R injury is a characteristic of hibernating mammals. The present study sought to identify circulating metabolites in the rat as biomarkers for metabolic alterations associated with poor outcome after HS. Arctic ground squirrels (AGS), a hibernating species that resists I/R injury independent of decreased body temperature (warm I/R), was used as a negative control. Methodology/principal findings: Male Sprague-Dawley rats and AGS were subject to HS by withdrawing blood to a mean arterial pressure (MAP) of 35 mmHg and maintaining the low MAP for 20 min before reperfusing with Ringers. The animals' temperature was maintained at 37 +/- 0.5 degrees C for the duration of the experiment. Plasma samples were taken immediately before hemorrhage and three hours after reperfusion. Hydrophilic and lipid metabolites from plasma were then analyzed via H-1-NMR from unprocessed plasma and lipid extracts, respectively. Rats, susceptible to I/R injury, had a qualitative shift in their hydrophilic metabolic fingerprint including differential activation of glucose and anaerobic metabolism and had alterations in several metabolites during I/R indicative of metabolic adjustments and organ damage. In contrast, I/R injury resistant AGS, regardless of season or body temperature, maintained a stable metabolic homeostasis revealed by a qualitative H-1-NMR metabolic profile with few changes in quantified metabolites during HS-induced global I/R. Conclusions/significance: An increase in circulating metabolites indicative of anaerobic metabolism and activation of glycolytic pathways is associated with poor prognosis after HS in rats. These same biomarkers are absent in AGS after HS with warm I/R.	[Bogren, Lori K.; Murphy, Carl J.; Johnston, Erin L.; Drew, Kelly L.] Univ Alaska Fairbanks, Dept Chem & Biochem, Fairbanks, AK 99775 USA; [Bogren, Lori K.; Drew, Kelly L.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Sinha, Neeraj] Ctr Biomed Res, Lucknow, Uttar Pradesh, India; [Serkova, Natalie J.] Univ Colorado, Dept Anesthesiol, Aurora, CO USA; [Serkova, Natalie J.] Univ Colorado, Univ Colorado Canc Ctr, Aurora, CO USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Bogren, LK (corresponding author), Univ Alaska Fairbanks, Dept Chem & Biochem, Fairbanks, AK 99775 USA.	lkbogren@alaska.edu		Sinha, Neeraj/0000-0003-3235-6127	USAMRMC [W81XWH009-2-0134]; University of Alaska Graduate School Dissertation Completion Fellowship; University of Alaska Institute of Arctic Biology; Alaska INBRE; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS070779] Funding Source: NIH RePORTER	USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); University of Alaska Graduate School Dissertation Completion Fellowship; University of Alaska Institute of Arctic Biology; Alaska INBRE; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by USAMRMC W81XWH009-2-0134, the University of Alaska Graduate School Dissertation Completion Fellowship, the University of Alaska Institute of Arctic Biology, and Alaska INBRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zaid NS, 2007, ACTA CARDIOL, V62, P381, DOI 10.2143/AC.62.4.2022282; Almac E, 2012, RESUSCITATION, V83, P1166, DOI 10.1016/j.resuscitation.2012.02.011; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; BARNES BM, 1988, BIOL REPROD, V38, P616, DOI 10.1095/biolreprod38.3.616; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Barton RH, 2010, MOL BIOSYST, V6, P215, DOI 10.1039/b907021d; Bogren LKOJ, 2014, PLOS ONE UNPUB; Buck CL, 2003, HORM BEHAV, V43, P318, DOI 10.1016/S0018-506X(02)00050-8; Carey HV, 2006, FASEB J, V20, pA1382; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chaffin CL, 2013, EXP BIOL MED, V238, P539, DOI 10.1177/1535370213489437; Christian SL, 2008, J CEREBR BLOOD F MET, V28, P1307, DOI 10.1038/jcbfm.2008.20; Cohen MJ, 2010, J TRAUMA, V69, P31, DOI 10.1097/TA.0b013e3181e043fe; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Dave KR, 2006, STROKE, V37, P1261, DOI 10.1161/01.STR.0000217409.60731.38; Dave KR, 2012, COMP BIOCHEM PHYS B, V162, P1, DOI 10.1016/j.cbpb.2012.01.008; Dave KR, 2009, J NEUROCHEM, V110, P1170, DOI 10.1111/j.1471-4159.2009.06196.x; Engel FL, 1943, J EXP MED, V77, P397, DOI 10.1084/jem.77.5.397; Epperson LE, 2011, PHYSIOL GENOMICS, V43, P799, DOI 10.1152/physiolgenomics.00028.2011; Epperson LE, 2010, J COMP PHYSIOL B, V180, P599, DOI 10.1007/s00360-009-0422-9; Epperson LE, 2010, AM J PHYSIOL-REG I, V298, pR329, DOI 10.1152/ajpregu.00416.2009; Epperson LE, 2009, AM J PHYSL REGUL INT; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; GEISER F, 1988, J COMP PHYSIOL B, V158, P25, DOI 10.1007/BF00692726; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Hara Johsuke, 2008, Allergol Int, V57, P211, DOI 10.2332/allergolint.O-06-461; Hindle AG, 2011, AM J PHYSIOL-REG I, V301, pR1440, DOI 10.1152/ajpregu.00298.2011; Jani A, 2012, PHYSIOL GENOMICS, V44, P717, DOI 10.1152/physiolgenomics.00010.2012; Jani A, 2011, TRANSPLANTATION, V92, P1215, DOI 10.1097/TP.0b013e3182366401; Klein AH, 2010, SHOCK, V34, P565, DOI 10.1097/SHK.0b013e3181e15063; Koustova E, 2003, SURGERY, V134, P267, DOI 10.1067/msy.2003.245; KRIAT M, 1993, J LIPID RES, V34, P1009; Kurtz CC, 2006, AM J PHYSIOL-GASTR L, V291, pG895, DOI 10.1152/ajpgi.00155.2006; Lee JH, 2008, IEEE ENG MED BIO, P4891, DOI 10.1109/IEMBS.2008.4650310; Lindell SL, 2005, AM J PHYSIOL-GASTR L, V288, pG473, DOI 10.1152/ajpgi.00223.2004; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Martin SL, 2008, AM J PHYSIOL-REG I, V295, pR316, DOI 10.1152/ajpregu.00418.2007; McNelis J, 2001, AM J SURG, V182, P481, DOI 10.1016/S0002-9610(01)00755-3; Mongardon N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-45; Mulier KE, 2012, RESUSCITATION, V83, P253, DOI 10.1016/j.resuscitation.2011.08.003; Nelson CJ, 2010, COMP BIOCHEM PHYS D, V5, P265, DOI 10.1016/j.cbd.2010.07.002; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Niemann CU, 2006, SURGERY, V140, P404, DOI 10.1016/j.surg.2006.01.021; Niemann CU, 2005, ANESTH ANALG, V101, P1577, DOI 10.1213/01.ANE.0000184897.53609.2A; Ostadal B, 2009, EXP BIOL MED, V234, P1011, DOI 10.3181/0812-MR-362; Park Y, 2007, J SURG RES, V137, P96, DOI 10.1016/j.jss.2006.08.013; Podgoreanu MV, 2011, HIBERNATOR PHENOTYPE; Raedschelders K, 2012, PHARMACOL THERAPEUT, V133, P230, DOI 10.1016/j.pharmthera.2011.11.004; Rohrig R, 2014, J SURG RES, V186, P338, DOI 10.1016/j.jss.2013.09.005; Scribner DM, 2010, J SURG RES, V164, pE131, DOI 10.1016/j.jss.2010.07.046; Serkova N, 2005, KIDNEY INT, V67, P1142, DOI 10.1111/j.1523-1755.2005.00181.x; Serkova NJ, 2007, PHYSIOL GENOMICS, V31, P15, DOI 10.1152/physiolgenomics.00028.2007; Serkova NJ, 2012, BIOANALYSIS, V4, P321, DOI [10.4155/bio.11.320, 10.4155/BIO.11.320]; Serkova NJ, 2011, AM J RESP CRIT CARE, V184, P647, DOI 10.1164/rccm.201103-0474CI; Serkova NJ, 2006, J HEPATOL, V44, P956, DOI 10.1016/j.jhep.2005.07.009; Storey KB, 2010, GERONTOLOGY, V56, P220, DOI 10.1159/000228829; Stringer KA, 2011, AM J PHYSIOL-LUNG C, V300, pL4, DOI 10.1152/ajplung.00231.2010; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Tai KK, 2008, J NEURAL TRANSM, V115, P1011, DOI 10.1007/s00702-008-0050-7; Umeda K, 2009, SHOCK, V31, P40, DOI 10.1097/SHK.0b013e318177823a; Waters NJ, 2005, CHEM RES TOXICOL, V18, P639, DOI 10.1021/tx049869b; Williams CT, 2011, J EXP BIOL, V214, P1300, DOI 10.1242/jeb.052159; Wilson M, 2003, J EMERG MED, V24, P413, DOI 10.1016/S0736-4679(03)00042-8; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yang RJ, 2007, JPEN-PARENTER ENTER, V31, P94, DOI 10.1177/014860710703100294	71	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107493	10.1371/journal.pone.0107493	http://dx.doi.org/10.1371/journal.pone.0107493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211248	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900079
J	Bradbury, G; Trinder, M; Furness, B; Banks, AN; Caldow, RWG; Hume, D				Bradbury, Gareth; Trinder, Mark; Furness, Bob; Banks, Alex N.; Caldow, Richard W. G.; Hume, Duncan			Mapping Seabird Sensitivity to Offshore Wind Farms	PLOS ONE			English	Article							SPATIAL MODELS; CONSERVATION; VULNERABILITY; ABUNDANCE; BIRDS	We present a Geographic Information System (GIS) tool, SeaMaST (Seabird Mapping and Sensitivity Tool), to provide evidence on the use of sea areas by seabirds and inshore waterbirds in English territorial waters, mapping their relative sensitivity to offshore wind farms. SeaMaST is a freely available evidence source for use by all connected to the offshore wind industry and will assist statutory agencies in assessing potential risks to seabird populations from planned developments. Data were compiled from offshore boat and aerial observer surveys spanning the period 1979-2012. The data were analysed using distance analysis and Density Surface Modelling to produce predicted bird densities across a grid covering English territorial waters at a resolution of 3 kmx3 km. Coefficients of Variation were estimated for each grid cell density, as an indication of confidence in predictions. Offshore wind farm sensitivity scores were compiled for seabird species using English territorial waters. The comparative risks to each species of collision with turbines and displacement from operational turbines were reviewed and scored separately, and the scores were multiplied by the bird density estimates to produce relative sensitivity maps. The sensitivity maps reflected well the amassed distributions of the most sensitive species. SeaMaST is an important new tool for assessing potential impacts on seabird populations from offshore development at a time when multiple large areas of development are proposed which overlap with many seabird species' ranges. It will inform marine spatial planning as well as identifying priority areas of sea usage by marine birds. Example SeaMaST outputs are presented.	[Bradbury, Gareth] Wildfowl & Wetlands Trust Consulting Ltd, Slimbridge, Glos, England; [Trinder, Mark; Furness, Bob] MacArthur Green, Glasgow, Lanark, Scotland; [Banks, Alex N.; Caldow, Richard W. G.] Nat England, Exeter, Devon, England; [Hume, Duncan] Marine Management Org, Newcastle Upon Tyne, Tyne & Wear, England		Bradbury, G (corresponding author), Wildfowl & Wetlands Trust Consulting Ltd, Slimbridge, Glos, England.	gareth.bradbury@wwtconsulting.co.uk	Banks, Alex/R-9798-2019; Bradbury, Gareth/GQQ-1033-2022	Bradbury, Gareth/0000-0003-2802-041X	Natural England; MacArthur Green; Wildfowl & Wetlands Trust (Consulting) Ltd; Marine Management Organisation	Natural England; MacArthur Green; Wildfowl & Wetlands Trust (Consulting) Ltd; Marine Management Organisation	This project was funded by Natural England and the Marine Management Organisation who also conceived and managed the project and helped with the preparation of this manuscript. Co-authors Mark Trinder and Bob Furness are employed by MacArthur Green. Co-author Gareth Bradbury is employed by Wildfowl & Wetlands Trust (Consulting) Ltd. MacArthur Green and Wildfowl & Wetlands Trust (Consulting) Ltd provided support in the form of salaries for authors Mark Trinder, Bob Furness and Gareth Bradbury, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Band, 2012, USING COLLISION RISK; Bradbury G, 2011, DIGITAL AERIAL SURVE; Buckland S.T., 2001, pi; Buckland ST, 2012, J APPL ECOL, V49, P960, DOI 10.1111/j.1365-2664.2012.02150.x; Burt I, 2009, COMP VISUAL DIGITAL; Camphuysen KJ, 2004, BAM022002 COWRIE NIO; Cramp S, 1977, BIRDS W PALEARCTIC; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; del Hoyo J, 2013, HDB BIRDS WORLD; Dillingham PW, 2008, BIOL CONSERV, V141, P1783, DOI 10.1016/j.biocon.2008.04.022; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Eaton Mark A., 2009, British Birds, V102, P296; Furness R. W., 2012, VULNERABILITY SCOTTI; Furness RW, 2013, J ENVIRON MANAGE, V119, P56, DOI 10.1016/j.jenvman.2013.01.025; Furness RW, 2000, MAR ECOL PROG SER, V202, P253, DOI 10.3354/meps202253; Furrer R., 2012, FIELDS TOOLS SPATIAL; Garthe S, 2004, J APPL ECOL, V41, P724, DOI 10.1111/j.0021-8901.2004.00918.x; Glutz von Blotzheim U.N., 1982, HDB VOGEL MITTELEURO, V8; Hedley Sharon L., 1999, Journal of Cetacean Research and Management, V1, P255; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; Heiberger RM, 2013, STAT ANAL DATA DISPL; JNCC, 1995, EUR SEAB SEA DAT COD; King J.G., 1979, CONSERVATION MARINE, P227; Kober K, 2010, 431 JOINT NAT CONS C; Kober K, 2012, 461 JOINT NAT CONS C; Langston R, 2003, WINDFARMS BIRD ANAL; Marine Management Organisation, 2013, DRAFT E INSH E OFFSH; Marine Management Organisation, 2014, MAR PLANN GUID LOC A; Marra G, 2011, COMPUT STAT DATA AN, V55, P2372, DOI 10.1016/j.csda.2011.02.004; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Miller DL, 2013, DSM DENSITY SURFACE; Mitchell PI, 2004, SEABIRD POPULATIONS; Morris W. F., 2002, QUANTITATIVE CONSERV; Nelson B. N., 2002, ATLANTIC GANNET; O'Brien SH, 2008, BIRD STUDY, V55, P152, DOI 10.1080/00063650809461517; Petersen I, 2011, ABUNDANCE DISTRIBUTI; R Core Team, 2018, R LANG ENV STAT COMP; Reid J.B., 1998, BIOL CONSERVATION FA, V102, P291; Rexstad E, 2012, SOSS01; SAETHER BE, 1989, ORNIS SCAND, V20, P13, DOI 10.2307/3676702; Schwemmer P, 2011, ECOL APPL, V21, P1851, DOI 10.1890/10-0615.1; Skov H., 1995, IMPORTANT BIRD AREAS; Smith L, 2007, WELSH BIRDS, V5, P4; Stienen Eric W.M., 2007, P71; Stone C.J., 1995, ATLAS SEABIRD DISTRI; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Wildfowl and Wetlands Trust Consulting, 2009, AER SURV WAT UK 2007, P297; Wildfowl & Wetlands Trust (Consulting) Limited, 2010, DET POP CONS STAT FA; WILLIAMS JM, 1995, IBIS, V137, pS147, DOI 10.1111/j.1474-919X.1995.tb08435.x; Williams R, 2011, CONSERV BIOL, V25, P526, DOI 10.1111/j.1523-1739.2011.01656.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2008, J ROY STAT SOC B, V70, P931, DOI 10.1111/j.1467-9868.2008.00665.x; Zydelis R, 2009, BIOL CONSERV, V142, P1269, DOI 10.1016/j.biocon.2009.02.025	54	47	50	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106366	10.1371/journal.pone.0106366	http://dx.doi.org/10.1371/journal.pone.0106366			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210739	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900010
J	Haller, BC; de Vos, JM; Keller, B; Hendry, AP; Conti, E				Haller, Benjamin C.; de Vos, Jurriaan M.; Keller, Barbara; Hendry, Andrew P.; Conti, Elena			A Tale of Two Morphs: Modeling Pollen Transfer, Magic Traits, and Reproductive Isolation in Parapatry	PLOS ONE			English	Article							LOCK-AND-KEY; SEXUAL SELECTION; ETHOLOGICAL ISOLATION; PHENOTYPIC SELECTION; STYLE POLYMORPHISM; DISTYLOUS TURNERA; SELF-INTERFERENCE; FLORAL SYMMETRY; MATE CHOICE; GENE FLOW	The evolution of the flower is commonly thought to have spurred angiosperm diversification. Similarly, particular floral traits might have promoted diversification within specific angiosperm clades. We hypothesize that traits promoting the precise positional transfer of pollen between flowers might promote diversification. In particular, precise pollen transfer might produce partial reproductive isolation that facilitates adaptive divergence between parapatric populations differing in their reproductive-organ positions. We investigate this hypothesis with an individual-based model of pollen transfer dynamics associated with heterostyly, a floral syndrome that depends on precise pollen transfer. Our model shows that precise pollen transfer can cause sexual selection leading to divergence in reproductive-organ positions between populations served by different pollinators, pleiotropically causing an increase in reproductive isolation through a "magic trait'' mechanism. Furthermore, this increased reproductive isolation facilitates adaptive divergence between the populations in an unlinked, ecologically selected trait. In a different pollination scenario, however, precise pollen transfer causes a decrease in adaptive divergence by promoting asymmetric gene flow. Our results highlight the idea that magic traits are not "magic'' in isolation; in particular, the effect size of magic traits in speciation depends on the external environment, and also on other traits that modify the strength of the magic trait's influence on non-random mating. Overall, we show that the evolutionary consequences of pollen transfer dynamics can depend strongly on the available pollinator fauna and on the morphological fit between flowers and pollinators. Furthermore, our results illustrate the potential importance of even weak reproductive isolating barriers in facilitating adaptive divergence.	[Haller, Benjamin C.; Hendry, Andrew P.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Haller, Benjamin C.; Hendry, Andrew P.] McGill Univ, Dept Biol, Montreal, PQ H3A 2K6, Canada; [de Vos, Jurriaan M.] Brown Univ, Dept Ecol & Evol Biol, Providence, RI 02912 USA; [de Vos, Jurriaan M.; Conti, Elena] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland	McGill University; McGill University; Brown University; University of Zurich	Haller, BC (corresponding author), McGill Univ, Redpath Museum, 859 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	benhaller@benhaller.com	Haller, Benjamin C/D-4156-2009; Conti, Elena/G-3720-2010	Haller, Benjamin C/0000-0003-1874-8327; Keller, Barbara/0000-0002-7903-8938; de Vos, Jurriaan M./0000-0001-6428-7774	National Science Foundation Graduate Research Fellowship [1038597]; University of Zurich; Swiss National Science Foundation Fellowship [PBZHP3_147199]; Institute of Systematic Botany (University of Zurich); Natural Sciences and Engineering Research Council of Canada	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of Zurich; Swiss National Science Foundation Fellowship(Swiss National Science Foundation (SNSF)); Institute of Systematic Botany (University of Zurich); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	BCH was supported by a National Science Foundation Graduate Research Fellowship (Grant No. 1038597, www.nsf.gov). JMdV was supported by the University of Zurich (www.uch.ch), and is supported by a Swiss National Science Foundation Fellowship (PBZHP3_147199, www.snf.ch). BK and EC thank the Institute of Systematic Botany (University of Zurich, www.systbot.uzh.ch) for financial and logistical support. APH is supported by the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2006, ANN BOT-LONDON, V97, P141, DOI 10.1093/aob/mcj012; Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Alcantara S, 2011, BIOL J LINN SOC, V102, P378, DOI 10.1111/j.1095-8312.2010.01567.x; Armbruster WS, 2009, ANN BOT-LONDON, V103, P1529, DOI 10.1093/aob/mcp095; Armbruster WS, 2009, EVOL ECOL, V23, P159, DOI 10.1007/s10682-008-9259-z; Baena-Diaz F, 2012, J EVOLUTION BIOL, V25, P574, DOI 10.1111/j.1420-9101.2012.02455.x; BAKER HG, 1964, EVOLUTION, V18, P507, DOI 10.1111/j.1558-5646.1964.tb01627.x; Barrett S. C. H., 2008, P3, DOI 10.1007/978-3-540-68486-2_1; Barrett SC, 1992, EVOLUTION FUNCTION H; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Barrett SCH, 2002, HEREDITY, V88, P154, DOI 10.1038/sj/hdy/6800020; BAWA KS, 1980, ANNU REV ECOL SYST, V11, P15, DOI 10.1146/annurev.es.11.110180.000311; BEACH JH, 1980, EVOLUTION, V34, P1138, DOI [10.2307/2408294, 10.1111/j.1558-5646.1980.tb04055.x]; Bierbach D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/148348; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Boulding EG, 2001, HEREDITY, V86, P313, DOI 10.1046/j.1365-2540.2001.00829.x; BRANTJES NBM, 1982, PLANT SYST EVOL, V141, P41, DOI 10.1007/BF01006478; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Campbell D.R., 2006, ECOLOGY EVOLUTION FL, P326; Casper BB, 1992, EVOLUTION FUNCTION H, P209; Cesaro AC, 2004, J EVOLUTION BIOL, V17, P1367, DOI 10.1111/j.1420-9101.2004.00767.x; CHARLESWORTH D, 1979, PROC R SOC SER B-BIO, V205, P513, DOI 10.1098/rspb.1979.0082; Coyne J.A., 2004, SPECIATION; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; Crepet WL, 2009, AM J BOT, V96, P366, DOI 10.3732/ajb.0800126; Cresswell JE, 2000, ECOLOGY, V81, P3244, DOI 10.1890/0012-9658(2000)081[3244:MOFAIF]2.0.CO;2; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; de Vos JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0075; de Vos JM, 2014, EVOLUTION, V68, P1042, DOI 10.1111/evo.12331; de Vos JM, 2012, FUNCT ECOL, V26, P854, DOI 10.1111/j.1365-2435.2012.02016.x; Dilcher D, 2000, P NATL ACAD SCI USA, V97, P7030, DOI 10.1073/pnas.97.13.7030; Dulberger R., 1992, EVOLUTION FUNCTION H, P41; Eaton DAR, 2012, ECOLOGY, V93, pS182, DOI 10.1890/11-0501.1; Eckert CG, 2000, ECOLOGY, V81, P532, DOI 10.1890/0012-9658(2000)081[0532:COAAGT]2.0.CO;2; Edelaar P, 2012, TRENDS ECOL EVOL, V27, P659, DOI 10.1016/j.tree.2012.07.009; Ellers J, 2003, EVOLUTION, V57, P1100, DOI 10.1111/j.0014-3820.2003.tb00319.x; Faivre AE, 2001, AM J BOT, V88, P841, DOI 10.2307/2657036; FEINSINGER P, 1987, OECOLOGIA, V73, P231, DOI 10.1007/BF00377512; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Ferrero V, 2011, PLANT SYST EVOL, V291, P267, DOI 10.1007/s00606-010-0387-x; GANDERS FR, 1979, NEW ZEAL J BOT, V17, P607, DOI 10.1080/0028825X.1979.10432574; Garcia-Robledo C, 2008, EVOL ECOL, V22, P743, DOI 10.1007/s10682-007-9198-0; Gavrilets S, 2004, FITNESS LANDSCAPES O; Geber M.A., 2006, ECOLOGY EVOLUTION FL, P102; Gilmartin PM, 2010, HEREDITY, V105, P161, DOI 10.1038/hdy.2010.69; Glemin S, 2013, EVOLUTION, V67, P225, DOI 10.1111/j.1558-5646.2012.01778.x; Gonzalez-Suarez M, 2013, ECOL LETT, V16, P242, DOI 10.1111/ele.12035; GRANT V, 1994, BIOL ZBL, V113, P43; GRANT V, 1994, P NATL ACAD SCI USA, V91, P3, DOI 10.1073/pnas.91.1.3; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Haller BC, 2014, EVOLUTION, V68, P483, DOI 10.1111/evo.12275; Haller BC, 2012, TRENDS ECOL EVOL, V27, P4, DOI 10.1016/j.tree.2011.09.005; Harder LD, 2004, PLANT SPEC BIOL, V19, P137, DOI 10.1111/j.1442-1984.2004.00110.x; Harder LD, 2013, ANN BOT-LONDON, V112, P1477, DOI 10.1093/aob/mcs252; HARDER LD, 1995, NATURE, V373, P512, DOI 10.1038/373512a0; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; Hendry AP, 2004, EVOL ECOL RES, V6, P1219; Hodges SA, 1997, INT J PLANT SCI, V158, pS81, DOI 10.1086/297508; Hunter JP, 1998, TRENDS ECOL EVOL, V13, P31, DOI 10.1016/S0169-5347(97)01273-1; Johnson S., 2006, ECOLOGY EVOLUTION FL, P295; Johnson SD, 2010, PHILOS T R SOC B, V365, P499, DOI 10.1098/rstb.2009.0243; Kay K. M., 2006, ECOLOGY EVOLUTION FL, P311; Kay KM, 2006, EVOLUTION, V60, P538; Keller B, 2014, FUNCT ECOL, V28, P1413, DOI 10.1111/1365-2435.12274; Keller B, 2012, ANN BOT-LONDON, V110, P1233, DOI 10.1093/aob/mcs199; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kingsolver JG, 2012, EVOL ECOL, V26, P1101, DOI 10.1007/s10682-012-9563-5; Labonne JDJ, 2008, GENOME, V51, P471, DOI 10.1139/G08-031; Labonne JDJ, 2010, HEREDITY, V105, P235, DOI 10.1038/hdy.2010.39; Labonne J, 2010, AM NAT, V176, P26, DOI 10.1086/652992; Lau P, 2003, OECOLOGIA, V135, P593, DOI 10.1007/s00442-003-1216-5; Li XX, 2013, J EVOLUTION BIOL, V26, P1949, DOI 10.1111/jeb.12193; Lloyd D.G, 1992, EVOLUTION FUNCTION H, P151; LLOYD DG, 1979, PLANT SYST EVOL, V131, P71, DOI 10.1007/BF00984123; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Maan ME, 2012, EVOL ECOL RES, V14, P779; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; MACIOR L W, 1982, Ohio Journal of Science, V82, P19; Martin NH, 2007, EVOLUTION, V61, P68, DOI 10.1111/j.1558-5646.2007.00006.x; Massinga PH, 2005, ANN BOT-LONDON, V95, P389, DOI 10.1093/aob/mci040; Muchhala N, 2007, P ROY SOC B-BIOL SCI, V274, P2731, DOI 10.1098/rspb.2007.0670; MUENCHOW GE, 1989, AM NAT, V133, P149, DOI 10.1086/284906; Neal PR, 1998, ANNU REV ECOL SYST, V29, P345, DOI 10.1146/annurev.ecolsys.29.1.345; Nosil P, 2005, EVOLUTION, V59, P705; ORNDUFF R, 1975, NEW PHYTOL, V75, P161, DOI 10.1111/j.1469-8137.1975.tb01383.x; Pelabon C, 2012, ADAPTIVE LANDSCAPE IN EVOLUTIONARY BIOLOGY, P150; Perez-Barrales R, 2010, J EVOLUTION BIOL, V23, P1117, DOI 10.1111/j.1420-9101.2010.01988.x; Perez-Barrales R, 2006, NEW PHYTOL, V171, P553, DOI 10.1111/j.1469-8137.2006.01819.x; Pfennig KS, 1998, P ROY SOC B-BIOL SCI, V265, P1743, DOI 10.1098/rspb.1998.0497; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; RICHARDS JH, 1993, AM J BOT, V80, P31, DOI 10.2307/2445117; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; Sanchez JM, 2010, ANN BOT-LONDON, V106, P321, DOI 10.1093/aob/mcq111; SANDERSON MJ, 1994, SCIENCE, V264, P1590, DOI 10.1126/science.264.5165.1590; Santos-Gally R, 2013, EVOLUTION, V67, P2072, DOI 10.1111/evo.12087; Sargent RD, 2004, P ROY SOC B-BIOL SCI, V271, P603, DOI 10.1098/rspb.2003.2644; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schwartz AK, 2006, EVOL ECOL RES, V8, P399; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; SHAPIRO AM, 1989, ANNU REV ENTOMOL, V34, P231, DOI 10.1146/annurev.en.34.010189.001311; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Sorenson MD, 2003, NATURE, V424, P928, DOI 10.1038/nature01863; Sota T, 1998, EVOLUTION, V52, P1507, DOI 10.1111/j.1558-5646.1998.tb02033.x; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; STEINER K E, 1989, Lindleyana, V4, P164; STILES FG, 1975, ECOLOGY, V56, P285, DOI 10.2307/1934961; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; STONE JL, 1995, AM J BOT, V82, P1390, DOI 10.2307/2445865; Valente LM, 2012, AM NAT, V180, P83, DOI 10.1086/666003; Vamosi JC, 2011, AM J BOT, V98, P460, DOI 10.3732/ajb.1000311; van der Niet T, 2012, TRENDS ECOL EVOL, V27, P353, DOI 10.1016/j.tree.2012.02.002; Weller SG, 2009, BOT J LINN SOC, V160, P249, DOI 10.1111/j.1095-8339.2009.00984.x; WILLSON MF, 1979, AM NAT, V113, P777, DOI 10.1086/283437; WOLFE LM, 1989, BIOL J LINN SOC, V36, P317, DOI 10.1111/j.1095-8312.1989.tb00498.x; Xu Shuqing, 2012, International Journal of Ecology, P1; Xu SQ, 2011, EVOLUTION, V65, P2606, DOI 10.1111/j.1558-5646.2011.01323.x	121	9	9	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106512	10.1371/journal.pone.0106512	http://dx.doi.org/10.1371/journal.pone.0106512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211280	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000341855900015
J	Lan, WX; Wang, ZH; Yang, ZZ; Ying, TL; Zhang, X; Tan, XS; Liu, ML; Cao, CY; Huang, ZX				Lan, Wenxian; Wang, Zhonghua; Yang, Zhongzheng; Ying, Tianlei; Zhang, Xu; Tan, Xiangshi; Liu, Maili; Cao, Chunyang; Huang, Zhong-Xian			Structural Basis for Cytochrome c Y67H Mutant to Function as a Peroxidase	PLOS ONE			English	Article							ALKALINE CONFORMATIONAL TRANSITION; YEAST ISO-1-CYTOCHROME-C; HYDROGEN-PEROXIDE; MET80X MUTANTS; PROTEIN; NMR; RESOLUTION; SPECTROSCOPY; TYROSINE-67; VARIANT	The catalytic activity of cytochrome c (cyt c) to peroxidize cardiolipin to its oxidized form is required for the release of proapoptotic factors from mitochondria, and for execution of the subsequent apoptotic steps. However, the structural basis for this peroxidation reaction remains unclear. In this paper, we determined the three-dimensional NMR solution structure of yeast cyt c Y67H variant with high peroxidase activity, which is almost similar to that of its native form. The structure reveals that the hydrogen bond between Met80 and residue 67 is disrupted. This change destabilizes the sixth coordination bond between heme Fe3+ ion and Met80 sulfur atom in the Y67H variant, and further makes it more easily be broken at low pH conditions. The steady-state studies indicate that the Y67H variant has the highest peroxidase activities when pH condition is between 4.0 and 5.2. Finally, a mechanism is suggested for the peroxidation of cardiolipin catalyzed by the Y67H variant, where the residue His67 acts as a distal histidine, its protonation facilitates O-O bond cleavage of H2O2 by functioning as an acidic catalyst.	[Lan, Wenxian; Yang, Zhongzheng; Cao, Chunyang] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Nat Prod & Bioorgan Chem, Shanghai 200032, Peoples R China; [Wang, Zhonghua; Ying, Tianlei; Tan, Xiangshi; Huang, Zhong-Xian] Fudan Univ, Dept Chem, Biol Chem Lab, Shanghai 200433, Peoples R China; [Zhang, Xu; Liu, Maili] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Fudan University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Cao, CY (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Nat Prod & Bioorgan Chem, 345 Lingling Lu, Shanghai 200032, Peoples R China.	ccao@mail.sioc.ac.cn; zxhuang@fudan.edu.cn	应, 天雷/P-5396-2019; Liu, Maili/A-8543-2011; Zhang, Xu/B-4753-2015	应, 天雷/0000-0002-9597-2843; Liu, Maili/0000-0002-9359-915X; 	National Basic Research Program of China [2009CB918600, 2011CB966300]; National Science Fundation of China [10979005, 20921091, 30900227]	National Basic Research Program of China(National Basic Research Program of China); National Science Fundation of China	This work was supported by National Basic Research Program of China under No. 2009CB918600 and 2011CB966300, and by National Science Fundation of China under No. 10979005, 20921091 and 30900227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assfalg M, 2003, J AM CHEM SOC, V125, P2913, DOI 10.1021/ja027180s; Baistrocchi P, 1996, BIOCHEMISTRY-US, V35, P13788, DOI 10.1021/bi961110e; BALDWIN DA, 1987, J INORG BIOCHEM, V30, P203, DOI 10.1016/0162-0134(87)80064-8; Banci L, 1997, BIOCHEMISTRY-US, V36, P8992, DOI 10.1021/bi963025c; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; BERGHUIS AM, 1994, J MOL BIOL, V235, P1326, DOI 10.1006/jmbi.1994.1086; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; CUTLER RL, 1987, PROTEIN ENG, V1, P95, DOI 10.1093/protein/1.2.95; DEPILLIS GD, 1991, J BIOL CHEM, V266, P19334; Diederix REM, 2001, EUR J BIOCHEM, V268, P4207, DOI 10.1046/j.1432-1327.2001.02335.x; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; GAO Y, 1990, BIOCHEMISTRY-US, V29, P6994, DOI 10.1021/bi00482a007; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuszewski J, 2000, J MAGN RESON, V146, P249, DOI 10.1006/jmre.2000.2142; Lan WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027219; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu Z, 2006, P NATL ACAD SCI USA, V103, P8965, DOI 10.1073/pnas.0603327103; MACURA S, 1982, J MAGN RESON, V47, P351, DOI 10.1016/0022-2364(82)90128-7; Murphy ME, 1993, THESIS U BRIT COLUMB, P96; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Ozaki S, 2000, COORDIN CHEM REV, V198, P39, DOI 10.1016/S0010-8545(00)00234-4; PETTIGREW GW, 1975, BIOCHEM J, V147, P291, DOI 10.1042/bj1470291; PIELAK GJ, 1988, EUR J BIOCHEM, V177, P167, DOI 10.1111/j.1432-1033.1988.tb14359.x; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pollock WBR, 1998, BIOCHEMISTRY-US, V37, P6124, DOI 10.1021/bi972188d; Rosell FI, 1998, J AM CHEM SOC, V120, P11234, DOI 10.1021/ja971756+; Rosell FI, 2002, BIOCHEMISTRY-US, V41, P7811, DOI 10.1021/bi016060e; Silkstone G, 2002, BIOPHYS CHEM, V98, P65, DOI 10.1016/S0301-4622(02)00085-6; Silkstone GG, 2005, J AM CHEM SOC, V127, P92, DOI 10.1021/ja045719b; TAKANO T, 1981, J MOL BIOL, V153, P79, DOI 10.1016/0022-2836(81)90528-3; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Villegas JA, 2000, CHEM BIOL, V7, P237, DOI 10.1016/S1074-5521(00)00098-3; Vinson VJ, 2009, SCIENCE, V324, P197, DOI 10.1126/science.324.5924.197; Wilson M. T., 1996, CYTOCHROME C MULTIDI, P611; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P130; Ying TL, 2010, CHEM COMMUN, V46, P3541, DOI 10.1039/b926261j; Ying TL, 2009, CHEM COMMUN, P4512, DOI 10.1039/b904347k	44	26	26	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107305	10.1371/journal.pone.0107305	http://dx.doi.org/10.1371/journal.pone.0107305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210769	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900059
J	Shen, D; Liu, T; Lin, QF; Lu, XD; Wang, Q; Lin, F; Mao, WD				Shen, Dong; Liu, Tao; Lin, Qingfen; Lu, Xiangdong; Wang, Qiong; Lin, Feng; Mao, Weidong			MGMT Promoter Methylation Correlates with an Overall Survival Benefit in Chinese High-Grade Glioblastoma Patients Treated with Radiotherapy and Alkylating Agent-Based Chemotherapy: A Single-Institution Study	PLOS ONE			English	Article							PROTEIN EXPRESSION; PREGNANT-WOMEN; TEMOZOLOMIDE; GENE; IMMUNOHISTOCHEMISTRY; H1N1	Promoter methylation of the O-6-methylguanine-DNA-methyltransferase (MGMT) gene has been considered a prognostic marker and has become more important in the treatment of glioblastoma. However, reports on the correlation between MGMT and clinical outcomes in Chinese glioblastoma patients are very scarce. In this study, quantitative methylation data were obtained by the pyrosequencing of tumor tissues from 128 GBM patients. The median overall survival (OS) was 13.1 months, with a 1-year survival of 45.3%. The pyrosequencing data were reproducible based on archived samples yielding data for all glioblastomas. MGMT promoter methylation was detected in 75/128 cases (58.6%), whereas 53/128 (41.4%) cases were unmethylated. Further survival analysis also revealed that methylation was an independent prognostic factor associated with prolonged OS but not with progression-free survival (PFS) (p = 0.029 and p = 0.112, respectively); the hazard radios were 0.63 (95% CI: 0.42-0.96) and 0.72 (95% CI: 0.48-1.09), respectively. These data indicated that MGMT methylation has prognostic significance in patients with newly diagnosed high-grade glioblastoma undergoing alkylating agent-based chemotherapy after surgical resection.	[Shen, Dong; Liu, Tao; Lin, Qingfen; Lu, Xiangdong; Wang, Qiong; Lin, Feng; Mao, Weidong] Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Oncol, Jiangyin, Peoples R China	Southeast University - China	Mao, WD (corresponding author), Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Oncol, Jiangyin, Peoples R China.	wdmao_jy@163.com		mao, weidong/0000-0002-9900-8058				Bady P, 2012, ACTA NEUROPATHOL, V124, P547, DOI 10.1007/s00401-012-1016-2; Berghoff AS, 2012, CLIN NEUROPATHOL, V31, P405, DOI 10.5414/NP300576; Carrillo JA, 2012, AM J NEURORADIOL, V33, P1349, DOI 10.3174/ajnr.A2950; Christians A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033449; Christmann M, 2010, INT J CANCER, V127, P2106, DOI 10.1002/ijc.25229; Costa BM, 2010, ONCOL REP, V23, P1655, DOI 10.3892/or_00000808; Della Puppa A, 2012, J NEURO-ONCOL, V106, P33, DOI 10.1007/s11060-011-0639-9; Donson AM, 2007, PEDIATR BLOOD CANCER, V48, P403, DOI 10.1002/pbc.20803; Drabycz S, 2010, NEUROIMAGE, V49, P1398, DOI 10.1016/j.neuroimage.2009.09.049; Dunn J, 2009, BRIT J CANCER, V101, P124, DOI 10.1038/sj.bjc.6605127; Ellington SR, 2011, AM J OBSTET GYNECOL, V204, pS21, DOI 10.1016/j.ajog.2011.02.038; Fabi A, 2009, ANTICANCER RES, V29, P2607; Gerstner ER, 2009, NEUROLOGY, V73, P1509, DOI 10.1212/WNL.0b013e3181bf9907; Hau P, 2007, DIS MARKERS, V23, P97, DOI 10.1155/2007/159242; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Kim YS, 2012, INT J RADIAT ONCOL, V84, P661, DOI 10.1016/j.ijrobp.2011.12.086; Kitange GJ, 2012, CLIN CANCER RES, V18, P4070, DOI 10.1158/1078-0432.CCR-12-0560; Kitange GJ, 2009, J NEURO-ONCOL, V92, P23, DOI 10.1007/s11060-008-9737-8; Lechapt-Zalcman E, 2012, CANCER-AM CANCER SOC, V118, P4545, DOI 10.1002/cncr.27441; Malley DS, 2011, ACTA NEUROPATHOL, V121, P651, DOI 10.1007/s00401-011-0803-5; Nehru GA, 2012, NEUROL INDIA, V60, P481, DOI 10.4103/0028-3886.103190; Park CK, 2009, NEUROPATHOLOGY, V29, P443, DOI 10.1111/j.1440-1789.2008.00998.x; Reifenberger G, 2012, INT J CANCER, V131, P1342, DOI 10.1002/ijc.27385; Romano A, 2013, EUR RADIOL, V23, P513, DOI 10.1007/s00330-012-2601-4; Sasai K, 2008, AM J SURG PATHOL, V32, P1220, DOI 10.1097/PAS.0b013e318164c3f0; SteelFisher GK, 2011, AM J OBSTET GYNECOL, V204, pS116, DOI 10.1016/j.ajog.2011.02.036; Tang K, 2012, MED ONCOL, V29, P1292, DOI 10.1007/s12032-011-9901-4; Thon N, 2011, J NEUROL NEUROSUR PS, V82, P441, DOI 10.1136/jnnp.2010.214593; Uno M, 2011, CLINICS, V66, P1747, DOI 10.1590/S1807-59322011001000013	29	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107558	10.1371/journal.pone.0107558	http://dx.doi.org/10.1371/journal.pone.0107558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211033	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900084
J	Stripp, ST; Lindenstrauss, U; Granich, C; Sawers, RG; Soboh, B				Stripp, Sven T.; Lindenstrauss, Ute; Granich, Claudia; Sawers, R. Gary; Soboh, Basem			The Influence of Oxygen on [NiFe]-Hydrogenase Cofactor Biosynthesis and How Ligation of Carbon Monoxide Precedes Cyanation	PLOS ONE			English	Article							MATURATION PROTEINS HYPC; ACTIVE-SITE; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; HYDROGENASES; ACTIVATION; MECHANISM; COMPLEX; CN; INTERMEDIATE	The class of [NiFe]-hydrogenases is characterized by a bimetallic cofactor comprising low-spin nickel and iron ions, the latter of which is modified with a single carbon monoxide (CO) and two cyanide (CN-) molecules. Generation of these ligands in vivo requires a complex maturation apparatus in which the HypC-HypD complex acts as a 'construction site' for the Fe-(CN)(2)CO portion of the cofactor. The order of addition of the CO and CN-ligands determines the ultimate structure and catalytic efficiency of the cofactor; however much debate surrounds the succession of events. Here, we present an FT-IR spectroscopic analysis of HypC-HypD isolated from a hydrogenase-competent wild-type strain of Escherichia coli. In contrast to previously reported samples, HypC-HypD showed spectral contributions indicative of an electron-rich Fe-CO cofactor, at the same time lacking any Fe-CN -signatures. This immature iron site binds external CO and undergoes oxidative damage when in contact with O-2. Binding of CO protects the site against loss of spectral features associated with O-2 damage. Our findings strongly suggest that CO ligation precedes cyanation in vivo. Furthermore, the results provide a rationale for the deleterious effects of O-2 on in vivo cofactor biosynthesis.	[Stripp, Sven T.] Free Univ Berlin, Dept Phys, Berlin, Germany; [Lindenstrauss, Ute; Granich, Claudia; Sawers, R. Gary; Soboh, Basem] Univ Halle Wittenberg, Inst Microbiol, Halle, Saale, Germany	Free University of Berlin; Martin Luther University Halle Wittenberg	Stripp, ST (corresponding author), Free Univ Berlin, Dept Phys, Berlin, Germany.	sven.stripp@fu-berlin.de	Stripp, Sven Timo/O-9051-2019	Stripp, Sven Timo/0000-0002-8412-0258	EU; DFG [SA 494/3-2]	EU(European Commission); DFG(German Research Foundation (DFG))	RGS acknowledges the EU for EFRE funds and the DFG (Grant SA 494/3-2) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albareda M, 2013, J PHYS CHEM B, V117, P13523, DOI 10.1021/jp407574n; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Burstel I, 2012, J BIOL CHEM, V287, P38845, DOI 10.1074/jbc.M112.376947; CASADABAN MJ, 1976, J MOL BIOL, V104, P557, DOI 10.1016/0022-2836(76)90120-0; Casalot L, 2001, TRENDS MICROBIOL, V9, P228, DOI 10.1016/S0966-842X(01)02009-1; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Fritsch J, 2013, NAT REV MICROBIOL, V11, P106, DOI 10.1038/nrmicro2940; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Happe RP, 1997, NATURE, V385, P126, DOI 10.1038/385126a0; Hexter SV, 2012, P NATL ACAD SCI USA, V109, P11516, DOI 10.1073/pnas.1204770109; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; Jeoung JH, 2007, SCIENCE, V318, P1461, DOI 10.1126/science.1148481; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Lukey MJ, 2011, J AM CHEM SOC, V133, P16881, DOI 10.1021/ja205393w; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Pinske C, 2011, BMC MICROBIOL, V11, P1; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Roseboom W, 2006, J BIOL INORG CHEM, V11, P102, DOI 10.1007/s00775-005-0040-2; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Shomura Y, 2012, J BIOL CHEM, V287, P28409, DOI 10.1074/jbc.M112.387134; Soboh B, 2013, FEBS LETT, V587, P2512, DOI 10.1016/j.febslet.2013.06.055; Soboh B, 2012, FEBS LETT, V586, P3882, DOI 10.1016/j.febslet.2012.09.019; STADTMAN ER, 1991, J BIOL CHEM, V266, P17201; Stripp ST, 2013, BIOCHEMISTRY-US, V52, P3289, DOI 10.1021/bi400302v; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; Tominaga T, 2013, P NATL ACAD SCI USA, V110, P20485, DOI 10.1073/pnas.1313620110; Tominaga T, 2012, ACTA CRYSTALLOGR F, V68, P1153, DOI 10.1107/S1744309112036421; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Watanabe S, 2012, STRUCTURE, V20, P2124, DOI 10.1016/j.str.2012.09.018; Watanabe S, 2012, BIOL CHEM, V393, P1089, DOI 10.1515/hsz-2012-0197; WINK DA, 1994, P NATL ACAD SCI USA, V91, P6604, DOI 10.1073/pnas.91.14.6604	40	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107488	10.1371/journal.pone.0107488	http://dx.doi.org/10.1371/journal.pone.0107488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211029	Green Submitted, Green Published, gold			2022-12-27	WOS:000341855900077
J	Deber, MPL; Hickman, DT; Nand, D; Baldus, M; Pfeifer, A; Muhs, A				Deber, Maria Pilar Lopez; Hickman, David T.; Nand, Deepak; Baldus, Marc; Pfeifer, Andrea; Muhs, Andreas			Engineering Amyloid-Like Assemblies from Unstructured Peptides via Site-Specific Lipid Conjugation	PLOS ONE			English	Article							BETA-SHEET; SECONDARY STRUCTURE; MOLECULAR-DYNAMICS; FIBRILS; NMR; HEXAFLUOROISOPROPANOL; ANTIPARALLEL; AGGREGATION; NUCLEATION; DISEASE	Aggregation of amyloid beta (A beta) into oligomers and fibrils is believed to play an important role in the development of Alzheimer's disease (AD). To gain further insight into the principles of aggregation, we have investigated the induction of beta-sheet secondary conformation from disordered native peptide sequences through lipidation, in 1-2% hexafluoroisopropanol (HFIP) in phosphate buffered saline (PBS). Several parameters, such as type and number of lipid chains, peptide sequence, peptide length and net charge, were explored keeping the ratio peptide/HFIP constant. The resulting lipoconjugates were characterized by several physico-chemical techniques: Circular Dichroism (CD), Attenuated Total Reflection InfraRed (ATR-IR), Thioflavin T (ThT) fluorescence, Dynamic Light Scattering (DLS), solid-state Nuclear Magnetic Resonance (ssNMR) spectroscopy and Electron Microscopy (EM). Our data demonstrate the generation of beta-sheet aggregates from numerous unstructured peptides under physiological pH, independent of the amino acid sequence. The amphiphilicity pattern and hydrophobicity of the scaffold were found to be key factors for their assembly into amyloid-like structures.	[Deber, Maria Pilar Lopez; Hickman, David T.; Pfeifer, Andrea; Muhs, Andreas] AC Immune SA, Lausanne, Switzerland; [Nand, Deepak; Baldus, Marc] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands	Utrecht University	Muhs, A (corresponding author), AC Immune SA, Lausanne, Switzerland.	andreas.muhs@acimmune.com	Baldus, Marc/C-2737-2009	Baldus, Marc/0000-0001-7068-5613				BIELECKI A, 1989, CHEM PHYS LETT, V155, P341, DOI 10.1016/0009-2614(89)87166-0; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Burkoth TS, 2000, J AM CHEM SOC, V122, P7883, DOI 10.1021/ja000645z; Cavalli S, 2006, J AM CHEM SOC, V128, P13959, DOI 10.1021/ja065479v; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Epand RM, 1997, BIOPOLYMERS, V43, P15, DOI 10.1002/(SICI)1097-0282(1997)43:1<15::AID-BIP3>3.0.CO;2-3; Forns P, 2000, BIOPOLYMERS, V54, P531, DOI 10.1002/1097-0282(200012)54:7<531::AID-BIP60>3.0.CO;2-X; Gordon DJ, 2004, BIOPHYS J, V86, P428, DOI 10.1016/S0006-3495(04)74119-3; Gursky O, 2000, BBA-PROTEIN STRUCT M, V1476, P93, DOI 10.1016/S0167-4838(99)00228-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hickman DT, 2011, J BIOL CHEM, V286, P13966, DOI 10.1074/jbc.M110.186338; Kim W, 2005, J BIOL CHEM, V280, P35069, DOI 10.1074/jbc.M505763200; Koers EJ, 2013, ANGEW CHEM INT EDIT, V52, P10905, DOI 10.1002/anie.201303374; KRUG M, 1989, BIOPOLYMERS, V28, P499, DOI 10.1002/bip.360280144; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lowik DWPM, 2003, ORG BIOMOL CHEM, V1, P1827, DOI 10.1039/b303749e; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Nichols MR, 2005, J BIOL CHEM, V280, P2471, DOI 10.1074/jbc.M410553200; Nichols MR, 2005, MICROSC RES TECHNIQ, V67, P164, DOI 10.1002/jemt.20189; Nichols MR, 2005, BIOCHEMISTRY-US, V44, P165, DOI 10.1021/bi048846t; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Pallavi B, 2003, J BIOL CHEM, V278, P12737, DOI 10.1074/jbc.M208598200; Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Qahwash IM, 2007, J BIOL CHEM, V282, P36987, DOI 10.1074/jbc.M702146200; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; Roccatano D, 2005, PROTEIN SCI, V14, P2582, DOI 10.1110/ps.051426605; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; Schneider R, 2011, J MOL BIOL, V412, P121, DOI 10.1016/j.jmb.2011.06.045; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Tycko R, 2003, BIOCHEMISTRY-US, V42, P3151, DOI 10.1021/bi027378p; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Yanagi K, 2011, J BIOL CHEM, V286, P23959, DOI 10.1074/jbc.M111.226688; Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189; Zhang QH, 2004, P NATL ACAD SCI USA, V101, P4752, DOI 10.1073/pnas.0400924101	38	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e105641	10.1371/journal.pone.0105641	http://dx.doi.org/10.1371/journal.pone.0105641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207975	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300010
J	Espinoza, M; Cappo, M; Heupel, MR; Tobin, AJ; Simpfendorfer, CA				Espinoza, Mario; Cappo, Mike; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.			Quantifying Shark Distribution Patterns and Species-Habitat Associations: Implications of Marine Park Zoning	PLOS ONE			English	Article							GREAT-BARRIER-REEF; GALEOCERDO-CUVIER; TIGER SHARKS; CARCHARHINUS-MELANOPTERUS; MOVEMENT PATTERNS; GENETIC-EVIDENCE; RISK; BIOLOGY; CONSERVATION; BIODIVERSITY	Quantifying shark distribution patterns and species-specific habitat associations in response to geographic and environmental drivers is critical to assessing risk of exposure to fishing, habitat degradation, and the effects of climate change. The present study examined shark distribution patterns, species-habitat associations, and marine reserve use with baited remote underwater video stations (BRUVS) along the entire Great Barrier Reef Marine Park (GBRMP) over a ten year period. Overall, 21 species of sharks from five families and two orders were recorded. Grey reef Carcharhinus amblyrhynchos, silvertip C. albimarginatus, tiger Galeocerdo cuvier, and sliteye Loxodon macrorhinus sharks were the most abundant species (>64% of shark abundances). Multivariate regression trees showed that hard coral cover produced the primary split separating shark assemblages. Four indicator species had consistently higher abundances and contributed to explaining most of the differences in shark assemblages: C. amblyrhynchos, C. albimarginatus, G. cuvier, and whitetip reef Triaenodon obesus sharks. Relative distance along the GBRMP had the greatest influence on shark occurrence and species richness, which increased at both ends of the sampling range (southern and northern sites) relative to intermediate latitudes. Hard coral cover and distance across the shelf were also important predictors of shark distribution. The relative abundance of sharks was significantly higher in non-fished sites, highlighting the conservation value and benefits of the GBRMP zoning. However, our results also showed that hard coral cover had a large effect on the abundance of reef-associated shark species, indicating that coral reef health may be important for the success of marine protected areas. Therefore, understanding shark distribution patterns, species-habitat associations, and the drivers responsible for those patterns is essential for developing sound management and conservation approaches.	[Espinoza, Mario; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Espinoza, Mario; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Espinoza, Mario] James Cook Univ, AIMS JCU, Australian Inst Marine Sci, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Cappo, Mike; Heupel, Michelle R.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	James Cook University; James Cook University; Australian Institute of Marine Science; James Cook University; Australian Institute of Marine Science	Espinoza, M (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.	mario.espinoza@my.jcu.edu.au	Simpfendorfer, Colin A/G-9681-2011	Simpfendorfer, Colin A/0000-0002-0295-2238; Heupel, Michelle/0000-0002-8245-7332	Australian Government's National Environmental Research Program [6.1]; Australian Research Council [FT100101004]; Australian Endeavour Scholarship; AIMS@JCU Scholarship; CRC Reef Research Centre; Fisheries Research and Development Corporation (FRDC); National Oceans Office	Australian Government's National Environmental Research Program(Australian Government); Australian Research Council(Australian Research Council); Australian Endeavour Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); AIMS@JCU Scholarship; CRC Reef Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Fisheries Research and Development Corporation (FRDC)(Fisheries R&D Corp); National Oceans Office	Funding for this analysis was provided by the Australian Government's National Environmental Research Program (Tropical Ecosystems Hub Project 6.1) awarded to MRH, CAS, and AJT. MRH was supported by a Future Fellowship (#FT100101004) from the Australian Research Council, and ME was supported by Australian Endeavour and AIMS@JCU Scholarships. This study is also an output of the 'Great Barrier Reef Seabed Biodiversity Project', which was funded by the CRC Reef Research Centre, the Fisheries Research and Development Corporation (FRDC), and the National Oceans Office, and led by R. Pitcher (Principal Investigator, CSIRO), P. Doherty (AIMS), J. Hooper (QM), and N. Gribble (QDPIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; Ayling A.M., 2008, ABUNDANCE PATTERNS R; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bridge T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048203; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; Chapman DD, 2013, SCIENCE, V339, P757, DOI 10.1126/science.339.6121.757-a; Chin A, 2013, AQUAT CONSERV, V23, P468, DOI 10.1002/aqc.2349; Chin A, 2012, MAR ECOL PROG SER, V460, P115, DOI 10.3354/meps09722; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Condie SA, 2006, MAR FRESHWATER RES, V57, P569, DOI 10.1071/MF06009; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Department of Employment Economic Development and Innovation Queensland (DEEDI), 2011, PLAN ASS QUEENSL E C; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dulvy NK, 2013, AQUAT CONSERV, V23, P357, DOI 10.1002/aqc.2358; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fabricius K, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P127; Fabricius KE, 2008, ECOLOGY, V89, P3163, DOI 10.1890/08-0005.1; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Gallagher AJ, 2014, MAR ECOL PROG SER, V496, P207, DOI 10.3354/meps10490; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Guisande C, 2013, BIODIVERS CONSERV, V22, P1703, DOI 10.1007/s10531-013-0507-3; Hancock GJ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003608; Harry AV, 2011, MAR FRESHWATER RES, V62, P710, DOI 10.1071/MF10155; Harvey ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080955; Harvey ES, 2012, FISH RES, V125, P108, DOI 10.1016/j.fishres.2012.01.026; Hearn A, 2010, MAR BIOL, V157, P1899, DOI 10.1007/s00227-010-1460-2; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2005, MAR ECOL PROG SER, V288, P285, DOI 10.3354/meps288285; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Heupel MR, 2014, MAR ECOL PROG SER, V496, P47, DOI 10.3354/meps10529; Heupel MR, 2009, FISH RES, V95, P350, DOI 10.1016/j.fishres.2008.10.005; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Hisano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025028; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; Hopley D., 1989, J AUST GEOGR STUD, V27, P47, DOI 10.1111/j.1467-8470.1989.tb00591.x; Knip DM, 2012, MAR BIOL, V159, P1647, DOI 10.1007/s00227-012-1950-5; Knip DM, 2012, BIOL CONSERV, V148, P200, DOI 10.1016/j.biocon.2012.01.008; Kyne PM, 2008, CHONDRICHTHYANS QUEE; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Lucifora LO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019356; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; McCauley DJ, 2012, ECOL APPL, V22, P1711, DOI 10.1890/11-1653.1; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Menni RC, 2010, BIODIVERS CONSERV, V19, P775, DOI 10.1007/s10531-009-9734-z; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Miller KI, 2014, OCEAN COAST MANAGE, V96, P51, DOI 10.1016/j.ocecoaman.2014.05.003; Morgan JAT, 2012, CONSERV GENET, V13, P455, DOI 10.1007/s10592-011-0298-6; Mourier J, 2013, MOL ECOL, V22, P201, DOI 10.1111/mec.12103; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; Papastamatiou YP, 2010, J EXP MAR BIOL ECOL, V386, P94, DOI 10.1016/j.jembe.2010.02.009; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Papastamatiou YP, B ECOL SOC AM, V94, P250; Pitcher C. R., 2009, V2, P51; Pitcher CR, 2014, FISH RES, V151, P136, DOI 10.1016/j.fishres.2013.10.024; Pitcher CR, 2007, SEABED BIODIVERSITY; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; R Development Core Team, 2005, R LANG ENV STAT COMP; RANDALL JE, 1977, PAC SCI, V31, P143; Robbins WD, 2006, THESIS J COOK U; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; STEVENS JD, 1989, AUST J MAR FRESH RES, V40, P129; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Syms C., 2008, WIND EFFECTS ENCY EC, V2008, P2940, DOI [10.1016/B978-008045405-4.00538-3, DOI 10.1016/B978-008045405-4.00538-3]; Tillett J, 2012, J FISH BIOL, V80, P2140, DOI 10.1111/j.1095-8649.2012.03228.x; Tobin AJ, 2014, ENVIRON BIOL FISH, V97, P821, DOI 10.1007/s10641-013-0182-y; Vianna GMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060331; Wachenfeld D.R., 1998, STATE GREAT BARRIER; Ward TJ, 1999, ECOL APPL, V9, P691; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; Westerberg H, 2011, FISH RES, V110, P459, DOI 10.1016/j.fishres.2011.06.002; White J, 2013, J EXP MAR BIOL ECOL, V448, P281, DOI 10.1016/j.jembe.2013.08.004; Whitney NM, 2012, J BIOGEOGR, V39, P1144, DOI 10.1111/j.1365-2699.2011.02660.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Zuur Alain F., 2009, P1	88	99	101	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106885	10.1371/journal.pone.0106885	http://dx.doi.org/10.1371/journal.pone.0106885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207545	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000342030300046
J	Fernandez-Mendez, M; Wenzhofer, F; Peeken, I; Sorensen, HL; Glud, RN; Boetius, A				Fernandez-Mendez, Mar; Wenzhoefer, Frank; Peeken, Ilka; Sorensen, Heidi L.; Glud, Ronnie N.; Boetius, Antje			Composition, Buoyancy Regulation and Fate of Ice Algal Aggregates in the Central Arctic Ocean	PLOS ONE			English	Article							MELTING SEA-ICE; EXOPOLYMERIC SUBSTANCES; PARTICLES TEP; CARBON; DYNAMICS; DIATOM; PHYTOPLANKTON; TEMPERATURE; ABUNDANCE; SINKING	Sea-ice diatoms are known to accumulate in large aggregates in and under sea ice and in melt ponds. There is recent evidence from the Arctic that such aggregates can contribute substantially to particle export when sinking from the ice. The role and regulation of microbial aggregation in the highly seasonal, nutrient-and light-limited Arctic sea-ice ecosystem is not well understood. To elucidate the mechanisms controlling the formation and export of algal aggregates from sea ice, we investigated samples taken in late summer 2011 and 2012, during two cruises to the Eurasian Basin of the Central Arctic Ocean. Spherical aggregates densely packed with pennate diatoms, as well as filamentous aggregates formed by Melosira arctica showed sign of different stages of degradation and physiological stoichiometries, with carbon to chlorophyll a ratios ranging from 110 to 66700, and carbon to nitrogen molar ratios of 8-35 and 9-40, respectively. Sub-ice algal aggregate densities ranged between 1 and 17 aggregates m 22, maintaining an estimated net primary production of 0.4-40 mg C m(-2) d(-1), and accounted for 3-80% of total phototrophic biomass and up to 94% of local net primary production. A potential factor controlling the buoyancy of the aggregates was light intensity, regulating photosynthetic oxygen production and the amount of gas bubbles trapped within the mucous matrix, even at low ambient nutrient concentrations. Our data-set was used to evaluate the distribution and importance of Arctic algal aggregates as carbon source for pelagic and benthic communities.	[Fernandez-Mendez, Mar; Wenzhoefer, Frank; Boetius, Antje] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany; [Fernandez-Mendez, Mar; Wenzhoefer, Frank; Boetius, Antje] Max Planck Inst Marine Microbiol, HGF MPG Grp Deep Sea Ecol & Technol, Bremen, Germany; [Peeken, Ilka] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Bremerhaven, Germany; [Peeken, Ilka; Boetius, Antje] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Sorensen, Heidi L.; Glud, Ronnie N.] Univ Southern Denmark, Nordic Ctr Earth Evolut, Odense, Denmark; [Sorensen, Heidi L.; Glud, Ronnie N.] Greenland Climate Res Ctr, Nuuk, Greenland; [Glud, Ronnie N.] Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Glud, Ronnie N.] Univ Aarhus, Arctic Res Ctr, Aarhus, Denmark	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen; University of Southern Denmark; UHI Millennium Institute; Aarhus University	Fernandez-Mendez, M (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany.	mmendez@awi.de	Boetius, Antje/D-5459-2013	Boetius, Antje/0000-0003-2117-4176; Glud, Ronnie N./0000-0002-7069-893X; Peeken, Ilka/0000-0003-1531-1664; Fernandez-Mendez, Mar/0000-0002-4968-1156	Commission for Scientific Research in Greenland (KVUG) [GCRC6507]; European Research Council through an Advanced Grant [ERC-2010-AdG20100224]; Danish National Research Foundation [DNRF53]; Danish Council for Independent Research [12-125843]; European Research Council Advanced Investigator grant [294757]	Commission for Scientific Research in Greenland (KVUG); European Research Council through an Advanced Grant; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); European Research Council Advanced Investigator grant(European Research Council (ERC))	HLS and RNG were supported by the Commission for Scientific Research in Greenland (KVUG; GCRC6507), the European Research Council through an Advanced Grant (ERC-2010-AdG20100224), the Danish National Research Foundation (DNRF53) and the Danish Council for Independent Research (12-125843). This study was supported by the European Research Council Advanced Investigator grant 294757 to AB. Additional support came from the Helmholtz Association and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi AS, 2006, J PHYCOL, V42, P363, DOI 10.1111/j.1529-8817.2006.00193.x; ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; Ambrose WG, 2005, POLAR BIOL, V28, P784, DOI 10.1007/s00300-005-0002-8; ARRIGO KR, 1992, J PHYCOL, V28, P746, DOI 10.1111/j.0022-3646.1992.00746.x; Aslam SN, 2012, J PHYCOL, V48, P1494, DOI 10.1111/jpy.12004; Assmy P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076599; Bachy C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00106; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; BOWER CE, 1980, CAN J FISH AQUAT SCI, V37, P794, DOI 10.1139/f80-106; BRADSTREET MSW, 1982, ARCTIC, V35, P1; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; Brown ZW, 2012, ICES J MAR SCI, V69, P1180, DOI 10.1093/icesjms/fss113; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; COTA GF, 1985, NATURE, V315, P219, DOI 10.1038/315219a0; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; Damm E, 2010, BIOGEOSCIENCES, V7, P1099, DOI 10.5194/bg-7-1099-2010; DICKIE G, 1852, J VOYAGE BAFFINS BAY, V2, pR191; Eicken H, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000583; Engel A, 2001, MAR ECOL PROG SER, V219, P1, DOI 10.3354/meps219001; Engel A, 2009, PRACTICAL GUIDELINES, P18; Fahl K, 2007, DEEP-SEA RES PT I, V54, P1256, DOI 10.1016/j.dsr.2007.04.014; GALLEGOS CL, 1983, LIMNOL OCEANOGR, V28, P698, DOI 10.4319/lo.1983.28.4.0698; Glud RN, 2014, LIMNOL OCEANOGR, V59, P1097, DOI 10.4319/lo.2014.59.4.1097; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Gradinger R, 1999, DEEP-SEA RES PT II, V46, P1457, DOI 10.1016/S0967-0645(99)00030-2; Gran H.H., 1904, SCI RES NORW N POLAR, VIV, P1; GUTT J, 1995, POLAR BIOL, V15, P247; Hendricks S., 2012, AIRBORNE SEA ICE PLU, DOI [10.1594/PANGAEA.803312, DOI 10.1594/PANGAEA.803312]; Hill VJ, 2013, PROG OCEANOGR, V110, P107, DOI 10.1016/j.pocean.2012.11.005; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; HORNER RA, 1988, POLAR BIOL, V8, P249, DOI 10.1007/BF00263173; Huston AL, 2002, DEEP-SEA RES PT 1, V49, P22, DOI [10.1016/S0967-0645(02)00186-8, DOI 10.1016/S0967-0645(02)00186-8]; Iversen MH, 2010, BIOGEOSCIENCES, V7, P2613, DOI 10.5194/bg-7-2613-2010; Jackson GA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023180; Ji RB, 2013, GLOBAL CHANGE BIOL, V19, P734, DOI 10.1111/gcb.12074; Juhl AR, 2011, MAR ECOL PROG SER, V436, P1, DOI 10.3354/meps09277; KIORBOE T, 1990, MAR BIOL, V107, P235, DOI 10.1007/BF01319822; KIORBOE T, 1993, J PLANKTON RES, V15, P993, DOI 10.1093/plankt/15.9.993; Klimant I, 1997, SENSOR ACTUAT B-CHEM, V38, P29, DOI 10.1016/S0925-4005(97)80168-2; Krembs C, 2002, DEEP-SEA RES PT I, V49, P2163, DOI 10.1016/S0967-0637(02)00122-X; Lalande C, 2013, PROG OCEANOGR, V109, P70, DOI 10.1016/j.pocean.2012.09.006; Lee SH, 2011, OCEANOGRAPHY, V24, P302, DOI 10.5670/oceanog.2011.81; LEGENDRE L, 1992, POLAR BIOL, V12, P429; Lehto N, 2014, BIOGEOCHEMISTRY, V119, P307, DOI 10.1007/s10533-014-9967-0; Leu E, 2011, PROG OCEANOGR, V90, P18, DOI 10.1016/j.pocean.2011.02.004; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Li WKW, 2004, DEEP-SEA RES PT I, V51, P1529, DOI 10.1016/j.dsr.2004.06.012; Manes SS, 2009, PHOTOSYNTH RES, V102, P53, DOI 10.1007/s11120-009-9489-0; Mari X, 1998, MAR ECOL PROG SER, V163, P63, DOI 10.3354/meps163063; Maslanik JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032043; McMinn A, 2007, POLAR BIOL, V30, P289, DOI 10.1007/s00300-006-0182-x; Melnikov IA, 2002, DEEP-SEA RES PT I, V49, P1623, DOI 10.1016/S0967-0637(02)00042-0; Melnikov IA, 1977, ARCTIC SEA ICE ECOSY; MEYERREIL LA, 1983, MAR BIOL, V77, P247, DOI 10.1007/BF00395813; Michel C, 2006, PROG OCEANOGR, V71, P379, DOI 10.1016/j.pocean.2006.09.006; Mundy CJ, 2011, POLAR BIOL, V34, P1869, DOI 10.1007/s00300-011-0998-x; Nansen F., 1906, NORWEGIAN N POLAR EX, V1893-1896, P1; Nicolaus M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053738; Perovich DK, 1996, CRREL MONOGR, P1; PETERSON BJ, 1980, ANNU REV ECOL SYST, V11, P359, DOI 10.1146/annurev.es.11.110180.002043; Piontek J, 2009, AQUAT MICROB ECOL, V54, P305, DOI 10.3354/ame01273; Poltermann M, 2001, POLAR BIOL, V24, P89, DOI 10.1007/s003000000177; Poulin M, 2014, DIATOM RES, V29, P213, DOI 10.1080/0269249X.2013.877085; RIEBESELL U, 1991, POLAR BIOL, V11, P239; Riedel A., 2003, TAXONOMY ABUNDANCE M; Riedel A, 2006, AQUAT MICROB ECOL, V45, P195, DOI 10.3354/ame045195; Rosel A, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007869; Rothrock DA, 1999, GEOPHYS RES LETT, V26, P3469, DOI 10.1029/1999GL010863; Rysgaard S, 2004, LIMNOL OCEANOGR, V49, P86, DOI 10.4319/lo.2004.49.1.0086; Sherr EB, 2003, DEEP-SEA RES PT I, V50, P557, DOI 10.1016/S0967-0637(03)00031-1; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Slagstad D, 2011, PROG OCEANOGR, V90, P117, DOI 10.1016/j.pocean.2011.02.009; Smayda T. J., 1970, Oceanogr. mar. Biol., V8, P353; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Stein R., 2004, ORGANIC CARBON CYCLE; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; SYVERTSEN EE, 1991, POLAR RES, V10, P277, DOI 10.1111/j.1751-8369.1991.tb00653.x; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thomas D.N., 2010, SEA ICE, V2nd; Tran S, 2013, BIOGEOSCIENCES, V10, P1909, DOI 10.5194/bg-10-1909-2013; von Quillfeldt Cecilie H., 2009, P285; WAITE AM, 1992, LIMNOL OCEANOGR, V37, P468, DOI 10.4319/lo.1992.37.3.0468; Watanabe E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4950; Wheeler PA, 1996, NATURE, V380, P697, DOI 10.1038/380697a0; Wood MA, 1990, MARINE MICROBIAL FOO, V4, P103; Zernova VV, 2000, OCEANOLOGY+, V40, P801	88	62	66	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107452	10.1371/journal.pone.0107452	http://dx.doi.org/10.1371/journal.pone.0107452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208058	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000342030300083
J	Grigg, JC; Shumayrikh, N; Sen, D				Grigg, Jason C.; Shumayrikh, Nisreen; Sen, Dipankar			G-Quadruplex Structures Formed by Expanded Hexanucleotide Repeat RNA and DNA from the Neurodegenerative Disease-Linked C9orf72 Gene Efficiently Sequester and Activate Heme	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID-BETA PEPTIDE; CATALYTIC DNA; PEROXIDASE-ACTIVITY; OXIDATIVE STRESS; DNAZYME; BINDING; SPECIFICITY; COMPLEXES; EXPANSION	The expansion of a (G(4)C(2))(n) repeat within the human C9orf72 gene has been causally linked to a number of neurodegenerative diseases, most notably familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Recent studies have shown that the repeat expansion alters gene function in four ways, disrupting the gene's normal cellular roles and introducing toxic gain of function at the level of both DNA and RNA. (G(4)C(2))(n) DNA, as well as the RNA transcribed from it, are found to fold into four-stranded G-quadruplex structures. It has been shown that the toxicity of the RNA G-quadruplexes, often localized in intracellular RNA foci, lies in their ability to sequester many important RNA binding proteins. Herein we propose that a distinct toxic property of such RNA and DNA G-quadruplexes from the C9orf72 gene may arise from their ability to bind and oxidatively activate cellular heme. We show that G-quadruplexes formed by both (G(4)C(2))(4) RNA and DNA not only complex tightly with heme but also enhance its intrinsic peroxidase and oxidase propensities. By contrast, the antisense (C(4)G(2))(4) RNA and DNA neither bind heme nor influence its oxidative activity. Curiously, the ability of C9orf72 DNA and transcripts to bind and activate heme mirror similar properties that have been reported for the Ab peptide and its oligomers in Alzheimer's disease neurons. It is therefore conceivable that C9orf72 RNA G-quadruplex tangles play roles in sequestering intracellular heme and promoting oxidative damage in ALS and FTD analogous to those proposed for Ab peptide and its tangles in Alzheimer's Disease. Given that neurodegenerative diseases in general are characterized by mitochondrial and respiratory malfunctions, the role of C9orf72 DNA and RNA in heme sequestration as well as its inappropriate activation in ALS and FTD neurons may warrant examination.	[Grigg, Jason C.; Sen, Dipankar] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Shumayrikh, Nisreen; Sen, Dipankar] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Sen, D (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	sen@sfu.ca			Natural Sciences and Engineering Research Council of Canada; Canadian Institute of Health Research; Saudi Ministry of Culture	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Saudi Ministry of Culture	DS received funding form the Natural Sciences and Engineering Research Council of Canada. JG received a Postdoctoral Fellowship from the Canadian Institute of Health Research. NS was supported by the Saudi Ministry of Culture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Atamna H, 2006, J ALZHEIMERS DIS, V10, P255; Atamna H, 2009, ARCH BIOCHEM BIOPHYS, V487, P59, DOI 10.1016/j.abb.2009.05.003; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bieniek KF, 2014, JAMA NEUROL, V71, P775, DOI 10.1001/jamaneurol.2013.6368; Campbell NH, 2012, METAL IONS LIFE SCI, V10, P119, DOI 10.1007/978-94-007-2172-2_4; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Golub E, 2011, ANGEW CHEM INT EDIT, V50, P1; Gunther MR, 2004, ARCH BIOCHEM BIOPHYS, V431, P207, DOI 10.1016/j.abb.2004.08.009; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Jeong SY, 2009, J NEUROSCI, V29, P570, DOI 10.1523/JNEUROSCI.5443-08.2009; Kong DM, 2009, BIOPOLYMERS, V91, P331, DOI 10.1002/bip.21135; Li T, 2009, CHEM-ASIAN J, V4, P918, DOI 10.1002/asia.200900019; Li YF, 1996, NAT STRUCT BIOL, V3, P743, DOI 10.1038/nsb0996-743; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Liu DX, 1999, FASEB J, V13, P2318, DOI 10.1096/fasebj.13.15.2318; Luedtke NW, 2009, CHIMIA, V63, P134, DOI 10.2533/chimia.2009.134; Maizels N, 2012, ANN NY ACAD SCI, V1267, P53, DOI 10.1111/j.1749-6632.2012.06586.x; Mignarri A, 2014, J NEUROL SCI, V341, P176, DOI 10.1016/j.jns.2014.03.030; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; Moss DJH, 2014, NEUROLOGY, V82, P292, DOI 10.1212/WNL.0000000000000061; Pletnikova O, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.009; Poon LCH, 2011, J AM CHEM SOC, V133, P1877, DOI 10.1021/ja108571a; Qi C, 2014, RSC ADV, V4, P1441, DOI 10.1039/c3ra45429k; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rojas AM, 2007, BIOTECHNOL LETT, V29, P227, DOI 10.1007/s10529-006-9228-y; Sadrzadeh S M Hossein, 2004, Am J Clin Pathol, V121 Suppl, pS64; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Sen D, 2011, CRIT REV BIOCHEM MOL, V46, P478, DOI 10.3109/10409238.2011.618220; Smith AG, 2011, METALLOMICS, V3, P955, DOI 10.1039/c1mt00085c; Taylor JP, 2014, NATURE, V507, P175, DOI 10.1038/nature13067; Travascio P, 1998, CHEM BIOL, V5, P505, DOI 10.1016/S1074-5521(98)90006-0; Travascio P, 1999, CHEM BIOL, V6, P779, DOI 10.1016/S1074-5521(99)80125-2; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; Wang Y, 1997, BIOCHEMISTRY-US, V36, P768, DOI 10.1021/bi962095g; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; Zamiri B, 2014, J BIOL CHEM, V289, P4653, DOI 10.1074/jbc.C113.502336; Zhou YL, 2013, ACS CHEM NEUROSCI, V4, P535, DOI 10.1021/cn300231q	44	41	41	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106449	10.1371/journal.pone.0106449	http://dx.doi.org/10.1371/journal.pone.0106449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207541	gold, Green Submitted, Green Published			2022-12-27	WOS:000342030300022
J	Koehler, JW; Hall, AT; Rolfe, PA; Honko, AN; Palacios, GF; Fair, JN; Muyembe, JJ; Mulembekani, P; Schoepp, RJ; Adesokan, A; Minogue, TD				Koehler, Jeffrey W.; Hall, Adrienne T.; Rolfe, P. Alexander; Honko, Anna N.; Palacios, Gustavo F.; Fair, Joseph N.; Muyembe, Jean-Jacques; Mulembekani, Prime; Schoepp, Randal J.; Adesokan, Adeyemi; Minogue, Timothy D.			Development and Evaluation of a Panel of Filovirus Sequence Capture Probes for Pathogen Detection by Next-Generation Sequencing	PLOS ONE			English	Article							MULTIPLEX; PCR; DIFFERENTIATION; ASSAYS; VIRUS	A detailed understanding of the circulating pathogens in a particular geographic location aids in effectively utilizing targeted, rapid diagnostic assays, thus allowing for appropriate therapeutic and containment procedures. This is especially important in regions prevalent for highly pathogenic viruses co-circulating with other endemic pathogens such as the malaria parasite. The importance of biosurveillance is highlighted by the ongoing Ebola virus disease outbreak in West Africa. For example, a more comprehensive assessment of the regional pathogens could have identified the risk of a filovirus disease outbreak earlier and led to an improved diagnostic and response capacity in the region. In this context, being able to rapidly screen a single sample for multiple pathogens in a single tube reaction could improve both diagnostics as well as pathogen surveillance. Here, probes were designed to capture identifying filovirus sequence for the ebolaviruses Sudan, Ebola, Reston, Tai Forest, and Bundibugyo and the Marburg virus variants Musoke, Ci67, and Angola. These probes were combined into a single probe panel, and the captured filovirus sequence was successfully identified using the MiSeq next-generation sequencing platform. This panel was then used to identify the specific filovirus from nonhuman primates experimentally infected with Ebola virus as well as Bundibugyo virus in human sera samples from the Democratic Republic of the Congo, thus demonstrating the utility for pathogen detection using clinical samples. While not as sensitive and rapid as real-time PCR, this panel, along with incorporating additional sequence capture probe panels, could be used for broad pathogen screening and biosurveillance.	[Koehler, Jeffrey W.; Hall, Adrienne T.; Schoepp, Randal J.; Minogue, Timothy D.] US Army, Med Res Inst Infect Dis, Diagnost Syst Div, Ft Detrick, MD 21702 USA; [Rolfe, P. Alexander; Adesokan, Adeyemi] Pathogenica Inc, Boston, MA USA; [Honko, Anna N.] US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Palacios, Gustavo F.] US Army, Med Res Inst Infect Dis, Ctr Genom Sci, Ft Detrick, MD 21702 USA; [Fair, Joseph N.] Metabiota, San Francisco, CA USA; [Muyembe, Jean-Jacques] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Mulembekani, Prime] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO	Institute Nacional de Recherche Biomedical	Minogue, TD (corresponding author), US Army, Med Res Inst Infect Dis, Diagnost Syst Div, Ft Detrick, MD 21702 USA.	timothy.d.minogue.civ@mail.mil	Palacios, Gustavo/I-7773-2015; Schoepp, Randal/L-8578-2019; Schoepp, Randal J./F-3330-2019; Honko, Anna/H-9539-2019	Palacios, Gustavo/0000-0001-5062-1938; Schoepp, Randal/0000-0002-5026-0404; Schoepp, Randal J./0000-0002-5026-0404; Honko, Anna/0000-0001-9165-148X; Rolfe, Alex/0000-0003-3540-1843	Defense Threat Reduction Agency (DTRA) [CB3630, CB2999]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This project was funded by the Defense Threat Reduction Agency (DTRA; http://dtra.mil) under grant numbers CB3630 and CB2999. Reference materials, including aliquots of diagnostic samples, were obtained through a collaboration with National Institute of Biomedical Research (French acronym INRB) in Kinshasa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P421; Baize S., 2014, N ENGL J MED; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06; Elbir H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002042; JAHRLING PB, 1990, LANCET, V335, P502, DOI 10.1016/0140-6736(90)90737-P; Janse I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-86; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kuhn JH, 2014, ARCH VIROL, V159, P1229, DOI 10.1007/s00705-013-1877-2; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Schoepp RJ, 2014, EMERG INFECT DIS; Shen PD, 2011, P NATL ACAD SCI USA, V108, P6549, DOI 10.1073/pnas.1018981108; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116	19	21	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107007	10.1371/journal.pone.0107007	http://dx.doi.org/10.1371/journal.pone.0107007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207553	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300054
J	Abugessaisa, I; Saevarsdottir, S; Tsipras, G; Lindblad, S; Sandin, C; Nikamo, P; Stahle, M; Malmstrom, V; Klareskog, L; Tegner, J				Abugessaisa, Imad; Saevarsdottir, Saedis; Tsipras, Giorgos; Lindblad, Staffan; Sandin, Charlotta; Nikamo, Pernilla; Stahle, Mona; Malmstrom, Vivianne; Klareskog, Lars; Tegner, Jesper			Accelerating Translational Research by Clinically Driven Development of an Informatics Platform-A Case Study	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; SYSTEMS MEDICINE; ASSOCIATION; RISK; MANAGEMENT; NETWORKS; THERAPY; BIOLOGY	Translational medicine is becoming increasingly dependent upon data generated from health care, clinical research, and molecular investigations. This increasing rate of production and diversity in data has brought about several challenges, including the need to integrate fragmented databases, enable secondary use of patient clinical data from health care in clinical research, and to create information systems that clinicians and biomedical researchers can readily use. Our case study effectively integrates requirements from the clinical and biomedical researcher perspectives in a translational medicine setting. Our three principal achievements are (a) a design of a user-friendly web-based system for management and integration of clinical and molecular databases, while adhering to proper de-identification and security measures; (b) providing a real-world test of the system functionalities using clinical cohorts; and (c) system integration with a clinical decision support system to demonstrate system interoperability. We engaged two active clinical cohorts, 747 psoriasis patients and 2001 rheumatoid arthritis patients, to demonstrate efficient query possibilities across the data sources, enable cohort stratification, extract variation in antibody patterns, study biomarker predictors of treatment response in RA patients, and to explore metabolic profiles of psoriasis patients. Finally, we demonstrated system interoperability by enabling integration with an established clinical decision support system in health care. To assure the usefulness and usability of the system, we followed two approaches. First, we created a graphical user interface supporting all user interactions. Secondly we carried out a system performance evaluation study where we measured the average response time in seconds for active users, http errors, and kilobits per second received and sent. The maximum response time was found to be 0.12 seconds; no server or client errors of any kind were detected. In conclusion, the system can readily be used by clinicians and biomedical researchers in a translational medicine setting.	[Abugessaisa, Imad; Tsipras, Giorgos; Tegner, Jesper] Karolinska Inst, Dept Med, Ctr Mol Med, Unit Computat Med, Stockholm, Sweden; [Saevarsdottir, Saedis; Sandin, Charlotta; Malmstrom, Vivianne; Klareskog, Lars] Karolinska Inst, Rheumatol Unit, Dept Med, Ctr Mol Med, Stockholm, Sweden; [Lindblad, Staffan] Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Nikamo, Pernilla; Stahle, Mona] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Dermatol & Venereol Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Tegner, J (corresponding author), Karolinska Inst, Dept Med, Ctr Mol Med, Unit Computat Med, Stockholm, Sweden.	jesper.tegner@ki.se	Abugessaisa, Imad/S-9275-2018; tegner, jesper N/R-5095-2017	Abugessaisa, Imad/0000-0001-7458-801X; tegner, jesper N/0000-0002-9568-5588; Saevarsdottir, Saedis/0000-0001-9392-6184; Klareskog, Lars/0000-0001-9601-6186	Stockholm County Council; Swedish Research Council; CERIC; SerC; FP7 SYNERGY-COPD; IMI BTCure project; Ake Wibergs Stiftelsen medicine research; Edvard Welande stiftelse Finsenstiftelse; Magn and Bergvalls Stiftelse	Stockholm County Council(Stockholm County Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); CERIC; SerC(Agency for Science Technology & Research (A*STAR)); FP7 SYNERGY-COPD; IMI BTCure project; Ake Wibergs Stiftelsen medicine research; Edvard Welande stiftelse Finsenstiftelse; Magn and Bergvalls Stiftelse	This research is supported by Stockholm County Council (SLL), Swedish Research Council (Tegner), Swedish Research Council, CERIC (Tegner, Abugessaisa), Swedish Research Council, SerC (Tegner, Abugessaisa), FP7 SYNERGY-COPD (Tegner), IMI BTCure project (Klareskog, Abugessaisa), and Ake Wibergs Stiftelsen medicine research (Abugessaisa, Nikamo). The contribution of Nikamo was supported by Edvard Welande stiftelse Finsenstiftelse and Magn and Bergvalls Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abugessaisa I, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-85; Armstrong April W, 2012, Dermatol Online J, V18, P2; Askling J, 2006, ANN RHEUM DIS, V65, P707, DOI 10.1136/ard.2005.045872; Blackwell B, 2003, P 1 AS PAC BIOINF C, V19, P35; Casters M, 2010, PENTAHO KETTLE SOLUT; Clermont G, 2009, GENOME MED, V1, DOI 10.1186/gm88; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gladman DD, 2009, DERMATOL THER, V22, P40, DOI 10.1111/j.1529-8019.2008.01215.x; Hansson M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4039; Hood L, 2012, NEW BIOTECHNOL, V29, P613, DOI 10.1016/j.nbt.2012.03.004; Hunter P, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0004; Joachim N, 2013, J STRATEGIC INF SYST, V22, P86, DOI 10.1016/j.jsis.2012.10.003; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Lowe Henry J, 2009, AMIA Annu Symp Proc, V2009, P391; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Nair RP, 2000, AM J HUM GENET, V66, P1833, DOI 10.1086/302932; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; O'Keefe CM, 2010, MED J AUSTRALIA, V193, P537, DOI 10.5694/j.1326-5377.2010.tb04041.x; Ohno-Machado L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004454; Okunieff P, 2006, ACTA ONCOL, V45, P808, DOI 10.1080/02841860600908954; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Scourias J, 1995, ASPECTS CLIENT SERVE; Snir O, 2009, ANN RHEUM DIS, V68, P736, DOI 10.1136/ard.2008.091355; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Szalma S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-68; Tak PP, 2012, RHEUMATOLOGY, V51, P600, DOI 10.1093/rheumatology/ker300; Tan K, 2008, GENOMICS, V91, P219, DOI 10.1016/j.ygeno.2007.11.005; Tegner J, 2013, PEDIATR RES, V73, P508, DOI 10.1038/pr.2013.19; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang WM, 2008, KNOWL-BASED SYST, V21, P52, DOI 10.1016/j.knosys.2006.11.015	39	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e104382	10.1371/journal.pone.0104382	http://dx.doi.org/10.1371/journal.pone.0104382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203647	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500005
J	Fraser, D; Hassall, C; Gorelick, R; Rybczynski, N				Fraser, Danielle; Hassall, Christopher; Gorelick, Root; Rybczynski, Natalia			Mean Annual Precipitation Explains Spatiotemporal Patterns of Cenozoic Mammal Beta Diversity and Latitudinal Diversity Gradients in North America	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES-DIVERSITY; EVOLUTIONARY PROCESSES; COMMUNITY COMPOSITION; POLAR AMPLIFICATION; GLOBAL PATTERNS; RANGE SHIFTS; GREAT-PLAINS; BODY-SIZE; SEA-ICE	Spatial diversity patterns are thought to be driven by climate-mediated processes. However, temporal patterns of community composition remain poorly studied. We provide two complementary analyses of North American mammal diversity, using (i) a paleontological dataset (2077 localities with 2493 taxon occurrences) spanning 21 discrete subdivisions of the Cenozoic based on North American Land Mammal Ages (36 Ma - present), and (ii) climate space model predictions for 744 extant mammals under eight scenarios of future climate change. Spatial variation in fossil mammal community structure (beta diversity) is highest at intermediate values of continental mean annual precipitation (MAP) estimated from paleosols (similar to 450 mm/year) and declines under both wetter and drier conditions, reflecting diversity patterns of modern mammals. Latitudinal gradients in community change (latitudinal turnover gradients, aka LTGs) increase in strength through the Cenozoic, but also show a cyclical pattern that is significantly explained by MAP. In general, LTGs are weakest when continental MAP is highest, similar to modern tropical ecosystems in which latitudinal diversity gradients are weak or undetectable. Projections under modeled climate change show no substantial change in beta diversity or LTG strength for North American mammals. Our results suggest that similar climate-mediated mechanisms might drive spatial and temporal patterns of community composition in both fossil and extant mammals. We also provide empirical evidence that the ecological processes on which climate space models are based are insufficient for accurately forecasting long-term mammalian response to anthropogenic climate change and inclusion of historical parameters may be essential.	[Fraser, Danielle; Hassall, Christopher; Gorelick, Root; Rybczynski, Natalia] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Fraser, Danielle; Rybczynski, Natalia] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Hassall, Christopher] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Gorelick, Root] Carleton Univ, Dept Math & Stat, Ottawa, ON K1S 5B6, Canada; [Gorelick, Root] Carleton Univ, Inst Interdisciplinary Studies, Ottawa, ON K1S 5B6, Canada	Carleton University; University of Leeds; Carleton University; Carleton University	Fraser, D (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	danielle_fraser@carleton.ca	Hassall, Christopher/H-2469-2013	Hassall, Christopher/0000-0002-3510-0728; Fraser, Danielle/0000-0002-0228-2617	Natural Science and Engineering Research Council of Canada (NSERC) postgraduate scholarship; Fulbright Traditional Student Award; Mary Dawson Pre-Doctoral Fellowship grant; Ontario Graduate Scholarship (OGS); Koningstein Scholarship for Excellence in Science and Engineering; Ontario Ministry of Research and Innovation Postdoctoral Fellowship; NSERC Discovery Grant [341399, 312193]	Natural Science and Engineering Research Council of Canada (NSERC) postgraduate scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fulbright Traditional Student Award; Mary Dawson Pre-Doctoral Fellowship grant; Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); Koningstein Scholarship for Excellence in Science and Engineering; Ontario Ministry of Research and Innovation Postdoctoral Fellowship(Ministry of Research and Innovation, Ontario); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	D. Fraser was supported by a Natural Science and Engineering Research Council of Canada (NSERC) postgraduate scholarship, a Fulbright Traditional Student Award, a Mary Dawson Pre-Doctoral Fellowship grant, an Ontario Graduate Scholarship (OGS), and a Koningstein Scholarship for Excellence in Science and Engineering. C. Hassall was supported by an Ontario Ministry of Research and Innovation Postdoctoral Fellowship. R. Gorelick was supported by an NSERC Discovery Grant (#341399). N. Rybczynski was supported by an NSERC Discovery Grant (#312193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev VA, 2005, CLIM DYNAM, V24, P655, DOI 10.1007/s00382-005-0018-3; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2000, SPECIAL REPORT EMISS; Atwater AL, 2011, EVOL ECOL RES, V13, P833; Ballantyne AP, 2006, PALAEOGEOGR PALAEOCL, V242, P188, DOI 10.1016/j.palaeo.2006.05.016; Ballantyne AP, 2010, GEOLOGY, V38, P603, DOI 10.1130/G30815.1; Barnosky AD, 2003, J MAMMAL, V84, P354, DOI 10.1644/1545-1542(2003)084<0354:MRTGWO>2.0.CO;2; Barnosky Anthony D., 2005, Journal of Mammalian Evolution, V12, P247, DOI 10.1007/s10914-005-4858-8; Barton K, 2013, MULTIMODEL INFERENCE; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1106, DOI 10.1111/j.1466-8238.2011.00753.x; Benson RBJ, 2012, BIOL LETTERS, V8, P127, DOI 10.1098/rsbl.2011.0460; Benton MJ, 2011, GEOL SOC SPEC PUBL, V358, P63, DOI 10.1144/SP358.6; Bivand, 2012, RGEOS INTERFACE GEOM; Bivand RS, 2008, USE R, P1; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Buckley LB, 2010, P ROYAL SOC, V277, P2121; CARRASCO MA, 2005, MIOCENE MAMMAL MAPPI; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clementz MT, 2011, SCIENCE, V332, P455, DOI 10.1126/science.1201182; Condamine FL, 2012, ECOL LETT, V15, P267, DOI 10.1111/j.1461-0248.2011.01737.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Csank AZ, 2011, EARTH PLANET SC LETT, V304, P291, DOI 10.1016/j.epsl.2011.02.030; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Currie DJ, 1999, ECOSCIENCE, V6, P392, DOI 10.1080/11956860.1999.11682541; CURRIE DJ, 1993, OIKOS, V67, P56, DOI 10.2307/3545095; Davis EB, 2005, GLOBAL ECOL BIOGEOGR, V14, P479, DOI 10.1111/j.1466-822x.2005.00183.x; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; Del Grosso S, 2008, ECOLOGY, V89, P2117, DOI 10.1890/07-0850.1; Development Core Team R, 2012, R LANG ENV STAT COMP; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Dornelas Maria, 2013, Proceedings of the Royal Society Biological Sciences Series B, V280, P1; Eberle J, 2009, GEOLOGY, V37, P499, DOI 10.1130/G25633A.1; Eberle JJ, 2010, EARTH PLANET SC LETT, V296, P481, DOI 10.1016/j.epsl.2010.06.005; Engle VD, 1999, J BIOGEOGR, V26, P1007, DOI 10.1046/j.1365-2699.1999.00341.x; Figueirido B, 2012, P NATL ACAD SCI USA, V109, P722, DOI 10.1073/pnas.1110246108; Finarelli JA, 2010, P ROY SOC B-BIOL SCI, V277, P2721, DOI 10.1098/rspb.2010.0348; Foster G.L., 2009, CLIMATE DISCUSSIONS, V5, P2439; Foster GL, 2012, EARTH PLANET SC LETT, V341, P243, DOI 10.1016/j.epsl.2012.06.007; Fox DL, 2012, GEOL SOC AM BULL, V124, P431, DOI 10.1130/B30402.1; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Freckleton RP, 2003, AM NAT, V161, P821, DOI 10.1086/374346; Girvetz EH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008320; Hassall C, 2012, BIODIVERS CONSERV, V21, P829, DOI 10.1007/s10531-011-0223-9; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Haywood AM, 2001, PALAEONTOL ELECTRON, V4, P1; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holland MM, 2003, CLIM DYNAM, V21, P221, DOI 10.1007/s00382-003-0332-6; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; Kaplan JO, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002559; Kent R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025440; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Lewin-Koh NJ, 2008, MAPTOOLS PACKAGE VER; Mannion PD, 2011, BIOL REV, V86, P157, DOI 10.1111/j.1469-185X.2010.00139.x; Mayhew PJ, 2012, P NATL ACAD SCI USA, V109, P15141, DOI 10.1073/pnas.1200844109; MCCOY ED, 1980, EVOLUTION, V34, P193, DOI 10.1111/j.1558-5646.1980.tb04805.x; Micheels A, 2009, PALAEONTOL ELECTRON, V12; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; OECHEL WC, 1994, TRENDS ECOL EVOL, V9, P324, DOI 10.1016/0169-5347(94)90152-X; Oksanen J, 2012, PACKAGE VEGAN VERSIO; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PATTERSON B. D., 2007, DIGITAL DISTRIBUTION; Pebesma E., 2005, R NEWS, V5, P9; Peng RD, 2007, GPCLIB PACKAGE VERSI; Polyak L, 2010, QUATERNARY SCI REV, V29, P1757, DOI 10.1016/j.quascirev.2010.02.010; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; Qian H, 2012, ACTA OECOL, V39, P67, DOI 10.1016/j.actao.2011.12.003; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P111, DOI 10.1111/j.1466-8238.2008.00415.x; Retallack GJ, 2007, J GEOL, V115, P271, DOI 10.1086/512753; Rose PJ, 2011, GEOLOGY, V39, P163, DOI 10.1130/G31099.1; Rybczynski N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2516; Secord R, 2012, SCIENCE, V335, P959, DOI 10.1126/science.1213859; Sepkoski JJ, 1997, J PALEONTOL, V71, P533, DOI 10.1017/S0022336000040026; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Soininen J, 2010, BIOSCIENCE, V60, P433, DOI 10.1525/bio.2010.60.6.7; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Stromberg CAE, 2011, PALEOBIOLOGY, V37, P50, DOI 10.1666/09067.1; Thuiller W, 2013, ECOL LETT, V16, P94, DOI 10.1111/ele.12104; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tripati AK, 2009, SCIENCE, V326, P1394, DOI 10.1126/science.1178296; Tuomisto H, 2006, ECOLOGY, V87, P2697, DOI 10.1890/0012-9658(2006)87[2697:AOEBDU]2.0.CO;2; VanderMeulen MA, 2001, EVOL ECOL RES, V3, P379; Vazquez DP, 2004, AM NAT, V164, pE1, DOI 10.1086/421445; Venables WN., 2002, MODERN APPL STAT S 4; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yasuhara M, 2012, ECOL LETT, V15, P1174, DOI 10.1111/j.1461-0248.2012.01828.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	98	25	25	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106499	10.1371/journal.pone.0106499	http://dx.doi.org/10.1371/journal.pone.0106499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203658	gold, Green Published			2022-12-27	WOS:000342684500026
J	Muhwezi, WW; Banura, C; Turiho, AK; Mirembe, F				Muhwezi, Wilson Winstons; Banura, Cecily; Turiho, Andrew Kampikaho; Mirembe, Florence			Parents' Knowledge, Risk Perception and Willingness to Allow Young Males to Receive Human Papillomavirus (HPV) Vaccines in Uganda	PLOS ONE			English	Article							PARTICLE VACCINE; CERVICAL-CANCER; BOYS RECEIVE; ACCEPTANCE; BURDEN; IMMUNOGENICITY; TRANSLATION; PREVALENCE; INFECTION; TYPE-18	The Ministry of Health in Uganda in collaboration with the Program for Appropriate Technology for Health (PATH) supported by Bill and Melinda Gates Foundation in 2008-2009 vaccinated approximately 10,000 girls with the bivalent humanpapilloma virus (HPV) vaccine. We assessed parent's knowledge, risk perception and willingness to allow son(s) to receive HPV vaccines in future through a cross-sectional survey of secondary school boys aged 10-23 years in 4 districts. 377 questionnaires were distributed per district and 870 were used in analysis. Parents that had ever heard about cervical cancer and HPV vaccines; those who would allow daughter(s) to be given the vaccine and those who thought that HPV infection was associated with genital warts were more willing to allow son(s) to receive the HPV vaccine. Unwilling parents considered HPV vaccination of boys unimportant (p = 0.003), believed that only females should receive the vaccine (p = 0.006), thought their son(s) couldn't contract HPV (p = 0.010), didn't know about HPV sexual transmissibility (p = 0.002), knew that males could not acquire HPV (p = 0.000) and never believed that the HPV vaccines could protect against HPV (p = 0.000). Acceptance of HPV vaccination of daughters and likelihood of recommending HPV vaccines to son(s) of friends and relatives predicted parental willingness to allow sons to receive HPV vaccines. Probable HPV vaccination of boys is a viable complement to that of girls. Successfulness of HPV vaccination relies on parental acceptability and sustained sensitization about usefulness of HPV vaccines even for boys is vital.	[Muhwezi, Wilson Winstons; Turiho, Andrew Kampikaho] Makerere Univ, Coll Hlth Sci, Dept Psychiat, Sch Med, Kampala, Uganda; [Banura, Cecily] Makerere Univ, Coll Hlth Sci, Sch Med, Child Hlth & Dev Ctr, Kampala, Uganda; [Mirembe, Florence] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Obstet & Gynecol, Kampala, Uganda	Makerere University; Makerere University; Makerere University	Muhwezi, WW (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Psychiat, Sch Med, Kampala, Uganda.	wilsonmuhwezi@hotmail.com			Millennium Science Initiatives (MSI), a Project of the World Bank to support science initiatives in Uganda through Uganda National Council for Science and Technology	Millennium Science Initiatives (MSI), a Project of the World Bank to support science initiatives in Uganda through Uganda National Council for Science and Technology	The authors are grateful for the financial support from The Millennium Science Initiatives (MSI), a Project of the World Bank to support science initiatives in Uganda through Uganda National Council for Science and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blamble D, 2010, CLIN NEWS ONCOLOGY H; Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Chang AM, 1999, J ADV NURS, V29, P316, DOI 10.1046/j.1365-2648.1999.00891.x; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Cuschieri K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4921; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dempsey AF, 2006, PEDIATRICS, V117, P1486, DOI 10.1542/peds.2005-1381; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Ferris DG, 2008, J AM BOARD FAM MED, V21, P31, DOI 10.3122/jabfm.2008.01.070103; Ferris DG, 2009, J AM BOARD FAM MED, V22, P34, DOI 10.3122/jabfm.2009.01.080008; Galagan SR, 2013, VACCINE, V31, P3072, DOI 10.1016/j.vaccine.2013.04.056; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2010, GYNECOL ONCOL, V117, pS20, DOI 10.1016/j.ygyno.2010.01.027; Giuliano AR, 2010, GYNECOL ONCOL, V117, pS15, DOI 10.1016/j.ygyno.2010.01.026; Gonik B., 2006, Infectious Diseases in Obstetrics and Gynecology, V13, P1, DOI 10.1155/IDOG/2006/36797; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Herdman M, 1997, QUAL LIFE RES, V6, P237; Hibbitts S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4928; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; Katahoire AR, 2013, INT J CHILD ADOLESC, V6, P133; Katahoire R A, 2008, Afr J Reprod Health, V12, P159; Keane MT, 2005, VACCINE, V23, P2486, DOI 10.1016/j.vaccine.2004.10.026; Koulova A, 2008, VACCINE, V26, P6529, DOI 10.1016/j.vaccine.2008.08.067; Maloney EM, 2006, ARCH OTOLARYNGOL, V132, P711, DOI 10.1001/archotol.132.7.711; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; Nielson CM, 2007, CANCER EPIDEM BIOMAR, V16, P1107; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; PATH and Child Health Development Centre (CHDC), 2009, SHAP STRAT INTR HPV; Petaja T, 2009, J ADOLESCENT HEALTH, V44, P33, DOI 10.1016/j.jadohealth.2008.10.002; Powell N, 2009, INT J CANCER, V125, P2425, DOI 10.1002/ijc.24571; Raosoft Inc., 2004, RAOS SAMPL SIZ CALC; Reiter PL, 2010, SEX TRANSM INFECT, V86, P241, DOI 10.1136/sti.2009.039065; Wamai RG, 2012, J COMMUN HEALTH, V37, P917, DOI 10.1007/s10900-012-9540-5; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2841, DOI 10.1002/cncr.23758; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zimet GD, 2010, GYNECOL ONCOL, V117, pS26, DOI 10.1016/j.ygyno.2010.01.028	37	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106686	10.1371/journal.pone.0106686	http://dx.doi.org/10.1371/journal.pone.0106686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IF	25203053	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500039
J	Zeng, YY; Han, ZR; Qiu, PJ; Zhou, ZJ; Tang, Y; Zhao, Y; Zheng, S; Xu, CC; Zhang, XL; Yin, PH; Jiang, XL; Lu, H; Yu, GL; Zhang, LJ				Zeng, Yangyang; Han, Zhangrun; Qiu, Peiju; Zhou, Zijing; Tang, Yang; Zhao, Yue; Zheng, Sha; Xu, Chenchen; Zhang, Xiuli; Yin, Pinghe; Jiang, Xiaolu; Lu, Hong; Yu, Guangli; Zhang, Lijuan			Salinity-Induced Anti-Angiogenesis Activities and Structural Changes of the Polysaccharides from Cultured Cordyceps Militaris	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; HEPARAN-SULFATE; BIOLOGICAL-PROPERTIES; SINENSIS; FUNGI; CHROMATOGRAPHY; EVOLUTION; SEQUENCE; MYCELIUM; GROWTH	Cordyceps is a rare and exotic mushroom that grows out of the head of a mummified caterpillar. Many companies are cultivating Cordyceps to meet the increased demand for its medicinal applications. However, the structures and functions of polysaccharides, one of the pharmaceutical active ingredients in Cordyceps, are difficult to reproduce in vitro. We hypothesized that mimicking the salty environment inside caterpillar bodies might make the cultured fungus synthesize polysaccharides with similar structures and functions to that of wild Cordyceps. By adding either sodium sulfate or sodium chloride into growth media, we observed the salinity-induced anti-angiogenesis activities of the polysaccharides purified from the cultured C. Militaris. To correlate the activities with the polysaccharide structures, we performed the C-13-NMR analysis and observed profound structural changes including different proportions of alpha and beta glycosidic bonds and appearances of uronic acid signals in the polysaccharides purified from the culture after the salts were added. By coupling the techniques of stable S-34-sulfate isotope labeling, aniline-and D-5-aniline tagging, and stable isotope facilitated uronic acid-reduction with LC-MS analysis, our data revealed for the first time the existence of covalently linked sulfate and the presence of polygalacuronic acids in the polysaccharides purified from the salt added C. Militaris culture. Our data showed that culturing C. Militaris with added salts changed the biosynthetic scheme and resulted in novel polysaccharide structures and functions. These findings might be insightful in terms of how to make C. Militaris cultures to reach or to exceed the potency of wild Cordyceps in future.	[Zeng, Yangyang; Han, Zhangrun; Qiu, Peiju; Zhou, Zijing; Tang, Yang; Zhao, Yue; Zheng, Sha; Xu, Chenchen; Zhang, Xiuli; Lu, Hong; Yu, Guangli; Zhang, Lijuan] Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Sch Med & Pharm, Key Lab Marine Drugs,Minist Educ, Qingdao, Peoples R China; [Yin, Pinghe] Jinan Univ, Dept Chem, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China; [Jiang, Xiaolu] Ocean Univ China, Coll Food Sci & Technol, Qingdao, Peoples R China	Ocean University of China; Jinan University; Ocean University of China	Zhang, LJ (corresponding author), Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Sch Med & Pharm, Key Lab Marine Drugs,Minist Educ, Qingdao, Peoples R China.	lijuangzhang@ouc.edu.cn			Natural Science Foundation of China [91129706]; Program for Science and Technology Development of Shandong Province [2012GSF11912]; Ministry of Education New Teacher's Fund [20130132120006]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Science and Technology Development of Shandong Province; Ministry of Education New Teacher's Fund	This work was supported by Natural Science Foundation of China (Grant No. 91129706), Program for Science and Technology Development of Shandong Province (Grant No. 2012GSF11912), and Ministry of Education New Teacher's Fund(Grant No. 20130132120006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Cleaver P. D., 2004, INT J MED MUSHROOMS, V6, P152; Das SK, 2010, FITOTERAPIA, V81, P961, DOI 10.1016/j.fitote.2010.07.010; Dundar M, 2009, AM J HUM GENET, V85, P873, DOI 10.1016/j.ajhg.2009.11.010; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Freimoser FM, 2003, MICROBIOL-SGM, V149, P239, DOI 10.1099/mic.0.25761-0; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; HONDA S, 1989, ANAL BIOCHEM, V180, P351, DOI 10.1016/0003-2697(89)90444-2; Hsu TH, 2002, FOOD CHEM, V78, P463, DOI 10.1016/S0308-8146(02)00158-9; Hu DJ, 2013, J SEP SCI, V36, P1, DOI 10.1002/jssc.201200874; Iemitsu M, 2006, AM J PHYSIOL-HEART C, V291, pH1290, DOI 10.1152/ajpheart.00820.2005; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Keire DA, 2010, J PHARMACEUT BIOMED, V52, P656, DOI 10.1016/j.jpba.2010.02.019; Li SP, 2006, J PHARMACEUT BIOMED, V41, P1571, DOI 10.1016/j.jpba.2006.01.046; Li SP, 2004, PHYTOMEDICINE, V11, P684, DOI 10.1016/j.phymed.2003.07.011; Lin YW, 2008, PROCESS BIOCHEM, V43, P244, DOI 10.1016/j.procbio.2007.11.020; Lu Hong, 2010, Glycobiol Insights, V2010, P13; Lu MK, 2010, FOOD CHEM, V118, P349, DOI 10.1016/j.foodchem.2009.04.126; Marth JD, 2008, NAT CELL BIOL, V10, P1015, DOI 10.1038/ncb0908-1015; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Novoa-Carballal R, 2013, MOL PHARMACEUT, V10, P3225, DOI 10.1021/mp400267m; Ohta Y, 2007, J AGR FOOD CHEM, V55, P10194, DOI 10.1021/jf0721287; Pan J, 2010, J BIOL CHEM, V285, P22964, DOI 10.1074/jbc.M109.063735; Pan J, 2010, NAT BIOTECHNOL, V28, P203, DOI 10.1038/nbt0310-203; Qiu PJ, 2011, MOL NUTR FOOD RES, V55, P1523, DOI 10.1002/mnfr.201100070; Samson SC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001727; Shashidhar MG, 2013, J FUNCT FOODS, V5, P1013, DOI 10.1016/j.jff.2013.04.018; Smiderle FR, 2013, CARBOHYD POLYM, V97, P74, DOI 10.1016/j.carbpol.2013.04.049; Song CH, 1998, J MICROBIOL BIOTECHN, V8, P536; Springer SA, 2013, J BIOL CHEM, V288, P6904, DOI 10.1074/jbc.R112.424523; Tessema M, 2012, ONCOGENE, V31, P4107, DOI 10.1038/onc.2011.577; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Vives RR, 2014, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00331; Wang BJ, 2003, CHEM RES CHINESE U, V19, P37; Wang BJ, 2005, FOOD CHEM TOXICOL, V43, P543, DOI 10.1016/j.fct.2004.12.008; Wang M, 2012, CARBOHYD POLYM, V89, P461, DOI 10.1016/j.carbpol.2012.03.029; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; Winkler D, 2010, FIELD MYCOL, V11, P60, DOI DOI 10.1016/J.FLDMYC.2010.04.009; Winkler D., 2005, MEMOIRE SOC ITALILAN, V33, P69; Xiong ChengHui, 2010, Mycology - An International Journal on Fungal Biology, V1, P25; Yan F, 2014, PHARM BIOL, V52, P157, DOI 10.3109/13880209.2013.820197; [杨威 YANG Wei], 2008, [中草药, Chinese Traditional and Herbal Drugs], V39, P531; Yoo HS, 2004, ACTA PHARMACOL SIN, V25, P657; Yu RM, 2004, FITOTERAPIA, V75, P465, DOI 10.1016/j.fitote.2004.04.003; Zeng Y, 2014, J OCEAN U C IN PRESS; [曾洋洋 Zeng Yangyang], 2013, [中国海洋药物, Chinese Journal of Marine Drugs], V32, P67; Zhang GQ, 2006, APPL MICROBIOL BIOT, V72, P1152, DOI 10.1007/s00253-006-0411-9; Zhang L, 2010, PROG MOL BIOL TRANSL, V93, P1; Zhang LJ, 1998, J BIOL CHEM, V273, P27998, DOI 10.1074/jbc.273.43.27998; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	52	19	20	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e103880	10.1371/journal.pone.0103880	http://dx.doi.org/10.1371/journal.pone.0103880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203294	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500002
J	Gold, MEL; Brochu, CA; Norell, MA				Gold, Maria Eugenia Leone; Brochu, Christopher A.; Norell, Mark A.			An Expanded Combined Evidence Approach to the Gavialis Problem Using Geometric Morphometric Data from Crocodylian Braincases and Eustachian Systems	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; EVOLUTION; GHARIAL; CROCODILE; TIME; TREE	The phylogenetic position of the Indian gharial (Gavialis gangeticus) is disputed - morphological characters place Gavialis as the sister to all other extant crocodylians, whereas molecular and combined analyses find Gavialis and the false gharial (Tomistoma schlegelii) to be sister taxa. Geometric morphometric techniques have only begun to be applied to this issue, but most of these studies have focused on the exterior of the skull. The braincase has provided useful phylogenetic information for basal crurotarsans, but has not been explored for the crown group. The Eustachian system is thought to vary phylogenetically in Crocodylia, but has not been analytically tested. To determine if gross morphology of the crocodylian braincase proves informative to the relationships of Gavialis and Tomistoma, we used two-and three-dimensional geometric morphometric approaches. Internal braincase images were obtained using high-resolution computerized tomography scans. A principal components analysis identified that the first component axis was primarily associated with size and did not show groupings that divide the specimens by phylogenetic affinity. Sliding semi-landmarks and a relative warp analysis indicate that a unique Eustachian morphology separates Gavialis from other extant members of Crocodylia. Ontogenetic expansion of the braincase results in a more dorsoventrally elongate median Eustachian canal. Changes in the shape of the Eustachian system do provide phylogenetic distinctions between major crocodylian clades. Each morphometric dataset, consisting of continuous morphological characters, was added independently to a combined cladistic analysis of discrete morphological and molecular characters. The braincase data alone produced a clade that included crocodylids and Gavialis, whereas the Eustachian data resulted in Gavialis being considered a basally divergent lineage. When each morphometric dataset was used in a combined analysis with discrete morphological and molecular characters, it generated a tree that matched the topology of the molecular phylogeny of Crocodylia.	[Gold, Maria Eugenia Leone; Norell, Mark A.] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Gold, Maria Eugenia Leone; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Brochu, Christopher A.] Univ Iowa, Dept Earth & Environm Sci, Iowa City, IA USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); University of Iowa	Gold, MEL (corresponding author), Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA.	egold@amnh.org			University of Iowa Department of Earth and Environmental Sciences; Littlefield Foundation; University of Texas at Austin; Richard Gilder Graduate School; American Museum of Natural History	University of Iowa Department of Earth and Environmental Sciences; Littlefield Foundation; University of Texas at Austin; Richard Gilder Graduate School; American Museum of Natural History	This work was funded by the University of Iowa Department of Earth and Environmental Sciences, the Littlefield Foundation, Tim Rowe (University of Texas at Austin), the Richard Gilder Graduate School, and the American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bookstein F.L, 1991, MORPHOMETRIC TOOLS L, P456; Brochu CA, 2004, J VERTEBR PALEONTOL, V24, P610, DOI 10.1671/0272-4634(2004)024[0610:ANLCGC]2.0.CO;2; Brochu CA, 1997, SYST BIOL, V46, P479, DOI 10.2307/2413693; Brochu CA, 2006, J VERTEBR PALEONTOL, V26, P466, DOI 10.1671/0272-4634(2006)26[466:ECGFTL]2.0.CO;2; Brochu CA, 2001, AM ZOOL, V41, P564, DOI 10.1668/0003-1569(2001)041[0564:CSISAT]2.0.CO;2; Brochu CA, 2012, J VERTEBR PALEONTOL, V32, P587, DOI 10.1080/02724634.2012.652324; Buscalioni AD, 2011, ZOOL J LINN SOC-LOND, V163, pS199, DOI 10.1111/j.1096-3642.2011.00718.x; Catalano SA, 2010, CLADISTICS, V26, P539, DOI 10.1111/j.1096-0031.2010.00302.x; Clark JM, 1997, SHADOW DINOSAURS EAR, P84; DENSMORE LD, 1983, EVOL BIOL, V16, P397; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; GATESY J, 1992, COPEIA, P241, DOI 10.2307/1446560; Gatesy J, 2003, SYST BIOL, V52, P403, DOI 10.1080/10635150390197037; Gold M. E. L, 2011, THESIS U IOWA IOWA C; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2006, CLADISTICS, V22, P589, DOI 10.1111/j.1096-0031.2006.00122.x; Goloboff PA, 2011, CLADISTICS, V27, P42, DOI 10.1111/j.1096-0031.2010.00318.x; Gower DJ, 2006, J VERTEBR PALEONTOL, V26, P79, DOI 10.1671/0272-4634(2006)26[79:TBOABE]2.0.CO;2; Gower DJ, 2002, ZOOL J LINN SOC-LOND, V136, P49, DOI 10.1046/j.1096-3642.2002.00025.x; Herring Susan W., 1993, P153; Hua S, 2004, J VERTEBR PALEONTOL, V24, P341, DOI 10.1671/1104; Janke A, 2005, J MOL EVOL, V61, P620, DOI 10.1007/s00239-004-0336-9; Jensen RJ, 2003, TAXON, V52, P663, DOI 10.2307/3647340; Jouve S, 2008, J VERTEBR PALEONTOL, V28, P409, DOI 10.1671/0272-4634(2008)28[409:TOACPP]2.0.CO;2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Langston W. Jr., 1973, P263; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Meganathan PR, 2010, MOL PHYLOGENET EVOL, V57, P393, DOI 10.1016/j.ympev.2010.06.011; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; NORELL MA, 1989, J HERPETOL, V23, P325, DOI 10.2307/1564042; Oaks JR, 2011, EVOLUTION, V65, P3285, DOI 10.1111/j.1558-5646.2011.01373.x; Pierce SE, 2008, J MORPHOL, V269, P840, DOI 10.1002/jmor.10627; Piras P, 2010, EVOL DEV, V12, P568, DOI 10.1111/j.1525-142X.2010.00442.x; Puertolas-Pascual E, 2014, HIST BIOL, V26, P91, DOI 10.1080/08912963.2012.763034; R Core Development Team, 2013, R LANG ENV STAT COMP; Rasband W., 2006, IMAGEJ; Rohlf F. J., 2005, TPSDIG DIGITIZE LAND; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1990, ANNU REV ECOL SYST, V21, P299, DOI 10.1146/annurev.es.21.110190.001503; Rohlf FJ, 2010, TPSDIG VERSION 2 16; Roos J, 2007, MOL PHYLOGENET EVOL, V45, P663, DOI 10.1016/j.ympev.2007.06.018; Sadlier R, 2009, THESIS U CHICAGO CHI; Smith UE, 2013, SYST BIOL, V62, P366, DOI 10.1093/sysbio/syt002; Tarsitano S.F., 1985, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V170, P27; TARSITANO SF, 1989, AM ZOOL, V29, P843; Wilberg E. W., 2012, THESIS U IOWA IOWA C; Wiley D. F., 2005, P IEEE VIS 2005; Willis RE, 2007, MOL PHYLOGENET EVOL, V43, P787, DOI 10.1016/j.ympev.2007.02.005; Willis RE, 2009, MOL PHYLOGENET EVOL, V53, P1049, DOI 10.1016/j.ympev.2009.09.003; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zhang M, 2011, MOL PHYLOGENET EVOL, V60, P62, DOI 10.1016/j.ympev.2011.03.029	52	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e105793	10.1371/journal.pone.0105793	http://dx.doi.org/10.1371/journal.pone.0105793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198124	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700017
J	Heuer, A; Rubner, O				Heuer, Andreas; Rubner, Oliver			Optimizing the Prediction Process: From Statistical Concepts to the Case Study of Soccer	PLOS ONE			English	Article							FOOTBALL; MODEL; PERFORMANCE; GOALS	3 We present a systematic approach for prediction purposes based on panel data, involving information about different interacting subjects and different times (here: two). The corresponding bivariate regression problem can be solved analytically for the final statistical estimation error. Furthermore, this expression is simplified for the special case that the subjects do not change their properties between the last measurement and the prediction period. This statistical framework is applied to the prediction of soccer matches, based on information from the previous and the present season. It is determined how well the outcome of soccer matches can be predicted theoretically. This optimum limit is compared with the actual quality of the prediction, taking the German premier league as an example. As a key step for the actual prediction process one has to identify appropriate observables which reflect the strength of the individual teams as close as possible. A criterion to distinguish different observables is presented. Surprisingly, chances for goals turn out to be much better suited than the goals themselves to characterize the strength of a team. Routes towards further improvement of the prediction are indicated. Finally, two specific applications are discussed.	[Heuer, Andreas; Rubner, Oliver] WWU Muenster, Inst Phys Chem, Munster, Germany; [Heuer, Andreas; Rubner, Oliver] WWU Muenster, Ctr Nonlinear Sci CeNoS, Munster, Germany		Heuer, A (corresponding author), WWU Muenster, Inst Phys Chem, Munster, Germany.	andheuer@uni-muenster.de			Deutsche Forschungsgemeinschaft; Open Access Publication Fund of University of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of University of Muenster	The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrey CL, 2014, ECON LETT, V123, P131, DOI 10.1016/j.econlet.2014.01.031; Andersson P, 2005, INT J FORECASTING, V21, P565, DOI 10.1016/j.ijforecast.2005.03.004; Bittner E, 2009, EUR PHYS J B, V67, P459, DOI 10.1140/epjb/e2008-00396-1; Bittner E, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/58002; Constantinou AC, 2012, KNOWL-BASED SYST, V36, P322, DOI 10.1016/j.knosys.2012.07.008; Dixon MJ, 1998, J ROY STAT SOC D-STA, V47, P523, DOI 10.1111/1467-9884.00152; Dixon MJ, 1997, J R STAT SOC C-APPL, V46, P265, DOI 10.1111/1467-9876.00065; Forrest D, 2000, INT J FORECASTING, V16, P317, DOI 10.1016/S0169-2070(00)00050-9; Freedman D, 2007, BAYES LINEAR STAT TH; Goddard J, 2005, INT J FORECASTING, V21, P331, DOI 10.1016/j.ijforecast.2004.08.002; Goddard J, 2004, J FORECASTING, V23, P51, DOI 10.1002/for.877; Goldstein M, 2005, STAT MODELS THEORY P; Heuer A, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38007; Heuer A, 2009, EUR PHYS J B, V67, P445, DOI 10.1140/epjb/e2009-00024-8; Heuer A, 2012, PERFEKTE TIIPP STAT; Heuer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047678; Hvattum LM, 2010, INT J FORECASTING, V26, P460, DOI 10.1016/j.ijforecast.2009.10.002; Judge TA, 2008, J APPL PSYCHOL, V93, P849, DOI 10.1037/0021-9010.93.4.849; Koning RH, 2000, J ROY STAT SOC D-STA, V49, P419, DOI 10.1111/1467-9884.00244; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee AJ., 1997, CHANCE, V10, P15, DOI [10.1080/09332480.1997.10554791, DOI 10.1080/09332480.1997.10554791]; Maher M, 1982, STAT NEERL, V36, P109, DOI [10.1111/j.1467-9574.1982.tb00782.x, DOI 10.1111/J.1467-9574.1982.TB00782.X, DOI 10.1111/j.1467-9574.1982.tb00782.x]; Rue H, 2000, J ROY STAT SOC D-STA, V49, P399, DOI 10.1111/1467-9884.00243; Schnitzlein DD, 2014, J POPUL ECON, V27, P69, DOI 10.1007/s00148-013-0468-6; Sire C, 2009, EUR PHYS J B, V67, P473, DOI 10.1140/epjb/e2008-00405-5; Song C, 2007, INT J FORECASTING, V23, P405, DOI 10.1016/j.ijforecast.2007.05.003; Woolridge J.M.., 2002, ECONOMETRICS ANAL CR	27	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e104647	10.1371/journal.pone.0104647	http://dx.doi.org/10.1371/journal.pone.0104647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198501	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700010
J	Kanagawa, M; Lu, ZP; Ito, C; Matsuda, C; Miyake, K; Toda, T				Kanagawa, Motoi; Lu, Zhongpeng; Ito, Chiyomi; Matsuda, Chie; Miyake, Katsuya; Toda, Tatsushi			Contribution of Dysferlin Deficiency to Skeletal Muscle Pathology in Asymptomatic and Severe Dystroglycanopathy Models: Generation of a New Model for Fukuyama Congenital Muscular Dystrophy	PLOS ONE			English	Article							FUKUTIN-RELATED PROTEIN; ALPHA-DYSTROGLYCAN; MEMBRANE REPAIR; LAMININ-BINDING; NATURAL MODEL; MUTATIONS; GLYCOSYLATION; MOUSE; DEFECTS; MICE	Defects in dystroglycan glycosylation are associated with a group of muscular dystrophies, termed dystroglycanopathies, that include Fukuyama congenital muscular dystrophy (FCMD). It is widely believed that abnormal glycosylation of dystroglycan leads to disease-causing membrane fragility. We previously generated knock-in mice carrying a founder retrotransposal insertion in fukutin, the gene responsible for FCMD, but these mice did not develop muscular dystrophy, which hindered exploring therapeutic strategies. We hypothesized that dysferlin functions may contribute to muscle cell viability in the knock-in mice; however, pathological interactions between glycosylation abnormalities and dysferlin defects remain unexplored. To investigate contributions of dysferlin deficiency to the pathology of dystroglycanopathy, we have crossed dysferlin-deficient dysferlin(sjl/sjl) mice to the fukutin-knock-in fukutin(Hp/-) and Large-deficient Large(myd/myd) mice, which are phenotypically distinct models of dystroglycanopathy. The fukutin(Hp/-) mice do not show a dystrophic phenotype; however, (dysferlin(sjl/sjl):fukutin(Hp/-)) mice showed a deteriorated phenotype compared with (dysferlin(sjl/sjl):fukutin(Hp/+)) mice. These data indicate that the absence of functional dysferlin in the asymptomatic fukutin(Hp/-) mice triggers disease manifestation and aggravates the dystrophic phenotype. A series of pathological analyses using double mutant mice for Large and dysferlin indicate that the protective effects of dysferlin appear diminished when the dystrophic pathology is severe and also may depend on the amount of dysferlin proteins. Together, our results show that dysferlin exerts protective effects on the fukutin(Hp/-) FCMD mouse model, and the (dysferlin(sjl/sjl):fukutin(Hp/-)) mice will be useful as a novel model for a recently proposed antisense oligonucleotide therapy for FCMD.	[Kanagawa, Motoi; Lu, Zhongpeng; Ito, Chiyomi; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 657, Japan; [Matsuda, Chie] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Miyake, Katsuya] Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa, Japan	Kobe University; National Institute of Advanced Industrial Science & Technology (AIST); Kagawa University	Toda, T (corresponding author), Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 657, Japan.	toda@med.kobe-u.ac.jp		Kanagawa, Motoi/0000-0003-0984-6398	Ministry of Health, Labor and Welfare of Japan [23B-5]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23249049, 24687017, 23659454, 24110508]; Senri Life Science Foundation; Takeda Science Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [26110712] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Senri Life Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Health, Labor and Welfare of Japan [Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (23B-5)] to T. T. and C. M. (http://www.mhlw.go.jp/english/index.html); the Ministry of Education, Culture, Sports, Science and Technology of Japan [a Grant-in-Aid for Scientific Research (A) 23249049 to T. T.; a Grant-in-Aid for Young Scientists (A) 24687017 to M. K.; a Grant-in-Aid for Exploratory Research (23659454 to M. K.); and a Grant-in-Aid for Scientific Research on Innovative Areas (Deciphering sugar chain-based signals regulating integrative neuronal functions) 24110508 to M. K.] (http://www.mext.go.jp/english/); a Senri Life Science Foundation grant to M. K. (http://www.senri-life.or.jp/); a Takeda Science Foundation grant to M. K. (http://www.takeda-sci.or.jp/); and a Naito Foundation grant to M. K. (https://www.naito-f.or.jp/jp/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Carss KJ, 2013, AM J HUM GENET, V93, P29, DOI 10.1016/j.ajhg.2013.05.009; Chan YM, 2010, HUM MOL GENET, V19, P3995, DOI 10.1093/hmg/ddq314; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Han R, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-35; Han R, 2010, J CLIN INVEST, V120, P4366, DOI 10.1172/JCI42390; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Holzfeind PJ, 2002, HUM MOL GENET, V11, P2673, DOI 10.1093/hmg/11.21.2673; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kanagawa M, 2013, HUM MOL GENET, V22, P3003, DOI 10.1093/hmg/ddt157; Kerr JP, 2013, P NATL ACAD SCI USA, V110, P20831, DOI 10.1073/pnas.1307960110; Klinge L, 2010, MUSCLE NERVE, V41, P166, DOI 10.1002/mus.21166; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kuga A, 2012, J BIOL CHEM, V287, P9560, DOI 10.1074/jbc.M111.271767; Kurahashi H, 2005, NEUROBIOL DIS, V19, P208, DOI 10.1016/j.nbd.2004.12.018; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Mariano A, 2013, FEBS J, V280, P4165, DOI 10.1111/febs.12261; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Murakami T, 2006, ANN NEUROL, V60, P597, DOI 10.1002/ana.20973; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Taniguchi-Ikeda M, 2011, NATURE, V478, P127, DOI 10.1038/nature10456; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Wang CH, 2011, AM J PATHOL, V178, P261, DOI 10.1016/j.ajpath.2010.11.020; Wells L, 2013, J BIOL CHEM, V288, P6930, DOI 10.1074/jbc.R112.438978; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	38	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106721	10.1371/journal.pone.0106721	http://dx.doi.org/10.1371/journal.pone.0106721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198651	gold, Green Submitted, Green Published			2022-12-27	WOS:000341304700042
J	Sotelo, T; Cartea, ME; Velasco, P; Soengas, P				Sotelo, Tamara; Elena Cartea, Maria; Velasco, Pablo; Soengas, Pilar			Identification of Antioxidant Capacity -Related QTLs in Brassica Oleracea	PLOS ONE			English	Article							BIOACTIVE COMPOUNDS; PHENOLIC-COMPOUNDS; IN-VITRO; VEGETABLES; BROCCOLI; CAROTENOIDS; EXTRACTS; POWER; FRAP; PREVENTION	Brassica vegetables possess high levels of antioxidant metabolites associated with beneficial health effects including vitamins, carotenoids, anthocyanins, soluble sugars and phenolics. Until now, no reports have been documented on the genetic basis of the antioxidant activity (AA) in Brassicas and the content of metabolites with AA like phenolics, anthocyanins and carotenoids. For this reason, this study aimed to: (1) study the relationship among different electron transfer (ET) methods for measuring AA, (2) study the relationship between these methods and phenolic, carotenoid and anthocyanin content, and (3) find QTLs of AA measured with ET assays and for phenolic, carotenoid and anthocyanin contents in leaves and flower buds in a DH population of B. oleracea as an early step in order to identify genes related to these traits. Low correlation coefficients among different methods for measuring AA suggest that it is necessary to employ more than one method at the same time. A total of 19 QTLs were detected for all traits. For AA methods, seven QTLs were found in leaves and six QTLs were found in flower buds. Meanwhile, for the content of metabolites with AA, two QTLs were found in leaves and four QTLs were found in flower buds. AA of the mapping population is related to phenolic compounds but also to carotenoid content. Three genomic regions determined variation for more than one ET method measuring AA. After the syntenic analysis with A. thaliana, several candidate genes related to phenylpropanoid biosynthesis are proposed for the QTLs found.	[Sotelo, Tamara; Elena Cartea, Maria; Velasco, Pablo; Soengas, Pilar] Spanish Council Sci Res MBG CSIC, Grp Genet Breeding & Biochem Brass, Dept Plant Genet, Mision Biol Galicia, Pontevedra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Mision Biologica de Galicia (MBG)	Sotelo, T (corresponding author), Spanish Council Sci Res MBG CSIC, Grp Genet Breeding & Biochem Brass, Dept Plant Genet, Mision Biol Galicia, Pontevedra, Spain.	tsotelo@mbg.csic.es	Velasco, Pablo/C-3902-2012	Velasco, Pablo/0000-0003-3046-8918	National Plan for Research and Development [AGL-2009-09922]; Ministry of Economy and Competitiveness	National Plan for Research and Development; Ministry of Economy and Competitiveness	This work was supported by the National Plan for Research and Development (AGL-2009-09922). Tamara Sotelo acknowledges a pre-doctoral research grant (F.P.I.) from the Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cao GH, 1996, J AGR FOOD CHEM, V44, P3426, DOI 10.1021/jf9602535; Charanjit Kaur, 2007, Journal of Food Biochemistry, V31, P621, DOI 10.1111/j.1745-4514.2007.00134.x; Dekker M, 2000, TRENDS FOOD SCI TECH, V11, P174, DOI 10.1016/S0924-2244(00)00062-5; Dewanto V, 2002, J AGR FOOD CHEM, V50, P3010, DOI 10.1021/jf0115589; Dobson P, 2012, J AGR FOOD CHEM, V60, P5360, DOI 10.1021/jf3005178; Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w; Gajewski M., 2007, Vegetable Crops Research Bulletin, V67, P149, DOI 10.2478/v10032-007-0039-z; Gawlik-Dziki U, 2008, FOOD CHEM, V109, P393, DOI 10.1016/j.foodchem.2007.12.058; Gouveia S, 2013, IND CROP PROD, V42, P573, DOI 10.1016/j.indcrop.2012.06.040; Guo JT, 2001, J FOOD DRUG ANAL, V9, P96; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; Hayashi E, 2012, THEOR APPL GENET, V124, P1487, DOI 10.1007/s00122-012-1803-0; He F, 2010, MOLECULES, V15, P9057, DOI 10.3390/molecules15129057; Heimler D, 2006, FOOD CHEM, V99, P464, DOI 10.1016/j.foodchem.2005.07.057; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Jin L, 2009, CEREAL CHEM, V86, P609, DOI 10.1094/CCHEM-86-6-0609; Krinsky NI, 2001, NUTRITION, V17, P815, DOI 10.1016/S0899-9007(01)00651-7; Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0; Kusznierewicz B, 2008, LWT-FOOD SCI TECHNOL, V41, P1, DOI 10.1016/j.lwt.2007.02.007; Li HY, 2012, FOOD RES INT, V46, P250, DOI 10.1016/j.foodres.2011.12.014; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Liu RuiHai, 2010, Food Engineering & Ingredients, V35, P18; Iniguez-Luy FL, 2009, THEOR APPL GENET, V120, P31, DOI 10.1007/s00122-009-1157-4; Mrkic V, 2006, J SCI FOOD AGR, V86, P1559, DOI 10.1002/jsfa.2554; MURRAY JR, 1991, PLANT PHYSIOL, V97, P343, DOI 10.1104/pp.97.1.343; Ng ZX, 2011, INT J FOOD SCI NUTR, V62, P158, DOI 10.3109/09637486.2010.526931; Nilsson J, 2006, J SCI FOOD AGR, V86, P528, DOI 10.1002/jsfa.2355; Nilsson J, 2005, MOL NUTR FOOD RES, V49, P239, DOI 10.1002/mnfr.200400083; Okmen B, 2011, TURK J AGRIC FOR, V35, P501, DOI 10.3906/tar-1008-1207; Ou BX, 2002, J AGR FOOD CHEM, V50, P3122, DOI 10.1021/jf0116606; Pace B, 2013, J FOOD ENG, V117, P74, DOI 10.1016/j.jfoodeng.2013.02.005; Paiva SAR, 1999, J AM COLL NUTR, V18, P426, DOI 10.1080/07315724.1999.10718880; Papst C, 2004, THEOR APPL GENET, V108, P1545, DOI 10.1007/s00122-003-1579-3; Pietrowska-Borek M, 2003, PLANT PHYSIOL, V131, P1401, DOI 10.1104/pp.011684; Podsedek A, 2006, INT J FOOD SCI TECH, V41, P49, DOI 10.1111/j.1365-2621.2006.01260.x; Podsedek A, 2007, LWT-FOOD SCI TECHNOL, V40, P1, DOI 10.1016/j.lwt.2005.07.023; Powers SK, 2004, J SPORT SCI, V22, P81, DOI 10.1080/0264041031000140563; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Samarth RM, 2008, FOOD CHEM, V106, P868, DOI 10.1016/j.foodchem.2007.05.005; Samec D, 2011, SCI HORTIC-AMSTERDAM, V128, P78, DOI 10.1016/j.scienta.2011.01.009; *SAS, 2008, SAS 9 2 SAS ENH LOGG; Schroder J, 2000, RECENT ADV PHYTOCHEM, V34, P55, DOI 10.1016/S0079-9920(00)80004-0; Shadle G, 2007, PHYTOCHEMISTRY, V68, P1521, DOI 10.1016/j.phytochem.2007.03.022; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Szeto YT, 2002, BRIT J NUTR, V87, P55, DOI 10.1079/BJN2001483; Utz HF, 2000, GENETICS, V154, P1839; UTZ HF, 2003, COMPUTER PROGRAM MAP; Vallejo F, 2004, J AGR FOOD CHEM, V52, P135, DOI 10.1021/jf0305128; Vallejo F, 2002, J SCI FOOD AGR, V82, P1293, DOI 10.1002/jsfa.1183; VINSON JA, 1995, ABSTR PAP AM CHEM S, V210, P242; Wang LI, 2004, CANCER CAUSE CONTROL, V15, P977, DOI 10.1007/s10552-004-1093-1; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Yang M, 2011, CURR MED CHEM, V18, P291, DOI 10.2174/092986711794088380; ZENG ZB, 1994, GENETICS, V136, P1457; Zhou KQ, 2006, LWT-FOOD SCI TECHNOL, V39, P1155, DOI 10.1016/j.lwt.2005.07.015	62	14	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107290	10.1371/journal.pone.0107290	http://dx.doi.org/10.1371/journal.pone.0107290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198771	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700104
J	Brinks, R; Landwehr, S; Fischer-Betz, R; Schneider, M; Giani, G				Brinks, Ralph; Landwehr, Sandra; Fischer-Betz, Rebecca; Schneider, Matthias; Giani, Guido			Lexis Diagram and Illness-Death Model: Simulating Populations in Chronic Disease Epidemiology	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AGE-SPECIFIC INCIDENCE; DIFFERENTIAL-EQUATION; DIABETES DURATION; PREVALENCE; MORTALITY; COHORT	Chronic diseases impose a tremendous global health problem of the 21st century. Epidemiological and public health models help to gain insight into the distribution and burden of chronic diseases. Moreover, the models may help to plan appropriate interventions against risk factors. To provide accurate results, models often need to take into account three different time-scales: calendar time, age, and duration since the onset of the disease. Incidence and mortality often change with age and calendar time. In many diseases such as, for example, diabetes and dementia, the mortality of the diseased persons additionally depends on the duration of the disease. The aim of this work is to describe an algorithm and a flexible software framework for the simulation of populations moving in an illness-death model that describes the epidemiology of a chronic disease in the face of the different times-scales. We set up a discrete event simulation in continuous time involving competing risks using the freely available statistical software R. Relevant events are birth, the onset (or diagnosis) of the disease and death with or without the disease. The Lexis diagram keeps track of the different time-scales. Input data are birth rates, incidence and mortality rates, which can be given as numerical values on a grid. The algorithm manages the complex interplay between the rates and the different time-scales. As a result, for each subject in the simulated population, the algorithm provides the calendar time of birth, the age of onset of the disease (if the subject contracts the disease) and the age at death. By this means, the impact of interventions may be estimated and compared.	[Brinks, Ralph; Landwehr, Sandra] German Diabet Ctr, Inst Epidemiol & Biometry, Dusseldorf, Germany; [Brinks, Ralph; Fischer-Betz, Rebecca; Schneider, Matthias] Univ Hosp, Polyclin Rheumatol, Dusseldorf, Germany; [Landwehr, Sandra; Giani, Guido] Univ Dusseldorf, Inst Stat Med, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Brinks, R (corresponding author), German Diabet Ctr, Inst Epidemiol & Biometry, Dusseldorf, Germany.	ralph.brinks@ddz.uni-duesseldorf.de	Brinks, Ralph/A-6194-2015	Brinks, Ralph/0000-0003-0961-6592	Hiller Foundation, Erkrath, Germany	Hiller Foundation, Erkrath, Germany	Financial support for this study was provided by a grant from the Hiller Foundation, Erkrath, Germany. The funder had no role in study design, data collection, analysis and interpretation, decision to publish, or preparation of the manuscript.	Aalen OO, 2008, STAT BIOL HEALTH, P1; [Anonymous], 1993, INTRO BOOTSTRAP; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Beyersmann J, 2011, COMPETING RISKS MULT; Brinks R, 2013, STAT NEERL, V67, P202, DOI 10.1111/stan.12003; Brinks R, 2013, STAT MED, V32, P2070, DOI 10.1002/sim.5651; Caro JJ, 2002, DIABETES CARE, V25, P476, DOI 10.2337/diacare.25.3.476; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Carstensen B, 2007, STAT MED, V26, P3018, DOI 10.1002/sim.2764; Chehab G, 2011, Z RHEUMATOL, V70, P480, DOI 10.1007/s00393-011-0758-x; Crowson CS, 2011, ARTHRITIS RHEUM-US, V63, P633, DOI 10.1002/art.30155; Dahlquist G, 1974, DOVER BOOKS MATH SER; Fox CS, 2004, DIABETES CARE, V27, P704, DOI 10.2337/diacare.27.3.704; Geerlings SW, 2002, PSYCHOL MED, V32, P609, DOI 10.1017/S0033291702005585; Hens N, 2010, EPIDEMIOL INFECT, V138, P802, DOI 10.1017/S0950268809990781; Jewell NP, 2004, HANDB STAT, V23, P625; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; KEIDING N, 1990, PHILOS T ROY SOC A, V332, P487, DOI 10.1098/rsta.1990.0128; KEIDING N, 1991, J R STAT SOC A STAT, V154, P371, DOI 10.2307/2983150; Keiding N, 2006, STAT MED, V25, P2343, DOI 10.1002/sim.2579; ONS, 2011, OFF NAT STAT POP EST; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; R Development Core Team, 2012, R LANG ENV STAT COMP; Rait G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3584; SIDDON RL, 1985, MED PHYS, V12, P252, DOI 10.1118/1.595715; Somers EC, 2007, ARTHRIT RHEUM-ARTHR, V57, P612, DOI 10.1002/art.22683; Sparring V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-377; Vandenbroucke JP, 2012, INT J EPIDEMIOL, V41, P1472, DOI 10.1093/ije/dys142; Vetterling W.T., 1988, NUMERICAL RECIPES C; World Health Organization, 2011, NONCOMMUNICABLE DIS; Yi Y, 2010, CURR MED RES OPIN, V26, P2105, DOI 10.1185/03007995.2010.494451	31	5	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106043	10.1371/journal.pone.0106043	http://dx.doi.org/10.1371/journal.pone.0106043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215502	gold, Green Published, Green Submitted			2022-12-27	WOS:000341774300006
J	Chen, MY; Chen, YP; Wu, MS; Yu, GY; Lin, WJ; Tan, TH; Su, YW				Chen, Ming-Yu; Chen, Ya-Ping; Wu, Ming-Sian; Yu, Guanni-Yi; Lin, Wen-Jye; Tan, Tse-Hua; Su, Yu-Wen			PP4 Is Essential for Germinal Center Formation and Class Switch Recombination in Mice	PLOS ONE			English	Article							IMMUNOGLOBULIN CLASS-SWITCH; PROTEIN PHOSPHATASE 4; MEMORY B; T-CELLS; ACTIVATION; COMPLEX; PROLIFERATION; TRANSCRIPTION; ORGANIZATION; EXPRESSION	PP4 is a serine/threonine phosphatase required for immunoglobulin (Ig) VDJ recombination and pro-B/pre-B cell development in mice. To elucidate the role of PP4 in mature B cells, we ablated the catalytic subunit of murine PP4 in vivo utilizing the CD23 promoter and cre-loxP recombination and generated CD(23cre)PP4(F/F) mice. The development of follicular and marginal zone B cells was unaffected in these mutants, but the proliferation of mature PP4-deficient B cells stimulated by in vitro treatment with either anti-IgM antibody (Ab) or LPS was partially impaired. Interestingly, the induction of CD80 and CD86 expression on these stimulated B cells was normal. Basal levels of serum Igs of all isotypes were strongly reduced in CD23(cre)PP4(F/F) mice, and their B cells showed a reduced efficiency of class switch recombination (CSR) in vitro upon stimulation by LPS or LPS plus IL-4. When CD23(cre)PP4(F/F) mice were challenged with either the T cell-dependent antigen TNP-KLH or the T cell-independent antigen TNP-Ficoll, or by H1N1 virus infection, the mutant animals failed to form germinal centers (GCs) in the spleen and the draining mediastinal lymph nodes, and did not efficiently mount antigen-specific humoral responses. In the resting state, PP4-deficient B cells exhibited pre-existing DNA fragmentation. Upon stimulation by DNA-damaging drug etoposide in vitro, mutant B cells showed increased cleavage of caspase 3. In addition, the mutant B cells displayed impaired CD40-mediated MAPK activation, abnormal IgM-mediated NF-kappa B activation, and reduced S phase entry upon IgM/CD40-stimulation. Taken together, our results establish a novel role for PP4 in CSR, and reveal crucial functions for PP4 in the maintenance of genomic stability, GC formation, and B cell-mediated immune responses.	[Chen, Ming-Yu; Chen, Ya-Ping; Lin, Wen-Jye; Tan, Tse-Hua; Su, Yu-Wen] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Miaoli County, Taiwan; [Wu, Ming-Sian; Yu, Guanni-Yi] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan; [Tan, Tse-Hua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Baylor College of Medicine	Su, YW (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Miaoli County, Taiwan.	yuwensu@nhri.org.tw	Tan, Tse-Hua/E-3983-2010; Su, Yu-Wen/E-8804-2010; Lin, Wen-Jye/D-1028-2016; Tan, Tse-Hua/ABD-7080-2021	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Lin, Wen-Jye/0000-0001-8821-9813	National Science Council [100-2320-B-400-003-MY3]; National Health Research Institute [IM-100-IM-101-PP-04, IM-102-PP-04]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	The study was funded by National Science Council 100-2320-B-400-003-MY3 (http://www.most.gov.tw/mp.aspx?mp=7), National Health Research Institute IM-100-IM-101-PP-04 and IM-102-PP-04 (http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya P, 2010, J IMMUNOL, V184, P6242, DOI 10.4049/jimmunol.1000507; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Brechmann M, 2012, IMMUNITY, V37, P697, DOI 10.1016/j.immuni.2012.07.014; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Chen L, 2008, FEBS LETT, V582, P2843, DOI 10.1016/j.febslet.2008.07.014; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hamel KM, 2012, AUTOIMMUNITY, V45, P333, DOI 10.3109/08916934.2012.665524; Helps NR, 1998, J CELL SCI, V111, P1331; Hoek KL, 2010, IMMUNITY, V33, P254, DOI 10.1016/j.immuni.2010.07.016; Hu MCT, 1998, J BIOL CHEM, V273, P33561, DOI 10.1074/jbc.273.50.33561; Kashiwada M, 1996, EUR J IMMUNOL, V26, P1451, DOI 10.1002/eji.1830260708; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kotnis A, 2009, PHILOS T R SOC B, V364, P653, DOI 10.1098/rstb.2008.0196; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Lee DH, 2012, EMBO J, V31, P2403, DOI 10.1038/emboj.2012.86; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; Liu J, 2012, CELL CYCLE, P11; LIU YJ, 1995, IMMUNITY, V2, P239, DOI 10.1016/1074-7613(95)90048-9; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Matthews AJ, 2014, ADV IMMUNOL, V122, P1, DOI 10.1016/B978-0-12-800267-4.00001-8; Mihindukulasuriya KA, 2004, J BIOL CHEM, V279, P46588, DOI 10.1074/jbc.M408067200; Mourtada-Maarabouni M, 2008, BBA-MOL CELL RES, V1783, P1490, DOI 10.1016/j.bbamcr.2008.03.005; Mourtada-Maarabouni M, 2009, LEUKEMIA RES, V33, P1539, DOI 10.1016/j.leukres.2009.05.013; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Salek-Ardakani S, 2011, J IMMUNOL, V186, P5294, DOI 10.4049/jimmunol.1100406; Shaltiel IA, 2014, P NATL ACAD SCI US; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Shui JW, 2007, MOL CELL BIOL, V27, P79, DOI 10.1128/MCB.00799-06; Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6; Su YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068804; Sumiyoshi E, 2002, J CELL SCI, V115, P1403; Toyo-oka K, 2008, J CELL BIOL, V180, P1133, DOI 10.1083/jcb.200705148; Tracy RB, 2000, SCIENCE, V288, P1058, DOI 10.1126/science.288.5468.1058; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Wang B, 2008, CELL RES, V18, P974, DOI 10.1038/cr.2008.274; Weng SF, 2012, CANCER EPIDEM BIOMAR, V21, P1336, DOI 10.1158/1055-9965.EPI-12-0223; Yeh PY, 2004, J BIOL CHEM, V279, P26143, DOI 10.1074/jbc.M402362200; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200	47	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107505	10.1371/journal.pone.0107505	http://dx.doi.org/10.1371/journal.pone.0107505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215539	gold, Green Submitted, Green Published			2022-12-27	WOS:000341774300071
J	Hirasawa, K; Shoji, N; Yoshii, Y; Haraguchi, S				Hirasawa, Kazunori; Shoji, Nobuyuki; Yoshii, Yukako; Haraguchi, Shota			Determination of Axial Length Requiring Adjustment of Measured Circumpapillary Retinal Nerve Fiber Layer Thickness for Ocular Magnification	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OPEN-ANGLE GLAUCOMA; CIRRUS HD-OCT; SPECTRAL-DOMAIN; RISK-FACTORS; REFRACTIVE ERRORS; TIME-DOMAIN; RURAL-POPULATION; CLOSURE GLAUCOMA; REPRODUCIBILITY	Purpose: To determine the axial length requiring adjustment of measured circumpapillary retinal nerve fiber layer (cpRNFL) thickness to account for ocular magnification during spectral-domain optical coherence tomography (SD-OCT). Methods: In this prospective study, 148 eyes of 148 healthy student volunteers were imaged by two examiners using three-dimensional SD-OCT. In 54 randomly selected eyes, total cpRNFL thickness was measured with and without adjustment for ocular magnification to establish intra-examiner and inter-examiner measurement error. The 148 eyes were then divided into three groups according to the error values: control group (difference in the corrected and uncorrected total cpRNFL thickness was within the measurement error range), thinner group (the corrected total cpRNFL thickness was less than the uncorrected one), and thicker group (the corrected total cpRNFL thickness was more than the uncorrected one). The cutoff values of axial length between the control and the other groups were calculated by receiver operating characteristic analysis. Results: Measurement error ranged from 4.2 to 5.3 mu m; the threshold value was defined as 5.3 mu m. The cutoff values of axial length between the thinner and the control groups and between the control and the thicker groups were 23.60 (area under the curve [AUC] = 0.959) and 25.55 (AUC = 0.944) mm, respectively. Conclusions: Axial lengths shorter than 23.60 mm and longer than 25.55 mm require adjustment of measured cpRNFL thickness to account for ocular magnification during SD-OCT.	[Hirasawa, Kazunori; Shoji, Nobuyuki; Yoshii, Yukako; Haraguchi, Shota] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Kanagawa, Japan	Kitasato University	Hirasawa, K (corresponding author), Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Kanagawa, Japan.	hirasawa@kitasato-u.ac.jp		Hirasawa, Kazunori/0000-0001-5100-005X				Aykut V, 2013, CURR EYE RES, V38, P1241, DOI 10.3109/02713683.2013.820328; Bendschneider D, 2010, J GLAUCOMA, V19, P475, DOI 10.1097/IJG.0b013e3181c4b0c7; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Bland JM, 1996, BRIT MED J, V312, P1654, DOI 10.1136/bmj.312.7047.1654; Bland JM, 1996, BRIT MED J, V313, P744; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Bourne RRA, 2004, OPHTHALMOLOGY, V111, P1150, DOI 10.1016/j.ophtha.2003.09.046; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Carpineto P, 2012, OPHTHALMOLOGICA, V227, P139, DOI 10.1159/000334967; Casson RJ, 2007, CLIN EXP OPHTHALMOL, V35, P739, DOI 10.1111/j.1442-9071.2007.01619.x; Cheng CY, 2003, INVEST OPHTH VIS SCI, V44, P4630, DOI 10.1167/iovs.03-0169; Cheung CY, 2011, INVEST OPHTH VIS SCI, V52, P9629, DOI 10.1167/iovs.11-7481; Dandona L, 2000, OPHTHALMOLOGY, V107, P1710, DOI 10.1016/S0161-6420(00)00274-8; Garas A, 2010, OPHTHALMOLOGY, V117, P738, DOI 10.1016/j.ophtha.2009.08.039; Gonzalez-Garcia AO, 2009, AM J OPHTHALMOL, V147, P1067, DOI 10.1016/j.ajo.2008.12.032; Hirasawa H, 2010, ARCH OPHTHALMOL-CHIC, V128, P1420, DOI 10.1001/archophthalmol.2010.244; Hong Jung Taeck, 2012, Korean J Ophthalmol, V26, P32, DOI 10.3341/kjo.2012.26.1.32; Hong S, 2010, JPN J OPHTHALMOL, V54, P43, DOI 10.1007/s10384-009-0762-8; Hougaard JL, 2006, GRAEF ARCH CLIN EXP, V244, P1607, DOI 10.1007/s00417-006-0372-9; Huang D, 2012, INVEST OPHTH VIS SCI, V53, P4990, DOI 10.1167/iovs.11-8214; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Kim MJ, 2010, BRIT J OPHTHALMOL, V94, P115, DOI 10.1136/bjo.2009.162206; Kuzin AA, 2010, OPHTHALMOLOGY, V117, P1713, DOI 10.1016/j.ophtha.2010.01.035; Leung CKS, 2006, INVEST OPHTH VIS SCI, V47, P5171, DOI 10.1167/iovs.06-0545; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Medeiros FA, 2005, AM J OPHTHALMOL, V139, P44, DOI 10.1016/j.ajo.2004.08.069; Medeiros FA, 2009, INVEST OPHTH VIS SCI, V50, P5741, DOI 10.1167/iovs.09-3715; Menke MN, 2008, INVEST OPHTH VIS SCI, V49, P5386, DOI 10.1167/iovs.07-1435; Moreno-Montanes J, 2013, J GLAUCOMA, V22, P243, DOI 10.1097/IJG.0b013e318237c878; Mwanza JC, 2011, OPHTHALMOLOGY, V118, P241, DOI 10.1016/j.ophtha.2010.06.036; Mwanza JC, 2010, INVEST OPHTH VIS SCI, V51, P5724, DOI 10.1167/iovs.10-5222; Oner V, 2013, BRIT J OPHTHALMOL, V97, P75, DOI 10.1136/bjophthalmol-2012-301865; Perera SA, 2010, ARCH OPHTHALMOL-CHIC, V128, P900, DOI 10.1001/archophthalmol.2010.125; Rao HL, 2010, OPHTHALMOLOGY, V117, P1692, DOI 10.1016/j.ophtha.2010.01.031; Savini G, 2012, BRIT J OPHTHALMOL, V96, P57, DOI 10.1136/bjo.2010.196782; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Sawaguchi S, 2012, OPHTHALMOLOGY, V119, P1134, DOI 10.1016/j.ophtha.2011.12.038; Seibold LK, 2010, AM J OPHTHALMOL, V150, P807, DOI 10.1016/j.ajo.2010.06.024; Shpak AA, 2012, GRAEF ARCH CLIN EXP, V250, P271, DOI 10.1007/s00417-011-1808-4; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Tan BB, 2012, J GLAUCOMA, V21, P266, DOI 10.1097/IJG.0b013e3182071cdd; Toteberg-Harms M, 2012, GRAEF ARCH CLIN EXP, V250, P279, DOI 10.1007/s00417-011-1811-9; Vijaya L, 2008, OPHTHALMOLOGY, V115, P655, DOI 10.1016/j.ophtha.2007.05.034; Vizzeri G, 2009, BRIT J OPHTHALMOL, V93, P775, DOI 10.1136/bjo.2008.150698; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Yoo YC, 2012, OPTOMETRY VISION SCI, V89, P4, DOI 10.1097/OPX.0b013e3182358008; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zangwill LM, 2000, OPHTHALMOLOGY, V107, P1309, DOI 10.1016/S0161-6420(00)00168-8	52	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107553	10.1371/journal.pone.0107553	http://dx.doi.org/10.1371/journal.pone.0107553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215521	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300079
J	Kyndt, T; Denil, S; Bauters, L; Van Criekinge, W; De Meyer, T				Kyndt, Tina; Denil, Simon; Bauters, Lander; Van Criekinge, Wim; De Meyer, Tim			Systemic Suppression of the Shoot Metabolism upon Rice Root Nematode Infection	PLOS ONE			English	Article							HIRSCHMANNIELLA-ORYZAE; TRANSCRIPTION FACTOR; BRASSINOSTEROIDS; RESPONSES; EXPRESSION; DEFENSE; KNOT; RESISTANCE; PATHWAY; GROWTH	Hirschmanniella oryzae is the most common plant-parasitic nematode in flooded rice cultivation systems. These migratory animals penetrate the plant roots and feed on the root cells, creating large cavities, extensive root necrosis and rotting. The objective of this study was to investigate the systemic response of the rice plant upon root infection by this nematode. RNA sequencing was applied on the above-ground parts of the rice plants at 3 and 7 days post inoculation. The data revealed significant modifications in the primary metabolism of the plant shoot, with a general suppression of for instance chlorophyll biosynthesis, the brassinosteroid pathway, and amino acid production. In the secondary metabolism, we detected a repression of the isoprenoid and shikimate pathways. These molecular changes can have dramatic consequences for the growth and yield of the rice plants, and could potentially change their susceptibility to above-ground pathogens and pests.	[Kyndt, Tina; Bauters, Lander] Univ Ghent, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Denil, Simon; Van Criekinge, Wim; De Meyer, Tim] Univ Ghent, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium; [Van Criekinge, Wim] Ghent Univ Hosp, NXTGNT, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University Hospital	Kyndt, T (corresponding author), Univ Ghent, Dept Mol Biotechnol, B-9000 Ghent, Belgium.	tina.kyndt@ugent.be	Kyndt, Tina/E-4346-2013; De Meyer, Tim/D-3892-2011	Kyndt, Tina/0000-0002-5267-5013; De Meyer, Tim/0000-0003-2994-9693	Fund for Scientific Research Flanders; IWT doctoral grant [SB101371]; Ghent University Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks'' [BOF_01GA0805]	Fund for Scientific Research Flanders(FWO); IWT doctoral grant; Ghent University Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks''(Ghent University)	TK is funded by a postdoctoral fellowship of the Fund for Scientific Research Flanders (http://www.fwo.be/). SD received an IWT doctoral grant SB101371 (http://www.iwt.be/). TDM is supported by the Ghent University Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks'', BOF_01GA0805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; ALSTON DG, 1991, J ECON ENTOMOL, V84, P267, DOI 10.1093/jee/84.1.267; BABATOLA JO, 1980, J NEMATOL, V12, P48; Bajguz A, 2009, PLANT PHYSIOL BIOCH, V47, P1, DOI 10.1016/j.plaphy.2008.10.002; Bar-Or C, 2005, EUR J PLANT PATHOL, V111, P181, DOI 10.1007/s10658-004-2134-z; Barcala M, 2010, PLANT J, V61, P698, DOI 10.1111/j.1365-313X.2009.04098.x; Bauters L, 2014, MOL PLANT PATHOL, V15, P352, DOI 10.1111/mpp.12098; Belkhadir Y, 2012, P NATL ACAD SCI USA, V109, P297, DOI 10.1073/pnas.1112840108; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bezemer TM, 2005, ECOL LETT, V8, P652, DOI 10.1111/j.1461-0248.2005.00762.x; Bezemer TM, 2004, J CHEM ECOL, V30, P53, DOI 10.1023/B:JOEC.0000013182.50662.2a; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bridge John, 2005, P87, DOI 10.1079/9780851997278.0087; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; Gheysen G, 1996, PESTIC SCI, V47, P95, DOI 10.1002/(SICI)1096-9063(199605)47:1&lt;95::AID-PS390&gt;3.0.CO;2-I; Hamamouch N, 2011, MOL PLANT PATHOL, V12, P355, DOI 10.1111/j.1364-3703.2010.00675.x; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hofmann J, 2010, PLANT J, V62, P1058, DOI 10.1111/j.1365-313X.2010.04217.x; Hooper D. J., 2005, PLANT PARASIT NEMAT, V2, P53, DOI DOI 10.1079/9780851997278.0053; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Jammes F, 2005, PLANT J, V44, P447, DOI 10.1111/j.1365-313X.2005.02532.x; Ji HL, 2013, J EXP BOT, V64, P3885, DOI 10.1093/jxb/ert219; Kaplan I, 2009, ECOL ENTOMOL, V34, P262, DOI 10.1111/j.1365-2311.2008.01062.x; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kutyniok M, 2012, J EXP BOT, V63, P6199, DOI 10.1093/jxb/ers274; Kyndt T, 2012, PLANT BIOLOGY, V14, P73, DOI 10.1111/j.1438-8677.2011.00524.x; Kyndt T., 2014, ANNU REV PHYTOPATHOL, V52, p7 1; Kyndt T, 2013, PLANTA, V238, P807, DOI 10.1007/s00425-013-1923-z; Kyndt T, 2012, NEW PHYTOL, V196, P887, DOI 10.1111/j.1469-8137.2012.04311.x; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Manninen AM, 1998, J CHEM ECOL, V24, P1315, DOI 10.1023/A:1021222731991; Narsai R, 2010, BMC PLANT BIOL, V10; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quan RD, 2010, PLANT BIOTECHNOL J, V8, P476, DOI 10.1111/j.1467-7652.2009.00492.x; Rashid M, 2012, EVOL BIOINFORM, V8, P321, DOI 10.4137/EBO.S9369; Reversat G, 1999, NEMATOLOGY, V1, P209, DOI 10.1163/156854199508027; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Torii KU, 2004, INT REV CYTOLOGY SUR, V234, P234; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Dam NM, 2009, ANNU REV ECOL EVOL S, V40, P373, DOI 10.1146/annurev.ecolsys.110308.120314; Vranova E, 2012, MOL PLANT, V5, P318, DOI 10.1093/mp/sss015; Wondafrash M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00087	48	13	13	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106858	10.1371/journal.pone.0106858	http://dx.doi.org/10.1371/journal.pone.0106858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216177	Green Published, gold			2022-12-27	WOS:000341774300027
J	Yun, HM; Lathrop, KL; Yang, EZ; Sun, M; Kagemann, L; Fu, V; Stolz, DB; Schuman, JS; Du, YQ				Yun, Hongmin; Lathrop, Kira L.; Yang, Enzhi; Sun, Ming; Kagemann, Larry; Fu, Valeria; Stolz, Donna B.; Schuman, Joel S.; Du, Yiqin			A Laser-Induced Mouse Model with Long-Term Intraocular Pressure Elevation	PLOS ONE			English	Article							PHOTOPIC NEGATIVE RESPONSE; RETINAL GANGLION-CELLS; TRABECULAR MESHWORK CELLULARITY; OPTICAL COHERENCE TOMOGRAPHY; CANAL ENDOTHELIAL-CELLS; OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION; AQUEOUS-HUMOR; RAT MODEL; EXTRACELLULAR-MATRIX	Purpose: To develop and characterize a mouse model with intraocular pressure (IOP) elevation after laser photocoagulation on the trabecular meshwork (TM), which may serve as a model to investigate the potential of stem cell-based therapies for glaucoma. Methods: IOP was measured in 281 adult C57BL/6 mice to determine normal IOP range. IOP elevation was induced unilaterally in 50 adult mice, by targeting the TM through the limbus with a 532-nm diode laser. IOP was measured up to 24 weeks post-treatment. The optic nerve damage was detected by electroretinography and assessed by semiautomatic counting of optic nerve axons. Effects of laser treatment on the TM were evaluated by histology, immunofluorescence staining, optical coherence tomography (OCT) and transmission electron microscopy (TEM). Results: The average IOP of C57BL/6 mice was 14.5 +/- 2.6 mmHg (Mean +/- SD). After laser treatment, IOP averaged above 20 mmHg throughout the follow-up period of 24 weeks. At 24 weeks, 57% of treated eyes had elevated IOP with the mean IOP of 22.5 +/- 2.5 mmHg (Mean +/- SED). The difference of average axon count (59.0%) between laser treated and untreated eyes was statistically significant. Photopic negative response (PhNR) by electroretinography was significantly decreased. CD45+ inflammatory cells invaded the TM within 1 week. The expression of SPARC was increased in the TM from 1 to 12 weeks. Histology showed the anterior chamber angle open after laser treatment. OCT indicated that most of the eyes with laser treatment had no synechia in the anterior chamber angles. TEM demonstrated disorganized and compacted extracellular matrix in the TM. Conclusions: An experimental murine ocular hypertension model with an open angle and optic nerve axon loss was produced with laser photocoagulation, which could be used to investigate stem cell-based therapies for restoration of the outflow pathway integrity for ocular hypertension or glaucoma.	[Yun, Hongmin; Lathrop, Kira L.; Yang, Enzhi; Kagemann, Larry; Fu, Valeria; Schuman, Joel S.; Du, Yiqin] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Yun, Hongmin; Yang, Enzhi; Schuman, Joel S.; Du, Yiqin] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Sun, Ming; Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol, Ctr Biol Imaging, Pittsburgh, PA USA; [Stolz, Donna B.; Schuman, Joel S.; Du, Yiqin] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Lathrop, Kira L.; Kagemann, Larry; Schuman, Joel S.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA; [Du, Yiqin] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Du, YQ (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	duy@upmc.edu	Schuman, Joel S/K-7304-2012; Du, Yiqin/A-7727-2018; Schuman, Joel S/M-2389-2019; DU, YIQIN/AAO-1566-2020	Schuman, Joel S/0000-0002-8885-3766; Schuman, Joel S/0000-0002-8885-3766; DU, YIQIN/0000-0002-4330-0957; Kagemann, Larry/0000-0001-8961-0187; YUN, HONGMIN/0000-0002-2975-3941	NIH [P30-EY008098]; Eye and Ear Foundation (Pittsburgh, Pennsylvania); Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY008098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye and Ear Foundation (Pittsburgh, Pennsylvania); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work has been supported by an anonymous philanthropic donation for stem cells and glaucoma research (YD); NIH Grant P30-EY008098; Eye and Ear Foundation (Pittsburgh, Pennsylvania); and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P4314, DOI 10.1167/iovs.03-0137; ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Alvarado JA, 2005, BRIT J OPHTHALMOL, V89, P1500, DOI 10.1136/bjo.2005.081307; Alvarado JA, 2004, AM J PHYSIOL-CELL PH, V286, pC621, DOI 10.1152/ajpcell.00108.2003; Alvarado Jorge A, 2005, Trans Am Ophthalmol Soc, V103, P148; Alvarado JA, 2010, AM J OPHTHALMOL, V150, P254, DOI 10.1016/j.ajo.2010.03.012; Baleriola J, 2008, MOL VIS, V14, P1513; Biermann J, 2012, EXP EYE RES, V104, P7, DOI 10.1016/j.exer.2012.08.011; BULLER C, 1990, INVEST OPHTH VIS SCI, V31, P2156; Camras LJ, 2010, CURR EYE RES, V35, P819, DOI 10.3109/02713683.2010.494241; Chiu K, 2007, J VIS EXP, V549; Chrysostomou V, 2013, INVEST OPHTH VIS SCI, V54, P4691, DOI 10.1167/iovs.13-12415; Du YQ, 2013, INVEST OPHTH VIS SCI, V54, P1450, DOI 10.1167/iovs.12-11056; Du YQ, 2012, INVEST OPHTH VIS SCI, V53, P1566, DOI 10.1167/iovs.11-9134; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Ethier CR, 2004, BIOPHYS J, V87, P2828, DOI 10.1529/biophysj.103.038133; Feng L, 2013, INVEST OPHTH VIS SCI, V54, P1106, DOI 10.1167/iovs.12-10791; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Friedlander M, 2012, INVEST OPHTH VIS SCI, V53, P2511, DOI 10.1167/iovs.12-9483p; Fu CT, 2012, J NEUROSCI, V32, P15859, DOI 10.1523/JNEUROSCI.0038-12.2012; Fu CT, 2010, INVEST OPHTH VIS SCI, V51, P980, DOI 10.1167/iovs.09-4324; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2250, DOI 10.1167/iovs.10-6311; Gabriele ML, 2010, INVEST OPHTH VIS SCI, V51, P6519, DOI 10.1167/iovs.10-5662; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Gasiorowski JZ, 2009, EXP EYE RES, V88, P671, DOI 10.1016/j.exer.2008.08.006; Grozdanic SD, 2003, INVEST OPHTH VIS SCI, V44, P4337, DOI 10.1167/iovs.03-0015; Gunn DJ, 2011, CLIN EXP OPHTHALMOL, V39, P555, DOI 10.1111/j.1442-9071.2010.02488.x; GUPTA D, 2004, GLAUCOMA DIAGNOSIS M, P31; Haddadin RI, 2009, INVEST OPHTH VIS SCI, V50, P3771, DOI 10.1167/iovs.08-2489; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Holder GE, 2001, PROG RETIN EYE RES, V20, P531, DOI 10.1016/S1350-9462(00)00030-6; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; Johnson M, 2006, EXP EYE RES, V82, P545, DOI 10.1016/j.exer.2005.10.011; Ko MK, 2013, MOL VIS, V19, P2561; Kwong JMK, 2013, EXP EYE RES, V112, P21, DOI 10.1016/j.exer.2013.04.008; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402; Liton PB, 2005, EXP GERONTOL, V40, P745, DOI 10.1016/j.exger.2005.06.005; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; Marina N, 2010, NAT PROTOC, V5, P1642, DOI 10.1038/nprot.2010.128; Oh DJ, 2013, INVEST OPHTH VIS SCI, V54, P3309, DOI 10.1167/iovs.12-11362; Preiser D, 2013, INVEST OPHTH VIS SCI, V54, P1182, DOI 10.1167/iovs.12-11201; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Read AT, 2007, EXP EYE RES, V84, P213, DOI 10.1016/j.exer.2006.10.001; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Stamer WD, 2012, CURR OPIN OPHTHALMOL, V23, P135, DOI 10.1097/ICU.0b013e32834ff23e; Swaminathan SS, 2013, INVEST OPHTH VIS SCI, V54, P2035, DOI 10.1167/iovs.12-10950; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; TRIPATHI RC, 1977, EXP EYE RES, V25, P403, DOI 10.1016/S0014-4835(77)80035-3; Tsuruga H, 2012, MOL VIS, V18, P2468; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Zhang YL, 2013, AFR J TRADIT COMPLEM, V10, P258, DOI 10.4314/ajtcam.v10i2.10	57	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107446	10.1371/journal.pone.0107446	http://dx.doi.org/10.1371/journal.pone.0107446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216052	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000341774300066
J	Anderson, DR; Duryee, MJ; Shurmur, SW; Um, JY; Bussey, WD; Hunter, CD; Garvin, RP; Sayles, HR; Mikuls, TR; Klassen, LW; Thiele, GM				Anderson, Daniel R.; Duryee, Michael J.; Shurmur, Scott W.; Um, John Y.; Bussey, Walter D.; Hunter, Carlos D.; Garvin, Robert P.; Sayles, Harlan R.; Mikuls, Ted R.; Klassen, Lynell W.; Thiele, Geoffrey M.			Unique Antibody Responses to Malondialdehyde-Acetaldehyde (MAA)-Protein Adducts Predict Coronary Artery Disease	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; C-REACTIVE PROTEIN; E-DEFICIENT MICE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR EVENTS; OXIDATIVE MODIFICATION; IMMUNE-COMPLEXES; OXIDIZED LDL; MYOCARDIAL-INFARCTION; RHEUMATOID-ARTHRITIS	Malondialdehyde-acetaldehyde adducts (MAA) have been implicated in atherosclerosis. The purpose of this study was to investigate the role of MAA in atherosclerotic disease. Serum samples from controls (n = 82) and patients with; non-obstructive coronary artery disease (CAD), (n = 40), acute myocardial infarction (AMI) (n = 42), or coronary artery bypass graft (CABG) surgery due to obstructive multi-vessel CAD (n = 72), were collected and tested for antibody isotypes to MAA-modifed human serum albumin (MAA-HSA). CAD patients had elevated relative levels of IgG and IgA anti-MAA, compared to control patients (p<0.001). AMI patients had a significantly increased relative levels of circulating IgG anti-MAA-HSA antibodies as compared to stable angina (p<0.03) or CABG patients (p<0.003). CABG patients had significantly increased relative levels of circulating IgA anti-MAA-HSA antibodies as compared to non-obstructive CAD (p<0.001) and AMI patients (p<0.001). Additionally, MAA-modified proteins were detected in the tissue of human AMI lesions. In conclusion, the IgM, IgG and IgA anti-MAA-HSA antibody isotypes are differentially and significantly associated with non-obstructive CAD, AMI, or obstructive multi-vessel CAD and may serve as biomarkers of atherosclerotic disease.	[Anderson, Daniel R.; Shurmur, Scott W.; Garvin, Robert P.] Univ Nebraska Med Ctr, Dept Internal Med, Div Cardiol, Omaha, NE 68198 USA; [Duryee, Michael J.; Hunter, Carlos D.; Mikuls, Ted R.; Klassen, Lynell W.; Thiele, Geoffrey M.] Vet Affairs Nebraska Western Iowa Hlth Care Syst, Res Serv, Omaha, NE USA; [Duryee, Michael J.; Hunter, Carlos D.; Sayles, Harlan R.; Mikuls, Ted R.; Klassen, Lynell W.; Thiele, Geoffrey M.] Univ Nebraska Med Ctr, Dept Internal Med, Div Rheumatol, Omaha, NE USA; [Um, John Y.; Bussey, Walter D.] Univ Nebraska Med Ctr, Dept Surg, Div Cardiothorac Surg, Omaha, NE USA; [Thiele, Geoffrey M.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Anderson, DR (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Cardiol, Omaha, NE 68198 USA.	danderso@unmc.edu	Shurmur, Scott/AAX-5382-2021	Duryee, Michael/0000-0001-9104-2238	NIH Student Loan Repayment Program (DRA); Division of Cardiology; Department of Internal Medicine at the University of Nebraska Medical Center, Omaha, Nebraska	NIH Student Loan Repayment Program (DRA); Division of Cardiology; Department of Internal Medicine at the University of Nebraska Medical Center, Omaha, Nebraska	This work was funded by the NIH Student Loan Repayment Program (DRA), the Division of Cardiology, and Department of Internal Medicine at the University of Nebraska Medical Center, Omaha, Nebraska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa M, 2004, CARDIOVASC PATHOL, V13, P125, DOI 10.1016/S1054-8807(04)00004-3; Anderson DR, 2013, CYTOKINE, V62, P395, DOI 10.1016/j.cyto.2013.03.020; Butcher MJ, 2012, CIRC RES, V110, P675, DOI 10.1161/CIRCRESAHA.111.261784; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; Duryee MJ, 2010, FREE RADICAL BIO MED, V49, P1480, DOI 10.1016/j.freeradbiomed.2010.08.001; Fu S, 1998, BIOCHEM J, V333, P519, DOI 10.1042/bj3330519; Furie KL, 2012, STROKE, V43, P3442, DOI 10.1161/STR.0b013e318266722a; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Heinecke JW, 1998, ATHEROSCLEROSIS, V141, P1, DOI 10.1016/S0021-9150(98)00173-7; Herrmann J, 2008, J AM COLL CARDIOL, V51, P2003, DOI 10.1016/j.jacc.2008.02.047; Hill GE, 1998, ATHEROSCLEROSIS, V141, P107, DOI 10.1016/S0021-9150(98)00153-1; Holvoet P, 1998, ACTA CARDIOL, V53, P253; Horkko S, 2000, FREE RADICAL BIO MED, V28, P1771, DOI 10.1016/S0891-5849(00)00333-6; Ketelhuth DFJ, 2011, THROMB HAEMOSTASIS, V106, P779, DOI 10.1160/TH11-05-0321; Kummu O, 2014, IMMUNOLOGY, V141, P416, DOI 10.1111/imm.12204; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Liu ZD, 2012, INFLAMM RES, V61, P1155, DOI 10.1007/s00011-012-0510-2; Lopes-Virella MF, 2012, ATHEROSCLEROSIS, V224, P526, DOI 10.1016/j.atherosclerosis.2012.08.006; Lopes-Virella MF, 2010, CLIN IMMUNOL, V134, P55, DOI 10.1016/j.clim.2009.04.001; Mikuls TR, 2006, ARTHRITIS RHEUM, V54, P3057, DOI 10.1002/art.22200; Milioti N, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/723539; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325, DOI 10.1161/01.ATV.10.3.325; Ravandi A, 2011, J LIPID RES, V52, P1829, DOI 10.1194/jlr.M015776; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rolla R, 2000, HEPATOLOGY, V31, P878, DOI 10.1053/he.2000.5373; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sampi M, 2010, J CLIN ENDOCR METAB, V95, P2467, DOI 10.1210/jc.2009-1858; Segev A, 2005, AM HEART J, V150, P1007, DOI 10.1016/j.ahj.2004.12.008; Sokolove J, 2013, ARTHRITIS RHEUM-US, V65, P1719, DOI 10.1002/art.37961; Thiele GM, 1998, ALCOHOL CLIN EXP RES, V22, P1731, DOI 10.1111/j.1530-0277.1998.tb03973.x; Tsimikas S, 2004, CIRCULATION, V110, P1406, DOI 10.1161/01.CIR.0000141728.23033.B5; Tsimikas S, 2003, J AM COLL CARDIOL, V41, P360, DOI 10.1016/S0735-1097(02)02769-9; Tsimikas S, 2007, J LIPID RES, V48, P425, DOI 10.1194/jlr.M600361-JLR200; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P2218, DOI 10.1016/j.jacc.2012.08.979; TUMA DJ, 1987, ALCOHOL CLIN EXP RES, V11, P579, DOI 10.1111/j.1530-0277.1987.tb00178.x; Tuma DJ, 1996, HEPATOLOGY, V23, P872, DOI 10.1002/hep.510230431; Uchida K, 2006, FREE RADICAL RES, V40, P1335, DOI 10.1080/10715760600902302; Vehkala L, 2013, ANN MED, V45, P501, DOI 10.3109/07853890.2013.841322; Veneskoski M, 2011, FREE RADICAL BIO MED, V51, P834, DOI 10.1016/j.freeradbiomed.2011.05.029; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Willis MS, 2004, INT IMMUNOPHARMACOL, V4, P885, DOI 10.1016/j.intimp.2004.04.004; Willis MS, 2002, ALCOHOL CLIN EXP RES, V26, P158; Willis MS, 2002, ALCOHOL CLIN EXP RES, V26, P94, DOI 10.1097/00000374-200201000-00013; Willis MS, 2003, INT IMMUNOPHARMACOL, V3, P1381, DOI 10.1016/S1567-5769(03)00136-X; Xu DS, 1997, CHEM RES TOXICOL, V10, P978, DOI 10.1021/tx970069t; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271	51	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107440	10.1371/journal.pone.0107440	http://dx.doi.org/10.1371/journal.pone.0107440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210746	Green Submitted, gold, Green Published			2022-12-27	WOS:000341855900074
J	Liddelow, SA; Dziegielewska, KM; Mollgard, K; Whish, SC; Noor, NM; Wheaton, BJ; Gehwolf, R; Wagner, A; Traweger, A; Bauer, H; Bauer, HC; Saunders, NR				Liddelow, Shane A.; Dziegielewska, Katarzyna M.; Mollgard, Kjeld; Whish, Sophie C.; Noor, Natassya M.; Wheaton, Benjamin J.; Gehwolf, Renate; Wagner, Andrea; Traweger, Andreas; Bauer, Hannelore; Bauer, Hans-Christian; Saunders, Norman R.			Cellular Specificity of the Blood-CSF Barrier for Albumin Transfer across the Choroid Plexus Epithelium	PLOS ONE			English	Article							CEREBROSPINAL-FLUID BARRIER; OPOSSUM MONODELPHIS-DOMESTICA; PLASMA-PROTEINS; FETAL SHEEP; BRAIN-DEVELOPMENT; NEURONAL UPTAKE; RAT EMBRYO; PERMEABILITY; MACROMOLECULES; EXPRESSION	To maintain the precise internal milieu of the mammalian central nervous system, well-controlled transfer of molecules from periphery into brain is required. Recently the soluble and cell-surface albumin-binding glycoprotein SPARC (secreted protein acidic and rich in cysteine) has been implicated in albumin transport into developing brain, however the exact mechanism remains unknown. We postulate that SPARC is a docking site for albumin, mediating its uptake and transfer by choroid plexus epithelial cells from blood into cerebrospinal fluid (CSF). We used in vivo physiological measurements of transfer of endogenous (mouse) and exogenous (human) albumins, in situ Proximity Ligation Assay (in situ PLA), and qRT-PCR experiments to examine the cellular mechanism mediating protein transfer across the blood-CSF interface. We report that at all developmental stages mouse albumin and SPARC gave positive signals with in situ PLAs in plasma, CSF and within individual plexus cells suggesting a possible molecular interaction. In contrast, in situ PLA experiments in brain sections from mice injected with human albumin showed positive signals for human albumin in the vascular compartment that were only rarely identifiable within choroid plexus cells and only at older ages. Concentrations of both endogenous mouse albumin and exogenous (intraperitoneally injected) human albumin were estimated in plasma and CSF and expressed as CSF/plasma concentration ratios. Human albumin was not transferred through the mouse blood-CSF barrier to the same extent as endogenous mouse albumin, confirming results from in situ PLA. During postnatal development Sparc gene expression was higher in early postnatal ages than in the adult and changed in response to altered levels of albumin in blood plasma in a differential and developmentally regulated manner. Here we propose a possible cellular route and mechanism by which albumin is transferred from blood into CSF across a sub-population of specialised choroid plexus epithelial cells.	[Liddelow, Shane A.; Dziegielewska, Katarzyna M.; Whish, Sophie C.; Noor, Natassya M.; Wheaton, Benjamin J.; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia; [Liddelow, Shane A.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Mollgard, Kjeld] Univ Copenhagen, Inst Cellular & Mol Med, Copenhagen, Denmark; [Wagner, Andrea; Bauer, Hannelore] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria; [Gehwolf, Renate; Wagner, Andrea; Traweger, Andreas; Bauer, Hans-Christian] Paracelsus Med Univ, Inst Tendon & Bone Regenerat, Salzburg, Austria	University of Melbourne; Stanford University; University of Copenhagen; Salzburg University; Paracelsus Private Medical University	Saunders, NR (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia.	n.saunders@unimelb.edu.au	Wheaton, Ben/AAC-7037-2021; Liddelow, Shane/ABE-6456-2020; Traweger, Andreas/M-1460-2015	Liddelow, Shane/0000-0002-0840-1437; Saunders, Norman/0000-0001-6660-7639; Gehwolf, Renate/0000-0002-2620-3127; Wheaton, Benjamin/0000-0003-0619-4777; Traweger, Andreas/0000-0002-0220-4766	National Health and Medical Research Council (NHMRC, Australia); NH&MRC CJ Martin Fellowship; Seventh Framework Program (EU); NHMRC; European Union Seventh Framework Program (FP7) [HEALTH-F2-2009-241778]	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); NH&MRC CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Seventh Framework Program (EU); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); European Union Seventh Framework Program (FP7)	The research leading to these results has received funding from the National Health and Medical Research Council (NHMRC, Australia) as part of an agreement with the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement No. HEALTH-F2-2009-241778. SL was funded by an NH&MRC CJ Martin Fellowship. SL, KD, HB, H-CB, RG, AW and NS are members of the Neurobid Consortium, funded by the Seventh Framework Program (EU) and NHMRC. KM is an adviser to the Neurobid Consortium. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADINOLFI M, 1976, NATURE, V259, P140, DOI 10.1038/259140a0; Andersen JT, 2013, J BIOL CHEM, V288, P24277, DOI 10.1074/jbc.M113.463000; Armit C, 2012, MAMM GENOME, V23, P514, DOI 10.1007/s00335-012-9407-1; BIRGE WJ, 1974, DEV BIOL, V41, P245, DOI 10.1016/0012-1606(74)90303-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAVANAGH ME, 1982, DEV NEUROSCI-BASEL, V5, P492, DOI 10.1159/000112710; DEANE EM, 1984, DEV COMP IMMUNOL, V8, P863, DOI 10.1016/0145-305X(84)90069-7; DZIEGIELEWSKA KM, 1986, COMP BIOCHEM PHYS B, V83, P561, DOI 10.1016/0305-0491(86)90297-X; DZIEGIELEWSKA KM, 1991, J PHYSIOL-LONDON, V439, P215, DOI 10.1113/jphysiol.1991.sp018664; DZIEGIELEWSKA KM, 1980, J PHYSIOL-LONDON, V300, P457, DOI 10.1113/jphysiol.1980.sp013172; DZIEGIELEWSKA KM, 1979, J PHYSIOL-LONDON, V292, P207, DOI 10.1113/jphysiol.1979.sp012847; DZIEGIELEWSKA KM, 1981, DEV BIOL, V83, P193, DOI 10.1016/S0012-1606(81)80024-3; DZIEGIELEWSKA KM, 1980, J PHYSIOL-LONDON, V300, P441, DOI 10.1113/jphysiol.1980.sp013171; Ek CJ, 2003, J COMP NEUROL, V460, P451, DOI 10.1002/cne.10661; HABGOOD MD, 1992, J PHYSIOL-LONDON, V456, P181, DOI 10.1113/jphysiol.1992.sp019332; HABGOOD MD, 1993, J PHYSIOL-LONDON, V468, P73, DOI 10.1113/jphysiol.1993.sp019760; HUXLEY VH, 1991, AM J PHYSIOL, V260, pH1645, DOI 10.1152/ajpheart.1991.260.5.H1645; Johansson PA, 2006, EUR J NEUROSCI, V24, P65, DOI 10.1111/j.1460-9568.2006.04904.x; Johansson PA, 2008, BIOESSAYS, V30, P237, DOI 10.1002/bies.20718; Knott GW, 1997, J PHYSIOL-LONDON, V499, P179, DOI 10.1113/jphysiol.1997.sp021919; Liddelow SA, 2011, EUR J NEUROSCI, V34, P1062, DOI 10.1111/j.1460-9568.2011.07821.x; Liddelow SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065629; Liddelow SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033554; Liddelow SA, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-16; Liddelow SA, 2009, EUR J NEUROSCI, V29, P253, DOI 10.1111/j.1460-9568.2008.06571.x; LOBERG EM, 1992, ACTA NEUROPATHOL, V84, P234; LOBERG EM, 1993, APMIS, V101, P777, DOI 10.1111/j.1699-0463.1993.tb00179.x; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; MENDIS DB, 1994, MOL BRAIN RES, V24, P11, DOI 10.1016/0169-328X(94)90112-0; MOLLGARD K, 1977, PROC R SOC SER B-BIO, V199, P321, DOI 10.1098/rspb.1977.0142; PERSSON L, 1976, ACTA NEUROPATHOL, V34, P125, DOI 10.1007/BF00684663; RAMEY BA, 1979, DEV BIOL, V68, P292, DOI 10.1016/0012-1606(79)90261-6; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Saunders NR, 2011, METHODS MOL BIOL, V686, P247, DOI 10.1007/978-1-60761-938-3_11; Saunders NR, 1992, PHYSL PHARM BLOOD BR, P327, DOI DOI 10.1007/978-3-642-76894-1_14; SCHNEEBERGER EE, 1984, AM J PHYSIOL, V247, pH206, DOI 10.1152/ajpheart.1984.247.2.H206; SCHNITZER JE, 1994, J BIOL CHEM, V269, P6072; SCHNITZER JE, 1992, AM J PHYSIOL, V263, pH1872, DOI 10.1152/ajpheart.1992.263.6.H1872; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Stehle G, 1997, CRIT REV ONCOL HEMAT, V26, P77, DOI 10.1016/S1040-8428(97)00015-2; Stolp HB, 2011, BRAIN, V134, P3236, DOI 10.1093/brain/awr237; Strazielle N, 2013, MOL PHARMACEUT, V10, P1473, DOI 10.1021/mp300518e; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230	45	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106592	10.1371/journal.pone.0106592	http://dx.doi.org/10.1371/journal.pone.0106592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211495	Green Published, gold			2022-12-27	WOS:000341855900017
J	Novoa, A; Gonzalez, L				Novoa, Ana; Gonzalez, Luis			Impacts of Carpobrotus edulis (L.) NEBr. on the Germination, Establishment and Survival of Native Plants: A Clue for Assessing Its Competitive Strength	PLOS ONE			English	Article							INVASION; GROWTH; SHRUB	Does Carpobrotus edulis have an impact on native plants? How do C. edulis' soil residual effects affect the maintenance of native populations? What is the extent of interspecific competition in its invasion process? In order to answer those questions, we established pure and mixed cultures of native species and C. edulis on soil collected from invaded and native areas of Mediterranean coastal dunes in the Iberian Peninsula. We examined the impact of the invader on the germination, growth and survival of seeds and adult plants of two native plant species (Malcolmia littorea (L.) R.Br, and Scabiosa atropurpurea L.) growing with ramets or seeds of C. edulis. Residual effects of C. edulis on soils affected the germination process and early growth of native plants in different ways, depending on plant species and density. Interspecific competition significantly reduced the germination and early growth of native plants but this result was soil, density, timing and plant species dependent. Also, at any density of adult individuals of C. edulis, established native adult plants were not competitive. Moreover, ramets of C. edulis had a lethal effect on native plants, which died in a short period of time. Even the presence of C. edulis seedlings prevents the recruitment of native species. In conclusion, C. edulis have strong negative impacts on the germination, growth and survival of the native species M. littorea and S. atropurpurea. These impacts were highly depended on the development stages of native and invasive plants. Our findings are crucial for new strategies of biodiversity conservation in coastal habitats.	[Novoa, Ana; Gonzalez, Luis] Univ Vigo, Fac Biol, Dept Biol Vexetal & Ciencias Solo, Vigo 36310, Spain	Universidade de Vigo	Novoa, A (corresponding author), Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa.	ANAN@sun.ac.za	González, Luís/F-6408-2010; Novoa, Ana/F-9034-2016; González, Luís/M-2582-2019	González, Luís/0000-0001-8091-9364; Novoa, Ana/0000-0001-7092-3917; González, Luís/0000-0001-8091-9364				Ammondt SA, 2012, RESTOR ECOL, V20, P638, DOI 10.1111/j.1526-100X.2011.00806.x; Brown CS, 2008, INVAS PLANT SCI MANA, V1, P399, DOI 10.1614/IPSM-08-082.1; Bubel N., 1988, NEW SEED STARTERS HD; Combs JK, 2011, ECOL APPL, V21, P2498, DOI 10.1890/10-2344.1; Conser C, 2009, BIOL INVASIONS, V11, P349, DOI 10.1007/s10530-008-9252-z; DANTONIO CM, 1991, AM J BOT, V78, P885, DOI 10.2307/2445167; de Wit CT, 1965, NETHERLANDS J AGRICU, V13, P212, DOI DOI 10.18174/NJAS.V13I2.17501; Del Vecchio S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070607; Del Vecchio S, 2012, J NAT CONSERV, V20, P357, DOI 10.1016/j.jnc.2012.08.001; Ens EJ, 2009, PLANT SOIL, V316, P125, DOI 10.1007/s11104-008-9765-3; Holdredge C, 2011, BIOL INVASIONS, V13, P423, DOI 10.1007/s10530-010-9836-2; Huangfu CH, 2011, ALLELOPATHY J, V27, P55; Hussain MI, 2008, ALLELOPATHY J, V22, P101; Khurana E, 2004, J TROP ECOL, V20, P385, DOI 10.1017/S026646740400135X; Kowarik I., 2003, BIOL INVASIONEN NEOP; Lee JA, 1998, NEW PHYTOL, V139, P127, DOI 10.1046/j.1469-8137.1998.00165.x; Ley C, 2007, MANUAL RESTAURACION; Lorenzo P, 2011, PLANT ECOL, V212, P403, DOI 10.1007/s11258-010-9831-9; Lorenzo P, 2010, APPL SOIL ECOL, V44, P245, DOI 10.1016/j.apsoil.2010.01.001; Mangla S, 2011, PLANT ECOL, V212, P531, DOI 10.1007/s11258-011-9909-z; Maun MA, 2009, BIOL COASTAL SAND DU; Novoa A, 2014, BIOL INVASIONS, V16, P429, DOI 10.1007/s10530-013-0531-y; Novoa A, 2013, BIOL CONSERV, V164, P1, DOI 10.1016/j.biocon.2013.04.008; Novoa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053166; Ren MX, 2009, WEED RES, V49, P449, DOI 10.1111/j.1365-3180.2009.00723.x; Santoro R, 2011, COMMUNITY ECOL, V12, P234, DOI 10.1556/ComEc.12.2011.2.12; Shadel WP, 2003, BIOL INVASIONS, V4, P413; Simberloff D, 2005, FRONT ECOL ENVIRON, V3, P12, DOI 10.2307/3868440; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; Tielborger K, 2009, OIKOS, V118, P792, DOI 10.1111/j.1600-0706.2008.17175.x; Tschirhart J, 2002, ECOL MODEL, V148, P191, DOI 10.1016/S0304-3800(01)00439-2; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x	32	37	37	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107557	10.1371/journal.pone.0107557	http://dx.doi.org/10.1371/journal.pone.0107557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210924	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900083
J	Shiraishi, N; Nishida, A; Shimodera, S; Sasaki, T; Oshima, N; Watanabe, N; Akechi, T; Furukawa, TA; Okazaki, Y				Shiraishi, Nao; Nishida, Atsushi; Shimodera, Shinji; Sasaki, Tsukasa; Oshima, Norihito; Watanabe, Norio; Akechi, Tatsuo; Furukawa, Toshiaki A.; Okazaki, Yuji			Relationship between Violent Behavior and Repeated Weight-Loss Dieting among Female Adolescents in Japan	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MENTAL-HEALTH STATUS; EATING-DISORDERS; CHILDHOOD ABUSE; RISK-FACTORS; BODY-IMAGE; OBESITY; ASSOCIATIONS; QUESTIONNAIRE; CONSEQUENCES	Purpose: To examine whether interpersonal violence perpetration and violence toward objects are associated with body mass index (BMI), body weight perception (BWP), and repeated weight-loss dieting in female adolescents. Methods: A cross-sectional survey using a self-report questionnaire was performed evaluating interpersonal violence perpetration, violence toward objects, the number of diets, BMI, BWP, the 12-item General Health Questionnaire (GHQ-12), victimization, substance use, and other psychosocial variables among 9,112 Japanese females aged between 12-18 years. Logistic regression analysis was conducted to analyze the contribution of BMI, BWP, and weight-control behavior to the incidence of violent behavior, while controlling for potential confounding factors. Results: The number of diets was associated with both interpersonal violence perpetration (OR = 1.18, 95% CI 1.08-1.29, p<0.001) and violence toward objects (OR = 1.34, 95% CI 1.24-1.45, p<0.001), after adjusting for age, BMI, BWP, the GHQ-12 total score, victimization, and substance use. In terms of BMI and BWP, the "overweight'' BWP was associated with violence toward objects (OR = 1.29, 95% CI 1.07-1.54, p<0.05). On the other hand, the "Underweight'' and "Slightly underweight'' BMI were related to violence toward objects [(OR = 1.28, 95% CI 1.01-1.62, p<0.05) and (OR = 1.27, 95% CI 1.07-1.51, p<0.05), respectively]. The "Underweight'' BWP was related to interpersonal violence perpetration (OR = 2.30, 95% CI 1.38-3.84, p<0.05). Conclusions: The cumulative number of diets is associated with violent behavior in female adolescents. In addition, underweight BMI and extreme BWP are associated with violent behavior.	[Shiraishi, Nao; Akechi, Tatsuo] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Mizuho Ku, Nagoya, Aichi, Japan; [Nishida, Atsushi] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Setagaya Ku, Tokyo 113, Japan; [Shimodera, Shinji] Kochi Univ, Kochi Med Sch, Dept Neuropsychiat, Nanngoku, Kohchi, Japan; [Sasaki, Tsukasa] Univ Tokyo, Grad Sch Educ, Lab Hlth Educ, Bunkyo Ku, Tokyo, Japan; [Oshima, Norihito] Univ Tokyo, Div Counseling & Support, Off Mental Hlth Support, Bunkyo Ku, Tokyo, Japan; [Watanabe, Norio] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Dept Clin Epidemiol, Kodaira, Tokyo, Japan; [Furukawa, Toshiaki A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav,Sakyo Ku, Kyoto, Japan; [Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Setagaya Ku, Tokyo, Japan	Nagoya City University; Tokyo Metropolitan Institute of Medical Science; Kochi University; University of Tokyo; University of Tokyo; National Center for Neurology & Psychiatry - Japan; Kyoto University	Shimodera, S (corresponding author), Kochi Univ, Kochi Med Sch, Dept Neuropsychiat, Nanngoku, Kohchi, Japan.	shimodes@kochi-u.ac.jp	Andoh, Akira/AAB-9303-2022; Furukawa, Toshi A./B-9259-2011	Furukawa, Toshi A./0000-0003-2159-3776	Ministry of Health, Labor, and Welfare of Japan [H19-kokoro-ippan-012]; Research Group for Schizophrenia in Japan	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research Group for Schizophrenia in Japan	This study was funded by a grant-in-aid for scientific research (#H19-kokoro-ippan-012) from the Ministry of Health, Labor, and Welfare of Japan and a grant-in-aid from the Research Group for Schizophrenia in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackard DM, 2002, J PSYCHOSOM RES, V52, P129, DOI 10.1016/S0022-3999(01)00269-0; Baksheev GN, 2011, PSYCHIAT RES, V187, P291, DOI 10.1016/j.psychres.2010.10.010; BALLIN A, 1992, AM J DIS CHILD, V146, P803, DOI 10.1001/archpedi.1992.02160190035015; Blaine B, 2008, J HEALTH PSYCHOL, V13, P1190, DOI 10.1177/1359105308095977; Blitstein JL, 2005, HEALTH EDUC BEHAV, V32, P175, DOI 10.1177/1090198104269516; Chang JJ, 2003, J ADOLESCENT HEALTH, V32, P272, DOI 10.1016/S1054-139X(02)00564-5; Cortese S, 2008, CRIT REV FOOD SCI, V48, P524, DOI 10.1080/10408390701540124; Crow S, 2006, J ADOLESCENT HEALTH, V38, P569, DOI 10.1016/j.jadohealth.2005.05.019; Daee A, 2002, SOUTH MED J, V95, P1032, DOI 10.1097/00007611-200209000-00021; Devaud C, 1998, INT J EAT DISORDER, V24, P207, DOI 10.1002/(SICI)1098-108X(199809)24:2&lt;207::AID-EAT10&gt;3.0.CO;2-W; Doi Y, 2003, PSYCHIAT CLIN NEUROS, V57, P379, DOI 10.1046/j.1440-1819.2003.01135.x; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Ellickson PL, 2001, J ADOLESCENT HEALTH, V28, P465, DOI 10.1016/S1054-139X(00)00202-0; Fang XM, 2010, ARCH GEN PSYCHIAT, V67, P1179, DOI 10.1001/archgenpsychiatry.2010.137; Favaro A, 2010, PSYCHOL MED, V40, P657, DOI 10.1017/S0033291709990973; FRENCH SA, 1995, AM J PUBLIC HEALTH, V85, P695, DOI 10.2105/AJPH.85.5.695; FRENCH SA, 1994, HEALTH PSYCHOL, V13, P195, DOI 10.1037/0278-6133.13.3.195; GOLDBERG DP, 1976, BRIT J PSYCHIAT, V129, P61, DOI 10.1192/bjp.129.1.61; Herrenkohl TI, 2000, J ADOLESCENT HEALTH, V26, P176, DOI 10.1016/S1054-139X(99)00065-8; Himes JH, 2005, ANN EPIDEMIOL, V15, P272, DOI 10.1016/j.annepidem.2004.08.010; Kaneita Y, 2007, J CLIN PSYCHIAT, V68, P1426, DOI 10.4088/JCP.v68n0916; Kaneko K, 1999, PSYCHIAT CLIN NEUROS, V53, P365, DOI 10.1046/j.1440-1819.1999.00559.x; Kato N., 2009, J JPN ASS HUM AUXO, V15, P37; Krug Etienne G, 2002, Biomedica, V22 Suppl 2, P327; Laufer Avital, 2003, Int J Adolesc Med Health, V15, P235; Maeda M, 1999, INT J HEMATOL, V69, P75; Mansson J, 2005, SCAND J PRIM HEALTH, V23, P28, DOI 10.1080/02813430510018428; Neumark-Sztainer D, 2006, J AM DIET ASSOC, V106, P559, DOI 10.1016/j.jada.2006.01.003; Neumark-Sztainer D, 2000, ARCH PEDIAT ADOL MED, V154, P569, DOI 10.1001/archpedi.154.6.569; Neumark-Sztainer D, 2004, J AM DIET ASSOC, V104, P913, DOI 10.1016/j.jada.2004.03.021; Neumark-Sztainer D, 2006, J ADOLESCENT HEALTH, V39, P244, DOI 10.1016/j.jadohealth.2005.12.001; Nishida A, 2008, SCHIZOPHR RES, V99, P125, DOI 10.1016/j.schres.2007.11.038; Ojala K, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-50; Polivy J, 1996, J AM DIET ASSOC, V96, P589, DOI 10.1016/S0002-8223(96)00161-7; PUGLIESE MT, 1983, NEW ENGL J MED, V309, P513, DOI 10.1056/NEJM198309013090901; Rayworth BB, 2004, EPIDEMIOLOGY, V15, P271, DOI 10.1097/01.ede.0000120047.07140.9d; RESNICK MD, 2004, J HLTH EC, V0035; Smith-Khuri E, 2004, ARCH PEDIAT ADOL MED, V158, P539, DOI 10.1001/archpedi.158.6.539; Smolak L, 2002, INT J EAT DISORDER, V31, P136, DOI 10.1002/eat.10008; Stice E, 2000, J ABNORM PSYCHOL, V109, P438, DOI 10.1037/0021-843X.109.3.438; STORY M, 1991, AM J DIS CHILD, V145, P994, DOI 10.1001/archpedi.1991.02160090046020; Suka Machi, 2005, Environmental Health and Preventive Medicine, V10, P324, DOI 10.1007/BF02898192; Swahn MH, 2004, J ADOLESCENT HEALTH, V34, P480, DOI 10.1016/S1054-139X(03)00368-9; WHO Regional Office for Europe, HLTH BEH SCH AG CHIL; Yoshimasu K, 2012, J CHILD PSYCHOL PSYC, V53, P1036, DOI 10.1111/j.1469-7610.2012.02567.x	45	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107744	10.1371/journal.pone.0107744	http://dx.doi.org/10.1371/journal.pone.0107744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1UA	25210854	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900092
J	Zhou, XJ; Liu, B; Shi, CL; Shi, XM				Zhou, Xiujuan; Liu, Bin; Shi, Chunlei; Shi, Xianming			Mutation of a Salmonella Serogroup-C1-Specific Gene Abrogates O-7-Antigen Biosynthesis and Triggers NaCl-Dependent Motility Deficiency	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; O-ANTIGEN TRANSLOCASE; ESCHERICHIA-COLI; SEROTYPE CHOLERAESUIS; MEMBRANE TOPOLOGY; SWARMING MOTILITY; BIOFILM FORMATION; IDENTIFICATION; FLAGELLAR; PROTEINS	Several molecular detection marker genes specific for a number of individual Salmonella serogroups have been recently identified in our lab by comparative genomics for the genotyping of diverse serogroups. To further understand the correlation between serotype and genotype, the function of a Salmonella serogroup-C1-specific gene (SC_2092) was analyzed in this study. It was indicated from the topological prediction using the deduced amino acid sequence of SC_2092 that this putative protein was highly similar to the confirmed Wzx flippases. Furthermore, SDS-PAGE revealed that lipopolysaccharide (LPS) biosynthesis, specifically O-antigen synthesis, was incomplete in an SC_2092 in-frame deletion mutant, and no agglutination reaction with the O-7 antibody was exhibited in this mutant. Therefore, it was revealed that this Salmonella serogroup-C1-specific gene SC_2092 encoded a putative flippase, which was required for O-7-polysaccharide biosynthesis, and was designated here as wzx(C1). Subsequently, the effects of the deletion of wzx(C1) on bacterial motility and sodium chloride (NaCl) tolerance were evaluated. The wzx(C1) mutant lacked swarming motility on solid surfaces and was impaired in swimming motility in soft agar. Moreover, microscopic examination and RT-qPCR exhibited that an increased auto-aggregation and a strong defect in flagella expression, respectively, were responsible for the reduced motility in this mutant. In addition, the wzx(C1) mutant was more sensitive than the wild-type strain to NaCl, and auto-aggregation of mutant cells was observed immediately up on the addition of 1% NaCl to the medium. Interestingly, the motility deficiency of the mutant strain, as well as the cell agglomeration and the decrease in flagellar expression, were relieved in a NaCl-free medium. This is the first study to experimentally demonstrate a connection between a Salmonella serogroup specific gene identified by comparative genomics with the synthesis of a specific O-antigen biosynthesis. Also, our results show that the mutation of wzx(C1) triggers a NaCl-dependent motility deficiency.	[Zhou, Xiujuan; Shi, Chunlei; Shi, Xianming] Shanghai Jiao Tong Univ, Sch Agr & Biol, MOST USDA Joint Res Ctr Food Safety, Shanghai 200030, Peoples R China; [Zhou, Xiujuan; Shi, Chunlei; Shi, Xianming] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Liu, Bin] Northwest Agr & Forestry Univ, Coll Food Sci & Engn, Yangling, Shaanxi, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Northwest A&F University - China	Shi, CL (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, MOST USDA Joint Res Ctr Food Safety, Shanghai 200030, Peoples R China.	clshi@sjtu.edu.cn; xmshi@sjtu.edu.cn	Shi, Chunlei/A-6428-2013	Shi, Chunlei/0000-0002-5847-7122	National Natural Science Foundation of China [31230058, 31000779]; Ministry of Science and Technology of China [2012AA101601, 2012BAK17B10, 2012BAD29B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was supported by the National Natural Science Foundation of China (grant Nos. 31230058 and 31000779) (http://www.nsfc.gov.cn/); Ministry of Science and Technology of China (grant Nos. 2012AA101601, 2012BAK17B10, and 2012BAD29B02) (http://www.most.gov.cn/). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bowden MG, 1998, MOL MICROBIOL, V30, P275, DOI 10.1046/j.1365-2958.1998.01060.x; BURDETT IDJ, 1974, J BACTERIOL, V119, P303, DOI 10.1128/JB.119.1.303-324.1974; Centers for Disease Control and Prevention, 2012, SALM; Chen Po-Lin, 2007, Journal of Microbiology Immunology and Infection, V40, P240; Chiu CH, 2006, PEDIATRICS, V117, pE1193, DOI 10.1542/peds.2005-2251; Chiu CH, 2004, CLIN MICROBIOL REV, V17, P311, DOI 10.1128/CMR.17.2.311-322.2004; Cong YG, 2011, FEMS MICROBIOL LETT, V317, P160, DOI 10.1111/j.1574-6968.2011.02225.x; Cunneen MM, 2008, FEMS MICROBIOL LETT, V287, P76, DOI 10.1111/j.1574-6968.2008.01295.x; Desroche N, 2005, J MICROBIOL METH, V60, P325, DOI 10.1016/j.mimet.2004.10.010; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Foley S L, 2008, J Anim Sci, V86, pE173; Gillespie BE, 2003, J FOOD PROTECT, V66, P2367, DOI 10.4315/0362-028X-66.12.2367; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Golden NJ, 2002, INFECT IMMUN, V70, P1761, DOI 10.1128/IAI.70.4.1761-1771.2002; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; International Food Safety Authorities Network (INFOSAN), 2007, 032007 INFOSAN; Islam ST, 2013, MBIO, V4, DOI 10.1128/mBio.00678-13; Islam ST, 2013, MICROBIOLOGYOPEN, V2, P350, DOI 10.1002/mbo3.72; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Islam ST, 2012, MOL MICROBIOL, V84, P1165, DOI 10.1111/j.1365-2958.2012.08084.x; Islam ST, 2010, MBIO, V1, DOI 10.1128/mBio.00189-10; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; LEE SJ, 1992, J GEN MICROBIOL, V138, P1843, DOI 10.1099/00221287-138-9-1843; Legendre G, 2011, J MICROBIOL, V49, P349, DOI 10.1007/s12275-011-0162-x; LINDBERG B, 1988, CARBOHYD RES, V174, P313, DOI 10.1016/0008-6215(88)85100-0; Liu B, 2011, INT J FOOD MICROBIOL, V144, P511, DOI 10.1016/j.ijfoodmicro.2010.11.010; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; LUK JMC, 1993, J CLIN MICROBIOL, V31, P2118, DOI 10.1128/JCM.31.8.2118-2123.1993; Marolda CL, 2010, J BACTERIOL, V192, P6160, DOI 10.1128/JB.00141-10; Misawa N, 2000, INFECT IMMUN, V68, P6168, DOI 10.1128/IAI.68.11.6168-6175.2000; Morgenstein RM, 2010, J BACTERIOL, V192, P3213, DOI 10.1128/JB.00196-10; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Partridge JD, 2013, J BACTERIOL, V195, P919, DOI 10.1128/JB.02064-12; Patrick JE, 2012, MOL MICROBIOL, V83, P14, DOI 10.1111/j.1365-2958.2011.07917.x; Pompilio A, 2008, FEMS MICROBIOL LETT, V287, P41, DOI 10.1111/j.1574-6968.2008.01292.x; Reeves PR, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P319; Ross IL, 2005, J CLIN MICROBIOL, V43, P1604, DOI 10.1128/JCM.43.4.1604-1611.2005; Rubires X, 1997, J BACTERIOL, V179, P7581, DOI 10.1128/jb.179.23.7581-7586.1997; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Shanks RMQ, 2008, INFECT IMMUN, V76, P2469, DOI 10.1128/IAI.01370-07; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Ulett GC, 2006, MICROBIOL-SGM, V152, P2101, DOI 10.1099/mic.0.28607-0; Wang L, 2002, J BACTERIOL, V184, P1669, DOI 10.1128/JB.184.6.1669-1677.2002	47	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106708	10.1371/journal.pone.0106708	http://dx.doi.org/10.1371/journal.pone.0106708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211341	gold, Green Submitted, Green Published			2022-12-27	WOS:000341855900024
J	Cuthbert, MO; Ashley, GM				Cuthbert, Mark O.; Ashley, Gail M.			A Spring Forward for Hominin Evolution in East Africa	PLOS ONE			English	Article							EARLY HUMAN HABITATS; OLDUVAI-GORGE; GROUNDWATER RECHARGE; FRESH-WATER; CLIMATE-CHANGE; RIFT BASIN; FLK NORTH; BED I; GEOCHEMISTRY; ENVIRONMENTS	Groundwater is essential to modern human survival during drought periods. There is also growing geological evidence of springs associated with stone tools and hominin fossils in the East African Rift System (EARS) during a critical period for hominin evolution (from 1.8 Ma). However it is not known how vulnerable these springs may have been to climate variability and whether groundwater availability may have played a part in human evolution. Recent interdisciplinary research at Olduvai Gorge, Tanzania, has documented climate fluctuations attributable to astronomic forcing and the presence of paleosprings directly associated with archaeological sites. Using palaeogeological reconstruction and groundwater modelling of the Olduvai Gorge paleo-catchment, we show how spring discharge was likely linked to East African climate variability of annual to Milankovitch cycle timescales. Under decadal to centennial timescales, spring flow would have been relatively invariant providing good water resource resilience through long droughts. For multi-millennial periods, modelled spring flows lag groundwater recharge by 100 s to 1000 years. The lag creates long buffer periods allowing hominins to adapt to new habitats as potable surface water from rivers or lakes became increasingly scarce. Localised groundwater systems are likely to have been widespread within the EARS providing refugia and intense competition during dry periods, thus being an important factor in natural selection and evolution, as well as a vital resource during hominin dispersal within and out of Africa.	[Cuthbert, Mark O.] UNSW Australia, Connected Waters Initiat Res Ctr, Sydney, NSW, Australia; [Cuthbert, Mark O.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Ashley, Gail M.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA	University of New South Wales Sydney; University of Birmingham; Rutgers State University New Brunswick	Cuthbert, MO (corresponding author), UNSW Australia, Connected Waters Initiat Res Ctr, Sydney, NSW, Australia.	m.cuthbert@bham.ac.uk	Cuthbert, Mark O/B-9709-2011	Cuthbert, Mark O/0000-0001-6721-022X	European Community's Seventh Framework Programme [FP7] [299091]; Spanish Ministry of Education and Science [I+D HUM2007-6381507-63815]; National Science Foundation (Sedimentary Geology and Paleobiology) [EAR-1349651]	European Community's Seventh Framework Programme [FP7]; Spanish Ministry of Education and Science(Spanish Government); National Science Foundation (Sedimentary Geology and Paleobiology)(National Science Foundation (NSF))	MOC was supported by funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement n <SUP>o</SUP>299091 (http://ec.europa.eu/research/mariecurieactions/). GMA received funding from the Spanish Ministry of Education and Science through the European project I+D HUM2007-6381507-63815 and under National Science Foundation grant(Sedimentary Geology and Paleobiology, EAR-1349651 to D. M. Deocampo and G. M. Ashley) (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley G.M., 2009, 50 GOLDEN ANNIVERSAR; Ashley GM, 2007, GEOLOGY, V35, P1091, DOI 10.1130/G24163A.1; Ashley GM, 2014, QUATERN INT, V322, P66, DOI 10.1016/j.quaint.2013.12.047; Ashley GM, 2010, QUATERNARY RES, V74, P333, DOI 10.1016/j.yqres.2010.08.006; Ashley GM, 2010, QUATERNARY RES, V74, P304, DOI 10.1016/j.yqres.2010.07.015; Ashley GM, 2010, J SEDIMENT RES, V80, P703, DOI 10.2110/jsr.2010.066; Ashley GM, 2009, PALAEOGEOGR PALAEOCL, V272, P1, DOI 10.1016/j.palaeo.2008.10.016; ASHLEY GM, 2002, SEPM SPECIAL PUBLICA, V73, P107, DOI DOI 10.2110/PEC.02.73.0107; Ashley GM, 2013, GEOLOGICAL SOC AM AB, V45; Ashley GM, 2013, QUATERN INT, V322-323, P54; Ashley GM, J SEDIMENTA IN PRESS, V84; Ashley GM, 2001, ARCHAEOLOGICAL SEDIM, P183; Ayenew T, 2008, J AFR EARTH SCI, V52, P97, DOI 10.1016/j.jafrearsci.2008.06.006; Bailey GN, 2011, J HUM EVOL, V60, P257, DOI 10.1016/j.jhevol.2010.01.004; Barboni D, 2010, QUATERNARY RES, V74, P344, DOI 10.1016/j.yqres.2010.09.005; Belcher WR, 2002, PROBABILITY DISTRIBU; Brutsaert W., 2005, HYDROLOGY INTRO; Campisano C. J., 2012, NATURE ED KNOWLEDGE, V4, P5; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Cruz FW, 2005, NATURE, V434, P63, DOI 10.1038/nature03365; Cuthbert MO, 2014, WATER RESOUR RES, V50, P2407, DOI 10.1002/2013WR014060; Cuthbert MO, 2010, J WATER CLIM CHANGE, V1, P234, DOI 10.2166/wcc.2010.040; Cuthbert MO, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008572; Darling WG, 1996, J AFR EARTH SCI, V22, P423, DOI 10.1016/0899-5362(96)00026-7; Dawson J.B., 2008, MEMOIRS, V33; Deino AL, 2006, EARTH PLANET SC LETT, V247, P41, DOI 10.1016/j.epsl.2006.04.009; Deino AL, 2012, J HUM EVOL, V63, P251, DOI 10.1016/j.jhevol.2012.05.004; Deocampo DM, 2009, AM J SCI, V309, P834, DOI 10.2475/09.2009.03; Deocampo DM, 2002, QUATERNARY RES, V57, P271, DOI 10.1006/qres.2001.2317; Dominguez-Rodrigo M, 2010, QUATERNARY RES, V74, P315, DOI 10.1016/j.yqres.2010.07.003; Dunkerley DL, 2008, EARTH SURF PROC LAND, V33, P226, DOI 10.1002/esp.1539; Feakins SJ, 2013, GEOLOGY, V41, P295, DOI 10.1130/G33845.1; Ferring R, 2011, P NATL ACAD SCI USA, V108, P10432, DOI 10.1073/pnas.1106638108; Finlayson C., 2014, IMPROBABLE PRIMATE W; Gleeson T, 2011, GEOPHYS RES LETT, V38; Greco R, 2013, HYDROL EARTH SYST SC, V17, P4001, DOI 10.5194/hess-17-4001-2013; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; Hogan J.E., 2004, GROUNDWATER RECHARGE; Houston J, 2002, HYDROL PROCESS, V16, P3019, DOI 10.1002/hyp.1086; Hover VC, 2003, CLAY CLAY MINER, V51, P231, DOI 10.1346/CCMN.2003.0510301; Johnson CR, 2009, SEDIMENTOLOGY, V56, P1115, DOI 10.1111/j.1365-3091.2008.01022.x; Joordens JCA, 2011, EARTH PLANET SC LETT, V307, P1, DOI 10.1016/j.epsl.2011.05.005; Kruseman G., 1997, INT ASS HYDROGEOLOGI, V19; Lee RKL, 2013, PALAEOGEOGR PALAEOCL, V374, P197, DOI 10.1016/j.palaeo.2013.01.019; Liutkus CM, 2005, GEOLOGY, V33, P377, DOI 10.1130/G21132.1; Liutkus CM, 2003, J SEDIMENT RES, V73, P691, DOI 10.1306/021303730691; MacDonald AM, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024009; Magill CR, 2013, P NATL ACAD SCI USA, V110, P1167, DOI 10.1073/pnas.1206276110; Magill CR, 2013, P NATL ACAD SCI USA, V110, P1175, DOI 10.1073/pnas.1209405109; Maslin Mark A., 2009, P151, DOI 10.1007/978-1-4020-9980-9_13; McBrearty S, 2005, NATURE, V437, P105, DOI 10.1038/nature04008; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; MCHENRY LJ, 2004, CHARACTERIZATION COR; Moghaddam AA, 2006, HYDROGEOL J, V14, P1319, DOI 10.1007/s10040-006-0036-1; Neubauer S, 2012, EVOL BIOL, V39, P568, DOI 10.1007/s11692-011-9156-1; Olago D, 2009, HYDROLOG SCI J, V54, P765, DOI 10.1623/hysj.54.4.765; Pool DR, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003255; Potts R, 1999, EVOL ANTHROPOL, V7, P81, DOI 10.1002/(SICI)1520-6505(1998)7:3<81::AID-EVAN3>3.3.CO;2-1; Potts R, 2012, CURR ANTHROPOL, V53, pS299, DOI 10.1086/667704; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Ruddiman W., 2013, EARTHSCLIMATE FUTURE; Scanlon BR, 2006, HYDROL PROCESS, V20, P3335, DOI 10.1002/hyp.6335; Segalen L, 2007, J HUM EVOL, V53, P549, DOI 10.1016/j.jhevol.2006.12.010; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Shultz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076750; Simmers I, 2003, IAH INT CONTRIBUTION, V23; Taylor RG, 2013, NAT CLIM CHANGE, V3, P374, DOI [10.1038/NCLIMATE1731, 10.1038/nclimate1731]; TOWNLEY LR, 1995, ADV WATER RESOUR, V18, P125, DOI 10.1016/0309-1708(95)00008-7; Trauth MH, 2007, J HUM EVOL, V53, P475, DOI 10.1016/j.jhevol.2006.12.009; Trauth MH, 2010, QUATERNARY SCI REV, V29, P2981, DOI 10.1016/j.quascirev.2010.07.007; Yihdego Y, 2013, J HYDROL, V503, P111, DOI 10.1016/j.jhydrol.2013.08.034	72	26	26	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107358	10.1371/journal.pone.0107358	http://dx.doi.org/10.1371/journal.pone.0107358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207544	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300078
J	Giora, J; Tarasconi, HM; Fialho, CB				Giora, Julia; Tarasconi, Hellen M.; Fialho, Clarice B.			Reproduction and Feeding of the Electric Fish Brachyhypopomus gauderio (Gymnotiformes: Hypopomidae) and the Discussion of a Life History Pattern for Gymnotiforms from High Latitudes	PLOS ONE			English	Article							EOD WAVE-FORM; OCCIDENTALIS GYMNOTIFORMES; TEMPERATURE SENSITIVITY; RIVER; TELEOSTEI; STRATEGIES; BIOLOGY; PINNICAUDATUS; SEASONALITY; GYMNOTIDAE	The reproductive biology and feeding habits of the electric fish Brachyhypopomus gauderio were studied. The species has seasonal reproductive behavior, with breeding occurring during the Southern Hemisphere spring and summer, and having a positive relation with the photoperiod variation. Brachyhypopomus gauderio was defined as a fractional spawner, with low relative fecundity and high first maturation size. Sexual dimorphism was registered, males undergoing hypertrophy of the distal portion of caudal filament. The results on reproductive biology herein obtained are in agreement with data concerning gymnotiforms from Southern Brazil and Uruguay, pointing to an ecological pattern for the species from high latitudes, differing from species with tropical distribution. According to the analysis of the food items, B. gauderio feed mainly on autochthonous insects, likewise the other gymnotiforms previously investigated, leading to conclude that there is no variation on the diet of the species of the order related to climatic conditions or even to habitat of occurrence.	[Giora, Julia; Tarasconi, Hellen M.; Fialho, Clarice B.] Univ Fed Rio Grande do Sul, Dept Zool, Lab Ictiol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Giora, J (corresponding author), Univ Fed Rio Grande do Sul, Dept Zool, Lab Ictiol, Porto Alegre, RS, Brazil.	jugiora@hotmail.com	Fialho, Clarice/AAI-2829-2021; Giora, Julia/B-9067-2013		Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; Programa Nacional de Pos Doutorado-PNPD-CAPES [2282/09]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [476821/2003-7, 478002/2006-8]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa Nacional de Pos Doutorado-PNPD-CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, and Programa Nacional de Pos Doutorado-PNPD-CAPES (process 2282/09) has funded the first author. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (process 476821/2003-7; 478002/2006-8) has supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEBISI AA, 1987, ARCH HYDROBIOL, V111, P151; Albert JS, 2005, SPR HDB AUD, V21, P360; Albert JS, 2001, PUBL MUS ZOOL U MICH, V190, P1; Alves-Gomes J. A., 1997, HOMEM AMBIENTE ECOLO, P509; [Anonymous], 1979, FISHERIES ECOLOGY FL; Ardanaz JL, 2001, J COMP PHYSIOL A, V187, P853, DOI 10.1007/s00359-001-0256-8; Arrington DA, 2002, ECOLOGY, V83, P2145, DOI 10.1890/0012-9658(2002)083[2145:HODFRO]2.0.CO;2; Assunu║ao M.I.S., 1995, ICHTHYOL EXPLOR FRES, V6, P175; Barbieri G, 1982, SPECTR J BRAS CIENC, V2, P25; Braga RR, 2012, REV FISH BIOL FISHER, V22, P915, DOI 10.1007/s11160-012-9273-7; Cognato DD, 2006, NEOTROP ICHTHYOL, V4, P339, DOI 10.1590/S1679-62252006000300005; Crampton WGR, 2005, COPEIA, P48, DOI 10.1643/CI-04-056R1; Crampton WGR, 1996, J FISH BIOL, V48, P298, DOI 10.1006/jfbi.1996.0029; Crampton WGR, 1998, J FISH BIOL, V53, P307, DOI 10.1111/j.1095-8649.1998.tb01034.x; Crampton WGR, 2013, PEIXES RIO MADIERA, VIII, P207; Crampton WGR, 2007, NEOTROP ICHTHYOL, V5, P425, DOI 10.1590/S1679-62252007000300022; Eschmeyer WN, 2011, ELECT DATABASE; Fryer G, 1972, CICHLID FISHES GREAT; Giora J, 2008, NEOTROP ICHTHYOL, V6, P159, DOI 10.1590/S1679-62252008000200002; Giora J, 2012, ENVIRON BIOL FISH, V94, P649, DOI 10.1007/s10641-011-9971-3; Giora Júlia, 2005, Neotrop. ichthyol., V3, P291, DOI 10.1590/S1679-62252005000200007; Giora J, 2009, ZOOTAXA, P60, DOI 10.11646/zootaxa.2093.1.4; Giora J, 2009, BRAZ ARCH BIOL TECHN, V52, P617, DOI 10.1590/S1516-89132009000300014; Goulding M., 1980, FISHES FOREST EXPLOR; GRANADOLORENCIO C, 1986, EKOL POL-POL J ECOL, V34, P95; Guillen E., 1984, Limnetica, V1, P304; HAGEDORN M, 1988, COPEIA, P324; HAGEDORN M, 1985, J COMP PHYSIOL A, V156, P511, DOI 10.1007/BF00613975; HOPKINS C D, 1974, Zeitschrift fuer Tierpsychologie, V35, P518; HOPKINS CD, 1974, BEHAVIOUR, V50, P270, DOI 10.1163/156853974X00499; HOPKINS CD, 1990, BRAIN BEHAV EVOLUT, V35, P350, DOI 10.1159/000115880; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Kirschbaum F, 2002, J PHYSIOLOGY-PARIS, V96, P557, DOI 10.1016/S0928-4257(03)00011-1; KIRSCHBAUM F, 1984, ENVIRON BIOL FISH, V10, P3, DOI 10.1007/BF00001658; KIRSCHBAUM F, 1975, EXPERIENTIA, V31, P1159, DOI 10.1007/BF02326767; KIRSCHBAUM F, 1979, BEHAV ECOL SOCIOBIOL, V4, P331, DOI 10.1007/BF00303241; Kirschbaum F, 2000, AQUA GEOGRAPHIA, V20, P95; KRAMER DL, 1978, ECOLOGY, V59, P976, DOI 10.2307/1938549; Loureiro M, 2006, COPEIA, P665; Lowe-McConnell RH., 1999, ESTUDOS ECOLOGICOS C; LUNDBERG JG, 1987, SCIENCE, V237, P81, DOI 10.1126/science.237.4810.81; Luz-Agostinho KDG, 2006, NEOTROP ICHTHYOL, V4, P61, DOI 10.1590/S1679-62252006000100005; Mago-Leccia F., 1994, ELECT FISHES CONTINE; McKaye K.R., 1984, P245; Merigoux S, 1998, J FISH BIOL, V52, P556, DOI 10.1111/j.1095-8649.1998.tb02017.x; Mims MC, 2012, ECOLOGY, V93, P35, DOI 10.1890/11-0370.1; Olden JD, 2010, AM FISH S S, V73, P83; Payne AI, 1986, ECOLOGY TROOPICAL LA; Penczak T, 2000, BRAZ ARCH BIOL TECHN, V43, P101; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pouilly M, 2003, J FISH BIOL, V62, P1137, DOI 10.1046/j.1095-8649.2003.00108.x; Py-Daniel Lúcia H. Rapp, 2005, Acta Amaz., V35, P97, DOI 10.1590/S0044-59672005000100015; Quintana L, 2004, J EXP BIOL, V207, P1843, DOI 10.1242/jeb.00954; Resende E. K., 2006, B PESQUISA DESENVOLV, V67, P1; Santos EP, 1978, DIANAMICA POPULACOES; Schaan AB, 2009, NEOTROP ICHTHYOL, V7, P737, DOI 10.1590/S1679-62252009000400023; Schwassmann H.O., 1971, P371; SCHWASSMANN H O, 1976, Biotropica, V8, P25, DOI 10.2307/2387817; Schwassmann HO, 1980, ENV PHYSL FISHES, P613; Silva A, 2002, J PHYSIOLOGY-PARIS, V96, P473, DOI 10.1016/S0928-4257(03)00003-2; Silva A, 2003, ENVIRON BIOL FISH, V66, P329, DOI 10.1023/A:1023986600069; Silva A, 1999, J COMP PHYSIOL A, V185, P187, DOI 10.1007/s003590050377; Soares M.G.M., 1979, Acta Amazonica, V9, P325; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Suzuzki HI, 1999, THESIS U FEDERAL SAO; Tedesco PA, 2008, OECOLOGIA, V156, P691, DOI 10.1007/s00442-008-1021-2; Triques Mauro L., 2003, Lundiana, V4, P61; Vazzoler A.E.A.M., 1996, BIOL REPROD PEIXES T; Vazzoler Anna Emilia A. De M., 1992, Revista Brasileira de Biologia, V52, P627; Winemiller KO, 1997, ENVIRON BIOL FISH, V49, P175, DOI 10.1023/A:1007376826609; WINEMILLER KO, 1989, OECOLOGIA, V81, P225, DOI 10.1007/BF00379810; Winemiller KO, 1987, THESIS U TEXAS; Zar JH, 1999, BIOSTATISTICAL ANAL	74	11	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106515	10.1371/journal.pone.0106515	http://dx.doi.org/10.1371/journal.pone.0106515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207924	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300025
J	Keith, H; Lindenmayer, DB; Mackey, BG; Blair, D; Carter, L; McBurney, L; Okada, S; Konishi-Nagano, T				Keith, Heather; Lindenmayer, David B.; Mackey, Brendan G.; Blair, David; Carter, Lauren; McBurney, Lachlan; Okada, Sachiko; Konishi-Nagano, Tomoko			Accounting for Biomass Carbon Stock Change Due to Wildfire in Temperate Forest Landscapes in Australia	PLOS ONE			English	Article							EUCALYPTUS-REGNANS FORESTS; WOODY FUEL CONSUMPTION; MOUNTAIN ASH FOREST; CLIMATE-CHANGE; BURNING EMISSIONS; EASTERN AUSTRALIA; CENTRAL HIGHLANDS; FIRE SEVERITY; TRACE GASES; RAIN-FOREST	Carbon stock change due to forest management and disturbance must be accounted for in UNFCCC national inventory reports and for signatories to the Kyoto Protocol. Impacts of disturbance on greenhouse gas (GHG) inventories are important for many countries with large forest estates prone to wildfires. Our objective was to measure changes in carbon stocks due to short-term combustion and to simulate longer-term carbon stock dynamics resulting from redistribution among biomass components following wildfire. We studied the impacts of a wildfire in 2009 that burnt temperate forest of tall, wet eucalypts in south-eastern Australia. Biomass combusted ranged from 40 to 58 tC ha(-1), which represented 6-7% and 9-14% in low-and high-severity fire, respectively, of the pre-fire total biomass carbon stock. Pre-fire total stock ranged from 400 to 1040 tC ha(-1) depending on forest age and disturbance history. An estimated 3.9 TgC was emitted from the 2009 fire within the forest region, representing 8.5% of total biomass carbon stock across the landscape. Carbon losses from combustion were large over hours to days during the wildfire, but from an ecosystem dynamics perspective, the proportion of total carbon stock combusted was relatively small. Furthermore, more than half the stock losses from combustion were derived from biomass components with short lifetimes. Most biomass remained on-site, although redistributed from living to dead components. Decomposition of these components and new regeneration constituted the greatest changes in carbon stocks over ensuing decades. A critical issue for carbon accounting policy arises because the timeframes of ecological processes of carbon stock change are longer than the periods for reporting GHG inventories for national emissions reductions targets. Carbon accounts should be comprehensive of all stock changes, but reporting against targets should be based on human-induced changes in carbon stocks to incentivise mitigation activities.	[Keith, Heather; Lindenmayer, David B.; Blair, David; Carter, Lauren; McBurney, Lachlan; Okada, Sachiko] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Mackey, Brendan G.] Griffith Univ, Griffith Climate Change Response Program, Nathan, Qld 4111, Australia; [Konishi-Nagano, Tomoko] Fujitsu Labs Ltd, Kawasaki, Kanagawa 211, Japan	Australian National University; Griffith University; Fujitsu Ltd; Fujitsu Laboratories Ltd	Keith, H (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Bldg 48, Canberra, ACT, Australia.	Heather.Keith@anu.edu.au	Mackey, Brendan/ABE-3805-2020	Mackey, Brendan/0000-0003-1996-4064				Amiro BD, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001390; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Andrew M., 1979, AUSTR RANGELAND J, V1, P225, DOI DOI 10.1071/RJ9790225; [Anonymous], 1992, UN FRAM CONV CLIM CH; ASHTON DH, 1975, AUST J BOT, V23, P867, DOI 10.1071/BT9750867; ASHTON DH, 1976, AUST J BOT, V24, P397, DOI 10.1071/BT9760397; ASHTON DH, 1975, AUST J BOT, V23, P413, DOI 10.1071/BT9750413; ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P301, DOI 10.1016/0378-1127(94)90115-5; Australian Treasury, 2011, STRONG GROWTH LOW PO; Banks, 1993, TREE RING ANAL 2 MOU; Barrett K, 2010, REMOTE SENS ENVIRON, V114, P1494, DOI 10.1016/j.rse.2010.02.001; Barrett K, 2013, REMOTE SENS ENVIRON, V130, P171, DOI 10.1016/j.rse.2012.11.017; Berry Sandra, 2007, Pacific Conservation Biology, V13, P120; Bootle K., 2005, WOOD AUSTR TYPES PRO, V2nd; CAHOON DR, 1992, NATURE, V359, P812, DOI 10.1038/359812a0; Campbell J, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000451; Canadell JG, 2007, ENVIRON SCI POLICY, V10, P370, DOI 10.1016/j.envsci.2007.01.009; CHAFE SC, 1985, WOOD SCI TECHNOL, V19, P329; Clarke HG, 2011, INT J WILDLAND FIRE, V20, P550, DOI 10.1071/WF10070; Cruz MG, 2012, FOREST ECOL MANAG, V284, P269, DOI 10.1016/j.foreco.2012.02.035; Cubasch U., 2013, CLIMATE CHANGE 2013; DCCEE, 2012, NAT INV REP 2010, V1; de Groot WJ, 2009, CAN J FOREST RES, V39, P367, DOI 10.1139/X08-192; Department of Sustainability and Environment, 2007, NAT RES REP SER, V07-1; Department of Sustainability and Environment, 1996, STUD OLD GROWTH FOR; Eggleston S, 2006, IPCC NATL GREENHOUSE, P664; Esplin B, 2003, REPORT INQUIRTY 2002; FELLER MC, 1980, AUST J ECOL, V5, P309, DOI 10.1111/j.1442-9993.1980.tb01255.x; Flinn D, 2007, FOREST MANAGEMENT AU, P103; French NHF, 2011, J GEOPHYS RES-BIOGEO, V116, DOI [10.1029/20t0JG001469, 10.1029/2010JG001469]; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Gifford R.M., 2000, 22 AUSTR GREENH OFF; Gill AM, 2013, ECOL APPL, V23, P438, DOI 10.1890/10-2213.1; Gill AM, 2008, INT J WILDLAND FIRE, V17, P688, DOI 10.1071/WF07145; Gough CM, 2007, GLOBAL CHANGE BIOL, V13, P1935, DOI 10.1111/j.1365-2486.2007.01406.x; GOULD JS, 1996, FINAL REPORT PREDICT; Gould JS, 2007, FOREST MANAGEMENT AU, P341; Grove SJ, 2009, FOREST ECOL MANAG, V258, P389, DOI 10.1016/j.foreco.2008.11.006; HARMON ME, 1990, SCIENCE, V247, P699, DOI 10.1126/science.247.4943.699; Hoelzemann JJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003666; Hollis JJ, 2011, AUST FORESTRY, V74, P81, DOI 10.1080/00049158.2011.10676350; Hollis JJ, 2010, FOREST ECOL MANAG, V260, P948, DOI 10.1016/j.foreco.2010.06.007; Horowitz LW, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002853; HURST DF, 1994, J GEOPHYS RES-ATMOS, V99, P16441, DOI 10.1029/94JD00670; ILLIC J, 2000, 18 AUSTR GREENH OFF; Ito A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004423; Jackson WD., 1968, P ECOL SOC AUST, V3, P9; Jacobs M. R., 1955, Growth habits of the Eucalypts.; Kasischke ES, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000461; Keith H, 2009, AGR FOREST METEOROL, V149, P535, DOI 10.1016/j.agrformet.2008.10.002; Keith H, 2000, 58 AUSTR GREENH OFF; KEITH H, 1991, THESIS AUSTR NATL U; Keith H, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00051.1; Keith H, 2010, GLOBAL CHANGE BIOL, V16, P2971, DOI 10.1111/j.1365-2486.2009.02146.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; King KJ, 2011, INT J WILDLAND FIRE, V20, P563, DOI 10.1071/WF09073; Kurz WA, 1999, ECOL APPL, V9, P526, DOI 10.1890/1051-0761(1999)009[0526:AYRAOC]2.0.CO;2; Kurz WA, 2008, P NATL ACAD SCI USA, V105, P1551, DOI 10.1073/pnas.0708133105; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lindenmayer D, 2009, FOREST PATTERN AND ECOLOGICAL PROCESS: A SYNTHESIS OF 25 YEARS OF RESEARCH, P1; Lindenmayer D., 2008, SALVAGE LOGGING ITS; Lindenmayer DB, 2006, CONSERV BIOL, V20, P1005, DOI 10.1111/j.1523-1739.2006.00501.x; Lindenmayer DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041864; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Lindenmayer DB, 2010, CAN J FOREST RES, V40, P48, DOI 10.1139/X09-185; Lindenmayer DB, 1999, FOREST ECOL MANAG, V123, P195, DOI 10.1016/S0378-1127(99)00047-X; Lindenmayer DB, 2000, FOREST ECOL MANAG, V134, P189, DOI 10.1016/S0378-1127(99)00257-1; Lindenmayer DB, 2010, FOREST PHOENIX GREAT; Macintosh A, 2011, WORKING PAPER SERIES, V2011; Macintosh A, 2011, CARBON MANAG, V2, P691, DOI 10.4155/CMT.11.64; Mackensen J, 1999, NATL CARBON ACCOUNTI; Mackey BG, 2002, WILDFIRE FIRE FUTURE; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; Mackowski C. W., 1987, THESIS U NEW ENGLAND; Manies KL, 2005, CAN J FOREST RES, V35, P472, DOI 10.1139/X04-179; Marsden-Smedley J. B., 2001, Tasforests, V13, P261; McCarthy MA, 1998, FOREST ECOL MANAG, V104, P43, DOI 10.1016/S0378-1127(97)00231-4; McCarthy MA, 1999, FOREST ECOL MANAG, V124, P193, DOI 10.1016/S0378-1127(99)00066-3; McCarthy MA, 2001, INT J WILDLAND FIRE, V10, P73, DOI 10.1071/WF01013; McKenzie N, 2001, 14 AUSTR GREENH OFF; Muhle J, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007350; Murphy BF, 2008, INT J CLIMATOL, V28, P859, DOI 10.1002/joc.1627; Noble W., 1977, ORDEAL FIRE WEEK STA; Ough K, 2001, AUST J BOT, V49, P645, DOI 10.1071/BT99053; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Penman J., 2003, GOOD PRACTICE GUIDAN; Pitman AJ, 2007, CLIMATIC CHANGE, V84, P383, DOI 10.1007/s10584-007-9243-6; POLGLASE PJ, 1992, PLANT SOIL, V142, P157, DOI 10.1007/BF00010962; Schlamadinger B, 2007, ENVIRON SCI POLICY, V10, P295, DOI 10.1016/j.envsci.2006.12.004; Scholes RJ, 1996, J GEOPHYS RES-ATMOS, V101, P23667, DOI 10.1029/96JD01623; Scholes RJ, 1996, J GEOPHYS RES-ATMOS, V101, P23677, DOI 10.1029/95JD02049; SEILER W, 1980, CLIMATIC CHANGE, V2, P207, DOI 10.1007/BF00137988; Shirai T, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000841; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Simkin R, 2008, AUSTRAL ECOL, V33, P747, DOI 10.1111/j.1442-9993.2008.01843.x; Slijepcevic A., 2001, Tasforests, V13, P281; Snowdon P, 2000, 17 AUSTR GREENH OFF; Stocks B. J., 2003, Journal of Geophysical Research, V108, pFFR5, DOI 10.1029/2001JD000484; Taylor C, 2014, CONSERV LETT, V7, P355, DOI 10.1111/conl.12122; Tng DYP, 2012, NEW PHYTOL, V196, P1001, DOI 10.1111/j.1469-8137.2012.04359.x; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Turner PAM, 2009, FOREST ECOL MANAG, V258, P366, DOI 10.1016/j.foreco.2009.04.021; UNFCCC, 2013, REV SUPP METH GOOD P; UNFCCC, 2013, NAT INV SUBM; UNFCCC, 2011, 17 C PART UNFCCC DUR; UNFCCC, 2012, AD HOC WORK GROUP DU; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753; van Gorsel E, 2013, AGR FOREST METEOROL, V182, P248, DOI 10.1016/j.agrformet.2013.04.027; VANWAGNER CE, 1968, FOREST SCI, V14, P20; Vivian LM, 2008, AUSTRAL ECOL, V33, P55, DOI 10.1111/j.1442-9993.2007.01790.x; WATSON CE, 1990, J GEOPHYS RES-ATMOS, V95, P16443, DOI 10.1029/JD095iD10p16443; Watson FGR, 1996, 967 COOP RES CTR; Williams AAJ, 2001, CLIMATIC CHANGE, V49, P171, DOI 10.1023/A:1010706116176; Wood SW, 2010, FOREST ECOL MANAG, V260, P438, DOI 10.1016/j.foreco.2010.04.037; [No title captured]	116	35	35	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107126	10.1371/journal.pone.0107126	http://dx.doi.org/10.1371/journal.pone.0107126			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208298	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300061
J	Biadglegne, F; Rodloff, AC; Sack, U				Biadglegne, Fantahun; Rodloff, Arne C.; Sack, Ulrich			A First Insight into High Prevalence of Undiagnosed Smear-Negative Pulmonary Tuberculosis in Northern Ethiopian Prisons: Implications for Greater Investment and Quality Control	PLOS ONE			English	Article							RISK-FACTORS; TRANSMISSION; DIAGNOSIS	Background: Tuberculosis (TB) transmission in prisons poses significant risks to inmates as well as the general population. Currently, there are no data on smear-negative pulmonary TB cases in prisons and by extension no data on the impact such cases have on TB incidence. This study was designed to obtain initial data on the prevalence of smear-negative cases of TB in prisons as well as preliminary risk factor analysis for such TB cases. Methods: This cross-sectional survey was conducted in November 2013 at eight main prisons located in the state of Amhara, Ethiopia. Interviews using a structured and pretested questionnaire were done first to identify symptomatic prisoners. Three consecutive sputum samples were collected and examined using acid fast bacilli (AFB) microscopy at the point of care. All smear-negative sputum samples were taken for culture and Xpert testing. Descriptive and multivariate analysis was done using SPSS version 16. Results: Overall the prevalence of smear-negative pulmonary TB cases in the study prisons was 8% (16/200). Using multivariate analysis, a contact history to TB patients in prison, educational level, cough and night sweating were found to be predictors of TB positivity among smear-negative pulmonary TB cases (p <= 0.05). Conclusions: In the studied prisons, high prevalence of undiagnosed TB cases using AFB microscopy was documented, which is an important public health concern that urgently needs to be addressed. Furthermore, patients with night sweating, non-productive cough, a contact history with TB patients and who are illiterate merit special attention, larger studies are warranted in the future to assess the associations more precisely. Further studies are also needed to examine TB transmission dynamics by patients with smear-negative pulmonary TB in a prison setting.	[Biadglegne, Fantahun] Bahir Dar Univ, Fac Med & Hlth Sci, Bahir Dar, Ethiopia; [Biadglegne, Fantahun; Rodloff, Arne C.] Univ Leipzig, Univ Hosp, Inst Med Microbiol & Epidemiol Infect Dis, D-04109 Leipzig, Germany; [Biadglegne, Fantahun; Sack, Ulrich] Univ Leipzig, Univ Hosp, Inst Clin Immunol, D-04109 Leipzig, Germany; [Biadglegne, Fantahun; Sack, Ulrich] Univ Leipzig, Translat Ctr Regenerat Med TRM Leipzig, D-04109 Leipzig, Germany	Bahir Dar University; Leipzig University; Leipzig University; Leipzig University	Biadglegne, F (corresponding author), Bahir Dar Univ, Fac Med & Hlth Sci, Bahir Dar, Ethiopia.	fantahun.degeneh@gmail.com	Degeneh, Fantahun/AAE-6826-2022; Sack, Ulrich/J-6301-2015; Degeneh, Fantahun/AAC-3138-2022	Sack, Ulrich/0000-0002-7813-0492; 	German Federal Ministry of Education and Research (BMBF, PtJ-Bio) [0315883]; Institute of Medical Microbiology and Epidemiology of Infectious Diseases, University Hospital Leipzig, Germany; Translational Centre for Regenerative Medicine (TRM), University Hospital Leipzig, Germany; German Academic Exchange Service (DAAD); University of Bahir Dar, Ethiopia	German Federal Ministry of Education and Research (BMBF, PtJ-Bio)(Federal Ministry of Education & Research (BMBF)); Institute of Medical Microbiology and Epidemiology of Infectious Diseases, University Hospital Leipzig, Germany; Translational Centre for Regenerative Medicine (TRM), University Hospital Leipzig, Germany; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); University of Bahir Dar, Ethiopia	This work was supported by: 1. German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 0315883); 2. the Institute of Medical Microbiology and Epidemiology of Infectious Diseases, University Hospital Leipzig, Germany; 3. Translational Centre for Regenerative Medicine (TRM), University Hospital Leipzig, Germany; 4. the German Academic Exchange Service (DAAD); 5. University of Bahir Dar, Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abebe DS, 2011, INT J TUBERC LUNG D, V15, P668, DOI 10.5588/ijtld.10.0363; Aerts A, 2000, INT J TUBERC LUNG D, V4, P1104; [Anonymous], 2011, GLOB TUB CONTR; [Anonymous], 2013, GLOB TUB CONTR; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020531; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Beggs CB, 2003, INT J TUBERC LUNG D, V7, P1015; Bergman N. J., 1995, Central African Journal of Medicine, V41, P1; Biadglegne F, 2014, TUBERCULOSIS EDINB, DOI [10.1016/j.tube.2014.05.002, DOI 10.1016/J.TUBE.2014.05.002.[]; Biadglegne F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081918; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P250; Desta Kassu, 2009, Ethiop Med J, V47, P17; Deutsces Institute fur Normung, 1986, DIN589433; Ferrari MJ, 2004, CAN MED ASSOC J, V171, P437, DOI 10.1503/cmaj.1041249; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Habeenzu C, 2007, INT J TUBERC LUNG D, V11, P1216; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1143; Hawken MP, 2001, INT J TUBERC LUNG D, V5, P360; Koffi N, 1997, INT J TUBERC LUNG D, V1, P250; Kolappan C, 2007, INT J TUBERC LUNG D, V11, P999; March F, 2000, AIDS, V14, P525, DOI 10.1097/00002030-200003310-00008; Ministry of Health of Ethiopia, 2012, GUID CLIN PROGR MAN; Ministry of Health of Ethiopia, 2007, AFB SMEARS MICR EXT; Moges B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-352; Nyangulu DS, 1997, LANCET, V350, P1284, DOI 10.1016/S0140-6736(97)05023-X; O'Grady J, 2011, TUBERCULOSIS, V91, P173, DOI 10.1016/j.tube.2010.12.002; Samb B, 1999, INT J TUBERC LUNG D, V3, P330; Samb B, 1997, INT J TUBERC LUNG D, V1, P25; Shah NS, 2012, INT J TUBERC LUNG D, V16, P1234, DOI 10.5588/ijtld.11.0794; Tadesse T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028258; Tessema TA, 2001, SCAND J INFECT DIS, V33, P355, DOI 10.1080/003655401750173986; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; World Health Organization, 2009, EP STRAT; World Health Organization ICRC, 2000, TUB CONTR PRIS MAN	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106869	10.1371/journal.pone.0106869	http://dx.doi.org/10.1371/journal.pone.0106869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203007	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500051
J	Jia, L; Li, L; Li, HP; Liu, SY; Wang, XL; Bao, ZY; Li, TY; Zhuang, DM; Liu, YJ; Li, JY				Jia, Lei; Li, Lin; Li, Hanping; Liu, Siyang; Wang, Xiaolin; Bao, Zuoyi; Li, Tianyi; Zhuang, Daomin; Liu, Yongjian; Li, Jingyun			Recombination Pattern Reanalysis of Some HIV-1 Circulating Recombination Forms Suggest the Necessity and Difficulty of Revision	PLOS ONE			English	Article							MOSAIC STRUCTURE; SUBTYPE-A; TYPE-1; IDENTIFICATION; VIRUSES; SEQUENCES; GENOME; DIVERSITY; ALGORITHM; INFECTION	Background: Recombination is one of the major mechanisms underlying the generation of HIV-1 variability. Currently 61 circulating recombinant forms of HIV-1 have been identified. With the development of recombination detection techniques and accumulation of HIV-1 reference stains, more accurate mosaic structures of circulating recombinant forms (CRFs), like CRF04 and CRF06, have undergone repeated analysis and upgrades. Such revisions may also be necessary for other CRFs. Unlike previous studies, whose results are based primarily on a single recombination detection program, the current study was based on multiple recombination analysis, which may have produced more impartial results. Methods: Representative references of 3 categories of intersubtype recombinants were selected, including BC recombinants (CRF07 and CRF08), BG recombinants (CRF23 and CRF24), and BF recombinants (CRF38 and CRF44). They were reanalyzed in detail using both the jumping profile hidden Markov model and RDP3. Results: The results indicate that revisions and upgrades are very necessary and the entire re-analysis suggested 2 types of revision: (i) length of inserted fragments; and (ii) number of inserted fragments. The reanalysis also indicated that determination of small regions of about 200 bases or fewer should be performed with more caution. Conclusion: Results indicated that the involvement of multiple recombination detection programs is very necessary. Additionally, results suggested two major challenges, one involving the difficulty of accurately determining the locations of breakpoints and the second involving identification of small regions of about 200 bases or fewer with greater caution. Both indicate the complexity of HIV-1 recombination. The resolution would depend critically on development of a recombination analysis algorithm, accumulation of HIV-1 stains, and a higher sequencing quality. With the changes in recombination pattern, phylogenetic relationships of some CRFs may also change. All these results may be critical to understand the role of recombination in a complex and dynamic HIV evolution.	[Jia, Lei; Li, Lin; Li, Hanping; Liu, Siyang; Wang, Xiaolin; Bao, Zuoyi; Li, Tianyi; Zhuang, Daomin; Liu, Yongjian; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Liu, YJ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing, Peoples R China.	yongjian325@sina.com; lijy@bmi.ac.cn			National Science and Technology Special Projects on Major Infectious Diseases [2012ZX10001-002]	National Science and Technology Special Projects on Major Infectious Diseases	This study is supported by the National Science and Technology Special Projects on Major Infectious Diseases (Grant No. 2012ZX10001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Wenfeng, 2002, AIDS Reviews, V4, P195; Aulicino PC, 2005, AIDS RES HUM RETROV, V21, P158, DOI 10.1089/aid.2005.21.158; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; Dowling WE, 2002, AIDS, V16, P1809, DOI 10.1097/00002030-200209060-00015; Gao F, 1998, J VIROL, V72, P10234, DOI 10.1128/JVI.72.12.10234-10241.1998; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; KOSTRIKIS LG, 1995, J VIROL, V69, P6122, DOI 10.1128/JVI.69.10.6122-6130.1995; Lau KA, 2007, AIDS REV, V9, P218; Lihana RW, 2012, AIDS REV, V14, P83; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Montavon C, 2002, J ACQ IMMUN DEF SYND, V29, P522, DOI 10.1097/00126334-200204150-00014; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Paraskevis D, 2001, J GEN VIROL, V82, P575, DOI 10.1099/0022-1317-82-3-575; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schultz AK, 2012, NUCLEIC ACIDS RES, V40, pW193, DOI 10.1093/nar/gks414; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Sentandreu V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003239; Sierra M, 2007, JAIDS-J ACQ IMM DEF, V45, P151, DOI 10.1097/QAI.0b013e318046ea47; SMITH JM, 1992, J MOL EVOL, V34, P126; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomson MM, 2002, J GEN VIROL, V83, P107, DOI 10.1099/0022-1317-83-1-107; Triques K, 2000, AIDS RES HUM RETROV, V16, P139, DOI 10.1089/088922200309485; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Visawapoka U, 2006, AIDS RES HUM RETROV, V22, P695, DOI 10.1089/aid.2006.22.695; Zhang M, 2005, AIDS RES HUM RETROV, V21, P955, DOI 10.1089/aid.2005.21.955	36	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107349	10.1371/journal.pone.0107349	http://dx.doi.org/10.1371/journal.pone.0107349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203725	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500087
J	Sobolesky, PM; Halushka, PV; Garrett-Mayer, E; Smith, MT; Moussa, O				Sobolesky, Philip M.; Halushka, Perry V.; Garrett-Mayer, Elizabeth; Smith, Michael T.; Moussa, Omar			Regulation of the Tumor Suppressor FOXO3 by the Thromboxane-A(2) Receptors in Urothelial Cancer	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; HUMAN UROEPITHELIAL CELLS; BLADDER-CANCER; PROMOTES TUMORIGENESIS; OXIDATIVE STRESS; HUMAN PLATELETS; BETA-ISOFORMS; BREAST-CANCER; IN-VITRO; KAPPA-B	The transcription factor FOXO3 is a well-established tumor suppressor whose activity, stability, and localization are regulated by phosphorylation and acetylation. Previous data by our laboratory demonstrated amplified thromboxane-A(2) signaling was associated with poor prognoses in bladder cancer patients and overexpression of the thromboxane-A2 isoform-beta receptor (TP beta), but not TP alpha, induced malignant transformation of immortalized bladder cells in vivo. Here, we describe a mechanism of TP mediated modulation of FOXO3 activity and localization by phosphorylation and deacetylation in a bladder cancer cell model. In vitro gain and loss of function studies performed in non-transformed cell lines, UROsta and SV-HUC, revealed knockdown of FOXO3 expression by shRNA increased cell migration and invasion, while exogenously overexpressing TP beta raised basal phosphorylated (p) FOXO3-S294 levels. Conversely, overexpression of ERK-resistant, mutant FOXO3 reduced increases in UMUC3 cell migration and invasion, including that mediated by TP agonist (U46619). Additionally, stimulation of UMUC3 cells with U46619 increased pFOXO3-S294 expression, which could be attenuated by treatment with a TP antagonist (PTXA(2)) or ERK inhibitor (U0126). Initially U46619 caused nuclear accumulation of pFOXO3-S294; however, prolonged stimulation increased FOXO3 cytoplasmic localization. U46619 stimulation decreased overall FOXO3 transcriptional activity, but was associated with increased expression of its pro-survival target, manganese superoxide dismutase. The data also shows that TP stimulation increased the expression of the histone deacetylase, SIRT1, and corresponded with decreased acetylated-FOXO3. Collectively, the data suggest a role for TP signaling in the regulation of FOXO3 activity, mediated in part through phosphorylation and deacetylation.	[Sobolesky, Philip M.; Smith, Michael T.; Moussa, Omar] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Sobolesky, Philip M.; Halushka, Perry V.; Garrett-Mayer, Elizabeth; Moussa, Omar] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Halushka, Perry V.] Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA; [Halushka, Perry V.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Garrett-Mayer, Elizabeth] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Moussa, O (corresponding author), Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA.	moussa@musc.edu		Sobolesky, Philip/0000-0002-3471-0081; Garrett-Mayer, Elizabeth/0000-0003-4709-0333	Cancer Center Support Grant [P30 CA138313]; National Cancer Institute, National Institutes of Health [RO1127905CA, UL1TR000062, UL1RR029882]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER	Cancer Center Support Grant; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Imaging facilities for this research were supported, in part, by Cancer Center Support Grant P30 CA138313 to the Hollings Cancer Center, MUSC. The research project described was in part supported by grants RO1127905CA, UL1TR000062, and UL1RR029882 from the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITOKALLIOTALLBERG A, 1985, BRIT J CANCER, V51, P671, DOI 10.1038/bjc.1985.101; Bertaggia E, 2012, AM J PHYSIOL-CELL PH, V302, pC587, DOI 10.1152/ajpcell.00142.2011; BLOCHLDAUM B, 1995, CLIN PHARMACOL THER, V58, P418, DOI 10.1016/0009-9236(95)90055-1; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cartier A, 2011, J CELL SCI, V124, P3292, DOI 10.1242/jcs.085795; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012293; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; de Braud F, 2002, CRIT REV ONCOL HEMAT, V41, P89, DOI 10.1016/S1040-8428(01)00128-7; Garcia A, 2005, BLOOD, V106, P3410, DOI 10.1182/blood-2005-05-1933; Gustafsson A, 2007, ACTA ONCOL, V46, P1107, DOI 10.1080/02841860701403061; Han XP, 2014, BIOMED REP, V2, P183, DOI 10.3892/br.2013.209; Hempel N, 2009, FREE RADICAL BIO MED, V46, P42, DOI 10.1016/j.freeradbiomed.2008.09.020; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; Hirata T, 1996, J CLIN INVEST, V97, P949, DOI 10.1172/JCI118518; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Jariyawat S, 1997, BIOCHEM MOL BIOL INT, V42, P113; Jin GS, 2004, ACTA MED OKAYAMA, V58, P197; Kim HS, 2005, FASEB J, V19, P1042, DOI 10.1096/fj.04-2841fje; KLAPAN I, 1995, AM J OTOLARYNG, V16, P396, DOI 10.1016/0196-0709(95)90077-2; Kobayashi Y, 2005, INT J MOL MED, V16, P237; KORT WJ, 1992, PROSTAG LEUKOTR ESS, V45, P319, DOI 10.1016/0952-3278(92)90090-6; Lanza-Jacoby S, 2003, CANCER EPIDEM BIOMAR, V12, P1486; Lee HY, 2008, ARTERIOSCL THROM VAS, V28, P302, DOI 10.1161/ATVBAHA.107.150664; Lee HY, 2008, ARTERIOSCL THROM VAS, V28, P112, DOI 10.1161/ATVBAHA.107.153304; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Li Li, 2011, Front Med, V5, P33, DOI 10.1007/s11684-011-0114-1; Li XL, 2009, CARCINOGENESIS, V30, P1606, DOI 10.1093/carcin/bgp161; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Lu MA, 2012, MED ONCOL, V29, P1258, DOI 10.1007/s12032-011-9919-7; MEISNER LF, 1988, CANCER RES, V48, P3215; Miggin SM, 2002, MOL PHARMACOL, V61, P817, DOI 10.1124/mol.61.4.817; Moussa O, 2008, ONCOGENE, V27, P55, DOI 10.1038/sj.onc.1210629; Moussa O, 2005, CANCER RES, V65, P11581, DOI 10.1158/0008-5472.CAN-05-1622; Moussa O, 2008, CANCER RES, V68, P4097, DOI 10.1158/0008-5472.CAN-07-6560; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; NEEDLEMAN P, 1976, SCIENCE, V193, P163, DOI 10.1126/science.945611; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; PRATT CI, 1992, CANCER RES, V52, P688; RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256; REMUZZI G, 1992, KIDNEY INT, V41, P1483, DOI 10.1038/ki.1992.217; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Sakai H, 2006, FEBS LETT, V580, P3368, DOI 10.1016/j.febslet.2006.05.007; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; Shiota M, 2010, CLIN CANCER RES, V16, P5654, DOI 10.1158/1078-0432.CCR-10-0376; Shiota M, 2010, CANCER SCI, V101, P1177, DOI 10.1111/j.1349-7006.2010.01503.x; Shukla S, 2009, INT J ONCOL, V34, P1613, DOI 10.3892/ijo_00000291; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Sternberg CN, 2000, BJU INT, V85, P599, DOI 10.1046/j.1464-410x.2000.00566.x; Turner EC, 2011, J BIOL CHEM, V286, P15440, DOI 10.1074/jbc.M110.181180; Valentin FO, 2004, J BIOL CHEM, V279, P8316, DOI 10.1074/jbc.M306761200; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Watkins Gareth, 2005, Int Semin Surg Oncol, V2, P23, DOI 10.1186/1477-7800-2-23; Weidinger C, 2008, ENDOCR-RELAT CANCER, V15, P917, DOI 10.1677/ERC-08-0153; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yun DH, 2009, EXP MOL MED, V41, P17, DOI 10.3858/emm.2009.41.1.003; Zhang W, 2009, J VASC RES, V46, P162, DOI 10.1159/000153247	63	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107530	10.1371/journal.pone.0107530	http://dx.doi.org/10.1371/journal.pone.0107530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202904	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500108
J	Lipp, OV; Kempnich, C; Jee, SH; Arnold, DH				Lipp, Ottmar V.; Kempnich, Clare; Jee, Sang Hoon; Arnold, Derek H.			Fear Conditioning to Subliminal Fear Relevant and Non Fear Relevant Stimuli	PLOS ONE			English	Article							CONTINUOUS FLASH SUPPRESSION; SKIN-CONDUCTANCE RESPONSES; BINOCULAR-RIVALRY; FACIAL EXPRESSIONS; MASKED STIMULI; PREPAREDNESS; EXTINCTION; RESISTANCE; FACES	A growing body of evidence suggests that conscious visual awareness is not a prerequisite for human fear learning. For instance, humans can learn to be fearful of subliminal fear relevant images - images depicting stimuli thought to have been fear relevant in our evolutionary context, such as snakes, spiders, and angry human faces. Such stimuli could have a privileged status in relation to manipulations used to suppress usually salient images from awareness, possibly due to the existence of a designated sub-cortical 'fear module'. Here we assess this proposition, and find it wanting. We use binocular masking to suppress awareness of images of snakes and wallabies (particularly cute, non-threatening marsupials). We find that subliminal presentations of both classes of image can induce differential fear conditioning. These data show that learning, as indexed by fear conditioning, is neither contingent on conscious visual awareness nor on subliminal conditional stimuli being fear relevant.	[Lipp, Ottmar V.] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia; [Lipp, Ottmar V.] Univ Queensland, Sci Learning Res Ctr, St Lucia, Qld, Australia; [Kempnich, Clare; Jee, Sang Hoon; Arnold, Derek H.] Univ Queensland, Dept Psychol, St Lucia, Qld, Australia	Curtin University; University of Queensland; University of Queensland	Lipp, OV (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia.	ottmar.lipp@curtin.edu.au	Lipp, Ottmar V./A-1254-2007	Lipp, Ottmar V./0000-0001-6734-8608; Arnold, Derek/0000-0003-1027-6222	Australian Research Council [DP110100460]	Australian Research Council(Australian Research Council)	This research was funded by the Australian Research Council (DP110100460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpers GW, 2006, COGNITION EMOTION, V20, P596, DOI 10.1080/02699930500282249; Alpers GW, 2005, INT J PSYCHOPHYSIOL, V57, P25, DOI 10.1016/j.ijpsycho.2005.01.008; Arnold DH, 2008, VISION RES, V48, P994, DOI 10.1016/j.visres.2008.01.020; ESTEVES F, 1994, PSYCHOPHYSIOLOGY, V31, P375, DOI 10.1111/j.1469-8986.1994.tb02446.x; ESTEVES F, 1994, COGNITION EMOTION, V8, P393, DOI 10.1080/02699939408408949; LOVIBOND PF, 1993, J EXP PSYCHOL GEN, V122, P449, DOI 10.1037/0096-3445.122.4.449; Mallan KM, 2013, COGNITION EMOTION, V27, P1168, DOI 10.1080/02699931.2013.778195; McNicol D., 1972, PRIMER SIGNAL DETECT; Mitchell CJ, 2009, BEHAV BRAIN SCI, V32, P183, DOI 10.1017/S0140525X09000855; Ohman A, 1998, J EXP PSYCHOL GEN, V127, P69, DOI 10.1037/0096-3445.127.1.69; OHMAN A, 1994, J ABNORM PSYCHOL, V103, P231, DOI 10.1037/0021-843X.103.2.231; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Prokasy W.F., 1973, ELECTRODERMAL ACTIVI, P157, DOI DOI 10.1016/B978-0-12-565950-5.50008-9; Raio CM, 2012, CURR BIOL, V22, pR477, DOI 10.1016/j.cub.2012.04.023; Rowles ME, 2012, PSYCHOPHYSIOLOGY, V49, P375, DOI 10.1111/j.1469-8986.2011.01308.x; SOARES JJF, 1993, PSYCHOPHYSIOLOGY, V30, P460, DOI 10.1111/j.1469-8986.1993.tb02069.x; Stein T, 2012, EMOTION, V12, P988, DOI 10.1037/a0026944; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882	20	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e99332	10.1371/journal.pone.0099332	http://dx.doi.org/10.1371/journal.pone.0099332			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JX	25198514	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700001
J	Liu, T; Zhao, L; Zhang, Y; Chen, W; Liu, D; Hou, HL; Ding, L; Li, X				Liu, Ting; Zhao, Le; Zhang, Yan; Chen, Wei; Liu, Dan; Hou, Huilian; Ding, Lu; Li, Xu			Ginsenoside 20(S)-Rg3 Targets HIF-1 alpha to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; MOLECULAR-MECHANISMS; PROTEIN-KINASE; RED-GINSENG; IN-VITRO; METASTASIS; RG3; APOPTOSIS; HIF-1; RG(3)	The prognosis of patients with ovarian cancer has remained poor mainly because of aggressive cancer progression. Since epithelial-mesenchymal transition (EMT) is an important mechanism mediating invasion and metastasis of cancer cells, targeting the EMT process with more efficacious and less toxic compounds to inhibit metastasis is of great therapeutic value for the treatment of ovarian cancer. We have found for the first time that the ginsenoside 20(S)-Rg3, a pharmacologically active component of the traditional Chinese herb Panax ginseng, potently blocks hypoxia-induced EMT of ovarian cancer cells in vitro and in vivo. Mechanistic studies confirm the mode of action of 20(S)-Rg3, which reduces the expression of hypoxia-inducible factor 1 alpha (HIF-1 alpha) by activating the ubiquitin-proteasome pathway to promote HIF-1 alpha degradation. A decrease in HIF-1 alpha in turn leads to up-regulation, via transcriptional suppression of Snail, of the epithelial cell-specific marker E-cadherin and down-regulation of the mesenchymal cell-specific marker vimentin under hypoxic conditions. Importantly, 20(S)-Rg3 effectively inhibits EMT in nude mouse xenograft models of ovarian cancer, promising a novel therapeutic agent for anticancer therapy.	[Liu, Ting; Zhao, Le; Zhang, Yan; Ding, Lu; Li, Xu] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Ctr Translat Med, Xian 710049, Peoples R China; [Chen, Wei] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Ctr Lab Med, Xian 710049, Peoples R China; [Liu, Dan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Obstet & Gynaecol, Xian 710049, Peoples R China; [Hou, Huilian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Pathol, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Li, X (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Ctr Translat Med, Xian 710049, Peoples R China.	lixu56@mail.xjtu.edu.cn			National Natural Science Foundation of China [30973429]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30973429). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Bae EA, 2006, PLANTA MED, V72, P627, DOI 10.1055/s-2006-931563; Bae JS, 2012, J NAT MED-TOKYO, V66, P476, DOI 10.1007/s11418-011-0609-8; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Choi JS, 2013, INT J MOL MED, V32, P1227, DOI 10.3892/ijmm.2013.1519; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Cui WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068771; Gardberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074923; Gillis CN, 1997, BIOCHEM PHARMACOL, V54, P1, DOI 10.1016/S0006-2952(97)00193-7; Goda N, 2003, ANTIOXID REDOX SIGN, V5, P467, DOI 10.1089/152308603768295212; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Haase VH, 2009, KIDNEY INT, V76, P492, DOI 10.1038/ki.2009.222; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Huang RYJ, 2012, CURR DRUG TARGETS, V13, P1649; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jeong KJ, 2014, J GINSENG RES, V38, P83, DOI 10.1016/j.jgr.2013.11.014; Keum YS, 2003, MUTAT RES-FUND MOL M, V523, P75, DOI 10.1016/S0027-5107(02)00323-8; Kim SM, 2010, EUR J PHARMACOL, V631, P1, DOI 10.1016/j.ejphar.2009.12.018; Kizaka-Kondoh S, 2009, ADV DRUG DELIVER REV, V61, P623, DOI 10.1016/j.addr.2009.01.006; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Lee JY, 2013, MOL CANCER THER, V12, P274, DOI 10.1158/1535-7163.MCT-12-0054; Lee SY, 2009, BIOSCI BIOTECH BIOCH, V73, P811, DOI 10.1271/bbb.80637; Li J, 2014, ASIAN PAC J CANCER P, V15, P2453, DOI 10.7314/APJCP.2014.15.6.2453; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066558; Lu JM, 2009, CURR VASC PHARMACOL, V7, P293, DOI 10.2174/157016109788340767; MOCHIZUKI M, 1995, BIOL PHARM BULL, V18, P1197, DOI 10.1248/bpb.18.1197; Nag SA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00025; Saponaro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053070; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Swisher EM, 2012, J NATL CANCER I, V104, P642, DOI 10.1093/jnci/djs203; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041586; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Xie XS, 2009, J ETHNOPHARMACOL, V122, P35, DOI 10.1016/j.jep.2008.11.020; Xu TM, 2008, CHINESE MED J-PEKING, V121, P1394, DOI 10.1097/00029330-200808010-00012; Xu TM, 2007, CHINESE MED J-PEKING, V120, P584, DOI 10.1097/00029330-200704010-00011; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yue PYK, 2006, BIOCHEM PHARMACOL, V72, P437, DOI 10.1016/j.bcp.2006.04.034	43	27	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e103887	10.1371/journal.pone.0103887	http://dx.doi.org/10.1371/journal.pone.0103887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197976	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700006
J	Wang, YN; Tang, ZL; Sun, YQ; Wang, HY; Wang, C; Yu, SB; Liu, J; Zhang, Y; Fan, B; Li, K; Liu, B				Wang, Yanan; Tang, Zhonglin; Sun, Yaqi; Wang, Hongyang; Wang, Chao; Yu, Shaobo; Liu, Jing; Zhang, Yu; Fan, Bin; Li, Kui; Liu, Bang			Analysis of Genome-Wide Copy Number Variations in Chinese Indigenous and Western Pig Breeds by 60 K SNP Genotyping Arrays	PLOS ONE			English	Article							PRODUCTION TRAITS; PROSTATE-CANCER; DUROC PIGS; IDENTIFICATION; GENE; DUPLICATION; PROTEIN; ASSOCIATION; EXPRESSION; VARIANTS	Copy number variations (CNVs) represent a substantial source of structural variants in mammals and contribute to both normal phenotypic variability and disease susceptibility. Although low-resolution CNV maps are produced in many domestic animals, and several reports have been published about the CNVs of porcine genome, the differences between Chinese and western pigs still remain to be elucidated. In this study, we used Porcine SNP60 BeadChip and PennCNV algorithm to perform a genome-wide CNV detection in 302 individuals from six Chinese indigenous breeds (Tongcheng, Laiwu, Luchuan, Bama, Wuzhishan and Ningxiang pigs), three western breeds (Yorkshire, Landrace and Duroc) and one hybrid (Tongcheng x Duroc). A total of 348 CNV Regions (CNVRs) across genome were identified, covering 150.49 Mb of the pig genome or 6.14% of the autosomal genome sequence. In these CNVRs, 213 CNVRs were found to exist only in the six Chinese indigenous breeds, and 60 CNVRs only in the three western breeds. The characters of CNVs in four Chinese normal size breeds (Luchuan, Tongcheng and Laiwu pigs) and two minipig breeds (Bama and Wuzhishan pigs) were also analyzed in this study. Functional annotation suggested that these CNVRs possess a great variety of molecular function and may play important roles in phenotypic and production traits between Chinese and western breeds. Our results are important complementary to the CNV map in pig genome, which provide new information about the diversity of Chinese and western pig breeds, and facilitate further research on porcine genome CNVs.	[Wang, Yanan; Sun, Yaqi; Wang, Hongyang; Wang, Chao; Yu, Shaobo; Liu, Jing; Zhang, Yu; Fan, Bin; Liu, Bang] Huazhong Agr Univ, Lab Mol Biol & Anim Breeding, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China; [Tang, Zhonglin; Li, Kui] Chinese Acad Agr Sci, Key Lab Farm Anim Genet Resources & Germplasm Inn, Minist Agr, Inst Anim Sci, Beijing 100193, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Li, K (corresponding author), Chinese Acad Agr Sci, Key Lab Farm Anim Genet Resources & Germplasm Inn, Minist Agr, Inst Anim Sci, Beijing 100193, Peoples R China.	kuili@caas.cn; liubang@mail.hzau.edu.cn			NSFC [31072012]; Major International Cooperation NSFC [31210103917]; National 863 programs [2011AA100302, 2011AA100304]; National Key Project [2013ZX08009-001]	NSFC(National Natural Science Foundation of China (NSFC)); Major International Cooperation NSFC; National 863 programs(National High Technology Research and Development Program of China); National Key Project	This work was supported by NSFC (31072012) (http://www.nsfc.gov.cn/), Major International Cooperation NSFC (31210103917) (http://www.nsfc.gov.cn/), National 863 programs (2011AA100302, 2011AA100304) (http://program.most.gov.cn/) and National Key Project (2013ZX08009-001) (http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Bridges CB, 1936, SCIENCE, V83, P210, DOI 10.1126/science.83.2148.210; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-733; Chen WT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023087; Clark PM, 2012, INFLAMM BOWEL DIS, V18, P2315, DOI 10.1002/ibd.22958; Cobrinik D, 2013, GENE CHROMOSOME CANC, V52, P1150, DOI 10.1002/gcc.22110; Coppieters F, 2014, GENET MED; De Giorgio MR, 2013, OBESITY, V21, P1389, DOI 10.1002/oby.20165; De La Hera DP, 2013, BIOCHEM J, V450, P47, DOI 10.1042/BJ20120739; de Smith AJ, 2008, CYTOGENET GENOME RES, V123, P17, DOI 10.1159/000184688; Ding Neng-Shui, 2006, Yi Chuan Xue Bao, V33, P213; Doan R, 2012, GENOME RES, V22, P899, DOI 10.1101/gr.128991.111; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Endo H, 2012, J BIOCHEM, V151, P139, DOI 10.1093/jb/mvr128; Fadista J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-284; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Feng GX, 2014, MOL MED REP, V9, P109, DOI 10.3892/mmr.2013.1772; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Giuffra E, 1999, MAMM GENOME, V10, P1132, DOI 10.1007/s003359901178; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Hirose K, 2014, ANIM SCI J, V85, P198, DOI 10.1111/asj.12134; Hirose K, 2011, ANIM SCI J, V82, P46, DOI 10.1111/j.1740-0929.2010.00816.x; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P717, DOI 10.1007/s10142-012-0295-y; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Jiang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021219; Jin GF, 2011, CARCINOGENESIS, V32, P1057, DOI 10.1093/carcin/bgr082; Kim TO, 2013, INT J MOL MED, V31, P1255, DOI 10.3892/ijmm.2013.1317; Kimura J, 2011, INT J CANCER, V128, P1524, DOI 10.1002/ijc.25475; Kohoutek J, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-12; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu JS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-229; Liu WX, 2014, EMBO J, V33, P46, DOI 10.1002/embj.201385315; Liu WN, 2009, CANCER RES, V69, P2176, DOI 10.1158/0008-5472.CAN-08-3151; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marklund S, 1998, GENOME RES, V8, P826, DOI 10.1101/gr.8.8.826; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; Moller MJ, 1996, MAMM GENOME, V7, P822, DOI 10.1007/s003359900244; Moriyama M, 2014, J INVEST DERMATOL, V134, P1627, DOI 10.1038/jid.2014.11; Mou LS, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.103648; Murgiano L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-186; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Nuttinck F, 2011, BIOL REPROD, V84, P1248, DOI 10.1095/biolreprod.110.088211; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Plummer NW, 2006, MAMM GENOME, V17, P119, DOI 10.1007/s00335-005-0098-8; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robinson AJ, 2012, EXP CELL RES, V318, P1316, DOI 10.1016/j.yexcr.2012.01.026; Sailani MR, 2013, GENOME RES, V23, P1410, DOI 10.1101/gr.147991.112; Schaefer E, 2014, GENET MED; Schrider DR, 2010, P ROY SOC B-BIOL SCI, V277, P3213, DOI 10.1098/rspb.2010.1180; Sekulic A, 2010, CANCER PREV RES, V3, P1277, DOI 10.1158/1940-6207.CAPR-10-0058; Seo BY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-81; Sha BY, 2009, J HUM GENET, V54, P199, DOI 10.1038/jhg.2009.10; Sisto M, 2014, CLIN EXP MED; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Sundstrom E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-365; Sundstrom E, 2012, PIGM CELL MELANOMA R, V25, P28, DOI 10.1111/j.1755-148X.2011.00902.x; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Venhoranta H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075659; Wang JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087571; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn641; Wang Y, 2012, ANIM GENET, V43, P282, DOI 10.1111/j.1365-2052.2011.02308.x; Wight TN, 2014, MATRIX BIOL, V35, P152, DOI 10.1016/j.matbio.2014.01.015; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Xu L, 2014, FUNCT INTEGR GENOMIC; Xue Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075240; Yang FQ, 2014, INT J CLIN EXP PATHO, V7, P110; Yang H, 2007, GENOMICS, V90, P249, DOI 10.1016/j.ygeno.2007.03.013; Ying J, 2006, LEUKEMIA, V20, P1173, DOI 10.1038/sj.leu.2404193; Yun J, 2014, MOL MED REP, V9, P285, DOI 10.3892/mmr.2013.1780; Zhou XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016358	80	15	18	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106780	10.1371/journal.pone.0106780	http://dx.doi.org/10.1371/journal.pone.0106780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198154	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700048
J	Huang, GH; Li, T; Li, XY; Tan, DM; Jiang, ZY; Wei, Y; Li, JC; Wang, AD				Huang, Guohui; Li, Tong; Li, Xinyue; Tan, Dongmei; Jiang, Zhongyu; Wei, Yun; Li, Juncai; Wang, Aide			Comparative Transcriptome Analysis of Climacteric Fruit of Chinese Pear (Pyrus ussuriensis) Reveals New Insights into Fruit Ripening	PLOS ONE			English	Article							ETHYLENE-RESPONSE FACTORS; TOMATO FRUIT; ABSCISIC-ACID; MOLECULAR CHARACTERIZATION; BIOSYNTHESIS; GENE; RNA; MATURATION; MUTATION; TOPHAT	The fruit of Pyrus ussuriensis is typically climacteric. During ripening, the fruits produce a large amount of ethylene, and their firmness drops rapidly. Although the molecular basis of climacteric fruit ripening has been studied in depth, some aspects remain unclear. Here, we compared the transcriptomes of pre- and post-climacteric fruits of Chinese pear (P. ussuriensis c. v. Nanguo) using RNA-seq. In total, 3,279 unigenes were differentially expressed between the pre- and post-climacteric fruits. Differentially expressed genes (DEGs) were subjected to Gene Ontology analysis, and 31 categories were significantly enriched in the groups 'biological process', 'molecular function' and 'cellular component'. The DEGs included genes related to plant hormones, such as ethylene, ABA, auxin, GA and brassinosteroid, and transcription factors, such as MADS, NAC, WRKY and HSF. Moreover, genes encoding enzymes related to DNA methylation, cytoskeletal proteins and heat shock proteins (HSPs) showed differential expression between the pre- and post-climacteric fruits. Select DEGs were subjected to further analysis using quantitative RT-PCR (qRT-PCR), and the results were consistent with those of RNA-seq. Our data suggest that in addition to ethylene, other hormones play important roles in regulating fruit ripening and may interact with ethylene signaling during this process. DNA methylation-related methyltransferase and cytoskeletal protein genes are also involved in fruit ripening. Our results provide useful information for future research on pear fruit ripening.	[Li, Tong; Li, Xinyue; Tan, Dongmei; Jiang, Zhongyu; Wei, Yun; Wang, Aide] Shenyang Agr Univ, Coll Hort, Shenyang 110161, Peoples R China; [Huang, Guohui] Eastern Liaoning Univ, Dept Hort, Dandong, Peoples R China; [Li, Juncai] Liaoning Acad Agr Sci, Inst Pomol, Div Pear Breeding, Xiongyue, Peoples R China	Shenyang Agricultural University; Liaodong University	Li, JC (corresponding author), Liaoning Acad Agr Sci, Inst Pomol, Div Pear Breeding, Xiongyue, Peoples R China.	lktljc@163.com; adwang333@163.com			Activating Foundation for Doctoral Researchers of Liaoning Province, China [20121140]; Innovative Program for Fruit Tree Research of Liaoning Province, China [LNGSCYTX-13/14-X]	Activating Foundation for Doctoral Researchers of Liaoning Province, China; Innovative Program for Fruit Tree Research of Liaoning Province, China	This work was supported by the Activating Foundation for Doctoral Researchers of Liaoning Province, China (20121140); and the Innovative Program for Fruit Tree Research of Liaoning Province, China (LNGSCYTX-13/14-X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bai SL, 2013, PLANT CELL PHYSIOL, V54, P1132, DOI 10.1093/pcp/pct067; Benjamini Y, 2001, ANN STAT, V29, P1165; Bottcher C, 2010, J EXP BOT, V61, P3615, DOI 10.1093/jxb/erq174; Cevik V, 2010, TREE GENET GENOMES, V6, P271, DOI 10.1007/s11295-009-0247-4; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Hao JJ, 2013, PLANT CELL REP, V32, P1017, DOI 10.1007/s00299-013-1438-x; Ireland HS, 2013, PLANT J, V73, P1044, DOI 10.1111/tpj.12094; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jiang YM, 2000, J PLANT GROWTH REGUL, V19, P106, DOI 10.1007/s003440000011; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li T, 2014, SCI HORTIC-AMSTERDAM, V171, P78, DOI 10.1016/j.scienta.2014.03.054; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; Martinez GA, 1996, J PLANT GROWTH REGUL, V15, P139, DOI 10.1007/BF00198929; McAtee P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00079; Medina-Escobar N, 1998, PLANT MOL BIOL, V36, P33, DOI 10.1023/A:1005994800671; Osorio S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00198; Sagar M, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25647; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Seymour G, 2008, CURR OPIN PLANT BIOL, V11, P58, DOI 10.1016/j.pbi.2007.09.003; Shan W, 2012, J EXP BOT, V63, P5171, DOI 10.1093/jxb/ers178; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Srivastava A, 2005, J PLANT GROWTH REGUL, V24, P67, DOI 10.1007/s00344-005-0015-0; Sun L, 2012, PLANT PHYSIOL, V158, P283, DOI 10.1104/pp.111.186866; Symons GM, 2012, J EXP BOT, V63, P4741, DOI 10.1093/jxb/ers147; Tan DM, 2013, PLANT MOL BIOL REP, V31, P204, DOI 10.1007/s11105-012-0490-y; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang AD, 2009, POSTHARVEST BIOL TEC, V52, P38, DOI 10.1016/j.postharvbio.2008.09.001; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang AD, 2012, J MOL BIOL RES, V2, P24, DOI 10.5539/jmbr.v2n1p24; Wang A, 2009, PLANT PHYSIOL, V151, P391, DOI 10.1104/pp.109.135822; Xiao YY, 2013, J EXP BOT, V64, P2499, DOI 10.1093/jxb/ert108; Xu KN, 2012, MOL BREEDING, V30, P899, DOI 10.1007/s11032-011-9674-7; Yokotani N, 2009, J EXP BOT, V60, P3433, DOI 10.1093/jxb/erp185; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462	41	33	36	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107562	10.1371/journal.pone.0107562	http://dx.doi.org/10.1371/journal.pone.0107562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215597	gold, Green Published, Green Submitted			2022-12-27	WOS:000341774300080
J	Tseng, JS; Wang, CL; Huang, MS; Chen, CY; Chang, CY; Yang, TY; Tsai, CR; Chen, KC; Hsu, KH; Tsai, MH; Yu, SL; Su, KY; Wu, CW; Yang, CT; Chen, YM; Chang, GC				Tseng, Jeng-Sen; Wang, Chih-Liang; Huang, Ming-Shyan; Chen, Chung-Yu; Chang, Cheng-Yu; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Wu, Chih-Wei; Yang, Cheng-Ta; Chen, Yuh-Min; Chang, Gee-Chen			Impact of EGFR Mutation Detection Methods on the Efficacy of Erlotinib in Patients with Advanced EGFR-Wild Type Lung Adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; QUALITY-OF-LIFE; CANCER PATIENTS; PHASE-III; GEFITINIB TREATMENT; TRIAL; NSCLC; CHEMOTHERAPY; GUIDELINE	Introduction: Methods used for epidermal growth factor receptor (EGFR) mutation testing vary widely. The impact of detection methods on the rates of response to EGFR-tyrosine kinase inhibitors (TKIs) in EGFR-wild type (wt) lung adenocarcinoma patients is unknown. Methods: We recruited the Group-I patients to evaluate the efficacy of erlotinib in patients with EGFR-wt lung adenocarcinoma by either direct sequencing (DS) or mutant type-specific sensitive (MtS) methods in six medical centers in Taiwan. Cross recheck of EGFR mutations was performed in patients who achieved objective response to erlotinib and had adequate specimens. The independent Group-II lung adenocarcinoma patients whose EGFR mutation status determined by DS were recruited to evaluate the potential limitations of three MtS methods. Results: In Group-I analysis, 38 of 261 EGFR-wt patients (14.6%) achieved partial response to erlotinib treatment. Nineteen patients (50.0%) had adequate specimens for cross recheck of EGFR mutations and 10 of them (52.6%) had changes in EGFR mutation status, 5 in 10 by DS and 5 in 9 by MtS methods originally. In Group-II analysis, 598 of 996 lung adenocarcinoma patients (60.0%) had detectable EGFR mutations. The accuracy rates of the three MtS methods, MALDI-TOF MS, Scorpions ARMS and Cobas, were 87.8%, 86.8% and 85.8%, respectively. Conclusions: A significant portion of the erlotinib responses in EGFR-wt lung adenocarcinoma patients were related to the limitations of detection methods, not only DS but also MtS methods with similar percentages. Prospective studies are needed to define the proper strategy for EGFR mutation testing.	[Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Tsai, Meen-Hsin; Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Tseng, Jeng-Sen; Chen, Kun-Chieh; Hsu, Kuo-Hsuan] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Wang, Chih-Liang; Yang, Cheng-Ta] Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan; [Wang, Chih-Liang] Chang Gung Univ, Dept Med, Taoyuan, Taiwan; [Huang, Ming-Shyan] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Huang, Ming-Shyan] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chen, Chung-Yu] Natl Taiwan Univ Hosp, Dept Internal Med, Yunlin Branch, Douliou City, Yunlin County, Taiwan; [Chang, Cheng-Yu] Far Eastern Mem Hosp, Dept Internal Med, Div Chest Med, Taipei, Taiwan; [Yang, Tsung-Ying; Chang, Gee-Chen] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Tsai, Chi-Ren] Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan; [Tsai, Chi-Ren] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Hsu, Kuo-Hsuan] Taichung Vet Gen Hosp, Dept Internal Med, Div Crit Care & Resp Therapy, Taichung, Taiwan; [Tsai, Meen-Hsin] Acad Sinica, Inst Stat Sci, Taipei 115, Taiwan; [Yu, Sung-Liang; Su, Kang-Yi] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Su, Kang-Yi] Natl Taiwan Univ, Ctr Genom Med, Taipei 10764, Taiwan; [Wu, Chih-Wei; Chen, Yuh-Min] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Yang, Cheng-Ta] Chang Gung Univ, Coll Med, Dept Resp Therapy, Taoyuan, Taiwan; [Chen, Yuh-Min] Taipei Med Univ, Coll Med Sci & Technol, Taipei, Taiwan; [Chang, Gee-Chen] Taichung Vet Gen Hosp, Ctr Comprehens Canc, Taichung, Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Hsing University; Taichung Veterans General Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Taipei Veterans General Hospital; Chang Gung University; Taipei Medical University; Taichung Veterans General Hospital	Chen, YM (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.	ymchen@vghtpe.gov.tw; august@vghtc.gov.tw	wang, chih-liang/GSD-6038-2022; SU, KANG-YI/GNM-5753-2022	SU, KANG-YI/0000-0002-6538-9526; YU, SUNG-LIANG/0000-0003-4535-9036; Tseng, Jeng-Sen/0000-0003-2341-4495; Yang, Cheng-Ta/0000-0003-1846-1027	National Science Council [NSC102-2325-B-002-078, NSC102-2319-B-002]	National Science Council(Ministry of Science and Technology, Taiwan)	We would like to thank Comprehensive Cancer Center of Taichung Veterans General Hospital for the assistance in data collection and management and acknowledge the technical services provided by the Pharmacogenomics Lab of the National Research Program for Biopharmaceuticals (NRPB) (TR6-3) and Integrated Core Facility for Functional Genomics of the National Core Facility Program for Biotechnology (NCFPB) (C5), which were supported by the National Science Council (NSC102-2325-B-002-078 and NSC102-2319-B-002).	Azzoli CG, 2012, J ONCOL PRACT, V8, P63, DOI 10.1200/JOP.2011.000374; Chen G, 2013, ANN ONCOL, V24, P1615, DOI 10.1093/annonc/mdt012; Chen YM, 2012, J THORAC ONCOL, V7, P412, DOI 10.1097/JTO.0b013e31823a39e8; Chiang CL, 2013, CANCER CHEMOTH PHARM, V71, P203, DOI 10.1007/s00280-012-1997-5; Chiu CH, 2014, J THORAC ONCOL, V9, P91, DOI 10.1097/JTO.0000000000000041; Cho J, 2011, CANCER RES, V71, P7587, DOI 10.1158/0008-5472.CAN-11-0821; Chou TY, 2005, CLIN CANCER RES, V11, P3750, DOI 10.1158/1078-0432.CCR-04-1981; Couraud S, 2014, CLIN CANC RES; Edge SB, 2009, AJCC CANC STAGING HD; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Er TK, 2014, DIAGN MOL PATHOL; Gregorc V, 2014, LANCET ONCOL, V15, P713, DOI 10.1016/S1470-2045(14)70162-7; Horiike A, 2007, CHEST, V131, P1628, DOI 10.1378/chest.06-1673; Jazieh AR, 2013, ANN THORAC MED, V8, P204, DOI 10.4103/1817-1737.118503; Kim HJ, 2012, LUNG CANCER, V75, P321, DOI 10.1016/j.lungcan.2011.08.005; Kimura H, 2014, LUNG CANCER, V83, P329, DOI 10.1016/j.lungcan.2013.12.012; Kobayashi T, 2012, CANCER CHEMOTH PHARM, V69, P1241, DOI 10.1007/s00280-012-1831-0; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Leighl NB, 2012, CURR ONCOL, V19, pS52, DOI 10.3747/co.19.1114; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Naoki K, 2011, INT J CLIN ONCOL, V16, P335, DOI 10.1007/s10147-011-0187-5; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Peters S, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds226; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Thongprasert S, 2011, J THORAC ONCOL, V6, P1872, DOI 10.1097/JTO.0b013e31822adaf7; Tseng JS, 2012, LUNG CANCER, V77, P128, DOI 10.1016/j.lungcan.2012.02.012; Wang CY, 2014, LUNG CANCER, V85, P152, DOI 10.1016/j.lungcan.2014.05.024; Wang F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-90; Wu JY, 2011, CLIN CANCER RES, V17, P3812, DOI 10.1158/1078-0432.CCR-10-3408; Wu KH, 2013, FUTURE ONCOL, V9, P1323, DOI 10.2217/fon.13.102; Yang JCH, 2013, J CLIN ONCOL, V31, P3342, DOI 10.1200/JCO.2012.46.1764; Yang TY, 2011, J CLIN ONCOL, V29, pE468, DOI 10.1200/JCO.2010.33.5802; Yeh P, 2013, CLIN CANCER RES, V19, P1894, DOI 10.1158/1078-0432.CCR-12-1894; Yoshioka H, 2010, J THORAC ONCOL, V5, P99, DOI 10.1097/JTO.0b013e3181c20063; Zhou Q, 2011, J CLIN ONCOL, V29, P3316, DOI 10.1200/JCO.2010.33.3757	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107160	10.1371/journal.pone.0107160	http://dx.doi.org/10.1371/journal.pone.0107160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215536	Green Submitted, gold, Green Published			2022-12-27	WOS:000341774300047
J	van der Wielen, N; van Avesaat, M; de Wit, NJW; Vogels, JTWE; Troost, F; Masclee, A; Koopmans, SJ; van der Meulen, J; Boekschoten, MV; Muller, M; Hendriks, HFJ; Witkamp, RF; Meijerink, J				van der Wielen, Nikkie; van Avesaat, Mark; de Wit, Nicole J. W.; Vogels, Jack T. W. E.; Troost, Freddy; Masclee, Ad; Koopmans, Sietse-Jan; van der Meulen, Jan; Boekschoten, Mark V.; Muller, Michael; Hendriks, Henk F. J.; Witkamp, Renger F.; Meijerink, Jocelijn			Cross-Species Comparison of Genes Related to Nutrient Sensing Mechanisms Expressed along the Intestine	PLOS ONE			English	Article							GLUCOSE COTRANSPORTER SGLT1; PEPTIDE-1 SECRETION; DIETARY-REGULATION; MOLECULAR-MECHANISMS; RECEPTOR EXPRESSION; SUCRASE-ISOMALTASE; TASTE RECEPTORS; AMINO-ACIDS; GUT; PIG	Introduction: Intestinal chemosensory receptors and transporters are able to detect food-derived molecules and are involved in the modulation of gut hormone release. Gut hormones play an important role in the regulation of food intake and the control of gastrointestinal functioning. This mechanism is often referred to as "nutrient sensing''. Knowledge of the distribution of chemosensors along the intestinal tract is important to gain insight in nutrient detection and sensing, both pivotal processes for the regulation of food intake. However, most knowledge is derived from rodents, whereas studies in man and pig are limited, and cross-species comparisons are lacking. Aim: To characterize and compare intestinal expression patterns of genes related to nutrient sensing in mice, pigs and humans. Methods: Mucosal biopsy samples taken at six locations in human intestine (n = 40) were analyzed by qPCR. Intestinal scrapings from 14 locations in pigs (n = 6) and from 10 locations in mice (n = 4) were analyzed by qPCR and microarray, respectively. The gene expression of glucagon, cholecystokinin, peptide YY, glucagon-like peptide-1 receptor, taste receptor T1R3, sodium/glucose cotransporter, peptide transporter-1, GPR120, taste receptor T1R1, GPR119 and GPR93 was investigated. Partial least squares (PLS) modeling was used to compare the intestinal expression pattern between the three species. Results and conclusion: The studied genes were found to display specific expression patterns along the intestinal tract. PLS analysis showed a high similarity between human, pig and mouse in the expression of genes related to nutrient sensing in the distal ileum, and between human and pig in the colon. The gene expression pattern was most deviating between the species in the proximal intestine. Our results give new insights in interspecies similarities and provide new leads for translational research and models aiming to modulate food intake processes in man.	[van der Wielen, Nikkie; van Avesaat, Mark; Troost, Freddy; Masclee, Ad; Boekschoten, Mark V.; Hendriks, Henk F. J.] Top Inst Food & Nutr, Wageningen, Netherlands; [van der Wielen, Nikkie; de Wit, Nicole J. W.; Boekschoten, Mark V.; Muller, Michael; Witkamp, Renger F.; Meijerink, Jocelijn] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [van Avesaat, Mark; Troost, Freddy; Masclee, Ad] Maastricht Univ, Med Ctr, NUTRIM, Dept Internal Med,Div Gastroenterol & Hepatol, Maastricht, Netherlands; [Koopmans, Sietse-Jan] Wageningen Univ, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands; [Koopmans, Sietse-Jan; van der Meulen, Jan] Univ Wageningen & Res Ctr, Anim Sci Grp, Lelystad, Netherlands; [Hendriks, Henk F. J.] TNO, Netherlands Org Appl Sci Res, NL-3700 AJ Zeist, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Maastricht University; Wageningen University & Research; Animal Sciences Group of Wageningen UR; Wageningen University & Research; Netherlands Organization Applied Science Research	Meijerink, J (corresponding author), Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.	jocelijn.meijerink@wur.nl	Witkamp, Renger/I-7622-2012; Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Hendriks, Henk/AAU-5987-2021; Boekschoten, Mark/AAS-4597-2021; Troost, Freddy/B-2782-2015	Witkamp, Renger/0000-0002-7935-8261; Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Boekschoten, Mark/0000-0002-2139-0795; van der Wielen, Nikkie/0000-0001-8450-5556; van der Meulen, Jan/0000-0002-9451-2335	program council of TI Food and Nutrition [WM-001]	program council of TI Food and Nutrition	This study was funded by the program council of TI Food and Nutrition (http://www.tifn.nl/) (grant WM-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balen D, 2008, AM J PHYSIOL-CELL PH, V295, pC475, DOI 10.1152/ajpcell.00180.2008; Berthoud HR, 2008, NEUROGASTROENT MOTIL, V20, P64, DOI 10.1111/j.1365-2982.2008.01104.x; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breen DM, 2013, DIABETES, V62, P3005, DOI 10.2337/db13-0523; Breer H, 2012, HISTOCHEM CELL BIOL, V138, P13, DOI 10.1007/s00418-012-0954-z; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Daly K, 2013, AM J PHYSIOL-GASTR L, V304, pG271, DOI 10.1152/ajpgi.00074.2012; Davidov E, 2004, OMICS, V8, P267, DOI 10.1089/omi.2004.8.267; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; de Wit NJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019145; Diakogiannaki E, 2013, DIABETOLOGIA, V56, P2688, DOI 10.1007/s00125-013-3037-3; Duca FA, 2013, INT J OBESITY, V37, P375, DOI 10.1038/ijo.2012.45; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; ERICKSON RH, 1995, BIOCHEM BIOPH RES CO, V216, P249, DOI 10.1006/bbrc.1995.2617; Ezcurra M, 2013, CURR OPIN PHARMACOL, V13, P922, DOI 10.1016/j.coph.2013.08.013; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; Goodman BE, 2010, ADV PHYSIOL EDUC, V34, P44, DOI 10.1152/advan.00094.2009; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Gribble FM, 2003, DIABETES, V52, P1147, DOI 10.2337/diabetes.52.5.1147; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Haid D, 2013, HISTOCHEM CELL BIOL, V140, P137, DOI 10.1007/s00418-013-1080-2; Hendriks WH, 2012, BRIT J NUTR, V108, pS247, DOI 10.1017/S0007114512002395; Herrera-Ruiz D, 2001, AAPS PHARMSCI, V3; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2013, TRENDS ENDOCRIN MET, V24, P92, DOI 10.1016/j.tem.2012.11.006; Jonsdottir K, 2008, OPEN PATHOLOGY J, V2; Kishi K, 1999, J NUTR, V129, P953, DOI 10.1093/jn/129.5.953; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Kolodziejczak D, 2013, AM J PHYSIOL-GASTR L, V304, pG897, DOI 10.1152/ajpgi.00160.2012; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Liou AP, 2013, J ANIM SCI, V91, P1946, DOI 10.2527/jas.2012-5910; Ma K, 2012, PHARM RES-DORDR, V29, P535, DOI 10.1007/s11095-011-0580-9; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Martens H., 1992, MULTIVARIATE CALIBRA; Masubuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054500; Moran AW, 2010, BRIT J NUTR, V104, P637, DOI 10.1017/S0007114510000917; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Perrier E, 2013, EUR J CLIN NUTR, V67, P939, DOI 10.1038/ejcn.2013.93; Rasoamanana R, 2012, P NUTR SOC, V71, P446, DOI 10.1017/S0029665112000110; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Richards P, 2013, DIABETES; ROWAN AM, 1994, BRIT J NUTR, V71, P29, DOI 10.1079/BJN19940108; Shiraga T, 1999, GASTROENTEROLOGY, V116, P354, DOI 10.1016/S0016-5085(99)70132-0; SJOLUND K, 1983, GASTROENTEROLOGY, V85, P1120; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Thamotharan M, 1999, METABOLISM, V48, P681, DOI 10.1016/S0026-0495(99)90164-6; van den Bosch HM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-267; Van Haver ER, 2005, VLAAMS DIERGENEESKD, P65; Wang W, 2009, AMINO ACIDS, V37, P593, DOI 10.1007/s00726-008-0178-7; Widmayer P, 2012, INT J OBESITY, V36, P1353, DOI 10.1038/ijo.2011.216; Wopereis S, 2012, PHYSIOL GENOMICS, V44, P293, DOI 10.1152/physiolgenomics.00072.2011; YASUTAKE H, 1995, BBA-GEN SUBJECTS, V1243, P270, DOI 10.1016/0304-4165(94)00143-L; Young RL, 2013, DIABETES, V62, P3532, DOI 10.2337/db13-0581; Ziegler TR, 2002, AM J CLIN NUTR, V75, P922, DOI 10.1093/ajcn/75.5.922	61	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107531	10.1371/journal.pone.0107531	http://dx.doi.org/10.1371/journal.pone.0107531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216051	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300074
J	Doleschall, M; Szabo, JA; Pazmandi, J; Szilagyi, A; Koncz, K; Farkas, H; Toth, M; Igaz, P; Glaz, E; Prohaszka, Z; Korbonits, M; Racz, K; Fust, G; Patocs, A				Doleschall, Marton; Szabo, Julianna Anna; Pazmandi, Julia; Szilagyi, Agnes; Koncz, Klara; Farkas, Henriette; Toth, Miklos; Igaz, Peter; Glaz, Edit; Prohaszka, Zoltan; Korbonits, Marta; Racz, Karoly; Fuest, George; Patocs, Attila			Common Genetic Variants of the Human Steroid 21-Hydroxylase Gene (CYP21A2) Are Related to Differences in Circulating Hormone Levels	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; COPY NUMBER; HAPLOTYPE RECONSTRUCTION; 4TH COMPONENT; COMPLEMENT; ALDOSTERONE; CORTISOL; DISEASE; DEFICIENCY; MECHANISMS	Purpose: Systematic evaluation of the potential relationship between the common genetic variants of CYP21A2 and hormone levels. Methods: The relationships of CYP21A2 intron 2 polymorphisms and haplotypes with diverse baseline and stimulated blood hormone levels were studied in 106 subjects with non-functioning adrenal incidentaloma (NFAI). The rationale for using NFAI subjects is dual: i) their baseline hormone profiles do not differ from those of healthy subjects and ii) hormone levels after stimulation tests are available. Results: The carriers (N = 27) of a well-defined CYP21A2 haplotype cluster (c5) had significantly elevated levels of cortisol (p = 0.0110), and 17-hydroxyprogesterone (p = 0.0001) after ACTH stimulation, and 11-deoxycortisol after metyrapone administration (p = 0.0017), but the hormone values were in normal ranges. In addition, the carriers (N = 33) of the C allele of the rs6462 polymorphism had a higher baseline aldosterone level (p = 0.0006). The prevalence of these genetic variants of CYP21A2 did not differ between NFAI and healthy subjects. Conclusions: The common CYP21A2 variants presumably exert the same effect on hormone levels in the healthy and disease-affected populations. Therefore, they may contribute to complex diseases such as some cardiovascular diseases, and may influence the genotype-phenotype correlation in patients with congenital adrenal hyperplasia (CAH) including the individual need for hormone substitution.	[Doleschall, Marton; Szabo, Julianna Anna; Szilagyi, Agnes; Farkas, Henriette; Prohaszka, Zoltan; Fuest, George] Semmelweis Univ, Dept Internal Med 3, H-1085 Budapest, Hungary; [Doleschall, Marton; Racz, Karoly; Patocs, Attila] Hungarian Acad Sci, Mol Med Res Grp, Budapest, Hungary; [Doleschall, Marton; Koncz, Klara; Racz, Karoly; Patocs, Attila] Semmelweis Univ, H-1085 Budapest, Hungary; [Doleschall, Marton; Korbonits, Marta] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Pazmandi, Julia; Koncz, Klara; Toth, Miklos; Igaz, Peter; Glaz, Edit; Racz, Karoly] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Koncz, Klara; Patocs, Attila] Hungarian Acad Sci, Lendulet Hereditary Endocrine Tumours Res Grp, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; University of London; Queen Mary University London; Semmelweis University; Hungarian Academy of Sciences	Doleschall, M (corresponding author), Semmelweis Univ, Dept Internal Med 3, H-1085 Budapest, Hungary.	m.doleschall@qmul.ac.uk	Doleschall, Marton/F-5386-2011; Doleschall, Marton/AAF-7742-2020; Szilagyi, Agnes/F-2337-2010; Prohászka, Zoltán/F-2191-2010; Igaz, Peter/D-3081-2014	Doleschall, Marton/0000-0002-0909-5232; Doleschall, Marton/0000-0002-0909-5232; Szilagyi, Agnes/0000-0002-9769-3215; Prohászka, Zoltán/0000-0003-1761-7982; Igaz, Peter/0000-0003-2192-554X; Korbonits, Marta/0000-0002-4101-9432; Patocs, Attila/0000-0001-7506-674X; Farkas, Henriette/0000-0003-2929-1721	Hungarian Scientific Research Fund (OTKA) [PD100648]; Technology Innovation Fund, National Developmental Agency [KTIA-AIK-2012-12-1-0010]; Hungarian Academy of Sciences	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Technology Innovation Fund, National Developmental Agency; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	Hungarian Scientific Research Fund (OTKA, PD100648 (AP)) Technology Innovation Fund, National Developmental Agency (KTIA-AIK-2012-12-1-0010). AP is the recipient of a "Lendulet'' grant from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arason GJ, 2007, CLIN EXP IMMUNOL, V149, P132, DOI 10.1111/j.1365-2249.2007.03391.x; Auchus RJ, 2013, J CLIN ENDOCR METAB, V98, P2645, DOI 10.1210/jc.2013-1440; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Banlaki Z, 2012, GENES IMMUN, V13, P530, DOI 10.1038/gene.2012.29; Banlaki Z, 2013, GENOME BIOL EVOL, V5, P98, DOI 10.1093/gbe/evs121; Banlaki Z, 2012, CLIN ENDOCRINOL, V76, P478, DOI 10.1111/j.1365-2265.2011.04247.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barzon L, 2007, J ENDOCRINOL INVEST, V30, P615, DOI 10.1007/BF03346358; BAUER JH, 1993, DRUG AGING, V3, P238, DOI 10.2165/00002512-199303030-00005; Baumgartner-Parzer SM, 2002, CLIN ENDOCRINOL, V56, P811, DOI 10.1046/j.1365-2265.2002.01299.x; Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; Hoehe MR, 2003, PHARMACOGENOMICS, V4, P547, DOI 10.1517/phgs.4.5.547.23791; Koppens PFJ, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e53; Koppens PFJ, 2002, HUM GENET, V111, P405, DOI 10.1007/s00439-002-0810-7; KRAMER J, 1991, HUM GENET, V86, P595; Lefebvre H, 2013, EUR J ENDOCRINOL, V169, pR115, DOI 10.1530/EJE-13-0308; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mantero F, 2000, J CLIN ENDOCR METAB, V85, P637, DOI 10.1210/jc.85.2.637; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; New MI, 2013, P NATL ACAD SCI USA, V110, P2611, DOI 10.1073/pnas.1300057110; Patocs A, 2002, EUR J ENDOCRINOL, V147, P349, DOI 10.1530/eje.0.1470349; Posada D, 2005, BIOINFORMATICS, V21, P2130, DOI 10.1093/bioinformatics/bti293; RACZ K, 1993, J CLIN ENDOCR METAB, V77, P677, DOI 10.1210/jc.77.3.677; Sereg M, 2011, STEROIDS, V76, P38, DOI 10.1016/j.steroids.2010.08.007; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Szabo JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081977; Szilagyi A, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-1; Toth M, 2000, J ENDOCRINOL INVEST, V23, P287, DOI 10.1007/BF03343725; Vassiliadi DA, 2011, NAT REV ENDOCRINOL, V7, P668, DOI 10.1038/nrendo.2011.92; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; Yang ZY, 1999, J BIOL CHEM, V274, P12147, DOI 10.1074/jbc.274.17.12147; Young WF, 2007, NEW ENGL J MED, V356, P601, DOI 10.1056/NEJMcp065470; Zeiger MA, 2011, J CLIN ENDOCR METAB, V96, P2004, DOI 10.1210/jc.2011-0085	42	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107244	10.1371/journal.pone.0107244	http://dx.doi.org/10.1371/journal.pone.0107244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210767	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000341855900051
J	Hsu, CM; de Palmas, S; Kuo, CY; Denis, V; Chen, CA				Hsu, Chia-Min; de Palmas, Stephane; Kuo, Chao-Yang; Denis, Vianney; Chen, Chaolun Allen			Identification of Scleractinian Coral Recruits Using Fluorescent Censusing and DNA Barcoding Techniques	PLOS ONE			English	Article							CLIMATE-CHANGE; SEQUENCE EVOLUTION; TEMPORAL VARIATION; GENETIC-STRUCTURE; MITOCHONDRIAL; COMMUNITY; PATTERNS; ANTHOZOA; REPRODUCTION; ABUNDANCE	The identification of coral recruits has been problematic due to a lack of definitive morphological characters being available for higher taxonomic resolution. In this study, we tested whether fluorescent detection of coral recruits used in combinations of different DNA-barcoding markers (cytochrome oxidase I gene [COI], open reading frame [ORF], and nuclear Pax-C intron [PaxC]) could be useful for increasing the resolution of coral spat identification in ecological studies. One hundred and fifty settlement plates were emplaced at nine sites on the fringing reefs of Kenting National Park in southern Taiwan between April 2011 and September 2012. A total of 248 living coral spats and juveniles (with basal areas ranging from 0.21 to 134.57 mm(2)) were detected on the plates with the aid of fluorescent light and collected for molecular analyses. Using the COI DNA barcoding technique, 90.3% (224/248) of coral spats were successfully identified into six genera, including Acropora, Isopora, Montipora, Pocillopora, Porites, and Pavona. PaxC further separated I. cuneata and I. palifera of Isopora from Acropora, and ORF successfully identified the species of Pocillopora (except P. meandrina and P. eydouxi). Moreover, other cnidarian species such as actinarians, zoanthids, and Millepora species were visually found using fluorescence and identified by COI DNA barcoding. This combination of existing approaches greatly improved the taxonomic resolution of early coral life stages, which to date has been mainly limited to the family level based on skeletal identification. Overall, this study suggests important improvements for the identification of coral recruits in ecological studies.	[Hsu, Chia-Min; de Palmas, Stephane; Kuo, Chao-Yang; Denis, Vianney; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Hsu, Chia-Min; Chen, Chaolun Allen] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Kuo, Chao-Yang] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Chen, Chaolun Allen] Acad Sinica, Taiwan Int Grad Program TIGP Biodivers, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Taiwan University; James Cook University; Academia Sinica - Taiwan	Chen, CA (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	cac@gate.sinica.edu.tw	, de PALMAS Stéphane/AAS-8982-2021; Denis, Vianney/E-6868-2013	, de PALMAS Stéphane/0000-0002-2567-1789; Denis, Vianney/0000-0002-0914-5586	NSC; Kenting National Park; Academia Sinica Thematic Grant [AS-100-TPA02-SUB3]	NSC(Ministry of Science and Technology, Taiwan); Kenting National Park; Academia Sinica Thematic Grant	This study was supported by a long-term ecological research grant from the NSC (http://web1.nsc.gov.tw/mp.aspx?mp=7), Kenting National Park (http://www.ktnp.gov.tw/eng/), and Academia Sinica Thematic Grant (AS-100-TPA02-SUB3) to CAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock RC, 2003, ZOOL STUD, V42, P211; Babcock RC, 1992, 7 U PHIL MAR SCI I B; Baird AH, 2000, CORAL REEFS, V19, P179, DOI 10.1007/PL00006955; Baird AH, 2006, CORAL REEFS, V25, P73, DOI 10.1007/s00338-005-0072-7; Birkeland C., 1982, Proceedings of the International Coral Reef Symposium, P339; Birkeland C., 1977, Proceedings int Coral Reef Symp, V3, P15; Blakeway D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075281; BROCK RE, 1979, MAR BIOL, V51, P381, DOI 10.1007/BF00389216; Chen AC, 2012, LONG TERM ECOLOGICAL, P1; Christiansen NA, 2009, CORAL REEFS, V28, P47, DOI 10.1007/s00338-008-0429-9; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Dai CF, 1992, P 7 INT COR REEF S G, V1, P448; Darling ES, 2013, GLOBAL CHANGE BIOL, V19, P1930, DOI 10.1111/gcb.12191; FISK DA, 1990, MAR BIOL, V107, P485, DOI 10.1007/BF01313433; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fox HE, 2004, MAR ECOL PROG SER, V269, P131, DOI 10.3354/meps269131; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; Glassom D, 2004, MAR BIOL, V144, P641, DOI 10.1007/s00227-003-1243-0; Green DH, 2011, J EXP MAR BIOL ECOL, V397, P220, DOI 10.1016/j.jembe.2010.12.004; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ho MJ, 2014, ZOOL STUD, V53, DOI 10.1186/1810-522X-53-5; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; Keshavmurthy S, 2014, PEERJ, V2, DOI 10.7717/peerj.327; Keshavmurthy S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01520; Keshavmurthy S, 2012, MOL ECOL, V21, P4393, DOI 10.1111/j.1365-294X.2012.05704.x; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Kuo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044364; Kuo KM, 2010, ZOOL STUD, V49, P724; Lee HJ, 1999, CONT SHELF RES, V19, P871, DOI 10.1016/S0278-4343(99)00006-0; Liu PJ, 2009, MAR ENVIRON RES, V68, P106, DOI 10.1016/j.marenvres.2009.04.009; Liu PJ, 2009, LIMNOL OCEANOGR, V54, P1167, DOI 10.4319/lo.2009.54.4.1167; Martinez S, 2013, ICES J MAR SCI, V70, P1294, DOI 10.1093/icesjms/fst035; Mazel CH, 2005, LIMNOL OCEANOGR-METH, V3, P499, DOI 10.4319/lom.2005.3.499; Meng PJ, 2008, ENVIRON POLLUT, V156, P76; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; Nozawa Y, 2006, MAR BIOL, V149, P1047, DOI 10.1007/s00227-006-0285-5; Nozawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081474; Nozawa Y, 2008, J EXP MAR BIOL ECOL, V367, P127, DOI 10.1016/j.jembe.2008.09.004; Piniak GA, 2005, CORAL REEFS, V24, P496, DOI 10.1007/s00338-005-0495-1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richards ZT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003240; RICHMOND RH, 1985, MAR ECOL PROG SER, V22, P181, DOI 10.3354/meps022181; ROGERS CS, 1984, CORAL REEFS, V3, P69, DOI 10.1007/BF00263756; Rubin ET, 2008, P 11 INT COR REEF S, V1, P326; Salinas-de-Leon P, 2011, ESTUAR COAST SHELF S, V93, P80, DOI 10.1016/j.ecss.2011.02.016; Sawall Y, 2010, HELGOLAND MAR RES, V64, P357, DOI 10.1007/s10152-010-0192-5; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schmidt-Roach S, 2013, ZOOTAXA, V3626, P576, DOI 10.11646/zootaxa.3626.4.11; Schmidt-Roach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050847; Schmidt-Roach S, 2008, J EXP MAR BIOL ECOL, V367, P37, DOI 10.1016/j.jembe.2008.08.012; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Shearer TL, 2006, MAR ECOL PROG SER, V306, P133, DOI 10.3354/meps306133; Shearer TL, 2005, CORAL REEFS, V24, P57, DOI 10.1007/s00338-004-0442-6; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Soong K, 2003, CORAL REEFS, V22, P224, DOI 10.1007/s00338-003-0311-8; Suzuki G, 2008, MAR ECOL PROG SER, V355, P149, DOI 10.3354/meps07253; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TOMASCIK T, 1991, MAR ECOL PROG SER, V77, P261, DOI 10.3354/meps077261; Tseng CC, 2005, CORAL REEFS, V24, P502, DOI 10.1007/s00338-005-0499-x; van Oppen MJH, 1999, P ROY SOC B-BIOL SCI, V266, P179, DOI 10.1098/rspb.1999.0619; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Veron J.E.N, 2000, CORALS WORLD; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Ward RD, 2008, MOL ECOL RESOUR, V8, P1202, DOI 10.1111/j.1755-0998.2008.02332.x; Wu ZY, 2012, COMMUNITY STRUCTURE, P54; Yeoh SR, 2010, MAR BIOL, V157, P351, DOI 10.1007/s00227-009-1322-y	74	18	18	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107366	10.1371/journal.pone.0107366	http://dx.doi.org/10.1371/journal.pone.0107366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211345	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000341855900064
J	Shevlin, E; Miggin, SM				Shevlin, Enda; Miggin, Sinead M.			The TIR-Domain Containing Adaptor TRAM Is Required for TLR7 Mediated RANTES Production	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; PATTERN-RECOGNITION; SIGNALING PATHWAY; INTERFERON-BETA; TRIF; IFN; TOLL-LIKE-RECEPTOR-4; INDUCTION; EXPRESSION	Toll-like receptor 7 (TLR7) plays a vital role in the immune response to ssRNA viruses such as human rhinovirus (HRV) and Influenza, against which there are currently no treatments or vaccines with long term efficacy available. Clearly, a more comprehensive understanding of the TLR7 signaling axis will contribute to its molecular targeting. TRIF related adaptor molecule (TRAM) plays a vital role in TLR4 signaling by recruiting TRIF to TLR4, followed by endosomal trafficking of the complex and initiation of IRF3 dependent type I interferon production as well as NF-kappa B dependent pro-inflammatory cytokine production. Towards understanding the molecular mechanisms that regulate TLR7 functionality, we found that TRAM(-/-) murine macrophages exhibited a transcriptional and translational impairment in TLR7 mediated RANTES, but not TNF alpha, production. Suppression of TRAM expression in human macrophages also resulted in an impairment in TLR7 mediated CCL5 and IFN-beta, but not TNFa, gene induction. Furthermore, suppression of endogenous human TRAM expression in human macrophages significantly impaired RV16 induced CCL5 and IFN-beta, but not TNF alpha gene induction. Additionally, TRAM-G2A dose-dependently inhibited TLR7 mediated activation of CCL5, IFN beta and IFN alpha reporter genes. TLR7-mediated phosphorylation and nuclear translocation of IRF3 was impaired in TRAM(-/-) cells. Finally, co-immunoprecipitation studies indicated that TRAM physically interacts with MyD88 upon TLR7 stimulation, but not under basal conditions. Our results clearly demonstrate that TRAM plays a, hitherto unappreciated, role in TLR7 signaling through a novel signaling axis containing, but not limited to, MyD88, TRAM and IRF3 towards the activation of anti-viral immunity.	[Shevlin, Enda; Miggin, Sinead M.] Natl Univ Ireland Maynooth, Dept Biol, Inst Immunol, Maynooth, Kildare, Ireland	Maynooth University	Miggin, SM (corresponding author), Natl Univ Ireland Maynooth, Dept Biol, Inst Immunol, Maynooth, Kildare, Ireland.	sinead.miggin@nuim.ie		Miggin, Sinead/0000-0002-3421-3552	Health Research Board of Ireland	Health Research Board of Ireland	This work was supported by the Health Research Board of Ireland (to ES and SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Ahmed S, 2013, J IMMUNOL, V190, P2217, DOI 10.4049/jimmunol.1201630; Bao MS, 2013, PROTEIN CELL, V4, P40, DOI 10.1007/s13238-012-2104-8; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Brencicova E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00037; Carrigan SO, 2010, J IMMUNOL, V185, P3602, DOI 10.4049/jimmunol.0903429; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Choi YJ, 2010, J BIOL CHEM, V285, P37570, DOI 10.1074/jbc.M110.158394; Choi YJ, 2010, J BIOL CHEM, V285, P21382, DOI 10.1074/jbc.M110.115022; Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Guiducci C, 2009, J INTERN MED, V265, P43, DOI 10.1111/j.1365-2796.2008.02050.x; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Morris I, 2012, NOVEL TRIF INDEPENDE; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038423; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Siednienko J, 2011, J IMMUNOL, V186, P2514, DOI 10.4049/jimmunol.1003093; Siednienko J, 2010, EUR J IMMUNOL, V40, P3150, DOI 10.1002/eji.201040547; Thackray LB, 2012, J VIROL, V86, P13515, DOI 10.1128/JVI.01824-12; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	37	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107141	10.1371/journal.pone.0107141	http://dx.doi.org/10.1371/journal.pone.0107141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211222	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000341855900047
J	Bolt, OC; Ehlers, A; Clark, DM				Bolt, Olivia C.; Ehlers, Anke; Clark, David M.			Faces in a Crowd: High Socially Anxious Individuals Estimate that More People Are Looking at Them than Low Socially Anxious Individuals	PLOS ONE			English	Article							ANXIETY DISORDER; FEAR; PHOBIA; SELF; PERFORMANCE; MODEL; CONE	Background: People with social anxiety disorder are afraid of being scrutinized by others and often feel that they are the excessive focus of other people's attention. This study investigated whether, when compared to low socially anxious individuals, high socially anxious individuals overestimate the proportion of people in a crowd who are observing them. It was hypothesized that any potential overestimation would be modulated by self-focused attention. Method: Forty-eight high and 48 low socially anxious participants performed a "faces in a crowd'' computer task during which they briefly saw matrices of faces, which varied in terms of the proportion of people who were looking at them. Participants estimated the proportion of people who were looking at them. The task was performed once with mirrors present (to induce an enhanced self-focused state) and once without mirrors present (neutral state). Results: Participants' subjective estimates and the objective proportion of faces looking towards them were strongly correlated in both the high and low socially anxious groups. However, high socially anxious participants estimated that more people were looking at them than low socially anxious participants. In the first phase of the experiment, but not in the later phases, this effect was magnified in the mirror condition. Discussion: This study provides preliminary evidence of a social anxiety related perceptual difference that may be amplified by self-focused attention. Clinical implications are discussed.	[Bolt, Olivia C.] Kings Coll London, Dept Psychol, London, England; [Bolt, Olivia C.] Mental Hlth Biomed Res Ctr South London, Natl Inst Hlth Res, London, England; [Bolt, Olivia C.] Maudsley NHS Fdn Trust, London, England; [Ehlers, Anke; Clark, David M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, Oxon, England	University of London; King's College London; South London & Maudsley NHS Trust; University of Oxford	Bolt, OC (corresponding author), Canterbury Christ Church Univ, Salomons Ctr Appl Psychol, Tunbridge Wells, Kent, England.	ocb1@canterbury.ac.uk; david.clark@psy.ox.ac.uk	Ehlers, Anke/G-8713-2014	Ehlers, Anke/0000-0002-8742-0192; Clark, David/0000-0002-8173-6022	Wellcome Trust [069777]; NIHR Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust; King's College London	Wellcome Trust(Wellcome Trust); NIHR Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust; King's College London(General Electric)	This work was supported by Wellcome Trust (069777) "Cognitive processes in the maintenance and treatment of posttraumatic stress disorder and social phobia" to AE and DMC (http://www.wellcome.ac.uk/); NIHR Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust and King's College London to OCB (http://brc.slam.nhs.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Beck A.T., 1979, COGNITIVE THERAPY EM; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bogels SM, 1997, CLIN PSYCHOL PSYCHOT, V4, P251, DOI 10.1002/(SICI)1099-0879(199712)4:4<251::AID-CPP136>3.0.CO;2-5; Bogels SM, 2010, DEPRESS ANXIETY, V27, P168, DOI 10.1002/da.20670; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; EHLERS A, 1992, J ABNORM PSYCHOL, V101, P371, DOI 10.1037/0021-843X.101.3.371; EHLERS A, 1995, J ABNORM PSYCHOL, V104, P164, DOI 10.1037/0021-843X.104.1.164; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; Gamer M, 2011, COGNITION EMOTION, V25, P756, DOI 10.1080/02699931.2010.503117; Gilboa-Schechtman E, 1999, COGNITION EMOTION, V13, P305, DOI 10.1080/026999399379294; Harbort J, 2013, BEHAV RES THER, V51, P359, DOI 10.1016/j.brat.2013.03.009; Hofmann Stefan G., 2007, Cognitive Behaviour Therapy, V36, P193, DOI 10.1080/16506070701421313; LEARY MR, 1983, PERS SOC PSYCHOL B, V9, P371, DOI 10.1177/0146167283093007; RAPEE RM, 1992, J ABNORM PSYCHOL, V101, P728, DOI 10.1037/0021-843X.101.4.728; RAPEE RM, 1994, ANXIETY, V1, P114; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Rodebaugh TL, 2011, J ANXIETY DISORD, V25, P623, DOI 10.1016/j.janxdis.2011.02.002; Schulze L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00872; SLAPION MJ, 1981, COGNITIVE THER RES, V5, P115, DOI 10.1007/BF01172332; STOPA L, 1993, BEHAV RES THER, V31, P255, DOI 10.1016/0005-7967(93)90024-O; Stopa L, 2001, BEHAV COGN PSYCHOTH, V29, P423, DOI 10.1017/S1352465801004039; Veljaca KA, 1998, BEHAV RES THER, V36, P311, DOI 10.1016/S0005-7967(98)00016-3	23	2	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106400	10.1371/journal.pone.0106400	http://dx.doi.org/10.1371/journal.pone.0106400			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25208221	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300020
J	Risher, WC; Ustunkaya, T; Alvarado, JS; Eroglu, C				Risher, W. Christopher; Ustunkaya, Tuna; Alvarado, Jonnathan Singh; Eroglu, Cagla			Rapid Golgi Analysis Method for Efficient and Unbiased Classification of Dendritic Spines	PLOS ONE			English	Article							SYNAPTOGENESIS	Dendritic spines are the primary recipients of excitatory synaptic input in the brain. Spine morphology provides important information on the functional state of ongoing synaptic transmission. One of the most commonly used methods to visualize spines is Golgi-Cox staining, which is appealing both due to ease of sample preparation and wide applicability to multiple species including humans. However, the classification of spines is a time-consuming and often expensive task that yields widely varying results between individuals. Here, we present a novel approach to this analysis technique that uses the unique geometry of different spine shapes to categorize spines on a purely objective basis. This rapid Golgi spine analysis method successfully conveyed the maturational shift in spine types during development in the mouse primary visual cortex. This approach, built upon freely available software, can be utilized by researchers studying a broad range of synaptic connectivity phenotypes in both development and disease.	[Risher, W. Christopher; Ustunkaya, Tuna; Alvarado, Jonnathan Singh; Eroglu, Cagla] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Risher, W. Christopher; Eroglu, Cagla] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Eroglu, Cagla] Duke Inst Brain Sci, Durham, NC USA	Duke University; Duke University	Eroglu, C (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	cagla.eroglu@dm.duke.edu	Ustunkaya, Tuna/I-2713-2018; Eroglu, Cagla/P-5315-2014; Risher, W Christopher/AAZ-3982-2020	Eroglu, Cagla/0000-0002-7204-0218; Risher, W Christopher/0000-0002-2230-2865	National Institutes of Health/National Institute on Drug Abuse [DA031833]; Esther and Joseph Klingenstein Fund; Alfred P. Sloan Foundation; National Institutes of Health/National Institute of Neurological Disorders and Stroke [2T32NS51156-6, 1F32NS083283-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS083283, T32NS051156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031833] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Esther and Joseph Klingenstein Fund(Klingenstein Philanthropies); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by DA031833 (CE), National Institutes of Health/National Institute on Drug Abuse (www.nih.gov; www.drugabuse.gov), Esther and Joseph Klingenstein Fund (CE) (www.klingfund.org), Alfred P. Sloan Foundation (CE) (www.sloan.org), and 2T32NS51156-6 and 1F32NS083283-01A1 (WCR), National Institutes of Health/National Institute of Neurological Disorders and Stroke (www.nih.gov; www.ninds.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Das G, 2012, GOLGI COX METHOD, V1018, P313; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Ma YY, 2013, EPILEPSIA, V54, P1232, DOI 10.1111/epi.12195; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Ramon Y, 1951, B LOS ANGELES NEUROL, V17, P5; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	15	157	157	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107591	10.1371/journal.pone.0107591	http://dx.doi.org/10.1371/journal.pone.0107591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208214	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300092
J	Grassmann, F; Schoenberger, PGA; Brandl, C; Schick, T; Hasler, D; Meister, G; Fleckenstein, M; Lindner, M; Helbig, H; Fauser, S; Weber, BHF				Grassmann, Felix; Schoenberger, Peter G. A.; Brandl, Caroline; Schick, Tina; Hasler, Daniele; Meister, Gunter; Fleckenstein, Monika; Lindner, Moritz; Helbig, Horst; Fauser, Sascha; Weber, Bernhard H. F.			A Circulating MicroRNA Profile Is Associated with Late-Stage Neovascular Age-Related Macular Degeneration	PLOS ONE			English	Article							PREVALENCE; SEVERITY; RNA	Age-related macular degeneration (AMD) is the leading cause of severe vision impairment in Western populations over 55 years. A growing number of gene variants have been identified which are strongly associated with an altered risk to develop AMD. Nevertheless, gene-based biomarkers which could be dysregulated at defined stages of AMD may point toward key processes in disease mechanism and thus may support efforts to design novel treatment regimens for this blinding disorder. Circulating microRNAs (cmiRNAs) which are carried by nanosized exosomes or microvesicles in blood plasma or serum, have been recognized as valuable indicators for various age-related diseases. We therefore aimed to elucidate the role of cmiRNAs in AMD by genome-wide miRNA expression profiling and replication analyses in 147 controls and 129 neovascular AMD patients. We identified three microRNAs differentially secreted in neovascular (NV) AMD (hsa-mir-301-3p, p(corrected) = 5.6*10(-5), hsa-mir-361-5p, p(corrected) = 8.0*10(-4) and hsa-mir-424-5p, p(corrected) = 9.6*10(-3)). A combined profile of the three miRNAs revealed an area under the curve (AUC) value of 0.727 and was highly associated with NV AMD (p = 1.2*10(-8)). To evaluate subtype-specificity, an additional 59 AMD cases with pure unilateral or bilateral geographic atrophy (GA) were analyzed for microRNAs hsa-mir-301-3p, hsa-mir-361-5p, and hsa-mir-424-5p. While we found no significant differences between GA AMD and controls neither individually nor for a combined microRNAs profile, hsa-mir-424-5p levels remained significantly higher in GA AMD when compared to NV (p(corrected)<0.005). Pathway enrichment analysis on genes predicted to be regulated by microRNAs hsa-mir-301-3p, hsa-mir-361-5p, and hsa-mir-424-5p, suggests canonical TGF beta, mTOR and related pathways to be involved in NV AMD. In addition, knockdown of hsa-mir-361-5p resulted in increased neovascularization in an in vitro angiogenesis assay.	[Grassmann, Felix; Schoenberger, Peter G. A.; Brandl, Caroline; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Brandl, Caroline; Helbig, Horst] Univ Hosp Regensburg, Dept Ophthalmol, Regensburg, Germany; [Schick, Tina; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Hasler, Daniele; Meister, Gunter] Univ Regensburg, Lab RNA Biol, Biochem Ctr Regensburg BZR, D-93053 Regensburg, Germany; [Fleckenstein, Monika; Lindner, Moritz] Univ Bonn, Dept Ophthalmol, Bonn, Germany	University of Regensburg; University of Regensburg; University of Cologne; University of Regensburg; University of Bonn	Weber, BHF (corresponding author), Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany.	bweb@klinik.uni-regensburg.de	Hasler, Daniele/AAA-5411-2021; Lindner, Moritz/AAC-8639-2021	Hasler, Daniele/0000-0002-1786-0563; Lindner, Moritz/0000-0002-4416-3421; Fleckenstein, Monika/0000-0001-8321-8037; Grassmann, Felix/0000-0003-1390-7528; Weber, Bernhard H.F./0000-0002-8808-7723; Brandl, Caroline/0000-0001-8223-6137	Deutsche Forschungsgemeinschaft [WE 1259/19-1, FL 658/4-1]; Novartis Pharma [3625340]; Alcon Research Institute	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Novartis Pharma; Alcon Research Institute(Novartis)	This study was supported in part by grants from the Deutsche Forschungsgemeinschaft (WE 1259/19-1 to BHFW, FL 658/4-1 to MF), Novartis Pharma (grant #3625340) and the Alcon Research Institute (to BHFW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Carpentier GMM, 2012, 4 IMAGEJ USER DEV C, P198; Chongsuvivatwong Virasakdi, 2012, EP EP CALC R PACK VE; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dreyhaupt J, 2005, OPHTHAL EPIDEMIOL, V12, P353, DOI 10.1080/09286580591005723; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Grassmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037979; Hagan Emily L, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5172; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hurteau GJ, 2006, CELL CYCLE, V5, P1951, DOI 10.4161/cc.5.17.3133; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; Kanitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049568; Klein ML, 2010, OPHTHALMOLOGY, V117, P1554, DOI 10.1016/j.ophtha.2009.12.012; Koh JT, 2007, ACS CHEM BIOL, V2, P599, DOI 10.1021/cb700183s; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Lasser C, 2012, EXPERT OPIN BIOL TH, V12, pS189, DOI 10.1517/14712598.2012.680018; Leveziel N, 2010, INVEST OPHTH VIS SCI, V51, P2620, DOI 10.1167/iovs.09-4423; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; R Core Team, 2021, R LANGUAGE ENV STAT; Ristau T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093459; Scott AW, 2013, CURR OPIN OPHTHALMOL, V24, P190, DOI 10.1097/ICU.0b013e32835fefee; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; VanNewkirk MR, 2000, OPHTHALMOLOGY, V107, P1593, DOI 10.1016/S0161-6420(00)00175-5; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhao HP, 2013, STROKE, V44, P1706, DOI 10.1161/STROKEAHA.111.000504	36	53	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107461	10.1371/journal.pone.0107461	http://dx.doi.org/10.1371/journal.pone.0107461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203061	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500101
J	Alves, TL; de Freitas, AFM; van Eijk, MEC; Mantel-Teeuwisse, AK				Alves, Teresa Leonardo; de Freitas, Auramarina F. Martins; van Eijk, Martine E. C.; Mantel-Teeuwisse, Aukje K.			Compliance of Disease Awareness Campaigns in Printed Dutch Media with National and International Regulatory Guidelines	PLOS ONE			English	Article							EXPOSURE; INDUSTRY	Background: The European legislation prohibits prescription-only medicines' advertising but allows pharmaceutical companies to provide information to the public on health and diseases, provided there is no direct or indirect reference to a pharmaceutical product. Various forms of promotion have become increasingly common in Europe including "disease-oriented'' campaigns. Objectives: To explore examples of disease awareness campaigns by pharmaceutical companies in the Netherlands, by assessing their compliance with the World Health Organization (WHO) Ethical Criteria for medicinal drug promotion and the Dutch guidelines for provision of information by pharmaceutical companies. Methods: Materials referring to health/disease and treatments published in the most widely circulated newspapers and magazines were collected from March to May 2012. An evaluation tool was developed based on relevant underlying principles from the WHO ethical criteria and Dutch self-regulation guidelines. Collected disease awareness advertisements were used to pilot the evaluation tool and to explore the consistency of information provided with the WHO and Dutch criteria. Findings: Eighty materials met our inclusion criteria; 71 were published in newspapers and 9 in magazines. The large majority were news items but 21 were disease awareness advertisements, of which 5 were duplicates. Fifteen out of the 16 disease awareness campaigns were non-compliant with current guidelines mainly due to lack of balance (n = 12), absence of listed author and/or sponsor (n = 8), use of misleading or incomplete information (n = 5) and use of promotional information (n = 5). None mentioned a pharmaceutical product directly. Conclusion: Disease Awareness Campaigns are present in Dutch printed media. Although no brand names were mentioned, the lack of compliance of disease awareness campaigns with the current regulations is alarming. There were information deficiencies and evidence of information bias. A key concern is that the context in which the information is provided, mostly through indirect referral, is likely to support treatment with the sponsor's product.	[Alves, Teresa Leonardo; de Freitas, Auramarina F. Martins; Mantel-Teeuwisse, Aukje K.] Univ Utrecht, World Hlth Org Collaborating Ctr Pharmaceut Polic, Utrecht Inst Pharmaceut Sci UIPS, Utrecht, Netherlands	Utrecht University; World Health Organization	Mantel-Teeuwisse, AK (corresponding author), Univ Utrecht, World Hlth Org Collaborating Ctr Pharmaceut Polic, Utrecht Inst Pharmaceut Sci UIPS, Utrecht, Netherlands.	A.K.Mantel@uu.nl	Mantel-Teeuwisse, Aukje/I-8902-2016					Agresti A, 2007, INTRO CATEGORICAL DA; Braun SR, 2013, JAMA INTERN MED, V173, P1458, DOI 10.1001/jamainternmed.2013.6892; Cassels A, 2003, CMAJ, V168; Castleberry SB, 2008, J BUSINESS CASE 0204, V4, P2; European Medicines Agency Committee for medicinal products for human use, 2011, ZOEL NOM AC ESTR SUM; Haimowitz IJ, 2011, HEALTHCARE RELATIONSHIP MARKETING: STRATEGY, DESIGN AND MEASUREMENT, P1; Hall D, 2011, AUST FAM PHYSICIAN, V40, P143; Hall DV, 2009, MED J AUSTRALIA, V191, P625, DOI 10.5694/j.1326-5377.2009.tb03355.x; HARRABIN R, 2003, HLTH NEWS RISK REPOR; Hogue MCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034314; Huh J, 2005, J HEALTH COMMUN, V10, P711, DOI 10.1080/10810730500326716; Instituut voor Media Auditing, 2011, HARD CIJF JAAR 2011; Keuringsraad Openlijke Aanprijzing Geneesmiddelen, 2013, COD PUBL GEN; Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, 2012, VERG LIN PHARM WEEKB; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Leonardo Alves T, 2007, GEN HLTH FOR; Mintzes B, 2012, ANNU REV PUBL HEALTH, V33, P259, DOI 10.1146/annurev-publhealth-031811-124540; Mintzes Barbara, 1998, BLURRING BOUNDARIES; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Nuland S, 2009, INFORMATIEAANBOD OP; Nuland S, 2009, PUBLIC INFORM MARKET; Quick JD, 2003, LANCET, V362, P747, DOI 10.1016/S0140-6736(03)14217-1; Schwartz LM, 2013, JAMA INTERN MED, P1; Stichting CGR, 2011, LEIDRAAD INFORM UR G; 't Jong GW, 2004, BMJ-BRIT MED J, V328, P931, DOI 10.1136/bmj.38007.711481.F7; Tiner R, 2002, BRIT MED J, V325, P216, DOI 10.1136/bmj.325.7357.216; Trafimow D, 2013, AM J BIOETHICS, V13, P21, DOI 10.1080/15265161.2013.776131; Vitry AI, 2012, MED J AUSTRALIA, V196, P619, DOI 10.5694/mja11.11299; WHO, 1988, ETH CRIT MED DRUG PR; Wielondek M, 2005, J MED MARKETING, V5, P264, DOI DOI 10.1057/PALGRA-VE.JMM.5040239; Woloshin S, 2006, PLOS MED, V3, P452, DOI 10.1371/journal.pmed.0030170; Zetterqvist AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062609	32	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106599	10.1371/journal.pone.0106599	http://dx.doi.org/10.1371/journal.pone.0106599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198776	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700033
J	Oberoi, S; Zamperlini-Netto, G; Beyene, J; Treister, NS; Sung, L				Oberoi, Sapna; Zamperlini-Netto, Gabriele; Beyene, Joseph; Treister, Nathaniel S.; Sung, Lillian			Effect of Prophylactic Low Level Laser Therapy on Oral Mucositis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							NECK-CANCER-PATIENTS; BONE-MARROW-TRANSPLANTATION; BEAM-CONDITIONING CHEMOTHERAPY; RADIATION-INDUCED MUCOSITIS; HIGH-DOSE MELPHALAN; HELIUM-NEON LASER; LOW-POWER LASER; CONCURRENT CHEMORADIOTHERAPY; ASSESSMENT SCALE; CLINICAL-TRIAL	Background: Objective was to determine whether prophylactic low level laser therapy (LLLT) reduces the risk of severe mucositis as compared to placebo or no therapy. Methods: MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials were searched until February 2014 for randomized controlled trials (RCTs) comparing prophylactic LLLT with placebo or no therapy in patients with cancer or undergoing hematopoietic stem cell transplantation (HSCT). All analyses used random effects models. Results: Eighteen RCTs (1144 patients) were included. Prophylactic LLLT reduced the overall risk of severe mucositis (risk ratio (RR) 0.37, 95% confidence interval (CI) 0.20 to 0.67; P = 0.001). LLLT also reduced the following outcomes when compared to placebo/no therapy: severe mucositis at the time of anticipated maximal mucositis (RR 0.34, 95% CI 0.20 to 0.59), overall mean grade of mucositis (standardized mean difference -1.49, 95% CI -2.02 to -0.95), duration of severe mucositis (weighted mean difference -5.32, 95% CI -9.45 to -1.19) and incidence of severe pain (RR 0.26, 95% CI 0.18 to 0.37). Conclusion: Prophylactic LLLT reduced severe mucositis and pain in patients with cancer and HSCT recipients. Future research should identify the optimal characteristics of LLLT and determine feasibility in the clinical setting.	[Oberoi, Sapna; Zamperlini-Netto, Gabriele; Sung, Lillian] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; [Beyene, Joseph; Sung, Lillian] Hosp Sick Children, Program Child Hlth Evaluat Sci, Peter Gilgan Ctr Res & Learning, Toronto, ON M5G 1X8, Canada; [Beyene, Joseph] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Treister, Nathaniel S.] Brigham & Womens Hosp, Div Oral Med & Dent, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; Harvard University; Brigham & Women's Hospital	Sung, L (corresponding author), Hosp Sick Children, Div Haematol Oncol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	lillian.sung@sickkids.ca		Treister, Nathaniel/0000-0002-5596-7222				Antunes HS, 2013, RADIOTHER ONCOL, V109, P297, DOI 10.1016/j.radonc.2013.08.010; Antunes HS, 2007, BLOOD, V109, P2250, DOI 10.1182/blood-2006-07-035022; Antunes HS, 2013, SUPPORT CARE CANCER, V21, pS199; Arbabi-Kalati Farshid, 2013, Acta Med Iran, V51, P157; Bensadoun RJ, 1999, SUPPORT CARE CANCER, V7, P244, DOI 10.1007/s005200050256; Bensadoun RJ, 2002, J ORAL LASER APPL, P115; Bjordal JM, 2011, SUPPORT CARE CANCER, V19, P1069, DOI 10.1007/s00520-011-1202-0; Blijlevens N, 2008, J CLIN ONCOL, V26, P1519, DOI 10.1200/JCO.2007.13.6028; Bowen JM, 2013, SUPPORT CARE CANCER, V21, P303, DOI 10.1007/s00520-012-1592-7; Chor A, 2010, EUR J HAEMATOL, V84, P178, DOI 10.1111/j.1600-0609.2009.01336.x; Collins JJ, 2002, J PAIN SYMPTOM MANAG, V23, P10, DOI 10.1016/S0885-3924(01)00375-X; Collins JJ, 2000, J PAIN SYMPTOM MANAG, V19, P363, DOI 10.1016/S0885-3924(00)00127-5; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Cowen D, 1997, INT J RADIAT ONCOL, V38, P697, DOI 10.1016/S0360-3016(97)00076-X; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Cruz LB, 2007, PEDIATR BLOOD CANCER, V48, P435, DOI 10.1002/pbc.20943; de Lima AG, 2012, INT J RADIAT ONCOL, V82, P270, DOI 10.1016/j.ijrobp.2010.10.012; Elting LS, 2003, CANCER, V98, P1531, DOI 10.1002/cncr.11671; Enwemeka CS, 2006, PHOTOMED LASER SURG, V24, P457, DOI 10.1089/pho.2006.24.457; Enwemeka CS, 2001, LASER THER, V13, P95; Epstein JB, 2007, CANCER-AM CANCER SOC, V109, P1914, DOI 10.1002/cncr.22620; Gautam AP, 2013, SUPPORT CARE CANCER, V21, P1421, DOI 10.1007/s00520-012-1684-4; Gautam AP, 2012, RADIOTHER ONCOL, V104, P349, DOI 10.1016/j.radonc.2012.06.011; Gautam AP, 2012, ORAL ONCOL, V48, P893, DOI 10.1016/j.oraloncology.2012.03.008; Henry DH, 2008, SUPPORT CARE CANCER, V16, P791, DOI 10.1007/s00520-007-0380-2; Higginson IJ, 2004, FATIGUE CANC, pxvii; Hode L, 2005, PHOTOMED LASER SURG, V23, P431, DOI 10.1089/pho.2005.23.431; Hodgson BD, 2012, SUPPORT CARE CANCER, V20, P1405, DOI 10.1007/s00520-011-1223-8; Khouri Vivian Youssef, 2009, Braz. Dent. J., V20, P215, DOI 10.1590/S0103-64402009000300008; Lalla RV, 2014, CANCER; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Silva GBL, 2011, PHOTOMED LASER SURG, V29, P27, DOI 10.1089/pho.2009.2699; Lopes Carlos de Oliveira, 2006, Radiol Bras, V39, P131, DOI 10.1590/S0100-39842006000200012; Maiya GA, 2006, INDIAN J MED RES, V124, P399; McCann S, 2009, BONE MARROW TRANSPL, V43, P141, DOI 10.1038/bmt.2008.299; Migliorati C, 2013, SUPPORT CARE CANCER, V21, P333, DOI 10.1007/s00520-012-1605-6; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Organization W.H, 1979, WHO HDB REP RES CANC; Oton-Leite AF, 2013, SPEC CARE DENT, V33, P294, DOI 10.1111/j.1754-4505.2012.00303.x; Oton-Leite AF, 2012, HEAD NECK-J SCI SPEC, V34, P398, DOI 10.1002/hed.21737; Peterman A, 2001, J Natl Cancer Inst Monogr, P45; Pires-Santos GM, 2012, MED ORAL PATOL ORAL, V17, pS252; Schubert MM, 2007, SUPPORT CARE CANCER, V15, P1145, DOI 10.1007/s00520-007-0238-7; SCHUBERT MM, 1992, CANCER, V69, P2469, DOI 10.1002/1097-0142(19920515)69:10<2469::AID-CNCR2820691015>3.0.CO;2-W; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 1999, CANCER-AM CANCER SOC, V85, P2103, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0; Stolik S, 2000, J PHOTOCH PHOTOBIO B, V57, P90, DOI 10.1016/S1011-1344(00)00082-8; Tardieu C, 1996, ORAL ONCOL, V32B, P381, DOI 10.1016/S0964-1955(96)00026-7; Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8; Vera-Llonch M, 2006, CANCER-AM CANCER SOC, V106, P329, DOI 10.1002/cncr.21622; Vera-Llonch M, 2007, SUPPORT CARE CANCER, V15, P491, DOI 10.1007/s00520-006-0176-9; Vogelzang NJ, 1997, SEMIN HEMATOL, V34, P4; WOO SB, 1993, CANCER, V72, P1612, DOI 10.1002/1097-0142(19930901)72:5<1612::AID-CNCR2820720520>3.0.CO;2-Q; Worthington HV, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000978.pub5	55	102	107	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107418	10.1371/journal.pone.0107418	http://dx.doi.org/10.1371/journal.pone.0107418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198431	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700110
J	Salvestrini, C; Lucas, M; Lionetti, P; Torrente, F; James, S; Phillips, AD; Murch, SH				Salvestrini, Camilla; Lucas, Mark; Lionetti, Paolo; Torrente, Franco; James, Sean; Phillips, Alan D.; Murch, Simon H.			Matrix Expansion and Syncytial Aggregation of Syndecan-1(+) Cells Underpin Villous Atrophy in Coeliac Disease	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; SMALL INTESTINAL-MUCOSA; GLIADIN FRAGMENTS; DENDRITIC CELLS; DUODENAL MUCOSA; HUMAN MONOCYTES; JEJUNAL MUCOSA; PLASMA-CELL; PATHOGENESIS; EXPRESSION	Background: We studied the expression of sulphated glycosaminoglycans (GAGs) in coeliac disease (CD) mucosa, as they are critical determinants of tissue volume, which increases in active disease. We also examined mucosal expression of IL-6, which stimulates excess GAG synthesis in disorders such as Grave's ophthalmopathy. Methods: We stained archival jejunal biopsies from 5 children with CD at diagnosis, on gluten-free diet and challenge for sulphated GAGs. We then examined duodenal biopsies from 9 children with CD compared to 9 histological normal controls, staining for sulphated GAGs, heparan sulphate proteoglycans (HSPG), short-chain HSPG (Delta-HSPG) and the proteoglycan syndecan-1 (CD138), which is expressed on epithelium and plasma cells. We confirmed findings with a second monoclonal in another 12 coeliac children. We determined mucosal IL-6 expression by immunohistochemistry and PCR in 9 further cases and controls, and used quantitative real time PCR for other Th17 pathway cytokines in an additional 10 cases and controls. Results: In CD, HSPG expression was lost in the epithelial compartment but contrastingly maintained within an expanded lamina propria. Within the upper lamina propria, clusters of syndecan-1+ plasma cells formed extensive syncytial sheets, comprising adherent plasma cells, lysed cells with punctate cytoplasmic staining and shed syndecan ectodomains. A dense infiltrate of IL-6(+) mononuclear cells was detected in active coeliac disease, also localised to the upper lamina propria, with significantly increased mRNA expression of IL-6 and IL-17A but not IL-23 p19. Conclusions: Matrix expansion, through syndecan-1+ cell recruitment and lamina propria GAG increase, underpins villous atrophy in coeliac disease. The syndecan-1+ cell syncytia and excess GAG production recapitulate elements of the invertebrate encapsulation reaction, itself dependent on insect transglutaminase and glutaminated early response proteins. As in other matrix expansion disorders, IL-6 is upregulated and represents a logical target for immunotherapy in patients with coeliac disease refractory to gluten-free diet.	[Salvestrini, Camilla; Torrente, Franco] Addenbrookes Hosp, Dept Paediat Gastroenterol, Cambridge, England; [Lucas, Mark; Phillips, Alan D.] UCL, Ctr Paediat Gastroenterol, London WC1E 6BT, England; [Lionetti, Paolo] Univ Florence, Meyer Hosp, Dept Paediat, Florence, Italy; [James, Sean] Univ Hosp Coventry & Warwickshire, Dept Pathol, Coventry, W Midlands, England; [Murch, Simon H.] Warwick Med Sch, Div Metab & Vasc Hlth, Coventry, W Midlands, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Warwick; University of Warwick	Murch, SH (corresponding author), Warwick Med Sch, Div Metab & Vasc Hlth, Coventry, W Midlands, England.	s.murch@warwick.ac.uk	Lionetti, Paolo/AAC-2626-2019	Lionetti, Paolo/0000-0001-8029-3904	NIH grant [DK058957]; Eulie Peto Research Legacy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058957] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eulie Peto Research Legacy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ML was supported by NIH grant DK058957 to Prof JB Kaper, Center for Vaccine Development, University of Maryland, USA. The work was supported in part by an unrestricted grant from the Eulie Peto Research Legacy to SHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Amadi B, 2009, AM J CLIN NUTR, V89, P592, DOI 10.3945/ajcn.2008.27092; Antunes SLG, 1999, INT J LEPROSY, V67, P24; BAHN RS, 1993, NEW ENGL J MED, V329, P1468; Bernardo D, 2007, GUT, V56, P889, DOI 10.1136/gut.2006.118265; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bode L, 2006, J BIOL CHEM, V281, P7809, DOI 10.1074/jbc.M510722200; Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; Caruso R, 2014, CLIN SCI, V126, P451, DOI 10.1042/CS20130478; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; CHEN CC, 1987, INT J PARASITOL, V17, P789, DOI 10.1016/0020-7519(87)90060-9; Chladkova B, 2011, J CELL MOL MED, V15, P938, DOI 10.1111/j.1582-4934.2010.01066.x; Cho MY, 1999, EUR J BIOCHEM, V262, P737, DOI 10.1046/j.1432-1327.1999.00416.x; Colombo G, 2002, NEUROIMMUNOMODULAT, V10, P208, DOI 10.1159/000068323; COMPER WD, 1978, PHYSIOL REV, V58, P255, DOI 10.1152/physrev.1978.58.1.255; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CROMPTON DW, 1964, PARASITOLOGY, V54, P721, DOI 10.1017/S0031182000082731; DHESI I, 1984, VIRCHOWS ARCH A, V403, P173, DOI 10.1007/BF00695233; DUNCAN MR, 1991, J INVEST DERMATOL, V97, P686, DOI 10.1111/1523-1747.ep12483971; Every D, 2005, J CEREAL SCI, V42, P185, DOI 10.1016/j.jcs.2005.04.003; Fernandez S, 2011, AM J GASTROENTEROL, V106, P528, DOI 10.1038/ajg.2010.465; Greco L, 1997, J PEDIATR GASTR NUTR, V24, pS14; GRESSNER AM, 1994, EUR J CLIN CHEM CLIN, V32, P225; Grimaldi A, 2012, CELL TISSUE RES, V350, P491, DOI 10.1007/s00441-012-1503-8; Harris KM, 2010, CLIN IMMUNOL, V135, P430, DOI 10.1016/j.clim.2010.01.003; Hayashida K, 2008, J BIOL CHEM, V283, P35435, DOI 10.1074/jbc.M804172200; Hosseininaveh V, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.7001; Huang J, 1999, AM J RESP CRIT CARE, V160, P725, DOI 10.1164/ajrccm.160.2.9809040; Jelinkova L, 2004, FEBS LETT, V571, P81, DOI 10.1016/j.febslet.2004.06.057; Kemppainen T, 2005, HISTOPATHOLOGY, V46, P64, DOI 10.1111/j.1365-2559.2005.02001.x; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Konarev AV, 2011, J AGR FOOD CHEM, V59, P2462, DOI 10.1021/jf103867g; LAVO B, 1990, GUT, V31, P153, DOI 10.1136/gut.31.2.153; LOEHRY CA, 1969, GUT, V10, P6, DOI 10.1136/gut.10.1.6; Londei M, 2005, MOL IMMUNOL, V42, P913, DOI 10.1016/j.molimm.2004.12.005; Morton RS, 1999, J PERIODONTOL, V70, P1464, DOI 10.1902/jop.1999.70.12.1464; MURCH SH, 1993, LANCET, V341, P711, DOI 10.1016/0140-6736(93)90485-Y; Nanayakkara M, 2013, AM J CLIN NUTR, V98, P1123, DOI 10.3945/ajcn.112.054544; Narita R, 2004, FEBS LETT, V576, P127, DOI 10.1016/j.febslet.2004.08.073; Palova-Jelinkova L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062426; PARRINELLO N, 1984, BIOL BULL, V167, P238, DOI 10.2307/1541351; Qiao SW, 2012, SEMIN IMMUNOPATHOL, V34, P523, DOI 10.1007/s00281-012-0314-z; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rakhimova M, 2009, J CLIN IMMUNOL, V29, P29, DOI 10.1007/s10875-008-9228-x; Reijmers RM, 2013, FEBS J, V280, P2180, DOI 10.1111/febs.12180; SALT G, 1963, PARASITOLOGY, V53, P527, DOI 10.1017/S0031182000073960; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; SHINER M, 1973, GUT, V14, P1, DOI 10.1136/gut.14.1.1; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Tack GJ, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-159; Tuckova L, 2002, J LEUKOCYTE BIOL, V71, P625; VINSON SB, 1990, ARCH INSECT BIOCHEM, V13, P3, DOI 10.1002/arch.940130103; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711	57	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106005	10.1371/journal.pone.0106005	http://dx.doi.org/10.1371/journal.pone.0106005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198673	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700022
J	Turabelidze, A; Guo, SJ; Chung, AY; Chen, L; Dai, Y; Marucha, PT; DiPietro, LA				Turabelidze, Anna; Guo, Shujuan; Chung, Allison Yen; Chen, Lin; Dai, Yang; Marucha, Phillip T.; DiPietro, Luisa A.			Intrinsic Differences between Oral and Skin Keratinocytes	PLOS ONE			English	Article							KINASE-B-GAMMA; EXTRACELLULAR-MATRIX; MUCOSAL; EXPRESSION; FETAL; STIMULATION; REQUIREMENT; HIF-1-ALPHA; MIGRATION; BETA	Keratinocytes cover both the skin and some oral mucosa, but the morphology of each tissue and the behavior of the keratinocytes from these two sites are different. One significant dissimilarity between the two sites is the response to injury. Oral mucosal wounds heal faster and with less inflammation than equivalent cutaneous wounds. We hypothesized that oral and skin keratinocytes might have intrinsic differences at baseline as well as in the response to injury, and that such differences would be reflected in gene expression profiles.	[Dai, Yang] Univ Illinois, Coll Engn, Richard & Loan Hill Dept Bioengn, Chicago, IL USA; [Turabelidze, Anna; Guo, Shujuan; Chung, Allison Yen; Chen, Lin; DiPietro, Luisa A.] Univ Illinois, Coll Dent, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60607 USA; [Marucha, Phillip T.] Oregon Hlth & Sci Univ, Sch Dent, Portland, OR 97201 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Oregon Health & Science University	DiPietro, LA (corresponding author), Univ Illinois, Coll Dent, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60607 USA.	Ldipiet@uic.edu			 [RO1-GM50875];  [P20-GM078426];  [F30 (F30 DE019054-05)]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE019054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM078426, R01GM050875] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was supported by Grants RO1-GM50875 (LAD), P20-GM078426 (LAD) and F30 (F30 DE019054-05) (AT). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIGMS, NIDCR, or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov N, 2004, THROMB HAEMOSTASIS, V92, P288, DOI 10.1160/TH03-07-0446; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Asikainen TM, 2005, FREE RADICAL BIO MED, V38, P1002, DOI 10.1016/j.freeradbiomed.2004.12.004; BUSSI M, 1995, ACTA OTO-LARYNGOL, V115, P348, DOI 10.3109/00016489509139327; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen L, 2012, J DENT RES, V91, P871, DOI 10.1177/0022034512454435; Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471; Colwell AS, 2007, PLAST RECONSTR SURG, V119, P1440, DOI 10.1097/01.prs.0000256049.53562.39; Deng MX, 2006, MOL BIOL CELL, V17, P3446, DOI 10.1091/mbc.E06-02-0102; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Grohmann M, 2005, EXP CELL RES, V308, P469, DOI 10.1016/j.yexcr.2005.05.003; HATA K, 1995, ANN PLAS SURG, V34, P530, DOI 10.1097/00000637-199505000-00013; Kagimoto Y, 2008, J LEUKOCYTE BIOL, V83, P165, DOI 10.1189/jlb.0307137; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Li J, 1996, J ORAL PATHOL MED, V25, P112, DOI 10.1111/j.1600-0714.1996.tb00204.x; Li J, 1996, J INVEST DERMATOL, V106, P661, DOI 10.1111/1523-1747.ep12345482; Li J, 1996, J ORAL PATHOL MED, V25, P157, DOI 10.1111/j.1600-0714.1996.tb00213.x; Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x; Madlener M, 1998, ARCH DERMATOL RES, V290, pS24, DOI 10.1007/PL00007450; Mak K, 2009, J DERMATOL SCI, V56, P168, DOI 10.1016/j.jdermsci.2009.09.005; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; O'Shaughnessy KD, 2009, WOUND REPAIR REGEN, V17, P700, DOI 10.1111/j.1524-475X.2009.00534.x; Paez Juan, 2003, Cancer Treat Res, V115, P145; REILLY JS, 1980, OTOLARYNG HEAD NECK, V88, P139, DOI 10.1177/019459988008800207; SALO T, 1994, LAB INVEST, V70, P176; Sandulache VC, 2005, CELL TRANSPLANT, V14, P331, DOI 10.3727/000000005783983025; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Schrementi ME, 2008, WOUND REPAIR REGEN, V16, P80, DOI 10.1111/j.1524-475X.2007.00320.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Stephens P, 2001, BRIT J DERMATOL, V144, P229, DOI 10.1046/j.1365-2133.2001.04006.x; Szpaderska AM, 2005, J DENT RES, V84, P309, DOI 10.1177/154405910508400403; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Taniyama Yoshiaki, 2005, J Mol Cell Cardiol, V38, P375, DOI 10.1016/j.yjmcc.2004.12.002; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Walsh LJ, 1996, AUST DENT J, V41, P75, DOI 10.1111/j.1834-7819.1996.tb05916.x; Wang XQ, 2010, EXP DERMATOL, V19, pE289, DOI 10.1111/j.1600-0625.2009.00978.x; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; Wright GL, 2008, FASEB J, V22, P3264, DOI 10.1096/fj.08-106468	39	76	78	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e101480	10.1371/journal.pone.0101480	http://dx.doi.org/10.1371/journal.pone.0101480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198578	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700002
J	Lysy, Z; Lovblom, LE; Halpern, EM; Ngo, M; Ng, E; Orszag, A; Breiner, A; Bril, V; Perkins, BA				Lysy, Zoe; Lovblom, Leif E.; Halpern, Elise M.; Ngo, Mylan; Ng, Eduardo; Orszag, Andrej; Breiner, Ari; Bril, Vera; Perkins, Bruce A.			Measurement of Cooling Detection Thresholds for Identification of Diabetic Sensorimotor Polyneuropathy in Type 1 Diabetes	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; DISTAL SYMMETRIC POLYNEUROPATHY; CORNEAL CONFOCAL MICROSCOPY; PERIPHERAL NEUROPATHY; ELECTRODIAGNOSTIC-MEDICINE; AMERICAN-ASSOCIATION; PHYSICAL-MEDICINE; EPIDEMIOLOGY; TESTS; INTERVENTIONS	Objective: Compared to recently-studied novel morphological measures, conventional small nerve fiber functional tests have not been systematically studied for identification of diabetic sensorimotor polyneuropathy (DSP). We aimed to determine and compare the diagnostic performance of cooling detection thresholds (CDT) in a cross-sectional type 1 diabetes cohort. Research Design and Methods: 136 subjects with type 1 diabetes and 52 healthy volunteers underwent clinical and electrophysiological examination for DSP classification concomitantly with the Toronto Clinical Neuropathy Score (TCNS) and three small fiber function tests: CDT, heart rate variability (HRV), and laser doppler imaging of axon-mediated neurogenic flare responses to cutaneous heating (LDIFLARE). Area under the curve (AUC) and optimal thresholds were determined by receiver operating characteristic (ROC) curves in the type 1 diabetes cohort. Results: Type 1 diabetes subjects were 42 +/- 17 years of age with mean HbA1c 7.9 +/- 1.7%. Fifty-nine (45%) met the case definition for DSP. CDT values were lowest in cases with DSP (18.3 +/- 8.4 degrees C) compared to controls without DSP (28.4 +/- 3.5 degrees C) and to healthy volunteers (29.6 +/- 1.8 degrees C; p-value for both comparisons<0.0001). AUC(CDT) was 0.863 which was similar to AUC(TCNS) (0.858, p = 0.24) and AUC(HRV) (0.788, p = 0.05), but exceeded AUC(LDIFLARE) (0.750, p = 0.001). The threshold of <25.1 degrees C was equivalent to the lower bound of the healthy volunteer 95% distribution [25.1, 30.8 degrees C] and performed with 83% sensitivity and 82% specificity. Conclusions: Akin to novel small fiber morphological measures, CDT is a functional test that identifies DSP with very good diagnostic performance. These findings support further research that revisits the role of CDT in early DSP detection.	[Lysy, Zoe; Lovblom, Leif E.; Orszag, Andrej; Perkins, Bruce A.] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada; [Ngo, Mylan; Ng, Eduardo; Breiner, Ari; Bril, Vera] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada	University of Toronto; University of Toronto	Perkins, BA (corresponding author), Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada.	bperkins@mtsinai.on.ca	BRIL, vera/ABA-6509-2020; Perkins, Bruce A/L-3726-2017	Lovblom, Leif Erik/0000-0002-6774-8924; Orszag, Andrej/0000-0002-0027-1607	JDRF [17-2008-715]	JDRF(Juvenile Diabetes Research Foundation)	Funding was provided by JDRF (Grant Number 17-2008-715, website http://jdrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2012, DIABETES CARE, V35, P821, DOI 10.2337/dc11-1396; Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Breiner A, 2014, DIABETES CARE, V37, P1418, DOI 10.2337/dc13-2005; Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048; Bril V, 2013, CAN J DIABETES, V37, pS142, DOI 10.1016/j.jcjd.2013.01.039; Dyck PJ, 2010, MUSCLE NERVE, V42, P157, DOI 10.1002/mus.21661; DYCK PJ, 1992, NEUROLOGY, V42, P1164, DOI 10.1212/WNL.42.6.1164; DYCK PJ, 1987, DIABETES CARE, V10, P432, DOI 10.2337/diacare.10.4.432; Ekoe JM, 2013, CAN J DIABETES, V37, pS12, DOI 10.1016/j.jcjd.2013.01.012; England JD, 2009, NEUROLOGY, V72, P185, DOI 10.1212/01.wnl.0000336370.51010.a1; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; Green AQ, 2010, DIABETES CARE, V33, P174, DOI 10.2337/dc09-0101; Haas L, 2013, DIABETES CARE, V36, pS100, DOI [10.2337/dc13-S100, 10.2337/dc13-S004]; Halpern EM, 2013, J DIABETES COMPLICAT, V27, P240, DOI 10.1016/j.jdiacomp.2012.10.011; Harris SB., 2006, CAN J DIABETES, V30, P1, DOI DOI 10.1016/S1499-2671(06)02005-3; Janes H, 2008, AM J EPIDEMIOL, V168, P89, DOI 10.1093/aje/kwn099; Krishnan STM, 2002, BRIT MED J, V325, P946, DOI 10.1136/bmj.325.7370.946; Malik RA, 2011, DIABETES-METAB RES, V27, P678, DOI 10.1002/dmrr.1222; Martin CL, 2014, DIABETES CARE, V37, P31, DOI 10.2337/dc13-2114; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; MOST RS, 1983, DIABETES CARE, V6, P87, DOI 10.2337/diacare.6.1.87; Orlov S, 2012, DIABETES CARE, V35, P809, DOI 10.2337/dc11-1652; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Perkins BA, 2010, DIABETES CARE, V33, P1549, DOI 10.2337/dc09-1835; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Singleton JR, 2001, DIABETES CARE, V24, P1448, DOI 10.2337/diacare.24.8.1448; Smith AG, 2008, NEUROLOGIST, V14, P23, DOI 10.1097/NRL.0b013e31815a3956; Smith AG, 2001, NEUROLOGY, V57, P1701, DOI 10.1212/WNL.57.9.1701; STALBERG EV, 1989, MUSCLE NERVE, V12, P993, DOI 10.1002/mus.880121207; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tavakoli M, 2010, DIABETES CARE, V33, P1792, DOI 10.2337/dc10-0253; Tesfaye S, 2005, NEW ENGL J MED, V352, P341, DOI 10.1056/NEJMoa032782; Tesfaye S, 2013, DIABETES CARE, V36, P2456, DOI 10.2337/dc12-1964; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Umapathi T, 2007, MUSCLE NERVE, V35, P591, DOI 10.1002/mus.20732; Zinman LH, 2004, DIABETES CARE, V27, P1674, DOI 10.2337/diacare.27.7.1674	41	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106995	10.1371/journal.pone.0106995	http://dx.doi.org/10.1371/journal.pone.0106995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216179	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300035
J	Tote, E; Lamperti, M; Bondani, M; Salerno, D; Cassina, V; Nardo, L				Tote, Edoardo; Lamperti, Marco; Bondani, Maria; Salerno, Domenico; Cassina, Valeria; Nardo, Luca			Full Genotyping of a Highly Polymorphic Human Gene Trait by Time-Resolved Fluorescence Resonance Energy Transfer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DISEASE SUSCEPTIBILITY; DIABETES-MELLITUS; HLA-DQB1 GENE; RESISTANCE; ALLELES; HOMOZYGOSITY	The ability of detecting the subtle variations occurring, among different individuals, within specific DNA sequences encompassed in highly polymorphic genes discloses new applications in genomics and diagnostics. DQB1 is a gene of the HLA-II DQ locus of the Human Leukocyte Antigens (HLA) system. The polymorphisms of the trait of the DQB1 gene including codons 52-57 modulate the susceptibility to a number of severe pathologies. Moreover, the donor-receiver tissue compatibility in bone marrow transplantations is routinely assessed through crossed genotyping of DQB and DQA. For the above reasons, the development of rapid, reliable and cost-effective typing technologies of DQB1 in general, and more specifically of the codons 52-57, is a relevant although challenging task. Quantitative assessment of the fluorescence resonance energy transfer (FRET) efficiency between chromophores labelling the opposite ends of gene-specific oligonucleotide probes has proven to be a powerful tool to type DNA polymorphisms with single-nucleotide resolution. The FRET efficiency can be most conveniently quantified by applying a time-resolved fluorescence analysis methodology, i.e. time-correlated single-photon counting, which allows working on very diluted template specimens and in the presence of fluorescent contaminants. Here we present a full in-vitro characterization of the fluorescence responses of two probes when hybridized to oligonucleotide mixtures mimicking all the possible genotypes of the codons 52-57 trait of DQB1 (8 homozygous and 28 heterozygous). We show that each genotype can be effectively tagged by the combination of the fluorescence decay constants extrapolated from the data obtained with such probes.	[Tote, Edoardo; Lamperti, Marco] Univ Insubria, Dept Sci & High Technol, Como, Italy; [Bondani, Maria] CNR, Inst Photon & Nanotechnol, Como, Italy; [Salerno, Domenico; Cassina, Valeria; Nardo, Luca] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy	University of Insubria; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); University of Milano-Bicocca	Nardo, L (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy.	luca.nardo@unimib.it	Lamperti, Marco/ABG-7501-2021; Salerno, Domenico/D-7565-2014; Bondani, Maria/E-7063-2011; Lamperti, Marco/E-1076-2013	Lamperti, Marco/0000-0001-5972-8723; Salerno, Domenico/0000-0001-8160-8349; Lamperti, Marco/0000-0001-5972-8723; Nardo, Luca/0000-0002-8013-2905; cassina, valeria/0000-0002-0254-8243				Al Attar HA, 2008, BIOSENS BIOELECTRON, V23, P1466, DOI 10.1016/j.bios.2008.01.005; Andreoni A, 2009, PHOTOCH PHOTOBIO SCI, V8, P1202, DOI 10.1039/b906043j; Andreoni A, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2278216; Andreoni A, 2009, MOL CELL PROBE, V23, P119, DOI 10.1016/j.mcp.2008.12.008; Arranz E, 1997, EXP CLIN IMMUNOGENET, V14, P286; Congia M, 1996, HEPATOLOGY, V24, P1338, DOI 10.1002/hep.510240603; ERLICH HA, 1991, DIABETES, V40, P478, DOI 10.2337/diabetes.40.4.478; GAVRILOV DK, 1994, ACTA DIABETOL, V31, P82, DOI 10.1007/BF00570540; Gaylord BS, 2005, P NATL ACAD SCI USA, V102, P34, DOI 10.1073/pnas.0407578101; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Iannuzzi MC, 2003, AM J RESP CRIT CARE, V167, P1225, DOI 10.1164/rccm.200209-1097OC; Kaushansky N, 2009, J IMMUNOL, V183, P3531, DOI 10.4049/jimmunol.0900784; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; MANTOVANI V, 1993, CLIN EXP IMMUNOL, V91, P153; Medrano LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048403; Marsh S, 2002, HUM MUTAT, V20, P174, DOI 10.1002/humu.10115; Megiorni F, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-88; Nardo L, 2013, J MOL BIOL RES, V3, P15, DOI 10.5539/jmbr.v3n1p15; Nardo L, 2012, DNA RES, V19, P347, DOI 10.1093/dnares/dss017; OLERUP O, 1992, P NATL ACAD SCI USA, V89, P10653, DOI 10.1073/pnas.89.22.10653; Pelin Z, 1998, TISSUE ANTIGENS, V51, P96, DOI 10.1111/j.1399-0039.1998.tb02952.x; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SANTAMARIA P, 1994, J CLIN ENDOCR METAB, V78, P878, DOI 10.1210/jc.78.4.878; Schork NJ, 2000, CLIN GENET, V58, P250, DOI 10.1034/j.1399-0004.2000.580402.x; Tyagi S, 1998, NAT BIOTECHNOL, V16, P49, DOI 10.1038/nbt0198-49; UNDERHILL J, 1992, HEPATOLOGY, V16, P1404, DOI 10.1002/hep.1840160616; Vazquez-Garcia MN, 1998, J HEPATOL, V28, P985, DOI 10.1016/S0168-8278(98)80347-4	28	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107310	10.1371/journal.pone.0107310	http://dx.doi.org/10.1371/journal.pone.0107310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215592	gold, Green Published, Green Submitted			2022-12-27	WOS:000341774300056
J	Tun, AW; Chaiyarit, S; Kaewsutthi, S; Katanyoo, W; Chuenkongkaew, W; Kuwano, M; Tomonaga, T; Peerapittayamongkol, C; Thongboonkerd, V; Lertrit, P				Tun, Aung Win; Chaiyarit, Sakdithep; Kaewsutthi, Supannee; Katanyoo, Wanphen; Chuenkongkaew, Wanicha; Kuwano, Masayoshi; Tomonaga, Takeshi; Peerapittayamongkol, Chayanon; Thongboonkerd, Visith; Lertrit, Patcharee			Profiling the Mitochondrial Proteome of Leber's Hereditary Optic Neuropathy (LHON) in Thailand: Down-Regulation of Bioenergetics and Mitochondrial Protein Quality Control Pathways in Fibroblasts with the 11778G > A Mutation	PLOS ONE			English	Article							CYTOCHROME-C; RAT-HEART; GENE; CELL; EXPRESSION; IDENTIFICATION; CATALASE; MODIFIER; PENETRANCE; CHAPERONES	Leber's Hereditary Optic Neuropathy (LHON) is one of the commonest mitochondrial diseases. It causes total blindness, and predominantly affects young males. For the disease to develop, it is necessary for an individual to carry one of the primary mtDNA mutations 11778G>A, 14484T>C or 3460G>A. However these mutations are not sufficient to cause disease, and they do not explain the characteristic features of LHON such as the higher prevalence in males, incomplete penetrance, and relatively later age of onset. In order to explore the roles of nuclear encoded mitochondrial proteins in development of LHON, we applied a proteomic approach to samples from affected and unaffected individuals from 3 pedigrees and from 5 unrelated controls. Two-dimensional electrophoresis followed by MS/MS analysis in the mitochondrial lysate identified 17 proteins which were differentially expressed between LHON cases and unrelated controls, and 24 proteins which were differentially expressed between unaffected relatives and unrelated controls. The proteomic data were successfully validated by western blot analysis of 3 selected proteins. All of the proteins identified in the study were mitochondrial proteins and most of them were down regulated in 11778G>A mutant fibroblasts. These proteins included: subunits of OXPHOS enzyme complexes, proteins involved in intermediary metabolic processes, nucleoid related proteins, chaperones, cristae remodelling proteins and an anti-oxidant enzyme. The protein profiles of both the affected and unaffected 11778G>A carriers shared many features which differed from those of unrelated control group, revealing similar proteomic responses to 11778G>A mutation in both affected and unaffected individuals. Differentially expressed proteins revealed two broad groups: a cluster of bioenergetic pathway proteins and a cluster involved in protein quality control system. Defects in these systems are likely to impede the function of retinal ganglion cells, and may lead to the development of LHON in synergy with the primary mtDNA mutation.	[Tun, Aung Win; Kaewsutthi, Supannee; Katanyoo, Wanphen; Peerapittayamongkol, Chayanon; Lertrit, Patcharee] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand; [Chaiyarit, Sakdithep; Thongboonkerd, Visith] Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev,Med Prote Unit, Bangkok 10700, Thailand; [Chuenkongkaew, Wanicha] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Ophthalmol, Bangkok 10700, Thailand; [Kuwano, Masayoshi; Tomonaga, Takeshi] Natl Inst Biomed Innovat, Lab Proteome Res, Osaka, Japan; [Thongboonkerd, Visith] Mahidol Univ, Ctr Res Complex Syst Sci, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; National Institute of Health Sciences - Japan; Mahidol University	Thongboonkerd, V (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev,Med Prote Unit, Bangkok 10700, Thailand.	thongboonkerd@dr.com; patcharee.ler@mahidol.ac.th	Chaiyarit, Sakdithep/GYQ-7334-2022; Thongboonkerd, Visith/C-6920-2009; Peerapittayamongkol, Chayanon/K-7965-2019; Chaiyarit, Sakdithep/AAV-7834-2021	Thongboonkerd, Visith/0000-0001-7865-0765; Tun, Aung Win/0000-0002-4810-9094; chuenkongkaew, wanicha/0000-0002-2219-6601	Thailand Research Fund [BRG518006, RTA5680004]; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Siriraj Graduate Thesis Scholarship	Thailand Research Fund(Thailand Research Fund (TRF)); Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Siriraj Graduate Thesis Scholarship	This study was supported by The Thailand Research Fund (http://www.trf.or.th) (BRG518006 to PL and RTA5680004 to VT), Office of the Higher Education Commission (http://www.inter.mua.go.th/main2/index.php) and Mahidol University (http://www.mahidol.ac.th) under the National Research Universities Initiative, and Siriraj Graduate Thesis Scholarship to AWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2010, BRIT J OPHTHALMOL, V94, P256, DOI 10.1136/bjo.2009.165571; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ali YO, 2010, MOLECULES, V15, P6859, DOI 10.3390/molecules15106859; Angebault Claire, 2011, BMC Res Notes, V4, P557, DOI 10.1186/1756-0500-4-557; Bai JX, 2001, BIOL SIGNAL RECEPT, V10, P189; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258; Bini L, 1997, ELECTROPHORESIS, V18, P2832, DOI 10.1002/elps.1150181519; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Bunai K, 2005, J CHROMATOGR B, V815, P227, DOI 10.1016/j.jchromb.2004.08.030; Burte F, 2011, J PROTEOME RES, V10, P1974, DOI 10.1021/pr101211k; Caldas J, 2012, BIOINFORMATICS, V28, P246, DOI 10.1093/bioinformatics/btr634; Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009; Carelli V, 2007, BIOSCIENCE REP, V27, P173, DOI 10.1007/s10540-007-9045-0; Chaiyarit S, 2009, ANAL BIOCHEM, V394, P249, DOI 10.1016/j.ab.2009.07.026; Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385; Chuenkongkaew Wanicha, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P167; Chuenkongkaew WL, 2001, JPN J OPHTHALMOL, V45, P665, DOI 10.1016/S0021-5155(01)00423-3; Cortopassi G, 2006, MITOCHONDRION, V6, P161, DOI 10.1016/j.mito.2006.05.002; Danielson SR, 2005, BRAIN, V128, P1026, DOI 10.1093/brain/awh447; Ferreira R, 2013, TALANTA, V115, P277, DOI 10.1016/j.talanta.2013.04.026; GERARD B, 1993, EUR J PEDIATR, V152, P270; Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; Hansen J, 2007, J NEUROL, V254, P897, DOI 10.1007/s00415-006-0470-y; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; HARDING AE, 1995, AM J HUM GENET, V57, P77; HARDING AE, 1995, MUSCLE NERVE, pS82; Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176; Hudson G, 2009, MOL VIS, V15, P870; Istikharah R, 2013, EXP EYE RES, V116, P55, DOI 10.1016/j.exer.2013.08.007; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane L, 2012, NUCLEIC ACIDS RES, V40, pD76, DOI 10.1093/nar/gkr1179; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; Magen D, 2008, AM J HUM GENET, V83, P30, DOI 10.1016/j.ajhg.2008.05.016; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Pejznochova M, 2008, PHYSIOL RES, V57, P947, DOI 10.33549/physiolres.931246; Petruzzella V, 2007, BIOCHEM BIOPH RES CO, V355, P181, DOI 10.1016/j.bbrc.2007.01.140; Phasukkijwatana N, 2010, HUM GENET, V128, P39, DOI 10.1007/s00439-010-0821-8; Phasukkijwatana N, 2006, J HUM GENET, V51, P1110, DOI 10.1007/s10038-006-0073-6; Qian YP, 2011, MITOCHONDRION, V11, P871, DOI 10.1016/j.mito.2011.06.006; Rabilloud T, 2002, BIOCHEMISTRY-US, V41, P144, DOI 10.1021/bi0114776; RADI R, 1991, J BIOL CHEM, V266, P22028; RADI R, 1993, FREE RADICAL BIO MED, V15, P653, DOI 10.1016/0891-5849(93)90169-U; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607; SINGER KH, 1989, J INVEST DERMATOL, V92, P166, DOI 10.1111/1523-1747.ep12276685; Smith AC, 2012, NUCLEIC ACIDS RES, V40, pD1160, DOI 10.1093/nar/gkr1101; Storey ADaJD, 2014, Q VALUE ESTIMATION F; Strimmer BKaK, 2012, ESTIMATION LOCAL FAL; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Van Laar VS, 2008, NEUROBIOL DIS, V29, P477, DOI 10.1016/j.nbd.2007.11.007; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002	62	14	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106779	10.1371/journal.pone.0106779	http://dx.doi.org/10.1371/journal.pone.0106779			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215595	gold, Green Published, Green Submitted			2022-12-27	WOS:000341774300024
J	He, GP; Ye, S; Hui, JJ; Shen, DD; Qi, CP; Xu, LH; Qian, YC				He, Guoping; Ye, Shan; Hui, Jingjiao; Shen, Dandan; Qi, Chuanping; Xu, Lianhong; Qian, Yichao			Interrelationships between ALOX5AP Polymorphisms, Serum Leukotriene B4 Level and Risk of Acute Coronary Syndrome	PLOS ONE			English	Article							ENCODING 5-LIPOXYGENASE-ACTIVATING PROTEIN; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS SUSCEPTIBILITY; ISCHEMIC-STROKE; CONFERS RISK; GENE; ASSOCIATION; VARIANTS; POPULATION; DISEASE	Background: We investigated the relationships between the ALOX5AP gene rs10507391 and rs4769874 polymorphisms, serum levels of leukotriene (LT) B4, and risk of acute coronary syndrome (ACS). Methods: A total of 709 participants, comprising 508 ACS patients (ACS group) and 201 noncoronary artery disease patients with chest pain (control group) were recruited from the Han population of the Changwu region in China. Two polymorphic loci were genotyped using polymerase chain reaction and restriction fragment length polymorphism analysis. Serum LTB4 level was determined by enzyme-linked immunosorbent assay. Results: Serum LTB4 levels were significantly higher (P<0.001) in the ACS group (median/interquartile range, 470.27/316.32 pg/ml) than in the control group (233.05/226.82 pg/ml). No statistical differences were observed between genotype, allele and haplotype frequencies for the tested loci in either the ACS group or the control group, even after adjustments were made for conventional risk factors by multivariate logistic regression. This suggests there is no association between the ALOX5AP rs10507391 and rs4769874 polymorphisms and ACS risk. Elevated serum LTB4 level was closely linked to ACS risk, and may be independent of traditional risk factors as a risk factor for ACS (P<0.001). There was no significant association between serum LTB4 levels and the two variants in either the ACS group or the control group. Conclusions: Rs10507391, rs4769874 and its haplotypes in ALOX5AP are unrelated to ACS risk in the Chinese Han population of Changwu, but elevated serum LTB4 level is strongly associated with ACS risk. Serum LTB4 level is not subject to the influence of either the rs10507391, rs4769874 or the haplotype.	[He, Guoping; Ye, Shan; Hui, Jingjiao; Shen, Dandan; Qian, Yichao] Jiangsu Univ, Affiliated Wujin Hosp, Dept Cardiol, Changzhou, Jiangsu, Peoples R China; [Qi, Chuanping; Xu, Lianhong] Jiangsu Univ, Affiliated Wujin Hosp, Cent Lab, Changzhou, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	He, GP (corresponding author), Jiangsu Univ, Affiliated Wujin Hosp, Dept Cardiol, Changzhou, Jiangsu, Peoples R China.	guopinghe6@sina.com			Changzhou Wujin technology division	Changzhou Wujin technology division	This study was supported by Changzhou Wujin technology division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevan S, 2008, STROKE, V39, P1109, DOI 10.1161/STROKEAHA.107.491969; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Chen Michael S, 2003, Cardiol Rev, V11, P113, DOI 10.1097/01.CRD.0000064422.16013.ED; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Helgadottir A, 2005, AM J HUM GENET, V76, P505, DOI 10.1086/428066; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Huang H, 2010, ARCH MED RES, V41, P634, DOI 10.1016/j.arcmed.2010.11.001; Kajimoto K, 2005, CIRC J, V69, P1029, DOI 10.1253/circj.69.1029; Kaushal R, 2007, HUM GENET, V121, P601, DOI 10.1007/s00439-007-0338-y; Kostulas K, 2007, J NEUROL SCI, V263, P113, DOI 10.1016/j.jns.2007.06.042; Lemaitre Rozenn N, 2009, Atherosclerosis, V204, pe58, DOI 10.1016/j.atherosclerosis.2008.10.011; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Maznyczka A, 2008, ATHEROSCLEROSIS, V199, P328, DOI 10.1016/j.atherosclerosis.2007.11.027; Maznyczka A, 2007, CLIN SCI, V112, P411, DOI 10.1042/CS20060271; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Mukae S, 2003, CIRC J, V67, P16, DOI 10.1253/circj.67.16; Nicolete R, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-36; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Zintzaras E, 2009, AM J EPIDEMIOL, V169, P523, DOI 10.1093/aje/kwn368	23	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106596	10.1371/journal.pone.0106596	http://dx.doi.org/10.1371/journal.pone.0106596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210744	Green Submitted, Green Published, gold			2022-12-27	WOS:000341855900018
J	Macias, D; Stips, A; Garcia-Gorriz, E				Macias, Diego; Stips, Adolf; Garcia-Gorriz, Elisa			Application of the Singular Spectrum Analysis Technique to Study the Recent Hiatus on the Global Surface Temperature Record	PLOS ONE			English	Article							OCEAN HEAT UPTAKE; PREDICTION	Global surface temperature has been increasing since the beginning of the 20th century but with a highly variable warming rate, and the alternation of rapid warming periods with 'hiatus' decades is a constant throughout the series. The superimposition of a secular warming trend with natural multidecadal variability is the most accepted explanation for such a pattern. Since the start of the 21st century, the surface global mean temperature has not risen at the same rate as the top-of-atmosphere radiative energy input or greenhouse gas emissions, provoking scientific and social interest in determining the causes of this apparent discrepancy. Multidecadal natural variability is the most commonly proposed cause for the present hiatus period. Here, we analyze the HadCRUT4 surface temperature database with spectral techniques to separate a multidecadal oscillation (MDV) from a secular trend (ST). Both signals combined account for nearly 88% of the total variability of the temperature series showing the main acceleration/deceleration periods already described elsewhere. Three stalling periods with very little warming could be found within the series, from 1878 to 1907, from 1945 to 1969 and from 2001 to the end of the series, all of them coincided with a cooling phase of the MDV. Henceforth, MDV seems to be the main cause of the different hiatus periods shown by the global surface temperature records. However, and contrary to the two previous events, during the current hiatus period, the ST shows a strong fluctuation on the warming rate, with a large acceleration (0.0085 degrees C year(-1) to 0.017 degrees C year(-1)) during 1992-2001 and a sharp deceleration (0.017 degrees C year(-1) to 0.003 degrees C year(-1)) from 2002 onwards. This is the first time in the observational record that the ST shows such variability, so determining the causes and consequences of this change of behavior needs to be addressed by the scientific community.	[Macias, Diego; Stips, Adolf; Garcia-Gorriz, Elisa] European Commiss, Inst Environm & Sustainabil, Water Res Unit, Joint Res Ctr, Ispra, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Macias, D (corresponding author), European Commiss, Inst Environm & Sustainabil, Water Res Unit, Joint Res Ctr, Ispra, Italy.	diego.macias-moy@jrc.ec.europa.eu	Macías, Diego/G-1972-2010	Macías, Diego/0000-0002-7772-255X				Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; FOLLAND CK, 1984, NATURE, V310, P670, DOI 10.1038/310670a0; Fyfe JC, 2013, NAT CLIM CHANGE, V3, P767, DOI 10.1038/nclimate1972; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Guemas V, 2013, NAT CLIM CHANGE, V3, P649, DOI [10.1038/nclimate1863, 10.1038/NCLIMATE1863]; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Hunt BG, 2011, CLIM DYNAM, V36, P509, DOI 10.1007/s00382-010-0799-x; Kaufmann RK, 2011, P NATL ACAD SCI USA, V108, P11790, DOI 10.1073/pnas.1102467108; Keenlyside NS, 2008, NATURE, V453, P84, DOI 10.1038/nature06921; Kosaka Y, 2013, NATURE, V12534; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Lyman JM, 2010, NATURE, V465, P334, DOI 10.1038/nature09043; Macias D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081591; Meehl GA, 2013, J CLIMATE, V26, P7298, DOI 10.1175/JCLI-D-12-00548.1; Meehl GA, 2011, NAT CLIM CHANGE, V1, P360, DOI 10.1038/NCLIMATE1229; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; Santer BD, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016263; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Solomon S, 2011, SCIENCE, V333, P866, DOI 10.1126/science.1206027; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Stocker T.F., 2013, CONTRIBUTION WORKING; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; VAUTARD R, 1992, PHYSICA D, V58, P95, DOI 10.1016/0167-2789(92)90103-T; Watanabe M, 2013, GEOPHYS RES LETT, V40, P3175, DOI 10.1002/grl.50541; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Wu ZW, 2011, CLIM DYNAM, V37, P1661, DOI 10.1007/s00382-010-0938-4	27	14	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107222	10.1371/journal.pone.0107222	http://dx.doi.org/10.1371/journal.pone.0107222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208060	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300067
J	Van Epps, P; Matining, RM; Tassiopoulos, K; Anthony, DD; Landay, A; Kalayjian, RC; Canaday, DH				Van Epps, Puja; Matining, Roy M.; Tassiopoulos, Katherine; Anthony, Donald D.; Landay, Alan; Kalayjian, Robert C.; Canaday, David H.			Older Age Is Associated with Peripheral Blood Expansion of Naive B Cells in HIV-Infected Subjects on Antiretroviral Therapy	PLOS ONE			English	Article							HOMEOSTATIC PROLIFERATION; BONE-MARROW; DISEASE; IMMUNOSENESCENCE; CHILDREN; POPULATIONS; DYSFUNCTION; MECHANISMS	Older HIV infected subjects were previously found to have significant B cell expansion during initial antiretroviral therapy in a prospective age-differentiated cohort of older and younger (>= 45 vs. <= 30 years) HIV-infected subjects initiating antiretroviral therapy (ART) through the AIDS Clinical Trials Group. Here to further describe this expansion, using a subset of subjects from the same cohort, we characterized B cell phenotypes at baseline and after 192 weeks of ART in both older and younger HIV-infected groups and compared them to uninfected age-matched controls. We also examined whether phenotypes at baseline associated with response to tetanus and hepatitis A vaccine at 12 weeks. Forty six subjects were analyzed in the HIV infected group (21 older, 25 younger) and 30 in the control group (15 per age group). We observed naive B cells to normalize in younger subjects after 192 weeks of ART, while in older subjects naive B cells increased to greater levels than those of controls (p = 0.045). Absolute resting memory (RM) cell count was significantly lower in the older HIV infected group at baseline compared to controls and numbers normalized after 192 weeks of ART (p<0.001). Baseline RM cell count positively correlated with week 12 increase in antibody to tetanus vaccine among both younger and older HIV-infected subjects combined (p = 0.01), but not in controls. The age-associated naive B cell expansion is a novel finding and we discuss several possible explanations for this observation. Relationship between RM cells at baseline and tetanus responses may lead to insights about the effects of HIV infection on B cell memory function and vaccine responses.	[Van Epps, Puja; Anthony, Donald D.; Canaday, David H.] Case Western Reserve Univ, Louis Stokes Cleveland VA Med Ctr, Dept Infect Dis, Geriatr Res Ctr Clin Core GRECC, Cleveland, OH 44106 USA; [Matining, Roy M.; Tassiopoulos, Katherine] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Landay, Alan] Rush Presbyterian St Lukes Med Ctr, Dept Immunol & Microbiol, Chicago, IL USA; [Kalayjian, Robert C.] Metrohlth Med Ctr, Dept Infect Dis, Cleveland, OH USA; [Kalayjian, Robert C.] Louis Stokes Cleveland VA Med Ctr, Geriatr Res Ctr Clin Core GRECC, Cleveland, OH USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Rush University; MetroHealth System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Van Epps, P (corresponding author), Case Western Reserve Univ, Louis Stokes Cleveland VA Med Ctr, Dept Infect Dis, Geriatr Res Ctr Clin Core GRECC, Cleveland, OH 44106 USA.	puja.vanepps@va.gov			NIH [AI-069501, AI-68634, AI-68636, AI-36219]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069501, U01AI068636, UM1AI068634, P30AI036219, U01AI068634, UM1AI106701, UM1AI068636, UM1AI069501] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH AI-069501, AI-68634, AI-68636, and AI-36219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsina L, 2013, VACCINE, V31, P2417, DOI 10.1016/j.vaccine.2013.03.035; BARBI M, 1992, AIDS, V6, P1465, DOI 10.1097/00002030-199212000-00007; Bhatia R, 2012, J NEUROVIROL, V18, P247, DOI 10.1007/s13365-011-0073-y; Cabatingan MS, 2002, J IMMUNOL, V169, P6795, DOI 10.4049/jimmunol.169.12.6795; Colonna-Romano G, 2008, REJUV RES, V11, P433, DOI 10.1089/rej.2008.0664; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Demberg T, 2012, J VIROL, V86, P12591, DOI 10.1128/JVI.00298-12; Ho J, 2006, P NATL ACAD SCI USA, V103, P19436, DOI 10.1073/pnas.0609515103; Jiang Wei, 2012, Am J Immunol, V8, P44; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Kalayjian RC, 2013, AIDS, V27, P1563, DOI 10.1097/QAD.0b013e32835fabc2; Listi F, 2006, ANN NY ACAD SCI, V1089, P487, DOI 10.1196/annals.1386.013; MAUCH P, 1982, BLOOD, V60, P245; Meyer-Bahlburg A, 2008, J EXP MED, V205, P155, DOI 10.1084/jem.20071088; Moir S, 2008, J ALLERGY CLIN IMMUN, V122, P12, DOI 10.1016/j.jaci.2008.04.034; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Pensieroso S, 2013, AIDS; Quiros-Roldan E, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-94; Ruffin N, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00090; RYDER RW, 1993, J PEDIATR-US, V122, P697, DOI 10.1016/S0022-3476(06)80007-7; Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89; Weksler ME, 2000, J CLIN IMMUNOL, V20, P240, DOI 10.1023/A:1006659401385	24	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107064	10.1371/journal.pone.0107064	http://dx.doi.org/10.1371/journal.pone.0107064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207968	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300058
J	Zhu, HL; Bao, JM; Liu, SG; Chen, Q; Shen, H				Zhu, Haili; Bao, Jiming; Liu, Shuguang; Chen, Qing; Shen, Hong			Null Genotypes of GSTM1 and GSTT1 and Endometriosis Risk: A Meta-Analysis of 25 Case-Control Studies	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; DETOXIFICATION GENE POLYMORPHISMS; ADVANCED-STAGE ENDOMETRIOSIS; POLYCHLORINATED-BIPHENYLS; NORTHERN INDIA; T1 GENES; ASSOCIATION; WOMEN; SUSCEPTIBILITY; M1	Endometriosis is one of the most frequent benign gynecological disorders. Numerous studies have shown an association between GSTM1 and/or GSTT1 polymorphisms and endometriosis susceptibility. However, these associations remain inconclusive. To derive a more precise estimation, we conducted a comprehensive search to identify all existing studies and then performed a meta-analysis. Electronic literature searches of the PubMed, Chinese Biomedical, and China National Knowledge Infrastructure databases were performed up to December 2013. GSTM1-, GSTT1-, and dual-null genotypes were analyzed independently, and pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated by comparing the null genotype with other genotypes using the random-effects or fixed-effects model. Twenty-five and 16 independent studies on GSTM1 and GSTT1 polymorphisms, respectively, and five GSTM1-GSTT1 interaction analyses were identified and included in this meta-analysis. Both GSTM1- and GSTT1-null genotypes increased risk of endometriosis (OR = 1.54, 95% CI: 1.30-1.83, P<0.001; OR = 1.41, 95% CI: 1.10-1.82, P = 0.007; respectively). Moreover, we found a significant positive association between the dual null genotype GSTM1-GSTT1 and endometriosis susceptibility (OR = 1.33, 95% CI: 1.03-1.72, P = 0.027). This meta-analysis provides evidence that null genotypes of GSTM1 and/or GSTT1 contribute to risk of endometriosis. Further investigations are required to confirm these findings.	[Zhu, Haili; Liu, Shuguang; Shen, Hong] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Zhu, Haili; Liu, Shuguang; Shen, Hong] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Bao, Jiming] Southern Med Univ, Nanfang Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Chen, Qing] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Shen, H (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	shenhong2010168@163.com			National Natural Science Foundation of China [81271729]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (No. 81271729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aban M, 2007, J REPROD MED, V52, P715; An XF, 2009, JILIN MED J, V30, P1614; Arvanitis DA, 2003, FERTIL STERIL, V79, P702, DOI 10.1016/S0015-0282(02)04817-3; Babu KA, 2005, PHARMACOGENET GENOM, V15, P167, DOI 10.1097/01213011-200503000-00005; Baranov V. S., 1999, Genetika, V35, P243; Baranov VS, 1996, HUM GENET, V97, P516, DOI 10.1007/BF02267078; Baranova H, 1997, MOL HUM REPROD, V3, P775, DOI 10.1093/molehr/3.9.775; Baranova H, 1999, MOL HUM REPROD, V5, P636, DOI 10.1093/molehr/5.7.636; Baxter SW, 2001, CARCINOGENESIS, V22, P63, DOI 10.1093/carcin/22.1.63; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Cao YH, 2009, MATERN CHILD HLTH J, V24, P805; De Felip E, 2004, TOXICOL LETT, V150, P203, DOI 10.1016/j.toxlet.2004.01.008; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding Yan, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P101; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Guo SW, 2006, EUR J OBSTET GYN R B, V124, P134, DOI 10.1016/j.ejogrb.2005.10.002; Guo SW, 2005, MOL HUM REPROD, V11, P729, DOI 10.1093/molehr/gah206; Hadfield RM, 2001, MOL HUM REPROD, V7, P1073, DOI 10.1093/molehr/7.11.1073; Huang PC, 2010, HUM REPROD, V25, P986, DOI 10.1093/humrep/deq015; Hur SE, 2005, MOL HUM REPROD, V11, P15, DOI 10.1093/molehr/gah127; Ivaschenko T. E., 2003, Genetika, V39, P525; Josephy P.D., 2010, HUM GENOMICS PROTEOM, V4, P876; Kim SH, 2007, HUM REPROD, V22, P1866, DOI 10.1093/humrep/dem112; Lin J, 2003, CHINESE MED J-PEKING, V116, P777; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marinho C, 2007, BIOCHEM BIOPH RES CO, V353, P344, DOI 10.1016/j.bbrc.2006.12.019; Matsuzaka Yasunari, 2012, Environmental Health and Preventive Medicine, V17, P512, DOI 10.1007/s12199-012-0281-y; MELIS GB, 1994, ANN NY ACAD SCI, V734, P352, DOI 10.1111/j.1749-6632.1994.tb21765.x; Mittal RD, 2007, J GASTROEN HEPATOL, V22, P920, DOI 10.1111/j.1440-1746.2006.04538.x; Monizane M, 2004, J SOC GYNECOL INVEST, V11, P118, DOI 10.1016/j.jsgi.2003.07.009; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Pauwels A, 2001, HUM REPROD, V16, P2050, DOI 10.1093/humrep/16.10.2050; PEARSON WR, 1993, AM J HUM GENET, V53, P220; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Peng Dong-xian, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P458; Qiu L, 2008, EUR J CANCER, V44, P2241, DOI 10.1016/j.ejca.2008.06.024; Roya R, 2009, INDIAN J MED RES, V129, P395; RUSHMORE TH, 1993, J BIOL CHEM, V268, P11475; Sobti RC, 2005, CANCER GENET CYTOGEN, V156, P68, DOI 10.1016/j.cancergencyto.2004.04.001; Srivastava DSL, 2005, BJU INT, V95, P170, DOI 10.1111/j.1464-410X.2005.05271.x; Stefanson H, 2002, HUM REPROD, V17, P555, DOI 10.1093/humrep/17.3.555; Steinhoff C, 2000, ARCH TOXICOL, V74, P521, DOI 10.1007/s002040000161; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Trabert B, 2011, FERTIL STERIL, V96, P1401, DOI 10.1016/j.fertnstert.2011.09.004; Vichi S, 2012, FERTIL STERIL, V97, P1143, DOI 10.1016/j.fertnstert.2012.02.027; Wang GY, 2006, BIOCHEM BIOPH RES CO, V341, P310, DOI 10.1016/j.bbrc.2005.12.195; Webb G, 1996, GENOMICS, V33, P121, DOI 10.1006/geno.1996.0167; Wu CH, 2012, AM J REPROD IMMUNOL, V67, P160, DOI 10.1111/j.1600-0897.2011.01077.x; Yang LP, 2009, MATERN CHILD HLTH J, V24, P2556; Zhong SL, 2006, CLIN CHIM ACTA, V364, P205, DOI 10.1016/j.cccn.2005.06.021	57	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106761	10.1371/journal.pone.0106761	http://dx.doi.org/10.1371/journal.pone.0106761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208225	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300037
J	Brower-Sinning, R; Zhong, DN; Good, M; Firek, B; Baker, R; Sodhi, CP; Hackam, DJ; Morowitz, MJ				Brower-Sinning, Rachel; Zhong, Diana; Good, Misty; Firek, Brian; Baker, Robyn; Sodhi, Chhinder P.; Hackam, David J.; Morowitz, Michael J.			Mucosa-Associated Bacterial Diversity in Necrotizing Enterocolitis	PLOS ONE			English	Article							GUT MICROBIOTA; COLONIZATION; INFANTS; DOMINATION; TISSUE	Background: Previous studies of infant fecal samples have failed to clarify the role of gut bacteria in the pathogenesis of NEC. We sought to characterize bacterial communities within intestinal tissue resected from infants with and without NEC. Methods: 26 intestinal samples were resected from 19 infants, including 16 NEC samples and 10 non-NEC samples. Bacterial 16S rRNA gene sequences were amplified and sequenced. Analysis allowed for taxonomic identification, and quantitative PCR was used to quantify the bacterial load within samples. Results: NEC samples generally contained an increased total burden of bacteria. NEC and non-NEC sample sets were both marked by high inter-individual variability and an abundance of opportunistic pathogens. There was no statistically significant distinction between the composition of NEC and non-NEC microbial communities. K-means clustering enabled us to identify several stable clusters, including clusters of NEC and midgut volvulus samples enriched with Clostridium and Bacteroides. Another cluster containing both NEC and non-NEC samples was marked by an abundance of Enterobacteriaceae and decreased diversity among NEC samples. Conclusions: The results indicate that NEC is a disease without a uniform pattern of microbial colonization, but that NEC is associated with an abundance of strict anaerobes and a decrease in community diversity.	[Brower-Sinning, Rachel; Firek, Brian; Sodhi, Chhinder P.; Hackam, David J.; Morowitz, Michael J.] Childrens Hosp Pittsburgh, Div Pediat Surg, Pittsburgh, PA 15213 USA; [Good, Misty; Baker, Robyn] Childrens Hosp Pittsburgh, Div Newborn Med, Pittsburgh, PA 15213 USA; [Brower-Sinning, Rachel; Zhong, Diana; Firek, Brian; Sodhi, Chhinder P.; Hackam, David J.; Morowitz, Michael J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Good, Misty] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Morowitz, MJ (corresponding author), Childrens Hosp Pittsburgh, Div Pediat Surg, Pittsburgh, PA 15213 USA.	Michael.morowitz@chp.edu	Zhong, Diana/AAD-6224-2022; Good, Misty/AAI-6192-2020	Zhong, Diana/0000-0001-7487-7698; Good, Misty/0000-0002-0264-5721; Hackam, David/0000-0001-5195-8807	National Institutes of Health (Bethesda, MD, USA) [1R01AI092531-01]; March of Dimes Foundation (White Plains, NY, USA) [5-FY10-103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078238] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation (White Plains, NY, USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (Bethesda, MD, USA) Grant 1R01AI092531-01 to M. J. M. and March of Dimes Foundation (White Plains, NY, USA) Research Grant 5-FY10-103 to M. J. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; BLAKEY JL, 1985, J PEDIATR GASTR NUTR, V4, P591, DOI 10.1097/00005176-198508000-00017; Bucher BT, 2011, J PEDIATR SURG, V46, P1029, DOI 10.1016/j.jpedsurg.2011.03.026; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2011, J PEDIATR GASTR NUTR, V53, P512, DOI 10.1097/MPG.0b013e318227e518; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dittmar E, 2008, EUR J PEDIATR, V167, P891, DOI 10.1007/s00431-007-0614-9; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ferraris L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030594; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Normann E, 2013, ACTA PAEDIATR, V102, P129, DOI 10.1111/apa.12059; Smith B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-73; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Stewart CJ, 2013, ARCH DIS CHILD-FETAL, V98, pF298, DOI 10.1136/archdischild-2012-302119; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Ullrich T, 2012, PEDIATR INFECT DIS J, V31, P413, DOI 10.1097/INF.0b013e318242534a; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	33	59	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e105046	10.1371/journal.pone.0105046	http://dx.doi.org/10.1371/journal.pone.0105046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203729	Green Published, Green Accepted, gold			2022-12-27	WOS:000342684500006
J	Fonseca-de-Souza, AL; Freitas-Mesquita, AL; Vieira, LP; Majerowicz, D; Daflon-Yunes, N; Soares-de-Medeiros, LCA; Miranda, K; Gondim, KC; Meyer-Fernandes, JR				Fonseca-de-Souza, Andre Luiz; Freitas-Mesquita, Anita Leocadio; Vieira, Lisvane Paes; Majerowicz, David; Daflon-Yunes, Nathalia; Almeida Soares-de-Medeiros, Lia Carolina; Miranda, Kildare; Gondim, Katia Calp; Meyer-Fernandes, Jose Roberto			Identification and Characterization of an Ecto-Pyrophosphatase Activity in Intact Epimastigotes of Trypanosoma rangeli	PLOS ONE			English	Article							VACUOLAR H+-PYROPHOSPHATASE; TRANSLOCATING INORGANIC PYROPHOSPHATASE; PROTON-PUMPING PYROPHOSPHATASE; PHOSPHATASE ACTIVITY; ARCHAEBACTERIAL PYROPHOSPHATASE; RHODOSPIRILLUM-RUBRUM; LEISHMANIA-DONOVANI; MOLECULAR-CLONING; PLANT; ACIDOCALCISOMES	In this study, we performed the molecular and biochemical characterization of an ecto-enzyme present in Trypanosoma rangeli that is involved with the hydrolysis of extracellular inorganic pyrophosphate. PCR analysis identified a putative proton-pyrophosphatase (H+-PPase) in the epimastigote forms of T. rangeli. This protein was recognized with Western blot and flow cytometry analysis using an antibody against the H+-PPase of Arabidopsis thaliana. Immunofluorescence microscopy confirmed that this protein is located in the plasma membrane of T. rangeli. Biochemical assays revealed that the optimum pH for the ecto-PPase activity was 7.5, as previously demonstrated for other organisms. Sodium fluoride (NaF) and aminomethylenediphosphonate (AMDP) were able to inhibit approximately 75% and 90% of the ecto-PPase activity, respectively. This ecto-PPase activity was stimulated in a dose-dependent manner by MgCl2. In the presence of MgCl2, this activity was inhibited by millimolar concentrations of CaCl2. The ecto-PPase activity of T. rangeli decreased with increasing cell proliferation in vitro, thereby suggesting a role for this enzyme in the acquisition of inorganic phosphate (Pi). Moreover, this activity was modulated by the extracellular concentration of Pi and increased approximately two-fold when the cells were maintained in culture medium depleted of Pi. All of these results confirmed the occurrence of an ecto-PPase located in the plasma membrane of T. rangeli that possibly plays an important role in phosphate metabolism of this protozoan.	[Fonseca-de-Souza, Andre Luiz] Ctr Univ Estadual Zona Oeste, Lab Terapia & Fisiol Celular & Mol, Rio De Janeiro, Brazil; [Freitas-Mesquita, Anita Leocadio; Vieira, Lisvane Paes; Majerowicz, David; Daflon-Yunes, Nathalia; Almeida Soares-de-Medeiros, Lia Carolina; Gondim, Katia Calp; Meyer-Fernandes, Jose Roberto] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, CCS, Rio De Janeiro, Brazil; [Freitas-Mesquita, Anita Leocadio; Vieira, Lisvane Paes; Almeida Soares-de-Medeiros, Lia Carolina; Miranda, Kildare; Meyer-Fernandes, Jose Roberto] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Daflon-Yunes, Nathalia; Almeida Soares-de-Medeiros, Lia Carolina; Miranda, Kildare] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, CCS, BR-21941 Rio De Janeiro, Brazil; [Gondim, Katia Calp] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Centro Universitario Estadual da Zona Oeste; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Meyer-Fernandes, JR (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, CCS, Rio De Janeiro, Brazil.	meyer@bioqmed.ufrj.br	Majerowicz, David/B-5361-2016; Majerowicz, David/S-6136-2019; Vieira, Lisvane Paes/AAI-6761-2020; Gondim, Katia C./AAN-4059-2020	Majerowicz, David/0000-0001-7916-5315; Majerowicz, David/0000-0001-7916-5315; Vieira, Lisvane Paes/0000-0001-8589-5939; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Brazilian Agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avaeva SM, 2000, BIOCHEMISTRY-MOSCOW+, V65, P361; Baltscheffsky M, 1998, BBA-BIOENERGETICS, V1364, P301, DOI 10.1016/S0005-2728(98)00062-0; BAYKOV AA, 1992, ARCH BIOCHEM BIOPHYS, V294, P238, DOI 10.1016/0003-9861(92)90163-Q; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Cuba C.A.C., 1975, Revista Inst Med trop Sao Paulo, V17, P283; d'Alessandro A., 1976, P327; de Oliveira MA, 2001, J INVERTEBR PATHOL, V77, P22, DOI 10.1006/jipa.2000.4988; Leite MDS, 2007, EXP PARASITOL, V115, P315, DOI 10.1016/j.exppara.2006.09.002; Dick CF, 2010, EXP PARASITOL, V124, P386, DOI 10.1016/j.exppara.2009.12.006; Docampo R, 1999, PARASITOL TODAY, V15, P443, DOI 10.1016/S0169-4758(99)01531-8; Dos-Santos ALA, 2013, EXP PARASITOL, V135, P459, DOI 10.1016/j.exppara.2013.08.014; Drozdowicz YM, 1999, FEBS LETT, V460, P505, DOI 10.1016/S0014-5793(99)01404-0; Drozdowicz YM, 2000, PLANT PHYSIOL, V123, P353, DOI 10.1104/pp.123.1.353; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fonseca FV, 2006, EXP PARASITOL, V112, P76, DOI 10.1016/j.exppara.2005.09.005; Fonseca-De-Souza AL, 2008, ACTA TROP, V107, P153, DOI 10.1016/j.actatropica.2008.05.017; Fonseca-De-Souza AL, 2009, EXP PARASITOL, V122, P242, DOI 10.1016/j.exppara.2009.03.006; Freitas-Mesquita AL, 2014, EXP PARASITOL, V137, P8, DOI 10.1016/j.exppara.2013.11.008; Halonen P, 2005, BIOCHEMISTRY-US, V44, P4004, DOI 10.1021/bi047926u; HECKER H, 1990, PARASITOL RES, V76, P311, DOI 10.1007/BF00928185; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; Hoare A.C., 1972, ZOOLOGICAL MONOGRAPH, P401; Islam MK, 2006, PARASITOLOGY, V133, P497, DOI 10.1017/S0031182006000576; Islam MK, 2003, EUR J BIOCHEM, V270, P2814, DOI 10.1046/j.1432-1033.2003.03658.x; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HN, 2007, ORG LETT, V9, P243, DOI 10.1021/ol062685z; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lopez-Castejon G, 2011, CELL MOL LIFE SCI, V68, P3095, DOI 10.1007/s00018-010-0609-y; Luo SH, 1999, FEBS LETT, V460, P217, DOI 10.1016/S0014-5793(99)01353-8; Maeshima M, 2001, ANNU REV PLANT PHYS, V52, P469, DOI 10.1146/annurev.arplant.52.1.469; MAESHIMA M, 1991, EUR J BIOCHEM, V196, P11, DOI 10.1111/j.1432-1033.1991.tb15779.x; Marchesini N, 2000, BIOCHEM J, V347, P243, DOI 10.1042/0264-6021:3470243; Martinez R, 2002, MOL BIOCHEM PARASIT, V120, P205, DOI 10.1016/S0166-6851(01)00456-X; McIntosh MT, 2002, INT J PARASITOL, V32, P1, DOI 10.1016/S0020-7519(01)00325-3; McIntosh MT, 2001, MOL BIOCHEM PARASIT, V114, P183, DOI 10.1016/S0166-6851(01)00251-1; Medeiros LCS, 2011, J EUKARYOT MICROBIOL, V58, P416, DOI 10.1111/j.1550-7408.2011.00565.x; Merckel MC, 2001, STRUCTURE, V9, P289, DOI 10.1016/S0969-2126(01)00587-1; MEYER W, 1995, ARCH BIOCHEM BIOPHYS, V319, P149, DOI 10.1006/abbi.1995.1277; MEYER W, 1992, EUR J BIOCHEM, V207, P741, DOI 10.1111/j.1432-1033.1992.tb17104.x; MEYERFERNANDES JR, 1988, ARCH BIOCHEM BIOPHYS, V266, P132, DOI 10.1016/0003-9861(88)90243-3; Motta LS, 2009, INSECT BIOCHEM MOLEC, V39, P198, DOI 10.1016/j.ibmb.2008.11.003; NYREN P, 1991, BIOCHEMISTRY-US, V30, P2883, DOI 10.1021/bi00225a022; Perez-Castineira Jose R., 2001, International Microbiology, V4, P135; Perez-Castineira JR, 2002, BIOCHEM BIOPH RES CO, V294, P567, DOI 10.1016/S0006-291X(02)00517-X; REA PA, 1992, TRENDS BIOCHEM SCI, V17, P348, DOI 10.1016/0968-0004(92)90313-X; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; REEVES RE, 1976, TRENDS BIOCHEM SCI, V1, P53, DOI 10.1016/S0968-0004(76)80189-2; Robinson DC, 1996, PLANT PHYSIOL, V111, P645, DOI 10.1104/pp.111.2.645; Rodina EV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P897, DOI 10.1134/S0006297908080075; Rodrigues CO, 1999, BIOCHEM J, V340, P759, DOI 10.1042/0264-6021:3400759; Rodrigues CO, 1999, MOL CELL BIOL, V19, P7712; Rodrigues CO, 2000, BIOCHEM J, V349, P737, DOI 10.1042/bj3490737; Samygina VR, 2007, J MOL BIOL, V366, P1305, DOI 10.1016/j.jmb.2006.11.082; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; SATO MH, 1994, J BIOL CHEM, V269, P6725; SATO MH, 1991, FEBS LETT, V290, P177, DOI 10.1016/0014-5793(91)81254-6; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Scott DA, 2000, J BIOL CHEM, V275, P24215, DOI 10.1074/jbc.M002454200; Sen SS, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1382, DOI 10.1134/S000629790912013X; Serrano A, 2007, IUBMB LIFE, V59, P76, DOI 10.1080/15216540701258132; Seufferheld M, 2003, J BIOL CHEM, V278, P29971, DOI 10.1074/jbc.M304548200; Shintani T, 1998, FEBS LETT, V439, P263, DOI 10.1016/S0014-5793(98)01381-7; Sun YM, 2008, ORG BIOMOL CHEM, V6, P3044, DOI 10.1039/b808422j; TAKLE GB, 1988, T ROY SOC TROP MED H, V82, P247, DOI 10.1016/0035-9203(88)90434-8; TOBIE EJ, 1970, J INVERTEBR PATHOL, V15, P118, DOI 10.1016/0022-2011(70)90106-0; Urbina JA, 1999, J BIOL CHEM, V274, P33609, DOI 10.1074/jbc.274.47.33609; VICKERMAN K, 1994, INT J PARASITOL, V24, P1317, DOI 10.1016/0020-7519(94)90198-8; Wood H G, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P85; WOOD HG, 1977, FED PROC, V36, P2197; WU JJ, 1991, FEBS LETT, V283, P57, DOI 10.1016/0014-5793(91)80552-E; ZHEN RG, 1994, PLANT PHYSIOL, V104, P153, DOI 10.1104/pp.104.1.153	72	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106852	10.1371/journal.pone.0106852	http://dx.doi.org/10.1371/journal.pone.0106852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203926	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500047
J	Jung, WH; Jang, JH; Park, JW; Kim, E; Goo, EH; Im, OS; Kwon, JS				Jung, Wi Hoon; Jang, Joon Hwan; Park, Jin Woo; Kim, Euitae; Goo, Eun-Hoe; Im, Oh-Soo; Kwon, Jun Soo			Unravelling the Intrinsic Functional Organization of the Human Striatum: A Parcellation and Connectivity Study Based on Resting-State fMRI	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ANTI-CORRELATED NETWORKS; BASAL GANGLIA; HUMAN BRAIN; CORTICOSTRIATAL CIRCUITS; DIFFUSION TRACTOGRAPHY; HUNTINGTONS-DISEASE; GLOBAL SIGNAL; PUTAMEN; CORTEX	As the main input hub of the basal ganglia, the striatum receives projections from the cerebral cortex. Many studies have provided evidence for multiple parallel corticostriatal loops based on the structural and functional connectivity profiles of the human striatum. A recent resting-state fMRI study revealed the topography of striatum by assigning each voxel in the striatum to its most strongly correlated cortical network among the cognitive, affective, and motor networks. However, it remains unclear what patterns of striatal parcellation would result from performing the clustering without subsequent assignment to cortical networks. Thus, we applied unsupervised clustering algorithms to parcellate the human striatum based on its functional connectivity patterns to other brain regions without any anatomically or functionally defined cortical targets. Functional connectivity maps of striatal subdivisions, identified through clustering analyses, were also computed. Our findings were consistent with recent accounts of the functional distinctions of the striatum as well as with recent studies about its functional and anatomical connectivity. For example, we found functional connections between dorsal and ventral striatal clusters and the areas involved in cognitive and affective processes, respectively, and between rostral and caudal putamen clusters and the areas involved in cognitive and motor processes, respectively. This study confirms prior findings, showing similar striatal parcellation patterns between the present and prior studies. Given such striking similarity, it is suggested that striatal subregions are functionally linked to cortical networks involving specific functions rather than discrete portions of cortical regions. Our findings also demonstrate that the clustering of functional connectivity patterns is a reliable feature in parcellating the striatum into anatomically and functionally meaningful subdivisions. The striatal subdivisions identified here may have important implications for understanding the relationship between corticostriatal dysfunction and various neurodegenerative and psychiatric disorders.	[Jung, Wi Hoon; Kwon, Jun Soo] Seoul Natl Univ, Med Res Ctr, Inst Human Behav Med, Seoul, South Korea; [Jang, Joon Hwan; Park, Jin Woo; Kwon, Jun Soo] Seoul Natl Univ, Dept Psychiat, Coll Med, Seoul, South Korea; [Kim, Euitae] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea; [Goo, Eun-Hoe] Cheong Ju Univ, Dept Radiol Sci, Cheongju, South Korea; [Im, Oh-Soo] Seoul Natl Univ Hosp, Dept Diagnost Radiol, Seoul 110744, South Korea; [Kwon, Jun Soo] Seoul Natl Univ, Coll Nat Sci, Deparment Brain & Cognit Sci, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kwon, JS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Human Behav Med, Seoul, South Korea.	kwonjs@snu.ac.kr	Jung, Wi Hoon/J-4033-2019	Park, Jin Woo/0000-0003-0801-8208; Jung, Wi Hoon/0000-0002-8697-9584	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120476]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2013R1A2A1A03071089]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120476) and was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2013R1A2A1A03071089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Arbabshirani MR, 2013, HUM BRAIN MAPP, V34, P2959, DOI 10.1002/hbm.22118; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Barnes KA, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00018; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bingel U, 2004, CEREB CORTEX, V14, P1340, DOI 10.1093/cercor/bhh094; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Camara E, 2009, FRONT NEUROSCI-SWITZ, V3, P350, DOI 10.3389/neuro.01.034.2009; Carbonell F, 2014, NEUROIMAGE, V86, P343, DOI 10.1016/j.neuroimage.2013.10.013; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Ell SW, 2012, HORIZON NEUROSCIENCE, P29; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fudge JL, 2004, J COMP NEUROL, V476, P330, DOI 10.1002/cne.20228; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; HARRIS GJ, 1992, ANN NEUROL, V31, P69, DOI 10.1002/ana.410310113; Jung WH, 2013, NEUROIMAGE-CLIN, V3, P27, DOI 10.1016/j.nicl.2013.06.013; Kahnt T, 2012, J NEUROSCI, V32, P6240, DOI 10.1523/JNEUROSCI.0257-12.2012; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; Kim DJ, 2013, HUM BRAIN MAPP, V34, P1371, DOI 10.1002/hbm.21517; Kim JH, 2010, NEUROIMAGE, V49, P2375, DOI 10.1016/j.neuroimage.2009.10.016; Lawrence AD, 1998, TRENDS COGN SCI, V2, P379, DOI 10.1016/S1364-6613(98)01231-5; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; LILES SL, 1985, BRAIN RES, V339, P245, DOI 10.1016/0006-8993(85)90089-7; Linnman C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-8; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Oh JS, 2012, HUM BRAIN MAPP, V33, P2441, DOI 10.1002/hbm.21372; Porubska K, 2006, NEUROIMAGE, V32, P1273, DOI 10.1016/j.neuroimage.2006.04.216; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; RUSSCHEN FT, 1985, BRAIN RES, V329, P241, DOI 10.1016/0006-8993(85)90530-X; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Seger CA, 2005, J NEUROSCI, V25, P2941, DOI 10.1523/JNEUROSCI.3401-04.2005; Starr CJ, 2011, BRAIN, V134, P1987, DOI 10.1093/brain/awr117; Tziortzi AC, 2014, CEREB CORTEX, V24, P1165, DOI 10.1093/cercor/bhs397; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Verstynen TD, 2012, J NEUROPHYSIOL, V107, P2984, DOI 10.1152/jn.00995.2011; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wang YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076315; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wig GS, 2014, NEUROIMAGE, V93, P276, DOI 10.1016/j.neuroimage.2013.07.035; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	60	54	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106768	10.1371/journal.pone.0106768	http://dx.doi.org/10.1371/journal.pone.0106768			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203441	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500042
J	Mikalsen, AB; Nilsen, P; Froystad-Saugen, M; Lindmo, K; Eliassen, TM; Rode, M; Evensen, O				Mikalsen, Aase B.; Nilsen, Pal; Froystad-Saugen, Marianne; Lindmo, Karine; Eliassen, Trygve M.; Rode, Marit; Evensen, Oystein			Characterization of a Novel Calicivirus Causing Systemic Infection in Atlantic Salmon (Salmo salar L.): Proposal for a New Genus of Caliciviridae	PLOS ONE			English	Article							PORCINE ENTERIC CALICIVIRUS; REPRESENTATIONAL DIFFERENCE ANALYSIS; MOLECULAR CHARACTERIZATION; SERIAL PROPAGATION; GIRELLA-NIGRICANS; PISCINE REOVIRUS; RNA VIRUS; NOROVIRUSES; IDENTIFICATION; SUBTYPE	The Caliciviridae is a family of viruses infecting humans, a wide range of animals, birds and marine fish and mammals, resulting in a wide spectrum of diseases. We describe the identification and genetic characterization of a novel calicivirus replicating in Atlantic salmon. The virus has a high prevalence in farmed salmon and is found in fish suffering from several diseases and conditions and also in presumable healthy fish. A challenge and vaccination trial shows that the calicivirus replicates in Atlantic salmon and establishes a systemic infection, which can be reduced by vaccination with formalin-inactivated virus preparation. The virus, named Atlantic salmon calicivirus (ASCV), is found in two genetically distinct variants, a cell culture isolated and a variant sequenced directly from field material. The genomes are 7,4 kb and contain two open reading frames where typical conserved amino acid motifs and domains predict a gene order reminiscent of calicivirus genomes. Phylogenetic analysis performed on extracted capsid amino acid sequences segregated the two ASCV variants in a unique cluster sharing root with the branch of noroviruses infecting humans and the unassigned Tulane virus and St-Valerien like viruses, infecting rhesus monkey and pig, respectively, with relatively large distance to the marine calicivirus subgroup of vesiviruses. Based on the analyses presented, the ASCV is predicted to represent a new genus of Caliciviridae for which we propose the name Salovirus.	[Mikalsen, Aase B.; Evensen, Oystein] Norwegian Univ Life Sci, Fac Vet Med & Biosci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Nilsen, Pal; Froystad-Saugen, Marianne; Lindmo, Karine; Eliassen, Trygve M.; Rode, Marit] Pharmaq AS, Oslo, Norway	Norwegian University of Life Sciences	Mikalsen, AB (corresponding author), Norwegian Univ Life Sci, Fac Vet Med & Biosci, Dept Basic Sci & Aquat Med, Oslo, Norway.	aase.mikalsen@nmbu.no	Evensen, Øystein/O-3011-2015	Evensen, Øystein/0000-0002-4856-3043; Mikalsen, Aase B./0000-0001-6367-9629	Research Council of Norway [216177]; PHARMAQ; Pharmaq AS	Research Council of Norway(Research Council of Norway); PHARMAQ; Pharmaq AS	This work was supported by the Research Council of Norway, project no. 216177, "Studies of virulence mechanisms and host responses to infection with piscine myocarditis virus (PMCV)'' to OE and by PHARMAQ. The Research Council of Norway had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors PN, MF-S, KL, TME and MR are employed by the funder Pharmaq AS. Pharmaq AS provided support in the form of salaries for authors PN, MF-S, KL, TME and MR and operating costs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank-Wolf BR, 2010, VET MICROBIOL, V140, P204, DOI 10.1016/j.vetmic.2009.08.021; Chi SC, 1999, J FISH DIS, V22, P173, DOI 10.1046/j.1365-2761.1999.00152.x; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; Di Martino B, 2010, RES VET SCI, V89, P279, DOI 10.1016/j.rvsc.2010.03.011; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Farkas T, 2010, J GEN VIROL, V91, P734, DOI 10.1099/vir.0.015263-0; FLYNN WT, 1988, J CLIN MICROBIOL, V26, P206, DOI 10.1128/JCM.26.2.206-212.1988; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Green K. Y., 2007, FIELDS VIROLOGY, V1, P949; Guo M, 1999, J VIROL, V73, P9625, DOI 10.1128/JVI.73.11.9625-9631.1999; Haugland O, 2011, J VIROL, V85, P5275, DOI 10.1128/JVI.02154-10; Hodneland K, 2005, DIS AQUAT ORGAN, V66, P113, DOI 10.3354/dao066113; Karlsen M, 2006, ARCH VIROL, V151, P861, DOI 10.1007/s00705-005-0687-6; L'Homme Y, 2009, VIRUS GENES, V39, P66, DOI 10.1007/s11262-009-0360-3; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Matson DO, 1996, ARCH VIROL, V141, P2443, DOI 10.1007/BF01718642; Mikalsen AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037269; Oliver SL, 2003, J VIROL, V77, P2789, DOI 10.1128/JVI.77.4.2789-2798.2003; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; PARWANI AV, 1991, ARCH VIROL, V120, P115, DOI 10.1007/BF01310954; Pastorian K, 2000, ANAL BIOCHEM, V283, P89, DOI 10.1006/abio.2000.4622; Pesavento PA, 2008, VET CLIN N AM-SMALL, V38, P775, DOI 10.1016/j.cvsm.2008.03.002; Petterson E, 2013, J GEN VIROL, V94, P1945, DOI 10.1099/vir.0.052563-0; Sato T, 2011, VIRUS GENES, V43, P72, DOI 10.1007/s11262-011-0617-5; Scipioni A, 2008, VET J, V178, P32, DOI 10.1016/j.tvjl.2007.11.012; Sjoblom J, 1992, EMULSIONS FUNDAMENTA; Smiley JR, 2002, J VIROL, V76, P10089, DOI 10.1128/JVI.76.20.10089-10098.2002; SMITH AW, 1973, NATURE, V244, P108, DOI 10.1038/244108a0; SMITH AW, 1981, ARCH VIROL, V67, P165, DOI 10.1007/BF01318600; Smith AW, 1998, EMERG INFECT DIS, V4, P13, DOI 10.3201/eid0401.980103; SMITH AW, 1980, SCIENCE, V209, P940, DOI 10.1126/science.7403862; Sosnovtsev SV, 2000, VIROLOGY, V277, P193, DOI 10.1006/viro.2000.0579; Sosnovtsev SV, 2005, J VIROL, V79, P4012, DOI 10.1128/JVI.79.7.4012-4024.2005; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiel HJ, 1999, VET MICROBIOL, V69, P55, DOI 10.1016/S0378-1135(99)00088-7; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034987; Wang QH, 2005, EMERG INFECT DIS, V11, P1874, DOI 10.3201/eid1112.050485; Wiik-Nielsen CR, 2012, J FISH DIS, V35, P169, DOI 10.1111/j.1365-2761.2011.01328.x; Wolf S, 2012, ARCH VIROL, V157, P1499, DOI 10.1007/s00705-012-1326-7; Wolf S, 2011, ARCH VIROL, V156, P1143, DOI 10.1007/s00705-011-0964-5; Wolf S, 2009, VET MICROBIOL, V133, P184, DOI 10.1016/j.vetmic.2008.06.019	45	40	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107132	10.1371/journal.pone.0107132	http://dx.doi.org/10.1371/journal.pone.0107132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203050	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500071
J	Kwong, TE; Brachman, KJ				Kwong, Tru E.; Brachman, Kyle J.			Strategy Choice Mediates the Link between Auditory Processing and Spelling	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SPEECH-PERCEPTION; FAMILIAL RISK; FREQUENCY DISCRIMINATION; PHONOLOGICAL AWARENESS; CORTICAL RESPONSES; IMPAIRED CHILDREN; READING-ABILITY; GENETIC RISK; DYSLEXIA	Relations among linguistic auditory processing, nonlinguistic auditory processing, spelling ability, and spelling strategy choice were examined. Sixty-three undergraduate students completed measures of auditory processing (one involving distinguishing similar tones, one involving distinguishing similar phonemes, and one involving selecting appropriate spellings for individual phonemes). Participants also completed a modified version of a standardized spelling test, and a secondary spelling test with retrospective strategy reports. Once testing was completed, participants were divided into phonological versus nonphonological spellers on the basis of the number of words they spelled using phonological strategies only. Results indicated a) moderate to strong positive correlations among the different auditory processing tasks in terms of reaction time, but not accuracy levels, and b) weak to moderate positive correlations between measures of linguistic auditory processing (phoneme distinction and phoneme spelling choice in the presence of foils) and spelling ability for phonological spellers, but not for nonphonological spellers. These results suggest a possible explanation for past contradictory research on auditory processing and spelling, which has been divided in terms of whether or not disabled spellers seemed to have poorer auditory processing than did typically developing spellers, and suggest implications for teaching spelling to children with good versus poor auditory processing abilities.	[Kwong, Tru E.; Brachman, Kyle J.] Mt Royal Univ, Dept Psychol, Calgary, AB, Canada	Mount Royal University	Kwong, TE (corresponding author), Mt Royal Univ, Dept Psychol, Calgary, AB, Canada.	tkwong@mtroyal.ca						Amitay S, 2002, BRAIN, V125, P2272, DOI 10.1093/brain/awf231; Amitay S, 2002, JARO-J ASSOC RES OTO, V3, P302, DOI 10.1007/s101620010093; Au A, 2008, PERCEPT PSYCHOPHYS, V70, P697, DOI 10.3758/PP.70.4.697; Barron RW, 1980, COGNITIVE PROCESS, P195; Bishop DVM, 1999, J SPEECH LANG HEAR R, V42, P155, DOI 10.1044/jslhr.4201.155; Boets B, 2008, BRAIN LANG, V106, P29, DOI 10.1016/j.bandl.2007.12.004; Boets B, 2007, BRAIN LANG, V101, P19, DOI 10.1016/j.bandl.2006.06.009; Boets B, 2011, RES DEV DISABIL, V32, P560, DOI 10.1016/j.ridd.2010.12.020; Booth JR, 2000, SCI STUD READ, V4, P101, DOI DOI 10.1207/S1532799XSSR0402_02; Breier JI, 2002, J EXP CHILD PSYCHOL, V82, P226, DOI 10.1016/S0022-0965(02)00005-X; Bretherton L, 2003, J EXP CHILD PSYCHOL, V84, P218, DOI 10.1016/S0022-0965(03)00023-7; Breznitz Z, 1997, J EDUC PSYCHOL, V89, P103, DOI 10.1037/0022-0663.89.1.103; BRUCK M, 1988, APPL PSYCHOLINGUIST, V9, P77, DOI 10.1017/S0142716400000461; BRUCK M, 1990, APPL PSYCHOLINGUIST, V11, P425, DOI 10.1017/S0142716400009668; Chiappe P, 2001, J EXP CHILD PSYCHOL, V80, P58, DOI 10.1006/jecp.2000.2624; FOORMAN BR, 1989, J LEARN DISABIL, V22, P349, DOI 10.1177/002221948902200605; France SJ, 2002, PERCEPT PSYCHOPHYS, V64, P169, DOI 10.3758/BF03195783; Frith U., 1980, COGNITIVE PROCESS, P495, DOI DOI 10.1017/S0141347300007606; Furnes B, 2009, J RES READ, V32, P275, DOI 10.1111/j.1467-9817.2009.01393.x; Gilbertson M, 1998, LANG SPEECH HEAR SER, V29, P109, DOI 10.1044/0161-1461.2902.109; Guttorm TK, 2003, J NEURAL TRANSM, V110, P1059, DOI 10.1007/s00702-003-0014-x; Guttorm TK, 2001, J LEARN DISABIL-US, V34, P534, DOI 10.1177/002221940103400606; Habib M, 2002, INT J LANG COMM DIS, V37, P289, DOI 10.1080/13682820210136278; Halliday LF, 2006, J RES READ, V29, P213, DOI 10.1111/j.1467-9817.2006.00286.x; Hamalainen JA, 2011, INT J PSYCHOPHYSIOL, V81, P51, DOI 10.1016/j.ijpsycho.2011.04.005; Hammil D. D., 2009, TEST WRITTEN LANGUAG, VFourth; Heath SM, 2006, COGN NEUROPSYCHOL, V23, P905, DOI 10.1080/02643290500538398; Hill NI, 1999, J ACOUST SOC AM, V106, pL53, DOI 10.1121/1.428154; Kwong TE, 2005, DEV PSYCHOL, V41, P148, DOI 10.1037/0012-1649.41.1.148; Leppanen PHT, 2010, CORTEX, V46, P1362, DOI 10.1016/j.cortex.2010.06.003; Leppanen PHT, 2002, DEV NEUROPSYCHOL, V22, P407, DOI 10.1207/S15326942dn2201_4; Leppanen PHT, 1999, NEUROREPORT, V10, P969, DOI 10.1097/00001756-199904060-00014; Lewis BA, 2002, READING WRITING INTE, V15, P389, DOI DOI 10.1023/A:1015237202592; McAnally KI, 1996, P ROY SOC B-BIOL SCI, V263, P961, DOI 10.1098/rspb.1996.0142; McArthur GM, 2008, COGNITION, V107, P946, DOI 10.1016/j.cognition.2007.12.005; Mody M, 1997, J EXP CHILD PSYCHOL, V64, P199, DOI 10.1006/jecp.1996.2343; MORAIS J, 1984, PERCEPT MOTOR SKILL, V58, P221, DOI 10.2466/PMS.58.1.221-222; Pihko E, 1999, NEUROREPORT, V10, P901, DOI 10.1097/00001756-199904060-00002; Reece C, 2001, APPL PSYCHOLINGUIST, V22, P139, DOI 10.1017/S0142716401002016; Richardson U, 2004, DYSLEXIA, V10, P215, DOI 10.1002/dys.276; Rittle-Johnson B, 1999, CHILD DEV, V70, P332, DOI 10.1111/1467-8624.00025; Robinson KM, 2001, J EDUC PSYCHOL, V93, P211, DOI 10.1037/0022-0663.93.1.211; Schulte-Korne G, 1998, PERCEPT MOTOR SKILL, V86, P1043, DOI 10.2466/pms.1998.86.3.1043; Shrager J, 1998, PSYCHOL SCI, V9, P405, DOI 10.1111/1467-9280.00076; Stein JF, 1995, IRISH J PSYCHOL, V16, P220, DOI 10.1080/03033910.1995.10558058; Talcott Joel B, 2002, Dyslexia, V8, P204, DOI 10.1002/dys.224; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; TALLAL P, 1985, BRAIN LANG, V25, P314, DOI 10.1016/0093-934X(85)90087-2; Treiman R, 1998, J EXP CHILD PSYCHOL, V68, P3, DOI 10.1006/jecp.1997.2410; Treiman R, 1997, CHILD DEV, V68, P229, DOI 10.1111/j.1467-8624.1997.tb01937.x; TREIMAN R, 1993, J EXP CHILD PSYCHOL, V56, P267, DOI 10.1006/jecp.1993.1035; Treiman R, 2004, PSYCHON B REV, V11, P338, DOI 10.3758/BF03196580; Varnhagen CK, 2000, M SOC SCI STUD READ; WATSON BU, 1992, J SPEECH HEAR RES, V35, P148, DOI 10.1044/jshr.3501.148; WATSON BU, 1993, J SPEECH HEAR RES, V36, P850, DOI 10.1044/jshr.3604.850; Wilkinson G.S., 1993, WRAT 3 WIDE RANGE AC	57	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107131	10.1371/journal.pone.0107131	http://dx.doi.org/10.1371/journal.pone.0107131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JX	25198787	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700084
J	Linero, I; Chaparro, O				Linero, Itali; Chaparro, Orlando			Paracrine Effect of Mesenchymal Stem Cells Derived from Human Adipose Tissue in Bone Regeneration	PLOS ONE			English	Article							GROWTH-FACTOR; CONDITIONED MEDIUM; STROMAL CELLS; MSCS; DIFFERENTIATION; MECHANISMS; FIBROBLAST; EXPRESSION; SURVIVAL; DELIVERY	Mesenchymal stem cell (MSC) transplantation has proved to be a promising strategy in cell therapy and regenerative medicine. Although their mechanism of action is not completely clear, it has been suggested that their therapeutic activity may be mediated by a paracrine effect. The main goal of this study was to evaluate by radiographic, morphometric and histological analysis the ability of mesenchymal stem cells derived from human adipose tissue (Ad-MSC) and their conditioned medium (CM), to repair surgical bone lesions using an in vivo model (rabbit mandibles). The results demonstrated that both, Ad-MSC and CM, induce bone regeneration in surgically created lesions in rabbit's jaws, suggesting that Ad-MSC improve the process of bone regeneration mainly by releasing paracrine factors. The evidence of the paracrine effect of MSC on bone regeneration has a major impact on regenerative medicine, and the use of their CM can address some issues and difficulties related to cell transplants. In particular, CM can be easily stored and transported, and is easier to handle by medical personnel during clinical procedures.	[Linero, Itali] Univ Nacl Colombia, Fac Dent, Bogota, Colombia; [Chaparro, Orlando] Univ Nacl Colombia, Fac Med, Bogota, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia	Chaparro, O (corresponding author), Univ Nacl Colombia, Fac Med, Bogota, Colombia.	ochaparrog@unal.edu.co			Direccion de Investigacion Sede Bogota (DIB) of the Universidad Nacional de Colombia	Direccion de Investigacion Sede Bogota (DIB) of the Universidad Nacional de Colombia	This work has been financially supported by the Direccion de Investigacion Sede Bogota (DIB) of the Universidad Nacional de Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2014, BONE, V61, P82, DOI 10.1016/j.bone.2013.12.029; Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Bai Y, 2013, INT IMMUNOPHARMACOL, V16, P214, DOI 10.1016/j.intimp.2013.04.001; Behnia H, 2011, J CRANIOMAXILLOFAC S, V40, P2; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bryan N, 2009, BIOMATERIALS, V30, P180, DOI 10.1016/j.biomaterials.2008.09.003; Chatterjea A, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/215625; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen Y, 2008, INT J BIOCHEM CELL B, V40, P815, DOI 10.1016/j.biocel.2008.01.007; Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gao J, 1998, J DENT RES, V77, P1708, DOI 10.1177/00220345980770090701; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Horie M, 2012, OSTEOARTHR CARTILAGE, V20, P1197, DOI 10.1016/j.joca.2012.06.002; Horn AP, 2009, NEUROSCI RES, V63, P35, DOI 10.1016/j.neures.2008.10.001; Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005; Inukai T, 2013, BIOCHEM BIOPH RES CO, V430, P763, DOI 10.1016/j.bbrc.2012.11.074; Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jones E, 2011, INJURY, V42, P562, DOI 10.1016/j.injury.2011.03.030; Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573; Kazakos K, 2011, J CRANIO MAXILL SURG, V39, P49, DOI 10.1016/j.jcms.2010.03.005; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Khojasteh A, 2013, OR SURG OR MED OR PA, V116, pE405, DOI 10.1016/j.oooo.2012.01.044; Kotobuki N, 2008, CELL TRANSPLANT, V17, P705, DOI 10.3727/096368908786092793; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Li F, 2012, BIOCHEM BIOPH RES CO, V426, P475, DOI 10.1016/j.bbrc.2012.08.095; Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049; Linero I, 2014, REV BIOMEDICA, V34; Maltman DJ, 2011, NEUROCHEM INT, V59, P347, DOI 10.1016/j.neuint.2011.06.008; Marquez L, 2013, INJURY, V44, P558, DOI 10.1016/j.injury.2012.10.014; Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mendoza Jose J, 2010, PLASTIC RECONSTRUCTI, V126, P1699; Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Monaco E, 2011, THERIOGENOLOGY, V75, P1381, DOI 10.1016/j.theriogenology.2010.11.020; Morad G, 2013, ARCH ORAL BIOL, V58, P1818, DOI 10.1016/j.archoralbio.2013.08.011; Nauth A, 2011, INJURY, V42, P574, DOI 10.1016/j.injury.2011.03.034; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Osugi M, 2012, TISSUE ENG PT A, V18, P1479, DOI [10.1089/ten.tea.2011.0325, 10.1089/ten.TEA.2011.0325]; Pagni G, 2012, ADV DRUG DELIVER REV, V64, P1310, DOI 10.1016/j.addr.2012.03.005; Parekkadan B, 2007, BIOCHEM BIOPH RES CO, V363, P247, DOI 10.1016/j.bbrc.2007.05.150; Polacek M, 2011, CELL TRANSPLANT, V20, P1381, DOI 10.3727/096368910X550215; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Stockmann P, 2012, J CRANIO MAXILL SURG, V40, P310, DOI 10.1016/j.jcms.2011.05.004; Timmers L, 2011, STEM CELL RES, V6, P206, DOI 10.1016/j.scr.2011.01.001; van Koppen Arianne, 2012, PLoS One, V7, pe38746, DOI 10.1371/journal.pone.0038746; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; Yamachika E, 2012, J MOL HISTOL, V43, P223, DOI 10.1007/s10735-011-9385-8; Yamagata M, 2013, STROKE, V44, P551, DOI 10.1161/STROKEAHA.112.676759; Zimmermann CE, 2011, TISSUE ENG PT A, V17, P1147, DOI [10.1089/ten.tea.2009.0577, 10.1089/ten.TEA.2009.0577]; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	57	203	209	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107001	10.1371/journal.pone.0107001	http://dx.doi.org/10.1371/journal.pone.0107001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198551	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700071
J	Ng, HJ; Lopez-Perez, M; Webb, HK; Gomez, D; Sawabe, T; Ryan, J; Vyssotski, M; Bizet, C; Malherbe, F; Mikhailov, VV; Crawford, RJ; Ivanova, EP				Ng, Hooi Jun; Lopez-Perez, Mario; Webb, Hayden K.; Gomez, Daniela; Sawabe, Tomoo; Ryan, Jason; Vyssotski, Mikhail; Bizet, Chantal; Malherbe, Francois; Mikhailov, Valery V.; Crawford, Russell J.; Ivanova, Elena P.			Marinobacter salarius sp nov and Marinobacter similis sp nov., Isolated from Sea Water	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DNA-DNA HYBRIDIZATION; GENOME SEQUENCE; HALOPHILIC BACTERIUM; NUCLEOTIDE-SEQUENCES; GYRB; IDENTIFICATION; PSEUDOMONAS; STRAINS; CLASSIFICATION	Two non-pigmented, motile, Gram-negative marine bacteria designated R9SW1(T) and A3d10(T) were isolated from sea water samples collected from Chazhma Bay, Gulf of Peter the Great, Sea of Japan, Pacific Ocean, Russia and St. Kilda Beach, Port Phillip Bay, the Tasman Sea, Pacific Ocean, respectively. Both organisms were found to grow between 4 degrees C and 40 degrees C, between pH 6 to 9, and are moderately halophilic, tolerating up to 20% (w/v) NaCl. Both strains were found to be able to degrade Tween 40 and 80, but only strain R9SW1(T) was found to be able to degrade starch. The major fatty acids were characteristic for the genus Marinobacter including C-16:0, C-16:1 omega 7c, C-18:1 omega 9c and C-18:1 omega 7c. The G+C content of the DNA for strains R9SW1(T) and A3d10(T) were determined to be 57.1 mol% and 57.6 mol%, respectively. The two new strains share 97.6% of their 16S rRNA gene sequences, with 82.3% similarity in the average nucleotide identity (ANI), 19.8% similarity in the in silico genome-to-genome distance (GGD), 68.1% similarity in the average amino acid identity (AAI) of all conserved protein-coding genes, and 31 of the Karlin's genomic signature dissimilarity. A phylogenetic analysis showed that R9SW1(T) clusters with M. algicola DG893(T) sharing 99.40%, and A3d10(T) clusters with M. sediminum R65(T) sharing 99.53% of 16S rRNA gene sequence similarities. The results of the genomic and polyphasic taxonomic study, including genomic, genetic, phenotypic, chemotaxonomic and phylogenetic analyses based on the 16S rRNA, gyrB and rpoD gene sequence similarities, the analysis of the protein profiles generated using MALDI-TOF mass spectrometry, and DNA-DNA relatedness data, indicated that strains R9SW1(T) and A3d10(T) represent two novel species of the genus Marinobacter. The names Marinobacter salarius sp. nov., with the type strain R9SW1(T) (= LMG 27497(T) = JCM 19399(T) = CIP 110588(T) = KMM 7502(T)) and Marinobacter similis sp. nov., with the type strain A3d10(T) (= JCM 19398(T) = CIP 110589(T) = KMM 7501(T)), are proposed.	[Ng, Hooi Jun; Webb, Hayden K.; Gomez, Daniela; Malherbe, Francois; Crawford, Russell J.; Ivanova, Elena P.] Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia; [Lopez-Perez, Mario] Univ Miguel Hernandez, Apartado, San Juan De Ali, Spain; [Sawabe, Tomoo] Hokkaido Univ, Fac Fisheries, Microbiol Lab, Hakodate, Hokkaido 041, Japan; [Ryan, Jason; Vyssotski, Mikhail] Callaghan Innovat, Wellington, New Zealand; [Bizet, Chantal] Inst Pasteur, Collect Inst Pasteur, Paris, France; [Mikhailov, Valery V.] Russian Acad Sci, GB Elyakov Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Primorski Krai, Russia	Swinburne University of Technology; Universidad Miguel Hernandez de Elche; Hokkaido University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences	Ivanova, EP (corresponding author), Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.	eivanova@swin.edu.au	Malherbe, François Clément/ABG-8109-2020; Ivanova, Elena P/B-1255-2019; López-Pérez, Mario/ABG-1904-2020; Mikhailov, Valery V/M-6780-2013	Malherbe, François Clément/0000-0001-6127-4169; Ivanova, Elena P/0000-0002-5509-8071; López-Pérez, Mario/0000-0002-3996-6780; Webb, Hayden/0000-0003-2858-0177; Crawford, Russell/0000-0003-1054-5285	Genome Information Upgrading Program of National BioResource Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Federal Agency for Science of the Ministry of Education and Science of the Russian Federation [2-2.16]; Russian Foundation for Basic Research; Presidium of the Russian Academy of Sciences [02-04-48211]	Genome Information Upgrading Program of National BioResource Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Federal Agency for Science of the Ministry of Education and Science of the Russian Federation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported in part by Genome Information Upgrading Program of National BioResource Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. Water sample collection was within the research program funded by the Federal Agency for Science of the Ministry of Education and Science of the Russian Federation, grant 2-2.16, and by the Russian Foundation for Basic Research and grant 'Molecular and Cell Biology' from the Presidium of the Russian Academy of Sciences, grant 02-04-48211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Alperi A, 2008, INT MICROBIOL, V11, P185, DOI 10.2436/20.1501.01.59; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral GRS, 2014, INT J SYST EVOL MICR, V64, P357, DOI 10.1099/ijs.0.057927-0; Antunes A, 2007, INT J SYST EVOL MICR, V57, P1035, DOI 10.1099/ijs.0.64862-0; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Berlendis S, 2010, APPL BIOCHEM BIOTECH, V160, P1992, DOI 10.1007/s12010-009-8746-1; Bowman J.P., 2005, BERGEYS MANUAL SYSTE, P443; CASHION P, 1977, ANAL BIOCHEM, V81, P461, DOI 10.1016/0003-2697(77)90720-5; Chun J, 2014, INT J SYST EVOL MICR, V64, P316, DOI 10.1099/ijs.0.054171-0; Cilia V, 1996, MOL BIOL EVOL, V13, P451, DOI 10.1093/oxfordjournals.molbev.a025606; Cui ZS, 2008, ENVIRON MICROBIOL, V10, P2138, DOI 10.1111/j.1462-2920.2008.01637.x; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dastgheib SMM, 2012, APPL MICROBIOL BIOT, V95, P789, DOI 10.1007/s00253-011-3706-4; DELEY J, 1970, EUR J BIOCHEM, V12, P133; Didelot X, 2010, GENETICS, V186, P1435, DOI 10.1534/genetics.110.120121; Dubois D, 2010, J CLIN MICROBIOL, V48, P941, DOI 10.1128/JCM.00413-09; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Everest GJ, 2009, ANTON LEEUW INT J G, V95, P1, DOI 10.1007/s10482-008-9280-9; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Gardes A, 2010, STAND GENOMIC SCI, V3, P97, DOI 10.4056/sigs.922139; GAUTHIER MJ, 1992, INT J SYST BACTERIOL, V42, P568, DOI 10.1099/00207713-42-4-568; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Gorshkova NM, 2003, INT J SYST EVOL MICR, V53, P2073, DOI 10.1099/ijs.0.02693-0; Green DH, 2006, INT J SYST EVOL MICR, V56, P523, DOI 10.1099/ijs.0.63447-0; Grimaud R, 2012, J BACTERIOL, V194, P3539, DOI 10.1128/JB.00500-12; Gu J, 2007, INT J SYST EVOL MICR, V57, P250, DOI 10.1099/ijs.0.64522-0; Ng HJ, 2013, ANTON LEEUW INT J G, V103, P265, DOI 10.1007/s10482-012-9807-y; HUSS VAR, 1983, SYST APPL MICROBIOL, V4, P184, DOI 10.1016/S0723-2020(83)80048-4; Huu NB, 1999, INT J SYST BACTERIOL, V49, P367, DOI 10.1099/00207713-49-2-367; Ivanova EP, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00442-14; Ivanova EP, 2013, ANTON LEEUW INT J G, V103, P877, DOI 10.1007/s10482-012-9869-x; Ivanova EP, 1996, INT J SYST BACTERIOL, V46, P223, DOI 10.1099/00207713-46-1-223; Ivanova EP, 2005, RUSS J MAR BIOL, V31, P65, DOI DOI 10.1007/S11179-005-0046-1; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Kaeppel EC, 2012, INT J SYST EVOL MICR, V62, P124, DOI 10.1099/ijs.0.030189-0; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirby BM, 2010, ANTON LEEUW INT J G, V97, P131, DOI 10.1007/s10482-009-9393-9; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Lagier JC, 2012, STAND GENOMIC SCI, V7, P200, DOI 10.4056/sigs.3086474; Lal D, 2015, J BASIC MICROB, V55, P363, DOI 10.1002/jobm.201300211; Le Roux F, 2005, INT J SYST EVOL MICR, V55, P2251, DOI 10.1099/ijs.0.63666-0; Lee OO, 2012, INT J SYST EVOL MICR, V62, P1980, DOI 10.1099/ijs.0.028811-0; Marquez MC, 2005, INT J SYST EVOL MICR, V55, P1349, DOI 10.1099/ijs.0.63591-0; Martin S, 2003, INT J SYST EVOL MICR, V53, P1383, DOI 10.1099/ijs.0.02528-0; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Montes MJ, 2008, INT J SYST EVOL MICR, V58, P1346, DOI 10.1099/ijs.0.65298-0; Puthucheary SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030205; Ramasamy D, 2014, INT J SYST EVOL MICR, V64, P384, DOI 10.1099/ijs.0.057091-0; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roh SW, 2008, INT J SYST EVOL MICR, V58, P2866, DOI 10.1099/ijs.0.65522-0; Romanenko LA, 2005, INT J SYST EVOL MICR, V55, P143, DOI 10.1099/ijs.0.63258-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Shivaji S, 2005, INT J SYST EVOL MICR, V55, P1453, DOI 10.1099/ijs.0.63478-0; Smibert Robert M., 1994, P607; SVETASHEV VI, 1995, SYST APPL MICROBIOL, V18, P37, DOI 10.1016/S0723-2020(11)80446-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tancsics A, 2014, INT J SYST EVOL MICR, V64, P298, DOI 10.1099/ijs.0.059097-0; Thompson CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-913; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Webb HK, 2009, MICROBES ENVIRON, V24, P39, DOI 10.1264/jsme2.ME08538; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; Yamamoto S, 1998, INT J SYST BACTERIOL, V48, P813, DOI 10.1099/00207713-48-3-813; Yoon JH, 2004, INT J SYST EVOL MICR, V54, P1799, DOI 10.1099/ijs.0.63151-0	70	27	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106514	10.1371/journal.pone.0106514	http://dx.doi.org/10.1371/journal.pone.0106514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198502	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700030
J	Fernandez-Moya, SM; Carrington, M; Estevez, AM				Fernandez-Moya, Sandra M.; Carrington, Mark; Estevez, Antonio M.			Depletion of the RNA-Binding Protein RBP33 Results in Increased Expression of Silenced RNA Polymerase II Transcripts in Trypanosoma brucei	PLOS ONE			English	Article							INDUCIBLE EXPRESSION; GENE-EXPRESSION; BLOOD-STREAM; DNA; INTERFERENCE; TERMINATION; HETEROCHROMATIN; PREDICTION; SEQUENCES; DISTINCT	We have characterized the RNA-binding protein RBP33 in Trypanosoma brucei, and found that it localizes to the nucleus and is essential for viability. The subset of RNAs bound to RBP33 was determined by immunoprecipitation of ribonucleoprotein complexes followed by deep sequencing. Most RBP33-bound transcripts are predicted to be non-coding. Among these, over one-third are located close to the end of transcriptional units (TUs) or have an antisense orientation within a TU. Depletion of RBP33 resulted in an increase in the level of RNAs derived from regions that are normally silenced, such as strand-switch regions, retroposon and repeat sequences. Our work provides the first example of an RNA-binding protein involved in the regulation of gene silencing in trypanosomes.	[Fernandez-Moya, Sandra M.; Estevez, Antonio M.] CSIC, IPBLN, Granada, Spain; [Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Cambridge	Estevez, AM (corresponding author), CSIC, IPBLN, Granada, Spain.	aestevez@ipb.csic.es	Carrington, Mark/N-3653-2019; FERNÁNDEZ MOYA, SANDRA MARÍA Maria/AAB-1054-2020; Estevez, Antonio M/K-7835-2014; Carrington, Mark/N-4892-2018	Carrington, Mark/0000-0002-6435-7266; FERNÁNDEZ MOYA, SANDRA MARÍA Maria/0000-0002-5894-4296; Estevez, Antonio M/0000-0002-8272-5405; Carrington, Mark/0000-0002-6435-7266	Spanish Plan Nacional [BFU 2009-07510]; Wellcome Trust [085956/Z/08/Z]; Royal Society Joint Project grant [2008/R2]	Spanish Plan Nacional(Spanish Government); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society Joint Project grant(Royal Society of London)	AME was funded by Spanish Plan Nacional, grant BFU 2009-07510. MC was funded by The Wellcome Trust, grant 085956/Z/08/Z. AME and MC were jointly funded by the Royal Society Joint Project grant, grant 2008/R2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Clayton CE, 2014, MOL BIOCH PARASITOL; Clayton CE, 2005, METH MOL B, V309, P39; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; Creamer KM, 2011, WIRES RNA, V2, P632, DOI 10.1002/wrna.80; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Fernandez-Moya SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048870; Genest PA, 2005, NUCLEIC ACIDS RES, V33, P1699, DOI 10.1093/nar/gki304; Guerra-Giraidez C, 2002, J CELL SCI, V115, P2651; Haenni S, 2009, NUCLEIC ACIDS RES, V37, P5007, DOI 10.1093/nar/gkp513; Haile S, 2007, MOL BIOCHEM PARASIT, V151, P52, DOI 10.1016/j.molbiopara.2006.10.005; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lowell JE, 2005, J CELL SCI, V118, P5721, DOI 10.1242/jcs.02688; Marina DB, 2013, GENE DEV, V27, P1851, DOI 10.1101/gad.226019.113; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Martinez-Calvillo S, 2004, EUKARYOT CELL, V3, P506, DOI 10.1128/EC.3.2.506-517.2004; MICHAELI S, 1992, MOL BIOCHEM PARASIT, V51, P55, DOI 10.1016/0166-6851(92)90200-4; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Patrick KL, 2009, P NATL ACAD SCI USA, V106, P17933, DOI 10.1073/pnas.0907766106; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Tschudi C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-427; van Luenen HGAM, 2012, CELL, V150, P909, DOI 10.1016/j.cell.2012.07.030; Vasquez JJ, 2014, NUCLEIC ACIDS RES, V42, P3623, DOI 10.1093/nar/gkt1386; Webb S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r8; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhu YY, 2013, MOL CELL, V49, P298, DOI 10.1016/j.molcel.2012.11.011	40	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107608	10.1371/journal.pone.0107608	http://dx.doi.org/10.1371/journal.pone.0107608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215501	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300086
J	Xie, XF; Song, YB; Zhang, YL; Pan, X; Dong, M				Xie, Xiu-Fang; Song, Yao-Bin; Zhang, Ya-Lin; Pan, Xu; Dong, Ming			Phylogenetic Meta-Analysis of the Functional Traits of Clonal Plants Foraging in Changing Environments	PLOS ONE			English	Article							FILE-DRAWER PROBLEM; MORPHOLOGICAL PLASTICITY; NUTRIENT AVAILABILITY; QUANTITATIVE REVIEWS; GROWTH; HERB; COMPETITION; RESOURCE; LIGHT; INTEGRATION	Foraging behavior, one of the adaptive strategies of clonal plants, has stimulated a tremendous amount of research. However, it is a matter of debate whether there is any general pattern in the foraging traits (functional traits related to foraging behavior) of clonal plants in response to diverse environments. We collected data from 97 published papers concerning the relationships between foraging traits (e.g., spacer length, specific spacer length, branch intensity and branch angle) of clonal plants and essential resources (e.g., light, nutrients and water) for plant growth and reproduction. We incorporated the phylogenetic information of 85 plant species to examine the universality of foraging hypotheses using phylogenetic meta-analysis. The trends toward forming longer spacers and fewer branches in shaded environments were detected in clonal plants, but no evidence for a relation between foraging traits and nutrient availability was detected, except that there was a positive correlation between branch intensity and nutrient availability in stoloniferous plants. The response of the foraging traits of clonal plants to water availability was also not obvious. Additionally, our results indicated that the foraging traits of stoloniferous plants were more sensitive to resource availability than those of rhizomatous plants. In consideration of plant phylogeny, these results implied that the foraging traits of clonal plants (notably stoloniferous plants) only responded to light intensity in a general pattern but did not respond to nutrient or water availability. In conclusion, our findings on the effects of the environment on the foraging traits of clonal plants avoided the confounding effects of phylogeny because we incorporated phylogeny into the meta-analysis.	[Xie, Xiu-Fang; Song, Yao-Bin; Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China; [Xie, Xiu-Fang; Zhang, Ya-Lin; Pan, Xu; Dong, Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Hangzhou Normal University; Chinese Academy of Sciences; Institute of Botany, CAS	Song, YB (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China.	ybsong@hznu.edu.cn; dongmingchina@126.com		xie, xiu fang/0000-0002-7405-9844	NFSC [31261120580]; Hangzhou Normal University [201203]; Project of Zhejiang Key Scientific and Technological Innovation Team [2010R50039]	NFSC(National Natural Science Foundation of China (NSFC)); Hangzhou Normal University; Project of Zhejiang Key Scientific and Technological Innovation Team	This research was supported by NFSC grants (31261120580, http://www.nsfc.gov.cn), the Innovative R & D grant (201203) from Hangzhou Normal University, and the Project of Zhejiang Key Scientific and Technological Innovation Team (2010R50039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2008, EVOLUTION, V62, P567, DOI 10.1111/j.1558-5646.2007.00314.x; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Beckmann M, 2012, J VEG SCI, V23, P1197, DOI 10.1111/j.1654-1103.2012.01454.x; Begg C., 1994, HDB RES SYNTHESIS, P399; Bell DL, 2008, AM J BOT, V95, P59, DOI 10.3732/ajb.95.1.59; Bolnick DI, 2005, ECOLOGY, V86, P2771, DOI 10.1890/04-1249; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Chamberlain SA, 2012, ECOL LETT, V15, P627, DOI 10.1111/j.1461-0248.2012.01776.x; de Vries FT, 2012, OECOLOGIA, V170, P821, DOI 10.1007/s00442-012-2331-y; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; DONG M, 1993, NEW PHYTOL, V124, P291, DOI 10.1111/j.1469-8137.1993.tb03819.x; Dong M, 1997, PLANT ECOL, V131, P233, DOI 10.1023/A:1009783921753; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Dong M, 1996, VEGETATIO, V123, P183, DOI 10.1007/BF00118270; DONG M, 1995, VEGETATIO, V116, P25; Dong Ming, 1996, Acta Botanica Sinica, V38, P828; EVANS JP, 1995, ECOLOGY, V76, P1147, DOI 10.2307/1940922; Fedorov S, 2008, GETDATA GRAPH DIGITI; Fischer M, 2001, EVOL ECOL, V15, P565, DOI 10.1023/A:1016013721469; Gates S, 2002, J ANIM ECOL, V71, P547, DOI 10.1046/j.1365-2656.2002.00634.x; GUREVITCH J, 1992, AM NAT, V140, P539, DOI 10.1086/285428; Gurevitch J, 2001, ADV ECOL RES, V32, P199, DOI 10.1016/S0065-2504(01)32013-5; Gurevitch J., 2001, DESIGNS ANAL ECOLOGI, P347; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Honnay O, 2008, EVOL ECOL, V22, P299, DOI 10.1007/s10682-007-9202-8; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; HUTCHINGS MJ, 1988, TRENDS ECOL EVOL, V3, P200, DOI 10.1016/0169-5347(88)90007-9; Jonsdottir I.S., 1997, ECOLOGY EVOLUTION CL, P109; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; Kolasa J., 1991, ECOLOGICAL HETEROGEN, V86, P1, DOI DOI 10.1007/978-1-4612-3062-5_1; Lajeunesse MJ, 2011, BIOINFORMATICS, V27, P2603, DOI 10.1093/bioinformatics/btr438; Lajeunesse MJ, 2009, AM NAT, V174, P369, DOI 10.1086/603628; Lajeunesse MJ, 2003, ECOL LETT, V6, P448, DOI 10.1046/j.1461-0248.2003.00448.x; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Lovell P, 1985, STUDIES PLANT DEMOGR, P209; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nakagawa S, 2012, EVOLUTIONARY ECOLOGY, P1; Oborny B, 2012, ECOL MODEL, V234, P20, DOI 10.1016/j.ecolmodel.2011.12.017; PRACH K, 1994, SPEC FEAT VEGET SCI, V4, P307; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1111/j.0014-3820.2005.tb01004.x; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rosenthal R, 1991, METAANALYTIC PROCEDU; Sachs T, 2001, EVOL ECOL, V15, P485, DOI 10.1023/A:1016053402813; SLADE AJ, 1987, J ECOL, V75, P95, DOI 10.2307/2260538; SLADE AJ, 1987, J ECOL, V75, P639, DOI 10.2307/2260196; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; Song YB, 2014, PAKISTAN J IN PRESS; Stoll P, 1998, J ECOL, V86, P341, DOI 10.1046/j.1365-2745.1998.00263.x; Sullivan L, 2010, PLANT ECOL, V207, P121, DOI 10.1007/s11258-009-9658-4; SULTAN SE, 1987, EVOL BIOL, V21, P127; SUTHERLAND WJ, 1988, OIKOS, V52, P239, DOI 10.2307/3565196; Tamm A, 2001, EVOL ECOL, V15, P383, DOI 10.1023/A:1016093116926; THOMPSON L, 1988, OECOLOGIA, V75, P343, DOI 10.1007/BF00376935; van Kleunen M, 2000, EVOLUTION, V54, P1947, DOI 10.1111/j.0014-3820.2000.tb01239.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; VANDERHOEVEN EC, 1990, VEGETATIO, V86, P151; Wang MC, 1998, PSYCHOL METHODS, V3, P46, DOI 10.1037/1082-989X.3.1.46; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Weigelt A, 2005, PLANT ECOL, V176, P57, DOI 10.1007/s11258-004-0016-2; Wolf F.M., 1986, METAANALYSIS QUANTIT	66	28	29	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107114	10.1371/journal.pone.0107114	http://dx.doi.org/10.1371/journal.pone.0107114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216101	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300043
J	Gomez, F; Aranda, A; Campo, P; Diaz-Perales, A; Blanca-Lopez, N; Perkins, J; Garrido, M; Blanca, M; Mayorga, C; Torres, MJ				Gomez, Francisca; Aranda, Ana; Campo, Paloma; Diaz-Perales, Araceli; Blanca-Lopez, Natalia; Perkins, James; Garrido, Maria; Blanca, Miguel; Mayorga, Cristobalina; Jose Torres, Maria			High Prevalence of Lipid Transfer Protein Sensitization in Apple Allergic Patients with Systemic Symptoms	PLOS ONE			English	Article							FOOD HYPERSENSITIVITY; POLLEN SENSITIZATION; MALUS-DOMESTICA; DOUBLE-BLIND; IN-VIVO; PROFILIN; IDENTIFICATION; REACTIVITY; DIAGNOSIS; BET-V-2	Background: Apple allergy manifests as two main groups of clinical entities reflecting different patterns of allergen sensitization: oral allergy syndrome (OAS) and generalized symptoms (GS). Objective: We analysed the sensitization profile to a wide panel of different components of food allergens (rMal d 1, Mal d 2, rMal d 3, rMal d 4, rPru p 3, rBet v 1 and Pho d 2) for a population of Mediterranean patients with OAS and GS to apple. Methods: Patients (N = 81) with a history of apple allergy that could be confirmed by positive prick-prick test and/or double-blind-placebo-controlled food challenge (DBPCFC), were included. Skin prick test (SPT) and ELISA were performed using a panel of inhalant, fruit and nut allergens. ELISA and ELISA inhibition studies were performed in order to analyse the sensitization patterns. Results: Thirty-five cases (43.2%) had OAS and 46 (56.8%) GS. SPT showed a significantly higher number of positive results with peach, cherry and hazelnut in those with GS. ELISA showed a significantly high percentage of positive cases to rMal d 3, rMal d 4, rPru p 3 and Pho d 2 in patients with OAS and GS compared to controls, and to rBet v 1 in patients with OAS vs controls and between OAS and GS patients. Three different patterns of recognition were detected: positive to LTP (rMal d 3 or rPru p 3), positive to profilin (rMal d 4 and Pho d 2), or positive to both. There were also patients with rMal d 1 recognition who showed cross-reactivity to rBet v 1. Conclusion: In an apple allergy population with a high incidence of pollinosis different patterns of sensitization may occur. LTP is most often involved in those with GS. Profilin, though more prevalent in patients with OAS, has been shown to sensitise patients with both types of symptoms.	[Gomez, Francisca; Campo, Paloma; Blanca, Miguel; Mayorga, Cristobalina; Jose Torres, Maria] Reg Univ Hosp Malaga, UMA, IBIMA, Allergy Serv, Malaga, Spain; [Aranda, Ana; Perkins, James; Mayorga, Cristobalina] Reg Univ Hosp Malaga, UMA, IBIMA, Res Lab, Malaga, Spain; [Diaz-Perales, Araceli; Garrido, Maria] Ctr Plant Biotechnol & Genom, Dept Biotechnol, Madrid, Spain; [Blanca-Lopez, Natalia] Infanta Leonor Hosp, Allergy Serv, Madrid, Spain	Universidad de Malaga; Universidad de Malaga; Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP); Hospital Universitario Infanta Leonor	Torres, MJ (corresponding author), Reg Univ Hosp Malaga, UMA, IBIMA, Allergy Serv, Malaga, Spain.	mjtorresj@gmail.com	Torres, Maria/GVU-3391-2022; Mayorga, Cristobalina/D-7167-2018; Garrido-Arandia, Maria/ABG-9760-2020; Díaz-Perales, Araceli/D-8433-2016; Mayorga, Lina/FBO-7730-2022; Torres, María José/T-3518-2017; Perkins, James Richard/H-8629-2017	Mayorga, Cristobalina/0000-0001-8852-8077; Díaz-Perales, Araceli/0000-0002-1093-3627; Torres, María José/0000-0001-5228-471X; Perkins, James Richard/0000-0003-4108-096X; Garrido Arandia, Maria/0000-0001-6114-5754	FIS-Thematic Networks and Co-operative Research Centre: RIRAAF [RD07/0064]; FIS-Thematic Networks and Co-operative Research Centre: ISCIII [PI12/02481]	FIS-Thematic Networks and Co-operative Research Centre: RIRAAF; FIS-Thematic Networks and Co-operative Research Centre: ISCIII	The study was funded by the FIS-Thematic Networks and Co-operative Research Centres: RIRAAF (RD07/0064) and ISCIII PI12/02481. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MBS, 2011, CLIN REV ALLERG IMMU, V41, P4, DOI 10.1007/s12016-009-8177-3; Asero R, 2008, CLIN EXP ALLERGY, V38, P1033, DOI 10.1111/j.1365-2222.2008.02980.x; Asero R, 2000, INT ARCH ALLERGY IMM, V122, P20, DOI 10.1159/000024355; Barber D, 2008, ALLERGY, V63, P1550, DOI 10.1111/j.1398-9995.2008.01807.x; Bolhaar STHP, 2005, J ALLERGY CLIN IMMUN, V116, P1080, DOI 10.1016/j.jaci.2005.07.004; Cuesta-Herranz J, 2000, CLIN EXP ALLERGY, V30, P1411, DOI 10.1046/j.1365-2222.2000.00868.x; Cuesta-Herranz J, 2010, INT ARCH ALLERGY IMM, V153, P182, DOI 10.1159/000312636; Diaz-Perales A, 2000, CLIN EXP ALLERGY, V30, P1403, DOI 10.1046/j.1365-2222.2000.00909.x; DREBORG S, 1993, ALLERGY, V48, P49, DOI 10.1111/j.1398-9995.1993.tb04756.x; EBNER C, 1995, J ALLERGY CLIN IMMUN, V95, P962, DOI 10.1016/S0091-6749(95)70096-X; ERIKSSON NE, 1982, ALLERGY, V37, P437, DOI 10.1111/j.1398-9995.1982.tb02323.x; Fernandez-Rivas M, 1997, J ALLERGY CLIN IMMUN, V100, P728, DOI 10.1016/S0091-6749(97)70265-3; Fernandez-Rivas M, 2006, J ALLERGY CLIN IMMUN, V118, P481, DOI 10.1016/j.jaci.2006.05.012; Garcia-Selles FJ, 2002, INT ARCH ALLERGY IMM, V128, P115, DOI 10.1159/000059401; Gonzalez-Mancebo E, 2008, J ALLERGY CLIN IMMUN, V121, P1507, DOI 10.1016/j.jaci.2008.01.029; Kanny G, 2001, J ALLERGY CLIN IMMUN, V108, P133, DOI 10.1067/mai.2001.116427; KIVITY S, 1994, CLIN EXP ALLERGY, V24, P19, DOI 10.1111/j.1365-2222.1994.tb00911.x; Krebitz M, 2003, J MOL BIOL, V329, P721, DOI 10.1016/S0022-2836(03)00403-0; Ma Y, 2006, CLIN EXP ALLERGY, V36, P1087, DOI 10.1111/j.1365-2222.2006.02541.x; Mari A, 2003, CLIN EXP ALLERGY, V33, P1419, DOI 10.1046/j.1365-2222.2003.01773.x; Mari A, 2001, INT ARCH ALLERGY IMM, V125, P57, DOI 10.1159/000053797; ORTOLANI C, 1988, ANN ALLERGY, V61, P47; Palacin A, 2010, CLIN EXP ALLERGY, V40, P1422, DOI 10.1111/j.1365-2222.2010.03578.x; Palacin A, 2012, PLOS ONE; Pastorello EA, 1999, J ALLERGY CLIN IMMUN, V104, P1099, DOI 10.1016/S0091-6749(99)70095-3; Pastorello EA, 2011, INT ARCH ALLERGY IMM, V156, P362, DOI 10.1159/000324440; Scheurer S, 2001, J CHROMATOGR B, V756, P315, DOI 10.1016/S0378-4347(01)00090-1; VANEKKREBITZ M, 1995, BIOCHEM BIOPH RES CO, V214, P538, DOI 10.1006/bbrc.1995.2320	28	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107304	10.1371/journal.pone.0107304	http://dx.doi.org/10.1371/journal.pone.0107304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210741	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900058
J	Jose, JC; Chatterjee, P; Sengupta, N				Jose, Jaya C.; Chatterjee, Prathit; Sengupta, Neelanjana			Cross Dimerization of Amyloid-beta and alpha Synuclein Proteins in Aqueous Environment: A Molecular Dynamics Simulations Study	PLOS ONE			English	Article							BINDING INTERFACES SIMILARITIES; LOCALLY PLANAR SURFACES; ASP23-LYS28 SALT-BRIDGE; LEWY-BODY-DISEASE; A-BETA; ALZHEIMERS-DISEASE; STRUCTURAL ENSEMBLE; GLOBULAR-PROTEINS; DESOLVATION COSTS; OXIDATIVE STRESS	Self-assembly of the intrinsically unstructured proteins, amyloid beta (A beta) and alpha synclein (alpha Syn), are associated with Alzheimer's Disease, and Parkinson's and Lewy Body Diseases, respectively. Importantly, pathological overlaps between these neurodegenerative diseases, and the possibilities of interactions between A beta and alpha Syn in biological milieu emerge from several recent clinical reports and in vitro studies. Nevertheless, there are very few molecular level studies that have probed the nature of spontaneous interactions between these two sequentially dissimilar proteins and key characteristics of the resulting cross complexes. In this study, we have used atomistic molecular dynamics simulations to probe the possibility of cross dimerization between alpha Syn(1-95) and A beta(1-42), and thereby gain insights into their plausible early assembly pathways in aqueous environment. Our analyses indicate a strong probability of association between the two sequences, with inter-protein attractive electrostatic interactions playing dominant roles. Principal component analysis revealed significant heterogeneity in the strength and nature of the associations in the key interaction modes. In most, the interactions of repeating Lys residues, mainly in the imperfect repeats 'KTKEGV' present in alpha Syn(1-95) were found to be essential for cross interactions and formation of inter-protein salt bridges. Additionally, a hydrophobicity driven interaction mode devoid of salt bridges, where the non-amyloid component (NAC) region of alpha Syn(1-95) came in contact with the hydrophobic core of A beta(1-42) was observed. The existence of such hetero complexes, and therefore hetero assembly pathways may lead to polymorphic aggregates with variations in pathological attributes. Our results provide a perspective on development of therapeutic strategies for preventing pathogenic interactions between these proteins.	[Jose, Jaya C.; Chatterjee, Prathit; Sengupta, Neelanjana] CSIR, Natl Chem Lab, Div Phys Chem, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Sengupta, N (corresponding author), CSIR, Natl Chem Lab, Div Phys Chem, Pune, Maharashtra, India.	n.sengupta@ncl.res.in		Chatterjee, Prathit/0000-0002-5293-5153	CSIR 12th FYP Multi-Scale Simulation and Modeling project (MSM) [CSC0129]; Center of Excellence for Sustainable Polymer Industry through Research Innovation & Training (CoE-SPIRIT) through Department of Chemical and Petrochemicals	CSIR 12th FYP Multi-Scale Simulation and Modeling project (MSM); Center of Excellence for Sustainable Polymer Industry through Research Innovation & Training (CoE-SPIRIT) through Department of Chemical and Petrochemicals	Funding for this project was received from CSIR 12th FYP Multi-Scale Simulation and Modeling project (or MSM; project number CSC0129), and from Center of Excellence for Sustainable Polymer Industry through Research Innovation & Training (CoE-SPIRIT), established through a grant from the Department of Chemical and Petrochemicals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2014, J BIOL CHEM M, V113, DOI DOI 10.1074/JBC.M113.524520; Anand P, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3021062; [Anonymous], CCP4 NEWSLETT PROTEI; Ball KA, 2011, BIOCHEMISTRY-US, V50, P7612, DOI 10.1021/bi200732x; Barz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034345; Bate C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-55; Berhanu WM, 2013, ACS CHEM NEUROSCI, V4, P1488, DOI 10.1021/cn400141x; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Cappai R, 2008, NEUROCHEM RES, V33, P526, DOI 10.1007/s11064-007-9469-8; Chatelier RC, 1996, BIOPHYS J, V71, P2367, DOI 10.1016/S0006-3495(96)79430-4; Cheng PN, 2012, NAT CHEM, V4, P927, DOI [10.1038/NCHEM.1433, 10.1038/nchem.1433]; Chong SH, 2012, P NATL ACAD SCI USA, V109, P7636, DOI 10.1073/pnas.1120646109; Crews L, 2009, NEUROTOX RES, V16, P306, DOI 10.1007/s12640-009-9073-6; da Silva FL, 2013, NEUROCHEM INT, V62, P103, DOI 10.1016/j.neuint.2012.10.001; de Oliveira CAF, 2007, J CHEM PHYS, V127; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Dutt S, 2013, J ORG CHEM, V78, P6721, DOI 10.1021/jo4009673; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fadouloglou VE, 2009, J CHEM THEORY COMPUT, V5, P3299, DOI 10.1021/ct9002338; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Furini S, 2013, NUCLEIC ACIDS RES, V41, P3963, DOI 10.1093/nar/gkt099; Games D, 2013, AM J PATHOL, V182, P940, DOI 10.1016/j.ajpath.2012.11.018; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Gvritishvili AG, 2008, PROTEIN SCI, V17, P1285, DOI 10.1110/ps.034975.108; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hamelberg D., 2007, J CHEM PHYS, V127; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jana AK, 2013, PHYS CHEM CHEM PHYS, V15, P837, DOI 10.1039/c2cp42933k; Jana AK, 2012, BIOPHYS J, V102, P1889, DOI 10.1016/j.bpj.2012.03.036; Jellinger KA, 2011, THESCIENTIFICWORLDJO, V11, P1893, DOI 10.1100/2011/371893; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kanda S, 2000, NEUROSCIENCE, V97, P279, DOI 10.1016/S0306-4522(00)00077-4; Kim HY, 2007, CHEMBIOCHEM, V8, P1671, DOI 10.1002/cbic.200700366; Lajtha A, 2009, HDB NEUROCHEMISTRY M, P599; Lee C, 2011, J COMPUT CHEM, V32, P349, DOI 10.1002/jcc.21628; Li J, 2011, BIOPHYS J, V100, P1076, DOI 10.1016/j.bpj.2010.12.3741; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Liao MQ, 2007, FEBS LETT, V581, P1161, DOI 10.1016/j.febslet.2007.02.026; Lin YS, 2012, BIOPHYS J, V102, P315, DOI 10.1016/j.bpj.2011.12.002; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Viet MH, 2011, J PHYS CHEM B, V115, P7433, DOI 10.1021/jp1116728; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Markwick PRL, 2011, PHYS CHEM CHEM PHYS, V13, P20053, DOI 10.1039/c1cp22100k; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Meuzelaar H, 2014, J PHYS CHEM LETT, V5, P900, DOI 10.1021/jz500029a; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Minton AP, 1999, BIOPHYS J, V76, P176, DOI 10.1016/S0006-3495(99)77187-0; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Nguyen PH, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4866902; Ono K, 2012, J NEUROCHEM, V122, P883, DOI 10.1111/j.1471-4159.2012.07847.x; OSAPAY K, 1991, J AM CHEM SOC, V113, P9436, DOI 10.1021/ja00025a002; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Prabhudesai S, 2012, NEUROTHERAPEUTICS, V9, P464, DOI 10.1007/s13311-012-0105-1; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rao JN, 2010, J AM CHEM SOC, V132, P8657, DOI 10.1021/ja100646t; Reddy G, 2009, J PHYS CHEM B, V113, P1162, DOI 10.1021/jp808914c; Resende R, 2013, NEUROCHEM RES, V38, P797, DOI 10.1007/s11064-013-0982-7; Rezaei-Ghaleh N, 2014, J AM CHEM SOC, V136, P4913, DOI 10.1021/ja411707y; Rosenman DJ, 2013, J MOL BIOL, V425, P3338, DOI 10.1016/j.jmb.2013.06.021; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salari R, 2012, J PHYS CHEM B, V116, P2561, DOI 10.1021/jp210172b; Salari R, 2010, J PHYS CHEM LETT, V1, P2844, DOI 10.1021/jz1010863; Schafer H, 2001, PROTEINS, V43, P45, DOI 10.1002/1097-0134(20010401)43:1<45::AID-PROT1016>3.0.CO;2-N; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Sinha S, 2011, J AM CHEM SOC, V133, P16958, DOI 10.1021/ja206279b; Sinha SK, 2010, LANGMUIR, V26, P9911, DOI 10.1021/la1012389; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tarus B, 2006, J AM CHEM SOC, V128, P16159, DOI 10.1021/ja064872y; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Ullman O, 2011, J AM CHEM SOC, V133, P19536, DOI 10.1021/ja208657z; Wan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076045; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wise-Scira O, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3662490; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288	93	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106883	10.1371/journal.pone.0106883	http://dx.doi.org/10.1371/journal.pone.0106883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210774	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900027
J	Kwak, MJ; Jeong, H; Madhaiyan, M; Lee, Y; Sa, TM; Oh, TK; Kim, JF				Kwak, Min-Jung; Jeong, Haeyoung; Madhaiyan, Munusamy; Lee, Yi; Sa, Tong-Min; Oh, Tae Kwang; Kim, Jihyun F.			Genome Information of Methylobacterium oryzae, a Plant-Probiotic Methylotroph in the Phyllosphere	PLOS ONE			English	Article							AEROBIC ANOXYGENIC PHOTOTROPHS; ACYL-HOMOSERINE LACTONE; GROWTH PROMOTION; EXTORQUENS AM1; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE; THIOSULFATE OXIDATION; PSEUDOMONAS-SYRINGAE; MIXOTROPHIC GROWTH; DEFENSE RESPONSES; ESCHERICHIA-COLI	Pink-pigmented facultative methylotrophs in the Rhizobiales are widespread in the environment, and many Methylobacterium species associated with plants produce plant growth-promoting substances. To gain insights into the life style at the phyllosphere and the genetic bases of plant growth promotion, we determined and analyzed the complete genome sequence of Methylobacterium oryzae CBMB20(T), a strain isolated from rice stem. The genome consists of a 6.29-Mb chromosome and four plasmids, designated as pMOC1 to pMOC4. Among the 6,274 coding sequences in the chromosome, the bacterium has, besides most of the genes for the central metabolism, all of the essential genes for the assimilation and dissimilation of methanol that are either located in methylotrophy islands or dispersed. M. oryzae is equipped with several kinds of genes for adaptation to plant surfaces such as defense against UV radiation, oxidative stress, desiccation, or nutrient deficiency, as well as high proportion of genes related to motility and signaling. Moreover, it has an array of genes involved in metabolic pathways that may contribute to promotion of plant growth; they include auxin biosynthesis, cytokine biosynthesis, vitamin B-12 biosynthesis, urea metabolism, biosorption of heavy metals or decrease of metal toxicity, pyrroloquinoline quinone biosynthesis, 1-aminocyclopropane-1-carboxylate deamination, phosphate solubilization, and thiosulfate oxidation. Through the genome analysis of M. oryzae, we provide information on the full gene complement of M. oryzae that resides in the aerial parts of plants and enhances plant growth. The plant-associated lifestyle of M. oryzae pertaining to methylotrophy and plant growth promotion, and its potential as a candidate for a bioinoculant targeted to the phyllosphere and focused on phytostimulation are illuminated.	[Kwak, Min-Jung; Kim, Jihyun F.] Yonsei Univ, Dept Syst Biol, Seoul 120749, South Korea; [Kwak, Min-Jung; Kim, Jihyun F.] Yonsei Univ, Div Life Sci, Seoul 120749, South Korea; [Kwak, Min-Jung; Jeong, Haeyoung; Oh, Tae Kwang; Kim, Jihyun F.] Korea Res Inst Biosci & Biotechnol, Taejon, South Korea; [Kwak, Min-Jung] Univ Sci & Technol, Biosyst & Bioengn Program, Taejon, South Korea; [Madhaiyan, Munusamy; Sa, Tong-Min] Chungbuk Natl Univ, Dept Agr Chem, Chongju, South Korea; [Madhaiyan, Munusamy] Natl Univ Singapore, Temasek Life Sci Lab, Biomat & Biocatalysts Grp, Singapore 117548, Singapore; [Lee, Yi] Chungbuk Natl Univ, Dept Ind Plant Sci & Technol, Chongju, South Korea; [Oh, Tae Kwang] 21C Frontier Microbial Genom & Applicat Ctr, Taejon, South Korea	Yonsei University; Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; National University of Singapore; Chungbuk National University	Kim, JF (corresponding author), Yonsei Univ, Dept Syst Biol, Seoul 120749, South Korea.	jfk1@yonsei.ac.kr	Kim, Jihyun F./B-6286-2013	Madhaiyan, Munusamy/0000-0002-0274-8931; Jeong, Haeyoung/0000-0002-4479-4573; Kwak, Min-Jung/0000-0002-0551-4807	Korean Ministry of Education, Science and Technology through the 21st Century Frontier R&D Program of Microbial Genomics and Applications Center; Rural Development Administration through the Next-Generation BioGreen 21 Program [PJ008201012012]; National Research Foundation of Korea [NRF-2011-0017670]	Korean Ministry of Education, Science and Technology through the 21st Century Frontier R&D Program of Microbial Genomics and Applications Center; Rural Development Administration through the Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	The authors are grateful for the financial assistance from the Korean Ministry of Education, Science and Technology through the 21st Century Frontier R&D Program of Microbial Genomics and Applications Center, the Rural Development Administration through the Next-Generation BioGreen 21 Program (PJ008201012012), and the National Research Foundation of Korea (NRF-2011-0017670). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD P, 1988, ANTIVIR RES, V9, P315, DOI 10.1016/0166-3542(88)90026-5; Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Anandham R, 2007, CAN J MICROBIOL, V53, P869, DOI 10.1139/W07-057; Anandham R, 2009, J MICROBIOL BIOTECHN, V19, P17, DOI 10.4014/jmb.0802.127; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bartel Bonnie, 1997, Annu Rev Plant Physiol Plant Mol Biol, V48, P51, DOI 10.1146/annurev.arplant.48.1.51; BASILE DV, 1985, BRYOLOGIST, V88, P77, DOI 10.2307/3242585; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Beattie GA, 1999, PHYTOPATHOLOGY, V89, P353, DOI 10.1094/PHYTO.1999.89.5.353; Beckers G, 2004, J BACTERIOL, V186, P7645, DOI 10.1128/JB.186.22.7645-7652.2004; Belimov AA, 2001, CAN J MICROBIOL, V47, P642, DOI 10.1139/cjm-47-7-642; Blanco Y, 2005, J BIOSCI BIOENG, V99, P366, DOI 10.1263/jbb.99.366; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Bonnin E, 2008, CARBOHYD POLYM, V74, P411, DOI 10.1016/j.carbpol.2008.03.014; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chimento DP, 2003, J MOL BIOL, V332, P999, DOI 10.1016/j.jmb.2003.07.005; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2007, J BACTERIOL, V189, P4020, DOI 10.1128/JB.00045-07; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; CORPE WA, 1985, J MICROBIOL METH, V3, P215, DOI 10.1016/0167-7012(85)90049-1; Csotonyi JT, 2010, ADV EXP MED BIOL, V675, P3, DOI 10.1007/978-1-4419-1528-3_1; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Dhillon BK, 2013, NUCLEIC ACIDS RES, V41, pW129, DOI 10.1093/nar/gkt394; Dorr J, 1998, MOL MICROBIOL, V30, P7, DOI 10.1046/j.1365-2958.1998.01010.x; Dosanjh NS, 2007, BIOCHEMISTRY-US, V46, P2520, DOI 10.1021/bi062092w; Ermolenko DN, 2002, CELL MOL LIFE SCI, V59, P1902, DOI 10.1007/PL00012513; FIALA V, 1990, NEW PHYTOL, V115, P609, DOI 10.1111/j.1469-8137.1990.tb00492.x; Francez-Charlot A, 2009, P NATL ACAD SCI USA, V106, P3467, DOI 10.1073/pnas.0810291106; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Galbally IE, 2002, J ATMOS CHEM, V43, P195, DOI 10.1023/A:1020684815474; GOOSEN N, 1992, J BACTERIOL, V174, P1426, DOI 10.1128/jb.174.4.1426-1427.1992; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Gourion B, 2006, P NATL ACAD SCI USA, V103, P13186, DOI 10.1073/pnas.0603530103; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Green PN, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P257, DOI 10.1007/0-387-30745-1_14; GREEN PN, 1988, INT J SYST BACTERIOL, V38, P124, DOI 10.1099/00207713-38-1-124; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gross DC, 2003, PSEUDOMONAS SYRINGAE AND RELATED PATHOGENS: BIOLOGY AND GENETICS, P137; HAEFELE DM, 1987, APPL ENVIRON MICROB, V53, P2528, DOI 10.1128/AEM.53.10.2528-2533.1987; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Idris R, 2004, APPL ENVIRON MICROB, V70, P2667, DOI 10.1128/AEM.70.5.2667-2677.2004; Indiragandhi P, 2008, WORLD J MICROB BIOT, V24, P1037, DOI 10.1007/s11274-007-9572-7; Jourand P, 2005, MOL PLANT MICROBE IN, V18, P1061, DOI 10.1094/MPMI-18-1061; Kakimoto T, 2003, J PLANT RES, V116, P233, DOI 10.1007/s10265-003-0095-5; Kaneko T, 2010, DNA RES, V17, P37, DOI 10.1093/dnares/dsp026; Kannenberg EL, 1999, NATURWISSENSCHAFTEN, V86, P168, DOI 10.1007/s001140050592; KNANI M, 1994, MICROBIOL-UK, V140, P2755, DOI 10.1099/00221287-140-10-2755; Koenig RL, 2002, J BACTERIOL, V184, P1832, DOI 10.1128/JB.184.7.1832-1842.2002; Koski LB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-151; Kutschera U, 2007, PLANT SIGNAL BEHAV, V2, P74, DOI 10.4161/psb.2.2.4073; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; LAWRENCE AJ, 1970, J GEN MICROBIOL, V63, P371, DOI 10.1099/00221287-63-3-371; Lee HS, 2006, BIOL FERTIL SOILS, V42; Leveau JHJ, 2009, NATURE, V461, P741, DOI 10.1038/461741a; Lidstrom ME, 2002, J BACTERIOL, V184, P1818, DOI 10.1128/JB.184.7.1818.2002; Lindow SE, 2002, CURR OPIN BIOTECH, V13, P238, DOI 10.1016/S0958-1669(02)00313-0; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lugtenberg BJJ, 1999, ENVIRON MICROBIOL, V1, P9, DOI 10.1046/j.1462-2920.1999.00005.x; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; Ma WB, 2003, ANTON LEEUW INT J G, V83, P285, DOI 10.1023/A:1023360919140; Madhaiyan M, 2007, CHEMOSPHERE, V69, P220, DOI 10.1016/j.chemosphere.2007.04.017; Madhaiyan M, 2006, CURR MICROBIOL, V53, P270, DOI 10.1007/s00284-005-0452-9; Madhaiyan M, 2009, MICROBIOL RES, V164, P114, DOI 10.1016/j.micres.2006.08.009; Madhaiyan M, 2007, J MICROBIOL BIOTECHN, V17, P1645; Madhaiyan M, 2007, PLANTA, V226, P867, DOI 10.1007/s00425-007-0532-0; Madhaiyan M, 2007, INT J SYST EVOL MICR, V57, P326, DOI 10.1099/ijs.0.64603-0; Madhaiyan M, 2006, PLANTA, V224, P268, DOI 10.1007/s00425-005-0211-y; Marx CJ, 2012, J BACTERIOL, V194, P4746, DOI 10.1128/JB.01009-12; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; McDonald IR, 2001, INT J SYST EVOL MICR, V51, P119, DOI 10.1099/00207713-51-1-119; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Okubo Y, 2007, OMICS, V11, P325, DOI 10.1089/omi.2007.0027; Omer ZS, 2004, PLANT GROWTH REGUL, V43, P93, DOI 10.1023/B:GROW.0000038360.09079.ad; Omer ZS, 2004, FEMS MICROBIOL ECOL, V47, P319, DOI 10.1016/S0168-6496(04)00003-0; Penalver CGN, 2006, FEBS LETT, V580, P561, DOI 10.1016/j.febslet.2005.12.062; Penrose DM, 2001, CAN J MICROBIOL, V47, P368, DOI 10.1139/cjm-47-4-368; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Poonguzhali S, 2008, APPL MICROBIOL BIOT, V78, P1033, DOI 10.1007/s00253-008-1398-1; Poonguzhali S, 2007, J MICROBIOL BIOTECHN, V17, P226; Rodriguez H, 2006, PLANT SOIL, V287, P15, DOI 10.1007/s11104-006-9056-9; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Ryu J, 2006, J MICROBIOL BIOTECHN, V16, P1622; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Springer AL, 1996, J BACTERIOL, V178, P2154, DOI 10.1128/jb.178.7.2154-2157.1996; Stiefel P, 2013, APPL ENVIRON MICROB, V79, P4895, DOI 10.1128/AEM.01087-13; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sy A, 2005, APPL ENVIRON MICROB, V71, P7245, DOI 10.1128/AEM.71.11.7245-7252.2005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Trotsenko YA, 2001, MICROBIOLOGY+, V70, P623, DOI 10.1023/A:1013167612105; Van Aken B, 2004, INT J SYST EVOL MICR, V54, P1191, DOI 10.1099/ijs.0.02796-0; Van Aken B, 2004, APPL ENVIRON MICROB, V70, P508, DOI 10.1128/AEM.70.1.508-517.2004; Van Dien SJ, 2003, APPL ENVIRON MICROB, V69, P7563, DOI 10.1128/AEM.69.12.7563-7566.2003; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; VANDERHOEF LN, 1981, PLANT PHYSIOL, V67, P146, DOI 10.1104/pp.67.1.146; Vidyalakshmi R., 2009, World Journal of Agricultural Sciences, V5, P270; Vorholt JA, 2002, ARCH MICROBIOL, V178, P239, DOI 10.1007/s00203-002-0450-2; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Wang N, 1999, J BACTERIOL, V181, P1603, DOI 10.1128/JB.181.5.1603-1609.1999; Yergeau E, 2009, ISME J, V3, P340, DOI 10.1038/ismej.2008.111; Yim WJ, 2010, 19 WORLD C SOIL SCI; Yu XL, 2013, P NATL ACAD SCI USA, V110, pE425, DOI 10.1073/pnas.1221892110; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101	114	47	51	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106704	10.1371/journal.pone.0106704	http://dx.doi.org/10.1371/journal.pone.0106704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211235	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900023
J	Legrand, F; Boulkedid, R; Elie, V; Leroux, S; Valls, E; Valls-i-Soler, A; Van den Anker, JN; Jacqz-Aigrain, E				Legrand, Frederic; Boulkedid, Rym; Elie, Valery; Leroux, Stephanie; Valls, Elizabeth; Valls-i-Soler, Adolfo; Van den Anker, Johannes N.; Jacqz-Aigrain, Evelyne			A Delphi Process to Optimize Quality and Performance of Drug Evaluation in Neonates	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; CLINICAL-TRIALS; INTENSIVE-CARE; CHILDREN; PHARMACOLOGY; RECRUITMENT; GUIDELINES; MEDICINES; LESSONS; NETWORK	Background: Neonatal trials remain difficult to conduct for several reasons: in particular the need for study sites to have an existing infrastructure in place, with trained investigators and validated quality procedures to ensure good clinical, laboratory practices and a respect for high ethical standards. The objective of this work was to identify the major criteria considered necessary for selecting neonatal intensive care units that are able to perform drug evaluations competently. Methodology and Main Findings: This Delphi process was conducted with an international multidisciplinary panel of 25 experts from 13 countries, selected to be part of two committees (a scientific committee and an expert committee), in order to validate criteria required to perform drug evaluation in neonates. Eighty six items were initially selected and classified under 7 headings: "NICUs description - Level of care'' (21), "Ability to perform drug trials: NICU organization and processes (15), "Research Experience'' (12), "Scientific competencies and area of expertise'' (8), "Quality Management'' (16), "Training and educational capacity'' (8) and "Public involvement'' (6). Sixty-one items were retained and headings were rearranged after the first round, 34 were selected after the second round. A third round was required to validate 13 additional items. The final set includes 47 items divided under 5 headings. Conclusion: A set of 47 relevant criteria will help to NICUs that want to implement, conduct or participate in drug trials within a neonatal network identify important issues to be aware of. Summary Points: 1) Neonatal trials remain difficult to conduct for several reasons: in particular the need for study sites to have an existing infrastructure in place, with trained investigators and validated quality procedures to ensure good clinical, laboratory practices and a respect for high ethical standards. 2) The present Delphi study was conducted with an international multidisciplinary panel of 25 experts from 13 countries and aims to identify the major criteria considered necessary for selecting neonatal intensive care units (NICUs) that are able to perform drug evaluations competently. 3) Of the 86 items initially selected and classified under 7 headings - "NICUs description - Level of care'' (21), "Ability to perform drug trials: NICU organization and processes (15), "Research Experience'' (12), "Scientific competencies and area of expertise'' (8), "Quality Management'' (16), "Training and educational capacity'' (8) and "Public involvement'' (6) - 47 items were selected following a three rounds Delphi process. 4) The present consensus will help NICUs to implement, conduct or participate in drug trials within a neonatal network.	[Legrand, Frederic; Elie, Valery; Leroux, Stephanie; Jacqz-Aigrain, Evelyne] Univ Paris 07, Hop Robert Debre, AP HP,Ctr Invest Clin Pediat, Dept Paediat Pharmacol & Pharmacogenet,Inserm CIC, Paris, France; [Boulkedid, Rym] Hop Robert Debre, AP HP, Unite Rech Clin, Inserm CIE5,Ctr Inves Clin Epidemiol Clin, F-75019 Paris, France; [Valls, Elizabeth; Valls-i-Soler, Adolfo] Univ Basque Country, Cruces Univ Hosp, Neonatal Intens Care Unit, Barakaldo Bilbao, Spain; [Van den Anker, Johannes N.] Childrens Natl Hlth Syst, Div Clin Pharmacol, Washington, DC USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hospital Universitario Cruces; University of Basque Country; Children's National Health System	Jacqz-Aigrain, E (corresponding author), Univ Paris 07, Hop Robert Debre, AP HP,Ctr Invest Clin Pediat, Dept Paediat Pharmacol & Pharmacogenet,Inserm CIC, Paris, France.	evelyne.jacqzaigrain@gmail.com	Jacqz-Aigrain, Evelyne/AAW-7089-2021	Jacqz-Aigrain, Evelyne/0000-0002-4285-7067	European Union (Global Research in Paediatrics Network - GRiP) [261060]	European Union (Global Research in Paediatrics Network - GRiP)	The research leading to these results has received funding from the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no. 261060 (Global Research in Paediatrics Network - GRiP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GUID INV MED PROD TE; Billett AL, 2013, PEDIATRICS, V131, pS196, DOI 10.1542/peds.2012-3786F; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Bush Andrew, 2006, Paediatr Drugs, V8, P271, DOI 10.2165/00148581-200608050-00001; Campbell MK, 2007, HEALTH TECHNOL ASSES, V11; Cella M, 2011, BRIT J CLIN PHARMACO, V72, P454, DOI 10.1111/j.1365-2125.2011.03992.x; Doyle LW, 2006, SEMIN FETAL NEONAT M, V11, P139, DOI 10.1016/j.siny.2005.11.009; Ellsbury DL, 2012, CLIN PERINATOL, V39, P1, DOI 10.1016/j.clp.2011.12.001; Franck LS, 2005, J PERINAT NEONAT NUR, V19, P177, DOI 10.1097/00005237-200504000-00015; Green B, 1999, HEALTH SOC CARE COMM, V7, P198, DOI 10.1046/j.1365-2524.1999.00176.x; Griffin T, 2006, J PERINAT NEONAT NUR, V20, P98, DOI 10.1097/00005237-200601000-00029; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Horbar J D, 1999, Pediatrics, V103, P350; Horbar JD, 2010, CLIN PERINATOL, V37, P29, DOI 10.1016/j.clp.2010.01.003; Jacqz-Aigrain E, 2012, PEDIATR CLIN N AM, V59, P1117, DOI 10.1016/j.pcl.2012.07.004; Jairath N, 1994, Can J Nurs Adm, V7, P29; Kaguelidou F, 2013, J CLIN EPIDEMIOL, V66, P1151, DOI 10.1016/j.jclinepi.2013.04.015; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Lake ET, 2012, JAMA-J AM MED ASSOC, V307, P1709, DOI 10.1001/jama.2012.504; Lannon CM, 2013, PEDIATRICS, V131, pS189, DOI 10.1542/peds.2012-3786E; Laventhal N, 2012, PEDIATR CLIN N AM, V59, P1205, DOI 10.1016/j.pcl.2012.07.007; McKechnie L, 2006, ARCH DIS CHILD-FETAL, V91, P374, DOI 10.1136/adc.2005.075036; Menoni V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018484; Moran C, 2009, CLIN PHARMACOL THER, V86, P589, DOI 10.1038/clpt.2009.175; Nahata MC, 2008, CLIN THER, V30, P2112, DOI 10.1016/j.clinthera.2008.11.020; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Richey RH, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-81; Ruperto N, 2012, ARCH DIS CHILD, V97, P185, DOI 10.1136/archdischild-2011-300286; Shilling V, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15150; Tod M, 2008, CLIN PHARMACOKINET, V47, P231, DOI 10.2165/00003088-200847040-00002; Ward FR, 2010, J EMPIR RES HUM RES, V5, P47, DOI 10.1525/jer.2010.5.2.47; WHITEHEAD J, 1983, BIOMETRICS, V39, P227, DOI 10.2307/2530822	33	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e104976	10.1371/journal.pone.0104976	http://dx.doi.org/10.1371/journal.pone.0104976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210742	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900002
J	Schreuder, LJ; Parish, T				Schreuder, Lise J.; Parish, Tanya			Mycobacterium tuberculosis DosR is Required for Activity of the P-mbtB and P-mbtI Promoters under Hypoxia	PLOS ONE			English	Article							GENE-EXPRESSION; NONREPLICATING PERSISTENCE; IRON STORAGE; MACROPHAGES; REGULATOR; SURVIVAL; INFECTION; GROWTH; IDER; TRANSCRIPTION	Mycobacterium tuberculosis has the ability to survive for extended periods of time under conditions of low oxygen, low pH, low iron and low nutrients. The mycobactins (M. tuberculosis siderophores) play a key role in scavenging iron from the environment and are induced in response to low iron in an IdeR-regulated manner. We demonstrate that the promoters of two mycobactin gene (mbt) operons are also expressed during adaptation to low oxygen, and that this expression is dependent on the DosR regulator. Up-regulation of mbt operons induced by low iron was not DosR-dependent. DosR is a member of a two component regulatory system which responds to oxygen availability. Deletion of the DosR regulator led to increased expression of bacterioferritin and increased capacity to grow under iron depletion. These data provide a link between the mycobacterial response to two conditions likely to be encountered in vivo, low iron and low oxygen.	[Schreuder, Lise J.; Parish, Tanya] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA	University of London; Queen Mary University London	Parish, T (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.	tanya.parish@idri.org			Bill and Melinda Gates Foundation [42786]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded by grant no. 42786 from the Bill and Melinda Gates Foundation to the Imaging TB Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Carroll P, 2009, ASSAYING PROMOTER AC; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Chim N, 2013, J INORG BIOCH; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Dhingra S, 2012, FEMS MICROBIOL LETT, V330, P66, DOI 10.1111/j.1574-6968.2012.02534.x; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Ghosh S, 2011, MOL BIOSYST, V7, P2750, DOI 10.1039/c1mb05093a; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Lugo-Villarino G, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00405; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12; Parish T, 2003, J BACTERIOL, V185, P6702, DOI 10.1128/JB.185.22.6702-6706.2003; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad Tige R., 2008, V465, P13, DOI 10.1007/978-1-59745-207-6_2; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Saunders BM, 1999, IMMUNOLOGY, V98, P324; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Trauner A, 2012, J BIOL CHEM, V287, P24053, DOI 10.1074/jbc.M112.364851; Wayne L. G., 2001, VITRO MODEL HYPOXICA; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	37	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107283	10.1371/journal.pone.0107283	http://dx.doi.org/10.1371/journal.pone.0107283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211224	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900055
J	Goodwin, JS; Jaramillo, E; Yang, L; Kuo, YF; Tan, A				Goodwin, James S.; Jaramillo, Elizabeth; Yang, Liu; Kuo, Yong-Fang; Tan, Alai			Is Anyone Listening? Variation in PSA Screening among Providers for Men 75+before and after United States Preventive Services Task Force Recommendations against It: A Retrospective Cohort Study	PLOS ONE			English	Article							PRIMARY-CARE PHYSICIANS; PROSTATE-CANCER; OLDER-ADULTS; QUALITY INDICATORS; US; IMPACT; CERTIFICATION; PUBLICATION; MAMMOGRAPHY; ALGORITHMS	Background: In 2008, the United States Preventive Services Task Force recommended against prostate specific antigen (PSA) testing for cancer screening in men age 75+. Purpose: To assess PSA screening by primary care physicians (PCPs) before and after recommendations. Methods: In 2013, this retrospective cohort study analyzed PCPs in Texas with 20+ male patients aged 75+ in both 2007 and 2010, with Parts A and B Medicare. The main outcome was percent of PCP's male patients 75+ who received PSA testing ordered by the PCP in 2007 and 2010, with no recent symptoms suggestive of prostate cancer. Results: In both 2007 and 2010, 1,083 PCPs cared for at least 20 men aged 75 or older. The rate of PSA screening ordered by PCPs was 33.2% in 2007 and 30.6% in 2010. In multilevel analyses controlling for patient characteristics, the variation in PSA screening attributable to the PCP (intraclass correlation coefficient) increased from 23% in 2007 to 26% in 2010, p<0.001. Men with PCPs older than age 60 had 9% lower odds (95% CI, 1-17%) in 2010 compared to 2007 of receiving a PSA test, vs. a 4% increase (95% CI, 4% decrease to 12% increase) in men with PCPs aged 50 or younger. Patients with Board Certified PCPs had a 12% lower odds (95% CI, 8% to 16%) from 2007 to 2010, vs. 2% increase (95% CI 11% decrease to 18% increase) in men with PCPs without board certification. Conclusions: The USPSTF recommendation did not increase consensus among PCPs regarding PSA screening of older men.	[Goodwin, James S.; Jaramillo, Elizabeth; Yang, Liu; Kuo, Yong-Fang; Tan, Alai] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA; [Goodwin, James S.; Jaramillo, Elizabeth] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Goodwin, James S.; Kuo, Yong-Fang; Tan, Alai] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Goodwin, JS (corresponding author), Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA.	jsgoodwi@utmb.edu			Cancer Prevention and Research Institute of Texas [RP101207]; National Institutes of Health [K05CA134923]; Agency for Healthcare Research and Quality [R24HS022134]; University of Texas Medical Branch Clinical and Translational Science [UL1TR00007]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R24HS022134] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K05CA134923] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000007] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); University of Texas Medical Branch Clinical and Translational Science; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was funded by The Comparative Effectiveness Research on Cancer in Texas (CERCIT) grant RP101207 from the Cancer Prevention and Research Institute of Texas; grant K05CA134923 from the National Institutes of Health; grant R24HS022134 from the Agency for Healthcare Research and Quality; and The University of Texas Medical Branch Clinical and Translational Science Award UL1TR00007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAFP, USPSTF ISS FIN REC R; Adams JL, 2010, NEW ENGL J MED, V362, P1014, DOI 10.1056/NEJMsa0906323; American Urological Association (AUA), 2000, ONCOLOGY WILLISTON P, V14, P267; Beaulieu MD, 2001, QJM-INT J MED, V94, P301, DOI 10.1093/qjmed/94.6.301; Bynum J, 2010, J AM GERIATR SOC, V58, P674, DOI 10.1111/j.1532-5415.2010.02761.x; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Chen J, 2006, J GEN INTERN MED, V21, P238, DOI 10.1111/j.1525-1497.2006.00326.x; Cowen ME, 2002, MED CARE, V40, P650, DOI 10.1097/00005650-200208000-00004; Economic Research Service of the US Department of Agriculture, 2013, RUR URB CONT COD; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gerber AS, 2010, HEALTH AFFAIR, V29, P1882, DOI 10.1377/hlthaff.2010.0185; Goodwin JS, 2013, JNCI-J NATL CANCER I, V105, P743, DOI 10.1093/jnci/djt039; Guerra CE, 2008, MED DECIS MAKING, V28, P681, DOI 10.1177/0272989X08315243; Hawley ST, 2000, MED CARE, V38, P392, DOI 10.1097/00005650-200004000-00006; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Howard DH, 2013, HEALTH AFFAIR, V32, P596, DOI 10.1377/hlthaff.2012.0555; Howrey BT, 2013, J GERONTOL A-BIOL, V68, P56, DOI 10.1093/gerona/gls135; Jaramillo E, 2013, JAMA-J AM MED ASSOC, V310, P1622, DOI 10.1001/jama.2013.277514; Katz MH, 2012, ARCH INTERN MED, V172, P178, DOI 10.1001/archinternmed.2011.1253; Lee SJ, 2011, JAMA-J AM MED ASSOC, V306, P1481, DOI 10.1001/jama.2011.1418; Medicare Learning Network, 2012, REM MED PROV COV PRO; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Murphy DG, 2014, BJU INT, V113, P186, DOI 10.1111/bju.12556; Nichols C, 2009, AM J MED QUAL, V24, P116, DOI 10.1177/1062860608328603; Norcini J, 2001, ACAD MED, V76, pS21, DOI 10.1097/00001888-200110001-00008; Pasad SM, 2012, JAMA-J AM MED ASSOC, V307, P1692; Pollack CE, 2012, ARCH INTERN MED, V172, P668, DOI 10.1001/archinternmed.2012.135; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ross JS, 2012, ARCH INTERN MED, V172, P1601, DOI 10.1001/archinternmed.2012.3726; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Shah BR, 2007, HEALTH SERV RES, V42, P1783, DOI 10.1111/j.1475-6773.2006.00681.x; Singal AK, 2013, HEALTH SERV RES, V48, P95, DOI 10.1111/j.1475-6773.2012.01433.x; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Sixma HJ, 1998, MED CARE, V36, P212, DOI 10.1097/00005650-199802000-00010; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Steinbrook R, 2007, NEW ENGL J MED, V356, P331, DOI 10.1056/NEJMp068282; Tan A, 2013, AM J EPIDEMIOL, V178, P974, DOI 10.1093/aje/kwt054; Tan A, 2013, J AM GERIATR SOC, V61, P380, DOI 10.1111/jgs.12151; Tasian GE, 2012, PROSTATE CANCER P D, V15, P189, DOI 10.1038/pcan.2011.59; Torke AM, 2013, JAMA INTERN MED, V173, P526, DOI 10.1001/jamainternmed.2013.2903; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Wallner Lauren, 2012, Perm J, V16, P4; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278; Wennberg JE, 2010, TRACKING MED RES QUE; Zeliadt SB, 2011, J NATL CANCER I, V103, P520, DOI 10.1093/jnci/djr007	47	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107352	10.1371/journal.pone.0107352	http://dx.doi.org/10.1371/journal.pone.0107352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25208250	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300077
J	Moen, A; Schistad, EI; Rygh, LJ; Roe, C; Gjerstad, J				Moen, Aurora; Schistad, Elina Iordanova; Rygh, Lars Jorgen; Roe, Cecilie; Gjerstad, Johannes			Role of IL1A rs1800587, IL1B rs1143627 and IL1RN rs2234677 Genotype Regarding Development of Chronic Lumbar Radicular Pain; a Prospective One-Year Study	PLOS ONE			English	Article							INTERVERTEBRAL DISC DEGENERATION; LOW-BACK-PAIN; ANTAGONIST GENE; INCREASED RISK; IN-VITRO; ALLELE 2; INTERLEUKIN-1; POLYMORPHISMS; HERNIATION; ASSOCIATION	Previous studies indicate that lumbar radicular pain following disc herniation may be associated with release of several proinflammatory mediators, including interleukin-1 (IL1). In the present study, we examined how genetic variability in IL1A (rs1800587 C>T), IL1B (rs1143627 T>C) and IL1RN (rs2234677 G>A) influenced the clinical outcome the first year after disc herniation. Patients (n = 258) with lumbar radicular pain due to disc herniation were recruited from two hospitals in Norway. Pain and disability were measured by visual analogue scale (VAS) and Oswestry Disability Index (ODI) over a 12 month period. The result showed that patients with the IL1A T allele, in combination with the IL1RN A allele had more pain and a slower recovery than other patients (VAS p = 0.049, ODI p = 0.059 rmANOVA; VAS p = 0.003, ODI p = 0.050 one-way ANOVA at 12 months). However, regarding the IL1B/IL1RN genotype, no clear effect on recovery was observed (VAS p = 0.175, ODI p = 0.055 rmANOVA; VAS p = 0.105, ODI p = 0.214 one-way ANOVA at 12 months). The data suggest that the IL1A T/IL1RN A genotype, but not the IL1B T/IL1RN A genotype, may increase the risk of a chronic outcome in patients following disc herniation.	[Moen, Aurora; Gjerstad, Johannes] Natl Inst Occupat Hlth, Oslo, Norway; [Moen, Aurora; Schistad, Elina Iordanova; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Schistad, Elina Iordanova; Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway; [Rygh, Lars Jorgen] Haukeland Hosp, Dept Anesthesiol & Intens Care, N-5021 Bergen, Norway; [Gjerstad, Johannes] Univ Oslo, Dept Mol Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Oslo	Moen, A (corresponding author), Natl Inst Occupat Hlth, Oslo, Norway.	aurora.moen@stami.no		Schistad, Elina/0000-0003-4239-3298				Clay FE, 1996, HUM GENET, V97, P723; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dominguez CA, 2013, PAIN, V154, P427, DOI 10.1016/j.pain.2012.12.003; Dominici R, 2002, IMMUNOGENETICS, V54, P82, DOI 10.1007/s00251-002-0445-9; Ghaffari M, 2008, OCCUP MED-OXFORD, V58, P341, DOI 10.1093/occmed/kqn006; Grotle M, 2003, J REHABIL MED, V35, P241, DOI 10.1080/16501970306094; Hoyland JA, 2008, RHEUMATOLOGY, V47, P809, DOI 10.1093/rheumatology/ken056; Jacobsen LM, 2013, CLIN J PAIN; Jimbo K, 2005, J NEUROSURG-SPINE, V2, P589, DOI 10.3171/spi.2005.2.5.0589; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; Karppinen J, 2008, EUR J PAIN, V12, P1018, DOI 10.1016/j.ejpain.2008.01.009; Karppinen J, 2008, SPINE, V33, P1236, DOI 10.1097/BRS.0b013e318170fd0e; Langdahl BL, 2000, J BONE MINER RES, V15, P402, DOI 10.1359/jbmr.2000.15.3.402; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Lind H, 2007, CYTOKINE, V38, P43, DOI 10.1016/j.cyto.2007.05.001; Liu L, 2009, PHARMACOGENET GENOM, V19, P869, DOI 10.1097/FPC.0b013e328331e68f; Olsen MB, 2012, J NEUROSCI, V32, P9831, DOI 10.1523/JNEUROSCI.1742-12.2012; Aparicio JP, 2011, EUR SPINE J, V20, P383, DOI 10.1007/s00586-011-1915-2; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; Schistad EI, 2014, CLIN J PAIN, V30, P869, DOI 10.1097/AJP.0000000000000048; Skoff AM, 2009, EXP NEUROL, V217, P395, DOI 10.1016/j.expneurol.2009.03.022; Solovieva S, 2004, EPIDEMIOLOGY, V15, P626, DOI 10.1097/01.ede.0000135179.04563.35; Solovieva S, 2004, PAIN, V109, P8, DOI 10.1016/j.pain.2003.10.020; Sommer C, 1999, NEUROSCI LETT, V270, P25, DOI 10.1016/S0304-3940(99)00450-4; Sorensen IG, 2011, SPINE, V36, P1541, DOI 10.1097/BRS.0b013e3181f9b8d4; Takahashi H, 1996, SPINE, V21, P218, DOI 10.1097/00007632-199601150-00011; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Tountas NA, 1999, GASTROENTEROLOGY, V117, P806, DOI 10.1016/S0016-5085(99)70338-0; Younes M, 2006, JOINT BONE SPINE, V73, P538, DOI 10.1016/j.jbspin.2005.10.022	29	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107301	10.1371/journal.pone.0107301	http://dx.doi.org/10.1371/journal.pone.0107301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207923	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300073
J	Xie, XM; Liang, QY				Xie, Xingmei; Liang, Qiaoyi			Establishment of a 10-Plex Quantitative Fluorescent-PCR Assay for Rapid Diagnosis of Sex Chromosome Aneuploidies	PLOS ONE			English	Article								Sex chromosome aneuploidies occur commonly in the general population, with an incidence of 1 in 400 newborns. However, no tests specifically targeting sex chromosomes have been carried out in prenatal diagnosis or newborn screening, resulting in late recognition of these diseases. In this study, a rapid diagnostic method for sex chromosome aneuploidies was established using Quantitative Fluorescent-PCR (QF-PCR). Ten markers were included in one multiplex QF-PCR assay, including two sex determination genes (AMXY and SRY), five X-linked short tandem repeats (STRs; DXS1053, DXS981, DXS6809, DXS1187, and DXS8377), one X/Y-common STR (X22), and two autosomal STRs (D13S305 and D21S11). Retrospective tests of 70 cases with known cytogenetic results indicated that the 10-plex QF-PCR assay could well determine sex chromosome copy numbers by both allelic peak numbers and a sex chromosome dosage calculation with the autosomal STRs as internal controls. Prospective comparison with cytogenetic karyotyping on 534 cases confirmed that the 10-plex QF-PCR assay could be well employed for sex chromosome aneuploidy diagnosis in at least the Chinese Han population. This is the first QF-PCR test for the diagnosis of sex chromosome aneuploidies in the Chinese population. This test is superior to previous designs by including up to 8 sex-linked markers covering different parts of sex chromosomes as well as employing internal controls for copy number dosage calculation in a single PCR reaction. Due to simple technique and data analysis, as well as easy implementation within routine clinical services, this method is of great clinical application value and could be widely applied.	[Xie, Xingmei; Liang, Qiaoyi] Guangzhou Women & Childrens Med Ctr, Prenatal Diagnost Ctr, Guangzhou, Guangdong, Peoples R China; [Liang, Qiaoyi] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Liang, Qiaoyi] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut,State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Liang, QY (corresponding author), Guangzhou Women & Childrens Med Ctr, Prenatal Diagnost Ctr, Guangzhou, Guangdong, Peoples R China.	JessieQY@cuhk.edu.hk	Liang, Qiaoyi Jessie/G-9612-2019	Liang, Qiaoyi Jessie/0000-0001-8496-3442	National Natural Science Foundation of China (NSFC) [81272304]; Shenzhen Municipal Science and Technology R & D funding of basic research program [JCYJ20130401151108652]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Science and Technology R & D funding of basic research program	=Y This study was supported by the National Natural Science Foundation of China (NSFC) ( 81272304) and a Shenzhen Municipal Science and Technology R & D funding of basic research program (JCYJ20130401151108652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Cirigliano V, 1999, PRENATAL DIAG, V19, P1099, DOI 10.1002/(SICI)1097-0223(199912)19:12<1099::AID-PD709>3.0.CO;2-2; Cirigliano V, 2002, MOL HUM REPROD, V8, P1042, DOI 10.1093/molehr/8.11.1042; Gravholt CH, 2005, HORM RES, V64, P86, DOI 10.1159/000087763; Gravholt Claus Højbjerg, 2005, Arq Bras Endocrinol Metab, V49, P145, DOI 10.1590/S0004-27302005000100019; Lathi RB, 2004, FERTIL STERIL, V81, P1270, DOI 10.1016/j.fertnstert.2003.09.065; LINDEN MG, 1995, PEDIATRICS, V96, P672; Schmidt W, 2000, MOL HUM REPROD, V6, P855, DOI 10.1093/molehr/6.9.855; Simpson JL, 2003, GENET MED, V5, P460, DOI 10.1097/01.GIM.0000095626.54201.D0	9	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106307	10.1371/journal.pone.0106307	http://dx.doi.org/10.1371/journal.pone.0106307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207978	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300018
J	Alves, DMCC; Terribile, LC; Brito, D				Alves, Davi M. C. C.; Terribile, Levi C.; Brito, Daniel			The Potential Impact of White-Nose Syndrome on the Conservation Status of North American Bats	PLOS ONE			English	Article							WEST-NILE-VIRUS; EMERGING DISEASE; EXTINCTION; EMERGENCE; SPREAD; RISK	White-Nose syndrome (WNS) is an emergent infectious disease that has already killed around six million bats in North America and has spread over two thousand kilometers from its epicenter. However, only a few studies on the possible impacts of the fungus on bat hosts were conducted, particularly concerning its implications for bat conservation. We predicted the consequences of WNS spread by generating a map with potential areas for its occurrence based on environmental conditions in sites where the disease already occurs, and overlaid it with the geographic distribution of all hibernating bats in North America. We assumed that all intersection localities would negatively affect local bat populations and reassessed their conservation status based on their potential population decline. Our results suggest that WNS will not spread widely throughout North America, being mostly restricted to the east and southeast regions. In contrast, our most pessimistic scenario of population decline indicated that the disease would threaten 32% of the bat species. Our results could help further conservation plans to preserve bat diversity in North America.	[Alves, Davi M. C. C.] Univ Fed Goias, Dept Ecol, Lab Ecol Teor & Sintese, Goiania, Go, Brazil; [Terribile, Levi C.] Univ Fed Goias, Lab Macroecol, Jatai, Go, Brazil; [Brito, Daniel] Univ Fed Goias, Dept Ecol, Lab Ecol Aplicada & Conservacao, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Alves, DMCC (corresponding author), Univ Fed Goias, Dept Ecol, Lab Ecol Teor & Sintese, Goiania, Go, Brazil.	davimello22@gmail.com	Brito, Daniel/A-4014-2008; Terribile, Levi Carina/AAW-1102-2021	Brito, Daniel/0000-0003-1131-4622; Terribile, Levi Carina/0000-0001-8420-9300	CNPq; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Daniel Brito is supported by CNPq and Davi Alves is supported by CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bat Conservation International, 2014, WHIT NOS SYNDR; Blehert DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002779; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Brito D, 2012, J NAT CONSERV, V20, P72, DOI 10.1016/j.jnc.2011.10.003; Brooks RT, 2011, BIODIVERS CONSERV, V20, P2537, DOI 10.1007/s10531-011-9996-0; Coleman J, 2011, NATL PLAN ASSISTING; Cryan PM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-47; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Oliveira G, 2014, ECOGRAPHY, V37, P637, DOI 10.1111/j.1600-0587.2013.00564.x; Dzal Y, 2011, BIOL LETTERS, V7, P392, DOI 10.1098/rsbl.2010.0859; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; European Space Agency, 2014, GLOBCOVER LAND COV M; Flory AR, 2012, J APPL ECOL, V49, P680, DOI 10.1111/j.1365-2664.2012.02129.x; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Hijmans R. J., 2013, PACKAGE DISMO SPECIE; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; International Union for Conservation of Nature and Natural Resources, 2014, SPAT DAT DOWNL; INTERNATIONAL UNION FOR CONSERVATION OF NATURE AND NATURAL RESOURCES, 2011, GUID US IUCN RED LIS; Jachowski DS, 2014, DIVERS DISTRIB, V20, P1002, DOI 10.1111/ddi.12192; Johnson PTJ, 2006, P NATL ACAD SCI USA, V103, P3011, DOI 10.1073/pnas.0600293103; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Knudsen GR, 2013, NORTHWEST SCI, V87, P292, DOI 10.3955/046.087.0401; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Maher SP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2301; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Ristaino JB, 2000, ANNU REV PHYTOPATHOL, V38, P541, DOI 10.1146/annurev.phyto.38.1.541; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Thogmartin WE, 2013, BIOL CONSERV, V160, P162, DOI 10.1016/j.biocon.2013.01.010; Thogmartin WE, 2012, J MAMMAL, V93, P1086, DOI 10.1644/11-MAMM-A-355.1; Varela S, 2014, ECOGRAPHY, V37, P1084, DOI 10.1111/j.1600-0587.2013.00441.x; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Vilela B, 2014, PACKAGE LETSR TOOLS; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; WHITENOSESYNDROME. org, 2014, WHIT NOS SYNDR MAP; Wilder AP, 2011, BIOL LETTERS, V7, P950, DOI 10.1098/rsbl.2011.0355; WORLDCLIM, 2014, FREE CLIM DAT EC MOD	49	16	18	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107395	10.1371/journal.pone.0107395	http://dx.doi.org/10.1371/journal.pone.0107395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203391	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500094
J	Bautista-Caro, MB; Arroyo-Villa, I; Castillo-Gallego, C; de Miguel, E; Peiteado, D; Plasencia-Rodriguez, C; Villalba, A; Sanchez-Mateos, P; Puig-Kroger, A; Martin-Mola, E; Miranda-Carus, ME				Bautista-Caro, Maria-Belen; Arroyo-Villa, Irene; Castillo-Gallego, Concepcion; de Miguel, Eugenio; Peiteado, Diana; Plasencia-Rodriguez, Chamaida; Villalba, Alejandro; Sanchez-Mateos, Paloma; Puig-Kroeger, Amaya; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia			Decreased Frequencies of Circulating Follicular Helper T Cell Counterparts and Plasmablasts in Ankylosing Spondylitis Patients Naive for TNF Blockers	PLOS ONE			English	Article							SOCIETY CLASSIFICATION CRITERIA; CXC CHEMOKINE RECEPTOR-5; SYSTEMIC AUTOIMMUNITY; AXIAL SPONDYLOARTHRITIS; DISEASE-ACTIVITY; RESPONSES; IMMUNITY; GUT; INFLAMMATION; PERMEABILITY	Follicular helper T cells (Tfh), localized in lymphoid organs, promote B cell differentiation and function. Circulating CD4 T cells expressing CXCR5, ICOS and/or PD-1 are counterparts of Tfh. Three subpopulations of circulating CD4+CXCR5+ cells have been described: CXCR3+CCR6-(Tfh-Th1), CXCR3-CCR6+ (Tfh-Th17), and CXCR3-CCR6-(Tfh-Th2). Only Tfh-Th17 and Tfh-Th2 function as B cell helpers. Our objective was to study the frequencies of circulating Tfh (cTfh), cTfh subsets and plasmablasts (CD19+CD20-CD27+CD38(high) cells), and the function of cTfh cells, in patients with Ankylosing Spondylitis (AS). To this end, peripheral blood was drawn from healthy controls (HC) (n = 50), AS patients naive for TNF blockers (AS/nb) (n = 25) and AS patients treated with TNF blockers (AS/b) (n = 25). The frequencies of cTfh and plasmablasts were determined by flow cytometry. Cocultures of magnetically sorted CD4+CXCR5+ T cells with autologous CD19+ CD27-naive B cells were established from 3 AS/nb patients and 3 HC, and concentrations of IgG, A and M were measured in supernatants. We obseved that AS/nb but not AS/b patients, demonstrated decreased frequencies of circulating CD4+CXCR5+ICOS+PD-1+ cells and plasmablasts, together with a decreased (Tfh-Th17+ Tfh-Th2)/Tfh-Th1 ratio. The amounts of IgG and IgA produced in cocultures of CD4+CXCR5+ T cells with CD19+CD27-B cells of AS/nb patients were significantly lower than observed in cocultures established from HC. In summary, AS/nb but not AS/b patients, demonstrate a decreased frequency of cTfh and plasmablasts, and an underrepresentation of cTfh subsets bearing a B helper phenotype. In addition, peripheral blood CD4+CXCR5+ T cells of AS/nb patients showed a decreased capacity to help B cells ex vivo.	[Bautista-Caro, Maria-Belen; Arroyo-Villa, Irene; Castillo-Gallego, Concepcion; de Miguel, Eugenio; Peiteado, Diana; Plasencia-Rodriguez, Chamaida; Villalba, Alejandro; Martin-Mola, Emilio; Miranda-Carus, Maria-Eugenia] Hosp Univ La Paz IdiPAZ, Dept Rheumatol, Madrid, Spain; [Sanchez-Mateos, Paloma; Puig-Kroeger, Amaya] Hosp Gen Univ Gregorio Maranon, Lab Inmunooncol, Madrid, Spain	Hospital Universitario La Paz; General University Gregorio Maranon Hospital	Miranda-Carus, ME (corresponding author), Hosp Univ La Paz IdiPAZ, Dept Rheumatol, Madrid, Spain.	mariaeugenia.miranda@salud.madrid.org	Puig, Amaya/B-6164-2015; Miranda-Carus, Maria-Eugenia/S-7403-2019; Sanchez-Mateos, Paloma/E-8931-2013	Puig, Amaya/0000-0003-2943-9757; Sanchez-Mateos, Paloma/0000-0001-6589-4445	Fondo de Investigacion Sanitaria grant from Ministerio de Economia y Competitividad/Instituto de Salud Carlos III (MINECO/ISCIII) [PI-13/00084]; RETICS Program, (Red de Investigacion en Inflamacion y enfermedades Reumaticas - RIER) from MINECO/ISCIII [RD12/0009/0012]; Comunidad Autonoma de Madrid/Fondo Europeo de Desarrollo Regional RAPHYME	Fondo de Investigacion Sanitaria grant from Ministerio de Economia y Competitividad/Instituto de Salud Carlos III (MINECO/ISCIII); RETICS Program, (Red de Investigacion en Inflamacion y enfermedades Reumaticas - RIER) from MINECO/ISCIII; Comunidad Autonoma de Madrid/Fondo Europeo de Desarrollo Regional RAPHYME	This work was supported by Fondo de Investigacion Sanitaria grant PI-13/00084 from Ministerio de Economia y Competitividad/Instituto de Salud Carlos III (MINECO/ISCIII) (www.isciii.es), by RETICS Program RD12/0009/0012 (Red de Investigacion en Inflamacion y enfermedades Reumaticas - RIER) from MINECO/ISCIII (www.isciii.es), and by Comunidad Autonoma de Madrid/Fondo Europeo de Desarrollo Regional RAPHYME (http://www.madrimasd.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus C, 2012, CURR OPIN RHEUMATOL, V24, P351, DOI 10.1097/BOR.0b013e3283534df4; Baerlecken NT, 2014, ANN RHEUM DIS, V73, P1211, DOI 10.1136/annrheumdis-2012-202208; Baraliakos X, 2014, ANN RHEUM DIS, V73, P1079, DOI 10.1136/annrheumdis-2012-202177; Bergqvist P, 2010, J IMMUNOL, V184, P3545, DOI 10.4049/jimmunol.0901895; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cantaert T, 2012, ARTHRITIS RHEUM-US, V64, P1859, DOI 10.1002/art.34364; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Chou CL, 2010, CLIN RHEUMATOL, V29, P875, DOI 10.1007/s10067-010-1413-7; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Demetter P, 2002, J PATHOL, V198, P517, DOI 10.1002/path.1235; Duftner C, 2006, RHEUMATOLOGY, V45, P38, DOI 10.1093/rheumatology/kei109; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021698; FRANSSEN MJAM, 1985, ANN RHEUM DIS, V44, P766, DOI 10.1136/ard.44.11.766; GEORGOPOULOS K, 1985, CLIN EXP IMMUNOL, V62, P662; Gibson PR, 2004, GUT, V53, P1724, DOI 10.1136/gut.2004.047092; Hron JD, 2004, J EXP MED, V200, P261, DOI 10.1084/jem.20040526; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710, DOI 10.1152/ajpgi.2001.280.4.G710; Ji YR, 2012, J BIOL CHEM, V287, P42269, DOI 10.1074/jbc.M112.374835; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Le Coz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075319; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Luo CM, 2013, J NEUROIMMUNOL, V256, P55, DOI 10.1016/j.jneuroim.2012.12.001; Machado P, 2011, ANN RHEUM DIS, V70, P47, DOI 10.1136/ard.2010.138594; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; MARTINEZGONZALEZ O, 1994, BRIT J RHEUMATOL, V33, P644; MIELANTS H, 1991, J RHEUMATOL, V18, P1542; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; RICHTER MB, 1983, CLIN EXP IMMUNOL, V53, P51; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Salinas GF, 2013, ANN RHEUM DIS, V72, P1037, DOI 10.1136/annrheumdis-2011-201270; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Song IH, 2010, ARTHRITIS RHEUM-US, V62, P1290, DOI 10.1002/art.27383; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Szabo K, 2013, CLIN IMMUNOL, V147, P95, DOI 10.1016/j.clim.2013.02.024; TRULL A, 1984, CLIN EXP IMMUNOL, V55, P74; Van Praet L, 2012, NAT REV RHEUMATOL, V8, P288, DOI 10.1038/nrrheum.2012.42; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vinuesa CG, 2011, IMMUNITY, V34, P10, DOI 10.1016/j.immuni.2011.01.006; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wang J, 2013, CLIN EXP IMMUNOL, V174, P212, DOI 10.1111/cei.12162; Wang M, 2011, RHEUMATOL INT, V31, P1009, DOI 10.1007/s00296-010-1403-8; Wu S, 2014, MOD RHEUMATOL; Xiao F, 2013, J RHEUMATOL, V40, P2029, DOI 10.3899/jrheum.130125; Zhu CL, 2012, J CLIN ENDOCR METAB, V97, P943, DOI 10.1210/jc.2011-2003; Zimmermann K, 2012, GUT MICROBES, V3, P42, DOI 10.4161/gmic.19344	52	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107086	10.1371/journal.pone.0107086	http://dx.doi.org/10.1371/journal.pone.0107086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203742	Green Submitted, gold, Green Published			2022-12-27	WOS:000342684500067
J	Mahmoud, AAA; Elshazly, SM				Mahmoud, Amr A. A.; Elshazly, Shimaa M.			Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats	PLOS ONE			English	Article							IMPROVES INSULIN SENSITIVITY; CORONARY-HEART-DISEASE; FATTY LIVER-DISEASE; ENDOTHELIAL DYSFUNCTION; NITRIC-OXIDE; HYPERTENSIVE-RATS; DIETARY FRUCTOSE; OXIDATIVE STRESS; RESISTANCE; FENOFIBRATE	The metabolic syndrome (MS) is characterized by insulin resistance, dyslipidemia and hypertension. It is associated with increased risk of cardiovascular diseases and type-2 diabetes. Consumption of fructose is linked to increased prevalence of MS. Ursodeoxycholic acid (UDCA) is a steroid bile acid with antioxidant, anti-inflammatory activities and has been shown to improve insulin resistance. The current study aims to investigate the effect of UDCA (150 mg/kg) on MS induced in rats by fructose administration (10%) in drinking water for 12 weeks. The effects of UDCA were compared to fenofibrate (100 mg/kg), an agonist of PPAR-a receptors. Treatment with UDCA or fenofibrate started from the 6 th week after fructose administration once daily. Fructose administration resulted in significant increase in body weight, elevations of blood glucose, serum insulin, cholesterol, triglycerides, advanced glycation end products (AGEs), uric acid levels, insulin resistance index and blood pressure compared to control rats. Moreover, fructose increased oxidative stress in aortic tissues indicated by significant increases of malondialdehyde (MDA), expression of iNOS and reduction of reduced glutathione (GSH) content. These disturbances were associated with decreased eNOS expression, increased infiltration of leukocytes and loss of aortic vascular elasticity. Treatment with UDCA successfully ameliorated the deleterious effects of fructose. The protective effect of UDCA could be attributed to its ability to decrease uric acid level, improve insulin resistance and diminish oxidative stress in vascular tissues. These results might support possible clinical application of UDCA in MS patients especially those present with liver diseases, taking into account its tolerability and safety. However, further investigations on human subjects are needed before the clinical application of UDCA for this indication.	[Mahmoud, Amr A. A.; Elshazly, Shimaa M.] Zagazig Univ, Fac Pharm, Dept Pharmacol, Zagazig, Egypt	Egyptian Knowledge Bank (EKB); Zagazig University	Elshazly, SM (corresponding author), Zagazig Univ, Fac Pharm, Dept Pharmacol, Zagazig, Egypt.	shimaa_elshazly@yahoo.com	Mahmoud, Amr A. A./Y-7062-2019	Mahmoud, Amr A. A./0000-0003-2959-0692				Angulo Paul, 2002, Curr Gastroenterol Rep, V4, P37, DOI 10.1007/s11894-002-0036-9; Ardestani A, 2007, INT J BIOL MACROMOL, V41, P572, DOI 10.1016/j.ijbiomac.2007.07.014; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Cavarape A, 2001, J ENDOCRINOL INVEST, V24, P838, DOI 10.1007/BF03343940; Chou CL, 2011, ARCH MED SCI, V7, P882, DOI 10.5114/aoms.2011.25566; Comar KM, 2006, ALIMENT PHARM THER, V23, P207, DOI 10.1111/j.1365-2036.2006.02751.x; DECAESTECKER JS, 1991, GUT, V32, P1061, DOI 10.1136/gut.32.9.1061; Delbosc S, 2005, ATHEROSCLEROSIS, V179, P43, DOI 10.1016/j.atherosclerosis.2004.10.018; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; HALLFRISCH J, 1990, FASEB J, V4, P2652, DOI 10.1096/fasebj.4.9.2189777; Hempfling W, 2003, ALIMENT PHARM THER, V18, P963, DOI 10.1046/j.1365-2036.2003.01792.x; Hink U, 2001, CIRC RES, V88, pE14; Ho Chiu-Yung, 2004, J Chin Med Assoc, V67, P245; Hodel C, 2002, TOXICOL LETT, V128, P159, DOI 10.1016/S0378-4274(02)00010-3; HULMAN S, 1994, PEDIATR RES, V36, P95, DOI 10.1203/00006450-199407001-00017; Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; IYER SN, 1994, LIFE SCI, V55, pPL139, DOI 10.1016/0024-3205(94)00750-0; Juan CC, 1998, J HYPERTENS, V16, P1775, DOI 10.1097/00004872-199816120-00010; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Koh KK, 2005, DIABETES CARE, V28, P1419, DOI 10.2337/diacare.28.6.1419; Kondrackiene J, 2005, GASTROENTEROLOGY, V129, P894, DOI 10.1053/j.gastro.2005.06.019; Laville M, 2009, OBES REV, V10, P24, DOI 10.1111/j.1467-789X.2008.00562.x; Le KA, 2006, CURR OPIN CLIN NUTR, V9, P469, DOI 10.1097/01.mco.0000232910.61612.4d; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Luketic V A, 1994, Gastroenterologist, V2, P74; Ma J, 2003, EUR J PHARMACOL, V464, P79, DOI 10.1016/S0014-2999(03)01373-6; Mahmoud MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063784; Mahmoud MF, 2012, ARCH PHARM RES, V35, P155, DOI 10.1007/s12272-012-0117-8; Makino I, 1998, J GASTROEN HEPATOL, V13, P659, DOI 10.1111/j.1440-1746.1998.tb00707.x; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Matsui HR, 1997, DIABETES, V46, P348, DOI 10.2337/diabetes.46.3.348; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller A, 2008, CURR OPIN GASTROEN, V24, P204, DOI 10.1097/MOG.0b013e3282f3f4c4; Miller AW, 1999, J VASC RES, V36, P385, DOI 10.1159/000025678; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Okada M, 2009, TOXICOL PATHOL, V37, P517, DOI 10.1177/0192623309336151; Polizio AH, 2006, CLIN EXP PHARMACOL P, V33, P734, DOI 10.1111/j.1440-1681.2006.04426.x; Ratziu V, 2011, J HEPATOL, V54, P1011, DOI 10.1016/j.jhep.2010.08.030; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RIGAL J, 1989, REV MED INTERNE, V10, P65, DOI 10.1016/S0248-8663(89)80119-5; Roy D, 1998, AM J PHYSIOL-ENDOC M, V274, pE692, DOI 10.1152/ajpendo.1998.274.4.E692; Ryan KE, 2007, ATHEROSCLEROSIS, V194, pE123, DOI 10.1016/j.atherosclerosis.2006.11.007; Sampathkumar R, 2005, METABOLISM, V54, P1002, DOI 10.1016/j.metabol.2005.02.017; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V294, pF710, DOI 10.1152/ajprenal.00454.2007; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006; SATOH K, 1978, CLIN CHIM ACTA, V90, P37; Shinozaki K, 1999, DIABETES, V48, P2437, DOI 10.2337/diabetes.48.12.2437; Sinisalo J, 1999, BRIT J CLIN PHARMACO, V47, P661, DOI 10.1046/j.1365-2125.1999.00940.x; Sokolovic D, 2013, DRUG CHEM TOXICOL, V36, P141, DOI 10.3109/01480545.2012.658919; Spiekermann S, 2003, CIRCULATION, V107, P1383, DOI 10.1161/01.CIR.0000056762.69302.46; Tabernero Antonia, 2002, BMC Pharmacol, V2, P10, DOI 10.1186/1471-2210-2-10; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Thirunavukkarasu V, 2004, NUTR METAB CARDIOVAS, V14, P351, DOI 10.1016/S0939-4753(04)80025-5; TOBEY TA, 1982, METABOLISM, V31, P608, DOI 10.1016/0026-0495(82)90100-7; Tran LT, 2009, MOL CELL BIOCHEM, V332, P145, DOI 10.1007/s11010-009-0184-4; Tsuchida T, 2012, METABOLISM, V61, P944, DOI 10.1016/j.metabol.2011.10.023; Ulker S, 2003, CARDIOVASC RES, V59, P488, DOI 10.1016/S0008-6363(03)00424-3; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Verma S, 1999, EUR J PHARMACOL, V373, pR1, DOI 10.1016/S0014-2999(99)00301-5; Vlassara H, 2001, DIABETES-METAB RES, V17, P436, DOI 10.1002/dmrr.233; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	71	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106993	10.1371/journal.pone.0106993	http://dx.doi.org/10.1371/journal.pone.0106993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202970	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500059
J	Vainer, GW; Saada, A; Kania-Almog, J; Amartely, A; Bar-Tana, J; Hertz, R				Vainer, Gilad W.; Saada, Ann; Kania-Almog, Juliane; Amartely, Adir; Bar-Tana, Jacob; Hertz, Rachel			PF-4708671 Activates AMPK Independently of p70S6K1 Inhibition	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN S6; CROSS-TALK; KINASE; MTOR; INSULIN	The P70 ribosomal protein S6 kinase 1 (P70S6K1) is activated by the mammalian target of rapamycin (mTORC1) and regulates proliferation, growth, and metabolism. PF-4708671 is a novel, cell-permeable, has been proposed to be a highly specific inhibitor of p70S6K1. It is used in micromolar concentration range to dissect signaling pathways downstream of mTORC1 and to study the function of p70S6K1. Here we show that PF-4708671 induces AMP-activated protein kinase (AMPK) phosphorylation and activation in immortalized mouse embryonic fibroblasts (MEF) independently of p70S6K1, due to specific inhibition of mitochondrial respiratory chain Complex I.	[Vainer, Gilad W.; Kania-Almog, Juliane] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Pathol, IL-69978 Tel Aviv, Israel; [Saada, Ann] Hadassah Hebrew Univ, Monique & Jacques Roboh Dept Genet Res, Med Ctr, Jerusalem, Israel; [Saada, Ann] Hadassah Hebrew Univ, Dept Genet & Metab Dis, Med Ctr, Jerusalem, Israel; [Amartely, Adir] Hadassah Hebrew Univ, Dept Pathol, Med Ctr, Jerusalem, Israel; [Bar-Tana, Jacob; Hertz, Rachel] Hebrew Univ Jerusalem, Sch Med, IL-91010 Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem	Vainer, GW (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Pathol, IL-69978 Tel Aviv, Israel.	giladwv@tlvmc.gov.il	Saada, Ann/J-6864-2017; Vainer, Gilad W./ABH-8314-2020	Saada, Ann/0000-0003-2951-0656; Vainer, Gilad W./0000-0002-8828-8138	Tel-Aviv Sourasky Medical Center; Israeli Ministry of Health [5938]; Israeli Cancer Association; Israeli Science Foundation (ISF) [1462]	Tel-Aviv Sourasky Medical Center; Israeli Ministry of Health; Israeli Cancer Association; Israeli Science Foundation (ISF)(Israel Science Foundation)	This work was financed in part by the Tel-Aviv Sourasky Medical Center and Mr. Daniel Levin donation (GWV); the Israeli Ministry of Health grant #5938 (GWV); The Israeli Cancer Association (GWV); and Israeli Science Foundation (ISF) grant #1462 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Xu J, 2012, CRIT REV FOOD SCI, V52, P373, DOI 10.1080/10408398.2010.500245	14	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107364	10.1371/journal.pone.0107364	http://dx.doi.org/10.1371/journal.pone.0107364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202971	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500089
J	Wolf, I; Shahmoon, S; Ben Ami, M; Levy-Shraga, Y; Mazor-Aronovitch, K; Pinhas-Hamiel, O; Yeshayahu, Y; Hemi, R; Kanety, H; Rubinek, T; Modan-Moses, D				Wolf, Ido; Shahmoon, Shiri; Ben Ami, Michal; Levy-Shraga, Yael; Mazor-Aronovitch, Kineret; Pinhas-Hamiel, Orit; Yeshayahu, Yonatan; Hemi, Rina; Kanety, Hannah; Rubinek, Tami; Modan-Moses, Dalit			Association between Decreased Klotho Blood Levels and Organic Growth Hormone Deficiency in Children with Growth Impairment	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; COMMUNITY-DWELLING ADULTS; SOLUBLE ALPHA-KLOTHO; PLASMA KLOTHO; TUMOR-SUPPRESSOR; PUBERTAL CHANGES; GH DEFICIENCY; SERUM-LEVELS; IGF-I; THERAPY	Objective: Klotho is an aging-modulating protein expressed mainly in the kidneys and choroid plexus, which can also be shed, released into the circulation and act as a hormone. Klotho deficient mice are smaller compared to their wild-type counterparts and their somatotropes show marked atrophy and reduced number of secretory granules. Recent data also indicated an association between klotho levels and growth hormone (GH) levels in acromegaly. We aimed to study the association between klotho levels and GH deficiency (GHD) in children with growth impairment. Design: Prospective study comprising 99 children and adolescents (aged 9.0 +/- 3.7 years, 49 male) undergoing GH stimulation tests for short stature (height-SDS = -2.1 +/- 0.6). Klotho serum levels were measured using an alpha-klotho ELISA kit. Results: Klotho levels were significantly lower (p<0.001) among children with organic GHD (n = 11, 727 +/- 273 pg/ml) compared to both GH sufficient participants (n = 59, 1497 +/- 754 pg/ml) and those with idiopathic GHD (n = 29, 1645 +/- 778 pg/ml). The difference between GHS children and children with idiopathic GHD was not significant. Klotho levels positively correlated with IGF-1-standard deviation scores (SDS) (R = 0.45, p<0.001), but were not associated with gender, pubertal status, age or anthropometric measurements. Conclusions: We have shown, for the first time, an association between low serum klotho levels and organic GHD. If validated by additional studies, serum klotho may serve as novel biomarker of organic GHD.	[Wolf, Ido; Shahmoon, Shiri; Rubinek, Tami] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Oncol, IL-69978 Tel Aviv, Israel; [Wolf, Ido; Shahmoon, Shiri; Pinhas-Hamiel, Orit; Modan-Moses, Dalit] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ben Ami, Michal; Levy-Shraga, Yael; Mazor-Aronovitch, Kineret; Pinhas-Hamiel, Orit; Yeshayahu, Yonatan; Modan-Moses, Dalit] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Pediat Endocrinol & Diabet Unit, Ramat Gan, Israel; [Hemi, Rina; Kanety, Hannah] Chaim Sheba Med Ctr, Inst Endocrinol, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Modan-Moses, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	dmodan@sheba.health.gov.il	Pinhas-Hamiel, Orit/K-5198-2013; Yeshayahu, Yonatan/Y-8019-2019	Yeshayahu, Yonatan/0000-0002-3864-9898	Benjamin and Rebecca Bernard foundation for pediatric research, Tel-Aviv University, Tel-Aviv, Israel	Benjamin and Rebecca Bernard foundation for pediatric research, Tel-Aviv University, Tel-Aviv, Israel	The study was supported by the Benjamin and Rebecca Bernard foundation for pediatric research, Tel-Aviv University, Tel-Aviv, Israel. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz L, 2011, CLIN CANCER RES, V17, P4254, DOI 10.1158/1078-0432.CCR-10-2749; Bacchetta J, 2012, PEDIATR NEPHROL, V27, P1131, DOI 10.1007/s00467-012-2110-3; Bacchetta J, 2010, J CLIN ENDOCR METAB, V95, P1741, DOI 10.1210/jc.2009-1576; Barth JH, 2008, ANN CLIN BIOCHEM, V45, P598, DOI 10.1258/acb.2008.008074; Bright GM, 1999, PEDIATRICS, V104, P1028; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Crasto CL, 2012, REJUV RES, V15, P295, DOI 10.1089/rej.2011.1268; Devaraj S, 2012, AM J CLIN PATHOL, V137, P479, DOI 10.1309/AJCPGPMAF7SFRBO4; Gardner J, 2011, J PEDIATR ENDOCR MET, V24, P645, DOI 10.1515/JPEM.2011.301; Gkentzi D, 2014, BONE, V66, P8, DOI 10.1016/j.bone.2014.05.012; Goldstein A, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e108; Heijboer AC, 2013, NEPHROL DIAL TRANSPL, V28, P2283, DOI 10.1093/ndt/gft236; Hokken-Koelega ACS, 2011, HORM RES PAEDIAT, V76, P6, DOI 10.1159/000330136; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Ito N, 2007, ENDOCR J, V54, P481, DOI 10.1507/endocrj.K06-217; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Neidert MC, 2013, EUR J ENDOCRINOL, V168, P575, DOI 10.1530/EJE-12-1045; NISHIYAMA S, 1992, J CLIN ENDOCR METAB, V74, P906, DOI 10.1210/jc.74.4.906; Pedersen L, 2013, CLIN BIOCHEM, V46, P1079, DOI 10.1016/j.clinbiochem.2013.05.046; Quigley Charmian A, 2013, Int J Pediatr Endocrinol, V2013, P6, DOI 10.1186/1687-9856-2013-6; Ranke MB, 2000, HORM RES, V54, P60, DOI 10.1159/000053233; Seiler S, 2013, KIDNEY INT, V83, P121, DOI 10.1038/ki.2012.288; Semba RD, 2011, J AM GERIATR SOC, V59, P1596, DOI 10.1111/j.1532-5415.2011.03558.x; Semba RD, 2011, J GERONTOL A-BIOL, V66, P794, DOI 10.1093/gerona/glr058; Siahanidou T, 2012, EUR J ENDOCRINOL, V167, P433, DOI 10.1530/EJE-12-0476; Sze L, 2012, J INTERN MED, V272, P93, DOI 10.1111/j.1365-2796.2012.02542.x; Tauber M, 1997, J CLIN ENDOCR METAB, V82, P352, DOI 10.1210/jc.82.2.352; Thomas M, 2003, HORM RES, V59, P7, DOI 10.1159/000067936; TOOGOOD AA, 1994, CLIN ENDOCRINOL, V41, P511, DOI 10.1111/j.1365-2265.1994.tb02583.x; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110	37	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107174	10.1371/journal.pone.0107174	http://dx.doi.org/10.1371/journal.pone.0107174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198618	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700092
J	Yuan, FJ; Fu, X; Shi, HF; Chen, GP; Dong, P; Zhang, WY				Yuan, Fengjiao; Fu, Xiao; Shi, Hengfei; Chen, Guopu; Dong, Ping; Zhang, Weiyun			Induction of Murine Macrophage M2 Polarization by Cigarette Smoke Extract via the JAK2/STAT3 Pathway	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; NITRIC-OXIDE; STAT3; ACTIVATION; PHENOTYPE; PROLIFERATION; INFLAMMATION; EXPRESSION; CELLS; IL-6	Cigarette smoking is a major pathogenic factor in lung cancer. Macrophages play an important role in host defense and adaptive immunity. These cells display diverse phenotypes for performing different functions. M2 type macrophages usually exhibit immunosuppressive and tumor-promoting characteristics. Although macrophage polarization toward the M2 phenotype has been observed in the lungs of cigarette smokers, the molecular basis of the process remains unclear. In this study, we evaluated the possible mechanisms for the polarization of mouse macrophages that are induced by cigarette smoking (CS) or cigarette smoke extract (CSE). The results showed that exposure to CSE suppressed the production of reactive oxygen species (ROS) and nitric oxide (NO) and down-regulated the phagocytic ability of Ana-1 cells. The CD163 expressions on the surface of macrophages from different sources were significantly increased in in vivo and in vitro studies. The M1 macrophage cytokines TNF-alpha, IL-12p40 and enzyme iNOS decreased in the culture supernatant, and their mRNA levels decreased depending on the time and concentration of CSE. In contrast, the M2 phenotype macrophage cytokines IL-10, IL-6, TGF-beta 1 and TGF-beta 2 were up-regulated. Moreover, phosphorylation of JAK2 and STAT3 was observed after the Ana-1 cells were treated with CSE. In addition, pretreating the Ana-1 cells with the STAT3 phosphorylation inhibitor WP1066 inhibited the CSE-induced CD163 expression, increased the mRNA level of IL-10 and significantly decreased the mRNA level of IL-12. In conclusion, we demonstrated that the M2 polarization of macrophages induced by CS could be mediated through JAK2/STAT3 pathway activation.	[Yuan, Fengjiao; Fu, Xiao; Shi, Hengfei; Chen, Guopu; Dong, Ping; Zhang, Weiyun] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Fu, Xiao] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Dong, P (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.	dongping@nju.edu.cn; zhangwy@nju.edu.cn			National Nature Science Foundation of China [81273121]; State Key Laboratory of Pharmaceutical Biotechnology [KF-GN-201301]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pharmaceutical Biotechnology	This study was financed by the National Nature Science Foundation of China (No. 81273121) and by State Key Laboratory of Pharmaceutical Biotechnology (KF-GN-201301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Boonsarngsuk V, 2009, RESPIROLOGY, V14, P1060, DOI 10.1111/j.1440-1843.2009.01604.x; Chen WX, 2010, CELL IMMUNOL, V262, P69, DOI 10.1016/j.cellimm.2010.01.001; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Covarrubias A, 2013, CELL RES, V23, P984, DOI 10.1038/cr.2013.88; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Fujiwara Y, 2011, ONCOL REP, V26, P1533, DOI 10.3892/or.2011.1454; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Isomoto H, 2009, DIGESTION, V79, P2, DOI 10.1159/000167859; Jyrkkio Sirkku, 2012, Duodecim, V128, P1081; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kunz LIZ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-34; Lin HY, 2013, BRIT J CANCER, V109, P731, DOI 10.1038/bjc.2013.349; Looyenga BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030820; Luo YP, 2010, ONCOGENE, V29, P662, DOI 10.1038/onc.2009.308; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Mantovani A, 2003, TUMORI J, V89, P459, DOI 10.1177/030089160308900501; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Matsukawa A, 2005, J IMMUNOL, V175, P3354, DOI 10.4049/jimmunol.175.5.3354; Matsukawa A, 2003, J IMMUNOL, V171, P6198, DOI 10.4049/jimmunol.171.11.6198; Mikko S, 2012, J GASTROEN HEPATOL, V27, P135, DOI 10.1111/j.1440-1746.2012.07017.x; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Ruhrberg C, 2010, NAT MED, V16, P861, DOI 10.1038/nm0810-861; Satarug S, 2012, CURR DRUG METAB, V13, P257, DOI 10.2174/138920012799320446; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Wang HC, 2011, MOL ENDOCRINOL, V25, P1145, DOI 10.1210/me.2010-0495; Wang K, 2012, AM J CHINESE MED, V40, P521, DOI 10.1142/S0192415X12500401; Wittel UA, 2012, INT J ONCOL, V41, P5, DOI 10.3892/ijo.2012.1414; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Yuan FJ, 2013, EXP TOXICOL PATHOL, V65, P1011, DOI 10.1016/j.etp.2013.02.004; Zhao X, 2012, ASIAN PAC J CANCER P, V13, P2873, DOI 10.7314/APJCP.2012.13.6.2873	41	61	65	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107063	10.1371/journal.pone.0107063	http://dx.doi.org/10.1371/journal.pone.0107063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198511	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700080
J	Jolivet, G; Braud, S; DaSilva, B; Passet, B; Harscoet, E; Viglietta, C; Gautier, T; Lagrost, L; Daniel-Carlier, N; Houdebine, LM; Harosh, I				Jolivet, Genevieve; Braud, Sandrine; DaSilva, Bruno; Passet, Bruno; Harscoet, Erwana; Viglietta, Celine; Gautier, Thomas; Lagrost, Laurent; Daniel-Carlier, Nathalie; Houdebine, Louis-Marie; Harosh, Itzik			Induction of Body Weight Loss through RNAi-Knockdown of APOBEC1 Gene Expression in Transgenic Rabbits	PLOS ONE			English	Article							APOLIPOPROTEIN-B; EDITING ENZYME; ANDERSONS-DISEASE; MICE; B100; DIET; B48	In the search of new strategies to fight against obesity, we targeted a gene pathway involved in energy uptake. We have thus investigated the APOB mRNA editing protein (APOBEC1) gene pathway that is involved in fat absorption in the intestine. The APOB gene encodes two proteins, APOB100 and APOB48, via the editing of a single nucleotide in the APOB mRNA by the APOBEC1 enzyme. The APOB48 protein is mandatory for the synthesis of chylomicrons by intestinal cells to transport dietary lipids and cholesterol. We produced transgenic rabbits expressing permanently and ubiquitously a small hairpin RNA targeting the rabbit APOBEC1 mRNA. These rabbits exhibited a moderately but significantly reduced level of APOBEC1 gene expression in the intestine, a reduced level of editing of the APOB mRNA, a reduced level of synthesis of chylomicrons after a food challenge, a reduced total mass of body lipids and finally presented a sustained lean phenotype without any obvious physiological disorder. Interestingly, no compensatory mechanism opposed to the phenotype. These lean transgenic rabbits were crossed with transgenic rabbits expressing in the intestine the human APOBEC1 gene. Double transgenic animals did not present any lean phenotype, thus proving that the intestinal expression of the human APOBEC1 transgene was able to counterbalance the reduction of the rabbit APOBEC1 gene expression. Thus, a moderate reduction of the APOBEC1 dependent editing induces a lean phenotype at least in the rabbit species. This suggests that the APOBEC1 gene might be a novel target for obesity treatment.	[Jolivet, Genevieve; DaSilva, Bruno; Harscoet, Erwana; Viglietta, Celine; Daniel-Carlier, Nathalie; Houdebine, Louis-Marie] INRA, UMR1198, Jouy En Josas, France; [Braud, Sandrine; Harosh, Itzik] ObeTherapy Biotechnol, Evry, France; [Gautier, Thomas; Lagrost, Laurent] Univ Bourgogne, INSERM, UMR866, Dijon, France; [Passet, Bruno] INRA, UMR1313, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Jolivet, G (corresponding author), INRA, UMR1198, Jouy En Josas, France.	genevieve.jolivet@jouy.inra.fr; harosh@obetherapy.com	Gautier, Thomas/Q-5371-2018	Gautier, Thomas/0000-0003-1119-7382	Agence Nationale de la Recherche [ANR-06-RIB-FATSTOP]; ObeTherapy Biotechnology	Agence Nationale de la Recherche(French National Research Agency (ANR)); ObeTherapy Biotechnology	This study was funded by Agence Nationale de la Recherche (ANR-06-RIB-FATSTOP) to ObeTherapy as leader of the program and to INRA. Sandrine Braud and Itzik Harosh are employees of and shareholders in ObeTherapy Biotechnology. ObeTherapy Biotechnology provided support in the form of salaries for authors SB and IH, had a direct role in the study design, and analysis, decision to publish, and preparation of the manuscript.	Anant S, 2002, TRENDS CARDIOVAS MED, V12, P311, DOI 10.1016/S1050-1738(02)00180-9; Anant S, 2001, CURR OPIN LIPIDOL, V12, P159, DOI 10.1097/00041433-200104000-00009; Blanc V, 2012, J LIPID RES, V53, P2643, DOI 10.1194/jlr.M030494; CHAN L, 1995, BIOCHIMIE, V77, P75, DOI 10.1016/0300-9084(96)88107-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Daniel-Carlier N, 2013, TRANSGENIC RES, V22, P489, DOI 10.1007/s11248-012-9649-4; Dannoura AH, 1999, ARTERIOSCL THROM VAS, V19, P2494, DOI 10.1161/01.ATV.19.10.2494; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; Fortun-Lamothe L, 2002, LIVEST PROD SCI, V78, P133, DOI 10.1016/S0301-6226(02)00087-8; Georges A, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-1; Gonzalez Jimenez Emilio, 2011, Endocrinol Nutr, V58, P492, DOI 10.1016/j.endonu.2011.06.004; Greeve J, 1996, J LIPID RES, V37, P2001; GREEVE J, 1993, J LIPID RES, V34, P1367; Hatch F T, 1968, Adv Lipid Res, V6, P1; Hirano K, 1996, J BIOL CHEM, V271, P9887, DOI 10.1074/jbc.271.17.9887; Kendrick JS, 2001, BIOCHEM J, V356, P821, DOI 10.1042/0264-6021:3560821; Kinoshita M, 2010, EXP ANIM TOKYO, V59, P459, DOI 10.1538/expanim.59.459; Lo CM, 2008, AM J PHYSIOL-GASTR L, V294, pG344, DOI 10.1152/ajpgi.00123.2007; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, pW104, DOI 10.1093/nar/gkn250; Mathus-Vliegen EMH, 2012, OBESITY FACTS, V5, P460, DOI 10.1159/000341193; Morrison JR, 1996, P NATL ACAD SCI USA, V93, P7154, DOI 10.1073/pnas.93.14.7154; Nakamuta M, 1996, J BIOL CHEM, V271, P25981, DOI 10.1074/jbc.271.42.25981; NAKAMUTA M, 1995, J BIOL CHEM, V270, P13042, DOI 10.1074/jbc.270.22.13042; Okada T, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-78; Picone O, 2011, THERIOGENOLOGY, V75, P287, DOI 10.1016/j.theriogenology.2010.08.015; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Yamamoto T, 2009, BIOTECHNOL LETT, V31, P1695, DOI 10.1007/s10529-009-0065-7; YAMANAKA S, 1994, J BIOL CHEM, V269, P21725; Zhang XJ, 2008, J NUTR, V138, P515, DOI 10.1093/jn/138.3.515	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106655	10.1371/journal.pone.0106655	http://dx.doi.org/10.1371/journal.pone.0106655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216115	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300019
J	Zeng, YL; Tan, XF; Zhang, L; Jiang, N; Cao, HP				Zeng, Yanling; Tan, Xiaofeng; Zhang, Lin; Jiang, Nan; Cao, Heping			Identification and Expression of Fructose-1,6-Bisphosphate Aldolase Genes and Their Relations to Oil Content in Developing Seeds of Tea Oil Tree (Camellia oleifera)	PLOS ONE			English	Article							PROTEIN-DESATURASE; SHELLS; TUNG; BIOSYNTHESIS; ANTIOXIDANT; EVOLUTION	Tea oil tree (Camellia oleifera, Co) provides a fine edible oil source in China. Tea oil from the seeds is very beneficial to human health. Fructose-1,6-bisphosphate aldolase (FBA) hydrolyzes fructose-1,6-bisphosphate into dihydroxyacetone phosphate and glyceraldehyde 3-phosphate, two critical metabolites for oil biosynthesis. The objectives of this study were to identify FBA genes and investigate the relationship between FBA gene expression and oil content in developing seeds of tea oil tree. In this paper, four developmentally up-regulated CoFBA genes were identified in Camellia oleifera seeds based on the transcriptome from two seed developmental stages corresponding to the initiation and peak stages of lipid biosynthesis. The expression of CoFBA genes, along with three key oil biosynthesis genes CoACP, CoFAD2 and CoSAD were analyzed in seeds from eight developmental stages by real-time quantitative PCR. The oil content and fatty acid composition were also analyzed. The results showed that CoFBA and CoSAD mRNA levels were well-correlated with oil content whereas CoFAD2 gene expression levels were correlated with fatty acid composition in Camellia seeds. We propose that CoFBA and CoSAD are two important factors for determining tea oil yield because CoFBA gene controls the flux of key intermediates for oil biosynthesis and CoSAD gene controls the synthesis of oleic acid, which accounts for 80% of fatty acids in tea oil. These findings suggest that tea oil yield could be improved by enhanced expression of CoFBA and CoSAD genes in transgenic plants.	[Zeng, Yanling; Tan, Xiaofeng; Zhang, Lin; Jiang, Nan] Cent South Univ Forestry & Technol, Key Lab Cultivat & Protect Nonwood Forest Trees, Minist Educ, Changsha, Hunan, Peoples R China; [Zeng, Yanling; Tan, Xiaofeng; Zhang, Lin; Jiang, Nan] Cent South Univ Forestry & Technol, Key Lab Non Wood Forest Prod State Forestry Adm, Changsha, Hunan, Peoples R China; [Jiang, Nan] Hunan Univ Technol, Key Lab Green Packaging & Biol Nanotechnol, Zhuzhou, Hunan, Peoples R China; [Cao, Heping] USDA ARS, So Reg Res Ctr, New Orleans, LA USA	Central South University of Forestry & Technology; Central South University of Forestry & Technology; Hunan University of Technology; United States Department of Agriculture (USDA)	Tan, XF (corresponding author), Cent South Univ Forestry & Technol, Key Lab Cultivat & Protect Nonwood Forest Trees, Minist Educ, Changsha, Hunan, Peoples R China.	tanxiaofengcn@126.com; Heping.Cao@ars.usda.gov	Cao, Heping/AAC-1666-2021; tan, xiao/GZL-0264-2022; JIANG, NAN/AHB-1945-2022	Cao, Heping/0000-0002-0958-1468	Natural Science Foundation of Hunan Province [14JJ2014]; National Natural Science Foundation [31070603]; Youth Scientific Research Foundation of Central South University of Forestry and Technology [QJ2011008A]; Key Project of Chinese Ministry of Education [212126]; Outstanding Youth of the Education Department of Hunan Province [11B131]; USDA-ARS Quality and Utilization of Agricultural Products Research Program 306 through CRIS [6435-41000-102-00D]	Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Youth Scientific Research Foundation of Central South University of Forestry and Technology; Key Project of Chinese Ministry of Education(Ministry of Education, China); Outstanding Youth of the Education Department of Hunan Province; USDA-ARS Quality and Utilization of Agricultural Products Research Program 306 through CRIS	This work was supported by the Natural Science Foundation of Hunan Province (Grant No. 14JJ2014), the National Natural Science Foundation (Grant No. 31070603), Youth Scientific Research Foundation of Central South University of Forestry and Technology (Grant No. QJ2011008A), the Key Project of Chinese Ministry of Education (Grant No. 212126), the Outstanding Youth of the Education Department of Hunan Province (Grant No. 11B131), and USDA-ARS Quality and Utilization of Agricultural Products Research Program 306 through CRIS 6435-41000-102-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Cao H, 2014, PLOS ONE, V9; Cao HP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076946, 10.1371/journal.pone.0052853]; Cao HP, 2012, J AGR FOOD CHEM, V60, P12296, DOI 10.1021/jf304690e; Cao Heping, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-249; Chen LY, 2013, FITOTERAPIA, V84, P123, DOI 10.1016/j.fitote.2012.11.009; Cheng YT, 2014, J AGR FOOD CHEM; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Feas X, 2013, MOLECULES, V18, P4573, DOI 10.3390/molecules18044573; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; [郭静怡 Guo Jingyi], 2010, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V30, P66; Haake V, 1999, PLANT J, V17, P479, DOI 10.1046/j.1365-313X.1999.00391.x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Lee CP, 2006, J AGR FOOD CHEM, V54, P779, DOI 10.1021/jf052325a; [刘思峰 Liu Sifeng], 2013, [系统工程理论与实践, Systems Engineering-Theory & Practice], V33, P2041; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; [龙洪旭 Long Hongxu], 2010, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V30, P31; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Prescott D J, 1975, Methods Enzymol, V35, P95, DOI 10.1016/0076-6879(75)35143-4; RUTTER WJ, 1964, FED PROC, V23, P1248; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; [谭晓风 TAN Xiao-feng], 2010, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V30, P1; [谭晓风 TAN Xiao-feng], 2008, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V28, P8; Tan XiaoFeng, 2006, Scientia Silvae Sinicae, V42, P43; Tan XiaoFeng, 2008, Scientia Silvae Sinicae, V44, P70; Thelen JJ, 2002, METAB ENG, V4, P12, DOI 10.1006/mben.2001.0204; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Wang BM, 2012, PAK J BOT, V44, P961; [王小艺 Wang Xiaoyi], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P76; Ye Y, 2013, INDIAN J EXP BIOL, V51, P458; Ye Y, 2012, FITOTERAPIA, V83, P1585, DOI 10.1016/j.fitote.2012.09.006; Ye Y, 2012, INT J MOL SCI, V13, P12401, DOI 10.3390/ijms131012401; Yukawa Y, 1996, PLANT CELL PHYSIOL, V37, P201, DOI 10.1093/oxfordjournals.pcp.a028932; [曾艳玲 Zeng Yanling], 2014, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V29, P26; Zhang DangQuan, 2008, Scientia Silvae Sinicae, V44, P155; Zhang L, 2014, PLOS ONE IN PRESS, V9; Zhu F, 2012, J CENTRAL S U FOREST, V32, P51; Zhuang RL, 2008, TEA OIL TREE CAMELLI, P339	44	37	42	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107422	10.1371/journal.pone.0107422	http://dx.doi.org/10.1371/journal.pone.0107422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215538	gold, Green Published, Green Submitted			2022-12-27	WOS:000341774300063
J	Gomez-Serrano, MA; Lopez-Lopez, P				Angel Gomez-Serrano, Miguel; Lopez-Lopez, Pascual			Nest Site Selection by Kentish Plover Suggests a Trade-Off between Nest-Crypsis and Predator Detection Strategies	PLOS ONE			English	Article							SEA-LEVEL RISE; SOUTHERN HIGH-PLAINS; HUMAN DISTURBANCE; SNOWY PLOVERS; CHARADRIUS-ALEXANDRINUS; REPRODUCTIVE SUCCESS; EGGSHELL EVIDENCE; HABITAT; SHOREBIRDS; BEACH	Predation is one of the main causes of adult mortality and breeding failure for ground-nesting birds. Micro-habitat structure around nests plays a critical role in minimizing predation risk. Plovers nest in sites with little vegetation cover to maximize the incubating adult visibility, but many studies suggest a trade-off between nest-crypsis and predator detection strategies. However, this trade-off has not been explored in detail because methods used so far do not allow estimating the visibility with regards to critical factors such as slope or plant permeability to vision. Here, we tested the hypothesis that Kentish plovers select exposed sites according to a predator detection strategy, and the hypothesis that more concealed nests survive longer according to a crypsis strategy. To this end, we obtained an accurate estimation of the incubating adult's field of vision through a custom built inverted periscope. Our results showed that plovers selected nest sites with higher visibility than control points randomly selected with regards to humans and dogs, although nests located in sites with higher vegetation cover survived longer. In addition, the flushing distance (i.e., the distance at which incubating adults leave the nest when they detect a potential predator) decreased with vegetation cover. Consequently, the advantages of concealing the nest were limited by the ability to detect predators, thus indirectly supporting the existence of the trade-off between crypsis and predator detection. Finally, human disturbance also constrained nest choice, forcing plovers to move to inland sites that were less suitable because of higher vegetation cover, and modulated flushing behavior, since plovers that were habituated to humans left their nests closer to potential predators. This constraint on the width of suitable breeding habitat is particularly relevant for the conservation of Kentish Plover in sand beaches, especially under the current context of coastal regression and increase of recreational activities.	[Angel Gomez-Serrano, Miguel; Lopez-Lopez, Pascual] Univ Alicante, CIBIO Res Inst, Vertebrates Zool Res Grp, E-03080 Alicante, Spain	Universitat d'Alacant	Gomez-Serrano, MA (corresponding author), Univ Alicante, CIBIO Res Inst, Vertebrates Zool Res Grp, E-03080 Alicante, Spain.	miguel.gomez@uv.es	López-López, Pascual/C-1039-2011; Gómez-Serrano, Miguel Angel/AAS-5912-2020	López-López, Pascual/0000-0001-5269-652X; Gomez-Serrano, Miguel Angel/0000-0002-3281-6333	Conselleria de Infraestructuras, Territorio y Medio Ambiente (Generalitat Valenciana); Spanish Ministry of Economy and Competitiveness [JCI-2011-09588]	Conselleria de Infraestructuras, Territorio y Medio Ambiente (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Economy and Competitiveness(Spanish Government)	Our work received partial funding only during the years 2000 and 2001 by the Conselleria de Infraestructuras, Territorio y Medio Ambiente (Generalitat Valenciana; www.citma.gva.es). PLL is supported by a "Juan de la Cierva'' postdoctoral grant of the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/) (reference JCI-2011-09588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello-Lammens ME, 2011, GLOBAL CHANGE BIOL, V17, P3644, DOI 10.1111/j.1365-2486.2011.02497.x; Amat JA, 2004, ANIM BEHAV, V67, P293, DOI 10.1016/j.anbehav.2003.06.014; [Anonymous], [No title captured]; Anteau MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030347; Beauvais GP, 2003, WEST N AM NATURALIST, V63, P88; BirdLife International, 2014, SPEC FACTSH CHAR AL; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; BURGER J, 1994, ESTUARIES, V17, P695, DOI 10.2307/1352418; Burrell Noah S., 2012, Wildfowl, V62, P204; Colwell MA, 2005, J FIELD ORNITHOL, V76, P373, DOI 10.1648/0273-8570-76.4.373; Colwell MA, 1997, CONDOR, V99, P337, DOI 10.2307/1369939; Colwell MA, 2010, SHOREBIRD ECOLOGY, CONSERVATION, AND MANAGEMENT, P1; Colwell MA, 2011, IBIS, V153, P303, DOI 10.1111/j.1474-919X.2011.01100.x; Colwell Mark A., 2006, Wader Study Group Bulletin, V111, P50; Cresswell W, 1997, ANIM BEHAV, V53, P93, DOI 10.1006/anbe.1996.0281; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Dominguez J, 2003, ARDEOLA, V50, P15; Figuerola J, 2005, LIBRO ROJO AVES ESPA, P228; Figuerola J, 2003, ATLAS AVES REPROD ES, P76; Forstmeier W, 2004, OIKOS, V104, P487, DOI 10.1111/j.0030-1299.1999.12698.x; Fraga Rosendo M., 1996, Ardeola, V43, P69; Frid A, 2002, CONSERV ECOL, V6; GALBRAITH H, 1988, J APPL ECOL, V25, P487, DOI 10.2307/2403839; Gochfeld M., 1984, Behavior of Marine Animals, V5, P289; Gotmark F, 1995, J AVIAN BIOL, V26, P305, DOI 10.2307/3677045; Grant G.S., 1982, ORNITHOL MONOGR, V30, P1, DOI [10.2307/40166669, DOI 10.2307/40166669]; Ikuta LA, 2003, BIOL CONSERV, V112, P447, DOI 10.1016/S0006-3207(02)00324-5; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Koivula K, 1998, OECOLOGIA, V116, P348, DOI 10.1007/s004420050597; Kupper C, 2009, AUK, V126, P839, DOI 10.1525/auk.2009.08174; Lack D., 1968, pvii; Lafferty KD, 2001, BIOL CONSERV, V101, P315, DOI 10.1016/S0006-3207(01)00075-1; Lafferty KD, 2001, BIODIVERS CONSERV, V10, P1; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mabee TJ, 2006, J FIELD ORNITHOL, V77, P163, DOI 10.1111/j.1557-9263.2006.00037.x; Mabee TJ, 1997, WILSON BULL, V109, P307; Magana M, 2010, IBIS, V152, P77, DOI 10.1111/j.1474-919X.2009.00976.x; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; Martin TE, 1988, EVOL ECOL, V2, P37, DOI 10.1007/BF02071587; Mayer PM, 2009, OECOLOGIA, V159, P893, DOI 10.1007/s00442-008-1266-9; Medeiros R, 2012, WATERBIRDS, V35, P512, DOI 10.1675/063.035.0402; METCALFE NB, 1984, ANIM BEHAV, V32, P981, DOI 10.1016/S0003-3472(84)80210-9; Muir JJ, 2010, CONDOR, V112, P507, DOI 10.1525/cond.2010.090196; Munsell Color, 1992, MUNSELL SOIL COLOR C; Newton I., 1998, POPULATION LIMITATIO; Norte AC, 2004, ARDEOLA, V51, P255; Oltra C., 1997, AVES LIMICOLAS ESPAN, P175; PAGE GW, 1985, AUK, V102, P347, DOI 10.2307/4086778; Page GW, 2009, BIRDS N AM ONLINE, DOI [10.2173/bna.154, DOI 10.2173/BNA.154]; PFISTER C, 1992, BIOL CONSERV, V60, P115, DOI 10.1016/0006-3207(92)91162-L; R Core Team, 2021, R LANGUAGE ENV STAT; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; ROBERTS G, 1993, BEHAVIOUR, V126, P29, DOI 10.1163/156853993X00326; Saalfeld ST, 2012, J WILDLIFE MANAGE, V76, P1703, DOI 10.1002/jwmg.404; Saalfeld ST, 2011, WATERBIRDS, V34, P389, DOI 10.1675/063.034.0401; SANJAUME E, 1991, LANDSCAPE ECOL, V6, P57, DOI 10.1007/BF00157745; Schulz Rainer, 1993, Wader Study Group Bulletin, V68, P83; Seavey JR, 2011, BIOL CONSERV, V144, P393, DOI 10.1016/j.biocon.2010.09.017; St Clair JJH, 2010, BEHAV ECOL, V21, P1285, DOI 10.1093/beheco/arq144; Therneau T, 2012, COXME MIXED EFFECTS; van Paassen Aad G., 1984, Wildfowl, V35, P173; WARRINER JS, 1986, WILSON BULL, V98, P15; Webber AF, 2013, ECOL EVOL, V3, P853, DOI 10.1002/ece3.511; Weston MA, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P94; Whittingham MJ, 2002, J AVIAN BIOL, V33, P184, DOI 10.1034/j.1600-048X.2002.330210.x; Willson MF, 2001, CONSERV BIOL, V15, P447, DOI 10.1046/j.1523-1739.2001.015002447.x; Yanes M, 1996, J ARID ENVIRON, V32, P469, DOI 10.1006/jare.1996.0040	68	28	32	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107121	10.1371/journal.pone.0107121	http://dx.doi.org/10.1371/journal.pone.0107121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208045	Green Published, gold			2022-12-27	WOS:000342030300059
J	Davis, TW; Watson, SB; Rozmarynowycz, MJ; Ciborowski, JJH; McKay, RM; Bullerjahn, GS				Davis, Timothy W.; Watson, Susan B.; Rozmarynowycz, Mark J.; Ciborowski, Jan J. H.; McKay, Robert Michael; Bullerjahn, George S.			Phylogenies of Microcystin-Producing Cyanobacteria in the Lower Laurentian Great Lakes Suggest Extensive Genetic Connectivity	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; ST-CLAIR; SUBG. DOLICHOSPERMUM; GENUS ANABAENA; WESTERN BASIN; ERIE; PHOSPHORUS; SPP.; DIVERSITY; NUTRIENT	Lake St. Clair is the smallest lake in the Laurentian Great Lakes system. MODIS satellite imagery suggests that high algal biomass events have occurred annually along the southern shore during late summer. In this study, we evaluated these events and tested the hypothesis that summer bloom material derived from Lake St. Clair may enter Lake Erie via the Detroit River and represent an overlooked source of potentially toxic Microcystis biomass to the western basin of Lake Erie. We conducted a seasonally and spatially resolved study carried out in the summer of 2013. Our goals were to: 1) track the development of the 2013 summer south-east shore bloom 2) conduct a spatial survey to characterize the extent of toxicity, taxonomic diversity of the total phytoplankton population and the phylogenetic diversity of potential MC-producing cyanobacteria (Microcystis, Planktothrix and Anabaena) during a high biomass event, and 3) compare the strains of potential MC-producers in Lake St. Clair with strains from Lake Erie and Lake Ontario. Our results demonstrated a clear predominance of cyanobacteria during a late August bloom event, primarily dominated by Microcystis, which we traced along the Lake St. Clair coastline downstream to the Detroit River's outflow at Lake Erie. Microcystin levels exceeded the Province of Ontario Drinking Water Quality Standard (1.5 mu g L-1) for safe drinking water at most sites, reaching up to five times this level in some areas. Microcystis was the predominant microcystin producer, and all toxic Microcystis strains found in Lake St. Clair were genetically similar to toxic Microcystis strains found in lakes Erie and Ontario. These findings suggest extensive genetic connectivity among the three systems.	[Davis, Timothy W.; Watson, Susan B.] Environm Canada, Canadian Ctr Inland Waters, Burlington, ON L7R 4A6, Canada; [Rozmarynowycz, Mark J.; McKay, Robert Michael; Bullerjahn, George S.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Ciborowski, Jan J. H.] Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada	Environment & Climate Change Canada; University System of Ohio; Bowling Green State University; University of Windsor	Davis, TW (corresponding author), NOAA, Great Lakes Environm Res Lab, 2205 Commonwealth Blvd, Ann Arbor, MI 48105 USA.	timothy.davis@noaa.gov	McKay, Robert Michael/P-3759-2017; Ciborowski, Jan J.H./AAC-8247-2019; Bullerjahn, George S/F-4428-2010	McKay, Robert Michael/0000-0003-2723-5371; Ciborowski, Jan J.H./0000-0002-6588-0366; Bullerjahn, George/0000-0001-5319-7896	Environment Canada's Great Lakes Nutrient Initiative; Ohio Water Resources Center [G12AP20099, 60039769]	Environment Canada's Great Lakes Nutrient Initiative; Ohio Water Resources Center	This article includes research supported by funds from Environment Canada's Great Lakes Nutrient Initiative awarded to Sue Watson and by Ohio Water Resources Center, award G12AP20099, subaward number 60039769 awarded to George Bullerjahn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, SUSSWASSERFLORA MITT; Bolsenga S.J., 1993, LAKE ERIE LAKE ST CL; Carmichael W, 2008, ADV EXP MED BIOL, V619, P105, DOI 10.1007/978-0-387-75865-7_4; Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; CARTER DS, 1992, ENVIRON SCI TECHNOL, V26, P1333, DOI 10.1021/es00031a009; Chaffin J.D., 2013, ADV MICROBIOLOGY, V3, P16, DOI [10.4236/aim.2013.36A003, DOI 10.4236/AIM.2013.36A003]; Chaffin JD, 2014, J APPL PHYCOL, V26, P299, DOI 10.1007/s10811-013-0118-0; Chaffin JD, 2011, J GREAT LAKES RES, V37, P92, DOI 10.1016/j.jglr.2010.11.016; Codd GA, 2005, AQUAT ECOL SER, V3, P1; Conroy JD, 2005, AM MIDL NAT, V153, P20, DOI 10.1674/0003-0031(2005)153[0020:DDMALE]2.0.CO;2; Conroy JD, 2005, J GREAT LAKES RES, V31, P89, DOI 10.1016/S0380-1330(05)70307-5; Corkum LD, 1996, ARCH HYDROBIOL, V136, P391; Cox E. J., 1996, IDENTIFICATION FRESH; Davis TW, 2012, HARMFUL ALGAE, V15, P26, DOI 10.1016/j.hal.2011.11.002; Davis TW, 2010, AQUAT MICROB ECOL, V61, P149, DOI 10.3354/ame01445; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Derecki JA, 1983, TRAVEL TIMES GREAT L; Dyble J, 2008, ENVIRON TOXICOL, V23, P507, DOI 10.1002/tox.20370; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Environment Canada, 1994, MAJ IONS NUTR MAN AN, V1; Findlay H.J., 2001, PROTOCOLS MEASURING; Fischer WJ, 2001, ENVIRON SCI TECHNOL, V35, P4849, DOI 10.1021/es011182f; Fuller K, 2002, GREAT LAKES ENV ATLA, P1; Harke MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069834; Harke MJ, 2012, MICROB ECOL, V63, P188, DOI 10.1007/s00248-011-9894-8; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Hisbergues M, 2003, ARCH MICROBIOL, V180, P402, DOI 10.1007/s00203-003-0605-9; Hoagland P, 2002, ESTUARIES, V25, P819, DOI 10.1007/BF02804908; Hotto AM, 2007, APPL ENVIRON MICROB, V73, P4570, DOI 10.1128/AEM.00318-07; Hudnell, 2008, ADV EXPT MED BIOL, V619; Javornicky P, 1971, PYRRHOPHYTA COMMON C; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Joung SH, 2006, J MICROBIOL, V44, P562; Komarek J., 2004, CZECH PHYCOL, V4, P1; Komarek J., 2005, CYANOPROKARYOTA 2, V19; Komarek J., 2002, CZECH PHYCOL OLOMOUC, V2, P1; Komarek J, 2007, FOTTEA, V7, P1, DOI 10.5507/fot.2007.001; Komarek J, 2008, FOTTEA, V8, P1, DOI 10.5507/fot.2008.001; Komarkova J, 2010, HYDROBIOLOGIA, V639, P69, DOI 10.1007/s10750-009-0015-3; KONOPKA A, 1978, APPL ENVIRON MICROB, V36, P572, DOI 10.1128/AEM.36.4.572-576.1978; Kutovaya OA, 2012, HARMFUL ALGAE, V15, P71, DOI 10.1016/j.hal.2011.11.007; LEACH J H, 1980, Journal of Great Lakes Research, V6, P141; LEACH JH, 1991, HYDROBIOLOGIA, V219, P187, DOI 10.1007/BF00024755; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; Michalak AM, 2013, P NATL ACAD SCI USA, V110, P6448, DOI 10.1073/pnas.1216006110; Millie DF, 2009, AQUAT ECOL, V43, P915, DOI 10.1007/s10452-009-9238-7; MUNAWAR M, 1991, HYDROBIOLOGIA, V219, P203, DOI 10.1007/BF00024756; Munawar M, 1996, PHYTOPLANKTON DYNAMI, V1, P221; NICHOLLS KH, 1993, J GREAT LAKES RES, V19, P637, DOI 10.1016/S0380-1330(93)71251-4; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Otsuka S, 2001, INT J SYST EVOL MICR, V51, P873, DOI 10.1099/00207713-51-3-873; Paerl H, 2008, ADV EXP MED BIOL, V619, P217, DOI 10.1007/978-0-387-75865-7_10; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paul VJ, 2008, ADV EXP MED BIOL, V619, P239, DOI 10.1007/978-0-387-75865-7_11; Porta D, 2005, J GREAT LAKES RES, V31, P63, DOI 10.1016/S0380-1330(05)70305-1; PRESCOTT GW, 1982, ALGAE W GREAT LAKES; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; RICHARDS RP, 1993, J GREAT LAKES RES, V19, P200, DOI 10.1016/S0380-1330(93)71211-3; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Rinta-Kanto JM, 2006, APPL ENVIRON MICROB, V72, P5083, DOI 10.1128/AEM.00312-06; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P665, DOI 10.1016/j.hal.2008.12.004; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P385, DOI 10.1016/j.hal.2008.08.026; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235; SPRULES WG, 1991, HYDROBIOLOGIA, V219, P229, DOI 10.1007/BF00024757; Starmach K, 1980, FLORA SLODKOWODNA PO, V5; Steffen MM, J GREAT LAK IN PRESS, V40, P215; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; TAKAMURA N, 1985, J PLANKTON RES, V7, P303, DOI 10.1093/plankt/7.3.303; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vanderploeg HA, 2001, CAN J FISH AQUAT SCI, V58, P1208, DOI 10.1139/cjfas-58-6-1208; Vijayavel K, 2013, J GREAT LAKES RES, V39, P560, DOI 10.1016/j.jglr.2013.09.018; WALLEN DG, 1990, J GREAT LAKES RES, V16, P339, DOI 10.1016/S0380-1330(90)71428-1; Wang H, 2009, WATER SCI TECHNOL, V60, P1837, DOI 10.2166/wst.2009.517; Wehr J. D., 2003, FRESHWATER ALGAE N A; Wilhelm SW, 2003, AQUAT MICROB ECOL, V32, P275, DOI 10.3354/ame032275	76	31	31	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106093	10.1371/journal.pone.0106093	http://dx.doi.org/10.1371/journal.pone.0106093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207941	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300017
J	Fu, JJ; Sun, YF; Chu, XT; Xu, YF; Hu, TM				Fu, Juanjuan; Sun, Yongfang; Chu, Xitong; Xu, Yuefei; Hu, Tianming			Exogenous 5-Aminolevulenic Acid Promotes Seed Germination in Elymus nutans against Oxidative Damage Induced by Cold Stress	PLOS ONE			English	Article							PHOTOSYNTHETIC GAS-EXCHANGE; PHOENIX-DACTYLIFERA L.; MEMBRANE H+-ATPASE; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; LOW-TEMPERATURE; BRASSICA-NAPUS; ASCORBATE PEROXIDASE; LIPID-PEROXIDATION; DROUGHT STRESS	The protective effects of 5-aminolevulenic acid (ALA) on germination of Elymus nutans Griseb. seeds under cold stress were investigated. Seeds of E. nutans (Damxung, DX and Zhengdao, ZD) were pre-soaked with various concentrations (0, 0.1, 0.5, 1, 5, 10 and 25 mg l(-1)) of ALA for 24 h before germination under cold stress (5 degrees C). Seeds of ZD were more susceptible to cold stress than DX seeds. Both seeds treated with ALA at low concentrations (0.1-1 mg l(-1)) had higher final germination percentage (FGP) and dry weight at 5 degrees C than non-ALA-treated seeds, whereas exposure to higher ALA concentrations (5-25 mg l(-1)) brought about a dose dependent decrease. The highest FGP and dry weight of germinating seeds were obtained from seeds pre-soaked with 1 mg l(-1) ALA. After 5 d of cold stress, pretreatment with ALA provided significant protection against cold stress in the germinating seeds, significantly enhancing seed respiration rate and ATP synthesis. ALA pre-treatment also increased reduced glutathione (GSH), ascorbic acid (AsA), total glutathione, and total ascorbate concentrations, and the activities of superoxide dismutase (SOD), catalase (CAT), ascorbate peroxidase (APX) and glutathione reductase (GR), whereas decreased the contents of malondialdehyde (MDA) and hydrogen peroxide (H2O2), and superoxide radical (O-2(center dot-)) release in both germinating seeds under cold stress. In addition, application of ALA increased H+ ATPase activity and endogenous ALA concentration compared with cold stress alone. Results indicate that ALA considered as an endogenous plant growth regulator could effectively protect E. nutans seeds from cold-induced oxidative damage during germination without any adverse effect.	[Fu, Juanjuan; Sun, Yongfang; Chu, Xitong; Xu, Yuefei; Hu, Tianming] Northwest A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi Provinc, Peoples R China	Northwest A&F University - China	Xu, YF (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi Provinc, Peoples R China.	xuyfgrass@gmail.com; hutianming@126.com		Fu, Juanjuan/0000-0001-8178-6698	Northwest A & F University Fundamental Research Special Fund [QN2011100]; Key Projects in the National Science & Technology Pillar Program [2011BAD17B05]	Northwest A & F University Fundamental Research Special Fund; Key Projects in the National Science & Technology Pillar Program	This work was supported by Northwest A & F University Fundamental Research Special Fund (No. QN2011100) and Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period (No. 2011BAD17B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affourtit C, 2001, BBA-BIOENERGETICS, V1504, P58, DOI 10.1016/S0005-2728(00)00239-5; Ahn SJ, 1999, PHYSIOL PLANTARUM, V106, P35, DOI 10.1034/j.1399-3054.1999.106105.x; Akram NA, 2013, J PLANT GROWTH REGUL, V32, P663, DOI 10.1007/s00344-013-9325-9; Ali B, 2013, ECOTOX ENVIRON SAFE, V92, P271, DOI 10.1016/j.ecoenv.2013.02.006; Aroca R, 2001, PLANT SCI, V161, P719, DOI 10.1016/S0168-9452(01)00460-5; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Awad MA, 2008, SCI HORTIC-AMSTERDAM, V118, P48, DOI 10.1016/j.scienta.2008.05.034; Balestrasse KB, 2010, PHYTOCHEMISTRY, V71, P2038, DOI 10.1016/j.phytochem.2010.07.012; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BHAYA D, 1985, P NATL ACAD SCI USA, V82, P5370, DOI 10.1073/pnas.82.16.5370; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Chen M.J., 2002, CHINA FEEDING PLANT; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Dong Y.C., 2007, CROPS THEIR WILD REL; Duan M, 2012, PLANT PHYSIOL BIOCH, V58, P37, DOI 10.1016/j.plaphy.2012.06.007; Eisvand HR, 2010, SEED SCI TECHNOL, V38, P280, DOI 10.15258/sst.2010.38.2.02; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Fernandez-Torquemada Y, 2013, ESTUAR COAST SHELF S, V119, P64, DOI 10.1016/j.ecss.2012.12.013; Foyer CH, 2001, TRENDS PLANT SCI, V6, P486, DOI 10.1016/S1360-1385(01)02086-6; Gunes A, 2007, BIOL PLANTARUM, V51, P571, DOI 10.1007/s10535-007-0125-6; HAREL E, 1972, BIOCHEM BIOPH RES CO, V49, P364, DOI 10.1016/0006-291X(72)90419-6; Imahori Y, 2008, POSTHARVEST BIOL TEC, V49, P54, DOI 10.1016/j.postharvbio.2007.10.017; Janicka-Russak M, 2012, J PLANT RES, V125, P291, DOI 10.1007/s10265-011-0438-6; Jisha KC, 2013, ACTA PHYSIOL PLANT, V35, P1381, DOI 10.1007/s11738-012-1186-5; KAMPFENKEL K, 1995, ANAL BIOCHEM, V225, P165, DOI 10.1006/abio.1995.1127; Kim HS, 2013, J PLANT PHYSIOL, V170, P828, DOI 10.1016/j.jplph.2013.01.007; Korkmaz A, 2009, SCI HORTIC-AMSTERDAM, V119, P98, DOI 10.1016/j.scienta.2008.07.016; Korkmaz A, 2010, ENVIRON EXP BOT, V67, P495, DOI 10.1016/j.envexpbot.2009.07.009; LAW MY, 1983, BIOCHEM J, V210, P899, DOI 10.1042/bj2100899; Li DM, 2011, SCI HORTIC-AMSTERDAM, V130, P820, DOI 10.1016/j.scienta.2011.09.010; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu D, 2013, ACTA PHYSIOL PLANT, V35, P2747, DOI 10.1007/s11738-013-1307-9; Liu ZJ, 2009, SCI HORTIC-AMSTERDAM, V121, P138, DOI 10.1016/j.scienta.2009.01.032; Logan BA, 1998, J EXP BOT, V49, P1869, DOI 10.1093/jexbot/49.328.1869; Maruyama-Nakashita A, 2010, SOIL SCI PLANT NUTR, V56, P281, DOI 10.1111/j.1747-0765.2010.00458.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Naeem MS, 2011, ACTA PHYSIOL PLANT, V33, P517, DOI 10.1007/s11738-010-0575-x; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nishihara E, 2003, J PLANT PHYSIOL, V160, P1085, DOI 10.1078/0176-1617-00991; [汪良驹 Wang Liangju], 2003, [植物生理学通讯, Plant Physiology Communications], V39, P185; PALMGREN MG, 1990, PLANT PHYSIOL, V92, P871, DOI 10.1104/pp.92.4.871; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Pattanayak GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026532; Petrussa E, 2008, J PLANT PHYSIOL, V165, P1360, DOI 10.1016/j.jplph.2007.10.012; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; SCHAEDLE M, 1977, PLANT PHYSIOL, V59, P1011, DOI 10.1104/pp.59.5.1011; Schonhof I, 2007, AGR ECOSYST ENVIRON, V119, P103, DOI 10.1016/j.agee.2006.06.018; Smirnoff N, 2005, BIOL SCI SER, P1, DOI 10.1002/9780470988565; Sugie A, 2006, GENES GENET SYST, V81, P349, DOI 10.1266/ggs.81.349; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Veljovic-Jovanovic S, 2002, PLANT PHYSIOL BIOCH, V40, P501, DOI 10.1016/S0981-9428(02)01417-1; Wang LJ, 2005, J INTEGR PLANT BIOL, V47, P1084, DOI 10.1111/j.1744-7909.2005.00150.x; Xu YF, 2010, J PLANT PHYSIOL, V167, P512, DOI 10.1016/j.jplph.2009.10.010; Youssef T, 2008, J PLANT GROWTH REGUL, V27, P1, DOI 10.1007/s00344-007-9025-4; Zhang J, 2012, BIOL PLANTARUM, V56, P780, DOI 10.1007/s10535-012-0136-9; Zheng CF, 2009, ENVIRON EXP BOT, V67, P222, DOI 10.1016/j.envexpbot.2009.05.002	59	22	26	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107152	10.1371/journal.pone.0107152	http://dx.doi.org/10.1371/journal.pone.0107152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207651	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300063
J	Kelil, A; Dubreuil, B; Levy, ED; Michnick, SW				Kelil, Abdellali; Dubreuil, Benjamin; Levy, Emmanuel D.; Michnick, Stephen W.			Fast and Accurate Discovery of Degenerate Linear Motifs in Protein Sequences	PLOS ONE			English	Article							WEB SERVER; PREDICTION; DATABASE; DISORDER; IDENTIFICATION; DOMAINS; REGIONS	Linear motifs mediate a wide variety of cellular functions, which makes their characterization in protein sequences crucial to understanding cellular systems. However, the short length and degenerate nature of linear motifs make their discovery a difficult problem. Here, we introduce MotifHound, an algorithm particularly suited for the discovery of small and degenerate linear motifs. MotifHound performs an exact and exhaustive enumeration of all motifs present in proteins of interest, including all of their degenerate forms, and scores the overrepresentation of each motif based on its occurrence in proteins of interest relative to a background (e.g., proteome) using the hypergeometric distribution. To assess MotifHound, we benchmarked it together with state-of-the-art algorithms. The benchmark consists of 11,880 sets of proteins from S. cerevisiae; in each set, we artificially spiked-in one motif varying in terms of three key parameters, (i) number of occurrences, (ii) length and (iii) the number of degenerate or "wildcard'' positions. The benchmark enabled the evaluation of the impact of these three properties on the performance of the different algorithms. The results showed that MotifHound and SLiMFinder were the most accurate in detecting degenerate linear motifs. Interestingly, MotifHound was 15 to 20 times faster at comparable accuracy and performed best in the discovery of highly degenerate motifs. We complemented the benchmark by an analysis of proteins experimentally shown to bind the FUS1 SH3 domain from S. cerevisiae. Using the full-length protein partners as sole information, MotifHound recapitulated most experimentally determined motifs binding to the FUS1 SH3 domain. Moreover, these motifs exhibited properties typical of SH3 binding peptides, e. g., high intrinsic disorder and evolutionary conservation, despite the fact that none of these properties were used as prior information. MotifHound is available (http://michnick.bcm.umontreal.ca or http://tinyurl.com/motifhound) together with the benchmark that can be used as a reference to assess future developments in motif discovery.	Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Ctr Robert Cedergren, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Levy, ED (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	emmanuel.levy@weizmann.ac.il; stephen.michnick@umontreal.ca	dubreuil, benjamin/P-6157-2019	dubreuil, benjamin/0000-0002-8229-641X; Kelil, Abdellali/0000-0002-0406-2052	"Fonds quebecois de la recherche sur la nature et les technologies" postdoctoral fellowships program; Human Frontier Science Project postdoctoral fellowships program; Weizmann Institute of Science; Canadian Institutes of Health Research [MOP-GMX-152556, MOP-GMX-231013]	"Fonds quebecois de la recherche sur la nature et les technologies" postdoctoral fellowships program; Human Frontier Science Project postdoctoral fellowships program; Weizmann Institute of Science; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	AK acknowledges the "Fonds quebecois de la recherche sur la nature et les technologies" postdoctoral fellowships program for financial support. EDL acknowledges the Human Frontier Science Project postdoctoral fellowships program and the Weizmann Institute of Science for financial support. EDL is incumbent of the Recanati Career Development Chair of Cancer Research. SWM acknowledges support from Canadian Institutes of Health Research grants MOP-GMX-152556 and MOP-GMX-231013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azoitei ML, 2012, J MOL BIOL, V415, P175, DOI 10.1016/j.jmb.2011.10.003; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bellay J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r14; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Byrne DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044879; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Davey NE, 2010, FRONT BIOSCI-LANDMRK, V15, P801, DOI 10.2741/3647; Davey NE, 2009, BIOINFORMATICS, V25, P443, DOI 10.1093/bioinformatics/btn664; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinh H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041425; Dogruel M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-19; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Encinar JA, 2009, BIOINFORMATICS, V25, P2418, DOI 10.1093/bioinformatics/btp424; Fernandez-Ballester G, 2009, J MOL BIOL, V388, P902, DOI 10.1016/j.jmb.2009.03.038; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kim JM, 2008, J MOL BIOL, V377, P889, DOI 10.1016/j.jmb.2008.01.063; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lieber DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014444; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; London Nir, 2012, Methods Mol Biol, V857, P375, DOI 10.1007/978-1-61779-588-6_17; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Marsico A, 2010, NUCLEIC ACIDS RES, V38, pD181, DOI 10.1093/nar/gkp1042; Mi T, 2012, NUCLEIC ACIDS RES, V40, pD252, DOI 10.1093/nar/gkr1189; Minguez P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.31; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Mooney C, 2012, J MOL BIOL, V415, P193, DOI 10.1016/j.jmb.2011.10.025; Mosca R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014969; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; NEUWALD AF, 1994, J MOL BIOL, V239, P698, DOI 10.1006/jmbi.1994.1407; Ng P, 2006, BIOINFORMATICS, V22, pE393, DOI 10.1093/bioinformatics/btl245; Nguyen Ba Alex N, 2012, Sci Signal, V5, prs1, DOI 10.1126/scisignal.2002515; Parthasarathi L, 2008, J CHEM INF MODEL, V48, P1943, DOI 10.1021/ci800174c; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Ren S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S26; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Skilling J, 2006, BAYESIAN ANAL, V1, P833, DOI 10.1214/06-BA127; Stollar EJ, 2009, J BIOL CHEM, V284, P26918, DOI 10.1074/jbc.M109.028431; Tan SH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-502; Van Roey K, 2012, CURR OPIN STRUC BIOL, V22, P378, DOI 10.1016/j.sbi.2012.03.004; Wagner M, 2005, J COMPUT BIOL, V12, P355, DOI 10.1089/cmb.2005.12.355; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Zia A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-151	61	6	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106081	10.1371/journal.pone.0106081	http://dx.doi.org/10.1371/journal.pone.0106081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207816	gold, Green Submitted, Green Published			2022-12-27	WOS:000342030300016
J	Liu, AQ; Ge, LY; Lu, XL; Luo, XL; Cai, YL; Ye, XQ; Geng, FF				Liu, Ai-Qun; Ge, Lian-Ying; Lu, Xiao-Ling; Luo, Xiao-Ling; Cai, Yan-Ling; Ye, Xing-Qing; Geng, Fang-Fang			Silencing of the hTERT Gene by shRNA Inhibits Colon Cancer SW480 Cell Growth In Vitro and In Vivo	PLOS ONE			English	Article							TELOMERASE REVERSE-TRANSCRIPTASE; RNA INTERFERENCE; COLORECTAL-CANCER; MAMMALIAN-CELLS; APOPTOSIS; EXPRESSION; THERAPY; CARCINOMA; MODULATION; DISEASE	Human telomerase reverse transcriptase (hTERT) is the key enzyme responsible for synthesizing and maintaining the telomeres on the ends of chromosomes, and it is essential for cell proliferation. This has made hTERT a focus of oncology research and an attractive target for anticancer drug development. In this study, we designed a small interfering RNA (siRNA) targeting the catalytic subunit of hTERT and tested its effects on the growth of telomerase-positive human colon carcinoma SW480 cells in vitro, as well as on the tumorigenicity of these cells in nude mice. Transient and stable transfection of hTERT siRNA into colon cancer SW480 cells suppressed hTERT expression, reduced telomerase activity and inhibited cell growth and proliferation. Knocking down hTERT expression in SW480 tumors xenografted into nude mice significantly slowed tumor growth and promoted tumor cell apoptosis. Our results suggest that hTERT is involved in carcinogenesis of human colon carcinoma, and they highlight the therapeutic potential of a hTERT knock-down approach.	[Liu, Ai-Qun; Ge, Lian-Ying; Cai, Yan-Ling; Geng, Fang-Fang] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Endoscopy, Nanning, Guangxi, Peoples R China; [Lu, Xiao-Ling] Guangxi Med Univ, Natl Ctr Int Res Biol Targeting Diag & Therapy, Guangxi Key Lab Biol Targeting Diag & Therapy Res, Nanning, Guangxi, Peoples R China; [Luo, Xiao-Ling] Guangxi Med Univ, Sci & Technol Agcy, Nanning, Guangxi, Peoples R China; [Ye, Xing-Qing] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Pathol, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Liu, AQ (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Endoscopy, Nanning, Guangxi, Peoples R China.	liuaiqun_2004@163.com; gelianying2008@163.com	lu, xl/HDO-8340-2022		Natural Science Foundation of Guangxi [2010GXNSF013238]; Programs for Changjiang Scholars and Innovative Research Teams at University [IRT1119]	Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); Programs for Changjiang Scholars and Innovative Research Teams at University	This study was supported by the Natural Science Foundation of Guangxi (grant 2010GXNSF013238, http://www.gxst.gov.cn/zwgk/kjxmgl/xmxdgg/600619_7.shtml) and the Programs for Changjiang Scholars and Innovative Research Teams at University (No. IRT1119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Bayne S, 2005, MOL CELL ENDOCRINOL, V240, P11, DOI 10.1016/j.mce.2005.05.009; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gandellini P, 2007, BIOCHEM PHARMACOL, V73, P1703, DOI 10.1016/j.bcp.2007.01.035; Ge LH, 2011, ONCOL LETT, V2, P1121, DOI 10.3892/ol.2011.388; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Han YH, 2007, AM J PHYSIOL-RENAL, V293, pF511, DOI 10.1152/ajprenal.00385.2006; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hiyama E, 1997, CANCER RES, V57, P326; Janknecht R, 2004, FEBS LETT, V564, P9, DOI 10.1016/S0014-5793(04)00356-4; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Kim S, 2012, CANCER GENE THER, V19, P263, DOI 10.1038/cgt.2011.88; Kosciolek BA, 2003, MOL CANCER THER, V2, P209; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; Li Y, 2011, CANCER GENE THER, V18, P318, DOI 10.1038/cgt.2010.81; Liu L, 2004, GENE, V340, P1, DOI 10.1016/j.gene.2004.06.011; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nascimento PDS, 2006, ONCOL REP, V16, P423; O'Sullivan GC, 2007, INT J CANCER, V121, P1930, DOI 10.1002/ijc.22893; Phatak P, 2007, BRIT J PHARMACOL, V152, P1003, DOI 10.1038/sj.bjp.0707374; Reis Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028694; Rodrigues CMP, 1998, MOL MED, V4, P165, DOI 10.1007/BF03401914; Scholefield JH, 2002, GUT, V51, pV3, DOI 10.1136/gut.51.suppl_5.v3; Sesso A, 2012, ANAT REC, V295, P1647, DOI 10.1002/ar.22553; Sharma GG, 2003, ONCOGENE, V22, P131, DOI 10.1038/sj.onc.1206063; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shen Y, 2008, CANCER BIOL THER, V7, P228, DOI 10.4161/cbt.7.2.5259; Shi XP, 2009, CLIN CANCER RES, V15, P1686, DOI 10.1158/1078-0432.CCR-08-2141; Terrin L, 2008, CLIN CANCER RES, V14, P7444, DOI 10.1158/1078-0432.CCR-08-0478; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; Wang SC, 2008, NEOPLASIA, V10, P399, DOI 10.1593/neo.07613; Xia W, 2012, THER DELIV, V3, P439, DOI 10.4155/TDE.12.24; Xia W, 2012, J CONTROL RELEASE, V157, P427, DOI 10.1016/j.jconrel.2011.10.011; Yang ZR, 2007, CANCER GENE THER, V14, P599, DOI 10.1038/sj.cgt.7701054; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533; Zamzami N, 1997, J BIOENERG BIOMEMBR, V29, P185, DOI 10.1023/A:1022694131572; Zhang WX, 2013, INT J ONCOL, V43, P1228, DOI 10.3892/ijo.2013.2051; Zhang YY, 2011, CELL BIOCHEM BIOPHYS, V61, P595, DOI 10.1007/s12013-011-9242-0; Zhao H, 2008, EUR J PHARMACOL, V579, P50, DOI 10.1016/j.ejphar.2007.10.008	44	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107019	10.1371/journal.pone.0107019	http://dx.doi.org/10.1371/journal.pone.0107019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207650	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300055
J	Mohammadi, S; Jones, L; Gorbet, M				Mohammadi, Saman; Jones, Lyndon; Gorbet, Maud			Extended Latanoprost Release from Commercial Contact Lenses: In Vitro Studies Using Corneal Models	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEMS; BETA-BLOCKING-AGENTS; CELL-CULTURE MODELS; PENETRATION BEHAVIOR; KETOTIFEN FUMARATE; METABOLISM; PERMEABILITY; TRANSPORTER; BARRIER; EYE	In this study, we compared, for the first time, the release of a 432 kDa prostaglandin F-2 alpha analogue drug, Latanoprost, from commercially available contact lenses using in vitro models with corneal epithelial cells. Conventional polyHEMA-based and silicone hydrogel soft contact lenses were soaked in drug solution (131 mu g/ml solution in phosphate buffered saline). The drug release from the contact lens material and its diffusion through three in vitro models was studied. The three in vitro models consisted of a polyethylene terephthalate (PET) membrane without corneal epithelial cells, a PET membrane with a monolayer of human corneal epithelial cells (HCEC), and a PET membrane with stratified HCEC. In the cell-based in vitro corneal epithelium models, a zero order release was obtained with the silicone hydrogel materials (linear for the duration of the experiment) whereby, after 48 hours, between 4 to 6 mu g of latanoprost (an amount well within the range of the prescribed daily dose for glaucoma patients) was released. In the absence of cells, a significantly lower amount of drug, between 0.3 to 0.5 mu g, was released, (p<0.001). The difference observed in release from the hydrogel lens materials in the presence and absence of cells emphasizes the importance of using an in vitro corneal model that is more representative of the physiological conditions in the eye to more adequately characterize ophthalmic drug delivery materials. Our results demonstrate how in vitro models with corneal epithelial cells may allow better prediction of in vivo release. It also highlights the potential of drug-soaked silicone hydrogel contact lens materials for drug delivery purposes.	[Mohammadi, Saman; Gorbet, Maud] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Jones, Lyndon; Gorbet, Maud] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON N2L 3G1, Canada; [Jones, Lyndon; Gorbet, Maud] Univ Waterloo, Ctr Contact Lens Res, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo; University of Waterloo	Gorbet, M (corresponding author), Univ Waterloo, Waterloo, ON N2L 3G1, Canada.	mgorbet@uwaterloo.ca	Jones, Lyndon W/Q-5691-2016; Jones, Lyndon/AAH-9472-2021	Jones, Lyndon W/0000-0002-7409-7349; Jones, Lyndon/0000-0002-7409-7349	Collaborative Health Research Project grant - NSERC; CIHR	Collaborative Health Research Project grant - NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	The funding for this project was provided by a Collaborative Health Research Project grant (jointly funded by NSERC and CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAIE M, 1987, EXP EYE RES, V44, P73, DOI 10.1016/S0014-4835(87)80027-1; BASU S, 1994, PROSTAG LEUKOTR ESS, V50, P161, DOI 10.1016/0952-3278(94)90139-2; Booth BA, 2007, DRUG AGING, V24, P581, DOI 10.2165/00002512-200724070-00006; Chauhan A, 2012, CONTACT LENS SPECTRU, V27, P23; Choonara YE, 2010, J PHARM SCI-US, V99, P2219, DOI 10.1002/jps.21987; Ciolino JB, 2009, SEMIN OPHTHALMOL, V24, P156, DOI 10.1080/08820530902802161; Conway Barbara R, 2008, Recent Pat Drug Deliv Formul, V2, P1, DOI 10.2174/187221108783331410; Costa VP, 2010, J SUPERCRIT FLUID, V52, P306, DOI 10.1016/j.supflu.2010.02.001; Duvvuri S, 2004, CURR DRUG METAB, V5, P507, DOI 10.2174/1389200043335342; FRIEDMAN Z, 1985, ARCH OPHTHALMOL-CHIC, V103, P963; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Hariharan S, 2009, J OCUL PHARMACOL TH, V25, P487, DOI 10.1089/jop.2009.0049; Hehl EM, 1999, EUR J CLIN PHARMACOL, V55, P317, DOI 10.1007/s002280050635; HILLMAN JS, 1975, T OPHTHAL SOC UK, V95, P79; Hornof M, 2005, EUR J PHARM BIOPHARM, V60, P207, DOI 10.1016/j.ejpb.2005.01.009; HUANG HS, 1983, J PHARM SCI, V72, P1272, DOI 10.1002/jps.2600721109; HUANG HS, 1983, J PHARM SCI, V72, P1279, DOI 10.1002/jps.2600721110; JAIN MR, 1988, BRIT J OPHTHALMOL, V72, P150, DOI 10.1136/bjo.72.2.150; JARVINEN K, 1995, ADV DRUG DELIVER REV, V16, P3, DOI 10.1016/0169-409X(95)00010-5; Karlgard CCS, 2003, INT J PHARM, V257, P141, DOI 10.1016/S0378-5173(03)00124-8; Kim J, 2010, J CONTROL RELEASE, V148, P110, DOI 10.1016/j.jconrel.2010.07.119; Kraft ME, 2010, INVEST OPHTH VIS SCI, V51, P2504, DOI 10.1167/iovs.09-4290; Lavik E, 2011, EYE, V25, P578, DOI 10.1038/eye.2011.82; Mannermaa E, 2006, ADV DRUG DELIVER REV, V58, P1136, DOI 10.1016/j.addr.2006.07.024; Maurice D.M., 1984, HDB EXPT PHARM, V69, P19; Peng CC, 2011, J CONTROL RELEASE, V154, P267, DOI 10.1016/j.jconrel.2011.06.028; Postnikoff CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096448; Reichl S, 2004, BRIT J OPHTHALMOL, V88, P560, DOI 10.1136/bjo.2003.028225; Reichl S, 2011, EXPERT OPIN DRUG MET, V7, P559, DOI 10.1517/17425255.2011.562195; Sachdev M, 2011, J CURRENT GLAUCOMA P, V5, P21; Sedlacek J, 1965, Cesk Oftalmol, V21, P509; Shah B, 2011, J CURRENT GLAUCOMA P, V5, P15; Shirasaki Y, 2008, J PHARM SCI-US, V97, P2462, DOI 10.1002/jps.21200; Sjoquist B, 2002, SURV OPHTHALMOL, V47, pS6, DOI 10.1016/S0039-6257(02)00302-8; Sjoquist B, 1998, DRUG METAB DISPOS, V26, P745; Soluri A, 2012, OPTOMETRY VISION SCI, V89, P1140, DOI 10.1097/OPX.0b013e3182639dc8; Tabuchi N, 2009, J OLEO SCI, V58, P43, DOI 10.5650/jos.58.43; Tian X, 2001, EYE CONTACT LENS, V27, P212; Tian Xin, 2001, CLAO Journal, V27, P216; Vaughan AD, 2010, AICHE J, V56, P268, DOI 10.1002/aic.11949; Wander AH, 2011, EYE CONTACT LENS, V37, P39, DOI 10.1097/ICL.0b013e3181f84f92; White CJ, 2011, J DRUG DELIV SCI TEC, V21, P369, DOI 10.1016/S1773-2247(11)50062-0; White CJ, 2011, BIOMATERIALS, V32, P5698, DOI 10.1016/j.biomaterials.2011.04.044; Xiang CD, 2009, DRUG METAB DISPOS, V37, P992, DOI 10.1124/dmd.108.026286; Xu JK, 2011, DRUG DELIV, V18, P150, DOI 10.3109/10717544.2010.522612; Zhang T, 2008, DRUG METAB DISPOS, V36, P1300, DOI 10.1124/dmd.108.021121; ZIESKE JD, 1994, EXP CELL RES, V214, P621, DOI 10.1006/excr.1994.1300	47	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106653	10.1371/journal.pone.0106653	http://dx.doi.org/10.1371/journal.pone.0106653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207851	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300033
J	Pereira, IT; Ramos, EAS; Costa, ET; Camargo, AA; Manica, GCM; Klassen, LMB; Chequin, A; Braun-Prado, K; Pedrosa, FD; Souza, EM; Costa, FF; Klassen, G				Pereira, Isabela T.; Ramos, Edneia A. S.; Costa, Erico T.; Camargo, Anamaria A.; Manica, Graciele C. M.; Klassen, Liliane M. B.; Chequin, Andressa; Braun-Prado, Karin; Pedrosa, Fabio de O.; Souza, Emanuel M.; Costa, Fabricio F.; Klassen, Giseli			Fibronectin Affects Transient MMP2 Gene Expression through DNA Demethylation Changes in Non-Invasive Breast Cancer Cell Lines	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TUMOR INVASION; METASTASIS; ARCHITECTURE; ASSOCIATION; ACTIVATION; ZYMOGRAPHY; SUBSTRATE; MIGRATION; EXPOSURE	Metastasis accounts for more than 90% of cancer deaths. Cells from primary solid tumors may invade adjacent tissues and migrate to distant sites where they establish new colonies. The tumor microenvironment is now recognized as an important participant in the signaling that induces cancer cell migration. An essential process for metastasis is extracellular matrix (ECM) degradation by metalloproteases (MMPs), which allows tumor cells to invade local tissues and to reach blood vessels. The members of this protein family include gelatinase A, or MMP-2, which is responsible for the degradation of type IV collagen, the most abundant component of the basal membrane, that separates epithelial cells in the stroma. It is known that fibronectin is capable of promoting the expression of MMP-2 in MCF7 breast cancer cells in culture. In addition, it was already shown that the MMP2 gene expression is regulated by epigenetic mechanisms. In this work, we showed that fibronectin was able to induce MMP2 expression by 30% decrease in its promoter methylation. In addition, a histone marker for an open chromatin conformation was significantly increased. These results indicate a new role for fibronectin in the communication between cancer cells and the ECM, promoting epigenetic modifications.	[Pereira, Isabela T.; Ramos, Edneia A. S.; Manica, Graciele C. M.; Klassen, Liliane M. B.; Chequin, Andressa; Braun-Prado, Karin; Klassen, Giseli] Univ Fed Parana, Dept Basic Pathol, BR-80060000 Curitiba, Parana, Brazil; [Costa, Erico T.; Camargo, Anamaria A.] Sirio Libanes Hosp, Ctr Mol Oncol, Ludwig Inst Canc Res, Sao Paulo, Brazil; [Pedrosa, Fabio de O.; Souza, Emanuel M.] Univ Fed Parana, Dept Biochem & Mol Biol, BR-80060000 Curitiba, Parana, Brazil; [Costa, Fabricio F.] Northwestern Univ, Feinberg Sch Med, Ann & Robert Lurie Childrens Hosp, Canc Biol & Epigen Program,Chicago Res Ctr, Chicago, IL 60611 USA; [Costa, Fabricio F.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA	Universidade Federal do Parana; Hospital Sirio Libanes; Ludwig Institute for Cancer Research; Universidade Federal do Parana; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Klassen, G (corresponding author), Univ Fed Parana, Dept Basic Pathol, BR-80060000 Curitiba, Parana, Brazil.	giseli@ufpr.br	Costa, Fabricio/M-5309-2017; Manica, Graciele cristiane/AGY-7037-2022; Cavalieri, Edneia ASR/Q-9636-2019; Klassen, Giseli/AAF-3962-2019; Braun-Prado, Karin/C-4282-2014; Klassen, Giseli/F-8753-2012; Pereira, Isabela/AAW-5731-2021; Camargo, Anamaria A/E-9388-2012	Cavalieri, Edneia ASR/0000-0002-8855-5988; Klassen, Giseli/0000-0001-5336-6178; Klassen, Giseli/0000-0001-5336-6178; Camargo, Anamaria A/0000-0002-6076-9597; braun prado, Karin/0000-0002-9652-0566; Pereira, Isabela/0000-0001-8951-9965	Brazilian Research Council (CNPq) [479211/2012-4]; Coordination of Improvement of Higher Education Personnel (CAPES)	Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Brazilian Research Council (CNPq) (process 479211/2012-4) and Coordination of Improvement of Higher Education Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artacho-Cordon F, 2012, SURG ONCOL, V21, pE143, DOI 10.1016/j.suronc.2012.06.001; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Carraher CL, 2013, J BIOL CHEM, V288, P14805, DOI 10.1074/jbc.M112.435271; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chernov AV, 2009, J BIOL CHEM, V284, P12727, DOI 10.1074/jbc.M900273200; Chik F, 2011, CARCINOGENESIS, V32, P224, DOI 10.1093/carcin/bgq221; Das S, 2008, LIFE SCI, V82, P467, DOI 10.1016/j.lfs.2007.12.013; Duffy SW, 2005, J MED SCREEN, V12, P128, DOI 10.1258/0969141054855319; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; Helleman J, 2008, CLIN CANCER RES, V14, P5555, DOI 10.1158/1078-0432.CCR-08-0555; Hurtubise A, 2006, CANCER CHEMOTH PHARM, V58, P618, DOI 10.1007/s00280-006-0225-6; Instituto Nacional de Cancer (INCA), 2014, EST 2014; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Ivascu A, 2007, INT J ONCOL, V31, P1403; Kagey JD, 2010, MOL CANCER RES, V8, P1048, DOI 10.1158/1541-7786.MCR-10-0189; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Leber TM, 1997, ANAL BIOCHEM, V249, P24, DOI 10.1006/abio.1997.2170; Lelievre SA, 2009, BBA-GEN SUBJECTS, V1790, P925, DOI 10.1016/j.bbagen.2009.03.013; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Malouf GG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r144; Mayor R, 2011, EPIGENETICS-US, V6, P1138, DOI 10.4161/epi.6.9.16066; McGarvey KM, 2008, CANCER RES, V68, P5753, DOI 10.1158/0008-5472.CAN-08-0700; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Mitra A, 2006, J CANCER RES CLIN, V132, P505, DOI 10.1007/s00432-006-0096-6; Moroz A, 2013, BIOCHEM BIOPH RES CO, V430, P1319, DOI 10.1016/j.bbrc.2012.12.031; Ni XJ, 2014, CANCER SCI, V105, P18, DOI 10.1111/cas.12309; Park J, 2013, ONCOGENE; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pryzbylkowski P, 2008, BREAST CANCER RES TR, V111, P15, DOI 10.1007/s10549-007-9751-0; Rose N. R., 2014, BIOCH BIOPHYSICA ACT; Rothbart SB, 2014, BIOCH BIOPHYSICA ACT; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stanton H, 1998, J CELL SCI, V111, P2789; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391	42	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e105806	10.1371/journal.pone.0105806	http://dx.doi.org/10.1371/journal.pone.0105806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208219	Green Published, gold			2022-12-27	WOS:000342030300012
J	Cao, HP; Sethumadhavan, K; Grimm, CC; Ullah, AHJ				Cao, Heping; Sethumadhavan, Kandan; Grimm, Casey C.; Ullah, Abul H. J.			Characterization of a Soluble Phosphatidic Acid Phosphatase in Bitter Melon (Momordica charantia)	PLOS ONE			English	Article							CONJUGATED LINOLENIC ACID; SEED OIL-RICH; SACCHAROMYCES-CEREVISIAE; COLON CARCINOGENESIS; INSULIN-RESISTANCE; PPAR-GAMMA; PURIFICATION; GOURD; RATS; PROLIFERATION	Momordica charantia is often called bitter melon, bitter gourd or bitter squash because its fruit has a bitter taste. The fruit has been widely used as vegetable and herbal medicine. Alpha-eleostearic acid is the major fatty acid in the seeds, but little is known about its biosynthesis. As an initial step towards understanding the biochemical mechanism of fatty acid accumulation in bitter melon seeds, this study focused on a soluble phosphatidic acid phosphatase (PAP, 3-sn-phosphatidate phosphohydrolase, EC 3.1.3.4) that hydrolyzes the phosphomonoester bond in phosphatidate yielding diacylglycerol and P-i. PAPs are typically categorized into two subfamilies: Mg2+-dependent soluble PAP and Mg2+-independent membrane-associated PAP. We report here the partial purification and characterization of an Mg2+-independent PAP activity from developing cotyledons of bitter melon. PAP protein was partially purified by successive centrifugation and UNOsphere Q and S columns from the soluble extract. PAP activity was optimized at pH 6.5 and 53-60 degrees C and unaffected by up to 0.3 mM MgCl2. The K-m and V-max values for dioleoyl-phosphatidic acid were 595.4 mu M and 104.9 eta kat/mg of protein, respectively. PAP activity was inhibited by NaF, Na3VO4, Triton X-100, FeSO4 and CuSO4, but stimulated by MnSO4, ZnSO4 and Co(NO3)(2). In-gel activity assay and mass spectrometry showed that PAP activity was copurified with a number of other proteins. This study suggests that PAP protein is probably associated with other proteins in bitter melon seeds and that a new class of PAP exists as a soluble and Mg2+-independent enzyme in plants.	[Cao, Heping; Sethumadhavan, Kandan; Grimm, Casey C.; Ullah, Abul H. J.] ARS, USDA, So Reg Res Ctr, New Orleans, LA 70130 USA	United States Department of Agriculture (USDA)	Cao, HP (corresponding author), ARS, USDA, So Reg Res Ctr, New Orleans, LA 70130 USA.	Heping.Cao@ars.usda.gov	Cao, Heping/AAC-1666-2021	Cao, Heping/0000-0002-0958-1468	USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 [CRIS 6435-41000-102-00D, 6435-41000-102-10N]	USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306	This work was supported by the USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS 6435-41000-102-00D and 6435-41000-102-10N. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2012, MOLECULES, V17, P9631, DOI 10.3390/molecules17089631; Bao B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084075; Brennan VC, 2012, J MED FOOD, V15, P325, DOI 10.1089/jmf.2011.0158; BUTTERWITH SC, 1984, BIOCHEM J, V220, P825, DOI 10.1042/bj2200825; Cao HP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076946, 10.1371/journal.pone.0052853]; Cao HP, 2012, APPL MICROBIOL BIOT, V96, P711, DOI 10.1007/s00253-012-3869-7; Cao Heping, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-249; Cao HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P135, DOI 10.1006/abbi.1999.1547; Chao CY, 2011, J ETHNOPHARMACOL, V135, P156, DOI 10.1016/j.jep.2011.03.001; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Dhar P, 1999, LIPIDS, V34, P109, DOI 10.1007/s11745-999-0343-2; Dhar Pubali, 2006, J Oleo Sci, V56, P19; Efird JT, 2014, INT J ENV RES PUB HE, V11, P2328, DOI 10.3390/ijerph110202328; Grossmann ME, 2009, CANCER PREV RES, V2, P879, DOI 10.1158/1940-6207.CAPR-09-0088; Gurbuz I, 2000, J ETHNOPHARMACOL, V71, P77, DOI 10.1016/S0378-8741(99)00178-6; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; Hsieh CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072917; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kim Hyun Young, 2013, Prev Nutr Food Sci, V18, P18, DOI 10.3746/pnf.2013.18.1.018; Kocsis MG, 1996, LIPIDS, V31, P785, DOI 10.1007/BF02522974; Kohno H, 2004, INT J CANCER, V110, P896, DOI 10.1002/ijc.20179; Kohno H, 2004, CANCER SCI, V95, P481, DOI 10.1111/j.1349-7006.2004.tb03236.x; Kwatra D, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/702869; LIN YP, 1989, J BIOL CHEM, V264, P8641; Liu XR, 2010, SPECTROSC SPECT ANAL, V30, P2265, DOI 10.3964/j.issn.1000-0593(2010)08-2265-04; Mardani Saeed, 2014, J Nephropathol, V3, P35, DOI 10.12860/jnp.2014.08; Oishi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P735, DOI 10.1271/bbb.60570; Ozbakis Dengiz Gunnur, 2005, Turk J Gastroenterol, V16, P85; OZBUN JL, 1971, PLANT PHYSIOL, V48, P765, DOI 10.1104/pp.48.6.765; Padmashree A, 2011, J SCI FOOD AGR, V91, P776, DOI 10.1002/jsfa.4251; Piskin A, 2014, J DERMATOL TREAT, V25, P350, DOI 10.3109/09546634.2012.713459; Rajamoorthi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078006; Saha SS, 2012, BRIT J NUTR, V108, P974, DOI 10.1017/S0007114511006325; Shih CC, 2014, PHYTOTHER RES, V28, P363, DOI 10.1002/ptr.5003; SMITH SW, 1957, J BIOL CHEM, V228, P915; Suzuki R, 2001, LIPIDS, V36, P477, DOI 10.1007/s11745-001-0746-0; ULLAH AHJ, 1987, PREP BIOCHEM, V17, P397, DOI 10.1080/00327488708062504; Ullah AHJ, 2013, ADV BIOL CHEM, V3, P11; Ullah AHJ, 2012, ADV BIOL CHEM, V2, P403; Wang HY, 2014, FOOD CHEM TOXICOL, V69, P347, DOI 10.1016/j.fct.2014.04.008; Yasui Y, 2005, PROSTAG LEUKOTR ESS, V73, P113, DOI 10.1016/j.plefa.2005.04.013; Zeng YW, 2013, ASIAN PAC J CANCER P, V14, P1585, DOI 10.7314/APJCP.2013.14.3.1585	43	3	4	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106403	10.1371/journal.pone.0106403	http://dx.doi.org/10.1371/journal.pone.0106403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203006	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500020
J	Fan, CB; Wei, JY; Yuan, CL; Wang, X; Jiang, CW; Zhou, CC; Yang, M				Fan, Chuanbo; Wei, Jinyu; Yuan, Chenglu; Wang, Xin; Jiang, Chuanwu; Zhou, Changchun; Yang, Ming			The Functional TP53 rs1042522 and MDM4 rs4245739 Genetic Variants Contribute to Non-Hodgkin Lymphoma Risk	PLOS ONE			English	Article							P53 ARG72PRO POLYMORPHISM; GENOME-WIDE ASSOCIATION; CODON 72 POLYMORPHISM; CANCER; SUSCEPTIBILITY; EPIDEMIOLOGY; REGULATOR; MICRORNA; SURVIVAL; PROTEIN	As a heterogeneous kind of malignances, Non-Hodgkin lymphoma (NHL) is the most common hematologic cancer worldwide with the significantly increased morbidity in China. Accumulated evidences demonstrated that oncoprotein MDM4 plays a crucial role in the TP53 tumor suppressor signaling pathway. An rs4245739 A>C polymorphism locating in the MDM4 3'-untranslated region creates a miR-191 target site and results in allele-specific MDM4 expression. In this study, we examined the association between this polymorphism as well as the TP53 Arg72Pro (rs1042522 G>C) genetic variant and Non-Hodgkin Lymphoma (NHL) risk in a Chinese Han population. Genotypes were determined in 200 NHL cases and 400 controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by logistic regression. We found significantly increased NHL risk among carriers of the TP53 72Pro allele compared with those with the 72Arg allele (P=0.002 for the Pro/Pro genotype). We also observed a significantly decreased NHL risks among carriers of the MDM4 rs4245739 C allele compared with those with the A allele in Chinese (P=0.014 for the AC genotype). Stratified analyses revealed the associations between these SNPs and NHL risk are especially noteworthy in young or male individuals. Additionally, the associations are much pronounced in NHL patients with B-cell lymphomas or grade 3 or 4 disease. Our results indicate that the TP53 Arg72Pro and the MDM4 rs4245739 polymorphisms contribute to NHL susceptibility and support the hypothesis that genetic variants in the TP53 pathway genes can act as important modifiers of NHL risk.	[Fan, Chuanbo; Wang, Xin] Shandong Univ, Dept Hematol, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Fan, Chuanbo] Qingdao Hiser Med Ctr, Dept Hematol, Qingdao, Shandong, Peoples R China; [Jiang, Chuanwu] Qingdao Hiser Med Ctr, Dept Radiol, Qingdao, Shandong, Peoples R China; [Yuan, Chenglu] Shandong Univ, Qilu Hosp, Dept Hematol, Qingdao, Shandong, Peoples R China; [Wei, Jinyu; Yang, Ming] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China; [Zhou, Changchun] Shandong Acad Med Sci, Shandong Canc Hosp, Clin Lab, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Beijing University of Chemical Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Yang, M (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China.	zcc5858@126.com; yangm@mail.buct.edu.cn	Pinheiro, Maísa/E-7424-2012; , CC. Zhou/AGI-1229-2022; Yang, Ming/G-4705-2012	Yang, Ming/0000-0002-7722-7487	Beijing City Talent Training Project [2012D009016000002]; Beijing Higher Education Young Elite Teacher Project [YETP0521]; National Natural Science Foundation of China [81201586, 31271382]; Beijing Natural Science Foundation [5122020]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13045]; open project of State Key Laboratory of Molecular Oncology [SKL-KF-2013-03]	Beijing City Talent Training Project; Beijing Higher Education Young Elite Teacher Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); open project of State Key Laboratory of Molecular Oncology	This work was supported by Beijing City Talent Training Project (2012D009016000002), Beijing Higher Education Young Elite Teacher Project (YETP0521), National Natural Science Foundation of China (81201586 & 31271382), Beijing Natural Science Foundation (5122020), Program for Changjiang Scholars and Innovative Research Team in University (IRT13045) and the open project of State Key Laboratory of Molecular Oncology (SKL-KF-2013-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Bittenbring J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-116; Chen JD, 1996, MOL CELL BIOL, V16, P2445; Chen YD, 2013, J NEURO-ONCOL, V111, P145, DOI 10.1007/s11060-012-1007-0; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Engels EA, 2007, CANCER EPIDEM BIOMAR, V16, P401, DOI 10.1158/1055-9965.EPI-06-1056; Grulich AE, 2005, PATHOLOGY, V37, P409, DOI 10.1080/00313020500370192; Havranek O, 2011, LEUKEMIA RES, V35, P1117, DOI 10.1016/j.leukres.2011.04.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim HN, 2010, AM J HEMATOL, V85, P822, DOI 10.1002/ajh.21834; Landers JE, 1997, CANCER RES, V57, P3562; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Liu JB, 2013, BREAST CANCER RES TR, V140, P151, DOI 10.1007/s10549-013-2615-x; Macsween KF, 2003, LANCET INFECT DIS, V3, P131, DOI 10.1016/S1473-3099(03)00543-7; Manns A, 1999, LANCET, V353, P1951, DOI 10.1016/S0140-6736(98)09460-4; McEvoy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042739; Muller AMS, 2005, ANN HEMATOL, V84, P1, DOI 10.1007/s00277-004-0939-7; Nagpal N, 2013, CARCINOGENESIS, V34, P1889, DOI 10.1093/carcin/bgt107; Orsted DD, 2007, J EXP MED, V204, P1295, DOI 10.1084/jem.20062476; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Weng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045820; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Xiong SB, 2010, CANCER RES, V70, P7148, DOI 10.1158/0008-5472.CAN-10-1457; Yang M, 2012, CANCER-AM CANCER SOC, V118, P4681, DOI 10.1002/cncr.27455; Zhou LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064331	34	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107047	10.1371/journal.pone.0107047	http://dx.doi.org/10.1371/journal.pone.0107047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203442	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500064
J	Goschl, F; Engel, AK; Friese, U				Goeschl, Florian; Engel, Andreas K.; Friese, Uwe			Attention Modulates Visual-Tactile Interaction in Spatial Pattern Matching	PLOS ONE			English	Article							AUDITORY OBJECT RECOGNITION; GAMMA-BAND ACTIVITY; MULTISENSORY INTEGRATION; AUDIOVISUAL INTEGRATION; SELECTIVE ATTENTION; ENHANCEMENT; MODALITIES; RESPONSES; HUMANS; TASK	Factors influencing crossmodal interactions are manifold and operate in a stimulus-driven, bottom-up fashion, as well as via top-down control. Here, we evaluate the interplay of stimulus congruence and attention in a visual-tactile task. To this end, we used a matching paradigm requiring the identification of spatial patterns that were concurrently presented visually on a computer screen and haptically to the fingertips by means of a Braille stimulator. Stimulation in our paradigm was always bimodal with only the allocation of attention being manipulated between conditions. In separate blocks of the experiment, participants were instructed to (a) focus on a single modality to detect a specific target pattern, (b) pay attention to both modalities to detect a specific target pattern, or (c) to explicitly evaluate if the patterns in both modalities were congruent or not. For visual as well as tactile targets, congruent stimulus pairs led to quicker and more accurate detection compared to incongruent stimulation. This congruence facilitation effect was more prominent under divided attention. Incongruent stimulation led to behavioral decrements under divided attention as compared to selectively attending a single sensory channel. Additionally, when participants were asked to evaluate congruence explicitly, congruent stimulation was associated with better performance than incongruent stimulation. Our results extend previous findings from audiovisual studies, showing that stimulus congruence also resulted in behavioral improvements in visuotactile pattern matching. The interplay of stimulus processing and attentional control seems to be organized in a highly flexible fashion, with the integration of signals depending on both bottom-up and top-down factors, rather than occurring in an 'all-or-nothing' manner.	[Goeschl, Florian; Engel, Andreas K.; Friese, Uwe] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Goschl, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany.	f.goeschl@uke.de	Engel, Andreas K./AAH-6384-2019; Engel, Andreas K/C-7781-2012	Engel, Andreas K./0000-0003-4899-8466; Engel, Andreas K/0000-0003-4899-8466	DFG [SFB 936/A3]; EU [ERC-2010-AdG-269716]	DFG(German Research Foundation (DFG)); EU(European Commission)	This research was supported by grants from the DFG (SFB 936/A3; http://www.dfg.de) and the EU (ERC-2010-AdG-269716; https://www.erc.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen EL, 2003, J VISION, V3, P64, DOI 10.1167/3.1.7; Boudreau CE, 2006, J NEUROPHYSIOL, V96, P2377, DOI 10.1152/jn.01072.2005; Buchholz VN, 2012, J NEUROPHYSIOL, V107, P3135, DOI 10.1152/jn.01188.2011; Chen YC, 2010, COGNITION, V114, P389, DOI 10.1016/j.cognition.2009.10.012; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Diederich A, 2007, PERCEPT PSYCHOPHYS, V69, P56, DOI 10.3758/BF03194453; Doehrmann O, 2008, BRAIN RES, V1242, P136, DOI 10.1016/j.brainres.2008.03.071; Forster B, 2002, EXP BRAIN RES, V143, P480, DOI 10.1007/s00221-002-1017-9; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Gallace A, 2011, PSYCHOL BULL, V137, P538, DOI 10.1037/a0022335; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gillmeister H, 2007, BRAIN RES, V1160, P58, DOI 10.1016/j.brainres.2007.03.041; Girard S, 2013, EXP BRAIN RES, V224, P275, DOI 10.1007/s00221-012-3308-0; Hein G, 2007, J NEUROSCI, V27, P7881, DOI 10.1523/JNEUROSCI.1740-07.2007; Holmes NP, 2005, CURR BIOL, V15, pR762, DOI 10.1016/j.cub.2005.08.058; Hugenschmidt CE, 2009, NEUROREPORT, V20, P349, DOI 10.1097/WNR.0b013e328323ab07; Hummel F, 2005, CEREB CORTEX, V15, P670, DOI 10.1093/cercor/bhh170; Kanayama N, 2012, NEUROIMAGE, V59, P3406, DOI 10.1016/j.neuroimage.2011.11.076; Kanayama N, 2009, NEUROREPORT, V20, P289, DOI 10.1097/WNR.0b013e328322ca63; Laurienti PJ, 2004, EXP BRAIN RES, V158, P405, DOI 10.1007/s00221-004-1913-2; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Macmillan N. A., 1991, DETECTION THEORY USE; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Mishra J, 2012, J NEUROSCI, V32, P12294, DOI 10.1523/JNEUROSCI.0867-12.2012; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Mozolic JL, 2008, EXP BRAIN RES, V184, P39, DOI 10.1007/s00221-007-1080-3; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; Rach S, 2011, PSYCHOL RES-PSYCH FO, V75, P77, DOI 10.1007/s00426-010-0289-0; Roder B, 2007, P NATL ACAD SCI USA, V104, P4753, DOI 10.1073/pnas.0607158104; Schneider TR, 2008, NEUROIMAGE, V42, P1244, DOI 10.1016/j.neuroimage.2008.05.033; Schneider TR, 2011, J NEUROSCI, V31, P2502, DOI 10.1523/JNEUROSCI.6447-09.2011; Spence C, 2012, NEW HDB MULTISENSORY, P241; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stein BE., 1993, MERGING SENSES; Talsma D, 2012, NEW HDB MULTISENSORY, P371; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Townsend J. T., 1983, STOCHASTIC MODELING	38	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106896	10.1371/journal.pone.0106896	http://dx.doi.org/10.1371/journal.pone.0106896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203102	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500052
J	Jorgez, CJ; Rosenfeld, JA; Wilken, NR; Vangapandu, HV; Sahin, A; Pham, D; Carvalho, CMB; Bandholz, A; Miller, A; Weaver, DD; Burton, B; Babu, D; Bamforth, JS; Wilks, T; Flynn, DP; Roeder, E; Patel, A; Cheung, SW; Lupski, JR; Lamb, DJ				Jorgez, Carolina J.; Rosenfeld, Jill A.; Wilken, Nathan R.; Vangapandu, Hima V.; Sahin, Aysegul; Dung Pham; Carvalho, Claudia M. B.; Bandholz, Anne; Miller, Amanda; Weaver, David D.; Burton, Barbara; Babu, Deepti; Bamforth, John S.; Wilks, Timothy; Flynn, Daniel P.; Roeder, Elizabeth; Patel, Ankita; Cheung, Sau W.; Lupski, James R.; Lamb, Dolores J.			Genitourinary Defects Associated with Genomic Deletions in 2p15 Encompassing OTX1	PLOS ONE			English	Article							RECOGNIZED MICRODELETION SYNDROME; BLADDER-EXSTROPHY; RISK-FACTORS; DYSMORPHIC FEATURES; MICE LACKING; MB DELETION; CRYPTORCHIDISM; PATIENT; FERTILITY; IDENTIFICATION	Normal development of the genitourinary (GU) tract is a complex process that frequently goes awry. In male children the most frequent congenital GU anomalies are cryptorchidism (1-4%), hypospadias (1%) and micropenis (0.35%). Bladder exstrophy and epispadias complex (BEEC) (1:47000) occurs less frequently but significantly impacts patients' lives. Array comparative genomic hybridization (aCGH) identified seven individuals with overlapping deletions in the 2p15 region (66.0 kb-5.6 Mb). Six of these patients have GU defects, while the remaining patient has no GU defect. These deletions encompass the transcription factor OTX1. Subjects 2-7 had large de novo CNVs (2.39-6.31 Mb) and exhibited features similar to those associated with the 2p15p16.1 and 2p15p14 microdeletion syndromes, including developmental delay, short stature, and variable GU defects. Subject-1 with BEEC had the smallest deletion (66 kb), which deleted only one copy of OTX1. Otx1-null mice have seizures, prepubescent transient growth retardation and gonadal defects. Two subjects have short stature, two have seizures, and six have GU defects, mainly affecting the external genitalia. The presence of GU defects in six patients in our cohort and eight of thirteen patients reported with deletions within 2p14p16.1 (two with deletion of OTX1) suggest that genes in 2p15 are important for GU development. Genitalia defects in these patients could result from the effect of OTX1 on pituitary hormone secretion or on the regulation of SHH signaling, which is crucial for development of the bladder and genitalia.	[Jorgez, Carolina J.; Lamb, Dolores J.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [Jorgez, Carolina J.; Wilken, Nathan R.; Vangapandu, Hima V.; Sahin, Aysegul; Dung Pham; Lamb, Dolores J.] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Lamb, Dolores J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Carvalho, Claudia M. B.; Patel, Ankita; Cheung, Sau W.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Rosenfeld, Jill A.; Bandholz, Anne] PerkinElmer Inc, Signature Genom Labs, Spokane, WA USA; [Miller, Amanda; Weaver, David D.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Burton, Barbara] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Babu, Deepti; Bamforth, John S.] Univ Alberta, Edmonton, AB, Canada; [Wilks, Timothy] Madigan Army Med Ctr, Dept Pediat, Tacoma, WA 98431 USA; [Flynn, Daniel P.] St Lukes Childrens Specialty Ctr, Dept Childrens Endocrinol, Boise, ID USA; [Roeder, Elizabeth] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Indiana University System; Indiana University Bloomington; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Alberta; Madigan Army Medical Center; University of Texas System; University of Texas Health San Antonio	Jorgez, CJ (corresponding author), Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA.	cj129804@bcm.edu; dlamb@bcm.edu		Vangapandu, Hima/0000-0003-4762-1990	NIH [K12 DK0083014]; Multidisciplinary K12 Urologic Research (KURe) Career Development Program; National Institute of Kidney and Digestive Diseases [R01DK078121]; Signature Genomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078121, K12DK083014] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multidisciplinary K12 Urologic Research (KURe) Career Development Program; National Institute of Kidney and Digestive Diseases; Signature Genomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH grants K12 DK0083014, the Multidisciplinary K12 Urologic Research (KURe) Career Development Program awarded to DJL (CJJ is a K12 Scholar) and R01DK078121 (DJL) from the National Institute of Kidney and Digestive Diseases to DJL. Signature Genomics provided support in the form of salaries for authors (JAR and AB) at the time of the study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Acampora D, 1998, DEVELOPMENT, V125, P1229; Acampora D, 1999, DEVELOPMENT, V126, P1417; Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; Akre O, 1999, EPIDEMIOLOGY, V10, P364, DOI 10.1097/00001648-199907000-00005; Ballif BC, 2008, CLIN GENET, V74, P469, DOI 10.1111/j.1399-0004.2008.01094.x; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Brouwers MM, 2012, J PEDIATR UROL, V8, P59, DOI 10.1016/j.jpurol.2010.11.001; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Caton AR, 2007, BIRTH DEFECTS RES A, V79, P781, DOI 10.1002/bdra.20402; Chabchoub E, 2008, J MED GENET, V45, P189, DOI 10.1136/jmg.2007.056176; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; CUNHA GR, 1992, J ANDROL, V13, P465; De Leeuw N, 2008, J MED GENET, V45, P122, DOI 10.1136/jmg.2007.054049; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Ebert A, 2005, J UROLOGY, V174, P1094, DOI 10.1097/01.ju.0000169171.97538.ed; Ebert AK, 2010, J PEDIATR UROL, V6, P6, DOI 10.1016/j.jpurol.2009.06.002; Etchin J, 2013, BRIT J HAEMATOL, V161, P117, DOI 10.1111/bjh.12231; Felix TM, 2010, AM J MED GENET A, V152A, P2604, DOI 10.1002/ajmg.a.33612; Gaspari L, 2011, HUM REPROD, V26, P3155, DOI 10.1093/humrep/der283; Grinspon RP, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00051; Gupta AD, 2014, BJU INT, V113, P137, DOI 10.1111/bju.12389; Hadziselimovic F, 2001, LANCET, V358, P1156, DOI 10.1016/S0140-6736(01)06274-2; Hancarova M, 2013, GENE, V516, P158, DOI 10.1016/j.gene.2012.12.027; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Hucthagowder V, 2012, EUR J MED GENET, V55, P485, DOI 10.1016/j.ejmg.2012.04.003; JOB JC, 1977, ACTA ENDOCRINOL-COP, V85, P644, DOI 10.1530/acta.0.0850644; JOHNSON DE, 1968, SURGERY, V63, P919; Jorgez CJ, 2011, J CLIN ENDOCR METAB, V96, pE674, DOI 10.1210/jc.2010-2018; Kanto S, 2004, INT J UROL, V11, P640, DOI 10.1111/j.1442-2042.2004.00853.x; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kolon TF, 2014, J UROL; Koutros S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058195; Larder R, 2013, MOL CELL ENDOCRINOL, V377, P16, DOI 10.1016/j.mce.2013.06.026; Lee PA, 2001, HORM RES, V55, P28, DOI 10.1159/000049960; Liang JS, 2009, J MED GENET, V46, P645, DOI 10.1136/jmg.2008.059220; LIPSHULTZ LI, 1976, NEW ENGL J MED, V295, P15, DOI 10.1056/NEJM197607012950104; Liu XD, 2011, EUR J HUM GENET, V19, P1264, DOI 10.1038/ejhg.2011.112; Lui TTH, 2011, MOL CELL BIOL, V31, P2053, DOI 10.1128/MCB.01094-10; Lupski JR, 2009, GENOME MED, V1, DOI 10.1186/gm42; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Miller KD, 2001, HORM RES, V55, P249, DOI 10.1159/000050005; Nelson CP, 2005, J UROLOGY, V173, P1728, DOI 10.1097/01.ju.0000154821.21521.9b; Paulozzi LJ, 1997, PEDIATRICS, V100, P831, DOI 10.1542/peds.100.5.831; Piccione M, 2012, EUR J MED GENET, V55, P238, DOI 10.1016/j.ejmg.2012.01.014; PIKE MC, 1986, LANCET, V1, P1246; Poalas K, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-25; Prontera P, 2011, AM J MED GENET A, V155A, P2473, DOI 10.1002/ajmg.a.33875; Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037; Rajcan-Separovic E, 2007, J MED GENET, V44, P269, DOI 10.1136/jmg.2006.045013; Reutter H, 2011, J PEDIATR-US, V159, P825, DOI 10.1016/j.jpeds.2011.04.042; Sijstermans K, 2008, INT J ANDROL, V31, P1, DOI 10.1111/j.1365-2605.2007.00770.x; Song RF, 2011, PEDIATR NEPHROL, V26, P353, DOI 10.1007/s00467-010-1629-4; Tannour-Louet M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015392; Traylor RN, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-17; Williams G, 2008, J AM SOC NEPHROL, V19, P847, DOI 10.1681/ASN.2007020245; Wohlleber E, 2011, EUR J MED GENET, V54, P67, DOI 10.1016/j.ejmg.2010.09.012	58	25	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107028	10.1371/journal.pone.0107028	http://dx.doi.org/10.1371/journal.pone.0107028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203062	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500061
J	Lombardo, M; Serrao, S; Lombardo, G				Lombardo, Marco; Serrao, Sebastiano; Lombardo, Giuseppe			Technical Factors Influencing Cone Packing Density Estimates in Adaptive Optics Flood Illuminated Retinal Images	PLOS ONE			English	Article							SCANNING LASER OPHTHALMOSCOPE; PHOTORECEPTOR DENSITY; MACULAR DEGENERATION; PARAFOVEAL CONES; ECCENTRICITY; RESOLUTION; EYE; AGE; VARIABILITY; AGREEMENT	Purpose: To investigate the influence of various technical factors on the variation of cone packing density estimates in adaptive optics flood illuminated retinal images. Methods: Adaptive optics images of the photoreceptor mosaic were obtained in fifteen healthy subjects. The cone density and Voronoi diagrams were assessed in sampling windows of 320x320 mu m, 160x160 mu m and 64x64 mu m at 1.5 degree temporal and superior eccentricity from the preferred locus of fixation (PRL). The technical factors that have been analyzed included the sampling window size, the corrected retinal magnification factor (RMFcorr), the conversion from radial to linear distance from the PRL, the displacement between the PRL and foveal center and the manual checking of cone identification algorithm. Bland-Altman analysis was used to assess the agreement between cone density estimated within the different sampling window conditions. Results: The cone density declined with decreasing sampling area and data between areas of different size showed low agreement. A high agreement was found between sampling areas of the same size when comparing density calculated with or without using individual RMFcorr. The agreement between cone density measured at radial and linear distances from the PRL and between data referred to the PRL or the foveal center was moderate. The percentage of Voronoi tiles with hexagonal packing arrangement was comparable between sampling areas of different size. The boundary effect, presence of any retinal vessels, and the manual selection of cones missed by the automated identification algorithm were identified as the factors influencing variation of cone packing arrangements in Voronoi diagrams. Conclusions: The sampling window size is the main technical factor that influences variation of cone density. Clear identification of each cone in the image and the use of a large buffer zone are necessary to minimize factors influencing variation of Voronoi diagrams of the cone mosaic.	[Lombardo, Marco; Serrao, Sebastiano] Fdn GB Bietti IRCCS, Rome, Italy; [Lombardo, Giuseppe] CNR IPCF Unit Support Cosenza, Arcavacata Di Rende, Italy; [Lombardo, Giuseppe] Vis Engn Italy Srl, Rome, Italy	IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR)	Lombardo, M (corresponding author), Fdn GB Bietti IRCCS, Rome, Italy.	mlombardo@visioeng.it	; Lombardo, Giuseppe/B-2656-2012	Lombardo, Marco/0000-0001-8842-7102; Lombardo, Giuseppe/0000-0002-9416-967X				Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boretsky A, 2012, LASER SURG MED, V44, P603, DOI 10.1002/lsm.22070; Chiu SJ, 2013, BIOMED OPT EXPRESS, V4, P924, DOI 10.1364/BOE.4.000924; Chui TYP, 2008, INVEST OPHTH VIS SCI, V49, P4679, DOI 10.1167/iovs.08-2135; Chui TYP, 2008, J OPT SOC AM A, V25, P3021, DOI 10.1364/JOSAA.25.003021; Coletta NJ, 2006, VISION RES, V46, P636, DOI 10.1016/j.visres.2005.05.025; Costa LD, 2007, NEUROINFORMATICS, V5, P59, DOI 10.1385/NI:5:1:59; CURCIO CA, 1992, VISUAL NEUROSCI, V9, P169, DOI 10.1017/S0952523800009639; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dees EW, 2011, BIOMED OPT EXPRESS, V2, P1351, DOI 10.1364/BOE.2.001351; DRASDO N, 1974, BRIT J OPHTHALMOL, V58, P709, DOI 10.1136/bjo.58.8.709; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Garrioch R, 2012, OPTOMETRY VISION SCI, V89, P632, DOI 10.1097/OPX.0b013e3182540562; Godara P, 2012, ADV EXP MED BIOL, V723, P451, DOI 10.1007/978-1-4614-0631-0_57; HOLDEN AL, 1988, BRIT J OPHTHALMOL, V72, P228, DOI 10.1136/bjo.72.3.228; Kulcsar C, 2013, IMAGING APPL OPTICS; Li KY, 2007, J OPT SOC AM A, V24, P1358, DOI 10.1364/JOSAA.24.001358; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Lombardo M, 2014, RETINA-J RET VIT DIS, V34, P546, DOI 10.1097/IAE.0b013e3182a10850; Lombardo M, 2013, BIOMED OPT EXPRESS, V4, P1318, DOI 10.1364/BOE.4.001318; Lombardo M, 2013, RETINA-J RET VIT DIS, V33, P1640, DOI 10.1097/IAE.0b013e3182807642; Lombardo M, 2013, OPHTHAL PHYSL OPT, V33, P516, DOI 10.1111/opo.12053; Lombardo M, 2013, SENSORS-BASEL, V13, P334, DOI 10.3390/s130100334; Lombardo M, 2012, OPHTHALMOLOGY, V119, P1498, DOI 10.1016/j.ophtha.2012.03.019; Lombardo M, 2012, J CATARACT REFR SURG, V38, P1147, DOI 10.1016/j.jcrs.2012.02.033; Merino D, 2011, BIOMED OPT EXPRESS, V2, P2189, DOI 10.1364/BOE.2.002189; Park SP, 2013, EXP EYE RES, V108, P1, DOI 10.1016/j.exer.2012.12.011; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Song HX, 2011, INVEST OPHTH VIS SCI, V52, P7376, DOI 10.1167/iovs.11-7199; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Xue B, 2007, J OPT SOC AM A, V24, P1364, DOI 10.1364/JOSAA.24.001364; Zayit-Soudry S, 2013, INVEST OPHTH VIS SCI, V54, P7498, DOI 10.1167/iovs.13-12433	34	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107402	10.1371/journal.pone.0107402	http://dx.doi.org/10.1371/journal.pone.0107402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203681	Green Published, gold			2022-12-27	WOS:000342684500097
J	Zakszewski, E; Adluru, N; Tromp, DPM; Kalin, N; Alexander, AL				Zakszewski, Elizabeth; Adluru, Nagesh; Tromp, Do P. M.; Kalin, Ned; Alexander, Andrew L.			A Diffusion-Tensor-Based White Matter Atlas for Rhesus Macaques	PLOS ONE			English	Article							HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; ANTERIOR COMMISSURE; PREFRONTAL CORTEX; INTERNAL CAPSULE; CORPUS-CALLOSUM; MONKEY; PATHWAYS; PROJECTIONS; MRI	Atlases of key white matter (WM) structures in humans are widely available, and are very useful for region of interest (ROI)-based analyses of WM properties. There are histology-based atlases of cortical areas in the rhesus macaque, but none currently of specific WM structures. Since ROI-based analysis of WM pathways is also useful in studies using rhesus diffusion tensor imaging (DTI) data, we have here created an atlas based on a publicly available DTI-based template of young rhesus macaques. The atlas was constructed to mimic the structure of an existing human atlas that is widely used, making results translatable between species. Parcellations were carefully hand-drawn on a principle-direction color-coded fractional anisotropy image of the population template. The resulting atlas can be used as a reference to which registration of individual rhesus data can be performed for the purpose of white-matter parcellation. Alternatively, specific ROIs from the atlas may be warped into individual space to be used in ROI-based group analyses. This atlas will be made publicly available so that it may be used as a resource for DTI studies of rhesus macaques.	[Zakszewski, Elizabeth; Adluru, Nagesh; Alexander, Andrew L.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA; [Tromp, Do P. M.; Kalin, Ned] Univ Wisconsin, Hlth Emot Res Inst, Madison, WI USA; [Kalin, Ned; Alexander, Andrew L.] Univ Wisconsin, Dept Psychiat, Wisconsin Psychiat Inst & Clin, Madison, WI 53706 USA; [Zakszewski, Elizabeth; Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, Wisconsin Inst Med Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zakszewski, E (corresponding author), Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA.	ezakszewski@mcw.edu		Kalin, Ned/0000-0003-1184-0868; Zakszewski, Elizabeth/0000-0002-9191-8380	National Institutes of Health [MH046729, MH081884, AG043125, P50 MH84051, P50 NIMH100031, P30 HD003352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084051, R01MH081884, R01MH046729, P50MH100031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043125] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grants MH046729, MH081884, AG043125, P50 MH84051, P50 NIMH100031, and P30 HD003352. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adluru N, 2012, NEUROIMAGE, V59, P306, DOI 10.1016/j.neuroimage.2011.07.029; Al Masri O., 2011, NEUROANATOMY, V10, P1; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Baur V, 2011, J PSYCHIATR RES, V45, P1366, DOI 10.1016/j.jpsychires.2011.05.007; Bernal B, 2010, MAGN RESON IMAGING, V28, P217, DOI 10.1016/j.mri.2009.07.008; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Capitanio JP, 2008, LANCET, V371, P1126, DOI 10.1016/S0140-6736(08)60489-4; CARMAN JB, 1965, J NEUROL NEUROSUR PS, V28, P71, DOI 10.1136/jnnp.28.1.71; Carpenter M., 1983, HUMAN NEUROANATOMY; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chan WY, 2010, BIPOLAR DISORD, V12, P383, DOI 10.1111/j.1399-5618.2010.00829.x; DEVITO JL, 1982, EXP BRAIN RES, V46, P107; Duffau H, 2002, BRAIN, V125, P199, DOI 10.1093/brain/awf016; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Duong TQ, 2010, METHODS, V50, P125, DOI 10.1016/j.ymeth.2009.08.001; Faria AV, 2011, NEUROIMAGE, V54, P1854, DOI 10.1016/j.neuroimage.2010.09.061; Fitch WT, 2012, PHILOS T R SOC B, V367, P1933, DOI 10.1098/rstb.2012.0103; Ford AA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00400; Fox AS, 2010, J NEUROSCI, V30, P7023, DOI 10.1523/JNEUROSCI.5952-09.2010; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; Gray H., 2000, ANATOMY HUMAN BODY; Haber SN, 2000, J NEUROSCI, V20, P2369; HARDY TL, 1979, APPL NEUROPHYSIOL, V42, P160; HARTING JK, 1977, J COMP NEUROL, V173, P583, DOI 10.1002/cne.901730311; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; Hofer S., 2008, OPEN MED IMAGING J, V2, P32, DOI [10.2174/1874347100802010032, DOI 10.2174/1874347100802010032]; Howell LL, 2008, ANN NY ACAD SCI, V1141, P176, DOI 10.1196/annals.1441.023; Imperati D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023437; Jbabdi S, 2013, J NEUROSCI, V33, P3190, DOI 10.1523/JNEUROSCI.2457-12.2013; Jeon T, 2012, P INT SOC MAGN RES M; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; Kim H, 2008, EPILEPSY RES, V81, P136, DOI 10.1016/j.eplepsyres.2008.05.005; KOLIATSOS VE, 1988, BRAIN RES, V463, P133, DOI 10.1016/0006-8993(88)90535-5; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; KRIEG WJS, 1947, ANAT REC, V97, P418; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; Lawes INC, 2008, NEUROIMAGE, V39, P62, DOI 10.1016/j.neuroimage.2007.06.041; Lee SH, 2013, SCHIZOPHR RES, V143, P231, DOI 10.1016/j.schres.2012.11.029; Logothetis NK, 2007, COMBINED MRI HISTOLO; Mak-Fan KM, 2013, AUTISM, V17, P541, DOI 10.1177/1362361312442596; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; MESULAM MM, 1977, BRAIN RES, V136, P393, DOI 10.1016/0006-8993(77)90066-X; MINOR LB, 1990, EXP BRAIN RES, V83, P9; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Moscufo N, 2012, AGE, V34, P405, DOI 10.1007/s11357-011-9242-4; Motzkin JC, 2011, J NEUROSCI, V31, P17348, DOI 10.1523/JNEUROSCI.4215-11.2011; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; NAESER MA, 1989, BRAIN, V112, P1, DOI 10.1093/brain/112.1.1; O'Donnell LJ, 2013, NEUROIMAGE, V80, P283, DOI 10.1016/j.neuroimage.2013.04.066; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110; Oishi K., 2010, MRI ATLAS HUMAN WHIT; Oishi K, 2011, BRAIN CONNECT, V1, P37, DOI 10.1089/brain.2011.0005; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Oscarsson O, 1969, J PHYSL, P129; Paul LK, 2011, J NEURODEV DISORD, V3, P3, DOI 10.1007/s11689-010-9059-y; Paxinos G., 2009, RHESUS MONKEY BRAIN; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; RISSE GL, 1978, NEUROPSYCHOLOGIA, V16, P23, DOI 10.1016/0028-3932(78)90039-8; Ruchalski K, 2012, RADIOL RES PRACT, V2012, DOI 10.1155/2012/258524; Sandell JH, 2003, J COMP NEUROL, V466, P14, DOI 10.1002/cne.10859; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; SELEMON LD, 1985, J NEUROSCI, V5, P776; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Staudt M, 2000, NEUROPEDIATRICS, V31, P257, DOI 10.1055/s-2000-9239; Stedman TL, 2006, STEDMANS MED DICT; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Thiebaut de Schotten M, 2012, CORTEX, V48, P82, DOI 10.1016/j.cortex.2011.10.001; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Yang DS, 2009, NEUROSCI LETT, V459, P19, DOI 10.1016/j.neulet.2009.04.058; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhou SY, 2003, BIOL PSYCHIAT, V54, P427, DOI 10.1016/S0006-3223(03)00007-6; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	91	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107398	10.1371/journal.pone.0107398	http://dx.doi.org/10.1371/journal.pone.0107398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203614	gold, Green Submitted, Green Published			2022-12-27	WOS:000342684500096
J	De Cock, VC; Bayard, S; Jaussent, I; Charif, M; Grini, M; Langenier, MC; Yu, H; Lopez, R; Geny, C; Carlander, B; Dauvilliers, Y				De Cock, Valerie Cochen; Bayard, Sophie; Jaussent, Isabelle; Charif, Mahmoud; Grini, Magda; Langenier, Muriel Croisier; Yu, Huan; Lopez, Regis; Geny, Christian; Carlander, Bertrand; Dauvilliers, Yves			Daytime Sleepiness in Parkinson's Disease: A Reappraisal	PLOS ONE			English	Article							OF-THE-LITERATURE; DOPAMINE AGONISTS; PAIN; DYSFUNCTION; DISORDERS; INSOMNIA; APNEA; PD	Background: Excessive daytime sleepiness is a frequent complaint in Parkinson's disease (PD); however the frequency and risk factors for objective sleepiness remain mostly unknown. We investigated both the frequency and determinants of self-reported and objective daytime sleepiness in patients with Parkinson's disease (PD) using a wide range of potential predictors. Methods: One hundred and thirty four consecutive patients with PD, without selection bias for sleep complaint, underwent a semi-structured clinical interview and a one night polysomnography followed by a multiple sleep latency test (MSLT). Demographic characteristics, medical history, PD course and severity, daytime sleepiness, depressive and insomnia symptoms, treatment intake, pain, restless legs syndrome, REM sleep behaviour disorder, and nighttime sleep measures were collected. Self-reported daytime sleepiness was defined by an Epworth Sleepiness Scale (ESS) score above 10. A mean sleep latency on MSLT below 8 minutes defined objective daytime sleepiness. Results: Of 134 patients with PD, 46.3% had subjective and only 13.4% had objective sleepiness with a weak negative correlation between ESS and MSLT latency. A high body mass index (BMI) was associated with both ESS and MSLT, a pain complaint with ESS, and a higher apnea/hypopnea index with MSLT. However, no associations were found between both objective and subjective sleepiness, and measures of motor disability, disease onset, medication (type and dose), depression, insomnia, restless legs syndrome, REM sleep behaviour disorder and nighttime sleep evaluation. Conclusion: We found a high frequency of self-reported EDS in PD, a finding which is however not confirmed by the gold standard neurophysiological evaluation. Current treatment options for EDS in PD are very limited; it thus remains to be determined whether decreasing pain and BMI in association with the treatment of sleep apnea syndrome would decrease significantly daytime sleepiness in PD.	[De Cock, Valerie Cochen; Bayard, Sophie; Langenier, Muriel Croisier; Lopez, Regis; Carlander, Bertrand; Dauvilliers, Yves] Hop Gui de Chauliac, Unite Troubles Sommeil, Montpellier, France; [De Cock, Valerie Cochen; Charif, Mahmoud; Grini, Magda; Geny, Christian; Carlander, Bertrand; Dauvilliers, Yves] Hop Gui de Chauliac, Serv Neurol, Montpellier, France; [Jaussent, Isabelle; Lopez, Regis; Dauvilliers, Yves] Univ Montpellier I, INSERM, U1061, Montpellier, France; [Yu, Huan] Shanghai Fudan Univ, Shanghai Huashan Hosp, Dept Neurol, Shanghai, Peoples R China	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Fudan University	Dauvilliers, Y (corresponding author), Hop Gui de Chauliac, Unite Troubles Sommeil, Montpellier, France.	ydauvilliers@yahoo.fr	Lopez, Regis/X-4694-2019; yu, huan/T-5615-2017	Lopez, Regis/0000-0001-8591-0553; Jaussent, Isabelle/0000-0002-8205-7590; Dauvilliers, yves/0000-0003-0683-6506				Arnulf I, 2002, NEUROLOGY, V58, P1019, DOI 10.1212/WNL.58.7.1019; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Brodsky MA, 2003, MOVEMENT DISORD, V18, P668, DOI 10.1002/mds.10429; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chung S, 2013, J CLIN SLEEP MED, V9, P1131, DOI 10.5664/jcsm.3150; Compta Y, 2009, BRAIN, V132, P3308, DOI 10.1093/brain/awp263; Fil A, 2013, PARKINSONISM RELAT D, V19, P285, DOI 10.1016/j.parkreldis.2012.11.009; Frucht S, 1999, NEUROLOGY, V52, P1908, DOI 10.1212/WNL.52.9.1908; Ghorayeb I, 2007, MOVEMENT DISORD, V22, P1567, DOI 10.1002/mds.21541; Hobson DE, 2002, JAMA-J AM MED ASSOC, V287, P455, DOI 10.1001/jama.287.4.455; Hughes AJ, 2001, NEUROLOGY, V57, pS34; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaynak D, 2005, EUR J NEUROL, V12, P199, DOI 10.1111/j.1468-1331.2004.00971.x; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; Lelieveld IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040166; Manni R, 2004, SLEEP MED, V5, P189, DOI 10.1016/j.sleep.2003.01.001; Monaca C, 2006, SLEEP MED, V7, P448, DOI 10.1016/j.sleep.2005.12.002; Neikrug AB, 2014, SLEEP, V37, P177, DOI 10.5665/sleep.3332; NEU HC, 1967, AM REV RESPIR DIS, V95, P33; Ohayon MM, 2012, ARCH GEN PSYCHIAT, V69, P71, DOI 10.1001/archgenpsychiatry.2011.1240; Ohayon MM, 2009, J PSYCHIATR RES, V43, P1243, DOI 10.1016/j.jpsychires.2009.10.007; Olanow CW, 2007, MOVEMENT DISORD, V22, pS335, DOI 10.1002/mds.21675; Ondo WG, 2001, NEUROLOGY, V57, P1392, DOI 10.1212/WNL.57.8.1392; Poryazova R, 2010, EUR NEUROL, V63, P129, DOI 10.1159/000276402; Razmy A, 2004, ARCH NEUROL-CHICAGO, V61, P97, DOI 10.1001/archneur.61.1.97; Shpirer I, 2006, MOVEMENT DISORD, V21, P1432, DOI 10.1002/mds.21002; Tan EK, 2002, NEUROLOGY, V58, P465, DOI 10.1212/WNL.58.3.465; Vgontzas AN, 1998, ARCH INTERN MED, V158, P1333, DOI 10.1001/archinte.158.12.1333; Videnovic A, 2014, JAMA NEUROL, V71, P463, DOI 10.1001/jamaneurol.2013.6239; Yong MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022511	31	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107278	10.1371/journal.pone.0107278	http://dx.doi.org/10.1371/journal.pone.0107278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198548	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700101
J	Junemann, S; Prior, K; Albersmeier, A; Albaum, S; Kalinowski, J; Goesmann, A; Stoye, J; Harmsen, D				Juenemann, Sebastian; Prior, Karola; Albersmeier, Andreas; Albaum, Stefan; Kalinowski, Joern; Goesmann, Alexander; Stoye, Jens; Harmsen, Dag			GABenchToB: A Genome Assembly Benchmark Tuned on Bacteria and Benchtop Sequencers	PLOS ONE			English	Article							DE-BRUIJN GRAPHS; ALGORITHMS; READS; GAUGE	De novo genome assembly is the process of reconstructing a complete genomic sequence from countless small sequencing reads. Due to the complexity of this task, numerous genome assemblers have been developed to cope with different requirements and the different kinds of data provided by sequencers within the fast evolving field of next-generation sequencing technologies. In particular, the recently introduced generation of benchtop sequencers, like Illumina's MiSeq and Ion Torrent's Personal Genome Machine (PGM), popularized the easy, fast, and cheap sequencing of bacterial organisms to a broad range of academic and clinical institutions. With a strong pragmatic focus, here, we give a novel insight into the line of assembly evaluation surveys as we benchmark popular de novo genome assemblers based on bacterial data generated by benchtop sequencers. Therefore, single-library assemblies were generated, assembled, and compared to each other by metrics describing assembly contiguity and accuracy, and also by practice-oriented criteria as for instance computing time. In addition, we extensively analyzed the effect of the depth of coverage on the genome assemblies within reasonable ranges and the k-mer optimization problem of de Bruijn Graph assemblers. Our results show that, although both MiSeq and PGM allow for good genome assemblies, they require different approaches. They not only pair with different assembler types, but also affect assemblies differently regarding the depth of coverage where oversampling can become problematic. Assemblies vary greatly with respect to contiguity and accuracy but also by the requirement on the computing power. Consequently, no assembler can be rated best for all preconditions. Instead, the given kind of data, the demands on assembly quality, and the available computing infrastructure determines which assembler suits best. The data sets, scripts and all additional information needed to replicate our results are freely available at ftp://ftp.cebitec.uni-bielefeld.de/pub/GABenchToB.	[Juenemann, Sebastian; Prior, Karola; Harmsen, Dag] Univ Munster, Dept Periodontol, D-48149 Munster, Germany; [Juenemann, Sebastian; Stoye, Jens] Univ Bielefeld, Ctr Biotechnol, Inst Bioinformat, D-33615 Bielefeld, Germany; [Albersmeier, Andreas; Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Albaum, Stefan] Univ Bielefeld, Ctr Biotechnol, Bioinformat Resource Facil, D-33615 Bielefeld, Germany; [Goesmann, Alexander] Univ Giessen, D-35390 Giessen, Germany; [Stoye, Jens] Univ Bielefeld, Fac Technol, Genome Informat Grp, D-33615 Bielefeld, Germany	University of Munster; University of Bielefeld; University of Bielefeld; University of Bielefeld; Justus Liebig University Giessen; University of Bielefeld	Junemann, S (corresponding author), Univ Munster, Dept Periodontol, D-48149 Munster, Germany.	jueneman@cebitec.uni-bielefeld.de		Goesmann, Alexander/0000-0002-7086-2568; Junemann, Sebastian/0000-0002-3714-0328	German Federal Ministry of Education and Research (BMBF) [FKZ 01KI1012B, FKZ 031A190]; European Commission's Seventh Framework Programme (EU PathoNGenTrace project) [278864]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission's Seventh Framework Programme (EU PathoNGenTrace project)	This work was supported in parts by grants of the German Federal Ministry of Education and Research (BMBF) in the framework of the FBI-Zoo project (FKZ 01KI1012B), of the Technology Platform Bioinformatics (TPB) project (FKZ 031A190) and by the European Commission's Seventh Framework Programme (EU PathoNGenTrace project agreement no. 278864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; CLC bio, 2014, CLC ASS CELL; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; DNASTAR, 2014, SEQMAN NGEN; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Ghodsi Mohammadreza, 2013, BMC Res Notes, V6, P334, DOI 10.1186/1756-0500-6-334; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Haiminen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024182; Hubisz MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017034; Illumina, 2009, NOVO ASSEMBLY USING; Jevons PM, 1961, BRIT MED J, V1, P124; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li ZY, 2012, BRIEF FUNCT GENOMICS, V11, P25, DOI 10.1093/bfgp/elr035; Life Sciences, 2014, GS NOVO ASS; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magoc T, 2013, BIOINFORMATICS, V29, P1718, DOI 10.1093/bioinformatics/btt273; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; Narzisi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019175; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Salmela L, 2011, BIOINFORMATICS, V27, P1455, DOI 10.1093/bioinformatics/btr170; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Sarkar D, 2008, USE R, P1; Scheibye-Alsing K, 2009, COMPUT BIOL CHEM, V33, P121, DOI 10.1016/j.compbiolchem.2008.11.003; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Team RDC, 2011, R LANG ENV STAT COMP; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915; Zimin AV Marc, 2013, BIOINFORMATICS, V29, P2669	44	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107014	10.1371/journal.pone.0107014	http://dx.doi.org/10.1371/journal.pone.0107014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198770	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700074
J	Pennati, A; Deng, JS; Galipeau, J				Pennati, Andrea; Deng, Jiusheng; Galipeau, Jacques			Maltose-Binding Protein Fusion Allows for High Level Bacterial Expression and Purification of Bioactive Mammalian Cytokine Derivatives	PLOS ONE			English	Article							REGULATORY B-CELLS; COLONY-STIMULATING FACTOR; ESCHERICHIA-COLI; THERAPEUTIC PROTEINS; RECOMBINANT PROTEINS; CANCER-IMMUNOTHERAPY; FACTOR-XA; IN-VIVO; GM-CSF; FUSOKINE	Fusokines are chimeric proteins generated by the physical coupling of cytokines in a single polypeptide, resulting in proteins with highly pleiotropic activity and the potential to treat cancer and autoimmune ailments. For instance, the fusokine GIFT15 (GM-CSF and Interleukin 15 Fusion Transgene) has been shown to be a powerful immunosuppressive protein able to convert naive B cells into IL-10-producing B cells. To date, the mammalian cell systems used for the expression of GIFT15 allow for secretion of the protein in the culturing media, an inefficient system for producing GMP-compliant fusokines. In this study we report the bacterial expression of bioactive recombinant GIFT15 (rGIFT15). Indeed, there is a constant demand to improve the expression systems for therapeutic proteins. Expression of a maltose-binding protein (MBP) fusion protein efficiently allowed the accumulation of soluble protein in the intracellular milieu. Optimizing the bacterial culture significantly increased the yield of recombinant protein. The biological activity of rGIFT15 was comparable to that of fusokine derived from a mammalian source. This approach led to the production of soluble, endotoxin-free functional protein, averaging 5 mg of rGIFT15 per liter of culture. This process is amenable to scale up for the development of Food and Drug Administration (FDA)-compliant immune-modulatory rGIFT15.	[Pennati, Andrea; Deng, Jiusheng; Galipeau, Jacques] Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Galipeau, Jacques] Emory Univ, Dept Pediat, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Galipeau, J (corresponding author), Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA.	jgalipe@emory.edu	Galipeau, Jacques/R-9909-2019	Galipeau, Jacques/0000-0002-9374-1996	National Institute of Health [5R01AI093881]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093881] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health (5R01AI093881). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedei A, 2013, RECENT PAT ANTI-CANC, V8, P126; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Barre B, 2003, J BIOL CHEM, V278, P2990, DOI 10.1074/jbc.M210422200; Berthelot JM, 2013, JOINT BONE SPINE, V80, P18, DOI 10.1016/j.jbspin.2012.04.010; Beveridge RA, 1998, CANCER INVEST, V16, P366, DOI 10.3109/07357909809115775; Chirmule N, 2012, AAPS J, V14, P296, DOI 10.1208/s12248-012-9340-y; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; De Groot AS, 2009, CLIN IMMUNOL, V131, P189, DOI 10.1016/j.clim.2009.01.009; Deng Jiusheng, 2012, Infectious Disorders - Drug Targets, V12, P248; Do BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089906; Ferrer-Miralles N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-17; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; HE MG, 1993, J PROTEIN CHEM, V12, P1, DOI 10.1007/BF01024906; Hermeling S, 2004, PHARM RES-DORDR, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6; Hsieh J, 2012, MOL THER, V20, P1767, DOI 10.1038/mt.2012.127; Hwang PM, 2014, FEBS LETT, V588, P247, DOI 10.1016/j.febslet.2013.09.028; Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2; Jeong TH, 2014, PROTEIN EXPRES PURIF, V95, P211, DOI 10.1016/j.pep.2014.01.001; Kalampokis I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3907; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; LAVALLIE ER, 1995, CURR OPIN BIOTECH, V6, P501, DOI 10.1016/0958-1669(95)80083-2; Li PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069405; Molineux G., 2012, 20 YEARS G CSF CLIN, DOI 10.1007/978-3-0348-0218-5; NAGATA S, 1980, NATURE, V284, P316, DOI 10.1038/284316a0; Nagata S, 1992, Biotechnology, V24, P299; Paquin A, 2001, HUM GENE THER, V12, P13, DOI 10.1089/104303401450924; Penafuerte C, 2012, ONCOIMMUNOLOGY, V1, P224, DOI 10.4161/onci.1.2.18458; Penafuerte C, 2012, CANCER RES, V72, P1210, DOI 10.1158/0008-5472.CAN-11-1659; Penafuerte C, 2009, CANCER RES, V69, P9020, DOI 10.1158/0008-5472.CAN-09-2322; Rafei M, 2007, BLOOD, V109, P2234, DOI 10.1182/blood-2006-07-037473; Rafei M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-121; Rafei M, 2009, IMMUNOTHERAPY-UK, V1, P913, DOI 10.2217/IMT.09.65; Rafei M, 2009, NAT MED, V15, P1038, DOI 10.1038/nm.2003; Rafei M, 2009, J IMMUNOL, V183, P1759, DOI 10.4049/jimmunol.0900523; Ratanji KD, 2014, J IMMUNOTOXICOL, V11, P99, DOI 10.3109/1547691X.2013.821564; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Stagg J, 2004, CANCER RES, V64, P8795, DOI 10.1158/0008-5472.CAN-04-1776; Sun P, 2011, METHODS MOL BIOL, V705, P259, DOI 10.1007/978-1-61737-967-3_16; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Walls D, 2011, METHODS MOL BIOL, V681, P151, DOI 10.1007/978-1-60761-913-0_9; Williams P, 2011, J INTERN MED, V269, P74, DOI 10.1111/j.1365-2796.2010.02314.x; Williams P, 2011, J IMMUNOL, V186, P5527, DOI 10.4049/jimmunol.1003699; Williams P, 2010, J IMMUNOL, V185, P7358, DOI 10.4049/jimmunol.1002201; Williams P, 2010, MOL THER, V18, P1293, DOI 10.1038/mt.2010.49; Yang M, 2013, CELL MOL IMMUNOL, V10, P122, DOI 10.1038/cmi.2012.60	50	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106724	10.1371/journal.pone.0106724	http://dx.doi.org/10.1371/journal.pone.0106724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198691	gold, Green Submitted, Green Published			2022-12-27	WOS:000341304700043
J	Virmouni, SA; Sandi, C; Al-Mahdawi, S; Pook, MA				Virmouni, Sara Anjomani; Sandi, Chiranjeevi; Al-Mahdawi, Sahar; Pook, Mark A.			Cellular, Molecular and Functional Characterisation of YAC Transgenic Mouse Models of Friedreich Ataxia	PLOS ONE			English	Article							GAA TRIPLET-REPEAT; FRATAXIN DEFICIENCY; INTERFERON-GAMMA; DENTATE NUCLEUS; IRON; MUTATION; EXPANSION; EXPRESSION; PATHOLOGY; STRESS	Background: Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disorder, caused by a GAA repeat expansion mutation within intron 1 of the FXN gene. We have previously established and performed preliminary characterisation of several human FXN yeast artificial chromosome (YAC) transgenic FRDA mouse models containing GAA repeat expansions, Y47R (9 GAA repeats), YG8R (90 and 190 GAA repeats) and YG22R (190 GAA repeats). Methodology/Principal Findings: We now report extended cellular, molecular and functional characterisation of these FXN YAC transgenic mouse models. FXN transgene copy number analysis of the FRDA mice demonstrated that the YG22R and Y47R lines each have a single copy of the FXN transgene while the YG8R line has two copies. Single integration sites of all transgenes were confirmed by fluorescence in situ hybridisation (FISH) analysis of metaphase and interphase chromosomes. We identified significant functional deficits, together with a degree of glucose intolerance and insulin hypersensitivity, in YG8R and YG22R FRDA mice compared to Y47R and wild-type control mice. We also confirmed increased somatic GAA repeat instability in the cerebellum and brain of YG22R and YG8R mice, together with significantly reduced levels of FXN mRNA and protein in the brain and liver of YG8R and YG22R compared to Y47R. Conclusions/Significance: Together these studies provide a detailed characterisation of our GAA repeat expansion-based YAC transgenic FRDA mouse models that will help investigations of FRDA disease mechanisms and therapy.	[Virmouni, Sara Anjomani; Sandi, Chiranjeevi; Al-Mahdawi, Sahar; Pook, Mark A.] Brunel Univ London, Div Biosci, Dept Life Sci, Coll Hlth & Life Sci, Uxbridge, Middx, England	Brunel University	Pook, MA (corresponding author), Brunel Univ London, Div Biosci, Dept Life Sci, Coll Hlth & Life Sci, Uxbridge, Middx, England.	Mark.Pook@brunel.ac.uk			European Union [242193/EFACTS]; Ataxia UK; FARA	European Union(European Commission); Ataxia UK; FARA	The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement number 242193/EFACTS, Ataxia UK and FARA to MAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; Cnop M, 2012, ANN NEUROL, V72, P971, DOI 10.1002/ana.23698; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gottesfeld JM, 2009, FUTUR NEUROL, V4, P775, DOI 10.2217/FNL.09.55; Koeppen AH, 2007, ACTA NEUROPATHOL, V114, P163, DOI 10.1007/s00401-007-0220-y; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2; Pandolfo M, 2002, ADV EXP MED BIOL, V516, P99; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Pook MA, 2001, NEUROGENETICS, V3, P185; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Sandi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089488; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Sarsero JP, 2004, MAMM GENOME, V15, P370, DOI 10.1007/s00335-004-3019-3; Shan YX, 2013, ANTIOXID REDOX SIGN, V19, P1481, DOI 10.1089/ars.2012.4537; Tomassini B, 2012, HUM MOL GENET, V21, P2855, DOI 10.1093/hmg/dds110; Waldvogel D, 1999, ANN NEUROL, V46, P123, DOI 10.1002/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H; Willis JH, 2008, MOL GENET METAB, V94, P491, DOI 10.1016/j.ymgme.2008.03.019; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Young HA, 2007, CURR TOP MICROBIOL, V316, P97	29	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107416	10.1371/journal.pone.0107416	http://dx.doi.org/10.1371/journal.pone.0107416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198290	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700109
J	Tang, S; Liao, X; Shi, B; Qu, YZ; Huang, ZY; Lin, Q; Guo, XD; Pei, FX				Tang, Shuo; Liao, Xiang; Shi, Bo; Qu, Yanzhen; Huang, Zeyu; Lin, Qiang; Guo, Xiaodong; Pei, Fuxing			The Effects of Controlled Release of Neurotrophin-3 from PCLA Scaffolds on the Survival and Neuronal Differentiation of Transplanted Neural Stem Cells in a Rat Spinal Cord Injury Model	PLOS ONE			English	Article							GROWTH-FACTOR; SILK FIBROIN; PROGENITOR CELLS; REGENERATION; TRANSECTION; RECEPTORS; DELIVERY	Neural stem cells (NSCs) have emerged as a potential source for cell replacement therapy following spinal cord injury (SCI). However, poor survival and low neuronal differentiation remain major obstacles to the use of NSCs. Biomaterials with neurotrophic factors are promising strategies for promoting the proliferation and differentiation of NSCs. Silk fibroin (SF) matrices were demonstrated to successfully deliver growth factors and preserve their potency. In this study, by incorporating NT-3 into a SF coating, we successfully developed NT-3-immobilized scaffolds (membranes and conduits). Sustained release of bioactive NT-3 from the conduits for up to 8 weeks was achieved. Cell viability was confirmed using live/dead staining after 14 days in culture. The efficacy of the immobilized NT-3 was confirmed by assessing NSC neuronal differentiation in vitro. NSC neuronal differentiation was 55.2 +/- 4.1% on the NT-3-immobilized membranes, which was significantly higher than that on the NT-3 free membrane. Furthermore, 8 weeks after the NSCs were seeded into conduits and implanted in rats with a transected SCI, the conduit+NT-3+NSCs group achieved higher NSC survival (75.8 +/- 15.1%) and neuronal differentiation (21.5 +/- 5.2%) compared with the conduit+NSCs group. The animals that received the conduit+NT-3+NSCs treatment also showed improved functional outcomes, as well as increased axonal regeneration. These results indicate the feasibility of fabricating NT-3-immobilized scaffolds using the adsorption of NT-3/SF coating method, as well as the potential of these scaffolds to induce SCI repair by promoting survival and neuronal differentiation of transplanted NSCs.	[Tang, Shuo; Huang, Zeyu; Pei, Fuxing] Sichuan Univ, West China Hosp, Dept Orthopaed, Chengdu 610064, Peoples R China; [Liao, Xiang] Shenzhen Nanshan Hosp, Dept Pain Med, Shenzhen, Peoples R China; [Shi, Bo] Mianyang Ctr Hosp, Dept Orthopaed, Mianyang, Peoples R China; [Qu, Yanzhen; Guo, Xiaodong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, Wuhan 430074, Peoples R China; [Lin, Qiang] Guangdong Hosp Tradit Chinese Med, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China	Sichuan University; Huazhong University of Science & Technology; Guangzhou University of Chinese Medicine	Lin, Q (corresponding author), Guangdong Hosp Tradit Chinese Med, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China.	qiang_linm@163.com; xiaodongguo@hust.edu.cn; peifuxing@vip.163.com	Huang, ZeYu/G-1340-2015	Huang, ZeYu/0000-0002-0456-8379	National Natural Science Foundation of China (NSFC) [81401787, 81371939, 81000812]; International Science & Technology Cooperation Program of China [2013DFG32690]; Science & Technology Bureau of Chengdu City-West China Hospital Joint Foundation [ZH13034]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Science & Technology Bureau of Chengdu City-West China Hospital Joint Foundation	This work was financially supported by the National Natural Science Foundation of China (NSFC, No. 81401787, 81371939 and 81000812), the International Science & Technology Cooperation Program of China (2013DFG32690), as well as the Science & Technology Bureau of Chengdu City-West China Hospital Joint Foundation (ZH13034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Adams M, 2004, SPINAL CORD, V42, P273, DOI 10.1038/sj.sc.3101597; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chiu LLY, 2011, J TISSUE ENG REGEN M, V5, P69, DOI 10.1002/term.292; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Guo XD, 2012, CELL TRANSPLANT, V21, P1177, DOI 10.3727/096368911X612503; He LM, 2009, TISSUE ENG PART C-ME, V15, P243, DOI 10.1089/ten.tec.2008.0255; Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b; Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273; Kim DH, 1999, J NEUROSCI, V19, P6213, DOI 10.1523/JNEUROSCI.19-14-06213.1999; Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021744; Krych AJ, 2009, ACTA BIOMATER, V5, P2551, DOI 10.1016/j.actbio.2009.03.021; Lim MS, 2007, BIOCHEM BIOPH RES CO, V357, P903, DOI 10.1016/j.bbrc.2007.04.045; Lowry N, 2012, BIOMATERIALS, V33, P2892, DOI 10.1016/j.biomaterials.2011.12.048; Lu HX, 2011, MED SCI MONITOR, V17, pBR305, DOI 10.12659/MSM.882039; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388; Meade KA, 2013, J BIOL CHEM, V288, P5530, DOI 10.1074/jbc.M112.423012; Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008; Sandker MJ, 2013, BIOMATERIALS, V34, P8002, DOI 10.1016/j.biomaterials.2013.07.046; Santos T, 2012, ACS NANO, V6, P10463, DOI 10.1021/nn304541h; Shchepelina O, 2011, ADV MATER, V23, P4655, DOI 10.1002/adma.201102234; Steward O, 2006, EXP NEUROL, V198, P483, DOI 10.1016/j.expneurol.2005.12.034; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Taddei P, 2005, BIOPOLYMERS, V78, P249, DOI 10.1002/bip.20275; Tang S, 2013, BIOMATERIALS, V34, P7086, DOI 10.1016/j.biomaterials.2013.05.080; Tang S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015008; Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034; Wang JM, 2011, BIOMATERIALS, V32, P7454, DOI 10.1016/j.biomaterials.2011.06.036; Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006; Wang YF, 2009, J CONTROL RELEASE, V140, P218, DOI 10.1016/j.jconrel.2009.05.025; Weishaupt N, 2012, EXP NEUROL, V238, P254, DOI 10.1016/j.expneurol.2012.09.001; Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007; Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006; Yang ZY, 2010, BIOMATERIALS, V31, P4846, DOI 10.1016/j.biomaterials.2010.02.015	36	29	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107517	10.1371/journal.pone.0107517	http://dx.doi.org/10.1371/journal.pone.0107517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215612	Green Submitted, Green Published, gold			2022-12-27	WOS:000341774300072
J	Wang, AL; Yao, ZC; Zheng, WW; Zhang, HY				Wang, Ailin; Yao, Zhichao; Zheng, Weiwei; Zhang, Hongyu			Bacterial Communities in the Gut and Reproductive Organs of Bactrocera minax (Diptera: Tephritidae) Based on 454 Pyrosequencing	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FRUIT-FLY; CERATITIS-CAPITATA; INTESTINAL-TRACT; DIVERSITY; ABUNDANCE; DORSALIS	The citrus fruit fly Bactrocera minax is associated with diverse bacterial communities. We used a 454 pyrosequencing technology to study in depth the microbial communities associated with gut and reproductive organs of Bactrocera minax. Our dataset consisted of 100,749 reads with an average length of 400 bp. The saturated rarefaction curves and species richness indices indicate that the sampling was comprehensive. We found highly diverse bacterial communities, with individual sample containing approximately 361 microbial operational taxonomic units (OTUs). A total of 17 bacterial phyla were obtained from the flies. A phylogenetic analysis of 16S rDNA revealed that Proteobacteria was dominant in all samples (75%-95%). Actinobacteria and Firmicutes were also commonly found in the total clones. Klebsiella, Citrobacter, Enterobacter, and Serratia were the major genera. However, bacterial diversity (Chao1, Shannon and Simpson indices) and community structure (PCA analysis) varied across samples. Female ovary has the most diverse bacteria, followed by male testis, and the bacteria diversity of reproductive organs is richer than that of the gut. The observed variation can be caused by sex and tissue, possibly to meet the host's physiological demands.	[Wang, Ailin; Yao, Zhichao; Zheng, Weiwei; Zhang, Hongyu] Huazhong Agr Univ, Coll Plant Sci & Technol, Inst Urban & Hort Pests, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Wang, Ailin; Yao, Zhichao; Zheng, Weiwei; Zhang, Hongyu] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Zhang, HY (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Inst Urban & Hort Pests, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	hongyu.zhang@mail.hzau.edu.cn			China Agriculture Research System [CARS-27]; Fundamental Research Funds for the Central Universities [2014PY005]; Special Fund for Agroscientific Research in the Public Interest [200903047]	China Agriculture Research System; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Agroscientific Research in the Public Interest	This research was supported by the China Agriculture Research System (CARS-27), the Fundamental Research Funds for the Central Universities (NO. 2014PY005), and the Special Fund for Agroscientific Research in the Public Interest (No. 200903047). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behar A, 2008, J INSECT PHYSIOL, V54, P1377, DOI 10.1016/j.jinsphys.2008.07.011; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Ben Ami E, 2010, ISME J, V4, P28, DOI 10.1038/ismej.2009.82; Ben-Yosef M, 2008, PHYSIOL ENTOMOL, V33, P145, DOI 10.1111/j.1365-3032.2008.00617.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dillon RJ, 2010, ANTON LEEUW INT J G, V97, P69, DOI 10.1007/s10482-009-9389-5; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FITT GP, 1985, OECOLOGIA, V67, P447, DOI 10.1007/BF00384954; Grimont F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P219, DOI 10.1007/0-387-30746-x_11; Guerrero DM, 2010, SURG INFECT, V11, P49, DOI 10.1089/sur.2009.022; Hua WY, 2010, METHOD STUDY APPL 45; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Joachimiak MP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-225; Jones RT, 2011, APPL ENVIRON MICROB, V77, P8345, DOI 10.1128/AEM.05974-11; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kuzina LV, 2001, CURR MICROBIOL, V42, P290, DOI 10.1007/s002840010219; Lan J, 2009, PLANT QUARANTINE, V23; [兰杰 Lan Jie], 2010, [植物保护, Plant Protection], V36, P159; LLOYD AC, 1986, AUST J BIOL SCI, V39, P361, DOI 10.1071/BI9860361; Lundgren JG, 2007, ANN ENTOMOL SOC AM, V100, P275, DOI 10.1603/0013-8746(2007)100[275:BCWDTO]2.0.CO;2; Marchini D, 2002, CURR MICROBIOL, V44, P120, DOI 10.1007/s00284-001-0061-1; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; PEDERSEN JC, 1993, BIOL FERT SOILS, V16, P227, DOI 10.1007/BF00361413; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Romero A, 2006, MED VET ENTOMOL, V20, P115, DOI 10.1111/j.1365-2915.2006.00602.x; Sant'Anna MRV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042531; SANTAVY DL, 1990, APPL ENVIRON MICROB, V56, P1750, DOI 10.1128/AEM.56.6.1750-1762.1990; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schrempf H, 2001, ANTON LEEUW INT J G, V79, P285, DOI 10.1023/A:1012058205158; Shi ZH, 2012, INT J MOL SCI, V13, P6266, DOI 10.3390/ijms13056266; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Venn AA, 2008, BIOL BULL-US, V215, P243, DOI 10.2307/25470708; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Xiang H, 2012, INSECT SCI, V19, P86, DOI 10.1111/j.1744-7917.2011.01435.x; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Zhang H, 2008, J APPL MICROBIOL, V105, P1277, DOI 10.1111/j.1365-2672.2008.03867.x; Zhang H., 2012, PHOTOGRAPHIC GUIDE K	49	35	41	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106988	10.1371/journal.pone.0106988	http://dx.doi.org/10.1371/journal.pone.0106988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215866	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300033
J	Fu, JF; Chen, HL; Yang, J; Yi, CH; Zheng, S				Fu, Jian-Fei; Chen, Hai-Long; Yang, Jiao; Yi, Cheng-Hao; Zheng, Shu			Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Clinically Node-Positive Breast Cancer after Neoadjuvant Chemotherapy: A Meta-Analysis	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; DISSECTION	Sentinel lymph node biopsy (SLNB) has replaced conventional axillary lymph node dissection (ALND) in axillary node-negative breast cancer patients. However, the use of SLNB remains controversial in patients after neoadjuvant chemotherapy (NAC). The aim of this review is to evaluate the feasibility and accuracy of SLNB after NAC in clinically node-positive patients. Systematic searches were performed in the PubMed, Embase, and Cochrane Library databases from 1993 to December 2013 for studies on node-positive breast cancer patients who underwent SLNB after NAC followed by ALND. Of 436 identified studies, 15 were included in this review, with a total of 2,471 patients. The pooled identification rate (IR) of SLNB was 89% [95% confidence interval (CI) 85-93%], and the false negative rate (FNR) of SLNB was 14% (95% CI 10-17%). The heterogeneity of FNR was analyzed by meta-regression, and the results revealed that immunohistochemistry (IHC) staining may represent an independent factor (P = 0.04). FNR was lower in the IHC combined with hematoxylin and eosin (H&E) staining subgroup than in the H&E staining alone subgroup, with values of 8.7% versus 16.0%, respectively (P = 0.001). Thus, SLNB was feasible after NAC in node-positive breast cancer patients. In addition, the IR of SLNB was respectable, although the FNR of SLNB was poor and requires further improvement. These findings indicate that IHC may improve the accuracy of SLNB.	[Fu, Jian-Fei; Chen, Hai-Long; Yang, Jiao; Yi, Cheng-Hao; Zheng, Shu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Fu, Jian-Fei; Chen, Hai-Long; Yang, Jiao; Yi, Cheng-Hao; Zheng, Shu] Chinese Minist Educ, Key Lab Mol Biol Med Sci, Key Lab Canc Prevent & Intervent, Hangzhou, Zhejiang, Peoples R China; [Fu, Jian-Fei] Zhejiang Univ, Sch Med, Jinhua Hosp, Dept Oncol,Jinhua Cent Hosp, Jinhua City, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, S (corresponding author), Chinese Minist Educ, Key Lab Mol Biol Med Sci, Key Lab Canc Prevent & Intervent, Hangzhou, Zhejiang, Peoples R China.	zhengshu@zju.edu.cn						Alvarado R, 2012, ANN SURG ONCOL, V19, P3177, DOI 10.1245/s10434-012-2484-2; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Boughey JC, 2013, JAMA-J AM MED ASSOC, V310, P1455, DOI 10.1001/jama.2013.278932; Brown AS, 2010, CANCER-AM CANCER SOC, V116, P2878, DOI 10.1002/cncr.25066; Canavese G, 2011, EJSO-EUR J SURG ONC, V37, P688, DOI 10.1016/j.ejso.2011.05.012; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Classe JM, 2009, J CLIN ONCOL, V27, P726, DOI 10.1200/JCO.2008.18.3228; Cure H, 2002, BREAST CANCER RES TR, V76, P37, DOI 10.1023/A:1020274709327; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fraile M, 2000, ANN ONCOL, V11, P701, DOI 10.1023/A:1008377910967; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Hack TF, 1999, J CLIN ONCOL, V17, P143, DOI 10.1200/JCO.1999.17.1.143; Hunt KK, 2012, ANN SURG, V256, P428, DOI 10.1097/SLA.0b013e3182654494; Keune JD, 2010, AM J SURG, V199, P477, DOI 10.1016/j.amjsurg.2009.03.012; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; Kuehn T, 2013, LANCET ONCOL, V14, P609, DOI 10.1016/S1470-2045(13)70166-9; Lee S, 2007, BREAST CANCER RES TR, V102, P283, DOI 10.1007/s10549-006-9330-9; Miltenburg DM, 1999, J SURG RES, V84, P138, DOI 10.1006/jsre.1999.5629; Newman EA, 2007, ANN SURG ONCOL, V14, P2946, DOI 10.1245/s10434-007-9403-y; Ozmen V, 2010, EJSO-EUR J SURG ONC, V36, P23, DOI 10.1016/j.ejso.2009.10.015; Park S, 2013, ANN SURG ONCOL, V20, P2858, DOI 10.1245/s10434-013-2992-8; Rebollo-Aguirre AC, 2012, REV ESP MED NUCL IMA, V31, P117, DOI 10.1016/j.remn.2011.04.007; Rouzier R, 2002, J CLIN ONCOL, V20, P1304, DOI 10.1200/JCO.20.5.1304; Shen J, 2007, CANCER-AM CANCER SOC, V109, P1255, DOI 10.1002/cncr.22540; Takei H, 2013, INT J CLIN ONCOL, V18, P547, DOI 10.1007/s10147-012-0418-4; Tan VKM, 2011, J SURG ONCOL, V104, P97, DOI 10.1002/jso.21911; Thomas S, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/870263; van Deurzen CHM, 2009, EUR J CANCER, V45, P3124, DOI 10.1016/j.ejca.2009.08.001; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xing Y, 2006, BRIT J SURG, V93, P539, DOI 10.1002/bjs.5209; Yagata H, 2013, CLIN BREAST CANCER, V13, P471, DOI 10.1016/j.clbc.2013.08.014	32	66	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e105316	10.1371/journal.pone.0105316	http://dx.doi.org/10.1371/journal.pone.0105316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210779	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900003
J	Matsunaga, K; Tanabe, K; Inoue, H; Okuya, S; Ohta, Y; Akiyama, M; Taguchi, A; Kora, Y; Okayama, N; Yamada, Y; Wada, Y; Amemiya, S; Sugihara, S; Nakao, Y; Oka, Y; Tanizawa, Y				Matsunaga, Kimie; Tanabe, Katsuya; Inoue, Hiroshi; Okuya, Shigeru; Ohta, Yasuharu; Akiyama, Masaru; Taguchi, Akihiko; Kora, Yukari; Okayama, Naoko; Yamada, Yuichiro; Wada, Yasuhiko; Amemiya, Shin; Sugihara, Shigetaka; Nakao, Yuzo; Oka, Yoshitomo; Tanizawa, Yukio			Wolfram Syndrome in the Japanese Population; Molecular Analysis of WFS1 Gene and Characterization of Clinical Features	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GENOTYPE-PHENOTYPE CORRELATION; PANCREATIC BETA-CELLS; OPTIC ATROPHY; DIABETES-MELLITUS; PROTEIN; MUTATION; NEURODEGENERATION; IDENTIFICATION; EXPRESSION	Background: Wolfram syndrome (WFS) is a recessive neurologic and endocrinologic degenerative disorder, and is also known as DIDMOAD (Diabetes Insipidus, early-onset Diabetes Mellitus, progressive Optic Atrophy and Deafness) syndrome. Most affected individuals carry recessive mutations in the Wolfram syndrome 1 gene (WFS1). However, the phenotypic pleiomorphism, rarity and molecular complexity of this disease complicate our efforts to understand WFS. To address this limitation, we aimed to describe complications and to elucidate the contributions of WFS1 mutations to clinical manifestations in Japanese patients with WFS. Methodology: The minimal ascertainment criterion for diagnosing WFS was having both early onset diabetes mellitus and bilateral optic atrophy. Genetic analysis for WFS1 was performed by direct sequencing. Principal Findings: Sixty-seven patients were identified nationally for a prevalence of one per 710,000, with 33 patients (49%) having all 4 components of DIDMOAD. In 40 subjects who agreed to participate in this investigation from 30 unrelated families, the earliest manifestation was DM at a median age of 8.7 years, followed by OA at a median age of 15.8 years. However, either OA or DI was the first diagnosed feature in 6 subjects. In 10, features other than DM predated OA. Twenty-seven patients (67.5%) had a broad spectrum of recessive mutations in WFS1. Two patients had mutations in only one allele. Eleven patients (27.5%) had intact WFS1 alleles. Ages at onset of both DM and OA in patients with recessive WFS1 mutations were indistinguishable from those in patients without WFS1 mutations. In the patients with predicted complete loss-of-function mutations, ages at the onsets of both DM and OA were significantly earlier than those in patients with predicted partial-loss-of function mutations. Conclusion/Significance: This study emphasizes the clinical and genetic heterogeneity in patients with WFS. Genotype-phenotype correlations may exist in patients with WFS1 mutations, as demonstrated by the disease onset.	[Matsunaga, Kimie; Tanabe, Katsuya; Inoue, Hiroshi; Okuya, Shigeru; Ohta, Yasuharu; Akiyama, Masaru; Taguchi, Akihiko; Kora, Yukari; Tanizawa, Yukio] Yamaguchi Univ, Grad Sch Med, Div Endocrinol Metab Hematol Sci & Therapeut, Ube, Yamaguchi 755, Japan; [Okayama, Naoko] Yamaguchi Univ, Div Lab, Ube, Yamaguchi, Japan; [Yamada, Yuichiro] Akita Univ, Grad Sch Med, Dept Endocrinol, Akita 010, Japan; [Wada, Yasuhiko] Kochi Univ, Dept Hlth & Nutr, Kochi 780, Japan; [Amemiya, Shin] Saitama Med Univ, Dept Pediat, Moroyama, Saitama, Japan; [Sugihara, Shigetaka] Tokyo Womens Med Univ, Med Ctr East, Dept Pediat, Tokyo, Japan; [Nakao, Yuzo] Kinki Univ, Sakai Hosp, Div Ophthalmol, Sakai, Osaka, Japan; [Oka, Yoshitomo] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Sendai, Miyagi 980, Japan	Yamaguchi University; Yamaguchi University; Akita University; Kochi University; Saitama Medical University; Tokyo Women's Medical University; Kindai University (Kinki University); Tohoku University	Tanabe, K (corresponding author), Yamaguchi Univ, Grad Sch Med, Div Endocrinol Metab Hematol Sci & Therapeut, Ube, Yamaguchi 755, Japan.	ktanabe@yamaguchi-u.ac.jp; tanizawa@yamaguchi-u.ac.jp	Yamada, Yuichiro/G-4766-2011		Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, and Science [16390096, 18390103, 20390093, 22590984, 25461357]; Banyu International Science Foundation;  [H16-genome-003]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Banyu International Science Foundation; 	This study was supported in part by a grant for intractable disease (to Y. Tanizawa) from the Ministry of Health, Labor and Welfare of Japan, Grants-in-Aid for Scientific Research (grant no. 16390096, 18390103 and 20390093 to Y. Tanizawa, 22590984 and 25461357 to K. Tanabe) from the Ministry of Education, Culture, Sports, and Science, a grant H16-genome-003 (to Y. Oka and Y. Tanizawa), and a grant from the Banyu International Science Foundation (to Y. Tanizawa and K. Tanabe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2009, DIABETOLOGIA, V52, P653, DOI 10.1007/s00125-009-1270-6; Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Cano A, 2007, AM J MED GENET A, V143A, P1605, DOI 10.1002/ajmg.a.31809; Chaussenot A, 2011, ANN NEUROL, V69, P501, DOI 10.1002/ana.22160; D'Annunzio G, 2008, DIABETES CARE, V31, P1743, DOI 10.2337/dc08-0178; de Heredia ML, 2013, GENET MED, V15, P497, DOI 10.1038/gim.2012.180; Florez JC, 2008, DIABETOLOGIA, V51, P451, DOI 10.1007/s00125-007-0891-x; Fonseca SG, 2012, NAT CELL BIOL, V14, P1105, DOI 10.1038/ncb2578; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Franks PW, 2008, DIABETOLOGIA, V51, P458, DOI 10.1007/s00125-007-0887-6; Gharanei S, 2013, HUM MOL GENET, V22, P203, DOI 10.1093/hmg/dds400; Giuliano Fabienne, 2005, Hum Mutat, V25, P99, DOI 10.1002/humu.9300; Hatanaka M, 2011, HUM MOL GENET, V20, P1274, DOI 10.1093/hmg/ddq568; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Inukai K, 2005, DIABETES RES CLIN PR, V69, P136, DOI 10.1016/j.diabres.2005.01.002; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Marshall BA, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-64; Medlej R, 2004, J CLIN ENDOCR METAB, V89, P1656, DOI 10.1210/jc.2002-030015; Minton JAL, 2003, REV ENDOCR METAB DIS, V4, P53, DOI 10.1023/A:1021875403463; Nakamura A, 2006, DIABETES RES CLIN PR, V73, P215, DOI 10.1016/j.diabres.2005.12.007; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Rohayem J, 2011, DIABETES CARE, V34, P1503, DOI 10.2337/dc10-1937; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Wasson J, 2008, DIABETOLOGIA, V51, P391, DOI 10.1007/s00125-007-0920-9; Wolfram DJ, 1938, P MAYO CLIN, V13, P715; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yamaguchi S, 2004, BIOCHEM BIOPH RES CO, V325, P250, DOI 10.1016/j.bbrc.2004.10.017	29	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106906	10.1371/journal.pone.0106906	http://dx.doi.org/10.1371/journal.pone.0106906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211237	Green Submitted, gold, Green Published			2022-12-27	WOS:000341855900031
J	Min, JH; Waters, P; Vincent, A; Cho, HJ; Joo, BE; Woo, SY; Lee, SY; Shin, HY; Lee, KH; Kim, BJ				Min, Ju-Hong; Waters, Patrick; Vincent, Angela; Cho, Hye-Jin; Joo, Byung-Euk; Woo, Sook-Young; Lee, Soo-Youn; Shin, Hee-Young; Lee, Kwang Ho; Kim, Byoung Joon			Low Levels of Vitamin D in Neuromyelitis Optica Spectrum Disorder: Association with Disease Disability	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MULTIPLE-SCLEROSIS PATIENTS; T-CELL FUNCTION; D DEFICIENCY; 1,25-DIHYDROXYVITAMIN D-3; INTERLEUKIN-6 RECEPTOR; AQUAPORIN-4 ANTIBODIES; RHEUMATOID-ARTHRITIS; SERUM; IMMUNOLOGY	Patients with autoimmune disorders often have low levels of 25-hydroxyvitamin D [25(OH)D-3], which correlates with disability or disease activity. Vitamin D may play a role in neuromyelitis optica (NMO) or NMO spectrum disorder (NMOSD), as an important factor involved in immunological pathways. We investigated the relationship between vitamin D levels and disease related disability and clinical activity in patients with NMOSD. Blood samples from 51 patients with NMOSD who were positive for anti-aquaporin4-antibody (AQP4-ab) and 204 healthy controls were collected for 25(OH)D-3 measurement. Clinical parameters, including expanded disability status scale (EDSS) score, annualized relapse rate (ARR) and time of blood sampling relative to attack, were determined in patients with NMOSD. We found that 25(OH)D-3 levels were significantly lower in patients with NMOSD compared to healthy controls. There was no difference between 25(OH)D-3 levels in blood samples taken at relapse or remission, and no association between 25(OH)D-3 levels and ARR, but there was an inverse correlation between 25(OH)D-3 levels and EDSS scores in patients with NMOSD. It remains to be determined whether low vitamin D levels predispose to NMO and/or modify disease severity, or are secondary to neurological disability. In either case the results could also be of relevance to other neurological diseases such as multiple sclerosis as well as NMO.	[Min, Ju-Hong; Cho, Hye-Jin; Joo, Byung-Euk; Lee, Kwang Ho; Kim, Byoung Joon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Waters, Patrick; Vincent, Angela] John Radcliffe Hosp, Neuroimmunol Grp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Woo, Sook-Young] Samsung Biomed Res Inst, Biostat Team, Seoul, South Korea; [Lee, Soo-Youn] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul, South Korea; [Shin, Hee-Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Hlth Promot, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; University of Oxford; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, BJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	bjkim@skku.edu	Waters, Patrick/Y-3753-2019; Vincent, Angela/AAE-7310-2019; Waters, Patrick/AAF-2658-2019; Lee, Soo Youn/F-4614-2014	Waters, Patrick/0000-0003-4142-2667; Waters, Patrick/0000-0003-4142-2667; LEE, SOO-YOUN/0000-0001-7595-4042	Samsung Medical Center [CRO112042]	Samsung Medical Center(Samsung)	This work was supported by a grant of Samsung Medical Center (CRO112042) (http://www.samsunghospital.com/dept/main/index.do?DP_CODE=SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agmon-Levin N, 2013, CLIN REV ALLERG IMMU, V45, P256, DOI 10.1007/s12016-012-8342-y; Ayzenberg I, 2013, JAMA NEUROL, V70, P394, DOI 10.1001/jamaneurol.2013.1246; Bogaczewicz J, 2012, LUPUS, V21, P477, DOI 10.1177/0961203311427549; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Chaiamnuay S, 2013, JCR-J CLIN RHEUMATOL, V19, P121, DOI 10.1097/RHU.0b013e318289bd16; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Chihara N, 2011, P NATL ACAD SCI USA, V108, P3701, DOI 10.1073/pnas.1017385108; Choi HS, 2011, J CLIN ENDOCR METAB, V96, P643, DOI 10.1210/jc.2010-2133; Craig SM, 2010, J RHEUMATOL, V37, P275, DOI 10.3899/jrheum.090705; Emerah AA, 2013, MOL BIOL REP, V40, P6151, DOI 10.1007/s11033-013-2726-9; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Jacob A, 2013, J NEUROL NEUROSUR PS, V84, P922, DOI 10.1136/jnnp-2012-302310; Kamen DL, 2006, AUTOIMMUN REV, V5, P114, DOI 10.1016/j.autrev.2005.05.009; Kang ES, 2012, ANN LAB MED, V32, P331, DOI 10.3343/alm.2012.32.5.331; Kim SH, 2012, NEUROLOGY, V78, P1179, DOI 10.1212/WNL.0b013e31824f8069; LEMIRE JM, 1992, AUTOIMMUNITY, V12, P143, DOI 10.3109/08916939209150321; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Luo J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/101805; Marrie Ruth Ann, 2013, Int J MS Care, V15, P113, DOI 10.7224/1537-2073.2012-048; Mealy MA, 2012, ARCH NEUROL-CHICAGO, V69, P352, DOI 10.1001/archneurol.2011.1974; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Mitsdoerffer M, 2013, ANN NY ACAD SCI, V1283, P57, DOI 10.1111/nyas.12118; Mok CC, 2012, LUPUS, V21, P36, DOI 10.1177/0961203311422094; Navarro-Millan I, 2012, CLIN THER, V34, P788, DOI 10.1016/j.clinthera.2012.02.014; Pozuelo-Moyano B, 2013, NEUROEPIDEMIOLOGY, V40, P147, DOI 10.1159/000345122; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Rossini M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3195; Runia TF, 2012, NEUROLOGY, V79, P261, DOI 10.1212/WNL.0b013e31825fdec7; Simon KC, 2012, CURR OPIN NEUROL, V25, P246, DOI 10.1097/WCO.0b013e3283533a7e; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; Smolders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006635; Smolders J, 2009, AUTOIMMUN REV, V8, P621, DOI 10.1016/j.autrev.2009.02.009; Soilu-Hanninen M, 2005, MULT SCLER J, V11, P266, DOI 10.1191/1352458505ms1157oa; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Weinstock-Guttman B, 2011, J NEUROL NEUROSUR PS, V82, P189, DOI 10.1136/jnnp.2010.227942; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2007, INT REV NEUROBIOL, V79, P665, DOI 10.1016/S0074-7742(07)79029-3; Zella JB, 2003, ARCH BIOCHEM BIOPHYS, V417, P77, DOI 10.1016/S0003-9861(03)00338-2; Zold E, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2533	44	26	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107274	10.1371/journal.pone.0107274	http://dx.doi.org/10.1371/journal.pone.0107274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211011	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900053
J	Prancl, J; Kaplan, Z; Travnicek, P; Jarolimova, V				Prancl, Jan; Kaplan, Zdenek; Travnicek, Pavel; Jarolimova, Vlasta			Genome Size as a Key to Evolutionary Complex Aquatic Plants: Polyploidy and Hybridization in Callitriche (Plantaginaceae)	PLOS ONE			English	Article							RANUNCULUS SUBGENUS BATRACHIUM; NUCLEAR-DNA CONTENT; CHROMOSOME-NUMBERS; GENETIC-VARIATION; FLOW-CYTOMETRY; INTERSPECIFIC HYBRIDIZATION; GEOGRAPHIC-DISTRIBUTION; SPECIES BOUNDARIES; MOLECULAR ANALYSIS; LEAF DIMORPHISM	Despite their complex evolutionary histories, aquatic plants are highly underrepresented in contemporary biosystematic studies. Of them, the genus Callitriche is particularly interesting because of such evolutionary features as wide variation in chromosome numbers and pollination systems. However, taxonomic difficulties have prevented broader investigation of this genus. In this study we applied flow cytometry to Callitriche for the first time in order to gain an insight into evolutionary processes and genome size differentiation in the genus. Flow cytometry complemented by confirmation of chromosome counts was applied to an extensive dataset of 1077 Callitriche individuals from 495 localities in 11 European countries and the USA. Genome size was determined for 12 taxa. The results suggest that many important processes have interacted in the evolution of the genus, including polyploidization and hybridization. Incongruence between genome size and ploidy level, intraspecific variation in genome size, formation of autotriploid and hybridization between species with different pollination systems were also detected. Hybridization takes place particularly in the diploid - tetraploid complex C. cophocarpa - C. platycarpa, for which the triploid hybrids were frequently recorded in the area of co-occurrence of its parents. A hitherto unknown hybrid (probably C. hamulata x C. cophocarpa) with a unique chromosome number was discovered in the Czech Republic. However, hybridization occurs very rarely among most of the studied species. The main ecological preferences were also compared among the taxa collected. Although Callitriche taxa often grow in mixed populations, the ecological preferences of individual species are distinctly different in some cases. Anyway, flow cytometry is a very efficient method for taxonomic delimitation, determination and investigation of Callitriche species, and is even able to distinguish homoploid taxa and identify introduced species.	[Prancl, Jan; Kaplan, Zdenek; Travnicek, Pavel; Jarolimova, Vlasta] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Prancl, Jan; Travnicek, Pavel] Charles Univ Prague, Dept Bot, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague	Prancl, J (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	jan.prancl@ibot.cas.cz	Travnicek, Pavel/G-9028-2012; Prančl, Jan/V-8067-2017; Prančl, Jan/ABC-9121-2020; Kaplan, Zdenek/A-3751-2012	Travnicek, Pavel/0000-0002-5806-1645; Prančl, Jan/0000-0003-4308-0824; Kaplan, Zdenek/0000-0003-1707-7461	Czech Science Foundation (Centre of Excellence PLADIAS) [14-36079G]; Academy of Sciences of the Czech Republic [RVO 67985939]; Postdoc USB project through the EU Education for Competitiveness Operational Programme - European Social Fund [CZ.1.07/2.3.00/30.0006]; Czech State Budget	Czech Science Foundation (Centre of Excellence PLADIAS); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Postdoc USB project through the EU Education for Competitiveness Operational Programme - European Social Fund; Czech State Budget	The research was supported by the Czech Science Foundation (project no. 14-36079G, Centre of Excellence PLADIAS), with additional support provided by the Academy of Sciences of the Czech Republic (long-term research development project no. RVO 67985939), institutional resources of Ministry of Education, Youth and Sports of the Czech Republic for the support of science and research, and by the Postdoc USB project (no. CZ.1.07/2.3.00/30.0006 to PT) realized through the EU Education for Competitiveness Operational Programme (funded by the European Social Fund and the Czech State Budget). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustynowicz J, 2014, ARCH ENVIRON CON TOX, V66, P572, DOI 10.1007/s00244-013-9995-0; Augustynowicz J, 2014, CENT EUR J CHEM, V12, P519, DOI 10.2478/s11532-013-0404-3; Augustynowicz J, 2013, CENT EUR J CHEM, V11, P295, DOI 10.2478/s11532-012-0161-8; Augustynowicz J, 2010, CHEMOSPHERE, V79, P1077, DOI 10.1016/j.chemosphere.2010.03.019; Baczkiewicz A, 2007, BIOL LETTERS, V44, P103; BARRETT SCH, 1993, AQUAT BOT, V44, P105, DOI 10.1016/0304-3770(93)90068-8; Bennert HW, 2011, ANN BOT-LONDON, V108, P867, DOI 10.1093/aob/mcr208; Buczkowska K, 2008, ACTA BIOL CRACOV BOT, V50, P63; COOK CDK, 1985, AQUAT BOT, V21, P111, DOI 10.1016/0304-3770(85)90084-1; COOK CDK, 1988, ANN MO BOT GARD, V75, P768, DOI 10.2307/2399365; Cook CDK., 1970, TAXON, V19, P161, DOI [10.2307/1217948, DOI 10.2307/1217948]; DAHLGREN G, 1991, PLANT SYST EVOL, V177, P193, DOI 10.1007/BF00937957; Dawson I, 1998, AUSTR ANTARCTIC ISLA; Demars BOL, 2003, WATSONIA, V24, P389; DERSCH G, 1986, Goettinger Floristische Rundbriefe, V20, P79; DESCHAMP PA, 1984, AM J BOT, V71, P319, DOI 10.2307/2443492; DESCHAMP PA, 1985, AM J BOT, V72, P1377, DOI 10.2307/2443509; Diao Y, 2006, CARYOLOGIA, V59, P25, DOI 10.1080/00087114.2006.10797894; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Ekrt L, 2010, AM J BOT, V97, P1208, DOI 10.3732/ajb.0900206; Ekrt L, 2009, PRESLIA, V81, P261; Fassett NC, 1951, RHODORA, V53, P185; Fassett NC, 1951, RHODORA, V53, P161; Fassett NC, 1951, RHODORA, V53, P137; FASSETT NORMAN C., 1951, RHODORA, V53, P137; Fiasson JL, 1997, BIOCHEM SYST ECOL, V25, P327, DOI 10.1016/S0305-1978(97)00021-5; Francis D, 2008, ANN BOT-LONDON, V101, P747, DOI 10.1093/aob/mcn038; Gomarasca S, 2012, PL BIOSYSTEMS, V147, P459; GRACE JB, 1993, AQUAT BOT, V44, P159, DOI 10.1016/0304-3770(93)90070-D; GUPTA PP, 1980, CYTOLOGIA, V45, P307, DOI 10.1508/cytologia.45.307; GUPTA PP, 1978, CYTOLOGIA, V43, P477, DOI 10.1508/cytologia.43.477; Hanusova K, 2014, PLOS ONE IN PRESS; Hedberg O, 2001, BIOL SKRIF, V54, P19; Hollingsworth PM, 1998, AQUAT BOT, V60, P337, DOI 10.1016/S0304-3770(97)00101-0; HONG DY, 1991, NORD J BOT, V11, P41; Husak S, 2000, KVETENA CESKE REPUBL, V6, P709; Jones H, 1955, ANN BOT, V19, P370; JONES HERBERT, 1955, ANN BOT, V19, P225; Kabatova K, 2014, PRESLIA, V86, P131; Kaplan Z, 2004, FOLIA GEOBOT, V39, P431, DOI 10.1007/BF02803212; Kaplan Z, 2004, PRESLIA, V76, P141; Kaplan Z, 2003, PLANT SYST EVOL, V239, P95, DOI 10.1007/s00606-002-0252-7; Kaplan Z, 2002, FOLIA GEOBOT, V37, P141, DOI 10.1007/BF02804229; Kaplan Z, 2007, ANN BOT-LONDON, V99, P1213, DOI 10.1093/aob/mcm072; Kaplan Z, 2006, PRESLIA, V78, P303; Kaplan Z, 2013, PRESLIA, V85, P421; Kaplan Z, 2013, AQUAT BOT, V105, P34, DOI 10.1016/j.aquabot.2012.11.002; Kaplan Z, 2011, NORD J BOT, V29, P477, DOI 10.1111/j.1756-1051.2011.01240.x; Kaplan Z, 2011, TAXON, V60, P758, DOI 10.1002/tax.603011; Kaplan Z, 2010, PRESLIA, V82, P261; Kaplan Z, 2009, PRESLIA, V81, P387; Kaplan Z, 2009, SYST BOT, V34, P625, DOI 10.1600/036364409790139745; Kaplan Zdenek, 2001, Preslia (Prague), V73, P333; King RA, 2001, BOT J LINN SOC, V135, P67, DOI 10.1006/bojl.2000.0354; Kolar F, 2013, ANN BOT-LONDON, V111, P1095, DOI 10.1093/aob/mct074; Kolar F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039988; Kur P, 2012, PRESLIA, V84, P905; Landolt E., 1986, BIOSYSTEMATIC INVEST; Lansdown R. V., 2006, Watsonia, V26, P105; Lansdown RV, 2008, HANDBOOK, V11; Leong-Skornickova J, 2007, ANN BOT-LONDON, V100, P505, DOI 10.1093/aob/mcm144; Les DH, 2003, INT J PLANT SCI, V164, P917, DOI 10.1086/378650; LES DH, 1988, ANN MO BOT GARD, V75, P819, DOI 10.2307/2399370; LES DH, 1993, AQUAT BOT, V44, P181, DOI 10.1016/0304-3770(93)90071-4; Letz DR, 2012, PRESLIA, V84, P33; Loureiro J, 2008, CYTOM PART A, V73A, P579, DOI 10.1002/cyto.a.20578; Loureiro J, 2010, PRESLIA, V82, P3; Maberly SC, 2002, AQUAT BOT, V73, P1, DOI 10.1016/S0304-3770(01)00229-7; MADSEN TV, 1991, AQUAT BOT, V40, P321, DOI 10.1016/0304-3770(91)90078-J; Mandak B, 2012, FLORA, V207, P530, DOI 10.1016/j.flora.2012.03.010; MARTINSSON K, 1991, NORD J BOT, V11, P143, DOI 10.1111/j.1756-1051.1991.tb01814.x; MARTINSSON K, 1993, GRANA, V32, P198, DOI 10.1080/00173139309429983; MARTINSSON K, 1985, Svensk Botanisk Tidskrift, V79, P165; Martinsson Karin, 1996, Acta Universitatis Upsaliensis Symbolae Botanicae Upsalienses, V31, P123; MASON R., 1959, AUSTRALIAN JOUR BOT, V7, P295, DOI 10.1071/BT9590295; MCCOMB AJ, 1965, ANN BOT-LONDON, V29, P445, DOI 10.1093/oxfordjournals.aob.a083965; McCracken A, 2013, ECOL EVOL, V3, P1427, DOI 10.1002/ece3.530; Moody ML, 2007, BIOL INVASIONS, V9, P559, DOI 10.1007/s10530-006-9058-9; Moody ML, 2010, SYST BOT, V35, P121, DOI 10.1600/036364410790862470; Morozowska M, 2010, AQUAT BOT, V93, P250, DOI 10.1016/j.aquabot.2010.08.004; Morton A, 2008, DISTRIBUTION MAPPING; Mraz P, 2011, PLANT SYST EVOL, V293, P237, DOI 10.1007/s00606-011-0441-3; MUSGRAVE A, 1972, NATURE-NEW BIOL, V238, P93, DOI 10.1038/newbio238093a0; Niketic M, 2013, BOT J LINN SOC, V172, P205, DOI 10.1111/boj.12050; Otto F, 1990, Methods Cell Biol, V33, P105; Pellicer J, 2013, GENOME, V56, P437, DOI 10.1139/gen-2013-0039; Pellicer J, 2012, ANN BOT-LONDON, V110, P1185, DOI 10.1093/aob/mcs185; Philbrick CT, 2000, AQUAT BOT, V68, P123, DOI 10.1016/S0304-3770(00)00114-5; Philbrick CT, 1996, BIOSCIENCE, V46, P813, DOI 10.2307/1312967; PHILBRICK CT, 1992, AM J BOT, V79, P887, DOI 10.2307/2444998; PHILBRICK CT, 1992, SYST BOT, V17, P282, DOI 10.2307/2419523; PHILBRICK CT, 1984, AM J BOT, V71, P882, DOI 10.2307/2443480; PHILBRICK CT, 1988, ANN MO BOT GARD, V75, P836, DOI 10.2307/2399371; Philbrick CT, 1998, RHODORA, V100, P25; PIJNACKER LP, 1988, ACTA BOT NEERL, V37, P129, DOI 10.1111/j.1438-8677.1988.tb01587.x; Prancl J., 2012, ZPRAVY CESKE BOT SPO, V47, P209; Prancl J, 2014, URT, V38, P29; Prancl J, 2013, ZPRAVY CES BOT SPOLE, V48, P179; Preston C. D., 1998, Watsonia, V22, P69; Sand-Jensen K, 1999, INT REV HYDROBIOL, V84, P497; Sand-Jensen K, 2008, FRESHWATER BIOL, V53, P714, DOI 10.1111/j.1365-2427.2007.01928.x; SAVIDGE J. P., 1960, PROC LINN SOC LONDON, V171, P128; SAVIDGE JP, 1959, P BOT SOC BRIT ISLES, V3, P335; SCHOTSMAN H. D., 1958, BER BAYERISCHEN BOT GES, V32, P128; SCHOTSMAN H D, 1982, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V4, P111; Schotsman H. D, 1961, BER SCHWEIZ BOT GES, V71, P5; Schotsman H.D., 1974, B CTR DETUDES RECHER, V10, P285; Schotsman H. D., 1967, FLORE FRANCE, V1, P1; Schotsman H.D., 1977, B CTR DETUDES RECHER, V11, P241; SCHOTSMAN HD, 1954, ACTA BOT NEERL, V3, P313; Schotsman HD, 1961, B SOC NEUCHAT SC NAT, V84, P89; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; Simova I, 2012, P ROY SOC B-BIOL SCI, V279, P867, DOI 10.1098/rspb.2011.1284; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SOLTIS DE, 1993, CRIT REV PLANT SCI, V12, P243, DOI 10.1080/713608048; Soltis DE, 2010, TAXON, V59, P1387, DOI 10.1002/tax.595006; Stift M, 2010, AM J BOT, V97, P1858, DOI 10.3732/ajb.1000048; Suda J, 2007, ANN BOT-LONDON, V100, P1323, DOI 10.1093/aob/mcm218; Suda J, 2010, PRESLIA, V82, P97; Tanaka Norio, 2007, Bulletin of the National Museum of Nature and Science Series B-Botany, V33, P133; Travnicek P, 2012, ANN BOT-LONDON, V110, P977, DOI 10.1093/aob/mcs171; Travnicek P, 2011, ANN BOT-LONDON, V107, P77, DOI 10.1093/aob/mcq217; Triest L, 2006, HYDROBIOLOGIA, V570, P73, DOI 10.1007/s10750-006-0164-6; TURALA K, 1969, ACTA BIOL CRACOV BOT, V12, P9; Urbanska-Worytkiewicz K, 1980, VEROFF GEOBOT I ETH, V70, P30; Vialette-Guiraud ACM, 2011, ANN BOT-LONDON, V108, P589, DOI 10.1093/aob/mcr088; Vit P, 2014, PRESLIA, V86, P95; Volkova PA, 2010, TAXON, V59, P483, DOI 10.1002/tax.592013; Wang W. Q., 2011, Journal of Botany, V2011, P570319, DOI 10.1155/2011/570319; WEBSTER S D, 1988, Watsonia, V17, P1; Wiegleb G, 1998, FOLIA GEOBOT, V33, P241, DOI 10.1007/BF03216205; Wiegleb G., 1983, G TT FLOR RUNDBR, V17, P101; Winter S, 2013, PLANT ECOL DIVERS, V6, P217, DOI 10.1080/17550874.2013.771475; WONG CH, 1967, AUST J BIOL SCI, V20, P1053, DOI 10.1071/BI9671053; Zahradnikova K, 1982, FLORA SLOVENSKA, V3, P463	135	27	30	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e105997	10.1371/journal.pone.0105997	http://dx.doi.org/10.1371/journal.pone.0105997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211149	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900006
J	Walper, SA; Liu, JL; Zabetakis, D; Anderson, GP; Goldman, ER				Walper, Scott A.; Liu, Jinny L.; Zabetakis, Daniel; Anderson, George P.; Goldman, Ellen R.			Development and Evaluation of Single Domain Antibodies for Vaccinia and the L1 Antigen	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; THERMAL-STABILITY; DISULFIDE BOND; VIRUS; PROTEIN; FRAGMENTS; SELECTION; IMMUNOGLOBULIN; STABILIZATION; IMMUNOGENICITY	There is ongoing interest to develop high affinity, thermal stable recognition elements to replace conventional antibodies in biothreat detection assays. As part of this effort, single domain antibodies that target vaccinia virus were developed. Two llamas were immunized with killed viral particles followed by boosts with the recombinant membrane protein, L1, to stimulate the immune response for envelope and membrane proteins of the virus. The variable domains of the induced heavy chain antibodies were selected from M13 phage display libraries developed from isolated RNA. Selection via biopanning on the L1 antigen produced single domain antibodies that were specific and had affinities ranging from 4x10(-9) M to 7.0x10(-10) M, as determined by surface plasmon resonance. Several showed good ability to refold after heat denaturation. These L1-binding single domain antibodies, however, failed to recognize the killed vaccinia antigen. Useful vaccinia binding single domain antibodies were isolated by a second selection using the killed virus as the target. The virus binding single domain antibodies were incorporated in sandwich assays as both capture and tracer using the MAGPIX system yielding limits of detection down to 4x10(5) pfu/ml, a four-fold improvement over the limit obtained using conventional antibodies. This work demonstrates the development of anti-vaccinia single domain antibodies and their incorporation into sandwich assays for viral detection. It also highlights the properties of high affinity and thermal stability that are hallmarks of single domain antibodies.	[Walper, Scott A.; Liu, Jinny L.; Zabetakis, Daniel; Anderson, George P.; Goldman, Ellen R.] Naval Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Goldman, ER (corresponding author), Naval Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA.	ellen.goldman@nrl.navy.mil	Anderson, George P/D-2461-2011; Walper, Scott/A-5110-2018	Anderson, George P/0000-0001-7545-9893; Walper, Scott/0000-0002-9436-3456	Defense Threat Reduction Agency [CBCALL12-DIAGB5-2-0037]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	Funding for this project was provided by the Defense Threat Reduction Agency CBCALL12-DIAGB5-2-0037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa-Ogawa Y, 2014, J BIOL CHEM, V289, P15666, DOI 10.1074/jbc.M113.534222; Aldaz-Carroll L, 2005, VIROLOGY, V341, P59, DOI 10.1016/j.virol.2005.07.006; Anderson GP, 2010, ANAL CHEM, V82, P7202, DOI 10.1021/ac100961x; Conway JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008818; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Dona V, 2010, J AGR FOOD CHEM, V58, P918, DOI 10.1021/jf902973c; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Eyer L, 2012, VET MED-CZECH, V57, P439, DOI 10.17221/6336-VETMED; Gaidamakova EK, 2012, CELL HOST MICROBE, V12, P117, DOI 10.1016/j.chom.2012.05.011; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; Goldman ER, 2011, TOXINS, V3, P1405, DOI 10.3390/toxins3111405; Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053; GROENE WS, 1992, J VIROL METHODS, V38, P93, DOI 10.1016/0166-0934(92)90172-A; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; HANSON CV, 1978, J GEN VIROL, V40, P345, DOI 10.1099/0022-1317-40-2-345; Harmsen MM, 2006, APPL MICROBIOL BIOT, V72, P544, DOI 10.1007/s00253-005-0300-7; Hussack G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028218; Liu JL, 2014, MOL IMMUNOL, V59, P194, DOI 10.1016/j.molimm.2014.02.014; Liu JL, 2013, J IMMUNOL METHODS, V393, P1, DOI 10.1016/j.jim.2013.04.001; Liu JL, 2013, MOL IMMUNOL, V53, P118, DOI 10.1016/j.molimm.2012.07.010; Lowman H.B, 2004, PHAGE DISPLAY; Maves RC, 2010, CLIN VACCINE IMMUNOL, V17, P304, DOI 10.1128/CVI.00353-09; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; RAVANELLO MP, 1994, J VIROL, V68, P6401, DOI 10.1128/JVI.68.10.6401-6410.1994; RAVANELLO MP, 1994, J GEN VIROL, V75, P1479, DOI 10.1099/0022-1317-75-6-1479; REDFIELD DC, 1981, INFECT IMMUN, V32, P1216, DOI 10.1128/IAI.32.3.1216-1226.1981; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Sherwood LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061232; Su HP, 2005, P NATL ACAD SCI USA, V102, P4240, DOI 10.1073/pnas.0501103102; Townsend MB, 2013, J VIROL METHODS, V187, P37, DOI 10.1016/j.jviromet.2012.08.023; Turner KB, 2014, PROTEIN ENG DES SEL, V27, P89, DOI 10.1093/protein/gzu001; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Walper SA, 2013, ANTIBODIES, V2, P152, DOI 10.3390/antib2010152; Walper SA, 2013, J IMMUNOL METHODS, V388, P68, DOI 10.1016/j.jim.2012.11.014; Walper SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032801; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; WOLFFE EJ, 1995, VIROLOGY, V211, P53, DOI 10.1006/viro.1995.1378	41	22	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106263	10.1371/journal.pone.0106263	http://dx.doi.org/10.1371/journal.pone.0106263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211488	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900009
J	Yeung, CYC; Taylor, SH; Garva, R; Holmes, DF; Zeef, LA; Soininen, R; Boot-Handford, RP; Kadler, KE				Yeung, Ching-Yan Chloe; Taylor, Susan H.; Garva, Richa; Holmes, David F.; Zeef, Leo A.; Soininen, Raija; Boot-Handford, Raymond P.; Kadler, Karl E.			Arhgap28 Is a RhoGAP that Inactivates RhoA and Downregulates Stress Fibers	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; MYOSIN LIGHT-CHAIN; CANCER 1 DLC1; GENE-EXPRESSION; FIBRONECTIN MATRIX; MEMBRANE PROTRUSION; ACTIN CYTOSKELETON; BINDING PROTEIN; FOCAL ADHESIONS	The small GTPase RhoA is a major regulator of actin reorganization during the formation of stress fibers; thus identifying molecules that regulate Rho activity is necessary for a complete understanding of the mechanisms that determine cell contractility. Here, we have identified Arhgap28 as a Rho GTPase activating protein (RhoGAP) that switches RhoA to its inactive form. We generated an Arhgap28-LacZ reporter mouse that revealed gene expression in soft tissues at E12.5, prebone structures of the limb at E15.5, and prominent expression restricted mostly to ribs and limb long bones at E18.5 days of development. Expression of recombinant Arhgap28-V5 in human osteosarcoma SaOS-2 cells caused a reduction in the basal level of RhoA activation and disruption of actin stress fibers. Extracellular matrix assembly studies using a 3-dimensional cell culture system showed that Arhgap28 was upregulated during Rho-dependent assembly of the ECM. Taken together, these observations led to the hypothesis that an Arhgap28 knockout mouse model would show a connective tissue phenotype, perhaps affecting bone. Arhgap28-null mice were viable and appeared normal, suggesting that there could be compensation from other RhoGAPs. Indeed, we showed that expression of Arhgap6 (a closely related RhoGAP) was upregulated in Arhgap28-null bone tissue. An upregulation in RhoA expression was also detected suggesting that Arhgap28 may be able to additionally regulate Rho signaling at a transcriptional level. Microarray analyses revealed that Col2a1, Col9a1, Matn3, and Comp that encode extracellular matrix proteins were downregulated in Arhgap28-null bone. Although mutations in these genes cause bone dysplasias no bone phenotype was detected in the Arhgap-28 null mice. Together, these data suggest that the regulation of Rho by RhoGAPs, including Arhgap28, during the assembly and development of mechanically strong tissues is complex and may involve multiple RhoGAPs.	[Yeung, Ching-Yan Chloe; Taylor, Susan H.; Garva, Richa; Holmes, David F.; Boot-Handford, Raymond P.; Kadler, Karl E.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Zeef, Leo A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Soininen, Raija] Univ Oulu, Dept Dermatol, Oulu Ctr Cell Matrix Res, SF-90220 Oulu, Finland	University of Manchester; University of Manchester; University of Oulu	Yeung, CYC (corresponding author), Max Planck Inst Biol Ageing, Cologne, Germany.	chloe.yeung@age.mpg.de; karl.kadler@manchester.ac.uk	Yeung, Ching-Yan Chloé/W-7663-2019; Yeung, Ching-Yan Chloé/GPX-1457-2022; KADLER, KARL/ABI-2403-2020	Yeung, Ching-Yan Chloé/0000-0002-7076-8109; Yeung, Ching-Yan Chloé/0000-0002-7076-8109; KADLER, KARL/0000-0003-4977-4683; GARVA, RICHA/0000-0001-7752-8936; Taylor, Susan/0000-0001-9554-055X; Boot-Handford, Raymond/0000-0002-6167-8419	Wellcome Trust [091840/Z/10/Z]; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was generously funded by the Wellcome Trust (091840/Z/10/Z). C-YCY was funded by a PhD studentship from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Bayer ML, 2010, BIOMATERIALS, V31, P4889, DOI 10.1016/j.biomaterials.2010.02.062; Bordeleau F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038780; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Canty EG, 2006, J BIOL CHEM, V281, P38592, DOI 10.1074/jbc.M607581200; Cao X, 2012, P NATL ACAD SCI USA, V109, P1455, DOI 10.1073/pnas.1114368109; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chen ZX, 2011, MOL CELL BIOCHEM, V358, P221, DOI 10.1007/s11010-011-0938-7; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Francomano CA, 1996, CURR OPIN GENET DEV, V6, P301, DOI 10.1016/S0959-437X(96)80006-2; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson GC, 2012, HUM MUTAT, V33, P144, DOI 10.1002/humu.21611; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Kalson NS, 2013, P NATL ACAD SCI USA, V110, pE4743, DOI 10.1073/pnas.1314348110; Kalson NS, 2010, MATRIX BIOL, V29, P678, DOI 10.1016/j.matbio.2010.08.009; Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006; Kapacee Z, 2010, MATRIX BIOL, V29, P668, DOI 10.1016/j.matbio.2010.08.005; Keung AJ, 2011, STEM CELLS, V29, P1886, DOI 10.1002/stem.746; Kim TY, 2007, BIOCHEM BIOPH RES CO, V355, P72, DOI 10.1016/j.bbrc.2007.01.121; KOLODNEY MS, 1993, J BIOL CHEM, V268, P23850; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; MOSCOW JA, 1994, GENE, V144, P229, DOI 10.1016/0378-1119(94)90382-4; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; NODA M, 1995, FEBS LETT, V367, P246, DOI 10.1016/0014-5793(95)00573-R; Ohashi T, 2002, J CELL SCI, V115, P1221; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Prakash SK, 2000, HUM MOL GENET, V9, P477, DOI 10.1093/hmg/9.4.477; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	52	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107036	10.1371/journal.pone.0107036	http://dx.doi.org/10.1371/journal.pone.0107036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211221	Green Submitted, Green Published, gold			2022-12-27	WOS:000341855900039
J	Carty, SA; Koretzky, GA; Jordan, MS				Carty, Shannon A.; Koretzky, Gary A.; Jordan, Martha S.			Interleukin-4 Regulates Eomesodermin in CD8(+) T Cell Development and Differentiation	PLOS ONE			English	Article							IL-4 RECEPTOR; MEMORY; MICE; BET; STIMULATION; THYMOCYTES; RESPONSES; EFFECTOR; PROMOTES; GATA-3	Interleukin (IL)-4 is a cytokine classically associated with CD4(+) T helper type 2 differentiation, but has been recently shown to also be required for the development of CD8(+) innate-like lymphocytes. CD8(+) innate-like lymphocytes are non-conventional lymphocytes that exhibit characteristics typically associated with memory CD8(+) T cells, including expression of the T-box transcription factor Eomesodermin (Eomes). Here we investigate the signaling pathways required for IL-4 induction of Eomes and CD8(+) innate-like lymphocyte markers in murine CD8SP thymocytes and peripheral CD8(+) T cells. We demonstrate that IL-4 is sufficient to drive Eomes expression and the CD8(+) innate-like lymphocyte phenotype through cooperation between STAT6- and Akt-dependent pathways. Furthermore, we show that while IL-4 has little effect on the induction of Eomes in the setting of robust T cell receptor (TCR) activation, this cytokine promotes Eomes in the setting of attenuated TCR stimulation in mature CD8(+) T cells suggesting that cytokine signaling pathways may direct cell fate when TCR signals are limiting.	[Carty, Shannon A.; Koretzky, Gary A.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Koretzky, Gary A.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Jordan, Martha S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Jordan, MS (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	jordanm@mail.med.upenn.edu	Carty, Shannon/ABF-9536-2020; Koretzky, Gary/AAU-5381-2021	Carty, Shannon/0000-0003-2286-8014; 	National Institutes of Health [5K01AR52802, K12 HL 087064, K08 AI101008]; Abramson Family Cancer Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI101008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Family Cancer Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (http://www.nih.gov): 5K01AR52802 (M.S.J.), K12 HL 087064 (S. A. C.), K08 AI101008 (S. A. C.) and the Abramson Family Cancer Research Institute (G. A. K.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pinheiro AAD, 2007, J LEUKOCYTE BIOL, V81, P1102, DOI 10.1189/jlb.0906583; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Carvalho LH, 2002, NAT MED, V8, P166, DOI 10.1038/nm0202-166; Fukuyama T, 2009, MOL CELL BIOL, V29, P3894, DOI 10.1128/MCB.01598-08; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Gordon SM, 2011, J IMMUNOL, V186, P4573, DOI 10.4049/jimmunol.1100037; Hu J, 2007, EUR J IMMUNOL, V37, P2892, DOI 10.1002/eji.200737311; Huang LR, 2000, P NATL ACAD SCI USA, V97, P3406, DOI 10.1073/pnas.060026497; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010; Juntilla MM, 2007, P NATL ACAD SCI USA, V104, P12105, DOI 10.1073/pnas.0705285104; KAWAKAMI Y, 1988, J EXP MED, V168, P2183, DOI 10.1084/jem.168.6.2183; KINGSTON R, 1985, NATURE, V317, P811, DOI 10.1038/317811a0; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Lai DZ, 2011, J EXP MED, V208, P1093, DOI 10.1084/jem.20101527; Li W, 2005, IMMUNITY, V23, P375, DOI 10.1016/j.immuni.2005.09.002; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Min HS, 2011, J IMMUNOL, V186, P5749, DOI 10.4049/jimmunol.1002825; Nayar R, 2012, P NATL ACAD SCI USA, V109, pE2794, DOI 10.1073/pnas.1205742109; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Oliver JA, 2012, CYTOKINE, V57, P191, DOI 10.1016/j.cyto.2011.10.006; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Perkins C, 2006, J ALLERGY CLIN IMMUN, V118, P410, DOI 10.1016/j.jaci.2006.06.004; Perkins C, 2011, J EXP MED, V208, P853, DOI 10.1084/jem.20100023; Rafei M, 2011, J IMMUNOL, V187, P3133, DOI 10.4049/jimmunol.1101097; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sharma A, 2012, J IMMUNOL, V188, P3859, DOI 10.4049/jimmunol.1103729; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Stager S, 2003, INFECT IMMUN, V71, P4804, DOI 10.1128/IAI.71.8.4804-4807.2003; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tofukuji S, 2012, J IMMUNOL, V188, P4846, DOI 10.4049/jimmunol.1103799; Verykokakis M, 2010, IMMUNITY, V33, P203, DOI 10.1016/j.immuni.2010.07.013; Verykokakis M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009303; Wang YQ, 2013, NAT IMMUNOL, V14, P714, DOI 10.1038/ni.2623; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	43	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106659	10.1371/journal.pone.0106659	http://dx.doi.org/10.1371/journal.pone.0106659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207963	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300034
J	Castellano, I; Deambrogio, C; Muscara, F; Chiusa, L; Mariscotti, G; Bussone, R; Gazzetta, G; Macri, L; Cassoni, P; Sapino, A				Castellano, Isabella; Deambrogio, Cristina; Muscara, Francesca; Chiusa, Luigi; Mariscotti, Giovanna; Bussone, Riccardo; Gazzetta, Guglielmo; Macri, Luigia; Cassoni, Paola; Sapino, Anna			Efficiency of a Preoperative Axillary Ultrasound and Fine-Needle Aspiration Cytology to Detect Patients with Extensive Axillary Lymph Node Involvement	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; INTERNATIONAL MULTICENTER TOOL; TUMOR SIZE; METASTASIS; DISSECTION; BIOPSY; VALIDATION; CARCINOMA; DIAGNOSIS; NOMOGRAM	Background: Recent studies have demonstrated that axillary lymph node dissection (ALND) does not affect patient survival, even in those with one or two positive sentinel lymph nodes (SLNs). On the other hand, patients with 3 or more metastatic lymph nodes are eligible for chemotherapy. Therefore, it is crucial to identify a priori patients at risk of having a high number of metastatic axillary lymph nodes for their surgical and/or clinical management. Ultrasound (US) guided Fine-Needle Aspiration (FNA) has been proven to be a useful and highly specific method for detecting metastatic axillary lymph nodes. However, only one recent study has evaluated the efficiency of this method in identifying patients with high metastatic nodal involvement. Our aim was to validate US-guided FNA as a reliable method to discriminate a priori patients with >3 metastatic lymph nodes. Methods: A retrospective series of 1287 breast cancer patients who underwent a simultaneous preoperative breast and axillary US to stage their axilla was collected. A total of 365 patients, with either positive SLNs (278) or positive axillary lymph nodes detected via US-guided FNA (87), underwent ALND. In these two subgroups, we compared the number of metastatic lymph nodes in the axilla. Results: The number of metastatic axillary lymph nodes in patients who underwent US-guided FNA was significantly higher (63% had >3 metastatic lymph nodes) than that in patients with SLNs positive for micro- or macrometastases (3% and 27%, respectively) (P<0.001, chi(2) = 117.897). Conclusions: Preoperative axillary US-guided FNA could act as a reliable tool in identifying breast cancer patients with extensive nodal involvement.	[Castellano, Isabella; Deambrogio, Cristina; Muscara, Francesca; Chiusa, Luigi; Macri, Luigia; Cassoni, Paola; Sapino, Anna] Univ Turin, Dept Med Sci, Turin, Italy; [Mariscotti, Giovanna] Univ Turin, Molinette Hosp, Ist Radiol Diagnost & Iterventist, Citta Salute & Sci, Turin, Italy; [Bussone, Riccardo; Gazzetta, Guglielmo] StAnna Hosp, Citta Salute & Sci, Breast Surg Dept, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino	Castellano, I (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	isabella.castellano@unito.it	Castellano, Isabella/K-1888-2018; Cassoni, Paola/I-8544-2018; Sapino, Anna/J-4113-2018; Sapino, Anna/AGY-9901-2022	Sapino, Anna/0000-0003-3542-9571; Sapino, Anna/0000-0003-3542-9571; Castellano, isabella/0000-0002-9072-1615	Compagnia San Paolo di Torino, AIRC, MIUR-PRIN	Compagnia San Paolo di Torino, AIRC, MIUR-PRIN(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Compagnia San Paolo di Torino (www.compagnia.torino.it), AIRC 2010-2012, MIUR-PRIN 2008. There are no financial disclosures from any of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2013, AM J ROENTGENOL, V200, P696, DOI 10.2214/AJR.12.9036; Alvarez S, 2006, AM J ROENTGENOL, V186, P1342, DOI 10.2214/AJR.05.0936; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Cools-Lartigue J, 2013, ANN SURG ONCOL, V20, P819, DOI 10.1245/s10434-012-2609-7; Coutant C, 2009, BREAST CANCER RES TR, V113, P537, DOI 10.1007/s10549-008-9967-7; Cserni G, 2012, SURG ONCOL, V21, P59, DOI 10.1016/j.suronc.2011.12.001; Cyr A, 2012, ANN SURG ONCOL, V19, P3185, DOI 10.1245/s10434-012-2547-4; Degnim AC, 2005, AM J SURG, V190, P543, DOI 10.1016/j.amjsurg.2005.06.008; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Giuliano AE, 2000, J CLIN ONCOL, V18, P2553, DOI 10.1200/JCO.2000.18.13.2553; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Krishnamurthy S, 2002, CANCER, V95, P982, DOI 10.1002/cncr.10786; Lee B, 2013, AM J ROENTGENOL, V200, pW314, DOI 10.2214/AJR.12.9032; Meretoja TJ, 2013, BREAST CANCER RES TR, V138, P817, DOI 10.1007/s10549-013-2468-3; Meretoja TJ, 2012, JNCI-J NATL CANCER I, V104, P1888, DOI 10.1093/jnci/djs455; Montemurro F, 2012, CANCER-AM CANCER SOC, V118, P17, DOI 10.1002/cncr.26162; Perhavec A, 2010, BREAST CANCER RES TR, V119, P357, DOI 10.1007/s10549-009-0561-4; Pietribiasi F, 2006, Pathologica, V98, P167; Reynolds C, 1999, J CLIN ONCOL, V17, P1720, DOI 10.1200/JCO.1999.17.6.1720; Sapino A, 2003, BRIT J CANCER, V88, P702, DOI 10.1038/sj.bjc.6600744; Turner RR, 2000, CANCER-AM CANCER SOC, V89, P574, DOI 10.1002/1097-0142(20000801)89:3<574::AID-CNCR12>3.0.CO;2-Y; van Wely BJ, 2013, BREAST CANCER RES TR, V140, P113, DOI 10.1007/s10549-013-2624-9; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; Veronesi U, 1999, JNCI-J NATL CANCER I, V91, P368, DOI 10.1093/jnci/91.4.368; Wo JY, 2011, J CLIN ONCOL, V29, P2619, DOI 10.1200/JCO.2010.29.5907	26	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106640	10.1371/journal.pone.0106640	http://dx.doi.org/10.1371/journal.pone.0106640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207643	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300031
J	Song, AX; Yang, H; Gao, YG; Zhou, CJ; Zhang, YH; Hu, HY				Song, Ai-Xin; Yang, Hui; Gao, Yong-Guang; Zhou, Chen-Jie; Zhang, Yu-Hang; Hu, Hong-Yu			A Ubiquitin Shuttle DC-UbP/UBTD2 Reconciles Protein Ubiquitination and Deubiquitination via Linking UbE1 and USP5 Enzymes	PLOS ONE			English	Article							POLYUBIQUITIN CHAINS; DC-UBP; BINDING; DOMAIN; ISOPEPTIDASE; LIGASE; E1; DEGRADATION; ROLES; INHIBITION	The ubiquitination levels of protein substrates in eukaryotic cells are delicately orchestrated by various protein cofactors and enzymes. Dendritic cell-derived ubiquitin (Ub)-like protein (DC-UbP), also named as Ub domain-containing protein 2 (UBTD2), is a potential Ub shuttle protein comprised of a Ub-like (UbL) domain and a Ub-binding domain (UBD), but its biological function remains largely unknown. We identified two Ub-related enzymes, the deubiquitinating enzyme USP5 and the Ub-activating enzyme UbE1, as interacting partners of DC-UbP from HEK 293T cells. Biochemical studies revealed that the tandem UBA domains of USP5 and the C-terminal Ub-fold domain (UFD) of UbE1 directly interacted with the C-terminal UbL domain of DC-UbP but on the distinct surfaces. Overexpression of DC-UbP in HEK 293T cells enhanced the association of these two enzymes and thus prompted cellular ubiquitination, whereas knockdown of the protein reduced the cellular ubiquitination level. Together, DC-UbP may integrate the functions of USP5 and UbE1 through interacting with them, and thus reconcile the cellular ubiquitination and deubiquitination processes.	[Song, Ai-Xin; Yang, Hui; Gao, Yong-Guang; Zhou, Chen-Jie; Zhang, Yu-Hang; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China.	hyhu@sibcb.ac.cn	Gao, Yongguang/B-8546-2012	Gao, Yongguang/0000-0002-9359-4252	National Basic Research Program of China [2012CB911003, 2011CB911104]; National Natural Science Foundation of China [30600103, 30870485, 31270773]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the research grants from the National Basic Research Program of China (2012CB911003, 2011CB911104), and the National Natural Science Foundation of China (30600103, 30870485, 31270773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 1997, EMBO J, V16, P4826; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Avvakumov GV, 2012, BIOCHEMISTRY-US, V51, P1188, DOI 10.1021/bi200854q; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Chang YG, 2008, J BIOL CHEM, V283, P13370, DOI 10.1074/jbc.M800162200; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Chen PC, 2011, J NEUROSCI, V31, P17505, DOI 10.1523/JNEUROSCI.2922-11.2011; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; FALQUET L, 1995, FEBS LETT, V359, P73, DOI 10.1016/0014-5793(94)01451-6; Finley Daniel, 2004, Cell, VS116, pS29, DOI 10.1016/S0092-8674(03)00971-1; Gao XC, 2012, J BIOL CHEM, V287, P6044, DOI 10.1074/jbc.M111.294728; Gao YG, 2005, PROTEIN SCI, V14, P2044, DOI 10.1110/ps.051455505; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; HADARI T, 1992, J BIOL CHEM, V267, P719; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Liu SX, 2003, BIOCHEM BIOPH RES CO, V300, P800, DOI 10.1016/S0006-291X(02)02913-3; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Raasi Shahri, 2005, V301, P47; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Sato Y, 2012, J BIOL CHEM, V287, P25860, DOI 10.1074/jbc.M112.364752; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Song AX, 2010, PROTEIN SCI, V19, P1104, DOI 10.1002/pro.386; Szczepanowski RH, 2005, J BIOL CHEM, V280, P22006, DOI 10.1074/jbc.M502583200; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Xu GW, 2010, BLOOD, V115, P2251, DOI 10.1182/blood-2009-07-231191; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zhang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029362; Zhou ZR, 2008, PROTEIN SCI, V17, P1805, DOI 10.1110/ps.036384.108; Zhou ZR, 2012, BIOCHEM J, V441, P143, DOI 10.1042/BJ20110699	50	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107509	10.1371/journal.pone.0107509	http://dx.doi.org/10.1371/journal.pone.0107509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207809	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300088
J	Tang, JW; Gao, CX; Cowling, BJ; Koh, GC; Chu, D; Heilbronn, C; Lloyd, B; Pantelic, J; Nicolle, AD; Klettner, CA; Peiris, JSM; Sekhar, C; Cheong, DKW; Tham, KW; Koay, ESC; Tsui, W; Kwong, A; Chan, K; Li, YG				Tang, Julian W.; Gao, Caroline X.; Cowling, Benjamin J.; Koh, Gerald C.; Chu, Daniel; Heilbronn, Cherie; Lloyd, Belinda; Pantelic, Jovan; Nicolle, Andre D.; Klettner, Christian A.; Peiris, J. S. Malik; Sekhar, Chandra; Cheong, David K. W.; Tham, Kwok Wai; Koay, Evelyn S. C.; Tsui, Wendy; Kwong, Alfred; Chan, Kitty; Li, Yuguo			Absence of Detectable Influenza RNA Transmitted via Aerosol during Various Human Respiratory Activities - Experiments from Singapore and Hong Kong	PLOS ONE			English	Article							COUGH-GENERATED AEROSOL; AIRBORNE TRANSMISSION; VIRUS AEROSOLS; GUINEA-PIG; A VIRUS; PARTICLES; INFECTION; DEPOSITION; OUTBREAK; EXPOSURE	Two independent studies by two separate research teams (from Hong Kong and Singapore) failed to detect any influenza RNA landing on, or inhaled by, a life-like, human manikin target, after exposure to naturally influenza-infected volunteers. For the Hong Kong experiments, 9 influenza-infected volunteers were recruited to breathe, talk/count and cough, from 0.1 m and 0.5 m distance, onto a mouth-breathing manikin. Aerosolised droplets exhaled from the volunteers and entering the manikin's mouth were collected with PTFE filters and an aerosol sampler, in separate experiments. Virus detection was performed using an in-house influenza RNA reverse-transcription polymerase chain reaction (RT-PCR) assay. No influenza RNA was detected from any of the PTFE filters or air samples. For the Singapore experiments, 6 influenza-infected volunteers were asked to breathe (nasal/mouth breathing), talk (counting in English/second language), cough (from 1 m/0.1 m away) and laugh, onto a thermal, breathing manikin. The manikin's face was swabbed at specific points (around both eyes, the nostrils and the mouth) before and after exposure to each of these respiratory activities, and was cleaned between each activity with medical grade alcohol swabs. Shadowgraph imaging was used to record the generation of these respiratory aerosols from the infected volunteers and their impact onto the target manikin. No influenza RNA was detected from any of these swabs with either team's in-house diagnostic influenza assays. All the influenza-infected volunteers had diagnostic swabs taken at recruitment that confirmed influenza (A/H1, A/H3 or B) infection with high viral loads, ranging from 10(5)-10(8) copies/mL (Hong Kong volunteers/assay) and 10(4)-10(7) copies/mL influenza viral RNA (Singapore volunteers/assay). These findings suggest that influenza RNA may not be readily transmitted from naturally-infected human source to susceptible recipients via these natural respiratory activities, within these exposure time-frames. Various reasons are discussed in an attempt to explain these findings.	[Tang, Julian W.] Univ Alberta Hosp, Alberta Prov Lab Publ Hlth, Edmonton, AB T6G 2B7, Canada; [Tang, Julian W.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Tang, Julian W.; Nicolle, Andre D.; Klettner, Christian A.; Koay, Evelyn S. C.] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore; [Gao, Caroline X.; Li, Yuguo] Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China; [Gao, Caroline X.; Heilbronn, Cherie; Lloyd, Belinda] Eastern Hlth, Turning Point Alcohol & Drug Ctr, Melbourne, Vic, Australia; [Gao, Caroline X.; Heilbronn, Cherie; Lloyd, Belinda] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic 3004, Australia; [Cowling, Benjamin J.; Chu, Daniel; Peiris, J. S. Malik] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Koh, Gerald C.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Pantelic, Jovan] Univ Maryland, Dept Mech Engn, Baltimore, MD 21201 USA; [Sekhar, Chandra; Cheong, David K. W.; Tham, Kwok Wai] Natl Univ Singapore, Sch Design & Environm, Dept Bldg, Singapore 117548, Singapore; [Koay, Evelyn S. C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore; [Tsui, Wendy; Kwong, Alfred] Hosp Author, Hong Kong West Cluster, Dept Family Med & Primary Healthcare, Hong Kong, Hong Kong, Peoples R China; [Chan, Kitty] Univ Hong Kong, Univ Hlth Serv, Hong Kong, Hong Kong, Peoples R China	University of Alberta; University of Alberta; National University of Singapore; University of Hong Kong; Turning Point Alcohol & Drug Centre - Australia; Monash University; University of Hong Kong; National University of Singapore; University System of Maryland; University of Maryland Baltimore; National University of Singapore; National University of Singapore; University of Hong Kong	Tang, JW (corresponding author), Univ Alberta Hosp, Alberta Prov Lab Publ Hlth, Edmonton, AB T6G 2B7, Canada.	jwtang49@hotmail.com	Cowling, Benjamin John/C-4263-2009; GAO, Caroline X/AAU-7989-2021; Li, Yuguo/A-9469-2010; THAM, Kwok Wai/B-6541-2009; Peiris, Joseph Sriyal Malik/C-4380-2009; Sekhar, Chandra/F-3253-2017	Cowling, Benjamin John/0000-0002-6297-7154; GAO, Caroline X/0000-0002-0987-2759; Li, Yuguo/0000-0002-2281-4529; THAM, Kwok Wai/0000-0002-2957-1152; Koh, Choon Huat Gerald/0000-0002-6453-6897; Tang, Julian/0000-0002-4963-1028; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Sekhar, Chandra/0000-0002-0814-8662; Cheong, David/0000-0001-7680-4281; Chu, Daniel Ka Wing/0000-0002-9219-8979	Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; RGC GRF [HKU7142/12]; Singapore's National Medical Research Council [NMRC/1208/2009, NMRC/1247/2010]; Agency for Science, Technology and Research [A*STAR: SERC 1021290099]	Area of Excellence Scheme of the Hong Kong University Grants Committee; RGC GRF(Hong Kong Research Grants Council); Singapore's National Medical Research Council(National Medical Research Council, Singapore); Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR))	Funding for the Hong Kong study was supported by the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06) and a RGC GRF grant (HKU7142/12). Funding for the Singapore study and support for post-doctoral research fellows ADN and CAK were provided by grants to JWT/ESCK from Singapore's National Medical Research Council (NMRC/1208/2009 and NMRC/1247/2010) and Agency for Science, Technology and Research (A*STAR: SERC 1021290099), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; Bischoff WE, 2011, J INFECT DIS, V204, P193, DOI 10.1093/infdis/jir238; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chapin CV., 1912, SOURCES MODES INFECT; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; DUGUID JP, 1946, BRIT MED J, V1, P265, DOI 10.1136/bmj.1.4442.265; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Fabian TK, 2012, INT J MOL SCI, V13, P4295, DOI 10.3390/ijms13044295; Golshahi L, 2013, ANN BIOMED ENG, V41, P979, DOI 10.1007/s10439-013-0747-0; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Gupta JK, 2010, INDOOR AIR, V20, P31, DOI 10.1111/j.1600-0668.2009.00623.x; Han K, 2009, EMERG INFECT DIS, V15, P1578, DOI 10.3201/eid1510.091013; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Kaminski MM, 2013, J VIROL, V87, P1912, DOI 10.1128/JVI.02507-12; Kesavan J, 2010, AEROSOL SCI TECH, V44, P817, DOI 10.1080/02786826.2010.497513; Lee C, 2011, HAEMOPHILIA, V17, P1, DOI 10.1111/j.1365-2516.2010.02478.x; Lee HK, 2012, J MED VIROL, V84, P1646, DOI 10.1002/jmv.23375; Li YG, 2011, INDOOR AIR, V21, P89, DOI 10.1111/j.1600-0668.2011.00711.x; Licina D, 2014, BUILD ENVIRON; Lindsley WG, 2014, J OCCUP ENVIRON HYG, V11, P509, DOI 10.1080/15459624.2013.877591; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P681, DOI 10.1080/15459624.2012.725986; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P443, DOI 10.1080/15459624.2012.684582; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Storey-Bishoff J, 2008, J AEROSOL SCI, V39, P1055, DOI 10.1016/j.jaerosci.2008.07.011; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059970; Tang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034818; Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Voelker C, 2014, INDOOR AIR, V24, P567, DOI 10.1111/ina.12112; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wells WF, 1955, AIR HYG ECOL STUDY D; White MR, 2009, ORAL MICROBIOL IMMUN, V24, P18, DOI 10.1111/j.1399-302X.2008.00468.x; Wong BCK, 2010, CLIN INFECT DIS, V51, P1176, DOI 10.1086/656743	43	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107338	10.1371/journal.pone.0107338	http://dx.doi.org/10.1371/journal.pone.0107338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208000	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300075
J	Weiss, J; Coslovsky, M; Keel, I; Immer, FF; Juni, P				Weiss, Julius; Coslovsky, Michael; Keel, Isabelle; Immer, Franz F.; Jueni, Peter		Comite Natl Don Organes	Organ Donation in Switzerland - An Analysis of Factors Associated with Consent Rate	PLOS ONE			English	Article							QUALITATIVE LITERATURE; PRESUMED-CONSENT; CADAVERIC ORGAN; FAMILY-MEMBERS; DONOR; TRANSPLANTATION; WILLINGNESS; IMPROVEMENT; RELATIVES; DECISION	Background and Aim: Switzerland has a low post mortem organ donation rate. Here we examine variables that are associated with the consent of the deceased's next of kin (NOK) for organ donation, which is a prerequisite for donation in Switzerland. Methods and Analysis: During one year, we registered information from NOK of all deceased patients in Swiss intensive care units, who were approached for consent to organ donation. We collected data on patient demographics, characteristics of NOK, factors related to the request process and to the clinical setting. We analyzed the association of collected predictors with consent rate using univariable logistic regression models; predictors with p-values <0.2 were selected for a multivariable logistic regression. Results: Of 266 NOK approached for consent, consent was given in 137 (51.5%) cases. In multivariable analysis, we found associations of consent rates with Swiss nationality (OR 3.09, 95% CI: 1.46-6.54) and German language area (OR 0.31, 95% CI: 0.14-0.73). Consent rates tended to be higher if a parent was present during the request (OR 1.76, 95% CI: 0.93-3.33) and if the request was done before brain death was formally declared (OR 1.87, 95% CI: 0.90-3.87). Conclusion: Establishing an atmosphere of trust between the medical staff putting forward a request and the NOK, allowing sufficient time for the NOK to consider donation, and respecting personal values and cultural differences, could be of importance for increasing donation rates. Additional measures are needed to address the pronounced differences in consent rates between language regions.	[Weiss, Julius; Keel, Isabelle; Immer, Franz F.] Swiss Natl Fdn Organ Donat & Transplantat, Swisstransplant, Bern, Switzerland; [Coslovsky, Michael; Jueni, Peter] Univ Bern, CTU Bern, Dept Clin Res, Bern, Switzerland; [Coslovsky, Michael; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Bern; University of Bern	Immer, FF (corresponding author), Swiss Natl Fdn Organ Donat & Transplantat, Swisstransplant, Bern, Switzerland.	franz.immer@swisstransplant.org	Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670	Federal Office of Public Health; Swiss University Hospitals and transplant centres [G15]	Federal Office of Public Health; Swiss University Hospitals and transplant centres	SwissPOD is funded by the Federal Office of Public Health (www.bag.admin.ch), and the Swiss University Hospitals and transplant centres (G15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouna GM, 2008, TRANSPL P, V40, P34, DOI 10.1016/j.transproceed.2007.11.067; Balthasar A, 2009, AUSWERTUNGEN AUSGEWA; Barber K, 2006, BMJ-BRIT MED J, V332, P1124, DOI 10.1136/bmj.38804.658183.55; Bellali T, 2007, SOC SCI MED, V64, P439, DOI 10.1016/j.socscimed.2006.09.006; Brown CVR, 2010, J TRAUMA, V68, P447, DOI 10.1097/TA.0b013e3181caab8f; Council of Europe, 2012, NEWSLSETTER TRANSPLA, V17; Cuende N, 2007, AM J TRANSPLANT, V7, P1526, DOI 10.1111/j.1600-6143.2007.01792.x; de Groot YJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10481; Directorate General Health and Consumer Protection (SANCO), 2007, SPEC EUR 272 EUR ORG; DuBois James M, 2006, Prog Transplant, V16, P65; Exley Marsha, 2002, Crit Care Nurse, V22, P44; Garrick T, 2009, CELL TISSUE BANK, V10, P309, DOI 10.1007/s10561-009-9136-1; Howard DH, 2007, HEALTH SERV RES, V42, P2160, DOI 10.1111/j.1475-6773.2007.00732.x; Irving MJ, 2012, NEPHROL DIAL TRANSPL, V27, P2526, DOI 10.1093/ndt/gfr683; Jacoby L, 2010, AM J CRIT CARE, V19, pE52, DOI 10.4037/ajcc2010396; Kesselring A, 2007, AM J TRANSPLANT, V7, P211, DOI 10.1111/j.1600-6143.2006.01594.x; Matesanz R, 2009, TRANSPL P, V41, P3453, DOI 10.1016/j.transproceed.2009.09.011; Matesanz R, 2002, J NEPHROL, V15, P22; Matesanz R, 2011, TRANSPL INT, V24, P333, DOI 10.1111/j.1432-2277.2010.01204.x; Moraes BN, 2009, TRANSPL P, V41, P799, DOI 10.1016/j.transproceed.2009.02.043; Morgan SE, 2002, HEALTH COMMUN, V14, P121, DOI 10.1207/S15327027HC1401_6; Mossialos E, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-48; Newton JD, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-791; Paez G, 2009, TRANSPL P, V41, P2025, DOI 10.1016/j.transproceed.2009.05.020; Panczak R, 2012, J EPIDEMIOL COMMUN H, V66, P1129, DOI 10.1136/jech-2011-200699; Pelleriaux B, 2008, PROG TRANSPLANT, V18, P173; Randhawa G, 2012, BRIT J ANAESTH, V108, pI88, DOI 10.1093/bja/aer385; Rithalia A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3162; Rodrigue JR, 2008, PEDIATR CRIT CARE ME, V9, P180, DOI 10.1097/PCC.0b013e3181668605; Rodrigue JR, 2006, AM J TRANSPLANT, V6, P190, DOI 10.1111/j.1600-6143.2005.01130.x; Salim A, 2010, J TRAUMA, V69, P451, DOI 10.1097/TA.0b013e3181e7847a; Schaub F, 2013, DEUT MED WOCHENSCHR, V138, P2189, DOI 10.1055/s-0033-1349554; Schulz PJ, 2006, PATIENT EDUC COUNS, V64, P294, DOI 10.1016/j.pec.2006.03.009; Shafer TJ, 2008, CRIT CARE NURS Q, V31, P190, DOI 10.1097/01.CNQ.0000325044.78904.9b; Sheehy E, 2012, AM J TRANSPLANT, V12, P1598, DOI 10.1111/j.1600-6143.2011.03981.x; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; Siminoff LA, 2006, J GEN INTERN MED, V21, P995, DOI 10.1007/BF02743151; Simpkin AL, 2009, BMJ, V338; Swisstransplant, 2012, 2011 ANN REP; The International Registry in Organ Donation and Transplantation (IRODaT), 2013, PREL 2012 DAT; Vincent A, 2012, BRIT J ANAESTH, V108, pI80, DOI 10.1093/bja/aer353; Volz Wenger A, 2010, INT J PUBLIC HEALTH, V56, P217; Wakefield CE, 2011, PROG TRANSPLANT, V21, P161, DOI 10.7182/prtr.21.2.2071rgn834573152; Williams MA, 2003, CRIT CARE MED, V31, P1568, DOI 10.1097/01.CCM.0000063090.21056.A6; Wynn JJ, 2011, TRANSPL INT, V24, P324, DOI 10.1111/j.1432-2277.2010.01201.x; Xie WZ, 2013, CHINESE MED J-PEKING, V126, P2830, DOI 10.3760/cma.j.issn.0366-6999.20130460	46	19	19	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106845	10.1371/journal.pone.0106845	http://dx.doi.org/10.1371/journal.pone.0106845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25208215	Green Published, gold			2022-12-27	WOS:000342030300044
J	Brooks, MD; Jackson, E; Warrington, NM; Luo, JQ; Forys, JT; Taylor, S; Mao, DD; Leonard, JR; Kim, AH; Piwnica-Worms, D; Mitra, RD; Rubin, JB				Brooks, Michael D.; Jackson, Erin; Warrington, Nicole M.; Luo, Jingqin; Forys, Jason T.; Taylor, Sara; Mao, Diane D.; Leonard, Jeffrey R.; Kim, Albert H.; Piwnica-Worms, David; Mitra, Robi D.; Rubin, Joshua B.			PDE7B Is a Novel, Prognostically Significant Mediator of Glioblastoma Growth Whose Expression Is Regulated by Endothelial Cells	PLOS ONE			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; PROMOTE TUMOR ANGIOGENESIS; CYCLIC-AMP SUPPRESSION; CANCER STEM-CELLS; SELF-RENEWAL; BRAIN-TUMORS; GENE-EXPRESSION; BETA-ARRESTIN; UP-REGULATION; HUMAN GLIOMA	Cell-cell interactions between tumor cells and constituents of their microenvironment are critical determinants of tumor tissue biology and therapeutic responses. Interactions between glioblastoma (GBM) cells and endothelial cells (ECs) establish a purported cancer stem cell niche. We hypothesized that genes regulated by these interactions would be important, particularly as therapeutic targets. Using a computational approach, we deconvoluted expression data from a mixed physical co-culture of GBM cells and ECs and identified a previously undescribed upregulation of the cAMP specific phosphodiesterase PDE7B in GBM cells in response to direct contact with ECs. We further found that elevated PDE7B expression occurs in most GBM cases and has a negative effect on survival. PDE7B overexpression resulted in the expansion of a stem-like cell subpopulation in vitro and increased tumor growth and aggressiveness in an in vivo intracranial GBM model. Collectively these studies illustrate a novel approach for studying cell-cell interactions and identifying new therapeutic targets like PDE7B in GBM.	[Brooks, Michael D.; Warrington, Nicole M.; Forys, Jason T.; Rubin, Joshua B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Jackson, Erin; Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA; [Jackson, Erin; Piwnica-Worms, David] Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Luo, Jingqin] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Taylor, Sara; Mao, Diane D.; Leonard, Jeffrey R.; Kim, Albert H.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Brooks, Michael D.; Mitra, Robi D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Brooks, Michael D.; Mitra, Robi D.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Rubin, JB (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	rubin_j@kids.wustl.edu	Kim, Albert H./HGF-0057-2022	Mitra, Robi/0000-0002-2680-4264	NIH [RO1CA118389, 5R01NS07699302, P50 CA94056]; Taylor Rozier's Hope for a Cure Brain Tumor Foundation; Josie Foundation; NCI Cancer Center Support Grant [P30 CA91842]; Molecular Imaging Center at Washington University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA118389, P50CA094056, P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076993] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taylor Rozier's Hope for a Cure Brain Tumor Foundation; Josie Foundation; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Molecular Imaging Center at Washington University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH (www.nih.gov) RO1CA118389 (JBR), 5R01NS07699302 (RDM), the Taylor Rozier's Hope for a Cure Brain Tumor Foundation (JBR, taylorrozier.com), and The Josie Foundation (JBR, josiefoundation.org). The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant #P30 CA91842. Bioluminescence imaging studies were supported by The Molecular Imaging Center at Washington University School of Medicine and NIH P50 CA94056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, BIOINFORMATICS, V29, P1865, DOI 10.1093/bioinformatics/btt301; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charalambous C, 2005, J NEUROSURG, V102, P699, DOI 10.3171/jns.2005.102.4.0699; Chekenya M, 2002, NEUROPATH APPL NEURO, V28, P367, DOI 10.1046/j.1365-2990.2002.00412.x; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Santos RPC, 2011, TUMOR BIOL, V32, P145, DOI 10.1007/s13277-010-0108-7; Delort L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066284; Denysenko T, 2010, CELL BIOCHEM FUNCT, V28, P343, DOI 10.1002/cbf.1666; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; FURMAN MA, 1977, J NEUROSURG, V46, P477, DOI 10.3171/jns.1977.46.4.0477; Goldhoff P, 2008, CLIN CANCER RES, V14, P7717, DOI 10.1158/1078-0432.CCR-08-0827; Gong T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027156; Gonzalez-Garcia C, 2013, BR J PHARM; Gorin F, 2004, ACTA NEUROPATHOL, V107, P235, DOI 10.1007/s00401-003-0803-1; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Guo P, 2005, AM J PATHOL, V166, P877, DOI 10.1016/S0002-9440(10)62308-5; Hetman JM, 2000, P NATL ACAD SCI USA, V97, P472, DOI 10.1073/pnas.97.1.472; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kocher B, 2013, CANCER DISCOV, V3, P616, DOI 10.1158/2159-8290.CD-12-0503; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100; Mantamadiotis T, 2012, BIOESSAYS, V34, P293, DOI 10.1002/bies.201100133; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; Morrison C, 2011, J BIOL CHEM, V286, P34271, DOI 10.1074/jbc.M111.222513; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; PRASAD KN, 1975, CANCER, V36, P1338, DOI 10.1002/1097-0142(197510)36:4<1338::AID-CNCR2820360422>3.0.CO;2-1; Rao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033005; Rath BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054752; Safavi M, 2013, EXPERT OPIN DRUG DIS, V8, P733, DOI 10.1517/17460441.2013.787986; Sengupta R, 2011, TRENDS PHARMACOL SCI, V32, P337, DOI 10.1016/j.tips.2011.02.015; SHAKUR Y, 1993, BIOCHEM J, V292, P677, DOI 10.1042/bj2920677; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang JL, 2012, ADV EXP MED BIOL, V727, P174, DOI 10.1007/978-1-4614-0899-4_13; Warrington NM, 2007, CANCER RES, V67, P8588, DOI 10.1158/0008-5472.CAN-06-2220; Warrington NM, 2010, CANCER RES, V70, P5717, DOI 10.1158/0008-5472.CAN-09-3769; Woerner BM, 2012, MOL CANCER RES, V10, P156, DOI 10.1158/1541-7786.MCR-11-0411; Xu CP, 2010, INT IMMUNOPHARMACOL, V10, P1602, DOI 10.1016/j.intimp.2010.09.016; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yang LH, 2007, CANCER RES, V67, P651, DOI 10.1158/0008-5472.CAN-06-2762; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Yue XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032707; Zhang Z, 2006, NEUROPATH APPL NEURO, V32, P615, DOI 10.1111/j.1365-2990.2006.00770.x; Zhao YG, 2010, AM J PATHOL, V176, P3032, DOI 10.2353/ajpath.2010.090571; Zhu TS, 2011, CANCER RES, V71, P6061, DOI 10.1158/0008-5472.CAN-10-4269	61	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107397	10.1371/journal.pone.0107397	http://dx.doi.org/10.1371/journal.pone.0107397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203500	gold, Green Published			2022-12-27	WOS:000342684500095
J	Gutierrez, D; Ruas-Madiedo, P; Martinez, B; Rodriguez, A; Garcia, P				Gutierrez, Diana; Ruas-Madiedo, Patricia; Martinez, Beatriz; Rodriguez, Ana; Garcia, Pilar			Effective Removal of Staphylococcal Biofilms by the Endolysin LysH5	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; STREPTOCOCCUS-PNEUMONIAE; EPIDERMIDIS STRAINS; PERSISTER CELLS; LYTIC ACTIVITY; AUREUS; BACTERIAL; BACTERIOPHAGES; ERADICATION; DETACHMENT	Staphylococcal biofilms are a major concern in both clinical and food settings because they are an important source of contamination. The efficacy of established cleaning procedures is often hindered due to the ability of some antimicrobial compounds to induce biofilm formation, and to the presence of persister cells, a small bacterial subpopulation that exhibits multidrug tolerance. Phage lytic enzymes have demonstrated antimicrobial activity against planktonic and sessile bacteria. However, their ability to lyse and/or select persister cells remains largely unexplored so far. In this work, the lytic activity of the endolysin LysH5 against Staphylococcus aureus and Staphylococcus epidermidis biofilms was confirmed. LysH5 reduced staphylococcal sessile cell counts by 1-3 log units, compared with the untreated control, and sub-inhibitory concentrations of this protein did not induce biofilm formation. LysH5-surviving cells were not resistant to the lytic activity of this protein, suggesting that no persister cells were selected. Moreover, to prove the lytic ability of LysH5 against this subpopulation, both S. aureus exponential cultures and persister cells obtained after treatment with rifampicin and ciprofloxacin were subsequently treated with LysH5. The results demonstrated that besides the notable activity of endolysin LysH5 against staphylococcal biofilms, persister cells were also inhibited, which raises new opportunities as an adjuvant for some antibiotics.	[Gutierrez, Diana; Ruas-Madiedo, Patricia; Martinez, Beatriz; Rodriguez, Ana; Garcia, Pilar] Inst Prod Lacteos Asturias IPLA CSIC, Villaviciosa, Asturias, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA)	Garcia, P (corresponding author), Inst Prod Lacteos Asturias IPLA CSIC, Villaviciosa, Asturias, Spain.	pgarcia@ipla.csic.es	Gutiérrez, Diana/E-8712-2017; Rodriguez, Ana/H-4846-2012; Garcia, Pilar/AAP-3768-2020; Martínez, Beatriz/H-2953-2012; Ruas-Madiedo, Patricia/H-2502-2012; Rodríguez, Ana/GQR-0554-2022; Rodriguez, Ana/GLQ-7829-2022; Suárez, Pilar García/H-2544-2012	Gutiérrez, Diana/0000-0002-0473-1447; Rodriguez, Ana/0000-0002-1577-9905; Garcia, Pilar/0000-0003-1213-8165; Martínez, Beatriz/0000-0001-7692-1963; Ruas-Madiedo, Patricia/0000-0001-6158-9320; Rodriguez, Ana/0000-0002-1577-9905; Suárez, Pilar García/0000-0003-1213-8165	Ministry of Science and Innovation, Spain [AGL2012-40194-C02-01]; CSIC, Spain [PIE200970I090]	Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC, Spain	This research study was supported by grants AGL2012-40194-C02-01 (Ministry of Science and Innovation, Spain) and PIE200970I090 (CSIC, Spain). DG is a fellow of the Ministry of Science and Innovation, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerca N, 2007, LETT APPL MICROBIOL, V45, P313, DOI 10.1111/j.1472-765X.2007.02190.x; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Curtin JJ, 2006, ANTIMICROB AGENTS CH, V50, P1268, DOI 10.1128/AAC.50.4.1268-1275.2006; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Delgado S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-82; Domenech M, 2011, ANTIMICROB AGENTS CH, V55, P4144, DOI 10.1128/AAC.00492-11; Dulon M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-138; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Fenton Mark, 2013, Int J Microbiol, V2013, P625341, DOI 10.1155/2013/625341; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Garcia P, 2010, INT J FOOD MICROBIOL, V141, P151, DOI 10.1016/j.ijfoodmicro.2010.04.029; Gutierrez D, 2012, APPL ENVIRON MICROB, V78, P8547, DOI 10.1128/AEM.02045-12; Gutierrez D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-228; Herrera JJR, 2007, FOOD MICROBIOL, V24, P585, DOI 10.1016/j.fm.2007.01.001; Hussain M, 1997, INFECT IMMUN, V65, P519, DOI 10.1128/IAI.65.2.519-524.1997; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Jabbouri S, 2010, FEMS IMMUNOL MED MIC, V59, P280, DOI 10.1111/j.1574-695X.2010.00695.x; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Kaplan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00198-12; Kaplan JB, 2011, INT J ARTIF ORGANS, V34, P737, DOI 10.5301/ijao.5000027; Kelly D, 2012, LETT APPL MICROBIOL, V54, P286, DOI 10.1111/j.1472-765X.2012.03205.x; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Keren I, 2012, METHOD ENZYMOL, V517, P387, DOI 10.1016/B978-0-12-404634-4.00019-X; Kint CI, 2012, TRENDS MICROBIOL, V20, P577, DOI 10.1016/j.tim.2012.08.009; Le Loir Yves, 2003, Genet Mol Res, V2, P63; Lechner S, 2012, J MOL MICROB BIOTECH, V22, P235, DOI 10.1159/000342449; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Meng XP, 2011, APPL ENVIRON MICROB, V77, P8272, DOI 10.1128/AEM.05151-11; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Nelson DC, 2012, ADV VIRUS RES, V83, P299, DOI 10.1016/B978-0-12-394438-2.00007-4; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Obeso JM, 2008, INT J FOOD MICROBIOL, V128, P212, DOI 10.1016/j.ijfoodmicro.2008.08.010; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Rodriguez-Rubio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064671; Rodriguez-Rubio L, 2013, CRIT REV MICROBIOL, V39, P427, DOI 10.3109/1040841X.2012.723675; Saising J, 2012, ANTIMICROB AGENTS CH, V56, P5804, DOI 10.1128/AAC.01296-12; Sass P, 2007, APPL ENVIRON MICROB, V73, P347, DOI 10.1128/AEM.01616-06; Shen Y, 2013, J ANTIMICROB CHEMOTH, V68, P1818, DOI 10.1093/jac/dkt104; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Wu JA, 2003, ANTIMICROB AGENTS CH, V47, P3407, DOI 10.1128/AAC.47.11.3407-3414.2003	45	122	131	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107307	10.1371/journal.pone.0107307	http://dx.doi.org/10.1371/journal.pone.0107307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203125	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500082
J	Kuper, H; Monteath-van Dok, A; Wing, K; Danquah, L; Evans, J; Zuurmond, M; Gallinetti, J				Kuper, Hannah; Monteath-van Dok, Adrienne; Wing, Kevin; Danquah, Lisa; Evans, Jenny; Zuurmond, Maria; Gallinetti, Jacqueline			The Impact of Disability on the Lives of Children; Cross-Sectional Data Including 8,900 Children with Disabilities and 898,834 Children without Disabilities across 30 Countries	PLOS ONE			English	Article							NUTRITION; POVERTY; HEALTH	Background: Children with disabilities are widely believed to be less likely to attend school or access health care, and more vulnerable to poverty. There is currently little large-scale or internationally comparable evidence to support these claims. The aim of this study was to investigate the impact of disability on the lives of children sponsored by Plan International across 30 countries. Methods and Findings: We conducted a cross-sectional survey including 907,734 children aged 0-17 participating in the Plan International Sponsorship Programme across 30 countries in 2012. Parents/guardians were interviewed using standardised questionnaires including information on: age, sex, health, education, poverty, and water and sanitation facilities. Disability was assessed through a single question and information was collected on type of impairment. The dataset included 8,900 children with reported disabilities across 30 countries. The prevalence of disability ranged from 0.4%-3.0% and was higher in boys than girls in 22 of the 30 countries assessed - generally in the range of 1.3-1.4 fold higher. Children with disabilities were much less likely to attend formal education in comparison to children without disabilities in each of the 30 countries, with age-sex adjusted odds ratios exceeding 10 for nearly half of the countries. This relationship varied by impairment type. Among those attending school, children with disabilities were at a lower level of schooling for their age compared to children without disabilities. Children with disabilities were more likely to report experiencing a serious illness in the last 12 months, except in Niger. There was no clear relationship between disability and poverty. Conclusions: Children with disabilities are at risk of not fulfilling their educational potential and are more vulnerable to serious illness. This exclusion is likely to have a long-term deleterious impact on their lives unless services are adapted to promote their inclusion.	[Kuper, Hannah; Danquah, Lisa; Evans, Jenny; Zuurmond, Maria] Univ London London Sch Hyg & Trop Med, Dept Clin Res, Int Ctr Evidence Disabil, London WC1E 7HT, England; [Monteath-van Dok, Adrienne; Gallinetti, Jacqueline] Plan Int, Woking, Surrey, England; [Wing, Kevin] Univ London London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Dept, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Kuper, H (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Clin Res, Int Ctr Evidence Disabil, Keppel St, London WC1E 7HT, England.	hannah.kuper@lshtm.ac.uk	Evans, Jennifer/F-4672-2012; Wing, Kevin/I-7807-2015	Evans, Jennifer/0000-0002-6137-2030; Wing, Kevin/0000-0003-2335-9641	Plan International; STFC [ST/J001465/1] Funding Source: UKRI	Plan International; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was funded by Plan International. The data collection was the responsibility of Plan International. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Alavi Y, 2012, DISABIL REHABIL, V34, P1736, DOI 10.3109/09638288.2012.662260; [Anonymous], 2005, STAT WORLDS CHILDR 2; Bornstein MH, 2013, SOC SCI MED, V97, P307, DOI 10.1016/j.socscimed.2012.09.049; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 2008, WORLD BANK ECON REV, V22, P141, DOI 10.1093/wber/lhm021; Gottlieb CA, 2009, LANCET, V374, P1831, DOI 10.1016/S0140-6736(09)61871-7; Groce NE, 2013, LANCET GLOB HEALTH, V1, pE180, DOI 10.1016/S2214-109X(13)70056-1; Jeffery R., 2011, INCLUSIVE ED EXAMINI; Kalyanpur Maya., 2007, J INT ASS SPECIAL ED, V8, P69; Maas C., 2009, MEDIA RELEASE COALIT; Mont D, 2013, WORLD DEV, V48, P88, DOI 10.1016/j.worlddev.2013.04.001; Nanoo N, 2011, LIVES CHILDREN DISAB; Nesbitt RC, 2012, DISABIL REHABIL, V34, P1089, DOI 10.3109/09638288.2011.634943; Rischewski D, 2008, T ROY SOC TROP MED H, V102, P608, DOI 10.1016/j.trstmh.2008.02.023; Simkiss DE, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-119; Singal N, 2008, TEACH TEACH EDUC, V24, P1516, DOI 10.1016/j.tate.2008.01.008; Tomlinson M, 2009, LANCET, V374, P1857, DOI 10.1016/S0140-6736(09)61910-3; Trani JF, 2011, SOC SCI MED, V73, P1477, DOI 10.1016/j.socscimed.2011.08.040; UN, 1989, CONV RIGHTS CHILD; UNICEF, 2013, STAT WORLDS CHILDR 2; United Nations, 2011, REP SECR GEN STAT CO; United Nations Convention on the Rights of Persons with Disabilities (UNCRPD), 2006, CONV RIGHTS PERS DIS; United Nations Population Division, 2011, SEX DIFF CHILDH MORT; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Wu L, 2010, J HEALTH POPUL NUTR, V28, P585, DOI 10.3329/jhpn.v28i6.6607; Yousafzai AK, 2003, BRIT J NUTR, V90, P1097, DOI 10.1079/BJN2003991; Yousafzai AK, 2014, ARCH DIS CHILD, V0, P1	27	72	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107300	10.1371/journal.pone.0107300	http://dx.doi.org/10.1371/journal.pone.0107300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IF	25202999	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000342684500080
J	Png, ME; Yoong, JSY				Png, May Ee; Yoong, Joanne Su-Yin			Evaluating the Cost-Effectiveness of Lifestyle Modification versus Metformin Therapy for the Prevention of Diabetes in Singapore	PLOS ONE			English	Article							ILLNESS	Background: In Singapore, as diabetes is an increasingly important public health issue, the cost-effectiveness of pursuing lifestyle modification programs and/or alternative prevention strategies is of critical importance for policymakers. While the US Diabetes Prevention Program (DPP) compared weight loss through lifestyle modification with oral treatment of diabetes drug metformin to prevent/delay the onset of type 2 diabetes in pre-diabetic subjects, no data on either the actual or potential cost effectiveness of such a program is available for East or South-east Asian populations. This study estimates the 3-year cost-effectiveness of lifestyle modification and metformin among pre-diabetic subjects from a Singapore health system and societal perspective. Methodology: Cost effectiveness was analysed from 2010-2012 using a decision-based model to estimate the rates of getting diabetes, healthcare costs and health-related quality of life. Cost per quality-adjusted life year (QALY) was estimated using costs relevant to the time horizon of the study from Singapore. All costs are expressed in 2012 US dollars. Principal Findings: The total economic cost for non-diabetic subjects from the societal perspective was US$25,867, US$28,108 and US$26,177 for placebo, lifestyle modification and metformin intervention respectively. For diabetic patients, the total economic cost from the societal perspective was US$32,921, US$35,163 and US$33,232 for placebo, lifestyle modification and metformin intervention respectively. Lifestyle modification relative to placebo is likely to be associated with an incremental cost per QALY gained at US$36,663 while that of metformin intervention is likely to be US$6,367 from a societal perspective. Conclusion: Based on adaptation of the DPP data to local conditions, both lifestyle modification and metformin intervention are likely to be cost-effective and worth implementing in Singapore to prevent or delay the onset of type 2 diabetes. However, the cost of lifestyle modification from the societal perspective would have to be reduced in order to match the cost-effectiveness of metformin intervention.	[Png, May Ee; Yoong, Joanne Su-Yin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	National University of Singapore	Png, ME (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	png.mayee@gmail.com	Png, May Ee/AAG-4902-2019	Png, May Ee/0000-0001-5876-9363; Yoong, Joanne/0000-0002-0162-9885				Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426; Diabet Prevention Program Res Grp, 2003, DIABETES CARE, V26, P2518, DOI 10.2337/diacare.26.9.2518; Ettaro L, 2004, PHARMACOECONOMICS, V22, P149, DOI 10.2165/00019053-200422030-00002; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; George PP, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-44; Herman WH, 2003, DIABETES CARE, V26, P36; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; International Diabetes Federation, 2009, DIABETES ATLAS; International Diabetes Federation, 2012, GLOB GUID TYP 2 DIAB; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lim MK, 1998, J PUBLIC HEALTH MED, V20, P16; Ministry of Health, 2013, PRINC CAUS DEATH; Ministry of Health, 2013, COSTS FIN; Ministry of Health Singapore, 2013, NAT HLTH SURV 2010; Ministry of Manpower, 2014, HOURS WORK OV REST D; Ministry of Manpower, 2013, MED GROSS MONTH INC; Ministry of Manpower, 2011, REP WAG SING 2010 ST; National Diabetes Information Clearinghouse (NDIC), 2013, DIAB PREV PROGR DPP; Palmer AJ, 2012, PRIM CARE DIABETES, V6, P109, DOI 10.1016/j.pcd.2011.10.006; People's Association, 2013, AER CLASS; Phan TP, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000012; Ramachandran A, 2007, DIABETES CARE, V30, P2548, DOI 10.2337/dc07-0150; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Saw Swee Hock School of Public Health, 2013, FIN REP INT WORKPL S; Singapore Department of Statistics, 2009, REP HOUS EXP SURV 20; Singapore Department of Statistics, 2014, LAT DAT; Singapore Department of Statistics, 2014, TIM SER CPI 2009 100; Singapore Review Committee on National Health Policies, 1991, HLTH FAM HLTH NAT RE; Singapore Sports Council, 2013, GYM MEMB SCHEM; The World Bank, 2014, DAT OFF EXCH RAT LCU; Wee CF, 2013, GYM AVALANCHE; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; WILLIAMS SV, 1991, JAMA-J AM MED ASSOC, V266, P810, DOI 10.1001/jama.266.6.810; Willke RJ, 1998, HEALTH ECON, V7, P481, DOI 10.1002/(SICI)1099-1050(199809)7:6<481::AID-HEC353>3.3.CO;2-B; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; York D, 2008, J CONTIN EDUC HEALTH, V28, P99, DOI 10.1002/chp.165	37	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107225	10.1371/journal.pone.0107225	http://dx.doi.org/10.1371/journal.pone.0107225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IF	25203633	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500076
J	Sarkar, T; Bansal, R; Das, P				Sarkar, Tanmoy; Bansal, Rajesh; Das, Parimal			Whole Genome Sequencing Reveals Novel Non-Synonymous Mutation in Ectodysplasin A (EDA) Associated with Non-Syndromic X-Linked Dominant Congenital Tooth Agenesis	PLOS ONE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; MISSENSE MUTATIONS; ISOLATED HYPODONTIA; DENTAL AGENESIS; CLEFT-PALATE; PROTEIN; PAX9; OLIGODONTIA; DOMAIN; PREVALENCE	Congenital tooth agenesis in human is characterized by failure of tooth development during tooth organogenesis. 300 genes in mouse and 30 genes in human so far have been known to regulate tooth development. However, candidature of only 5 genes viz. PAX9, MSX1, AXIN2, WNT10A and EDA have been experimentally established for congenitally missing teeth like hypodontia and oligodontia. In this study an Indian family with multiple congenital tooth agenesis was identified. Pattern of inheritance was apparently autosomal dominant type with a rare possibility to be X-linked. Whole genome sequencing of two affected individuals was carried out which revealed 119 novel non-synonymous single nucleotide variations (SNVs) distributed among 117 genes. Out of these only one variation (c.956G>T) located at exon 9 of X-linked EDA gene was considered as pathogenic and validated among all the affected and unaffected family members and unrelated controls. This variation leads to p.Ser319Ile change in the TNF homology domain of EDA (transcript variant 1) protein. In silico analysis predicts that this Ser319 is well conserved across different vertebrate species and a part of putative receptor binding site. Structure based homology modeling predicts that this amino acid residue along with four other amino acid residues nearby, those when mutated known to cause selective tooth agenesis, form a cluster that may have functional significance. Taken together these results suggest that c.956G>T (p.Ser319Ile) mutation plausibly reduces the receptor binding activity of EDA leading to distinct tooth agenesis in this family.	[Sarkar, Tanmoy; Das, Parimal] Banaras Hindu Univ, Fac Sci, Ctr Genet Disorders, Varanasi, Uttar Pradesh, India; [Bansal, Rajesh] Banaras Hindu Univ, Inst Med Sci, Fac Dent Sci, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Das, P (corresponding author), Banaras Hindu Univ, Fac Sci, Ctr Genet Disorders, Varanasi, Uttar Pradesh, India.	parimal@bhu.ac.in			Department of Biotechnology, Govt. Of India [BT/PR12638/MED/12/467/2009]; University Grants Commission, Govt. Of India	Department of Biotechnology, Govt. Of India(Department of Biotechnology (DBT) India); University Grants Commission, Govt. Of India(University Grants Commission, India)	The authors acknowledge the financial support from Department of Biotechnology, Govt. Of India (Grant Number: BT/PR12638/MED/12/467/2009 dated 18/03/2010; http://dbtindia.nic.in/index.asp) for the present work. TS acknowledges the receipt of Senior Research Fellowship from University Grants Commission, Govt. Of India (http://www.ugc.ac.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bala Madhu, 2011, J Oral Maxillofac Pathol, V15, P244, DOI 10.4103/0973-029X.84515; CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659; COHEN MM, 1970, J DENT RES, V49, P1386, DOI 10.1177/00220345700490063901; Das P, 2003, AM J MED GENET A, V118A, P35, DOI 10.1002/ajmg.a.10011; De Coster PJ, 2009, J ORAL PATHOL MED, V38, P1, DOI 10.1111/j.1600-0714.2008.00699.x; Ezer S, 1999, HUM MOL GENET, V8, P2079, DOI 10.1093/hmg/8.11.2079; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Kantaputra P, 2011, AM J MED GENET A, V155A, P1119, DOI 10.1002/ajmg.a.33840; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kowalczyk-Quintas C, 2014, J BIOL CHEM, V289, P4273, DOI 10.1074/jbc.M113.535740; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Lee KE, 2014, J DENT RES, V93, P371, DOI 10.1177/0022034514522059; Li SF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002396; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mendoza-Fandino GA, 2011, CLIN GENET, V80, P265, DOI 10.1111/j.1399-0004.2010.01529.x; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Mues G, 2010, EUR J HUM GENET, V18, P19, DOI 10.1038/ejhg.2009.127; Piccione M, 2012, MINERVA PEDIATR, V64, P59; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; RANTA R, 1983, EUR J ORTHODONT, V5, P145, DOI 10.1093/ejo/5.2.145; RINTALA A, 1984, SCAND J PLAST RECONS, V18, P237, DOI 10.3109/02844318409052844; SILENGO MC, 1982, CLIN GENET, V21, P297; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Suri S, 2011, ANGLE ORTHOD, V81, P260, DOI 10.2319/070910-391.1; Tao R, 2006, J HUM GENET, V51, P498, DOI 10.1007/s10038-006-0389-2; Tarpey P, 2007, AM J MED GENET A, V143A, P390, DOI 10.1002/ajmg.a.31567; TEMPLE IK, 1989, J MED GENET, V26, P119, DOI 10.1136/jmg.26.2.119; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Wang J, 2011, ARCH ORAL BIOL, V56, P1027, DOI 10.1016/j.archoralbio.2011.03.023; Yang Y, 2013, J DENT RES, V92, P500, DOI 10.1177/0022034513487557	37	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106811	10.1371/journal.pone.0106811	http://dx.doi.org/10.1371/journal.pone.0106811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203534	Green Submitted, gold, Green Published			2022-12-27	WOS:000342684500043
J	Stanger, FV; Dehio, C; Schirmer, T				Stanger, Frederic V.; Dehio, Christoph; Schirmer, Tilman			Structure of the N-Terminal Gyrase B Fragment in Complex with ADP center dot P-i Reveals Rigid-Body Motion Induced by ATP Hydrolysis	PLOS ONE			English	Article							DNA; MECHANISM; TOPOISOMERASES; DOMAIN; VALIDATION; ENERGY	Type II DNA topoisomerases are essential enzymes that catalyze topological rearrangement of double-stranded DNA using the free energy generated by ATP hydrolysis. Bacterial DNA gyrase is a prototype of this family and is composed of two subunits (GyrA, GyrB) that form a GyrA(2)GyrB(2) heterotetramer. The N-terminal 43-kDa fragment of GyrB (GyrB43) from E. coli comprising the ATPase and the transducer domains has been studied extensively. The dimeric fragment is competent for ATP hydrolysis and its structure in complex with the substrate analog AMPPNP is known. Here, we have determined the remaining conformational states of the enzyme along the ATP hydrolysis reaction path by solving crystal structures of GyrB43 in complex with ADP.BeF3, ADP center dot P-i, and ADP. Upon hydrolysis, the enzyme undergoes an obligatory 12 degrees domain rearrangement to accommodate the 1.5 angstrom increase in distance between the gamma- and beta-phosphate of the nucleotide within the sealed binding site at the domain interface. Conserved residues from the QTK loop of the transducer domain (also part of the domain interface) couple the small structural change within the binding site with the rigid body motion. The domain reorientation is reflected in a significant 7 angstrom increase in the separation of the two transducer domains of the dimer that would embrace one of the DNA segments in full-length gyrase. The observed conformational change is likely to be relevant for the allosteric coordination of ATP hydrolysis with DNA binding, cleavage/re-ligation and/or strand passage.	[Stanger, Frederic V.; Schirmer, Tilman] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, Basel, Switzerland; [Stanger, Frederic V.; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland	University of Basel; University of Basel	Schirmer, T (corresponding author), Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, Basel, Switzerland.	tilman.schirmer@unibas.ch	Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016	Dehio, Christoph/0000-0001-7288-1052; Dehio, Christoph/0000-0001-7288-1052; Stanger, Frederic/0000-0002-9847-5084	European Research Council (ERC) [340330]; Swiss National Science Foundation [3100-132979, 31003A-138414]	European Research Council (ERC)(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the European Research Council (ERC) Advanced Investigator Grant (ERC-2013-AdG) "FIC-Mediated Post-Translational Modifications at the Pathogen-Host Interface: Elucidating Structure, Function and Role in Infection" (FICModFun) 340330 (to CD) and Swiss National Science Foundation grants 3100-132979 (to CD) and 31003A-138414 (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Bates AD, 2007, BIOCHEMISTRY-US, V46, P7929, DOI 10.1021/bi700789g; Bates AD, 2011, NUCLEIC ACIDS RES, V39, P6327, DOI 10.1093/nar/gkr258; Bendsen S, 2009, BIOCHEMISTRY-US, V48, P6508, DOI 10.1021/bi9005978; Brino L, 2000, J BIOL CHEM, V275, P9468, DOI 10.1074/jbc.275.13.9468; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corbett KD, 2005, STRUCTURE, V13, P873, DOI 10.1016/j.str.2005.03.013; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Corbett KD, 2003, EMBO J, V22, P151, DOI 10.1093/emboj/cdg008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gottler T, 2007, J MOL BIOL, V367, P1392, DOI 10.1016/j.jmb.2007.01.055; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Gubaev A, 2014, DNA REPAIR, V16, P23, DOI 10.1016/j.dnarep.2014.01.011; Gubaev A, 2011, P NATL ACAD SCI USA, V108, P14085, DOI 10.1073/pnas.1102100108; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kotting C, 2006, P NATL ACAD SCI USA, V103, P13911, DOI 10.1073/pnas.0604128103; MAXWELL A, 1984, J BIOL CHEM, V259, P4472; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pasqualato S, 2005, STRUCTURE, V13, P533, DOI 10.1016/j.str.2005.01.014; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sissi C, 2010, CELL MOL LIFE SCI, V67, P2001, DOI 10.1007/s00018-010-0299-5; Smith CV, 1998, BIOCHEMISTRY-US, V37, P9658, DOI 10.1021/bi9801309; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wei H, 2005, J BIOL CHEM, V280, P37041, DOI 10.1074/jbc.M506520200; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x	33	33	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107289	10.1371/journal.pone.0107289	http://dx.doi.org/10.1371/journal.pone.0107289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202966	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000342684500079
J	Sun, QC; Hou, YQ; Tan, QC; Li, GN				Sun, Qiucheng; Hou, Yueqian; Tan, Qingchang; Li, Guannan			A Flexible Calibration Method Using the Planar Target with a Square Pattern for Line Structured Light Vision System	PLOS ONE			English	Article							3-D OBJECT RETRIEVAL; CAMERA CALIBRATION; RECOGNITION	A flexible calibration approach for line structured light vision system is proposed in this paper. Firstly a camera model is established by transforming the points from the 2D image plane to the world coordinate frame, and the intrinsic parameters of camera can be obtained accurately. Then a novel calibration method for structured light projector is presented by moving a planar target with a square pattern randomly, and the method mainly involves three steps: first, a simple linear model is proposed, by which the plane equation of the target at any orientations can be determined based on the square's geometry information; second, the pixel coordinates of the light stripe center on the target images are extracted as the control points; finally, the points are projected into the camera coordinate frame with the help of the intrinsic parameters and the plane equations of the target, and the structured light plane can be determined by fitting these three-dimensional points. The experimental data show that the method has good repeatability and accuracy.	[Sun, Qiucheng] Changchun Normal Univ, Sch Math, Changchun, Peoples R China; [Hou, Yueqian] Changchun Univ, Coll Mech Sci & Engn, Changchun, Peoples R China; [Tan, Qingchang; Li, Guannan] Jilin Univ, Coll Mech Sci & Engn, Changchun 130023, Peoples R China	Changchun Normal University; Changchun University; Jilin University	Sun, QC (corresponding author), Changchun Normal Univ, Sch Math, Changchun, Peoples R China.	sunqiucheng@mail.ccut.edu.cn		sun, qiucheng/0000-0001-9769-3242	National Nature Science Foundation of China [61201084]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work described in this paper is supported by the National Nature Science Foundation of China under Grant 61201084. The role of funder is data collection and analysis.	Chen F, 2000, OPT ENG, V39, P10, DOI 10.1117/1.602438; Dewar R., 1988, P ROB VIS, V1, P5; Duan Fajie, 2000, Chinese Journal of Scientific Instrument, V21, P108; Gao Y, 2014, IEEE T IND ELECTRON, V61, P2088, DOI 10.1109/TIE.2013.2262760; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Gao Y, 2011, IEEE T MULTIMEDIA, V13, P1007, DOI 10.1109/TMM.2011.2160619; Guan T, 2009, IEEE T MULTIMEDIA, V11, P1393, DOI 10.1109/TMM.2009.2032684; Guan T, 2011, IEEE COMPUT GRAPH, V31, P56, DOI 10.1109/MCG.2010.23; Huynh DQ, 1999, INT J COMPUT VISION, V33, P73, DOI 10.1023/A:1008117315311; Jean Y B, PYRAMIDAL IMPLEMENTA; Kim MY, 2014, OPT LASER ENG, V55, P113, DOI 10.1016/j.optlaseng.2013.10.021; Leandry I, 2012, OPT LASER ENG, V50, P373, DOI 10.1016/j.optlaseng.2011.10.020; SOBEL I, 1978, COMPUT VISION GRAPH, V8, P127, DOI 10.1016/S0146-664X(78)80020-3; Steger C, 1998, IEEE T PATTERN ANAL, V20, P113, DOI 10.1109/34.659930; Sun QC, 2014, LASERS ENG UNPUB; TSAI RY, 1987, IEEE T ROBOTIC AUTOM, V3, P323, DOI 10.1109/JRA.1987.1087109; Wei ZZ, 2010, OPT LASER TECHNOL, V42, P570, DOI 10.1016/j.optlastec.2009.10.005; Xie ZX, 2010, MEASUREMENT, V43, P190, DOI 10.1016/j.measurement.2009.09.008; Xu J, 2013, OPT LASER TECHNOL, V48, P187, DOI 10.1016/j.optlastec.2012.09.035; Xu J, 2011, OPT LASER TECHNOL, V43, P1, DOI 10.1016/j.optlastec.2010.04.008; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718; Zhou FQ, 2005, IMAGE VISION COMPUT, V23, P59, DOI 10.1016/j.imavis.2004.07.006; Zhou FQ, 2012, OPT LASER TECHNOL, V44, P1840, DOI 10.1016/j.optlastec.2012.01.023	23	13	13	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106911	10.1371/journal.pone.0106911	http://dx.doi.org/10.1371/journal.pone.0106911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203507	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500055
J	Jonasson, JM; Cederholm, J; Gudbjornsdottir, S				Jonasson, Junmei Miao; Cederholm, Jan; Gudbjornsdottir, Soffia			Excess Body Weight and Cancer Risk in Patients with Type 2 Diabetes Who Were Registered in Swedish National Diabetes Register - Register-Based Cohort Study in Sweden	PLOS ONE			English	Article							BREAST-CANCER; COLORECTAL-CANCER; MASS INDEX; OBESITY; SIZE; MALIGNANCIES; ADIPONECTIN; MORTALITY; INSULIN; WOMEN	Aim: To assess the association between excess body weight and cancer risk in patients with type 2 diabetes (T2D) who were registered in the Swedish National Diabetes Register (NDR). Methods: This is a cohort study based on 25,268 patients with T2D and baseline BMI >= 18.5 kg/m(2) from NDR 1997-1999. Subjects were grouped according to BMI into normal weight (18.5 to 24.9), overweight (25 to 29.9) or obesity (30 or more). All subjects were followed until the first occurrence of cancer, or death, or the end of follow-up (December 31, 2009). Adjusted hazard ratios (HRs) and 95% confidence interval (CI) for cancer risks were estimated by Cox regression. Results: In men with T2D, overweight was associated with increased risks of all cancer [1.13 (1.02-1.27)], gastrointestinal cancer [1.34 (1.07-1.72)] and colorectal cancer [1.59 (1.18-2.13)]; obesity was related to higher risks of all cancer [1.17 (1.04-1.33)], gastrointestinal cancer [1.40 (1.08-1.82)] and colorectal cancer [1.62 (1.17-2.24)]. In women with T2D, obesity was associated with increased risk of all cancer [1.30 (1.12-1.51)], gastrointestinal cancer [1.40 (1.03-1.91)] and postmenopausal breast cancer [1.39 (1.00-1.91)]. Conclusions: Excess body weight was associated with increased risks of all cancer, gastrointestinal cancer and colorectal cancer in men with T2D. Obesity was related with elevated risks of all cancer, gestational cancer and postmenopausal breast cancer in women with T2D.	[Jonasson, Junmei Miao] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Jonasson, Junmei Miao] Nord Sch Publ Hlth NHV, Gothenburg, Sweden; [Cederholm, Jan] Uppsala Univ, Dept Publ Hlth & Caring Sci Family Med & Prevent, Uppsala, Sweden; [Gudbjornsdottir, Soffia] VGR, Registerctr, Gothenburg, Sweden; [Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Acad, Dept Med, Gothenburg, Sweden	University of Gothenburg; Uppsala University; University of Gothenburg	Jonasson, JM (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Gothenburg, Sweden.	junmei.jonasson@gu.se		Miao Jonasson, Junmei/0000-0003-0206-8538	Swedish Association of Local Authorities and Regions; Swedish Society of Medicine; VIMMER; VINNOVA; AGFOND; Lion Cancer foundation West	Swedish Association of Local Authorities and Regions; Swedish Society of Medicine; VIMMER; VINNOVA(Vinnova); AGFOND; Lion Cancer foundation West	This study was supported by The Swedish Association of Local Authorities and Regions, the Swedish Society of Medicine (JMJ, SG), and also VIMMER, VINNOVA, AGFOND and Lion Cancer foundation West (JMJ). Funding for the study had no influence on the study design, execution and publication of results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SO, 1997, JNCI-J NATL CANCER I, V89, P385, DOI 10.1093/jnci/89.5.385; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Carmichael AR, 2006, BJOG-INT J OBSTET GY, V113, P1160, DOI 10.1111/j.1471-0528.2006.01021.x; Cleveland RJ, 2012, CANCER CAUSE CONTROL, V23, P1193, DOI 10.1007/s10552-012-9989-7; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Hankinson Susan E, 2005, Breast Dis, V24, P3; Hense HW, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-15; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Jonasson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038784; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; KEY TJA, 1988, EUR J CANCER CLIN ON, V24, P29, DOI 10.1016/0277-5379(88)90173-3; MacInnis RJ, 2004, CANCER EPIDEM BIOMAR, V13, P553; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Schoen RE, 1999, JNCI-J NATL CANCER I, V91, P1147, DOI 10.1093/jnci/91.13.1147; Simard J, 2001, MOL CELL ENDOCRINOL, V171, P25, DOI 10.1016/S0303-7207(00)00387-7; Terry P, 2001, BRIT J CANCER, V85, P346, DOI 10.1054/bjoc.2001.1894; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664	20	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e105868	10.1371/journal.pone.0105868	http://dx.doi.org/10.1371/journal.pone.0105868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198347	gold, Green Submitted, Green Published			2022-12-27	WOS:000341304700019
J	Cook, SA; Salmon, P; Dunn, G; Fisher, P				Cook, Sharon A.; Salmon, Peter; Dunn, Graham; Fisher, Peter			Measuring Metacognition in Cancer: Validation of the Metacognitions Questionnaire 30 (MCQ-30)	PLOS ONE			English	Article							COVARIANCE STRUCTURE-ANALYSIS; STATE WORRY QUESTIONNAIRE; HOSPITAL ANXIETY; DEPRESSION SCALE; DISTRESS; DISEASE; STYLE; MODEL	Objective: The Metacognitions Questionnaire 30 assesses metacognitive beliefs and processes which are central to the metacognitive model of emotional disorder. As recent studies have begun to explore the utility of this model for understanding emotional distress after cancer diagnosis, it is important also to assess the validity of the Metacognitions Questionnaire 30 for use in cancer populations. Methods: 229 patients with primary breast or prostate cancer completed the Metacognitions Questionnaire 30 and the Hospital Anxiety and Depression Scale pre-treatment and again 12 months later. The structure and validity of the Metacognitions Questionnaire 30 were assessed using factor analyses and structural equation modelling. Results: Confirmatory and exploratory factor analyses provided evidence supporting the validity of the previously published 5-factor structure of the Metacognitions Questionnaire 30. Specifically, both pre-treatment and 12 months later, this solution provided the best fit to the data and all items loaded on their expected factors. Structural equation modelling indicated that two dimensions of metacognition (positive and negative beliefs about worry) were significantly associated with anxiety and depression as predicted, providing further evidence of validity. Conclusions: These findings provide initial evidence that the Metacognitions Questionnaire 30 is a valid measure for use in cancer populations.	[Cook, Sharon A.; Salmon, Peter; Fisher, Peter] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Cook, Sharon A.; Salmon, Peter] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England; [Dunn, Graham] Univ Manchester, Manchester, Lancs, England	University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Manchester	Cook, SA (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	sacook@liv.ac.uk	Salmon, Peter/H-5289-2018; Fisher, Peter/T-4121-2019	Salmon, Peter/0000-0001-6450-5209; Fisher, Peter/0000-0002-7388-720X	Medical Research Council [G0802425]; MRC [G0802425] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was conducted as part of a Population Health Scientist Fellowship (Ref G0802425) funded by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allott R, 2005, BRIT J PSYCHIAT, V187, P182, DOI 10.1192/bjp.187.2.182; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Browne MW, 1993, SAGE FOCUS EDITIONS, V154, P136, DOI DOI 10.1080/10705511.2012.687671; CartwrightHatton S, 1997, J ANXIETY DISORD, V11, P279, DOI 10.1016/S0887-6185(97)00011-X; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; MACCALLUM RC, 1992, PSYCHOL BULL, V111, P490, DOI 10.1037/0033-2909.111.3.490; McNicol K, 2013, CLIN CASE STUD, V12, P22, DOI 10.1177/1534650112461298; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; MOOREY S, 1991, BRIT J PSYCHIAT, V158, P255, DOI 10.1192/bjp.158.2.255; MUTHEN B, 1984, PSYCHOMETRIKA, V49, P115, DOI 10.1007/BF02294210; Muthen B., 2010, MPLUS USERS GUIDE; Muthen B, 1997, TECHNICAL REPORT; Normann N, 2014, DEPRESS ANXIETY, V31, P402, DOI 10.1002/da.22273; Spada MM, 2008, PERS INDIV DIFFER, V45, P238, DOI 10.1016/j.paid.2008.04.005; Spielberger C, 1983, MANUAL STAIT TRAIT A; Thewes B, 2013, PSYCHO-ONCOLOGY, V22, P2059, DOI 10.1002/pon.3252; Vodermaier A, 2011, SUPPORT CARE CANCER, V19, P1899, DOI 10.1007/s00520-011-1251-4; Wells A, 2004, BEHAV RES THER, V42, P385, DOI 10.1016/S0005-7967(03)00147-5; WELLS A, 1994, BEHAV RES THER, V32, P867, DOI 10.1016/0005-7967(94)90167-8; Wells A., 2000, EMOTIONAL DISORDERS, DOI DOI 10.1017/S0033291702225702; Wells A., 1994, ATTENTION EMOTION CL; Wells A, 2009, METACOGNTIVE THERAPY; Yilmaz AE, 2008, CLIN PSYCHOL PSYCHOT, V15, P424, DOI 10.1002/cpp.589; Yu C.Y., 2002, EVALUATING CUTOFF CR; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	25	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107302	10.1371/journal.pone.0107302	http://dx.doi.org/10.1371/journal.pone.0107302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP0SM	25215527	Green Published, gold, Green Accepted			2022-12-27	WOS:000341774300055
J	Bakal, JA; McAlister, FA; Liu, W; Ezekowitz, JA				Bakal, Jeffrey A.; McAlister, Finlay A.; Liu, Wei; Ezekowitz, Justin A.			Heart Failure Re-Admission: Measuring the Ever Shortening Gap between Repeat Heart Failure Hospitalizations	PLOS ONE			English	Article							COMORBIDITIES; READMISSION; DIAGNOSIS; OUTCOMES	Many quality-of-care and risk prediction metrics rely on time to first rehospitalization even though heart failure (HF) patients may undergo several repeat hospitalizations. The aim of this study is to compare repeat hospitalization models. Using a population-based cohort of 40,667 patients, we examined both HF and all cause re-hospitalizations using up to five years of follow-up. Two models were examined: the gap-time model which estimates the adjusted time between hospitalizations and a multistate model which considered patients to be in one of four states; community-dwelling, in hospital for HF, in hospital for any reason, or dead. The transition probabilities and times were then modeled using patient characteristics and number of repeat hospitalizations. We found that during the five years of follow-up roughly half of the patients returned for a subsequent hospitalization for each repeat hospitalization. Additionally, we noted that the unadjusted time between hospitalizations was reduced similar to 40% between each successive hospitalization. After adjustment each additional hospitalization was associated with a 28 day (95% CI: 22-35) reduction in time spent out of hospital. A similar pattern was seen when considering the four state model. A large proportion of patients had multiple repeat hospitalizations. Extending the gap between hospitalizations should be an important goal of treatment evaluation.	[Bakal, Jeffrey A.; McAlister, Finlay A.] Univ Alberta, Patient Hlth Outcomes Res & Clin Effectiveness Un, Edmonton, AB, Canada; [Bakal, Jeffrey A.; McAlister, Finlay A.] Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada; [Liu, Wei; Ezekowitz, Justin A.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Ezekowitz, JA (corresponding author), Univ Alberta, Div Cardiol, Edmonton, AB, Canada.	jae2@ualberta.ca	Bakal, Jeff/ABE-4051-2021; Ezekowitz, Justin A/C-4579-2013; McAlister, Finlay/C-4151-2013	Ezekowitz, Justin A/0000-0002-2724-4086; McAlister, Finlay/0000-0001-7435-3341; Bakal, Jeffrey/0000-0002-3658-2554				Anker SD, 2012, EUR HEART J, V33, P2764, DOI 10.1093/eurheartj/ehs277; Au AG, 2012, AM HEART J, V164, P365, DOI 10.1016/j.ahj.2012.06.010; Claggett B, 2013, EUR HEART J, V34, P869, DOI 10.1093/eurheartj/ehs485; Clement DY, 2009, BIOSTATISTICS, V10, P451, DOI 10.1093/biostatistics/kxp004; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019; Ezekowitz JA, 2011, EUR J HEART FAIL, V13, P142, DOI 10.1093/eurjhf/hfq185; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff DC, 2000, ARCH INTERN MED, V160, P197, DOI 10.1001/archinte.160.2.197; Hardin J, 2003, GEN ESTIMATING EQUAT, V68, P373; Jackson CH, 2011, J STAT SOFTW, V38, P1; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kelly PJ, 2000, STAT MED, V19, P13, DOI 10.1002/(SICI)1097-0258(20000115)19:1&lt;13::AID-SIM279&gt;3.0.CO;2-5; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; McAlister FA, 2013, CIRC-HEART FAIL, V6, P76, DOI 10.1161/CIRCHEARTFAILURE.112.971119; O'Connor C M, 2011, N Engl J Med, V365, P32, DOI 10.1056/NEJMoa1100171; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117	20	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106494	10.1371/journal.pone.0106494	http://dx.doi.org/10.1371/journal.pone.0106494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211034	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900013
J	Ka, MB; Gondois-Rey, F; Capo, C; Textoris, J; Million, M; Raoult, D; Olive, D; Mege, JL				Ka, Mignane B.; Gondois-Rey, Francoise; Capo, Christian; Textoris, Julien; Million, Mathieu; Raoult, Didier; Olive, Daniel; Mege, Jean-Louis			Imbalance of Circulating Monocyte Subsets and PD-1 Dysregulation in Q Fever Endocarditis: The Role of IL-10 in PD-1 Modulation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL-ACTIVATION; COXIELLA-BURNETII; PERIPHERAL-BLOOD; NATURAL-HISTORY; INTERLEUKIN-10; INFECTION; PROGRESSION; IMPAIRMENT; EXPRESSION	Q fever endocarditis, a severe complication of Q fever, is associated with a defective immune response, the mechanisms of which are poorly understood. We hypothesized that Q fever immune deficiency is related to altered distribution and activation of circulating monocyte subsets. Monocyte subsets were analyzed by flow cytometry in peripheral blood mononuclear cells from patients with Q fever endocarditis and controls. The proportion of classical monocytes (CD14(+)CD16(-) monocytes) was similar in patients and controls. In contrast, the patients with Q fever endocarditis exhibited a decrease in the non-classical and intermediate subsets of monocytes (CD16(+) monocytes). The altered distribution of monocyte subsets in Q fever endocarditis was associated with changes in their activation profile. Indeed, the expression of HLA-DR, a canonical activation molecule, and PD-1, a co-inhibitory molecule, was increased in intermediate monocytes. This profile was not restricted to CD16(+) monocytes because CD4(+) T cells also overexpressed PD-1. The mechanism leading to the overexpression of PD-1 did not require the LPS from C. burnetii but involved interleukin-10, an immunosuppressive cytokine. Indeed, the incubation of control monocytes with interleukin-10 led to a higher expression of PD-1 and neutralizing interleukin-10 prevented C. burnetii-stimulated PD-1 expression. Taken together, these results show that the immune suppression of Q fever endocarditis involves a cross-talk between monocytes and CD4(+) T cells expressing PD-1. The expression of PD-1 may be useful to assess chronic immune alterations in Q fever endocarditis.	[Ka, Mignane B.; Capo, Christian; Textoris, Julien; Million, Mathieu; Raoult, Didier; Mege, Jean-Louis] Aix Marseille Univ, Unite Rech Malad Infect Trop & Emergentes, UMR 63, CNRS 7278,IRD 198,INSERM U1095, Marseille, France; [Ka, Mignane B.; Gondois-Rey, Francoise; Olive, Daniel] Ctr Rech Cancerol Marseille, Inserm UMR 1068, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Mege, JL (corresponding author), Aix Marseille Univ, Unite Rech Malad Infect Trop & Emergentes, UMR 63, CNRS 7278,IRD 198,INSERM U1095, Marseille, France.	jean-louis.mege@univ-amu.fr	Million, Matthieu/F-7693-2011; RAOULT, Didier/A-8434-2008; Textoris, Julien/H-3317-2019; MEGE, JEAN-LOUIS/O-6063-2016	Million, Matthieu/0000-0002-5556-6947; RAOULT, Didier/0000-0002-0633-5974; Textoris, Julien/0000-0002-3821-9337; 				Azeredo EL, 2010, IMMUNOLOGY, V130, P202, DOI 10.1111/j.1365-2567.2009.03224.x; Barry AO, 2012, CELL HOST MICROBE, V12, P751, DOI 10.1016/j.chom.2012.10.015; Ben Amara A, 2012, ADV EXP MED BIOL, V984, P287, DOI 10.1007/978-94-007-4315-1_15; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Benoit M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008939; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Capo C, 1999, CLIN EXP IMMUNOL, V115, P120; Capo C, 1999, J IMMUNOL, V163, P6078; Capo C, 2012, ADV EXP MED BIOL, V984, P273, DOI 10.1007/978-94-007-4315-1_14; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Fenollar F, 2001, CLIN INFECT DIS, V33, P1309, DOI 10.1086/322666; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Gondois-Rey F, 2012, CYTOM PART A, V81A, P332, DOI 10.1002/cyto.a.22016; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Honstettre AL, 2003, J INFECT DIS, V187, P956, DOI 10.1086/368129; Houpikian P, 2005, MEDICINE, V84, P162, DOI 10.1097/01.md.0000165658.82869.17; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Layez C, 2012, FEMS IMMUNOL MED MIC, V64, P137, DOI 10.1111/j.1574-695X.2011.00902.x; Lepidi H, 2003, J INFECT DIS, V187, P1097, DOI 10.1086/368219; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Meghari S, 2006, EUR CYTOKINE NETW, V17, P253; Meghari S, 2006, J INFECT DIS, V194, P365, DOI 10.1086/505227; Million M, 2013, CLIN INFECT DIS, V57, P57, DOI 10.1093/cid/cit191; Narasaki CT, 2012, ADV EXP MED BIOL, V984, P65, DOI 10.1007/978-94-007-4315-1_4; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Raoult D, 2012, J INFECTION, V65, P102, DOI 10.1016/j.jinf.2012.04.006; Rigopoulou EI, 2005, CLIN IMMUNOL, V117, P57, DOI 10.1016/j.clim.2005.06.003; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; SAWYER LA, 1987, REV INFECT DIS, V9, P935; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Thuny F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031490; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	39	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107533	10.1371/journal.pone.0107533	http://dx.doi.org/10.1371/journal.pone.0107533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211350	gold, Green Submitted, Green Published			2022-12-27	WOS:000341855900080
J	Li, MZ; Deng, L; Wang, JJ; Xiao, LB; Wu, WH; Yang, SB; Li, WF				Li, Ming-zhe; Deng, Liang; Wang, Jing-jing; Xiao, Long-bin; Wu, Wen-hui; Yang, Shi-bin; Li, Wen-feng			Surgical Outcomes and Prognostic Factors of T4 Gastric Cancer Patients without Distant Metastasis	PLOS ONE			English	Article							RISK-FACTORS; PHASE-II; CHEMOTHERAPY; GASTRECTOMY; CISPLATIN; RESECTION; S-1	Objective: To evaluate surgical outcomes and prognostic factors for T4 gastric cancer treated with curative resection. Methods: Between January 1994 and December 2008, 94 patients diagnosed with histological T4 gastric carcinoma and treated with curative resection were recruited. Patient characteristics, surgical complications, survival, and prognostic factors were analyzed. Results: Postoperative morbidity and mortality were 18.1% and 2.1%, respectively. Multivariate analysis indicated lymph node metastasis (hazard ratio, 2.496; 95% confidence interval, 1.218-5.115; p = 0.012) was independent prognostic factor. Conclusions: For patients with T4 gastric cancer, lymph node metastasis was associated with poorer survival. Neoadjuvant chemotherapy or aggressive adjuvant chemotherapy after radical resection was strongly recommended for these patients.	[Li, Ming-zhe; Xiao, Long-bin; Wu, Wen-hui; Yang, Shi-bin; Li, Wen-feng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Liang] Sun Yat Sen Univ, Affiliated Hosp 1, Eastern Hosp, Dept Gen Surg 1, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Jing-jing] Hexian Memory Hosp Panyu Dist, Dept Lab, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xiao, LB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China.	xlb6204@126.com	wang, jing/GRS-7509-2022; Deng, Liang/GXH-6710-2022; WANG, JINGYI/GSJ-1241-2022					Aizawa M, 2011, WORLD J SURG, V35, P2717, DOI 10.1007/s00268-011-1269-2; BarNatan M, 1996, AM J SURG, V172, P24, DOI 10.1016/S0002-9610(96)00048-7; Brar SS, 2012, GASTRIC CANCER, V15, pS100, DOI 10.1007/s10120-011-0074-9; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; D'Amato A, 2004, HEPATO-GASTROENTEROL, V51, P609; Dikken JL, 2010, J CLIN ONCOL, V28, P2430, DOI 10.1200/JCO.2009.26.9654; Fukuda N, 2011, WORLD J GASTROENTERO, V17, P1180, DOI 10.3748/wjg.v17.i9.1180; Hirakawa M, 2013, CANCER CHEMOTH PHARM, V71, P789, DOI 10.1007/s00280-013-2073-5; Jeong O, 2009, J SURG ONCOL, V100, P115, DOI 10.1002/jso.21306; Kim JH, 2009, ASIAN J SURG, V32, P198, DOI 10.1016/S1015-9584(09)60395-X; Kim KH, 2012, J KOREAN SURG SOC, V83, P274, DOI 10.4174/jkss.2012.83.5.274; Kunisaki C, 2006, J AM COLL SURGEONS, V202, P223, DOI 10.1016/j.jamcollsurg.2005.10.020; Lordick Florian, 2005, Gastric Cancer, V8, P78, DOI 10.1007/s10120-005-0321-z; Martin RCG, 2002, J AM COLL SURGEONS, V194, P568, DOI 10.1016/S1072-7515(02)01116-X; Meng HB, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-144; Mita K, 2012, AM J SURG, V203, P107, DOI 10.1016/j.amjsurg.2010.12.007; Onate-Ocana LF, 2008, J SURG ONCOL, V98, P336, DOI 10.1002/jso.21118; Ozer I, 2009, AM J SURG, V198, P25, DOI 10.1016/j.amjsurg.2008.06.031; Persiani R, 2008, J AM COLL SURGEONS, V207, P13, DOI 10.1016/j.jamcollsurg.2007.12.050; Shiraishi N, 2007, J SURG ONCOL, V96, P14, DOI 10.1002/jso.20631; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Yoshikawa T, 2010, EJSO-EUR J SURG ONC, V36, P546, DOI 10.1016/j.ejso.2010.04.011	23	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107061	10.1371/journal.pone.0107061	http://dx.doi.org/10.1371/journal.pone.0107061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211331	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900040
J	Ochieng, JK; Schilders, K; Kool, H; Buscop-van Kempen, M; Boerema-De Munck, A; Grosveld, F; Wijnen, R; Tibboel, D; Rottier, RJ				Ochieng, Joshua Kapere; Schilders, Kim; Kool, Heleen; Buscop-van Kempen, Marjon; Boerema-De Munck, Anne; Grosveld, Frank; Wijnen, Rene; Tibboel, Dick; Rottier, Robbert J.			Differentiated Type II Pneumocytes Can Be Reprogrammed by Ectopic Sox2 Expression	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ANTERIOR FOREGUT ENDODERM; IN-VIVO; DIRECT CONVERSION; RESPIRATORY EPITHELIUM; FUNCTIONAL-NEURONS; HUMAN FIBROBLASTS; DEFINED FACTORS; INTESTINAL EPITHELIUM; LINEAGE CONVERSION	The adult lung contains several distinct stem cells, although their properties and full potential are still being sorted out. We previously showed that ectopic Sox2 expression in the developing lung manipulated the fate of differentiating cells. Here, we addressed the question whether fully differentiated cells could be redirected towards another cell type. Therefore, we used transgenic mice to express an inducible Sox2 construct in type II pneumocytes, which are situated in the distal, respiratory areas of the lung. Within three days after the induction of the transgene, the type II cells start to proliferate and form clusters of cuboidal cells. Prolonged Sox2 expression resulted in the reversal of the type II cell towards a more embryonic, precursor-like cell, being positive for the stem cell markers Sca1 and Ssea1. Moreover, the cells started to coexpress Spc and Cc10, characteristics of bronchioalveolar stem cells. We demonstrated that Sox2 directly regulates the expression of Sca1. Subsequently, these cells expressed Trp63, a marker for basal cells of the trachea. So, we show that the expression of one transcription factor in fully differentiated, distal lung cells changes their fate towards proximal cells through intermediate cell types. This may have implications for regenerative medicine, and repair of diseased and damaged lungs.	[Ochieng, Joshua Kapere; Schilders, Kim; Kool, Heleen; Buscop-van Kempen, Marjon; Boerema-De Munck, Anne; Wijnen, Rene; Tibboel, Dick; Rottier, Robbert J.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands; [Grosveld, Frank; Rottier, Robbert J.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Rottier, RJ (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands.	r.rottier@erasmusmc.nl	Wijnen, R.M.H./L-4758-2015	Kapere Ochieng, Joshua/0000-0001-5082-3353; Rottier, Robbert/0000-0002-9291-4971	Sophia Foundation for Medical research, SSWO [585]	Sophia Foundation for Medical research, SSWO	This work was supported by the Sophia Foundation for Medical research, SSWO, project nr 585. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen HY, 2012, STEM CELLS, V30, P1948, DOI 10.1002/stem.1150; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Cox JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015486; Driscoll Barbara, 2012, Methods Mol Biol, V879, P109, DOI 10.1007/978-1-61779-815-3_7; Ghosh M, 2011, AM J RESP CELL MOL, V45, P403, DOI 10.1165/rcmb.2010-0283OC; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Huang YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057695; Huang YD, 2012, AM J RESP CELL MOL, V46, P224, DOI 10.1165/rcmb.2011-0024OC; Ji SY, 2013, J CELL BIOCHEM, V114, P256, DOI 10.1002/jcb.24380; Kauffman S L, 1980, Int Rev Exp Pathol, V22, P131; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543; Lange AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005711; Lensch MW, 2013, STEM CELL REP, V1, P5, DOI 10.1016/j.stemcr.2013.05.001; Liu Y, 2013, LEUKEMIA; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; McQualter JL, 2012, STEM CELLS, V30, P811, DOI 10.1002/stem.1055; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Nemajerova A, 2012, CELL DEATH DIFFER, V19, P1268, DOI 10.1038/cdd.2012.45; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Ochieng JK, 2014, AM J RESP CELL MOL B; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rackley CR, 2012, J CLIN INVEST, V122, P2724, DOI 10.1172/JCI60519; Raghoebir L, 2012, J MOL CELL BIOL, V4, P377, DOI 10.1093/jmcb/mjs030; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds Susan D, 2012, Proc Am Thorac Soc, V9, P27, DOI 10.1513/pats.201201-008MS; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rippon HJ, 2006, STEM CELLS, V24, P1389, DOI 10.1634/stemcells.2005-0465; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Sancho-Martinez I, 2012, NAT CELL BIOL, V14, P892, DOI 10.1038/ncb2567; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Van Haute L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-105; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Wansleeben C, 2013, WIRES DEV BIOL, V2, P131, DOI 10.1002/wdev.58; Weiss D.J., 2013, STEM CELLS; Weiss Daniel J, 2011, Proc Am Thorac Soc, V8, P223, DOI 10.1513/pats.201012-071DW; Wu T, 2011, STEM CELLS, V29, P755, DOI 10.1002/stem.617; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Zheng D, 2013, AM J RESP CELL MOL B; Zheng DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071028; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	75	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107248	10.1371/journal.pone.0107248	http://dx.doi.org/10.1371/journal.pone.0107248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210856	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900052
J	Shamsi, BH; Ma, CF; Naqvi, S; Xiao, YF				Shamsi, Bilal Haider; Ma, Chaofeng; Naqvi, Saima; Xiao, Yanfeng			Effects of Pioglitazone Mediated Activation of PPAR-gamma on CIDEC and Obesity Related Changes in Mice	PLOS ONE			English	Article							DIET-INDUCED OBESITY; INSULIN-RESISTANCE; ADIPOCYTE DIFFERENTIATION; CARDIOVASCULAR-DISEASE; LIPID DROPLETS; ADIPOSE-TISSUE; VISCERAL FAT; METABOLISM; MECHANISMS; SENSITIVITY	Objective: Obesity is a metabolic disorder that can lead to high blood pressure, increased blood cholesterol and triglycerides, insulin resistance, and diabetes mellitus. The aim was to study the effects of pioglitazone mediated sensitization of peroxisome proliferator-activated receptor gamma (PPAR-gamma) on the relationship of Cell death-inducing DFFA-like effector C (CIDEC) with obesity related changes in mice. Methods: Sixty C57B/L6 mice weighing 10-12g at 3 weeks of age were randomly divided into 3 groups. Mice in Group 1 were fed on normal diet (ND) while Group 2 mice were given high fat diet (HFD), and Group 3 mice were given high fat diet and treated with Pioglitazone (HFD+P). Body weight, length and level of blood sugar were measured weekly. Quantitative real-time PCR, fluorescence microscopy, and ELISA were performed to analyze the expression of CIDEC and PPAR-gamma in visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT). Results: Body weight and length of mice increased gradually with time in all groups. Blood sugar in HFD mice started to increase significantly from the mid of late phase of obesity while pioglitazone attenuated blood sugar level in HFD+P mice. The mRNA expressions and protein levels of PPAR-gamma and CIDEC genes started to increase in HFD mice as compared to ND mice and decreased gradually during the late phase of obesity in VAT. Pioglitazone enhanced the expression of PPAR-gamma and CIDEC genes in HFD+P mice even during the late phase of obesity. Conclusion: It is insinuated that VAT is associated with late phase obesity CIDEC decrease and insulin resistance, while pioglitazone enhances CIDEC through activation of PPAR-gamma, increases its expression, and decreases lipolysis, hence preventing an increase of blood sugar in mice exposed to HFD.	[Shamsi, Bilal Haider; Xiao, Yanfeng] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Pediat, Xian 710049, Shaanxi Provinc, Peoples R China; [Ma, Chaofeng] Ctr Dis Control & Prevent CDC, Dept Pathol, Xian, Shaanxi Provinc, Peoples R China; [Naqvi, Saima] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Endocrinol, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Xiao, YF (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Pediat, Xian 710049, Shaanxi Provinc, Peoples R China.	xiaoyanfeng.xjtu@gmail.com			National Natural Science Foundation of China [81172689]; Xi'an Jiaotong University YJ (ZDJH) [201303(3)]; Higher Education Commission (HEC) Pakistan; Shaanxi Province International Co-operational Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xi'an Jiaotong University YJ (ZDJH); Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan); Shaanxi Province International Co-operational Foundation of China	The project was supported by the National Natural Science Foundation of China (81172689), The Major Research Funding Schemes of 2nd Affiliated Hospital of Xi'an Jiaotong University YJ (ZDJH) 201303(3), Higher Education Commission (HEC) Pakistan, and the Shaanxi Province International Co-operational Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chen L, 2006, J BIOL CHEM, V281, P24575, DOI 10.1074/jbc.M604147200; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Felber JP, 2002, INT J OBESITY, V26, pS39, DOI 10.1038/sj.ijo.0802126; Flach RJR, 2011, J BIOL CHEM, V286, P22195, DOI 10.1074/jbc.M110.210237; Gerhold DL, 2002, ENDOCRINOLOGY, V143, P2106, DOI 10.1210/en.143.6.2106; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; JEANRENAUD B, 1979, DIABETOLOGIA, V17, P133, DOI 10.1007/BF01219738; Kageyama H, 2003, BIOCHEM BIOPH RES CO, V305, P22, DOI 10.1016/S0006-291X(03)00663-6; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim YJ, 2008, BIOCHEM BIOPH RES CO, V377, P297, DOI 10.1016/j.bbrc.2008.09.129; Masternak MM, 2012, AGING CELL, V11, P73, DOI 10.1111/j.1474-9726.2011.00763.x; Menon V, 2014, AGING CELL, V13, P497, DOI 10.1111/acel.12201; Moreno-Navarrete JM, 2014, INT J OBESITY, V38, P865, DOI 10.1038/ijo.2013.171; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Rogue A, 2010, GENE EXPRESSION CHAN; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Tanabe Y, 2004, J CELL SCI, V117, P3605, DOI 10.1242/jcs.01207; Traini M, 2009, CURR OPIN LIPIDOL, V20, P147, DOI 10.1097/MOL.0b013e32832956c7; Tseng YH, 2002, J BIOL CHEM, V277, P31601, DOI 10.1074/jbc.M202932200; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	35	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106992	10.1371/journal.pone.0106992	http://dx.doi.org/10.1371/journal.pone.0106992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210844	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900036
J	Ilmberger, N; Gullert, S; Dannenberg, J; Rabausch, U; Torres, J; Wemheuer, B; Alawi, M; Poehlein, A; Chow, J; Turaev, D; Rattei, T; Schmeisser, C; Salomon, J; Olsen, PB; Daniel, R; Grundhoff, A; Borchert, MS; Streit, WR				Ilmberger, Nele; Guellert, Simon; Dannenberg, Joana; Rabausch, Ulrich; Torres, Jeremy; Wemheuer, Bernd; Alawi, Malik; Poehlein, Anja; Chow, Jennifer; Turaev, Dimitrij; Rattei, Thomas; Schmeisser, Christel; Salomon, Jesper; Olsen, Peter B.; Daniel, Rolf; Grundhoff, Adam; Borchert, Martin S.; Streit, Wolfgang R.			A Comparative Metagenome Survey of the Fecal Microbiota of a Breast- and a Plant-Fed Asian Elephant Reveals an Unexpectedly High Diversity of Glycoside Hydrolase Family Enzymes	PLOS ONE			English	Article							POLYSACCHARIDE UTILIZATION; FUNCTIONAL-CAPACITY; BUBALUS-BUBALIS; GUT BACTERIA; DATABASE; RUMEN; PROTEINS; MAMMALS; GENOMES; GENES	A phylogenetic and metagenomic study of elephant feces samples (derived from a three-weeks-old and a six-years-old Asian elephant) was conducted in order to describe the microbiota inhabiting this large land-living animal. The microbial diversity was examined via 16S rRNA gene analysis. We generated more than 44,000 GS-FLX+454 reads for each animal. For the baby elephant, 380 operational taxonomic units (OTUs) were identified at 97% sequence identity level; in the six-years-old animal, close to 3,000 OTUs were identified, suggesting high microbial diversity in the older animal. In both animals most OTUs belonged to Bacteroidetes and Firmicutes. Additionally, for the baby elephant a high number of Proteobacteria was detected. A metagenomic sequencing approach using Illumina technology resulted in the generation of 1.1 Gbp assembled DNA in contigs with a maximum size of 0.6 Mbp. A KEGG pathway analysis suggested high metabolic diversity regarding the use of polymers and aromatic and non-aromatic compounds. In line with the high phylogenetic diversity, a surprising and not previously described biodiversity of glycoside hydrolase (GH) genes was found. Enzymes of 84 GH families were detected. Polysaccharide utilization loci (PULs), which are found in Bacteroidetes, were highly abundant in the dataset; some of these comprised cellulase genes. Furthermore the highest coverage for GH5 and GH9 family enzymes was detected for Bacteroidetes, suggesting that bacteria of this phylum are mainly responsible for the degradation of cellulose in the Asian elephant. Altogether, this study delivers insight into the biomass conversion by one of the largest plant-fed and land-living animals.	[Ilmberger, Nele; Guellert, Simon; Dannenberg, Joana; Rabausch, Ulrich; Torres, Jeremy; Chow, Jennifer; Schmeisser, Christel; Streit, Wolfgang R.] Univ Hamburg, Biozentrum Klein Flottbek, Abt Mikrobiol & Biotechnol, Hamburg, Germany; [Wemheuer, Bernd; Poehlein, Anja] Univ Gottingen, Inst Microbiol & Genet, D-37073 Gottingen, Germany; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, Hamburg, Germany; [Turaev, Dimitrij; Rattei, Thomas] Univ Vienna, CUBE Div Computat Syst Biol, Dept Microbiol & Ecosyst Sci, Vienna, Austria; [Salomon, Jesper; Olsen, Peter B.; Borchert, Martin S.] Novozymes AS, Microbial Discovery, Bagsvaerd, Denmark; [Grundhoff, Adam] Heinrich Pette Inst, Leibniz Inst Expt Virol, Hamburg, Germany	University of Hamburg; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Vienna; Novozymes; Heinrich Pette Institute	Streit, WR (corresponding author), Univ Hamburg, Biozentrum Klein Flottbek, Abt Mikrobiol & Biotechnol, Hamburg, Germany.	wolfgang.streit@uni-hamburg.de	Daniel, Rolf/AAQ-5933-2021; , Malik/AAB-7437-2021; Streit, Wolfgang R/K-1366-2012; Streit, Wolfgang/S-3049-2019; Rattei, Thomas/F-1366-2011	Daniel, Rolf/0000-0002-8646-7925; , Malik/0000-0002-5993-7709; Streit, Wolfgang/0000-0001-7617-7396; Rattei, Thomas/0000-0002-0592-7791; Chow, Jennifer/0000-0002-7499-5325; Poehlein, Anja/0000-0002-2473-6202; Grundhoff, Adam/0000-0003-0940-7045	ministry of education and research "Bundesministerium fur Bildung und Forschung'' (BMBF) [FKZ 0315586F]; German Academic Exchange program (DAAD)	ministry of education and research "Bundesministerium fur Bildung und Forschung'' (BMBF); German Academic Exchange program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was in part funded by the ministry of education and research "Bundesministerium fur Bildung und Forschung'' (BMBF; http://www.bmbf.de/) within the network program ExpresSys and the grant FKZ 0315586F to WRS. JT was funded by the German Academic Exchange program (DAAD; https://www.daad.de/de/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051521; Bayane A, 2011, REV ENVIRON SCI BIO, V10, P43, DOI 10.1007/s11157-010-9209-4; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; BJORNHAG G, 1994, DIGESTIVE SYSTEM IN MAMMALS: FOOD, FORM, AND FUNCTION, P287, DOI 10.1017/CBO9780511661716.018; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collado MC, 2012, GUT MICROBES, V3, P352, DOI 10.4161/gmic.21215; Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63; Clauss M, 2003, OECOLOGIA, V136, P14, DOI 10.1007/s00442-003-1254-z; CRUTZEN P J, 1986, Tellus Series B Chemical and Physical Meteorology, V38, P271; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Ilmberger N, 2012, APPL MICROBIOL BIOT, V95, P135, DOI 10.1007/s00253-011-3732-2; Jacobs JP, 2014, FEBS LETT, V588, P4102, DOI 10.1016/j.febslet.2014.02.052; Kabisch A, 2014, ISME J, V8, P1492, DOI 10.1038/ismej.2014.4; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mackenzie AK, 2012, APPL ENVIRON MICROB, V78, P5935, DOI 10.1128/AEM.01164-12; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nakaya A, 2013, NUCLEIC ACIDS RES, V41, pD353, DOI 10.1093/nar/gks1239; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pope PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038571; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Singh KM, 2012, MOL BIOL REP, V39, P4841, DOI 10.1007/s11033-011-1278-0; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Strous M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00410; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; VAREL VH, 1987, J ANIM SCI, V65, P488, DOI 10.2527/jas1987.652488x; Ward TL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-116; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wemheuer B, 2014, FEMS MICROBIOL ECOL, V87, P378, DOI 10.1111/1574-6941.12230; Wemheuer B, 2013, ARCHAEA, V2013, DOI 10.1155/2013/136714; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yang SL, 2010, MOL BIOL REP, V37, P2063, DOI 10.1007/s11033-009-9664-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	52	55	57	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106707	10.1371/journal.pone.0106707	http://dx.doi.org/10.1371/journal.pone.0106707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208077	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300036
J	Ghawar, W; Attia, H; Bettaieb, J; Yazidi, R; Laouini, D; Ben Salah, A				Ghawar, Wissem; Attia, Hanene; Bettaieb, Jihene; Yazidi, Rihab; Laouini, Dhafer; Ben Salah, Afif			Genotype Profile of Leishmania major Strains Isolated from Tunisian Rodent Reservoir Hosts Revealed by Multilocus Microsatellite Typing	PLOS ONE			English	Article							ZOONOTIC CUTANEOUS LEISHMANIASIS; POPULATION-STRUCTURE; PSAMMOMYS-OBESUS; NATURAL INFECTION; IDENTIFICATION; DONOVANI; TROPICA; DNA; DIVERSITY; INFERENCE	Zoonotic cutaneous leishmaniasis (ZCL) caused by Leishmania (L.) major parasites represents a major health problem with a large spectrum of clinical manifestations. Psammomys (P.) obesus and Meriones (M.) shawi represent the most important host reservoirs of these parasites in Tunisia. We already reported that infection prevalence is different between these two rodent species. We aimed in this work to evaluate the importance of genetic diversity in L. major parasites isolated from different proven and suspected reservoirs for ZCL. Using the multilocus microsatellites typing (MLMT), we analyzed the genetic diversity among strains isolated from (i) P. obesus (n = 31), (ii) M. shawi (n = 8) and (iii) Mustela nivalis (n = 1), captured in Sidi Bouzid, an endemic region for ZCL located in the Center of Tunisia. Studied strains present a new homogeneous genotype profile so far as all tested markers and showed no polymorphism regardless of the parasite host-reservoir origin. This lack of genetic diversity among these L. major isolates is the first genetic information on strains isolated from Leishmania reservoirs hosts in Tunisia. This result indicates that rodent hosts are unlikely to exert a selective pressure on parasites and stresses on the similarity of geographic and ecological features in this study area. Overall, these results increase our knowledge among rodent reservoir hosts and L. major parasites interaction.	[Ghawar, Wissem; Bettaieb, Jihene; Yazidi, Rihab; Ben Salah, Afif] Inst Pasteur Tunis, Serv Med Epidemiol, Tunis, Tunisia; [Ghawar, Wissem; Attia, Hanene; Bettaieb, Jihene; Yazidi, Rihab; Laouini, Dhafer; Ben Salah, Afif] Inst Pasteur Tunis, LTCII, LR11IPT02, Tunis, Tunisia; [Ghawar, Wissem; Attia, Hanene; Bettaieb, Jihene; Yazidi, Rihab; Laouini, Dhafer; Ben Salah, Afif] Univ Tunis El Manar, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar	Laouini, D (corresponding author), Inst Pasteur Tunis, Serv Med Epidemiol, Tunis, Tunisia.	dhafer.laouini@pasteur.rns.tn; bensalah@pasteur.rns.tn	Ben Salah, Afif/AGW-8941-2022; Laouini, Dhafer/Q-6535-2019	Ben Salah, Afif/0000-0002-6696-4713; Laouini, Dhafer/0000-0003-1222-4880; Ghawar, Wissem/0000-0003-4004-6532; Attia, Hanene/0000-0002-7504-7909	US-NIAID-NIH [1P50AI074178-01]; Tunisian Ministry of Higher Education and Scientific Research (Laboratory of Transmission, Control and Immunobiology of Infections) [LR11IPT02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074178] Funding Source: NIH RePORTER	US-NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Tunisian Ministry of Higher Education and Scientific Research (Laboratory of Transmission, Control and Immunobiology of Infections); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is part of a research project supported by US-NIAID-NIH, Grant number 1P50AI074178-01, and approved by the Institutional Review Board of Pasteur Institute of Tunis; and the Tunisian Ministry of Higher Education and Scientific Research (Laboratory of Transmission, Control and Immunobiology of Infections, LR11IPT02). WG and HA were supported by the research project supported by the US-NIAID-NIH, Grant number 1P50AI074178-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jawabreh A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-183; Alam MZ, 2009, MICROBES INFECT, V11, P707, DOI 10.1016/j.micinf.2009.04.009; Ben Salah A, 2007, INT J EPIDEMIOL, V36, P991, DOI 10.1093/ije/dym125; BENISMAIL R, 1987, ANN SOC BELG MED TR, V67, P335; BENISMAIL R, 1989, ANN SOC BELG MED TR, V69, P35; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Dieringer D, 2003, GENOME RES, V13, P2242, DOI 10.1101/gr.1416703; EDRISSIAN GH, 1975, T ROY SOC TROP MED H, V69, P517, DOI 10.1016/0035-9203(75)90113-3; El Nahal H.S., 1982, Journal of the Egyptian Society of Parasitology, V12, P287; El Tai NO, 2000, T ROY SOC TROP MED H, V94, P575, DOI 10.1016/S0035-9203(00)90093-2; El Tai NO, 2001, EXP PARASITOL, V97, P35, DOI 10.1006/expr.2001.4592; ELBIHARI S, 1984, ANN TROP MED PARASIT, V78, P543, DOI 10.1080/00034983.1984.11811861; Elfari M, 2005, MICROBES INFECT, V7, P93, DOI 10.1016/j.micinf.2004.09.010; Fichet-Calvet E, 2000, J APPL ECOL, V37, P603, DOI 10.1046/j.1365-2664.2000.00522.x; Fichet-Calvet E, 2003, ANN TROP MED PARASIT, V97, P593, DOI 10.1179/000349803225001517; Gelanew T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000889; Ghawar W, 2011, VECTOR-BORNE ZOONOT, V11, P1561, DOI 10.1089/vbz.2011.0712; Ghawar W, 2011, VECTOR-BORNE ZOONOT, V11, P1507, DOI 10.1089/vbz.2011.0673; GITHURE JI, 1986, ANN TROP MED PARASIT, V80, P501, DOI 10.1080/00034983.1986.11812056; GUILVARD E, 1991, ANN PARASIT HUM COMP, V66, P96, DOI 10.1051/parasite/199166396; Hamarsheh O, 2009, MED VET ENTOMOL, V23, P69, DOI 10.1111/j.1365-2915.2008.00784.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Mahnaz T, 2006, ACTA TROP, V98, P52, DOI 10.1016/j.actatropica.2006.01.010; Mahnaz T, 2011, MICROBES INFECT, V13, P937, DOI 10.1016/j.micinf.2011.05.005; NADIM A, 1968, T ROY SOC TROP MED H, V62, P534, DOI 10.1016/0035-9203(68)90140-5; PIARROUX R, 1995, MOL BIOCHEM PARASIT, V73, P249, DOI 10.1016/0166-6851(95)00097-K; Pourmohammadi B, 2008, ANN TROP MED PARASIT, V102, P127, DOI 10.1179/136485908X252223; PRATLONG F, 1991, ANN PARASIT HUM COMP, V66, P100, DOI 10.1051/parasite/1991663100; Pritchard JK, 2000, GENETICS, V155, P945; RIOUX JA, 1982, CR ACAD SCI III-VIE, V294, P515; Rougeron V, 2008, MOL ECOL RESOUR, V8, P351, DOI 10.1111/j.1471-8286.2007.01953.x; Rougeron V, 2010, PARASITOLOGY, V137, P1879, DOI 10.1017/S0031182010000776; SCHLEIN Y, 1982, T ROY SOC TROP MED H, V76, P582, DOI 10.1016/0035-9203(82)90215-2; SCHLEIN Y, 1984, T ROY SOC TROP MED H, V78, P480, DOI 10.1016/0035-9203(84)90067-1; Schonian G, 2011, PARASITOLOGY, V138, P405, DOI 10.1017/S0031182010001538; Schonian G, 2008, TRENDS PARASITOL, V24, P135, DOI 10.1016/j.pt.2007.12.006; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Schonian G, 2001, T ROY SOC TROP MED H, V95, P217, DOI 10.1016/S0035-9203(01)90173-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wasserberg G, 2002, INT J PARASITOL, V32, P133, DOI 10.1016/S0020-7519(01)00326-5	41	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107043	10.1371/journal.pone.0107043	http://dx.doi.org/10.1371/journal.pone.0107043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203305	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500063
J	Hiragaki, S; Baba, K; Coulson, E; Kunst, S; Spessert, R; Tosini, G				Hiragaki, Susumu; Baba, Kenkichi; Coulson, Elise; Kunst, Stefanie; Spessert, Rainer; Tosini, Gianluca			Melatonin Signaling Modulates Clock Genes Expression in the Mouse Retina	PLOS ONE			English	Article							CIRCADIAN CLOCK; MAMMALIAN RETINA; MT(1) MELATONIN; MESSENGER-RNA; KAINIC ACID; RAT RETINA; PHOTORECEPTORS; RECEPTOR; LIGHT; MICE	Previous studies have shown that retinal melatonin plays an important role in the regulation of retinal daily and circadian rhythms. Melatonin exerts its influence by binding to G-protein coupled receptors named melatonin receptor type 1 and type 2 and both receptors are present in the mouse retina. Earlier studies have shown that clock genes are rhythmically expressed in the mouse retina and melatonin signaling may be implicated in the modulation of clock gene expression in this tissue. In this study we determined the daily and circadian expression patterns of Per1, Per2, Bmal1, Dbp, Nampt and c-fos in the retina and in the photoreceptor layer (using laser capture microdissection) in C3H-f+/+ and in melatonin receptors of knockout (MT1 and MT2) of the same genetic background using real-time quantitative RT-PCR. Our data indicated that clock and clock-controlled genes are rhythmically expressed in the retina and in the photoreceptor layer. Removal of melatonin signaling significantly affected the pattern of expression in the retina whereas in the photoreceptor layer only the Bmal1 circadian pattern of expression was affected by melatonin signaling removal. In conclusion, our data further support the notion that melatonin signaling may be important for the regulation of clock gene expression in the inner or ganglion cells layer, but not in photoreceptors.	[Hiragaki, Susumu; Coulson, Elise; Kunst, Stefanie; Tosini, Gianluca] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA; [Hiragaki, Susumu; Coulson, Elise; Kunst, Stefanie; Tosini, Gianluca] Morehouse Sch Med, Dept Pharmacol & Toxicol, Atlanta, GA 30310 USA; [Baba, Kenkichi; Kunst, Stefanie; Spessert, Rainer] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Funct & Clin Anat, D-55122 Mainz, Germany	Morehouse School of Medicine; Morehouse School of Medicine; Johannes Gutenberg University of Mainz	Tosini, G (corresponding author), Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA.	gtosini@msm.edu		tosini, gianluca/0000-0003-3645-4533	National Institutes of Health: National Eye Institute [EY022216]; National Institute of Neurological Disorders and Stroke [5U54NS083932]; National Center for Research Resources [G12-RR03034, U54RR026137]; Jay Roman Medical Student Endowment; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034, U54RR026137] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS083932] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health: National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Jay Roman Medical Student Endowment; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Support was provided by the National Institutes of Health: National Eye Institute (EY022216) to GT, National Institute of Neurological Disorders and Stroke (5U54NS083932), and the National Center for Research Resources (G12-RR03034, U54RR026137) to Morehouse School of Medicine. EC was supported by The Jay Roman Medical Student Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004302; Baba K, 2009, P NATL ACAD SCI USA, V106, P15043, DOI 10.1073/pnas.0904400106; CAHILL GM, 1992, VISUAL NEUROSCI, V8, P487, DOI 10.1017/S0952523800005009; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Conti A, 1996, J PINEAL RES, V20, P138, DOI 10.1111/j.1600-079X.1996.tb00249.x; Dinet V, 2007, J PINEAL RES, V42, P83, DOI 10.1111/j.1600-079X.2006.00387.x; Dinet V, 2007, CELL TISSUE RES, V330, P29, DOI 10.1007/s00441-007-0468-5; Dkhissi-Benyahya O, 2013, CELL MOL LIFE SCI, V70, P3435, DOI 10.1007/s00018-013-1338-9; Fujieda H, 1999, NEUROSCIENCE, V93, P793, DOI 10.1016/S0306-4522(99)00111-6; Fujieda H, 2000, VISUAL NEUROSCI, V17, P63, DOI 10.1017/S0952523800171068; Hafezi F, 1997, NAT MED, V3, P346, DOI 10.1038/nm0397-346; Jilg A, 2005, EUR J NEUROSCI, V22, P2845, DOI 10.1111/j.1460-9568.2005.04485.x; Liu CM, 2004, CELL TISSUE RES, V315, P197, DOI 10.1007/s00441-003-0822-1; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050602; McArthur AJ, 1997, ENDOCRINOLOGY, V138, P627, DOI 10.1210/en.138.2.627; McMahon DG, 2014, PROG RETIN EYE RES, V39, P58, DOI 10.1016/j.preteyeres.2013.12.001; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Pfeffer M, 2012, CHRONOBIOL INT, V29, P415, DOI 10.3109/07420528.2012.667859; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sakamoto K, 2006, MOL VIS, V12, P117; Sandu C, 2011, EUR J NEUROSCI, V34, P507, DOI 10.1111/j.1460-9568.2011.07772.x; Schneider K, 2010, J NEUROCHEM, V115, P585, DOI 10.1111/j.1471-4159.2010.06953.x; Sengupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024483; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Tosini G, 2012, EXP EYE RES, V103, P82, DOI 10.1016/j.exer.2012.08.009; Vivien-Roels B, 1998, J BIOL RHYTHM, V13, P403, DOI 10.1177/074873098129000228; von Gall C, 2002, NAT NEUROSCI, V5, P234, DOI 10.1038/nn806; Wiechmann AF, 2008, PROG RETIN EYE RES, V27, P137, DOI 10.1016/j.preteyeres.2007.10.001; ZAWILSKA JB, 1992, NEUROSCI LETT, V135, P71, DOI 10.1016/0304-3940(92)90138-W	35	43	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106819	10.1371/journal.pone.0106819	http://dx.doi.org/10.1371/journal.pone.0106819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203735	gold, Green Submitted, Green Published			2022-12-27	WOS:000342684500045
J	Saito, S; Sawada, K; Hirose, M; Mori, Y; Yoshioka, Y; Murase, K				Saito, Shigeyoshi; Sawada, Kazuhiko; Hirose, Miwa; Mori, Yuki; Yoshioka, Yoshichika; Murase, Kenya			Diffusion Tensor Imaging of Brain Abnormalities Induced by Prenatal Exposure to Radiation in Rodents	PLOS ONE			English	Article							ANISOTROPIC WATER DIFFUSION; WHITE-MATTER; NERVOUS-SYSTEM; CEREBRAL-CORTEX; X-IRRADIATION; MOUSE; MEDULLOBLASTOMA; CONTRAST	We assessed brain abnormalities in rats exposed prenatally to radiation (X-rays) using magnetic resonance imaging (MRI) and histological experiments. Pregnant rats were divided into 4 groups: the control group (n = 3) and 3 groups that were exposed to different radiation doses (0.5, 1.0, or 1.5 Gy; n = 3 each). Brain abnormalities were assessed in 32 neonatal male rats (8 per group). Ex vivo T-2-weighted imaging and diffusion tensor imaging (DTI) were performed using 11.7-T MRI. The expression of markers of myelin production (Kluver-Barrera staining, KB), nonpyramidal cells (calbindin-D28k staining, CaBP), and pyramidal cells (staining of the nonphosphorylated heavy-chain neurofilament SMI-32) were histologically evaluated. Decreased brain volume, increased ventricle volume, and thinner cortices were observed by MRI in irradiated rats. However, no abnormalities in the cortical 6-layered structure were observed via KB staining in radiation-exposed rats. The DTI color-coded map revealed a dose-dependent reduction in the anisotropic signal (vertical direction), which did not represent reduced numbers of pyramidal cells; rather, it indicated a signal reduction relative to the vertical direction because of low nerve cell density in the entire cortex. We conclude that DTI and histological experiments are useful tools for assessing cortical and hippocampal abnormalities after prenatal exposure to radiation in rats.	[Saito, Shigeyoshi; Murase, Kenya] Osaka Univ, Div Med Technol & Sci, Fac Hlth Sci, Dept Med Phys & Engn, Osaka, Japan; [Sawada, Kazuhiko; Hirose, Miwa] Tsukuba Int Univ, Fac Med & Hlth Sci, Tsuchiura, Ibaraki, Japan; [Mori, Yuki; Yoshioka, Yoshichika] Osaka Univ, Biofunct Imaging Lab, Immunol Frontier Res Ctr WPI IFReC, Osaka, Japan; [Saito, Shigeyoshi; Mori, Yuki; Yoshioka, Yoshichika; Murase, Kenya] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks CiNet, Osaka, Japan; [Saito, Shigeyoshi; Mori, Yuki; Yoshioka, Yoshichika; Murase, Kenya] Osaka Univ, Osaka, Japan	Osaka University; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Saito, S (corresponding author), Osaka Univ, Div Med Technol & Sci, Fac Hlth Sci, Dept Med Phys & Engn, Osaka, Japan.	saito@sahs.med.osaka-u.ac.jp	Mori, Yuki/AAH-9283-2020; Sawada, Kazuhiko/AAV-3923-2020	Mori, Yuki/0000-0003-4208-0005; 	Japan Society for the Promotion of Science [24791299, 24300167]; Grants-in-Aid for Scientific Research [26860996, 23228001] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid (No. 24791299 and No. 24300167) for Scientific Research (Kakenhi) of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaf Y, 2000, MAGNET RESON MED, V43, P191, DOI 10.1002/(SICI)1522-2594(200002)43:2<191::AID-MRM5>3.0.CO;2-B; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Autio J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024056; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BLOT W J, 1975, Journal of Radiation Research, V16, P82, DOI 10.1269/jrr.16.SUPPLEMENT_82; FUKUI Y, 1991, EXP NEUROL, V112, P292, DOI 10.1016/0014-4886(91)90129-Z; Gazdzinski LM, 2012, INT J RADIAT ONCOL, V84, pE631, DOI 10.1016/j.ijrobp.2012.06.053; Hayashi T, 2003, INT J RADIAT BIOL, V79, P129, DOI 10.1080/0955300021000038662; HOSHINO K, 1988, TERATOLOGY, V37, P257, DOI 10.1002/tera.1420370311; KAMEYAMA Y, 1987, Radioisotopes, V36, P542; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kimler BF, 1998, INT J RADIAT BIOL, V73, P423, DOI 10.1080/095530098142266; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; MIKI T, 1995, NEUROSCI RES, V23, P241, DOI 10.1016/0168-0102(95)00947-7; Miki T, 1999, DEV BRAIN RES, V112, P275, DOI 10.1016/S0165-3806(98)00177-1; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Mulhern RK, 1999, ANN NEUROL, V46, P834, DOI 10.1002/1531-8249(199912)46:6<834::AID-ANA5>3.0.CO;2-M; Nair G, 2005, NEUROIMAGE, V28, P165, DOI 10.1016/j.neuroimage.2005.05.049; OTAKE M, 1991, J RADIAT RES, V32, P249, DOI 10.1269/jrr.32.SUPPLEMENT_249; Otake M, 1998, INT J RADIAT BIOL, V74, P159, DOI 10.1080/095530098141555; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Reddick WE, 2000, MAGN RESON IMAGING, V18, P787, DOI 10.1016/S0730-725X(00)00182-X; Reyners H, 1999, INT J RADIAT BIOL, V75, P1327, DOI 10.1080/095530099139494; Saito S, 2012, NMR BIOMED, V25, P75, DOI 10.1002/nbm.1715; Saito S, 2011, RADIAT RES, V175, P1, DOI 10.1667/RR2134.1; Sjobeck M, 2005, INT J GERIATR PSYCH, V20, P919, DOI 10.1002/gps.1384; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sun XZ, 2002, J RADIAT RES, V43, P89, DOI 10.1269/jrr.43.89; Takai N, 2004, J RADIAT RES, V45, P563, DOI 10.1269/jrr.45.563; Taricco LD, 2009, AM J PHYS MED REHAB, V88, P431, DOI 10.1097/PHM.0b013e3181a0e249; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107368	10.1371/journal.pone.0107368	http://dx.doi.org/10.1371/journal.pone.0107368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202992	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500090
J	Salama, A; Fichou, N; Allard, M; Dubreil, L; De Beaurepaire, L; Viel, A; Jegou, D; Bosch, S; Bach, JM				Salama, Apolline; Fichou, Nolwenn; Allard, Marie; Dubreil, Laurence; De Beaurepaire, Laurence; Viel, Alexis; Jegou, Dominique; Boesch, Steffi; Bach, Jean-Marie			MicroRNA-29b Modulates Innate and Antigen-Specific Immune Responses in Mouse Models of Autoimmunity	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; INSULINOMA-RELEASED EXOSOMES; RNA OLIGONUCLEOTIDES; TNF-ALPHA; T-CELLS; EXPRESSION; INHIBITION; INTERFERON; CONTRIBUTE; RECEPTORS	In addition to important regulatory roles in gene expression through RNA interference, it has recently been shown that microRNAs display immune stimulatory effects through direct interaction with receptors of innate immunity of the Toll-like receptor family, aggravating neuronal damage and tumour growth. Yet no evidence exists on consequences of microRNA immune stimulatory actions in the context of an autoimmune disease. Using microRNA analogues, we here show that pancreatic beta cell-derived microRNA sequences induce pro-inflammatory (TNFa, IFNa, IL-12, IL-6) or suppressive (IL-10) cytokine secretion by primary mouse dendritic cells in a sequence-dependent manner. For miR-29b, immune stimulation in RAW264.7 macrophages involved the endosomal Toll-like receptor-7, independently of the canonical RNA interference pathway. In vivo, the systemic delivery of miR-29b activates CD11b+B220- myeloid and CD11b-B220+ plasmacytoid dendritic cells and induces IFNa, TNFa and IL-6 production in the serum of recipient mice. Strikingly, in a murine model of adoptive transfer of autoimmune diabetes, miR-29b reduces the cytolytic activity of transferred effector CD8+ T-cells, insulitis and disease incidence in a single standalone intervention. Endogenous miR-29b, spontaneously released from beta-cells within exosomes, stimulates TNFa secretion from spleen cells isolated from diabetes-prone NOD mice in vitro. Hence, microRNA sequences modulate innate and ongoing adaptive immune responses raising the question of their potential role in the breakdown of tolerance and opening up new applications for microRNA-based immune therapy.	[Salama, Apolline; Fichou, Nolwenn; Allard, Marie; De Beaurepaire, Laurence; Viel, Alexis; Jegou, Dominique; Boesch, Steffi; Bach, Jean-Marie] LUNAM Univ, Oniris, IECM, EA 4644, Nantes, France; [Salama, Apolline; Fichou, Nolwenn; Allard, Marie; Dubreil, Laurence; De Beaurepaire, Laurence; Viel, Alexis; Jegou, Dominique; Boesch, Steffi; Bach, Jean-Marie] INRA, F-44026 Nantes, France; [Dubreil, Laurence] LUNAM Univ, Oniris, PanTHER, UMR A0703, Nantes, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Bach, JM (corresponding author), LUNAM Univ, Oniris, IECM, EA 4644, Nantes, France.	jean-marie.bach@oniris-nantes.fr	Bosch, Steffi/A-1557-2009; Bach, Jean-Marie/AAR-1086-2020	Bosch, Steffi/0000-0002-0995-2775; De Beaurepaire, Laurence/0000-0001-5150-5410; Bach, Jean-Marie/0000-0002-5265-8854; Viel, Alexis/0000-0002-6930-9327	Association d'Aide aux Jeunes Diabetiques; Societe Francophone du Diabete; French Research Ministry; Region Pays de la Loire, France	Association d'Aide aux Jeunes Diabetiques; Societe Francophone du Diabete; French Research Ministry(Ministry of Research, France); Region Pays de la Loire, France(Region Pays de la Loire)	This work was supported by the Association d'Aide aux Jeunes Diabetiques (www.ajd-diabete.fr), the Societe Francophone du Diabete (www.sfdiabete.org), the French Research Ministry (www.enseignementsup-recherche.gouv.fr) and the Region Pays de la Loire, France (www.paysdelaloire.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Anz D, 2010, J IMMUNOL, V184, P939, DOI 10.4049/jimmunol.0901245; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Bashratyan R, 2013, EUR J IMMUNOL, V43, P2588, DOI 10.1002/eji.201343376; Bourquin C, 2007, BLOOD, V109, P2953, DOI 10.1182/blood-2006-07-033258; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Di Domizio J, 2012, P NATL ACAD SCI USA, V109, P14550, DOI 10.1073/pnas.1206923109; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Faustman DL, 2009, J MOL MED BERLIN, V87; Favaro E, 2014, DIABETOLOGIA, V57, P1664, DOI 10.1007/s00125-014-3262-4; Figliolini F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102521; Gantier MP, 2010, METHODS MOL BIOL, V623, P21, DOI 10.1007/978-1-60761-588-0_2; Green EA, 2000, IMMUNITY, V12, P459, DOI 10.1016/S1074-7613(00)80198-3; Grewal IS, 1996, J EXP MED, V184, P1963, DOI 10.1084/jem.184.5.1963; Grieco FA, 2011, SEMIN IMMUNOPATHOL, V33, P57, DOI 10.1007/s00281-010-0206-z; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kim DH, 2011, J IMMUNOL, V187, P5211, DOI 10.4049/jimmunol.1001388; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee AS, 2011, DIABETOLOGIA, V54, P1407, DOI 10.1007/s00125-011-2083-y; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Mi QS, 2010, CELL CYCLE, V9, P3127, DOI 10.4161/cc.9.15.12596; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nielsen Lotte B, 2012, Exp Diabetes Res, V2012, P896362, DOI 10.1155/2012/896362; Piaggio E, 2004, J AUTOIMMUN, V22, P115, DOI 10.1016/j.jaut.2003.10.004; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Roggli E, 2012, DIABETES, V61, P1742, DOI 10.2337/db11-1086; Salas-Perez F, 2013, IMMUNOBIOLOGY, V218, P733, DOI 10.1016/j.imbio.2012.08.276; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; Sheng HM, 2011, J IMMUNOL, V187, P1591, DOI 10.4049/jimmunol.1100231; Stoorvogel W, 2012, BLOOD, V119, P646, DOI 10.1182/blood-2011-11-389478; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vizler C, 2000, J IMMUNOL, V165, P6314, DOI 10.4049/jimmunol.165.11.6314; Wang YM, 2011, IMMUNOL REV, V243, P74, DOI 10.1111/j.1600-065X.2011.01049.x; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yu J, 2012, BLOOD, V120	49	48	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106153	10.1371/journal.pone.0106153	http://dx.doi.org/10.1371/journal.pone.0106153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203514	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500014
J	Duan, YK; Chen, L; Chen, YH; Fan, XG				Duan, Yankun; Chen, Lin; Chen, Yongheng; Fan, Xue-gong			c-Src Binds to the Cancer Drug Ruxolitinib with an Active Conformation	PLOS ONE			English	Article							KINASE DOMAIN MUTATIONS; CRYSTAL-STRUCTURES; INHIBITORS; IMATINIB; DESIGN; ABL; SPECIFICITY; SELECTIVITY; INCB018424; PREDICTION	The cancer drug Ruxolitinib is a potent janus kinase inhibitor approved for the treatment of the myeloproliferative neoplasms. In addition, Ruxolitinib has weak inhibitory activity against a panel of other kinases, including Src kinase. There is no structural information of Ruxolitinib binding to any kinase. In this paper, we determined the crystal structure of c-Src kinase domain in complex of Ruxolitinib at a resolution of 2.26 angstrom. C-Src kinase domain adopts the DFG-in active conformation upon Ruxolitinib binding, indicating Ruxolitinib is a type I inhibitor for c-Src. Ruxolitinib forms two hydrogen bonds with Met341, a water-mediated hydrogen bond with Thr338, and a number of van der Waals contacts with c-Src. Ruxolitinib was then docked into the ligand-binding pocket of a previously solved JAK1 structure. From the docking result, Ruxolitinib also binds JAK1 as a type I inhibitor, with more interactions and a higher shape complementarity with the ligand-binding pocket of JAK1 compared to that of c-Src. Since Ruxolitinib is a relatively small inhibitor and there is sizeable cavity between Ruxolitinib and c-Src ligand-binding pocket, we propose to modify Ruxolitinib to develop more potent inhibitors to c-Src.	[Duan, Yankun; Chen, Lin; Chen, Yongheng; Fan, Xue-gong] Cent S Univ, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Duan, Yankun; Chen, Lin; Chen, Yongheng; Fan, Xue-gong] Cent S Univ, Struct Biol Lab, Key Lab Canc Prote, Chinese Minist Hlth,XiangYa Hosp, Changsha, Hunan, Peoples R China; [Chen, Lin; Chen, Yongheng] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	Central South University; Central South University; University of Southern California	Chen, YH (corresponding author), Cent S Univ, Dept Infect Dis, Changsha, Hunan, Peoples R China.	yonghengchen@gmail.com; xgfan57@126.com			National Natural Science Foundation of China [81272971, 81372904]; National Institutes of Health (NIH) [5R01GM064642]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113009, R56AI113009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants from National Natural Science Foundation of China (Y.C., project numbers 81272971 and 81372904) and National Institutes of Health (NIH) (L.C., 5R01GM064642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bikker JA, 2009, J MED CHEM, V52, P1493, DOI 10.1021/jm8010542; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Chen YH, 2013, NUCLEIC ACIDS RES, V41, P8368, DOI 10.1093/nar/gkt584; Chen YH, 2012, CELL REP, V2, P1197, DOI 10.1016/j.celrep.2012.10.012; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Ghose AK, 2008, J MED CHEM, V51, P5149, DOI 10.1021/jm800475y; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jacobs MD, 2008, PROTEINS, V70, P1451, DOI 10.1002/prot.21633; Kufareva I, 2008, J MED CHEM, V51, P7921, DOI 10.1021/jm8010299; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mascarenhas J, 2012, CLIN CANCER RES, V18, P3008, DOI 10.1158/1078-0432.CCR-11-3145; Nagar B, 2002, CANCER RES, V62, P4236; Namboodiri HV, 2010, BIOCHEMISTRY-US, V49, P3611, DOI 10.1021/bi100070r; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; Treiber DK, 2013, CHEM BIOL, V20, P745, DOI 10.1016/j.chembiol.2013.06.001; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Williams NK, 2009, J MOL BIOL, V387, P219, DOI 10.1016/j.jmb.2009.01.041; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yu J, 2010, BIOINFORMATICS, V26, P46, DOI 10.1093/bioinformatics/btp599; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhou T, 2014, LEUKEMIA, V28, P471, DOI 10.1038/leu.2013.299; Zuccotto F, 2010, J MED CHEM, V53, P2681, DOI 10.1021/jm901443h	32	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106225	10.1371/journal.pone.0106225	http://dx.doi.org/10.1371/journal.pone.0106225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197973	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700026
J	Guevar, J; Penderis, J; Faller, K; Yeamans, C; Stalin, C; Gutierrez-Quintana, R				Guevar, Julien; Penderis, Jacques; Faller, Kiterie; Yeamans, Carmen; Stalin, Catherine; Gutierrez-Quintana, Rodrigo			Computer-Assisted Radiographic Calculation of Spinal Curvature in Brachycephalic "Screw-Tailed" Dog Breeds with Congenital Thoracic Vertebral Malformations: Reliability and Clinical Evaluation	PLOS ONE			English	Article							COBB-ANGLE; SCOLIOSIS; INTRAOBSERVER; INTEROBSERVER	The objectives of this study were: To investigate computer-assisted digital radiographic measurement of Cobb angles in dogs with congenital thoracic vertebral malformations, to determine its intra-and inter-observer reliability and its association with the presence of neurological deficits. Medical records were reviewed (2009-2013) to identify brachycephalic screw-tailed dog breeds with radiographic studies of the thoracic vertebral column and with at least one vertebral malformation present. Twenty-eight dogs were included in the study. The end vertebrae were defined as the cranial end plate of the vertebra cranial to the malformed vertebra and the caudal end plate of the vertebra caudal to the malformed vertebra. Three observers performed the measurements twice. Intraclass correlation coefficients were used to calculate the intra-and inter-observer reliabilities. The intraclass correlation coefficient was excellent for all intra-and inter-observer measurements using this method. There was a significant difference in the kyphotic Cobb angle between dogs with and without associated neurological deficits. The majority of dogs with neurological deficits had a kyphotic Cobb angle higher than 35 degrees. No significant difference in the scoliotic Cobb angle was observed. We concluded that the computer assisted digital radiographic measurement of the Cobb angle for kyphosis and scoliosis is a valid, reproducible and reliable method to quantify the degree of spinal curvature in brachycephalic screw-tailed dog breeds with congenital thoracic vertebral malformations.	[Guevar, Julien; Penderis, Jacques; Faller, Kiterie; Yeamans, Carmen; Stalin, Catherine; Gutierrez-Quintana, Rodrigo] Univ Glasgow, Sch Vet Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow	Gutierrez-Quintana, R (corresponding author), Univ Glasgow, Sch Vet Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Rodrigo.GutierrezQuintana@Glasgow.ac.uk		Faller, Kiterie ME/0000-0002-4525-7059; stalin, catherine/0000-0002-7196-5518				Aikawa T, 2007, VET SURG, V36, P432, DOI 10.1111/j.1532-950X.2007.00289.x; Aikawa T, 2014, VET SURG, V43, P301, DOI 10.1111/j.1532-950X.2014.12102.x; Angevine PD, 2008, NEUROSURGERY, V63, pA86, DOI 10.1227/01.NEU.0000320427.28377.F7; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; DONE SH, 1975, VET REC, V96, P313, DOI 10.1136/vr.96.14.313; Faller K, 2014, VET J, V200, P449, DOI 10.1016/j.tvjl.2014.03.027; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Gstoettner M, 2007, EUR SPINE J, V16, P1587, DOI 10.1007/s00586-007-0401-3; Gutierrez-Quintana R, 2014, VET RADIOL IN PRESS; Harrison DE, 2001, SPINE, V26, P235, DOI DOI 10.1097/00007632-200106010-00003; Langensiepen S, 2013, EUR SPINE J, V22, P2360, DOI 10.1007/s00586-013-2693-9; Moissonnier P, 2011, VET SURG, V40, P1029, DOI 10.1111/j.1532-950X.2011.00876.x; MORRISSY RT, 1990, J BONE JOINT SURG AM, V72A, P320, DOI 10.2106/00004623-199072030-00002; NASCA RJ, 1975, J BONE JOINT SURG AM, VA 57, P456, DOI 10.2106/00004623-197557040-00003; Philips MF, 1997, PEDIATR NEUROSURG, V26, P130, DOI 10.1159/000121178; Qiao J, 2012, J SPINAL DISORD TECH, V25, pE67, DOI 10.1097/BSD.0b013e3182463964; Sharp NJH, 2005, SMALL ANIMAL SPINAL, P121; Shea KG, 1998, SPINE, V23, P551, DOI 10.1097/00007632-199803010-00007; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Srinivasalu S, 2008, ASIAN SPINE J, V2, P90, DOI 10.4184/asj.2008.2.2.90; Tanure MC, 2010, SPINE J, V10, P769, DOI 10.1016/j.spinee.2010.02.020; Westworth DR, 2010, VET CLIN N AM-SMALL, V40, P951, DOI 10.1016/j.cvsm.2010.05.009; Zhang JH, 2010, MED BIOL ENG COMPUT, V48, P185, DOI 10.1007/s11517-009-0556-7	23	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106957	10.1371/journal.pone.0106957	http://dx.doi.org/10.1371/journal.pone.0106957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198374	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700069
J	Kiatpongsan, S; Kim, JJ				Kiatpongsan, Sorapop; Kim, Jane J.			Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries	PLOS ONE			English	Article							CERVICAL-CANCER	Background: Current prophylactic vaccines against human papillomavirus (HPV) target two of the most oncogenic types, HPV-16 and -18, which contribute to roughly 70% of cervical cancers worldwide. Second-generation HPV vaccines include a 9-valent vaccine, which targets five additional oncogenic HPV types (i.e., 31, 33, 45, 52, and 58) that contribute to another 15-30% of cervical cancer cases. The objective of this study was to determine a range of vaccine costs for which the 9-valent vaccine would be cost-effective in comparison to the current vaccines in two less developed countries (i.e., Kenya and Uganda). Methods and Findings: The analysis was performed using a natural history disease simulation model of HPV and cervical cancer. The mathematical model simulates individual women from an early age and tracks health events and resource use as they transition through clinically-relevant health states over their lifetime. Epidemiological data on HPV prevalence and cancer incidence were used to adapt the model to Kenya and Uganda. Health benefit, or effectiveness, from HPV vaccination was measured in terms of life expectancy, and costs were measured in international dollars (I$). The incremental cost of the 9-valent vaccine included the added cost of the vaccine counterbalanced by costs averted from additional cancer cases prevented. All future costs and health benefits were discounted at an annual rate of 3% in the base case analysis. We conducted sensitivity analyses to investigate how infection with multiple HPV types, unidentifiable HPV types in cancer cases, and cross-protection against non-vaccine types could affect the potential cost range of the 9-valent vaccine. In the base case analysis in Kenya, we found that vaccination with the 9-valent vaccine was very cost-effective (i.e., had an incremental cost-effectiveness ratio below per-capita GDP), compared to the current vaccines provided the added cost of the 9-valent vaccine did not exceed I$9.7 per vaccinated girl. To be considered very cost-effective, the added cost per vaccinated girl could go up to I$5.2 and I$16.2 in the worst-case and best-case scenarios, respectively. At a willingness-to-pay threshold of three times per-capita GDP where the 9-valent vaccine would be considered cost-effective, the thresholds of added costs associated with the 9-valent vaccine were I$27.3, I$14.5 and I$45.3 per vaccinated girl for the base case, worst-case and best-case scenarios, respectively. In Uganda, vaccination with the 9-valent vaccine was very cost-effective when the added cost of the 9-valent vaccine did not exceed I$8.3 per vaccinated girl. To be considered very cost-effective, the added cost per vaccinated girl could go up to I$4.5 and I$13.7 in the worst-case and best-case scenarios, respectively. At a willingness-to-pay threshold of three times per-capita GDP, the thresholds of added costs associated with the 9-valent vaccine were I$23.4, I$12.6 and I$38.4 per vaccinated girl for the base case, worst-case and best-case scenarios, respectively. Conclusions: This study provides a threshold range of incremental costs associated with the 9-valent HPV vaccine that would make it a cost-effective intervention in comparison to currently available HPV vaccines in Kenya and Uganda. These prices represent a 71% and 61% increase over the price offered to the GAVI Alliance ($5 per dose) for the currently available 2- and 4-valent vaccines in Kenya and Uganda, respectively. Despite evidence of cost-effectiveness, critical challenges around affordability and feasibility of HPV vaccination and other competing needs in low-resource settings such as Kenya and Uganda remain.	[Kiatpongsan, Sorapop] Harvard Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Kiatpongsan, Sorapop] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Bangkok 10330, Thailand; [Kiatpongsan, Sorapop] Chulalongkorn Univ, Sasin Grad Inst Business Adm, Bangkok, Thailand; [Kim, Jane J.] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Chulalongkorn University; Chulalongkorn University; Harvard University; Harvard T.H. Chan School of Public Health	Kiatpongsan, S (corresponding author), Harvard Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA.	sorapop@mail.harvard.edu	Kiatpongsan, Sorapop/ABG-7845-2021		Bill and Melinda Gates Foundation [30505]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was supported by the Bill and Melinda Gates Foundation (SK and JJK; Grant #30505). URL: http://www.gatesfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloomberg, 2013, PIV STUD INV 9 VAL H; Campos NG, 2012, INT J CANCER, V130, P2672, DOI 10.1002/ijc.26269; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clinicaltrials.gov, 2011, BROAD SPECTR HPV HUM; Denny L, 2000, CANCER-AM CANCER SOC, V89, P826, DOI 10.1002/1097-0142(20000815)89:4&lt;826::AID-CNCR15&gt;3.0.CO;2-5; GAVI, 2013, KEN 1 COUNTR PROT GI; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Kiatpongsan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048426; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; McNeil Jr Donald, NY TIMES; National Cancer Institute, HPV CANC; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; WHO/ICO Information Centre on Human Papilloma Virus (HPV) and Cervical Cancer, 2012, HPV TYP DISTR INV CE; World Health Organization, 2001, MACR HLTH INV HLTH E	14	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106836	10.1371/journal.pone.0106836	http://dx.doi.org/10.1371/journal.pone.0106836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198104	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700057
J	Niu, SY; Fan, GQ; Xu, EK; Deng, MJ; Zhao, ZL; Dong, YP				Niu, Suyan; Fan, Guoqiang; Xu, Enkai; Deng, Minjie; Zhao, Zhenli; Dong, Yanpeng			Transcriptome/Degradome-Wide Discovery of MicroRNAs and Transcript Targets in Two Paulownia australis Genotypes	PLOS ONE			English	Article							LECTIN RECEPTOR KINASES; GENE-EXPRESSION; SMALL RNAS; PLANT MICRORNAS; IDENTIFICATION; ARABIDOPSIS; PREDICTION; REVEALS; AUXIN; MIRNA	MicroRNAs (miRNAs) are involved in plant growth, development, and response to biotic and abiotic stresses. Most of the miRNAs that have been identified in model plants are well characterized, but till now, no reports have previously been published concerning miRNAs in Paulownia australis. In order to investigate miRNA-guided transcript target regulation in P. australis, small RNA libraries from two P. australis (diploids, PA2; and autotetraploids, PA4) genotypes were subjected to Solexa sequencing. As a result, 10,691,271 (PA2) and 10,712,733 (PA4) clean reads were obtained, and 45 conserved miRNAs belonging to 15 families, and 31 potential novel miRNAs candidates were identified. Compared with their expression levels in the PA2 plants, 26 miRNAs were up-regulated and 15 miRNAs were down-regulated in the PA4 plants. The relative expressions of 12 miRNAs were validated by quantitative real-time polymerase chain reaction. Using the degradome approach, 53 transcript targets were identified and annotated based on Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis. These targets were associated with development, stimulus response, metabolism, signaling transduction and biological regulation. Among them, 11 targets, including TCP transcription factors, auxin response factors, squamosa promoter-binding-like proteins, scarecrow-like proteins, L-type lectin-domain containing receptor kinases and zinc finger CCCH domain-containing protein, cleaved by four known miRNA family and two potentially novel miRNAs were found to be involved in regulating plant development, biotic and abiotic stresses. The findings will be helpful to facilitate studies on the functions of miRNAs and their transcript targets in Paulownia.	[Niu, Suyan; Fan, Guoqiang; Xu, Enkai; Deng, Minjie; Zhao, Zhenli; Dong, Yanpeng] Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China; [Niu, Suyan; Fan, Guoqiang; Xu, Enkai; Deng, Minjie; Zhao, Zhenli; Dong, Yanpeng] Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China.	zlxx64@126.com			National Natural Science Foundation of China [30271082, 30571496, U1204309]; Outstanding Talents Project of Henan Province [122101110700]; Transformation Project of the National Agricultural Scientific and Technological Achievement of China [2012GB2D000271]; Science and Technology Innovation Team Project of Zhengzhou City [121PCXTD515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Talents Project of Henan Province; Transformation Project of the National Agricultural Scientific and Technological Achievement of China; Science and Technology Innovation Team Project of Zhengzhou City	This work was supported by the National Natural Science Foundation of China (Grant nos. 30271082, 30571496, U1204309 to GQF) (http://www.nsfc.gov.cn/); Outstanding Talents Project of Henan Province (Grant no. 122101110700 to GQF); Transformation Project of the National Agricultural Scientific and Technological Achievement of China (Grant no. 2012GB2D000271 to GQF); and Science and Technology Innovation Team Project of Zhengzhou City (Grant no. 121PCXTD515 to GQF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; An FM, 2012, PLANT CELL PHYSIOL, V53, P1737, DOI 10.1093/pcp/pcs118; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayliss KL, 2005, AUSTRALAS PLANT PATH, V34, P123, DOI 10.1071/AP04089; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bouwmeester K, 2009, J EXP BOT, V60, P4383, DOI 10.1093/jxb/erp277; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chirko CP, 1996, FOREST ECOL MANAG, V83, P171, DOI 10.1016/0378-1127(96)03721-8; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Cifuentes M, 2010, NEW PHYTOL, V186, P29, DOI 10.1111/j.1469-8137.2009.03084.x; Cubas P, 2004, BIOESSAYS, V26, P1175, DOI 10.1002/bies.20119; Fan GQ, 2014, BIOCHIMIE, V102, P68, DOI 10.1016/j.biochi.2014.02.008; Fan GuoQiang, 2010, Journal of Northeast Forestry University, V38, P22; Fan GuoQiang, 2009, Journal of Northwest A & F University - Natural Science Edition, V37, P83; [范国强 Fan Guoqiang], 2007, [林业科学, Scientia Silvae Sinicae], V43, P31; [范国强 FAN GuoQiang], 2007, [植物生理学通讯, Plant Physiology Communications], V43, P109; Fan GuoQiang, 2002, Scientia Silvae Sinicae, V38, P29; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; Koyama T, 2007, PLANT CELL, V19, P473, DOI 10.1105/tpc.106.044792; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li BS, 2009, BIOCHEM BIOPH RES CO, V388, P272, DOI 10.1016/j.bbrc.2009.07.161; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Man MZ, 2000, BIOINFORMATICS, V16, P953, DOI 10.1093/bioinformatics/16.11.953; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Meng YJ, 2011, PLANT PHYSIOL, V157, P1583, DOI 10.1104/pp.111.187088; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Niu SY, 2014, PLANT CELL TISS ORG, V119, P457, DOI 10.1007/s11240-014-0546-9; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Ren YY, 2012, FUNCT INTEGR GENOMIC, V12, P327, DOI 10.1007/s10142-012-0271-6; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Sanchez C, 2007, TREE PHYSIOL, V27, P1459, DOI 10.1093/treephys/27.10.1459; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; Shen Y, 2013, BIOCHEM BIOPH RES CO, V441, P425, DOI 10.1016/j.bbrc.2013.10.113; Shuai P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-233; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Singh P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00124; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Vashisht D, 2014, BIOCHEM SOC T, V42, P352, DOI 10.1042/BST20130252; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044696; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wei MM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-66; Weir I, 2004, DEVELOPMENT, V131, P915, DOI 10.1242/dev.00993; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595; Xu XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070959; [翟晓巧 Zhai Xiaoqiao], 2012, [河南农业大学学报, Journal of Henan Agricultural University], V46, P651; Zhang JZ, 2012, MOL BIOTECHNOL, V51, P44, DOI 10.1007/s12033-011-9439-x; Zhang X, 2013, SCI SILV SIN, V10; [张晓申 Zhang Xiaoshen], 2012, [河南农业大学学报, Journal of Henan Agricultural University], V46, P646; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	80	17	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106736	10.1371/journal.pone.0106736	http://dx.doi.org/10.1371/journal.pone.0106736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198709	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700044
J	Pompey, JM; Morf, L; Singh, U				Pompey, Justine M.; Morf, Laura; Singh, Upinder			RNAi Pathway Genes Are Resistant to Small RNA Mediated Gene Silencing in the Protozoan Parasite Entamoeba histolytica	PLOS ONE			English	Article							ANTISENSE SMALL RNAS; C-ELEGANS; INTERFERENCE; PLANTS; MECHANISMS; HISTONE; IDENTIFICATION; PHAGOCYTOSIS; SUPPRESSORS; METHYLATION	The RNA interference pathway in the protist Entamoeba histolytica plays important roles in permanent gene silencing as well as in the regulation of virulence determinants. Recently, a novel RNA interference (RNAi)-based silencing technique was developed in this parasite that uses a gene endogenously silenced by small RNAs as a "trigger'' to induce silencing of other genes that are fused to it. Fusion to a trigger gene induces the production of gene-specific antisense small RNAs, resulting in robust and permanent silencing of the cognate gene. This approach has silenced multiple genes including those involved in virulence and transcriptional regulation. We now demonstrate that all tested genes of the amebic RNAi pathway are unable to be silenced using the trigger approach, including Argonaute genes (Ago2-1, Ago2-2, and Ago2-3), RNaseIII, and RNA-dependent RNA polymerase (RdRP). In all situations (except for RdRP), fusion to a trigger successfully induces production of gene-specific antisense small RNAs to the cognate gene. These small RNAs are capable of silencing a target gene in trans, indicating that they are functional; despite this, however, they cannot silence the RNAi pathway genes. Interestingly, when a trigger is fused to RdRP, small RNA induction to RdRP does not occur, a unique phenotype hinting that either RdRP is highly resistant to being a target of small RNAs or that small RNA generation may be controlled by RdRP. The inability of the small RNA pathway to silence RNAi genes in E. histolytica, despite the generation of functional small RNAs to these loci suggest that epigenetic factors may protect certain genomic loci and thus determine susceptibility to small RNA mediated silencing.	[Pompey, Justine M.; Singh, Upinder] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Morf, Laura; Singh, Upinder] Stanford Univ, Div Infect Dis, Sch Med, Dept Internal Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Singh, U (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	usingh@stanford.edu		Singh, Upinder/0000-0003-0630-0306	ASM Watkins fellowship; NIH [T32 AI07328, AI 53724, AI085178]; Swiss National Science Founation [PBZHP3-130988, PBZHP3-141513]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, R01AI053724, R21AI085178] Funding Source: NIH RePORTER	ASM Watkins fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Founation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JMP was supported by ASM Watkins fellowship; NIH T32 AI07328; LM was supported by Swiss National Science Founation (PBZHP3-130988 and PBZHP3-141513]; US by NIH AI 53724 and NIH AI085178. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista TM, 2011, J PROTEOMICS, V74, P1504, DOI 10.1016/j.jprot.2011.02.032; Baxt LA, 2010, EUKARYOT CELL, V9, P1283, DOI 10.1128/EC.00015-10; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Fisher O, 2004, NUCLEIC ACIDS RES, V32, P287, DOI 10.1093/nar/gkh161; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Huguenin M, 2010, PARASITOLOGY, V137, P619, DOI 10.1017/S0031182009991363; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; MacFarlane RC, 2007, EUKARYOT CELL, V6, P2139, DOI 10.1128/EC.00174-07; MacFarlane RC, 2008, EXP PARASITOL, V119, P296, DOI 10.1016/j.exppara.2008.02.001; Morf L, 2013, NUCLEIC ACIDS RES, V41, P9424, DOI 10.1093/nar/gkt717; Morf L, 2012, CURR OPIN MICROBIOL, V15, P469, DOI 10.1016/j.mib.2012.04.011; Mukherjee C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000409; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pearson RJ, 2013, J BIOL CHEM, V288, P4462, DOI 10.1074/jbc.M112.423467; Pratt A, 2009, J BIOL CHEM, P1; Pritt BS, 2008, MAYO CLIN PROC, V83, P1154, DOI 10.4065/83.10.1154; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Ramakrishnan G, 2004, MOL BIOCHEM PARASIT, V138, P205, DOI 10.1016/j.molbiopara.2004.09.002; Saito-Nakano Y, 2004, J BIOL CHEM, V279, P49497, DOI 10.1074/jbc.M403987200; She XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000624; Shi HF, 2006, RNA, V12, P2063, DOI 10.1261/rna.246906; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074465; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Volpe T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003731; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; WHO, 1997, EPIDEMIOLOGICAL B, P13; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang HB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-53; Zhang HB, 2011, J BIOL CHEM, V286, P44467, DOI 10.1074/jbc.M111.278184; Zhang HB, 2011, FUTURE MICROBIOL, V6, P103, DOI [10.2217/fmb.10.154, 10.2217/FMB.10.154]; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	46	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106477	10.1371/journal.pone.0106477	http://dx.doi.org/10.1371/journal.pone.0106477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198343	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700029
J	Crane, MJ; Lindenmayer, DB; Cunningham, RB				Crane, Mason J.; Lindenmayer, David B.; Cunningham, Ross B.			The Value of Countryside Elements in the Conservation of a Threatened Arboreal Marsupial Petaurus norfolcensis in Agricultural Landscapes of South-Eastern Australia-The Disproportional Value of Scattered Trees	PLOS ONE			English	Article							SQUIRREL GLIDER; HOME-RANGE; VARIEGATED LANDSCAPE; FEEDING-BEHAVIOR; PROTECTED AREAS; PADDOCK TREES; HABITAT; BIRDS; VEGETATION; NETWORK	Human activities, particularly agriculture, have transformed much of the world's terrestrial environment. Within these anthropogenic landscapes, a variety of relictual and semi-natural habitats exist, which we term countryside elements. The habitat value of countryside elements (hereafter termed 'elements') is increasingly recognised. We quantify the relative value of four kinds of such 'elements' (linear roadside remnants, native vegetation patches, scattered trees and tree plantings) used by a threatened Australian arboreal marsupial, the squirrel glider (Petaurus norfolcensis). We examined relationships between home range size and the availability of each 'element' and whether the usage was relative to predicted levels of use. The use of 'elements' by gliders was largely explained by their availability, but there was a preference for native vegetation patches and scattered trees. We found home range size was significantly smaller with increasing area of scattered trees and a contrasting effect with increasing area of linear roadside remnants or native vegetation patches. Our work showed that each 'element' was used and as such had a role in the conservation of the squirrel glider, but their relative value varied. We illustrate the need to assess the conservation value of countryside elements so they can be incorporated into the holistic management of agricultural landscapes. This work demonstrates the disproportional value of scattered trees, underscoring the need to specifically incorporate and/or enhance the protection and recruitment of scattered trees in biodiversity conservation policy and management.	[Crane, Mason J.; Lindenmayer, David B.; Cunningham, Ross B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University	Crane, MJ (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	mason.crane@anu.edu.au	Lindenmayer, David B/P-7183-2017; Crane, Mason/AAQ-1810-2021	Lindenmayer, David B/0000-0002-4766-4088; 				Anderson RH, 1961, CONTRIBUTIONS NEW S, V1-18, P1; Arnaud JF, 2003, LANDSCAPE ECOL, V18, P333, DOI 10.1023/A:1024409116214; Aung UM, 2007, J ENVIRON MANAGE, V84, P188, DOI 10.1016/j.jenvman.2006.05.016; Ball T, 2009, AUST J ZOOL, V57, P295, DOI 10.1071/ZO08095; Bennett A. F., 1999, LINKAGES LANDSCAPE R; Benson J. S., 2008, Cunninghamia, V10, P599; Burel F, 1996, CRIT REV PLANT SCI, V15, P169, DOI 10.1080/713608130; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Collard S, 2009, BIODIVERS CONSERV, V18, P1649, DOI 10.1007/s10531-008-9548-4; Crane MJ, 2008, WILDLIFE RES, V35, P663, DOI 10.1071/WR07142; Crane MJ, 2012, AUST J ZOOL, V60, P320, DOI 10.1071/ZO12080; CUMMINGS JR, 1994, AM MIDL NAT, V132, P209, DOI 10.2307/2426575; Cunningham RB, 2008, CONSERV BIOL, V22, P742, DOI 10.1111/j.1523-1739.2008.00924.x; Cunningham RB, 2007, ECOL APPL, V17, P609, DOI 10.1890/05-1892; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Fischer J, 2002, BIODIVERS CONSERV, V11, P833, DOI 10.1023/A:1015318328007; Fischer J, 2002, BIODIVERS CONSERV, V11, P807, DOI 10.1023/A:1015371511169; Fischer J, 2002, BIOL CONSERV, V106, P129, DOI 10.1016/S0006-3207(01)00241-5; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; GETZ LL, 1978, J MAMMAL, V59, P208, DOI 10.2307/1379900; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; Haslem A, 2008, AGR ECOSYST ENVIRON, V125, P191, DOI 10.1016/j.agee.2008.01.001; Hazell D, 2001, BIOL CONSERV, V102, P155, DOI 10.1016/S0006-3207(01)00096-9; Holland GJ, 2007, WILDLIFE RES, V34, P288, DOI 10.1071/WR06104; Ioja CI, 2010, BIOL CONSERV, V143, P2468, DOI 10.1016/j.biocon.2010.06.013; Lindenmayer D, 2012, LAND USE INTENSIFICATION: EFFECTS ON AGRICULTURE, BIODIVERSITY AND ECOLOGICAL PROCESSES, P1; Lindenmayer DB, 2014, CONSERV LETT, V7, P61, DOI 10.1111/conl.12013; Lindenmayer David B., 2010, Ecological Management & Restoration, V11, P27, DOI 10.1111/j.1442-8903.2010.00509.x; LINDENMAYER DB, 1993, BIOL CONSERV, V66, P207, DOI 10.1016/0006-3207(93)90006-M; Lumsden LF, 2005, BIOL CONSERV, V122, P205, DOI 10.1016/j.biocon.2004.07.006; Manning AD, 2004, BIOL CONSERV, V120, P363, DOI 10.1016/j.biocon.2004.03.008; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Maron M, 2007, BIOL CONSERV, V135, P587, DOI 10.1016/j.biocon.2006.10.051; Martin JK, 2007, AUSTRAL ECOL, V32, P686, DOI 10.1111/j.1442-9993.2007.01763.x; McCullagh P, 1989, GEN LINEAR MODELS; McLoughlin PD, 2003, ECOSCIENCE, V10, P11, DOI 10.1080/11956860.2003.11682744; Michael DR, 2008, J APPL ECOL, V45, P1742, DOI 10.1111/j.1365-2664.2008.01567.x; Mitchell MS, 2004, ECOL MODEL, V177, P209, DOI 10.1016/j.ecolmodel.2004.01.015; Munro NT, 2011, RESTOR ECOL, V19, P223, DOI 10.1111/j.1526-100X.2010.00703.x; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Pacheco R, 2013, BIODIVERS CONSERV, V22, P983, DOI 10.1007/s10531-013-0463-y; PRESSEY RL, 1994, AUST J ECOL, V19, P375, DOI 10.1111/j.1442-9993.1994.tb00503.x; Prober SM, 1996, AUST J BOT, V44, P57, DOI 10.1071/BT9960057; Recher H.F., 1987, P177; Renjifo LM, 2001, ECOL APPL, V11, P14, DOI 10.1890/1051-0761(2001)011[0014:EONAAL]2.0.CO;2; Rouget M, 2003, BIOL CONSERV, V112, P129, DOI 10.1016/S0006-3207(02)00396-8; Sarre A., 2002, TREES WATER SALT AUS; Sharpe DJ, 1998, WILDLIFE RES, V25, P243, DOI 10.1071/WR97037; Soderstrom B, 2003, AGR ECOSYST ENVIRON, V99, P113, DOI 10.1016/S0167-8809(03)00144-0; Spooner PG, 2005, AUST GEOGR, V36, P55, DOI 10.1080/00049180500050870; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; van der Ree R, 2004, BIOL CONSERV, V115, P241, DOI 10.1016/S0006-3207(03)00142-3; van der Ree R, 2003, J ZOOL, V259, P327, DOI 10.1017/S0952836902003229; van der Ree R, 2002, WILDLIFE RES, V29, P329, DOI 10.1071/WR01095; White G.C., 1990, ANAL WILDLIFE RADIO	58	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107178	10.1371/journal.pone.0107178	http://dx.doi.org/10.1371/journal.pone.0107178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25216045	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300050
J	Nakahara, K; Fujiwara, Y; Tsukahara, T; Yamagami, H; Tanigawa, T; Shiba, M; Tominaga, K; Watanabe, T; Urade, Y; Arakawa, T				Nakahara, Kenichi; Fujiwara, Yasuhiro; Tsukahara, Takuya; Yamagami, Hirokazu; Tanigawa, Tetsuya; Shiba, Masatsugu; Tominaga, Kazunari; Watanabe, Toshio; Urade, Yoshihiro; Arakawa, Tetsuo			Acid Reflux Directly Causes Sleep Disturbances in Rat with Chronic Esophagitis	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX; NIGHTTIME HEARTBURN; JAPANESE POPULATION; AROUSAL RESPONSE; DISEASE; ACTIVATION; EXPOSURE; RECEPTOR; GERD; ASSOCIATION	Background & Aims: Gastroesophageal reflux disease (GERD) is strongly associated with sleep disturbances. Proton pump inhibitor (PPI) therapy improves subjective but not objective sleep parameters in patients with GERD. This study aimed to investigate the association between GERD and sleep, and the effect of PPI on sleep by using a rat model of chronic acid reflux esophagitis. Methods: Acid reflux esophagitis was induced by ligating the transitional region between the forestomach and the glandular portion and then wrapping the duodenum near the pylorus. Rats underwent surgery for implantation of electrodes for electroencephalogram and electromyogram recordings, and they were transferred to a soundproof recording chamber. Polygraphic recordings were scored by using 10-s epochs for wake, rapid eye movement sleep, and non-rapid eye movement (NREM) sleep. To examine the role of acid reflux, rats were subcutaneously administered a PPI, omeprazole, at a dose of 20 mg/kg once daily. Results: Rats with reflux esophagitis presented with several erosions, ulcers, and mucosal thickening with basal hyperplasia and marked inflammatory infiltration. The reflux esophagitis group showed a 34.0% increase in wake (232.2 +/- 11.4 min and 173.3 +/- 7.4 min in the reflux esophagitis and control groups, respectively; p<0.01) accompanied by a reduction in NREM sleep during light period, an increase in sleep fragmentation, and more frequent stage transitions. The use of omeprazole significantly improved sleep disturbances caused by reflux esophagitis, and this effect was not observed when the PPI was withdrawn. Conclusions: Acid reflux directly causes sleep disturbances in rats with chronic esophagitis.	[Nakahara, Kenichi; Fujiwara, Yasuhiro; Tsukahara, Takuya; Yamagami, Hirokazu; Tanigawa, Tetsuya; Shiba, Masatsugu; Tominaga, Kazunari; Watanabe, Toshio; Arakawa, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 558, Japan; [Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 565, Japan; [Urade, Yoshihiro] Univ Tsukuba, World Premier Int Res Ctr, Int Inst Integrat Sleep Med, Mol Sleep Biol Lab, Tsukuba, Ibaraki, Japan	Osaka Metropolitan University; University of Tsukuba	Fujiwara, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 558, Japan.	yasu@med.osaka-cu.ac.jp	Tanigawa, Tetsuya/J-6131-2019	Tanigawa, Tetsuya/0000-0002-9305-1637	Ministry of Education, Culture, Sports, Science, and Technology in Japan [24590925]	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported, in part, by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (No. 24590925, YF). The remaining authors have no support or funding to report. The authors confirm no additional funding sources for this study, according to the PLOS ONE guide for authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2010, ALIMENT PHARM THER, V32, P787, DOI 10.1111/j.1365-2036.2010.04403.x; Chiba N, 1997, GASTROENTEROLOGY, V112, P1798, DOI 10.1053/gast.1997.v112.pm9178669; DENT J, 1980, J CLIN INVEST, V65, P256, DOI 10.1172/JCI109667; Dickman R, 2007, ALIMENT PHARM THER, V26, P41, DOI 10.1111/j.1365-2036.2007.03347.x; DODDS WJ, 1982, NEW ENGL J MED, V307, P1547, DOI 10.1056/NEJM198212163072503; Farup C, 2001, ARCH INTERN MED, V161, P45, DOI 10.1001/archinte.161.1.45; Fass R, 2005, CHEST, V127, P1658, DOI 10.1378/chest.127.5.1658; Fass R, 2011, AM J GASTROENTEROL, V106, P421, DOI 10.1038/ajg.2010.458; Fujiwara Y, 2012, J GASTROENTEROL, V47, P760, DOI 10.1007/s00535-012-0601-4; Fujiwara Y, 2010, DIGESTION, V81, P135, DOI 10.1159/000253849; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Gagliardi GS, 2009, CLIN GASTROENTEROL H, V7, P948, DOI 10.1016/j.cgh.2009.04.026; Gerson LB, 2009, CLIN GASTROENTEROL H, V7, P372, DOI 10.1016/j.cgh.2008.11.021; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Johnson DA, 2005, AM J GASTROENTEROL, V100, P1914, DOI 10.1111/j.1572-0241.2005.00285.x; Jung Hye-Kyung, 2010, J Neurogastroenterol Motil, V16, P22, DOI 10.5056/jnm.2010.16.1.22; Kusano M, 2008, J GASTROENTEROL, V43, P833, DOI 10.1007/s00535-008-2235-0; Kuzumaki N, 2007, NEUROSCI LETT, V415, P22, DOI 10.1016/j.neulet.2006.12.057; LANDIS CA, 1988, PAIN, V34, P93, DOI 10.1016/0304-3959(88)90186-8; Ma J, 2011, AM J PHYSIOL-GASTR L, V301, pG1075, DOI 10.1152/ajpgi.00336.2011; Maneerattanaporn M, 2009, NEUROGASTROENT MOTIL, V21, P97, DOI 10.1111/j.1365-2982.2008.01254.x; Matthews PJ, 2004, EUR J GASTROEN HEPAT, V16, P897, DOI 10.1097/00042737-200409000-00014; Mody R, 2009, CLIN GASTROENTEROL H, V7, P953, DOI 10.1016/j.cgh.2009.04.005; Narita M, 2011, PAIN, V152, P1358, DOI 10.1016/j.pain.2011.02.016; Niikura K, 2011, SYNAPSE, V65, P424, DOI 10.1002/syn.20859; Omura N, 1999, SCAND J GASTROENTERO, V34, P948; Orr WC, 2005, ALIMENT PHARM THER, V21, P103, DOI 10.1111/j.1365-2036.2005.02310.x; Orr WC, 2007, CHEST, V131, P460, DOI 10.1378/chest.06-1312; Oshima T, 2010, NEUROGASTROENT MOTIL, V22, P579, DOI 10.1111/j.1365-2982.2009.01450.x; Poh CH, 2010, NEUROGASTROENT MOTIL, V22, P387, DOI 10.1111/j.1365-2982.2009.01446.x; Poh CH, 2010, CLIN GASTROENTEROL H, V8, P851, DOI 10.1016/j.cgh.2010.05.022; Schey R, 2007, GASTROENTEROLOGY, V133, P1787, DOI 10.1053/j.gastro.2007.09.039; Shaker R, 2003, AM J GASTROENTEROL, V98, P1487, DOI 10.1016/S0002-9270(03)00360-5; Suganuma N, 2001, PSYCHIAT CLIN NEUROS, V55, P255, DOI 10.1046/j.1440-1819.2001.00848.x; Takemura Y, 2011, SYNAPSE, V65, P668, DOI 10.1002/syn.20898; The Gallup Organization, 1998, GALL ORG NAT SURV HB; The Gallup Organization, 2000, GALL ORG NAT SURV HB; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Yan MM, 2011, SLEEP BIOL RHYTHMS, V9, P46, DOI 10.1111/j.1479-8425.2010.00484.x	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106969	10.1371/journal.pone.0106969	http://dx.doi.org/10.1371/journal.pone.0106969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215524	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300031
J	Van Raemdonck, GAA; Tjalma, WAA; Coen, EP; Depuydt, CE; Van Ostade, XWM				Van Raemdonck, Geert A. A.; Tjalma, Wiebren A. A.; Coen, Edmond P.; Depuydt, Christophe E.; Van Ostade, Xaveer W. M.			Identification of Protein Biomarkers for Cervical Cancer Using Human Cervicovaginal Fluid	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; GENE AMPLIFICATION; PLASMA PROTEOME; FOLLOW-UP; HPV; ACTININ-4; MARKERS; ALPHA; WOMEN; PERSISTENCE	Objectives: Cervicovaginal fluid (CVF) can be considered as a potential source of biomarkers for diseases of the lower female reproductive tract. The fluid can easily be collected, thereby offering new opportunities such as the development of self tests. Our objective was to identify a CVF protein biomarker for cervical cancer or its precancerous state. Methods: A differential proteomics study was set up using CVF samples from healthy and precancerous women. Label-free spectral counting was applied to quantify protein abundances. Results: The proteome analysis revealed 16 candidate biomarkers of which alpha-actinin-4 (p = 0.001) and pyruvate kinase isozyme M1/M2 (p = 0.014) were most promising. Verification of alpha-actinin-4 by ELISA (n = 28) showed that this candidate biomarker discriminated between samples from healthy and both low-risk and high-risk HPV-infected women (p = 0.009). Additional analysis of longitudinal samples (n = 29) showed that alpha-actinin-4 levels correlated with virus persistence and clearing, with a discrimination of approximately 18 pg/ml. Conclusions: Our results show that CVF is an excellent source of protein biomarkers for detection of lower female genital tract pathologies and that alpha-actinin-4 derived from CVF is a promising candidate biomarker for the precancerous state of cervical cancer. Further studies regarding sensitivity and specificity of this biomarker will demonstrate its utility for improving current screening programs and/or its use for a cervical cancer self-diagnosis test.	[Van Raemdonck, Geert A. A.; Coen, Edmond P.; Van Ostade, Xaveer W. M.] Univ Antwerp, Ctr Prote & Mass Spectrometry CeProMa, Antwerp, Belgium; [Van Raemdonck, Geert A. A.; Coen, Edmond P.; Van Ostade, Xaveer W. M.] Univ Antwerp, Lab Prot Sci Prote & Epigenet Signaling PPES, Antwerp, Belgium; [Tjalma, Wiebren A. A.] Univ Antwerp Hosp, Dept Gynaecol & Gynaecol Oncol, Edegem, Belgium; [Depuydt, Christophe E.] Sonic Healthcare Benelux, Algemeen Medisch Lab Bvba, Dept Mol Diagnost, Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	Van Ostade, XWM (corresponding author), Univ Antwerp, Ctr Prote & Mass Spectrometry CeProMa, Antwerp, Belgium.	xaveer.vanostade@uantwerpen.be	Van Ostade, Xaveer WMP/D-1702-2015; Depuydt, Christophe/H-8592-2019; Van Ostade, Xaveer/AAG-9587-2020	Van Ostade, Xaveer WMP/0000-0003-4078-3014; Depuydt, Christophe/0000-0003-3462-6557; 	Institute for Science and Technology [093132]	Institute for Science and Technology	GVR received a grant from the Institute for Science and Technology (http://www.iwt.be/english/welcome) (project nr. 093132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Arnouk H, 2009, PROTEOM CLIN APPL, V3, P516, DOI 10.1002/prca.200800068; Bae SM, 2005, GYNECOL ONCOL, V99, P26, DOI 10.1016/j.ygyno.2005.05.041; Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Bradford L, 2013, CLIN OBSTET GYNECOL, V56, P76, DOI 10.1097/GRF.0b013e31828237ac; Brink AATP, 2006, J CLIN MICROBIOL, V44, P2518, DOI 10.1128/JCM.02440-05; Cerigo H, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012011; Choi YP, 2005, PROTEOMICS, V5, P1481, DOI 10.1002/pmic.200401021; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P504, DOI 10.1016/j.tem.2010.03.005; Crosignani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-642; Depuydt CE, 2007, J CELL MOL MED, V11, P881, DOI 10.1111/j.1582-4934.2007.00073.x; Depuydt CE, 2012, J CELL MOL MED, V16, P3096, DOI 10.1111/j.1582-4934.2012.01631.x; Dzuba IG, 2002, J WOMEN HEALTH GEN-B, V11, P265, DOI 10.1089/152460902753668466; Einstein MH, 2009, LANCET INFECT DIS, V9, P347, DOI 10.1016/S1473-3099(09)70108-2; Foley KS, 2013, BIOCHEM J, V452, P477, DOI 10.1042/BJ20121824; Gadducci A, 2008, CRIT REV ONCOL HEMAT, V66, P10, DOI 10.1016/j.critrevonc.2007.09.002; Gok M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1040; Good DM, 2007, J PROTEOME RES, V6, P4549, DOI 10.1021/pr070529w; Guo X, 2012, BIOMARKERS, V17, P352, DOI 10.3109/1354750X.2012.673133; Khurana S, 2012, J BIOL CHEM, V287, P35418, DOI 10.1074/jbc.M112.401364; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kjaer SK, 2016, BMJ-BRIT MED J, V353, DOI [10.1136/bmj.325.7364.572, 10.1136/bmj.i2820]; Lee KA, 2005, GYNECOL ONCOL, V99, P142, DOI 10.1016/j.ygyno.2005.05.039; Lin YW, 2006, INT J GYNECOL CANCER, V16, P1216, DOI 10.1111/j.1525-1438.2006.00583.x; Lomnytska MI, 2010, PROTEOM CLIN APPL, V4, P17, DOI 10.1002/prca.200900086; Maglennon GA, 2011, VIROLOGY, V414, P153, DOI 10.1016/j.virol.2011.03.019; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Nakatsuji H, 2008, MOL CELL BIOL, V28, P3324, DOI 10.1128/MCB.00144-08; Paavonen J, 2007, INT J INFECT DIS, V11, pS3, DOI 10.1016/S1201-9712(07)60015-0; Parker CE, 2014, MOL ONCOL, V8, P840, DOI 10.1016/j.molonc.2014.03.006; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Sjoeborg KD, 2010, GYNECOL ONCOL, V118, P29, DOI 10.1016/j.ygyno.2010.03.007; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Trottier H, 2010, CANCER RES, V70, P8569, DOI 10.1158/0008-5472.CAN-10-0621; Uleberg KE, 2011, CELL ONCOL, V34, P443, DOI 10.1007/s13402-011-0047-3; Wong YF, 2004, CANCER LETT, V211, P227, DOI 10.1016/j.canlet.2004.02.014; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Yamada S, 2010, INT J ORAL MAX SURG, V39, P61, DOI 10.1016/j.ijom.2009.10.003; Yamakawa K, 2007, J ANDROL, V28, P858, DOI 10.2164/jandrol.107.002824; Yamamoto S, 2012, HISTOPATHOLOGY, V60, P1073, DOI 10.1111/j.1365-2559.2011.04163.x; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Zegels G, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-63; Zegels G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-17; Zhu XQ, 2009, GYNECOL ONCOL, V112, P248, DOI 10.1016/j.ygyno.2008.09.045	47	33	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106488	10.1371/journal.pone.0106488	http://dx.doi.org/10.1371/journal.pone.0106488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215525	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300015
J	Baig, UI; Bhadbhade, BJ; Mariyam, D; Watve, MG				Baig, Ulfat I.; Bhadbhade, Bharati J.; Mariyam, Dincy; Watve, Milind G.			Protein Aggregation in E-coli: Short Term and Long Term Effects of Nutrient Density	PLOS ONE			English	Article							HEAT-SHOCK; FLUORESCENCE; SEGREGATION; CHAPERONES; EVOLUTION; DEATH	During exponential growth some cells of E. coli undergo senescence mediated by asymmetric segregation of damaged components, particularly protein aggregates. We showed previously that functional cell division asymmetry in E. coli was responsive to the nutritional environment. Short term exposure as well as long term selection in low calorie environments led to greater cell division symmetry and decreased frequency of senescent cells as compared to high calorie environments. We show here that long term selection in low nutrient environment decreased protein aggregation as revealed by fluorescence microscopy and proportion of insoluble proteins. Across selection lines protein aggregation was correlated significantly positively with the RNA content, presumably indicating metabolic rate. This suggests that the effects of caloric restriction on cell division symmetry and aging in E. coli may work via altered protein handling mechanisms. The demonstrable effects of long term selection on protein aggregation suggest that protein aggregation is an evolvable phenomenon rather than being a passive inevitable process. The aggregated proteins progressively disappeared on facing starvation indicating degradation and recycling demonstrating that protein aggregation is a reversible process in E. coli.	[Baig, Ulfat I.; Bhadbhade, Bharati J.] Abasaheb Garware Coll, Dept Microbiol, Pune, Maharashtra, India; [Baig, Ulfat I.; Mariyam, Dincy; Watve, Milind G.] Indian Inst Sci Educ & Res, Dept Biol, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Watve, MG (corresponding author), Indian Inst Sci Educ & Res, Dept Biol, Pune, Maharashtra, India.	milind@iiserpune.ac.in		Mariyam, Dincy/0000-0001-8075-4141	Rajiv Gandhi Science and Technology Commission's Maharashtra Gene Bank Project	Rajiv Gandhi Science and Technology Commission's Maharashtra Gene Bank Project	The authors would like to thank Rajiv Gandhi Science and Technology Commission's Maharashtra Gene Bank Project for the partial funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Ackermann M, 2007, AGING CELL, V6, P235, DOI 10.1111/j.1474-9726.2007.00281.x; Ares Manuel, 2012, Cold Spring Harb Protoc, V2012, P1024, DOI 10.1101/pdb.prot071068; Baig U, 2011, J OBES, V2011, DOI 10.1155/2011/861049; Baig UI, 2014, Q REV BIOL, V89, P209, DOI 10.1086/677572; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Butterfield DA, 2001, MECH AGEING DEV, V122, P945, DOI 10.1016/S0047-6374(01)00249-4; Carrio MM, 2005, J BACTERIOL, V187, P3599, DOI 10.1128/JB.187.10.3599-3601.2005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Coquel AS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003038; de Groot NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009383; Fossum S, 2007, EMBO J, V26, P4514, DOI 10.1038/sj.emboj.7601871; Gallagher SR, 2001, CURRENT PROTOCOLS HU; Jones OR, 2014, NATURE, V505, P169, DOI 10.1038/nature12789; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kumbhar C, 2013, NAT SCI, V05, P26, DOI [10.4236/ns.2013.54A005, DOI 10.4236/ns.2013.54A005]; Kwiatkowska J, 2008, RES MICROBIOL, V159, P651, DOI 10.1016/j.resmic.2008.09.008; Laskowska E, 2004, MICROBIOL-SGM, V150, P247, DOI 10.1099/mic.0.26470-0; Leszczynska D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054737; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Lloyd-Price J, 2012, J BACTERIOL, V194, P1747, DOI 10.1128/JB.06500-11; Lowder M, 2000, APPL ENVIRON MICROB, V66, P3160, DOI 10.1128/AEM.66.8.3160-3165.2000; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Maisonneuve E, 2008, J BACTERIOL, V190, P6070, DOI 10.1128/JB.00736-08; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; NEEL JV, 1962, AM J HUM GENET, V14, P353; Neumann M, 2002, J HISTOCHEM CYTOCHEM, V50, P437, DOI 10.1177/002215540205000315; Olson Bradley J S C, 2007, Curr Protoc Protein Sci, VChapter 3, DOI 10.1002/0471140864.ps0304s48; Rang CU, 2012, MICROBIOL-SGM, V158, P1553, DOI 10.1099/mic.0.057240-0; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; STRANDBERG L, 1991, APPL ENVIRON MICROB, V57, P1669, DOI 10.1128/AEM.57.6.1669-1674.1991; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Watve M, 2013, DOVES DIPLOMATS  SPR, DOI [10.1007/978-01-4614-4409-1_1, DOI 10.1007/978-01-4614-4409-1_1]; Watve M, 2006, P NATL ACAD SCI USA, V103, P14831, DOI 10.1073/pnas.0606499103; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373	40	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107445	10.1371/journal.pone.0107445	http://dx.doi.org/10.1371/journal.pone.0107445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210787	Green Submitted, Green Published, gold			2022-12-27	WOS:000341855900075
J	Klinck, R; Fourrier, A; Thibault, P; Toutant, J; Durand, M; Lapointe, E; Caillet-Boudin, ML; Sergeant, N; Gourdon, G; Meola, G; Furling, D; Puymirat, J; Chabot, B				Klinck, Roscoe; Fourrier, Angelique; Thibault, Philippe; Toutant, Johanne; Durand, Mathieu; Lapointe, Elvy; Caillet-Boudin, Marie-Laure; Sergeant, Nicolas; Gourdon, Genevieve; Meola, Giovanni; Furling, Denis; Puymirat, Jack; Chabot, Benoit			RBFOX1 Cooperates with MBNL1 to Control Splicing in Muscle, Including Events Altered in Myotonic Dystrophy Type 1	PLOS ONE			English	Article							EXPANDED CUG REPEATS; PRE-MESSENGER-RNA; SKELETAL-MUSCLE; GENE-EXPRESSION; MOUSE MODELS; CTG REPEATS; PROTEIN; BRAIN; OVEREXPRESSION; MICE	With the goal of identifying splicing alterations in myotonic dystrophy 1 (DM1) tissues that may yield insights into targets or mechanisms, we have surveyed mis-splicing events in three systems using a RT-PCR screening and validation platform. First, a transgenic mouse model expressing CUG-repeats identified splicing alterations shared with other mouse models of DM1. Second, using cell cultures from human embryonic muscle, we noted that DM1-associated splicing alterations were significantly enriched in cytoskeleton (e.g. SORBS1, TACC2, TTN, ACTN1 and DMD) and channel (e.g. KCND3 and TRPM4) genes. Third, of the splicing alterations occurring in adult DM1 tissues, one produced a dominant negative variant of the splicing regulator RBFOX1. Notably, half of the splicing events controlled by MBNL1 were co-regulated by RBFOX1, and several events in this category were mis-spliced in DM1 tissues. Our results suggest that reduced RBFOX1 activity in DM1 tissues may amplify several of the splicing alterations caused by the deficiency in MBNL1.	[Klinck, Roscoe; Toutant, Johanne; Chabot, Benoit] Univ Sherbrooke, Fac Med & Heath Sci, Dept Microbiol & Infectiol, Sherbrooke, PQ J1K 2R1, Canada; [Klinck, Roscoe; Thibault, Philippe; Durand, Mathieu; Lapointe, Elvy; Chabot, Benoit] Univ Sherbrooke, Fac Med & Heath Sci, Lab Funct Genom, Sherbrooke, PQ J1K 2R1, Canada; [Fourrier, Angelique; Puymirat, Jack] Univ Laval, CHUL Ctr Hosp Univ Quebec, Ctr Rech, Ste Foy, PQ, Canada; [Caillet-Boudin, Marie-Laure; Sergeant, Nicolas] Univ Lille Nord France, Inserm UMR 837, IMPRT IFR114, Lille, France; [Gourdon, Genevieve] Hop Necker EM, Inserm U781, Paris, France; [Gourdon, Genevieve] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France; [Meola, Giovanni] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Furling, Denis] Univ Paris 06, Inst Myol, Paris, France	University of Sherbrooke; University of Sherbrooke; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Milan; UDICE-French Research Universities; Sorbonne Universite	Puymirat, J (corresponding author), Univ Laval, CHUL Ctr Hosp Univ Quebec, Ctr Rech, Ste Foy, PQ, Canada.	jack.puymirat@crcchul.ulaval.ca; benoit.chabot@usherbrooke.ca	Furling, Denis/M-2346-2017; Gourdon, Genevieve/F-2996-2013; Sergeant, Nicolas/O-5467-2017; Meola, Giovanni/K-4775-2016	Furling, Denis/0000-0001-7912-4409; Gourdon, Genevieve/0000-0002-3319-1347; Sergeant, Nicolas/0000-0003-1448-124X; Meola, Giovanni/0000-0001-6396-717X; Chabot, Benoit/0000-0003-0994-0042	Canadian Institutes of Health Research [MOP93917]; Reseau de Medecine Genetique du Quebec - Fonds de recherche en sante du Quebec; Association francaise contre les myopathies [15650]; Muscular Dystrophy Association Canada/Canadian Institutes of Health Research [98658]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Reseau de Medecine Genetique du Quebec - Fonds de recherche en sante du Quebec; Association francaise contre les myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association Canada/Canadian Institutes of Health Research	This work was supported by the Canadian Institutes of Health Research (BC - MOP93917) (http://www.cihr-irsc.gc.ca/e/193.html); Reseau de Medecine Genetique du Quebec - Fonds de recherche en sante du Quebec (JP) (http://www.rmga.qc.ca/en/index.html, http://www.frsq.gouv.qc.ca/fr/index.shtml); Association francaise contre les myopathies (JP - 15650) (http://www.afm-telethon.com/); and Muscular Dystrophy Association Canada/Canadian Institutes of Health Research (JP - 98658) (http://mda.org/, http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Beaulieu D, 2012, NEUROBIOL DIS, V45, P122, DOI 10.1016/j.nbd.2011.06.014; Bland CS, 2010, NUCLEIC ACIDS RES, V38, P7651, DOI 10.1093/nar/gkq614; Burkin DJ, 1998, J CELL BIOL, V143, P1067, DOI 10.1083/jcb.143.4.1067; Carpentier C, 2014, BBA-MOL BASIS DIS, V1842, P654, DOI 10.1016/j.bbadis.2014.01.004; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; Dhaenens CM, 2008, EXP NEUROL, V210, P467, DOI 10.1016/j.expneurol.2007.11.020; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Furling D, 2001, HUM MOL GENET, V10, P2079, DOI 10.1093/hmg/10.19.2079; Gallagher TL, 2011, DEV BIOL, V359, P251, DOI 10.1016/j.ydbio.2011.08.025; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Gomes-Pereira M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030052; Gomes-Pereira M, 2011, TRENDS MOL MED, V17, P506, DOI 10.1016/j.molmed.2011.05.004; Hall MP, 2013, RNA, V19, P627, DOI 10.1261/rna.038422.113; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hao MQ, 2008, DEV DYNAM, V237, P403, DOI 10.1002/dvdy.21428; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Howell VM, 2008, GENETICS, V180, P1419, DOI 10.1534/genetics.108.094227; Howell VM, 2007, HUM MOL GENET, V16, P2506, DOI 10.1093/hmg/ddm206; Huguet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003043; Huichalaf C, 2010, FASEB J, V24, P3706, DOI 10.1096/fj.09-151159; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kiehl TR, 2001, MAMM GENOME, V12, P595, DOI 10.1007/s00335-001-2056-4; Kim DH, 2005, NUCLEIC ACIDS RES, V33, P3866, DOI 10.1093/nar/gki698; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Kolmerer B, 1996, J MOL BIOL, V256, P556, DOI 10.1006/jmbi.1996.0108; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Kuyumcu-Martinez NM, 2006, PROG MOLEC, V44, P133; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Machuca-Tzili LE, 2011, DIS MODEL MECH, V4, P381, DOI 10.1242/dmm.004150; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2005, CIRC RES, V97, P1152, DOI 10.1161/01.RES.0000193598.89753.e3; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Molinari S, 2004, MOL CELL BIOL, V24, P2944, DOI 10.1128/MCB.24.7.2944-2957.2004; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Orengo JP, 2011, ANN NEUROL, V69, P681, DOI 10.1002/ana.22278; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Pistoni M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003186; Rensen S, 2000, CYTOGENET CELL GENET, V89, P225, DOI 10.1159/000015619; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Tiwari S, 2006, IEEE T NANOTECHNOL, V5, P1, DOI 10.1109/TNANO.2005.861407; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Velazquez-Bernardino P, 2012, MOL BIOL REP, V39, P415, DOI 10.1007/s11033-011-0753-y; Venables JP, 2008, CANCER RES, V68, P9525, DOI 10.1158/0008-5472.CAN-08-1769; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Venables JP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3480; Venables JP, 2013, MOL CELL BIOL, V33, P396, DOI 10.1128/MCB.01174-12; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Ward AJ, 2010, HUM MOL GENET, V19, P3614, DOI 10.1093/hmg/ddq277; Yamashita Y, 2012, J HUM GENET, V57, P368, DOI 10.1038/jhg.2012.37; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355	70	33	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107324	10.1371/journal.pone.0107324	http://dx.doi.org/10.1371/journal.pone.0107324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211016	Green Submitted, Green Published, gold			2022-12-27	WOS:000341855900061
J	Wu, FF; He, XF; Shen, HW; Qin, GJ				Wu, Fei-Fei; He, Xiao-Feng; Shen, Hu-Wei; Qin, Gui-Jun			Association between the XRCC1 Polymorphisms and Thyroid Cancer Risk: A Meta-Analysis from Case-Control Studies	PLOS ONE			English	Article							EXCISION-REPAIR GENES; DNA-REPAIR; CARCINOMA RISK; VARIANTS; ARG194TRP; ARG280HIS; ARG399GLN; BIAS	Background: The previous published data on the association between the X-ray repair cross-conplementation group 1 (XRCC1) polymorphisms and thyroid cancer risk remained controversial. Hence, we performed a meta-analysis on all available studies that provided 1729 cases and 3774 controls (from 11 studies) for XRCC1 Arg399Gln, 1040 cases and 2487 controls for Arg194Trp (from 7 studies), and 1432 cases and 3356 controls for Arg280His (from 8 studies). Methodology/Principal Findings: PubMed, CNKI, and EMBASE database were searched to identify relevant studies. Overall, no significant association was found between XRCC1 Arg399Gln (recessive model: OR = 0.95, 95% CI = 0.77-1.15; dominant model: OR = 0.89, 95% CI = 0.75-1.05; homozygote model: OR = 0.92, 95% CI = 0.69-1.23; Heterozygote model: OR = 0.91, 95% CI = 0.80-1.03; additive model: OR = 0.93, 95% CI = 0.81-1.07), Arg194Trp (recessive model: OR = 1.41, 95% CI = 0.62-3.23; dominant model: OR = 1.01, 95% CI = 0.77-1.34; homozygote model: OR = 1.42, 95% CI = 0.55-3.67; Heterozygote model: OR = 1.03, 95% CI = 0.85-1.26; additive model: OR = 1.08, 95% CI = 0.81-1.42), and Arg280His (recessive model: OR = 1.08, 95% CI = 0.56-2.10; dominant model: OR = 1.01, 95% CI = 0.84-1.22; homozygote model: OR = 1.00, 95% CI = 0.51-1.96; Heterozygote model: OR = 1.04, 95% CI = 0.75-1.42; additive model: OR = 1.03, 95% CI = 0.86-1.23) and thyroid cancer risk when all the eligible studies were pooled into the meta-analysis. In the further stratified and sensitivity analyses, significant association was still not found in these three genetic polymorphisms. Conclusions/Significance: In summary, this meta-analysis indicates that XRCC1 Arg399Gln, Arg280His, and Arg194Trp are not associated with thyroid cancer.	[Wu, Fei-Fei; Qin, Gui-Jun] Zhengzhou Univ, Affiliated Hosp 1, Dept Endocrinol, Zhengzhou 450052, Peoples R China; [He, Xiao-Feng] Changzhi Med Coll, Peace Hosp, Dept Res, Changzhi, Peoples R China; [Shen, Hu-Wei] Changzhi Med Coll, Peace Hosp, Dept Endocrinol, Changzhi, Peoples R China	Zhengzhou University; Changzhi Medical College; Changzhi Medical College	Qin, GJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Endocrinol, Zhengzhou 450052, Peoples R China.	qinguijun123@163.com						Akulevich NM, 2009, ENDOCR-RELAT CANCER, V16, P491, DOI 10.1677/ERC-08-0336; Bao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064851; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Chiang FY, 2008, CLIN CANCER RES, V14, P5919, DOI 10.1158/1078-0432.CCR-08-0906; Davey SG, 1997, LANCET, V350, P1182, DOI DOI 10.1016/S0140-6736(05)63833-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Du Y, 2013, ASIAN PAC J CANCER P, V14, P5483, DOI 10.7314/APJCP.2013.14.9.5483; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fard-Esfahani Pezhman, 2011, Iranian Biomedical Journal, V15, P73; Garcia-Quispes WA, 2011, MUTAT RES-FUND MOL M, V709-10, P67, DOI 10.1016/j.mrfmmm.2011.03.003; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho T, 2009, THYROID, V19, P129, DOI 10.1089/thy.2008.0153; Hu Z, 2013, GENE, V528, P67, DOI 10.1016/j.gene.2013.07.005; LAMERDIN JE, 1995, GENOMICS, V25, P547, DOI 10.1016/0888-7543(95)80056-R; MANTEL N, 1959, J NATL CANCER I, V22, P719; Neta G, 2011, CARCINOGENESIS, V32, P1231, DOI 10.1093/carcin/bgr100; Preston-Martin S, 2003, CANCER CAUSE CONTROL, V14, P787, DOI 10.1023/A:1026312203045; Qian K, 2012, ASIAN PAC J CANCER P, V13, P6385, DOI 10.7314/APJCP.2012.13.12.6385; Ryu RA, 2011, J KOREAN MED SCI, V26, P991, DOI 10.3346/jkms.2011.26.8.991; Santos LS, 2012, ONCOL REP, V28, P1859, DOI 10.3892/or.2012.1975; Shen MR, 1998, CANCER RES, V58, P604; Shen NR, 1998, NUCLEIC ACIDS RES, V26, P1032, DOI 10.1093/nar/26.4.1032; Sigurdson AJ, 2009, RADIAT RES, V171, P77, DOI 10.1667/RR1327.1; Siraj AK, 2008, J ENDOCRINOL INVEST, V31, P893, DOI 10.1007/BF03346438; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Thacker J, 2003, DNA REPAIR, V2, P655, DOI 10.1016/S1568-7864(03)00062-4; Wang C, 2014, TUMOR BIOL, V35, P4791, DOI 10.1007/s13277-014-1629-2; Wein RO, 2005, OTOLARYNG CLIN N AM, V38, P161, DOI 10.1016/j.otc.2004.09.003; Zhu Qian-Xi, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P702	32	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e87764	10.1371/journal.pone.0087764	http://dx.doi.org/10.1371/journal.pone.0087764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211472	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900001
J	Xing, J; Gao, HJ; Wu, Y; Wu, YN; Li, HW; Yang, RQ				Xing, Jun; Gao, Huijiang; Wu, Yang; Wu, Yani; Li, Hongwang; Yang, Runqing			Generalized Linear Model for Mapping Discrete Trait Loci Implemented with LASSO Algorithm	PLOS ONE			English	Article							REGRESSION MIXTURE MODEL; COMPLEX BINARY TRAITS; OUTBRED POPULATIONS; ORDINAL TRAITS; EM ALGORITHM; CROSSES; RESISTANCE	Generalized estimating equation (GEE) algorithm under a heterogeneous residual variance model is an extension of the iteratively reweighted least squares (IRLS) method for continuous traits to discrete traits. In contrast to mixture model-based expectation-maximization (EM) algorithm, the GEE algorithm can well detect quantitative trait locus (QTL), especially large effect QTLs located in large marker intervals in the manner of high computing speed. Based on a single QTL model, however, the GEE algorithm has very limited statistical power to detect multiple QTLs because of ignoring other linked QTLs. In this study, the fast least absolute shrinkage and selection operator (LASSO) is derived for generalized linear model (GLM) with all possible link functions. Under a heterogeneous residual variance model, the LASSO for GLM is used to iteratively estimate the non-zero genetic effects of those loci over entire genome. The iteratively reweighted LASSO is therefore extended to mapping QTL for discrete traits, such as ordinal, binary, and Poisson traits. The simulated and real data analyses are conducted to demonstrate the efficiency of the proposed method to simultaneously identify multiple QTLs for binary and Poisson traits as examples.	[Xing, Jun] Harbin Med Univ, Tumor Hosp, Dept Gastroenterol, Harbin, Peoples R China; [Gao, Huijiang; Wu, Yang] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Wu, Yani; Li, Hongwang] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Yang, Runqing] Chinese Acad Fishery Sci, Res Ctr Fisheries Resource & Environm, Beijing, Peoples R China	Harbin Medical University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Shanghai Jiao Tong University; Chinese Academy of Fishery Sciences	Yang, RQ (corresponding author), Chinese Acad Fishery Sci, Res Ctr Fisheries Resource & Environm, Beijing, Peoples R China.	runqing_yang@yahoo.com	Wu, Yang/D-6754-2017	Wu, Yang/0000-0002-0128-7280	National Natural Science Foundations of China [30972077, 31172190]; Applied National Science and Technology Support Program in China [2012BAD26B01]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Applied National Science and Technology Support Program in China	This work was financially supported by the National Natural Science Foundations of China (30972077 and 31172190) and the Applied National Science and Technology Support Program in China (2012BAD26B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHURCHILL GA, 1994, GENETICS, V138, P963; Cui YH, 2006, GENETICS, V174, P2159, DOI 10.1534/genetics.106.061960; Cui YH, 2009, J THEOR BIOL, V256, P276, DOI 10.1016/j.jtbi.2008.10.003; Deng WP, 2006, GENETICS, V172, P1349, DOI 10.1534/genetics.105.047241; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hackett CA, 1995, BIOMETRICS, V51, P1252, DOI 10.2307/2533257; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Huang N, 1997, MOL BREEDING, V3, P105, DOI 10.1023/A:1009683603862; LANDER ES, 1989, GENETICS, V121, P185; Lange C, 2001, GENETICS, V159, P1325; Li J, 2006, GENETICS, V173, P1649, DOI 10.1534/genetics.105.054619; Liu Y, 2012, BRIEF BIOINFORM; McCullagh J. A., 1989, GEN LINEAR MODELS; Rao SQ, 1998, HEREDITY, V81, P214, DOI 10.1038/sj.hdy.6883780; Sillanpaa MJ, 1998, GENETICS, V148, P1373; Sundberg JP, 2003, MAJOR LOCUS MOUSE CH, P771; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725; Xu C, 2005, HEREDITY, V94, P119, DOI 10.1038/sj.hdy.6800583; Xu SZ, 2010, GENET RES, V92, P423, DOI 10.1017/S0016672310000583; Xu SZ, 1998, BEHAV GENET, V28, P341, DOI 10.1023/A:1021617618150; Xu SZ, 2003, GENET RES, V82, P127, DOI 10.1017/S0016672303006414; Xu SZ, 1996, GENETICS, V143, P1417; Yan JQ, 1998, GENETICS, V150, P1257; Yi NJ, 2007, GENETICS, V176, P1855, DOI 10.1534/genetics.107.071142; Yi NJ, 2009, GENETICS, V181, P1101, DOI 10.1534/genetics.108.099556; Yi NJ, 1999, HEREDITY, V82, P668, DOI 10.1046/j.1365-2540.1999.00529.x; Yi NJ, 1999, GENETICS, V153, P1029; Yi NJ, 2000, GENETICS, V155, P1391; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x	29	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106985	10.1371/journal.pone.0106985	http://dx.doi.org/10.1371/journal.pone.0106985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210765	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900035
J	Yoshizaki, T; Midorikawa, T; Hasegawa, K; Mitani, T; Komatsu, T; Togo, F				Yoshizaki, Takahiro; Midorikawa, Toru; Hasegawa, Kohe; Mitani, Takeshi; Komatsu, Taiki; Togo, Fumiharu			Associations between Diurnal 24-Hour Rhythm in Ambulatory Heart Rate Variability and the Timing and Amount of Meals during the Day Shift in Rotating Shift Workers	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; CIRCADIAN-RHYTHM; NIGHT-WORK; CLOCK; PHASE; MELATONIN; NUCLEUS; HEALTH; MODEL; RISK	It has not hitherto been clarified whether there is an association between dietary behavior and circadian variation in autonomic nervous system activity among shift workers. This study examines diurnal 24-h rhythm in heart rate variability (HRV) and dietary behavior among rotating shift workers, while taking into account the sleep-wake cycle and physical activity. The subjects were 11 female and 2 male nurses or caregivers working in a rotating 2-shift system at a health care facility. All the subjects were asked to undergo 24-h electrocardiograph and step count recordings, and to record the time of each meal and the amounts of each food and beverage consumed. Coarse graining spectral analysis was used for approximately 10-min segments of HRV to derive the total power (TOT: >0.04 Hz) of the periodic components and the integrated power of periodic components in the low-frequency (LF: 0.04-0.15 Hz) and high-frequency (HF: >0.15 Hz) ranges. Then the ratio of HF power to TOT (HF nu) and the ratio of LF power to HF power (LF/HF) were calculated to assess cardiac vagal tone and cardiac sympathovagal balance, respectively. Single cosinor analysis was used to obtain 24-h period variations in both variables of HRV. Acrophases of HF nu and LF/HF expressed in time since awakening were significantly (p < 0.05) delayed for subjects having breakfast at a later time after awakening. Multivariable regression analysis indicated that the timing of breakfast, the ratio of energy intake at dinner to total energy intake, and total energy intake were correlated to the acrophases of HF nu and/or LF/HF. These results suggest that the phase angle between circadian variation in cardiac autonomic nervous system activity and the sleep-wake cycle may be associated with dietary behavior in shift workers.	[Yoshizaki, Takahiro] Tokyo Univ Agr, Grad Sch Agr, Tokyo, Japan; [Yoshizaki, Takahiro] Toyo Univ, Fac Food & Nutr Sci, Tokyo, Japan; [Midorikawa, Toru; Hasegawa, Kohe; Mitani, Takeshi] Med Corp Doaikai, Hlth Care Facil, Chiba, Japan; [Komatsu, Taiki] Tokyo Univ Technol, Dept Phys Therapy, Sch Hlth Sci, Tokyo, Japan; [Togo, Fumiharu] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo, Japan	Tokyo University of Agriculture; Toyo University; Tokyo University of Technology; University of Tokyo	Togo, F (corresponding author), Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo, Japan.	tougou@p.u-tokyo.ac.jp			Japan Society for the Promotion of Science [20800085, 22500690]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a grant from the Japan Society for the Promotion of Science to FT (Grant-in-Aid for start-up 20800085, Scientific Research (C) 22500690). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1984, SCAND J WORK ENV HEA, V10, P409, DOI 10.5271/sjweh.2302; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Arendt J, 2010, OCCUP MED-OXFORD, V60, P10, DOI 10.1093/occmed/kqp162; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; Camm AJ, 1996, CIRCULATION, V93, P1043; Costa G, 2003, OCCUP MED-OXFORD, V53, P83, DOI 10.1093/occmed/kqg045; DEBOER RW, 1984, IEEE T BIO-MED ENG, V31, P384, DOI 10.1109/TBME.1984.325351; Fujino Y, 2006, AM J EPIDEMIOL, V164, P128, DOI 10.1093/aje/kwj185; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Goel N, 2009, J BIOL RHYTHM, V24, P85, DOI 10.1177/0748730408328914; Goichot B, 1998, AM J PHYSIOL-ENDOC M, V275, pE243, DOI 10.1152/ajpendo.1998.275.2.E243; HAMILTON PS, 1986, IEEE T BIO-MED ENG, V33, P1157, DOI 10.1109/TBME.1986.325695; Hu K, 2008, J BIOL RHYTHM, V23, P265, DOI 10.1177/0748730408316166; Kuroda H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00711; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Massin MM, 2000, ARCH DIS CHILD, V83, P179, DOI 10.1136/adc.83.2.179; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Nguyen J, 2010, NAT SCI SLEEP, V2, P9; Oyama Y, 2014, SHOCK, V41, P214, DOI 10.1097/SHK.0000000000000094; Patton DF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00185; Prasai MJ, 2008, DIABETES VASC DIS RE, V5, P89, DOI 10.3132/dvdr.2008.015; Ribeiro DCO, 1998, J ENDOCRINOL, V158, P305, DOI 10.1677/joe.0.1580305; SACK RL, 1992, SLEEP, V15, P434, DOI 10.1093/sleep/15.5.434; Salgado-Delgado R, 2008, NEUROSCIENCE, V154, P922, DOI 10.1016/j.neuroscience.2008.03.066; Salgado-Delgado R, 2010, J BIOL RHYTHM, V25, P421, DOI 10.1177/0748730410383403; SAUL JP, 1990, NEWS PHYSIOL SCI, V5, P32, DOI 10.1152/physiologyonline.1990.5.1.32; Scheer FAJL, 2001, AM J PHYSIOL-HEART C, V280, pH1391, DOI 10.1152/ajpheart.2001.280.3.H1391; Scheer FAJL, 2013, OBESITY, V21, P421, DOI 10.1002/oby.20351; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Science and Technology Agency, 2005, STAND TABL FOOD COMP, V5th ed.; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Togo F, 2005, INT J BIOMETEOROL, V50, P83, DOI 10.1007/s00484-005-0277-z; Togo F, 2009, IND HEALTH, V47, P589, DOI 10.2486/indhealth.47.589; Vandewalle G, 2007, J SLEEP RES, V16, P148, DOI 10.1111/j.1365-2869.2007.00581.x; Walters JF, 2003, MED SCI MONITOR, V9, pRA1; Wehrens SM, 2012, SCAND J WORK ENV HEA, V38, P171, DOI 10.5271/sjweh.3197; YAMAMOTO Y, 1994, AM J PHYSIOL, V266, pR40, DOI 10.1152/ajpregu.1994.266.1.R40; YAMAMOTO Y, 1991, J APPL PHYSIOL, V71, P1143, DOI 10.1152/jappl.1991.71.3.1143; Yannielli PC, 2007, J NEUROSCI, V27, P2890, DOI 10.1523/JNEUROSCI.3913-06.2007; Yoshida C, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-78; Yoshizaki T., 2010, Journal of Japanese Society of Nutrition and Food Science, V63, P161; Yoshizaki T, 2013, EUR J APPL PHYSIOL, V113, P2603, DOI 10.1007/s00421-013-2702-z; Yoshizaki T, 2013, PHYSIOL BEHAV, V118, P122, DOI 10.1016/j.physbeh.2013.05.010; Yoshizaki T, 2013, J BIOL RHYTHM, V28, P227, DOI 10.1177/0748730413489957	48	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106643	10.1371/journal.pone.0106643	http://dx.doi.org/10.1371/journal.pone.0106643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211024	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900021
J	Arnold, C; Ghezzehei, TA; Berhe, AA				Arnold, Chelsea; Ghezzehei, Teamrat A.; Berhe, Asmeret Asefaw			Early Spring, Severe Frost Events, and Drought Induce Rapid Carbon Loss in High Elevation Meadows	PLOS ONE			English	Article							WINTER WARMING EVENTS; CLIMATE-CHANGE; FLOWERING PHENOLOGY; MICROBIAL ACTIVITY; SNOW DEPTH; ALPINE; CALIFORNIA; MINERALIZATION; DECOMPOSITION; VARIABILITY	By the end of the 20th century, the onset of spring in the Sierra Nevada mountain range of California has been occurring on average three weeks earlier than historic records. Superimposed on this trend is an increase in the presence of highly anomalous "extreme'' years, where spring arrives either significantly late or early. The timing of the onset of continuous snowpack coupled to the date at which the snowmelt season is initiated play an important role in the development and sustainability of mountain ecosystems. In this study, we assess the impact of extreme winter precipitation variation on aboveground net primary productivity and soil respiration over three years (2011 to 2013). We found that the duration of snow cover, particularly the timing of the onset of a continuous snowpack and presence of early spring frost events contributed to a dramatic change in ecosystem processes. We found an average 100% increase in soil respiration in 2012 and 2103, compared to 2011, and an average 39% decline in aboveground net primary productivity observed over the same time period. The overall growing season length increased by 57 days in 2012 and 61 days in 2013. These results demonstrate the dependency of these keystone ecosystems on a stable climate and indicate that even small changes in climate can potentially alter their resiliency.	[Arnold, Chelsea; Ghezzehei, Teamrat A.; Berhe, Asmeret Asefaw] Univ Calif Merced, Sch Nat Sci, Atwater, CA 95301 USA	University of California System; University of California Merced	Berhe, AA (corresponding author), Univ Calif Merced, Sch Nat Sci, Atwater, CA 95301 USA.	AABerhe@UCMerced.edu	Ghezzehei, Teamrat A./G-7483-2011; Berhe, Asmeret Asefaw/D-4179-2011	Ghezzehei, Teamrat A./0000-0002-0287-6212; Berhe, Asmeret Asefaw/0000-0002-6986-7943	University of California Merced startup funds; Graduate Research Council	University of California Merced startup funds; Graduate Research Council	Funding for this study was provided by University of California Merced startup funds and Graduate Research Council grants to AAB and TAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDIAZ BH, 1991, AM MIDL NAT, V126, P30, DOI 10.2307/2426147; Alm J, 1999, ECOLOGY, V80, P161, DOI 10.1890/0012-9658(1999)080[0161:CBOABB]2.0.CO;2; Aurela M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020315; Bales RC, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004387; Baptist F, 2010, PLANT BIOLOGY, V12, P755, DOI 10.1111/j.1438-8677.2009.00286.x; Berhe AA, 2013, EARTH SURF PROC LAND, V38, P908, DOI 10.1002/esp.3408; Berhe AA, 2012, PLANT SOIL, V358, P371, DOI 10.1007/s11104-012-1156-0; Berlow EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072200; Bokhorst S, 2011, GLOBAL CHANGE BIOL, V17, P2817, DOI 10.1111/j.1365-2486.2011.02424.x; Bokhorst SF, 2009, J ECOL, V97, P1408, DOI 10.1111/j.1365-2745.2009.01554.x; Brown KA, 2013, THESIS CALIFORNIA ST; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Chivers MR, 2009, ECOSYSTEMS, V12, P1329, DOI 10.1007/s10021-009-9292-y; Clymo R. S., 1983, Mines: swamp, bog, fen and moor. General Studies. Vol.A., P159; Craine JM, 2012, P NATL ACAD SCI USA, V109, P3401, DOI 10.1073/pnas.1118438109; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Forrest J, 2010, ECOLOGY, V91, P431, DOI 10.1890/09-0099.1; Galvagno M, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025008; Hammersmark CT, 2008, RIVER RES APPL, V24, P735, DOI 10.1002/rra.1077; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Inouye D, 2001, ECOL LETT, V3, P457; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Inouye DW, 2002, OECOLOGIA, V130, P543, DOI 10.1007/s00442-001-0835-y; Jentsch A, 2008, CR GEOSCI, V340, P621, DOI 10.1016/j.crte.2008.07.002; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Jordan RP, 1978, THESIS U BRIT COLUMB; Kapnick S, 2009, CEC5002009016F PIER; Laiho R, 2006, SOIL BIOL BIOCHEM, V38, P2011, DOI 10.1016/j.soilbio.2006.02.017; Lipson DA, 2002, MICROB ECOL, V43, P307, DOI 10.1007/s00248-001-1057-x; Loheide SP, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007329; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nemergut DR, 2005, RES MICROBIOL, V156, P775, DOI 10.1016/j.resmic.2005.03.004; Neuner G, 2012, PLANTS IN ALPINE REGIONS: CELL PHYSIOLOGY OF ADAPTION AND SURVIVAL STRATEGIES, P163, DOI 10.1007/978-3-7091-0136-0_12; Null SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009932; ORCHARD VA, 1983, SOIL BIOL BIOCHEM, V15, P447, DOI 10.1016/0038-0717(83)90010-X; Pagano T, 2005, J HYDROMETEOROL, V6, P173, DOI 10.1175/JHM410.1; Price MV, 1998, ECOLOGY, V79, P1261, DOI 10.1890/0012-9658(1998)079[1261:EOEWOP]2.0.CO;2; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Stephens J. C., 1984, Reviews in Engineering Geology, V6, P107; Taylor DW, 1984, VEGETATION H M UNPUB; Thomson JD, 2010, PHILOS T R SOC B, V365, P3187, DOI 10.1098/rstb.2010.0115; TRANQUIL.W, 1964, ANN REV PLANT PHYSIO, V15, P345, DOI 10.1146/annurev.pp.15.060164.002021; Trujillo E, 2012, NAT GEOSCI, V5, P705, DOI [10.1038/NGEO1571, 10.1038/ngeo1571]; United States Department of Agriculture, STAFF SS SOIL SURV G; WALKER MD, 1995, ECOLOGY, V76, P1067, DOI 10.2307/1940916; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wipf S, 2009, CLIMATIC CHANGE, V94, P105, DOI [10.1007/s10584-009-9546-x, 10.1007/s10584-009-9546-X]; Xiang SR, 2008, SOIL BIOL BIOCHEM, V40, P2281, DOI 10.1016/j.soilbio.2008.05.004	50	16	16	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106058	10.1371/journal.pone.0106058	http://dx.doi.org/10.1371/journal.pone.0106058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207640	gold, Green Published			2022-12-27	WOS:000342030300015
J	Ensing, EP; Ciuti, S; de Wijs, FALM; Lentferink, DH; ten Hoedt, A; Boyce, MS; Hut, RA				Ensing, Erik P.; Ciuti, Simone; de Wijs, Freek A. L. M.; Lentferink, Dennis H.; ten Hoedt, Andre; Boyce, Mark S.; Hut, Roelof A.			GPS Based Daily Activity Patterns in European Red Deer and North American Elk (Cervus elaphus): Indication for a Weak Circadian Clock in Ungulates	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; BODY-TEMPERATURE; ROE DEER; BEHAVIOR; REINDEER; RHYTHMS; RADIOTELEMETRY; ORGANIZATION; MELATONIN; PREDATOR	Long-term tracking using global positioning systems (GPS) is widely used to study vertebrate movement ecology, including fine-scale habitat selection as well as large-scale migrations. These data have the potential to provide much more information about the behavior and ecology of wild vertebrates: here we explore the potential of using GPS datasets to assess timing of activity in a chronobiological context. We compared two different populations of deer (Cervus elaphus), one in the Netherlands (red deer), the other in Canada (elk). GPS tracking data were used to calculate the speed of the animals as a measure for activity to deduce unbiased daily activity rhythms over prolonged periods of time. Speed proved a valid measure for activity, this being validated by comparing GPS based activity data with head movements recorded by activity sensors, and the use of GPS locations was effective for generating long term chronobiological data. Deer showed crepuscular activity rhythms with activity peaks at sunrise (the Netherlands) or after sunrise (Canada) and at the end of civil twilight at dusk. The deer in Canada were mostly diurnal while the deer in the Netherlands were mostly nocturnal. On an annual scale, Canadian deer were more active during the summer months while deer in the Netherlands were more active during winter. We suggest that these differences were mainly driven by human disturbance (on a daily scale) and local weather (on an annual scale). In both populations, the crepuscular activity peaks in the morning and evening showed a stable timing relative to dawn and dusk twilight throughout the year, but marked periods of daily a-rhythmicity occurred in the individual records. We suggest that this might indicate that (changes in) light levels around twilight elicit a direct behavioral response while the contribution of an internal circadian timing mechanism might be weak or even absent.	[Ensing, Erik P.; de Wijs, Freek A. L. M.; Lentferink, Dennis H.; Hut, Roelof A.] Univ Groningen, Ctr Behaviour & Neurosci, Chronobiol Unit, Groningen, Netherlands; [Ciuti, Simone] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79106 Freiburg, Germany; [Ciuti, Simone; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [ten Hoedt, Andre] Nat Monumenten, Eenheid Veluwezoom, Rheden, Netherlands	University of Groningen; University of Freiburg; University of Alberta	Hut, RA (corresponding author), Univ Groningen, Ctr Behaviour & Neurosci, Chronobiol Unit, Groningen, Netherlands.	r.a.hut@rug.nl	Hut, Roelof A./I-3483-2012; Boyce, Mark S/A-2620-2014; Ciuti, Simone/D-7283-2013	Boyce, Mark S/0000-0001-5811-325X; Ciuti, Simone/0000-0003-1052-9509; Lentferink, Dennis/0000-0002-8747-1336	Alberta Conservation Association (ACA - Grant Eligible Conservation Fund) [ACA GECF 030-00-90-176]; Natural Sciences and Engineering Research Council of Canada (NSERC-CRD) [CRD 364323]; Shell Canada limited; Alberta Conservation Association (ACA - Grant Eligible Conservation Fund); Natural Sciences and Engineering Research Council of Canada (NSERC-CRD)	Alberta Conservation Association (ACA - Grant Eligible Conservation Fund); Natural Sciences and Engineering Research Council of Canada (NSERC-CRD)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Shell Canada limited; Alberta Conservation Association (ACA - Grant Eligible Conservation Fund); Natural Sciences and Engineering Research Council of Canada (NSERC-CRD)(Natural Sciences and Engineering Research Council of Canada (NSERC))	MSB and SC received funding from the Alberta Conservation Association (ACA - Grant Eligible Conservation Fund; ACA GECF 030-00-90-176 Boyce), the Natural Sciences and Engineering Research Council of Canada (NSERC-CRD; CRD 364323), and Shell Canada limited. URLs: http://www.montaneelk.com/; http://www.ab-conservation.com/go/default/; http://www.businessbiodiversity.ca/documents/14-Shell.pdf; http://www.nserc-crsng.gc.ca/Professors-Professeurs/rpp-pp/crd-rdc_eng.asp. Sponsor role: This study was funded by Alberta Conservation Association (ACA - Grant Eligible Conservation Fund), the Natural Sciences and Engineering Research Council of Canada (NSERC-CRD), and Shell Canada limited, as declared in the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce MS, 2010, PHILOS T R SOC B, V365, P2213, DOI 10.1098/rstb.2010.0080; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Clair CCS, 2009, BEHAVIOUR, V146, P393, DOI 10.1163/156853909X410973; DAAN S, 1975, OECOLOGIA, V18, P269, DOI 10.1007/BF00345851; EBLING FJP, 1988, J BIOL RHYTHM, V3, P365, DOI 10.1177/074873048800300406; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; GEORGII B, 1981, OECOLOGIA, V49, P127, DOI 10.1007/BF00376910; GEORGII B, 1983, OECOLOGIA, V58, P238, DOI 10.1007/BF00399224; Hut RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0433; Hut RA, 2012, PROG BRAIN RES, V199, P281, DOI 10.1016/B978-0-444-59427-3.00017-4; Jayakody S, 2008, WILDLIFE BIOL, V14, P81, DOI 10.2981/0909-6396(2008)14[81:RDCEVB]2.0.CO;2; Krop-Benesch A, 2013, ITAL J ZOOL, V80, P69, DOI 10.1080/11250003.2012.725777; Loe LE, 2010, J ZOOL, V280, P84, DOI 10.1111/j.1469-7998.2009.00647.x; Loe LE, 2007, OECOLOGIA, V152, P617, DOI 10.1007/s00442-007-0681-7; Loe LE, 2009, P ROY SOC B-BIOL SCI, V276, P2581, DOI 10.1098/rspb.2009.0224; Long RA, 2005, J MAMMAL, V86, P314, DOI 10.1644/BRG-224.1; Murphy Barbara A, 2011, J Circadian Rhythms, V9, P3, DOI 10.1186/1740-3391-9-3; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Pagon N, 2013, CHRONOBIOL INT, V30, P772, DOI 10.3109/07420528.2013.765887; Piccione G, 2013, BIOL RHYTHM RES, V44, P143, DOI 10.1080/09291016.2012.656245; Pipia A, 2008, BEHAVIOUR, V145, P1723, DOI 10.1163/156853908786279628; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Sibbald AM, 2011, EUR J WILDLIFE RES, V57, P817, DOI 10.1007/s10344-011-0493-2; Stokkan KA, 2007, J PINEAL RES, V43, P289, DOI 10.1111/j.1600-079X.2007.00476.x; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; van Oort BEH, 2005, NATURE, V438, P1095, DOI 10.1038/4381095a; van Oort BEH, 2007, NATURWISSENSCHAFTEN, V94, P183, DOI 10.1007/s00114-006-0174-2; Williams CT, 2012, BIOL LETTERS, V8, P31, DOI 10.1098/rsbl.2011.0435	29	76	82	5	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106997	10.1371/journal.pone.0106997	http://dx.doi.org/10.1371/journal.pone.0106997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208246	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300053
J	Yang, J; Chen, L; Kong, XY; Huang, T; Cai, YD				Yang, Jing; Chen, Lei; Kong, Xiangyin; Huang, Tao; Cai, Yu-Dong			Analysis of Tumor Suppressor Genes Based on Gene Ontology and the KEGG Pathway	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; CELL-CYCLE; RETINOBLASTOMA GENE; PROGNOSTIC-FACTORS; BREAST-CANCER; SWI/SNF COMPLEX; BLADDER-CANCER; G(1) CONTROL; P53 GENE; MUTATIONS	Cancer is a serious disease that causes many deaths every year. We urgently need to design effective treatments to cure this disease. Tumor suppressor genes (TSGs) are a type of gene that can protect cells from becoming cancerous. In view of this, correct identification of TSGs is an alternative method for identifying effective cancer therapies. In this study, we performed gene ontology (GO) and pathway enrichment analysis of the TSGs and non-TSGs. Some popular feature selection methods, including minimum redundancy maximum relevance (mRMR) and incremental feature selection (IFS), were employed to analyze the enrichment features. Accordingly, some GO terms and KEGG pathways, such as biological adhesion, cell cycle control, genomic stability maintenance and cell death regulation, were extracted, which are important factors for identifying TSGs. We hope these findings can help in building effective prediction methods for identifying TSGs and thereby, promoting the discovery of effective cancer treatments.	[Yang, Jing; Kong, Xiangyin] Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Inst Hlth Sci, Sch Med, Shanghai 200030, Peoples R China; [Yang, Jing; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Huang, Tao] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Maritime University; Icahn School of Medicine at Mount Sinai; Shanghai University	Kong, XY (corresponding author), Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Inst Hlth Sci, Sch Med, Shanghai 200030, Peoples R China.	xykong@sibs.ac.cn; tohuangtao@126.com; cai_yud@126.com	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; National Natural Science Foundation of China [31371335, 61202021, 61373028, 11371008, 81030015]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087, 12YZ120]; Shanghai Educational Development Foundation [12CG55]; First-class Discipline of Universities in Shanghai	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Educational Development Foundation; First-class Discipline of Universities in Shanghai	This work was supported by the National Basic Research Program of China (2011CB510102, 2011CB510101), the National Natural Science Foundation of China (31371335, 61202021, 61373028, 11371008, 81030015), Innovation Program of Shanghai Municipal Education Commission (12ZZ087, 12YZ120), the Shanghai Educational Development Foundation (12CG55) and the grant from "The First-class Discipline of Universities in Shanghai.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Brandau S, 2001, EUR UROL, V39, P491, DOI 10.1159/000052494; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2013, CURR BIOINFORM, V8, P545, DOI 10.2174/1574893611308050004; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293; Chen L, 2010, J COMPUT CHEM, V31, P1766, DOI 10.1002/jcc.21467; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cramer H., 1946, MATH METHODS STAT; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Delbridge AR, 2012, COLD SPRING HARB PER, V4; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Espada J, 2011, NUCLEIC ACIDS RES, V39, P9194, DOI 10.1093/nar/gkr658; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrison KM, 2008, PUBLIC HEALTH REP, V123, P618, DOI 10.1177/003335490812300512; He Z, 2011, COMPUTATIONAL ANAL P, P35; Hellebrekers DMEI, 2009, CLIN CANCER RES, V15, P3990, DOI 10.1158/1078-0432.CCR-09-0055; Hishida M, 2013, INT J ONCOL, V43, P88, DOI 10.3892/ijo.2013.1951; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Huang T, 2012, BIOCHIMIE, V94, P1017, DOI 10.1016/j.biochi.2011.12.024; Jacob ST, 2005, CANCER GENE THER, V12, P665, DOI 10.1038/sj.cgt.7700828; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katoh M, 2007, STEM CELL REV, V3, P30, DOI 10.1007/s12015-007-0006-6; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kendall M. G, 1979, ADV THEORY STAT, V4th; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; Kim MS, 2013, HUM PATHOL, V44, P2064, DOI 10.1016/j.humpath.2012.11.027; Knowles MA, 2006, CARCINOGENESIS, V27, P361, DOI 10.1093/carcin/bgi310; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Kuligina ES, 2013, FAM CANCER, V12, P129, DOI 10.1007/s10689-012-9575-x; Lee RS, 2013, NAT GENET, V45, P1268, DOI 10.1038/ng.2805; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Levitt NC, 2002, TRENDS MOL MED, V8, P179, DOI 10.1016/S1471-4914(02)02298-0; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043927; Li ZC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-325; Lu ZM, 2008, INT J ONCOL, V32, P643; Lu ZY, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P269; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Mandruzzato S, 1997, J EXP MED, V186, P785, DOI 10.1084/jem.186.5.785; Maroulakou IG, 2003, ANTICANCER RES, V23, P2101; Martin S, 2005, BIOINFORMATICS, V21, P218, DOI 10.1093/bioinformatics/bth483; Matos J, 2014, DNA REPAIR, V19, P176, DOI 10.1016/j.dnarep.2014.03.013; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Milton A, 2006, ONCOGENE, V25, P3212, DOI 10.1038/sj.onc.1209343; Mitrea DM, 2012, BIOL CHEM, V393, P259, DOI 10.1515/hsz-2011-0254; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nicoletto MO, 2001, CANCER TREAT REV, V27, P295, DOI 10.1053/ctrv.2001.0233; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; PIETILAINEN T, 1995, EUR J CANCER, V31A, P329, DOI 10.1016/0959-8049(94)00463-F; Platt  J., 1998, FAST TRAINING SUPPOR; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Risbridger GP, 2010, NAT REV CANCER, V10, P205, DOI 10.1038/nrc2795; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sharifi N, 2012, STEROIDS, V77, P719, DOI 10.1016/j.steroids.2012.03.015; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shiraishi M, 2002, ONCOGENE, V21, P3659, DOI 10.1038/sj.onc.1205453; Shlien A, 2010, CURR OPIN ONCOL, V22, P55, DOI 10.1097/CCO.0b013e328333dca4; Sigglekow ND, 2012, ANTICANCER RES, V32, P73; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Strathdee G, 2007, CARCINOGENESIS, V28, P299, DOI 10.1093/carcin/bgl133; Suzuki M, 2009, CANCER CHEMOTH PHARM, V64, P223, DOI 10.1007/s00280-008-0833-4; Tamura G, 2006, WORLD J GASTROENTERO, V12, P192, DOI 10.3748/wjg.v12.i2.192; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Ting K.M., 1997, STACKING BAGGED DAGG, P367; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; VOLKENANDT M, 1991, PIGM CELL RES, V4, P35, DOI 10.1111/j.1600-0749.1991.tb00311.x; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; WADAYAMA B, 1994, CANCER RES, V54, P3042; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Witten I. H., 2005, DATA MINING PRACTICA; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yan D, 2012, J BIOL CHEM, V287, P8598, DOI 10.1074/jbc.M111.322800; Yang J, 2008, ONCOGENE, V27, P5326, DOI 10.1038/onc.2008.165; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Young LC, 2003, J INVEST DERMATOL, V121, P435, DOI 10.1046/j.1523-1747.2003.12450.x; Zhang XJ, 2004, J INVEST DERMATOL, V122, P658, DOI 10.1111/j.0022-202X.2004.22321.x; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zheng HC, 2007, ANTICANCER RES, V27, P3561	117	52	52	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107202	10.1371/journal.pone.0107202	http://dx.doi.org/10.1371/journal.pone.0107202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207935	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300065
J	Yu, JG; Bonnerud, P; Eriksson, A; Stal, PS; Tegner, Y; Malm, C				Yu, Ji-Guo; Bonnerud, Patrik; Eriksson, Anders; Stal, Per S.; Tegner, Yelverton; Malm, Christer			Effects of Long Term Supplementation of Anabolic Androgen Steroids on Human Skeletal Muscle	PLOS ONE			English	Article							BODY-COMPOSITION; TESTOSTERONE SUPPLEMENTATION; STRENGTH; POWER; HEALTHY; HYPERTROPHY; PARAMETERS; EXERCISE; BLOOD; CELLS	The effects of long-term (over several years) anabolic androgen steroids (AAS) administration on human skeletal muscle are still unclear. In this study, seventeen strength training athletes were recruited and individually interviewed regarding self-administration of banned substances. Ten subjects admitted having taken AAS or AAS derivatives for the past 5 to 15 years (Doped) and the dosage and type of banned substances were recorded. The remaining seven subjects testified to having never used any banned substances (Clean). For all subjects, maximal muscle strength and body composition were tested, and biopsies from the vastus lateralis muscle were obtained. Using histochemistry and immunohistochemistry (IHC), muscle biopsies were evaluated for morphology including fiber type composition, fiber size, capillary variables and myonuclei. Compared with the Clean athletes, the Doped athletes had significantly higher lean leg mass, capillary per fibre and myonuclei per fiber. In contrast, the Doped athletes had significantly lower absolute value in maximal squat force and relative values in maximal squat force (relative to lean body mass, to lean leg mass and to muscle fiber area). Using multivariate statistics, an orthogonal projection of latent structure discriminant analysis (OPLS-DA) model was established, in which the maximal squat force relative to muscle mass and the maximal squat force relative to fiber area, together with capillary density and nuclei density were the most important variables for separating Doped from the Clean athletes (regression = 0.93 and prediction = 0.92, p<0.0001). In Doped athletes, AAS dose-dependent increases were observed in lean body mass, muscle fiber area, capillary density and myonuclei density. In conclusion, long term AAS supplementation led to increases in lean leg mass, muscle fiber size and a parallel improvement in muscle strength, and all were dose-dependent. Administration of AAS may induce sustained morphological changes in human skeletal muscle, leading to physical performance enhancement.	[Yu, Ji-Guo; Malm, Christer] Umea Univ, Dept Surg & Perioperat Sci, Sports Med Unit, Umea, Sweden; [Yu, Ji-Guo; Malm, Christer] Umea Univ, Sch Sport Sci, Umea, Sweden; [Bonnerud, Patrik; Eriksson, Anders; Tegner, Yelverton] Lulea Univ Technol, Dept Hlth Sci, S-95187 Lulea, Sweden; [Malm, Christer] Winternet, Boden, Sweden; [Stal, Per S.] Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden	Umea University; Umea University; Lulea University of Technology; Umea University	Malm, C (corresponding author), Umea Univ, Dept Surg & Perioperat Sci, Sports Med Unit, Umea, Sweden.	Christer.malm@idrott.umu.se	Malm, Christer B/O-3458-2014	Malm, Christer B/0000-0002-8436-2476; Stal, Per/0000-0002-9340-5298; Tegner, Yelverton/0000-0003-3628-0705; Yu, Jiguo/0000-0001-7607-475X	Swedish National Centre for Research in Sports; WADA [08C15CM]	Swedish National Centre for Research in Sports; WADA	This work was supported by grants from the Swedish National Centre for Research in Sports and WADA (Grant 08C15CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berning JM, 2004, J STRENGTH COND RES, V18, P908; Bhasin S, 2006, NAT CLIN PRACT ENDOC, V2, P146, DOI 10.1038/ncpendmet0120; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; BOONE JB, 1990, INT J SPORTS MED, V11, P293, DOI 10.1055/s-2007-1024810; CRIST DM, 1983, J APPL PHYSIOL, V54, P366, DOI 10.1152/jappl.1983.54.2.366; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; ELASHOFF JD, 1991, ANN INTERN MED, V115, P387, DOI 10.7326/0003-4819-115-5-387; Emmelot-Vonk MH, 2008, JAMA-J AM MED ASSOC, V299, P39, DOI 10.1001/jama.2007.51; Eriksson A, 2005, HISTOCHEM CELL BIOL, V124, P167, DOI 10.1007/s00418-005-0029-5; ERIKSSON A, 2006, STRENGTH TRAINING AN; FAHEY TD, 1973, MED SCI SPORT EXER, V5, P272; FOWLER WM, 1965, J APPL PHYSIOL, V20, P1038, DOI 10.1152/jappl.1965.20.5.1038; Friedl K, 2000, ANABOLIC STEROIDS SP, P139; FRIEDL KE, 1991, J STEROID BIOCHEM, V40, P607, DOI 10.1016/0960-0760(91)90283-B; Giorgi A, 1999, J Sci Med Sport, V2, P341, DOI 10.1016/S1440-2440(99)80007-3; Hartgens F, 2004, SPORTS MED, V34, P513, DOI 10.2165/00007256-200434080-00003; Hartgens F, 1996, INT J SPORTS MED, V17, P429, DOI 10.1055/s-2007-972873; Herbst KL, 2004, CURR OPIN CLIN NUTR, V7, P271, DOI 10.1097/00075197-200405000-00006; Hikim IS, 2002, AM J PHYSIOL-ENDOC M, V283, pE154, DOI 10.1152/ajpendo.00502.2001; Hoffman JR, 2009, J STRENGTH COND RES, V23, pS1, DOI 10.1519/JSC.0b013e31819df2e6; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x; Kadi F, 1999, MED SCI SPORT EXER, V31, P1528, DOI 10.1097/00005768-199911000-00006; Kuhn CM, 2002, RECENT PROG HORM RES, V57, P411, DOI 10.1210/rp.57.1.411; KUIPERS H, 1993, CAN J APPL PHYSIOL, V18, P189, DOI 10.1139/h93-015; Malm C, 2000, J PHYSIOL-LONDON, V529, P243, DOI 10.1111/j.1469-7793.2000.00243.x; Malm C, 2004, J PHYSIOL-LONDON, V556, P983, DOI 10.1113/jphysiol.2003.056598; McCall GE, 1998, CAN J APPL PHYSIOL, V23, P594, DOI 10.1139/h98-034; Nordstrom A, 2012, J STRENGTH COND RES, V26, P246, DOI 10.1519/JSC.0b013e318218daf0; Page S, 2008, JAMA-J AM MED ASSOC, V299, P1900, DOI 10.1001/jama.299.16.1900-a; Rogerson S, 2007, J STRENGTH COND RES, V21, P354; Saad F, 2011, EUR J ENDOCRINOL, V165, P675, DOI 10.1530/EJE-11-0221; Sinha-Hikim I, 2003, AM J PHYSIOL-ENDOC M, V285, pE197, DOI 10.1152/ajpendo.00370.2002; Sinha-Hikim I, 2006, J CLIN ENDOCR METAB, V91, P3024, DOI 10.1210/jc.2006-0357; Snyder EM, 2000, ENVIRON SCI POLLUT R, V7, P116, DOI 10.1065/espr199910.010; Stal PS, 2000, J ANAT, V197, P275, DOI 10.1017/S0021878299006627; Storer TW, 2008, J AM GERIATR SOC, V56, DOI 10.1111/j.1532-5415.2008.01927.x; Storer TW, 2003, J CLIN ENDOCR METAB, V88, P1478, DOI 10.1210/jc.2002-021231; Thiblin I, 2005, FUND CLIN PHARMACOL, V19, P27, DOI 10.1111/j.1472-8206.2004.00298.x; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; Weiss U, 1968, Schweiz Z Sportmed, V16, P79; Weitzel LR, 2009, CRIT CARE MED, V37, pS400; Yu JG, 2002, HISTOCHEM CELL BIOL, V118, P171, DOI 10.1007/s00418-002-0427-x; Yu JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062056; Zahner L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-147	45	32	34	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e105330	10.1371/journal.pone.0105330	http://dx.doi.org/10.1371/journal.pone.0105330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207812	Green Published, gold			2022-12-27	WOS:000342030300008
J	Aleksovska, K; Leoncini, E; Bonassi, S; Cesario, A; Boccia, S; Frustaci, A				Aleksovska, Katina; Leoncini, Emanuele; Bonassi, Stefano; Cesario, Alfredo; Boccia, Stefania; Frustaci, Alessandra			Systematic Review and Meta-Analysis of Circulating S100B Blood Levels in Schizophrenia	PLOS ONE			English	Review							INCREASED SERUM S100B; NEURON-SPECIFIC ENOLASE; NEGATIVE SYMPTOMS; S-100B PROTEIN; INFLAMMATION; MARKER; ANTIPSYCHOTICS; DYSFUNCTION; BIOMARKERS; DISORDER	S100B is a calcium-binding protein secreted in central nervous system from astrocytes and other glia cells. High blood S100B levels have been linked to brain damage and psychiatric disorders. S100B levels have been reported to be higher in schizophrenics than healthy controls. To quantify the relationship between S100B blood levels and schizophrenia a systematic literature review of case-control studies published on this topic within July 3rd 2014 was carried out using three bibliographic databases: Medline, Scopus and Web of Science. Studies reporting mean and standard deviation of S100B blood levels both in cases and controls were included in the meta-analysis. The meta-Mean Ratio (mMR) of S100B blood levels in cases compared to controls was used as a measure of effect along with its 95% Confidence Intervals (CI). 20 studies were included totaling for 994 cases and 785 controls. Schizophrenia patients showed 76% higher S100B blood levels than controls with mMR = 1.76 95% CI: 1.44-2.15. No difference could be found between drug-free patients with mMR = 1.84 95% CI: 1.24-2.74 and patients on antipsychotic medication with mMR = 1.75 95% CI: 1.41-2.16). Similarly, ethnicity and stage of disease didn't affect results. Although S100B could be regarded as a possible biomarker of schizophrenia, limitations should be accounted when interpreting results, especially because of the high heterogeneity that remained > 70%, even after carrying out subgroups analyses. These results point out that approaches based on traditional categorical diagnoses may be too restrictive and new approaches based on the characterization of new complex phenotypes should be considered.	[Aleksovska, Katina; Leoncini, Emanuele; Boccia, Stefania] Univ Cattolica Sacro Cuore, Dept Publ Hlth, Inst Publ Hlth, Sect Hyg, Rome, Italy; [Bonassi, Stefano; Frustaci, Alessandra] IRCCS San Raffaele Pisana, Area Syst Approaches & Non Communicable Dis, Unit Clin & Mol Epidemiol, Rome, Italy; [Cesario, Alfredo] IRCCS San Raffaele Pisana, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS San Raffaele Pisana; IRCCS San Raffaele Pisana	Frustaci, A (corresponding author), IRCCS San Raffaele Pisana, Area Syst Approaches & Non Communicable Dis, Unit Clin & Mol Epidemiol, Rome, Italy.	alessandra.frustaci@sanraffaele.it	Bonassi, Stefano/ABI-6281-2020; Boccia, Stefania/AFN-1666-2022; Boccia, Stefania/AAB-9533-2022; CESARIO, Alfredo/O-4215-2015; Frustaci, Alessandra/I-9378-2012; , emanuele/A-5466-2010	Bonassi, Stefano/0000-0003-3833-6717; Boccia, Stefania/0000-0002-1864-749X; Boccia, Stefania/0000-0002-1864-749X; CESARIO, Alfredo/0000-0003-4687-0709; Aleksovska, Katina/0000-0002-2372-4453; , emanuele/0000-0002-7669-8535				ADDINGTON D, 1993, BRIT J PSYCHIAT, V163, P39, DOI 10.1192/S0007125000292581; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Altamura AC, 2013, PROG NEURO-PSYCHOPH, V42, P63, DOI 10.1016/j.pnpbp.2012.08.015; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Anderson G, 2013, PROG NEURO-PSYCHOPH, V42, P1, DOI 10.1016/j.pnpbp.2012.10.008; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Andreasen NC, 1986, PSYCHIATR PSYCHOBIOL, V2, P108, DOI DOI 10.1017/S0767399X00003199; Ashe PC, 2001, PROG NEURO-PSYCHOPH, V25, P691, DOI 10.1016/S0278-5846(01)00159-2; Bousquet J, 2011, GENOME MED, V3, DOI 10.1186/gm259; Bradburn, 2001, SYSTEMATIC REV HLTH, DOI DOI 10.1002/9780470693926.CH15; Buschert J, 2013, J PSYCHIATR RES, V47, P1791, DOI 10.1016/j.jpsychires.2013.08.001; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Cesario A, 2014, CURR PHARM DES, V14; de Souza DF, 2013, PROG NEURO-PSYCHOPH, V43, P14, DOI 10.1016/j.pnpbp.2012.12.001; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Durany N, 2004, EUR PSYCHIAT, V19, P326, DOI 10.1016/j.eurpsy.2004.06.020; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falcone Tatiana, 2015, Clin Schizophr Relat Psychoses, V9, P65, DOI 10.3371/CSRP.FACA.030813; Flores M, 2013, PERS MED, V10, P565, DOI 10.2217/pme.13.57; Friedrich JO, 2011, J CLIN EPIDEMIOL, V64, P556, DOI 10.1016/j.jclinepi.2010.09.016; Fulle S, 2000, EXP PHYSIOL, V85, P243; Garate I, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-151; Gattaz WF, 2000, SCHIZOPHR RES, V43, P91, DOI 10.1016/S0920-9964(99)00146-2; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Grubb NR, 2007, HEART, V93, P1268, DOI 10.1136/hrt.2006.091314; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hayashi-Takagi A, 2014, BIOL PSYCHIAT, V75, P920, DOI 10.1016/j.biopsych.2013.09.035; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371; Kim HR, 2007, CLIN CHEM LAB MED, V45, P1561, DOI 10.1515/CCLM.2007.311; Kirkpatrick B, 2001, ARCH GEN PSYCHIAT, V58, P165, DOI 10.1001/archpsyc.58.2.165; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; LAGER AC, 1985, PSYCHIAT RES, V16, P27, DOI 10.1016/0165-1781(85)90025-3; Lara DR, 2001, J PSYCHIATR RES, V35, P11, DOI 10.1016/S0022-3956(01)00003-6; Ling SH, 2007, J PSYCHIAT RES, V41, P36, DOI 10.1016/j.jpsychires.2005.11.006; Liu JX, 2005, BIOCHEM BIOPH RES CO, V328, P335, DOI 10.1016/j.bbrc.2004.12.175; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mercier E, 2013, BMJ-BRIT MED J, V4, pf1757; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mondelli V, 2014, PSYCHOPHARMACOLOGY, V231, P317, DOI 10.1007/s00213-013-3383-3; Monji A, 2009, PSYCHIAT CLIN NEUROS, V63, P257, DOI 10.1111/j.1440-1819.2009.01945.x; O'Connell K, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-146; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pedersen A, 2008, PROG NEURO-PSYCHOPH, V32, P1789, DOI 10.1016/j.pnpbp.2008.07.017; Qi LY, 2009, NEUROSCI LETT, V462, P113, DOI 10.1016/j.neulet.2009.06.019; Raedler TJ, 1998, CURR OPIN NEUROBIOL, V8, P157, DOI 10.1016/S0959-4388(98)80019-6; Rothermundt M, 2001, MOL PSYCHIATR, V6, P445, DOI 10.1038/sj.mp.4000889; Rothermundt M, 2004, NEUROPSYCHOPHARMACOL, V29, P1004, DOI 10.1038/sj.npp.1300403; Rothermundt M, 2004, MOL PSYCHIATR, V9, P897, DOI 10.1038/sj.mp.4001548; Rothermundt M, 2007, PROG NEURO-PSYCHOPH, V31, P361, DOI 10.1016/j.pnpbp.2006.09.013; Sarandol A, 2007, PROG NEURO-PSYCHOPH, V31, P1164, DOI 10.1016/j.pnpbp.2007.03.008; Schmitt A, 2005, SCHIZOPHR RES, V80, P305, DOI 10.1016/j.schres.2005.04.013; Schroeter ML, 2009, MOL PSYCHIATR, V14, P235, DOI 10.1038/mp.2008.85; Schroeter ML, 2009, PSYCHIAT RES, V167, P66, DOI 10.1016/j.psychres.2008.01.002; Schroeter ML, 2003, SCHIZOPHR RES, V62, P231, DOI 10.1016/S0920-9964(02)00383-3; Sorci G, WORLD J BIOL CHEM, V4, P1; Steiner J, 2006, J NEUROL NEUROSUR PS, V77, P1284, DOI 10.1136/jnnp.2006.093427; Steiner J, 2010, MOL PSYCHIATR, V15, P3, DOI 10.1038/mp.2009.87; Steiner J, 2010, CARDIOVASC PSYCHIAT, V15, P3; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Steiner Johann, 2010, Cardiovasc Psychiatry Neurol, V2010, P480707, DOI 10.1155/2010/480707; Steiner J, 2012, BRAIN BEHAV IMMUN, V26, P564, DOI 10.1016/j.bbi.2012.01.018; Steiner J, 2009, BIOL PSYCHIAT, V65, P1107, DOI 10.1016/j.biopsych.2008.10.044; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Uzbay T, 2013, J PSYCHIATR RES, V47, P1054, DOI 10.1016/j.jpsychires.2013.04.004; van der Leeuw C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082535; Weickert CS, 2013, DIS MARKERS, V2013, P3, DOI 10.1155/2013/510402; Wells G.A., NEWCASTLE OTTAWA SCA; WHO, 2018, INT STAT CLASS DIS R; Wiesmann M, 1999, BIOL PSYCHIAT, V45, P1508, DOI 10.1016/S0006-3223(98)00217-0; Yelmo-Cruz S, 2013, PSYCHIAT CLIN NEUROS, V67, P67, DOI 10.1111/pcn.12024; Zhang XY, 2010, J PSYCHIATR RES, V44, P1236, DOI 10.1016/j.jpsychires.2010.04.023; Zhang XY, 2010, J PSYCHIATR RES, V44, P429, DOI 10.1016/j.jpsychires.2009.10.012	76	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106342	10.1371/journal.pone.0106342	http://dx.doi.org/10.1371/journal.pone.0106342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202915	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500018
J	Guo, HL; Ding, WW; Chen, JB; Chen, X; Zheng, YQ; Wang, ZY; Liu, JX				Guo, Hailin; Ding, Wanwen; Chen, Jingbo; Chen, Xuan; Zheng, Yiqi; Wang, Zhiyong; Liu, Jianxiu			Genetic Linkage Map Construction and QTL Mapping of Salt Tolerance Traits in Zoysiagrass (Zoysia japonica)	PLOS ONE			English	Article							AMPLIFIED POLYMORPHISM SRAP; SEQUENCE REPEAT MARKERS; SALINITY TOLERANCE; GOSSYPIUM-HIRSUTUM; RAPD MARKERS; RFLP MARKERS; DIVERSITY; AFLP; POPULATION; BRASSICA	Zoysiagrass (Zoysia Willd.) is an important warm season turfgrass that is grown in many parts of the world. Salt tolerance is an important trait in zoysiagrass breeding programs. In this study, a genetic linkage map was constructed using sequence-related amplified polymorphism markers and random amplified polymorphic DNA markers based on an F-1 population comprising 120 progeny derived from a cross between Zoysia japonica Z105 (salt-tolerant accession) and Z061 (salt-sensitive accession). The linkage map covered 1211 cM with an average marker distance of 5.0 cM and contained 24 linkage groups with 242 marker loci (217 sequence-related amplified polymorphism markers and 25 random amplified polymorphic DNA markers). Quantitative trait loci affecting the salt tolerance of zoysiagrass were identified using the constructed genetic linkage map. Two significant quantitative trait loci (qLF-1 and qLF-2) for leaf firing percentage were detected; qLF-1 at 36.3 cM on linkage group LG4 with a logarithm of odds value of 3.27, which explained 13.1% of the total variation of leaf firing and qLF-2 at 42.3 cM on LG5 with a logarithm of odds value of 2.88, which explained 29.7% of the total variation of leaf firing. A significant quantitative trait locus (qSCW-1) for reduced percentage of dry shoot clipping weight was detected at 44.1 cM on LG5 with a logarithm of odds value of 4.0, which explained 65.6% of the total variation. This study provides important information for further functional analysis of salt-tolerance genes in zoysiagrass. Molecular markers linked with quantitative trait loci for salt tolerance will be useful in zoysiagrass breeding programs using marker-assisted selection.	[Guo, Hailin; Ding, Wanwen; Chen, Jingbo; Chen, Xuan; Zheng, Yiqi; Wang, Zhiyong; Liu, Jianxiu] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Nanjing, Jiangsu, Peoples R China		Liu, JX (corresponding author), Jiangsu Prov & Chinese Acad Sci, Inst Bot, Nanjing, Jiangsu, Peoples R China.	turfunit@aliyun.com		Chen, Jingbo/0000-0001-8113-7823	National Natural Science Foundation of China [30800759]; National Science and Technology Support Program of China [2011BAD13B09, 2012BAB03B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China	This work was supported by the National Natural Science Foundation of China (Grant no. 30800759) and the National Science and Technology Support Program of China (Grant nos. 2011BAD13B09 and 2012BAB03B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja B, 2012, MOL BREEDING, V30, P1635, DOI 10.1007/s11032-012-9747-2; Anhalt UCM, 2008, THEOR APPL GENET, V117, P297, DOI 10.1007/s00122-008-0774-7; Bhardwaj M, 2010, J PLANT BIOCHEM BIOT, V19, P255, DOI 10.1007/BF03263351; Cai H, 2004, PLANT BREEDING, V123, P543, DOI 10.1111/j.1439-0523.2004.01022.x; Cai HW, 2005, THEOR APPL GENET, V112, P158, DOI 10.1007/s00122-005-0118-9; CHAKRAVARTI A, 1991, GENETICS, V128, P175; [陈静波 CHEN Jing-bo], 2009, [草业学报, Acta Prataculturae Sinica], V18, P107; Chen MM, 2010, TREES-STRUCT FUNCT, V24, P685, DOI 10.1007/s00468-010-0438-5; Chen X, 2008, MOL PLANT BREEDING, V6, P1233; Ding ChengLong, 2010, Acta Agrestia Sinica, V18, P703; EBINA M, 1999, PLANT AN GEN 7 C SAN, P17; Engelke M.C., 2002, TURFGRASS BIOL GENET, P271; Ferriol M, 2003, THEOR APPL GENET, V107, P271, DOI 10.1007/s00122-003-1242-z; Foolad MR, 1998, PLANT CELL REP, V17, P306, DOI 10.1007/s002990050398; FORBES I, 1952, AGRON J, V44, P194, DOI 10.2134/agronj1952.00021962004400040008x; FUKUOKA H, 1989, J JPN SOC TURFGRASS, V17, P183; Garcia AAF, 2004, GENET MOL BIOL, V27, P579, DOI 10.1590/S1415-47572004000400019; Geng JF, 2007, J AM SOC HORTIC SCI, V132, P816, DOI 10.21273/JASHS.132.6.816; Ghassemi F, 1995, SALINISATION LAND WA, P291; [郭海林 GUO Hai-lin], 2009, [草业学报, Acta Prataculturae Sinica], V18, P201; Guo HaiLin, 2012, Acta Agrestia Sinica, V20, P724; [郭海林 Guo Hailin], 2012, [植物遗传资源学报, Journal of Plant Genetic Resources], V13, P733; Guo HaiLin, 2004, Acta Prataculturae Sinica, V13, P106; Hamwieh A, 2011, EUPHYTICA, V179, P451, DOI 10.1007/s10681-011-0347-8; Harivandi A, 1992, TURFGRASS AGRON MONO, V32, P208; Kim DongMin, 2009, Journal of Crop Science and Biotechnology, V12, P121; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kumar A, 2012, MOL BIOL REP, V39, P4949, DOI 10.1007/s11033-011-1291-3; Leroy T, 2011, TREE GENET GENOMES, V7, P781, DOI 10.1007/s11295-011-0374-6; Li G, 2003, THEOR APPL GENET, V107, P168, DOI 10.1007/s00122-003-1236-x; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li ML, 2010, MOL BREEDING, V26, P467, DOI 10.1007/s11032-009-9386-4; Li ML, 2009, EUPHYTICA, V170, P327, DOI 10.1007/s10681-009-9990-8; LI S, 2012, ACTA PRATACULTURAE S, V21, P3, DOI DOI 10.1371/J0URNAL.PGEN.1002791; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; [李亚 Li Ya], 2004, [草地学报, Acta agrestia sinica], V12, P8; Lin ZX, 2009, EUPHYTICA, V166, P35, DOI 10.1007/s10681-008-9822-2; Ma LQ, 2007, EUPHYTICA, V153, P109, DOI 10.1007/s10681-006-9247-8; Marcum KB, 1998, CROP SCI, V38, P806, DOI 10.2135/cropsci1998.0011183X003800030031x; MARCUM KB, 1994, J AM SOC HORTIC SCI, V119, P779, DOI 10.21273/JASHS.119.4.779; Marcum KB, 1999, CROP SCI, V39, P1153, DOI 10.2135/cropsci1999.0011183X003900040034x; Okazaki K, 2007, THEOR APPL GENET, V114, P595, DOI 10.1007/s00122-006-0460-6; Parani M, 1998, THEOR APPL GENET, V97, P617, DOI 10.1007/s001220050937; Qian YL, 2000, CROP SCI, V40, P488, DOI 10.2135/cropsci2000.402488x; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Saha MC, 2005, THEOR APPL GENET, V110, P323, DOI 10.1007/s00122-004-1843-1; Shahid S.A., 2013, DEV SOIL SALINITY AS, P3; Sharma PC, 2011, MOL BREEDING, V27, P207, DOI 10.1007/s11032-010-9423-3; Sheng HM, 2006, PLANT SYST EVOL, V260, P25, DOI 10.1007/s00606-006-0413-1; Van Ooijen JW, 2001, JOINMAPR VERSION 3 0; VANOOIJEN JW, 2004, MAPQTL 5 0 SOFTWARE; Voorrips RE, 2002, MAPCHART 2 1; Wang JP, 2010, THEOR APPL GENET, V120, P607, DOI 10.1007/s00122-009-1179-y; Wang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080569; Weng JH, 2001, PLANT PROD SCI, V4, P313, DOI 10.1626/pps.4.313; Xu SZ, 1996, GENET RES, V68, P175, DOI 10.1017/S0016672300034066; XU WW, 1995, THEOR APPL GENET, V91, P947, DOI 10.1007/BF00223905; Xue DanDan, 2008, Acta Prataculturae Sinica, V17, P93; Xue DW, 2009, EUPHYTICA, V169, P187, DOI 10.1007/s10681-009-9919-2; Yaneshita M., 1997, International Turfgrass Society Research Journal, V8, P401; Yaneshita M, 1999, THEOR APPL GENET, V98, P751, DOI 10.1007/s001220051131; Yeboah MA, 2007, AFR J BIOTECHNOL, V6, P2784; Zhang Fei, 2007, Acta Prataculturae Sinica, V16, P34; Zhang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083023; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1; Zheng YQ, 2013, SCI HORTIC-AMSTERDAM, V156, P86, DOI 10.1016/j.scienta.2013.03.030	66	19	22	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107249	10.1371/journal.pone.0107249	http://dx.doi.org/10.1371/journal.pone.0107249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203715	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500077
J	Thorrington, D; Ramsay, M; van Hoek, AJ; Edmunds, WJ; Vivancos, R; Bukasa, A; Eames, K				Thorrington, Dominic; Ramsay, Mary; van Hoek, Albert Jan; Edmunds, W. John; Vivancos, Roberto; Bukasa, Antoaneta; Eames, Ken			The Effect of Measles on Health-Related Quality of Life: A Patient-Based Survey	PLOS ONE			English	Article								Background: Measles is a highly contagious and potentially fatal illness preventable through vaccination. Outbreaks in the UK and many other European countries have been increasing over recent years, with over 3,207 laboratory-confirmed cases reported by Public Health England from January 2012 to the end of June 2013. To aid rational decision making regarding measles control versus other use of healthcare resources, it is important to measure the severity of measles in units that are comparable to other diseases. The standard metric for this in the UK is the quality-adjust life year (QALY). To our knowledge, the impact of measles on health-related quality of life (HRQoL) in terms of QALYs has not been quantified. Methods and Findings: Individuals with confirmed measles were sent questionnaires requesting information on the short-term impact of the illness on their HRQoL using the EuroQol EQ-5D-3L questionnaire. HRQoL was reported for the day the questionnaire was received, the worst day of infection and at follow-up three weeks later. 507 questionnaires were sent to individuals with confirmed measles with 203 returned (40%). The majority of respondents were not vaccinated. The mean time off work or school was 9.6 days. The mean duration of perceived illness was 13.8 days. The mean number of QALYs lost was 0.019 (equivalent to 6.9 days). The overall burden of disease in terms of QALYs lost in England based on the total number of confirmed cases in the twelve month period from 1st June 2012 was estimated to be 44.2 QALYs. Conclusion: The short-term impact of measles infection on HRQoL is substantial, both at the level of the individual patient and in terms of the overall disease burden. This is the first attempt to quantify QALY-loss due to measles at a population level, and provides important parameters to guide future intervention and control measures.	[Thorrington, Dominic; Edmunds, W. John; Eames, Ken] Univ London London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1E 7HT, England; [Ramsay, Mary; van Hoek, Albert Jan; Bukasa, Antoaneta] Publ Hlth England Colindale, London, England; [Vivancos, Roberto] Publ Hlth England Cheshire & Merseyside, Liverpool, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; Public Health England	Thorrington, D (corresponding author), Univ London London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, Keppel St, London WC1E 7HT, England.	dominic.thorrington@lshtm.ac.uk	Ramsay, Mary Elizabeth/S-8281-2016	Ramsay, Mary Elizabeth/0000-0002-7156-7640; Vivancos, Roberto/0000-0002-8203-8867	Career Development Fellowship - National Institute for Health Research [NIHR-CDF-2011-04-019]; National Institute for Health Research [CDF-2011-04-019] Funding Source: researchfish	Career Development Fellowship - National Institute for Health Research; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a Career Development Fellowship supported by the National Institute for Health Research (grant number NIHR-CDF-2011-04-019). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute of Health Research or the Department of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala MV, 1998, J CLIN EPIDEMIOL, V51, P667, DOI 10.1016/S0895-4356(98)00036-5; Bedford H, 1998, LANCET, V351, P907, DOI 10.1016/S0140-6736(05)70320-2; Brisson M, 2003, ARCH DIS CHILD, V88, P862, DOI 10.1136/adc.88.10.862; Canaway AG, 2013, QUAL LIFE RES, V22, P173, DOI 10.1007/s11136-012-0119-5; Chen RT, 1998, LANCET, V351, P611, DOI 10.1016/S0140-6736(05)78423-3; Choi YH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-338; Department of Health, 2010, HLTH PROT LEG ENGL; EuroQol, 2004, MEAS SELF REP POP HL; Ghebrehewet S, 2012, EPIDEMIOL INFECT, P1; Gold MR, 1996, COST EFFECTIVENESS H; Health Protection Agency, 2010, HPA NAT MEASL GUID L; Hollmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060477; Honaker J, 2011, J STAT SOFTW, V45, P1; HPA, 2012, ADV TRAV COMM; HPA, 2012, INF DIS MEASL EP DAT; HPA, 2013, MEASL CAS DROP MMR S; KLARMAN HE, 1968, MED CARE, V6, P48, DOI 10.1097/00005650-196801000-00005; Lee JW, 1998, LANCET, V351, P905, DOI 10.1016/S0140-6736(98)26012-0; Maduma-Butshe A, 2013, J PUBLIC HEALTH-UK, V35, P27, DOI 10.1093/pubmed/fds052; Miners AH, 1999, HAEMOPHILIA, V5, P378; National Institute for Health and Clinical Excellence (NICE), 2008, GUID METH TECHN APPR; NHS, 2012, NHS IMM STAT ENGL 20; Oluboyede Y, 2011, EUR J HEALTH ECON, V14, P1; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; R Core Team, 2021, R LANGUAGE ENV STAT; Thorrington D, 2013, PUBL HLTH ENGL C, pS12; Torrance GW, 2001, MED DECIS MAKING, V21, P329, DOI 10.1177/02729890122062622; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030; Vivancos R, 2012, EURO SURVEILLANCE, V17, P20226; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wille N, 2010, QUAL LIFE RES, V19, P875, DOI 10.1007/s11136-010-9648-y; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wu XY, 2010, QUAL LIFE RES, V19, P969, DOI 10.1007/s11136-010-9663-z	33	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e105153	10.1371/journal.pone.0105153	http://dx.doi.org/10.1371/journal.pone.0105153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IF	25202905	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000342684500008
J	Zhao, W; Xu, W				Zhao, Wan; Xu, Wen			Migration and Differentiation of Neural Progenitor Cells after Recurrent Laryngeal Nerve Avulsion in Rats	PLOS ONE			English	Article							NEURONAL MIGRATION; SPINAL-CORD; ADULT-RAT; STEM; IDENTIFICATION; PROLIFERATION; NEUROGENESIS; DOUBLECORTIN; ASTROCYTES; SYSTEM	To investigate migration and differentiation of neural progenitor cells (NPCs) from the ependymal layer to the nucleus ambiguus (NA) after recurrent laryngeal nerve (RLN) avulsion. All of the animals received a CM-DiI injection in the left lateral ventricle. Forty-five adult rats were subjected to a left RLN avulsion injury, and nine rats were used as controls. 5-Bromo-2-deoxyuridine (BrdU) was injected intraperitoneally. Immunohistochemical analyses were performed in the brain stems at different time points after RLN injury. After RLN avulsion, the CM-DiI+ NPCs from the ependymal layer migrated to the lesioned NA. CM-DiI+/GFAP+ astrocytes, CM-DiI+/DCX+ neuroblasts and CM-DiI+/NeuN+ neurons were observed in the migratory stream. However, the ipsilateral NA included only CM-DiI+ astrocytes, not newborn neurons. After RLN avulsion, the NPCs in the ependymal layer of the 4th ventricle or central canal attempt to restore the damaged NA. We first confirm that the migratory stream includes both neurons and glia differentiated from the NPCs. However, only differentiated astrocytes are successfully incorporated into the NA. The presence of both cell types in the migratory process may play a role in repairing RLN injuries.	[Zhao, Wan; Xu, Wen] Capital Med Univ, Dept Otorhinolaryngol Head Neck Surg, Beijing Tongren Hosp, Beijing, Peoples R China; [Zhao, Wan] Anhui Med Univ, Anhui Prov Hosp, Dept Otorhinolaryngol Head Neck Surg, Hefei, Anhui, Peoples R China	Capital Medical University; Anhui Medical University	Xu, W (corresponding author), Capital Med Univ, Dept Otorhinolaryngol Head Neck Surg, Beijing Tongren Hosp, Beijing, Peoples R China.	entwen@trhos.com			Programs of National Natural Science Foundation of China [81170901]; Programs of Beijing Natural Science Foundation [7132053]	Programs of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programs of Beijing Natural Science Foundation	This research was supported by Programs of National Natural Science Foundation of China (81170901) and Programs of Beijing Natural Science Foundation (7132053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Chiang FY, 2005, SURGERY, V137, P342, DOI 10.1016/j.surg.2004.09.008; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Danilov AI, 2006, EUR J NEUROSCI, V23, P394, DOI 10.1111/j.1460-9568.2005.04563.x; Fagerlund M, 2011, RESTOR NEUROL NEUROS, V29, P47, DOI 10.3233/RNN-2011-0578; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gordon RJ, 2007, NEUROSCIENCE, V146, P1704, DOI 10.1016/j.neuroscience.2007.03.011; Guillemin GJ, 2003, GLIA, V41, P371, DOI 10.1002/glia.10175; Hamilton LK, 2009, NEUROSCIENCE, V164, P1044, DOI 10.1016/j.neuroscience.2009.09.006; Hou SW, 2008, STROKE, V39, P2837, DOI 10.1161/STROKEAHA.107.510982; Hydman J, 2005, LARYNGOSCOPE, V115, P619, DOI 10.1097/01.mlg.0000161362.43320.b2; Jablonska B, 2010, NAT NEUROSCI, V13, P541, DOI 10.1038/nn.2536; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Mori Y, 2007, LARYNGOSCOPE, V117, P1313, DOI 10.1097/MLG.0b013e31805f681f; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Parent JM, 2006, HIPPOCAMPUS, V16, P321, DOI 10.1002/hipo.20166; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Takaoka T, 2009, NEUROSCI RES, V65, P353, DOI 10.1016/j.neures.2009.08.012; Zhao W, 2014, ANN OTO RHINOL LARYN, V123, P490, DOI 10.1177/0003489414524170	23	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107288	10.1371/journal.pone.0107288	http://dx.doi.org/10.1371/journal.pone.0107288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202908	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500078
J	Bai, H; Zhu, J; Sun, YY; Liu, RR; Liu, N; Li, DL; Wen, J; Chen, JL				Bai, Hao; Zhu, Jing; Sun, Yanyan; Liu, Ranran; Liu, Nian; Li, Dongli; Wen, Jie; Chen, Jilan			Identification of Genes Related to Beak Deformity of Chickens Using Digital Gene Expression Profiling	PLOS ONE			English	Article							KERATIN; MUTATION; PROTEIN; EMBRYOS; CELLS	Frequencies of up to 3% of beak deformity (normally a crossed beak) occur in some indigenous chickens in China, such as and Beijing-You. Chickens with deformed beaks have reduced feed intake, growth rate, and abnormal behaviors. Beak deformity represents an economic as well as an animal welfare problem in the poultry industry. Because the genetic basis of beak deformity remains incompletely understood, the present study sought to identify important genes and metabolic pathways involved in this phenotype. Digital gene expression analysis was performed on deformed and normal beaks collected from Beijing-You chickens to detect global gene expression differences. A total of >11 million cDNA tags were sequenced, and 5,864,499 and 5,648,877 clean tags were obtained in the libraries of deformed and normal beaks, respectively. In total, 1,156 differentially expressed genes (DEG) were identified in the deformed beak with 409 being up-regulated and 747 down-regulated in the deformed beaks. qRT-PCR using eight genes was performed to verify the results of DGE profiling. Gene ontology (GO) analysis highlighted that genes of the keratin family on GGA25 were abundant among the DEGs. Pathway analysis showed that many DEGs were linked to the biosynthesis of unsaturated fatty acids and glycerolipid metabolism. Combining the analyses, 11 genes (MUC, LOC426217, BMP4, ACAA1, LPL, ALDH7A1, GLA, RETSAT, SDR16C5, WWOX, and MOGAT1) were highlighted as potential candidate genes for beak deformity in chickens. Some of these genes have been identified previously, while others have unknown function with respect to thus phenotype. To the best of our knowledge, this is the first genome-wide study to investigate the transcriptome differences in the deformed and normal beaks of chickens. The DEGs identified here are worthy of further functional characterization.	[Bai, Hao; Zhu, Jing; Sun, Yanyan; Liu, Ranran; Liu, Nian; Li, Dongli; Wen, Jie; Chen, Jilan] Chinese Acad Agr Sci, Key Lab Genet Resources & Utilizat Livestock, Inst Anim Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Chen, JL (corresponding author), Chinese Acad Agr Sci, Key Lab Genet Resources & Utilizat Livestock, Inst Anim Sci, Beijing 100193, Peoples R China.	chen.jilan@163.com		Bai, Hao/0000-0002-5738-4186; sun, yanyan/0000-0001-6425-7786; Chen, Jilan/0000-0002-9400-009X	National High Technology Research and Development Program (863 Program) [2011AA100305, 2008AA101009]; National Natural Science Foundation of China; Agricultural Science and Technology Innovation Program [ASTIP-IAS04]; Chinese Academy of Agricultural Sciences, China	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program; Chinese Academy of Agricultural Sciences, China	This work was funded by 1. National High Technology Research and Development Program (863 Program)(2011AA100305,2008AA101009), National Natural Science Foundation of China. http://www.nsfc.gov.cn/; and 2. Agricultural Science and Technology Innovation Program (ASTIP-IAS04), Chinese Academy of Agricultural Sciences, China. http://www.caas.cn/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chan T, 2005, RESP PHYSIOL NEUROBI, V145, P251, DOI 10.1016/j.resp.2004.09.005; Choi S, 2012, BIOCHEM BIOPH RES CO, V418, P191, DOI 10.1016/j.bbrc.2012.01.012; Clabaut C, 2009, EVOL DEV, V11, P636, DOI 10.1111/j.1525-142X.2009.00371.x; D'Alba L, 2011, BIOL LETTERS, V7, P543, DOI 10.1098/rsbl.2010.1163; Demery ZP, 2011, P ROY SOC B-BIOL SCI, V278, P3687, DOI 10.1098/rspb.2011.0374; Eckhart L, 2008, P NATL ACAD SCI USA, V105, P18419, DOI 10.1073/pnas.0805154105; Feng L, 2010, MOL BIOTECHNOL, V45, P101, DOI 10.1007/s12033-010-9249-6; Frixione E, 2000, CELL MOTIL CYTOSKEL, V46, P73, DOI 10.1002/1097-0169(200006)46:2<73::AID-CM1>3.0.CO;2-0; Gartrell BD, 2003, NEW ZEAL VET J, V51, P196, DOI 10.1080/00480169.2003.36365; Golder HM, 2011, BRIT POULTRY SCI, V52, P500, DOI 10.1080/00071668.2011.587183; Handel CM, 2010, AUK, V127, P882, DOI 10.1525/auk.2010.10111; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Jaszczak K, 2006, J ANIM FEED SCI, V15, P463, DOI 10.22358/jafs/66917/2006; Jheon AH, 2009, J DENT RES, V88, P12, DOI 10.1177/0022034508327757; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Lawrence JW, 2001, J BIOL CHEM, V276, P31521, DOI 10.1074/jbc.M103306200; MacDonald ME, 2004, DEV DYNAM, V230, P335, DOI 10.1002/dvdy.20041; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Pennisi E, 2004, SCIENCE, V305, P1383, DOI 10.1126/science.305.5689.1383; Plant MR, 2000, DEV BIOL, V222, P12, DOI 10.1006/dbio.2000.9706; Rintoul David A., 2005, Kansas Ornithological Society Bulletin, V56, P29; Seki Y, 2010, ACTA BIOMATER, V6, P331, DOI 10.1016/j.actbio.2009.08.026; Shen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032237; Song Y, 2004, DEV BIOL, V276, P313, DOI 10.1016/j.ydbio.2004.08.035; STEINERT PM, 1993, J INVEST DERMATOL, V100, P729, DOI 10.1111/1523-1747.ep12475665; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Torma H, 2011, DERM-ENDOCRINOL, V3, P136, DOI 10.4161/derm.3.3.15026; Tsudzuki M, 1998, J HERED, V89, P175, DOI 10.1093/jhered/89.2.175; Van Hemert C, 2010, AUK, V127, P746, DOI 10.1525/auk.2010.10132; VANPATTER HT, 1955, AM J PATHOL, V31, P73; Wu P, 2004, SCIENCE, V305, P1465, DOI 10.1126/science.1098109; Zhu J, 2012, CHINA POULTRY, V34, P2	35	19	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107050	10.1371/journal.pone.0107050	http://dx.doi.org/10.1371/journal.pone.0107050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198128	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700077
J	Hwang, DW; Jin, Y; Lee, DH; Kim, HY; Cho, HN; Chung, HJ; Park, Y; Youn, H; Lee, SJ; Lee, HJ; Kim, SU; Wang, KC; Lee, DS				Hwang, Do Won; Jin, Yeona; Lee, Do Hun; Kim, Han Young; Cho, Han Na; Chung, Hye Jin; Park, Yunwoong; Youn, Hyewon; Lee, Seung Jin; Lee, Hong J.; Kim, Seung U.; Wang, Kyu-Chang; Lee, Dong Soo			In Vivo Bioluminescence Imaging for Prolonged Survival of Transplanted Human Neural Stem Cells Using 3D Biocompatible Scaffold in Corticectomized Rat Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; PROGENITOR CELLS; FIREFLY LUCIFERASE; MOTOR FUNCTION; SPINAL-CORD; TISSUE; DIFFERENTIATION; EXPRESSION	Stem cell-based treatment of traumatic brain injury has been limited in its capacity to bring about complete functional recovery, because of the poor survival rate of the implanted stem cells. It is known that biocompatible biomaterials play a critical role in enhancing survival and proliferation of transplanted stem cells via provision of mechanical support. In this study, we noninvasively monitored in vivo behavior of implanted neural stem cells embedded within poly-L-lactic acid (PLLA) scaffold, and showed that they survived over prolonged periods in corticectomized rat model. Corticectomized rat models were established by motor-cortex ablation of the rat. F3 cells expressing enhanced firefly luciferase (F3-effLuc) were established through retroviral infection. The F3-effLuc within PLLA was monitored using IVIS-100 imaging system 7 days after corticectomized surgery. F3-effLuc within PLLA robustly adhered, and gradually increased luciferase signals of F3-effLuc within PLLA were detected in a day dependent manner. The implantation of F3-effLuc cells/PLLA complex into corticectomized rats showed longer-lasting luciferase activity than F3-effLuc cells alone. The bioluminescence signals from the PLLA-encapsulated cells were maintained for 14 days, compared with 8 days for the non-encapsulated cells. Immunostaining results revealed expression of the early neuronal marker, Tuj-1, in PLLA-F3-effLuc cells in the motor-cortexablated area. We observed noninvasively that the mechanical support by PLLA scaffold increased the survival of implanted neural stem cells in the corticectomized rat. The image-guided approach easily proved that scaffolds could provide supportive effect to implanted cells, increasing their viability in terms of enhancing therapeutic efficacy of stem-cell therapy.	[Hwang, Do Won; Jin, Yeona; Kim, Han Young; Park, Yunwoong; Youn, Hyewon; Lee, Dong Soo] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Hwang, Do Won; Kim, Han Young; Lee, Dong Soo] Seoul Natl Univ, WCU Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Lee, Do Hun] Univ Miami, Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Cho, Han Na; Chung, Hye Jin; Lee, Seung Jin] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Youn, Hyewon] Seoul Natl Univ, Canc Hosp, Canc Imaging Ctr, Seoul, South Korea; [Youn, Hyewon] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, Hong J.; Kim, Seung U.] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea; [Wang, Kyu-Chang] Seoul Natl Univ, Childrens Hosp, Div Pediat Neurosurg, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Miami; Ewha Womans University; Seoul National University (SNU); Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital	Wang, KC (corresponding author), Seoul Natl Univ, Childrens Hosp, Div Pediat Neurosurg, Seoul, South Korea.	kcwang@sun.ac.kr; dsl@plaza.snu.ac.kr		Youn, Hyewon/0000-0003-1006-2689	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2008799]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1299]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2008799), and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1299). The funders had no role in study design, collection and analysis of data, decision to publish, or preparation of the manuscript.	Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; Fialkov JA, 2003, J CRANIOFAC SURG, V14, P324, DOI 10.1097/00001665-200305000-00010; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gonzalez CLR, 2004, EUR J NEUROSCI, V20, P3442, DOI 10.1111/j.1460-9568.2004.03751.x; Hermanns S, 2001, J NEUROSCI METH, V110, P141, DOI 10.1016/S0165-0270(01)00427-7; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158; Hwang DW, 2008, EUR J NUCL MED MOL I, V35, P1887, DOI 10.1007/s00259-008-0751-z; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jung MR, 2011, J CONTROL RELEASE, V152, P294, DOI 10.1016/j.jconrel.2011.03.002; Lee DH, 2009, CHILD NERV SYST, V25, P1547, DOI 10.1007/s00381-009-0973-9; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; O'Connor SM, 2000, BIOSENS BIOELECTRON, V14, P871, DOI 10.1016/S0956-5663(99)00055-X; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Payne RG, 2002, BIOMATERIALS, V23, P4373, DOI 10.1016/S0142-9612(02)00185-0; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Rafuse VF, 2005, NEUROSCIENCE, V131, P899, DOI 10.1016/j.neuroscience.2004.11.048; Richardson RM, 2005, BRAIN RES, V1032, P11, DOI 10.1016/j.brainres.2004.10.043; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Saim AB, 2000, LARYNGOSCOPE, V110, P1694, DOI 10.1097/00005537-200010000-00023; Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sitthinamsuwan Bunpot, 2013, Journal of the Medical Association of Thailand, V96, P121; Srouji S, 2006, REGEN MED, V1, P519, DOI 10.2217/17460751.1.4.519; Tabata Yasuhiko, 2004, Congenital Anomalies, V44, P111, DOI 10.1111/j.1741-4520.2004.00024.x; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; Zhang X, 2013, SEIZURE, V9, P1059	41	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e105129	10.1371/journal.pone.0105129	http://dx.doi.org/10.1371/journal.pone.0105129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198726	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700014
J	Kopf, T; Schaefer, HL; Troetzmueller, M; Koefeler, H; Broenstrup, M; Konovalova, T; Schmitz, G				Kopf, Thomas; Schaefer, Hans-Ludwig; Troetzmueller, Martin; Koefeler, Harald; Broenstrup, Mark; Konovalova, Tatiana; Schmitz, Gerd			Influence of Fenofibrate Treatment on Triacylglycerides, Diacylglycerides and Fatty Acids in Fructose Fed Rats	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; ACTIVATED RECEPTOR-ALPHA; PPAR-ALPHA; GENE-EXPRESSION; OXIDATIVE STRESS; INSULIN-RESISTANCE; METABOLIC SYNDROME; DIABETES-MELLITUS; ENERGY-METABOLISM; LIPID EXTRACTION	Fenofibrate (FF) lowers plasma triglycerides via PPAR alpha activation. Here, we analyzed lipidomic changes upon FF treatment of fructose fed rats. Three groups with 6 animals each were defined as control, fructose-fed and fructose-fed/FF treated. Male Wistar Unilever Rats were subjected to 10% fructose-feeding for 20 days. On day 14, fenofibrate treatment (100 mg/kg p.o.) was initiated and maintained for 7 days. Lipid species in serum were analyzed using mass spectrometry (ESI-MS/MS; LCFT-MS, GC-MS) on days 0, 14 and 20 in all three groups. In addition, lipid levels in liver and intestine were determined. Shortchain TAGs increased in serum and liver upon fructose-feeding, while almost all TAG-species decreased under FF treatment. Long-chain unsaturated DAG-levels (36: 1, 36: 2, 36: 4, 38: 3, 38: 4, 38: 5) increased upon FF treatment in rat liver and decreased in rat serum. FAs, especially short-chain FAs (12: 0, 14: 0, 16: 0) increased during fructose-challenge. VLDL secretion increased upon fructose-feeding and together with FA-levels decreased to control levels during FF treatment. Fructose challenge of de novo fatty acid synthesis through fatty acid synthase (FAS) may enhance the release of FAs <= 16: 0 chain length, a process reversed by FF-mediated PPAR alpha-activation.	[Kopf, Thomas; Konovalova, Tatiana; Schmitz, Gerd] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany; [Schaefer, Hans-Ludwig; Broenstrup, Mark] Sanofi Aventis Germany, R&D DIAB Div, Biomarker & Diagnost, Frankfurt, Germany; [Troetzmueller, Martin; Koefeler, Harald] Med Univ Graz, ZMF, Core Facil Mass Spectrometry, Graz, Austria	University of Regensburg; Sanofi-Aventis; Medical University of Graz	Schmitz, G (corresponding author), Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany.	gerd.schmitz@klinik.uni-regensburg.de	Brönstrup, Mark/AAP-7598-2020	Brönstrup, Mark/0000-0002-8971-7045; Schmitz, Gerd/0000-0002-1325-1007; Kofeler, Harald/0000-0002-2725-9616	European Community [202272]; IP-Project LipidomicNet; BMBF ("SysMBo") [0315494C]	European Community(European Commission); IP-Project LipidomicNet; BMBF ("SysMBo")(Federal Ministry of Education & Research (BMBF))	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet and BMBF ("SysMBo," sponsorship number 0315494C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CALDWELL KD, 1988, ANAL CHEM, V60, pA959, DOI 10.1021/ac00168a001; Cariello NF, 2005, TOXICOL SCI, V88, P250, DOI 10.1093/toxsci/kfi273; Chirala SS, 2004, LIPIDS, V39, P1045, DOI 10.1007/s11745-004-1329-9; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Dobrzyn A, 2004, TRENDS CARDIOVAS MED, V14, P77, DOI 10.1016/j.tcm.2003.12.005; DOLE VP, 1960, J BIOL CHEM, V235, P2595; Duez H, 2005, ARTERIOSCL THROM VAS, V25, P585, DOI 10.1161/01.ATV.0000154140.73570.00; Ecker J, 2012, J CHROMATOGR B, V897, P98, DOI 10.1016/j.jchromb.2012.04.015; ELSHOURBAGY NA, 1990, J BIOL CHEM, V265, P1430; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550; Flowers MT, 2006, J CLIN INVEST, V116, P1478, DOI 10.1172/JCI28774; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Hiukka A, 2010, NAT REV ENDOCRINOL, V6, P454, DOI 10.1038/nrendo.2010.89; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Kopf T, 2013, J CHROMATOGR B, V938, P22, DOI 10.1016/j.jchromb.2013.08.016; Ledwith BJ, 1997, J BIOL CHEM, V272, P3707, DOI 10.1074/jbc.272.6.3707; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lu Y, 2011, PHYSIOL GENOMICS, V43, P1307, DOI 10.1152/physiolgenomics.00100.2011; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Montanaro MA, 2003, LIPIDS, V38, P827, DOI 10.1007/s11745-003-1132-7; Nishimura J, 2008, ARCH TOXICOL, V82, P641, DOI 10.1007/s00204-007-0278-2; Nishimura J, 2007, TOXICOL SCI, V97, P44, DOI 10.1093/toxsci/kfm011; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; NTAMBI JM, 1992, J BIOL CHEM, V267, P10925; O'Brien ML, 2005, CRIT REV TOXICOL, V35, P61, DOI 10.1080/10408440590905957; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Seo KW, 2004, FOOD CHEM TOXICOL, V42, P107, DOI 10.1016/j.fct.2003.08.010; Shearer BG, 2003, CURR MED CHEM, V10, P267, DOI 10.2174/0929867033368295; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Ueno T, 2009, INT J MOL MED, V23, P313, DOI 10.3892/ijmm_00000133; Vega GL, 2003, CLIN PHARMACOL THER, V74, P236, DOI 10.1016/S0009-9236(03)00170-X; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yetukuri L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023589; Yu YH, 2004, ANN MED, V36, P252, DOI 10.1080/07853890410028429	46	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106849	10.1371/journal.pone.0106849	http://dx.doi.org/10.1371/journal.pone.0106849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198467	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700060
J	Wildey, G; Chen, YW; Lent, I; Stetson, L; Pink, J; Barnholtz-Sloan, JS; Dowlati, A				Wildey, Gary; Chen, Yanwen; Lent, Ian; Stetson, Lindsay; Pink, John; Barnholtz-Sloan, Jill S.; Dowlati, Afshin			Pharmacogenomic Approach to Identify Drug Sensitivity in Small-Cell Lung Cancer	PLOS ONE			English	Article							DRIVER MUTATIONS; IDENTIFICATION; GENES; EXPRESSION	There are currently no molecular targeted approaches to treat small-cell lung cancer (SCLC) similar to those used successfully against non-small-cell lung cancer. This failure is attributable to our inability to identify clinically-relevant subtypes of this disease. Thus, a more systematic approach to drug discovery for SCLC is needed. In this regard, two comprehensive studies recently published in Nature, the Cancer Cell Line Encyclopedia and the Cancer Genome Project, provide a wealth of data regarding the drug sensitivity and genomic profiles of many different types of cancer cells. In the present study we have mined these two studies for new therapeutic agents for SCLC and identified heat shock proteins, cyclin-dependent kinases and polo-like kinases (PLK) as attractive molecular targets with little current clinical trial activity in SCLC. Remarkably, our analyses demonstrated that most SCLC cell lines clustered into a single, predominant subgroup by either gene expression or CNV analyses, leading us to take a pharmacogenomic approach to identify subgroups of drug-sensitive SCLC cells. Using PLK inhibitors as an example, we identified and validated a gene signature for drug sensitivity in SCLC cell lines. This gene signature could distinguish subpopulations among human SCLC tumors, suggesting its potential clinical utility. Finally, circos plots were constructed to yield a comprehensive view of how transcriptional, copy number and mutational elements affect PLK sensitivity in SCLC cell lines. Taken together, this study outlines an approach to predict drug sensitivity in SCLC to novel targeted therapeutics.	[Wildey, Gary; Chen, Yanwen; Lent, Ian; Stetson, Lindsay; Pink, John; Barnholtz-Sloan, Jill S.; Dowlati, Afshin] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Dowlati, Afshin] Case Western Reserve Univ, Div Hematol & Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Dowlati, A (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	afshin.dowlati@case.edu	Barnholtz-Sloan, Jill/A-4817-2011	Barnholtz-Sloan, Jill/0000-0001-6190-9304; Wildey, Gary/0000-0001-7105-1313	University Hospitals Seidman Cancer Center; National Cancer Institute [U01 CA062502]; Case Comprehensive Cancer Center (National Cancer Institute) [P30 CA043703]; National Science Foundation Graduate Research Fellowship Program; NATIONAL CANCER INSTITUTE [P30CA043703, U01CA062502] Funding Source: NIH RePORTER	University Hospitals Seidman Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Case Comprehensive Cancer Center (National Cancer Institute); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the University Hospitals Seidman Cancer Center and National Cancer Institute U01 CA062502 (GW, AD), the Translational Research Core Facility (IL, JP) and the Biostatistics & Bioinformatics Core Facility (YC, JSB-S) of the Case Comprehensive Cancer Center (National Cancer Institute P30 CA043703), and the National Science Foundation Graduate Research Fellowship Program (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bredenbeck A, 2008, GENE, V415, P68, DOI 10.1016/j.gene.2008.02.019; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; D'Angelo SP, 2010, CANCER BIOL THER, V10, P1, DOI 10.4161/cbt.10.1.12045; de Marinis F, 2013, J THORAC ONCOL, V8, P1091, DOI 10.1097/JTO.0b013e318293d88c; Gandi L, 2009, J CLIN ONCOL S, V27, p15s; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hurwitz JL, 2009, ONCOLOGIST, V14, P986, DOI 10.1634/theoncologist.2009-0026; Iwakawa R, 2013, GENE CHROMOSOME CANC, V52, P802, DOI 10.1002/gcc.22076; Jachan NS, 2013, CANCER DISCOV, V3, P1; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Karimi S, 2012, CLIN LUNG CANCER, V13, P214, DOI 10.1016/j.cllc.2011.09.007; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Nickolich M, 2014, CLIN LUNG CANCER, V15, P207, DOI 10.1016/j.cllc.2013.12.001; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sos ML, 2012, P NATL ACAD SCI USA, V109, P17034, DOI 10.1073/pnas.1207310109; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulloa-Montoya F, 2013, J CLIN ONCOL, V31, P2388, DOI 10.1200/JCO.2012.44.3762; Voortman J, 2010, P NATL ACAD SCI USA, V107, P13040, DOI 10.1073/pnas.1008132107; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; William WN, 2011, NAT REV CLIN ONCOL, V8, P611, DOI 10.1038/nrclinonc.2011.90	27	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106784	10.1371/journal.pone.0106784	http://dx.doi.org/10.1371/journal.pone.0106784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198282	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700049
J	Xiao, GY; Liu, IH; Cheng, CC; Chang, CC; Lee, YH; Cheng, WTK; Wu, SC				Xiao, Guan-Yu; Liu, I-Hsuan; Cheng, Chun-Chun; Chang, Chia-Chun; Lee, Yen-Hua; Cheng, Winston Teng-Kuei; Wu, Shinn-Chih			Amniotic Fluid Stem Cells Prevent Follicle Atresia and Rescue Fertility of Mice with Premature Ovarian Failure Induced by Chemotherapy	PLOS ONE			English	Article							BETA SUPERFAMILY MEMBERS; IN-VITRO; GRANULOSA-CELLS; NEUROTROPHIC FACTOR; CHILDHOOD-CANCER; MAMMALIAN OVARY; GROWTH-FACTOR; GERM-CELL; MOUSE; EXPRESSION	Chemotherapy used to treat cancer may cause irreversible premature ovarian failure (POF). Of late, amniotic fluid stem cells (AFSCs) provide a novel source for regenerative medicine because of their primitive stage, low immunogenicity, and easy accessibility. In this study, we isolated AFSCs from transgenic mice that ubiquitously express enhanced green fluorescence protein (EGFP). These AFSCs exhibited morphologies, immunophenotypes, and mesoderm trilineage differentiation potentials similar to mesenchymal stem cells (MSCs). Further, AFSCs proliferated faster than MSCs and expressed OCT4, a marker for pluripotency. To investigate their potential in recovering fertility in POF model, AFSCs were transplanted into the ovaries of mice with POF six weeks post induction using chemotherapeutic drugs, busulfan and cyclophosphamide. AFSCs could rescue the reproductive ability of mice with POF by preventing follicle atresia and sustaining the healthy follicles. Notably, the transplanted AFSCs did not differentiate into granulosa and germline cells in vivo. After one month, the decreased numbers of transplanted AFSCs accompanied with the reduced beneficial effects indicated that the therapeutic efficacy were directly from AFSCs. These findings demonstrated the therapeutic effects of AFSCs and suggested the promise of AFSCs for treating infertility and POF caused by chemotherapy.	[Xiao, Guan-Yu; Cheng, Chun-Chun; Chang, Chia-Chun; Wu, Shinn-Chih] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Liu, I-Hsuan; Lee, Yen-Hua; Cheng, Winston Teng-Kuei; Wu, Shinn-Chih] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan; [Liu, I-Hsuan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Cheng, Winston Teng-Kuei] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Tunghai University	Wu, SC (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan.	scw01@ntu.edu.tw	Liu, I-Hsuan/D-9043-2017	Liu, I-Hsuan/0000-0002-4524-3263; Wu, Shinn-Chih/0000-0001-8881-1550; Chang, Chia Chun/0000-0001-7942-6300	National Taiwan University [98R0066-41]; National Science Council (NSC) [101-2313-B-002-017-MY3]	National Taiwan University(National Taiwan University); National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by National Taiwan University (98R0066-41) and National Science Council (NSC, 101-2313-B-002-017-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Bollini S, 2011, STEM CELL REV REP, V7, P364, DOI 10.1007/s12015-010-9200-z; BRUNING PF, 1990, BRIT J CANCER, V61, P308, DOI 10.1038/bjc.1990.58; Bryant-Greenwood GD, 1998, PLACENTA, V19, P1, DOI 10.1016/S0143-4004(98)90092-3; Byrne J, 1999, TERATOLOGY, V59, P210, DOI 10.1002/(SICI)1096-9926(199904)59:4<210::AID-TERA4>3.0.CO;2-X; Carraro G, 2008, STEM CELLS, V26, P2902, DOI 10.1634/stemcells.2008-0090; Carter J, 2005, GYNECOL ONCOL, V97, P90, DOI 10.1016/j.ygyno.2004.12.019; Chang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076118; Chemaitilly W, 2006, J CLIN ENDOCR METAB, V91, P1723, DOI 10.1210/jc.2006-0020; Cheng CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036085; Cheng FC, 2010, J NEUROSURG, V112, P868, DOI 10.3171/2009.8.JNS09850; De Coppi P, 2007, J UROLOGY, V177, P369, DOI 10.1016/j.juro.2006.09.103; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Gemmis P, 2006, STEM CELLS DEV, V15, P719; Desmeules P, 2006, TOXICOL SCI, V90, P500, DOI 10.1093/toxsci/kfj086; Fu X, 2008, CYTOTHERAPY, V10, P353, DOI 10.1080/14653240802035926; Goswami D, 2005, HUM REPROD UPDATE, V11, P391, DOI 10.1093/humupd/dmi012; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hillier SG, 2001, MOL CELL ENDOCRINOL, V179, P39, DOI 10.1016/S0303-7207(01)00469-5; Hsiao FSH, 2010, CELL PROLIFERAT, V43, P235, DOI 10.1111/j.1365-2184.2010.00674.x; Hudson MM, 2010, OBSTET GYNECOL, V116, P1171, DOI 10.1097/AOG.0b013e3181f87c4b; HUGHES FM, 1991, ENDOCRINOLOGY, V129, P2415, DOI 10.1210/endo-129-5-2415; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Jeanes H, 2007, EXPERT OPIN PHARMACO, V8, P279, DOI 10.1517/14656566.8.3.279; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang JY, 2003, FRONT BIOSCI-LANDMRK, V8, pD222, DOI 10.2741/949; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Knight PG, 2003, ANIM REPROD SCI, V78, P165, DOI 10.1016/S0378-4320(03)00089-7; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Lai DM, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-34; Lee HJ, 2007, J CLIN ONCOL, V25, P3198, DOI 10.1200/JCO.2006.10.3028; Lee KH, 2007, THERIOGENOLOGY, V67, P228, DOI 10.1016/j.theriogenology.2006.07.014; Linher-Melville K, 2013, REPRODUCTION, V145, pR43, DOI 10.1530/REP-12-0219; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Mirabella T, 2012, STEM CELLS DEV, V21, P2179, DOI 10.1089/scd.2011.0639; Morita Y, 1999, MOL ENDOCRINOL, V13, P841, DOI 10.1210/me.13.6.841; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Petrillo SK, 2011, TOXICOL APPL PHARM, V253, P94, DOI 10.1016/j.taap.2011.03.012; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Rosendahl M, 2010, FERTIL STERIL, V94, P156, DOI 10.1016/j.fertnstert.2009.02.043; Shin SY, 2006, EUR J OBSTET GYN R B, V125, P233, DOI 10.1016/j.ejogrb.2005.10.027; Takehara Y, 2013, LAB INVEST, V93, P181, DOI 10.1038/labinvest.2012.167; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Zhao XJ, 2010, GYNECOL ONCOL, V118, P69, DOI 10.1016/j.ygyno.2010.03.021; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	57	67	71	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106538	10.1371/journal.pone.0106538	http://dx.doi.org/10.1371/journal.pone.0106538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198549	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700031
J	Cao, JX; Zhang, XY; Liu, JL; Li, D; Li, JL; Liu, YS; Wang, M; Xu, BL; Wang, HB; Wang, ZX				Cao, Jun-Xia; Zhang, Xiao-Yan; Liu, Jin-Long; Li, Duo; Li, Jun-Li; Liu, Yi-Shan; Wang, Min; Xu, Bei-Lei; Wang, Hai-Bo; Wang, Zheng-Xu			Clinical Efficacy of Tumor Antigen-Pulsed DC Treatment for High-Grade Glioma Patients: Evidence from a Meta-Analysis	PLOS ONE			English	Article							DENDRITIC CELL VACCINATION; CENTRAL-NERVOUS-SYSTEM; NEWLY-DIAGNOSED GLIOBLASTOMA; PHASE-I/II TRIAL; MALIGNANT GLIOMA; PEPTIDE VACCINATION; RECURRENT GLIOMA; IMMUNOTHERAPY; MULTIFORME; THERAPY	Background: The effectiveness of immunotherapy for high-grade glioma (HGG) patients remains controversial. To evaluate the therapeutic efficacy of dendritic cells (DCs) alone in the treatment of HGG, we performed a systematic review and meta-analysis in terms of patient survival with relevant published clinical studies. Materials and methods: A total of 409 patients, including historical cohorts, nonrandomized and randomized controls with HGG, were selected for the meta-analysis. Results: The treatment of HGG with DCs was associated with a significantly improved one-year survival (OS) (p<0.001) and 1.5-, 2-, 3-, 4-, and 5-year OS (p<0.001) compared with the non-DC group. A meta-analysis of the patient outcome data revealed that DC immunotherapy has a significant influence on progression-free survival (PFS) in HGG patients, who showed significantly improved 1-, 1.5-, 2-, 3-and 4-year PFS (p<0.001). The analysis of Karnofsky performance status (KPS) demonstrated no favorable results for DC cell therapy arm (p = 0.23). The percentages of CD3(+) CD8(+) and CD3(+) CD4(+) T cells and CD16(+) lymphocyte subset were not significantly increased in the DC group compared with the baseline levels observed before treatment (p. 0.05), whereas CD56(+) lymphocyte subset were significantly increased after DC treatment (p = 0.0001). Furthermore, the levels of IFN-gamma in the peripheral blood of HGG patients, which reflect the immune function of the patients, were significantly increased after DC immunotherapy (p<0.001). Conclusions: Thus, our meta-analysis showed that DC immunotherapy markedly prolongs survival rates and progression-free time, enhances immune function, and improves the efficacy of the treatment of HGG patients.	[Cao, Jun-Xia; Zhang, Xiao-Yan; Liu, Jin-Long; Li, Duo; Li, Jun-Li; Liu, Yi-Shan; Wang, Min; Xu, Bei-Lei; Wang, Hai-Bo; Wang, Zheng-Xu] Gen Hosp Beijing Mil Command, Biotherapy Ctr, Beijing Mil Command, Beijing, Peoples R China; [Cao, Jun-Xia] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Lab Dynam Immunobiol, Beijing 100084, Peoples R China	Seventh Medical Center of Chinese PLA General Hospital; Tsinghua University	Cao, JX (corresponding author), Gen Hosp Beijing Mil Command, Biotherapy Ctr, Beijing Mil Command, Beijing, Peoples R China.	13716111318@139.com; zhxwang18@hotmail.com			National Natural Science Foundation of China [31171427, 30971651, 30700974]; Beijing Municipal Science & Technology Project; Clinical characteristics and Application Research of Capital [Z121107001012136]; Postdoctoral Foundation of China [20060400775]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Project(Beijing Municipal Science & Technology Commission); Clinical characteristics and Application Research of Capital; Postdoctoral Foundation of China(China Postdoctoral Science Foundation)	This research work was supported by the National Natural Science Foundation of China (No. 31171427 and 30971651 to Zheng-Xu Wang); Beijing Municipal Science & Technology Project; Clinical characteristics and Application Research of Capital (No. Z121107001012136 to Zheng-Xu Wang); the National Natural Science Foundation of China (No. 30700974 to Jun-Xia Cao); and the Postdoctoral Foundation of China (No. 20060400775 to Jun-Xia Cao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardon H, 2012, CANCER IMMUNOL IMMUN, V61, P2033, DOI 10.1007/s00262-012-1261-1; Ardon H, 2010, PEDIATR BLOOD CANCER, V54, P519, DOI 10.1002/pbc.22319; Badhiwala J, 2013, EXPERT REV NEUROTHER, V13, P405, DOI [10.1586/ERN.13.23, 10.1586/ern.13.23]; Bregy A, 2013, CANCER TREAT REV, V39, P891, DOI 10.1016/j.ctrv.2013.05.007; Chang CN, 2011, J CLIN NEUROSCI, V18, P1048, DOI 10.1016/j.jocn.2010.11.034; Cho DY, 2012, WORLD NEUROSURG, V77, P736, DOI 10.1016/j.wneu.2011.08.020; De Vleeschouwer S, 2012, CANCER IMMUNOL IMMUN, V61, P2105, DOI 10.1007/s00262-012-1271-z; FABRY Z, 1994, IMMUNOL TODAY, V15, P218, DOI 10.1016/0167-5699(94)90247-X; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hussain SF, 2005, EXPERT REV ANTICANC, V5, P777, DOI 10.1586/14737140.5.5.777; Izumoto S, 2008, J NEUROSURG, V108, P963, DOI 10.3171/JNS/2008/108/5/0963; Jackson C, 2013, IMMUNOTHERAPY-UK, V5, P155, DOI [10.2217/IMT.12.155, 10.2217/imt.12.155]; Jackson C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/732413; Jie X, 2012, CELL BIOCHEM BIOPHYS, V62, P91, DOI 10.1007/s12013-011-9265-6; Kikuchi T, 2001, CANCER IMMUNOL IMMUN, V50, P337, DOI 10.1007/s002620100205; Li ZH, 2012, EXPERT OPIN BIOL TH, V12, P165, DOI 10.1517/14712598.2012.648180; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mineharu Y, 2013, NEUROL MED-CHIR, V53, P741, DOI 10.2176/nmc.ra2013-0234; Ogbomo H, 2011, TRENDS MOL MED, V17, P433, DOI 10.1016/j.molmed.2011.03.004; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Reardon DA, 2013, EXPERT REV VACCINES, V12, P597, DOI [10.1586/ERV.13.41, 10.1586/erv.13.41]; Ruzevick J, 2012, NEUROSURG CLIN N AM, V23, P459, DOI 10.1016/j.nec.2012.04.003; Sagar D, 2012, J NEUROIMMUNE PHARM, V7, P74, DOI 10.1007/s11481-011-9302-7; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shah AH, 2013, NEUROSURGERY, V73, P863, DOI 10.1227/NEU.0000000000000107; van Gool Stefaan, 2013, Immunotherapy, V5, P1043, DOI 10.2217/imt.13.86; Van Gool S, 2012, EXPERT REV NEUROTHER, V12, P1173, DOI [10.1586/ERN.12.107, 10.1586/ern.12.107]; Van Gool S, 2009, BRAIN PATHOL, V19, P694, DOI 10.1111/j.1750-3639.2009.00316.x; Wang ZX, 2014, WORLD J GASTROENTERO, V20, P1095, DOI 10.3748/wjg.v20.i4.1095; Wheeler CJ, 2008, CANCER RES, V68, P5955, DOI 10.1158/0008-5472.CAN-07-5973; Wheeler CJ, 2004, CLIN CANCER RES, V10, P5316, DOI 10.1158/1078-0432.CCR-04-0497; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Xu X, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/764213; Yamanaka R, 2003, BRIT J CANCER, V89, P1172, DOI 10.1038/sj.bjc.6601268; Yamanaka R, 2005, CLIN CANCER RES, V11, P4160, DOI 10.1158/1078-0432.CCR-05-0120; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505	39	33	33	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107173	10.1371/journal.pone.0107173	http://dx.doi.org/10.1371/journal.pone.0107173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215607	Green Published, gold			2022-12-27	WOS:000341774300048
J	Elliott, GC; Gurtu, R; McCollum, C; Newman, WG; Wang, T				Elliott, Graeme C.; Gurtu, Rockesh; McCollum, Charles; Newman, William G.; Wang, Tao			Foramen Ovale Closure Is a Process of Endothelial-to-Mesenchymal Transition Leading to Fibrosis	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; TRANSCRANIAL DOPPLER; STROMAL FIBROBLASTS; CARDIAC DEVELOPMENT; LEFT SHUNT; NOTCH; MUTATIONS; GENE; PREVALENCE; EXPRESSION	Patent foramen ovale (PFO) is an atrial septal deformity present in around 25% of the general population. PFO is associated with major causes of morbidity, including stroke and migraine. PFO appears to be heritable but genes involved in the closure of foramen ovale have not been identified. The aim of this study is to determine molecular pathways and genes that are responsible to the postnatal closure of the foramen ovale. Using Sprague-Dawley rat hearts as a model we analysed the dynamic histological changes and gene expressions at the foramen ovale region between embryonic day 20 and postnatal day 7. We observed a gradual loss of the endothelial marker PECAM1, an upregulation of the mesenchymal marker vimentin and alpha-smooth muscle actin, the elevation of the transcription factor Snail, and an increase of fibroblast activation protein (FAP) in the foramen ovale region as well as the deposition of collagen-rich connective tissues at the closed foramen ovale, suggesting endothelial-to-mesenchymal transition (EndMT) occurring during foramen ovale closure which leads to fibrosis. In addition, Notch1 and Notch3 receptors, Notch ligand Jagged1 and Notch effector HRT1 were highly expressed in the endocardium of the foramen ovale region during EndMT. Activation of Notch3 alone in an endothelial cell culture model was able to drive EndMT and transform endothelial cells to mesenchymal phenotype. Our data demonstrate for the first time that FO closure is a process of EndMT-mediated fibrosis, and Notch signalling is an important player participating in this process. Elucidation of the molecular mechanisms of the closure of foramen ovale informs the pathogenesis of PFO and may provide potential options for screening and prevention of PFO related conditions.	[Elliott, Graeme C.; Newman, William G.; Wang, Tao] Univ Manchester, Fac Med & Human Sci, Ctr Genom Med, Inst Human Dev, Manchester, Lancs, England; [Gurtu, Rockesh; McCollum, Charles] Univ S Manchester Hosp, Educ & Res Ctr, Acad Surg Unit, Manchester M20 8LR, Lancs, England; [Newman, William G.] Cent Manchester Univ Hosp NHS Fdn Trust, Ctr Genom Med, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester	Wang, T (corresponding author), Univ Manchester, Fac Med & Human Sci, Ctr Genom Med, Inst Human Dev, Manchester, Lancs, England.	tao.wang@manchester.ac.uk		Newman, William/0000-0002-6382-4678	BBSRC Doctoral Training Account PhD Studentship; Manchester Biomedical Research Centre; Manchester Surgical Research Trust	BBSRC Doctoral Training Account PhD Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Manchester Surgical Research Trust	This work is supported by BBSRC Doctoral Training Account PhD Studentship, Manchester Biomedical Research Centre and Manchester Surgical Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2011, ACTA OPHTHALMOL, V89, pE115, DOI 10.1111/j.1755-3768.2010.01916.x; Anderson RH, 2002, HEART, V88, P104, DOI 10.1136/heart.88.1.104; Angeli S, 2001, EUR NEUROL, V46, P198, DOI 10.1159/000050804; Arquizan C, 2001, STROKE, V32, P1563, DOI 10.1161/01.STR.32.7.1563; ARRECHEDERA H, 1987, J MOL CELL CARDIOL, V19, P641, DOI 10.1016/S0022-2828(87)80372-3; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Belvis R, 2009, CLIN NEUROL NEUROSUR, V111, P574, DOI 10.1016/j.clineuro.2009.04.004; Berthet K, 2000, STROKE, V31, P398, DOI 10.1161/01.STR.31.2.398; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Chang AC, DEV CELL, V21, P288; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Cole-Jeffrey CT, 2012, ANAT REC, V295, P764, DOI 10.1002/ar.22432; Dalla Volta Giorgio, 2005, J Headache Pain, V6, P328, DOI 10.1007/s10194-005-0223-9; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Elliott GC, CLIN NEUROL NEUROSUR; Fox ER, 2003, AM HEART J, V145, P730, DOI 10.1067/mhj.2003.5; Fu YX, 2009, J BIOL CHEM, V284, P19452, DOI 10.1074/jbc.M109.011833; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Ghersi G, 2002, J BIOL CHEM, V277, P29231, DOI 10.1074/jbc.M202770200; Guerin P, 2005, CARDIOVASC INTER RAD, V28, P164, DOI 10.1007/s00270-004-0035-3; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Hara H, 2005, J AM COLL CARDIOL, V46, P1768, DOI 10.1016/j.jacc.2005.08.038; Henriksson ML, 2011, AM J PATHOL, V178, P1387, DOI 10.1016/j.ajpath.2010.12.008; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; HUTCHINS GM, 1981, AM J CARDIOL, V47, P90, DOI 10.1016/0002-9149(81)90295-2; Iguchi Y, 2008, CEREBROVASC DIS, V26, P409, DOI 10.1159/000151682; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Kizer JR, 2005, NEW ENGL J MED, V353, P2361, DOI 10.1056/NEJMcp043981; Krebs LT, 2000, GENE DEV, V14, P1343; Krishnan SC, 2010, JACC-CARDIOVASC INTE, V3, P98, DOI 10.1016/j.jcin.2009.07.017; Levy MT, 2002, LIVER, V22, P93, DOI 10.1034/j.1600-0676.2002.01503.x; Li QY, 1997, NAT GENET, V15, P21; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Mansencal N, 2008, AM J CARDIOL, V101, P1035, DOI 10.1016/j.amjcard.2007.11.056; MOMMA K, 1992, PEDIATR RES, V32, P669, DOI 10.1203/00006450-199212000-00008; Monserrat L, 2007, EUR HEART J, V28, P1953, DOI 10.1093/eurheartj/ehm239; MOON RE, 1989, LANCET, V1, P513; Niedermeyer J, 2001, INT J DEV BIOL, V45, P445; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Snarr BS, 2007, DEV DYNAM, V236, P1287, DOI 10.1002/dvdy.21074; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Wang T, 2007, CELL SIGNAL, V19, P2458, DOI 10.1016/j.cellsig.2007.07.019; Wang XM, 2008, FRONT BIOSCI-LANDMRK, V13, P3168, DOI 10.2741/2918; Wilmshurst PT, 2004, HEART, V90, P1315, DOI 10.1136/hrt.2003.025700; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910; Zicari E, 2008, STROKE, V39, P2155, DOI 10.1161/STROKEAHA.107.506311	51	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107175	10.1371/journal.pone.0107175	http://dx.doi.org/10.1371/journal.pone.0107175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215881	gold, Green Published, Green Submitted			2022-12-27	WOS:000341774300049
J	Deng, XQ; Gu, W; Li, YY; Liu, M; Li, Y; Gao, XW				Deng, Xingqi; Gu, Wei; Li, Yanyan; Liu, Mei; Li, Yan; Gao, Xiwen			Age-Group-Specific Associations between the Severity of Obstructive Sleep Apnea and Relevant Risk Factors in Male and Female Patients	PLOS ONE			English	Article							HEART HEALTH; POPULATION; GENDER; PREVALENCE; REGRESSION; DISEASE; ADULTS; WOMEN; MEN	Aim: To seek accurate and credible correlation manner between gender, age, and obesity; and the severity of obstructive sleep apnea (OSA) in large-scale population. Methods: Totals of 1,975 male and 378 female OSA patients were sequentially recruited. Centralized covariant tendencies between age, body mass index (BMI), and waist hip ratio (WHR); and OSA severity, were explored in a gender-specific manner via multiple statistical analyses. The accuracies of observed correlations were further evaluated by adaptive multiple linear regression. Results: All of age, BMI, WHR, smoking, drinking, and OSA severity differed between males and females. BMI and WHR were positively and (approximately) linearly associated with OSA severity in both males and females. Restricted cubic spline analysis was more effective than was the Pearson correlation approach in correlating age with AHI, and provided age crossover points allowing further piecewise linear modeling for both males and females. Multiple linear regression showed that increasing age was associated with OSA exacerbation in males aged <= 40 years and in females aged 45-53 years. BMI, WHR, and diabetes were independently associated with OSA severity in males with age-group-specific pattern. In females, only BMI was associated with OSA severity at all ages. Conclusions: In male patients, BMI and WHR are prominent risk factors for OSA exacerbation. Age and diabetes are associated with OSA severity in males of particular ages. In females, BMI is also a prominent risk factor for severe OSA, and OSA severity increased with age in the range 45-53 years.	[Deng, Xingqi; Gu, Wei; Li, Yanyan; Liu, Mei] Ctr Hosp Minhang Dist, Dept Emergency Med, Shanghai, Peoples R China; [Li, Yan; Gao, Xiwen] Ctr Hosp Minhang Dist, Dept Resp Med, Shanghai, Peoples R China		Deng, XQ (corresponding author), Ctr Hosp Minhang Dist, Dept Emergency Med, Shanghai, Peoples R China.	dxq2000@hotmail.com			Program for Development of Key Disciplines of Shanghai [ZK2012A23]	Program for Development of Key Disciplines of Shanghai	This work was supported by the Program for Development of Key Disciplines of Shanghai (series number: ZK2012A23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurora RN, 2013, LANCET RESP MED, V1, P329, DOI 10.1016/S2213-2600(13)70039-0; Avlonitou E, 2012, SLEEP BREATH, V16, P563, DOI 10.1007/s11325-011-0543-8; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Damiani MF, 2013, CHEST, V143, P1512, DOI 10.1378/chest.12-2997; Drager LF, 2013, J AM COLL CARDIOL, V62, P569, DOI 10.1016/j.jacc.2013.05.045; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Dyken ME, 2012, CHEST, V141, P528, DOI 10.1378/chest.11-0773; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Kapsimalis F, 2002, SLEEP, V25, P499, DOI 10.1093/sleep/25.5.497; Kapsimalis F, 2002, SLEEP, V25, P412; Ko GTC, 1998, DIABETES CARE, V21, P2094, DOI 10.2337/diacare.21.12.2094; Lam JCM, 2010, INDIAN J MED RES, V131, P165; Monahan K, 2011, CURR OPIN CARDIOL, V26, P541, DOI 10.1097/HCO.0b013e32834b806a; Myers KA, 2013, JAMA-J AM MED ASSOC, V310, P731, DOI 10.1001/jama.2013.276185; Newman AB, 2005, ARCH INTERN MED, V165, P2408, DOI 10.1001/archinte.165.20.2408; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Pillar F, 2000, AM J RESP CRIT CARE, V162, P1627, DOI 10.1164/ajrccm.162.5.2003131; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Sanchez-Garcia S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-2; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Sharma Hanish, 2008, Indian J Chest Dis Allied Sci, V50, P137; Sin DD, 1999, AM J RESP CRIT CARE, V160, P1101, DOI 10.1164/ajrccm.160.4.9903020; Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Witkowski A, 2013, EUROINTERVENTION, V9, pR105, DOI 10.4244/EIJV9SRA18; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893; Yuan S, 2012, STAT MED, V31, P3789, DOI 10.1002/sim.5433	27	27	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107380	10.1371/journal.pone.0107380	http://dx.doi.org/10.1371/journal.pone.0107380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211035	gold, Green Published			2022-12-27	WOS:000341855900069
J	Srinivasrao, G; Park, JE; Kim, S; Ahn, M; Cheong, C; Nam, KY; Gunasekaran, P; Hwang, E; Kim, NH; Shin, SY; Lee, KS; Ryu, E; Bang, JK				Srinivasrao, Ganipisetti; Park, Jung-Eun; Kim, Sungmin; Ahn, Mija; Cheong, Chaejoon; Nam, Ky-Youb; Gunasekaran, Pethaiah; Hwang, Eunha; Kim, Nam-Hyung; Shin, Song Yub; Lee, Kyung S.; Ryu, Eunkyung; Bang, Jeong Kyu			Design and Synthesis of a Cell-Permeable, Drug-Like Small Molecule Inhibitor Targeting the Polo-Box Domain of Polo-Like Kinase 1	PLOS ONE			English	Article							PLK1; PEPTIDE; POLO-LIKE-KINASE-1; RECOGNITION; AFFINITY	Background: Polo-like kinase-1 (Plk1) plays a crucial role in cell proliferation and the inhibition of Plk1 has been considered as a potential target for specific inhibitory drugs in anti-cancer therapy. Several research groups have identified peptide-based inhibitors that target the polo-box domain (PBD) of Plk1 and bind to the protein with high affinity in in vitro assays. However, inadequate proteolytic resistance and cell permeability of the peptides hinder the development of these peptide-based inhibitors into novel therapeutic compounds. Methodology/Principal Findings: In order to overcome the shortcomings of peptide-based inhibitors, we designed and synthesized small molecule inhibitors. Among these molecules, bg-34 exhibited a high binding affinity for Plk1-PBD and it could cross the cell membrane in its unmodified form. Furthermore, bg-34-dependent inhibition of Plk1-PBD was sufficient for inducing apoptosis in HeLa cells. Moreover, modeling studies performed on Plk1-PBD in complex with bg-34 revealed that bg-34 can interact effectively with Plk1-PBD. Conclusion/Significance: We demonstrated that the molecule bg-34 is a potential drug candidate that exhibits anti-Plk1-PBD activity and possesses the favorable characteristics of high cell permeability and stability. We also determined that bg-34 induced apoptotic cell death by inhibiting Plk1-PBD in HeLa cells at the same concentration as PEGylated 4j peptide, which can inhibit Plk1-PBD activity 1000 times more effectively than bg-34 can in in vitro assays. This study may help to design and develop drug-like small molecule as Plk1-PBD inhibitor for better therapeutic activity.	[Srinivasrao, Ganipisetti; Kim, Sungmin; Ahn, Mija; Cheong, Chaejoon; Hwang, Eunha; Ryu, Eunkyung; Bang, Jeong Kyu] Korea Basic Sci Inst, Div Magnet Resonance, Ochang, Chung Buk, South Korea; [Park, Jung-Eun; Lee, Kyung S.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Nam, Ky-Youb] Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea; [Nam, Ky-Youb] Asan Med Ctr, Dept Convergence Med, Seoul, South Korea; [Gunasekaran, Pethaiah; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Mol Embryol Lab, Cheongju, Chung Buk, South Korea; [Shin, Song Yub] Chosun Univ, Grad Sch, Dept Biomat, Gwangju, South Korea; [Shin, Song Yub] Chosun Univ, Sch Med, Dept Cellular & Mol Med, Gwangju, South Korea	Korea Basic Science Institute (KBSI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Chungbuk National University; Chosun University; Chosun University	Ryu, E (corresponding author), Korea Basic Sci Inst, Div Magnet Resonance, Ochang, Chung Buk, South Korea.	ekryu@kbsi.re.kr; bangjk@kbsi.re.kr	GANIPISETTI, SRINIVASRAO/AAA-6802-2022; Pethaiah, Dr Gunasekaran/L-8226-2018; GANIPISETTI, SRINIVASRAO/AAP-6825-2020; Cheong, Chaejoon/GWC-3135-2022	Pethaiah, Dr Gunasekaran/0000-0001-8436-4183; GANIPISETTI, SRINIVASRAO/0000-0001-9803-8813; 	Korea Basic Science Institute's Research Program grant [T34418]; Next-Generation BioGreen 21 Program, RuralDevelopment Administration [PJ009594]; NATIONAL CANCER INSTITUTE [ZIABC010681] Funding Source: NIH RePORTER	Korea Basic Science Institute's Research Program grant; Next-Generation BioGreen 21 Program, RuralDevelopment Administration; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Korea Basic Science Institute's Research Program grant T34418 (JKB) and the Next-Generation BioGreen 21 Program (#PJ009594), RuralDevelopment Administration (NHK). K.-Y. Nam would like to thank Professor Kyoung Tai No (Yonsei Univ.) for allowing to access the computational resources in his group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2011, EUR J ORG CHEM, V2011, P234, DOI 10.1002/ejoc.201001423; Bang J, 2008, CHEMMEDCHEM, V3, P230, DOI 10.1002/cmdc.200700281; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Donaldson MM, 2001, J CELL SCI, V114, P2357; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Garcia-Alvarez B, 2007, P NATL ACAD SCI USA, V104, P3107, DOI 10.1073/pnas.0609131104; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Glover DM, 1996, J CELL BIOL, V135, P1681, DOI 10.1083/jcb.135.6.1681; Horton DA, 2003, CHEM REV, V103, P893, DOI 10.1021/cr020033s; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Liao CZ, 2010, ACS MED CHEM LETT, V1, P110, DOI 10.1021/ml100020e; Liu F, 2012, CHEMBIOCHEM, V13, P1291, DOI 10.1002/cbic.201200206; Liu F, 2012, ACS CHEM BIOL, V7, P805, DOI 10.1021/cb200469a; Liu F, 2011, NAT CHEM BIOL, V7, P595, DOI 10.1038/nchembio.614; McInnes C, 2012, MOL CANCER THER, V11, P1683, DOI 10.1158/1535-7163.MCT-12-0006-T; Murugan RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080043; Murugan RN, 2013, BIOORGAN MED CHEM, V21, P2623, DOI 10.1016/j.bmc.2013.02.020; Murugan RN, 2011, MOL CELLS, V32, P209, DOI 10.1007/s10059-011-0126-3; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Qian WJ, 2012, BIOORG MED CHEM LETT, V22, P7306, DOI 10.1016/j.bmcl.2012.10.093; Qian WJ, 2013, BIOORGAN MED CHEM, V21, P3996, DOI 10.1016/j.bmc.2012.05.036; Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013; Sledz P, 2012, ANGEW CHEM INT EDIT, V51, P7680, DOI 10.1002/anie.201202660; Sledz P, 2011, ANGEW CHEM INT EDIT, V50, P4003, DOI 10.1002/anie.201008019; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Watanabe N, 2009, J BIOL CHEM, V284, P2344, DOI 10.1074/jbc.M805308200; XIANGMING H, 2007, ARKIVOC, V13, P150; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628	36	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107432	10.1371/journal.pone.0107432	http://dx.doi.org/10.1371/journal.pone.0107432			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211362	gold, Green Submitted, Green Published			2022-12-27	WOS:000341855900072
J	Xie, CC; Zhou, K; Wang, XY; Blomgren, K; Zhu, CL				Xie, Cuicui; Zhou, Kai; Wang, Xiaoyang; Blomgren, Klas; Zhu, Changlian			Therapeutic Benefits of Delayed Lithium Administration in the Neonatal Rat after Cerebral Hypoxia-Ischemia	PLOS ONE			English	Article							BRAIN-DAMAGE; POTENTIAL MECHANISMS; NEUROPROTECTION; IMMATURE; OUTCOMES; INJURY; HYPOTHERMIA; ACTIVATION; DISORDER; RECOVERY	Aim: We have previously shown that lithium treatment immediately after hypoxia-ischemia (HI) in neonatal rats affords both short-and long-term neuroprotection. The aim of this study was to evaluate possible therapeutic benefits when lithium treatment was delayed 5 days, a time point when most cell death is over. Methods: Eight-day-old male rats were subjected to unilateral HI and 2 mmol/kg lithium chloride was injected intraperitoneally 5 days after the insult. Additional lithium injections of 1 mmol/kg were administered at 24 h intervals for the next 14 days. Brain injury was evaluated 12 weeks after HI. Serum cytokine measurements and behavioral analysis were performed before sacrificing the animals. Results: Brain injury, as indicated by tissue loss, was reduced by 38.7%, from 276.5 +/- 27.4 mm(3) in the vehicle-treated group to 169.3 +/- 25.9 mm(3) in the lithium-treated group 12 weeks after HI (p<0.01). Motor hyperactivity and anxiety-like behavior after HI were normalized by lithium treatment. Lithium treatment increased neurogenesis in the dentate gyrus as indicated by doublecortin labeling. Serum cytokine levels, including IL-1 alpha, IL-1 beta, and IL-6, were still elevated as late as 5 weeks after HI, but lithium treatment normalized these cytokine levels. Conclusions: Delayed lithium treatment conferred long-term neuroprotection in neonatal rats after HI, and this opens a new avenue for future development of treatment strategies for neonatal brain injury that can be administered after the acute injury phase.	[Xie, Cuicui; Zhou, Kai; Blomgren, Klas; Zhu, Changlian] Univ Gothenburg, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Gothenburg, Sweden; [Xie, Cuicui; Zhou, Kai; Blomgren, Klas] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Wang, Xiaoyang] Univ Gothenburg, Inst Neurosci & Physiol, Perinatal Ctr, Gothenburg, Sweden; [Wang, Xiaoyang; Zhu, Changlian] Zhengzhou Univ, Affiliated Hosp 3, Dept Pediat, Zhengzhou 450052, Peoples R China; [Blomgren, Klas] Univ Gothenburg, Queen Silvia Childrens Hosp, Dept Pediat, Gothenburg, Sweden; [Zhu, Changlian] Zhengzhou Childrens Hosp, Dept Pediat, Zhengzhou, Peoples R China	University of Gothenburg; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg; Zhengzhou University; Queen Silvia Children's Hospital; University of Gothenburg	Zhu, CL (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Gothenburg, Sweden.	changlian.zhu@neuro.gu.se	Zhu, Changlian/AAN-6205-2020	Zhu, Changlian/0000-0002-5029-6730; Wang, Xiaoyang/0000-0001-9717-8160; Blomgren, Klas/0000-0002-0476-7271	Swedish Research Council [K2012-99X-21988-01-3]; National Natural Science Foundation of China [31271152]; Swedish Childhood Cancer Foundation [PROJ10/032]; Swedish governmental (ALF) [ALFGBG-291241]	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swedish Childhood Cancer Foundation(European Commission); Swedish governmental (ALF)	This work was supported by the Swedish Research Council (K2012-99X-21988-01-3), the National Natural Science Foundation of China (31271152), the Swedish Childhood Cancer Foundation (PROJ10/032), Swedish governmental grants to scientists working in health care (ALF)(ALFGBG-291241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Camins A, 2009, CNS NEUROSCI THER, V15, P333, DOI 10.1111/j.1755-5949.2009.00086.x; Chuang DM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00015; Contestabile A, 2013, J CLIN INVEST, V123, P348, DOI 10.1172/JCI64650; Doverhag C, 2010, NEUROBIOL DIS, V38, P36, DOI 10.1016/j.nbd.2009.12.024; Drury PP, 2010, SEMIN FETAL NEONAT M, V15, P287, DOI 10.1016/j.siny.2010.05.005; Dzietko M, 2013, TRANSL STROKE RES, V4, P189, DOI 10.1007/s12975-012-0221-6; Findling RL, 2011, J CHILD ADOL PSYCHOP, V21, P195, DOI 10.1089/cap.2010.0084; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; Geddes R, 2001, DEV NEUROSCI-BASEL, V23, P180, DOI 10.1159/000046140; Hagberg H, 2009, J CHILD NEUROL, V24, P1141, DOI 10.1177/0883073809338212; Huo KM, 2012, MOL CELL NEUROSCI, V51, P32, DOI 10.1016/j.mcn.2012.07.002; Jenkins DD, 2012, J CEREBR BLOOD F MET, V32, P1888, DOI 10.1038/jcbfm.2012.83; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Lawn JE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000389; Lee KY, 2007, BRAIN RES, V1129, P89, DOI 10.1016/j.brainres.2006.10.055; Leonardo CC, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-13; Li HF, 2011, J CEREBR BLOOD F MET, V31, P2106, DOI 10.1038/jcbfm.2011.75; Li Q, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.33; Licht RW, 2012, CNS NEUROSCI THER, V18, P219, DOI 10.1111/j.1755-5949.2011.00260.x; Malhi GS, 2013, CNS DRUGS, V27, P135, DOI 10.1007/s40263-013-0039-0; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Perrone S, 2012, J MATERN-FETAL NEO M, V25, P83, DOI 10.3109/14767058.2012.663168; Qiu L, 2007, J CEREBR BLOOD F MET, V27, P785, DOI 10.1038/sj.jcbfm.9600385; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; Wang XY, 2009, J IMMUNOL, V183, P7471, DOI 10.4049/jimmunol.0900762; Wang XY, 2001, BIOL NEONATE, V79, P172; Wideroe M, 2011, NEONATOLOGY, V100, P363, DOI 10.1159/000328705; Winerdal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036422; Xu JH, 2003, STROKE, V34, P1287, DOI 10.1161/01.STR.0000066308.25088.64; Yan XB, 2007, BEHAV BRAIN RES, V177, P282, DOI 10.1016/j.bbr.2006.11.021; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhu C, 2007, CELL DEATH DIFFER, V14, P775, DOI 10.1038/sj.cdd.4402053; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545; Zhu CL, 2009, PEDIATRICS, V124, pE218, DOI 10.1542/peds.2008-3553; Zhu CL, 2009, J CEREBR BLOOD F MET, V29, P342, DOI 10.1038/jcbfm.2008.124	39	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107192	10.1371/journal.pone.0107192	http://dx.doi.org/10.1371/journal.pone.0107192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211332	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900048
J	Rojas, JM; Castillo, SB; Folguera, G; Abades, S; Bozinovic, F				Rojas, Jose M.; Castillo, Simon B.; Folguera, Guillermo; Abades, Sebastian; Bozinovic, Francisco			Coping with Daily Thermal Variability: Behavioural Performance of an Ectotherm Model in a Warming World	PLOS ONE			English	Article							ARMADILLIDIUM-VULGARE ISOPODA; LAEVIS LATREILLE ISOPODA; LIFE-HISTORY TRAITS; ENVIRONMENTAL-TEMPERATURE; THERMOREGULATORY BEHAVIOR; PHENOTYPIC PLASTICITY; TERRESTRIAL ISOPOD; FRACTAL DIMENSION; SEARCH BEHAVIOR; ACCLIMATION	Global climate change poses one of the greatest threats to species persistence. Most analyses of the potential biological impacts have focused on changes in mean temperature, but changes in thermal variance will also impact organisms and populations. We assessed the effects of acclimation to daily variance of temperature on dispersal and exploratory behavior in the terrestrial isopod Porcellio laevis in an open field. Acclimation treatments were 24 +/- 0, 24 +/- 4 and 24 +/- 8 degrees C. Because the performance of ectotherms relates nonlinearly to temperature, we predicted that animals acclimated to a higher daily thermal variation should minimize the time exposed in the centre of open field, -i.e. increase the linearity of displacements. Consistent with our prediction, isopods acclimated to a thermally variable environment reduce their exploratory behaviour, hypothetically to minimize their exposure to adverse environmental conditions. This scenario as well as the long latency of animals after releases acclimated to variable environments is consistent with this idea. We suggested that to develop more realistic predictions about the biological impacts of climate change, one must consider the interactions between the mean and variance of environmental temperature on animals' performance.	[Rojas, Jose M.; Castillo, Simon B.; Abades, Sebastian; Bozinovic, Francisco] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Rojas, Jose M.; Castillo, Simon B.; Abades, Sebastian; Bozinovic, Francisco] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile; [Rojas, Jose M.] Univ Santo Tomas, Ctr Invest & Innovac Cambio Climat, Santiago, Chile; [Folguera, Guillermo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Filosofia Biol Grp, Buenos Aires, DF, Argentina; [Folguera, Guillermo] Univ Buenos Aires, Fac Filosofia & Letras, Buenos Aires, DF, Argentina; [Abades, Sebastian] Inst Ecol & Biodiversidad, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad Santo Tomas; University of Buenos Aires; University of Buenos Aires	Bozinovic, F (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile.	fbozinovic@bio.puc.cl		Abades, Sebastian/0000-0001-5704-4037; Castillo, Simon P/0000-0002-0606-2160	Fondo Nacional de Ciencia y Tecnologia [1130015]; Centro de Ecologia Aplicada y Sustentabilidad	Fondo Nacional de Ciencia y Tecnologia; Centro de Ecologia Aplicada y Sustentabilidad	This study was funded by Fondo Nacional de Ciencia y Tecnologia grant #1130015 and Centro de Ecologia Aplicada y Sustentabilidad, Line 3 to FB. The authors thank L. A. Ebensperger and F. M. Jaksic for helpful comments. Experimental protocols followed the rules of The Ethics and Biosafety Committee of the Faculty of Biological Sciences at the Catholic University of Chile, permit No. CBB-100/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Bacigalupe LD, 2007, COMP BIOCHEM PHYS A, V147, P349, DOI 10.1016/j.cbpa.2007.01.001; Baker MB, 2005, ANIM BEHAV, V69, P1131, DOI 10.1016/j.anbehav.2004.07.017; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bozinovic F, 2013, EVOL ECOL RES, V15, P579; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; Bozinovic F, 2011, PHYSIOL BIOCHEM ZOOL, V84, P543, DOI 10.1086/662551; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Canals M, 2011, COMPLEXITY, V17, P35, DOI 10.1002/cplx.20370; Carbines GD., 1992, INT J COMP PSYCHOL, V5, P138; Castaneda LE, 2004, EVOL ECOL RES, V6, P579; Chapperon C, 2013, ECOL RES, V28, P407, DOI 10.1007/s11284-013-1030-4; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dray S, 2010, ECOL RES, V25, P673, DOI 10.1007/s11284-010-0701-7; Estay SA, 2014, OIKOS, V123, P131, DOI 10.1111/j.1600-0706.2013.00607.x; Folguera G, 2011, COMP BIOCHEM PHYS A, V159, P242, DOI 10.1016/j.cbpa.2011.03.002; Folguera G, 2010, J INSECT PHYSIOL, V56, P1679, DOI 10.1016/j.jinsphys.2010.06.015; Folguera G, 2009, COMP BIOCHEM PHYS A, V154, P389, DOI 10.1016/j.cbpa.2009.07.008; Frost AJ, 2013, ANIM BEHAV, V85, P1199, DOI 10.1016/j.anbehav.2013.03.006; Greenaway P, 1998, ISR J ZOOL, V44, P473; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Hassall M, 2005, OECOLOGIA, V143, P51, DOI 10.1007/s00442-004-1772-3; Hassall M, 2007, INVERTEBR BIOL, V126, P46, DOI 10.1111/j.1744-7410.2007.00075.x; Hassall M, 2010, BEHAVIOUR, V147, P151, DOI 10.1163/000579509X12512861455834; Heinz SK, 2005, LANDSCAPE ECOL, V20, P83, DOI 10.1007/s10980-004-0678-0; Helden AJ, 1998, ISR J ZOOL, V44, P379; Helmuth B, 2010, J EXP BIOL, V213, P995, DOI 10.1242/jeb.038463; Helmuth B, 2009, J EXP BIOL, V212, P753, DOI 10.1242/jeb.023861; HOFFMANN G, 1983, BEHAV ECOL SOCIOBIOL, V13, P81, DOI 10.1007/BF00293798; HOFFMANN G, 1983, BEHAV ECOL SOCIOBIOL, V13, P93, DOI 10.1007/BF00293799; HUGHES RN, 1978, J BIOL PSYCHOL, V20, P35; HUGHES RN, 1967, ANIM BEHAV, V15, P282, DOI 10.1016/0003-3472(67)90013-9; HUSAIN MZ, 1979, CRUSTACEANA, V36, P277, DOI 10.1163/156854079X00753; HUTCHISON VH, 1979, AM ZOOL, V19, P367; Jaksic FM, 2001, REV CHIL HIST NAT, V74, P477; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Lankau R, 2011, EVOL APPL, V4, P315, DOI 10.1111/j.1752-4571.2010.00171.x; Lardies MA, 2006, EVOL ECOL RES, V8, P455; Lardies MA, 2004, CAN J ZOOL, V82, P677, DOI 10.1139/Z04-033; Lardies MA, 2008, EVOL ECOL RES, V10, P747; Marais E, 2008, ECOL LETT, V11, P1027, DOI 10.1111/j.1461-0248.2008.01213.x; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; MILLER RH, 1987, AM MIDL NAT, V117, P192, DOI 10.2307/2425719; Munoz JLP, 2008, J THERM BIOL, V33, P149, DOI 10.1016/j.jtherbio.2007.10.002; Munoz JLP, 2005, COMP BIOCHEM PHYS A, V142, P92, DOI 10.1016/j.cbpa.2005.08.002; NAIR GA, 1976, P INDIAN ACAD SCI B, V84, P165; Nams VO, 2006, ACTA BIOTHEOR, V54, P1, DOI 10.1007/s10441-006-5954-8; Nams VO, 1996, LANDSCAPE ECOL, V11, P289, DOI 10.1007/BF02059856; PARIS OH, 1963, ECOL MONOGR, V33, P1, DOI 10.2307/1948475; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; Root Terry I., 2005, P61; SCHULTZ G A, 1972, Crustaceana Supplement (Leiden), V3, P79; SCHULTZ GA, 1961, SYST ZOOL, V10, P193, DOI 10.2307/2411617; Sih A, 2013, ANIM BEHAV, V85, P1077, DOI 10.1016/j.anbehav.2013.02.017; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Solomon Susan, 2008, CLIMATE CHANGE 2007; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Team RDC, 2019, R LANG ENV STAT COMP; Tepler S, 2011, BIOL BULL-US, V220, P107, DOI 10.1086/BBLv220n2p107; Turchin Peter, 1998; Warburg M.R., 1984, Symposia of the Zoological Society of London, P339; Warburg MR, 2001, J CRUSTACEAN BIOL, V21, P375, DOI 10.1651/0278-0372(2001)021[0375:NSBIAP]2.0.CO;2; WARBURG MR, 1968, AM ZOOL, V8, P545; Westerberg L, 2008, ECOL MODEL, V213, P263, DOI 10.1016/j.ecolmodel.2007.12.011; WIENS JA, 1995, ECOLOGY, V76, P663, DOI 10.2307/1941226; Wingfield JC, 2013, ANIM BEHAV, V85, P1127, DOI 10.1016/j.anbehav.2013.02.018; Zuur Alain F., 2009, P1	70	7	7	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106897	10.1371/journal.pone.0106897	http://dx.doi.org/10.1371/journal.pone.0106897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207653	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300047
J	Schoonderwaldt, E; Altenmuller, E				Schoonderwaldt, Erwin; Altenmueller, Eckart			Coordination in Fast Repetitive Violin-Bowing Patterns	PLOS ONE			English	Article							UPPER-LIMB MOVEMENT; SENSORIMOTOR SYNCHRONIZATION; ARM MOVEMENTS; PERFORMANCE; PERCEPTION; PARAMETERS; FEEDBACK; MOTION; INTERLIMB; SKILL	We present a study of coordination behavior in complex violin-bowing patterns involving simultaneous bow changes (reversal of bowing direction) and string crossings (changing from one string to another). Twenty-two violinists (8 advanced amateurs, 8 students with violin as major subject, and 6 elite professionals) participated in the experiment. We investigated the influence of a variety of performance conditions (specific bowing patterns, dynamic level, tempo, and transposition) and level of expertise on coordination behavior (a.o., relative phase and amplitude) and stability. It was found that the general coordination behavior was highly consistent, characterized by a systematic phase lead of bow inclination over bow velocity of about 15 degrees (i.e., string crossings were consistently timed earlier than bow changes). Within similar conditions, a high individual consistency was found, whereas the inter-individual agreement was considerably less. Furthermore, systematic influences of performance conditions on coordination behavior and stability were found, which could be partly explained in terms of particular performance constraints. Concerning level of expertise, only subtle differences were found, the student and professional groups (higher level of expertise) showing a slightly higher stability than the amateur group (lower level of expertise). The general coordination behavior as observed in the current study showed a high agreement with perceptual preferences reported in an earlier study to similar bowing patterns, implying that complex bowing trajectories for an important part emerge from auditory-motor interaction.	[Schoonderwaldt, Erwin; Altenmueller, Eckart] Hanover Univ Mus Drama & Media, Inst Mus Physiol & Musicians Med, Hanover, NH 03755 USA		Schoonderwaldt, E (corresponding author), Hanover Univ Mus Drama & Media, Inst Mus Physiol & Musicians Med, Hanover, NH 03755 USA.	schoondw@gmail.com	Altenmuller, Eckart/AAB-9948-2021		Alexander von Humboldt foundation	Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	ES was supported by the Alexander von Humboldt foundation (http://www.humboldt-foundation.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKENFELT A, 1989, J ACOUST SOC AM, V86, P503, DOI 10.1121/1.398230; Baader AP, 2005, COGNITIVE BRAIN RES, V23, P436, DOI 10.1016/j.cogbrainres.2004.11.008; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; BEEK PJ, 1995, HUM MOVEMENT SCI, V14, P573, DOI 10.1016/0167-9457(95)00028-5; BYBLOW WD, 1995, J MOTOR BEHAV, V27, P123, DOI 10.1080/00222895.1995.9941705; Demoucron M, 2013, P STOCKH MUS AC C 20; Demoucron M, 2009, ACTA ACUST UNITED AC, V95, P718, DOI 10.3813/AAA.918200; Dietrich S, 2012, EXP BRAIN RES, V218, P237, DOI 10.1007/s00221-012-3005-z; Dounskaia N, 2002, EXP BRAIN RES, V146, P11, DOI 10.1007/s00221-002-1144-3; Dounskaia N, 2000, EXP BRAIN RES, V135, P127, DOI 10.1007/s002210000495; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Feijen L, 2010, J MOTOR BEHAV, V42, P295, DOI 10.1080/00222895.2010.504760; Furuya S, 2008, EXP BRAIN RES, V185, P581, DOI 10.1007/s00221-007-1184-9; Goebl W, 2008, EXP BRAIN RES, V186, P471, DOI 10.1007/s00221-007-1252-1; Goebl W, 2009, MUSIC PERCEPT, V26, P427, DOI 10.1525/MP.2009.26.5.427; Guettler K, 2002, ACTA ACUST UNITED AC, V88, P970; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hermann Thomas, 2011, SONIFICATION HDB; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Hodgson P, 1958, MOTION STUDY VIOLIN; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; Jabusch HC, 2009, HUM MOVEMENT SCI, V28, P74, DOI 10.1016/j.humov.2008.08.001; Kazennikov O, 2009, MOTOR CONTROL, V13, P297, DOI 10.1123/mcj.13.3.297; Keller PE, 2010, MUSIC PERCEPT, V28, P27, DOI 10.1525/MP.2010.28.1.27; Keller PE, 2008, EMERG COMMUN-STUD NE, V10, P205; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KELSO JAS, 1991, EXP BRAIN RES, V85, P432; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Konczak J, 2009, J MOTOR BEHAV, V41, P243, DOI 10.3200/JMBR.41.3.243-252; Kovacs AJ, 2011, ACTA PSYCHOL, V136, P311, DOI 10.1016/j.actpsy.2010.12.004; Kovacs AJ, 2010, EXP BRAIN RES, V201, P249, DOI 10.1007/s00221-009-2031-y; Kovacs AJ, 2009, EXP BRAIN RES, V193, P129, DOI 10.1007/s00221-008-1676-2; Lamb PF, 2014, CLIN BIOMECH, V29, P484, DOI 10.1016/j.clinbiomech.2014.03.008; Langsrud Y, 2003, STAT COMPUT, V13, P163, DOI 10.1023/A:1023260610025; Lawrence M. A., 2013, EASY ANAL VISUALIZAT; LEE TD, 1995, J MOTOR BEHAV, V27, P263, DOI 10.1080/00222895.1995.9941716; Li Y, 2005, J NEUROPHYSIOL, V94, P2139, DOI 10.1152/jn.00312.2005; Li Y, 2005, EXP BRAIN RES, V163, P515, DOI 10.1007/s00221-004-2206-5; Loehr JD, 2011, Q J EXP PSYCHOL, V64, P2153, DOI 10.1080/17470218.2011.603427; Maes PJ, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01008; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Moore GP, 2010, BIOL CYBERN, V103, P401, DOI 10.1007/s00422-010-0407-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ollen J.E., 2006, THESIS OHIO STATE U; Palmer C, 2009, MUSIC PERCEPT, V26, P439, DOI 10.1525/MP.2009.26.5.439; Pfordresher P. Q., 2006, ADV COGN PSYCHOL, V2, P183, DOI [10.2478/v10053-008-0054-8, DOI 10.2478/V10053-008-0054-8]; Pfordresher PQ, 2011, J EXP PSYCHOL HUMAN, V37, P566, DOI 10.1037/a0021487; R Core Team, 2021, R LANGUAGE ENV STAT; Rasamimanana N, 2008, J NEW MUSIC RES, V37, P339, DOI 10.1080/09298210902731386; Rasamimanana N, 2009, LECT NOTES ARTIF INT, V5085, P216; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2008, HUM MOVEMENT SCI, V27, P423, DOI 10.1016/j.humov.2008.02.016; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; SCHELLENG JC, 1973, J ACOUST SOC AM, V53, P26, DOI 10.1121/1.1913322; SCHONER G, 1992, J MOTOR BEHAV, V24, P29, DOI 10.1080/00222895.1992.9941599; Schoonderwaldt E, 2009, J ACOUST SOC AM, V126, P2695, DOI 10.1121/1.3227640; Schoonderwaldt E, 2009, J ACOUST SOC AM, V126, P2709, DOI 10.1121/1.3203209; Schoonderwaldt E., 2011, P INT S PERF SCI, P649; Schoonderwaldt E, 2013, P STOCKH MUS AC C; Schoonderwaldt E, 2010, P 2 VIENN TALK U MUS, P133; Schoonderwaldt E, 2012, P AC 2012 NANT FRANC; Schoonderwaldt E, 2013, P M AC MONTR, V19, DOI [10.1121/1.4801072, DOI 10.1121/1.4801072]; Schoonderwaldt E, 2013, J ACOUST SOC AM, V133, P4311, DOI 10.1121/1.4802635; Shan GB, 2003, MED PROBL PERFORM AR, V18, P3; Sigrist R, 2013, PSYCHON B REV, V20, P21, DOI 10.3758/s13423-012-0333-8; SOECHTING JF, 1986, NEUROSCIENCE, V17, P295, DOI 10.1016/0306-4522(86)90248-4; Sofianidis G, 2012, HUM MOVEMENT SCI, V31, P553, DOI 10.1016/j.humov.2011.07.007; Swinnen SP, 1997, HUM MOVEMENT SCI, V16, P749, DOI 10.1016/S0167-9457(97)00020-1; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Szende O, 1971, PHYSL VIOLIN PLAYING; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; Turner-Stokes L, 1999, CLIN BIOMECH, V14, P426, DOI 10.1016/S0268-0033(98)00110-7; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; van der Steen MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00253; VELDPAUS FE, 1988, J BIOMECH, V21, P45, DOI 10.1016/0021-9290(88)90190-X; Verrel J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00157; Verrel J, 2013, EXP BRAIN RES, V224, P323, DOI 10.1007/s00221-012-3314-2; Visentin P, 2003, MED PROBL PERFORM AR, V18, P91; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; WILLIAMS SM, 1986, CORTEX, V22, P325, DOI 10.1016/S0010-9452(86)80058-2; WINOLD H, 1994, ECOL PSYCHOL, V6, P1, DOI 10.1207/s15326969eco0601_1; Woodhouse J, 2004, ACTA ACUST UNITED AC, V90, P579; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	84	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106615	10.1371/journal.pone.0106615	http://dx.doi.org/10.1371/journal.pone.0106615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25207542	Green Published, gold, Green Submitted			2022-12-27	WOS:000342030300030
J	Wang, L; Yao, ZQ; Moorman, JP; Xu, YJ; Ning, SB				Wang, Ling; Yao, Zhi Q.; Moorman, Jonathan P.; Xu, Yanji; Ning, Shunbin			Gene Expression Profiling Identifies IRF4-Associated Molecular Signatures in Hematological Malignancies	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; REGULATORY FACTOR 4; B-CELL LYMPHOMA; ACUTE LYMPHOBLASTIC-LEUKEMIA; BATF-IRF INTERACTIONS; MULTIPLE-MYELOMA; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTORS; BURKITTS-LYMPHOMA; SIGNALING PATHWAY	The lymphocyte-specific transcription factor Interferon (IFN) Regulatory Factor 4 (IRF4) is implicated in certain types of lymphoid and myeloid malignancies. However, the molecular mechanisms underlying its interactions with these malignancies are largely unknown. In this study, we have first profiled molecular signatures associated with IRF4 expression in associated cancers, by analyzing existing gene expression profiling datasets. Our results show that IRF4 is overexpressed in melanoma, in addition to previously reported contexts including leukemia, myeloma, and lymphoma, and that IRF4 is associated with a unique gene expression pattern in each context. A pool of important genes involved in B-cell development, oncogenesis, cell cycle regulation, and cell death including BATF, LIMD1, CFLAR, PIM2, and CCND2 are common signatures associated with IRF4 in non-Hodgkin B cell lymphomas. We confirmed the correlation of IRF4 with LIMD1 and CFLAR in a panel of cell lines derived from lymphomas. Moreover, we profiled the IRF4 transcriptome in the context of EBV latent infection, and confirmed several genes including IFI27, IFI44, GBP1, and ARHGAP18, as well as CFLAR as novel targets for IRF4. These results provide valuable information for understanding the IRF4 regulatory network, and improve our knowledge of the unique roles of IRF4 in different hematological malignancies.	[Wang, Ling; Yao, Zhi Q.; Moorman, Jonathan P.; Ning, Shunbin] E Tennessee State Univ, Quillen Dishner Coll Med, Ctr Inflammat Infect Dis & Immun, Johnson City, TN 37614 USA; [Yao, Zhi Q.; Moorman, Jonathan P.] James H Quillen VA Med Ctr, HIV HCV Program, Johnson City, TN USA; [Xu, Yanji] Shaun & Lilly Int LLC, Collierville, TN USA	East Tennessee State University	Ning, SB (corresponding author), E Tennessee State Univ, Quillen Dishner Coll Med, Ctr Inflammat Infect Dis & Immun, Johnson City, TN 37614 USA.	nings1@etsu.edu	Ning, Shunbin/I-3961-2019; Ning, Shunbin/AAC-6895-2021	Ning, Shunbin/0000-0001-5484-5779; 	American Society of Hematology Scholar Award	American Society of Hematology Scholar Award	This work is supported by the American Society of Hematology Scholar Award to SN (http://www.hematology.org/Awards/Career-Training/463.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso SR, 2004, AM J PATHOL, V164, P193, DOI 10.1016/S0002-9440(10)63110-0; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beasley GM, 2011, J CLIN ONCOL, V29, P1210, DOI 10.1200/JCO.2010.32.1224; Biswas PS, 2010, IMMUNOL REV, V233, P79, DOI 10.1111/j.0105-2896.2009.00864.x; Britzen-Laurent N, 2013, CARCINOGENESIS, V34, P153, DOI 10.1093/carcin/bgs310; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Chang CC, 2002, BLOOD, V100, P4671, DOI 10.1182/blood-2002-01-0104; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cheriyath V, 2011, J INTERF CYTOK RES, V31, P173, DOI 10.1089/jir.2010.0105; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; CONTRERASBRODIN BA, 1991, J GEN VIROL, V72, P3025, DOI 10.1099/0022-1317-72-12-3025; Coustan-Smith E, 2011, BLOOD, V117, P6267, DOI 10.1182/blood-2010-12-324004; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Duffy DL, 2010, AM J HUM GENET, V87, P6, DOI 10.1016/j.ajhg.2010.05.017; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Farrow MA, 2011, J BIOL CHEM, V286, P2567, DOI 10.1074/jbc.M110.154377; Feldman AL, 2009, LEUKEMIA, V23, P574, DOI 10.1038/leu.2008.320; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Gualco G, 2010, APPL IMMUNOHISTO M M, V18, P301, DOI 10.1097/PAI.0b013e3181cf1126; Hallen LC, 2007, J INTERF CYTOK RES, V27, P675, DOI 10.1089/jir.2007.0021; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Huggins CJ, 2008, CANCER LETT, V267, P55, DOI 10.1016/j.canlet.2008.03.015; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; HURLEY EA, 1991, J VIROL, V65, P3958, DOI 10.1128/JVI.65.7.3958-3963.1991; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; James V, 2010, P NATL ACAD SCI USA, V107, P12499, DOI 10.1073/pnas.0914987107; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lu RQ, 2008, TRENDS IMMUNOL, V29, P487, DOI 10.1016/j.it.2008.07.006; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; Mamane Y, 2000, IMMUNITY, V12, P129, DOI 10.1016/S1074-7613(00)80166-1; Mamane Y, 2002, J INTERF CYTOK RES, V22, P135, DOI 10.1089/107999002753452746; Mamane Y, 2002, ONCOGENE, V21, P6751, DOI 10.1038/sj.onc.1205843; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Ning S, 2013, J ONCOBIOMARKERS, V1, P6; Nonkwelo C, 1996, J VIROL, V70, P623, DOI 10.1128/JVI.70.1.623-627.1996; Pena-Chilet M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-160; Praetorius C, 2013, CELL, V155, P1022, DOI 10.1016/j.cell.2013.10.022; Ramos JC, 2007, BLOOD, V109, P3060, DOI 10.1182/blood-2006-07-036368; Rosebeck S, 2008, APOPTOSIS, V13, P562, DOI 10.1007/s10495-008-0190-0; Rui LX, 2011, NAT IMMUNOL, V12, P933, DOI 10.1038/ni.2094; Safa A. R., 2012, Experimental Oncology, V34, P176; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Salaverria I, 2011, BLOOD, V118, P139, DOI 10.1182/blood-2011-01-330795; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaffer AL, 2009, CLIN CANCER RES, V15, P2954, DOI 10.1158/1078-0432.CCR-08-1845; Sharma S, 2002, J IMMUNOL, V169, P3120, DOI 10.4049/jimmunol.169.6.3120; Sharma S, 2000, AIDS RES HUM RETROV, V16, P1613, DOI 10.1089/08892220050193047; Sharp TV, 2004, P NATL ACAD SCI USA, V101, P16531, DOI 10.1073/pnas.0407123101; Sharp TV, 2008, P NATL ACAD SCI USA, V105, P19932, DOI 10.1073/pnas.0805003105; Spender LC, 2006, J GEN VIROL, V87, P2859, DOI 10.1099/vir.0.82128-0; Sundram U, 2003, MODERN PATHOL, V16, P802, DOI 10.1097/01.MP.0000081726.49886.CF; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tsuzuki S, 2007, CANCER SCI, V98, P698, DOI 10.1111/j.1349-7006.2007.00443.x; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Wang L, 2013, J VIROL, V87, P9672, DOI 10.1128/JVI.01435-13; Wang L, 2011, J VIROL, V85, P8328, DOI 10.1128/JVI.00570-11; Xu DS, 2008, J VIROL, V82, P6251, DOI 10.1128/JVI.00163-08; Xu DS, 2011, J BIOL CHEM, V286, P18261, DOI 10.1074/jbc.M110.210542; Yang DF, 2009, CANCER RES, V69, P1080, DOI 10.1158/0008-5472.CAN-08-2520; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745	69	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106788	10.1371/journal.pone.0106788	http://dx.doi.org/10.1371/journal.pone.0106788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207815	gold, Green Submitted, Green Published			2022-12-27	WOS:000342030300040
J	Chandrashekar, S; Guinness, L; Pickles, M; Shetty, GY; Alary, M; Vickerman, P; Vassall, A				Chandrashekar, Sudhashree; Guinness, Lorna; Pickles, Michael; Shetty, Govindraj Y.; Alary, Michel; Vickerman, Peter; Vassall, Anna		Charme-1 Evaluation Grp	The Costs of Scaling Up HIV Prevention for High Risk Groups: Lessons Learned from the Avahan Programme in India	PLOS ONE			English	Article							FEMALE SEX WORKERS; ANDHRA-PRADESH; INTERVENTIONS; EFFICIENCY; OUTPUTS; IMPACT; INCOME; MEN	Objective: The study objective is to measure, analyse costs of scaling up HIV prevention for high-risk groups in India, in order to assist the design of future HIV prevention programmes in South Asia and beyond. Design: Prospective costing study. Methods: This study is one of the most comprehensive studies of the costs of HIV prevention for high-risk groups to date in both its scope and size. HIV prevention included outreach, sexually transmitted infections (STI) services, condom provision, expertise enhancement, community mobilisation and enabling environment activities. Economic costs were collected from 138 non-government organisations (NGOs) in 64 districts, four state level lead implementing partners (SLPs), and the national programme level (Bill and Melinda Gates Foundation (BMGF)) office over four years using a top down costing approach, presented in US$ 2011. Results: Mean total unit costs (2004-08) per person reached at least once a year and per monthly contact were US$ 235(56-1864) and US$ 82(12-969) respectively. 35% of the cost was incurred by NGOs, 30% at the state level SLP and 35% at the national programme level. The proportion of total costs by activity were 34% for expertise enhancement, 37% for programme management (including support and supervision), 22% for core HIV prevention activities (outreach and STI services) and 7% for community mobilisation and enabling environment activities. Total unit cost per person reached fell sharply as the programme expanded due to declining unit costs above the service level (from US$ 477 per person reached in 2004 to US$ 145 per person reached in 2008). At the service level also unit costs decreased slightly over time from US$ 68 to US$ 64 per person reached. Conclusions: Scaling up HIV prevention for high risk groups requires significant investment in expertise enhancement and programme administration. However, unit costs decreased with programme expansion in spite of an increase in the scope of activities.	[Chandrashekar, Sudhashree; Guinness, Lorna; Pickles, Michael; Vickerman, Peter; Vassall, Anna] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Chandrashekar, Sudhashree] St Johns Res Inst, Bangalore, Karnataka, India; [Pickles, Michael] Univ London Imperial Coll Sci Technol & Med, London, England; [Shetty, Govindraj Y.] Karnataka Hlth Promot Trust, Bangalore, Karnataka, India; [Alary, Michel] Ctr Rech CHU Quebec, URESP, Quebec City, PQ, Canada; [Alary, Michel] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada	University of London; London School of Hygiene & Tropical Medicine; St. John's National Academy of Health Sciences; St. John's Research Institute; Imperial College London; Laval University	Vassall, A (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Anna.Vassall@lshtm.ac.uk	Guinness, Lorna/AAN-3875-2020	Vickerman, Peter/0000-0002-8291-5890; Vassall, Anna/0000-0002-2911-1375; Pickles, Michael/0000-0002-6754-3945; Guinness, Lorna/0000-0002-1013-4200	Bill and Melinda Gates Foundation; International development and Research Centre Grant as a part of Global Health leadership award [IDRC-103460-074]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International development and Research Centre Grant as a part of Global Health leadership award	Bill and Melinda Gates Foundation and International development and Research Centre Grant No: IDRC-103460-074 as a part of Global Health leadership award to Dr. Sudha Chandrashekar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandrashekar S, 2010, SEX TRANSM INFECT, V86, pI89, DOI 10.1136/sti.2009.038547; Chandrashekar S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S7; Dandona L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-98; Dandona L, 2005, NATL MED J INDIA, V18, P26; Dandona L, 2010, COST EFFECTIVENESS H; Dandona L, 2009, AIDS, V23, P233, DOI 10.1097/QAD.0b013e328320accc; Dandona L, 2008, AIDS, V22, pS43, DOI 10.1097/01.aids.0000327622.24232.aa; Foundation BMGF, 2008, NEW DELH IND US IT L; Foundation BMGF, 2008, AV IND AIDS IN BUS H; Foundation BMGF, 2010, AV COMM MIM PROGR HI; Fung ICH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-195; Guinness L, 2005, B WORLD HEALTH ORGAN, V83, P747; Guinness Lorna, 2007, Cost Eff Resour Alloc, V5, P13, DOI 10.1186/1478-7547-5-13; Kumar SGP, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-82; Marseille E, 2004, HEALTH SERV RES, V39, P1996; Marseille E, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-108; Prinja S, 2011, SEX TRANSM INFECT, V87, P354, DOI 10.1136/sti.2010.047829; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; Verma R, 2010, SEX TRANSM INFECT, V86, pI76, DOI 10.1136/sti.2009.039115; Wheeler T, 2012, J EPIDEMIOL COMMUN H, V66, pII16, DOI 10.1136/jech-2012-201081	21	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106582	10.1371/journal.pone.0106582	http://dx.doi.org/10.1371/journal.pone.0106582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203052	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000342684500031
J	Giannakopoulou, A; Schornack, S; Bozkurt, TO; Haart, D; Ro, DK; Faraldos, JA; Kamoun, S; O'Maille, PE				Giannakopoulou, Artemis; Schornack, Sebastian; Bozkurt, Tolga O.; Haart, Dave; Ro, Dae-Kyun; Faraldos, Juan A.; Kamoun, Sophien; O'Maille, Paul E.			Variation in Capsidiol Sensitivity between Phytophthora infestans and Phytophthora capsici Is Consistent with Their Host Range	PLOS ONE			English	Article							POSTINFECTIONAL INHIBITORS; NICOTIANA-BENTHAMIANA; PEPPER FRUIT; RESISTANCE; PATHOGEN; ELICITOR; TOBACCO; POTATO; PLANTS; ACCUMULATION	Plants protect themselves against a variety of invading pathogenic organisms via sophisticated defence mechanisms. These responses include deployment of specialized antimicrobial compounds, such as phytoalexins, that rapidly accumulate at pathogen infection sites. However, the extent to which these compounds contribute to species-level resistance and their spectrum of action remain poorly understood. Capsidiol, a defense related phytoalexin, is produced by several solanaceous plants including pepper and tobacco during microbial attack. Interestingly, capsidiol differentially affects growth and germination of the oomycete pathogens Phytophthora infestans and Phytophthora capsici, although the underlying molecular mechanisms remain unknown. In this study we revisited the differential effect of capsidiol on P. infestans and P. capsici, using highly pure capsidiol preparations obtained from yeast engineered to express the capsidiol biosynthetic pathway. Taking advantage of transgenic Phytophthora strains expressing fluorescent markers, we developed a fluorescence-based method to determine the differential effect of capsidiol on Phytophtora growth. Using these assays, we confirm major differences in capsidiol sensitivity between P. infestans and P. capsici and demonstrate that capsidiol alters the growth behaviour of both Phytophthora species. Finally, we report intraspecific variation within P. infestans isolates towards capsidiol tolerance pointing to an arms race between the plant and the pathogens in deployment of defence related phytoalexins.	[Giannakopoulou, Artemis; Schornack, Sebastian; Bozkurt, Tolga O.; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England; [Schornack, Sebastian] Univ Cambridge, Sainsbury Lab, Cambridge, England; [Bozkurt, Tolga O.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London, England; [Haart, Dave; O'Maille, Paul E.] Inst Food Res, Food & Hlth Programme, Norwich NR4 7UA, Norfolk, England; [Ro, Dae-Kyun] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Faraldos, Juan A.] Cardiff Univ, Sch Chem, Cardiff CF10 3AX, S Glam, Wales; [O'Maille, Paul E.] John Innes Ctr Plant Sci Res, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Cambridge; Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Calgary; Cardiff University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Kamoun, S (corresponding author), Sainsbury Lab, Norwich, Norfolk, England.	sophien.kamoun@tsl.ac.uk; paul.o'maille@jic.ac.uk	Bozkurt, Tolga O/C-9764-2014; Bozkurt, Tolga Osman/AAA-8014-2019; Schornack, Sebastian/A-3650-2011; Kamoun, Sophien/B-3529-2009; Faraldos, Juan/A-7311-2014; Ro, Dae-Kyun/G-9289-2012; Schornack, Sebastian/AAE-4897-2020	Bozkurt, Tolga O/0000-0003-0507-6875; Bozkurt, Tolga Osman/0000-0003-0507-6875; Schornack, Sebastian/0000-0002-7836-5881; Kamoun, Sophien/0000-0002-0290-0315; Faraldos, Juan/0000-0003-0738-0838; Ro, Dae-Kyun/0000-0003-1288-5347; Schornack, Sebastian/0000-0002-7836-5881	Biotechnology and Biological Sciences Research Council Institute Strategic Programme (ISP) at the John Innes Centre [BB/J004561/1]; Biotechnology and Biological Sciences Research Council ISP grant at the Institute of Food Research [BB/I015345/1]; Gatsby Charitable Foundation; Norwich Research Park Ph.D. student fellowship; Onassis Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044433] Funding Source: researchfish; BBSRC [BBS/E/F/00044433] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council Institute Strategic Programme (ISP) at the John Innes Centre(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council ISP grant at the Institute of Food Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; Norwich Research Park Ph.D. student fellowship; Onassis Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge support from the Biotechnology and Biological Sciences Research Council Institute Strategic Programme (ISP) Grant BB/J004561/1 (Understanding and Exploiting Plant and Microbial Secondary Metabolism) at the John Innes Centre and ISP grant BB/I015345/1 (Food and Health) at the Institute of Food Research. Work at The Sainsbury laboratory was supported by the Gatsby Charitable Foundation (http://www.gatsby.org.uk). AG received support from the Norwich Research Park Ph.D. student fellowship and Onassis Foundation (http://www.onassis.gr/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Ahmed AS, 2000, EUR J PLANT PATHOL, V106, P817, DOI 10.1023/A:1008780022925; Blum M, 2010, FUNGAL GENET BIOL, V47, P499, DOI 10.1016/j.fgb.2010.02.009; Blum M, 2010, MOL PLANT PATHOL, V11, P227, DOI 10.1111/j.1364-3703.2009.00604.x; Bozkurt TO, 2011, P NATL ACAD SCI USA, V108, P20832, DOI 10.1073/pnas.1112708109; CANE DE, 1990, CHEM REV, V90, P1089, DOI 10.1021/cr00105a002; Chaparro-Garcia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016608; Coleman JJ, 2011, MOL PLANT MICROBE IN, V24, P368, DOI 10.1094/MPMI-09-10-0198; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; De Marino S, 2006, J AGR FOOD CHEM, V54, P7508, DOI 10.1021/jf061404z; DELSERONE LM, 1992, PHYTOCHEMISTRY, V31, P3813, DOI 10.1016/S0031-9422(00)97534-4; Egea C, 1996, PHYSIOL PLANTARUM, V98, P737, DOI 10.1111/j.1399-3054.1996.tb06679.x; Grosskinsky DK, 2011, PLANT PHYSIOL, V157, P815, DOI 10.1104/pp.111.182931; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; HARGREAVES JA, 1977, PHYSIOL PLANT PATHOL, V11, P227, DOI 10.1016/0048-4059(77)90064-9; HOITINK HAJ, 1969, PHYTOPATHOLOGY, V59, P708; Huitema E, 2011, METHODS MOL BIOL, V712, P129, DOI 10.1007/978-1-61737-998-7_11; JONES DR, 1975, PHYTOPATHOLOGY, V65, P1286, DOI 10.1094/Phyto-65-1286; JONES DR, 1975, PHYTOPATHOLOGY, V65, P1417, DOI 10.1094/Phyto-65-1417; Judelson HS, 2006, MOL PLANT PATHOL, V7, P17, DOI [10.1111/J.1364-3703.2005.00313.X, 10.1111/j.1364-3703.2004.00256.x-i1]; Jupe J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r63; Kamoun S, 1998, PLANT CELL, V10, P1413, DOI 10.1105/tpc.10.9.1413; Kamoun S, 2005, PLANT DIS, V89, P692, DOI 10.1094/PD-89-0692; Kamoun S, 1999, TRENDS PLANT SCI, V4, P196, DOI 10.1016/S1360-1385(99)01404-1; Keller H, 1998, PLANTA, V205, P467, DOI 10.1007/s004250050345; KLaS Kamoun, 2009, OOMYCETE GENETICS GE; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Li Y, 2012, G3-GENES GENOM GENET, V2, P1529, DOI 10.1534/g3.112.004150; Literakova P, 2010, J CHROMATOGR SCI, V48, P436, DOI 10.1093/chromsci/48.6.436; Ma CJ, 2008, BIOTECHNOL LETT, V30, P961, DOI 10.1007/s10529-007-9624-y; Maldonado-Bonilla LD, 2008, EUR J PLANT PATHOL, V121, P439, DOI 10.1007/s10658-007-9262-1; Matsukawa M, 2013, MOL PLANT MICROBE IN, V26, P880, DOI 10.1094/MPMI-12-12-0301-R; MILAT ML, 1991, PHYTOPATHOLOGY, V81, P1364, DOI 10.1094/Phyto-81-1364; O'Maille PE, 2008, NAT CHEM BIOL, V4, P617, DOI 10.1038/nchembio.113; Pais M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-211; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; Randall E, 2014, MOL PLANT PATHOLOGY; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Shibata Y, 2010, MOL PLANT MICROBE IN, V23, P1130, DOI 10.1094/MPMI-23-9-1130; STOESSL A, 1973, PHYTOPATHOLOGY, V63, P1225, DOI 10.1094/Phyto-63-1225; Nguyen TD, 2012, METHOD ENZYMOL, V517, P261, DOI 10.1016/B978-0-12-404634-4.00013-9; van West P, 1998, FUNGAL GENET BIOL, V23, P126, DOI 10.1006/fgbi.1998.1036; Vleeshouwers VGAA, 2000, PLANTA, V210, P853, DOI 10.1007/s004250050690; WARD EWB, 1976, PHYTOPATHOLOGY, V66, P175, DOI 10.1094/Phyto-66-175; WARD EWB, 1972, PHYTOPATHOLOGY, V62, P1186, DOI 10.1094/Phyto-62-1186; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	48	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107462	10.1371/journal.pone.0107462	http://dx.doi.org/10.1371/journal.pone.0107462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203155	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000342684500102
J	Silva, AER; Menezes, AMB; Assuncao, MCF; Goncalves, H; Demarco, FF; Vargas-Ferreira, F; Peres, MA				Ribeiro Silva, Alexandre Emidio; Baptista Menezes, Ana Maria; Formoso Assuncao, Maria Cecilia; Goncalves, Helen; Demarco, Flavio Fernando; Vargas-Ferreira, Fabiana; Peres, Marco Aurelio			Validation of Self-Reported Information on Dental Caries in a Birth Cohort at 18 Years of Age	PLOS ONE			English	Article							ORAL-HEALTH; CLINICAL EXAMINATION; PERIODONTAL-DISEASE; FOLLOW-UP; VALIDITY; QUESTIONNAIRE; ADULTS	Objective: Estimate the prevalence of dental caries based on clinical examinations and self-reports and compare differences in the prevalence and effect measures between the two methods among 18-year-olds belonging to a 1993 birth cohort in the city of Pelotas, Brazil. Method: Data on self-reported caries, socio-demographic aspects and oral health behaviour were collected using a questionnaire administered to adolescents aged 18 years (n = 4041). Clinical caries was evaluated (n = 1014) by a dentist who had undergone training and calibration exercises. Prevalence rates of clinical and self-reported caries, sensitivity, specificity, positive and negative predictive values, absolute and relative bias, and inflation factors were calculated. Prevalence ratios of dental caries were estimated for each risk factor. Results: The prevalence of clinical and self-reported caries (DMFT>1) was 66.5% (95% CI: 63.6%-69.3%) and 60.3% (95% CI: 58.8%-61.8%), respectively. Self-reports underestimated the prevalence of dental caries by 9.3% in comparison to clinical evaluations. The analysis of the validity of self-reports regarding the DMFT index indicated high sensitivity (81.8%; 95% CI: 78.7%-84.7%) and specificity (78.1%; 95% CI: 73.3%-82.4%) in relation to the gold standard (clinical evaluation). Both the clinical and self-reported evaluations were associated with gender, schooling and self-rated oral health. Clinical dental caries was associated with visits to the dentist in the previous year. Self-reported dental caries was associated with daily tooth brushing frequency. Conclusions: Based on the present findings, self-reported information on dental caries using the DMFT index requires further studies prior to its use in the analysis of risk factors, but is valid for population-based health surveys with the aim of planning and monitoring oral health actions directed at adolescents.	[Ribeiro Silva, Alexandre Emidio; Baptista Menezes, Ana Maria; Formoso Assuncao, Maria Cecilia; Goncalves, Helen; Demarco, Flavio Fernando; Vargas-Ferreira, Fabiana] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, RS, Brazil; [Peres, Marco Aurelio] Univ Adelaide, Sch Dent, Australian Res Ctr Populat Oral Hlth, Adelaide, SA, Australia	Universidade Federal de Pelotas; University of Adelaide	Silva, AER (corresponding author), Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, RS, Brazil.	emidio3@ig.com.br	Demarco, Flavio/AAT-8991-2020; Gonçalves, Helen/P-2381-2018; Silva, Alexandre ER/E-8404-2013; Silva, Alexandre/O-2742-2019; Peres, Marco A/D-1623-2013; Menezes, Ana MB/G-7266-2012; Gonçalves, Helen/M-1603-2017; Vargas-Ferreira, Fabiana/V-6274-2017	Demarco, Flavio/0000-0003-2276-491X; Silva, Alexandre/0000-0001-6402-0789; Peres, Marco A/0000-0002-8329-2808; Menezes, Ana MB/0000-0002-2996-9427; Gonçalves, Helen/0000-0001-6470-3352; Vargas-Ferreira, Fabiana/0000-0003-3567-4737	Wellcome Trust; European Union; National Programme for Centres of Excellence (PRONEX), Brazilian agency; National Research Council (CNPq), Brazilian agency; Ministry of Health, Brazilian agency	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); National Programme for Centres of Excellence (PRONEX), Brazilian agency; National Research Council (CNPq), Brazilian agency(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health, Brazilian agency	The cohort study was funded by Wellcome Trust. The initial phases of the cohort were funded by the European Union and the Brazilian agencies National Programme for Centres of Excellence (PRONEX), National Research Council (CNPq) and the Ministry of Health. The providers of funding played no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albandar JM, 2011, J PERIODONTOL, V82, P337, DOI 10.1902/jop.2011.100638; Araujo CL, 2010, CAD SAUDE PUBLICA, V26, P1875, DOI 10.1590/S0102-311X2010001000003; Axelsson G, 1995, COMMUNITY DENT ORAL, V23, P365, DOI 10.1111/j.1600-0528.1995.tb00264.x; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Blicher B, 2005, J DENT RES, V84, P881, DOI 10.1177/154405910508401003; Brasil. Ministerio da Saude, 2012, DEP AT BAS SB BRAS 2; Brasil. Ministerio da Saude, 2012, DEP AT BAS COND SAUD; Costa SM, 2012, INT J ENV RES PUB HE, V9, P3540, DOI 10.3390/ijerph9103540; Gilbert GH, 1997, J PUBLIC HEALTH DENT, V57, P176, DOI 10.1111/j.1752-7325.1997.tb02970.x; Gooch B F, 1989, J Dent Educ, V53, P629; HELOE LA, 1972, SCAND J DENT RES, V80, P495; Joshipura KJ, 2002, J PUBLIC HEALTH DENT, V62, P115, DOI 10.1111/j.1752-7325.2002.tb03431.x; KONONEN M, 1986, COMMUNITY DENT ORAL, V14, P258, DOI 10.1111/j.1600-0528.1986.tb01067.x; Moreira Rafael da Silveira, 2005, Cad. Saúde Pública, V21, P1665, DOI 10.1590/S0102-311X2005000600013; PALMQVIST S, 1991, COMMUNITY DENT ORAL, V19, P249, DOI 10.1111/j.1600-0528.1991.tb00160.x; Peres MA, 2012, J PERIODONTOL, V83, P369, DOI 10.1902/jop.2011.110250; Peres MA, 2010, CAD SAUDE PUBLICA, V26, P1990, DOI 10.1590/S0102-311X2010001000016; Pinelli C, 2007, CLIN ORAL INVEST, V11, P431, DOI 10.1007/s00784-007-0133-0; Pitiphat W, 2002, J PUBLIC HEALTH DENT, V62, P122, DOI 10.1111/j.1752-7325.2002.tb03432.x; REISINE ST, 1980, SOC SCI MED-MED SOC, V14, P597, DOI 10.1016/S0271-7123(80)80068-X; Szklo M, 2004, EPIDEMIOLOGY BASICS; Taylor GW, 2007, J PERIODONTOL, V78, P1407, DOI 10.1902/jop.2007.060481; Victora CG, 2008, INT J EPIDEMIOL, V37, P704, DOI 10.1093/ije/dym177; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	24	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106382	10.1371/journal.pone.0106382	http://dx.doi.org/10.1371/journal.pone.0106382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202969	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500019
J	Sevcenco, S; Haitel, A; Ponhold, L; Susani, M; Fajkovic, H; Shariat, SF; Hiess, M; Spick, C; Szarvas, T; Baltzer, PAT				Sevcenco, Sabina; Haitel, Andrea; Ponhold, Lothar; Susani, Martin; Fajkovic, Harun; Shariat, Shahrokh F.; Hiess, Manuela; Spick, Claudio; Szarvas, Tibor; Baltzer, Pascal A. T.			Quantitative Apparent Diffusion Coefficient Measurements Obtained by 3-Tesla MRI Are Correlated with Biomarkers of Bladder Cancer Proliferative Activity	PLOS ONE			English	Article							RADICAL CYSTECTOMY; PREDICTIVE-VALUE; WEIGHTED MRI; GRADE; CARCINOMA; STAGE; VALIDATION; DIAGNOSIS; DISEASE; LESIONS	Purpose: To investigate the association between Apparent Diffusion Coefficient (ADC) values and cell cycle and proliferative biomarkers (p53, p21, Ki67,) in order to establish its potential role as a noninvasive biomarker for prediction of cell cycle, proliferative activity and biological aggressiveness in bladder cancer. Materials and Methods: Patients with bladder cancer who underwent 3,0 Tesla DW-MRI of the bladder before TUR-B or radical cystectomy were eligible for this prospective IRB-approved study. Histological specimen were immunohistochemically stained for the following markers: p53, p21 and ki67. Two board-certified uropathologists reviewed the specimens blinded to DW-MRI results. Histological grade and T-stage were classified according to the WHO 2004 and the 2009 TNM classification, respectively. Nonparametric univariate and multivariate statistics including correlation, logistic regression and ROC analysis were applied. Results: Muscle invasive bladder cancer was histologically confirmed in 10 out of 41 patients. All examined tissue biomarkers were significantly correlated with ADC values (p < 0.05, respectively). Based on multivariate analysis, p53 and ADC are both independent prognostic factors for muscle invasiveness of bladder cancer (>/ = T2). (p = 0.013 and p = 0.018). Conclusion: ADC values are associated with cell cycle and proliferative biomarkers and do thereby reflect invasive and proliferative potential in bladder cancer. ADC and p53 are both independent prognostic factors for muscle invasiveness in bladder cancer.	[Sevcenco, Sabina; Fajkovic, Harun; Shariat, Shahrokh F.; Hiess, Manuela; Szarvas, Tibor] Med Univ Vienna, Dept Urol, Vienna, Austria; [Haitel, Andrea; Susani, Martin] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Ponhold, Lothar; Spick, Claudio; Baltzer, Pascal A. T.] Med Univ Vienna, Dept Biomed Imaging & Image Guided therapy, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Baltzer, PAT (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided therapy, Vienna, Austria.	pascal.baltzer@meduniwien.ac.at	SZARVAS, t./L-4422-2017	SZARVAS, t./0000-0002-6321-0799; Baltzer, Pascal/0000-0002-3755-5398; Spick, Claudio/0000-0002-2628-0907				[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Avcu S, 2011, BRIT J RADIOL, V84, P875, DOI 10.1259/bjr/30591350; El-Assmy A, 2012, BJU INT, V110, pE622, DOI 10.1111/j.1464-410X.2012.11345.x; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; Hatakenaka Masamitsu, 2008, Magn Reson Med Sci, V7, P23, DOI 10.2463/mrms.7.23; Kamat AM, 2013, EUR UROL, V63, P4, DOI 10.1016/j.eururo.2012.09.057; Kobayashi S, 2014, J MAGN RESON IMAGING, V39, P172, DOI 10.1002/jmri.24148; Kobayashi S, 2011, EUR RADIOL, V21, P2178, DOI 10.1007/s00330-011-2174-7; Margulis V, 2006, CLIN CANCER RES, V12, P7369, DOI 10.1158/1078-0432.CCR-06-1472; Margulis V, 2009, JNCI-J NATL CANCER I, V101, P114, DOI 10.1093/jnci/djn451; Rosenkrantz AB, 2013, AM J ROENTGENOL, V201, P1254, DOI 10.2214/AJR.12.10348; Rosenkrantz AB, 2012, J MAGN RESON IMAGING, V35, P1478, DOI 10.1002/jmri.23590; Shariat SF, 2008, CANCER-AM CANCER SOC, V112, P315, DOI 10.1002/cncr.23162; Shariat SF, 2007, J UROLOGY, V177, P481, DOI 10.1016/j.juro.2006.09.038; Shariat SF, 2014, BJU INT, V113, P70, DOI 10.1111/bju.12343; Stein JP, 1998, J NATL CANCER I, V90, P1072, DOI 10.1093/jnci/90.14.1072; Svatek RS, 2011, BJU INT, V107, P898, DOI 10.1111/j.1464-410X.2010.09628.x; Takeuchi M, 2009, RADIOLOGY, V251, P112, DOI 10.1148/radiol.2511080873; Watanabe H, 2009, AM J ROENTGENOL, V192, P1361, DOI 10.2214/AJR.08.1430; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046	21	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106866	10.1371/journal.pone.0106866	http://dx.doi.org/10.1371/journal.pone.0106866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202965	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500049
J	Collins, GH; Petersen, SL; Carr, CA; Pielstick, L				Collins, Gail H.; Petersen, Steven L.; Carr, Craig A.; Pielstick, Leon			Testing VHF/GPS Collar Design and Safety in the Study of Free-Roaming Horses	PLOS ONE			English	Article							GPS COLLAR; HABITAT SELECTION; FERAL HORSES; TRACKING; SYSTEM; PERFORMANCE; BISON; DEER	Effective and safe monitoring techniques are needed by U. S. land managers to understand free-roaming horse behavior and habitat use and to aid in making informed management decisions. Global positioning system (GPS) and very high frequency (VHF) radio collars can be used to provide high spatial and temporal resolution information for detecting free-roaming horse movement. GPS and VHF collars are a common tool used in wildlife management, but have rarely been used for free-roaming horse research and monitoring in the United States. The purpose of this study was to evaluate the design, safety, and detachment device on GPS/VHF collars used to collect free-roaming horse location and movement data. Between 2009 and 2010, 28 domestic and feral horses were marked with commercial and custom designed VHF/GPS collars. Individual horses were evaluated for damage caused by the collar placement, and following initial observations, collar design was modified to reduce the potential for injury. After collar modifications, which included the addition of collar length adjustments to both sides of the collar allowing for better alignment of collar and neck shapes, adding foam padding to the custom collars to replicate the commercial collar foam padding, and repositioning the detachment device to reduce wear along the jowl, we observed little to no evidence of collar wear on horses. Neither custom-built nor commercial collars caused injury to study horses, however, most of the custom-built collars failed to collect data. During the evaluation of collar detachment devices, we had an 89% success rate of collar devices detaching correctly. This study showed that free-roaming horses can be safely marked with GPS and/or VHF collars with minimal risk of injury, and that these collars can be a useful tool for monitoring horses without creating a risk to horse health and wellness.	[Collins, Gail H.] US Fish & Wildlife Serv, Lakeview, OR USA; [Petersen, Steven L.] Brigham Young Univ, Dept Plant & Wildlife Serv, Provo, UT 84602 USA; [Carr, Craig A.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA	United States Department of the Interior; US Fish & Wildlife Service; Brigham Young University; Montana State University System; Montana State University Bozeman	Petersen, SL (corresponding author), Brigham Young Univ, Dept Plant & Wildlife Serv, Provo, UT 84602 USA.	Steven_Petersen@byu.edu			United States Fish and Wildlife Service; United States Bureau of Land Management (BLM); Roaring Springs Ranch, Oregon State University; Brigham Young University; Fish and Wildlife Service; BLM	United States Fish and Wildlife Service(US Fish & Wildlife Service); United States Bureau of Land Management (BLM); Roaring Springs Ranch, Oregon State University; Brigham Young University; Fish and Wildlife Service(US Fish & Wildlife Service); BLM	Research was funded and supported by the United States Fish and Wildlife Service, the United States Bureau of Land Management (BLM), the Roaring Springs Ranch, Oregon State University, and Brigham Young University. The Fish and Wildlife Service and BLM did provide funds for the purchase of the GPS collars. These funds were allocated through budgets for the purchase of this equipment. Those who provided the funds to Gail Collins were not involved in this study. Funding sources at Brigham Young University and Oregon State University had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Anderson EW, 1998, SR990 OR AGR EXP STA; Babin JS, 2011, ECOLOGY, V92, P240, DOI 10.1890/10-0252.1; Biggs JR, 2001, WEST N AM NATURALIST, V61, P213; Bowman JL, 2000, WILDLIFE SOC B, V28, P141; Breck Stewart, 2012, Rangelands, V34, P6; Brooks C, 2008, J WILDLIFE MANAGE, V72, P527, DOI 10.2193/2007-061; Carr CA, 2012, 65 ANN M SOC RANG MA; Carr CA, 2011, 18 ANN M WILDL SOC 2; Clark PE, 2014, J ARID ENVIRON, V100, P78, DOI 10.1016/j.jaridenv.2013.10.012; Clark PE, 2006, RANGELAND ECOL MANAG, V59, P334, DOI 10.2111/05-162R.1; Dettki Holger, 2004, Alces, V40, P13; Dick BL, 2013, WILDLIFE SOC B, V37, P887, DOI 10.1002/wsb.320; Dussault C, 1999, WILDLIFE SOC B, V27, P965; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Ganskopp D, 2006, RANGELAND ECOL MANAG, V59, P189, DOI 10.2111/04-152R1.1; GARROTT RA, 1985, J WILDLIFE MANAGE, V49, P758, DOI 10.2307/3801707; Girard TL, 2013, RANGELAND ECOL MANAG, V66, P428, DOI 10.2111/REM-D-12-00081.1; Hampson BA, 2010, EQUINE VET J, V42, P582, DOI 10.1111/j.2042-3306.2010.00203.x; Hampson BA, 2010, AUST VET J, V88, P176, DOI 10.1111/j.1751-0813.2010.00564.x; Heard DC, 2008, J WILDLIFE MANAGE, V72, P596, DOI 10.2193/2007-175; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; HELLGREN EC, 1988, WILDLIFE SOC B, V16, P216; Hinkes MT, 2005, J WILDLIFE MANAGE, V69, P1147, DOI 10.2193/0022-541X(2005)069[1147:IOPGOC]2.0.CO;2; Johnson DD, 2008, RANGELAND ECOL MANAG, V61, P226, DOI 10.2111/07-044.1; Kaczensky P, 2008, J APPL ECOL, V45, P1762, DOI 10.1111/j.1365-2664.2008.01565.x; Krausman PR, 2004, WILDLIFE SOC B, V32, P987, DOI 10.2193/0091-7648(2004)032[0987:FTFNLI]2.0.CO;2; Lenarz MS, 2009, J WILDLIFE MANAGE, V73, P503, DOI 10.2193/2008-265; Mech LD, 2002, CRITIQUE WILDLIFE RA, P23; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Nagy JA, 2011, ECOL APPL, V21, P2334, DOI 10.1890/10-1410.1; National Academy of Sciences, 2013, US SCI IMPR BLM WILD; REMPEL RS, 1995, J WILDLIFE MANAGE, V59, P543, DOI 10.2307/3802461; Rodgers AR, 1996, WILDLIFE SOC B, V24, P559; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; SINIFF DB, 1986, J RANGE MANAGE, V39, P296, DOI 10.2307/3899765; Turner LW, 2000, CAN J ANIM SCI, V80, P405, DOI 10.4141/A99-093; Ungar ED, 2005, RANGELAND ECOL MANAG, V58, P256, DOI 10.2111/1551-5028(2005)58[256:IOAAFG]2.0.CO;2; von Hunerbein K, 2000, NATURWISSENSCHAFTEN, V87, P278, DOI 10.1007/s001140050721; Webb SL, 2011, POPUL ECOL, V53, P483, DOI 10.1007/s10144-010-0258-x	39	19	19	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e103189	10.1371/journal.pone.0103189	http://dx.doi.org/10.1371/journal.pone.0103189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198704	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700003
J	Jiang, SY; Vanitha, J; Bai, YA; Ramachandran, S				Jiang, Shu-Ye; Vanitha, Jeevanandam; Bai, Yanan; Ramachandran, Srinivasan			A Novel Binary T-Vector with the GFP Reporter Gene for Promoter Characterization	PLOS ONE			English	Article							POLLEN-SPECIFIC EXPRESSION; ANTHER-SPECIFIC GENE; DIRECT CLONING; MOLECULAR CHARACTERIZATION; MALE GAMETOPHYTE; PCR; SEQUENCE; REVEALS; SYSTEM; PLANTS	Several strategies have been developed to clone PCR fragments into desired vectors. However, most of commercially available T-vectors are not binary vectors and cannot be directly used for Agrobacterium-mediated plant genetic transformation. In this study, a novel binary T-vector was constructed by integrating two AhdI restriction sites into the backbone vector pCAMBIA 1300. The T-vector also contains a GFP reporter gene and thus, can be used to analyze promoter activity by monitoring the reporter gene. On the other hand, identification and characterization of various promoters not only benefit the functional annotation of their genes but also provide alternative candidates to be used to drive interesting genes for plant genetic improvement by transgenesis. More than 1,000 putative pollen-specific rice genes have been identified in a genome-wide level. Among them, 67 highly expressed genes were further characterized. One of the pollen-specific genes LOC_Os10g35930 was further surveyed in its expression patterns with more details by quantitative real-time reverse-transcription PCR (qRT-PCR) analysis. Finally, its promoter activity was further investigated by analyzing transgenic rice plants carrying the promoter::GFP cassette, which was constructed from the newly developed T-vector. The reporter GFP gene expression in these transgenic plants showed that the promoter was active only in mature but not in germinated pollens.	[Jiang, Shu-Ye; Vanitha, Jeevanandam; Bai, Yanan; Ramachandran, Srinivasan] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore	Ramachandran, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	sri@tll.org.sg		Jiang, Shu-Ye/0000-0003-4867-2335	National Research Foundation, Prime Minister's Office, Singapore under its Competitive Research Programme (CRP) [NRF-CRP7-2010-02]	National Research Foundation, Prime Minister's Office, Singapore under its Competitive Research Programme (CRP)(National Research Foundation, Singapore)	This research is supported by the National Research Foundation, Prime Minister's Office, Singapore, under its Competitive Research Programme (CRP Award No. NRF-CRP7-2010-02). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANI D, 1992, PLANT J, V2, P331; Anderson SN, 2013, PLANT J, V76, P729, DOI 10.1111/tpj.12336; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Borovkov AY, 1997, BIOTECHNIQUES, V22, P812, DOI 10.2144/97225bm04; CARPENTER JL, 1992, PLANT CELL, V4, P557, DOI 10.1105/tpc.4.5.557; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; da Costa-Nunes JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2003-5-1-205; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dimov SG, 2012, MOL BIOL REP, V39, P6133, DOI 10.1007/s11033-011-1429-3; Engel ML, 2005, PLANT PHYSIOL, V138, P2124, DOI 10.1104/pp.104.054213; Filichkin SA, 2004, PLANT PHYSIOL, V134, P1080, DOI 10.1104/pp.103.035998; Gu JS, 2011, MOL BIOTECHNOL, V47, P229, DOI 10.1007/s12033-010-9333-y; Gupta R, 2002, PLANT CELL, V14, P2495, DOI 10.1105/tpc.005702; Hamilton DA, 1998, PLANT MOL BIOL, V38, P663, DOI 10.1023/A:1006083725102; HAMILTON DA, 1992, PLANT MOL BIOL, V18, P211, DOI 10.1007/BF00034950; HANSON DD, 1989, PLANT CELL, V1, P173, DOI 10.1105/tpc.1.2.173; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; Janner CR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-441; Jiang S, 2005, PLANT MOL BIOL, V57, P835, DOI 10.1007/s11103-005-2859-x; Jiang SY, 2007, PLANT MOL BIOL, V65, P385, DOI 10.1007/s11103-007-9233-0; Jun SY, 2010, MOL BIOTECHNOL, V45, P9, DOI 10.1007/s12033-009-9233-1; KAUFMAN DL, 1990, BIOTECHNIQUES, V9, P304; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kempe K, 2011, MOL BREEDING, V27, P417, DOI 10.1007/s11032-011-9555-0; Khurana R, 2013, BIOTECHNOL LETT, V35, P455, DOI 10.1007/s10529-012-1100-7; Khurana R, 2013, TRANSGENIC RES, V22, P31, DOI 10.1007/s11248-012-9621-3; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Okada T, 2005, PLANT CELL PHYSIOL, V46, P797, DOI 10.1093/pcp/pci075; Oo MM, 2014, PLANT REPROD, V27, P47, DOI 10.1007/s00497-014-0239-x; Park JI, 2006, PLANT CELL REP, V25, P466, DOI 10.1007/s00299-005-0077-2; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Russell SD, 2012, NEW PHYTOL, V195, P560, DOI 10.1111/j.1469-8137.2012.04199.x; Schneidereit A, 2003, PLANT PHYSIOL, V133, P182, DOI 10.1104/pp.103.026674; Scholz-Starke J, 2003, PLANT PHYSIOL, V131, P70, DOI 10.1104/pp.012666; STINSON JR, 1987, PLANT PHYSIOL, V83, P442, DOI 10.1104/pp.83.2.442; Swapna L, 2011, MOL BIOTECHNOL, V48, P49, DOI 10.1007/s12033-010-9347-5; TWELL D, 1990, DEVELOPMENT, V109, P705; TWELL D, 1989, MOL GEN GENET, V217, P240, DOI 10.1007/BF02464887; TWELL D, 1991, GENE DEV, V5, P496, DOI 10.1101/gad.5.3.496; Twell D, 2002, PLANT REPROD ANN PLA, V6, P86; VANTUNEN AJ, 1990, PLANT CELL, V2, P393, DOI 10.1105/tpc.2.5.393; Wei LQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-338; WETERINGS K, 1995, PLANT J, V8, P55, DOI 10.1046/j.1365-313X.1995.08010055.x; Zhao Yaofeng, 2009, Avicenna Journal of Medical Biotechnology, V1, P37; Zhou M Y, 2000, Curr Issues Mol Biol, V2, P1	49	2	2	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107328	10.1371/journal.pone.0107328	http://dx.doi.org/10.1371/journal.pone.0107328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197968	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700106
J	Tian, XY; Tian, YF; Moldobaeva, N; Sarich, N; Birukova, AA				Tian, Xinyong; Tian, Yufeng; Moldobaeva, Nurgul; Sarich, Nicolene; Birukova, Anna A.			Microtubule Dynamics Control HGF-Induced Lung Endothelial Barrier Enhancement	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; NUCLEOTIDE EXCHANGE FACTOR; OXIDIZED PHOSPHOLIPIDS; ACTIN CYTOSKELETON; S1P(1) RECEPTOR; RHO-PATHWAY; INJURY; DYSFUNCTION; GEF-H1; RAC	Microtubules (MT) play a vital role in many cellular functions, but their role in peripheral actin cytoskeletal dynamics which is essential for control of endothelial barrier and monolayer integrity is less understood. We have previously described the enhancement of lung endothelial cell (EC) barrier by hepatocyte growth factor (HGF) which was associated with Rac1-mediated remodeling of actin cytoskeleton. This study investigated involvement of MT-dependent mechanisms in the HGF-induced enhancement of EC barrier. HGF-induced Rac1 activation was accompanied by phosphorylation of stathmin, a regulator of MT dynamics. HGF also stimulated MT peripheral growth monitored by time lapse imaging and tracking analysis of EB-1-decorated MT growing tips, and increased the pool of acetylated tubulin. These effects were abolished by EC pretreatment with HGF receptor inhibitor, downregulation of Rac1 pathway, or by expression of a stathmin-S63A phosphorylation deficient mutant. Expression of stathmin-S63A abolished the HGF protective effects against thrombin-induced activation of RhoA cascade, permeability increase, and EC barrier dysfunction. These results demonstrate a novel MT-dependent mechanism of HGF-induced EC barrier regulation via Rac1/PAK1/stathmin-dependent control of MT dynamics.	[Tian, Xinyong; Tian, Yufeng; Moldobaeva, Nurgul; Sarich, Nicolene; Birukova, Anna A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Birukova, AA (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	abirukov@medicine.bsd.uchicago.edu			National Institutes of Health National Heart, Lung, and Blood Institute [HL089257, HL107920]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107920, R01HL089257, R56HL107920] Funding Source: NIH RePORTER	National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding to AB: National Institutes of Health National Heart, Lung, and Blood Institute HL089257 and HL107920. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2005, J CELL PHYSIOL, V204, P934, DOI 10.1002/jcp.20359; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Deng JC, 2011, COMPR PHYSIOL, V1, P81, DOI 10.1002/cphy.c090011; Frank JA, 2003, CRIT CARE, V7, P233, DOI 10.1186/cc1829; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gierke S, 2012, CURR BIOL, V22, P753, DOI 10.1016/j.cub.2012.02.069; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rosen EM, 1995, ADV CANCER RES, V67, P257, DOI 10.1016/S0065-230X(08)60715-0; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Shimabukuro DW, 2003, CRIT CARE MED, V31, pS524, DOI 10.1097/01.CCM.0000081437.06466.B3; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Tian XY, 2012, FASEB J, V26, P3862, DOI 10.1096/fj.12-207746; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; Verin AD, 2001, AM J PHYSIOL-LUNG C, V281, pL565, DOI 10.1152/ajplung.2001.281.3.L565; Wadsworth P, 1996, CELL MOTIL CYTOSKEL, V35, P225, DOI 10.1002/(SICI)1097-0169(1996)35:3<225::AID-CM5>3.0.CO;2-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Yvon AMC, 2000, J CELL BIOL, V151, P1003, DOI 10.1083/jcb.151.5.1003; Zhang DH, 2001, J MUSCLE RES CELL M, V22, P193, DOI 10.1023/A:1010502201519; Zhang LL, 2000, J NEUROSCI RES, V59, P489, DOI 10.1002/(SICI)1097-4547(20000215)59:4<489::AID-JNR3>3.0.CO;2-9	45	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e105912	10.1371/journal.pone.0105912	http://dx.doi.org/10.1371/journal.pone.0105912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198505	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700020
J	Daniels, VW; Smans, K; Royaux, I; Chypre, M; Swinnen, JV; Zaidi, N				Daniels, Veerle W.; Smans, Karine; Royaux, Ines; Chypre, Melanie; Swinnen, Johannes V.; Zaidi, Nousheen			Cancer Cells Differentially Activate and Thrive on De Novo Lipid Synthesis Pathways in a Low-Lipid Environment	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; ACETYL-COA-CARBOXYLASE; BREAST-CANCER; GROWTH; LIPOGENESIS; EXPRESSION; APOPTOSIS; ALPHA; CHEMOTHERAPEUTICS; CHOLESTEROL	Increased lipogenesis is a hallmark of a wide variety of cancers and is under intense investigation as potential antineoplastic target. Although brisk lipogenesis is observed in the presence of exogenous lipids, evidence is mounting that these lipids may adversely affect the efficacy of inhibitors of lipogenic pathways. Therefore, to fully exploit the therapeutic potential of lipid synthesis inhibitors, a better understanding of the interrelationship between de novo lipid synthesis and exogenous lipids and their respective role in cancer cell proliferation and therapeutic response to lipogenesis inhibitors is of critical importance. Here, we show that the proliferation of various cancer cell lines (PC3M, HepG2, HOP62 and T24) is attenuated when cultured in lipid-reduced conditions in a cell line-dependent manner, with PC3M being the least affected. Interestingly, all cell lines - lipogenic (PC3M, HepG2, HOP62) as well as non-lipogenic (T24) - raised their lipogenic activity in these conditions, albeit to a different degree. Cells that attained the highest lipogenic activity under these conditions were best able to cope with lipid reduction in term of proliferative capacity. Supplementation of the medium with very low density lipoproteins, free fatty acids and cholesterol reversed this activation, indicating that the mere lack of lipids is sufficient to activate de novo lipogenesis in cancer cells. Consequently, cancer cells grown in lipid-reduced conditions became more dependent on de novo lipid synthesis pathways and were more sensitive to inhibitors of lipogenic pathways, like Soraphen A and Simvastatin. Collectively, these data indicate that limitation of access to exogenous lipids, as may occur in intact tumors, activates de novo lipogenesis is cancer cells, helps them to thrive under these conditions and makes them more vulnerable to lipogenesis inhibitors. These observations have important implications for the design of new antineoplastic strategies targeting the cancer cell's lipid metabolism.	[Daniels, Veerle W.; Swinnen, Johannes V.; Zaidi, Nousheen] Univ Leuven, KU Leuven, Fac Med, Dept Oncol,Lab Lipid Metab & Canc, Leuven, Belgium; [Smans, Karine; Royaux, Ines; Chypre, Melanie; Zaidi, Nousheen] Janssen Res & Dev, Dept Oncol, Beerse, Belgium; [Zaidi, Nousheen] Univ Punjab, Lahore, Pakistan	KU Leuven; Johnson & Johnson; Janssen Pharmaceuticals; University of Punjab	Zaidi, N (corresponding author), Univ Leuven, KU Leuven, Fac Med, Dept Oncol,Lab Lipid Metab & Canc, Leuven, Belgium.	nzzaidi@yahoo.com	Swinnen, Johannes V/AAA-2214-2022; Zaidi, Nousheen/AAX-1776-2020	Swinnen, Johannes V/0000-0002-7720-5077; Zaidi, Nousheen/0000-0002-3896-0088; Daniels, Veerle/0000-0002-2052-1423	Scientific Research Foundation-Flanders (FWO) [G.0691.12]; KU Leuven Concerted Research Actions (GOA) [GOA/11/2009]; Interuniversity Attraction Poles - Belgian Federal Science Policy Office (IAP Belspo) [IAP7-32]; Janssen Pharmaceutica NV	Scientific Research Foundation-Flanders (FWO)(FWO); KU Leuven Concerted Research Actions (GOA); Interuniversity Attraction Poles - Belgian Federal Science Policy Office (IAP Belspo); Janssen Pharmaceutica NV(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was supported by grants from: Scientific Research Foundation-Flanders (FWO, http://www.fwo.be/en/) G.0691.12 (JVS), KU Leuven Concerted Research Actions (GOA, http://www.kuleuven.be/onderzoek/kernprojecten/goa.htm) GOA/11/2009 (JVS), and Interuniversity Attraction Poles - Belgian Federal Science Policy Office (IAP Belspo, http://www.belspo.be/belspo/index_en.stm) IAP7-32 (JVS). VWD is a research assistant of the Scientific Research Foundation-Flanders (FWO) and the Flemish League against Cancer (VLK, http://www.tegenkanker.be/home). Co-authors KS, IR, MC, and NZ are employed by Janssen Pharmaceutica NV. Janssen Pharmaceutica NV provided support in the form of salaries for authors KS, IR, MC and NZ. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Brusselmans K, 2007, J BIOL CHEM, V282, P18777, DOI 10.1074/jbc.M611763200; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chlebowski RT, 2006, JNCI-J NATL CANCER I, V98, P1767, DOI 10.1093/jnci/djj494; De Schrijver E, 2003, CANCER RES, V63, P3799; Donnelly C, 2009, NUTR CANCER, V61, P114, DOI 10.1080/01635580802348666; Dufau I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-15; Filhoulaud G, 2013, TRENDS ENDOCRIN MET, V24, P257, DOI 10.1016/j.tem.2013.01.003; George RF, 2012, EUR J MED CHEM, V47, P377, DOI 10.1016/j.ejmech.2011.11.006; GERTH K, 1994, J ANTIBIOT, V47, P23, DOI 10.7164/antibiotics.47.23; Goepfert C, 2012, BMC P S8, V5, pP61; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Harvatine KJ, 2006, J NUTR, V136, P2468, DOI 10.1093/jn/136.10.2468; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Kuchiba A, 2012, JNCI-J NATL CANCER I, V104, P415, DOI 10.1093/jnci/djr542; Kuemmerle NB, 2011, MOL CANCER THER, V10, P427, DOI 10.1158/1535-7163.MCT-10-0802; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Martin BJ, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/412581; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; MEDES G, 1953, CANCER RES, V13, P27; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; Pruksakorn D, 2010, PROTEOMICS, V10, P3896, DOI 10.1002/pmic.201000137; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; SABINE JR, 1967, CANCER RES, V27, P793; Sebti SM, 2005, CANCER CELL, V7, P297, DOI 10.1016/j.ccr.2005.04.005; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Swinnen JV, 2000, ONCOGENE, V19, P5173, DOI 10.1038/sj.onc.1203889; VAHLENSIECK HF, 1994, CURR GENET, V25, P95, DOI 10.1007/BF00309532; Wu CH, 2011, J FOOD SCI, V76, pT65, DOI 10.1111/j.1750-3841.2010.02033.x; Ye J RA, 2011, COLD SPRING HARBOR P, V3; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200; Zaidi N, 2013, PROG LIPID RES, V52, P585, DOI 10.1016/j.plipres.2013.08.005; Zaidi N, 2012, MOL CANCER THER, V11, P1925, DOI 10.1158/1535-7163.MCT-12-0095	37	74	75	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106913	10.1371/journal.pone.0106913	http://dx.doi.org/10.1371/journal.pone.0106913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215509	Green Published, gold, Green Submitted			2022-12-27	WOS:000341774300030
J	Mathur, MB; Patel, RB; Gould, M; Uyeki, TM; Bhattacharya, J; Xiao, Y; Gillaspie, Y; Chae, C; Khazeni, N				Mathur, Maya B.; Patel, Rita B.; Gould, Michael; Uyeki, Timothy M.; Bhattacharya, Jay; Xiao, Yang; Gillaspie, Yoshi; Chae, Charlotte; Khazeni, Nayer			Seasonal Patterns in Human A (H5N1) Virus Infection: Analysis of Global Cases	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; OUTBREAKS; ASIA	Background: Human cases of highly pathogenic avian influenza (HPAI) A (H5N1) have high mortality. Despite abundant data on seasonal patterns in influenza epidemics, it is unknown whether similar patterns exist for human HPAI H5N1 cases worldwide. Such knowledge could help decrease avian-to-human transmission through increased prevention and control activities during peak periods. Methods: We performed a systematic search of published human HPAI H5N1 cases to date, collecting month, year, country, season, hemisphere, and climate data. We used negative binomial regression to predict changes in case incidence as a function of season. To investigate hemisphere as a potential moderator, we used AIC and the likelihood-ratio test to compare the season-only model to nested models including a main effect or interaction with hemisphere. Finally, we visually assessed replication of seasonal patterns across climate groups based on the Koppen-Geiger climate classification. Findings: We identified 617 human cases (611 with complete seasonal data) occurring in 15 countries in Southeast Asia, Africa, and the Middle East. Case occurrence was much higher in winter (n = 285, p = 0.03) than summer (n = 64), and the winter peak occurred across diverse climate groups. There was no significant interaction between hemisphere and season. Interpretation: Across diverse climates, HPAI H5N1 virus infection in humans increases significantly in winter. This is consistent with increased poultry outbreaks and HPAI H5N1 virus transmission during cold and dry conditions. Prioritizing prevention and control activities among poultry and focusing public health messaging to reduce poultry exposures during winter months may help to reduce zoonotic transmission of HPAI H5N1 virus in resource-limited settings.	[Mathur, Maya B.] Stanford Univ, Dept Med, Quantitat Sci Unit, Stanford, CA 94305 USA; [Patel, Rita B.; Gillaspie, Yoshi; Chae, Charlotte; Khazeni, Nayer] Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Gould, Michael] Kaiser Permanente So Calif, Pasadena, CA 91101 USA; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Bhattacharya, Jay; Khazeni, Nayer] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bhattacharya, Jay; Khazeni, Nayer] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Xiao, Yang] Univ S Carolina, Dept Languages Literatures & Cultures, Columbia, SC 29208 USA	Stanford University; Stanford University; Kaiser Permanente; Centers for Disease Control & Prevention - USA; Stanford University; Stanford University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Mathur, MB (corresponding author), Stanford Univ, Dept Med, Quantitat Sci Unit, Stanford, CA 94305 USA.	mmathur@stanford.edu		Xiao-Desai, Yang/0000-0002-3609-2758	Agency for Healthcare Research and Quality [1K08 HS019816]; Southern California Permanente Medical Group; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS019816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Southern California Permanente Medical Group; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Agency for Healthcare Research and Quality (1K08 HS019816, Dr. Khazeni). See http://www.ahrq.gov/. The Southern California Permanente Medical Group provided support in the form of a salary for author MG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdelwhab EM, 2011, EPIDEMIOL INFECT, V139, P647, DOI 10.1017/S0950268810003122; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; Bird SM, 2008, LANCET, V372, P696, DOI 10.1016/S0140-6736(08)61126-5; Chmielewski R, 2011, ANNU REV FOOD SCI T, V2, P37, DOI 10.1146/annurev-food-022510-133710; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Cunha BA, 2004, INFECT DIS CLIN N AM, V18, P141, DOI 10.1016/S0891-5520(03)00095-3; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liu CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000191; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Minh PQ, 2009, TRANSBOUND EMERG DIS, V56, P311, DOI 10.1111/j.1865-1682.2009.01086.x; Murakami DR, 2008, INT J INFECT DIS, V12, pE99, DOI 10.1016/j.ijid.2008.05.247; Murray EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024042; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; UCLA Statistical Consulting Group, R DAT AN EX POISS RE; World Health Organization, WHO H5N1 CLIN CAS SU; World Health Organization, 2013, WHO CAS DEF HUM INF; Yalcin C, 2010, AVIAN DIS, V54, P390, DOI 10.1637/8710-031809-Reg.1; Young H. D. A., 2011, U PHYS MODERN PHYS; Zeileis A., 2007, REGRESSION MODELS CO	26	16	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106171	10.1371/journal.pone.0106171	http://dx.doi.org/10.1371/journal.pone.0106171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215608	gold, Green Submitted, Green Published			2022-12-27	WOS:000341774300008
J	Xu, XJ; Zhao, PN; Chen, SJ				Xu, Xiaojun; Zhao, Peinan; Chen, Shi-Jie			Vfold: A Web Server for RNA Structure and Folding Thermodynamics Prediction	PLOS ONE			English	Article							COARSE-GRAINED MODEL; DE-NOVO PREDICTION; SECONDARY STRUCTURE; STABILITY; PSEUDOKNOTS; LANDSCAPE; DATABASE	Background: The ever increasing discovery of non-coding RNAs leads to unprecedented demand for the accurate modeling of RNA folding, including the predictions of two-dimensional (base pair) and three-dimensional all-atom structures and folding stabilities. Accurate modeling of RNA structure and stability has far-reaching impact on our understanding of RNA functions in human health and our ability to design RNA-based therapeutic strategies. Results: The Vfold server offers a web interface to predict (a) RNA two-dimensional structure from the nucleotide sequence, (b) three-dimensional structure from the two-dimensional structure and the sequence, and (c) folding thermodynamics (heat capacity melting curve) from the sequence. To predict the two-dimensional structure (base pairs), the server generates an ensemble of structures, including loop structures with the different intra-loop mismatches, and evaluates the free energies using the experimental parameters for the base stacks and the loop entropy parameters given by a coarse-grained RNA folding model (the Vfold model) for the loops. To predict the three-dimensional structure, the server assembles the motif scaffolds using structure templates extracted from the known PDB structures and refines the structure using all-atom energy minimization. Conclusions: The Vfold-based web server provides a user friendly tool for the prediction of RNA structure and stability. The web server and the source codes are freely accessible for public use at "http://rna.physics.missouri.edu''.	[Chen, Shi-Jie] Univ Missouri, Dept Phys, Columbia, MO 65211 USA; Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Chen, SJ (corresponding author), Univ Missouri, Dept Phys, Columbia, MO 65211 USA.	chenshi@missouri.edu		Xu, Xiaojun/0000-0002-6380-698X; Chen, Shi-Jie/0000-0002-8093-7244	National Institutes of Health (NIH) [GM063732]; National Science Foundation (NSF) [MCB0920411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063732] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) grant GM063732 and National Science Foundation (NSF) grant MCB0920411. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronescu MS, 2010, RNA, V16, P26, DOI 10.1261/rna.1689910; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w; Cao S, 2005, RNA, V11, P1884, DOI 10.1261/rna.2109105; Cao S, 2006, NUCLEIC ACIDS RES, V34, P2634, DOI 10.1093/nar/gkl346; Cao S, 2014, RNA, V20, P835, DOI 10.1261/rna.043976.113; Cao S, 2011, RNA, V17, P2130, DOI 10.1261/rna.026658.111; Cao S, 2011, J PHYS CHEM B, V115, P4216, DOI 10.1021/jp112059y; Cao S, 2009, RNA, V15, P696, DOI 10.1261/rna.1429009; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; Doudna JA, 2002, NATURE, V418, P222, DOI 10.1038/418222a; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Hajdin CE, 2010, RNA, V16, P1340, DOI 10.1261/rna.1837410; Hajiaghayi M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-22; Havgaard JH, 2005, NUCLEIC ACIDS RES, V33, pW650, DOI 10.1093/nar/gki473; Hobartner C, 2003, J MOL BIOL, V325, P421, DOI 10.1016/S0022-2836(02)01243-3; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lin JC, 2008, J AM CHEM SOC, V130, P14080, DOI 10.1021/ja8063638; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; Mathews DH, 2002, J MOL BIOL, V317, P191, DOI 10.1006/jmbi.2001.5351; Onoa B, 2004, CURR OPIN STRUC BIOL, V14, P374, DOI 10.1016/j.sbi.2004.04.001; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Petrov AI, 2011, NUCLEIC ACIDS RES, V39, pW50, DOI 10.1093/nar/gkr249; Popenda M, 2008, NUCLEIC ACIDS RES, V36, pD386, DOI 10.1093/nar/gkm786; Ren JH, 2005, RNA, V11, P1494, DOI 10.1261/rna.7284905; Rother K, 2011, J MOL MODEL, V17, P2325, DOI 10.1007/s00894-010-0951-x; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Senter E, 2014, J MATH BIOL IN PRESS; Shapiro BA, 2007, CURR OPIN STRUC BIOL, V17, P157, DOI 10.1016/j.sbi.2007.03.001; Sharma S, 2008, BIOINFORMATICS, V24, P1951, DOI 10.1093/bioinformatics/btn328; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Xayaphoummine A, 2005, NUCLEIC ACIDS RES, V33, pW605, DOI 10.1093/nar/gki447; Xia Z, 2013, J PHYS CHEM B, V117, P3135, DOI 10.1021/jp400751w; Xia Z, 2010, J PHYS CHEM B, V114, P13497, DOI 10.1021/jp104926t; Xu XJ, 2012, J AM CHEM SOC, V134, P12499, DOI 10.1021/ja3013819; Zhang J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2895050; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	100	103	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107504	10.1371/journal.pone.0107504	http://dx.doi.org/10.1371/journal.pone.0107504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215508	gold, Green Published, Green Submitted			2022-12-27	WOS:000341774300070
J	Goikoetxea, E; Murgia, X; Serna-Grande, P; Valls-i-Soler, A; Rey-Santano, C; Rivas, A; Anton, R; Basterretxea, FJ; Minambres, L; Mendez, E; Lopez-Arraiza, A; Larrabe-Barrena, JL; Gomez-Solaetxe, MA				Goikoetxea, Estibalitz; Murgia, Xabier; Serna-Grande, Pablo; Valls-i-Soler, Adolf; Rey-Santano, Carmen; Rivas, Alejandro; Anton, Raul; Basterretxea, Francisco J.; Minambres, Lorena; Mendez, Estibaliz; Lopez-Arraiza, Alberto; Luis Larrabe-Barrena, Juan; Angel Gomez-Solaetxe, Miguel			In Vitro Surfactant and Perfluorocarbon Aerosol Deposition in a Neonatal Physical Model of the Upper Conducting Airways	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; DOSE-RESPONSE; GAS-EXCHANGE; BLOOD-FLOW; OPEN-LABEL; THERAPY; INHALATION; NEBULIZATION; VENTILATION	Objective: Aerosol delivery holds potential to release surfactant or perfluorocarbon (PFC) to the lungs of neonates with respiratory distress syndrome with minimal airway manipulation. Nevertheless, lung deposition in neonates tends to be very low due to extremely low lung volumes, narrow airways and high respiratory rates. In the present study, the feasibility of enhancing lung deposition by intracorporeal delivery of aerosols was investigated using a physical model of neonatal conducting airways. Methods: The main characteristics of the surfactant and PFC aerosols produced by a nebulization system, including the distal air pressure and air flow rate, liquid flow rate and mass median aerodynamic diameter (MMAD), were measured at different driving pressures (4-7 bar). Then, a three-dimensional model of the upper conducting airways of a neonate was manufactured by rapid prototyping and a deposition study was conducted. Results: The nebulization system produced relatively large amounts of aerosol ranging between 0.3 +/- 0.0 ml/min for surfactant at a driving pressure of 4 bar, and 2.0 +/- 0.1 ml/min for distilled water (H(2)Od) at 6 bar, with MMADs between 2.61 +/- 0.1 mu m for PFD at 7 bar and 10.18 +/- 0.4 mu m for FC-75 at 6 bar. The deposition study showed that for surfactant and H(2)Od aerosols, the highest percentage of the aerosolized mass (similar to 65%) was collected beyond the third generation of branching in the airway model. The use of this delivery system in combination with continuous positive airway pressure set at 5 cmH(2)O only increased total airway pressure by 1.59 cmH(2)O at the highest driving pressure (7 bar). Conclusion: This aerosol generating system has the potential to deliver relatively large amounts of surfactant and PFC beyond the third generation of branching in a neonatal airway model with minimal alteration of pre-set respiratory support.	[Goikoetxea, Estibalitz; Murgia, Xabier; Serna-Grande, Pablo; Rey-Santano, Carmen] Cruces Univ Hosp, Res Unit Expt Neonatal Resp Physiol, Baracaldo, Bizkaia, Spain; [Valls-i-Soler, Adolf] Cruces Univ Hosp, Neonatal Intens Care Unit, Baracaldo, Bizkaia, Spain; [Rivas, Alejandro; Anton, Raul] Univ Navarra, TECNUN, Dept Mech Engn, Thermal & Fluids Engn Div, San Sebastian, Gipuzkoa, Spain; [Basterretxea, Francisco J.; Minambres, Lorena; Mendez, Estibaliz] Univ Basque Country, Fac Sci & Technol, Dept Phys Chem, Leioa, Bizkaia, Spain; [Lopez-Arraiza, Alberto; Luis Larrabe-Barrena, Juan; Angel Gomez-Solaetxe, Miguel] Univ Basque Country, High Tech Sch Maritime Studies, Dept Elect & Electrotech, Bilbao, Bizkaia, Spain	Hospital Universitario Cruces; Hospital Universitario Cruces; University of Navarra; University of Basque Country; University of Basque Country	Goikoetxea, E (corresponding author), Cruces Univ Hosp, Res Unit Expt Neonatal Resp Physiol, Baracaldo, Bizkaia, Spain.	esti-goikoetxea@hotmail.com	Anton, Raul/E-8504-2013; Rivas, Alejandro/A-3281-2009; SOLAECHE, MIGUEL ANGEL GOMEZ/ABH-3309-2020; Lopez-Arraiza, Alberto/C-6519-2014	Anton, Raul/0000-0003-1329-5891; Rivas, Alejandro/0000-0001-7755-8748; SOLAECHE, MIGUEL ANGEL GOMEZ/0000-0003-1509-046X; BASTERRECHEA ELGUEZABAL, FRANCISCO JOSE/0000-0002-0420-2625; Lopez-Arraiza, Alberto/0000-0002-3258-1888; Serna Grande, Pablo/0000-0002-3701-0822	SAIOTEK program of the Basque Government [HODEI01, SA-2011/00227]; University of the Basque Country [IT 583-13, IT 520-10, UFI 11/23]	SAIOTEK program of the Basque Government; University of the Basque Country	This work has been supported by the SAIOTEK 2011 program of the Basque Government (HODEI01, SA-2011/00227) and by the University of the Basque Country (consolidated groups IT 583-13, IT 520-10 and UFI 11/23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroe M, 1998, PRENAT NEONAT MED, V3, P346; Berggren E, 2000, ACTA PAEDIATR, V89, P460, DOI 10.1080/080352500750028195; Capstick TGD, 2012, EXPERT REV RESP MED, V6, P91, DOI [10.1586/ERS.11.89, 10.1586/ers.11.89]; CARLTON DP, 1995, PEDIATR RES, V37, P265, DOI 10.1203/00006450-199503000-00003; Dijk PH, 1997, INTENS CARE MED, V23, P1070, DOI 10.1007/s001340050458; Dijk PH, 1997, INTENS CARE MED, V23, P1077, DOI 10.1007/s001340050459; Dubus JC, 2005, PEDIATR RES, V58, P10, DOI 10.1203/01.PDR.0000156244.84422.55; ENHORNING G, 1972, PEDIATRICS, V50, P58; Finer NN, 2010, J AEROSOL MED PULM D, V23, P303, DOI 10.1089/jamp.2009.0758; Fok TF, 1996, PEDIATR PULM, V21, P301, DOI 10.1002/(SICI)1099-0496(199605)21:5<301::AID-PPUL5>3.0.CO;2-P; FUHRMAN BP, 1991, CRIT CARE MED, V19, P712, DOI 10.1097/00003246-199105000-00019; Gastiasoro-Cuesta E, 2001, Pediatr Crit Care Med, V2, P334, DOI 10.1097/00130478-200110000-00010; Gopel W, 2011, LANCET, V378, P1627, DOI 10.1016/S0140-6736(11)60986-0; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Janssens HM, 2001, J AEROSOL MED, V14, P433, DOI 10.1089/08942680152744640; Jeng MJ, 2003, PEDIATR RES, V53, P81, DOI 10.1203/01.PDR.0000041520.50792.0A; Jobe AH, 2001, CURR OPIN PEDIATR, V13, P124, DOI 10.1097/00008480-200104000-00006; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jorch G, 1997, PEDIATR PULM, V24, P222, DOI 10.1002/(SICI)1099-0496(199709)24:3<222::AID-PPUL9>3.0.CO;2-O; Kacmarek RM, 2006, AM J RESP CRIT CARE, V173, P882, DOI 10.1164/rccm.200508-1196OC; Kandler MA, 2004, PEDIATR RES, V56, P191, DOI 10.1203/01.PDR.0000132667.47744.F4; Kandler MA, 2001, AM J RESP CRIT CARE, V164, P31, DOI 10.1164/ajrccm.164.1.2010049; Kohler E, 2008, ARCH DIS CHILD-FETAL, V93, pF275, DOI 10.1136/adc.2007.121285; Mazela J, 2007, CURR OPIN PEDIATR, V19, P155, DOI 10.1097/MOP.0b013e32807fb013; Mazela J, 2011, EUR J PEDIATR, V170, P433, DOI 10.1007/s00431-010-1292-6; Minocchieri S, 2008, PEDIATR RES, V64, P141, DOI 10.1203/PDR.0b013e318175dcfa; Murgia X, 2012, PEDIATR RES, V72, P393, DOI 10.1038/pr.2012.90; Murgia X, 2011, J AEROSOL MED PULM D, V24, P81, DOI 10.1089/jamp.2010.0831; Rey-Santano C, 2013, PEDIATR RES, V73, P639, DOI 10.1038/pr.2013.24; Rozanek M, 2007, INT J BIOMEDICAL SCI, P249; Rudiger M, 2004, J CRIT CARE, V19, P42, DOI 10.1016/j.jcrc.2004.02.008; SEIDNER SR, 1995, AM J RESP CRIT CARE, V152, P113, DOI 10.1164/ajrccm.152.1.7599809; Sinha IP, 2011, RES REP NEONATOL, V1, P67, DOI 10.2147/RRN.S24050; Sweet DG, 2013, NEONATOLOGY, V103, P353, DOI 10.1159/000349928; Tashiro K, 1996, CRIT CARE MED, V24, P488, DOI 10.1097/00003246-199603000-00020; von der Hardt K, 2004, CRIT CARE MED, V32, P1200, DOI 10.1097/01.CCM.0000124876.31138.F6; Walsh BK, 2013, RESP CARE, V58, P367, DOI 10.4187/respcare.02189; Rojas-Reyes MX, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000510.pub2; YEH HC, 1980, B MATH BIOL, V42, P461, DOI 10.1007/BF02460796	39	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106835	10.1371/journal.pone.0106835	http://dx.doi.org/10.1371/journal.pone.0106835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211475	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900025
J	Zhou, CH; Pan, J; Huang, H; Zhu, YZ; Zhang, MX; Liu, L; Wu, YQ				Zhou, Cheng-Hua; Pan, Jin; Huang, He; Zhu, Yangzi; Zhang, Mingxing; Liu, Lian; Wu, Yuqing			Salusin-beta, but Not Salusin-alpha, Promotes Human Umbilical Vein Endothelial Cell Inflammation via the p38 MAPK/JNK-NF-kappa B Pathway	PLOS ONE			English	Article							RECEPTOR-DEFICIENT MICE; TUMOR-NECROSIS-FACTOR; ATHEROSCLEROSIS; MECHANISMS; PROGRESSION; SUPPRESSES	Objective: Recently, salusin-beta has been reported to have pro-alpha therosclerotic effects, but salusin-alpha has anti-atherosclerotic effects. Our previous study has shown that salusin-beta but not salusin-alpha promotes vascular inflammation in apoE-deficient mice. However, the underlying mechanism remains unknown. In this study, we observed the effect of salusins on inflammatory responses and the MAPK-NF-kappa B signaling pathway in human umbilical vein endothelial cells (HUVECs). Methods and Results: HUVECs were incubated with different concentrations of salusin-alpha and salusin-beta. The levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) were determined using enzyme-linked immunosorbent assay (ELISA). The mRNA expressions of vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) were quantified using quantitative real-time polymerase chain reaction (PCR). The protein expressions of VCAM-1, MCP-1, I-kappa B alpha, NF-kappa B, p-JNK and p-p38 MAPK were measured using western blotting analysis. Our results showed that in HUVECs, salusin-beta could up-regulate the levels of IL-6, TNF-alpha, VCAM-1 and MCP-1, promote I-kappa B alpha degradation and NF-kappa B activation, and increase the phosphorylation of JNK and p38 MAPK. These effects could be inhibited by p38 MAPK inhibitor SB203580 and/or JNK inhibitor SP600125. In contrast, salusin-alpha could selectively decrease VCAM-1 protein, but did not show any effect on the expressions of VCAM-1 mRNA, TNF-alpha, IL-6, MCP-1, I-kappa B alpha, NF-kappa B, p-JNK or p-p38 MAPK. Conclusion: Salusin-beta was able to promote inflammatory responses in HUVECs via the p38 MAPK-NF-kappa B and JNK-NF-kappa B pathways. In contrast, salusin-alpha failed to show any significant effects on the inflammatory responses in HUVECs. These results provide further insight into the mechanisms behind salusins in vascular inflammation and offer a potential target for the prevention and treatment of atherosclerosis.	[Zhou, Cheng-Hua; Pan, Jin; Zhang, Mingxing; Liu, Lian] Xuzhou Med Coll, Sch Pharm, Xuzhou, Peoples R China; [Huang, He; Zhu, Yangzi; Wu, Yuqing] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Peoples R China; [Wu, Yuqing] Xuzhou Med Coll, Dept Anesthet Pharmacol, Xuzhou, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Zhou, CH (corresponding author), Xuzhou Med Coll, Sch Pharm, Xuzhou, Peoples R China.	chzhou1212@126.com; xzmcyqwu@126.com	zhang, xu/GYE-3558-2022	zhu, yangzi/0000-0002-4709-4652	National Natural Science Foundation of China [81001431]; Natural Science Foundation of Jiangsu Higher Education Institutions of China [11KJB310014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Higher Education Institutions of China	This work is supported by the National Natural Science Foundation of China (81001431, http://www.nsfc.gov.cn) and the Natural Science Foundation of Jiangsu Higher Education Institutions of China (11KJB310014, http://www.ec.js.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Bui QT, 2009, INT J BIOCHEM CELL B, V41, P2109, DOI 10.1016/j.biocel.2009.06.002; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Galkina E, 2007, CURR DRUG TARGETS, V8, P1239, DOI 10.2174/138945007783220650; Ghosh J, 2009, TOXICOL APPL PHARM, V240, P73, DOI 10.1016/j.taap.2009.07.008; Hansson GK, 2009, J THROMB HAEMOST, V7, P328, DOI 10.1111/j.1538-7836.2009.03416.x; Koya T, 2012, AM J PHYSIOL-HEART C, V303, pH96, DOI 10.1152/ajpheart.00009.2012; Kumar A, 2005, FASEB J, V19, P443, DOI 10.1096/fj.03-1364fje; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lin ML, 2010, MOL CARCINOGEN, V49, P783, DOI 10.1002/mc.20652; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Missiou A, 2010, CIRCULATION, V121, P2033, DOI 10.1161/CIRCULATIONAHA.109.895037; Nagashima M, 2010, ATHEROSCLEROSIS, V212, P70, DOI 10.1016/j.atherosclerosis.2010.04.027; Olejarz W, 2014, EUR J CLIN INVEST, V44, P54, DOI 10.1111/eci.12191; Reuther-Madrid JY, 2002, MOL CELL BIOL, V22, P8175, DOI 10.1128/MCB.22.23.8175-8183.2002; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shi X, 2013, INFECT IMMUN, V81, P2197, DOI 10.1128/IAI.01280-12; Shichiri M, 2003, NAT MED, V9, P1166, DOI 10.1038/nm913; Watanabe T, 2008, HYPERTENS RES, V31, P463, DOI 10.1291/hypres.31.463; Watanabe T, 2008, CIRCULATION, V117, P638, DOI 10.1161/CIRCULATIONAHA.107.712539; Zhou CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091468; Zhou CH, 2012, CAN J PHYSIOL PHARM, V90, P463, DOI 10.1139/Y2012-022	23	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107555	10.1371/journal.pone.0107555	http://dx.doi.org/10.1371/journal.pone.0107555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210730	Green Submitted, gold, Green Published			2022-12-27	WOS:000341855900082
J	Alia-Klein, N; Wang, GJ; Preston-Campbell, RN; Moeller, SJ; Parvaz, MA; Zhu, W; Jayne, MC; Wong, C; Tomasi, D; Goldstein, RZ; Fowler, JS; Volkow, ND				Alia-Klein, Nelly; Wang, Gene-Jack; Preston-Campbell, Rebecca N.; Moeller, Scott J.; Parvaz, Muhammad A.; Zhu, Wei; Jayne, Millard C.; Wong, Chris; Tomasi, Dardo; Goldstein, Rita Z.; Fowler, Joanna S.; Volkow, Nora D.			Reactions to Media Violence: It's in the Brain of the Beholder	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; VENTROMEDIAL PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; DEFAULT MODE; DECISION-MAKING; RESTING STATE; BLOOD-FLOW; AGGRESSION; PERSONALITY; BEHAVIOR	Media portraying violence is part of daily exposures. The extent to which violent media exposure impacts brain and behavior has been debated. Yet there is not enough experimental data to inform this debate. We hypothesize that reaction to violent media is critically dependent on personality/trait differences between viewers, where those with the propensity for physical assault will respond to the media differently than controls. The source of the variability, we further hypothesize, is reflected in autonomic response and brain functioning that differentiate those with aggression tendencies from others. To test this hypothesis we pre-selected a group of aggressive individuals and non-aggressive controls from the normal healthy population; we documented brain, blood-pressure, and behavioral responses during resting baseline and while the groups were watching media violence and emotional media that did not portray violence. Positron Emission Tomography was used with [F-18] fluoro-deoxyglucose (FDG) to image brain metabolic activity, a marker of brain function, during rest and during film viewing while blood-pressure and mood ratings were intermittently collected. Results pointed to robust resting baseline differences between groups. Aggressive individuals had lower relative glucose metabolism in the medial orbitofrontal cortex correlating with poor self-control and greater glucose metabolism in other regions of the default-mode network (DMN) where precuneus correlated with negative emotionality. These brain results were similar while watching the violent media, during which aggressive viewers reported being more Inspired and Determined and less Upset and Nervous, and also showed a progressive decline in systolic blood-pressure compared to controls. Furthermore, the blood-pressure and brain activation in orbitofrontal cortex and precuneus were differentially coupled between the groups. These results demonstrate that individual differences in trait aggression strongly couple with brain, behavioral, and autonomic reactivity to media violence which should factor into debates about the impact of media violence on the public.	[Alia-Klein, Nelly; Wang, Gene-Jack; Preston-Campbell, Rebecca N.; Moeller, Scott J.; Parvaz, Muhammad A.; Goldstein, Rita Z.] Icahn Sch Med Mt Sinai, Dept Psychiat, Friedman Brain Inst, New York, NY 10029 USA; [Alia-Klein, Nelly; Moeller, Scott J.; Goldstein, Rita Z.] Icahn Sch Med Mt Sinai, Dept Neurosci, Friedman Brain Inst, New York, NY 10029 USA; [Wang, Gene-Jack; Jayne, Millard C.; Wong, Chris; Tomasi, Dardo; Volkow, Nora D.] NIAAA, Lab Neuroimaging, Bethesda, MD USA; [Zhu, Wei] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Fowler, Joanna S.] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory	Alia-Klein, N (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, Friedman Brain Inst, New York, NY 10029 USA.	nelly.alia-klein@mssm.edu	Tomasi, Dardo/J-2127-2015; Alia-Klein, Nelly/C-3154-2013; Parvaz, Muhammad/GPF-9163-2022; Moeller, Scott/L-5549-2016; Moeller, Scott J/AAV-1861-2021	Moeller, Scott/0000-0002-4449-0844; Parvaz, Muhammad/0000-0002-2671-2327	Brookhaven National Laboratory [DE-AC02-98CH10886]; National Institute of Mental Health [R01MH090134]; National Institute of Mental Health NIDA; NIH [K05DA020001]; National Institute of Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA033088, K05DA020001] Funding Source: NIH RePORTER	Brookhaven National Laboratory(United States Department of Energy (DOE)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Mental Health NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute on Drug Abuse (NIDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by (1) Brookhaven National Laboratory under contract DE-AC02-98CH10886, http://www.bnl.gov/world/; (2) National Institute of Mental Health: R01MH090134 (NAK), http://www.nimh.nih.gov/index.shtml; and (3) National Institute of Mental Health NIDA and NIH K05DA020001 (JSF) and the National Institute of Alcohol Abuse and Alcoholism Intramural Program, http://www.drugabuse.gov/ and http://www.niaaa.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Anderson CA, 2002, SCIENCE, V295, P2377, DOI 10.1126/science.1070765; Anderson CA, 2008, PERS SOC PSYCHOL B, V34, P462, DOI 10.1177/0146167207311282; Bailey K, 2011, COGN AFFECT BEHAV NE, V11, P259, DOI 10.3758/s13415-011-0029-y; Bartholow BD, 2006, J EXP SOC PSYCHOL, V42, P532, DOI 10.1016/j.jesp.2005.08.006; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Beck AT, 1996, PSYCHOL ASSESS; BERKOWITZ L, 1984, PSYCHOL BULL, V95, P410, DOI 10.1037/0033-2909.95.3.410; Blonigen DM, 2007, CAMBRIDGE HDB VIOLEN; Bushman BJ, 2006, ARCH PEDIAT ADOL MED, V160, P348, DOI 10.1001/archpedi.160.4.348; BUSHMAN BJ, 1990, J PERS SOC PSYCHOL, V58, P156, DOI 10.1037/0022-3514.58.1.156; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carnagey NL, 2007, AGGRESSIVE BEHAV, V33, P118, DOI 10.1002/ab.20173; Chou YH, 2013, PSYCHIAT RES-NEUROIM, V212, P65, DOI 10.1016/j.pscychresns.2012.10.002; Christakou A, 2009, J NEUROSCI, V29, P11020, DOI 10.1523/JNEUROSCI.1279-09.2009; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio A.R., 2005, DESCARTES ERROR EMOT; Dang LC, 2012, J COGNITIVE NEUROSCI, V24, P1960, DOI 10.1162/jocn_a_00252; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Dorfel D, 2009, EUR J NEUROSCI, V30, P1947, DOI 10.1111/j.1460-9568.2009.06973.x; Engelhardt CR, 2011, AGGRESSIVE BEHAV, V37, P538, DOI 10.1002/ab.20411; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fanti KA, 2009, AGGRESSIVE BEHAV, V35, P179, DOI 10.1002/ab.20295; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Funk JB, 2005, CHILD ADOL PSYCH CL, V14, P387, DOI 10.1016/j.chc.2005.02.009; Gianaros PJ, 2009, HYPERTENSION, V53, P819, DOI 10.1161/HYPERTENSIONAHA.108.126227; Gianaros PJ, 2009, NEUOIMAGE, V47; GOYER PF, 1994, NEUROPSYCHOPHARMACOL, V10, P21, DOI 10.1038/npp.1994.3; Hicks BM, 2004, PSYCHOL ASSESSMENT, V16, P276, DOI 10.1037/1040-3590.16.3.276; HOKANSON JE, 1962, J ABNORM PSYCHOL, V65, P232, DOI 10.1037/h0043800; HOKANSON JE, 1962, J ABNORM PSYCHOL, V64, P446, DOI 10.1037/h0040236; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Hosie J, 2014, AGGRESSIVE BEHAV, V40, P189, DOI 10.1002/ab.21510; Huesmann L. Rowell, 2007, WHY OBSERVING VIOLEN; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; Kelly CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001268; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Krueger RF, 2007, J ABNORM PSYCHOL, V116, P645, DOI 10.1037/0021-843X.116.4.645; Madan A, 2014, J YOUTH ADOLESCENCE, V43, P116, DOI 10.1007/s10964-013-0017-3; Mathiak K, 2006, HUM BRAIN MAPP, V27, P948, DOI 10.1002/hbm.20234; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McDermott KB, 1999, MEMORY, V7, P661; Mujica-Parodi LR, 2009, HUM BRAIN MAPP, V30, P47, DOI 10.1002/hbm.20483; Murray JP, 2006, MEDIA PSYCHOL, V8, P25, DOI 10.1207/S1532785XMEP0801_3; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; New AS, 2002, ARCH GEN PSYCHIAT, V59, P621, DOI 10.1001/archpsyc.59.7.621; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PHELPS ME, 1976, J NUCL MED, V17, P603; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raine A, 1996, ANN NY ACAD SCI, V794, P46, DOI 10.1111/j.1749-6632.1996.tb32508.x; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rudebeck PH, 2008, COGN AFFECT BEHAV NE, V8, P485, DOI 10.3758/CABN.8.4.485; Sampaio A, 2013, BRAIN STRUCT FUNCT; Schluter T, 2013, J NEUROSCI, V 33, P16889, DOI 10.1523/JNEUROSCI.1398-13.2013; Shannon BJ, 2011, P NATL ACAD SCI USA, V108, P11241, DOI 10.1073/pnas.1108241108; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Siever LJ, 1999, NEUROPSYCHOPHARMACOL, V20, P413, DOI 10.1016/S0893-133X(98)00111-0; Spinella M, 2002, INT J NEUROSCI, V112, P1359, DOI 10.1080/00207450290158250; Stevens J. P, 1992, APPL MULTIVARIATE ST; Strenziok M, 2011, SOC COGN AFFECT NEUR, V6, P537, DOI 10.1093/scan/nsq079; Swing EL, 2014, AGGRESS BEHAV; TELLEGEN A, 1997, PERSONALITY MEASURES; Thienel R, 2009, INT J NEUROPSYCHOPH, V12, P1295, DOI 10.1017/S1461145709990551; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; WANG GJ, 1993, RADIOLOGY, V186, P59, DOI 10.1148/radiology.186.1.8416587; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wei LQ, 2014, HUM BRAIN MAPP, V35, P331, DOI 10.1002/hbm.22176; Wiggett AJ, 2011, J COGNITIVE NEUROSCI, V23, P1765, DOI 10.1162/jocn.2010.21552; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023	82	13	13	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107260	10.1371/journal.pone.0107260	http://dx.doi.org/10.1371/journal.pone.0107260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25208327	Green Published, gold			2022-12-27	WOS:000342030300069
J	Muller, E; Zill, JM; Dirmaier, J; Harter, M; Scholl, I				Mueller, Evamaria; Zill, Joerdis M.; Dirmaier, Joerg; Haerter, Martin; Scholl, Isabelle			Assessment of Trust in Physician: A Systematic Review of Measures	PLOS ONE			English	Article							PATIENT TRUST; METHODOLOGICAL QUALITY; INTERPERSONAL-TRUST; MEDICAL-PROFESSION; SCALE; VALIDATION; COSMIN; INSTRUMENTS; PERFORMANCE; ENGLISH	Over the last decades, trust in physician has gained in importance. Studies have shown that trust in physician is associated with positive health behaviors in patients. However, the validity of empirical findings fundamentally depends on the quality of the measures in use. Our aim was to provide an overview of trust in physician measures and to evaluate the methodological quality of the psychometric studies and the quality of psychometric properties of identified measures. We conducted an electronic search in three databases (Medline, EMBASE and PsycInfo). The secondary search strategy included reference and citation tracking of included full texts and consultation of experts in the field. Retrieved records were screened independently by two reviewers. Full texts that reported on testing of psychometric properties of trust in physician measures were included in the review. Study characteristics and psychometric properties were extracted. We evaluated the quality of design, methods and reporting of studies with the COnsensus based Standards for the selection of health status Measurement INstruments (COSMIN) checklist. The quality of psychometric properties was assessed with Terwee's 2007 quality criteria. After screening 3284 records and assessing 169 full texts for eligibility, fourteen studies on seven trust in physician measures were included. Most of the studies were conducted in the USA and used English measures. All but one measure were generic. Sample sizes range from 25 to 1199 participants, recruited in very heterogeneous settings. Quality assessments revealed several flaws in the methodological quality of studies. COSMIN scores were mainly fair or poor. The overall quality of measures' psychometric properties was intermediate. Several trust in physician measures have been developed over the last years, but further psychometric evaluation of these measures is strongly recommended. The methodological quality of psychometric property studies could be improved by adhering to quality criteria like the COSMIN checklist.	[Mueller, Evamaria; Zill, Joerdis M.; Dirmaier, Joerg; Haerter, Martin; Scholl, Isabelle] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Scholl, I (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	i.scholl@uke.de	Scholl, Isabelle/AAN-9450-2020	Scholl, Isabelle/0000-0002-7639-0880; Harter, Martin/0000-0001-7443-9890	German Federal Ministry of Education and Research [01GX1043]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This project (project number: 01GX1043) is funded by the German Federal Ministry of Education and Research (http://www.bmbf.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LA, 1990, PSYCHOL REP, V67, P1091, DOI 10.2466/pr0.1990.67.3f.1091; Bachinger SM, 2009, PATIENT EDUC COUNS, V76, P126, DOI 10.1016/j.pec.2008.11.020; Becker ER, 2008, MED CARE, V46, P795, DOI 10.1097/MLR.0b013e31817919c0; Bonds Denise E, 2004, BMC Fam Pract, V5, P26, DOI 10.1186/1471-2296-5-26; Bova C, 2006, RES NURS HEALTH, V29, P477, DOI 10.1002/nur.20158; Bova C, 2012, RES NURS HEALTH, V35, P397, DOI 10.1002/nur.21484; Calnan Michael, 2006, J Health Organ Manag, V20, P349, DOI 10.1108/14777260610701759; CATERINICCHIO RP, 1979, SOC SCI MED-MED SOC, VA13, P81, DOI 10.1016/0160-7979(79)90011-0; Donnelly Vidis, 2011, Irish Journal of Psychological Medicine, V28, P21, DOI 10.1017/S0790966700011861; Dugan E, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-64; Egede LE, 2008, J GEN INTERN MED, V23, P808, DOI 10.1007/s11606-008-0613-1; Fondacaro Mark, 2005, Soc Justice Res, V18, P63, DOI 10.1007/s11211-005-3393-3; Freburger JK, 2003, ARTHRIT RHEUM-ARTHR, V49, P51, DOI 10.1002/art.10925; Glattacker M, 2007, PHYS MED REHAB KUROR, V17, P141, DOI 10.1055/s-2007-940008; Hall MA, 2002, MED CARE RES REV, V59, P293, DOI 10.1177/1077558702059003004; Hall MA, 2001, MILBANK Q, V79, P613, DOI 10.1111/1468-0009.00223; Hall MA, 2002, HEALTH SERV RES, V37, P1419, DOI 10.1111/1475-6773.01070; Hall Mark A, 2006, J Health Organ Manag, V20, P456, DOI 10.1108/14777260610701812; Hillen MA, 2012, SUPPORT CARE CANCER, V20, P1787, DOI 10.1007/s00520-011-1276-8; Hillen MA, 2013, PATIENT EDUC COUNS, V91, P25, DOI 10.1016/j.pec.2012.11.004; Hillen MA, 2011, PSYCHO-ONCOLOGY, V20, P227, DOI 10.1002/pon.1745; Kao A, 1998, JAMA-J AM MED ASSOC, V280, P1709; Krajewska-Kulak E, 2011, GINEKOL POL, V82, P905; Leisen B, 2001, Health Mark Q, V19, P23, DOI 10.1300/J026v19n01_03; Mavis B, 2006, TEACH LEARN MED, V18, P130, DOI 10.1207/s15328015tlm1802_7; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Ommen O, 2008, PATIENT EDUC COUNS, V73, P196, DOI 10.1016/j.pec.2008.03.016; Ozawa S, 2013, SOC SCI MED, V91, P10, DOI 10.1016/j.socscimed.2013.05.005; Pearson SD, 2000, J GEN INTERN MED, V15, P509, DOI 10.1046/j.1525-1497.2000.11002.x; Ramsay J, 2000, FAM PRACT, V17, P372, DOI 10.1093/fampra/17.5.372; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Safran DG, 1998, J FAM PRACTICE, V47, P213; Scholl I, 2012, DIMENSIONS PATIENTCE; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thom DH, 1999, MED CARE, V37, P510, DOI 10.1097/00005650-199905000-00010; Tijssen M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-117; Vissman AT, 2013, AIDS CARE, V25, P356, DOI 10.1080/09540121.2012.701722; Weech-Maldonado R, 2012, MED CARE, V50, pS22, DOI 10.1097/MLR.0b013e318263134b	42	55	56	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106844	10.1371/journal.pone.0106844	http://dx.doi.org/10.1371/journal.pone.0106844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP4EP	25208074	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300043
J	Fontanilla, IKC; Maria, IMPS; Garcia, JRM; Ghate, H; Naggs, F; Wade, CM				Fontanilla, Ian Kendrich C.; Sta Maria, Inna Mikaella P.; Garcia, James Rainier M.; Ghate, Hemant; Naggs, Fred; Wade, Christopher M.			Restricted Genetic Variation in Populations of Achatina (Lissachatina) fulica outside of East Africa and the Indian Ocean Islands Points to the Indian Ocean Islands as the Earliest Known Common Source	PLOS ONE			English	Article							ANGIOSTRONGYLUS-CANTONENSIS; SOUTH-AMERICA; APPLE SNAILS; DNA; DISPERSAL; DIVERSITY	The Giant African Land Snail, Achatina (=Lissachatina) fulica Bowdich, 1822, is a tropical crop pest species with a widespread distribution across East Africa, the Indian subcontinent, Southeast Asia, the Pacific, the Caribbean, and North and South America. Its current distribution is attributed primarily to the introduction of the snail to new areas by Man within the last 200 years. This study determined the extent of genetic diversity in global A. fulica populations using the mitochondrial 16S ribosomal RNA gene. A total of 560 individuals were evaluated from 39 global populations obtained from 26 territories. Results reveal 18 distinct A. fulica haplotypes; 14 are found in East Africa and the Indian Ocean islands, but only two haplotypes from the Indian Ocean islands emerged from this region, the C haplotype, now distributed across the tropics, and the D haplotype in Ecuador and Bolivia. Haplotype E from the Philippines, F from New Caledonia and Barbados, O from India and Q from Ecuador are variants of the emergent C haplotype. For the non-native populations, the lack of genetic variation points to founder effects due to the lack of multiple introductions from the native range. Our current data could only point with certainty to the Indian Ocean islands as the earliest known common source of A. fulica across the globe, which necessitates further sampling in East Africa to determine the source populations of the emergent haplotypes.	[Fontanilla, Ian Kendrich C.; Wade, Christopher M.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Fontanilla, Ian Kendrich C.; Sta Maria, Inna Mikaella P.; Garcia, James Rainier M.] Univ Philippines, Inst Biol, DNA Barcoding Lab, Quezon City 1101, Philippines; [Ghate, Hemant] Modern Coll, Dept Zool, Pune, Maharashtra, India; [Naggs, Fred] Nat Hist Museum, Dept Zool, London SW7 5BD, England	University of Nottingham; University of the Philippines System; University of the Philippines Diliman; Natural History Museum London	Wade, CM (corresponding author), Univ Nottingham, Sch Biol, Univ Pk, Nottingham NG7 2RD, England.	Chris.Wade@nottingham.ac.uk	Garcia, Juberlan/E-8928-2017	Wade, Christopher/0000-0002-1269-9694	University of the Philippines System; Leverhulme Trust [F/00114U]; Energy Development Corporation; Center for Interdisciplinary Studies of the University of the Philippines System	University of the Philippines System; Leverhulme Trust(Leverhulme Trust); Energy Development Corporation; Center for Interdisciplinary Studies of the University of the Philippines System	The work has been funded by the University of the Philippines System for the PhD grant provided to IKCF, the Leverhulme Trust (F/00114U), the Energy Development Corporation, and the Center for Interdisciplinary Studies of the University of the Philippines System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALICATA JE, 1966, CAN J ZOOLOG, V44, P1041, DOI 10.1139/z66-111; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BEQUAERT JOSEPH C., 1950, BULL MUS COMP ZOOL HARVARD UNIV, V105, P1; Blanford WT, 1868, ANN MAGAZINE NATURAL, V1, P110; Borrero Francisco J., 2009, Tentacle, V17, P6; Budha PB., 2008, MALACOLOGIST, V50, P19; Cowie Robert H., 2003, P93; de Vasconcellos MC, 2001, REV SAUDE PUBL, V35, P582, DOI 10.1590/S0034-89102001000600013; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Emberton KC, 1997, BIODIVERS CONSERV, V6, P1123, DOI 10.1023/A:1018384101789; Fields H. Angela, 2006, Journal of the Barbados Museum and Historical Society, V52, P233; Godwin-Austen H. H., 1908, Proceedings of the Malacological Society of London, V8; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Gregoric DEG, 2011, AM MALACOL BULL, V29, P135, DOI 10.4003/006.029.0205; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Jarett V. H. C., 1931, Hong Kong Naturalist, V2, P262; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; KLIKS MM, 1992, SOC SCI MED, V34, P199, DOI 10.1016/0277-9536(92)90097-A; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOWE S, 2000, 100 WORLDS WORST INA; Lydeard C, 2000, MOL PHYLOGENET EVOL, V15, P83, DOI 10.1006/mpev.1999.0719; Marquardt W.C., 2000, PARASITOLOGY VECTOR; Mead A.R., 1961, GIANT AFRICAN LAND S; Mead AR., 1979, PULMONATES, V2B; Moore D, 1998, CURRENT PROTOCOLS MO, P201; Naggs Fred, 1997, Archives of Natural History, V24, P37, DOI 10.3366/anh.1997.24.1.37; NAPPO-PAS, 2008, 1 NAPPOPAS; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Paiva CL, 1999, ENCONTROSOBRE EDUCAC; PANGGA G. A., 1949, Philippine Journal of Agriculture, V14, P337; PEMBERTON C. E., 1938, HAWAIIAN PLANTERS REC, V42, P135; Pinceel J, 2005, GENETICA, V125, P155, DOI 10.1007/s10709-005-5816-3; Poucher C, 1975, ANN M FLA STATE HORT, V88, P523; Raut S. K., 2002, P55, DOI 10.1079/9780851993201.0055; Schotman C.Y.L., 1989, 19 PROVEG FAO REG OF, P16; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; Staden R, 2000, Methods Mol Biol, V132, P115; Stadler T, 2005, MOL ECOL, V14, P2465, DOI 10.1111/j.1365-294X.2005.02603.x; Thiengo SC, 2007, BIOL INVASIONS, V9, P693, DOI 10.1007/s10530-006-9069-6; Tran CT, 2008, MALACOLOGIA, V50, P351; WANG H, 1993, NUCLEIC ACIDS RES, V21, P4153, DOI 10.1093/nar/21.17.4153	42	34	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e105151	10.1371/journal.pone.0105151	http://dx.doi.org/10.1371/journal.pone.0105151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203830	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500007
J	Li, L; Assanangkornchai, S; Duo, L; McNeil, E; Li, JH				Li, Lei; Assanangkornchai, Sawitri; Duo, Lin; McNeil, Edward; Li, Jianhua			Risk Behaviors, Prevalence of HIV and Hepatitis C Virus Infection and Population Size of Current Injection Drug Users in a China-Myanmar Border City: Results from a Respondent-Driven Sampling Survey in 2012	PLOS ONE			English	Article							GLOBAL EPIDEMIOLOGY; TRANSMISSION; YUNNAN; PEOPLE; HIDDEN	Background: Injection drug use has been the major cause of HIV/AIDS in China in the past two decades. We measured the prevalences of HIV and hepatitis C virus (HCV) prevalence and their associated risk factors among current injection drug users (IDUs) in Ruili city, a border region connecting China with Myanmar that has been undergoing serious drug use and HIV spread problems. An estimate of the number of current IDUs is also presented. Methods: In 2012, Chinese IDUs who had injected within the past six months and aged >= 18 years were recruited using a respondent-driven sampling (RDS) technique. Participants underwent interviews and serological testing for HIV, HBV, HCV and syphilis. Logistic regression indentified factors associated with HIV and HCV infections. Multiplier method was used to obtain an estimate of the size of the current IDU population via combining available service data and findings from our survey. Results: Among 370 IDUs recruited, the prevalence of HIV and HCV was 18.3% and 41.5%, respectively. 27.1% of participants had shared a needle/syringe in their lifetime. Consistent condom use rates were low among both regular (6.8%) and non-regular (30.4%) partners. Factors independently associated with being HIV positive included HCV infection, having a longer history of injection drug use and experience of needle/syringe sharing. Participants with HCV infection were more likely to be HIV positive, have injected more types of drugs, have shared other injection equipments and have unprotected sex with regular sex partners. The estimated number of current IDUs in Ruili city was 2,714 (95% CI: 1,617-5,846). Conclusions: IDUs may continue to be a critical subpopulation for transmission of HIV and other infections in this region because of the increasing population and persistent high risk of injection and sexual behaviours. Developing innovative strategies that can improve accessibility of current harm reduction services and incorporate more comprehensive contents is urgently needed.	[Li, Lei; Li, Jianhua] Yunnan Inst Drug Abuse, Kunming, Yunnan, Peoples R China; [Li, Lei; Assanangkornchai, Sawitri; McNeil, Edward] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkla, Thailand; [Duo, Lin] HIV AIDS Asia Reg Program Yunnan Management Off, Kunming, Yunnan, Peoples R China	Prince of Songkla University	Assanangkornchai, S (corresponding author), Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkla, Thailand.	savitree.a@psu.ac.th		Assanangkornchai, Sawitri/0000-0003-2174-3287; McNeil, Edward Braddon/0000-0002-9492-1040	HIV/AIDS Asia Regional Program (HAARP) Yunnan Management Office; National Science and Technology Development Agency, Ministry of Science and Technology, Thailand	HIV/AIDS Asia Regional Program (HAARP) Yunnan Management Office; National Science and Technology Development Agency, Ministry of Science and Technology, Thailand	Funding for this research was provided by HIV/AIDS Asia Regional Program (HAARP) Yunnan Management Office (http://www.ynaidsxm.com/). The Epidemiology Unit, Prince of Songkla University is partially supported by the National Science and Technology Development Agency, Ministry of Science and Technology, Thailand (http://www.nstda.or.th/eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Amin J, 2006, LANCET, V368, P938, DOI 10.1016/S0140-6736(06)69374-4; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Brouwer KC, 2009, J IMMIGR MINOR HEALT, V11, P1, DOI 10.1007/s10903-008-9119-5; Burrows Dave, 2006, Cad. Saúde Pública, V22, P871, DOI 10.1590/S0102-311X2006000400025; Crofts N, 1997, ADDICTION, V92, P999, DOI 10.1111/j.1360-0443.1997.tb02979.x; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; Des Jarlais DC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-53; Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;347::AID-IJC4&gt;3.0.CO;2-2; Duan Song, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1226; Elizabeth P, 2003, JOINT UNAIDS IMPACT; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heimer R, 2010, DRUG ALCOHOL DEPEN, V109, P79, DOI 10.1016/j.drugalcdep.2009.12.010; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jia YJ, 2008, INT J EPIDEMIOL, V37, P1287, DOI 10.1093/ije/dyn196; Johnston LG, 2013, SEX TRANSM DIS, V40, P304, DOI 10.1097/OLQ.0b013e31827fd650; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Lai S, 2001, J ACQ IMMUN DEF SYND, V26, P365, DOI 10.1097/00126334-200104010-00014; Li J, 2011, SEX TRANSM DIS, V38, P1161, DOI 10.1097/OLQ.0b013e3182315772; Li Jonathan J., 2010, Hormones & Cancer, V1, P1, DOI 10.1007/s12672-010-0010-1; Li Z, 2010, CHINESE J AIDS STD, V2, P187; Liu HJ, 2006, SEX TRANSM DIS, V33, P111, DOI 10.1097/01.olq.0000199762.28231.ee; M lh J, 2010, J ACQ IMMUN DEF SYND, V53, P34; Ma Y, 1990, ZHONGHUA LIU XING BI, V11, P184; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Matthews-Greer JM, 2001, CLIN DIAGN LAB IMMUN, V8, P690, DOI 10.1128/CDLI.8.4.690-694.2001; Medhi GK, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-9; Ministry of Health Ministry of Public Security & State Drug Administration, 2006, GUID PIL STUD COMM D; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Patrick DM, 2001, CAN MED ASSOC J, V165, P889; Saranga A, 2008, INT J DRUG POLICY, V19, pS25, DOI 10.1016/j.drugpo.2007.11.008; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stark K, 1997, INT J EPIDEMIOL, V26, P1359, DOI 10.1093/ije/26.6.1359; State Council HIV/AIDS Working Committee Office UN Theme Group on HIV/AIDS in China, 2007, JOINT ASS HIV AIDS P; State Council of China, 2006, CHIN ACT PLAN RED PR; Terrault NA, 2002, HEPATOLOGY, V36, pS99, DOI 10.1053/jhep.2002.36797; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; UNODC & UNAIDS, 2010, CHIN COUNTR ADV BRIE; Wu Z, 2010, J ACQ IMMUN DEF SYND, V53, P1, DOI DOI 10.1097/QAI.0B013E3181C7D379; Yao Y, 2009, INT J INFECT DIS, V13, P154, DOI 10.1016/j.ijid.2008.05.1228; Yap L., 2002, International Journal of Drug Policy, V13, P57, DOI 10.1016/S0955-3959(01)00118-9; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Yu XF, 2003, AIDS RES HUM RETROV, V19, P1051, DOI 10.1089/088922203322588422; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042937; Zule WA, 2007, SEX TRANSM DIS, V34, P689, DOI 10.1097/01.olq.0000260949.35304.22	48	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106899	10.1371/journal.pone.0106899	http://dx.doi.org/10.1371/journal.pone.0106899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203256	gold, Green Submitted, Green Published			2022-12-27	WOS:000342684500053
J	Miller, S; Rao, S; Wang, WY; Liu, HT; Wang, JD; Gavva, NR				Miller, Silke; Rao, Sara; Wang, Weiya; Liu, Hantao; Wang, Judy; Gavva, Narender R.			Antibodies to the Extracellular Pore Loop of TRPM8 Act as Antagonists of Channel Activation	PLOS ONE			English	Article							TRPM8-EXPRESSING SENSORY NEURONS; RECEPTOR POTENTIAL CHANNELS; COLD RECEPTOR; BODY-TEMPERATURE; TRANSIENT; REVEALS; MENTHOL; HYPERSENSITIVITY; THERMOSENSATION; TRANSDUCTION	The mammalian transient receptor potential melastatin channel 8 (TRPM8) is highly expressed in trigeminal and dorsal root ganglia. TRPM8 is activated by cold temperature or compounds that cause a cooling sensation, such as menthol or icilin. TRPM8 may play a role in cold hypersensitivity and hyperalgesia in various pain syndromes. Therefore, TRPM8 antagonists are pursued as therapeutics. In this study we explored the feasibility of blocking TRPM8 activation with antibodies. We report the functional characterization of a rabbit polyclonal antibody, ACC-049, directed against the third extracellular loop near the pore region of the human TRPM8 channel. ACC-049 acted as a full antagonist at recombinantly expressed human and rodent TRPM8 channels in cell based agonist-induced Ca-45(2+) uptake assays. Further, several poly-and monoclonal antibodies that recognize the same region also blocked icilin activation of not only recombinantly expressed TRPM8, but also endogenous TRPM8 expressed in rat dorsal root ganglion neurons revealing the feasibility of generating monoclonal antibody antagonists. We conclude that antagonist antibodies are valuable tools to investigate TRPM8 function and may ultimately pave the way for development of therapeutic antibodies.	[Miller, Silke; Rao, Sara; Wang, Weiya; Liu, Hantao; Wang, Judy; Gavva, Narender R.] Amgen Inc, Dept Neurosci, Thousand Oaks, CA 91320 USA	Amgen	Gavva, NR (corresponding author), Amgen Inc, Dept Neurosci, Thousand Oaks, CA 91320 USA.	ngavva@amgen.com	Miller, Silke/AAE-5858-2021	Miller, Silke/0000-0002-1124-3484				Almeida MC, 2012, J NEUROSCI, V32, P2086, DOI 10.1523/JNEUROSCI.5606-11.2012; Balayssac D, 2011, EXPERT OPIN DRUG SAF, V10, P407, DOI 10.1517/14740338.2011.543417; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Earley S, 2010, CLIN SCI, V119, P19, DOI 10.1042/CS20090641; Gavva NR, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-36; Gavva NR, 2005, MOL PHARMACOL, V68, P1524, DOI 10.1124/mol.105.015727; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Gore VK, 2006, US Pat Appl Publ US, Patent No. 20020060420; Gore VK, 2006, [Preparation of imidazolylpyridinylpiperazines as vanilloid receptor ligands for treatment of pain, US Pat Appl Publ US], Patent No. [A20060084641, 20060084641]; Gore VK, 2006, [Preparation of imidazolylpyridinylpiperazines as vanilloid receptor ligands for treatment of pain, US Pat Appl Publ US], Patent No. 20060084640; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; Klionsky L, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-39; Klionsky L, 2006, J PHARMACOL EXP THER, V319, P192, DOI 10.1124/jpet.106.108092; Knowlton WM, 2013, J NEUROSCI, V33, P2837, DOI 10.1523/JNEUROSCI.1943-12.2013; Lashinger ESR, 2008, AM J PHYSIOL-RENAL, V295, pF803, DOI 10.1152/ajprenal.90269.2008; Latorre R, 2011, PHYSIOLOGY, V26, P273, DOI 10.1152/physiol.00004.2011; Lee KJ, 2014, J PHARMACOL EXP THER, V350, P223, DOI 10.1124/jpet.114.215574; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; McCoy DD, 2011, AM J PHYSIOL-REG I, V300, pR1278, DOI 10.1152/ajpregu.00631.2010; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mukerji Gaurav, 2006, BMC Urol, V6, P6, DOI 10.1186/1471-2490-6-6; Naylor DJ, 2009, OPEN DRUG DISCOVERY, V1, P36; Naylor J, 2008, BRIT J PHARMACOL, V155, P567, DOI 10.1038/bjp.2008.283; Patel R, 2014, J PHARMACOL EXP THER, V349, P47, DOI 10.1124/jpet.113.211243; Pedretti A, 2009, BBA-BIOMEMBRANES, V1788, P973, DOI 10.1016/j.bbamem.2009.02.007; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Tajino K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017504; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Watschinger K, 2008, CHANNELS, V2, P461, DOI 10.4161/chan.2.6.6793; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Zhou BY, 1998, J GEN PHYSIOL, V111, P555, DOI 10.1085/jgp.111.4.555	40	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107151	10.1371/journal.pone.0107151	http://dx.doi.org/10.1371/journal.pone.0107151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203266	gold, Green Submitted, Green Published			2022-12-27	WOS:000342684500073
J	Motte, J; Alten, F; Ewering, C; Osada, N; Kadas, EM; Brandt, AU; Oberwahrenbrock, T; Clemens, CR; Eter, N; Paul, F; Marziniak, M				Motte, Jeremias; Alten, Florian; Ewering, Carina; Osada, Nani; Kadas, Ella M.; Brandt, Alexander U.; Oberwahrenbrock, Timm; Clemens, Christoph R.; Eter, Nicole; Paul, Friedemann; Marziniak, Martin			Vessel Labeling in Combined Confocal Scanning Laser Ophthalmoscopy and Optical Coherence Tomography Images: Criteria for Blood Vessel Discrimination	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; NEURITIS; FILTER; LAYER	Introduction: The diagnostic potential of optical coherence tomography (OCT) in neurological diseases is intensively discussed. Besides the sectional view of the retina, modern OCT scanners produce a simultaneous top-view confocal scanning laser ophthalmoscopy (cSLO) image including the option to evaluate retinal vessels. A correct discrimination between arteries and veins (labeling) is vital for detecting vascular differences between healthy subjects and patients. Up to now, criteria for labeling (cSLO) images generated by OCT scanners do not exist. Objective: This study reviewed labeling criteria originally developed for color fundus photography (CFP) images. Methods: The criteria were modified to reflect the cSLO technique, followed by development of a protocol for labeling blood vessels. These criteria were based on main aspects such as central light reflex, brightness, and vessel thickness, as well as on some additional criteria such as vascular crossing patterns and the context of the vessel tree. Results and Conclusion: They demonstrated excellent inter-rater agreement and validity, which seems to indicate that labeling of images might no longer require more than one rater. This algorithm extends the diagnostic possibilities offered by OCT investigations.	[Motte, Jeremias; Ewering, Carina; Marziniak, Martin] Univ Munster, Dept Neurol, Med Ctr, D-48149 Munster, Germany; [Alten, Florian; Clemens, Christoph R.; Eter, Nicole] Univ Munster, Dept Ophthalmol, Med Ctr, D-48149 Munster, Germany; [Kadas, Ella M.; Brandt, Alexander U.; Oberwahrenbrock, Timm; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Kadas, Ella M.; Brandt, Alexander U.; Oberwahrenbrock, Timm; Paul, Friedemann] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Kadas, Ella M.; Brandt, Alexander U.; Oberwahrenbrock, Timm; Paul, Friedemann] Max Delbruck Ctr Mol Med, Berlin, Germany; [Paul, Friedemann] Charite, Dept Neurol, D-13353 Berlin, Germany; [Marziniak, Martin] Isar Amper Klinikum, Dept Neurol, Haar, Germany; [Osada, Nani] Univ Munster, Inst Med Informat, D-48149 Munster, Germany	University of Munster; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster	Marziniak, M (corresponding author), Univ Munster, Dept Neurol, Med Ctr, D-48149 Munster, Germany.	Martin.Marziniak@kbo.de	Paul, Friedemann/ABF-9415-2020	paul, friedemann/0000-0002-6378-0070; Motte, Jeremias/0000-0002-6624-8565	Novartis Germany	Novartis Germany(Novartis)	Novartis Germany has funded the OCT scanner (http://www.novartis.de) with an unrestricted grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034891; Chrastek R, 2002, P IAPR WORKSH MACH V, P240; Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Frost S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.150; Gang L, 2002, IEEE T BIO-MED ENG, V49, P168, DOI 10.1109/10.979356; Green AJ, 2009, J NEUROL NEUROSUR PS, V80, P1002, DOI 10.1136/jnnp.2008.166207; Greenberg Benjamin M, 2010, Ther Adv Neurol Disord, V3, P153, DOI 10.1177/1756285610368890; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kondermann C, 2007, P SPIE MED IMAGING; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Narasimha-Iyer H, 2007, IEEE T BIO-MED ENG, V54, P1427, DOI 10.1109/TBME.2007.900804; Oberwahrenbrock T, 2013, MULT SCLER J, V19, P1887, DOI 10.1177/1352458513489757; Oberwahrenbrock T, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/530305; Paik MC., 2004, STAT METHODS RATES P, V3; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Roth NM, 2013, EUR J NEUROL, V20, P1170, DOI 10.1111/ene.12146; Sachs L, 2004, ANGEW STAT ANWENDUNG, DOI DOI 10.1007/978-3-662-05744-5; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Stricker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023024; Subei AM, 2009, CURR OPIN OPHTHALMOL, V20, P462, DOI 10.1097/ICU.0b013e3283313d4e; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Welsch U, 2006, SOBOTTA LEHRBUCH HIS; Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844	25	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e102034	10.1371/journal.pone.0102034	http://dx.doi.org/10.1371/journal.pone.0102034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203135	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000342684500001
J	Nassar, AP; Farias, AQ; d' Albuquerque, LAC; Carrilho, FJ; Malbouisson, LMS				Nassar Junior, Antonio Paulo; Farias, Alberto Queiroz; Carneiro d' Albuquerque, Luiz Augusto; Carrilho, Flair Jose; Sa Malbouisson, Luiz Marcelo			Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CONTROLLED-TRIAL; NORADRENALINE; PILOT; CIRRHOSIS; ALBUMIN; PREDICTORS; DIAGNOSIS; SURVIVAL	Background: Hepatorenal syndrome (HRS) is a severe and progressive functional renal failure occurring in patients with cirrhosis and ascites. Terlipressin is recognized as an effective treatment of HRS, but it is expensive and not widely available. Norepinephrine could be an effective alternative. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of norepinephrine compared to terlipressin in the management of HRS. Methods: We searched the Medline, Embase, Scopus, CENTRAL, Lilacs and Scielo databases for randomized trials of norepinephrine and terlipressin in the treatment of HRS up to January 2014. Two reviewers collected data and assessed the outcomes and risk of bias. The primary outcome was the reversal of HRS. Secondary outcomes were mortality, recurrence of HRS and adverse events. Results: Four studies comprising 154 patients were included. All trials were considered to be at overall high risk of bias. There was no difference in the reversal of HRS (RR = 0.97, 95% CI = 0.76 to 1.23), mortality at 30 days (RR = 0.89, 95% CI = 0.68 to 1.17) and recurrence of HRS (RR = 0.72; 95% CI = 0.36 to 1.45) between norepinephrine and terlipressin. Adverse events were less common with norepinephrine (RR = 0.36, 95% CI = 0.15 to 0.83). Conclusions: Norepinephrine seems to be an attractive alternative to terlipressin in the treatment of HRS and is associated with less adverse events. However, these findings are based on data extracted from only four small studies.	[Nassar Junior, Antonio Paulo; Sa Malbouisson, Luiz Marcelo] Univ Sao Paulo, Dept Gastroenterol, Intens Care Unit, Sao Paulo, Brazil; [Farias, Alberto Queiroz; Carrilho, Flair Jose] Univ Sao Paulo, Dept Gastroenterol, Discipline Gastroenterol, Sao Paulo, Brazil; [Carneiro d' Albuquerque, Luiz Augusto] Univ Sao Paulo, Dept Gastroenterol, Liver & Gastrointestinal Transplant Div, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Nassar, AP (corresponding author), Univ Sao Paulo, Dept Gastroenterol, Intens Care Unit, Sao Paulo, Brazil.	paulo_nassar@yahoo.com.br	Farias, Alberto/ABB-1291-2020; Nassar, Antonio Paulo/AAS-9246-2021; Carrilho, Flair J/I-3046-2012; D'Albuquerque, Luiz A Carneiro/I-4011-2012; Nassar, Antonio P/I-5508-2015; Sa Malbouisson, Luiz Marcelo/F-4819-2012	Farias, Alberto/0000-0002-5572-663X; Nassar, Antonio Paulo/0000-0002-0522-7445; D'Albuquerque, Luiz A Carneiro/0000-0001-7607-7168; Nassar, Antonio P/0000-0002-0522-7445; Sa Malbouisson, Luiz Marcelo/0000-0002-3261-5603				Alessandria C, 2007, J HEPATOL, V47, P499, DOI 10.1016/j.jhep.2007.04.010; Angeli P, 2012, J HEPATOL, V57, P1135, DOI 10.1016/j.jhep.2012.06.024; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Arroyo V, 2011, NAT REV NEPHROL, V7, P517, DOI 10.1038/nrneph.2011.96; de Carvalho GC, 2012, ANN HEPATOL, V11, P90; Dobre M, 2011, INT UROL NEPHROL, V43, P175, DOI 10.1007/s11255-010-9725-8; Duvoux C, 2002, HEPATOLOGY, V36, P374, DOI 10.1053/jhep.2002.34343; Ghosh S, 2013, LIVER INT, V33, P1187, DOI 10.1111/liv.12179; GINES A, 1993, GASTROENTEROLOGY, V105, P229, DOI 10.1016/0016-5085(93)90031-7; GLUUD LL, 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD005162.PUB3; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hiremath SB, 2013, INDIAN J PHARMACOL, V45, P54, DOI 10.4103/0253-7613.106436; Kiszka-Kanowitz M, 2004, SCAND J GASTROENTERO, V39, P486, DOI 10.1080/00365520310008728; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Martin-Llahi M, 2008, GASTROENTEROLOGY, V134, P1352, DOI 10.1053/j.gastro.2008.02.024; Narahara Y, 2009, J GASTROEN HEPATOL, V24, P1791, DOI 10.1111/j.1440-1746.2009.05873.x; Nazar A, 2010, HEPATOLOGY, V51, P219, DOI 10.1002/hep.23283; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; Salerno F, 2011, J HEPATOL, V55, P1241, DOI 10.1016/j.jhep.2011.03.012; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1360, DOI 10.1053/j.gastro.2008.02.014; Sharma P, 2008, AM J GASTROENTEROL, V103, P1689, DOI 10.1111/j.1572-0241.2008.01828.x; Singh V, 2012, J HEPATOL, V56, P1293, DOI 10.1016/j.jhep.2012.01.012; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80	23	68	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107466	10.1371/journal.pone.0107466	http://dx.doi.org/10.1371/journal.pone.0107466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203311	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500103
J	Raisanen, S; Selander, T; Cartwright, R; Gissler, M; Kramer, MR; Laine, K; Heinonen, S				Raisanen, Sari; Selander, Tuomas; Cartwright, Rufus; Gissler, Mika; Kramer, Michael R.; Laine, Katariina; Heinonen, Seppo			The Association of Episiotomy with Obstetric Anal Sphincter Injury-A Population Based Matched Cohort Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RISK-FACTORS; VAGINAL DELIVERY; ROUTINE; QUALITY; WOMEN	Objectives: To estimate the independent association of episiotomy with obstetric anal sphincter injuries (OASIS) using first a cross-sectional and then a matched pair analysis. Design: A matched cohort. Setting: Data was gathered from the Finnish Medical Birth Register from 2004-2011. Population: All singleton vaginal births (n = 303,758). Methods: Women resulting matched pairs (n = 63,925) were matched based on baseline risk of OASIS defined based on parity (first or second/subsequent vaginal births), age, birth weight, mode of delivery, prior caesarean section, and length of active second stage of birth. Results: In cross-sectional analysis episiotomy was associated with a 12% lower incidence of OASIS (adjusted odds ratio (aOR) 0.88, 95% confidence interval (CI) 0.80 to 0.98) in first vaginal births and with a 132% increased incidence of OASIS in second or subsequent vaginal births (aOR 2.32, 95% CI 1.77 to 3.03). In matched pair analysis episiotomy was associated with a 23% (aOR 0.77, 95% CI 0.69 to 0.86) lower incidence of OASIS in first vaginal births and a 61% (aOR 1.61, 95% CI 1.14 to 2.29) increased incidence of OASIS in second or subsequent vaginal births compared to women who gave birth without an episiotomy. The matched pair analysis showed a 12.5% and a 31.6% reduction in aORs of OASIS associated with episiotomy, respectively. Conclusions: A matched pair analysis showed a substantial reduction in the aORs of OASIS with episiotomy, due to confounding by indication. This indicates that results of observational studies evaluating an association between episiotomy and OASIS should be interpreted with caution.	[Raisanen, Sari; Kramer, Michael R.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Raisanen, Sari; Heinonen, Seppo] Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland; [Selander, Tuomas] Kuopio Univ Hosp, Dept Sci, Serv Ctr, SF-70210 Kuopio, Finland; [Cartwright, Rufus] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Gissler, Mika] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Laine, Katariina] Oslo Univ Hosp, Dept Obstet, Ulleval, Norway; [Laine, Katariina] Univ Oslo, Fac Med, Oslo, Norway; [Heinonen, Seppo] Univ Eastern Finland, Sch Med, Kuopio, Finland	Emory University; Rollins School Public Health; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Imperial College London; Finland National Institute for Health & Welfare; University of Oslo; University of Oslo; University of Eastern Finland	Raisanen, S (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	shraisan@student.uef.fi	Kramer, Michael R/A-3195-2013; Laine, Katariina/N-8363-2017	Kramer, Michael R/0000-0002-6372-6170; Laine, Katariina/0000-0001-9970-8401; Gissler, Mika/0000-0001-8254-7525; Cartwright, Rufus/0000-0001-5501-319X	Saastamoinen Foundation; Emil Aaltonen Foundation; Medical Research Council [G1100377, MR/K006525/1] Funding Source: researchfish; National Institute for Health Research [ACF-2008-21-040] Funding Source: researchfish; MRC [G1100377, MR/K006525/1] Funding Source: UKRI	Saastamoinen Foundation; Emil Aaltonen Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The first author (SR) was supported by the Saastamoinen Foundation and Emil Aaltonen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews V, 2006, BIRTH-ISS PERINAT C, V33, P117, DOI 10.1111/j.0730-7659.2006.00088.x; [Anonymous], 1993, Lancet, V342, P1517; Baghestan E, 2010, OBSTET GYNECOL, V116, P25, DOI 10.1097/AOG.0b013e3181e2f50b; Boyko EJ, 2013, J DIABETES COMPLICAT, V27, P642, DOI 10.1016/j.jdiacomp.2013.07.007; Carroli G, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub2; Dandolu V, 2005, INT UROGYNECOL J, V16, P304, DOI 10.1007/s00192-005-1297-2; Dannecker C, 2004, ACTA OBSTET GYN SCAN, V83, P364, DOI 10.1111/j.0001-6349.2004.00366.x; de Leeuw JW, 2008, BJOG-INT J OBSTET GY, V115, P104, DOI 10.1111/j.1471-0528.2007.01554.x; de Leeuw JW, 2001, BRIT J OBSTET GYNAEC, V108, P383, DOI 10.1016/S0306-5456(00)00090-5; de Leeuw JW, 2001, ACTA OBSTET GYN SCAN, V80, P830, DOI 10.1034/j.1600-0412.2001.080009830.x; Gissler M, 2002, MED INFORM INTERNET, V27, P33, DOI 10.1080/14639230110119234; HARRISON RF, 1984, BRIT MED J, V288, P1971, DOI 10.1136/bmj.288.6435.1971; Kalis V, 2012, BJOG-INT J OBSTET GY, V119, P522, DOI 10.1111/j.1471-0528.2011.03268.x; Kallen B, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/148616; KLEIN MC, 1995, CAN MED ASSOC J, V153, P769; Miettinen OS, 2011, EPIDEMIOLOGICAL RES; Murphy DJ, 2008, BJOG-INT J OBSTET GY, V115, P1695, DOI 10.1111/j.1471-0528.2008.01960.x; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P897, DOI 10.1001/jama.2010.1205; Raisanen S, 2013, BMJ OPEN, V3; Raisanen SH, 2009, ACTA OBSTET GYN SCAN, V88, P1365, DOI 10.3109/00016340903295626; Rodriguez A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.007; Sultan AH, 1999, CLIN RISK, V5, P193, DOI [DOI 10.1177/135626229900500601, 10.1177/135626229900500601]; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637	24	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107053	10.1371/journal.pone.0107053	http://dx.doi.org/10.1371/journal.pone.0107053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203655	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500066
J	Raupach, MJ; Hendrich, L; Kuechler, SM; Deister, F; Moriniere, J; Gossner, MM				Raupach, Michael J.; Hendrich, Lars; Kuechler, Stefan M.; Deister, Fabian; Moriniere, Jerome; Gossner, Martin M.			Building-Up of a DNA Barcode Library for True Bugs (Insecta: Hemiptera: Heteroptera) of Germany Reveals Taxonomic Uncertainties and Surprises	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; MITOCHONDRIAL-DNA; DIVERSITY; BIODIVERSITY; COLEOPTERA; PHYLOGEOGRAPHY; BIOGEOGRAPHY; EPHEMEROPTERA; SYSTEMATICS; POPULATION	During the last few years, DNA barcoding has become an efficient method for the identification of species. In the case of insects, most published DNA barcoding studies focus on species of the Ephemeroptera, Trichoptera, Hymenoptera and especially Lepidoptera. In this study we test the efficiency of DNA barcoding for true bugs (Hemiptera: Heteroptera), an ecological and economical highly important as well as morphologically diverse insect taxon. As part of our study we analyzed DNA barcodes for 1742 specimens of 457 species, comprising 39 families of the Heteroptera. We found low nucleotide distances with a minimum pairwise K2P distance <2.2% within 21 species pairs (39 species). For ten of these species pairs (18 species), minimum pairwise distances were zero. In contrast to this, deep intraspecific sequence divergences with maximum pairwise distances >2.2% were detected for 16 traditionally recognized and valid species. With a successful identification rate of 91.5% (418 species) our study emphasizes the use of DNA barcodes for the identification of true bugs and represents an important step in building-up a comprehensive barcode library for true bugs in Germany and Central Europe as well. Our study also highlights the urgent necessity of taxonomic revisions for various taxa of the Heteroptera, with a special focus on various species of the Miridae. In this context we found evidence for on-going hybridization events within various taxonomically challenging genera (e.g. Nabis Latreille, 1802 (Nabidae), Lygus Hahn, 1833 (Miridae), Phytocoris Fallen, 1814 (Miridae)) as well as the putative existence of cryptic species (e.g. Aneurus avenius (Duffour, 1833) (Aradidae) or Orius niger (Wolff, 1811) (Anthocoridae)).	[Raupach, Michael J.; Deister, Fabian] German Ctr Marine Biodivers DZMB, Wilhelmshaven, Germany; [Hendrich, Lars] Bavarian State Collect Zool SNSB ZSM, Sekt Insecta varia, Munich, Germany; [Kuechler, Stefan M.] Univ Bayreuth, Dept Anim Ecol 2, Bayreuth, Germany; [Moriniere, Jerome] Bavarian State Collect Zool SNSB ZSM, Barcoding Fauna Bavar, Munich, Germany; [Gossner, Martin M.] Tech Univ Munich, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany	University of Bayreuth; Technical University of Munich	Raupach, MJ (corresponding author), German Ctr Marine Biodivers DZMB, Wilhelmshaven, Germany.	mraupach@senckenberg.de; hendrich@zsm.mwn.de	Gossner, Martin M./J-2730-2015; Raupach, Michael J./AAF-7566-2020; Raupach, Michael/G-7072-2012	Gossner, Martin M./0000-0003-1516-6364; Raupach, Michael J./0000-0001-8299-6697; Deister, Fabian/0000-0002-3172-3223	Bavarian State Government (BFB); German Federal Ministry of Education and Research [GBOL2:01LI1101B]; Government of Canada to Genome Canada through the Ontario Genomics Institute; DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" [WE 3018/21-1]	Bavarian State Government (BFB); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Government of Canada to Genome Canada through the Ontario Genomics Institute; DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"	The project was supported by grants from the Bavarian State Government (BFB) and the German Federal Ministry of Education and Research (GBOL2:01LI1101B). The sequencing work was supported by funding from the Government of Canada to Genome Canada through the Ontario Genomics Institute, while the Ontario Ministry of Research and Innovation and NSERC supported development of the BOLD informatics platform. Many species were collected in the framework of the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (WE 3018/21-1) by MMG, who was also supported by this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich JR, 2012, PSYCHE, V2012, P2; Andersen NM, 2004, OCEANOGR MAR BIOL, V42, P119; Astrin JJ, 2012, MOL PHYLOGENET EVOL, V63, P1, DOI 10.1016/j.ympev.2011.11.018; Aukema B, 2013, HETEROPTERA FAUNA EU; Aukema B, 2013, CATALOGUE HETEROPTER, V6; Balke M, 2011, PROJECT BARCODING FA; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Bertrand C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-153; Bluthgen N, 2006, INSECT SOC, V53, P194, DOI 10.1007/s00040-005-0858-1; Brandle M, 2001, BIODIVERS CONSERV, V10, P1497, DOI 10.1023/A:1011815325503; Burange PS, 2012, ANN ENTOMOL SOC AM, V105, P917, DOI 10.1603/AN11146; Butcher BA, 2012, ZOOTAXA, P7; Cassis G, 2012, ANNU REV ENTOMOL, V57, P377, DOI 10.1146/annurev-ento-121510-133533; Cassis G, 2007, TREE LIFE TAXONOMY S, P193; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Damgaard J, 2005, INSECT SYST EVOL, V36, P395, DOI 10.1163/187631205788838537; Damgaard J, 2008, INSECT SYST EVOL, V39, P107, DOI 10.1163/187631208788784156; Delaunay P, 2011, CLIN INFECT DIS, V52, P200, DOI 10.1093/cid/ciq102; Derjanschi V, 2005, FAUNA FRANCE, V90; Derjanschi V, 2005, FAUNA FRANCE HEMIPTE, V1; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; deWaard JR, 2009, BIODIVERS CONSERV, V18, P3825, DOI 10.1007/s10531-009-9682-7; DeWaard Jeremy R., 2008, V410, P275; Di Giulio M, 2001, J APPL ECOL, V38, P310, DOI 10.1046/j.1365-2664.2001.00605.x; Duelli P, 1998, BIODIVERS CONSERV, V7, P297, DOI 10.1023/A:1008873510817; Ebach MC, 2011, ZOOTAXA, P67, DOI 10.11646/zootaxa.2742.1.5; Engstrand RC, 2010, MITOCHONDR DNA, V21, P38, DOI 10.3109/19401736.2010.536226; ERLANDSSON A, 1988, OIKOS, V53, P203, DOI 10.2307/3566063; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferri G, 2009, INT J LEGAL MED, V123, P395, DOI 10.1007/s00414-009-0356-5; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gillespie D. R., 2003, Journal of the Entomological Society of British Columbia, V100, P43; Gomez-Polo P, 2013, BIOL CONTROL, V67, P440, DOI 10.1016/j.biocontrol.2013.09.017; Goodell PB, 2008, J INSECT SCI, V8, P49; Greenstone MH, 2011, MOL ECOL RESOUR, V11, P629, DOI 10.1111/j.1755-0998.2011.03007.x; Gunther Hannes, 2000, Mitteilungen des Internationalen Entomologischen Vereins E. V. Frankfurt A. M. Supplement, V7, P1; Hajibabaei M, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-28; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hausmann A, 2011, SPIXIANA, V34, P47; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heiss E, 2007, FAUNA FRANCE, V91; Hendrich L, 2011, ZOOKEYS, P11, DOI 10.3897/zookeys.79.803; Henry Thomas J., 2009, P223, DOI 10.1002/9781444308211.ch10; Hobolth A, 2011, GENOME RES, V21, P349, DOI 10.1101/gr.114751.110; Hoffmann H-J, 2003, ENTOMOFAUNA GERMANIC, V8, P209; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Ingegno BL, 2011, BIOL CONTROL, V58, P174, DOI 10.1016/j.biocontrol.2011.06.003; Ito K, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0118; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jung S, 2011, MOL ECOL RESOUR, V11, P266, DOI 10.1111/j.1755-0998.2010.02945.x; Kerzhner IM, 2001, CATALOGUE HETEROPTER; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klausnitzer B, 2010, NACHRICHTENBLATT BAY, V59, P99111; Li M, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.79; Lis JA, 2012, HETEROPTERA POLONIAE, V4, P13; Maddison DR, 2008, ANN CARNEGIE MUS, V77, P147, DOI 10.2992/0097-4463-77.1.147; Meiklejohn KA, 2011, INT J LEGAL MED, V125, P27, DOI 10.1007/s00414-009-0395-y; Mende MB, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-83; Mroz Ewa, 2007, Genus (Wroclaw), P77; Musolin DL, 2007, GLOBAL CHANGE BIOL, V13, P1565, DOI 10.1111/j.1365-2486.2007.01395.x; Neigel J, 2007, CORAL REEFS, V26, P487, DOI 10.1007/s00338-007-0248-4; Nokkala C, 2007, EUR J ENTOMOL, V104, P661, DOI 10.14411/eje.2007.083; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Pericart J, 1998, FAUNA FRANCE B, V84A; Pericart J, 1990, FAUNA FRANCE, V77; Pericart J, 1987, HEMIPTERES NABIDAE E; Pericart J, 1998, FAUNA FRANCE, V84B; Pericart J, 2010, FAUNA FRANCE HEMIPTE, V3; Pericart J, 1984, FAUNA FRANCE, V70; Pericart J, 1998, FAUNA FRANCE HEMIPTE, V2; Pericart J, 1998, FAUNA FRANCE HEMIPTE, V1; Pericart J, 2010, FAUNA FRANCE, V93; Pericart J, 1972, HEMIPTERES ANTHOCORI; Pericart J, 1998, FAUNA FRANCE HEMIPTE, V3; Pericart J, 1998, FAUNA FRANCE C, V84C; Pericart J, 1983, FAUNA FRANCE, V69; Piccinali RV, 2009, J MED ENTOMOL, V46, P796, DOI 10.1603/033.046.0410; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Putshkov PV, 2009, FAUNA FRANCE, V92; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Raupach MJ., 2011, ANGEW CARABIDOLOGIE, V9, P63; Remane R., 1964, Zoologische Beitraege Berlin (NS), V10, P253; Ribes J, 2013, FAUNA FRANCE, V96; Ribes J, 2013, FAUNA FRANCE HEMIPTE, V2; Riedel A, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.280.3906; RIEGER C, 1990, DEUT ENTOMOL Z, V37, P285, DOI 10.1002/mmnd.19900370409; Ross H, 1932, PRAKTIKUM GALLENKUND; Roth S, 2002, ENTOMOLOGISCHE ABHAN, V60, P5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaefer CW., 2000, HETEROPTERA EC IMPOR, V1; Schuh R. T., 1995, True bugs of the world (Hemiptera: Heteroptera): classification and natural history.; Schuh RT, 2002, ON LINE SYSTEMATIC C; Schwartz MD, 1998, REVISION NEARARCTIC; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Skern M, 2010, LIMNOLOGICA, V40, P241, DOI 10.1016/j.limno.2009.09.002; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Smith Robert L., 1997, P116; Southwood T. R. E., 1953, Entomologist's Monthly Magazine, V89, P294; Stahls G, 2008, MOL PHYLOGENET EVOL, V46, P82, DOI 10.1016/j.ympev.2007.09.009; Stichel W, 1955, ILLUSTRIERTE BESTIMM, V4, P1; Stichel W, 1955, ILLUSTRIERTE BESTIMM, V1, P1; Stichel W, 1955, ILLUSTRIERTE BESTIMM, V2, P169; Stichel W, 1955, ILLUSTRIERTE BESTIMM, V5, P1; Stichel W, 1955, ILLUSTRIERTE BESTIMM, V3, P1; Stoev P, 2010, ZOOKEYS, P29, DOI 10.3897/zookeys.50.504; STONEDAHL GM, 1988, B AM MUS NAT HIST, V188, P3; Stonedahl GM, 1990, B AM MUS NAT HIST, V190, P1; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Suzuki T, 2014, MOL PHYLOGENET EVOL, V72, P7, DOI 10.1016/j.ympev.2013.12.008; Tallamy Douglas W., 1997, P94; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; van Helsdingen Peter J., 2011, Arachnologische Mitteilungen, P55, DOI 10.5431/aramit4007; Virolainen KM, 2000, P ROY SOC B-BIOL SCI, V267, P1143, DOI 10.1098/rspb.2000.1120; Wachmann E, 2012, WANZEN, V5; Wachmann E, 2004, WANZEN 2 TIERWELT DE; Wagner E, 1966, TIERWELT DEUTSCHLAND, V54; Wagner E, 1964, HETEROPTERES MIRIDAE; Wagner E, 1952, BLINDWANZEN ODER MIR; Wagner E, 1967, TIERWELT DEUTSCHLAND, V55; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wesener Thomas, 2012, Zootaxa, V3258, P58; Wesener T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028035; Wheeler AG, 2001, BIOL PLANT BUGS HEMI; Whitfield JB, 2012, DALY DOYENS INTRO IN; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Woodcock TS, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-40; Zaldivar-Riveron A, 2010, MITOCHONDR DNA, V21, P18, DOI 10.3109/19401736.2010.523701; Zhou CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034528; Zhou X, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-4; Zhou X, 2011, J N AM BENTHOL SOC, V30, P131, DOI 10.1899/10-010.1	140	84	92	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106940	10.1371/journal.pone.0106940	http://dx.doi.org/10.1371/journal.pone.0106940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203616	Green Submitted, Green Published, gold			2022-12-27	WOS:000342684500056
J	Liu, XS; Jin, HL; Zhang, GE; Lin, XK; Chen, C; Sun, JY; Zhang, Y; Zhang, Q; Yu, JR				Liu, Xiaosun; Jin, Hailong; Zhang, Geer; Lin, Xianke; Chen, Chao; Sun, Jianyi; Zhang, Yu; Zhang, Qing; Yu, Jiren			Intratumor IL-17-Positive Mast Cells Are the Major Source of the IL-17 That Is Predictive of Survival in Gastric Cancer Patients	PLOS ONE			English	Article							REGULATORY T-CELLS; INTERLEUKIN 17; LUNG-CANCER; NEUTROPHIL RECRUITMENT; CLINICAL-RELEVANCE; TUMOR-DEVELOPMENT; TH17 CELLS; INFLAMMATION; PREVALENCE; EXPRESSION	Interleukin-17 (IL-17) is prevalent in tumor tissue and suppresses effective anti-tumor immune responses. However, the source of the increased tumor-infiltrating IL-17 and its contribution to tumor progression in human gastric cancer remain poorly understood. In this study, we enrolled 112 gastric cancer patients, immunofluorescence was used to evaluate the colocalization of CD3, CD4, CD56, CD20, CD68, and mast cell tryptase (MCT) with IL-17. Immunohistochemistry was used to evaluate the distribution of microvessel density (CD34), CD66b(+), CD68(+), and FoxP3(+) cells in different microanatomical areas. Prognostic value was determined by Kaplan-Meier analysis and a Cox regression model. The results showed that mast cells, but not T cells or macrophages, were the predominant cell type producing IL-17 in gastric cancer. Significant positive correlations were detected between densities of mast cell-derived IL-17 and microvessels, neutrophils, and regulatory T cells (Tregs). Futhermore, we found that the majority of vascular endothelial cells expressing Interleukin-17 receptor (IL-17R). Kaplan-Meier analysis revealed that increasing intratumor infiltrated mast cells and IL-17(+) cells, as well as MCT+ IL-17(+) cells, were significantly associated with worse overall survival. These findings indicated that mast cells were the major source of IL-17 in gastric cancer, and intratumor IL-17 infiltration may have promoted tumor progression by enhancing angiogenesis in the tumor microenvironment through the axis of IL-17/IL-17R. IL-17-positive mast cells showed a prognostic factor in gastric cancer, indicating that immunotherapy targeting mast cells might be an effective strategy to control intratumor IL-17 infiltration, and consequently reverse immunosuppression in the tumor microenvironment, facilitating cancer immunotherapy.	[Liu, Xiaosun; Jin, Hailong; Zhang, Geer; Lin, Xianke; Chen, Chao; Sun, Jianyi; Zhang, Yu; Zhang, Qing; Yu, Jiren] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastrointestinal Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yu, JR (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastrointestinal Surg, Hangzhou 310003, Zhejiang, Peoples R China.	yujr0909@zju.edu.cn			National Science Foundation of China [81273254/H1006]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	XSL was supported by the grant of The National Science Foundation of China (81273254/H1006), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests:	Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884; Ganeshan K, 2012, J IMMUNOL, V188, P594, DOI 10.4049/jimmunol.1102389; Gu FM, 2012, ANN SURG ONCOL, V19, P2506, DOI 10.1245/s10434-012-2268-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haudenschild D, 2002, J BIOL CHEM, V277, P4309, DOI 10.1074/jbc.M109372200; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; He JJ, 2013, J NEUROPATH EXP NEUR, V72, P152, DOI 10.1097/NEN.0b013e318281262e; Honorati MC, 2007, J CANCER RES CLIN, V133, P1017, DOI 10.1007/s00432-007-0296-8; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kono H, 2011, J IMMUNOL, V187, P4818, DOI 10.4049/jimmunol.1100490; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128; Nie XM, 2012, CLIN IMMUNOL, V142, P269, DOI 10.1016/j.clim.2011.11.001; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Takahashi H, 2005, IMMUNOL LETT, V98, P189, DOI 10.1016/j.imlet.2004.11.012; Tartour E, 1999, CANCER RES, V59, P3698; Van de Velde ALR, 2012, ACTA CLIN BELG, V67, P399, DOI 10.2143/ACB.67.6.2062703; Walkington LA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1265; Wang B, 2013, CANCER IMMUNOL IMMUN, V62, P1575, DOI 10.1007/s00262-013-1460-4; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Woo EY, 2001, CANCER RES, V61, P4766; Yamada Y, 2012, J SURG RES, V178, P685, DOI 10.1016/j.jss.2012.07.055; Yapici U, 2011, TRANSPL INT, V24, P1008, DOI 10.1111/j.1432-2277.2011.01302.x; Zhang GE, 2013, INT J MOL SCI, V14, P13005, DOI 10.3390/ijms140713005; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zheng YW, 2013, CANCER INVEST, V31, P197, DOI 10.3109/07357907.2013.775294; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195; Zhuang Y, 2012, GASTROENTEROLOGY, V143, P951, DOI 10.1053/j.gastro.2012.06.010	43	40	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106834	10.1371/journal.pone.0106834	http://dx.doi.org/10.1371/journal.pone.0106834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197971	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700056
J	Robles, L; Vaziri, ND; Li, SR; Masuda, Y; Takasu, C; Takasu, M; Vo, K; Farzaneh, SH; Stamos, MJ; Ichii, H				Robles, Lourdes; Vaziri, Nosratola D.; Li, Shiri; Masuda, Yuichi; Takasu, Chie; Takasu, Mizuki; Vo, Kelly; Farzaneh, Seyed H.; Stamos, Michael J.; Ichii, Hirohito			Dimethyl Fumarate Protects Pancreatic Islet Cells and Non-Endocrine Tissue in L-Arginine-Induced Chronic Pancreatitis	PLOS ONE			English	Article							NRF2 ANTIOXIDANT PATHWAY; MULTIPLE-SCLEROSIS; KAPPA-B; ACTIVATION; PSORIASIS; RATS; EXPRESSION; DRUG	Background: Chronic pancreatitis (CP) is a progressive disorder resulting in the destruction and fibrosis of the pancreatic parenchyma which ultimately leads to impairment of the endocrine and exocrine functions. Dimethyl Fumarate (DMF) was recently approved by FDA for treatment of patients with multiple sclerosis. DMF's unique anti-oxidant and anti-inflammatory properties make it an interesting drug to test on other inflammatory conditions. This study was undertaken to determine the effects of DMF on islet cells and non-endocrine tissue in a rodent model of L-Arginine-induced CP. Methods: Male Wistar rats fed daily DMF (25 mg/kg) or vehicle by oral gavage were given 5 IP injections of L-Arginine (250 mg/100 gx2, 1 hr apart). Rats were assessed with weights and intra-peritoneal glucose tolerance tests (IPGTT, 2 g/kg). Islets were isolated and assessed for islet mass and viability with flow cytometry. Non-endocrine tissue was assessed for histology, myeloperoxidase (MPO), and lipid peroxidation level (MDA). In vitro assessments included determination of heme oxygenase (HO-1) protein expression by Western blot. Results: Weight gain was significantly reduced in untreated CP group at 6 weeks. IPGTT revealed significant impairment in untreated CP group and its restoration with DMF therapy (P<0.05). Untreated CP rats had pancreatic atrophy, severe acinar architectural damage, edema, and fatty infiltration as well as elevated MDA and MPO levels, which were significantly improved by DMF treatment. After islet isolation, the volume of non-endocrine tissue was significantly smaller in untreated CP group. Although islet counts were similar in the two groups, islet viability was significantly reduced in untreated CP group and improved with DMF treatment. In vitro incubation of human pancreatic tissue with DMF significantly increased HO-1 expression. Conclusion: Administration of DMF attenuated L-Arginine-induced CP and islet function in rats. DMF treatment could be a possible strategy to improve clinical outcome in patients with CP.	[Ichii, Hirohito] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ichii, H (corresponding author), Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA.	hichii@uci.edu	Ichii, Hirohito/AAV-8256-2021; Stamos, Michael Jerry/I-2465-2019	Stamos, Michael Jerry/0000-0003-2068-7391; Ichii, Hirohito/0000-0002-3635-5773	Juvenile Diabetes Research Foundation International [17-2011-609];  [NIH-NCRR UL1 TR000153];  [KL2 TR000147]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000147, UL1TR000153] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was in part supported by grants from: NIH-NCRR UL1 TR000153, KL2 TR000147, and the Juvenile Diabetes Research Foundation International 17-2011-609. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Chen JM, 2012, CLIN RES HEPATOL GAS, V36, P334, DOI 10.1016/j.clinre.2012.05.003; Fitzsimmons D, 2005, AM J GASTROENTEROL, V100, P918, DOI 10.1111/j.1572-0241.2005.40859.x; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jupp J, 2010, BEST PRACT RES CL GA, V24, P219, DOI 10.1016/j.bpg.2010.03.005; Kikuchi G, 2005, BIOCHEM BIOPH RES CO, V338, P558, DOI 10.1016/j.bbrc.2005.08.020; Kostromina E, 2010, ENDOCRINOLOGY, V151, P2050, DOI 10.1210/en.2009-1199; Lau HY, 2012, QUANTITATING INFLAMM; Lehmann JCU, 2007, J INVEST DERMATOL, V127, P835, DOI 10.1038/sj.jid.5700686; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li ZD, 2006, WORLD J GASTROENTERO, V12, P137, DOI 10.3748/wjg.v12.i1.137; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; MCENTEE GP, 1987, BRIT J SURG, V74, P402, DOI 10.1002/bjs.1800740528; Meili-Butz S, 2008, EUR J PHARMACOL, V586, P251, DOI 10.1016/j.ejphar.2008.02.038; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Onai Y, 2004, CARDIOVASC RES, V63, P51, DOI 10.1016/j.cardiores.2004.03.002; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Ricordi C., 1995, METHODS CELL TRANSPL; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Seidel C, 2002, DEV BRAIN RES, V138, P71, DOI 10.1016/S0165-3806(02)00466-2; Stoof TJ, 2001, BRIT J DERMATOL, V144, P1114, DOI 10.1046/j.1365-2133.2001.04220.x; Takacs T, 2002, PANCREAS, V25, P277, DOI 10.1097/00006676-200210000-00010; WEAVER C, 1994, EXP MOL PATHOL, V60, P71, DOI 10.1006/exmp.1994.1007; Yamaguchi T, 2005, PANCREAS, V31, P365, DOI 10.1097/01.mpa.0000179729.61457.e5	30	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107111	10.1371/journal.pone.0107111	http://dx.doi.org/10.1371/journal.pone.0107111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198679	Green Published, gold			2022-12-27	WOS:000341304700082
J	Frehn, L; Jansen, A; Bennek, E; Mandic, AD; Temizel, I; Tischendorf, S; Verdier, J; Tacke, F; Streetz, K; Trautwein, C; Sellge, G				Frehn, Lisa; Jansen, Anke; Bennek, Eveline; Mandic, Ana D.; Temizel, Ilknur; Tischendorf, Stefanie; Verdier, Julien; Tacke, Frank; Streetz, Konrad; Trautwein, Christian; Sellge, Gernot			Distinct Patterns of IgG and IgA against Food and Microbial Antigens in Serum and Feces of Patients with Inflammatory Bowel Diseases	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE ANTIBODIES; CROHNS-DISEASE; BAKERS-YEAST; BACTERIA; MANNAN; CLASSIFICATION; ASSOCIATION; RESPONSES; ALLERGY; DIET	Background: Inflammatory bowel disease (IBD) is associated with a defective intestinal barrier and enhanced adaptive immune responses against commensal microbiota. Immune responses against food antigens in IBD patients remain poorly defined. Methods: IgG and IgA specific for food and microfloral antigens (wheat and milk extracts; purified ovalbumin; Escherichia coli and Bacteroides fragilis lysates; mannan from Saccharomyces cerevisiae) were analyzed by ELISA in the serum and feces of patients with Crohn's disease (CD; n = 52 for serum and n = 20 for feces), ulcerative colitis (UC; n = 29; n = 17), acute gastroenteritis/colitis (AGE; n = 12; n = 9) as well as non-inflammatory controls (n = 61; n = 39). Results: Serum anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-B. fragilis IgG and IgA levels were increased in CD patients whereas antibody (Ab) levels against E. coli and food antigens were not significantly different within the patient groups and controls. Subgroup analysis revealed that CD patients with severe diseases defined by stricturing and penetrating lesions have slightly higher anti-food and anti-microbial IgA levels whereas CD and UC patients with arthropathy have decreased anti-food IgG levels. Treatment with anti-TNF-alpha Abs in CD patients was associated with significantly decreased ASCA IgG and IgA and anti-E. coli IgG. In the feces specific IgG levels against all antigens were higher in CD and AGE patients while specific IgA levels were higher in non-IBD patients. Anti-food IgG and IgA levels did not correlate with food intolerance. Summary: In contrast to anti-microbial Abs, we found only minor changes in serum anti-food Ab levels in specific subgroups of IBD patients. Fecal Ab levels towards microbial and food antigens show distinct patterns in controls, CD and UC patients.	[Frehn, Lisa; Jansen, Anke; Bennek, Eveline; Mandic, Ana D.; Temizel, Ilknur; Tischendorf, Stefanie; Verdier, Julien; Tacke, Frank; Streetz, Konrad; Trautwein, Christian; Sellge, Gernot] RWTH Univ, Univ Hosp Aachen, Dept Internal Med 3, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Sellge, G (corresponding author), RWTH Univ, Univ Hosp Aachen, Dept Internal Med 3, Aachen, Germany.	gsellge@ukaachen.de	Tacke, Frank/ABF-2212-2020	Verdier, Julien/0000-0002-5618-0579	German Research Foundation [DFG SE 1122/1]; European Union's Seventh Framework Programme (FP7) [305564]	German Research Foundation(German Research Foundation (DFG)); European Union's Seventh Framework Programme (FP7)	The research leading to these results has received funding from the German Research Foundation (DFG SE 1122/1) and the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 305564 (SysmedIBD). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams RJ, 2008, AM J GASTROENTEROL, V103, P386, DOI 10.1111/j.1572-0241.2007.01577.x; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Arnott IDR, 2004, AM J GASTROENTEROL, V99, P2376, DOI 10.1111/j.1572-0241.2004.40417.x; Bentz S, 2010, DIGESTION, V81, P252, DOI 10.1159/000264649; BJORKSTEN F, 1977, CLIN ALLERGY, V7, P473, DOI 10.1111/j.1365-2222.1977.tb01478.x; BRIGNOLA C, 1986, HEPATO-GASTROENTEROL, V33, P128; Cashman KD, 2003, EUR J GASTROEN HEPAT, V15, P607, DOI 10.1097/00042737-200306000-00005; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Graham DB, 2013, TRENDS IMMUNOL, V34, P371, DOI 10.1016/j.it.2013.04.001; Haas A, 2011, GUT, V60, P1506, DOI 10.1136/gut.2010.224774; Harmsen HJM, 2012, CLIN VACCINE IMMUNOL, V19, P515, DOI 10.1128/CVI.05517-11; HARVEY RF, 1980, LANCET, V1, P514; Huber A, 1998, INT ARCH ALLERGY IMM, V115, P67, DOI 10.1159/000023832; Hvatum M, 2006, GUT, V55, P1240, DOI 10.1136/gut.2005.076901; Iqbal N, 2002, J EXP MED, V195, P71, DOI 10.1084/jem.2001889; Klebl FH, 2003, INFLAMM BOWEL DIS, V9, P302, DOI 10.1097/00054725-200309000-00003; LERNER A, 1989, ACTA PAEDIATR SCAND, V78, P384, DOI 10.1111/j.1651-2227.1989.tb11097.x; LINDBERG E, 1992, GUT, V33, P909, DOI 10.1136/gut.33.7.909; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Lonnkvist MH, 2009, EUR J GASTROEN HEPAT, V21, P1168, DOI 10.1097/MEG.0b013e32832b125c; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; MAIN J, 1988, BRIT MED J, V297, P1105, DOI 10.1136/bmj.297.6656.1105; Mallant-Hent RC, 2006, WORLD J GASTROENTERO, V12, P292, DOI 10.3748/wjg.v12.i2.292; Mallant-Hent RC, 2006, EUR J GASTROEN HEPAT, V18, P75, DOI 10.1097/00042737-200601000-00013; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; PEARSON M, 1993, GUT, V34, P783, DOI 10.1136/gut.34.6.783; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Quinton JF, 1998, GUT, V42, P788, DOI 10.1136/gut.42.6.788; RACHMILEWITZ D, 1989, BMJ-BRIT MED J, V298, P82, DOI 10.1136/bmj.298.6666.82; Rajendran N, 2010, WORLD J GASTROENTERO, V16, P1442, DOI 10.3748/wjg.v16.i12.1442; Rieder F, 2012, DIGEST DIS, V30, P55, DOI 10.1159/000342603; Ruel J, 2014, NAT REV GASTRO HEPAT, V11, P88, DOI 10.1038/nrgastro.2013.240; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schoepfer AM, 2009, INFLAMM BOWEL DIS, V15, P1358, DOI 10.1002/ibd.20892; Sendid B, 1996, CLIN DIAGN LAB IMMUN, V3, P219, DOI 10.1128/CDLI.3.2.219-226.1996; Standaert-Vitse A, 2006, GASTROENTEROLOGY, V130, P1764, DOI 10.1053/j.gastro.2006.02.009; Suzuki H, 2008, AM J GASTROENTEROL, V103, P656, DOI 10.1111/j.1572-0241.2007.01642.x; Verdier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062780; Virta LJ, 2013, J PEDIATR GASTR NUTR, V56, P649, DOI 10.1097/MPG.0b013e318285e9d8	39	27	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e106750	10.1371/journal.pone.0106750	http://dx.doi.org/10.1371/journal.pone.0106750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215528	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300023
J	Ball, DA; Lux, MW; Adames, NR; Peccoud, J				Ball, David A.; Lux, Matthew W.; Adames, Neil R.; Peccoud, Jean			Adaptive Imaging Cytometry to Estimate Parameters of Gene Networks Models in Systems and Synthetic Biology	PLOS ONE			English	Article							SINGLE-CELL; FLUORESCENCE MICROSCOPY; POSITIVE FEEDBACK; EXPRESSION; CYCLE; PROTEINS; DYNAMICS; MEMORY; ACQUISITION; MATURATION	The use of microfluidics in live cell imaging allows the acquisition of dense time-series from individual cells that can be perturbed through computer-controlled changes of growth medium. Systems and synthetic biologists frequently perform gene expression studies that require changes in growth conditions to characterize the stability of switches, the transfer function of a genetic device, or the oscillations of gene networks. It is rarely possible to know a priori at what times the various changes should be made, and the success of the experiment is unknown until all of the image processing is completed well after the completion of the experiment. This results in wasted time and resources, due to the need to repeat the experiment to fine-tune the imaging parameters. To overcome this limitation, we have developed an adaptive imaging platform called GenoSIGHT that processes images as they are recorded, and uses the resulting data to make real-time adjustments to experimental conditions. We have validated this closed-loop control of the experiment using galactose-inducible expression of the yellow fluorescent protein Venus in Saccharomyces cerevisiae. We show that adaptive imaging improves the reproducibility of gene expression data resulting in more accurate estimates of gene network parameters while increasing productivity ten-fold.	[Ball, David A.; Lux, Matthew W.; Adames, Neil R.; Peccoud, Jean] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Peccoud, J (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	peccoud@vt.edu	Peccoud, Jean/A-2374-2008; Lux, Matthew/A-3602-2010; Lux, Matthew/AFW-4004-2022; Adames, Neil/S-1460-2017; Adames, Neil/AAO-7913-2020	Peccoud, Jean/0000-0001-7649-6127; Adames, Neil/0000-0003-4331-9348; Adames, Neil/0000-0003-4331-9348	National Science Foundation [0850100, 0963988]; National Institutes of Health [R01-GM078989, R01GM095955]; Science Application International Corporation; Department of Defense SMART Scholarship under OSD-T & E (Office of Secretary Defense-Test and Evaluation), National Defense Education Program (NDEP)/BA-1, Basic Research [Defense-Wide/PE0601120D8Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078989, R01GM095955] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Application International Corporation; Department of Defense SMART Scholarship under OSD-T & E (Office of Secretary Defense-Test and Evaluation), National Defense Education Program (NDEP)/BA-1, Basic Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported by Awards 0850100 and 0963988 from the National Science Foundation. It was also supported by grants R01-GM078989 and R01GM095955 from the National Institutes of Health. MWL was supported by a fellowship from Science Application International Corporation and by a Department of Defense SMART Scholarship under OSD-T & E (Office of Secretary Defense-Test and Evaluation), Defense-Wide/PE0601120D8Z National Defense Education Program (NDEP)/BA-1, Basic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Ball DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026272; Ball DA, 2011, CELL CYCLE, V10, P999, DOI 10.4161/cc.10.6.14966; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Bhat PJ, 2009, J BIOSCIENCES, V34, P513, DOI 10.1007/s12038-009-0070-y; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Ducret A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007282; Edelstein A., 2001, COMPUTER CONTROL MIC; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Jackson C, 2011, BIOINFORMATICS, V27, P1854, DOI 10.1093/bioinformatics/btr286; Jackson C, 2009, IEEE T IMAG IN PRESS; Jackson C, 2007, IEEE IMAGE PROC, P3041; Jin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001763; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Kundu S, 2007, GENE DEV, V21, P997, DOI 10.1101/gad.1506607; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Maska M, 2014, BIOINFORMATICS, V30, P1609, DOI 10.1093/bioinformatics/btu080; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Merryman TE, 2005, IEEE T IMAGE PROCESS, V14, P1246, DOI 10.1109/TIP.2005.855861; Mondragon-Palomino O, 2011, SCIENCE, V333, P1315, DOI 10.1126/science.1205369; Munsky B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.75; Muzzey D, 2009, ANNU REV CELL DEV BI, V25, P301, DOI 10.1146/annurev.cellbio.042308.113408; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Park JS, 2014, P NATL ACAD SCI US; Prindle A, 2014, NATURE; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Santos A, 1997, J MICROSC-OXFORD, V188, P264, DOI 10.1046/j.1365-2818.1997.2630819.x; Selimkhanov J, 2012, CURR OPIN BIOTECH, V23, P34, DOI 10.1016/j.copbio.2011.11.006; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Verma M, 2003, J BIOL CHEM, V278, P48764, DOI 10.1074/jbc.M303526200; Vollath D, 1987, AUTOMATIC FOCUSING C; Wang QL, 2010, CYTOM PART A, V77A, P101, DOI 10.1002/cyto.a.20812; Zacharioudakis L, 2007, CURR BIOL, V17, P2041, DOI 10.1016/j.cub.2007.10.044; Zhang Q, 2013, P NATL ACAD SCI USA, V110, P14012, DOI 10.1073/pnas.1306113110	43	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107087	10.1371/journal.pone.0107087	http://dx.doi.org/10.1371/journal.pone.0107087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210731	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900042
J	Brodeur, MB; Guerard, K; Bouras, M				Brodeur, Mathieu B.; Guerard, Katherine; Bouras, Maria			Bank of Standardized Stimuli (BOSS) Phase II: 930 New Normative Photos	PLOS ONE			English	Article							NAME AGREEMENT; VISUAL COMPLEXITY; IMAGE AGREEMENT; NAMING TIMES; NORMS; SET; PICTURES; FAMILIARITY; SNODGRASS; FRENCH	Researchers have only recently started to take advantage of the developments in technology and communication for sharing data and documents. However, the exchange of experimental material has not taken advantage of this progress yet. In order to facilitate access to experimental material, the Bank of Standardized Stimuli (BOSS) project was created as a free standardized set of visual stimuli accessible to all researchers, through a normative database. The BOSS is currently the largest existing photo bank providing norms for more than 15 dimensions (e.g. familiarity, visual complexity, manipulability, etc.), making the BOSS an extremely useful research tool and a mean to homogenize scientific data worldwide. The first phase of the BOSS was completed in 2010, and contained 538 normative photos. The second phase of the BOSS project presented in this article, builds on the previous phase by adding 930 new normative photo stimuli. New categories of concepts were introduced, including animals, building infrastructures, body parts, and vehicles and the number of photos in other categories was increased. All new photos of the BOSS were normalized relative to their name, familiarity, visual complexity, object agreement, viewpoint agreement, and manipulability. The availability of these norms is a precious asset that should be considered for characterizing the stimuli as a function of the requirements of research and for controlling for potential confounding effects.	[Brodeur, Mathieu B.] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Brodeur, Mathieu B.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Guerard, Katherine] Univ Moncton, Dept Psychol, Moncton, NB E1A 3E9, Canada; [Bouras, Maria] Univ Sheffield, Dept Educ, Sheffield, S Yorkshire, England	McGill University; McGill University; University of Moncton; University of Sheffield	Brodeur, MB (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	mathieu.brodeur@douglas.mcgill.ca			Natural Sciences and Engineering Research Council of Canada [388752-2012]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by the Natural Sciences and Engineering Research Council of Canada #388752-2012 (www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlington RL, 2009, J CLIN EXP NEUROPSYC, V31, P731, DOI 10.1080/13803390802488103; Alario FX, 2004, BEHAV RES METH INS C, V36, P140, DOI 10.3758/BF03195559; Barbarotto R, 2002, NEUROPSYCHOLOGIA, V40, P1637, DOI 10.1016/S0028-3932(02)00029-5; Barry C, 1997, Q J EXP PSYCHOL-A, V50, P560, DOI 10.1080/783663595; BERMAN S, 1989, BEHAV RES METH INSTR, V21, P371, DOI 10.3758/BF03202800; BIEDERMAN I, 1988, COGNITIVE PSYCHOL, V20, P38, DOI 10.1016/0010-0285(88)90024-2; Bonin P, 2003, BEHAV RES METH INS C, V35, P158, DOI 10.3758/BF03195507; Brielmann AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084373; Brodeur MB, 2012, BEHAV RES METHODS, V44, P961, DOI 10.3758/s13428-011-0184-7; Brodeur MB, 2011, ACTA PSYCHOL, V137, P359, DOI 10.1016/j.actpsy.2011.04.005; Brodeur MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010773; BRODIE EE, 1991, AM J PSYCHOL, V104, P517, DOI 10.2307/1422939; Cuetos F, 2003, BEHAV RES METH INS C, V35, P168, DOI 10.3758/BF03195508; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; Dan-Glauser ES, 2011, BEHAV RES METHODS, V43, P468, DOI 10.3758/s13428-011-0064-1; De Winter J, 2004, BEHAV RES METH INS C, V36, P604, DOI 10.3758/BF03206541; Dell'acqua R, 2000, BEHAV RES METH INS C, V32, P588, DOI 10.3758/BF03200832; Denkinger B, 2014, BEHAV RES METHODS, V46, P229, DOI 10.3758/s13428-013-0338-x; Filliter JH, 2005, BRAIN COGNITION, V57, P61, DOI 10.1016/j.bandc.2004.08.022; Guerard K, 2015, BEHAV RES METHODS, V47, P572, DOI 10.3758/s13428-014-0495-6; Guerard K, 2015, BEHAV RES METHODS, V47, P443, DOI 10.3758/s13428-014-0488-5; Janssen N, 2011, BEHAV RES METHODS, V43, P478, DOI 10.3758/s13428-011-0065-0; Moreno-Martinez FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037527; Kremin H, 2003, BRAIN COGNITION, V53, P243, DOI 10.1016/S0278-2626(03)00119-2; Lagace S, 2013, BEHAV RES METHODS, V45, P772, DOI 10.3758/s13428-012-0283-0; Laws KR, 2000, BRAIN LANG, V75, P123, DOI 10.1006/brln.2000.2348; Laws KR, 2005, CORTEX, V41, P842, DOI 10.1016/S0010-9452(08)70303-4; Laws KR, 2004, PERS INDIV DIFFER, V36, P23, DOI 10.1016/S0191-8869(03)00048-5; Laws KR, 1999, NEUROPSYCHOLOGIA, V37, P1263, DOI 10.1016/S0028-3932(99)00018-4; Laws KR, 2001, BEHAV BRAIN SCI, V24, P486, DOI 10.1017/S0140525X01324159; Leder H, 1999, PERCEPTION, V28, P1171, DOI 10.1068/p2674; Magnie MN, 2003, J CLIN EXP NEUROPSYC, V25, P521, DOI 10.1076/jcen.25.4.521.13873; Migo EM, 2013, BEHAV RES METHODS, V45, P344, DOI 10.3758/s13428-012-0255-4; Nishimoto T, 2005, BEHAV RES METHODS, V37, P398, DOI 10.3758/BF03192709; Nishimoto T, 2010, BEHAV RES METHODS, V42, P685, DOI 10.3758/BRM.42.3.685; O'Sullivan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047802; Op de Beeck H, 2001, PERCEPTION, V30, P1337; Pompeia S, 2001, ARQ NEURO-PSIQUIAT, V59, P330, DOI 10.1590/S0004-282X2001000300004; RHODES G, 1987, COGNITIVE PSYCHOL, V19, P473, DOI 10.1016/0010-0285(87)90016-8; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Salmon JP, 2010, BEHAV RES METHODS, V42, P82, DOI 10.3758/BRM.42.1.82; Sanfeliu MC, 1996, BEHAV RES METH INSTR, V28, P537, DOI 10.3758/BF03200541; Sirois M, 2006, BEHAV RES METHODS, V38, P300, DOI 10.3758/BF03192781; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SNODGRASS JG, 1988, PERCEPT MOTOR SKILL, V67, P3, DOI 10.2466/pms.1988.67.1.3; VERFAILLIE K, 1995, PERCEPT PSYCHOPHYS, V57, P925, DOI 10.3758/BF03205454; Viggiano MP, 2004, CORTEX, V40, P491, DOI 10.1016/S0010-9452(08)70142-4; Weekes BS, 2007, BEHAV RES METHODS, V39, P335, DOI 10.3758/BF03193165	48	189	189	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106953	10.1371/journal.pone.0106953	http://dx.doi.org/10.1371/journal.pone.0106953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211489	Green Submitted, Green Published, gold			2022-12-27	WOS:000341855900033
J	Sissoko, D; Trottier, H; Malvy, D; Johri, M				Sissoko, Daouda; Trottier, Helen; Malvy, Denis; Johri, Mira			The Influence of Compositional and Contextual Factors on Non-Receipt of Basic Vaccines among Children of 12-23-Month Old in India: A Multilevel Analysis	PLOS ONE			English	Article							CHILDHOOD IMMUNIZATION; HEALTH INTERVENTIONS; MATERNAL EDUCATION; MOTHERS REPORTS; VACCINATION; COVERAGE; EQUITY; ASSOCIATION; COUNTRIES; COUNTDOWN	Background: Children unreached by vaccination are at higher risk of poor health outcomes and India accounts for nearly a quarter of unvaccinated children worldwide. The objective of this study was to investigate compositional and contextual determinants of non-receipt of childhood vaccines in India using multilevel modelling. Methods and Findings: We studied characteristics of unvaccinated children using the District Level Health and Facility Survey 3, a nationally representative probability sample containing 65 617 children aged 12-23 months from 34 Indian states and territories. We developed four-level Bayesian binomial regression models to examine the determinants of non-vaccination. The analysis considered two outcomes: completely unvaccinated (CUV) children who had not received any of the eight vaccine doses recommended by India's Universal Immunization Programme, and children who had not received any dose from routine immunisation services (no RI). The no RI category includes CUV children and those who received only polio doses administered via mass campaigns. Overall, 4.83% (95% CI: 4.62-5.06) of children were CUV while 12.01% (11.68-12.35) had received no RI. Individual compositional factors strongly associated with CUV were: non-receipt of tetanus immunisation for mothers during pregnancy (OR = 3.65 [95% Crl: 3.30-4.02]), poorest household wealth index (OR = 2.44 [1.81-3.22] no maternal schooling (OR = 2.43 [1.41-4.05]) and no paternal schooling (OR = 1.83 [1.30-2.48]). In rural settings, the influence of maternal illiteracy disappeared whereas the role of household wealth index was reinforced. Factors associated with no RI were similar to those for CUV, but effect sizes for individual compositional factors were generally larger. Low maternal education was the strongest risk factor associated with no RI in all models. All multilevel models found significant variability at community, district, and state levels net of compositional factors. Conclusion: Non-vaccination in India is strongly related to compositional characteristics and is geographically distinct. Tailored strategies are required to overcome current barriers to immunisation.	[Sissoko, Daouda; Trottier, Helen] Univ Montreal, Fac Publ Hlth, Dept Social & Prevent Med, Montreal, PQ, Canada; [Sissoko, Daouda; Trottier, Helen] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Sissoko, Daouda; Johri, Mira] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Int Hlth Unit USI, Montreal, PQ, Canada; [Malvy, Denis] Ctr Hosp Univ Bordeaux, Dept Malad Infect & Trop, Bordeaux, France; [Malvy, Denis] Univ Bordeaux, INSERM 897, Bordeaux, France; [Malvy, Denis] Univ Bordeaux, Ctr Rene Labusquiere, Bordeaux, France; [Johri, Mira] Univ Montreal, Sch Publ Hlth, Dept Hlth Adm, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Universite de Montreal	Sissoko, D (corresponding author), Univ Montreal, Fac Publ Hlth, Dept Social & Prevent Med, Montreal, PQ, Canada.	daouda.sissoko@umontreal.ca	Johri, Mira/D-5104-2013; MALVY, Denis/T-7930-2019; Sissoko, Daouda/L-9193-2013	Johri, Mira/0000-0001-5642-787X; Sissoko, Daouda/0000-0002-8890-7170	French Rotary District 1690 (Bursary Henri Sabourin); Strategic Training Program in Global Health Research; Canadian Institutes of Health Research; Quebec Population Health Research Network; Fonds de la recherche en sante du Quebec	French Rotary District 1690 (Bursary Henri Sabourin); Strategic Training Program in Global Health Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Quebec Population Health Research Network; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	DS holds a Canadian Institutes of Health Research Fellowship Award for Health Professionals. DS was also funded by French Rotary District 1690 (Bursary Henri Sabourin) and the Strategic Training Program in Global Health Research, a partnership of the Canadian Institutes of Health Research and the Quebec Population Health Research Network. HT holds a salary award (chercheur boursier) from the Fonds de la recherche en sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya BA, 2011, MATERN CHILD HLTH J, V15, P1389, DOI 10.1007/s10995-010-0670-z; Agarwal S, 2005, INDIAN PEDIATR, V42, P653; Anand A, 2012, J INFECT DIS, V205, pS28, DOI 10.1093/infdis/jir794; Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P190; [Anonymous], 2013, GLOBAL IMMUNIZATION; Antai D, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.238; Aylward B, 2011, VACCINE, V29, pD80, DOI 10.1016/j.vaccine.2011.10.005; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; Boerma JT, 1993, QUALITY DATA CHILD I, P81; Brearley L, 2013, VACCINE, V31, pB103, DOI 10.1016/j.vaccine.2012.11.088; Browne W., 2009, MCMC ESTIMATION MLWI; Browne WJ, 2006, BAYESIAN ANAL, V1, P473, DOI 10.1214/06-BA117; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Cassell JA, 2006, HEALTH POLICY PLANN, V21, P373, DOI 10.1093/heapol/czl020; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P858; Choi JY, 2006, SOC SCI MED, V63, P107, DOI 10.1016/j.socscimed.2005.11.063; Corsi D., 2009, BMC INT HLTH HUMA S1, V9, P1, DOI DOI 10.1186/1472-698X-9-S1-S3; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Duclos P, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S2; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Gage AJ, 1997, DEMOGRAPHY, V34, P295, DOI 10.2307/2061706; GAREABALLAH ET, 1989, B WORLD HEALTH ORGAN, V67, P669; Gaudin S, 2006, SOC SCI MED, V62, P694, DOI 10.1016/j.socscimed.2005.06.042; George K, 1990, Indian J Pediatr, V57, P588, DOI 10.1007/BF02726779; Ghei K, 2010, ARCH PEDIAT ADOL MED, V164, P243, DOI 10.1001/archpediatrics.2009.277; Grassly NC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0140; Griffiths P, 2004, HEALTH PLACE, V10, P183, DOI 10.1016/j.healthplace.2003.07.001; Guo G, 2000, ANNU REV SOCIOL, V26, P441, DOI 10.1146/annurev.soc.26.1.441; International Institute for Population Sciences, 2010, DISTR LEV HOUS FAC S; KEJA K, 1988, World Health Statistics Quarterly, V41, P59; Kiros GE, 2004, SOC SCI MED, V59, P2603, DOI 10.1016/j.socscimed.2004.04.009; Kogan MD, 1998, PEDIATRICS, V102, P25, DOI 10.1542/peds.102.1.25; Langsten R, 1998, SOC SCI MED, V46, P1205, DOI 10.1016/S0277-9536(97)10049-1; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lauridsen J, 2011, HEALTH ECON REV, V1, DOI 10.1186/2191-1991-1-11; Leckie G., 2011, RUNMLWIN STATA MODUL; Mathew JL, 2012, INDIAN PEDIATR, V49, P203, DOI 10.1007/s13312-012-0063-z; Matthews Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000327; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Parashar S, 2005, SOC SCI MED, V61, P989, DOI 10.1016/j.socscimed.2004.12.023; Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Rodriguez G, 2001, J ROY STAT SOC A STA, V164, P339, DOI 10.1111/1467-985X.00206; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steele F, 1996, J ROY STAT SOC A STA, V159, P289, DOI 10.2307/2983175; Sullivan MC, 2010, J COMMUN HEALTH, V35, P53, DOI 10.1007/s10900-009-9192-2; Taneja GS KS, 2013, INDIAN J COMMUNITY H, V25, P5; Theall KP, 2011, J EPIDEMIOL COMMUN H, V65, P688, DOI 10.1136/jech.2009.097956; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Uddin MJ, 2010, VACCINE, V28, P1221, DOI 10.1016/j.vaccine.2009.11.028; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Vikram K, 2012, SOC SCI MED, V75, P331, DOI 10.1016/j.socscimed.2012.02.043; Wiysonge CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037905	59	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106528	10.1371/journal.pone.0106528	http://dx.doi.org/10.1371/journal.pone.0106528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1UA	25211356	gold, Green Submitted, Green Published			2022-12-27	WOS:000341855900016
J	Swift, JM; Swift, SN; Allen, MR; Bloomfield, SA				Swift, Joshua M.; Swift, Sibyl N.; Allen, Matthew R.; Bloomfield, Susan A.			Beta-1 Adrenergic Agonist Treatment Mitigates Negative Changes in Cancellous Bone Microarchitecture and Inhibits Osteocyte Apoptosis during Disuse	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; UNLOADING INDUCES RESISTANCE; OSTEOBLAST-LIKE CELLS; QUALITY-OF-LIFE; GROWTH-FACTOR-I; FEMALE RATS; ADULT RATS; RECEPTORS; EXPRESSION; FRACTURES	The sympathetic nervous system (SNS) plays an important role in mediating bone remodeling. However, the exact role that beta-1 adrenergic receptors (beta1AR) have in this process has not been elucidated. We have previously demonstrated the ability of dobutamine (DOB), primarily a beta1AR agonist, to inhibit reductions in cancellous bone formation and mitigate disuse-induced loss of bone mass. The purpose of this study was to characterize the independent and combined effects of DOB and hindlimb unloading (HU) on cancellous bone microarchitecture, tissue-level bone cell activity, and osteocyte apoptosis. Male Sprague-Dawley rats, aged 6-mos, were assigned to either normal cage activity (CC) or HU (n = 18/group) for 28 days. Animals were administered either daily DOB (4 mg/kg BW/d) or an equal volume of saline (VEH) (n = 9/gp). Unloading resulted in significantly lower distal femur cancellous BV/TV (-33%), Tb.Th (-11%), and Tb.N (-25%) compared to ambulatory controls (CC-VEH). DOB treatment during HU attenuated these changes in cancellous bone microarchitecture, resulting in greater BV/TV (+29%), Tb.Th (+7%), and Tb.N (+21%) vs. HU-VEH. Distal femur cancellous vBMD (+11%) and total BMC (+8%) were significantly greater in DOB-vs. VEH-treated unloaded rats. Administration of DOB during HU resulted in significantly greater osteoid surface (+158%) and osteoblast surface (+110%) vs. HU-VEH group. Furthermore, Oc.S/BS was significantly greater in HU-DOB (+55%) vs. CC-DOB group. DOB treatment during unloading fully restored bone formation, resulting in significantly greater bone formation rate (+200%) than in HU-VEH rats. HU resulted in an increased percentage of apoptotic cancellous osteocytes (+85%), reduced osteocyte number (-16%), lower percentage of occupied osteocytic lacunae (-30%) as compared to CC-VEH, these parameters were all normalized with DOB treatment. Altogether, these data indicate that beta1AR agonist treatment during disuse mitigates negative changes in cancellous bone microarchitecture and inhibits increases in osteocyte apoptosis.	[Swift, Joshua M.; Bloomfield, Susan A.] Texas A&M Univ, Dept Hlth, College Stn, TX USA; [Swift, Joshua M.; Bloomfield, Susan A.] Texas A&M Univ, Dept Kinesiol, College Stn, TX USA; [Swift, Sibyl N.; Bloomfield, Susan A.] Texas A&M Univ, Intercollegiate Fac Nutr, College Stn, TX USA; [Allen, Matthew R.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Indiana University System; Indiana University Bloomington	Swift, JM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Radiat Biol, Dept Mil & Emergency Med, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA.	joshua.swift@usuhs.edu			NASA [NCC 9-58]; National Space Biomedical Research Institute; Sydney and JL Huffines Institute for Sports Medicine and Human Performance; Texas Chapter of the American College of Sports Medicine; National Space Biomedical Research Institute Graduate Fellowship [NSBRI-RFP-05-02]	NASA(National Aeronautics & Space Administration (NASA)); National Space Biomedical Research Institute; Sydney and JL Huffines Institute for Sports Medicine and Human Performance; Texas Chapter of the American College of Sports Medicine; National Space Biomedical Research Institute Graduate Fellowship	These studies were funded through the NASA Cooperative Agreement NCC 9-58 with the National Space Biomedical Research Institute (SAB), the Sydney and JL Huffines Institute for Sports Medicine and Human Performance (JMS), and the Texas Chapter of the American College of Sports Medicine ( JMS). JMS was supported by a National Space Biomedical Research Institute Graduate Fellowship NSBRI-RFP-05-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi JD, 2001, OSTEOPOROSIS INT, V12, P903, DOI 10.1007/s001980170017; Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Allen MR, 2003, J APPL PHYSIOL, V94, P642, DOI 10.1152/japplphysiol.00656.2002; [Anonymous], 2002, AM BON HLTH STAT OST; Baek K, 2008, J APPL PHYSIOL, V104, P1086, DOI 10.1152/japplphysiol.01209.2007; Basso N, 2006, BONE, V39, P807, DOI 10.1016/j.bone.2006.04.014; Bloomfield SA, 1997, J APPL PHYSIOL, V83, P172, DOI 10.1152/jappl.1997.83.1.172; Bloomfield SA, 2002, BONE, V31, P149, DOI 10.1016/S8756-3282(02)00785-8; Bonnet N, 2007, J APPL PHYSIOL, V102, P1502, DOI 10.1152/japplphysiol.00815.2006; Bonnet N, 2007, J APPL PHYSIOL, V103, P524, DOI 10.1152/japplphysiol.01319.2006; Bonnet N, 2005, BONE, V37, P622, DOI 10.1016/j.bone.2005.07.012; Bonnet N, 2005, MED SCI SPORT EXER, V37, P1493, DOI 10.1249/01.mss.0000177592.82507.95; Bouxsein ML, 2009, ENDOCRINOLOGY, V150, P144, DOI 10.1210/en.2008-0843; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Chen X, 2007, J BONE MINER RES, V22, P656, DOI 10.1359/JBMR.070122; Cooper C., 1997, AM J MED S2A, V103, P12, DOI DOI 10.1016/S0002-9343(97)90022-X; Dufour C, 2007, EXP CELL RES, V313, P394, DOI 10.1016/j.yexcr.2006.10.021; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; Kellenberger S, 1998, BONE, V22, P471, DOI 10.1016/S8756-3282(98)00026-X; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Kondo H, 2013, AM J PHYSIOL-ENDOC M, V304, pE507, DOI 10.1152/ajpendo.00191.2012; MOORE RE, 1993, BONE MINER, V23, P301, DOI 10.1016/S0169-6009(08)80105-5; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pierroz DD, 2012, J BONE MINER RES, V27, P1252, DOI 10.1002/jbmr.1594; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Sakata T, 2003, BONE, V32, P669, DOI 10.1016/S8756-3282(03)00088-7; Swift JM, 2013, MED SCI SPORT EXER, V45, P1665, DOI 10.1249/MSS.0b013e31828d39bc; Swift JM, 2011, J BONE MINER RES, V26, P2140, DOI 10.1002/jbmr.407; Swift JM, 2010, J BONE MINER RES, V25, P564, DOI 10.1359/jbmr.090811; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Togari A, 1997, NEUROSCI LETT, V233, P125, DOI 10.1016/S0304-3940(97)00649-6; Turner RT, 2006, J APPL PHYSIOL, V101, P881, DOI 10.1152/japplphysiol.01622.2005	35	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106904	10.1371/journal.pone.0106904	http://dx.doi.org/10.1371/journal.pone.0106904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211027	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900029
J	Pellissier, S; Dantzer, C; Mondillon, L; Trocme, C; Gauchez, AS; Ducros, V; Mathieu, N; Toussaint, B; Fournier, A; Canini, F; Bonaz, B				Pellissier, Sonia; Dantzer, Cecile; Mondillon, Laurie; Trocme, Candice; Gauchez, Anne-Sophie; Ducros, Veronique; Mathieu, Nicolas; Toussaint, Bertrand; Fournier, Alicia; Canini, Frederic; Bonaz, Bruno			Relationship between Vagal Tone, Cortisol, TNF-Alpha, Epinephrine and Negative Affects in Crohn's Disease and Irritable Bowel Syndrome	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; NERVOUS-SYSTEM FUNCTION; SALIVARY CORTISOL; STRESS; ANXIETY; ALLOSTASIS; WOMEN; GUT; CATECHOLAMINE	Crohn's disease (CD) and irritable bowel syndrome (IBS) involve brain-gut dysfunctions where vagus nerve is an important component. The aim of this work was to study the association between vagal tone and markers of stress and inflammation in patients with CD or IBS compared to healthy subjects (controls). The study was performed in 73 subjects (26 controls, 21 CD in remission and 26 IBS patients). The day prior to the experiment, salivary cortisol was measured at 8:00 AM and 10:00 PM. The day of the experiment, subjects completed questionnaires for anxiety (STAI) and depressive symptoms (CES-D). After 30 min of rest, ECG was recorded for heart rate variability (HRV) analysis. Plasma cortisol, epinephrine, norepinephrine, TNF-alpha and IL-6 were measured in blood samples taken at the end of ECG recording. Compared with controls, CD and IBS patients had higher scores of state-anxiety and depressive symptomatology. A subgroup classification based on HRV-normalized high frequency band (HFnu) as a marker of vagal tone, showed that control subjects with high vagal tone had significantly lower evening salivary cortisol levels than subjects with low vagal tone. Such an effect was not observed in CD and IBS patients. Moreover, an inverse association (r = -0.48; p<0.05) was observed between the vagal tone and TNF-alpha level in CD patients exclusively. In contrast, in IBS patients, vagal tone was inversely correlated with plasma epinephrine (r = -0.39; p<0.05). No relationship was observed between vagal tone and IL-6, norepinephrine or negative affects (anxiety and depressive symptomatology) in any group. In conclusion, these data argue for an imbalance between the hypothalamus-pituitary-adrenal axis and the vagal tone in CD and IBS patients. Furthermore, they highlight the specific homeostatic link between vagal tone and TNF-alpha in CD and epinephrine in IBS and argue for the relevance of vagus nerve reinforcement interventions in those diseases.	[Pellissier, Sonia; Bonaz, Bruno] Univ Grenoble 1, Grenoble Inst Neurosci, INSERM, Ctr Rech Equipe Stress & Interact Neurodigest EA3, Grenoble, France; [Pellissier, Sonia] Univ Savoie, Dept Psychol, Chambery, France; [Dantzer, Cecile] Univ Savoie, Lab Interuniv Psychol Personnalite Personnalite C, Chambery, France; [Mondillon, Laurie; Fournier, Alicia] Univ Blaise Pascal, CNRS, LAPSCO, Lab Psychol Sociale & Cognit,UMR6024, Clermont Ferrand, France; [Trocme, Candice; Gauchez, Anne-Sophie; Ducros, Veronique; Toussaint, Bertrand] CHU Grenoble, Inst Biol, F-38043 Grenoble, France; [Mathieu, Nicolas; Bonaz, Bruno] CHU Grenoble, Clin Univ Hepatogastroenterol, F-38043 Grenoble, France; [Toussaint, Bertrand] Univ Grenoble 1, Lab TIMC TheREx UMR 5525, Grenoble, France; [Canini, Frederic] Inst Rech Biomed Armees, Unite Neurophysiol Stress, Bretigny Sur Orge, France; [Canini, Frederic] Ecole Val de Grace, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Clermont Auvergne (UCA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Pellissier, S (corresponding author), Univ Grenoble 1, Grenoble Inst Neurosci, INSERM, Ctr Rech Equipe Stress & Interact Neurodigest EA3, Grenoble, France.	sonia.pellissier@univ-savoie.fr	toussaint, bertrand b/M-7127-2014; GAUCHEZ, Anne-Sophie/M-5534-2014	GAUCHEZ, Anne-Sophie/0000-0003-2332-0966; Dantzer, Cecile/0000-0001-9109-5444; Fournier, Alicia/0000-0003-3637-5982; Pellissier, Sonia/0000-0002-0033-2561	Association Francois Aupetit (AFA); Societe Nationale Francaise de Gastroenterologie (SNFGE); Direction Hospitaliere de Recherche Clinique (DHRC) of the Grenoble hospital	Association Francois Aupetit (AFA); Societe Nationale Francaise de Gastroenterologie (SNFGE); Direction Hospitaliere de Recherche Clinique (DHRC) of the Grenoble hospital	This work was supported by the Association Francois Aupetit (AFA), the Societe Nationale Francaise de Gastroenterologie (SNFGE) and the Direction Hospitaliere de Recherche Clinique (DHRC) of the Grenoble hospital. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Bitton A, 2008, GUT, V57, P1386, DOI 10.1136/gut.2007.134817; Boisse L, 2009, CLIN EXP PHARMACOL P, V36, P1026, DOI 10.1111/j.1440-1681.2009.05242.x; Bonaz B, 2013, Minerva Gastroenterol Dietol, V59, P241; Bonaz B, 2013, NEUROGASTROENT MOTIL, V25, P208, DOI 10.1111/nmo.12076; Bonaz B, 2012, AMYGDALA DISCRETE MU; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Bosani M, 2009, BIOL-TARGETS THER, V3, P77; Brown GL, 2008, PSYCHIAT RES, V159, P67, DOI 10.1016/j.psychres.2007.06.012; Bruchon-Schweitzer ML, 1993, MANUEL INVENTAIRE AN; Burr RL, 2009, NEUROGASTROENT MOTIL, V21, P1148, DOI 10.1111/j.1365-2982.2009.01351.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Drossman Douglas A, 2006, J Gastrointestin Liver Dis, V15, P237; Elsenbruch S, 2010, GUT, V59, P489, DOI 10.1136/gut.2008.175000; FitzGerald LZ, 2009, WESTERN J NURS RES, V31, P818, DOI 10.1177/0193945909339320; Fuhrer R, 1989, DESCRIPTION TRADUCTI, V4, P163; Galvis G, 2006, J MOL NEUROSCI, V30, P107, DOI 10.1385/JMN:30:1:107; Garakani Amir, 2003, Am J Ther, V10, P61, DOI 10.1097/00045391-200301000-00014; Garg M, 2015, J RENIN-ANGIO-ALDO S, V16, P559, DOI 10.1177/1470320314521086; Goehler LE, 2007, BRAIN BEHAV IMMUN, V21, P721, DOI 10.1016/j.bbi.2007.02.005; Grover M, 2009, CLIN GASTROENTEROL H, V7, P48, DOI 10.1016/j.cgh.2008.08.032; HARVEY RF, 1980, LANCET, V1, P514; Holzer P, 2001, WIEN KLIN WOCHENSCHR, V113, P647; Hue O, 2000, MED SCI SPORT EXER, V32, P1582; Huston JM, 2011, J INTERN MED, V269, P45, DOI 10.1111/j.1365-2796.2010.02321.x; Jarrett ME, 2008, DIGEST DIS SCI, V53, P694, DOI 10.1007/s10620-007-9943-9; Joo HM, 2010, J KOREAN NEUROSURG S, V47, P345, DOI 10.3340/jkns.2010.47.5.345; Kmiez Zbigniew, 1998, Archivum Immunologiae et Therapiae Experimentalis, V46, P143; Kong LT, 2013, J PSYCHIATR NEUROSCI, V38, P417, DOI 10.1503/jpn.120117; Kovacs Z, 2007, INT J PSYCHIAT MED, V37, P245, DOI 10.2190/PM.37.3.a; Lichtenstein GR, 2013, THER ADV GASTROENTER, V6, P269, DOI 10.1177/1756283X13479826; Lombardi F, 1996, CARDIOVASC RES, V32, P208, DOI 10.1016/0008-6363(96)00116-2; Long MD, 2010, AM J GASTROENTEROL, V105, P1796, DOI 10.1038/ajg.2010.162; McEwen BS, 2010, HORM BEHAV, V57, P105, DOI 10.1016/j.yhbeh.2009.09.011; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; Nemoto W, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-38; Nikolic VN, 2013, J CARDIOL, V62, P37, DOI 10.1016/j.jjcc.2013.02.013; Nunnally J. C, 1978, MCGRAW HILL SERIES P, V2nd; Papaioannou V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00174; Patil SA, 2013, DIGEST DIS SCI, V58, P209, DOI 10.1007/s10620-012-2323-0; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Pellissier S, 2007, GASTROENTEROLOGY, V132, pA72; Pellissier S, 2010, PSYCHONEUROENDOCRINO, V35, P653, DOI 10.1016/j.psyneuen.2009.10.004; Peters A, 2012, PHYSIOL BEHAV, V106, P1, DOI 10.1016/j.physbeh.2011.12.019; Ponikowski P, 1996, AM J CARDIOL, V77, P1320, DOI 10.1016/S0002-9149(96)00199-3; PORGES SW, 1992, PEDIATRICS, V90, P498; Prater KE, 2013, DEPRESS ANXIETY, V30, P234, DOI 10.1002/da.22014; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; SAUL JP, 1988, AM J CARDIOL, V61, P1292, DOI 10.1016/0002-9149(88)91172-1; SHINKAI S, 1993, INT ARCH OCC ENV HEA, V64, P499, DOI 10.1007/BF00381098; Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; Thayer JF, 2006, INT J PSYCHOPHYSIOL, V59, P244, DOI 10.1016/j.ijpsycho.2005.10.013; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thompson WG, 1999, GUT, V45, P43; Tran BW, 2010, ACTA DERM-VENEREOL, V90, P354, DOI 10.2340/00015555-0890; Vedhara K, 2003, BIOL PSYCHOL, V62, P89, DOI 10.1016/S0301-0511(02)00128-X; Weber CS, 2010, EUR J APPL PHYSIOL, V109, P201, DOI 10.1007/s00421-009-1341-x; Xie JL, 2008, WORLD J GASTROENTERO, V14, P378, DOI 10.3748/wjg.14.378; Yeragani VK, 1998, PSYCHIAT RES, V78, P89, DOI 10.1016/S0165-1781(97)00136-4	71	108	110	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e105328	10.1371/journal.pone.0105328	http://dx.doi.org/10.1371/journal.pone.0105328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207649	gold, Green Published, Green Submitted			2022-12-27	WOS:000342030300007
J	Tarokh, L; Carskadon, MA; Achermann, P				Tarokh, Leila; Carskadon, Mary A.; Achermann, Peter			Early Adolescent Cognitive Gains Are Marked by Increased Sleep EEG Coherence	PLOS ONE			English	Article							SLOW-WAVE ACTIVITY; INTELLECTUAL ABILITY; CONNECTIVITY; CHILDREN	Although the increases in cognitive capacities of adolescent humans are concurrent with significant cortical restructuring, functional associations between these phenomena are unclear. We examined the association between cortical development, as measured by the sleep EEG, and cognitive performance in a sample of 9/10 year olds followed up 1 to 3 years later. Our cognitive measures included a response inhibition task (Stroop), an executive control task (Trail Making), and a verbal fluency task (FAS). We correlated sleep EEG measures of power and intra-hemispheric coherence at the initial assessment with performance at that assessment. In addition we correlated the rate of change across assessments in sleep EEG measures with the rate of change in performance. We found no correlation between sleep EEG power and performance on cognitive tasks for the initial assessment. In contrast, we found a significant correlation of the rate of change in intra-hemispheric coherence for the sigma band (11 to 16 Hz) with rate of change in performance on the Stroop (r = 0.61; p<0.02) and Trail Making (r = 20.51; p<0.02) but no association for the FAS. Thus, plastic changes in connectivity (i.e., sleep EEG coherence) were associated with improvement in complex cognitive function.	[Tarokh, Leila] Univ Bern, Univ Hosp Child & Adolescent Psychiat & Psychothe, Bern, Switzerland; [Tarokh, Leila; Achermann, Peter] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Tarokh, Leila; Carskadon, Mary A.] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA; [Carskadon, Mary A.] Univ S Australia, Sch Psychol Social Work & Social Policy, Ctr Sleep Res, Adelaide, SA 5001, Australia; [Achermann, Peter] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Achermann, Peter] Univ Zurich, Ctr Neurosci, Zurich, Switzerland; [Achermann, Peter] ETH, Zurich, Switzerland; [Achermann, Peter] Univ Zurich, Zurich Ctr Interdisciplinary Sleep Res, Zurich, Switzerland	University of Bern; University Hospital of Bern; University of Zurich; Brown University; University of South Australia; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Tarokh, L (corresponding author), Univ Bern, Univ Hosp Child & Adolescent Psychiat & Psychothe, Bern, Switzerland.	Leila_Tarokh@brown.edu	Achermann, Peter/N-1215-2014	Achermann, Peter/0000-0002-0208-3511; Tarokh, Leila/0000-0003-4014-428X	Swiss National Science Foundation [320030-130766];  [AA13252]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013252] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Grant AA13252 (to M.A.C.) and the Swiss National Science Foundation Grant (320030-130766 to P.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arffa S, 2007, ARCH CLIN NEUROPSYCH, V22, P969, DOI 10.1016/j.acn.2007.08.001; Buchmann A, 2011, CEREB CORTEX, V21, P607, DOI 10.1093/cercor/bhq129; Curtin F, 1998, BIOL PSYCHIAT, V44, P775, DOI 10.1016/S0006-3223(98)00043-2; DIJK DJ, 1993, BRAIN RES, V626, P190, DOI 10.1016/0006-8993(93)90579-C; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Geiger A, 2011, SLEEP, V34, P181, DOI 10.1093/sleep/34.2.181; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Jenni OG, 2004, AM J PHYSIOL-REG I, V286, pR528, DOI 10.1152/ajpregu.00503.2003; Kurth S, 2013, BRAIN SCI, V3, P1445, DOI 10.3390/brainsci3041445; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Reitan RM, 1985, HALSTEAD REITAN NEUR; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shaw P, 2009, ARCH GEN PSYCHIAT, V66, P888, DOI 10.1001/archgenpsychiatry.2009.103; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spreen O, 1998, COMPENDIUM NEUROPSYC; STERIADE M, 1985, J NEUROPHYSIOL, V54, P1473, DOI 10.1152/jn.1985.54.6.1473; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tamnes CK, 2013, J COGNITIVE NEUROSCI, V25, P1611, DOI 10.1162/jocn_a_00434; Tarokh L, 2010, NEUROSCIENCE, V171, P622, DOI 10.1016/j.neuroscience.2010.08.071; Tarokh L, 2010, SLEEP; Tarokh L, 2012, ALCOHOL CLIN EXP RES, V36, P1530, DOI 10.1111/j.1530-0277.2012.01756.x; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; UCHIDA S, 1991, BRAIN RES BULL, V27, P93, DOI 10.1016/0361-9230(91)90286-S; Warby SC, 2014, NAT METHODS, V11, P385, DOI [10.1038/nmeth.2855, 10.1038/NMETH.2855]	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106847	10.1371/journal.pone.0106847	http://dx.doi.org/10.1371/journal.pone.0106847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208326	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000342030300045
J	Huang, ZP; Zhang, P; Wang, HQ; Yan, LN; Wang, WT				Huang, Zhiping; Zhang, Peng; Wang, Haiqing; Yan, Lunan; Wang, Wentao			Comparing Outcomes of Two Vascular Inflow Occlusion Techniques and Treatment without Vascular Occlusion during Major Hepatectomy in Patients with Hepatitis B-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVER RESECTION; PRINGLE MANEUVER; BLOOD-LOSS; SURGICAL COMPLICATIONS; EXCLUSION; CLASSIFICATION; MECHANISMS; MORBIDITY	Background: Significant hemorrhage together with blood transfusion has negative impact on postoperative morbidity, mortality, and long-term survival of liver resection. Various techniques of vascular occlusion have been developed to reduce intraoperative blood loss. The objective of this study was to compare the outcomes of Pringle maneuver, hemi-hepatic vascular occlusion, and treatment without vascular occlusion used during liver resection. Method: Data of 574 patients with Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), who underwent major hepatectomy between January 2009 to March 2013 by Pringle maneuver (N = 158), hemi-hepatic vascular inflow occlusion (N = 216), or without any vascular occlusion (N = 200), were included in this retrospective study. Perioperative blood transfusion, intraoperative blood loss, and postoperative liver function, and surgical complications were analyzed and compared between the three groups. Result: There were no significant difference observed in postoperative bilirubin, liver enzyme, and albumin levels between three groups (P > 0.05). 5 patients (2.5%) in no occlusion group, 2 (1.3%) in Pringle group, and 8 (3.7%) in hemi-hepatic group had liver failure; but, there were no differences (P > 0.05). The overall postoperative complications rate between three groups did not reach significant differences (33.5% vs 34.2% vs 42.6%, respectively; P > 0.05). However, significant differences in intraoperative blood loss between no occlusion group (638.2 +/- 426.8 ml) and Pringle group (518.0 +/- 451.0 ml) or hemi-hepatic group (513.0 +/- 366.7 ml) (P < 0.01). Conclusion: Although there were no differences found between three groups regarding postoperative complications rate, no vascular occlusion group had more blood loss than the other two groups during liver resection.	[Huang, Zhiping] Chongqing Med Univ, Yongchuan Hosp, Dept Hepatopancreatobiliary Surg, Chongqing, Peoples R China; [Zhang, Peng; Wang, Haiqing; Yan, Lunan; Wang, Wentao] Sichuan Univ, Dept Liver Surg, Liver Transplantat Ctr, West China Hosp, Chengdu, Sichuan Provinc, Peoples R China	Chongqing Medical University; Sichuan University	Wang, WT (corresponding author), Sichuan Univ, Dept Liver Surg, Liver Transplantat Ctr, West China Hosp, Chengdu, Sichuan Provinc, Peoples R China.	wwthzhp@163.com			National Sciences and Technology Major Project of China [2012ZX10002-016, 2012ZX10002-017]	National Sciences and Technology Major Project of China	This study is supported by a grant from the National Sciences and Technology Major Project of China (2012ZX10002-016) and (2012ZX10002-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; Belghiti J, 1999, ANN SURG, V229, P369, DOI 10.1097/00000658-199903000-00010; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Carini R, 2003, GASTROENTEROLOGY, V125, P1480, DOI 10.1016/j.gastro.2003.05.005; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chau GY, 2005, WORLD J SURG, V29, P1374, DOI 10.1007/s00268-005-7766-4; Chikamoto A, 2012, HEPATO-GASTROENTEROL, V59, P1213, DOI 10.5754/hge09778; Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d; Clavien PA, 2000, ANN SURG, V232, P155, DOI 10.1097/00000658-200008000-00001; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Feng XB, 2009, MED HYPOTHESES, V72, P398, DOI 10.1016/j.mehy.2008.11.029; HEANEY JP, 1966, ANN SURG, V163, P237, DOI 10.1097/00000658-196602000-00013; HEPP J, 1956, PRESSE MED, V64, P947; HUGUET C, 1978, SURG GYNECOL OBSTET, V147, P689; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Katz SC, 2009, ANN SURG, V249, P617, DOI 10.1097/SLA.0b013e31819ed22f; Kusano T, 2009, EJSO-EUR J SURG ONC, V35, P1179, DOI 10.1016/j.ejso.2009.04.008; LAI ECS, 1995, ANN SURG, V221, P291, DOI 10.1097/00000658-199503000-00012; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; MAKUUCHI M, 1987, SURG GYNECOL OBSTET, V164, P155; Man K, 1997, ANN SURG, V226, P704, DOI 10.1097/00000658-199712000-00007; McGlynn KA, 2001, INT J CANCER, V94, P290, DOI 10.1002/ijc.1456; Ni JS, 2013, J GASTROINTEST SURG, V17, P1414, DOI 10.1007/s11605-013-2236-z; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pol B, 1999, EUR J SURG, V165, P446; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Si-Yuan FU, 2011, AM J SURG, V201, P62, DOI 10.1016/j.amjsurg.2009.09.029; Smyrniotis V, 2004, AM J SURG, V187, P398, DOI 10.1016/j.amjsurg.2003.12.001; Tanaka K, 2006, J GASTROINTEST SURG, V10, P980, DOI 10.1016/j.gassur.2006.01.012; TANIGUCHI H, 1992, BRIT J SURG, V79, P672, DOI 10.1002/bjs.1800790726; Une Y, 1998, ASIAN J SURG, V21, P219; van der Bilt JDW, 2005, HEPATOLOGY, V42, P165, DOI 10.1002/hep.20739; Weigand Kilian, 2012, HPB Surg, V2012, P176723, DOI 10.1155/2012/176723; Wen TF, 2007, HEPATOL RES, V37, P346, DOI 10.1111/j.1872-034X.2007.00061.x; YAMAOKA Y, 1992, ARCH SURG-CHICAGO, V127, P276; Yan L N, 1994, Zhonghua Wai Ke Za Zhi, V32, P35	42	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107303	10.1371/journal.pone.0107303	http://dx.doi.org/10.1371/journal.pone.0107303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203056	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500081
J	Kim, SH; Park, DE; Lee, HS; Kang, HR; Cho, SH				Kim, Sae-Hoon; Park, Da-Eun; Lee, Hyun-Seung; Kang, Hye-Ryun; Cho, Sang-Heon			Chronic Low Dose Chlorine Exposure Aggravates Allergic Inflammation and Airway Hyperresponsiveness and Activates Inflammasome Pathway	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; BRONCHIAL RESPONSIVENESS; ECOLOGICAL ASSOCIATION; RESPIRATORY SYMPTOMS; NITROGEN TRICHLORIDE; SWIMMING POOLS; ASTHMA; CELLS; IL-33; GAS	Background: Epidemiologic clinical studies suggested that chronic exposure to chlorine products is associated with development of asthma and aggravation of asthmatic symptoms. However, its underlying mechanism was not clearly understood. Studies were undertaken to define the effects and mechanisms of chronic low-dose chlorine exposure in the pathogenesis of airway inflammation and airway hyperresponsiveness (AHR). Methods: Six week-old female BALB/c mice were sensitized and challenged with OVA in the presence and absence of chronic low dose chlorine exposure of naturally vaporized gas of 5% sodium hypochlorite solution. Airway inflammation and AHR were evaluated by bronchoalveolar lavage (BAL) cell recovery and non-invasive phlethysmography, respectively. Real-time qPCR, Western blot assay, and ELISA were used to evaluate the mRNA and protein expressions of cytokines and other inflammatory mediators. Human A549 and murine epithelial (A549 and MLE12) and macrophage (AMJ2-C11) cells were used to define the responses to low dose chlorine exposure in vitro. Results: Chronic low dose chlorine exposure significantly augmented airway inflammation and AHR in OVA-sensitized and challenged mice. The expression of Th2 cytokines IL-4 and IL-5 and proinflammatory cytokine IL-1 beta and IL-33 were significantly increased in OVA/Cl group compared with OVA group. The chlorine exposure also activates the major molecules associated with inflammasome pathway in the macrophages with increased expression of epithelial alarmins IL-33 and TSLP in vitro. Conclusion: Chronic low dose exposure of chlorine aggravates allergic Th2 inflammation and AHR potentially through activation of inflammasome danger signaling pathways.	[Kim, Sae-Hoon; Kang, Hye-Ryun; Cho, Sang-Heon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Sae-Hoon; Park, Da-Eun; Lee, Hyun-Seung; Kang, Hye-Ryun; Cho, Sang-Heon] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul 151, South Korea; [Kim, Sae-Hoon] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, HR (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	helenmed@snu.ac.kr; shcho@snu.ac.kr			National Research Foundation of Korea (NRF) Grant - Korean Government (Ministry of Education) [E00055]; Seoul National University Bundang Hospital (SNUBH) Research Fund [11-2010-027]	National Research Foundation of Korea (NRF) Grant - Korean Government (Ministry of Education); Seoul National University Bundang Hospital (SNUBH) Research Fund	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (Ministry of Education) (no. Grant Number E00055), and grant no. 11-2010-027 from the Seoul National University Bundang Hospital (SNUBH) Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchinsky AL, 2006, J TRAUMA, V60, P944, DOI 10.1097/01.ta.0000205862.57701.48; Bernard A, 2008, EUR RESPIR J, V32, P979, DOI 10.1183/09031936.00114807; Bernard A, 2007, CURR MED CHEM, V14, P1771; Bernard A, 2006, ENVIRON HEALTH PERSP, V114, P1567, DOI 10.1289/ehp.8461; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; Carbonnelle S, 2002, BIOMARKERS, V7, P464, DOI 10.1080/13547500210166612; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; DAS R, 1993, TOXICOL IND HEALTH, V9, P439, DOI 10.1177/074823379300900304; Demnati R, 1998, TOXICOL SCI, V45, P242, DOI 10.1006/toxs.1998.2532; EUN HC, 1984, CONTACT DERMATITIS, V11, P45, DOI 10.1111/j.1600-0536.1984.tb00172.x; Evans RB, 2005, LUNG, V183, P151, DOI 10.1007/s00408-004-2530-3; Hams E, 2012, CURR OPIN PHARMACOL, V12, P503, DOI 10.1016/j.coph.2012.06.001; Helenius IJ, 1998, J ALLERGY CLIN IMMUN, V101, P646, DOI 10.1016/S0091-6749(98)70173-3; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; HOSTYNEK JJ, 1989, CONTACT DERMATITIS, V20, P32, DOI 10.1111/j.1600-0536.1989.tb03092.x; Hox V, 2011, TOXICOL LETT, V204, P101, DOI 10.1016/j.toxlet.2011.04.017; Jacobs JH, 2007, EUR RESPIR J, V29, P690, DOI 10.1183/09031936.00024706; Jeon SG, 2007, J ALLERGY CLIN IMMUN, V119, P831, DOI 10.1016/j.jaci.2006.12.653; Kettle AJ, 2014, BBA-GEN SUBJECTS, V1840, P781, DOI 10.1016/j.bbagen.2013.07.004; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Martin JG, 2003, AM J RESP CRIT CARE, V168, P568, DOI 10.1164/rccm.200201-021OC; Massin N, 1998, OCCUP ENVIRON MED, V55, P258, DOI 10.1136/oem.55.4.258; Medina-Ramon M, 2006, EUR RESPIR J, V27, P1196, DOI 10.1183/09031936.06.00085405; Medina-Ramon M, 2005, OCCUP ENVIRON MED, V62, P598, DOI 10.1136/oem.2004.017640; Meyer ML, 2012, AM J PHYSIOL-LUNG C, V303, pL181, DOI 10.1152/ajplung.00084.2012; Meyerholz DK, 2009, TOXICOL PATHOL, V37, P249, DOI 10.1177/0192623308329342; Miyake Y, 2004, ENVIRON RES, V94, P33, DOI 10.1016/S0013-9351(03)00068-9; Nagarkar DR, 2012, J ALLERGY CLIN IMMUN, V130, P225, DOI 10.1016/j.jaci.2012.04.019; Nickmilder M, 2007, OCCUP ENVIRON MED, V64, P37, DOI 10.1136/oem.2005.025452; Oboki K, 2011, ALLERGY ASTHMA IMMUN, V3, P81, DOI 10.4168/aair.2011.3.2.81; Quirce S, 2010, J INVEST ALLERG CLIN, V20, P542; Rochman Y, 2008, CURR OPIN PHARMACOL, V8, P249, DOI 10.1016/j.coph.2008.03.002; Sasseville D, 1999, CONTACT DERMATITIS, V41, P347, DOI 10.1111/j.1600-0536.1999.tb06190.x; SCHRAUFSTATTER IU, 1990, J CLIN INVEST, V85, P554, DOI 10.1172/JCI114472; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; TATSUMI T, 1994, AM J PHYSIOL-HEART C, V267, pH1597, DOI 10.1152/ajpheart.1994.267.4.H1597; Varraso R, 2002, TOXICOL IND HEALTH, V18, P269, DOI 10.1191/0748233702th150oa; Waern I, 2013, MUCOSAL IMMUNOL, V6, P911, DOI 10.1038/mi.2012.129; Wang YH, 2009, CLIN EXP ALLERGY, V39, P798, DOI 10.1111/j.1365-2222.2009.03241.x; Wangi JK, 2008, CELL MOL IMMUNOL, V5, P99, DOI 10.1038/cmi.2008.12; White Carl W, 2010, Proc Am Thorac Soc, V7, P257, DOI 10.1513/pats.201001-008SM; Willart Monique A. M., 2010, Allergology International, V59, P95, DOI 10.2332/allergolint.09-RAI-0162; Wu WH, 2010, J ALLERGY CLIN IMMUN, V126, P290, DOI 10.1016/j.jaci.2010.05.024	45	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106861	10.1371/journal.pone.0106861	http://dx.doi.org/10.1371/journal.pone.0106861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202911	gold, Green Published, Green Submitted			2022-12-27	WOS:000342684500048
J	Kriesell, HJ; Elwen, SH; Nastasi, A; Gridley, T				Kriesell, Hannah Joy; Elwen, Simon Harvey; Nastasi, Aurora; Gridley, Tess			Identification and Characteristics of Signature Whistles in Wild Bottlenose Dolphins (Tursiops truncatus) from Namibia	PLOS ONE			English	Article							STEREOTYPED CALLS; CAPTIVE DOLPHINS; FREQUENCY; BEHAVIOR; CATEGORIZATION; RECOGNITION; DISCRIMINATION; VOCALIZATIONS; COMMUNICATION; INFORMATION	A signature whistle type is a learned, individually distinctive whistle type in a dolphin's acoustic repertoire that broadcasts the identity of the whistle owner. The acquisition and use of signature whistles indicates complex cognitive functioning that requires wider investigation in wild dolphin populations. Here we identify signature whistle types from a population of approximately 100 wild common bottlenose dolphins (Tursiops truncatus) inhabiting Walvis Bay, and describe signature whistle occurrence, acoustic parameters and temporal production. A catalogue of 43 repeatedly emitted whistle types (REWTs) was generated by analysing 79 hrs of acoustic recordings. From this, 28 signature whistle types were identified using a method based on the temporal patterns in whistle sequences. A visual classification task conducted by 5 naive judges showed high levels of agreement in classification of whistles (Fleiss-Kappa statistic, kappa = 0.848, Z = 55.3, P<0.001) and supported our categorisation. Signature whistle structure remained stable over time and location, with most types (82%) recorded in 2 or more years, and 4 identified at Walvis Bay and a second field site approximately 450 km away. Whistle acoustic parameters were consistent with those of signature whistles documented in Sarasota Bay (Florida, USA). We provide evidence of possible two-voice signature whistle production by a common bottlenose dolphin. Although signature whistle types have potential use as a marker for studying individual habitat use, we only identified approximately 28% of those from the Walvis Bay population, despite considerable recording effort. We found that signature whistle type diversity was higher in larger dolphin groups and groups with calves present. This is the first study describing signature whistles in a wild free-ranging T. truncatus population inhabiting African waters and it provides a baseline on which more in depth behavioural studies can be based.	[Kriesell, Hannah Joy] Univ Gottingen, Dept Conservat Biol, D-37073 Gottingen, Germany; [Elwen, Simon Harvey; Gridley, Tess] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, Gauteng, South Africa; [Kriesell, Hannah Joy; Elwen, Simon Harvey; Nastasi, Aurora; Gridley, Tess] Namibian Dolphin Project, Walvis Bay, Namibia; [Nastasi, Aurora] Univ Roma La Sapienza, Dipartimento Sci Terra, I-00185 Rome, Italy	University of Gottingen; University of Pretoria; Sapienza University Rome	Gridley, T (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, Gauteng, South Africa.	tessgridley@yahoo.co.uk		Elwen, Simon/0000-0002-7467-6121; Gridley, Teresa/0000-0003-0925-5782	Nedbank Go Green Fund of Namibia; Rufford Small Grants Foundation; Idea Wild Fund; Natural Environment Research Council; University of Pretoria; Sapienza University of Rome; Claude Leon Foundation	Nedbank Go Green Fund of Namibia; Rufford Small Grants Foundation; Idea Wild Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Pretoria; Sapienza University of Rome; Claude Leon Foundation	This study was funded by Nedbank Go Green Fund of Namibia (www.nedbank.com.na/hdetail.aspx?itemguid = 833f4cd9-323f-497d-ad1f-9f641b9dfd73), Rufford Small Grants Foundation (www.rufford.org), Idea Wild Fund (www.ideawild.org), Natural Environment Research Council (www.nerc.ac.uk), University of Pretoria (www.up.ac.za), Sapienza University of Rome (www.uniroma1.it), and Claude Leon Foundation (www.leonfoundation.co.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; Badyaev AV, 1997, AUK, V114, P40, DOI 10.2307/4089063; BAHRICK HP, 1975, J EXP PSYCHOL GEN, V104, P54, DOI 10.1037/0096-3445.104.1.54; BEST PB, 2007, COMMON BOTTLENOSE DO, P338; Boughman JW, 2003, SPR HDB AUD, V16, P138; BRUCK JN, 2013, PROCEEDINGS OF THE R, P280; Buckstaff KC, 2004, MAR MAMMAL SCI, V20, P709, DOI 10.1111/j.1748-7692.2004.tb01189.x; CALDWELL MC, 1979, BEHAV MARINE ANIMALS, P369; CALDWELL MC, 1990, THE BOTTLENOSE DOLPH, P199; Cheney DL, 1996, ANIM BEHAV, V52, P507, DOI 10.1006/anbe.1996.0193; Chmelnitsky EG, 2012, J ACOUST SOC AM, V131, P4821, DOI 10.1121/1.4707501; Cook MLH, 2004, P ROY SOC B-BIOL SCI, V271, P1043, DOI 10.1098/rspb.2003.2610; *CORN BIOAC RES PR, 2011, RAVEN PRO INTERACTIV; Cortopassi KA, 2006, ANIM BEHAV, V71, P1141, DOI 10.1016/j.anbehav.2005.09.011; Cranford TW, 1996, J MORPHOL, V228, P223; Crawley M.J., 2007, R BOOK; Deecke VB, 2006, J ACOUST SOC AM, V119, P645, DOI 10.1121/1.2139067; Ding Wang, 1995, Aquatic Mammals, V21, P65; Esch HC, 2009, MAR MAMMAL SCI, V25, P976, DOI 10.1111/j.1748-7692.2009.00289.x; Esch HC, 2009, J MAMMAL, V90, P638, DOI 10.1644/08-MAMM-A-069R.1; FINDLAY KP, 1992, S AFR J MARINE SCI, V12, P237; Fripp D, 2005, ANIM COGN, V8, P17, DOI 10.1007/s10071-004-0225-z; Gotz T, 2006, BIOL LETTERS, V2, P5, DOI 10.1098/rsbl.2005.0407; Gridley T, 2011, THESIS; Gridley T, 2014, MAR MAMMAL SCI, V30, P512, DOI 10.1111/mms.12054; Gridley T, 2012, J ACOUST SOC AM, V132, P4032, DOI 10.1121/1.4763990; Harley HE, 2008, BEHAV PROCESS, V77, P243, DOI 10.1016/j.beproc.2007.11.002; Hawkins ER, 2010, J ACOUST SOC AM, V127, P2652, DOI 10.1121/1.3308465; Hernandez EN, 2010, J ACOUST SOC AM, V127, P3232, DOI 10.1121/1.3365254; Illmann G, 2002, BEHAVIOUR, V139, P487, DOI 10.1163/15685390260135970; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; Janik VM, 2013, J COMP PHYSIOL A, V199, P479, DOI 10.1007/s00359-013-0817-7; Janik VM, 2013, TRENDS COGN SCI, V17, P157, DOI 10.1016/j.tics.2013.02.005; Janik VM, 2013, MAR MAMMAL SCI, V29, P109, DOI 10.1111/j.1748-7692.2011.00549.x; Janik VM, 2009, ADV STUD BEHAV, V40, P123, DOI 10.1016/S0065-3454(09)40004-4; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; JANIK VM, 1994, BEHAV ECOL SOCIOBIOL, V35, P243, DOI 10.1007/s002650050094; Janik VM, 2000, SCIENCE, V289, P1355, DOI 10.1126/science.289.5483.1355; Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Jensen FH, 2011, P ROY SOC B-BIOL SCI, V278, P3017, DOI 10.1098/rspb.2010.2604; Jones AE, 2001, ANIM BEHAV, V62, P791, DOI 10.1006/anbe.2001.1810; Jones GJ, 2002, MAR MAMMAL SCI, V18, P374, DOI 10.1111/j.1748-7692.2002.tb01044.x; KING SL, 2013, PROCEEDINGS OF THE R, P280; King SL, 2013, P NATL ACAD SCI USA, V110, P13216, DOI 10.1073/pnas.1304459110; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lengagne T, 1999, P ROY SOC B-BIOL SCI, V266, P1623, DOI 10.1098/rspb.1999.0824; LILLY JC, 1961, SCIENCE, V133, P1689, DOI 10.1126/science.133.3465.1689; Lopez BD, 2011, MAMM BIOL, V76, P180, DOI 10.1016/j.mambio.2010.06.006; Madsen PT, 2012, BIOL LETTERS, V8, P211, DOI 10.1098/rsbl.2011.0701; Madsen PT, 2013, J EXP BIOL, V216, P4091, DOI 10.1242/jeb.091306; Mathevon N, 1997, IBIS, V139, P513, DOI 10.1111/j.1474-919X.1997.tb04667.x; May-Collado LJ, 2008, J MAMMAL, V89, P1229, DOI 10.1644/07-MAMM-A-310.1; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; Miksis JL, 2002, J ACOUST SOC AM, V112, P728, DOI 10.1121/1.1496079; Miller PJO, 2007, J ACOUST SOC AM, V121, P3932, DOI 10.1121/1.2722056; Miller PJO, 2002, BEHAV ECOL SOCIOBIOL, V52, P262, DOI 10.1007/s00265-002-0508-9; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Naguib M, 2003, J ACOUST SOC AM, V113, P1749, DOI 10.1121/1.1539050; NAKAHARA F, 2011, JOURNAL OF ETHOLOGY; Nousek AE, 2006, BIOL LETT-UK, V2, P481, DOI 10.1098/rsbl.2006.0517; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Quick NJ, 2008, J COMP PSYCHOL, V122, P305, DOI 10.1037/0735-7036.122.3.305; Quick NJ, 2012, P ROY SOC B-BIOL SCI, V279, P2539, DOI 10.1098/rspb.2011.2537; R Core Team, 2021, R LANGUAGE ENV STAT; Robertson T., 2012, NAMIBIAS COAST OCEAN; Sayigh LS, 2007, ANIM BEHAV, V74, P1631, DOI 10.1016/j.anbehav.2007.02.018; SAYIGH LS, 1995, BEHAV ECOL SOCIOBIOL, V36, P171, DOI 10.1007/s002650050137; SAYIGH LS, 1990, BEHAV ECOL SOCIOBIOL, V26, P247; Siegel S., 2009, NONPARAMETRIC STAT B, V2nd; Simard P, 2011, J ACOUST SOC AM, V130, P3068, DOI 10.1121/1.3641442; Smolker R, 1999, ETHOLOGY, V105, P595, DOI 10.1046/j.1439-0310.1999.00441.x; SMOLKER RA, 1993, BEHAV ECOL SOCIOBIOL, V33, P393; TERRY AMR, 2005, FRONTIERS IN ZOOLOGY, V2; TYACK P, 1986, BEHAV ECOL SOCIOBIOL, V18, P251, DOI 10.1007/BF00300001; van der Woude SE, 2009, J ACOUST SOC AM, V126, P1552, DOI 10.1121/1.3177272; Wanker R, 1998, BEHAV ECOL SOCIOBIOL, V43, P197, DOI 10.1007/s002650050481; Watwood SL, 2005, ANIM BEHAV, V69, P1373, DOI 10.1016/j.anbehav.2004.08.019; Watwood SL, 2004, BEHAV ECOL SOCIOBIOL, V55, P531, DOI 10.1007/s00265-003-0724-y; Wood S., 2006, GEN ADDITIVE MODELS, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Xitco MJ, 1996, ANIM LEARN BEHAV, V24, P355, DOI 10.3758/BF03199007	82	39	39	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106317	10.1371/journal.pone.0106317	http://dx.doi.org/10.1371/journal.pone.0106317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203814	gold, Green Published			2022-12-27	WOS:000342684500017
J	Henriques, BJ; Lucas, TG; Rodrigues, JV; Frederiksen, JH; Teixeira, MS; Tiranti, V; Bross, P; Gomes, CM				Henriques, Barbara J.; Lucas, Tania G.; Rodrigues, Joao V.; Frederiksen, Jane H.; Teixeira, Miguel S.; Tiranti, Valeria; Bross, Peter; Gomes, Claudio M.			Ethylmalonic Encephalopathy ETHE1 R163W/R163Q Mutations Alter Protein Stability and Redox Properties of the Iron Centre	PLOS ONE			English	Article							ACYL-COA DEHYDROGENASE; DEFICIENCY; FERREDOXIN; SULFIDE; VARIANT; GENE; IDENTIFICATION; DIOXYGENASE; ZINC; SITE	ETHE1 is an iron-containing protein from the metallo beta-lactamase family involved in the mitochondrial sulfide oxidation pathway. Mutations in ETHE1 causing loss of function result in sulfide toxicity and in the rare fatal disease Ethylmalonic Encephalopathy (EE). Frequently mutations resulting in depletion of ETHE1 in patient cells are due to severe structural and folding defects. However, some ETHE1 mutations yield nearly normal protein levels and in these cases disease mechanism was suspected to lie in compromised catalytic activity. To address this issue and to elicit how ETHE1 dysfunction results in EE, we have investigated two such pathological mutations, ETHE1-p.Arg163Gln and p.Arg163Trp. In addition, we report a number of benchmark properties of wild type human ETHE1, including for the first time the redox properties of the mononuclear iron centre. We show that loss of function in these variants results from a combination of decreased protein stability and activity. Although structural assessment revealed that the protein fold is not perturbed by mutations, both variants have decreased thermal stabilities and higher proteolytic susceptibilities. ETHE1 wild type and variants bind 1 +/- 0.2 mol iron/protein and no zinc; however, the variants exhibited only approximate to 10% of wild-type catalytically activity. Analysis of the redox properties of ETHE1 mononuclear iron centre revealed that the variants have lowered reduction potentials with respect to that of the wild type. This illustrates how point mutation-induced loss of function may arise via very discrete subtle conformational effects on the protein fold and active site chemistry, without extensive disruption of the protein structure or protein-cofactor association.	[Henriques, Barbara J.; Lucas, Tania G.; Rodrigues, Joao V.; Frederiksen, Jane H.; Teixeira, Miguel S.; Gomes, Claudio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal; [Frederiksen, Jane H.; Bross, Peter] Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus, Denmark; [Tiranti, Valeria] Fdn IRCCS Neurol Inst Carlo Besta, Unit Mol Neurogenet, Milan, Italy	Universidade Nova de Lisboa; Aarhus University; IRCCS Istituto Neurologico Besta	Bross, P (corresponding author), Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus, Denmark.	peter.bross@clin.au.dk; gomes@itqb.unl.pt	Lucas, Tânia/B-6144-2018; Rodrigues, João/B-4235-2008; Tiranti, Valeria/AFN-5783-2022; Rodrigues, João/GVU-7735-2022; Teixeira, Miguel/M-1509-2019; Bross, Peter/B-7219-2013; Henriques, Bárbara J/A-1814-2016; Teixeira, Miguel/A-9098-2011; Gomes, Cláudio M./A-8152-2008; Tiranti, Valeria/J-8233-2016; Rodrigues, Joao V/B-4877-2016	Lucas, Tânia/0000-0002-3967-6476; Rodrigues, João/0000-0002-5605-656X; Tiranti, Valeria/0000-0002-3584-7338; Teixeira, Miguel/0000-0003-4124-6237; Bross, Peter/0000-0001-9526-8525; Henriques, Bárbara J/0000-0002-1724-9545; Teixeira, Miguel/0000-0003-4124-6237; Gomes, Cláudio M./0000-0003-4662-6933; Tiranti, Valeria/0000-0002-3584-7338; Rodrigues, Joao V/0000-0002-5605-656X; Hubertz Frederiksen, Jane/0000-0001-7719-4673	Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal) [PTDC/EBB-BIO/117793/2010, PEstOE/EQB/LA0004/2011, SFRH/BPD/74475/2010, SFRH/BD/89690/2012, SFRH/BPD/34763/2007]; Helga og Peter Kornings Fond	Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal)(Portuguese Foundation for Science and Technology); Helga og Peter Kornings Fond	The work was supported by the Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal) through a research grant PTDC/EBB-BIO/117793/2010 (to C. M. G.), a strategic grant PEstOE/EQB/LA0004/2011 (to the ITQB Laboratorio Associado), fellowships SFRH/BPD/74475/2010 (to B.J.H.), SFRH/BD/89690/2012 (to T. G. L.) and SFRH/BPD/34763/2007 (to J.V.R.), and a travel grant by the Helga og Peter Kornings Fond (to P. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BS, 1997, HUM MOL GENET, V6, P695, DOI 10.1093/hmg/6.5.695; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Gomes CM, 2002, PROTEIN SCI, V11, P707, DOI 10.1110/ps.31202; Gregersen N, 1998, HUM MOL GENET, V7, P619, DOI 10.1093/hmg/7.4.619; Henriques BJ, 2010, BBA-MOL BASIS DIS, V1802, P1070, DOI 10.1016/j.bbadis.2010.07.015; Henriques BJ, 2009, J BIOL CHEM, V284, P4222, DOI 10.1074/jbc.M805719200; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kuchler B, 1999, BIOCHEM J, V337, P225, DOI 10.1042/0264-6021:3370225; Leal SS, 2007, PROTEINS, V68, P606, DOI 10.1002/prot.21448; Leal SS, 2004, J BIOL INORG CHEM, V9, P987, DOI 10.1007/s00775-004-0599-z; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; Mineri R, 2008, J MED GENET, V45, P473, DOI 10.1136/jmg.2008.058271; Moczygemba C, 2001, PROTEIN SCI, V10, P1539, DOI 10.1110/ps.49401; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; Sabel CE, 2010, ANAL BIOCHEM, V397, P218, DOI 10.1016/j.ab.2009.10.037; Tiranti V, 2006, J MED GENET, V43, P340, DOI 10.1136/jmg.2005.036210; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2013, COLD SPRING HARB PER, V5; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Wang R, 2014, TRENDS BIOCHEM SCI, V39, P227, DOI 10.1016/j.tibs.2014.03.003; Zafeiriou DI, 2007, NEUROPEDIATRICS, V38, P78, DOI 10.1055/s-2007-984447; Zhang Y, 2013, MOL CELL BIOL, V33, P1104, DOI 10.1128/MCB.01215-12	25	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107157	10.1371/journal.pone.0107157	http://dx.doi.org/10.1371/journal.pone.0107157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198162	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700088
J	De Chiara, L; Rodriguez-Pineiro, AM; Cordero, OJ; Vazquez-Tunas, L; Ayude, D; Rodriguez-Berrocal, FJ; de la Cadena, MP				De Chiara, Loretta; Rodriguez-Pineiro, Ana M.; Cordero, Oscar J.; Vazquez-Tunas, Lidia; Ayude, Daniel; Rodriguez-Berrocal, Francisco J.; Paez de la Cadena, Maria			Postoperative Serum Levels of sCD26 for Surveillance in Colorectal Cancer Patients	PLOS ONE			English	Article							FOLLOW-UP; CARCINOEMBRYONIC ANTIGEN; CURATIVE RESECTION; TUMOR-MARKERS; COLON-CANCER; PEPTIDASE-IV; CD26 LEVELS; UPDATE; RECOMMENDATIONS; CD26/DPPIV	One of the main aims of the follow-up after curative resection of colorectal cancer is the early detection and treatment of tumor recurrence. We previously demonstrated decreased preoperative soluble CD26 (sCD26) levels in serum from colorectal cancer patients. We extended now the study to investigate if sCD26 levels in postoperative serum serve as marker of recurrence of the disease during surveillance. Soluble sCD26 was measured in pre-and postoperative serum samples of 43 patients with primary colorectal cancer. Carcinoembryonic antigen, carbohydrate antigen 19.9 and 72.4 levels were also measured during surveillance. The average follow-up period was 41.8 +/- 20.8 months. sCD26 levels during follow-up showed well-defined patterns in patients without disease (n = 28), and in patients with tumor persistence (n = 2), local recurrence (n = 3) or distant metastasis (n = 10). Disease-free patients showed stable levels between 460-850 ng/mL during follow-up, while high (over 850 ng/mL) and unstable sCD26 levels were found before recurrence was diagnosed. The mean maximum/minimum sCD26 ratios during surveillance were 1.52, 2.12 and 2.63 for patients with no recurrence, local recurrence and metastasis, respectively (p = 0.005). From the cut-off obtained from a receiver operator characteristics (ROC) curve built with the maximum/minimum sCD26 ratios and the upper and lower cut-offs of sCD26, we were able to discriminate patients with and without recurrent disease. We propose that the measurement of serum sCD26 during the follow-up of patients diagnosed of colorectal cancer could be valuable for the early detection of local and distant recurrence. A large, randomized, prospective trial should be performed to confirm our findings.	[De Chiara, Loretta; Rodriguez-Pineiro, Ana M.; Ayude, Daniel; Rodriguez-Berrocal, Francisco J.; Paez de la Cadena, Maria] Univ Vigo, Dept Bioquim Genet & Inmunol, Vigo 36310, Pontevedra, Spain; [Cordero, Oscar J.] Univ Santiago de Compostela, Dept Bioquim & Biol Mol, Santiago De Compostela, A Coruna, Spain; [Vazquez-Tunas, Lidia] Complejo Hosp Univ Vigo, Serv Oncol, Vigo 36310, Pontevedra, Spain	Universidade de Vigo; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Vigo	De Chiara, L (corresponding author), Univ Vigo, Dept Bioquim Genet & Inmunol, Vigo 36310, Pontevedra, Spain.	ldechiara@uvigo.es	de la Cadena, Maria Paez/M-2364-2014; Rodriguez-Pineiro, Ana M./AAF-6353-2020; De Chiara, Loretta/D-6926-2018; Cordero, Oscar J/K-5415-2015	de la Cadena, Maria Paez/0000-0002-8317-8861; De Chiara, Loretta/0000-0001-7700-6417; Cordero, Oscar J/0000-0003-1026-124X	Agrupacion Estrategica INBIOMED (Investigacion en Biomedicina) from DXPCTSUG (Direccion Xeral de Promocion Cientifica e Tecnoloxica do Sistema Universitario de Galicia) [2012/273, CN 2011/024]; FEDER (Fondo Europeo de Desarrollo Regional); Fundacion Cientifica de la Asociacion Espanola contra el Cancer [GCB13131592CAST]	Agrupacion Estrategica INBIOMED (Investigacion en Biomedicina) from DXPCTSUG (Direccion Xeral de Promocion Cientifica e Tecnoloxica do Sistema Universitario de Galicia); FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); Fundacion Cientifica de la Asociacion Espanola contra el Cancer	This work was partially supported by Agrupacion Estrategica INBIOMED (Investigacion en Biomedicina) (2012/273 and CN 2011/024), from DXPCTSUG (Direccion Xeral de Promocion Cientifica e Tecnoloxica do Sistema Universitario de Galicia) and FEDER (Fondo Europeo de Desarrollo Regional) funding. LD is supported by "Fundacion Cientifica de la Asociacion Espanola contra el Cancer'' (GCB13131592CAST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Cavallo F, 2011, CANCER IMMUNOL IMMUN, V60, P319, DOI 10.1007/s00262-010-0968-0; Chen T, 2004, J BIOL REG HOMEOS AG, V18, P47; Chen WT, 2003, CANCER METAST REV, V22, P259, DOI 10.1023/A:1023055600919; Cordero OJ, 2000, BRIT J CANCER, V83, P1139, DOI 10.1054/bjoc.2000.1410; Cordero OJ, 2011, WORLD J CLIN ONCOL, V2, P245, DOI 10.5306/wjco.v2.i6.245; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Dang NH, 2002, HISTOL HISTOPATHOL, V17, P1213, DOI 10.14670/HH-17.1213; De Chiara L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-333; De Chiara L, 2009, DIS MARKERS, V27, P311, DOI [10.3233/DMA-2009-0679, 10.1155/2009/986295]; Duffy MJ, 2014, INT J CANCER, V134, P2513, DOI 10.1002/ijc.28384; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Goldstein MJ, 2005, CANCER INVEST, V23, P338, DOI 10.1081/CNV-200058878; Griesenberg D, 1999, ANTICANCER RES, V19, P2443; Hammond Kerry, 2007, Clin Colon Rectal Surg, V20, P249, DOI 10.1055/s-2007-984869; Jeffery M, 2007, COCHRANE DB SYST REV, V24; Kievit J, 2002, EUR J CANCER, V38, P986, DOI 10.1016/S0959-8049(02)00061-8; Lam CSC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098582; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Mayo Skye C, 2009, Expert Rev Gastroenterol Hepatol, V3, P131, DOI 10.1586/egh.09.8; MOERTEL CG, 1993, JAMA-J AM MED ASSOC, V270, P943, DOI 10.1001/jama.270.8.943; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062008; Renehan AG, 2002, BMJ-BRIT MED J, V324, P813, DOI 10.1136/bmj.324.7341.813; Rex DK, 2006, CA-CANCER J CLIN, V56, P160, DOI 10.3322/canjclin.56.3.160; Rodriguez-Moranta F, 2006, J CLIN ONCOL, V24, P386, DOI 10.1200/JCO.2005.02.0826; Rotolo N, 2007, SURG ONCOL, V16, pS141, DOI 10.1016/j.suronc.2007.10.007; Scheer Adena, 2009, Clin Colon Rectal Surg, V22, P242, DOI 10.1055/s-0029-1242464; Shimwell NJ, 2010, CANCER BIOMARK, V7, P123, DOI 10.3233/CBM-2010-0155; Tao S, 2012, BRIT J CANCER, V106, P1424, DOI 10.1038/bjc.2012.104; TENKATE J, 1986, INT J CANCER, V37, P479; Tsikitis VL, 2009, J CLIN ONCOL, V27, P3671, DOI 10.1200/JCO.2008.20.7050; Uematsu T, 2004, ANTICANCER RES, V24, P619	35	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107470	10.1371/journal.pone.0107470	http://dx.doi.org/10.1371/journal.pone.0107470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210927	Green Published, Green Submitted, gold			2022-12-27	WOS:000341855900076
J	Frenk, S; Oxley, D; Houseley, J				Frenk, Stephen; Oxley, David; Houseley, Jonathan			The Nuclear Exosome Is Active and Important during Budding Yeast Meiosis	PLOS ONE			English	Article							CAP-BINDING COMPLEX; CRYPTIC UNSTABLE TRANSCRIPTS; MESSENGER-RNA TURNOVER; DNA TOPOISOMERASE-I; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; RIBOSOMAL-RNA; QUALITY-CONTROL; BIDIRECTIONAL PROMOTERS; SELECTIVE ELIMINATION	Nuclear RNA degradation pathways are highly conserved across eukaryotes and play important roles in RNA quality control. Key substrates for exosomal degradation include aberrant functional RNAs and cryptic unstable transcripts (CUTs). It has recently been reported that the nuclear exosome is inactivated during meiosis in budding yeast through degradation of the subunit Rrp6, leading to the stabilisation of a subset of meiotic unannotated transcripts (MUTs) of unknown function. We have analysed the activity of the nuclear exosome during meiosis by deletion of TRF4, which encodes a key component of the exosome targeting complex TRAMP. We find that TRAMP mutants produce high levels of CUTs during meiosis that are undetectable in wild-type cells, showing that the nuclear exosome remains functional for CUT degradation, and we further report that the meiotic exosome complex contains Rrp6. Indeed Rrp6 over-expression is insufficient to suppress MUT transcripts, showing that the reduced amount of Rrp6 in meiotic cells does not directly cause MUT accumulation. Lack of TRAMP activity stabilises similar to 1600 CUTs in meiotic cells, which occupy 40% of the binding capacity of the nuclear cap binding complex (CBC). CBC mutants display defects in the formation of meiotic double strand breaks (DSBs), and we see similar defects in TRAMP mutants, suggesting that a key function of the nuclear exosome is to prevent saturation of the CBC complex by CUTs. Together, our results show that the nuclear exosome remains active in meiosis and has an important role in facilitating meiotic recombination.	[Frenk, Stephen; Houseley, Jonathan] Babraham Inst, Epigenet Programme, Cambridge, England; [Oxley, David] Babraham Inst, Prote Grp, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Houseley, J (corresponding author), Babraham Inst, Epigenet Programme, Cambridge, England.	jon.houseley@babraham.ac.uk	Houseley, Jon/AAF-7409-2021	Houseley, Jonathan/0000-0001-8509-1500	Wellcome Trust [088335]; MRC DTP scheme; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M766, BBS/E/B/000C0401, BBS/E/B/0000H247] Funding Source: researchfish; Medical Research Council [1128136] Funding Source: researchfish; BBSRC [BBS/E/B/0000M766, BBS/E/B/000C0401, BBS/E/B/0000H247] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC DTP scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust [grant number 088335], SF is funded through an MRC DTP scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Andersen PR, 2013, NAT STRUCT MOL BIOL, V20, P1367, DOI 10.1038/nsmb.2703; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Berchowitz LE, 2013, GENE DEV, V27, P2147, DOI 10.1101/gad.224253.113; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Castano IB, 1996, NUCLEIC ACIDS RES, V24, P2404, DOI 10.1093/nar/24.12.2404; Castano IB, 1996, GENE DEV, V10, P2564, DOI 10.1101/gad.10.20.2564; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Costello JL, 2011, J BIOL CHEM, V286, P4535, DOI 10.1074/jbc.M110.162826; Cruz C, 2014, ELIFE, V3, DOI 10.7554/eLife.01581; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; DICKINSON HG, 1977, PHILOS T ROY SOC B, V277, P327, DOI 10.1098/rstb.1977.0021; Egan ED, 2014, RNA, V20, P867, DOI 10.1261/rna.044479.114; El Hage A, 2013, METHODS MOL BIOL, V1054, P195, DOI 10.1007/978-1-62703-565-1_13; EMANUEL JR, 1981, J BACTERIOL, V145, P1342, DOI 10.1128/JB.145.3.1342-1350.1981; FRANK KR, 1978, MOL GEN GENET, V160, P59, DOI 10.1007/BF00275119; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Hilleren P, 2001, RNA, V7, P753, DOI 10.1017/S1355838201010147; Hossain MA, 2013, MOL CELL BIOL, V33, P785, DOI 10.1128/MCB.00947-12; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Iwanejko L, 1999, YEAST, V15, P1529, DOI 10.1002/(SICI)1097-0061(199910)15:14<1529::AID-YEA457>3.3.CO;2-P; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; Jenks MH, 2008, MOL CELL BIOL; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; KALT MR, 1979, J EXP ZOOL, V208, P77, DOI 10.1002/jez.1402080110; Kloimwieder A, 2011, G3-GENES GENOM GENET, V1, P143, DOI 10.1534/g3.111.000323; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lahudkar S, 2011, NUCLEIC ACIDS RES, V39, P2188, DOI 10.1093/nar/gkq1029; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Lidschreiber M, 2013, MOL CELL BIOL, V33, P3805, DOI 10.1128/MCB.00361-13; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; McKee AHZ, 1997, GENETICS, V146, P797; McKee AHZ, 1997, GENETICS, V146, P817; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nojima T, 2007, J BIOL CHEM, V282, P15645, DOI 10.1074/jbc.M700629200; Pabis M, 2013, RNA, V19, P1054, DOI 10.1261/rna.037069.112; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Prinz S, 1997, GENETICS, V146, P781; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; SADOFF BU, 1995, GENETICS, V141, P465; Shichino Y, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140022; St-Andre O, 2010, J BIOL CHEM, V285, P27859, DOI 10.1074/jbc.M110.150748; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014; Zanchin NIT, 1999, NUCLEIC ACIDS RES, V27, P1283, DOI 10.1093/nar/27.5.1283	77	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107648	10.1371/journal.pone.0107648	http://dx.doi.org/10.1371/journal.pone.0107648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210768	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900091
J	Pennacchietti, F; Abbruzzetti, S; Losi, A; Mandalari, C; Bedotti, R; Viappiani, C; Zanacchi, FC; Diaspro, A; Gartner, W				Pennacchietti, Francesca; Abbruzzetti, Stefania; Losi, Aba; Mandalari, Carmen; Bedotti, Roberta; Viappiani, Cristiano; Zanacchi, Francesca Cella; Diaspro, Alberto; Gaetner, Wolfgang			The Dark Recovery Rate in the Photocycle of the Bacterial Photoreceptor YtvA Is Affected by the Cellular Environment and by Hydration	PLOS ONE			English	Article							TREHALOSE-COATED MBCO; BLUE-LIGHT RECEPTOR; LOV DOMAIN; MUTATIONAL ANALYSIS; PHOT-LOV1 DOMAIN; EXTERNAL MATRIX; PROTEIN; RESOLUTION; MECHANISM; DYNAMICS	We report thermal recovery kinetics of the lit state into the parental dark state, measured for the blue light-sensing photoreceptor YtvA inside overexpressing E. coli and B. subtilis bacterial cells, performed for the wild type and several mutated proteins. Recovery was followed as a recovery of the fluorescence, as this property is only found for the parental but not for the photochemically generated lit state. When cells were deposited onto a microscope glass plate, the observed thermal recovery rate in the photocycle was found ca. ten times faster in comparison to purified YtvA in solution. When the E. coli or B. subtilis colonies were soaked in an isotonic buffer, the dark relaxation became again much slower and was very similar to that observed for YtvA in solution. The observed effects show that rate constants can be tuned by the cellular environment through factors such as hydration.	[Pennacchietti, Francesca; Zanacchi, Francesca Cella; Diaspro, Alberto] Fdn Ist Italiano Tecnol, Genoa, Italy; [Abbruzzetti, Stefania; Losi, Aba; Mandalari, Carmen; Bedotti, Roberta; Viappiani, Cristiano] Univ Parma, Dipartimento Fis & Sci Terra, I-43100 Parma, Italy; [Abbruzzetti, Stefania; Viappiani, Cristiano] CNR, NEST, Ist Nanosci, I-56100 Pisa, Italy; [Gaetner, Wolfgang] Max Planck Inst Chem Energy Convers CEC, Mulheim, Germany	Istituto Italiano di Tecnologia - IIT; University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Max Planck Society	Viappiani, C (corresponding author), Univ Parma, Dipartimento Fis & Sci Terra, I-43100 Parma, Italy.	cristiano.viappiani@unipr.it	Diaspro, Alberto/E-7833-2010; Cella Zanacchi, Francesca/H-4310-2011; Losi, Aba/M-8709-2015; abbruzzetti, stefania/AAE-5518-2020; Zanacchi, Francesca Cella/ABI-1651-2020; abbruzzetti, stefania/M-8640-2015; Viappiani, Cristiano/AAC-7579-2019	Diaspro, Alberto/0000-0002-4916-5928; Cella Zanacchi, Francesca/0000-0002-2427-3009; Losi, Aba/0000-0003-0497-2723; abbruzzetti, stefania/0000-0001-7685-8554; abbruzzetti, stefania/0000-0001-7685-8554; Viappiani, Cristiano/0000-0001-7470-4770; Pennacchietti, Francesca/0000-0003-1769-972X	Vigoni program; University of Parma; MiUR Programmi di Ricerca di Rilevante Interesse Nazionale PRIN [2010JFYFY2-002]	Vigoni program; University of Parma; MiUR Programmi di Ricerca di Rilevante Interesse Nazionale PRIN(Ministry of Education, Universities and Research (MIUR))	This work has been partially supported by the Vigoni program (to A.L. and W.G.), the University of Parma (fellowship to C.M.) and MiUR Programmi di Ricerca di Rilevante Interesse Nazionale PRIN 2010JFYFY2-002 (AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2005, CELL BIOCHEM BIOPHYS, V43, P431, DOI 10.1385/CBB:43:3:431; Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Alexandre MTA, 2009, BIOPHYS J, V97, P238, DOI 10.1016/j.bpj.2009.03.047; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chan RH, 2013, PHOTOCHEM PHOTOBIOL, V89, P361, DOI 10.1111/php.12004; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Cordone L, 2005, BBA-PROTEINS PROTEOM, V1749, P252, DOI 10.1016/j.bbapap.2005.03.004; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Frauenfelder H, 2002, BIOPHYS CHEM, V98, P35, DOI 10.1016/S0301-4622(02)00083-2; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Freddolino PL, 2006, BIOPHYS J, V91, P3630, DOI 10.1529/biophysj.106.088609; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Genick UK, 1998, NATURE, V392, P206, DOI 10.1038/32462; Giuffrida S, 2003, J PHYS CHEM B, V107, P13211, DOI 10.1021/jp036194x; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Kawano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082693; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Laan W, 2006, BIOCHEMISTRY-US, V45, P51, DOI 10.1021/bi051367p; Librizzi F, 2002, J CHEM PHYS, V116, P1193, DOI 10.1063/1.1426409; Losi A, 2004, BIOPHYS J, V86, P1051, DOI 10.1016/S0006-3495(04)74180-6; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Losi A, 2013, PHOTOCH PHOTOBIO SCI, V12, P231, DOI 10.1039/c2pp25254f; Mandalari C, 2013, PHOTOCH PHOTOBIO SCI, V12, P1144, DOI 10.1039/c3pp25404f; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/NCHEMBIO.1430, 10.1038/nchembio.1430]; Palazzo G, 2002, BIOPHYS J, V82, P558, DOI 10.1016/S0006-3495(02)75421-0; Pathak GP, 2013, BIOL CELL, V105, P59, DOI 10.1111/boc.201200056; Raffelberg S, 2013, BIOL CHEM, V394, P1517, DOI 10.1515/hsz-2013-0163; Raffelberg S, 2011, J AM CHEM SOC, V133, P5346, DOI 10.1021/ja1097379; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schmidt D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4019; Silva MR, 2013, CHEMBIOCHEM, V14, P1648, DOI 10.1002/cbic.201300217; Tang YF, 2010, PHOTOCH PHOTOBIO SCI, V9, P47, DOI 10.1039/b9pp00075e; Zayner JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087074; Zayner JP, 2013, BIOPHYS J, V105, P1027, DOI 10.1016/j.bpj.2013.07.010; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P8771, DOI 10.1021/bi200976a; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	43	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107489	10.1371/journal.pone.0107489	http://dx.doi.org/10.1371/journal.pone.0107489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25211155	Green Submitted, Green Published, gold			2022-12-27	WOS:000341855900078
J	Liu, SN; Wei, W; Chu, Y; Zhang, L; Shen, J; An, CJ				Liu, Suning; Wei, Wei; Chu, Yuan; Zhang, Long; Shen, Jie; An, Chunju			De Novo Transcriptome Analysis of Wing Development-Related Signaling Pathways in Locusta migratoria Manilensis and Ostrinia furnacalis (Guenee)	PLOS ONE			English	Article							LONG-RANGE ACTION; GRADIENT FORMATION; IMAGINAL DISC; MORPHOGEN GRADIENT; OPTOMOTOR-BLIND; DROSOPHILA; HEDGEHOG; DPP; NOTCH; PROTEIN	Background: Orthopteran migratory locust, Locusta migratoria, and lepidopteran Asian corn borer, Ostrinia furnacalis, are two types of insects undergoing incomplete and complete metamorphosis, respectively. Identification of candidate genes regulating wing development in these two insects would provide insights into the further study about the molecular mechanisms controlling metamorphosis development. We have sequenced the transcriptome of O. furnacalis larvae previously. Here we sequenced and characterized the transcriptome of L. migratoria wing discs with special emphasis on wing development-related signaling pathways. Methodology/Principal Findings: Illumina Hiseq2000 was used to sequence 8.38 Gb of the transcriptome from dissected nymphal wing discs. De novo assembly generated 91,907 unigenes with mean length of 610 nt. All unigenes were searched against five databases including Nt, Nr, Swiss-Prot, COG, and KEGG for annotations using blastn or blastx algorithm with an cut-off E-value of 10(-5). A total of 23,359 (25.4%) unigenes have homologs within at least one database. Based on sequence similarity to homologs known to regulate Drosophila melanogaster wing development, we identified 50 and 46 potential wing development-related unigenes from L. migratoria and O. furnacalis transcriptome, respectively. The identified unigenes encode putative orthologs for nearly all components of the Hedgehog (Hh), Decapentaplegic (Dpp), Notch (N), and Wingless (Wg) signaling pathways, which are essential for growth and pattern formation during wing development. We investigated the expression profiles of the component genes involved in these signaling pathways in forewings and hind wings of L. migratoria and O. furnacalis. The results revealed the tested genes had different expression patterns in two insects. Conclusions/Significance: This study provides the comprehensive sequence resource of the wing development-related signaling pathways of L. migratoria. The obtained data gives an insight into better understanding the molecular mechanisms involved in the wing development in L. migratoria and O. furnacalis, two insect species with different metamorphosis types.	[Liu, Suning; Wei, Wei; Chu, Yuan; Zhang, Long; Shen, Jie; An, Chunju] China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China	China Agricultural University	Shen, J (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China.	shenjie@cau.edu.cn; anchunju@cau.edu.cn	shen, jie/W-9807-2019; shen, jie/H-9087-2016	shen, jie/0000-0002-6021-7151; 	973 Program [2013CB114102, 2013CB127603]; National Natural Science Foundation of China [31172090]; Specialized Research Fund for the Doctoral Program of Higher Education [20120008110005]; Program for New Century Excellent Talents in University [NCET-11-0476]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the 973 Program (2013CB114102 and 2013CB127603), National Natural Science Foundation of China (31172090), the Specialized Research Fund for the Doctoral Program of Higher Education (20120008110005), and Program for New Century Excellent Talents in University (NCET-11-0476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Alberts B, 2002, MOL BIOL CELL, P1347; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Baena-Lopez LA, 2012, CURR OPIN CELL BIOL, V24, P166, DOI 10.1016/j.ceb.2011.12.010; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bangi E, 2006, DEVELOPMENT, V133, P3295, DOI 10.1242/dev.02513; BATE M, 1991, DEVELOPMENT, V112, P755; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brook WJ, 2000, BIOCHEM CELL BIOL, V78, P585, DOI 10.1139/bcb-78-5-585; Burglin TR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-127; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chan YM, 1998, CELL, V94, P423, DOI 10.1016/S0092-8674(00)81583-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Dudley R, 2002, BIOMECHANICS INSECT; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Fortini ME, 2000, TRENDS GENET, V16, P161, DOI 10.1016/S0168-9525(99)01939-3; GARCIABELLIDO A, 1976, DEV BIOL, V48, P132, DOI 10.1016/0012-1606(76)90052-X; Gibson G, 2010, JARO-J ASSOC RES OTO, V11, P527, DOI 10.1007/s10162-010-0243-2; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; Herrera SC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003446; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; MAINE EM, 1995, MOL PHYLOGENET EVOL, V4, P139, DOI 10.1006/mpev.1995.1014; Miaoulis IN, 1998, ANN ENTOMOL SOC AM, V91, P122, DOI 10.1093/aesa/91.1.122; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; NAFUS DM, 1991, TROP PEST MANAGE, V37, P41, DOI 10.1080/09670879109371535; Neto-Silva RM, 2009, ANNU REV CELL DEV BI, V25, P197, DOI 10.1146/annurev.cellbio.24.110707.175242; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Newfeld SJ, 1996, DEVELOPMENT, V122, P2099; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; Preston G, 1997, PCR CLONING PROTOCOL, P433; Rafel N, 2008, DEVELOPMENT, V135, P3995, DOI 10.1242/dev.027789; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Shen DX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086436, 10.1371/journal.pone.0105709]; Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784; Shen J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-23; Simmons RB, 1996, J INSECT BEHAV, V9, P909, DOI 10.1007/BF02208978; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Strigini M, 1997, DEVELOPMENT, V124, P4697; Sudo S, 2005, EXP MECH, V45, P550, DOI 10.1177/001445105059989; Swarup S., 2012, COLD SPRING HARB PER, V4; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; UVAROV B. P., 1936, Bulletin of Entomological Research, V27, P91, DOI 10.1017/S0007485300058144; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Waldron JA, 2012, BIOCHEM SOC T, V40, P891, DOI 10.1042/BST20120035; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zecca M, 2002, DEVELOPMENT, V129, P1357; Zhang XB, 2010, CHINESE BULL ENTOMOL, V1, P009, DOI DOI 10.3724/SP.J.1047.2010.00009; Zhang XB, 2013, DEVELOPMENT, V140, P2917, DOI 10.1242/dev.094300; Zhu Jia-Ying, 2013, PLoS ONE, V8, pe54411, DOI 10.1371/journal.pone.0054411	77	15	18	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106770	10.1371/journal.pone.0106770	http://dx.doi.org/10.1371/journal.pone.0106770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207539	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300038
J	Phillips, AN; Cambiano, V; Nakagawa, F; Ford, D; Lundgren, JD; Roset-Bahmanyar, E; Roman, F; Effelterre, T				Phillips, Andrew N.; Cambiano, Valentina; Nakagawa, Fumiyo; Ford, Deborah; Lundgren, Jens D.; Roset-Bahmanyar, Edith; Roman, Francois; Van Effelterre, Thierry			Potential Future Impact of a Partially Effective HIV Vaccine in a Southern African Setting	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RISK BEHAVIOR; INFECTION; THAILAND; EFFICACY; MODEL; TRANSMISSION; PROTECTION; REDUCTION; STATES	Background: It is important for public health and within the HIV vaccine development field to understand the potential population level impact of an HIV vaccine of partial efficacy-both in preventing infection and in reducing viral load in vaccinated individuals who become infected-in the context of a realistic future implementation scenario in resource limited settings. Methods: An individual level model of HIV transmission, progression and the effect of antiretroviral therapy was used to predict the outcome to 2060 of introduction in 2025 of a partially effective vaccine with various combinations of efficacy characteristics, in the context of continued ART roll-out in southern Africa. Results: In the context of our base case epidemic (in 2015 HIV prevalence 28% and incidence 1.7 per 100 person years), a vaccine with only 30% preventative efficacy could make a substantial difference in the rate with which HIV incidence declines; the impact on incidence in relative terms is projected to increase over time, with a projected 67% lower HIV incidence in 2060 compared with no vaccine introduction. The projected mean decline in the general adult population death rate 2040-2060 is 11%. A vaccine with no prevention efficacy but which reduces viral load by 1 log is predicted to result in a modest (14%) reduction in HIV incidence and an 8% reduction in death rate in the general adult population (mean 2040-2060). These effects were broadly similar in multivariable uncertainty analysis. Interpretation: Introduction of a partially effective preventive HIV vaccine would make a substantial long-term impact on HIV epidemics in southern Africa, in addition to the effects of ART. Development of an HIV vaccine, even of relatively low apparent efficacy at the individual level, remains a critical global public health goal.	[Phillips, Andrew N.; Cambiano, Valentina; Nakagawa, Fumiyo] UCL, Res Dept Infect & Populat Hlth, London, England; [Ford, Deborah] UCL, Inst Clin Trials & Methodol, London, England; [Lundgren, Jens D.] Univ Copenhagen, Rigshosp, Dept Infect Dis, CHIP, DK-2100 Copenhagen, Denmark; [Roset-Bahmanyar, Edith; Roman, Francois; Van Effelterre, Thierry] GlaxoSmithKline Vaccines, Wavre, Belgium	University of London; University College London; University of London; University College London; Rigshospitalet; University of Copenhagen; GlaxoSmithKline	Phillips, AN (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	andrew.phillips@ucl.ac.uk	Lundgren, Jens/AAE-6876-2019; Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; Nakagawa, Fumiyo/0000-0002-6646-8744	GlaxoSmithKline Biologicals SA; Medical Research Council [MC_UU_12023/17] Funding Source: researchfish; MRC [MC_UU_12023/17] Funding Source: UKRI	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this project was provided by GlaxoSmithKline Biologicals SA to AP through UCL Consultants for the delivery of model outcomes. Before the start of the modelling analysis GSK Biologicals specified the potential vaccine characteristics to compare. There was no subsequent involvement of GlaxoSmithKline Biologicals SA, except GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy, but the authors are solely responsible for final content and interpretation.	Abu-Raddad LJ, 2007, JAIDS-J ACQ IMM DEF, V45, P454, DOI 10.1097/QAI.0b013e3180959a94; Amirfar S, 2006, JAIDS-J ACQ IMM DEF, V43, P219, DOI 10.1097/01.qai.0000230526.79341.83; Anderson RM, 1996, LANCET, V348, P1010, DOI 10.1016/S0140-6736(96)07100-0; ANDERSON RM, 1995, P ROY SOC B-BIOL SCI, V261, P147, DOI 10.1098/rspb.1995.0129; Andersson KM, 2011, VACCINE, V29, P6092, DOI 10.1016/j.vaccine.2011.06.060; Boily MC, 2008, LANCET INFECT DIS, V8, P200, DOI 10.1016/S1473-3099(07)70292-X; Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Esparza J, 2013, VACCINE, V31, P3502, DOI 10.1016/j.vaccine.2013.05.018; Gray GE, 2013, VACCINE, V31, P2089, DOI 10.1016/j.vaccine.2013.01.031; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Gray RT, 2011, VACCINE, V29, P6125, DOI 10.1016/j.vaccine.2011.06.061; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Hontelez JAC, 2011, VACCINE, V29, P6100, DOI 10.1016/j.vaccine.2011.06.059; Kaldor JM, 2010, AIDS, V24, P2564, DOI 10.1097/QAD.0b013e32833ead96; KOOPMAN JS, 1995, AM J EPIDEMIOL, V142, P1113, DOI 10.1093/oxfordjournals.aje.a117564; Kribs-Zaleta CM, 2000, MATH BIOSCI, V164, P183, DOI 10.1016/S0025-5564(00)00003-1; Long EF, 2011, VACCINE, V29, P6113, DOI 10.1016/j.vaccine.2011.04.013; Longini IM, 1999, STAT MED, V18, P53, DOI 10.1002/(SICI)1097-0258(19990115)18:1&lt;53::AID-SIM996&gt;3.0.CO;2-0; Massad E, 2001, MATH COMPUT MODEL, V34, P345, DOI 10.1016/S0895-7177(01)00066-8; McLean AR, 1995, TRENDS MICROBIOL, V3, P458, DOI 10.1016/S0966-842X(00)89010-1; Nagelkerke NJD, 2011, VACCINE, V29, P6079, DOI 10.1016/j.vaccine.2011.06.048; Owens DK, 1998, AIDS, V12, P1057, DOI 10.1097/00002030-199809000-00013; Phillips AN, 1996, SCIENCE, V271, P497, DOI 10.1126/science.271.5248.497; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rida W, 2009, B MATH BIOL, V71, P648, DOI 10.1007/s11538-008-9375-5; Schneider K, 2011, VACCINE, V29, P6086, DOI 10.1016/j.vaccine.2011.06.074; Smith RJ, 2004, LANCET INFECT DIS, V4, P636, DOI 10.1016/S1473-3099(04)01148-X; UNAIDS, 2012, GLOBAL REPORT UNAIDS	31	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107214	10.1371/journal.pone.0107214	http://dx.doi.org/10.1371/journal.pone.0107214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207973	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300066
J	Soto, I; Howell, GR; John, CW; Kief, JL; Libby, RT; John, SWM				Soto, Ileana; Howell, Gareth R.; John, Cai W.; Kief, Joseph L.; Libby, Richard T.; John, Simon W. M.			DBA/2J Mice Are Susceptible to Diabetic Nephropathy and Diabetic Exacerbation of IOP Elevation	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; OPTIC-NERVE; INS2(AKITA) MOUSE; NEURAL APOPTOSIS; EARLY-ONSET; NEURODEGENERATION; MELLITUS; MODEL	Some pathological manifestations of diabetes in the eye include retinopathy, cataracts and elevated intraocular pressure (IOP). Loss of retinal ganglion cells (RGCs) in non-proliferative stages of diabetic retinopathy and small increases in IOP in diabetic patients has raised the possibility that diabetes affects the development and progression of ocular hypertension and glaucoma. The Ins2(Akita) mutation is known to cause diabetes and retinopathy on a C57BL/6J (B6) background by as early as 3 months of age. Here, the impact of the Akita mutation on glaucoma was assessed using DBA/2J (D2) mice, a widely used mouse model of ocular hypertension induced glaucoma. In D2.Ins2(Akita/+) mice, the contribution of diabetes to vascular permeability, IOP elevation, RGC loss, and glaucoma development was assessed. D2.Ins2(Akita/+) mice developed a severe diabetic nephropathy and early mortality between 6-8 months of age. This agrees with previous reports showing that the D2 background is more susceptible to diabetes than the B6 background. In addition, D2.Ins2(Akita/+) mice had vascular leakage, astrocyte reactivity and a significant increase in IOP. However no RGC loss and no anterograde axonal transport dysfunction were found at 8.5 months of age. Therefore, our data show that despite severe diabetes and an increased IOP compared to controls, RGCs do not lose axon transport or degenerate. This may be due to a DBA/2J-specific genetic modifier(s) that could provide novel and important avenues for developing new therapies for diabetic retinopathy and possibly glaucoma.	[Soto, Ileana; Howell, Gareth R.; John, Cai W.; Kief, Joseph L.; John, Simon W. M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Howell, Gareth R.; John, Simon W. M.] Howard Hughes Med Inst, Bar Harbor, ME USA; [Libby, Richard T.] Univ Rochester, Med Ctr, Dept Ophthalmol, Rochester, NY 14642 USA; [Libby, Richard T.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [John, Simon W. M.] Tufts Univ Med, Dept Ophthalmol, Boston, MA USA	Jackson Laboratory; Howard Hughes Medical Institute; University of Rochester; University of Rochester; Tufts University	John, SWM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	simon.john@jax.org		Soto, Ileana/0000-0002-9315-816X; Libby, Richard/0000-0003-2844-7632	NIH [EY011721, EY021525, EY018606]; Howard Hughes Medical Institute; Barbara and Joseph Cohen Foundation; NATIONAL EYE INSTITUTE [R01EY018606, R01EY021525, R01EY011721, R29EY011721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Barbara and Joseph Cohen Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by NIH grants EY011721 (SWMJ) EY021525 (GRH), EY018606 (RTL), www.nih.gov; the Howard Hughes Medical Institute; and Barbara and Joseph Cohen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2004, INVEST OPHTH VIS SCI, V45, P2760, DOI 10.1167/iovs.03-1392; Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; ARMSTRONG JR, 1960, AM J OPHTHALMOL, V50, P55, DOI 10.1016/0002-9394(60)90840-0; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BECKER B, 1971, AM J OPHTHALMOL, V71, P1; Bongers EMHF, 2005, EUR J HUM GENET, V13, P935, DOI 10.1038/sj.ejhg.5201446; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Ebneter A, 2011, ARCH OPHTHALMOL-CHIC, V129, P1337, DOI 10.1001/archophthalmol.2011.269; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Gastinger MJ, 2008, INVEST OPHTH VIS SCI, V49, P2635, DOI 10.1167/iovs.07-0683; Gordon MO, 2008, ARCH OPHTHALMOL-CHIC, V126, P280, DOI 10.1001/archophthalmol.2007.35; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Han ZC, 2013, INVEST OPHTH VIS SCI, V54, P574, DOI 10.1167/iovs.12-10959; Hombrebueno JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097970; Howell GR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-76; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; John SWM, 1997, INVEST OPHTH VIS SCI, V38, P249; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Kanamori A, 2004, CURR EYE RES, V28, P47, DOI 10.1076/ceyr.28.1.47.23487; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; KLEIN BEK, 1984, OPHTHALMOLOGY, V91, P1356; Kruger SJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P1234, DOI 10.1001/archopht.121.9.1234; Li Y, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-19; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Liu W, 2012, J CELL BIOCH; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; MOSS SE, 1988, OPHTHALMOLOGY, V95, P1340; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nickells RW, 2012, ANNU REV NEUROSCI, V35, P153, DOI 10.1146/annurev.neuro.051508.135728; Oshitari T, 2007, AM J OPHTHALMOL, V143, P363, DOI 10.1016/j.ajo.2006.09.033; Perry J, 2007, PEDIATR DEVEL PATHOL, V10, P369, DOI 10.2350/06-11-0193.1; Qian HH, 2011, EXP DIABETES RES, DOI 10.1155/2011/693426; Quigley HA, 2009, ARCH OPHTHALMOL-CHIC, V127, P227, DOI 10.1001/archophthalmol.2008.596; Sheehan S, 2007, AM J PHYSIOL-RENAL, V293, pF1649, DOI 10.1152/ajprenal.00233.2007; Smith R.S., 2002, SYSTEMATIC EVALUATIO; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Su W, 2007, AM J PHYSIOL-REG I, V292, pR1761, DOI 10.1152/ajpregu.00319.2006; Templeton JP, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-90; TIELSCH JM, 1995, OPHTHALMOLOGY, V102, P48; Uchimura K, 2006, TRENDS IMMUNOL, V27, P559, DOI 10.1016/j.it.2006.10.007; Vahedi K, 2011, CURR OPIN NEUROL, V24, P63, DOI 10.1097/WCO.0b013e32834232c6; Walton DS, 2005, J GLAUCOMA, V14, P181, DOI 10.1097/01.ijg.0000158850.07732.05; Wong VHY, 2011, CLIN EXP OPTOM, V94, P4, DOI 10.1111/j.1444-0938.2010.00546.x; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Yuan Zhigang, 2007, Community Eye Health, V20, P73; Zhang YL, 2014, DIABETES, V63, P2097, DOI 10.2337/db12-1459; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9	52	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107291	10.1371/journal.pone.0107291	http://dx.doi.org/10.1371/journal.pone.0107291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207540	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300070
J	Clohisey, SMR; Dzhindzhev, NS; Ohkura, H				Clohisey, Sara M. R.; Dzhindzhev, Nikola S.; Ohkura, Hiroyuki			Kank Is an EB1 Interacting Protein that Localises to Muscle-Tendon Attachment Sites in Drosophila	PLOS ONE			English	Article							MICROTUBULE PLUS ENDS; FUNCTIONAL DOMAINS; IN-VIVO; BEHAVIOR; GENE; IDENTIFICATION; EXPRESSION; DELETION; JUNCTION; DYNAMICS	Little is known about how microtubules are regulated in different cell types during development. EB1 plays a central role in the regulation of microtubule plus ends. It directly binds to microtubule plus ends and recruits proteins which regulate microtubule dynamics and behaviour. We report the identification of Kank, the sole Drosophila orthologue of human Kank proteins, as an EB1 interactor that predominantly localises to embryonic attachment sites between muscle and tendon cells. Human Kank1 was identified as a tumour suppressor and has documented roles in actin regulation and cell polarity in cultured mammalian cells. We found that Drosophila Kank binds EB1 directly and this interaction is essential for Kank localisation to microtubule plus ends in cultured cells. Kank protein is expressed throughout fly development and increases during embryogenesis. In late embryos, it accumulates to sites of attachment between muscle and epidermal cells. A kank deletion mutant was generated. We found that the mutant is viable and fertile without noticeable defects. Further analysis showed that Kank is dispensable for muscle function in larvae. This is in sharp contrast to C. elegans in which the Kank orthologue VAB-19 is required for development by stabilising attachment structures between muscle and epidermal cells.	[Clohisey, Sara M. R.; Dzhindzhev, Nikola S.; Ohkura, Hiroyuki] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Clohisey, SMR (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	h.ohkura@ed.ac.uk	Clohisey, Sara/AAB-9321-2021	Clohisey, Sara/0000-0001-7489-9846; Ohkura, Hiroyuki/0000-0003-4059-431X; Dzhindzhev, Nikola/0000-0001-9866-3600	Cancer Research UK [9201]; Wellcome Trust [081849, 092076, 098030]	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by research grants from Cancer Research UK (9201; www.cancerresearchuk.org) and Wellcome Trust (081849, 092076, 098030; www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016; Ashburner M., 1989, DROSOPHILA LAB HDB; Batlevi Y, 2010, P NATL ACAD SCI USA, V107, P742, DOI 10.1073/pnas.0907967107; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bottenberg W, 2009, MECH DEVELOP, V126, P489, DOI 10.1016/j.mod.2009.04.004; Dettman RW, 2001, GENETICS, V158, P253; Ding M, 2003, DEVELOPMENT, V130, P5791, DOI 10.1242/dev.00791; Djiane A, 2013, EMBO J, V32, P60, DOI 10.1038/emboj.2012.326; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; FYRBERG EA, 1990, ANNU REV CELL BIOL, V6, P559, DOI 10.1146/annurev.cb.06.110190.003015; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Harada JN, 2005, GENOME RES, V15, P1136, DOI 10.1101/gr.3889305; Hong JW, 2013, DEV BIOL, V380, P335, DOI 10.1016/j.ydbio.2013.05.015; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; LEISS D, 1988, DEVELOPMENT, V104, P525; Lerer I, 2005, HUM MOL GENET, V14, P3911, DOI 10.1093/hmg/ddi415; Li CP, 2011, EUR PHYS J-SPEC TOP, V193, P1, DOI 10.1140/epjst/e2011-01377-3; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; MOGENSEN MM, 1988, J CELL SCI, V91, P431; PIERRE P, 1994, J CELL SCI, V107, P1909; Prokop A, 1998, J CELL BIOL, V143, P1283, DOI 10.1083/jcb.143.5.1283; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Roy BC, 2009, J CELL BIOL, V184, P253, DOI 10.1083/jcb.200805147; Sambrook J., 2002, MOL CLONING LAB MANU; Sarkar S, 2002, J BIOL CHEM, V277, P36585, DOI 10.1074/jbc.M204244200; Sellin J, 2009, DEV BIOL, V326, P444, DOI 10.1016/j.ydbio.2008.10.041; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; SLOBODA RD, 1975, P NATL ACAD SCI USA, V72, P177, DOI 10.1073/pnas.72.1.177; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; Strumpf D, 1998, J CELL BIOL, V143, P1259, DOI 10.1083/jcb.143.5.1259; SU LK, 1995, CANCER RES, V55, P2972; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Ubhi Kiren K., 2007, Invertebrate Neuroscience, V7, P165, DOI 10.1007/s10158-007-0052-4; Vanzo RJ, 2013, EUR J MED GENET, V56, P256, DOI 10.1016/j.ejmg.2013.02.006; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Wang Y, 2005, BIOCHEM BIOPH RES CO, V330, P1247, DOI 10.1016/j.bbrc.2005.03.106; Wang Y, 2006, J CELL SCI, V119, P4002, DOI 10.1242/jcs.03169; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	47	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106112	10.1371/journal.pone.0106112	http://dx.doi.org/10.1371/journal.pone.0106112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203404	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500013
J	Venditti, CC; Casselman, R; Young, I; Karumanchi, SA; Smith, GN				Venditti, Carolina C.; Casselman, Richard; Young, Iain; Karumanchi, S. Ananth; Smith, Graeme N.			Carbon Monoxide Prevents Hypertension and Proteinuria in an Adenovirus sFlt-1 Preeclampsia-Like Mouse Model	PLOS ONE			English	Article							CIRCULATING ANGIOGENIC FACTORS; GROWTH-FACTOR RECEPTOR-1; CIGARETTE-SMOKING; GENE-EXPRESSION; HEME OXYGENASE; PREGNANCY; RISK; WOMEN; REGULATOR; PRESSURE	Preeclampsia (PE) remains a leading cause of maternal and neonatal morbidity and mortality worldwide. Smoking cigarettes is associated with a decreased incidence of PE. Based on this observation and previous work, we hypothesize that women who smoke have a lower risk of developing PE because of elevated levels of carbon monoxide (CO) in their blood. The objective of this study was to determine if low-dose CO in ambient air could attenuate the late pregnancy hypertension (HTN) and proteinuria in the Adenovirus (Ad) sFlt-1 PE-like mouse model. Continuous low-dose CO treatment (250 ppm) was started on E10.5 and maintained until E17.5. Compared to control and Ad empty vector, AdsFlt-1 mice displayed late-gestation HTN (E14.5-17.5) (P < 0.05), proteinuria (P < 0.05) and reduced Bowman's space which were all prevented with CO treatment. Use of the Ad (with/without sFlt-1) or CO had no effect (p > 0.05) on litter size, fetal resorption numbers and fetal or placental weights. This study shows that treatment with CO can prevent HTN and proteinuria in a mouse model of PE. It provides a possible mechanism for the reduced incidence of PE in smoking women, and supports the possibility of using CO as a future treatment for PE.	[Venditti, Carolina C.; Casselman, Richard; Smith, Graeme N.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Young, Iain] Queens Univ, Dept Hlth Sci, Kingston, ON, Canada; [Smith, Graeme N.] Kingston Gen Hosp, Dept Obstet & Gynecol, Kingston, ON K7L 2V7, Canada; [Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Queens University - Canada; Queens University - Canada; Queens University - Canada; Harvard University; Beth Israel Deaconess Medical Center	Smith, GN (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	gns@queensu.ca	Karumanchi, Subbian Ananth/AAI-1694-2021; Smith, Graeme Neil/ABB-6863-2021	Smith, Graeme Neil/0000-0002-3128-4523	Obstetrics and Gynecology Department at Kingston General Hospital	Obstetrics and Gynecology Department at Kingston General Hospital	Funding was provided by the Obstetrics and Gynecology Department at Kingston General Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge SA, 2005, FREE RADICAL BIO MED, V38, P979, DOI 10.1016/j.freeradbiomed.2004.11.002; Bainbridge SA, 2005, MED HYPOTHESES, V64, P17, DOI 10.1016/j.mehy.2004.06.019; Bainbridge SA, 2002, PLACENTA, V23, P563, DOI 10.1053/plac.2002.0845; Bainbridge SA, 2006, AM J PATHOL, V169, P774, DOI 10.2353/ajpath.2006.060184; Baum M, 2000, AM J OBSTET GYNECOL, V183, P900, DOI 10.1067/mob.2000.109047; Bergmann A, 2010, J CELL MOL MED, V14, P1857, DOI 10.1111/j.1582-4934.2009.00820.x; Botros FT, 2005, KIDNEY INT, V68, P2745, DOI 10.1111/j.1523-1755.2005.00745.x; Cao J, 2009, INT J BIOCHEM CELL B, V41, P1025, DOI 10.1016/j.biocel.2008.10.025; Cockell AP, 1997, BRIT J OBSTET GYNAEC, V104, P235, DOI 10.1111/j.1471-0528.1997.tb11052.x; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; El-Mousleh T, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-4; England LJ, 2003, AM J OBSTET GYNECOL, V189, P939, DOI 10.1067/S0002-9378(03)00661-6; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; Farina A, 2008, PRENATAL DIAG, V28, P956, DOI 10.1002/pd.2109; George EM, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/486053; George EM, 2011, AM J PHYSIOL-REG I, V301, pR1495, DOI 10.1152/ajpregu.00325.2011; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Granger JP, 2002, MICROCIRCULATION, V9, P147, DOI 10.1038/sj.mn.7800137; Hayman R, 1999, J SOC GYNECOL INVEST, V6, P3, DOI 10.1016/S1071-5576(98)00044-6; Kreiser Doron, 2004, J Perinatol, V24, P213, DOI 10.1038/sj.jp.7211062; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098; Lu F, 2007, AM J OBSTET GYNECOL, V197, pS3, DOI 10.1016/j.ajog.2007.10.008; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Mateus J, 2011, AM J PHYSIOL-HEART C, V301, pH1781, DOI 10.1152/ajpheart.00373.2011; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; NEUZIL J, 1993, FEBS LETT, V331, P281, DOI 10.1016/0014-5793(93)80353-V; Orsolic N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-117; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Sabaawy HE, 2001, HYPERTENSION, V38, P210, DOI 10.1161/01.HYP.38.2.210; Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sollwedel A, 2005, J IMMUNOL, V175, P4875, DOI 10.4049/jimmunol.175.8.4875; SPARGO B, 1959, ARCH PATHOL, V68, P593; Suzuki H, 2009, HYPERTENSION, V54, P1129, DOI 10.1161/HYPERTENSIONAHA.109.134668; Venditti CC, 2013, AM J PHYSIOL-REG I, V305, pR939, DOI 10.1152/ajpregu.00204.2013; Venditti CC, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-101; Vuorela P, 2000, OBSTET GYNECOL, V95, P353, DOI 10.1016/S0029-7844(99)00565-7; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yang LM, 2004, HYPERTENSION, V43, P1221, DOI 10.1161/01.HYP.0000126287.62060.e6; Zhai DS, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.03.022	44	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106502	10.1371/journal.pone.0106502	http://dx.doi.org/10.1371/journal.pone.0106502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25202912	Green Published, Green Submitted, gold			2022-12-27	WOS:000342684500028
J	Weinl, C; Wasylyk, C; Garrido, MG; Sothilingam, V; Beck, SC; Riehle, H; Stritt, C; Roux, MJ; Seeliger, MW; Wasylyk, B; Nordheim, A				Weinl, Christine; Wasylyk, Christine; Garrido, Marina Garcia; Sothilingam, Vithiyanjali; Beck, Susanne C.; Riehle, Heidemarie; Stritt, Christine; Roux, Michel J.; Seeliger, Mathias W.; Wasylyk, Bohdan; Nordheim, Alfred			Elk3 Deficiency Causes Transient Impairment in Post-Natal Retinal Vascular Development and Formation of Tortuous Arteries in Adult Murine Retinae	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; TERNARY COMPLEX; TRANSCRIPTION FACTOR; ANGIOGENESIS; RETINOPATHY; DISEASE; ACTIN; MICE; NET; SRF	Serum Response Factor (SRF) fulfills essential roles in post-natal retinal angiogenesis and adult neovascularization. These functions have been attributed to the recruitment by SRF of the cofactors Myocardin-Related Transcription Factors MRTF-A and -B, but not the Ternary Complex Factors (TCFs) Elk1 and Elk4. The role of the third TCF, Elk3, remained unknown. We generated a new Elk3 knockout mouse line and showed that Elk3 had specific, non-redundant functions in the retinal vasculature. In Elk3((-/-)) mice, post-natal retinal angiogenesis was transiently delayed until P8, after which it proceeded normally. Interestingly, tortuous arteries developed in Elk3((-/-)) mice from the age of four weeks, and persisted into late adulthood. Tortuous vessels have been observed in human pathologies, e.g. in ROP and FEVR. These human disorders were linked to altered activities of vascular endothelial growth factor (VEGF) in the affected eyes. However, in Elk3((-/-)) mice, we did not observe any changes in VEGF or several other potential confounding factors, including mural cell coverage and blood pressure. Instead, concurrent with the post-natal transient delay of radial outgrowth and the formation of adult tortuous arteries, Elk3-dependent effects on the expression of Angiopoietin/Tie-signalling components were observed. Moreover, in vitro microvessel sprouting and microtube formation from P10 and adult aortic ring explants were reduced. Collectively, these results indicate that Elk3 has distinct roles in maintaining retinal artery integrity. The Elk3 knockout mouse is presented as a new animal model to study retinal artery tortuousity in mice and human patients.	[Weinl, Christine; Riehle, Heidemarie; Stritt, Christine; Nordheim, Alfred] Univ Tubingen, Dept Mol Biol, Interfac Inst Cell Biol, Tubingen, Germany; [Wasylyk, Christine; Roux, Michel J.; Wasylyk, Bohdan] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Wasylyk, Christine; Roux, Michel J.; Wasylyk, Bohdan] Ctr Natl Rech Sci, Illkirch Graffenstaden, France; [Wasylyk, Christine; Roux, Michel J.; Wasylyk, Bohdan] Inst Natl Sante & Rech Med, Illkirch Graffenstaden, France; [Wasylyk, Christine; Roux, Michel J.; Wasylyk, Bohdan] Univ Strasbourg, Illkirch Graffenstaden, France; [Garrido, Marina Garcia; Sothilingam, Vithiyanjali; Beck, Susanne C.; Seeliger, Mathias W.] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Div Ocular Neurodegenerat, Tubingen, Germany	Eberhard Karls University of Tubingen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Nordheim, A (corresponding author), Univ Tubingen, Dept Mol Biol, Interfac Inst Cell Biol, Tubingen, Germany.	alfred.nordheim@uni-tuebingen.de	Wasylyk, Bohdan/ABG-6778-2020; Roux, Michel J/A-3213-2009	Wasylyk, Bohdan/0000-0002-1718-1237; Roux, Michel J/0000-0002-5812-5215; Nordheim, Alfred/0000-0003-4680-0778	Hyponet, PLBIO; Fondation ARC pour la recherche sur le cancer, SF; Centre national de la recherche scientifique; Universite Strasbourg; Deutsche Forschungsgemeinschaft [Se837/6-2]; German Cancer Aid [109886]	Hyponet, PLBIO; Fondation ARC pour la recherche sur le cancer, SF; Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Strasbourg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe)	This work was supported by Hyponet, PLBIO2010 (http://www.e-cancer.fr, BW); Fondation ARC pour la recherche sur le cancer, SF2010 (http://www.recherche-cancer.net, BW); Centre national de la recherche scientifique, institutional funds (BW); Universite Strasbourg, institutional funds (http://www.unistra.fr, BW); Deutsche Forschungsgemeinschaft, Se837/6-2 (http://www.dfg.de, MWS); and German Cancer Aid, 109886 (http://www.krebshilfe.de, AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Ayadi A, 2001, EMBO J, V20, P5139, DOI 10.1093/emboj/20.18.5139; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Cesari F, 2004, MOL CELL BIOL, V24, P294, DOI 10.1128/MCB.24.1.294-305.2004; Costello P, 2010, J IMMUNOL, V185, P1082, DOI 10.4049/jimmunol.1000472; Costello PS, 2004, NAT IMMUNOL, V5, P289, DOI 10.1038/ni1038; D'Amico G, 2014, J CLIN INVEST, V124, P824, DOI 10.1172/JCI68897; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Favazza TL, 2013, DOC OPHTHALMOL, V127, P3, DOI 10.1007/s10633-013-9392-z; Feng YX, 2009, THROMB HAEMOSTASIS, V102, P120, DOI 10.1160/TH08-09-0567; Franco CA, 2013, DEVELOPMENT, V140, P2321, DOI 10.1242/dev.091074; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Heo SH, 2014, INT J BIOL SCI, V10, P438, DOI 10.7150/ijbs.8095; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kashani AH, 2014, OPHTHALMOLOGY; Labriola LT, 2009, SEMIN OPHTHALMOL, V24, P247, DOI 10.3109/08820530903389353; Meyer S, 2005, KLIN PADIATR, V217, P36, DOI 10.1055/s-2004-822635; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; Nishina S, 2009, OPHTHALMOLOGY, V116, P2442, DOI 10.1016/j.ophtha.2009.05.011; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Pressler A, 2010, AM J CARDIOL, V105, P740, DOI 10.1016/j.amjcard.2009.10.070; Robinson R, 2011, INVEST OPHTH VIS SCI, V52, P7423, DOI 10.1167/iovs.11-7912; Saidi T, 2011, INVEST OPHTH VIS SCI, V52, P8993, DOI 10.1167/iovs.11-8423; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Shamsa K, 2010, AM J CARDIOL, V105, P408, DOI 10.1016/j.amjcard.2009.09.046; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SUZUKI MT, 1985, EXP ANIM TOKYO, V34, P131, DOI 10.1538/expanim1978.34.2_131; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Tsui I, 2009, SEMIN OPHTHALMOL, V24, P262, DOI 10.3109/08820530903400739; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Weinhold B, 2000, EMBO J, V19, P5835, DOI 10.1093/emboj/19.21.5835; Weinl C, 2013, J CLIN INVEST, V123, P2193, DOI 10.1172/JCI64201; Wozniak MA, 2012, CURR BIOL, V22, P2017, DOI 10.1016/j.cub.2012.08.050; Zheng H, 2003, GENE DEV, V17, P2283, DOI 10.1101/gad.272503	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e107048	10.1371/journal.pone.0107048	http://dx.doi.org/10.1371/journal.pone.0107048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3IF	25203538	Green Submitted, gold, Green Published			2022-12-27	WOS:000342684500065
J	Brockmeier, EK; Jayasinghe, BS; Pine, WE; Wilkinson, KA; Denslow, ND				Brockmeier, Erica K.; Jayasinghe, B. Sumith; Pine, William E.; Wilkinson, Krystan A.; Denslow, Nancy D.			Exposure to Paper Mill Effluent at a Site in North Central Florida Elicits Molecular-Level Changes in Gene Expression Indicative of Progesterone and Androgen Exposure	PLOS ONE			English	Article							MOSQUITOFISH GAMBUSIA-HOLBROOKI; EASTERN MOSQUITOFISH; FEMALE MOSQUITOFISH; PIMEPHALES-PROMELAS; FENHOLLOWAY RIVER; IN-VITRO; ANAL FIN; ANDROSTENEDIONE; AFFINIS; PULP	Endocrine disrupting compounds (EDCs) are chemicals that negatively impact endocrine system function, with effluent from paper mills one example of this class of chemicals. In Florida, female Eastern mosquitofish (Gambusia holbrooki) have been observed with male secondary sexual characteristics at three paper mill-impacted sites, indicative of EDC exposure, and are still found at one site on the Fenholloway River. The potential impacts that paper mill effluent exposure has on the G. holbrooki endocrine system and the stream ecosystem are unknown. The objective of this study was to use gene expression analysis to determine if exposure to an androgen receptor agonist was occurring and to couple this analysis with in vitro assays to evaluate the presence of androgen and progesterone receptor active chemicals in the Fenholloway River. Focused gene expression analyses of masculinized G. holbrooki from downstream of the Fenholloway River paper mill were indicative of androgen exposure, while genes related to reproduction indicated potential progesterone exposure. Hepatic microarray analysis revealed an increase in the expression of metabolic genes in Fenholloway River fish, with similarities in genes and biological processes compared to G. holbrooki exposed to androgens. Water samples collected downstream of the paper mill and at a reference site indicated that progesterone and androgen receptor active chemicals were present at both sites, which corroborates previous chemical analyses. Results indicate that G. holbrooki downstream of the Fenholloway River paper mill are impacted by a mixture of both androgens and progesterones. This research provides data on the mechanisms of how paper mill effluents in Florida are acting as endocrine disruptors.	[Brockmeier, Erica K.; Jayasinghe, B. Sumith; Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Ctr Environm & Human Toxicol, Gainesville, FL 32610 USA; [Pine, William E.; Wilkinson, Krystan A.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA; [Wilkinson, Krystan A.] Mote Marine Lab, Chicago Zool Soc, Sarasota, FL 34236 USA; [Denslow, Nancy D.] Univ Florida, Genet Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Mote Marine Laboratory & Aquarium; State University System of Florida; University of Florida	Brockmeier, EK (corresponding author), Univ Florida, Dept Physiol Sci, Ctr Environm & Human Toxicol, Gainesville, FL 32610 USA.	ekanderson@ufl.edu; ndenslow@ufl.edu		Wilkinson, Krystan A./0000-0002-2921-6011; Brockmeier, Erica/0000-0002-7451-4325	University of Florida College of Veterinary Medicine Faculty Grant; U.S. Environmental Protection Agency Science to Achieve Results (STAR) Fellowship [91728101-0]	University of Florida College of Veterinary Medicine Faculty Grant; U.S. Environmental Protection Agency Science to Achieve Results (STAR) Fellowship	This study was supported by the University of Florida College of Veterinary Medicine Faculty Grant. Additional support to EB was provided by the U.S. Environmental Protection Agency Science to Achieve Results (STAR) Fellowship 91728101-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI [10.1897/1551-5028(2003)022&lt;1350:EOTAGP&gt;2.0.CO;2, 10.1002/etc.5620220623]; Arukwe Augustine, 2003, Comp Hepatol, V2, P4; Bortone SA, 1999, B ENVIRON CONTAM TOX, V63, P150, DOI 10.1007/s001289900960; Bortone SA, 1981, ASS SE BIOL B, V28, P67; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brockmeier EK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-660; Brockmeier EK, 2013, AQUAT TOXICOL, V128, P163, DOI 10.1016/j.aquatox.2012.12.007; Carson JD, 2008, ENVIRON TOXICOL CHEM, V27, P1273, DOI 10.1897/07-515; Costigan SL, 2012, AQUAT TOXICOL, V122, P44, DOI 10.1016/j.aquatox.2012.05.011; Denslow ND, 2007, MOL BIOSYST, V3, P172, DOI 10.1039/b612802p; Dorts J, 2009, AQUAT TOXICOL, V91, P44, DOI 10.1016/j.aquatox.2008.10.002; Durhan EJ, 2002, ENVIRON TOXICOL CHEM, V21, P1973, DOI [10.1002/etc.5620210927, 10.1897/1551-5028(2002)021&lt;1973:EOAAAA&gt;2.0.CO;2]; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Escher BI, 2014, ENVIRON SCI TECHNOL, V48, P1940, DOI 10.1021/es403899t; HAYNES JL, 1995, COPEIA, P147; Hewitt LM, 2008, ENVIRON TOXICOL CHEM, V27, P1226; Hou LP, 2011, AQUAT TOXICOL, V103, P140, DOI 10.1016/j.aquatox.2011.02.018; HOWELL WM, 1980, COPEIA, P676; Jenkins R, 2001, ENVIRON TOXICOL CHEM, V20, P1325, DOI 10.1002/etc.5620200622; Jenkins RL, 2004, ENVIRON HEALTH PERSP, V112, P1508, DOI 10.1289/ehp.7161; Jenkins RL, 2003, TOXICOL SCI, V73, P53, DOI 10.1093/toxsci/kfg042; Kristensen T, 2007, AQUAT TOXICOL, V81, P245, DOI 10.1016/j.aquatox.2006.12.005; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Mori T, 1998, J STEROID BIOCHEM, V67, P133, DOI 10.1016/S0960-0760(98)00099-5; Ogino Y, 2004, FEBS LETT, V575, P119, DOI 10.1016/j.febslet.2004.08.046; Ogino Y, 2011, EVOL DEV, V13, P315, DOI 10.1111/j.1525-142X.2011.00482.x; Orlando EF, 2007, AQUAT TOXICOL, V84, P399, DOI 10.1016/j.aquatox.2007.06.018; Orlando EF, 2007, 2 HLTH PERSP, V110, P429; Orrego R, 2010, AQUAT TOXICOL, V99, P160, DOI 10.1016/j.aquatox.2010.04.016; Parks LG, 2001, TOXICOL SCI, V62, P257, DOI 10.1093/toxsci/62.2.257; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schirra F, 2007, CURR EYE RES, V32, P393, DOI 10.1080/02713680701316674; Stanko JP, 2007, ENVIRON TOXICOL CHEM, V26, P920, DOI 10.1897/06-201R.1; Toft G, 2004, AQUAT TOXICOL, V70, P213, DOI 10.1016/j.aquatox.2004.09.002; Tremblay L, 1999, ENVIRON TOXICOL CHEM, V18, P329, DOI [10.1002/etc.5620180233, 10.1897/1551-5028(1999)018&lt;0329:CBTEOT&gt;2.3.CO;2]; Turner CL, 1941, BIOL BULL-US, V80, P371, DOI 10.2307/1537723; Villeneuve DL, 2006, AQUAT TOXICOL, V76, P353, DOI 10.1016/j.aquatox.2005.10.016; Wartman CA, 2009, AQUAT TOXICOL, V92, P131, DOI 10.1016/j.aquatox.2009.02.003; Werner J, 2010, ENVIRON TOXICOL CHEM, V29, P430, DOI 10.1002/etc.48	39	16	16	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106644	10.1371/journal.pone.0106644	http://dx.doi.org/10.1371/journal.pone.0106644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198161	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700038
J	Liu, ZM; Chen, Y; Tao, RC; Xv, J; Meng, JY; Yong, XZ				Liu, Zhenmin; Chen, Yi; Tao, Renchuan; Xv, Jing; Meng, Jianyuan; Yong, Xiangzhi			Tacrolimus-Based versus Cyclosporine-Based Immunosuppression in Hepatitis C Virus-Infected Patients after Liver Transplantation: A Meta-Analysis and Systematic Review	PLOS ONE			English	Article							CALCINEURIN INHIBITORS; RECURRENT HEPATITIS; FIBROSIS PROGRESSION; RANDOMIZED-TRIALS; NATURAL-HISTORY; META-REGRESSION; HCV RECURRENCE; RECIPIENTS; REPLICATION; IMPACT	Background: Most liver transplant recipients receive calcineurin inhibitors (CNIs), especially tacrolimus and cyclosporine, as immunosuppressant agents to prevent rejection. A controversy exists as to whether the outcomes of hepatitis C virus (HCV)-infected liver transplant patients differ based on the CNIs used. This meta-analysis compares the clinical outcomes of tacrolimus-based and cyclosporine-based immunosuppression, especially cases of HCV recurrence in liver transplant patients with end-stage liver disease caused by HCV infection. Methods: Related articles were identified from the Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, Medline, and Embase. Meta-analyses were performed for the results of homogeneous studies. Results: Nine randomized or quasi-randomized controlled trials were included. The total effect size of mortality (RR = 0.98, 95% CI: 0.77-1.25, P = 0.87) and graft loss (RR = 1.05, 95% CI: 0.83-1.33, P = 0.67) showed no significant difference between the two groups irrespective of duration of immunosuppressant therapy after liver transplantation. In addition, the HCV recurrence-induced mortality (RR = 1.11, 95% CI: 0.66-1.89, P = 0.69), graft loss (RR = 1.62, 95% CI: 0.64-4.07, P = 0.31) and retransplantation (RR = 1.40, 95% CI: 0.48-4.09, P = 0.54), as well as available biopsies, confirmed that histological HCV recurrences (RR = 0.92, 95% CI: 0.71-1.19, P = 0.51) were similar. Conclusion: These results suggested no difference in posttransplant HCV recurrence-induced mortality, graft loss and retransplantation, as well as histological HCV recurrence in patients treated with tacrolimus-based and cyclosporine-based immunosuppresion.	[Liu, Zhenmin; Chen, Yi; Tao, Renchuan; Yong, Xiangzhi] Guangxi Med Univ, Dept Periodontol & Oral Med, Coll Stomatol, Nanning, Guangxi, Peoples R China; [Xv, Jing; Meng, Jianyuan] Guangxi Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Tao, RC (corresponding author), Guangxi Med Univ, Dept Periodontol & Oral Med, Coll Stomatol, Nanning, Guangxi, Peoples R China.	taorenchuan@gmail.com			National Natural Science Foundation of China [NSFC81260167]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (NSFC81260167), funder's website: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal K, 2013, DIGEST LIVER DIS, V45, pS349, DOI 10.1016/j.dld.2013.07.014; Barbier L, 2013, J HEPATOL, V59, P1223, DOI 10.1016/j.jhep.2013.07.032; Ben-Ari Z, 2003, TRANSPL P, V35, P612, DOI 10.1016/S0041-1345(03)00009-5; Berenguer M, 2005, J HEPATOL, V42, P448, DOI 10.1016/j.jhep.2005.01.011; Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993; Berenguer M, 2000, J HEPATOL, V32, P673, DOI 10.1016/S0168-8278(00)80231-7; Berenguer M, 2007, LIVER TRANSPLANT, V13, P21, DOI 10.1002/lt.21035; Berenguer M, 2010, TRANSPLANTATION, V90, P1204, DOI 10.1097/TP.0b013e3181fa93fa; CANAFAX DM, 1983, CLIN PHARMACY, V2, P515; Charlton M, 1998, HEPATOLOGY, V28, P823, DOI 10.1002/hep.510280333; Ciria R, 2013, WORLD J HEPATOL, V5, P237, DOI 10.4254/wjh.v5.i5.237; Cooke GS, 2013, J VIRAL HEPATITIS, V20, P600, DOI 10.1111/jvh.12123; Dumortier J, 2013, LIVER TRANSPLANT, V19, P529, DOI 10.1002/lt.23638; Firpi RJ, 2006, LIVER TRANSPLANT, V12, P51, DOI 10.1002/lt.20532; Firpi RJ, 2010, DIGEST DIS SCI, V55, P196, DOI 10.1007/s10620-009-0981-3; Foxton MR, 2006, AM J TRANSPLANT, V6, P1922, DOI 10.1111/j.1600-6143.2006.01408.x; Gane EJ, 2008, LIVER TRANSPLANT, V14, pS36, DOI 10.1002/lt.21646; Ghobrial RM, 2001, ANN SURG, V234, P384, DOI 10.1097/00000658-200109000-00012; GORDON RD, 1986, SURG CLIN N AM, V66, P541; Kim RD, 2012, DIGEST DIS SCI, V57, P568, DOI 10.1007/s10620-011-1871-z; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lai JC, 2011, HEPATOLOGY, V54, P418, DOI 10.1002/hep.24390; Levy G, 2014, AM J TRANSPLANT, V14, P635, DOI 10.1111/ajt.12620; Levy G, 2006, LIVER TRANSPLANT, V12, P1464, DOI 10.1002/lt.20802; Martin P, 2004, LIVER TRANSPLANT, V10, P1258, DOI 10.1002/lt.20222; MUELLER AR, 1995, CLIN TRANSPLANT, V9, P176; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; Samonakis DN, 2012, J HEPATOL, V56, P973, DOI 10.1016/j.jhep.2011.06.031; Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350; Segev DL, 2008, LIVER TRANSPLANT, V14, P512, DOI 10.1002/lt.21396; Selzner N, 2009, TRANSPLANTATION, V88, P1214, DOI 10.1097/TP.0b013e3181bd783c; Sgourakis G, 2009, TRANSPL INT, V22, P892, DOI 10.1111/j.1432-2277.2009.00893.x; Shenoy S, 2008, LIVER TRANSPLANT, V14, P173, DOI 10.1002/lt.21355; Villamil F, 2006, TRANSPL P, V38, P2964, DOI 10.1016/j.transproceed.2006.08.131; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Wiesner RH, 1998, TRANSPLANTATION, V66, P493, DOI 10.1097/00007890-199808270-00014; ZEEVI A, 1987, TRANSPLANT P, V19, P40; Zervos XA, 1998, TRANSPLANTATION, V65, P1044, DOI 10.1097/00007890-199804270-00006	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107057	10.1371/journal.pone.0107057	http://dx.doi.org/10.1371/journal.pone.0107057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198195	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700078
J	Dreier, M; Borutta, B; Seidel, G; Munch, I; Kramer, S; Toppich, J; Dierks, ML; Walter, U				Dreier, Maren; Borutta, Birgit; Seidel, Gabriele; Muench, Inga; Kramer, Silke; Toeppich, Juergen; Dierks, Marie-Luise; Walter, Ulla			Communicating the Benefits and Harms of Colorectal Cancer Screening Needed for an Informed Choice: A Systematic Evaluation of Leaflets and Booklets	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DECISION AID; INFORMATION; OVERDIAGNOSIS; CRITERIA; ADULTS	Objective: Evidence-based health information (EBHI) can support informed choice regarding whether or not to attend colorectal cancer (CRC) screening. The present study aimed to assess if German leaflets and booklets appropriately inform consumers on the benefits and harms of CRC screening. Methods: A systematic search for print media on CRC screening was performed via email enquiry and internet search. The identified documents were assessed for the presence and correctness of information on benefits and harms by two reviewers independently using a comprehensive list of criteria. Results: Many of the 28 leaflets and 13 booklets identified presented unbalanced information on the benefits and harms of CRC screening: one-third did not provide any information on harms. Numeracy information was often lacking. Ten cross-language examples of common misinterpretations or basically false and misleading information were identified. Discussion: Most of the CRC screening leaflets and booklets in Germany do not meet current EBHI standards. After the study, the publishers of the information materials were provided feedback, including a discussion of our findings. The results can be used to revise existing information materials or to develop new materials that provide correct, balanced, quantified, understandable and unbiased information on CRC screening.	[Dreier, Maren; Borutta, Birgit; Seidel, Gabriele; Muench, Inga; Kramer, Silke; Dierks, Marie-Luise; Walter, Ulla] Hannover Med Sch, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany; [Toeppich, Juergen] Fed Ctr Hlth Educ BZgA, Cologne, Germany	Hannover Medical School	Dreier, M (corresponding author), Hannover Med Sch, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany.	Dreier.Maren@mh-hannover.de			German Federal Ministry of Health; Institute for Epidemiology, Social Medicine and Health System Research	German Federal Ministry of Health; Institute for Epidemiology, Social Medicine and Health System Research	This work was supported in part by the German Federal Ministry of Health. Further support came from internal funding sources supplied by the Institute for Epidemiology, Social Medicine and Health System Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006776.pub2; Austoker J, 2012, ENDOSCOPY S3, V44, pSE164; Bretthauer M, 2013, BRIT J SURG, V100, P55, DOI 10.1002/bjs.8995; Bunge M, 2010, PATIENT EDUC COUNS, V78, P316, DOI 10.1016/j.pec.2009.10.029; Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; Dreier M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-843; Eckstrom E, 2013, J GEN INTERN MED, V28, P292, DOI 10.1007/s11606-012-2227-x; Elmore JG, 2012, ANN INTERN MED, V156, P536, DOI 10.7326/0003-4819-156-7-201204030-00012; Elmunzer BJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001352; Elwyn G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004705; General Medical Council, 2008, CONS PAT DOCT MAK DE; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6386; Hawkes N, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6905; Heleno B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5334; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hirschberg I, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-405; Jorgensen KJ, 2009, J MED ETHICS, V35, P268, DOI 10.1136/jme.2008.027961; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Khazaal Y, 2012, PSYCHIAT QUART, V83, P15, DOI 10.1007/s11126-011-9179-x; Marteau TM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2138; National Cancer Institute, TESTS DET COL CANC; National Cancer Plan Germany, 2012, AKT STAND NAT KREBSP; Nuovo J, 2002, JAMA-J AM MED ASSOC, V287, P2813, DOI 10.1001/jama.287.21.2813; Patera N, 2010, SCREENING COLORECT 1; Pox CP, 2012, GASTROENTEROLOGY, V142, P1460, DOI 10.1053/j.gastro.2012.03.022; Raffle AE, 2007, SCREENING EVIDENCE P, P1; Smith SK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5370; Smith SK, 2009, PATIENT EDUC COUNS, V75, P358, DOI 10.1016/j.pec.2009.01.012; Steckelberg A, 2001, Z Arztl Fortbild Qualitatssich, V95, P535; Steckelberg A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3193; van Dam L, 2013, EUR J CANCER, V49, P2321, DOI 10.1016/j.ejca.2013.03.007; Wagner CV, 2011, EVID BASED NURS, V14, P36; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Woloshin S, 2012, NEW ENGL J MED, V367, P1677, DOI 10.1056/NEJMp1209407	37	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e107575	10.1371/journal.pone.0107575	http://dx.doi.org/10.1371/journal.pone.0107575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP0SM	25215867	Green Published, Green Submitted, gold			2022-12-27	WOS:000341774300081
J	Hammarsten, P; Winther, J; Rudolfsson, SH; Haggstrom, J; Karalija, A; Egevad, L; Granfors, T; Fowler, CJ				Hammarsten, Peter; Winther, Johanna; Rudolfsson, Stina H.; Haggstrom, Jenny; Karalija, Amar; Egevad, Lars; Granfors, Torvald; Fowler, Christopher J.			ErbB2 Receptor Immunoreactivity in Prostate Cancer: Relationship to the Androgen Receptor, Disease Severity at Diagnosis and Disease Outcome	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HOUSEKEEPING GENES; GLEASON SCORE; ADULT RATS; EXPRESSION; HER-2/NEU; HER2; TESTOSTERONE; TISSUE; CELLS	Background: ErbB2 is a member of the epidermal growth factor family of tyrosine kinases that is centrally involved in the pathogenesis of prostate cancer and several studies have reported that a high expression of this protein has prognostic value. In the present study, we have investigated whether tumour ErbB2 immunoreactivity (ErbB2-IR) has clinically useful prognostic value, i.e. that it provides additional prognostic information to that provided by routine clinical tests (Gleason score, tumour stage). Methodology/Principal Findings: ErbB2-IR was measured in a well-characterised tissue microarray of tumour and nonmalignant samples obtained at diagnosis. Additionally, mRNA levels of ErbB2-IR in the prostate were determined in the rat following manipulation of circulating androgen levels. Tumour ErbB2-IR was significantly associated with the downstream signalling molecule phosphorylated-Akt and with the cell proliferation marker Ki-67. The significant association of tumour ErbB2-IR with the Gleason score at diagnosis was lost when controlled for the association of both parameters with Ki-67. In the rat prostate, mRNA for ErbB2 was inversely associated with circulating androgen levels. There was no association between ErbB2-IR and the androgen receptor (AR)-IR in the tumours, but an interaction between the two parameters was seen with respect to their association with the tumour stage. Tumour ErbB2-IR was confirmed to be a prognostic marker for disease-specific survival, but it did not provide significant additive information to the Gleason score or to Ki-67. Conclusions/Significance: It is concluded that tumour ErbB2-IR is of limited clinical value as a prognostic marker to aid treatment decisions, but could be of pathophysiological importance in prostate cancer.	[Hammarsten, Peter] Umea Univ, Dept Med Biosci, Umea, Sweden; [Winther, Johanna; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Rudolfsson, Stina H.] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Haggstrom, Jenny] Umea Univ, Dept Stat, Umea Sch Business & Econ, S-90187 Umea, Sweden; [Karalija, Amar] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Egevad, Lars] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Granfors, Torvald] Cent Hosp Vasteras, Dept Urol, Vasteras, Sweden	Umea University; Umea University; Umea University; Umea University; Umea University; Karolinska Institutet; Karolinska University Hospital; Vasteras Central Hospital	Hammarsten, P (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	peter.hammarsten@medbio.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874; Rudolfsson, Stina/0000-0001-8241-1089; Haggstrom, Jenny/0000-0002-9086-7403	Swedish Research Council [12158]; Swedish Cancer Society [CAN2010/437]; Lion's Cancer Research Foundation, Umea University; Cancer Research Foundation in Northern Sweden; Research Funds of the Medical Faculty, Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Lion's Cancer Research Foundation, Umea University; Cancer Research Foundation in Northern Sweden; Research Funds of the Medical Faculty, Umea University	This work was supported by grants from the Swedish Research Council (Grant no. 12158, medicine, C.J. Fowler); the Swedish Cancer Society (Grant no. CAN2010/437, C.J. Fowler); Lion's Cancer Research Foundation, Umea University (P. Hammarsten and C.J. Fowler); the Cancer Research Foundation in Northern Sweden (P. Hammarsten), and the Research Funds of the Medical Faculty, Umea University (C.J. Fowler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2011, P NATL ACAD SCI USA, V108, P16392, DOI 10.1073/pnas.1101263108; Berger R, 2006, CANCER RES, V66, P5723, DOI 10.1158/0008-5472.CAN-05-3928; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; Byun J, 2009, INT J CANCER, V125, P2603, DOI 10.1002/ijc.24680; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Eccles SA, 2011, INT J DEV BIOL, V55, P685, DOI 10.1387/ijdb.113396se; Egevad L, 2002, BJU INT, V89, P538, DOI 10.1046/j.1464-410X.2002.02669.x; Fan Jerome, 2006, CJEM, V8, P19; Franck-Lissbrant I, 1998, ENDOCRINOLOGY, V139, P451, DOI 10.1210/en.139.2.451; Gregory CW, 2005, CLIN CANCER RES, V11, P1704, DOI 10.1158/1078-0432.CCR-04-1158; Hammarsten P, 2007, PROSTATE, V67, P573, DOI 10.1002/pros.20529; Hammarsten P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047994; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Hus F-N, 2011, AM J PHYSIOL-ENDOC M, V300, pE902; Jathal MKm, 2001, IMMUNOL ENDOCR METAB, V11, P131; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; Khimani AH, 2005, BIOTECHNIQUES, V38, P739, DOI 10.2144/05385ST04; Le Page C, 2012, PROSTATE, V72, P777, DOI 10.1002/pros.21483; Lehmann R., 1977, BIOMETRICAL J, V19, P229; Lyne JC, 1997, CANCER J SCI AM, V3, P21; Marengo SR, 1997, MOL CARCINOGEN, V19, P165; Mendoza N, 2002, CANCER RES, V62, P5485; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Myers RB, 1999, INT J CANCER, V82, P424, DOI 10.1002/(SICI)1097-0215(19990730)82:3<424::AID-IJC16>3.0.CO;2-B; Osman I, 2001, CLIN CANCER RES, V7, P2643; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Ricciardelli C, 2008, PROSTATE, V68, P830, DOI 10.1002/pros.20747; Sendur MAN, 2012, CURR MED RES OPIN, V28, P1709, DOI 10.1185/03007995.2012.728132; Neto AS, 2010, J UROLOGY, V184, P842, DOI 10.1016/j.juro.2010.04.077; Veltri RW, 2008, PROSTATE, V68, P1806, DOI 10.1002/pros.20848; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2014	9	9							e105063	10.1371/journal.pone.0105063	http://dx.doi.org/10.1371/journal.pone.0105063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0SM	25215939	gold, Green Published, Green Submitted			2022-12-27	WOS:000341774300001
J	Fu, ZJ; Li, WH; Zhang, QB; Wang, L; Zhang, XX; Song, GL; Fu, ZY; Ding, D; Liu, ZH; Tang, JH				Fu, Zhongjun; Li, Weihua; Zhang, Qinbin; Wang, Long; Zhang, Xiaoxiang; Song, Guiliang; Fu, Zhiyuan; Ding, Dong; Liu, Zonghua; Tang, Jihua			Quantitative Trait Loci for Mercury Accumulation in Maize (Zea mays L.) Identified Using a RIL Population	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; ARABIDOPSIS-THALIANA; INORGANIC MERCURY; RICE; PLANT; METHYLMERCURY; TOLERANCE; PHYTOREMEDIATION; BIOACCUMULATION; CONTAMINATION	To investigate the genetic mechanism of mercury accumulation in maize (Zea mays L.), a population of 194 recombinant inbred lines derived from an elite hybrid Yuyu 22, was used to identify quantitative trait loci (QTLs) for mercury accumulation at two locations. The results showed that the average Hg concentration in the different tissues of maize followed the order: leaves > bracts > stems > axis > kernels. Twenty-three QTLs for mercury accumulation in five tissues were detected on chromosomes 1, 4, 7, 8, 9 and 10, which explained 6.44% to 26.60% of the phenotype variance. The QTLs included five QTLs for Hg concentration in kernels, three QTLs for Hg concentration in the axis, six QTLs for Hg concentration in stems, four QTLs for Hg concentration in bracts and five QTLs for Hg concentration in leaves. Interestingly, three QTLs, qKHC9a, qKHC9b, and qBHC9 were in linkage with two QTLs for drought tolerance. In addition, qLHC1 was in linkage with two QTLs for arsenic accumulation. The study demonstrated the concentration of Hg in Hg-contaminated paddy soil could be reduced, and maize production maintained simultaneously by selecting and breeding maize Hg pollution-safe cultivars (PSCs).	[Fu, Zhongjun; Li, Weihua; Zhang, Qinbin; Wang, Long; Zhang, Xiaoxiang; Song, Guiliang; Fu, Zhiyuan; Ding, Dong; Liu, Zonghua; Tang, Jihua] Henan Agr Univ, Coll Agron, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crops Sci, Zhengzhou, Peoples R China; [Fu, Zhongjun] Chongqing Acad Agr Sci, Maize Res Inst, Chongqing, Peoples R China	Henan Agricultural University	Liu, ZH (corresponding author), Henan Agr Univ, Coll Agron, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crops Sci, Zhengzhou, Peoples R China.	zhliu4000@sohu.com; tangjihua1@163.com		fu, zhiyuan/0000-0002-9078-5133	State Key Basic Research and Development Plan of China [2014CB138203]; Scientific Personnel Innovation Fund of Henan Province in China	State Key Basic Research and Development Plan of China(National Basic Research Program of China); Scientific Personnel Innovation Fund of Henan Province in China	This work was supported by the State Key Basic Research and Development Plan of China (2014CB138203) and Scientific Personnel Innovation Fund of Henan Province in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas ES, 2012, IRANIAN J TOXICOLOGY, V15, P541; Boening DW, 2000, CHEMOSPHERE, V40, P1335, DOI 10.1016/S0045-6535(99)00283-0; Chen J, 2009, ECOTOXICOLOGY, V18, P110, DOI 10.1007/s10646-008-0264-3; Chen YA, 2012, PLANT PHYSIOL BIOCH, V55, P23, DOI 10.1016/j.plaphy.2012.03.008; Chen Z, 2012, PLANT SCI, V197, P10, DOI 10.1016/j.plantsci.2012.08.005; China National Environmental Monitoring Station, 1990, BACKGR EL CONC CHIN, P8; Chinese National Standard Agency, 1994, GB276294 CHIN NAT ST; Ding D, 2011, PLOS ONE, V6; Drum DA, 2009, BIOMETALS, V22, P697, DOI 10.1007/s10534-009-9212-9; Du X, 2005, ENVIRON EXP BOT, V54, P1, DOI 10.1016/j.envexpbot.2004.05.001; Elbaz A, 2010, ECOTOXICOLOGY, V19, P1285, DOI 10.1007/s10646-010-0514-z; Grant CA, 2008, SCI TOTAL ENVIRON, V390, P301, DOI 10.1016/j.scitotenv.2007.10.038; Gupta P, 2013, PLANT PHYSIOL BIOCH, V62, P63, DOI 10.1016/j.plaphy.2012.10.008; Han FX, 2006, SCI TOTAL ENVIRON, V368, P753, DOI 10.1016/j.scitotenv.2006.02.026; Han Y, 2007, J INTEGR PLANT BIOL, V49, P1703, DOI 10.1111/j.1744-7909.2007.00592.x; Heaton ACP, 2005, WATER AIR SOIL POLL, V161, P137, DOI 10.1007/s11270-005-7111-4; Heidenreich B, 2001, PLANT CELL ENVIRON, V24, P1227, DOI 10.1046/j.0016-8025.2001.00775.x; Horvat M, 2003, SCI TOTAL ENVIRON, V304, P231, DOI 10.1016/S0048-9697(02)00572-7; Hsieh JL, 2009, J HAZARD MATER, V161, P920, DOI 10.1016/j.jhazmat.2008.04.079; Israr M, 2006, CHEMOSPHERE, V65, P591, DOI 10.1016/j.chemosphere.2006.02.016; Karenlampi S, 2000, ENVIRON POLLUT, V107, P225, DOI 10.1016/S0269-7491(99)00141-4; Kramer U, 2005, CURR OPIN BIOTECH, V16, P133, DOI 10.1016/j.copbio.2005.02.006; Li P, 2009, J HAZARD MATER, V168, P591, DOI 10.1016/j.jhazmat.2009.03.031; Liu Ruhai, 2004, Yingyong Shengtai Xuebao, V15, P287; Liu WX, 2007, B ENVIRON CONTAM TOX, V79, P209, DOI 10.1007/s00128-007-9164-0; Liu Y, 2011, ENVIRON EXP BOT, V71, P158, DOI 10.1016/j.envexpbot.2010.11.010; Meng B, 2010, J AGR FOOD CHEM, V58, P4951, DOI 10.1021/jf904557x; Meng M, 2014, ENVIRON POLLUT, V184, P179, DOI 10.1016/j.envpol.2013.08.030; Zheng N, 2007, ENVIRON GEOCHEM HLTH, V29, P385, DOI 10.1007/s10653-007-9083-3; Niu ZC, 2011, ENVIRON POLLUT, V159, P2684, DOI 10.1016/j.envpol.2011.05.029; Patra M, 2000, BOT REV, V66, P379, DOI 10.1007/BF02868923; Qiu GL, 2008, J AGR FOOD CHEM, V56, P2465, DOI 10.1021/jf073391a; Rodriguez L, 2007, INT J PHYTOREMEDIAT, V9, P1, DOI 10.1080/15226510601139359; Rothenberg SE, 2012, SCI TOTAL ENVIRON, V426, P272, DOI 10.1016/j.scitotenv.2012.03.024; Ruben RA, 2006, PLANT SOIL, V279, P41, DOI DOI 10.1007/S11104-005-3900-1; Rugh CL, 1996, P NATL ACAD SCI USA, V93, P3182, DOI 10.1073/pnas.93.8.3182; Ruiz ON, 2011, PLANT BIOTECHNOL J, V9, P609, DOI 10.1111/j.1467-7652.2011.00616.x; Savenstrand H, 2004, PLANT PHYSIOL BIOCH, V42, P135, DOI 10.1016/j.plaphy.2003.11.005; Shen Q, 2011, PLANT CELL ENVIRON, V34, P752, DOI 10.1111/j.1365-3040.2011.02279.x; Sierra MJ, 2008, FOOD CHEM TOXICOL, V46, P2143, DOI 10.1016/j.fct.2008.02.009; Sierra MJ, 2011, INT J PHYTOREMEDIAT, V13, P765, DOI 10.1080/15226514.2010.525559; Smits EAHP, 2006, FRONT ECOL ENVIRON, V4, P203; Tamas L, 2010, PLANTA, V231, P221, DOI 10.1007/s00425-009-1042-z; Tang JH, 2007, EUPHYTICA, V155, P117, DOI 10.1007/s10681-006-9312-3; Wang CQ, 2013, RICE SCI, V20, P238, DOI 10.1016/S1672-6308(13)60124-9; Wang YD, 2004, J ENVIRON QUAL, V33, P1779, DOI 10.2134/jeq2004.1779; Wei YY, 2011, PLANT CELL PHYSIOL, V52, P1665, DOI 10.1093/pcp/pcr102; Wuana R. A., 2010, African Journal of General Agriculture, V6, P275; Xylander M, 1996, BOT ACTA, V109, P222, DOI 10.1111/j.1438-8677.1996.tb00567.x; Yamaguchi H, 2010, J EXP BOT, V61, P423, DOI 10.1093/jxb/erp313; Yu H, 2006, SCI TOTAL ENVIRON, V370, P302, DOI 10.1016/j.scitotenv.2006.06.013; Yu YJ, 2011, J FOOD AGRIC ENVIRON, V9, P748; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang H, 2010, ENVIRON SCI TECHNOL, V44, P4499, DOI 10.1021/es903565t; Zhang L, 2007, ENVIRON INT, V33, P108, DOI 10.1016/j.envint.2006.06.022; Zhang WH, 1999, PLANT PHYSIOL, V120, P849, DOI 10.1104/pp.120.3.849; Zhou ZS, 2007, J INORG BIOCHEM, V101, P1, DOI 10.1016/j.jinorgbio.2006.05.011; Zornoza P., 2009, J ENVIRON SCI, V22, P421	58	10	12	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e107243	10.1371/journal.pone.0107243	http://dx.doi.org/10.1371/journal.pone.0107243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210737	gold, Green Published, Green Submitted			2022-12-27	WOS:000341855900050
J	Haddock, CJ; Blomenkamp, K; Gautam, M; James, J; Mielcarska, J; Gogol, E; Teckman, J; Skowyra, D				Haddock, Christopher J.; Blomenkamp, Keith; Gautam, Madhav; James, Jared; Mielcarska, Joanna; Gogol, Edward; Teckman, Jeffrey; Skowyra, Dorota			PiZ Mouse Liver Accumulates Polyubiquitin Conjugates That Associate with Catalytically Active 26S Proteasomes	PLOS ONE			English	Article							MUTANT ALPHA(1)-ANTITRYPSIN Z; ENDOPLASMIC-RETICULUM; PROTEIN-DEGRADATION; OXIDATIVE STRESS; CELLULAR-MODEL; MYELOMA CELLS; UBIQUITIN; ALPHA-1-ANTITRYPSIN; DISEASE; SYSTEM	Accumulation of aggregation-prone human alpha 1 antitrypsin mutant Z (AT-Z) protein in PiZ mouse liver stimulates features of liver injury typical of human alpha 1 antitrypsin type ZZ deficiency, an autosomal recessive genetic disorder. Ubiquitin-mediated proteolysis by the 26S proteasome counteracts AT-Z accumulation and plays other roles that, when inhibited, could exacerbate the injury. However, it is unknown how the conditions of AT-Z mediated liver injury affect the 26S proteasome. To address this question, we developed a rapid extraction strategy that preserves polyubiquitin conjugates in the presence of catalytically active 26S proteasomes and allows their separation from deposits of insoluble AT-Z. Compared to WT, PiZ extracts had about 4-fold more polyubiquitin conjugates with no apparent change in the levels of the 26S and 20S proteasomes, and unassembled subunits. The polyubiquitin conjugates had similar affinities to ubiquitin-binding domain of Psmd4 and co-purified with similar amounts of catalytically active 26S complexes. These data show that polyubiquitin conjugates were accumulating despite normal recruitment to catalytically active 26S proteasomes that were available in excess, and suggest that a defect at the 26S proteasome other than compromised binding to polyubiquitin chain or peptidase activity played a role in the accumulation. In support of this idea, PiZ extracts were characterized by high molecular weight, reduction-sensitive forms of selected subunits, including ATPase subunits that unfold substrates and regulate access to proteolytic core. Older WT mice acquired similar alterations, implying that they result from common aspects of oxidative stress. The changes were most pronounced on unassembled subunits, but some subunits were altered even in the 26S proteasomes co-purified with polyubiquitin conjugates. Thus, AT-Z protein aggregates indirectly impair degradation of polyubiquitinated proteins at the level of the 26S proteasome, possibly by inducing oxidative stress-mediated modifications that compromise substrate delivery to proteolytic core.	[Haddock, Christopher J.; Gautam, Madhav; James, Jared; Mielcarska, Joanna; Teckman, Jeffrey] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Blomenkamp, Keith; Teckman, Jeffrey] St Louis Univ, Sch Med, Dept Pediat, St Louis, MO 63104 USA; [Gogol, Edward] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA	Saint Louis University; Saint Louis University; University of Missouri System; University of Missouri Kansas City	Skowyra, D (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	skowyrad@slu.edu		Teckman, Jeffrey/0000-0002-4870-2621	National Institutes of Health F33 Fellowship [AI098415-01]; American Diabetes Association Research Grant [7-11-BS138]; Alpha 1 Foundation; St. Louis University Liver Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F33AI098415] Funding Source: NIH RePORTER	National Institutes of Health F33 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Research Grant(American Diabetes Association); Alpha 1 Foundation; St. Louis University Liver Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health F33 Fellowship AI098415-01 (DS), American Diabetes Association Research Grant 7-11-BS138 (DS), Alpha 1 Foundation (JT), and St. Louis University Liver Center (JT), funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek G.H., 2013, J AMINO ACIDS, V2013, DOI DOI 10.1155/2013/183421; Bancroft J, 1980, THEORY PRACTICE HIST, P187; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; CARLSON JA, 1989, J CLIN INVEST, V83, P1183, DOI 10.1172/JCI113999; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Deriziotis P, 2008, BBA-MOL BASIS DIS, V1782, P713, DOI 10.1016/j.bbadis.2008.06.011; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; DYCAICO MJ, 1989, MOL BIOL MED, V6, P137; DYCAICO MJ, 1988, SCIENCE, V242, P1409, DOI 10.1126/science.3264419; Elliott PR, 2000, PROTEIN SCI, V9, P1274, DOI 10.1110/ps.9.7.1274; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gillardon F, 2007, J NEUROCHEM, V101, P1483, DOI 10.1111/j.1471-4159.2006.04438.x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Hidvegi T, 2007, J BIOL CHEM, V282, P27769, DOI 10.1074/jbc.M704330200; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Huntington James A., 2001, Science Progress, V84, P125, DOI 10.3184/003685001783239032; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kaushal S, 2010, EXP BIOL MED, V235, P700, DOI 10.1258/ebm.2010.009297; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Kruse KB, 2006, AUTOPHAGY, V2, P135, DOI 10.4161/auto.2.2.2388; Lander GC, 2013, CURR OPIN STRUC BIOL, V23, P243, DOI 10.1016/j.sbi.2013.02.004; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Laurell CB, 1967, CLIN CHIM ACTA, V11, P395; Lindblad D, 2007, HEPATOLOGY, V46, P1228, DOI 10.1002/hep.21822; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; Mandrusiak LM, 2003, HUM MOL GENET, V12, P1497, DOI 10.1093/hmg/ddg161; Marcus NY, 2012, EXP BIOL MED, V237, P1163, DOI 10.1258/ebm.2012.012106; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Melkani GC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004024; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Nyquist K, 2014, TRENDS BIOCHEM SCI, V39, P53, DOI 10.1016/j.tibs.2013.11.003; Ortega Z, 2007, CELL MOL LIFE SCI, V64, P2245, DOI 10.1007/s00018-007-7222-8; Ortega Z, 2010, J NEUROSCI, V30, P3675, DOI 10.1523/JNEUROSCI.5673-09.2010; Pan SJ, 2009, HEPATOLOGY, V50, P275, DOI 10.1002/hep.22974; Papp E, 2006, FASEB J, V20, P1018, DOI 10.1096/fj.05-5065fje; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Piitulainen E, 2005, CHEST, V128, P2076, DOI 10.1378/chest.128.4.2076; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Shabaneh TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056132; Sifers Richard N, 2010, Proc Am Thorac Soc, V7, P376, DOI 10.1513/pats.201001-011AW; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5; SVEGER T, 1976, NEW ENGL J MED, V294, P1316, DOI 10.1056/NEJM197606102942404; SVEGER T, 1988, ACTA PAEDIATR SCAND, V77, P847, DOI 10.1111/j.1651-2227.1988.tb10767.x; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2004, AM J PHYSIOL-GASTR L, V286, pG851, DOI 10.1152/ajpgi.00175.2003; Teckman JH, 2002, AM J PHYSIOL-GASTR L, V283, pG1156, DOI 10.1152/ajpgi.00041.2002; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V278, pG39, DOI 10.1152/ajpgi.2000.278.1.G39; Teckman JH, 2001, J BIOL CHEM, V276, P44865, DOI 10.1074/jbc.M103703200; Tsutsui Y, 2008, J BIOL CHEM, V283, P30804, DOI 10.1074/jbc.M804048200; Valera AG, 2005, NEUROSCIENTIST, V11, P583, DOI 10.1177/1073858405280639; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; von Bernhardi R, 2012, ANTIOXID REDOX SIGN, V16, P974, DOI 10.1089/ars.2011.4082; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Zemskov EA, 2003, NEUROREPORT, V14, P1435, DOI 10.1097/00001756-200308060-00006	80	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2014	9	9							e106371	10.1371/journal.pone.0106371	http://dx.doi.org/10.1371/journal.pone.0106371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1UA	25210780	Green Published, gold, Green Submitted			2022-12-27	WOS:000341855900011
J	He, DY; Li, R; Huang, Q; Lei, P				He, Dayi; Li, Ran; Huang, Qi; Lei, Ping			Maximum Entropy Principle Based Estimation of Performance Distribution in Queueing Theory	PLOS ONE			English	Article							G/G/1 QUEUE; N-POLICY; SYSTEMS; SERVER; M/G/1; NETWORKS; APPROXIMATIONS; EQUILIBRIUM; BLOCKING; PRIORITY	In related research on queuing systems, in order to determine the system state, there is a widespread practice to assume that the system is stable and that distributions of the customer arrival ratio and service ratio are known information. In this study, the queuing system is looked at as a black box without any assumptions on the distribution of the arrival and service ratios and only keeping the assumption on the stability of the queuing system. By applying the principle of maximum entropy, the performance distribution of queuing systems is derived from some easily accessible indexes, such as the capacity of the system, the mean number of customers in the system, and the mean utilization of the servers. Some special cases are modeled and their performance distributions are derived. Using the chi-square goodness of fit test, the accuracy and generality for practical purposes of the principle of maximum entropy approach is demonstrated.	[He, Dayi; Li, Ran; Huang, Qi; Lei, Ping] China Univ Geosci, Sch Humanities & Econ Management, Lab Resources & Environm Management, Beijing, Peoples R China	China University of Geosciences	Lei, P (corresponding author), China Univ Geosci, Sch Humanities & Econ Management, Lab Resources & Environm Management, Beijing, Peoples R China.	leipingleiping@hotmail.com	He, Dayi/GRS-0898-2022	He, Dayi/0000-0002-8890-7998	Key Laboratory of Carrying Capacity Assessment for Resource and Environment, MLR [CCA2012.05]; Fundamental Research Funds for the Central Universities [2-9-2012-86]	Key Laboratory of Carrying Capacity Assessment for Resource and Environment, MLR; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the Key Laboratory of Carrying Capacity Assessment for Resource and Environment, MLR (CCA2012.05) and supported by the Fundamental Research Funds for the Central Universities (2-9-2012-86). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFA AS, 1991, ACTA INFORM, V28, P801, DOI 10.1007/BF01261657; Arizono Y, 1991, J OPERATIONAL RES SO, V41, P69; BARD Y, 1980, IBM J RES DEV, V24, P563, DOI 10.1147/rd.245.0563; ELAFFENDI MA, 1983, ACTA INFORM, V19, P339, DOI 10.1007/BF00290731; FALIN GI, 1994, ACTA INFORM, V31, P559, DOI 10.1007/BF01213207; FERDINAN.AE, 1970, IBM J RES DEV, V14, P539, DOI 10.1147/rd.145.0539; Golan A., 1996, MAXIMUM ENTROPY ECON; He DY, 2002, THEORIES PRACTICES S, V22, P97; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Kapur J. N., 1992, ENTROPY OPTIMIZATION; Ke JC, 2008, J COMPUT APPL MATH, V221, P1, DOI 10.1016/j.cam.2007.10.001; KOUVATSOS D, 1994, EUR J OPER RES, V77, P496, DOI 10.1016/0377-2217(94)90413-8; Kouvatsos D, 2003, PERFORM EVALUATION, V51, P191, DOI 10.1016/S0166-5316(02)00092-5; KOUVATSOS D, 1989, ACTA INFORM, V27, P247, DOI 10.1007/BF00572990; KOUVATSOS DD, 1988, J OPER RES SOC, V39, P183, DOI 10.1057/jors.1988.30; KOUVATSOS DD, 1988, ACTA INFORM, V26, P241, DOI 10.1007/BF00299634; KOUVATSOS DD, 1986, ACTA INFORM, V23, P545, DOI 10.1007/BF00288469; Shore J. E., 1978, AFIPS Conference Proceedings vol.47. 1978 National Computer Conference, P483; SHORE JE, 1982, ACTA INFORM, V17, P43, DOI 10.1007/BF00262975; Skianis CA, 1998, ANN OPER RES, V79, P143, DOI 10.1023/A:1018966520483; Tadj L, 2001, MATH COMPUT MODEL, V34, P19, DOI 10.1016/S0895-7177(01)00045-0; Walstra RJ, 1985, SIGMETRICS PERFORMAN, V13, P27; Wang KH, 2002, APPL MATH MODEL, V26, P1151, DOI 10.1016/S0307-904X(02)00056-2; WU JS, 1992, J OPER RES SOC, V43, P1063, DOI 10.2307/2584103; WU JS, 1989, J OPER RES SOC, V40, P815, DOI 10.1057/palgrave.jors.0400909	25	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106965	10.1371/journal.pone.0106965	http://dx.doi.org/10.1371/journal.pone.0106965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25207992	Green Published, Green Submitted, gold			2022-12-27	WOS:000342030300051
J	Poormohammadi, H; Eslahchi, C; Tusserkani, R				Poormohammadi, Hadi; Eslahchi, Changiz; Tusserkani, Ruzbeh			TripNet: A Method for Constructing Rooted Phylogenetic Networks from Rooted Triplets	PLOS ONE			English	Article							SET	The problem of constructing an optimal rooted phylogenetic network from an arbitrary set of rooted triplets is an NP-hard problem. In this paper, we present a heuristic algorithm called TripNet, which tries to construct a rooted phylogenetic network with the minimum number of reticulation nodes from an arbitrary set of rooted triplets. Despite of current methods that work for dense set of rooted triplets, a key innovation is the applicability of TripNet to non-dense set of rooted triplets. We prove some theorems to clarify the performance of the algorithm. To demonstrate the efficiency of TripNet, we compared TripNet with SIMPLISTIC. It is the only available software which has the ability to return some rooted phylogenetic network consistent with a given dense set of rooted triplets. But the results show that for complex networks with high levels, the SIMPLISTIC running time increased abruptly. However in all cases TripNet outputs an appropriate rooted phylogenetic network in an acceptable time. Also we tetsed TripNet on the Yeast data. The results show that Both TripNet and optimal networks have the same clustering and TripNet produced a level-3 network which contains only one more reticulation node than the optimal network.	[Poormohammadi, Hadi] Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran; [Eslahchi, Changiz] Shahid Beheshti Univ, Dept Comp Sci, GC, Tehran, Iran; [Tusserkani, Ruzbeh] Inst Res Fundamental Sci IPM, Sch Comp Sci, Tehran, Iran	Shahid Beheshti University	Eslahchi, C (corresponding author), Shahid Beheshti Univ, Dept Comp Sci, GC, Tehran, Iran.	ch-eslahchi@sbu.ac.ir	Poormohammadi, Hadi/AAC-2603-2022		Institute for Research in Fundamental Sciences (IPM), Tehran, Iran [BS-1392-1-05]	Institute for Research in Fundamental Sciences (IPM), Tehran, Iran	This work is supported in part by a grant (BS-1392-1-05) from the Institute for Research in Fundamental Sciences (IPM), Tehran, Iran. The funders had used the clusters of this institute for data collection and data analysis of this work.	AHO AV, 1981, SIAM J COMPUT, V10, P405, DOI 10.1137/0210030; Grassly NC, 1997, TREEVOLE PROGRAM SIM; Huber K, 2010, IEEE ACM T COMPUTATI; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Huson DH, 2010, PHYLOGENETIC NETWORK; Jansson J, 2006, SIAM J COMPUT, V35, P1098, DOI 10.1137/S0097539704446529; Karp R., 1972, P S COMPL COMP COMP, P85; To TH, 2009, LECT NOTES COMPUT SC, V5577, P275, DOI 10.1007/978-3-642-02441-2_25; van Iersel L, 2011, ALGORITHMICA, V60, P207, DOI 10.1007/s00453-009-9333-0; van Iersel L, 2009, IEEE ACM T COMPUT BI, V6, P667, DOI 10.1109/TCBB.2009.22	11	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e106531	10.1371/journal.pone.0106531	http://dx.doi.org/10.1371/journal.pone.0106531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208028	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300027
J	Sheets, L; Hagen, MW; Nicolson, T				Sheets, Lavinia; Hagen, Matthew W.; Nicolson, Teresa			Characterization of Ribeye Subunits in Zebrafish Hair Cells Reveals That Exogenous Ribeye B-Domain and CtBP1 Localize to the Basal Ends of Synaptic Ribbons	PLOS ONE			English	Article							CA2+ CHANNELS; SYNAPSES; PROTEINS; EXOCYTOSIS; RELEASE; BASSOON; GENES	Synaptic ribbons are presynaptic structures formed by the self-association of RIBEYE-the main structural component of ribbon synapses. RIBEYE consists of two domains: a unique N-terminal A-domain and a C-terminal B-domain that is identical to the transcription co-repressor C-terminal binding protein 2 (CtBP2). Previous studies in cell lines have shown that RIBEYE A-domain alone is sufficient to form ribbon-like aggregates and that both A- and B-domains form homo-and heterotypic interactions. As these interactions are likely the basis for synaptic-ribbon assembly and structural plasticity, we wanted to examine how zebrafish Ribeye A- and B-domains interact with synaptic ribbons in vivo. To that end, we characterized the localization of exogenously expressed Ribeye A-and B-domains and the closely related protein, CtBP1, in the hair cells of transgenic zebrafish larvae. Unexpectedly, exogenously expressed Ribeye A-domain showed variable patterns of localization in hair cells; one zebrafish paralog of A-domain failed to self-associate or localize to synaptic ribbons, while the other self-assembled but sometimes failed to localize to synaptic ribbons. By contrast, Ribeye B-domain/CtBP2 was robustly localized to synaptic ribbons. Moreover, both exogenously expressed B-domain/CtBP2 and CtBP1 were preferentially localized to the basal end of ribbons adjacent to the postsynaptic density. Overexpression of B-domain/CtBP2 also appeared to affect synaptic-ribbon composition; endogenous levels of ribbon-localized Ribeye were significantly reduced as hair cells matured in B-domain/CtBP2 transgenic larvae compared to wild-type. These results reveal how exogenously expressed Ribeye domains interact with synaptic ribbons, and suggest a potential organization of elements within the ribbon body.	[Sheets, Lavinia] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Sheets, Lavinia] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Hagen, Matthew W.; Nicolson, Teresa] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Hagen, Matthew W.; Nicolson, Teresa] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Oregon Health & Science University; Oregon Health & Science University	Sheets, L (corresponding author), Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA.	Lavinia_Sheets@meei.harvard.edu		Sheets, Lavinia/0000-0001-5231-2450; Hagen, Matthew/0000-0002-9812-2262	National Institutes of Health [R01 DC006880]; Howard Hughes Medical Institute; National Institute on Deafness and Other Communicative Disorders (Eaton-Peabody Lab) [P30 DC05029]; Jean Vollum Fund; Amelia Peabody Charitable Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute on Deafness and Other Communicative Disorders (Eaton-Peabody Lab); Jean Vollum Fund; Amelia Peabody Charitable Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding was provided by National Institutes of Health R01 DC006880 (TN), Howard Hughes Medical Institute (TN), National Institute on Deafness and Other Communicative Disorders P30 DC05029 (M. Charles Liberman Core Grant, Eaton-Peabody Lab), Jean Vollum Fund (MWH), and Amelia Peabody Charitable Fund (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Hubler D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039710; Hull C, 2006, J NEUROPHYSIOL, V96, P2025, DOI 10.1152/jn.00364.2006; Kantardzhieva A, 2012, J PROTEOME RES, V11, P1163, DOI 10.1021/pr2008972; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kim MH, 2013, J PHYSIOL-LONDON, V591, P3167, DOI 10.1113/jphysiol.2012.249482; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Magupalli VG, 2008, J NEUROSCI, V28, P7954, DOI 10.1523/JNEUROSCI.1964-08.2008; Nouvian R, 2006, J MEMBRANE BIOL, V209, P153, DOI 10.1007/s00232-005-0854-4; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Regus-Leidig H, 2010, MOL VIS, V16, P2690; Safieddine S, 2012, ANNU REV NEUROSCI, V35, P509, DOI 10.1146/annurev-neuro-061010-113705; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Schnee ME, 2011, NEURON, V70, P326, DOI 10.1016/j.neuron.2011.01.031; Schwarz K, 2011, J NEUROSCI, V31, P15996, DOI 10.1523/JNEUROSCI.2965-11.2011; Sheets L, 2012, J NEUROSCI, V32, P17273, DOI 10.1523/JNEUROSCI.3005-12.2012; Sheets L, 2011, DEVELOPMENT, V138, P1309, DOI 10.1242/dev.059451; Snellman J, 2011, NAT NEUROSCI, V14, P1135, DOI 10.1038/nn.2870; Spiwoks-Becker I, 2004, EUR J NEUROSCI, V19, P1559, DOI 10.1111/j.1460-9568.2004.03198.x; Spiwoks-Becker I, 2008, CELL TISSUE RES, V333, P185, DOI 10.1007/s00441-008-0627-3; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; Verger A, 2006, MOL CELL BIOL, V26, P4882, DOI 10.1128/MCB.02402-05; Vollrath L, 1996, MICROSC RES TECHNIQ, V35, P472, DOI 10.1002/(SICI)1097-0029(19961215)35:6<472::AID-JEMT6>3.0.CO;2-K; Wan L, 2005, J NEUROSCI, V25, P941, DOI 10.1523/JNEUROSCI.4657-04.2005; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wittig JH, 2008, J NEUROPHYSIOL, V100, P1724, DOI 10.1152/jn.90322.2008; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004	33	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2014	9	9							e107256	10.1371/journal.pone.0107256	http://dx.doi.org/10.1371/journal.pone.0107256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4EP	25208216	Green Submitted, Green Published, gold			2022-12-27	WOS:000342030300068
J	Jobson, L; Dalgleish, T				Jobson, Laura; Dalgleish, Tim			Cultural Differences in the Relationship between Intrusions and Trauma Narratives Using the Trauma Film Paradigm	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INVOLUNTARY AUTOBIOGRAPHICAL MEMORIES; SELF-DESCRIPTION; CHINESE; AMERICAN; STORIES; ADULTS; DISSOCIATION; PERSPECTIVE; INSTRUMENT	Two studies explored the influence of culture on the relationship between British and East Asian adults' autobiographical remembering of trauma film material and associated intrusions. Participants were shown aversive film clips to elicit intrusive images. Then participants provided a post-film narrative of the film content (only Study 1). In both studies, participants reported intrusive images for the film in an intrusion diary during the week after viewing. On returning the diary, participants provided a narrative of the film (delayed). The trauma film narratives were scored for memory-content variables. It was found that for British participants, higher levels of autonomous orientation (i.e. expressions of autonomy and self-determination) and self-focus in the delayed narratives were correlated significantly with fewer intrusions. For the East Asian group, lower levels of autonomous orientation and greater focus on others were correlated significantly with fewer intrusions. Additionally, Study 2 found that by removing the post-film narrative task there was a significant increase in the number of intrusions relative to Study 1, suggesting that the opportunity to develop a narrative resulted in fewer intrusions. These findings suggest that the greater the integration and contextualization of the trauma memory, and the more the trauma memory reflects culturally appropriate remembering, the fewer the intrusions.	[Jobson, Laura; Dalgleish, Tim] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Jobson, Laura] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Dalgleish, Tim] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England	University of East Anglia	Jobson, L (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge, England.	L.Jobson@uea.ac.uk	Dalgleish, Tim/E-8341-2010	Dalgleish, Tim/0000-0002-7304-2231; Jobson, Laura/0000-0002-1534-897X	National Institute for Health Research Postdoctoral Fellowship [PDF-2010-03-25]; National Institute for Health Research (NIHR) [PDF-2010-03-25]; Medical Research Council [MC_U105579215] Funding Source: researchfish	National Institute for Health Research Postdoctoral Fellowship(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Laura Jobson is funded by a National Institute for Health Research Postdoctoral Fellowship (PDF-2010-03-25) (http://www.nihr.ac.uk/research/Pages/default.aspx). This article presents independent research funded by the National Institute for Health Research (NIHR) (PDF-2010-03-25). The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berntsen D, 1996, APPL COGNITIVE PSYCH, V10, P435, DOI 10.1002/(SICI)1099-0720(199610)10:5<435::AID-ACP408>3.0.CO;2-L; Bourne C, 2010, J BEHAV THER EXP PSY, V41, P316, DOI 10.1016/j.jbtep.2010.03.001; Brewin CR, 2014, PSYCHOL BULL, V140, P69, DOI 10.1037/a0033722; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Brewin CR, 2001, BRIT J MED PSYCHOL, V74, P467, DOI 10.1348/000711201161118; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Dalgleish T, 2004, PSYCHOL BULL, V130, P228, DOI 10.1037/0033-2909.130.2.228; Deeprose C, 2012, J BEHAV THER EXP PSY, V43, P758, DOI 10.1016/j.jbtep.2011.10.008; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Diamond Adele, ANNU REV PSYCHOL, V64, P135, DOI [DOI 10.1146/annurev-clinpsy-032813-153724, 10.1146/annurev-psych-113011-143750, DOI 10.1146/ANNUREV-PSYCH-113011-143750]; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Foa EB, 2009, EFFECTIVE TREATMENTS, V2nd; Hagenaars MA, 2008, COGNITION EMOTION, V22, P944, DOI 10.1080/02699930701575151; Han JJ, 1998, DEV PSYCHOL, V34, P701, DOI 10.1037/0012-1649.34.4.701; Holmes EA, 2004, J EXP PSYCHOL GEN, V133, P3, DOI 10.1037/0096-3445.133.1.3; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; Holmes EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013706; Holmes EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004153; Jobson L., 2012, UNDERSTANDING AUTOBI; Jobson L, 2008, J CROSS CULT PSYCHOL, V39, P75, DOI 10.1177/0022022107312073; Jobson L, 2011, APPL COGNITIVE PSYCH, V25, P175, DOI 10.1002/acp.1660; Jobson L, 2009, CLIN PSYCHOL REV, V29, P368, DOI 10.1016/j.cpr.2009.03.002; Johannessen KB, 2010, CONSCIOUS COGN, V19, P847, DOI 10.1016/j.concog.2010.01.009; Krans J, 2010, J ANXIETY DISORD, V24, P134, DOI 10.1016/j.janxdis.2009.09.009; Krans J, 2010, J TRAUMA DISSOCIATIO, V11, P73, DOI 10.1080/15299730903318483; Krans J, 2009, MEMORY, V17, P809, DOI 10.1080/09658210903130780; Krans J, 2009, BEHAV RES THER, V47, P426, DOI 10.1016/j.brat.2009.01.009; Kuhn MH, 1954, AM SOCIOL REV, V19, P68, DOI 10.2307/2088175; Lee L, 1998, HDB ASIAN AM PSYCHOL; Logan S, 2012, J BEHAV THER EXP PSY, V43, P815, DOI 10.1016/j.jbtep.2011.12.003; Markus HR, 2010, PERSPECT PSYCHOL SCI, V5, P420, DOI 10.1177/1745691610375557; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Nixon RDV, 2007, BEHAV RES THER, V45, P2652, DOI 10.1016/j.brat.2007.06.010; Nixon RDV, 2009, BEHAV THER, V40, P368, DOI 10.1016/j.beth.2008.10.004; Park DC, 2010, PERSPECT PSYCHOL SCI, V5, P391, DOI 10.1177/1745691610374591; Ross M, 2002, PERS SOC PSYCHOL B, V28, P1040, DOI 10.1177/01461672022811003; Ross M, 2010, PERSPECT PSYCHOL SCI, V5, P401, DOI 10.1177/1745691610375555; Rubin DC, 2009, MEM COGNITION, V37, P679, DOI 10.3758/37.5.679; Schartau PES, 2009, J ABNORM PSYCHOL, V118, P15, DOI 10.1037/a0012906; Stuart ADP, 2006, BEHAV RES THER, V44, P611, DOI 10.1016/j.brat.2005.04.004; TRAFIMOW D, 1991, J PERS SOC PSYCHOL, V60, P649, DOI 10.1037/0022-3514.60.5.649; TRIANDIS HC, 1989, PSYCHOL REV, V96, P506, DOI 10.1037/0033-295X.96.3.506; Wang Q, 1998, COGNITION, V69, P73, DOI 10.1016/S0010-0277(98)00061-4; Wang Q, 2005, MEMORY, V13, P594, DOI 10.1080/09658210444000223; Wang Q, 2000, MEMORY, V8, P159, DOI 10.1080/096582100387588; Wang Q, 2004, J PERS, V72, P911, DOI 10.1111/j.0022-3506.2004.00285.x; Wang Q, 2001, J PERS SOC PSYCHOL, V81, P220, DOI 10.1037//0022-3514.81.2.220; Wang Q, 2000, CHILD DEV, V71, P1329, DOI 10.1111/1467-8624.00231; Wang Q, 2008, COGNITION, V108, P117, DOI 10.1016/j.cognition.2008.02.002	53	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2014	9	9							e106759	10.1371/journal.pone.0106759	http://dx.doi.org/10.1371/journal.pone.0106759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3IF	25203300	Green Published, gold, Green Submitted			2022-12-27	WOS:000342684500041
J	Culotti, A; Packman, AI				Culotti, Alessandro; Packman, Aaron I.			Pseudomonas aeruginosa Promotes Escherichia coli Biofilm Formation in Nutrient-Limited Medium	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; BACTERIAL BIOFILMS; SURVIVAL; GROWTH; INDOLE; ENVIRONMENT; CHEMOTAXIS; DETACHMENT; DISPERSAL; DYNAMICS	Biofilms have been implicated as an important reservoir for pathogens and commensal enteric bacteria such as Escherichia coli in natural and engineered water systems. However, the processes that regulate the survival of E. coli in aquatic biofilms have not been thoroughly studied. We examined the effects of hydrodynamic shear and nutrient concentrations on E. coli colonization of pre-established Pseudomonas aeruginosa biofilms, co-inoculation of E. coli and P. aeruginosa biofilms, and P. aeruginosa colonization of pre-established E. coli biofilms. In nutritionally-limited R2A medium, E. coli dominated biofilms when co-inoculated with P. aeruginosa, and successfully colonized and overgrew pre-established P. aeruginosa biofilms. In more enriched media, P. aeruginosa formed larger clusters, but E. coli still extensively overgrew and colonized the interior of P. aeruginosa clusters. In mono-culture, E. coli formed sparse and discontinuous biofilms. After P. aeruginosa was introduced to these biofilms, E. coli growth increased substantially, resulting in patterns of biofilm colonization similar to those observed under other sequences of organism introduction, i.e., E. coli overgrew P. aeruginosa and colonized the interior of P. aeruginosa clusters. These results demonstrate that E. coli not only persists in aquatic biofilms under depleted nutritional conditions, but interactions with P. aeruginosa can greatly increase E. coli growth in biofilms under these experimental conditions.	[Culotti, Alessandro; Packman, Aaron I.] Northwestern Univ, Dept Civil & Environm Engn, McCormick Sch Engn, Evanston, IL 60208 USA	Northwestern University	Packman, AI (corresponding author), Northwestern Univ, Dept Civil & Environm Engn, McCormick Sch Engn, Evanston, IL 60208 USA.	a-packman@northwestern.edu	Packman, Aaron/B-7085-2009		Water Research Foundation [4259]	Water Research Foundation	This work was supported by the Water Research Foundation Project 4259 (website: http://www.waterrf.org/Pages/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Banning N, 2003, MICROBIOL-SGM, V149, P47, DOI 10.1099/mic.0.25938-0; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Chu WH, 2012, APPL ENVIRON MICROB, V78, P411, DOI 10.1128/AEM.06396-11; Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Fass S, 1996, WATER RES, V30, P2215, DOI 10.1016/0043-1354(96)00100-5; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Heo YJ, 2007, J MICROBIOL BIOTECHN, V17, P180; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004; Ica T, 2012, APPL ENVIRON MICROB, V78, P1033, DOI 10.1128/AEM.07364-11; ISAACS H, 1994, MICROBIOL-UK, V140, P2125, DOI 10.1099/13500872-140-8-2125; Ishii S, 2008, MICROBES ENVIRON, V23, P101, DOI 10.1264/jsme2.23.101; Juhna T, 2007, APPL ENVIRON MICROB, V73, P3755, DOI 10.1128/AEM.00313-07; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Kaplan JB, 2003, J BACTERIOL, V185, P1399, DOI 10.1128/JB.185.4.1399-1404.2003; LeChevallier MW, 1996, APPL ENVIRON MICROB, V62, P2201, DOI 10.1128/AEM.62.7.2201-2211.1996; LECHEVALLIER MW, 1987, APPL ENVIRON MICROB, V53, P2714, DOI 10.1128/AEM.53.12.2714-2724.1987; Leclerc H, 2001, ANNU REV MICROBIOL, V55, P201, DOI 10.1146/annurev.micro.55.1.201; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x; Lehtola MJ, 2007, APPL ENVIRON MICROB, V73, P2854, DOI 10.1128/AEM.02916-06; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Murga R, 2001, MICROBIOL-SGM, V147, P3121, DOI 10.1099/00221287-147-11-3121; Neuhard, 1987, ESCHERICHIA COLI SAL, V1, P445; Park SR, 2001, WATER RES, V35, P1624, DOI 10.1016/S0043-1354(00)00582-0; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Purevdorj-Gage B, 2005, MICROBIOL-SGM, V151, P1569, DOI 10.1099/mic.0.27536-0; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Song JSL, 2014, BIOTECHNOL BIOENG, V111, P597, DOI 10.1002/bit.25107; STOUT JE, 1985, APPL ENVIRON MICROB, V49, P221, DOI 10.1128/AEM.49.1.221-228.1985; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; U.S.E.P, 1986, QUAL CRIT WAT; Waite RD, 2009, J BACTERIOL, V191, P1349, DOI 10.1128/JB.01458-08; Williams MM, 2003, APPL ENVIRON MICROB, V69, P5463, DOI 10.1128/AEM.69.9.5463-5471.2003; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Zhang W, 2013, FEMS MICROBIOL ECOL, V84, P344, DOI 10.1111/1574-6941.12066; Zhang W, 2011, BIOTECHNOL BIOENG, V108, P2571, DOI 10.1002/bit.23234; Zhuang WJ, 2012, ADV HEALTHC MATER, V1, P225, DOI 10.1002/adhm.201100043	47	37	40	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107186	10.1371/journal.pone.0107186	http://dx.doi.org/10.1371/journal.pone.0107186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25198725	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700093
J	Ji, X; Xu, H; Zhang, H; Hillery, CA; Gao, HQ; Pritchard, KA				Ji, Xiang; Xu, Hao; Zhang, Hao; Hillery, Cheryl A.; Gao, Hai-qing; Pritchard, Kirkwood A., Jr.			Anion Exchange HPLC Isolation of High-Density Lipoprotein (HDL) and On-Line Estimation of Proinflammatory HDL	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; CHOLESTEROL LEVELS; ANTIINFLAMMATORY PROPERTIES; INHIBITS 3; ATHEROSCLEROSIS; INFLUENZA; TRANSPORT; VASODILATION; LOVASTATIN; PROTEINS	Proinflammatory high-density lipoprotein (p-HDL) is a biomarker of cardiovascular disease. Sickle cell disease (SCD) is characterized by chronic states of oxidative stress that many consider to play a role in forming p-HDL. To measure p-HDL, apolipoprotein (apo) B containing lipoproteins are precipitated. Supernatant HDL is incubated with an oxidant/LDL or an oxidant alone and rates of HDL oxidation monitored with dichlorofluorescein (DCFH). Although apoB precipitation is convenient for isolating HDL, the resulting supernatant matrix likely influences HDL oxidation. To determine effects of supernatants on p-HDL measurements we purified HDL from plasma from SCD subjects by anion exchange (AE) chromatography, determined its rate of oxidation relative to supernatant HDL. SCD decreased total cholesterol but not triglycerides or HDL and increased cell-free (cf) hemoglobin (Hb) and xanthine oxidase (XO). HDL isolated by AE-HPLC had lower p-HDL levels than HDL in supernatants after apoB precipitation. XO+xanthine (X) and cf Hb accelerated purified HDL oxidation. Although the plate and AE-HPLC assays both showed p-HDL directly correlated with cf-Hb in SCD plasma, the plate assay yielded p-HDL data that was influenced more by cf-Hb than AE-HPLC generated p-HDL data. The AE-HPLC p-HDL assay reduces the influence of the supernatants and shows that SCD increases p-HDL.	[Ji, Xiang; Gao, Hai-qing] Shandong Univ, Qilu Hosp, Dept Geriatr, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250100, Shandong, Peoples R China; [Ji, Xiang; Xu, Hao; Zhang, Hao; Gao, Hai-qing; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA; [Hillery, Cheryl A.] Med Coll Wisconsin, Dept Pediat, Div Hematol, Milwaukee, WI 53226 USA; [Hillery, Cheryl A.] Blood Res Inst, Milwaukee, WI USA; [Xu, Hao; Zhang, Hao; Hillery, Cheryl A.; Pritchard, Kirkwood A., Jr.] Childrens Res Inst, Milwaukee, WI USA; [Xu, Hao; Zhang, Hao; Hillery, Cheryl A.; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Milwaukee, WI 53226 USA	Shandong University; Medical College of Wisconsin; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Pritchard, KA (corresponding author), Med Coll Wisconsin, Dept Surg, Div Pediat Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	kpritch@mcw.edu	He, Zhen/D-1275-2009	He, Zhen/0000-0001-6302-6556	American Heart Association [11SDG5120015]; National Institutes of Health [HL-102996, HL-102836, U54 HL-090503]; Midwest Athletes Against Childhood Cancer Fund; Chinese Government Graduate Student Overseas Study Program by China Scholarship Council [201206220063]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL090503, R01HL102836, R01HL112270, R21HL102996] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Athletes Against Childhood Cancer Fund; Chinese Government Graduate Student Overseas Study Program by China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 11SDG5120015 (to HZ); National Institutes of Health Grants HL-102996 (to KAP), HL-102836 (to KAP and CAH), U54 HL-090503 (to CAH) and Midwest Athletes Against Childhood Cancer Fund (to CAH). Chinese Government Graduate Student Overseas Study Program by China Scholarship Council (File No. 201206220063) to XJ and HQG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Aslan M, 2001, P NATL ACAD SCI USA, V98, P15215, DOI 10.1073/pnas.221292098; ASSMANN G, 1993, CIRCULATION, V87, P28; CHUANG PT, 1990, ARTERIOSCLEROSIS, V10, P188, DOI 10.1161/01.ATV.10.2.188; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Frei AC, 2008, BLOOD, V112, P398, DOI 10.1182/blood-2007-12-126714; Gharavi NM, 2007, ARTERIOSCL THROM VAS, V27, P1346, DOI 10.1161/ATVBAHA.107.141283; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gurfinkel EP, 2002, CIRCULATION, V105, P2143, DOI 10.1161/01.CIR.0000016182.85461.F4; Hanson MS, 2012, AM J PHYSL HEART CIR; HATEFI Y, 1969, P NATL ACAD SCI USA, V62, P1129, DOI 10.1073/pnas.62.4.1129; Hillery CA, 2000, BRIT J HAEMATOL, V109, P322, DOI 10.1046/j.1365-2141.2000.02040.x; Hirowatari Y, 2003, J LIPID RES, V44, P1404, DOI 10.1194/jlr.D300003-JLR200; ITSKOVITZ HD, 1989, CLIN THER, V11, P862; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kuvin JT, 2002, AM HEART J, V144, P165, DOI 10.1067/mhj.2002.123145; Mastorikou M, 2006, DIABETES, V55, P3099, DOI 10.2337/db06-0723; Navab M, 2000, J LIPID RES, V41, P1481; Navab M, 2000, J LIPID RES, V41, P1495; NAVAB M, 1995, AM J CARDIOL, V76, pC18, DOI 10.1016/S0002-9149(99)80466-4; Navab M, 2001, J LIPID RES, V42, P1308; Ou JS, 2005, CIRC RES, V97, P1190, DOI 10.1161/01.RES.0000190634.60042.cb; Pritchard KA, 2004, AM J PHYSIOL-LUNG C, V286, pL705, DOI 10.1152/ajplung.00288.2002; REYNOLDS GD, 1985, AM J PATHOL, V121, P200; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; TILLETT HE, 1983, INT J EPIDEMIOL, V12, P344, DOI 10.1093/ije/12.3.344; TOLKACHEVA NV, 1989, VOP MED KHIM, V35, P89; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; Woo JMP, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3020; Wood KC, 2008, FREE RADICAL BIO MED, V44, P1506, DOI 10.1016/j.freeradbiomed.2008.01.008; Xu H, 2006, FASEB J, V20, pA198; Yuditskaya S, 2009, BLOOD, V113, P1122, DOI 10.1182/blood-2008-03-142604; Zorn U, 2001, ELECTROPHORESIS, V22, P1143, DOI 10.1002/1522-2683()22:6<1143::AID-ELPS1143>3.0.CO;2-Q	38	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91089	10.1371/journal.pone.0091089	http://dx.doi.org/10.1371/journal.pone.0091089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	25202990	Green Published, Green Submitted, gold			2022-12-27	WOS:000332485800098
J	Machado, L; Magnusson, M; Paul, NA; de Nys, R; Tomkins, N				Machado, Lorenna; Magnusson, Marie; Paul, Nicholas A.; de Nys, Rocky; Tomkins, Nigel			Effects of Marine and Freshwater Macroalgae on In Vitro Total Gas and Methane Production	PLOS ONE			English	Article							RED ALGA ASPARAGOPSIS; VOLATILE FATTY-ACIDS; RUMINAL FERMENTATION; ASCOPHYLLUM-NODOSUM; REGRESSION TREES; MITIGATION; EMISSIONS; FORAGE; METHANOGENESIS; DIGESTION	This study aimed to evaluate the effects of twenty species of tropical macroalgae on in vitro fermentation parameters, total gas production (TGP) and methane (CH4) production when incubated in rumen fluid from cattle fed a low quality roughage diet. Primary biochemical parameters of macroalgae were characterized and included proximate, elemental, and fatty acid (FAME) analysis. Macroalgae and the control, decorticated cottonseed meal (DCS), were incubated in vitro for 72 h, where gas production was continuously monitored. Post-fermentation parameters, including CH4 production, pH, ammonia, apparent organic matter degradability (OMd), and volatile fatty acid (VFA) concentrations were measured. All species of macroalgae had lower TGP and CH4 production than DCS. Dictyota and Asparagopsis had the strongest effects, inhibiting TGP by 53.2% and 61.8%, and CH4 production by 92.2% and 98.9% after 72 h, respectively. Both species also resulted in the lowest total VFA concentration, and the highest molar concentration of propionate among all species analysed, indicating that anaerobic fermentation was affected. Overall, there were no strong relationships between TGP or CH4 production and the >70 biochemical parameters analysed. However, zinc concentrations >0.10 g.kg(-1) may potentially interact with other biochemical components to influence TGP and CH4 production. The lack of relationship between the primary biochemistry of species and gas parameters suggests that significant decreases in TGP and CH4 production are associated with secondary metabolites produced by effective macroalgae. The most effective species, Asparagopsis, offers the most promising alternative for mitigation of enteric CH4 emissions.	[Machado, Lorenna; Magnusson, Marie; Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Machado, Lorenna; Magnusson, Marie; Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Tomkins, Nigel] James Cook Univ, CSIRO Anim Food & Hlth Sci, Townsville, Qld 4811, Australia	James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Machado, L (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	lorenna.machado@my.jcu.edu.au	Paul, Nicholas/B-6496-2009; de Nys, Rocky/D-6741-2012; Machado, Lorenna/I-1434-2015; Pavan, Fernando/F-6046-2010; Magnusson, Marie/D-8996-2012; Cardoso, Rosilene Fressatti/J-4796-2015	de Nys, Rocky/0000-0003-3869-4928; Machado, Lorenna/0000-0002-1554-6108; Pavan, Fernando/0000-0002-6969-3963; Magnusson, Marie/0000-0002-3141-8544; Paul, Nicholas/0000-0002-9275-1535; Cardoso, Rosilene Fressatti/0000-0001-6228-4780	Australian Government Department of Agriculture, Fisheries and Forestry as part of its Carbon Farming Futures Filling the Research Gap Program; Australian Government through the Australian Renewable Energy Agency; Advanced Manufacturing Cooperative Research Centre (AMCRC); Australian Government's Cooperative Research Centre Scheme	Australian Government Department of Agriculture, Fisheries and Forestry as part of its Carbon Farming Futures Filling the Research Gap Program(Australian GovernmentDepartment of Agriculture and Water Resources); Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This project is supported by funding from the Australian Government Department of Agriculture, Fisheries and Forestry as part of its Carbon Farming Futures Filling the Research Gap Program. The project is also supported by the Australian Government through the Australian Renewable Energy Agency, and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AL, 2012, TROP ANIM HEALTH PRO, V44, P953, DOI 10.1007/s11250-011-9992-0; [Anonymous], 1970, AGR HDB; Arelovich HM, 2000, J ANIM SCI, V78, P2972; Bach SJ, 2008, ANIM FEED SCI TECH, V142, P17, DOI 10.1016/j.anifeedsci.2007.05.033; Beauchemin KA, 2008, AUST J EXP AGR, V48, P21, DOI 10.1071/EA07199; BIDLACK JE, 1992, CAN J PLANT SCI, V72, P809, DOI 10.4141/cjps92-097; Blunt JW, 2013, NAT PROD REP, V30, P237, DOI [10.1039/c2np20112g, 10.1039/d0np00089b]; Boyd RS, 2012, PLANT SCI, V195, P88, DOI 10.1016/j.plantsci.2012.06.012; Bozic AK, 2009, BIORESOURCE TECHNOL, V100, P4017, DOI 10.1016/j.biortech.2008.12.061; Breiman L., 1984, CLASSIFICATION REGRE; Bueno ICS, 2005, ANIM FEED SCI TECH, V123, P95, DOI 10.1016/j.anifeedsci.2005.05.003; Channiwala SA, 2002, FUEL, V81, P1051, DOI 10.1016/S0016-2361(01)00131-4; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Chojnacka K, 2012, HANDBOOK OF MARINE MACROALGAE: BIOTECHNOLOGY AND APPLIED PHYCOLOGY, P478; CHOPIN T, 2009, SEAWEEDS THEIR MARIC, V3, P4477; Chowdhury S, 1995, AGR SCI BIOD SUST WO, P3; Cottle DJ, 2011, ANIM PROD SCI, V51, P491, DOI 10.1071/AN10163; COTTYN BG, 1968, J AGR FOOD CHEM, V16, P105, DOI 10.1021/jf60155a002; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; del Val Antonio Gonzalez, 2001, International Microbiology, V4, P35; FOLCH J, 1957, J BIOL CHEM, V226, P497; Genovese G, 2009, MAR DRUGS, V7, P361, DOI 10.3390/md7030361; Getachew G, 1998, ANIM FEED SCI TECH, V72, P261, DOI 10.1016/S0377-8401(97)00189-2; Goel G, 2012, TROP ANIM HEALTH PRO, V44, P729, DOI 10.1007/s11250-011-9966-2; Gorley C.K., 2006, GETTING STARTED PRIM; Gosch BJ, 2012, GCB BIOENERGY, V4, P919, DOI 10.1111/j.1757-1707.2012.01175.x; Grainger C, 2008, AUST J EXP AGR, V48, P73, DOI 10.1071/EA07224; Grainger C, 2011, ANIM FEED SCI TECH, V166-67, P308, DOI 10.1016/j.anifeedsci.2011.04.021; Henry B, 2012, CROP PASTURE SCI, V63, P191, DOI 10.1071/CP11169; Jayanegara A, 2011, ANIM FEED SCI TECH, V163, P231, DOI 10.1016/j.anifeedsci.2010.11.009; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Ktita SR, 2010, SMALL RUMINANT RES, V91, P116, DOI 10.1016/j.smallrumres.2010.01.012; Lee HJ, 2003, ASIAN AUSTRAL J ANIM, V16, P1143, DOI 10.5713/ajas.2003.1143; Lourenco Sergio O., 2002, Phycological Research, V50, P233; MacArtain P, 2007, NUTR REV, V65, P535, DOI 10.1111/j.1753-4887.2007.tb00278.x; Marin A, 2009, REV BIOL TROP, V57, P1271; McGinn SM, 2004, J ANIM SCI, V82, P3346; Meale SJ, 2012, ASIAN AUSTRAL J ANIM, V25, P86, DOI 10.5713/ajas.2011.11249; MOORE RE, 1977, ACCOUNTS CHEM RES, V10, P40, DOI 10.1021/ar50110a002; Morgavi DP, 2010, ANIMAL, V4, P1024, DOI 10.1017/S1751731110000546; Nagadi S, 2000, ANIM FEED SCI TECH, V87, P231, DOI 10.1016/S0377-8401(00)00197-8; O'Sullivan L, 2010, MAR DRUGS, V8, P2038, DOI 10.3390/md8072038; OTTENSTEIN DM, 1971, J CHROMATOGR SCI, V9, P673, DOI 10.1093/chromsci/9.11.673; Patra AK, 2006, ANIM FEED SCI TECH, V128, P276, DOI 10.1016/j.anifeedsci.2005.11.001; Patra AK, 2010, PHYTOCHEMISTRY, V71, P1198, DOI 10.1016/j.phytochem.2010.05.010; Patra AK, 2012, ENVIRON MONIT ASSESS, V184, P1929, DOI 10.1007/s10661-011-2090-y; Paul NA, 2006, MAR ECOL PROG SER, V306, P87, DOI 10.3354/meps306087; Paul VJ, 2004, NAT PROD REP, V21, P189, DOI 10.1039/b302334f; PLAYNE MJ, 1985, J SCI FOOD AGR, V36, P638, DOI 10.1002/jsfa.2740360803; Reay D., 2010, METHANE CLIMATE CHAN, P1; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; Sawidis T, 2001, ENVIRON INT, V27, P43, DOI 10.1016/S0160-4120(01)00052-6; Singh S, 2012, ANIM FEED SCI TECH, V178, P2, DOI 10.1016/j.anifeedsci.2012.08.019; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Tavendale MH, 2005, ANIM FEED SCI TECH, V123, P403, DOI 10.1016/j.anifeedsci.2005.04.037; VanNevel CJ, 1996, ENVIRON MONIT ASSESS, V42, P73, DOI 10.1007/BF00394043; Wang Y, 2008, ANIM FEED SCI TECH, V145, P375, DOI 10.1016/j.anifeedsci.2007.03.013; Wuebbles DJ, 2002, EARTH-SCI REV, V57, P177, DOI 10.1016/S0012-8252(01)00062-9	59	97	104	10	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85289	10.1371/journal.pone.0085289	http://dx.doi.org/10.1371/journal.pone.0085289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465524	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000330283100035
J	Wang, J; Huang, SK; Zhao, M; Yang, M; Zhong, JL; Gu, YY; Peng, H; Che, YQ; Huang, CZ				Wang, Jia; Huang, Sheng-kai; Zhao, Mei; Yang, Mei; Zhong, Jia-ling; Gu, Yu-yu; Peng, Hua; Che, Yi-qun; Huang, Chang-zhi			Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; EXPRESSION PROFILE; BIOMARKERS; SERUM; TUMOR; DIAGNOSIS; METASTASIS; MARKERS; MIR-31	Prognosis of patients with colorectal cancer (CRC) is generally poor because of the lack of simple, convenient, and noninvasive tools for CRC detection at the early stage. The discovery of microRNAs (miRNAs) and their different expression profiles among different kinds of diseases has opened a new avenue for tumor diagnosis. We built a serum microRNA expression profile signature and tested its specificity and sensitivity as a biomarker in the diagnosis of CRC. We also studied its possible role in monitoring the progression of CRC. We conducted a two phase case-control test to identify serum miRNAs as biomarkers for CRC diagnosis. Using quantitative reverse transcription polymerase chain reactions, we tested ten candidate miRNAs in a training set (30 CRCs vs 30 controls). Risk score analysis was used to evaluate the diagnostic value of the serum miRNA profiling system. Other independent samples, including 83 CRCs and 59 controls, were used to validate the diagnostic model. In the training set, six serum miRNAs (miR-21, let-7g, miR-31, miR-92a, miR-181b, and miR-203) had significantly different expression levels between the CRCs and healthy controls. Risk score analysis demonstrated that the six-miRNA-based biomarker signature had high sensitivity and specificity for distinguishing the CRC samples from cancer-free controls. The areas under the receiver operating characteristic (ROC) curve of the six-miRNA signature profiles were 0.900 and 0.923 for the two sets of serum samples, respectively. However, for the same serum samples, the areas under the ROC curve used by the tumor markers carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) were only 0.649 and 0.598, respectively. The expression levels of the six serum miRNAs were also correlated with CRC progression. Thus, the identified six-miRNA signature can be used as a noninvasive biomarker for the diagnosis of CRC, with relatively high sensitivity and specificity.	[Wang, Jia; Huang, Sheng-kai; Zhao, Mei; Yang, Mei; Zhong, Jia-ling; Gu, Yu-yu; Peng, Hua; Huang, Chang-zhi] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Che, Yi-qun] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Che, YQ (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Clin Lab, Beijing 100730, Peoples R China.	cyq@cicams.ac.cn; huangpumc@163.com			National Key Basic Research Program of China [2007CB914700]	National Key Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Key Basic Research Program of China (2007CB914700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Burch JA, 2007, J MED SCREEN, V14, P132, DOI 10.1258/096914107782066220; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Chen ZL, 2011, J BIOL CHEM, V286, P10725, DOI 10.1074/jbc.M110.165654; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Corte H, 2012, DIGEST LIVER DIS, V44, P195, DOI 10.1016/j.dld.2011.10.010; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Duttagupta R, 2013, WIRES RNA, V4, P129, DOI 10.1002/wrna.1149; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Garcia-Bilbao A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-43; Hewitson P, 2007, COCHRANE DATABASE SY, V1; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li ZY, 2012, ONCOL LETT, V3, P346, DOI 10.3892/ol.2011.497; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Liu JQ, 2012, INT J CANCER, V131, P683, DOI 10.1002/ijc.26422; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murakoshi Y, 2011, CANCER SCI, V102, P630, DOI 10.1111/j.1349-7006.2010.01818.x; Nilsson S., 2012, PLOS ONE, V7; Nugent M, 2011, EJSO-EUR J SURG ONC, V37, P649, DOI 10.1016/j.ejso.2011.05.005; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Takeshita N, 2013, BRIT J CANCER, V108, P644, DOI 10.1038/bjc.2013.8; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044398; Wang S, 2013, CLIN TRANSL ONCOL, V15, P849, DOI 10.1007/s12094-013-1014-4; Zhang YY, 2010, MED ONCOL, V27, P685, DOI 10.1007/s12032-009-9269-x	35	218	228	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e87451	10.1371/journal.pone.0087451	http://dx.doi.org/10.1371/journal.pone.0087451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709885	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800003
J	Zhao, ZJ; Chi, QS; Liu, QS; Zheng, WH; Liu, JS; Wang, DH				Zhao, Zhi-Jun; Chi, Qing-Sheng; Liu, Quan-Sheng; Zheng, Wei-Hong; Liu, Jin-Song; Wang, De-Hua			The Shift of Thermoneutral Zone in Striped Hamster Acclimated to Different Temperatures	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; BASAL METABOLIC-RATE; CYTOCHROME-C-OXIDASE; DJUNGARIAN HAMSTER; ENERGY-METABOLISM; BODY-TEMPERATURE; NONSHIVERING THERMOGENESIS; THERMAL CONDUCTANCE; UNCOUPLING PROTEIN; PHODOPUS-SUNGORUS	Temperature affects all biological functions and will therefore modulate ecologically significant interactions between animals and their environment. Here, we examined the effect of ambient temperature (T-a) on the thermal biology and energy budget in striped hamsters acclimated to cold (5 degrees C), warm (21 degrees C) and hot temperatures (31 degrees C). Thermoneutral zone (TNZ) was 22.5-32.5 degrees C, 25-32.5 degrees C and 30-32.5 degrees C in the cold-, warm- and hot-acclimated hamsters, respectively. The cold acclimation decreased the lower critical temperature and made the TNZ wider, and hot exposure elevated the lower critical temperature, resulting in a narrow TNZ. Within the TNZ, cold-acclimated hamsters showed a significantly higher rate of metabolism and thermogenesis than those acclimated to hot temperature. Digestive enzymes activities, including intestinal sucrase, maltase, L-alanine aminopeptidase-N and leucine aminopeptidase were higher in the cold than in the hot. The changes in metabolic rate and thermogenesis at different temperatures were in parallel with cytochrome c oxidase activity and uncoupling protein 1 gene expression of brown adipose tissue. This suggests that the shift of the lower critical temperature of TNZ is possibly associated with the rate of metabolism and thermogenesis, as well as with the digestive capacity of the gastrointestinal tract at different T-a. The upper critical temperature of TNZ may be independent of the changes in T-a. The changes of lower critical temperature of TNZ are an important strategy in adaption to variations of T-a.	[Zhao, Zhi-Jun; Zheng, Wei-Hong; Liu, Jin-Song] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China; [Zhao, Zhi-Jun; Chi, Qing-Sheng; Wang, De-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Liu, Quan-Sheng] Guangdong Entomol Inst, Guangdong Key Lab Integrated Pest Management Agr, Guangzhou, Guangdong, Peoples R China	Wenzhou University; Chinese Academy of Sciences; Institute of Zoology, CAS; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Zhao, ZJ (corresponding author), Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China.	zhao73@foxmail.com	Liu, Quan-Sheng/A-2041-2013	Liu, Quan-Sheng/0000-0002-3001-9170; ji, li li/0000-0001-8483-1554	State Key Laboratory of Integrated Management of Pest Insects and Rodents [ChineseIPM1209]; National Natural Science Foundation of China [31270458, 31070367]	State Key Laboratory of Integrated Management of Pest Insects and Rodents; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded the State Key Laboratory of Integrated Management of Pest Insects and Rodents (no. ChineseIPM1209) and also partly supported by grants (no. 31270458 and 31070367) from the National Natural Science Foundation of China to ZJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; BLIGH J, 1973, Journal of Applied Physiology, V35, P941; BRADLEY SR, 1980, COMP BIOCHEM PHYS A, V65, P465, DOI 10.1016/0300-9629(80)90060-2; Broekman M, 2006, PHYSIOL BEHAV, V89, P750, DOI 10.1016/j.physbeh.2006.08.023; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brzek P, 2009, J EXP BIOL, V212, P1284, DOI 10.1242/jeb.023911; Burness GP, 1998, PHYSIOL ZOOL, V71, P247, DOI 10.1086/515917; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chi QS, 2011, J COMP PHYSIOL B, V181, P91, DOI 10.1007/s00360-010-0506-6; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; DELRIO CM, 1990, PHYSIOL ZOOL, V63, P987, DOI 10.1086/physzool.63.5.30152625; Glanville EJ, 2010, COMP BIOCHEM PHYS A, V155, P383, DOI 10.1016/j.cbpa.2009.12.008; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; GORDON CJ, 1990, PHYSIOL BEHAV, V47, P963, DOI 10.1016/0031-9384(90)90025-Y; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; Grodzinski W., 1975, International biol Progm, V5, P173; HAMMOND KA, 1991, PHYSIOL ZOOL, V64, P541, DOI 10.1086/physzool.64.2.30158190; Hammond KA, 2001, J EXP BIOL, V204, P1991; HAMMOND KA, 1995, J MAMMAL, V76, P232, DOI 10.2307/1382331; HELDMAIER G, 1989, J BIOL RHYTHM, V4, P251, DOI 10.1177/074873048900400211; HELDMAIER G, 1971, Z VERGL PHYSIOL, V73, P222, DOI 10.1007/BF00304134; HELDMAIER G, 1981, J COMP PHYSIOL, V142, P429, DOI 10.1007/BF00688972; HIMMSHAGEN J, 1985, ANNU REV NUTR, V5, P69, DOI 10.1146/annurev.nu.05.070185.000441; HIMMSHAGEN J, 1984, NEW ENGL J MED, V311, P1549, DOI 10.1056/NEJM198412133112407; IUPS Thermal Commission, 2001, JPN J PHYSIOL, V51, P245; Jefimow M, 2004, COMP BIOCHEM PHYS A, V139, P379, DOI 10.1016/j.cbpb.2004.10.007; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Kauffman AS, 2003, PHYSIOL BEHAV, V79, P247, DOI 10.1016/S0031-9384(03)00115-X; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Klingenspor M, 1996, BIOCHEM J, V316, P607, DOI 10.1042/bj3160607; Konarzewski M, 1995, EVOLUTION, V49, P1239, DOI 10.2307/2410448; Kronfeld-Schor N, 2000, PHYSIOL BIOCHEM ZOOL, V73, P37, DOI 10.1086/316718; Liu Jin-Song, 2003, Acta Zoologica Sinica, V49, P451; Liu QS, 2007, J COMP PHYSIOL B, V177, P509, DOI 10.1007/s00360-007-0149-4; Lovegrove BG, 2005, J COMP PHYSIOL B, V175, P231, DOI 10.1007/s00360-005-0477-1; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASUDA A, 1988, J EXP ZOOL, V248, P133, DOI 10.1002/jez.1402480202; MCDEVITT RM, 1994, PHYSIOL ZOOL, V67, P1117, DOI 10.1086/physzool.67.5.30163885; McNab, 1974, OHIO J SCI, V74, P370; MCNAB BK, 1980, PHYSIOL ZOOL, V53, P145, DOI 10.1086/physzool.53.2.30152577; Naya DE, 2005, J COMP PHYSIOL B, V175, P31, DOI 10.1007/s00360-004-0459-8; Nespolo RF, 2002, J EXP BIOL, V205, P2697; Romanovsky AA, 2002, J APPL PHYSIOL, V92, P2667, DOI 10.1152/japplphysiol.01173.2001; Schleucher E, 2001, COMP BIOCHEM PHYS A, V129, P821, DOI 10.1016/S1095-6433(01)00356-7; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; Song ZG, 2003, J THERM BIOL, V28, P509, DOI 10.1016/S0306-4565(03)00051-2; Song ZG, 2002, ACTA THERIOL, V47, P417, DOI 10.1007/BF03192466; Speakman JR, 1996, PHYSIOL ZOOL, V69, P746, DOI 10.1086/physzool.69.4.30164228; Sundin U, 1978, AM J PHYSIOL, V252R, P822; Terblanche SE, 2000, COMP BIOCHEM PHYS B, V127, P319, DOI 10.1016/S0305-0491(00)00269-8; TOLOZA EM, 1991, AM J PHYSIOL, V261, pG608, DOI 10.1152/ajpgi.1991.261.4.G608; Wang D, 1999, J COMP PHYSIOL B, V169, P77, DOI 10.1007/s003600050196; Wang D.-H, 2003, Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology, V134A, pS96; WIESINGER H, 1990, CAN J PHYSIOL PHARM, V68, P195, DOI 10.1139/y90-030; WIESINGER H, 1989, PFLUG ARCH EUR J PHY, V413, P667, DOI 10.1007/BF00581818; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; Wooden KM, 2002, J EXP BIOL, V205, P2099; Zhang XY, 2006, HORM BEHAV, V50, P61, DOI 10.1016/j.yhbeh.2006.01.005; Zhang Z., 1998, ECOLOGY MANAGEMENT R; Zhao Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052044, 10.1371/journal.pone.0061814, 10.1371/journal.pone.0080574]; Zhao ZJ, 2011, PHYSIOL BIOCHEM ZOOL, V84, P560, DOI 10.1086/662553; Zhao ZJ, 2010, J THERM BIOL, V35, P401, DOI 10.1016/j.jtherbio.2010.08.005; Zhao ZJ, 2010, J EXP BIOL, V213, P3988, DOI 10.1242/jeb.046821; Zhao ZJ, 2010, J THERM BIOL, V35, P52, DOI 10.1016/j.jtherbio.2009.10.008; Zhao ZJ, 2005, PHYSIOL BEHAV, V85, P143, DOI 10.1016/j.physbeh.2005.03.014	68	30	34	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84396	10.1371/journal.pone.0084396	http://dx.doi.org/10.1371/journal.pone.0084396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400087	gold, Green Submitted, Green Published			2022-12-27	WOS:000329462700021
